data_1p4s_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1p4s _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.5 mtt . . . . . 0 CA--C 1.558 1.276 0 CA-C-O 122.772 1.273 . . . . 0.0 111.881 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.469 ' HG3' HH11 ' A' ' 2' ' ' ARG 0.3 5.8 ttm-85 -150.27 152.99 35.37 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 116.612 2.079 . . . . 0.0 116.612 -162.777 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.5 t -141.59 145.04 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 CA-C-O 124.176 1.941 . . . . 0.0 111.098 -174.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -125.26 135.41 52.49 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 112.509 -2.132 . . . . 0.0 106.944 175.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.98 114.35 23.68 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-O 122.452 1.12 . . . . 0.0 110.533 -169.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.29 160.9 17.85 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 113.053 -1.885 . . . . 0.0 110.562 -168.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 151.8 149.36 5.06 Favored Glycine 0 CA--C 1.555 2.548 0 CA-C-O 118.2 -1.333 . . . . 0.0 114.129 169.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo . . . . . 0 CA--C 1.574 2.511 0 C-N-CA 123.375 2.717 . . . . 0.0 116.532 169.576 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.1 mtmm . . . . . 0 N--CA 1.485 1.294 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -51.27 -27.45 16.11 Favored Glycine 0 CA--C 1.554 2.509 0 N-CA-C 120.416 2.926 . . . . 0.0 120.416 174.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.9 m -66.87 -52.29 45.24 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 119.663 1.731 . . . . 0.0 112.682 174.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.25 10.6 mm-40 -75.39 -15.63 60.44 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 115.904 -1.998 . . . . 0.0 112.455 171.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.85 -44.32 66.66 Favored 'General case' 0 C--N 1.374 1.637 0 CA-C-N 123.684 2.947 . . . . 0.0 114.319 168.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.78 -46.41 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 CA-C-N 119.282 0.946 . . . . 0.0 112.737 174.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -54.94 -44.25 74.14 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 116.623 2.083 . . . . 0.0 116.623 169.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.1 tp -67.24 -32.54 73.63 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 172.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.78 -38.89 92.42 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 167.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -59.33 -40.72 87.21 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 117.491 -1.243 . . . . 0.0 114.106 166.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -65.62 -49.09 70.0 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 172.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 65.8 mt -82.72 -25.0 33.33 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 117.383 2.364 . . . . 0.0 117.383 -177.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.56 41.31 7.37 Favored Glycine 0 CA--C 1.556 2.616 0 N-CA-C 117.521 1.768 . . . . 0.0 117.521 -172.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.441 ' CG2' ' HA ' ' A' ' 81' ' ' PHE . 22.8 mm -115.68 157.91 43.26 Favored Pre-proline 0 CA--C 1.57 1.738 0 CA-C-N 118.678 1.239 . . . . 0.0 113.748 -168.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -74.65 101.19 1.42 Allowed 'Trans proline' 0 CA--C 1.566 2.111 0 C-N-CA 121.885 1.723 . . . . 0.0 113.294 160.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -72.34 107.74 5.09 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.158 -0.964 . . . . 0.0 108.424 165.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.479 ' CD1' ' HB3' ' A' ' 71' ' ' ARG . 31.3 mm -104.25 109.38 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 176.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 74.1 p -96.45 128.96 43.86 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 168.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 18.4 p -68.36 -16.59 63.99 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 117.051 2.241 . . . . 0.0 117.051 -171.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.466 ' CA ' ' HZ3' ' A' ' 50' ' ' LYS . . . -80.37 -23.25 61.1 Favored Glycine 0 CA--C 1.543 1.809 0 N-CA-C 118.932 2.333 . . . . 0.0 118.932 167.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -80.38 -52.63 7.45 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 -168.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -62.88 -39.09 93.39 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 173.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.407 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 7.9 m-85 -65.2 -47.09 78.11 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 172.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -54.25 -42.06 69.47 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 168.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.8 ttt180 -59.11 -40.36 85.11 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 168.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -68.35 -23.83 64.74 Favored 'General case' 0 CA--C 1.579 2.07 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 168.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 63.6 mt -64.1 -48.69 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 CA-C-N 120.75 1.614 . . . . 0.0 110.448 167.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -64.42 -37.67 88.32 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -67.02 -40.93 87.37 Favored 'General case' 0 CA--C 1.561 1.391 0 N-CA-C 116.236 1.939 . . . . 0.0 116.236 173.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.28 69.26 1.04 Allowed Glycine 0 CA--C 1.543 1.844 0 CA-C-O 118.473 -1.182 . . . . 0.0 114.66 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.784 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 67.5 p -92.02 -49.86 6.0 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-N 118.737 1.268 . . . . 0.0 114.291 175.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.784 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.251 73.8 mttt 105.84 -41.49 0.0 OUTLIER 'General case' 0 CA--C 1.57 1.729 0 CA-C-O 116.376 -1.774 . . . . 0.0 111.307 -172.477 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.07 -14.13 58.1 Favored 'General case' 0 CA--C 1.569 1.711 0 CA-C-N 123.059 2.663 . . . . 0.0 112.988 163.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.694 ' O ' ' HB3' ' A' ' 50' ' ' LYS . . . -58.22 -56.48 24.97 Favored Glycine 0 C--N 1.355 1.605 0 CA-C-N 120.574 1.534 . . . . 0.0 114.825 169.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.289 6.2 p -76.44 -50.01 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.478 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 -169.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -64.91 -48.48 74.04 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 121.09 1.768 . . . . 0.0 112.582 174.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.12 -29.15 66.03 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 114.819 1.415 . . . . 0.0 114.819 -177.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.694 ' HB3' ' O ' ' A' ' 46' ' ' GLY . 35.8 tptt -72.78 -34.73 67.14 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 168.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.601 ' CG ' ' O ' ' A' ' 51' ' ' ARG . 42.9 ttt180 -74.64 -55.89 5.4 Favored 'General case' 0 CA--C 1.591 2.522 1 CA-C-O 85.878 -16.296 . . . . 0.0 117.639 -179.715 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -27.64 -66.22 0.07 Allowed 'General case' 0 N--CA 1.495 1.814 1 O-C-N 108.766 -8.709 . . . . 0.0 120.43 146.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.6 tp -59.32 -29.32 67.54 Favored 'General case' 0 CA--C 1.573 1.861 0 N-CA-C 116.388 1.996 . . . . 0.0 116.388 174.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -92.39 -41.6 10.24 Favored 'General case' 0 CA--C 1.566 1.588 0 CA-C-O 116.554 -1.689 . . . . 0.0 115.155 169.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -87.94 -41.15 13.36 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 121.976 2.171 . . . . 0.0 114.906 -174.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.511 ' HA2' HH12 ' A' ' 88' ' ' ARG . . . 128.83 5.35 4.91 Favored Glycine 0 CA--C 1.541 1.669 0 N-CA-C 119.095 2.398 . . . . 0.0 119.095 168.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -83.41 173.71 11.28 Favored 'General case' 0 CA--C 1.575 1.91 0 CA-C-N 119.86 1.83 . . . . 0.0 110.067 167.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.5 pp -76.18 128.77 35.62 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.205 -1.559 . . . . 0.0 114.398 -166.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.6 p -115.88 128.72 25.75 Favored Pre-proline 0 CA--C 1.571 1.779 0 CA-C-O 117.656 -1.164 . . . . 0.0 109.447 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -60.11 149.33 85.41 Favored 'Trans proline' 0 CA--C 1.559 1.77 0 C-N-CA 123.396 2.731 . . . . 0.0 116.275 173.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 64.0 m -76.87 -45.88 26.63 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -64.27 -46.56 83.17 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 -169.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.7 pp -57.86 -42.13 83.87 Favored 'General case' 0 CA--C 1.56 1.347 0 N-CA-C 116.709 2.114 . . . . 0.0 116.709 169.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.4 m -61.46 -48.79 79.53 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 174.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -66.94 -20.05 65.83 Favored 'General case' 0 CA--C 1.575 1.919 0 N-CA-C 115.443 1.645 . . . . 0.0 115.443 167.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -72.26 -47.56 49.31 Favored 'General case' 0 CA--C 1.556 1.203 0 CA-C-N 120.529 1.513 . . . . 0.0 114.197 169.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.9 mt -63.72 -38.46 91.2 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 169.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 51.9 t -56.55 -50.93 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 CA-C-O 117.582 -1.199 . . . . 0.0 111.55 167.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -60.05 -36.8 78.11 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 116.563 2.06 . . . . 0.0 116.563 172.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -58.16 -45.79 86.82 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 117.282 -1.342 . . . . 0.0 112.971 169.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.479 ' HB3' ' CD1' ' A' ' 29' ' ' ILE . 40.9 mmt180 -87.03 6.12 34.06 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 120.407 3.484 . . . . 0.0 120.407 167.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 50.7 mt -68.2 -49.94 57.5 Favored 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 105.473 -2.047 . . . . 0.0 105.473 153.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 . . . . . 0 N--CA 1.503 2.176 0 CA-C-N 121.375 1.898 . . . . 0.0 110.879 -163.81 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.56 0 CA-C-O 123.156 1.42 . . . . 0.0 113.945 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.441 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . 45.2 p90 -176.18 138.93 0.34 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 112.018 -2.091 . . . . 0.0 109.58 173.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 44.6 mt -111.35 112.99 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 104.059 -2.571 . . . . 0.0 104.059 174.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.5 mt -96.7 147.42 23.93 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 168.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -134.11 131.72 39.05 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.8 0.81 . . . . 0.0 111.043 169.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 71.03 37.59 64.16 Favored Glycine 0 CA--C 1.551 2.297 0 CA-C-O 117.249 -1.862 . . . . 0.0 117.62 176.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -104.79 -56.02 0.09 OUTLIER Pre-proline 0 N--CA 1.496 1.834 0 CA-C-O 114.873 -2.489 . . . . 0.0 109.657 177.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.79 70.97 1.09 Allowed 'Trans proline' 0 CA--C 1.566 2.088 0 CA-C-N 124.921 2.793 . . . . 0.0 118.873 168.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.511 HH12 ' HA2' ' A' ' 56' ' ' GLY . 4.1 ptm180 -76.46 -31.57 57.88 Favored 'General case' 0 CA--C 1.567 1.602 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 167.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.485 ' HA ' ' HG3' ' A' ' 147' ' ' GLU . 77.6 p -141.59 134.62 29.06 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 -166.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -51.51 -38.29 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-N 120.298 1.408 . . . . 0.0 113.843 177.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.8 -38.62 91.61 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 120.753 3.612 . . . . 0.0 120.753 174.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -74.32 -47.81 32.26 Favored 'General case' 0 CA--C 1.587 2.401 0 CA-C-N 122.99 2.632 . . . . 0.0 111.802 166.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.33 -35.16 69.53 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 118.493 2.775 . . . . 0.0 118.493 -176.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.4 tttt -59.93 -26.6 66.09 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 116.571 2.063 . . . . 0.0 116.571 170.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.35 -43.86 84.87 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 168.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 23.6 tp -61.72 -37.93 86.01 Favored 'General case' 0 CA--C 1.569 1.695 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 169.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 28.9 t60 -67.85 -41.65 82.59 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 120.405 1.457 . . . . 0.0 113.749 169.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 1.363 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 0.5 OUTLIER -53.24 -35.05 59.56 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 167.414 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 1.2 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 63.3 mtt -85.39 -29.57 24.31 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 118.317 2.71 . . . . 0.0 118.317 171.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.662 ' HA ' ' HG1' ' A' ' 105' ' ' THR . 1.7 tt -69.35 -54.65 13.44 Favored 'General case' 0 N--CA 1.502 2.16 0 CA-C-N 122.076 2.216 . . . . 0.0 111.126 173.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -77.23 -50.37 13.06 Favored 'General case' 0 CA--C 1.563 1.48 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 174.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 1.363 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 23.3 tpp180 -71.93 -46.06 58.93 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 178.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 1.2 ' HB3' ' O ' ' A' ' 99' ' ' MET . 21.5 tpp180 -63.94 -49.66 71.71 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 119.036 0.835 . . . . 0.0 111.793 167.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 106.31 50.07 0.89 Allowed Glycine 0 N--CA 1.485 1.941 0 CA-C-O 121.767 0.648 . . . . 0.0 114.162 167.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.662 ' HG1' ' HA ' ' A' ' 100' ' ' LEU . 6.8 p -92.67 168.96 10.87 Favored 'General case' 0 CA--C 1.567 1.612 0 CA-C-N 113.207 -1.496 . . . . 0.0 110.712 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.47 132.14 45.11 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.034 -1.041 . . . . 0.0 110.919 -175.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 6.4 tp -105.79 96.99 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 174.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -100.25 -77.04 0.54 Allowed 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 115.391 -2.242 . . . . 0.0 107.69 166.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -140.71 126.14 18.82 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 122.25 2.295 . . . . 0.0 115.5 -171.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 72.8 t -88.92 116.58 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 101.406 -3.553 . . . . 0.0 101.406 160.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.294 20.7 tp -112.93 90.22 3.29 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 113.14 -1.846 . . . . 0.0 109.17 -165.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -89.71 132.22 35.29 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -177.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -97.73 123.87 41.84 Favored 'General case' 0 CA--C 1.566 1.584 0 CA-C-O 123.202 1.477 . . . . 0.0 110.594 -172.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -93.4 104.01 16.19 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 127.299 2.24 . . . . 0.0 108.868 173.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.2 m . . . . . 0 CA--C 1.566 1.594 0 CA-C-N 113.12 -1.855 . . . . 0.0 109.837 -165.6 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 . . . . . 0 N--CA 1.501 2.11 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -60.58 -42.65 97.14 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 167.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 13.6 tpt -61.5 -32.15 72.17 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 168.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -60.96 -49.1 78.81 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 166.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 29.1 t -65.13 -25.46 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 169.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -65.45 -49.43 69.17 Favored 'General case' 0 CA--C 1.577 1.982 0 CA-C-N 119.74 1.154 . . . . 0.0 111.864 169.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -61.34 -44.51 97.07 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 117.71 2.485 . . . . 0.0 117.71 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -56.18 -32.22 64.14 Favored 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 117.785 2.513 . . . . 0.0 117.785 177.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.485 ' HG3' ' HA ' ' A' ' 89' ' ' SER . 4.4 mm-40 -121.38 -40.5 2.57 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 118.684 2.846 . . . . 0.0 118.684 -163.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 95.7 m -46.64 -39.96 12.24 Favored 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 118.226 2.676 . . . . 0.0 118.226 -167.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.38 -61.16 4.12 Favored Pre-proline 0 CA--C 1.579 2.07 0 CA-C-O 116.17 -1.871 . . . . 0.0 112.05 173.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -52.01 -32.58 49.0 Favored 'Trans proline' 0 CA--C 1.578 2.692 0 C-N-CA 123.374 2.716 . . . . 0.0 118.568 167.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -66.57 -51.51 55.69 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 125.193 1.397 . . . . 0.0 111.462 176.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 1.186 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 47.7 tp -64.49 -21.23 66.61 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 171.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -71.92 -48.73 43.37 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 122.657 2.48 . . . . 0.0 112.944 164.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -61.03 -56.74 17.42 Favored 'General case' 0 CA--C 1.57 1.718 0 CA-C-N 120.191 1.359 . . . . 0.0 112.711 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -77.13 -28.04 54.17 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-O 115.348 -2.263 . . . . 0.0 112.774 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 1.186 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 38.3 ttt180 -60.35 -37.23 80.04 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 124.017 3.099 . . . . 0.0 116.259 169.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -67.76 -37.91 82.74 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 167.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -79.96 -33.22 39.7 Favored 'General case' 0 CA--C 1.579 2.09 0 N-CA-C 119.623 3.194 . . . . 0.0 119.623 177.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.1 pp -82.01 174.72 10.98 Favored 'General case' 0 CA--C 1.575 1.907 0 N-CA-C 121.324 3.824 . . . . 0.0 121.324 -159.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -128.64 139.66 52.15 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 164.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.1 t -102.77 152.56 21.1 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 122.515 1.15 . . . . 0.0 112.362 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 53.2 t -120.26 139.29 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 168.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -94.52 134.53 36.96 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 167.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -157.88 95.56 1.42 Allowed 'General case' 0 N--CA 1.484 1.243 0 CA-C-O 122.791 1.281 . . . . 0.0 110.886 -164.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.482 1.126 0 CA-C-N 113.143 -1.844 . . . . 0.0 106.878 -171.483 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 . . . . . 0 N--CA 1.501 2.078 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -61.26 -48.71 80.16 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 169.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 69.9 t -55.74 -39.44 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 173.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -60.43 -35.62 76.26 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 168.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -58.81 -48.33 81.67 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 171.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 81.5 mtt-85 -60.8 -36.85 80.08 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 117.874 2.546 . . . . 0.0 117.874 168.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.85 -44.09 97.47 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 172.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . 0.272 0.2 OUTLIER -71.26 -38.7 71.87 Favored 'General case' 0 N--CA 1.507 2.383 0 CA-C-N 120.014 1.279 . . . . 0.0 114.332 169.031 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -49.57 -39.3 34.53 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 168.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -70.3 -52.53 22.16 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 166.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -102.29 -60.03 1.61 Allowed 'General case' 0 CA--C 1.564 1.515 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -169.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.633 ' O ' ' CB ' ' A' ' 181' ' ' LYS . . . -79.22 -37.0 25.88 Favored Glycine 0 CA--C 1.551 2.34 0 CA-C-N 121.554 1.979 . . . . 0.0 118.036 -170.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.633 ' CB ' ' O ' ' A' ' 180' ' ' GLY . 37.2 ttmt . . . . . 0 C--O 1.252 1.212 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -177.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.7 mtt . . . . . 0 N--CA 1.483 1.217 0 CA-C-O 121.76 0.791 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.51 ' HB3' ' HA2' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -160.42 155.36 24.37 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -166.8 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.6 t -135.07 150.67 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 114.34 -1.3 . . . . 0.0 111.607 -168.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.447 HD23 HH12 ' A' ' 2' ' ' ARG . 2.2 mm? -125.7 122.13 35.42 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 114.003 -1.453 . . . . 0.0 108.607 169.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.8 tt -95.91 119.54 34.59 Favored 'General case' 0 CA--C 1.572 1.8 0 CA-C-O 122.504 1.145 . . . . 0.0 111.94 -173.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 33.0 mt -104.8 160.03 15.32 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 111.074 -2.785 . . . . 0.0 110.97 175.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 165.68 129.46 1.05 Allowed Glycine 0 CA--C 1.549 2.19 0 CA-C-O 117.355 -1.803 . . . . 0.0 113.77 171.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo . . . . . 0 CA--C 1.581 2.855 0 CA-C-N 122.035 2.917 . . . . 0.0 114.881 168.061 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.6 mttt . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -50.53 -22.03 5.12 Favored Glycine 0 CA--C 1.554 2.496 0 N-CA-C 120.955 3.142 . . . . 0.0 120.955 174.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 98.1 m -68.27 -53.0 27.54 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 120.036 1.918 . . . . 0.0 112.265 173.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.261 14.4 mm-40 -76.48 -15.43 59.9 Favored 'General case' 0 CA--C 1.574 1.87 0 CA-C-O 115.508 -2.187 . . . . 0.0 112.295 171.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.96 -41.49 67.66 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 124.211 3.187 . . . . 0.0 115.265 167.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.5 t -70.89 -40.66 76.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 CA-C-O 117.84 -1.076 . . . . 0.0 111.766 173.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -61.44 -42.11 98.24 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 169.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 23.6 mt -67.93 -32.4 72.82 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 170.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.02 -40.12 96.78 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 120.267 1.394 . . . . 0.0 114.446 167.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -59.77 -37.6 79.5 Favored 'General case' 0 CA--C 1.565 1.554 0 N-CA-C 114.889 1.441 . . . . 0.0 114.889 166.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -68.61 -53.99 19.22 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 120.561 1.528 . . . . 0.0 114.787 174.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.4 mp -81.73 -22.83 37.07 Favored 'General case' 0 CA--C 1.573 1.861 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 -177.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.68 38.64 7.46 Favored Glycine 0 CA--C 1.555 2.546 0 N-CA-C 117.507 1.763 . . . . 0.0 117.507 -174.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.458 ' CG2' ' HA ' ' A' ' 81' ' ' PHE . 23.6 mm -106.46 157.02 35.99 Favored Pre-proline 0 CA--C 1.565 1.551 0 CA-C-N 118.647 1.224 . . . . 0.0 112.876 -169.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -73.79 102.86 1.56 Allowed 'Trans proline' 0 CA--C 1.558 1.724 0 C-N-CA 121.49 1.46 . . . . 0.0 111.968 159.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.7 tm0? -69.48 106.54 3.02 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 166.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 34.2 mm -97.95 109.33 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 63.4 p -95.59 129.22 42.86 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 169.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.3 p -74.07 2.17 9.45 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 117.241 2.311 . . . . 0.0 117.241 -174.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -97.14 -22.17 18.16 Favored Glycine 0 CA--C 1.54 1.628 0 N-CA-C 118.703 2.241 . . . . 0.0 118.703 163.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -81.21 -54.27 5.65 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 119.37 1.585 . . . . 0.0 114.618 -168.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -65.44 -38.66 90.52 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 113.037 0.755 . . . . 0.0 113.037 175.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.449 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 56.8 m-85 -68.79 -42.48 77.3 Favored 'General case' 0 CA--C 1.56 1.332 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 173.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 73.9 ttt180 -58.76 -42.24 88.44 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 115.046 1.498 . . . . 0.0 115.046 169.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.411 ' HD2' ' HA ' ' A' ' 37' ' ' ARG . 10.4 tpt180 -61.51 -39.02 89.48 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 115.227 1.566 . . . . 0.0 115.227 169.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -68.82 -27.57 65.96 Favored 'General case' 0 CA--C 1.575 1.932 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 168.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . 0.696 HD11 ' HB3' ' A' ' 50' ' ' LYS . 86.1 mt -63.86 -43.94 97.96 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 CA-C-N 120.104 1.32 . . . . 0.0 111.251 167.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -64.02 -42.31 97.17 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 173.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -65.51 -41.74 92.82 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 173.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.4 70.83 1.17 Allowed Glycine 0 CA--C 1.539 1.593 0 CA-C-O 118.091 -1.394 . . . . 0.0 113.368 -177.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.545 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 67.0 p -92.16 -65.62 0.99 Allowed 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 119.187 1.494 . . . . 0.0 111.644 177.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.545 ' CB ' ' O ' ' A' ' 43' ' ' THR . 21.2 ptmt 128.81 -55.68 0.0 OUTLIER 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 123.934 0.894 . . . . 0.0 109.899 -166.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -75.76 -6.57 51.25 Favored 'General case' 0 CA--C 1.568 1.638 0 CA-C-O 118.136 -0.935 . . . . 0.0 113.021 167.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.22 -54.21 11.8 Favored Glycine 0 CA--C 1.544 1.905 0 CA-C-N 120.652 1.569 . . . . 0.0 113.254 166.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.292 11.9 p -76.22 -46.62 33.03 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.706 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 -169.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -56.38 -49.28 74.91 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 121.744 2.065 . . . . 0.0 113.339 169.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.03 -38.5 91.28 Favored 'General case' 0 C--N 1.348 0.527 0 CA-C-N 113.517 -1.674 . . . . 0.0 114.293 -176.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.696 ' HB3' HD11 ' A' ' 39' ' ' ILE . 5.1 tptt -80.14 -17.16 53.27 Favored 'General case' 0 CA--C 1.565 1.545 0 CA-C-O 116.809 -1.567 . . . . 0.0 113.855 173.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 62.6 mtp180 -76.59 -55.61 5.37 Favored 'General case' 0 CA--C 1.598 2.815 1 CA-C-O 86.227 -16.13 . . . . 0.0 118.297 172.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.425 ' HA ' ' H ' ' A' ' 57' ' ' ASP 0.346 0.1 OUTLIER -38.02 -61.57 0.64 Allowed 'General case' 0 N--CA 1.516 2.847 1 O-C-N 109.303 -8.373 . . . . 0.0 120.564 149.349 . . . . . . . . 5 4 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 60.3 mt -58.05 -23.66 55.31 Favored 'General case' 0 N--CA 1.518 2.948 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 177.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -93.32 -49.41 5.96 Favored 'General case' 0 CA--C 1.571 1.763 0 CA-C-O 116.486 -1.721 . . . . 0.0 114.56 166.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -104.28 -5.57 21.72 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 118.112 2.634 . . . . 0.0 118.112 -170.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.646 ' HA2' HH11 ' A' ' 88' ' ' ARG . . . 73.64 47.09 22.22 Favored Glycine 0 CA--C 1.544 1.847 0 CA-C-N 122.203 2.274 . . . . 0.0 115.241 -178.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.425 ' H ' ' HA ' ' A' ' 52' ' ' TYR . 78.9 m-20 -101.51 -175.3 2.82 Favored 'General case' 0 CA--C 1.568 1.642 0 C-N-CA 123.763 0.825 . . . . 0.0 110.807 -170.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 74.7 mt -100.56 99.6 10.2 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.4 t -148.26 130.93 7.86 Favored Pre-proline 0 CA--C 1.586 2.353 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -169.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -50.15 161.01 1.18 Allowed 'Trans proline' 0 CA--C 1.567 2.152 0 C-N-CA 124.446 3.43 . . . . 0.0 120.955 -177.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 58.4 m -91.25 -53.88 4.16 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -174.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -57.86 -36.35 72.2 Favored 'General case' 0 N--CA 1.506 2.366 0 N-CA-C 117.412 2.375 . . . . 0.0 117.412 -171.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 79.5 mt -46.54 -45.56 18.73 Favored 'General case' 0 N--CA 1.506 2.358 0 N-CA-C 118.137 2.643 . . . . 0.0 118.137 170.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.2 m -70.04 -48.88 56.1 Favored 'General case' 0 CA--C 1.562 1.422 0 CA-C-N 112.223 -2.262 . . . . 0.0 112.756 177.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.64 -22.86 62.47 Favored 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 167.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -75.85 -42.36 49.72 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 125.395 1.478 . . . . 0.0 114.908 171.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.8 mt -59.53 -50.39 74.1 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 168.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 87.7 t -63.07 -47.8 90.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 CA-C-O 118.023 -0.989 . . . . 0.0 111.72 177.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -64.4 -30.4 71.44 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 116.443 2.016 . . . . 0.0 116.443 172.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -60.85 -41.21 95.4 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 119.714 1.143 . . . . 0.0 113.255 168.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 20.5 ttm-85 -81.52 -13.94 57.5 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 119.021 2.971 . . . . 0.0 119.021 169.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.8 mt -95.08 -16.86 22.34 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 117.656 2.465 . . . . 0.0 117.656 175.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 . . . . . 0 N--CA 1.5 2.048 0 N-CA-C 118.014 2.598 . . . . 0.0 118.014 176.197 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.51 ' HA2' ' HB3' ' A' ' 2' ' ' ARG . . . . . . . . 0 N--CA 1.482 1.723 0 CA-C-O 122.9 1.278 . . . . 0.0 114.256 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.458 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . 37.6 p90 178.58 135.76 0.08 Allowed 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 112.208 -1.996 . . . . 0.0 111.88 -178.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 21.7 mt -115.23 109.55 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 174.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.7 mt -106.15 126.0 51.68 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 174.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -108.09 127.71 54.04 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 119.272 0.942 . . . . 0.0 110.36 176.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.39 37.93 80.05 Favored Glycine 0 CA--C 1.556 2.653 0 N-CA-C 117.202 1.641 . . . . 0.0 117.202 -176.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -92.87 -54.06 0.25 Allowed Pre-proline 0 N--CA 1.494 1.765 0 CA-C-O 114.935 -2.46 . . . . 0.0 108.223 175.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -65.3 70.87 0.29 Allowed 'Trans proline' 0 CA--C 1.571 2.344 0 CA-C-N 124.343 2.587 . . . . 0.0 117.289 165.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.646 HH11 ' HA2' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -71.67 -24.28 61.81 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 166.714 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.8 t -150.93 151.39 32.09 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 -176.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 36.7 t -62.07 -40.25 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 CA-C-O 117.924 -1.036 . . . . 0.0 112.173 174.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -68.66 -25.37 64.77 Favored 'General case' 0 CA--C 1.55 0.981 0 N-CA-C 119.656 3.206 . . . . 0.0 119.656 174.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.04 -51.34 12.52 Favored 'General case' 0 CA--C 1.589 2.462 0 CA-C-N 123.405 2.82 . . . . 0.0 110.078 163.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -54.58 -28.11 43.78 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 117.834 2.531 . . . . 0.0 117.834 -176.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -58.79 -32.71 69.58 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 166.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.67 -44.31 86.66 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 169.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.6 tp -60.63 -39.03 86.75 Favored 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 170.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 47.8 t60 -70.08 -42.86 72.22 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 120.021 1.282 . . . . 0.0 113.973 171.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 1.153 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 32.1 mt-10 -52.1 -36.46 51.0 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 166.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 1.136 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 25.2 ttt -84.37 -24.49 29.67 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 117.927 2.566 . . . . 0.0 117.927 171.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.468 ' HA ' ' HG1' ' A' ' 105' ' ' THR . 66.3 tp -65.77 -55.65 16.12 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 120.771 1.623 . . . . 0.0 112.572 169.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -79.79 -50.8 10.02 Favored 'General case' 0 CA--C 1.562 1.427 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 175.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 1.153 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 73.4 ttt180 -66.87 -45.69 77.29 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 176.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 1.136 ' HB3' ' O ' ' A' ' 99' ' ' MET . 1.2 tmt_? -63.24 -55.85 21.44 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.01 0.524 . . . . 0.0 111.168 165.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.34 46.83 1.04 Allowed Glycine 0 N--CA 1.48 1.603 0 O-C-N 124.013 0.82 . . . . 0.0 113.347 169.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.468 ' HG1' ' HA ' ' A' ' 100' ' ' LEU . 67.4 p -93.53 152.28 19.15 Favored 'General case' 0 CA--C 1.561 1.39 0 O-C-N 124.402 0.707 . . . . 0.0 109.666 175.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -82.73 129.1 34.92 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.444 -0.785 . . . . 0.0 111.557 -169.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 7.6 tp -89.99 107.68 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 -173.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -90.33 -68.04 0.81 Allowed 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 117.006 -1.473 . . . . 0.0 107.082 168.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -159.0 137.92 11.16 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 120.887 1.676 . . . . 0.0 114.513 177.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.6 t -91.91 109.71 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.676 0 N-CA-C 100.863 -3.755 . . . . 0.0 100.863 161.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.309 25.8 tp -111.68 103.61 11.92 Favored 'General case' 0 CA--C 1.558 1.288 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.858 -161.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -94.12 129.65 40.61 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.449 0.643 . . . . 0.0 112.248 -177.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -92.55 119.04 31.62 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-O 123.157 1.456 . . . . 0.0 110.164 -178.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -84.08 96.8 9.02 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 112.527 -2.124 . . . . 0.0 109.347 168.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.0 p . . . . . 0 N--CA 1.485 1.276 0 C-N-CA 125.245 1.418 . . . . 0.0 107.922 -168.453 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 . . . . . 0 N--CA 1.501 2.104 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 70.0 mtp180 -57.96 -39.69 78.76 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 165.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 25.3 ttt -64.58 -30.96 71.99 Favored 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 168.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -62.85 -48.03 80.79 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 168.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.5 p -66.47 -35.61 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 171.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -53.94 -54.07 43.92 Favored 'General case' 0 CA--C 1.585 2.3 0 CA-C-N 120.073 1.306 . . . . 0.0 111.436 167.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 32.4 ttp180 -51.99 -32.97 35.98 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 119.296 3.073 . . . . 0.0 119.296 172.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -52.86 -38.56 61.69 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 173.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -140.34 26.73 2.15 Favored 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 117.534 2.42 . . . . 0.0 117.534 -177.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 39.5 m -47.69 -37.39 12.89 Favored 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 116.053 1.872 . . . . 0.0 116.053 173.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -69.73 -60.2 3.98 Favored Pre-proline 0 CA--C 1.578 2.026 0 CA-C-O 116.75 -1.595 . . . . 0.0 112.102 172.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -49.87 -30.79 24.62 Favored 'Trans proline' 0 CA--C 1.576 2.605 0 C-N-CA 123.375 2.716 . . . . 0.0 118.562 167.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -63.86 -55.39 23.15 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 125.515 1.526 . . . . 0.0 111.722 173.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.913 ' O ' ' HB2' ' A' ' 156' ' ' ARG 0.317 0.0 OUTLIER -63.41 -26.11 68.59 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 177.021 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -70.52 -50.92 32.7 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 120.68 1.582 . . . . 0.0 114.182 167.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -67.93 -53.91 22.75 Favored 'General case' 0 CA--C 1.557 1.225 0 CA-C-N 120.007 1.276 . . . . 0.0 111.398 -176.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . 0.256 67.5 m-85 -84.98 -19.69 31.69 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-O 114.959 -2.448 . . . . 0.0 113.387 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.913 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 40.6 ttt180 -70.73 -35.62 72.77 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 125.077 3.58 . . . . 0.0 115.073 168.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -69.01 -37.59 78.76 Favored 'General case' 0 CA--C 1.573 1.854 0 CA-C-N 120.08 1.309 . . . . 0.0 113.906 167.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -84.2 -33.03 24.24 Favored 'General case' 0 CA--C 1.572 1.791 0 N-CA-C 118.727 2.862 . . . . 0.0 118.727 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.8 pp -75.46 172.05 13.2 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 118.437 2.754 . . . . 0.0 118.437 -162.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -131.83 141.31 49.39 Favored 'General case' 0 CA--C 1.558 1.258 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 166.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 54.5 m -99.9 146.67 26.39 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 122.351 1.072 . . . . 0.0 110.731 -173.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 30.0 t -123.39 134.34 66.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 167.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -93.83 130.11 39.98 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 167.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -154.7 93.63 1.59 Allowed 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 122.623 1.201 . . . . 0.0 111.9 -163.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.1 t . . . . . 0 N--CA 1.484 1.251 0 CA-C-N 114.16 -1.382 . . . . 0.0 107.391 -176.207 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 . . . . . 0 N--CA 1.5 2.056 0 N-CA-C 116.153 1.909 . . . . 0.0 116.153 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -59.94 -49.61 77.0 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 170.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 94.5 t -56.69 -37.92 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 173.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -61.42 -34.55 75.57 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 167.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -61.0 -43.24 99.18 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 170.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 81.1 mtt-85 -66.65 -33.87 76.61 Favored 'General case' 0 CA--C 1.554 1.131 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 169.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.23 -47.1 85.91 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 171.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . 0.294 0.5 OUTLIER -69.3 -34.0 74.02 Favored 'General case' 0 N--CA 1.504 2.228 0 CA-C-N 120.196 1.362 . . . . 0.0 114.506 169.214 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 29.3 mtp180 -49.23 -45.26 44.33 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 166.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -67.39 -51.33 53.23 Favored 'General case' 0 CA--C 1.565 1.546 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 168.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.81 -62.88 1.39 Allowed 'General case' 0 CA--C 1.566 1.571 0 CA-C-O 117.981 -1.009 . . . . 0.0 112.84 -175.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.898 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -91.39 -54.92 1.89 Allowed Glycine 0 CA--C 1.552 2.402 0 CA-C-O 117.983 -1.454 . . . . 0.0 114.802 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.898 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 55.0 tttp . . . . . 0 C--O 1.251 1.169 0 CA-C-N 119.861 1.83 . . . . 0.0 109.612 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.0 mtt . . . . . 0 CA--C 1.561 1.371 0 CA-C-O 122.933 1.349 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . 0.309 11.7 mpt_? -122.67 167.48 13.38 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 120.747 3.61 . . . . 0.0 120.747 -164.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.1 p -148.25 141.24 18.74 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.656 0 CA-C-O 123.87 1.795 . . . . 0.0 112.568 166.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -116.55 136.99 52.52 Favored 'General case' 0 CA--C 1.56 1.341 0 CA-C-N 111.971 -2.377 . . . . 0.0 104.853 166.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.5 mt -111.85 128.81 56.24 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 122.693 1.235 . . . . 0.0 111.433 -176.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.8 mp -130.75 155.42 46.67 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 111.564 -2.562 . . . . 0.0 111.455 -164.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 144.5 168.87 12.84 Favored Glycine 0 CA--C 1.554 2.522 0 CA-C-O 119.134 -0.814 . . . . 0.0 114.701 169.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo . . . . . 0 CA--C 1.573 2.474 0 C-N-CA 123.462 2.774 . . . . 0.0 113.448 172.195 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.484 1.232 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.12 -32.81 57.11 Favored Glycine 0 CA--C 1.553 2.469 0 N-CA-C 120.057 2.783 . . . . 0.0 120.057 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 78.5 m -63.21 -48.79 76.84 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 119.116 1.458 . . . . 0.0 113.294 172.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.252 6.7 mm-40 -75.57 -15.85 60.32 Favored 'General case' 0 CA--C 1.57 1.713 0 CA-C-O 115.749 -2.072 . . . . 0.0 111.972 172.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.31 -47.44 61.12 Favored 'General case' 0 C--N 1.374 1.642 0 CA-C-N 123.605 2.911 . . . . 0.0 114.249 168.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.7 p -66.36 -42.11 90.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 174.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -63.96 -41.7 97.48 Favored 'General case' 0 CA--C 1.565 1.54 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 171.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mt -66.35 -30.91 71.4 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-N 120.819 1.645 . . . . 0.0 114.724 170.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.9 -42.88 98.89 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 167.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -58.46 -39.95 81.28 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 167.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.4 tptt -63.47 -55.54 23.32 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 172.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.0 mt -82.53 -21.51 35.36 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 117.068 2.247 . . . . 0.0 117.068 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.65 34.87 8.16 Favored Glycine 0 CA--C 1.556 2.614 0 N-CA-C 118.06 1.984 . . . . 0.0 118.06 -177.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.459 ' CG2' ' HA ' ' A' ' 81' ' ' PHE . 16.9 mm -109.06 159.42 31.21 Favored Pre-proline 0 CA--C 1.572 1.824 0 CA-C-N 119.059 1.429 . . . . 0.0 113.275 -168.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -83.88 101.53 0.9 Allowed 'Trans proline' 0 CA--C 1.568 2.184 0 C-N-CA 121.996 1.797 . . . . 0.0 110.592 163.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -59.54 113.94 2.47 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.647 0.779 . . . . 0.0 111.67 168.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 22.0 mm -98.35 106.21 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.212 0 N-CA-C 103.891 -2.633 . . . . 0.0 103.891 173.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 66.0 p -95.81 131.93 41.59 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 169.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.6 p -68.59 -11.21 59.7 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 117.312 2.338 . . . . 0.0 117.312 -174.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -87.65 -20.68 50.35 Favored Glycine 0 CA--C 1.544 1.846 0 N-CA-C 118.769 2.268 . . . . 0.0 118.769 166.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -81.63 -50.99 8.67 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 118.92 1.36 . . . . 0.0 114.652 -169.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -65.36 -37.75 87.98 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 174.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.534 ' HB3' ' CB ' ' A' ' 50' ' ' LYS . 27.2 m-85 -67.49 -41.88 83.81 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 169.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.515 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 73.2 ttt180 -57.08 -36.65 70.84 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 165.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.5 ttm180 -62.15 -43.05 99.69 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.568 1.147 . . . . 0.0 113.956 168.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -60.41 -43.81 96.33 Favored 'General case' 0 CA--C 1.573 1.852 0 CA-C-N 119.149 0.886 . . . . 0.0 113.255 167.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 81.2 mt -51.27 -39.06 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.599 0 C-N-CA 125.93 1.692 . . . . 0.0 113.76 167.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -73.22 -32.62 64.88 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 115.786 1.772 . . . . 0.0 115.786 169.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -70.18 -50.43 40.28 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 175.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 166.33 -32.12 0.21 Allowed Glycine 0 CA--C 1.546 2.012 0 N-CA-C 117.818 1.887 . . . . 0.0 117.818 -169.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.641 ' O ' ' HG3' ' A' ' 44' ' ' LYS 0.322 44.7 p 49.45 125.29 0.0 OUTLIER 'General case' 0 N--CA 1.424 -1.749 1 N-CA-C 124.336 4.939 . . . . 0.0 124.336 -176.473 . . . . . . . . 4 3 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.641 ' HG3' ' O ' ' A' ' 43' ' ' THR 0.352 56.5 mtpt -142.46 -24.12 0.66 Allowed 'General case' 0 N--CA 1.507 2.406 0 CA-C-N 110.073 -3.239 . . . . 0.0 118.538 146.13 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -97.86 -24.93 15.21 Favored 'General case' 0 N--CA 1.514 2.726 0 CA-C-N 123.567 2.894 . . . . 0.0 112.332 161.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -40.52 -64.49 1.17 Allowed Glycine 0 CA--C 1.531 1.053 0 C-N-CA 130.583 3.944 . . . . 0.0 115.756 167.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.3 p -72.33 -48.65 47.19 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 N-CA-C 116.223 1.935 . . . . 0.0 116.223 -171.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -66.36 -44.85 82.05 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 120.359 1.436 . . . . 0.0 112.707 176.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.12 -38.43 85.57 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.534 ' CB ' ' HB3' ' A' ' 35' ' ' PHE 0.348 15.3 tptt -81.28 -19.79 42.27 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-O 116.943 -1.503 . . . . 0.0 113.238 174.613 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.596 ' CG ' ' O ' ' A' ' 51' ' ' ARG . 33.9 ttt180 -81.23 -57.76 3.36 Favored 'General case' 0 CA--C 1.59 2.501 1 CA-C-O 85.358 -16.544 . . . . 0.0 118.654 174.711 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 16.8 m-30 -28.28 -62.23 0.11 Allowed 'General case' 0 N--CA 1.497 1.91 1 O-C-N 107.744 -9.347 . . . . 0.0 120.853 147.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.5 tp -59.05 -33.8 71.19 Favored 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 116.415 2.006 . . . . 0.0 116.415 171.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -90.04 -39.99 12.58 Favored 'General case' 0 CA--C 1.567 1.603 0 N-CA-C 115.543 1.682 . . . . 0.0 115.543 174.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.53 -40.22 16.56 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 117.004 -1.474 . . . . 0.0 114.776 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 151.15 -38.91 0.83 Allowed Glycine 0 N--CA 1.476 1.333 0 CA-C-N 120.924 1.693 . . . . 0.0 116.729 170.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -67.31 171.72 5.59 Favored 'General case' 0 CA--C 1.57 1.741 0 CA-C-N 118.269 1.035 . . . . 0.0 111.626 -177.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 89.4 mt -92.76 135.93 33.69 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 121.383 -0.823 . . . . 0.0 112.12 -167.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.558 HG12 HE21 ' A' ' 92' ' ' GLN . 2.4 p -103.99 136.82 19.14 Favored Pre-proline 0 CA--C 1.58 2.12 0 CA-C-O 118.137 -0.935 . . . . 0.0 109.239 173.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -55.31 146.53 60.87 Favored 'Trans proline' 0 CA--C 1.562 1.911 0 C-N-CA 123.836 3.024 . . . . 0.0 116.671 169.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.8 m -73.97 -48.68 28.78 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 -168.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -61.52 -39.35 90.71 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 116.675 2.102 . . . . 0.0 116.675 -170.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 26.2 mt -57.3 -48.52 78.7 Favored 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 116.506 2.039 . . . . 0.0 116.506 172.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.4 m -61.31 -50.9 71.09 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 112.946 -1.934 . . . . 0.0 113.088 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 -64.08 -19.14 65.04 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 168.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -72.22 -44.12 63.41 Favored 'General case' 0 CA--C 1.558 1.273 0 CA-C-N 121.146 1.793 . . . . 0.0 114.18 168.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 mt -59.19 -49.96 75.86 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 120.207 1.367 . . . . 0.0 114.228 167.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 67.4 t -60.87 -46.79 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 123.811 0.844 . . . . 0.0 113.035 176.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -70.72 -27.16 63.76 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 175.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -64.47 -37.98 89.41 Favored 'General case' 0 CA--C 1.563 1.475 0 CA-C-N 119.808 1.186 . . . . 0.0 112.714 167.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -79.08 -24.0 43.79 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 118.414 2.746 . . . . 0.0 118.414 169.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.0 mp -81.7 -34.46 30.62 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 117.237 2.31 . . . . 0.0 117.237 176.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 28.2 m120 . . . . . 0 N--CA 1.5 2.036 0 N-CA-C 116.832 2.16 . . . . 0.0 116.832 169.462 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.425 0 CA-C-O 123.413 1.563 . . . . 0.0 113.69 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.459 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . 19.7 p90 -172.63 132.53 0.58 Allowed 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 112.875 -1.662 . . . . 0.0 107.729 -174.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 4.3 mm -101.2 107.67 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.563 0 N-CA-C 102.729 -3.063 . . . . 0.0 102.729 168.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.4 mt -100.97 133.95 44.69 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 169.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -125.32 129.98 51.06 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 119.33 0.968 . . . . 0.0 111.778 177.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.02 41.73 80.4 Favored Glycine 0 CA--C 1.546 1.984 0 CA-C-O 116.198 -2.445 . . . . 0.0 116.717 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . 0.257 1.6 t80 -106.28 -55.22 0.08 OUTLIER Pre-proline 0 N--CA 1.502 2.151 0 CA-C-N 121.281 2.54 . . . . 0.0 108.771 174.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -67.53 72.64 0.63 Allowed 'Trans proline' 0 CA--C 1.572 2.382 0 CA-C-N 124.02 2.471 . . . . 0.0 117.688 165.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.99 17.34 17.93 Favored 'General case' 0 CA--C 1.572 1.827 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 168.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.7 t -167.55 120.15 0.91 Allowed 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 101.656 -3.461 . . . . 0.0 101.656 -177.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . 0.342 4.6 p -69.01 -21.13 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 CA-C-O 116.337 -1.792 . . . . 0.0 111.991 -176.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -64.38 -31.39 72.58 Favored 'General case' 0 CA--C 1.557 1.247 0 N-CA-C 117.896 2.554 . . . . 0.0 117.896 162.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.558 HE21 HG12 ' A' ' 59' ' ' VAL . 2.6 mm-40 -77.28 -51.57 10.67 Favored 'General case' 0 CA--C 1.585 2.32 0 CA-C-N 124.034 3.106 . . . . 0.0 111.412 164.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.27 -29.13 68.61 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 117.274 2.324 . . . . 0.0 117.274 -172.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 64.7 tttt -56.34 -35.32 67.49 Favored 'General case' 0 CA--C 1.557 1.213 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 167.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.32 -37.33 74.69 Favored 'General case' 0 CA--C 1.566 1.559 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 169.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 22.9 tp -65.55 -34.03 77.29 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 168.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.03 -42.28 89.78 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 121.549 1.977 . . . . 0.0 112.623 169.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 1.007 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 34.9 mt-10 -56.02 -34.92 66.3 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 115.154 1.539 . . . . 0.0 115.154 167.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 1.233 ' O ' ' HB2' ' A' ' 103' ' ' ARG . 20.7 ttt -85.78 -32.99 21.51 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 118.567 2.803 . . . . 0.0 118.567 178.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.8 -44.71 47.97 Favored 'General case' 0 N--CA 1.507 2.387 0 CA-C-N 121.375 1.898 . . . . 0.0 111.705 170.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -73.52 -53.5 10.42 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 119.221 0.919 . . . . 0.0 113.269 173.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 1.007 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 72.3 ttt180 -67.71 -40.75 84.24 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 116.013 1.857 . . . . 0.0 116.013 176.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 1.233 ' HB2' ' O ' ' A' ' 99' ' ' MET . 15.0 mmm180 -61.42 -60.18 4.11 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 118.622 0.646 . . . . 0.0 111.447 166.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 113.63 49.27 0.56 Allowed Glycine 0 N--CA 1.478 1.478 0 O-C-N 124.629 1.205 . . . . 0.0 113.632 169.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 73.2 p -86.92 146.16 26.27 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-N 114.388 -0.906 . . . . 0.0 109.399 171.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -69.13 132.15 46.11 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.526 -0.734 . . . . 0.0 111.394 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.9 tp -89.25 97.21 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -173.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -97.76 -65.58 0.95 Allowed 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 115.802 -2.046 . . . . 0.0 109.163 169.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -149.32 118.08 6.63 Favored 'General case' 0 C--N 1.366 1.295 0 CA-C-N 121.988 2.176 . . . . 0.0 114.88 -170.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -94.99 110.74 24.42 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.162 1 N-CA-C 98.888 -4.486 . . . . 0.0 98.888 161.042 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 40.9 tp -114.02 103.81 11.52 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.246 -162.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -100.2 123.39 44.38 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -176.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 6.8 m-30 -93.98 126.58 39.27 Favored 'General case' 0 CA--C 1.561 1.369 0 CA-C-O 122.471 1.129 . . . . 0.0 109.562 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.473 ' HB3' ' HA ' ' A' ' 163' ' ' ASP . 1.6 tmm_? -82.72 88.31 6.73 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 113.602 -1.635 . . . . 0.0 109.134 168.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.4 p . . . . . 0 CA--C 1.554 1.118 0 C-N-CA 125.758 1.623 . . . . 0.0 107.813 -169.496 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 . . . . . 0 N--CA 1.502 2.135 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 69.2 mtp180 -60.56 -38.68 85.34 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 169.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 56.1 mtt -71.62 -29.14 64.33 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 169.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -61.91 -50.35 72.53 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 120.459 1.482 . . . . 0.0 114.834 168.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.5 p -63.52 -33.83 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 169.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -54.21 -48.27 71.22 Favored 'General case' 0 CA--C 1.58 2.112 0 CA-C-N 119.983 1.265 . . . . 0.0 112.403 167.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -61.26 -45.57 93.98 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 117.859 2.54 . . . . 0.0 117.859 175.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -56.63 -32.1 64.99 Favored 'General case' 0 N--CA 1.507 2.385 0 N-CA-C 117.779 2.511 . . . . 0.0 117.779 177.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -114.61 -39.59 3.75 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 117.497 2.406 . . . . 0.0 117.497 -167.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 99.1 m -49.88 -34.2 19.44 Favored 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 117.525 2.417 . . . . 0.0 117.525 -168.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.8 -61.12 4.59 Favored Pre-proline 0 CA--C 1.581 2.168 0 CA-C-O 116.013 -1.946 . . . . 0.0 112.045 170.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -55.74 -30.06 74.2 Favored 'Trans proline' 0 CA--C 1.582 2.919 0 N-CA-C 119.947 3.018 . . . . 0.0 119.947 169.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.3 -55.18 30.71 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 126.442 1.897 . . . . 0.0 111.524 169.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 1.31 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 28.9 tp -67.1 -22.52 65.81 Favored 'General case' 0 CA--C 1.562 1.409 0 CA-C-O 116.699 -1.619 . . . . 0.0 114.437 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -71.99 -49.35 37.91 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 122.008 2.185 . . . . 0.0 112.354 164.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -67.81 -54.4 19.42 Favored 'General case' 0 CA--C 1.562 1.438 0 CA-C-N 121.214 1.825 . . . . 0.0 112.158 -177.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -77.39 -23.27 50.73 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 114.49 -2.671 . . . . 0.0 112.337 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 1.31 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 0.1 OUTLIER -64.45 -40.25 95.38 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 125.878 3.945 . . . . 0.0 115.739 167.735 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -62.09 -37.0 83.4 Favored 'General case' 0 CA--C 1.576 1.947 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 167.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -90.48 -35.63 14.99 Favored 'General case' 0 CA--C 1.576 1.98 0 N-CA-C 118.653 2.834 . . . . 0.0 118.653 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.3 pp -71.87 171.81 11.04 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 119.843 3.275 . . . . 0.0 119.843 -163.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -129.72 126.3 37.92 Favored 'General case' 0 CA--C 1.566 1.585 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 166.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.3 t -101.64 160.45 14.44 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 122.798 1.285 . . . . 0.0 113.265 -169.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.566 HG12 ' HG3' ' A' ' 174' ' ' ARG . 91.9 t -131.74 150.41 33.94 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.887 0 CA-C-N 113.456 -1.702 . . . . 0.0 107.335 169.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.473 ' HA ' ' HB3' ' A' ' 114' ' ' ARG . 13.4 t70 -107.06 127.03 53.11 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 167.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -164.83 126.95 2.2 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -162.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.0 t . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.34 -0.85 . . . . 0.0 108.845 167.627 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 . . . . . 0 N--CA 1.496 1.87 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.862 ' HB3' ' NH2' ' A' ' 174' ' ' ARG . 45.1 mt-10 -58.99 -54.9 41.87 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 172.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 93.6 t -58.13 -37.8 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 176.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -60.48 -36.13 77.55 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 168.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -63.59 -56.05 18.91 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 175.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.862 ' NH2' ' HB3' ' A' ' 170' ' ' GLU . 9.8 ptp180 -66.07 -25.93 67.26 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 118.001 2.593 . . . . 0.0 118.001 171.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.5 -41.62 88.6 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 167.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.3 mp -62.82 -41.69 99.42 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 117.676 -1.154 . . . . 0.0 113.831 167.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -54.96 -45.18 74.89 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 168.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.64 -46.59 88.55 Favored 'General case' 0 CA--C 1.559 1.313 0 N-CA-C 116.655 2.095 . . . . 0.0 116.655 171.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 6.2 tt -83.74 -57.01 3.39 Favored 'General case' 0 CA--C 1.567 1.604 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.428 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.653 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -110.39 -58.89 0.49 Allowed Glycine 0 CA--C 1.552 2.366 0 CA-C-O 117.727 -1.596 . . . . 0.0 114.924 -176.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.653 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 37.0 ttmt . . . . . 0 C--O 1.251 1.151 0 CA-C-N 120.357 2.079 . . . . 0.0 107.328 -175.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 ptp . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 121.681 0.753 . . . . 0.0 111.551 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.764 ' HB3' ' HA2' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -160.42 159.0 30.47 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -168.782 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 99.4 t -136.7 150.2 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.543 0 CA-C-O 124.107 1.908 . . . . 0.0 110.262 -166.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . 0.642 HD12 HH22 ' A' ' 2' ' ' ARG . 3.7 mt -117.46 134.04 55.29 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 127.234 2.214 . . . . 0.0 107.039 169.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 18.5 tp -116.65 119.35 35.23 Favored 'General case' 0 CA--C 1.571 1.769 0 CA-C-O 123.722 1.725 . . . . 0.0 108.716 -176.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -118.41 141.5 48.49 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 110.504 -3.044 . . . . 0.0 109.794 -166.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 171.2 167.85 32.05 Favored Glycine 0 CA--C 1.559 2.796 0 N-CA-C 116.04 1.176 . . . . 0.0 116.04 170.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo . . . . . 0 CA--C 1.574 2.5 0 C-N-CA 123.513 2.809 . . . . 0.0 116.002 174.906 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.853 0.359 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -51.06 -36.3 34.75 Favored Glycine 0 CA--C 1.554 2.509 0 N-CA-C 120.466 2.947 . . . . 0.0 120.466 -177.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 58.6 m -65.01 -52.45 56.07 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 119.151 1.475 . . . . 0.0 113.458 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.284 21.3 mp0 -76.51 -13.39 60.1 Favored 'General case' 0 CA--C 1.571 1.783 0 CA-C-O 115.545 -2.169 . . . . 0.0 112.329 171.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.39 -45.83 68.36 Favored 'General case' 0 C--N 1.373 1.619 0 CA-C-N 124.131 3.151 . . . . 0.0 114.389 166.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.9 p -66.22 -43.22 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-O 118.449 -0.786 . . . . 0.0 113.092 173.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.401 ' HB3' ' CE1' ' A' ' 172' ' ' PHE . 97.3 mttt -55.14 -48.61 73.46 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 116.6 2.074 . . . . 0.0 116.6 169.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 mt -66.16 -29.26 69.51 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 172.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.83 -39.83 94.21 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 167.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -59.32 -39.49 83.26 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 117.342 -1.313 . . . . 0.0 114.516 166.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -62.25 -58.89 6.08 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 120.901 1.682 . . . . 0.0 114.905 169.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.3 mt -82.31 -20.2 37.88 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 117.551 2.426 . . . . 0.0 117.551 -172.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.67 44.94 8.88 Favored Glycine 0 CA--C 1.553 2.432 0 CA-C-N 120.734 1.607 . . . . 0.0 117.071 -174.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.408 ' CG2' ' HA ' ' A' ' 81' ' ' PHE . 29.1 mm -112.32 156.02 42.74 Favored Pre-proline 0 CA--C 1.569 1.698 0 CA-C-N 118.219 1.01 . . . . 0.0 113.578 -168.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -73.04 100.65 1.24 Allowed 'Trans proline' 0 CA--C 1.562 1.894 0 C-N-CA 121.807 1.671 . . . . 0.0 112.685 160.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.23 105.34 4.61 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.302 -0.874 . . . . 0.0 108.809 167.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 44.6 mm -99.97 111.9 30.93 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 178.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.2 t -96.64 127.84 43.01 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 168.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 19.7 p -73.91 1.31 11.01 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 116.95 2.204 . . . . 0.0 116.95 -172.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.57 -18.67 29.71 Favored Glycine 0 CA--C 1.55 2.28 0 N-CA-C 118.014 1.966 . . . . 0.0 118.014 163.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -78.89 -55.87 4.82 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 119.494 1.647 . . . . 0.0 113.594 -168.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -57.0 -39.28 74.4 Favored 'General case' 0 CA--C 1.568 1.648 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 172.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.413 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 31.6 m-85 -69.84 -37.46 76.19 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 117.415 -1.279 . . . . 0.0 114.05 169.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -52.9 -39.95 63.16 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 115.478 1.658 . . . . 0.0 115.478 167.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.437 ' HD2' ' HA ' ' A' ' 37' ' ' ARG . 9.8 tpt180 -67.64 -39.99 84.59 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 172.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -64.99 -31.76 73.16 Favored 'General case' 0 CA--C 1.579 2.074 0 N-CA-C 115.634 1.716 . . . . 0.0 115.634 166.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 57.6 mt -59.89 -45.68 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 C-N-CA 126.023 1.729 . . . . 0.0 111.362 167.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -63.06 -41.48 99.47 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 172.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -71.74 -37.77 70.52 Favored 'General case' 0 CA--C 1.563 1.444 0 N-CA-C 116.823 2.157 . . . . 0.0 116.823 176.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.05 71.06 1.18 Allowed Glycine 0 CA--C 1.545 1.967 0 CA-C-O 117.782 -1.566 . . . . 0.0 115.179 -176.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.782 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 59.2 p -92.33 -51.26 5.24 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-N 119.684 1.742 . . . . 0.0 114.286 174.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.782 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.25 73.4 mttt 105.87 -40.52 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.777 0 CA-C-O 116.325 -1.798 . . . . 0.0 111.651 -171.549 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.06 -14.84 57.43 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 123.066 2.666 . . . . 0.0 112.968 164.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.3 -57.53 19.31 Favored Glycine 0 C--N 1.358 1.755 0 CA-C-N 120.299 1.409 . . . . 0.0 115.082 168.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.268 10.9 p -75.13 -47.5 35.8 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.394 0 N-CA-C 116.45 2.018 . . . . 0.0 116.45 -168.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -65.42 -46.86 78.3 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 120.783 1.629 . . . . 0.0 112.8 173.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.02 -33.81 75.29 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -178.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.413 ' HB2' ' HB3' ' A' ' 35' ' ' PHE . 13.6 tmtt? -66.68 -42.46 86.51 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 168.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.591 ' O ' ' CG ' ' A' ' 51' ' ' ARG . 31.6 ttt180 -73.0 -51.53 17.9 Favored 'General case' 0 CA--C 1.59 2.518 1 CA-C-O 85.079 -16.677 . . . . 0.0 118.318 -173.725 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 16.9 m-30 -31.57 -56.91 0.27 Allowed 'General case' 0 N--CA 1.495 1.793 1 O-C-N 109.216 -8.428 . . . . 0.0 121.693 146.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 35.8 mt -59.17 -44.68 92.16 Favored 'General case' 0 CA--C 1.578 2.039 0 CA-C-N 122.941 2.609 . . . . 0.0 114.411 166.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -80.79 -34.12 34.33 Favored 'General case' 0 CA--C 1.564 1.488 0 N-CA-C 116.941 2.2 . . . . 0.0 116.941 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -97.05 -33.77 11.41 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 175.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.47 20.19 6.69 Favored Glycine 0 CA--C 1.546 1.987 0 CA-C-N 122.452 2.387 . . . . 0.0 118.068 169.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -97.98 173.06 7.25 Favored 'General case' 0 CA--C 1.574 1.904 0 CA-C-N 118.998 1.399 . . . . 0.0 110.083 167.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.7 mt -72.71 130.31 40.22 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 119.828 -1.795 . . . . 0.0 114.923 -166.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.4 p -116.35 113.55 40.98 Favored Pre-proline 0 CA--C 1.57 1.745 0 C-N-CA 124.817 1.247 . . . . 0.0 108.936 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -60.6 153.06 64.22 Favored 'Trans proline' 0 CA--C 1.559 1.746 0 C-N-CA 123.425 2.75 . . . . 0.0 116.996 177.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 90.5 p -79.35 172.91 13.14 Favored 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 177.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . 0.453 ' O ' ' HB2' ' A' ' 66' ' ' GLU . 6.0 t70 81.89 -46.12 0.19 Allowed 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 125.839 1.656 . . . . 0.0 114.713 175.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 22.6 mt -60.83 -50.96 71.33 Favored 'General case' 0 N--CA 1.506 2.354 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 168.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.4 m -58.84 -50.83 72.53 Favored 'General case' 0 CA--C 1.566 1.591 0 CA-C-N 112.989 -1.914 . . . . 0.0 112.904 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -62.17 -28.44 69.66 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 115.216 1.561 . . . . 0.0 115.216 168.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -64.69 -44.37 90.52 Favored 'General case' 0 CA--C 1.555 1.171 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 171.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.3 mt -60.9 -48.99 79.29 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.214 1.191 . . . . 0.0 114.214 167.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 78.5 t -61.39 -51.82 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 CA-C-O 117.989 -1.005 . . . . 0.0 111.497 175.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -64.4 -28.38 69.65 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 174.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -64.05 -41.43 97.38 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 119.706 1.139 . . . . 0.0 112.806 168.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 27.8 ttm-85 -82.4 -9.2 59.54 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 119.001 2.963 . . . . 0.0 119.001 170.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 89.9 mt -99.49 -23.42 15.11 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 175.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 . . . . . 0 N--CA 1.5 2.028 0 N-CA-C 116.318 1.97 . . . . 0.0 116.318 172.168 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.764 ' HA2' ' HB3' ' A' ' 2' ' ' ARG . . . . . . . . 0 N--CA 1.483 1.786 0 CA-C-O 122.969 1.316 . . . . 0.0 112.612 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.408 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . 31.5 p90 -178.39 135.32 0.15 Allowed 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 113.355 -1.422 . . . . 0.0 112.111 -168.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 31.3 mt -109.5 106.03 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.545 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 174.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.9 mt -99.98 129.84 46.09 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.35 1.06 . . . . 0.0 110.261 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -124.22 115.96 21.91 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 118.501 0.591 . . . . 0.0 110.235 -172.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 75.18 32.64 55.72 Favored Glycine 0 CA--C 1.551 2.343 0 CA-C-O 117.549 -1.695 . . . . 0.0 117.046 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -95.9 -52.77 0.23 Allowed Pre-proline 0 N--CA 1.496 1.863 0 CA-C-O 115.068 -2.396 . . . . 0.0 108.664 174.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -66.13 70.7 0.4 Allowed 'Trans proline' 0 CA--C 1.573 2.437 0 CA-C-N 124.57 2.668 . . . . 0.0 117.835 165.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . 0.33 39.2 ttt-85 -72.61 -35.41 67.85 Favored 'General case' 0 CA--C 1.56 1.333 0 N-CA-C 116.789 2.144 . . . . 0.0 116.789 167.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.434 ' HG ' ' HG3' ' A' ' 147' ' ' GLU . 38.6 t -147.29 135.4 21.45 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 -169.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . 0.329 4.9 p -69.02 -19.0 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 CA-C-O 116.364 -1.779 . . . . 0.0 112.597 -178.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -68.08 -32.7 73.22 Favored 'General case' 0 CA--C 1.558 1.254 0 N-CA-C 118.781 2.882 . . . . 0.0 118.781 165.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -75.83 -50.35 15.39 Favored 'General case' 0 CA--C 1.587 2.387 0 CA-C-N 124.372 3.26 . . . . 0.0 111.204 164.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.73 -27.43 66.47 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 117.984 2.587 . . . . 0.0 117.984 -175.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 41.9 tttt -57.32 -33.91 68.2 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 167.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.35 -38.23 88.69 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 167.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 47.3 mt -66.9 -33.19 75.05 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 170.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -63.19 -55.02 28.55 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 120.064 1.302 . . . . 0.0 112.755 169.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 1.171 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 0.7 OUTLIER -49.73 -36.58 26.09 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 115.761 1.763 . . . . 0.0 115.761 168.13 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 1.169 ' O ' ' HB2' ' A' ' 103' ' ' ARG . 65.6 mtt -84.37 -28.84 26.71 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 117.802 2.519 . . . . 0.0 117.802 175.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 35.9 tp -65.23 -55.05 20.67 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 120.747 1.612 . . . . 0.0 111.862 170.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -80.1 -50.74 9.9 Favored 'General case' 0 CA--C 1.562 1.42 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 176.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 1.171 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 94.4 mtt180 -71.86 -42.15 67.21 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 177.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 1.169 ' HB2' ' O ' ' A' ' 99' ' ' MET . 43.6 mtt180 -65.18 -51.52 60.59 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 119.928 1.24 . . . . 0.0 111.621 164.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.4 44.33 1.26 Allowed Glycine 0 N--CA 1.48 1.612 0 C-N-CA 121.052 -0.594 . . . . 0.0 114.153 167.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 31.1 p -95.18 145.02 25.33 Favored 'General case' 0 CA--C 1.557 1.217 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 169.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -69.44 128.19 35.65 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.438 -0.789 . . . . 0.0 112.604 -169.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 4.5 tp -81.0 102.78 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 173.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . 0.268 24.2 t70 -96.5 -76.23 0.51 Allowed 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 116.111 -1.899 . . . . 0.0 106.8 167.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -138.87 127.14 22.78 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 121.141 1.791 . . . . 0.0 114.794 -173.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.4 t -93.66 109.92 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 103.144 -2.91 . . . . 0.0 103.144 162.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 91.3 mt -107.09 120.48 42.2 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 122.918 0.487 . . . . 0.0 109.873 -172.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -103.95 128.18 51.48 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 118.033 0.379 . . . . 0.0 110.358 177.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -91.46 119.42 31.41 Favored 'General case' 0 CA--C 1.556 1.192 0 CA-C-O 122.946 1.355 . . . . 0.0 109.584 177.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.415 ' HB3' ' HA ' ' A' ' 163' ' ' ASP . 17.7 tpt180 -82.0 93.59 6.99 Favored 'General case' 0 CA--C 1.557 1.224 0 CA-C-N 112.843 -1.98 . . . . 0.0 108.314 166.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.481 1.076 0 CA-C-N 113.605 -1.634 . . . . 0.0 108.286 -168.499 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 48.3 t30 . . . . . 0 N--CA 1.503 2.211 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 27.7 mtp180 -59.78 -38.4 81.75 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 167.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 63.3 mtt -65.64 -31.87 73.13 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 169.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -64.12 -49.63 71.43 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 168.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.6 p -65.97 -33.33 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 169.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -54.19 -51.41 64.48 Favored 'General case' 0 CA--C 1.579 2.077 0 CA-C-N 120.175 1.352 . . . . 0.0 111.191 167.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -55.61 -37.09 67.67 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 119.529 3.159 . . . . 0.0 119.529 173.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -51.46 -29.37 15.99 Favored 'General case' 0 N--CA 1.513 2.685 0 N-CA-C 117.844 2.535 . . . . 0.0 117.844 170.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.434 ' HG3' ' HG ' ' A' ' 89' ' ' SER . 21.9 mm-40 -121.88 -28.94 4.38 Favored 'General case' 0 CA--C 1.559 1.309 0 N-CA-C 118.852 2.908 . . . . 0.0 118.852 -166.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 33.5 m -42.78 -37.08 1.66 Allowed 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 118.053 2.612 . . . . 0.0 118.053 -168.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.5 -62.46 2.99 Favored Pre-proline 0 CA--C 1.581 2.172 0 CA-C-O 116.175 -1.869 . . . . 0.0 111.822 172.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -52.08 -36.56 66.14 Favored 'Trans proline' 0 CA--C 1.58 2.819 0 C-N-CA 123.554 2.836 . . . . 0.0 118.546 167.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.68 -54.54 44.09 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 125.427 1.491 . . . . 0.0 111.973 171.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 1.003 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 44.2 tp -67.39 -23.55 65.58 Favored 'General case' 0 CA--C 1.561 1.396 0 CA-C-O 116.669 -1.634 . . . . 0.0 114.456 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -72.43 -46.01 57.02 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 122.022 2.192 . . . . 0.0 112.743 165.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -67.81 -52.07 41.37 Favored 'General case' 0 CA--C 1.565 1.534 0 CA-C-N 120.499 1.499 . . . . 0.0 112.245 -177.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -81.03 -24.3 38.01 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-O 115.119 -2.372 . . . . 0.0 113.405 178.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 1.003 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 39.8 ttt180 -65.04 -36.41 84.26 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 124.565 3.348 . . . . 0.0 115.581 168.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -68.17 -37.33 80.86 Favored 'General case' 0 CA--C 1.574 1.896 0 CA-C-N 119.806 1.185 . . . . 0.0 114.026 167.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -80.14 -35.93 35.94 Favored 'General case' 0 CA--C 1.575 1.91 0 N-CA-C 119.009 2.966 . . . . 0.0 119.009 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.2 pp -79.96 174.77 11.25 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 118.917 2.932 . . . . 0.0 118.917 -161.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 61.3 tttt -135.18 140.64 45.52 Favored 'General case' 0 CA--C 1.564 1.495 0 C-N-CA 125.249 1.42 . . . . 0.0 108.075 167.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 58.0 m -88.76 146.89 24.75 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.358 1.075 . . . . 0.0 112.14 -169.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 58.4 t -134.8 137.49 50.83 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.559 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 167.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.415 ' HA ' ' HB3' ' A' ' 114' ' ' ARG . 29.6 t70 -95.39 138.78 32.6 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 168.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -162.24 101.31 1.09 Allowed 'General case' 0 N--CA 1.482 1.13 0 O-C-N 121.466 -0.771 . . . . 0.0 112.323 -165.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.9 t . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 173.775 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 . . . . . 0 N--CA 1.499 2.003 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.63 -51.95 67.62 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 171.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 79.5 t -55.47 -40.33 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 175.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.401 ' CE1' ' HB3' ' A' ' 19' ' ' LYS . 22.9 t80 -62.97 -33.2 74.89 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 169.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -62.02 -48.98 77.87 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 114.241 1.201 . . . . 0.0 114.241 171.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 80.0 mtt180 -58.93 -42.6 90.14 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 117.199 2.296 . . . . 0.0 117.199 169.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -58.93 -43.35 91.13 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 170.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.9 mp -64.84 -42.05 95.24 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 169.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -54.4 -41.25 69.06 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 116.412 2.004 . . . . 0.0 116.412 169.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -65.24 -51.67 59.36 Favored 'General case' 0 CA--C 1.561 1.37 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 169.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 7.4 tt -74.03 -57.65 3.83 Favored 'General case' 0 CA--C 1.566 1.574 0 CA-C-N 120.026 1.285 . . . . 0.0 112.636 -176.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.962 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -110.46 -57.66 0.5 Allowed Glycine 0 CA--C 1.552 2.362 0 CA-C-O 117.744 -1.587 . . . . 0.0 114.762 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.962 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 63.6 tttm . . . . . 0 C--O 1.251 1.173 0 CA-C-N 120.306 2.053 . . . . 0.0 109.212 -175.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.4 mmt . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 122.667 1.222 . . . . 0.0 111.444 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . 0.304 8.7 ttm-85 -148.59 147.07 28.57 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 118.162 2.652 . . . . 0.0 118.162 -158.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 37.7 t -142.76 148.83 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 124.624 2.154 . . . . 0.0 110.846 -172.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . 0.294 0.0 OUTLIER -135.56 122.03 20.63 Favored 'General case' 0 CA--C 1.564 1.513 0 CA-C-N 112.716 -2.038 . . . . 0.0 106.416 166.095 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.9 tt -97.98 133.31 42.63 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.823 1.649 . . . . 0.0 110.832 -166.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.6 mt -138.4 156.43 47.59 Favored 'General case' 0 CA--C 1.554 1.118 0 CA-C-N 113.98 -1.463 . . . . 0.0 111.174 -166.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 160.6 144.33 3.94 Favored Glycine 0 CA--C 1.555 2.544 0 CA-C-O 118.202 -1.332 . . . . 0.0 114.967 172.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo . . . . . 0 CA--C 1.579 2.733 0 CA-C-N 121.367 2.584 . . . . 0.0 114.847 169.966 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm . . . . . 0 N--CA 1.484 1.274 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -48.22 -33.07 10.33 Favored Glycine 0 CA--C 1.557 2.693 0 N-CA-C 120.175 2.83 . . . . 0.0 120.175 171.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 20.1 m -61.7 -52.18 65.34 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 118.872 1.336 . . . . 0.0 113.967 170.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.284 2.8 mp0 -75.09 -11.69 60.15 Favored 'General case' 0 CA--C 1.57 1.716 0 CA-C-O 115.719 -2.086 . . . . 0.0 112.683 171.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.91 -45.85 55.91 Favored 'General case' 0 C--N 1.372 1.581 0 CA-C-N 123.778 2.99 . . . . 0.0 113.929 166.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.3 p -65.22 -44.89 95.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 173.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.486 ' HB3' ' HE2' ' A' ' 172' ' ' PHE . 99.5 mttt -64.12 -46.06 85.84 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 116.325 1.972 . . . . 0.0 116.325 172.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.5 tp -65.26 -29.32 70.09 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 171.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.81 -45.15 93.97 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 168.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -52.71 -39.73 62.3 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 164.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -64.32 -48.2 76.52 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 170.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.7 mt -79.6 -19.01 50.33 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 116.505 2.039 . . . . 0.0 116.505 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.99 46.78 6.49 Favored Glycine 0 CA--C 1.554 2.513 0 CA-C-N 120.054 1.297 . . . . 0.0 116.14 -174.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.514 ' CD1' ' HA ' ' A' ' 81' ' ' PHE . 0.2 OUTLIER -130.86 147.93 68.17 Favored Pre-proline 0 CA--C 1.572 1.809 0 C-N-CA 125.855 1.662 . . . . 0.0 110.949 -165.773 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -75.55 106.73 2.32 Favored 'Trans proline' 0 CA--C 1.574 2.489 0 C-N-CA 121.85 1.7 . . . . 0.0 111.049 158.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.35 132.62 48.05 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 120.643 -1.286 . . . . 0.0 112.028 169.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -94.98 107.25 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 N-CA-C 103.478 -2.786 . . . . 0.0 103.478 174.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 76.3 p -98.24 125.06 43.16 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 168.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.9 p -68.76 -4.6 16.57 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 117.68 2.474 . . . . 0.0 117.68 -175.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.774 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -89.34 -26.06 26.71 Favored Glycine 0 CA--C 1.539 1.573 0 N-CA-C 118.898 2.319 . . . . 0.0 118.898 165.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -82.11 -55.61 4.45 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 -168.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -63.9 -40.1 95.72 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 175.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.421 ' HB3' ' CB ' ' A' ' 50' ' ' LYS . 20.1 m-85 -71.09 -44.97 64.6 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 116.35 -1.786 . . . . 0.0 114.612 173.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.774 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 72.5 ttt180 -52.46 -41.86 63.68 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 168.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -61.84 -41.25 97.58 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 168.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -67.61 -25.65 65.86 Favored 'General case' 0 CA--C 1.583 2.218 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 168.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 66.8 mt -61.64 -48.38 88.98 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.458 0 CA-C-N 121.054 1.752 . . . . 0.0 110.264 166.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -61.72 -40.91 96.71 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 175.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -65.94 -44.19 85.79 Favored 'General case' 0 CA--C 1.558 1.257 0 N-CA-C 116.069 1.878 . . . . 0.0 116.069 174.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.06 66.96 1.26 Allowed Glycine 0 CA--C 1.544 1.859 0 CA-C-O 118.784 -1.009 . . . . 0.0 114.301 -176.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.774 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 70.4 p -91.43 -48.45 6.88 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.774 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.274 38.9 mttp 107.77 -41.54 0.0 OUTLIER 'General case' 0 CA--C 1.571 1.752 0 CA-C-O 116.31 -1.805 . . . . 0.0 111.007 -172.431 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.4 pp -79.5 -18.66 51.47 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 123.108 2.686 . . . . 0.0 114.147 163.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.26 -55.77 28.64 Favored Glycine 0 CA--C 1.548 2.141 0 CA-C-O 122.419 1.011 . . . . 0.0 114.951 169.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 1.084 ' O ' ' HB2' ' A' ' 51' ' ' ARG . 1.0 OUTLIER -75.89 -43.73 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 N-CA-C 117.158 2.281 . . . . 0.0 117.158 -167.988 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -78.45 -24.79 45.86 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 122.369 2.349 . . . . 0.0 111.806 170.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.85 -47.76 70.96 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 123.163 2.71 . . . . 0.0 112.68 177.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.421 ' CB ' ' HB3' ' A' ' 35' ' ' PHE 0.356 38.5 tptt -81.56 -17.22 49.15 Favored 'General case' 0 CA--C 1.573 1.85 0 O-C-N 124.694 1.247 . . . . 0.0 114.339 173.111 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 1.084 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 21.5 ttt180 -83.61 -54.34 5.0 Favored 'General case' 0 CA--C 1.581 2.173 1 CA-C-O 85.034 -16.698 . . . . 0.0 118.562 175.691 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -37.99 -62.8 0.53 Allowed 'General case' 0 C--N 1.368 1.398 1 O-C-N 105.791 -10.568 . . . . 0.0 119.442 148.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . 0.271 1.2 tm? -41.18 -40.65 1.62 Allowed 'General case' 0 CA--C 1.58 2.123 0 CA-C-N 121.968 2.167 . . . . 0.0 116.845 170.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -90.72 -42.91 10.44 Favored 'General case' 0 CA--C 1.572 1.821 0 N-CA-C 117.045 2.239 . . . . 0.0 117.045 169.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -102.69 -23.45 13.83 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 118.31 2.707 . . . . 0.0 118.31 -169.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.48 32.45 7.32 Favored Glycine 0 CA--C 1.543 1.807 0 N-CA-C 118.58 2.192 . . . . 0.0 118.58 169.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -83.78 -127.09 0.03 OUTLIER 'General case' 0 CA--C 1.583 2.234 0 C-N-CA 123.833 0.853 . . . . 0.0 111.106 168.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 pp -128.81 179.08 5.91 Favored 'General case' 0 CA--C 1.573 1.835 0 C-N-CA 126.268 1.827 . . . . 0.0 110.462 169.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -163.9 138.84 4.76 Favored Pre-proline 0 CA--C 1.574 1.899 0 O-C-N 119.484 -2.01 . . . . 0.0 110.593 170.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -60.01 145.42 98.43 Favored 'Trans proline' 0 CA--C 1.562 1.919 0 C-N-CA 123.432 2.755 . . . . 0.0 115.999 169.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 95.3 p -78.61 173.15 12.72 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 77.27 -38.39 0.29 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 117.15 2.278 . . . . 0.0 117.15 173.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . 0.467 ' O ' ' HB2' ' A' ' 66' ' ' GLU . 4.4 pp -54.55 -43.07 71.69 Favored 'General case' 0 N--CA 1.507 2.416 0 N-CA-C 118.03 2.604 . . . . 0.0 118.03 170.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.4 m -60.91 -58.39 8.65 Favored 'General case' 0 CA--C 1.562 1.424 0 CA-C-N 111.5 -2.591 . . . . 0.0 112.082 176.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -62.38 -19.14 63.1 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 166.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 63' ' ' LEU . 6.1 mm-40 -65.52 -44.84 85.67 Favored 'General case' 0 CA--C 1.558 1.276 0 CA-C-N 120.729 1.604 . . . . 0.0 114.036 168.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.5 mt -63.66 -43.79 95.69 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 114.571 1.322 . . . . 0.0 114.571 167.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 81.8 t -59.82 -48.9 85.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 CA-C-O 117.967 -1.016 . . . . 0.0 112.45 170.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -57.6 -37.6 73.49 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 116.976 2.213 . . . . 0.0 116.976 169.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -60.19 -39.45 86.57 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 169.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 76.8 mtp85 -79.44 -12.41 59.89 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 117.805 2.52 . . . . 0.0 117.805 167.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.1 mp -91.65 -23.67 19.76 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 117.527 2.417 . . . . 0.0 117.527 176.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 30.3 p30 . . . . . 0 CA--C 1.578 2.054 0 N-CA-C 118.187 2.662 . . . . 0.0 118.187 168.418 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.502 0 CA-C-O 122.5 1.056 . . . . 0.0 113.337 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.514 ' HA ' ' CD1' ' A' ' 26' ' ' ILE 0.38 1.6 p90 171.75 139.21 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 113.605 -1.297 . . . . 0.0 111.357 163.11 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.9 mp -115.45 109.26 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 165.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.9 mt -100.36 108.99 21.15 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 168.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -103.61 129.29 50.85 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-N 120.111 1.323 . . . . 0.0 109.961 -173.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 67.49 47.17 64.21 Favored Glycine 0 CA--C 1.548 2.098 0 CA-C-O 116.609 -2.217 . . . . 0.0 116.191 -173.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -132.77 73.17 76.45 Favored Pre-proline 0 CA--C 1.568 1.67 0 CA-C-N 121.104 2.452 . . . . 0.0 115.297 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -97.94 -28.27 0.05 OUTLIER 'Trans proline' 0 CA--C 1.561 1.87 0 C-N-CA 122.817 2.344 . . . . 0.0 112.857 156.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 50.1 mtt85 41.64 24.28 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 118.324 2.713 . . . . 0.0 118.324 -163.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.468 ' HA ' ' HG3' ' A' ' 147' ' ' GLU . 27.6 t 103.99 153.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 127.164 2.185 . . . . 0.0 106.519 -170.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.551 HG13 ' HB2' ' A' ' 147' ' ' GLU 0.307 7.7 p -57.77 -27.34 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 119.647 -1.908 . . . . 0.0 112.366 169.23 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -70.0 -25.76 63.76 Favored 'General case' 0 CA--C 1.557 1.218 0 N-CA-C 119.471 3.138 . . . . 0.0 119.471 166.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.3 tm0? -74.28 -49.96 20.91 Favored 'General case' 0 CA--C 1.59 2.505 0 CA-C-N 124.592 3.36 . . . . 0.0 108.961 162.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -53.09 -25.44 12.9 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 117.845 2.535 . . . . 0.0 117.845 -176.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -59.14 -33.05 70.43 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 166.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.12 -41.29 74.14 Favored 'General case' 0 CA--C 1.571 1.784 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 169.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 28.9 tp -63.16 -36.48 83.77 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 168.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -56.3 -53.6 55.36 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 125.219 1.408 . . . . 0.0 112.719 167.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.789 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 11.0 mm-40 -49.92 -36.55 28.08 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 115.694 1.738 . . . . 0.0 115.694 166.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 1.16 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 24.9 ttt -83.45 -31.75 26.41 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 118.117 2.636 . . . . 0.0 118.117 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.512 ' HA ' ' HG1' ' A' ' 105' ' ' THR . 0.1 OUTLIER -74.52 -44.28 51.96 Favored 'General case' 0 N--CA 1.508 2.449 0 CA-C-N 121.741 2.064 . . . . 0.0 111.486 169.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -71.91 -57.6 4.17 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 119.496 1.044 . . . . 0.0 113.694 173.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.789 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 76.8 mtp180 -71.76 -36.55 70.43 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 178.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 1.16 ' HB3' ' O ' ' A' ' 99' ' ' MET . 57.4 ttt85 -61.16 -56.59 19.0 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 119.462 1.028 . . . . 0.0 111.736 165.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 111.7 49.87 0.62 Allowed Glycine 0 N--CA 1.481 1.672 0 O-C-N 124.231 0.957 . . . . 0.0 114.09 167.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.512 ' HG1' ' HA ' ' A' ' 100' ' ' LEU . 62.0 p -97.88 163.74 12.66 Favored 'General case' 0 CA--C 1.561 1.387 0 CA-C-N 114.015 -1.093 . . . . 0.0 111.075 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -84.63 134.57 34.38 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.158 -0.964 . . . . 0.0 109.128 177.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 8.9 tt -95.88 107.2 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 172.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -89.36 -60.44 1.95 Allowed 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 115.399 -2.239 . . . . 0.0 106.478 166.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -156.13 131.35 9.35 Favored 'General case' 0 C--N 1.369 1.419 0 CA-C-N 122.611 2.46 . . . . 0.0 116.463 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 39.2 t -88.66 107.86 18.21 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.629 0 N-CA-C 100.638 -3.838 . . . . 0.0 100.638 160.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.573 HD23 ' HB2' ' A' ' 160' ' ' LYS . 68.6 mt -104.27 108.83 20.42 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 118.318 -0.849 . . . . 0.0 109.616 -168.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -106.84 125.78 51.45 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.966 0.888 . . . . 0.0 109.857 -176.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -100.69 116.64 33.08 Favored 'General case' 0 CA--C 1.557 1.235 0 CA-C-O 122.568 1.175 . . . . 0.0 110.469 -169.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -79.64 97.81 6.68 Favored 'General case' 0 CA--C 1.556 1.191 0 CA-C-N 113.546 -1.661 . . . . 0.0 108.835 165.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.0 p . . . . . 0 CA--C 1.553 1.063 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 -169.265 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 . . . . . 0 N--CA 1.506 2.343 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -55.46 -39.11 69.95 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 166.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -67.6 -32.32 72.96 Favored 'General case' 0 CA--C 1.566 1.588 0 N-CA-C 114.97 1.471 . . . . 0.0 114.97 169.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -59.58 -54.18 49.44 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 120.561 1.528 . . . . 0.0 114.604 168.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . 0.253 7.3 p -63.67 -29.94 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 CA-C-O 117.085 -1.436 . . . . 0.0 114.054 170.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -56.65 -48.5 77.43 Favored 'General case' 0 CA--C 1.586 2.339 0 CA-C-N 121.441 1.928 . . . . 0.0 111.654 166.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.07 -21.2 11.74 Favored 'General case' 0 CA--C 1.564 1.493 0 N-CA-C 119.346 3.091 . . . . 0.0 119.346 170.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.31 -45.71 69.1 Favored 'General case' 0 N--CA 1.51 2.541 0 CA-C-N 121.339 1.882 . . . . 0.0 115.725 167.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.551 ' HB2' HG13 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -123.91 -18.57 5.95 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 120.742 3.608 . . . . 0.0 120.742 -167.31 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 53.7 m -43.72 -31.67 0.85 Allowed 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 117.899 2.555 . . . . 0.0 117.899 -169.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -71.48 -64.32 1.16 Allowed Pre-proline 0 CA--C 1.582 2.182 0 CA-C-O 116.123 -1.894 . . . . 0.0 112.21 172.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -56.53 -32.79 90.93 Favored 'Trans proline' 0 CA--C 1.579 2.772 0 CA-C-N 124.555 2.662 . . . . 0.0 118.905 168.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -63.2 -46.63 86.14 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 125.451 1.5 . . . . 0.0 112.711 171.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 1.065 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 54.2 tp -65.96 -21.91 66.45 Favored 'General case' 0 CA--C 1.57 1.719 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 169.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -70.62 -48.04 57.05 Favored 'General case' 0 CA--C 1.559 1.31 0 CA-C-N 122.362 2.346 . . . . 0.0 112.914 165.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -61.91 -54.31 43.72 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-N 120.271 1.396 . . . . 0.0 113.021 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -76.43 -27.52 56.28 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-O 115.739 -2.076 . . . . 0.0 113.438 178.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 1.065 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 26.0 ttt180 -62.34 -33.81 75.43 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 124.166 3.166 . . . . 0.0 116.754 169.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -70.57 -40.9 73.06 Favored 'General case' 0 CA--C 1.575 1.922 0 CA-C-N 119.708 1.14 . . . . 0.0 113.64 166.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -90.66 -19.69 23.34 Favored 'General case' 0 CA--C 1.575 1.932 0 N-CA-C 119.877 3.288 . . . . 0.0 119.877 -176.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.5 pp -78.06 172.16 13.93 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 119.887 3.291 . . . . 0.0 119.887 -160.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.573 ' HB2' HD23 ' A' ' 111' ' ' LEU . 90.5 mttt -132.65 123.98 27.41 Favored 'General case' 0 CA--C 1.563 1.45 0 N-CA-C 104.349 -2.463 . . . . 0.0 104.349 163.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.9 t -95.94 151.01 19.82 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 122.034 0.921 . . . . 0.0 111.99 -171.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.549 HG11 ' HG3' ' A' ' 174' ' ' ARG . 15.2 t -129.76 129.49 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 178.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -97.22 111.61 23.77 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 104.121 -2.548 . . . . 0.0 104.121 169.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -128.14 42.28 3.35 Favored 'General case' 0 N--CA 1.484 1.272 1 N-CA-C 123.571 4.656 . . . . 0.0 123.571 -156.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . 0.501 32.5 m . . . . . 0 CA--C 1.602 2.958 1 CA-C-O 109.702 -4.951 . . . . 0.0 106.98 169.031 . . . . . . . . 2 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 . . . . . 0 N--CA 1.504 2.261 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.576 ' HB3' ' NH2' ' A' ' 174' ' ' ARG . 50.3 mt-10 -59.14 -51.95 67.82 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 174.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 4.0 t -59.14 -36.25 61.78 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.925 0 CA-C-O 117.426 -1.273 . . . . 0.0 113.462 177.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.486 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 21.4 t80 -58.75 -40.64 84.46 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 121.082 1.764 . . . . 0.0 114.84 166.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -61.83 -54.44 42.17 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 178.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.576 ' NH2' ' HB3' ' A' ' 170' ' ' GLU . 11.4 ptp180 -69.08 -25.28 64.36 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 117.841 2.534 . . . . 0.0 117.841 172.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.56 -46.61 85.15 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 120.637 1.562 . . . . 0.0 113.862 168.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.3 mp -58.79 -43.91 90.58 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 167.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -53.47 -43.07 67.85 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 168.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.09 -44.96 90.73 Favored 'General case' 0 CA--C 1.56 1.364 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 172.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.81 -61.56 1.72 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 120.538 1.517 . . . . 0.0 110.897 172.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.886 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . 164.6 52.57 0.02 OUTLIER Glycine 0 CA--C 1.545 1.942 0 N-CA-C 118.795 2.278 . . . . 0.0 118.795 168.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.886 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 85.2 tttt . . . . . 0 C--O 1.252 1.187 0 CA-C-N 120.794 2.297 . . . . 0.0 110.565 168.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.2 mtt . . . . . 0 CA--C 1.556 1.206 0 CA-C-O 122.812 1.292 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . 0.309 11.6 mpt_? -120.57 171.44 8.56 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 121.231 3.789 . . . . 0.0 121.231 -163.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.6 p -150.16 144.58 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.297 0 CA-C-O 123.044 1.402 . . . . 0.0 111.633 166.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.2 pp -138.62 134.16 33.37 Favored 'General case' 0 CA--C 1.563 1.448 0 CA-C-N 113.676 -1.602 . . . . 0.0 109.714 169.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.5 121.36 44.81 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 115.675 1.731 . . . . 0.0 115.675 -161.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 85.7 mt -99.58 144.96 28.07 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 111.443 -2.617 . . . . 0.0 110.358 175.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 163.93 162.26 14.53 Favored Glycine 0 CA--C 1.557 2.681 0 CA-C-O 118.801 -0.999 . . . . 0.0 115.553 169.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo . . . . . 0 CA--C 1.578 2.711 0 C-N-CA 123.475 2.783 . . . . 0.0 111.838 175.597 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.6 mtmp? . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 121.807 0.813 . . . . 0.0 110.347 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -53.8 -28.35 38.81 Favored Glycine 0 CA--C 1.554 2.48 0 N-CA-C 120.421 2.928 . . . . 0.0 120.421 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.1 m -65.76 -53.0 46.4 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 119.328 1.564 . . . . 0.0 113.265 176.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.28 20.0 mp0 -76.64 -13.32 60.07 Favored 'General case' 0 CA--C 1.569 1.698 0 CA-C-O 114.895 -2.479 . . . . 0.0 112.43 169.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.38 -47.08 68.3 Favored 'General case' 0 C--N 1.376 1.729 0 CA-C-N 125.145 3.611 . . . . 0.0 113.703 166.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.1 p -66.8 -39.94 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 174.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -62.13 -43.99 97.61 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 116.305 1.965 . . . . 0.0 116.305 169.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.84 -32.36 73.84 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 119.996 1.271 . . . . 0.0 114.152 171.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.38 -42.3 95.56 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 115.292 1.589 . . . . 0.0 115.292 167.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -58.2 -39.53 79.22 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 167.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.3 mmmt -65.9 -54.88 20.81 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 174.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.3 mt -83.51 -19.8 35.07 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 116.775 2.139 . . . . 0.0 116.775 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.02 38.6 7.83 Favored Glycine 0 CA--C 1.554 2.512 0 N-CA-C 117.62 1.808 . . . . 0.0 117.62 -176.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.45 ' CG2' ' HA ' ' A' ' 81' ' ' PHE . 11.9 mm -107.51 158.52 33.04 Favored Pre-proline 0 CA--C 1.57 1.724 0 CA-C-N 118.565 1.182 . . . . 0.0 113.419 -168.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -82.82 99.77 0.93 Allowed 'Trans proline' 0 CA--C 1.571 2.338 0 C-N-CA 121.867 1.712 . . . . 0.0 111.372 163.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -64.04 112.24 2.88 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 123.831 0.852 . . . . 0.0 112.117 170.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 21.5 mm -99.83 108.48 22.79 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.1 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 59.8 p -97.79 128.64 44.56 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 168.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.9 p -69.02 -19.34 64.11 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 117.066 2.247 . . . . 0.0 117.066 -169.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -81.67 -19.88 64.96 Favored Glycine 0 CA--C 1.543 1.839 0 N-CA-C 119.102 2.401 . . . . 0.0 119.102 167.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -80.84 -51.4 8.65 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -169.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -65.13 -41.07 95.15 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 174.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.41 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 25.2 m-85 -66.4 -41.1 89.82 Favored 'General case' 0 CA--C 1.559 1.298 0 N-CA-C 115.702 1.741 . . . . 0.0 115.702 172.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.424 ' HD2' ' HA ' ' A' ' 36' ' ' ARG . 22.5 tpt180 -59.3 -42.72 91.99 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 120.544 1.52 . . . . 0.0 114.203 168.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -59.21 -39.21 81.98 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 168.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -69.62 -24.47 63.65 Favored 'General case' 0 CA--C 1.581 2.14 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 168.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.0 mt -63.17 -49.46 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 CA-C-N 120.675 1.579 . . . . 0.0 110.96 167.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -67.95 -33.52 74.83 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 114.301 1.222 . . . . 0.0 114.301 175.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -73.7 -35.86 65.2 Favored 'General case' 0 CA--C 1.564 1.498 0 N-CA-C 116.299 1.962 . . . . 0.0 116.299 173.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.77 73.76 1.28 Allowed Glycine 0 CA--C 1.542 1.76 0 CA-C-O 118.065 -1.409 . . . . 0.0 114.482 -176.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.554 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 64.7 p -90.8 -65.59 1.0 Allowed 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 119.262 1.531 . . . . 0.0 111.911 173.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.554 ' CB ' ' O ' ' A' ' 43' ' ' THR . 21.3 ptmt 130.27 -57.13 0.0 OUTLIER 'General case' 0 CA--C 1.569 1.702 0 C-N-CA 123.661 0.784 . . . . 0.0 109.581 -166.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -80.03 6.83 10.39 Favored 'General case' 0 CA--C 1.575 1.913 0 C-N-CA 124.249 1.019 . . . . 0.0 113.454 166.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.467 ' O ' ' HB3' ' A' ' 50' ' ' LYS . . . -86.79 -52.77 3.05 Favored Glycine 0 CA--C 1.535 1.333 0 O-C-N 121.21 -0.931 . . . . 0.0 112.892 165.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.312 7.4 p -80.14 -52.03 15.22 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.581 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -167.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -66.94 -44.37 80.8 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 121.013 1.733 . . . . 0.0 112.686 172.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.79 -30.8 69.46 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.467 ' HB3' ' O ' ' A' ' 46' ' ' GLY . 2.4 tptm -71.97 -36.87 69.95 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 167.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.579 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 46.5 ttt180 -70.78 -58.71 3.35 Favored 'General case' 0 CA--C 1.591 2.534 1 CA-C-O 87.3 -15.619 . . . . 0.0 117.829 -178.531 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . 0.253 10.9 m-30 -26.47 -68.81 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.587 1 O-C-N 110.452 -7.655 . . . . 0.0 119.644 146.512 . . . . . . . . 3 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 26.6 tp -57.3 -32.07 66.29 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 116.517 2.043 . . . . 0.0 116.517 175.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -88.78 -47.25 8.35 Favored 'General case' 0 CA--C 1.559 1.311 0 CA-C-O 116.831 -1.557 . . . . 0.0 114.395 170.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -158.24 46.33 0.34 Allowed 'General case' 0 CA--C 1.573 1.837 0 CA-C-N 121.401 1.909 . . . . 0.0 113.32 -168.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -161.21 60.89 0.29 Allowed Glycine 0 C--N 1.358 1.785 0 CA-C-N 121.906 2.139 . . . . 0.0 111.727 169.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . 0.279 4.8 t70 75.56 -115.05 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 124.301 1.041 . . . . 0.0 110.423 168.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.555 ' HA ' HH22 ' A' ' 88' ' ' ARG . 74.7 mt -133.47 128.79 36.17 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 119.507 1.049 . . . . 0.0 110.628 -174.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.0 p -89.27 141.03 28.79 Favored Pre-proline 0 CA--C 1.578 2.031 0 CA-C-O 117.429 -1.272 . . . . 0.0 108.095 167.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -50.66 143.81 27.7 Favored 'Trans proline' 0 CA--C 1.565 2.03 0 C-N-CA 123.451 2.767 . . . . 0.0 116.696 169.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 59.6 m -65.71 -42.75 90.74 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 117.064 2.246 . . . . 0.0 117.064 -169.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -59.5 -37.71 79.01 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 116.832 2.16 . . . . 0.0 116.832 -175.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 35.5 mt -54.87 -51.82 64.75 Favored 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 169.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.7 m -64.99 -50.77 65.01 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 112.889 -1.96 . . . . 0.0 113.064 -178.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.83 -20.01 64.64 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 167.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -72.48 -46.87 52.79 Favored 'General case' 0 CA--C 1.556 1.185 0 CA-C-N 120.441 1.473 . . . . 0.0 114.588 170.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.1 mt -61.22 -46.0 92.26 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 169.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 97.3 t -61.77 -48.78 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 118.025 -0.988 . . . . 0.0 112.017 175.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -63.03 -35.78 81.36 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 115.993 1.849 . . . . 0.0 115.993 172.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -57.55 -42.83 83.73 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 117.695 -1.145 . . . . 0.0 113.779 170.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 83.2 mtt180 -80.26 -15.55 56.72 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 118.497 2.777 . . . . 0.0 118.497 168.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.6 mt -83.69 -14.69 51.14 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 116.527 2.047 . . . . 0.0 116.527 169.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 . . . . . 0 N--CA 1.5 2.03 0 N-CA-C 117.17 2.285 . . . . 0.0 117.17 169.917 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.451 0 CA-C-O 123.495 1.608 . . . . 0.0 115.266 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.45 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . 8.9 p90 -173.44 131.87 0.46 Allowed 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 169.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 4.7 mm -104.65 108.21 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.504 0 N-CA-C 103.412 -2.81 . . . . 0.0 103.412 170.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 79.8 mt -100.09 138.82 36.63 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 171.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -127.9 127.96 44.31 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 119.575 1.08 . . . . 0.0 111.859 172.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 67.63 34.02 82.57 Favored Glycine 0 CA--C 1.552 2.373 0 N-CA-C 118.008 1.963 . . . . 0.0 118.008 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -94.34 -54.27 0.23 Allowed Pre-proline 0 N--CA 1.496 1.826 0 CA-C-O 114.956 -2.45 . . . . 0.0 108.968 173.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.3 68.63 1.42 Allowed 'Trans proline' 0 CA--C 1.565 2.071 0 CA-C-N 124.75 2.732 . . . . 0.0 118.82 167.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.555 HH22 ' HA ' ' A' ' 58' ' ' LEU . 26.8 ptt180 -66.61 -35.57 80.5 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 116.056 1.873 . . . . 0.0 116.056 166.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 37.7 t -149.18 141.17 23.81 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -168.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . 0.274 8.4 p -61.7 -27.24 41.77 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.653 0 CA-C-O 115.941 -1.981 . . . . 0.0 113.322 178.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -38.22 88.26 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 120.155 3.391 . . . . 0.0 120.155 166.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -75.68 -47.91 24.26 Favored 'General case' 0 CA--C 1.586 2.34 0 CA-C-N 123.356 2.798 . . . . 0.0 112.299 166.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.5 -31.0 70.07 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 -175.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -57.31 -29.72 64.15 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 168.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.18 -40.54 86.58 Favored 'General case' 0 CA--C 1.571 1.758 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 167.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . 0.479 ' HA ' ' HG3' ' A' ' 99' ' ' MET . 40.1 tp -62.61 -38.3 89.66 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 169.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 55.8 t60 -64.89 -44.51 89.37 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 120.413 1.46 . . . . 0.0 113.313 168.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.863 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 32.0 mt-10 -51.58 -40.52 59.96 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 167.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 1.296 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -84.63 -19.95 32.14 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 117.934 2.568 . . . . 0.0 117.934 175.184 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 60.2 tp -72.45 -52.71 14.7 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 121.175 1.807 . . . . 0.0 111.47 170.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -74.85 -55.9 5.32 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 171.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.863 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 36.9 ttm180 -68.99 -39.22 79.51 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 178.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 1.296 ' HB3' ' O ' ' A' ' 99' ' ' MET . 66.1 ttt180 -62.37 -58.38 7.87 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 119.639 1.108 . . . . 0.0 110.365 164.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 111.47 46.66 0.78 Allowed Glycine 0 N--CA 1.479 1.529 0 O-C-N 124.366 1.041 . . . . 0.0 113.651 168.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 37.2 p -101.26 147.21 26.55 Favored 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 173.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -68.22 130.06 41.79 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.346 -0.846 . . . . 0.0 112.572 -170.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 4.4 tp -85.48 98.53 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 175.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -97.51 -67.77 0.83 Allowed 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 115.765 -2.064 . . . . 0.0 108.388 168.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -149.34 120.84 7.95 Favored 'General case' 0 C--N 1.367 1.367 0 CA-C-N 121.999 2.181 . . . . 0.0 115.114 -170.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 19.4 t -94.09 109.77 22.54 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.691 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 163.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.748 HD23 ' HB2' ' A' ' 160' ' ' LYS . 80.1 mt -105.07 117.97 35.35 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 123.423 0.689 . . . . 0.0 112.082 -172.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -88.68 136.19 33.12 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.398 0.618 . . . . 0.0 112.086 169.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -101.53 112.33 24.85 Favored 'General case' 0 CA--C 1.558 1.28 0 CA-C-O 122.998 1.38 . . . . 0.0 108.118 176.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.484 ' HB3' ' HA ' ' A' ' 163' ' ' ASP . 17.0 tpt180 -83.79 101.87 11.92 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 112.889 -1.959 . . . . 0.0 109.157 171.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.5 p . . . . . 0 CA--C 1.556 1.185 0 CA-C-N 113.128 -1.851 . . . . 0.0 106.717 -169.349 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.9 t30 . . . . . 0 N--CA 1.497 1.904 0 N-CA-C 114.692 1.368 . . . . 0.0 114.692 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 63.4 mtp180 -63.36 -32.61 74.08 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 116.363 1.986 . . . . 0.0 116.363 170.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 48.3 mtt -72.42 -33.0 66.8 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 168.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -61.84 -51.48 68.04 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 169.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.3 p -64.26 -34.22 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 CA-C-O 117.466 -1.254 . . . . 0.0 114.128 171.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -53.2 -48.08 68.38 Favored 'General case' 0 CA--C 1.591 2.55 0 CA-C-N 120.404 1.456 . . . . 0.0 112.349 167.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 63.1 ttt180 -57.42 -37.83 73.39 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 119.115 3.005 . . . . 0.0 119.115 174.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -52.91 -34.16 53.75 Favored 'General case' 0 N--CA 1.512 2.673 0 N-CA-C 117.205 2.298 . . . . 0.0 117.205 170.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -110.83 -28.43 8.4 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 120.298 3.444 . . . . 0.0 120.298 -165.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 56.8 m -63.5 -30.67 71.75 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 117.093 2.257 . . . . 0.0 117.093 -166.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.58 -61.55 4.33 Favored Pre-proline 0 CA--C 1.58 2.118 0 CA-C-O 116.583 -1.675 . . . . 0.0 112.616 168.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -65.29 -33.11 49.64 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 123.161 2.574 . . . . 0.0 117.471 176.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.2 tt -63.07 -55.06 28.7 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 117.344 -1.312 . . . . 0.0 110.542 168.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.979 ' O ' ' HB2' ' A' ' 156' ' ' ARG 0.335 0.1 OUTLIER -57.21 -27.12 61.71 Favored 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 177.931 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -73.5 -41.97 62.41 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 116.126 -1.892 . . . . 0.0 113.115 165.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -66.88 -55.82 13.01 Favored 'General case' 0 CA--C 1.564 1.494 0 CA-C-N 122.719 2.509 . . . . 0.0 112.583 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -80.46 -30.74 37.47 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-O 115.174 -2.346 . . . . 0.0 112.017 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.979 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 37.6 ttt180 -63.02 -32.63 74.03 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 124.418 3.281 . . . . 0.0 116.177 171.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -68.42 -41.12 80.86 Favored 'General case' 0 CA--C 1.574 1.888 0 CA-C-N 119.236 0.926 . . . . 0.0 113.182 165.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -90.81 -21.03 21.69 Favored 'General case' 0 CA--C 1.578 2.047 0 N-CA-C 120.331 3.456 . . . . 0.0 120.331 -176.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.7 pp -80.82 -178.37 6.79 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 119.053 2.983 . . . . 0.0 119.053 -163.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.748 ' HB2' HD23 ' A' ' 111' ' ' LEU . 90.5 mttt -130.89 141.52 50.31 Favored 'General case' 0 CA--C 1.564 1.491 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 166.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 34.0 m -100.01 145.49 27.82 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 122.408 1.099 . . . . 0.0 110.672 -171.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 38.4 t -133.04 132.39 58.87 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.487 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 169.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.484 ' HA ' ' HB3' ' A' ' 114' ' ' ARG . 20.4 t70 -96.14 138.47 33.7 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 167.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . 0.253 . . -125.61 -132.35 0.25 Allowed 'General case' 0 N--CA 1.483 1.212 0 O-C-N 121.64 -0.663 . . . . 0.0 111.433 -165.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 31.3 t . . . . . 0 N--CA 1.497 1.886 0 C-N-CA 127.173 2.189 . . . . 0.0 112.674 167.275 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 . . . . . 0 N--CA 1.498 1.971 0 N-CA-C 116.142 1.904 . . . . 0.0 116.142 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.748 ' HB3' ' NH2' ' A' ' 174' ' ' ARG . 48.1 mt-10 -61.32 -52.45 64.65 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 118.023 -0.989 . . . . 0.0 113.507 169.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 99.5 t -57.51 -37.9 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 175.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -62.04 -33.9 75.24 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 116.424 2.009 . . . . 0.0 116.424 168.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.78 -53.23 43.11 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 174.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.748 ' NH2' ' HB3' ' A' ' 170' ' ' GLU . 10.5 ptp180 -65.66 -29.64 70.23 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 117.586 2.439 . . . . 0.0 117.586 170.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.71 -45.83 92.28 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 119.856 1.207 . . . . 0.0 114.172 167.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.92 -44.7 91.35 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-O 117.013 -1.47 . . . . 0.0 114.698 168.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 26.5 mmm180 -55.79 -43.1 76.49 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 170.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.74 -39.5 94.29 Favored 'General case' 0 CA--C 1.563 1.444 0 N-CA-C 116.477 2.028 . . . . 0.0 116.477 172.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 5.8 tt -75.0 -51.68 13.0 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 120.968 1.713 . . . . 0.0 112.077 170.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -149.5 -57.48 0.01 OUTLIER Glycine 0 CA--C 1.552 2.377 0 CA-C-O 117.486 -1.73 . . . . 0.0 115.801 -176.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt . . . . . 0 C--O 1.252 1.205 0 CA-C-N 120.774 2.287 . . . . 0.0 108.655 -172.777 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.9 ttm . . . . . 0 CA--C 1.56 1.334 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.47 166.77 32.1 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 118.414 2.746 . . . . 0.0 118.414 -166.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.4 p -126.71 146.07 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-O 122.923 1.344 . . . . 0.0 114.193 -166.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -119.89 113.34 20.43 Favored 'General case' 0 CA--C 1.559 1.307 0 N-CA-C 104.867 -2.271 . . . . 0.0 104.867 168.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.2 tt -101.73 131.24 48.12 Favored 'General case' 0 CA--C 1.562 1.408 0 C-N-CA 125.788 1.635 . . . . 0.0 111.348 -165.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.8 mt -135.48 165.8 24.66 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 125.378 1.471 . . . . 0.0 113.825 -167.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.43 124.7 0.94 Allowed Glycine 0 CA--C 1.557 2.665 0 CA-C-O 117.362 -1.799 . . . . 0.0 111.274 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo . . . . . 0 CA--C 1.579 2.745 0 CA-C-N 122.522 3.161 . . . . 0.0 114.101 176.939 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt . . . . . 0 N--CA 1.487 1.383 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -42.61 -42.15 4.55 Favored Glycine 0 CA--C 1.551 2.332 0 N-CA-C 121.207 3.243 . . . . 0.0 121.207 -175.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.1 m -61.97 -57.32 12.14 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 118.992 1.396 . . . . 0.0 113.835 178.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.259 3.7 mm-40 -76.49 -14.22 60.05 Favored 'General case' 0 CA--C 1.573 1.859 0 CA-C-O 116.175 -1.869 . . . . 0.0 111.528 175.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.63 -47.38 60.38 Favored 'General case' 0 C--N 1.373 1.608 0 CA-C-N 123.219 2.736 . . . . 0.0 114.476 168.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.2 p -66.12 -40.76 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 172.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -58.94 -44.22 91.36 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 116.321 1.971 . . . . 0.0 116.321 169.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.91 -35.46 80.69 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 172.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.21 -42.1 90.16 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 167.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -59.82 -36.23 76.35 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 167.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -64.87 -59.44 4.2 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 170.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.1 mt -80.28 -20.92 43.3 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 116.422 2.008 . . . . 0.0 116.422 -176.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.95 34.19 8.46 Favored Glycine 0 CA--C 1.554 2.501 0 N-CA-C 117.681 1.833 . . . . 0.0 117.681 -177.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.431 ' CG2' ' HA ' ' A' ' 81' ' ' PHE . 16.3 mm -104.64 156.07 36.47 Favored Pre-proline 0 CA--C 1.568 1.649 0 CA-C-N 118.987 1.394 . . . . 0.0 112.561 -169.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -80.72 100.69 1.24 Allowed 'Trans proline' 0 CA--C 1.569 2.257 0 C-N-CA 121.816 1.677 . . . . 0.0 110.099 162.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -58.81 109.11 0.75 Allowed 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 124.347 1.059 . . . . 0.0 112.002 170.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 35.7 mm -98.0 107.64 20.55 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 68.9 p -95.46 126.99 41.14 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 167.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.4 p -65.73 -22.1 66.58 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 -169.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.644 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -83.56 -13.02 76.92 Favored Glycine 0 CA--C 1.544 1.871 0 N-CA-C 119.168 2.427 . . . . 0.0 119.168 168.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -81.8 -51.21 8.37 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 119.197 1.498 . . . . 0.0 114.648 -171.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -66.2 -42.17 89.18 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 173.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.502 ' HB3' ' CB ' ' A' ' 50' ' ' LYS . 32.9 m-85 -59.56 -43.93 93.41 Favored 'General case' 0 CA--C 1.569 1.674 0 C-N-CA 125.403 1.481 . . . . 0.0 114.477 168.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.644 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 72.2 ttt180 -54.94 -42.56 72.45 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 168.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.3 ttt180 -60.36 -36.58 78.37 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 168.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -69.29 -26.54 64.79 Favored 'General case' 0 CA--C 1.581 2.168 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 167.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 58.7 mt -60.67 -52.18 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.376 0 CA-C-N 120.933 1.697 . . . . 0.0 110.235 167.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -65.4 -35.48 81.06 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -70.3 -38.44 75.0 Favored 'General case' 0 CA--C 1.562 1.426 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 174.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.35 68.84 1.24 Allowed Glycine 0 CA--C 1.543 1.842 0 CA-C-O 118.905 -0.941 . . . . 0.0 114.623 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.751 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 74.5 p -92.63 -47.25 7.2 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 177.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.751 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.254 75.5 mttt 104.84 -40.04 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.725 0 CA-C-O 116.227 -1.844 . . . . 0.0 111.694 -172.737 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -83.8 -12.41 55.69 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 123.09 2.677 . . . . 0.0 112.586 163.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.33 -56.23 26.29 Favored Glycine 0 CA--C 1.547 2.047 0 CA-C-N 120.905 1.684 . . . . 0.0 114.167 168.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.25 1.0 OUTLIER -74.33 -49.85 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 116.898 2.184 . . . . 0.0 116.898 -169.467 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -67.9 -38.59 83.19 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 119.907 1.23 . . . . 0.0 112.74 174.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.26 -35.85 66.29 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 117.969 -1.015 . . . . 0.0 113.594 -175.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.502 ' CB ' ' HB3' ' A' ' 35' ' ' PHE 0.33 1.7 tptt -81.14 -24.14 37.81 Favored 'General case' 0 CA--C 1.564 1.487 0 CA-C-O 116.961 -1.495 . . . . 0.0 113.36 173.022 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.587 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 40.6 ttt180 -75.56 -56.99 4.16 Favored 'General case' 0 CA--C 1.591 2.553 1 CA-C-O 86.613 -15.946 . . . . 0.0 117.686 176.815 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . 0.254 15.7 m-30 -27.38 -64.46 0.08 Allowed 'General case' 0 N--CA 1.499 1.979 1 O-C-N 108.837 -8.664 . . . . 0.0 120.192 146.491 . . . . . . . . 3 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.2 tp -53.89 -39.56 65.84 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 116.998 2.222 . . . . 0.0 116.998 172.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -90.18 -41.1 11.8 Favored 'General case' 0 CA--C 1.566 1.559 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 173.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -153.03 41.63 0.58 Allowed 'General case' 0 CA--C 1.571 1.757 0 CA-C-N 120.86 1.664 . . . . 0.0 114.887 -169.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -165.78 59.26 0.24 Allowed Glycine 0 C--N 1.354 1.559 0 O-C-N 119.419 -2.051 . . . . 0.0 111.779 168.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . 0.273 5.0 t70 71.51 -117.7 0.08 Allowed 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 124.018 0.927 . . . . 0.0 109.555 169.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.1 pp -124.93 143.65 50.76 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 123.637 0.775 . . . . 0.0 112.06 -176.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.1 p -96.93 130.92 28.86 Favored Pre-proline 0 CA--C 1.573 1.832 0 CA-C-O 117.676 -1.154 . . . . 0.0 107.924 167.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -49.34 134.89 31.91 Favored 'Trans proline' 0 CA--C 1.56 1.821 0 C-N-CA 123.537 2.825 . . . . 0.0 116.042 172.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.8 m -68.82 175.65 3.5 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -169.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.3 t70 86.09 -44.43 0.05 Allowed 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 126.339 1.856 . . . . 0.0 113.999 -176.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.8 mt -60.44 -47.37 86.39 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 168.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.8 m -57.6 -50.26 73.72 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 113.544 -1.662 . . . . 0.0 113.449 177.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -69.76 -21.25 63.45 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 168.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -65.59 -43.61 89.16 Favored 'General case' 0 CA--C 1.559 1.316 0 CA-C-N 120.557 1.526 . . . . 0.0 114.957 168.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 44.2 mt -65.56 -46.31 79.95 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 167.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -56.71 -50.99 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 172.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -65.09 -34.22 77.9 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 175.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -58.1 -43.34 87.06 Favored 'General case' 0 CA--C 1.559 1.31 0 CA-C-O 117.793 -1.098 . . . . 0.0 113.497 168.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -81.76 -9.82 59.52 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 119.256 3.058 . . . . 0.0 119.256 169.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 13.1 tp -87.66 -14.68 39.28 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 169.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 . . . . . 0 CA--C 1.583 2.218 0 N-CA-C 118.441 2.756 . . . . 0.0 118.441 168.491 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.784 0 N-CA-C 117.883 1.913 . . . . 0.0 117.883 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.431 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . 15.1 p90 -170.46 132.63 0.99 Allowed 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 114.189 -1.005 . . . . 0.0 108.88 -175.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.1 mm -102.43 105.48 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.577 0 N-CA-C 102.745 -3.057 . . . . 0.0 102.745 166.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -110.5 122.76 48.51 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -176.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.25 119.67 32.94 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 119.048 0.84 . . . . 0.0 110.467 -165.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.39 43.68 68.67 Favored Glycine 0 CA--C 1.548 2.094 0 CA-C-O 116.098 -2.501 . . . . 0.0 116.345 -174.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . 0.257 2.9 t80 -95.97 -57.32 0.2 Allowed Pre-proline 0 N--CA 1.504 2.234 0 CA-C-N 121.737 2.768 . . . . 0.0 108.276 176.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -60.59 59.67 0.09 OUTLIER 'Trans proline' 0 CA--C 1.577 2.654 0 N-CA-C 121.547 3.633 . . . . 0.0 121.547 168.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.528 HH11 ' HB2' ' A' ' 89' ' ' SER . 7.0 tmm_? -69.55 -28.43 66.0 Favored 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 166.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.528 ' HB2' HH11 ' A' ' 88' ' ' ARG . 30.3 t -151.68 155.51 38.48 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 120.279 1.399 . . . . 0.0 107.913 -176.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.5 t -61.87 -37.0 77.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-O 116.981 -1.485 . . . . 0.0 111.793 173.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.34 -40.41 77.94 Favored 'General case' 0 CA--C 1.558 1.268 0 N-CA-C 119.882 3.29 . . . . 0.0 119.882 169.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 22.3 mm100 -71.41 -48.21 51.17 Favored 'General case' 0 CA--C 1.589 2.471 0 CA-C-N 122.279 2.308 . . . . 0.0 113.322 168.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.78 -29.49 66.82 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 126.894 2.078 . . . . 0.0 116.05 -168.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 57.6 tttt -63.68 -31.57 72.78 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 166.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.97 -39.08 69.58 Favored 'General case' 0 CA--C 1.569 1.688 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 169.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 16.8 tp -63.01 -40.88 99.09 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 168.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -58.5 -52.49 65.43 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 119.431 1.014 . . . . 0.0 113.463 169.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.946 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 21.5 mm-40 -48.63 -41.79 32.19 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 115.956 1.836 . . . . 0.0 115.956 168.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 1.189 ' O ' ' HB2' ' A' ' 103' ' ' ARG . 55.1 mtt -84.12 -20.73 32.03 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 117.956 2.576 . . . . 0.0 117.956 175.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.485 ' HA ' ' HG1' ' A' ' 105' ' ' THR . 2.1 tt -75.73 -48.93 19.8 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-N 121.301 1.864 . . . . 0.0 110.866 172.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -72.45 -56.28 5.67 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 119.57 1.077 . . . . 0.0 113.199 169.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.946 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 70.6 ttt180 -64.15 -44.63 91.54 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 116.353 1.983 . . . . 0.0 116.353 177.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 1.189 ' HB2' ' O ' ' A' ' 99' ' ' MET . 15.3 mtp-105 -65.13 -53.92 37.84 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 118.992 0.814 . . . . 0.0 111.196 165.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 111.02 48.62 0.71 Allowed Glycine 0 N--CA 1.483 1.831 0 C-N-CA 120.808 -0.71 . . . . 0.0 114.752 166.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.485 ' HG1' ' HA ' ' A' ' 100' ' ' LEU . 71.7 p -89.91 158.14 17.55 Favored 'General case' 0 CA--C 1.563 1.479 0 CA-C-N 113.22 -1.49 . . . . 0.0 110.307 169.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -72.55 138.69 47.07 Favored 'General case' 0 N--CA 1.507 2.381 0 CA-C-O 122.37 1.081 . . . . 0.0 111.38 172.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.6 tp -98.99 102.72 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -95.12 -70.32 0.72 Allowed 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 116.738 -1.601 . . . . 0.0 108.032 166.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.91 124.23 7.61 Favored 'General case' 0 C--N 1.36 1.05 0 CA-C-N 120.938 1.699 . . . . 0.0 113.818 -169.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 24.0 t -92.29 108.92 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.638 1 N-CA-C 99.97 -4.085 . . . . 0.0 99.97 162.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.255 52.2 tp -118.94 114.48 22.63 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.937 0.895 . . . . 0.0 112.607 -159.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -103.17 127.81 50.34 Favored 'General case' 0 CA--C 1.563 1.454 0 CA-C-O 121.448 0.642 . . . . 0.0 112.34 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -95.79 113.9 25.58 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.902 1.281 . . . . 0.0 109.796 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -86.33 96.06 9.85 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.214 170.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 56.1 t . . . . . 0 CA--C 1.566 1.565 0 C-N-CA 127.891 2.476 . . . . 0.0 106.016 -171.734 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 . . . . . 0 N--CA 1.496 1.829 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 47.8 mmm-85 -60.65 -43.94 97.01 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 169.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 37.0 mtt -64.26 -32.99 74.8 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 115.833 1.79 . . . . 0.0 115.833 169.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -64.44 -48.65 74.51 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 170.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.8 -31.26 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 172.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -57.8 -52.38 65.72 Favored 'General case' 0 CA--C 1.581 2.164 0 CA-C-N 119.492 1.042 . . . . 0.0 111.452 166.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -52.83 -25.38 11.3 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 120.2 3.408 . . . . 0.0 120.2 169.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.89 -55.48 19.89 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 170.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -145.43 13.84 1.4 Allowed 'General case' 0 CA--C 1.563 1.467 0 N-CA-C 119.497 3.147 . . . . 0.0 119.497 -169.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 17.7 m -51.9 -29.19 18.96 Favored 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -70.81 -61.33 2.49 Favored Pre-proline 0 CA--C 1.58 2.102 0 CA-C-O 116.148 -1.882 . . . . 0.0 112.142 171.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -55.34 -27.8 59.64 Favored 'Trans proline' 0 CA--C 1.574 2.485 0 N-CA-C 119.492 2.843 . . . . 0.0 119.492 169.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -66.88 -53.01 36.54 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 125.156 1.383 . . . . 0.0 110.988 172.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.968 ' O ' ' HB2' ' A' ' 156' ' ' ARG 0.316 0.0 OUTLIER -61.32 -25.01 66.84 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 174.384 . . . . . . . . 4 4 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -71.3 -51.65 23.19 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 120.601 1.546 . . . . 0.0 113.667 166.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -62.66 -55.23 28.84 Favored 'General case' 0 CA--C 1.565 1.527 0 CA-C-N 120.045 1.293 . . . . 0.0 112.221 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -81.52 -25.94 35.53 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 115.153 -2.356 . . . . 0.0 113.399 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.968 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 43.9 ttt180 -67.3 -34.27 77.03 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 124.438 3.29 . . . . 0.0 115.919 170.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -69.5 -37.99 77.43 Favored 'General case' 0 CA--C 1.572 1.827 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 166.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -90.15 -24.37 21.08 Favored 'General case' 0 CA--C 1.575 1.926 0 N-CA-C 118.876 2.917 . . . . 0.0 118.876 -177.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.1 pp -76.06 178.75 6.09 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 117.478 2.399 . . . . 0.0 117.478 -165.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -128.91 129.31 45.33 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 169.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 27.1 m -100.38 149.95 23.11 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 122.079 0.943 . . . . 0.0 111.006 -171.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 4.1 t -128.14 134.74 64.42 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.663 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 167.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -110.86 121.43 45.32 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 104.435 -2.432 . . . . 0.0 104.435 166.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . 0.289 . . -165.58 162.03 18.8 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.095 0.958 . . . . 0.0 111.106 -161.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 4.5 t . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 160.574 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 7.4 t70 . . . . . 0 N--CA 1.508 2.451 0 CA-C-O 121.127 0.489 . . . . 0.0 111.869 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -55.15 -39.04 69.03 Favored 'General case' 0 CA--C 1.559 1.295 0 CA-C-O 116.651 -1.642 . . . . 0.0 113.429 165.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 89.5 t -56.34 -39.26 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 CA-C-N 121.363 1.892 . . . . 0.0 114.309 171.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -57.77 -39.03 76.5 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-N 120.472 1.487 . . . . 0.0 114.86 166.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -60.53 -46.85 88.66 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 115.481 1.659 . . . . 0.0 115.481 173.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 12.2 mtt-85 -61.48 -43.14 99.4 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 169.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.11 -40.37 70.39 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 169.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 8.4 mp -64.18 -49.12 73.28 Favored 'General case' 0 CA--C 1.565 1.533 0 CA-C-O 118.413 -0.804 . . . . 0.0 112.608 168.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 36.4 mtt180 -51.24 -40.81 59.65 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 117.581 2.437 . . . . 0.0 117.581 171.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.11 -51.53 66.19 Favored 'General case' 0 CA--C 1.561 1.4 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 169.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -99.65 -60.46 1.53 Allowed 'General case' 0 CA--C 1.565 1.538 0 CA-C-O 117.993 -1.003 . . . . 0.0 113.469 -169.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.822 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -102.82 -50.52 1.08 Allowed Glycine 0 CA--C 1.551 2.34 0 CA-C-N 120.537 1.517 . . . . 0.0 116.885 -169.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.822 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 87.0 tttt . . . . . 0 C--O 1.252 1.201 0 CA-C-N 119.489 1.645 . . . . 0.0 108.356 -174.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.0 mtt . . . . . 0 N--CA 1.482 1.125 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.613 ' HE ' ' HA2' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -149.01 174.9 11.79 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 116.685 2.105 . . . . 0.0 116.685 -168.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 93.5 t -133.75 147.22 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-O 122.992 1.377 . . . . 0.0 113.319 -164.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -121.63 117.57 27.03 Favored 'General case' 0 CA--C 1.56 1.347 0 CA-C-N 113.491 -1.686 . . . . 0.0 107.284 169.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 17.5 tp -99.87 125.13 45.79 Favored 'General case' 0 CA--C 1.575 1.908 0 CA-C-O 123.706 1.717 . . . . 0.0 109.389 -170.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.1 mt -122.23 161.01 24.03 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 110.021 -3.263 . . . . 0.0 112.481 -165.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 148.39 -179.68 25.05 Favored Glycine 0 CA--C 1.559 2.809 0 CA-C-N 115.258 -0.883 . . . . 0.0 114.821 170.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo . . . . . 0 CA--C 1.574 2.508 0 C-N-CA 123.355 2.703 . . . . 0.0 113.765 176.22 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.421 ' HB2' ' OD2' ' A' ' 84' ' ' ASP . 0.3 OUTLIER . . . . . 0 N--CA 1.501 2.085 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -49.48 -27.22 8.09 Favored Glycine 0 CA--C 1.553 2.465 0 N-CA-C 121.201 3.241 . . . . 0.0 121.201 177.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 52.0 m -66.99 -52.75 38.81 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 120.237 2.018 . . . . 0.0 112.598 173.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.291 0.6 OUTLIER -76.19 -13.88 60.17 Favored 'General case' 0 CA--C 1.568 1.667 0 CA-C-O 115.893 -2.003 . . . . 0.0 113.855 170.509 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.31 -47.17 36.37 Favored 'General case' 0 C--N 1.371 1.513 0 CA-C-N 123.421 2.828 . . . . 0.0 113.433 167.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.2 t -65.37 -36.74 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-N 120.06 1.3 . . . . 0.0 113.848 172.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -66.44 -45.78 78.67 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 171.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.0 tp -65.49 -30.65 71.45 Favored 'General case' 0 CA--C 1.574 1.902 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 170.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.22 -39.75 94.63 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 168.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -59.93 -37.7 80.25 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 166.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.3 tptt -64.3 -56.89 11.43 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 170.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 77.3 mt -83.23 -25.02 32.08 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 117.341 2.348 . . . . 0.0 117.341 -174.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.74 39.73 7.0 Favored Glycine 0 CA--C 1.556 2.612 0 N-CA-C 117.578 1.791 . . . . 0.0 117.578 -173.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 15.2 mm -104.56 154.69 38.27 Favored Pre-proline 0 CA--C 1.567 1.606 0 CA-C-O 117.567 -1.206 . . . . 0.0 113.11 -169.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -81.83 98.6 0.98 Allowed 'Trans proline' 0 CA--C 1.569 2.232 0 CA-C-N 122.219 1.828 . . . . 0.0 109.801 162.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -73.91 110.42 8.19 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.305 0.574 . . . . 0.0 110.189 176.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.0 mm -100.35 108.97 24.0 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 N-CA-C 105.515 -2.032 . . . . 0.0 105.515 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 72.7 p -96.98 127.74 43.25 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 171.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.0 p -67.29 -18.36 65.16 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 117.356 2.354 . . . . 0.0 117.356 -172.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -81.06 -20.24 65.49 Favored Glycine 0 CA--C 1.539 1.56 0 N-CA-C 119.242 2.457 . . . . 0.0 119.242 168.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -81.0 -51.47 8.48 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -169.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -64.3 -41.7 96.73 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 174.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.41 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 21.5 m-85 -68.92 -39.69 79.51 Favored 'General case' 0 CA--C 1.561 1.375 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 174.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.42 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 46.4 ttp180 -58.68 -41.71 86.81 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 120.473 1.488 . . . . 0.0 114.322 167.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -60.54 -38.71 85.36 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 168.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -67.55 -29.32 68.68 Favored 'General case' 0 CA--C 1.572 1.824 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 168.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 79.0 mt -62.7 -45.54 98.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 CA-C-N 120.111 1.323 . . . . 0.0 111.921 168.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -66.71 -38.96 87.77 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 120.25 1.387 . . . . 0.0 114.438 172.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -78.47 -27.85 46.38 Favored 'General case' 0 CA--C 1.562 1.413 0 N-CA-C 117.065 2.246 . . . . 0.0 117.065 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.11 72.99 1.23 Allowed Glycine 0 CA--C 1.545 1.935 0 CA-C-O 118.223 -1.321 . . . . 0.0 115.878 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.795 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 81.4 p -91.29 -45.92 8.34 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 172.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.795 ' HB2' ' O ' ' A' ' 43' ' ' THR . 75.6 mttt 104.56 -40.36 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.753 0 CA-C-O 116.493 -1.718 . . . . 0.0 111.633 -171.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -83.91 -10.32 58.06 Favored 'General case' 0 CA--C 1.574 1.894 0 CA-C-N 122.762 2.528 . . . . 0.0 113.222 163.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.21 -54.48 23.69 Favored Glycine 0 C--N 1.355 1.588 0 CA-C-N 120.385 1.448 . . . . 0.0 115.531 169.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.286 7.7 p -76.94 -47.5 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.514 0 N-CA-C 116.077 1.88 . . . . 0.0 116.077 -168.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -64.24 -48.31 76.29 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 121.111 1.778 . . . . 0.0 112.692 172.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.59 -28.04 64.57 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -178.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.41 ' HB2' ' HB3' ' A' ' 35' ' ' PHE . 10.8 tptt -74.91 -30.59 61.31 Favored 'General case' 0 CA--C 1.566 1.584 0 CA-C-O 115.909 -1.996 . . . . 0.0 113.762 168.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -57.02 -36.97 71.06 Favored 'General case' 0 CA--C 1.607 3.164 1 CA-C-O 90.989 -13.863 . . . . 0.0 119.424 164.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 9.5 m-30 -92.58 -49.65 6.0 Favored 'General case' 0 CA--C 1.591 2.538 2 O-C-N 110.588 -7.57 . . . . 0.0 100.415 -152.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.9 tp -51.38 -46.99 62.97 Favored 'General case' 0 CA--C 1.569 1.683 0 C-N-CA 126.209 1.803 . . . . 0.0 115.516 161.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -78.96 -41.9 28.14 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 176.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -95.38 -38.69 10.38 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -170.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.889 ' HA2' HH22 ' A' ' 88' ' ' ARG . . . 119.79 22.48 3.29 Favored Glycine 0 CA--C 1.541 1.685 0 N-CA-C 118.235 2.054 . . . . 0.0 118.235 168.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -97.3 -179.32 4.47 Favored 'General case' 0 CA--C 1.575 1.941 0 CA-C-N 118.805 1.303 . . . . 0.0 110.243 167.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.9 mt -82.34 127.97 33.76 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.184 -1.573 . . . . 0.0 114.382 -166.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.4 p -118.3 124.08 28.87 Favored Pre-proline 0 CA--C 1.572 1.806 0 C-N-CA 124.935 1.294 . . . . 0.0 110.485 -174.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -60.72 153.1 64.69 Favored 'Trans proline' 0 CA--C 1.56 1.81 0 C-N-CA 123.425 2.75 . . . . 0.0 116.337 172.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 97.2 p -80.24 -49.62 11.36 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 -177.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -63.61 -45.69 89.15 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 -169.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 pp -57.76 -43.1 85.23 Favored 'General case' 0 CA--C 1.562 1.421 0 N-CA-C 117.266 2.321 . . . . 0.0 117.266 169.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.0 m -62.24 -42.32 99.21 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 123.93 0.892 . . . . 0.0 112.578 174.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -62.77 -30.57 71.55 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 166.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.48 -42.35 83.1 Favored 'General case' 0 CA--C 1.555 1.138 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 174.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mt -64.75 -46.15 83.42 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 168.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -56.08 -51.13 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 169.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -60.83 -38.38 85.27 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 115.794 1.775 . . . . 0.0 115.794 174.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -57.23 -44.18 83.53 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 117.592 -1.194 . . . . 0.0 113.421 170.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -84.3 1.84 43.03 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 119.51 3.152 . . . . 0.0 119.51 168.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 21.7 tp -115.64 -5.91 12.18 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 117.813 2.524 . . . . 0.0 117.813 172.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 . . . . . 0 N--CA 1.503 2.204 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 169.737 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.613 ' HA2' ' HE ' ' A' ' 2' ' ' ARG . . . . . . . . 0 CA--C 1.531 1.083 0 CA-C-O 124.011 1.895 . . . . 0.0 113.639 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.473 ' O ' ' HB2' ' A' ' 2' ' ' ARG . 21.9 p90 -167.41 131.52 1.84 Allowed 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 111.719 -2.241 . . . . 0.0 109.092 172.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 17.5 mt -110.47 106.56 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 104.099 -2.556 . . . . 0.0 104.099 170.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.7 mt -110.35 112.75 24.9 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.718 0.807 . . . . 0.0 108.832 -176.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.421 ' OD2' ' HB2' ' A' ' 13' ' ' LYS . 35.4 t0 -109.46 128.65 55.31 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 118.732 0.696 . . . . 0.0 111.688 -175.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 73.54 35.39 55.77 Favored Glycine 0 CA--C 1.552 2.373 0 CA-C-O 117.563 -1.687 . . . . 0.0 117.279 176.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -103.56 -51.89 0.13 Allowed Pre-proline 0 N--CA 1.497 1.906 0 CA-C-O 114.761 -2.542 . . . . 0.0 109.333 173.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -62.08 71.61 0.1 Allowed 'Trans proline' 0 CA--C 1.568 2.22 0 CA-C-N 124.874 2.776 . . . . 0.0 118.838 165.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.889 HH22 ' HA2' ' A' ' 56' ' ' GLY . 1.4 ptm180 -78.05 -36.95 47.83 Favored 'General case' 0 CA--C 1.56 1.342 0 N-CA-C 115.54 1.681 . . . . 0.0 115.54 167.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 69.1 p -137.18 151.42 48.77 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 -168.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.2 t -71.01 -31.03 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-O 116.884 -1.532 . . . . 0.0 111.153 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.71 -40.21 94.23 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 120.149 3.388 . . . . 0.0 120.149 168.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -71.25 -49.29 44.7 Favored 'General case' 0 CA--C 1.589 2.456 0 CA-C-N 122.413 2.37 . . . . 0.0 112.462 168.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.6 -28.87 66.32 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 126.756 2.023 . . . . 0.0 115.646 -170.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.6 ttpm? -58.54 -31.95 68.42 Favored 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 166.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.05 -43.81 94.35 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 114.668 1.358 . . . . 0.0 114.668 168.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.0 mt -66.69 -33.82 76.49 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 172.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -66.22 -58.38 5.51 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 125.349 1.46 . . . . 0.0 112.646 173.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.964 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 47.8 mt-10 -54.66 -36.48 64.64 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 171.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 24.7 ttt -82.72 -40.62 20.33 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 176.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 24.6 tp -57.12 -61.79 2.21 Favored 'General case' 0 N--CA 1.508 2.431 0 CA-C-N 121.503 1.956 . . . . 0.0 110.499 174.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -81.74 -37.27 27.51 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 -177.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.964 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 52.8 ttt85 -60.29 -41.34 93.15 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 176.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.574 ' HB2' ' O ' ' A' ' 102' ' ' ARG . 54.9 ttt180 -174.92 41.72 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 114.464 -2.684 . . . . 0.0 115.851 168.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -114.77 -61.25 0.38 Allowed Glycine 0 C--N 1.362 2.021 0 CA-C-N 123.565 2.893 . . . . 0.0 113.441 174.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 23.5 p -148.28 159.4 44.02 Favored 'General case' 0 CA--C 1.554 1.13 0 CA-C-O 122.957 1.361 . . . . 0.0 112.894 -159.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -74.68 134.74 41.93 Favored 'General case' 0 N--CA 1.503 2.198 0 CA-C-N 114.379 -1.282 . . . . 0.0 113.439 176.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 4.7 tp -86.65 105.82 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.516 0 C-N-CA 125.06 1.344 . . . . 0.0 107.714 175.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -96.92 -70.4 0.72 Allowed 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 115.136 -2.364 . . . . 0.0 108.115 168.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -140.28 122.65 16.0 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 122.503 2.41 . . . . 0.0 115.015 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -92.83 107.81 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.417 0 N-CA-C 100.974 -3.713 . . . . 0.0 100.974 161.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.288 59.5 tp -114.5 105.24 12.87 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.753 -161.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -96.04 126.12 41.06 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.16 0.584 . . . . 0.0 111.541 -176.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -95.06 114.17 25.95 Favored 'General case' 0 CA--C 1.56 1.355 0 CA-C-O 122.537 1.16 . . . . 0.0 110.185 177.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -89.03 100.38 13.16 Favored 'General case' 0 CA--C 1.556 1.187 0 CA-C-N 113.597 -1.638 . . . . 0.0 109.459 168.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.4 p . . . . . 0 CA--C 1.561 1.387 0 C-N-CA 125.921 1.688 . . . . 0.0 108.376 -168.874 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 36.1 t30 . . . . . 0 N--CA 1.496 1.84 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.8 tpt85 -63.42 -45.98 88.5 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 169.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 46.3 mtt -61.31 -29.51 69.92 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 167.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -63.31 -43.76 96.9 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 167.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 20.5 t -70.49 -26.69 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.533 0 CA-C-N 120.088 1.313 . . . . 0.0 113.521 171.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -65.34 -56.75 10.89 Favored 'General case' 0 CA--C 1.583 2.242 0 CA-C-N 120.68 1.582 . . . . 0.0 110.766 167.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 54.3 ttt180 -52.78 -26.8 15.42 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 119.711 3.226 . . . . 0.0 119.711 172.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -47.46 -51.42 20.32 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 169.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -142.55 42.33 1.61 Allowed 'General case' 0 CA--C 1.563 1.461 0 N-CA-C 117.084 2.253 . . . . 0.0 117.084 176.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 36.7 m -49.25 -36.65 20.97 Favored 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 166.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.09 -59.28 6.53 Favored Pre-proline 0 CA--C 1.577 2.014 0 CA-C-O 116.556 -1.688 . . . . 0.0 111.891 172.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -53.03 -26.95 34.09 Favored 'Trans proline' 0 CA--C 1.577 2.666 0 N-CA-C 119.608 2.888 . . . . 0.0 119.608 168.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -65.25 -56.31 13.51 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 125.764 1.625 . . . . 0.0 111.371 172.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.873 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 44.4 tp -62.48 -24.19 67.33 Favored 'General case' 0 CA--C 1.571 1.776 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 175.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -71.23 -47.81 55.06 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 122.247 2.294 . . . . 0.0 113.745 166.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -60.77 -57.02 14.45 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 119.846 1.203 . . . . 0.0 111.966 177.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -80.2 -19.45 46.99 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 115.409 -2.234 . . . . 0.0 113.803 -178.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.873 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 33.2 ttt180 -74.21 -31.09 62.48 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 124.436 3.289 . . . . 0.0 116.202 168.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -68.77 -44.28 74.02 Favored 'General case' 0 CA--C 1.57 1.738 0 CA-C-N 119.688 1.131 . . . . 0.0 113.126 167.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -91.43 -30.21 16.62 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 119.164 3.024 . . . . 0.0 119.164 -176.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.5 pp -39.73 156.81 0.02 OUTLIER 'General case' 0 CA--C 1.582 2.183 1 N-CA-C 122.37 4.211 . . . . 0.0 122.37 -164.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -133.43 113.1 12.15 Favored 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 101.71 -3.441 . . . . 0.0 101.71 164.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 60.4 m -94.7 146.58 24.06 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 122.499 1.142 . . . . 0.0 110.349 -168.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 47.3 t -130.8 130.67 64.52 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.259 0 CA-C-N 113.654 -1.612 . . . . 0.0 106.721 169.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -98.48 117.9 33.96 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 100.892 -3.744 . . . . 0.0 100.892 163.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . 0.293 . . -105.41 -138.01 0.36 Allowed 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 -154.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . 0.252 14.6 m . . . . . 0 CA--C 1.573 1.849 1 N-CA-C 123.812 4.745 . . . . 0.0 123.812 -171.559 . . . . . . . . 2 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 . . . . . 0 N--CA 1.5 2.073 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -61.69 -49.11 77.81 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 117.737 -1.125 . . . . 0.0 112.535 169.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 3.0 t -54.43 -37.87 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 174.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -62.61 -38.16 89.07 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 116.119 1.896 . . . . 0.0 116.119 169.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -61.83 -48.02 82.46 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 175.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.553 ' HA ' ' HB2' ' A' ' 177' ' ' ARG . 1.2 ptt-85 -70.36 -29.14 65.74 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 117.036 2.235 . . . . 0.0 117.036 170.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.77 -46.63 88.75 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 169.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 10.9 mp -64.4 -43.33 94.75 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 117.411 -1.281 . . . . 0.0 111.402 167.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.553 ' HB2' ' HA ' ' A' ' 174' ' ' ARG . 41.1 mtt180 -46.64 -40.87 13.84 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 117.883 2.549 . . . . 0.0 117.883 169.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -69.0 -48.72 62.39 Favored 'General case' 0 CA--C 1.562 1.423 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 169.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.7 tt -83.13 -52.3 6.75 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 120.583 1.538 . . . . 0.0 114.336 -176.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -135.18 -60.18 0.06 OUTLIER Glycine 0 CA--C 1.551 2.284 0 CA-C-O 116.952 -2.027 . . . . 0.0 115.594 -170.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 39.7 ttmt . . . . . 0 C--O 1.251 1.17 0 CA-C-N 121.548 2.674 . . . . 0.0 109.595 -175.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.8 ttp . . . . . 0 CA--C 1.56 1.333 0 CA-C-O 122.382 1.086 . . . . 0.0 109.25 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . 0.275 11.4 mpt_? -124.5 167.73 14.05 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 120.878 3.659 . . . . 0.0 120.878 -162.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.3 p -148.11 151.18 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.695 0 CA-C-O 123.611 1.672 . . . . 0.0 113.067 167.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . 0.285 0.0 OUTLIER -143.56 133.87 24.58 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 113.922 -1.49 . . . . 0.0 110.99 166.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.759 ' CD1' ' HB2' ' A' ' 13' ' ' LYS . 3.7 tt -95.64 125.51 40.28 Favored 'General case' 0 CA--C 1.572 1.795 0 C-N-CA 125.188 1.395 . . . . 0.0 114.649 -165.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.6 mt -109.78 155.49 21.54 Favored 'General case' 0 CA--C 1.567 1.607 0 CA-C-N 110.559 -3.019 . . . . 0.0 109.847 169.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -174.36 99.49 0.14 Allowed Glycine 0 CA--C 1.55 2.24 0 CA-C-O 116.729 -2.15 . . . . 0.0 113.468 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.281 33.3 Cg_endo . . . . . 0 CA--C 1.58 2.778 0 CA-C-N 122.277 3.039 . . . . 0.0 111.853 175.25 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.759 ' HB2' ' CD1' ' A' ' 5' ' ' LEU . 32.1 mmtt . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.91 -35.74 92.4 Favored Glycine 0 CA--C 1.552 2.362 0 N-CA-C 118.609 2.204 . . . . 0.0 118.609 173.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 40.3 m -61.65 -53.48 55.6 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 119.324 1.562 . . . . 0.0 113.416 174.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.259 0.1 OUTLIER -79.59 -17.45 53.85 Favored 'General case' 0 CA--C 1.58 2.106 0 CA-C-O 116.639 -1.648 . . . . 0.0 111.491 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.28 -43.7 55.79 Favored 'General case' 0 C--N 1.374 1.633 0 CA-C-N 122.712 2.506 . . . . 0.0 115.337 168.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.5 t -65.77 -37.99 81.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 CA-C-O 117.691 -1.147 . . . . 0.0 112.335 170.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -59.68 -51.61 69.05 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 169.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.5 tp -64.37 -31.5 72.73 Favored 'General case' 0 CA--C 1.575 1.937 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 174.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.29 -39.46 93.97 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 168.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -63.73 -35.13 79.55 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 166.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 43.7 tptt -68.28 -55.49 11.98 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 174.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 65.0 mt -83.83 -26.51 29.46 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 116.648 2.092 . . . . 0.0 116.648 -178.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.27 39.28 6.44 Favored Glycine 0 CA--C 1.555 2.534 0 N-CA-C 117.313 1.685 . . . . 0.0 117.313 -172.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.463 ' CG2' ' HA ' ' A' ' 81' ' ' PHE . 20.4 mm -104.22 153.91 38.63 Favored Pre-proline 0 CA--C 1.567 1.605 0 CA-C-N 119.029 1.414 . . . . 0.0 112.271 -170.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -81.3 101.52 1.25 Allowed 'Trans proline' 0 CA--C 1.568 2.22 0 CA-C-N 121.65 1.625 . . . . 0.0 108.667 161.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.96 119.24 17.9 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 122.088 0.947 . . . . 0.0 110.197 173.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.449 HD11 ' HB3' ' A' ' 71' ' ' ARG . 1.8 mp -95.28 109.06 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 N-CA-C 104.089 -2.56 . . . . 0.0 104.089 176.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 78.0 p -97.41 128.15 43.96 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 166.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.8 p -67.33 -10.89 55.39 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 117.822 2.526 . . . . 0.0 117.822 -169.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -82.41 -27.85 42.08 Favored Glycine 0 CA--C 1.553 2.409 0 N-CA-C 117.951 1.94 . . . . 0.0 117.951 165.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -81.3 -46.14 15.17 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -168.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -69.68 -37.32 76.61 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 173.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.502 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 42.4 m-85 -65.67 -46.85 77.55 Favored 'General case' 0 CA--C 1.557 1.234 0 CA-C-O 116.538 -1.696 . . . . 0.0 112.855 170.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -54.84 -40.65 69.84 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 168.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -59.44 -40.47 86.9 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 169.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -68.39 -25.47 65.07 Favored 'General case' 0 CA--C 1.583 2.238 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 167.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.5 mt -62.91 -50.16 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 CA-C-N 120.383 1.447 . . . . 0.0 110.768 167.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.53 -31.55 69.83 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -67.76 -39.92 84.11 Favored 'General case' 0 CA--C 1.565 1.524 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 169.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.98 70.73 1.0 Allowed Glycine 0 CA--C 1.536 1.394 0 CA-C-O 118.577 -1.124 . . . . 0.0 112.886 175.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.566 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 56.9 p -96.18 -66.4 0.91 Allowed 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 118.291 1.046 . . . . 0.0 110.609 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.566 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.0 OUTLIER 124.88 -54.97 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 119.436 1.016 . . . . 0.0 110.117 -167.061 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.8 -15.04 62.14 Favored 'General case' 0 CA--C 1.57 1.747 0 CA-C-O 118.48 -0.771 . . . . 0.0 112.54 167.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.89 -53.66 44.03 Favored Glycine 0 CA--C 1.555 2.586 0 CA-C-N 120.102 1.319 . . . . 0.0 114.009 166.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -75.05 -50.88 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 -170.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -65.4 -41.8 93.25 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 120.908 1.685 . . . . 0.0 113.196 172.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.57 -24.26 56.61 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -176.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.502 ' HB2' ' HB3' ' A' ' 35' ' ' PHE . 9.6 tmtm? -76.18 -38.82 56.09 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 117.127 -1.416 . . . . 0.0 112.978 166.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.603 ' CG ' ' O ' ' A' ' 51' ' ' ARG . 51.1 ttt180 -70.58 -55.45 8.82 Favored 'General case' 0 CA--C 1.591 2.543 1 CA-C-O 86.101 -16.19 . . . . 0.0 118.413 -178.013 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 12.6 m-30 -33.15 -60.32 0.34 Allowed 'General case' 0 N--CA 1.496 1.858 1 O-C-N 109.089 -8.507 . . . . 0.0 121.273 146.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.7 tp -60.75 -23.67 65.14 Favored 'General case' 0 CA--C 1.576 1.966 0 CA-C-N 122.58 2.446 . . . . 0.0 117.226 169.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -93.09 -44.52 8.34 Favored 'General case' 0 CA--C 1.569 1.688 0 C-N-CA 126.112 1.765 . . . . 0.0 114.376 168.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.23 -36.27 24.74 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 116.669 2.1 . . . . 0.0 116.669 -177.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.97 40.04 2.55 Favored Glycine 0 CA--C 1.537 1.412 0 N-CA-C 116.157 1.223 . . . . 0.0 116.157 169.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -103.29 -135.94 0.34 Allowed 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 169.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.6 mt -105.56 108.57 20.16 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 120.857 1.662 . . . . 0.0 110.304 -170.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.3 p -112.05 109.58 54.6 Favored Pre-proline 0 CA--C 1.565 1.551 0 CA-C-O 117.483 -1.246 . . . . 0.0 108.23 175.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -64.28 154.82 69.01 Favored 'Trans proline' 0 CA--C 1.558 1.705 0 C-N-CA 123.094 2.529 . . . . 0.0 116.567 178.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 71.9 m -78.03 174.98 10.53 Favored 'General case' 0 CA--C 1.571 1.762 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.969 169.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.7 t70 83.17 -47.11 0.13 Allowed 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 125.884 1.674 . . . . 0.0 114.075 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 24.9 mt -65.47 -53.98 34.87 Favored 'General case' 0 N--CA 1.505 2.276 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 168.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 53.7 m -53.68 -49.85 67.1 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 113.112 -1.858 . . . . 0.0 113.678 169.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -59.63 -27.24 66.16 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 116.534 2.05 . . . . 0.0 116.534 167.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.57 -47.56 54.16 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 173.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.381 4.5 pp -74.59 -25.73 59.46 Favored 'General case' 0 CA--C 1.588 2.439 0 CA-C-N 119.743 1.156 . . . . 0.0 112.952 174.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.0 -48.01 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 CA-C-N 121.78 2.082 . . . . 0.0 112.816 165.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -58.57 -32.82 69.28 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 171.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -59.58 -45.84 90.68 Favored 'General case' 0 CA--C 1.566 1.585 0 CA-C-O 117.555 -1.212 . . . . 0.0 112.697 166.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.449 ' HB3' HD11 ' A' ' 29' ' ' ILE . 83.0 mtt180 -82.93 7.9 14.11 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 118.59 2.811 . . . . 0.0 118.59 167.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.8 mt -123.69 -5.87 8.06 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 118.294 2.701 . . . . 0.0 118.294 170.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 55.9 p30 . . . . . 0 N--CA 1.5 2.052 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 171.921 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.838 0 CA-C-O 123.993 1.885 . . . . 0.0 117.325 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.463 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . 13.9 p90 -171.39 135.84 0.97 Allowed 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 113.344 -1.428 . . . . 0.0 107.675 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 9.1 mt -111.56 108.92 26.69 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.542 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 172.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 26.2 mt -107.24 121.06 43.78 Favored 'General case' 0 N--CA 1.504 2.235 0 CA-C-O 117.402 -1.285 . . . . 0.0 110.009 177.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -117.74 118.17 31.34 Favored 'General case' 0 N--CA 1.506 2.369 0 CA-C-N 121.566 1.985 . . . . 0.0 111.588 -169.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 74.63 35.8 50.37 Favored Glycine 0 CA--C 1.555 2.537 0 CA-C-O 117.986 -1.452 . . . . 0.0 116.653 -174.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -94.64 -52.67 0.24 Allowed Pre-proline 0 N--CA 1.493 1.709 0 CA-C-O 115.361 -2.257 . . . . 0.0 108.672 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -68.41 68.71 1.04 Allowed 'Trans proline' 0 CA--C 1.57 2.321 0 CA-C-N 124.071 2.49 . . . . 0.0 117.623 164.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -20.99 61.47 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 165.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.2 m -147.19 143.38 28.16 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 -173.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . 0.313 9.8 p -69.54 -23.2 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 CA-C-O 116.158 -1.877 . . . . 0.0 112.337 175.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -63.43 -31.89 73.17 Favored 'General case' 0 CA--C 1.563 1.449 0 N-CA-C 118.943 2.942 . . . . 0.0 118.943 166.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -76.84 -48.16 19.26 Favored 'General case' 0 CA--C 1.588 2.409 0 CA-C-N 122.281 2.31 . . . . 0.0 112.159 165.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.36 -35.47 80.97 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 126.932 2.093 . . . . 0.0 116.003 -169.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.0 tttt -57.71 -29.48 64.74 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 115.683 1.735 . . . . 0.0 115.683 167.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.74 -41.0 72.39 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 168.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 23.6 tp -60.41 -40.36 90.69 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 168.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -56.12 -53.08 61.35 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 124.003 0.921 . . . . 0.0 113.147 168.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.904 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 14.3 mm-40 -46.88 -42.71 17.91 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 116.012 1.856 . . . . 0.0 116.012 167.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 1.306 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 58.7 mtt -83.87 -19.66 34.45 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 117.793 2.516 . . . . 0.0 117.793 177.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.655 HD12 ' HG1' ' A' ' 105' ' ' THR . 60.6 tp -73.81 -50.36 20.83 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 120.835 1.652 . . . . 0.0 111.741 169.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -74.2 -56.78 4.5 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 171.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.904 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 96.4 mtt180 -68.58 -37.98 80.29 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 177.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 1.306 ' HB3' ' O ' ' A' ' 99' ' ' MET . 70.7 ttt180 -62.25 -59.31 5.21 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 119.857 1.208 . . . . 0.0 110.193 164.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 113.11 46.22 0.71 Allowed Glycine 0 N--CA 1.48 1.632 0 O-C-N 124.435 1.085 . . . . 0.0 114.011 167.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.655 ' HG1' HD12 ' A' ' 100' ' ' LEU . 28.2 p -103.61 146.63 28.28 Favored 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 172.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -68.81 128.96 38.55 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.183 -0.948 . . . . 0.0 112.894 -170.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.8 tp -82.23 101.15 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -103.32 -72.0 0.71 Allowed 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 115.737 -2.078 . . . . 0.0 109.21 167.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -142.6 119.76 11.45 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 116.543 2.053 . . . . 0.0 116.543 -166.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 93.8 t -92.87 114.28 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 100.532 -3.877 . . . . 0.0 100.532 161.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 32.9 tp -117.96 109.47 16.54 Favored 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 122.778 0.431 . . . . 0.0 111.454 -165.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -96.64 115.91 28.23 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 122.986 0.514 . . . . 0.0 112.062 -178.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -93.09 108.86 20.36 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 175.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -103.13 110.89 23.0 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.949 0.899 . . . . 0.0 108.745 172.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . 0.31 1.3 t . . . . . 0 N--CA 1.499 1.984 0 CA-C-O 123.925 1.821 . . . . 0.0 108.252 159.688 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 . . . . . 0 N--CA 1.5 2.075 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -57.69 -45.45 85.65 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 166.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 25.1 ttt -64.18 -33.02 74.84 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 169.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -60.89 -48.92 79.61 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 169.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 12.4 p -65.32 -33.09 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 169.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -55.02 -49.57 71.2 Favored 'General case' 0 CA--C 1.581 2.162 0 CA-C-N 119.922 1.237 . . . . 0.0 111.652 167.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -56.74 -41.63 77.85 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 118.878 2.918 . . . . 0.0 118.878 171.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -46.71 -42.45 16.65 Favored 'General case' 0 N--CA 1.506 2.342 0 N-CA-C 117.969 2.581 . . . . 0.0 117.969 174.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -125.69 -29.3 3.17 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 117.597 2.443 . . . . 0.0 117.597 -166.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 51.7 m -45.97 -34.29 3.88 Favored 'General case' 0 N--CA 1.505 2.29 0 N-CA-C 117.543 2.423 . . . . 0.0 117.543 -171.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -66.86 -62.49 3.77 Favored Pre-proline 0 CA--C 1.583 2.247 0 CA-C-O 116.144 -1.884 . . . . 0.0 112.09 170.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -53.15 -35.86 74.78 Favored 'Trans proline' 0 CA--C 1.584 3.004 0 C-N-CA 123.632 2.888 . . . . 0.0 118.945 168.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.97 -53.75 54.86 Favored 'General case' 0 N--CA 1.496 1.875 0 C-N-CA 126.165 1.786 . . . . 0.0 112.174 169.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 1.299 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 28.8 tp -68.09 -21.57 64.96 Favored 'General case' 0 CA--C 1.563 1.467 0 CA-C-O 116.749 -1.596 . . . . 0.0 114.214 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -71.98 -49.02 40.76 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 121.961 2.164 . . . . 0.0 112.618 164.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -68.63 -51.75 38.8 Favored 'General case' 0 CA--C 1.567 1.613 0 CA-C-N 120.569 1.531 . . . . 0.0 112.302 -176.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -78.56 -26.23 45.59 Favored 'General case' 0 CA--C 1.554 1.109 0 CA-C-O 114.854 -2.498 . . . . 0.0 113.072 176.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 1.299 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 0.1 OUTLIER -60.96 -41.97 97.37 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 125.24 3.655 . . . . 0.0 115.543 168.393 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -62.87 -36.0 81.86 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 167.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -88.3 -34.42 17.68 Favored 'General case' 0 CA--C 1.576 1.977 0 N-CA-C 119.336 3.088 . . . . 0.0 119.336 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.1 pp -80.35 173.71 12.32 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 117.803 2.52 . . . . 0.0 117.803 -162.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -122.78 123.53 41.25 Favored 'General case' 0 CA--C 1.557 1.221 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 166.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 1.4 t -100.2 156.9 16.96 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 123.195 1.474 . . . . 0.0 110.241 -178.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 40.0 t -132.61 143.99 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.367 0 CA-C-N 113.096 -1.865 . . . . 0.0 106.651 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -95.05 120.25 34.94 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 100.32 -3.955 . . . . 0.0 100.32 164.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . 0.307 . . -99.34 -101.74 0.22 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 119.489 3.144 . . . . 0.0 119.489 -150.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 CA--C 1.564 1.492 0 N-CA-C 117.492 2.405 . . . . 0.0 117.492 -158.005 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 8.9 t70 . . . . . 0 N--CA 1.506 2.346 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -63.99 -44.76 91.7 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 174.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -40.58 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-O 117.947 -1.025 . . . . 0.0 113.667 172.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -54.7 -38.81 67.49 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 116.656 2.095 . . . . 0.0 116.656 166.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -62.57 -53.46 54.28 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.7 mtt85 -70.94 -28.38 64.44 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 117.91 2.559 . . . . 0.0 117.91 174.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.14 -45.42 94.74 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 167.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.5 mp -62.76 -43.17 99.51 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 117.852 -1.07 . . . . 0.0 113.641 168.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 39.6 mtt180 -52.56 -42.65 64.64 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 117.034 2.235 . . . . 0.0 117.034 169.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -66.8 -50.86 61.28 Favored 'General case' 0 CA--C 1.558 1.264 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 172.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.86 -59.59 2.67 Favored 'General case' 0 CA--C 1.569 1.688 0 CA-C-N 119.833 1.197 . . . . 0.0 112.565 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.638 ' O ' ' CB ' ' A' ' 181' ' ' LYS . . . -106.59 -55.68 0.66 Allowed Glycine 0 CA--C 1.55 2.249 0 CA-C-O 117.902 -1.499 . . . . 0.0 115.095 -175.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.638 ' CB ' ' O ' ' A' ' 180' ' ' GLY . 36.5 ttmt . . . . . 0 C--O 1.251 1.139 0 CA-C-N 120.13 1.965 . . . . 0.0 107.507 -175.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.9 mmt . . . . . 0 CA--C 1.555 1.154 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.98 169.74 21.03 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 115.837 1.791 . . . . 0.0 115.837 -165.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.9 t -131.51 148.57 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 123.66 1.695 . . . . 0.0 113.135 -162.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -119.47 113.54 20.92 Favored 'General case' 0 CA--C 1.558 1.262 0 CA-C-N 112.576 -2.102 . . . . 0.0 105.331 169.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.8 tp -99.67 127.03 45.78 Favored 'General case' 0 CA--C 1.562 1.424 0 CA-C-O 123.44 1.59 . . . . 0.0 108.399 -168.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.3 mt -134.67 163.73 29.11 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 111.695 -2.502 . . . . 0.0 113.277 -164.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 172.96 115.6 0.38 Allowed Glycine 0 CA--C 1.546 2.007 0 CA-C-O 117.015 -1.991 . . . . 0.0 110.953 -171.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 CA--C 1.577 2.656 0 CA-C-N 122.147 2.973 . . . . 0.0 115.196 168.751 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt . . . . . 0 N--CA 1.497 1.913 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -44.61 -33.49 3.31 Favored Glycine 0 CA--C 1.551 2.332 0 N-CA-C 120.887 3.115 . . . . 0.0 120.887 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.8 p -57.92 -61.12 2.76 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 119.322 1.561 . . . . 0.0 115.21 173.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.259 5.2 mm-40 -75.95 -12.53 60.16 Favored 'General case' 0 CA--C 1.567 1.598 0 CA-C-O 116.539 -1.696 . . . . 0.0 111.59 175.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.68 -50.56 42.73 Favored 'General case' 0 C--N 1.37 1.458 0 CA-C-N 122.57 2.441 . . . . 0.0 113.639 167.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.8 p -66.9 -39.83 84.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 173.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.555 ' HB3' ' CE1' ' A' ' 172' ' ' PHE . 58.5 mmtt -62.89 -42.48 99.79 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 116.21 1.929 . . . . 0.0 116.21 170.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 20.0 tp -66.67 -36.81 83.42 Favored 'General case' 0 CA--C 1.571 1.766 0 CA-C-N 120.04 1.291 . . . . 0.0 113.53 172.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.24 -39.29 86.21 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 166.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -56.59 -39.88 74.32 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 166.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -68.71 -53.44 22.16 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 174.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.1 mt -83.87 -23.81 31.12 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 117.274 2.324 . . . . 0.0 117.274 -176.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.91 35.42 7.72 Favored Glycine 0 CA--C 1.555 2.582 0 N-CA-C 117.8 1.88 . . . . 0.0 117.8 -174.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.0 mm -105.39 155.21 38.3 Favored Pre-proline 0 CA--C 1.57 1.722 0 CA-C-N 119.136 1.468 . . . . 0.0 112.434 -169.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -81.95 99.72 1.03 Allowed 'Trans proline' 0 CA--C 1.569 2.23 0 C-N-CA 121.695 1.596 . . . . 0.0 109.953 162.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.85 112.69 3.38 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 123.511 0.724 . . . . 0.0 110.539 170.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 27.3 mm -104.11 108.92 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 175.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.0 t -94.77 136.51 34.99 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 169.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.1 p -70.35 -6.53 35.98 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 117.531 2.419 . . . . 0.0 117.531 -177.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.481 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -89.72 -24.05 31.51 Favored Glycine 0 CA--C 1.544 1.886 0 N-CA-C 118.324 2.09 . . . . 0.0 118.324 165.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -81.18 -51.23 8.65 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -168.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -64.71 -39.08 93.04 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 174.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.513 ' HB3' ' CG ' ' A' ' 50' ' ' LYS . 41.6 m-85 -66.3 -37.6 85.78 Favored 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 116.183 1.92 . . . . 0.0 116.183 169.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.481 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 74.4 ttt180 -58.59 -41.05 84.91 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 166.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.409 ' HD2' ' HA ' ' A' ' 37' ' ' ARG . 10.1 tpt180 -63.81 -38.88 92.76 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 114.746 1.388 . . . . 0.0 114.746 169.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -64.28 -34.34 77.9 Favored 'General case' 0 CA--C 1.573 1.862 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 167.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 51.8 mt -59.35 -43.53 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 C-N-CA 124.994 1.318 . . . . 0.0 111.933 168.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -63.88 -40.62 96.95 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 170.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -72.68 -40.34 66.33 Favored 'General case' 0 CA--C 1.558 1.257 0 N-CA-C 116.266 1.95 . . . . 0.0 116.266 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.01 72.12 1.29 Allowed Glycine 0 CA--C 1.542 1.774 0 CA-C-O 118.383 -1.232 . . . . 0.0 113.965 -171.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.562 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 76.4 p -91.55 -65.47 1.01 Allowed 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 118.887 1.343 . . . . 0.0 111.267 177.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.562 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.0 OUTLIER 128.3 -55.76 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.942 0.897 . . . . 0.0 110.349 -167.422 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -74.67 -11.17 60.11 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 166.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.08 -54.31 25.06 Favored Glycine 0 CA--C 1.546 2.028 0 CA-C-N 119.324 0.965 . . . . 0.0 114.393 167.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.409 ' O ' ' HB2' ' A' ' 51' ' ' ARG 0.268 1.0 OUTLIER -76.44 -47.37 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 116.593 2.072 . . . . 0.0 116.593 -168.624 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -67.05 -36.81 82.89 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 120.985 1.72 . . . . 0.0 113.363 171.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -74.77 -34.24 62.43 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -177.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.513 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -73.92 -34.06 64.21 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 117.736 -1.126 . . . . 0.0 112.503 169.573 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.527 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 22.0 ttt180 -74.12 -51.12 16.62 Favored 'General case' 0 CA--C 1.586 2.359 1 CA-C-O 84.252 -17.07 . . . . 0.0 118.583 -178.761 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . 0.251 21.4 m-85 -36.83 -57.42 0.81 Allowed 'General case' 0 N--CA 1.494 1.769 2 O-C-N 107.666 -9.396 . . . . 0.0 122.029 147.869 . . . . . . . . 3 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 38.4 mt -57.43 -33.92 68.4 Favored 'General case' 0 N--CA 1.511 2.597 0 CA-C-N 123.241 2.746 . . . . 0.0 115.501 168.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -90.71 -38.38 13.09 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 175.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.96 -37.78 38.71 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 178.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.89 40.41 1.44 Allowed Glycine 0 CA--C 1.536 1.403 0 N-CA-C 116.475 1.35 . . . . 0.0 116.475 171.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -119.31 -142.94 0.36 Allowed 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 165.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 79.9 mt -129.92 133.77 47.06 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.307 -0.87 . . . . 0.0 109.77 -170.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.608 HG13 HH22 ' A' ' 88' ' ' ARG . 7.0 p -109.01 133.03 20.85 Favored Pre-proline 0 CA--C 1.573 1.863 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 172.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -54.95 146.72 55.85 Favored 'Trans proline' 0 CA--C 1.561 1.838 0 C-N-CA 123.33 2.687 . . . . 0.0 116.839 173.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 96.4 p -72.64 175.6 6.24 Favored 'General case' 0 CA--C 1.57 1.739 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 176.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.6 t70 81.04 -45.18 0.22 Allowed 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 125.822 1.649 . . . . 0.0 114.29 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 34.8 mt -62.3 -54.51 39.55 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 168.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.8 m -56.65 -48.72 76.95 Favored 'General case' 0 CA--C 1.571 1.765 0 CA-C-N 113.051 -1.886 . . . . 0.0 113.07 173.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -58.04 -35.28 71.09 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 168.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -64.95 -44.6 88.9 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 173.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.8 mt -62.93 -44.27 96.53 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 170.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 82.7 t -58.29 -46.77 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-O 117.799 -1.096 . . . . 0.0 112.463 170.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -60.0 -39.21 84.98 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 116.013 1.857 . . . . 0.0 116.013 172.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -58.67 -41.83 87.07 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 120.331 1.423 . . . . 0.0 113.44 169.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -82.11 2.01 33.37 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 119.198 3.036 . . . . 0.0 119.198 167.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 23.3 tp -121.68 -7.94 9.04 Favored 'General case' 0 CA--C 1.564 1.49 0 N-CA-C 118.407 2.743 . . . . 0.0 118.407 175.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 . . . . . 0 N--CA 1.504 2.251 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 174.494 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.687 0 N-CA-C 118.874 2.31 . . . . 0.0 118.874 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -175.89 136.75 0.32 Allowed 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 113.731 -1.234 . . . . 0.0 110.438 -169.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 22.6 mt -113.32 106.27 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 169.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 58.8 mt -105.72 120.52 41.89 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 123.151 0.58 . . . . 0.0 109.454 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -113.49 122.09 46.22 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 118.645 0.657 . . . . 0.0 110.621 -167.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 72.73 38.87 56.61 Favored Glycine 0 CA--C 1.548 2.114 0 CA-C-O 117.287 -1.841 . . . . 0.0 115.801 -178.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -99.66 -54.16 0.18 Allowed Pre-proline 0 N--CA 1.498 1.967 0 CA-C-O 115.359 -2.257 . . . . 0.0 107.536 176.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -60.87 70.04 0.08 OUTLIER 'Trans proline' 0 CA--C 1.575 2.555 0 N-CA-C 118.784 2.571 . . . . 0.0 118.784 164.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.608 HH22 HG13 ' A' ' 59' ' ' VAL . 4.5 ttm105 -69.94 -37.56 75.92 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 168.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.0 p -151.56 126.95 9.99 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 104.316 -2.475 . . . . 0.0 104.316 -164.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . 0.317 5.8 p -62.28 -21.3 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-O 116.089 -1.91 . . . . 0.0 113.6 -173.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.09 -36.92 85.61 Favored 'General case' 0 CA--C 1.557 1.221 0 N-CA-C 119.435 3.124 . . . . 0.0 119.435 165.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -73.04 -48.54 35.28 Favored 'General case' 0 CA--C 1.586 2.361 0 CA-C-N 124.422 3.283 . . . . 0.0 111.088 165.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.16 -32.03 67.8 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 118.078 2.621 . . . . 0.0 118.078 -174.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.537 ' O ' ' HB2' ' A' ' 98' ' ' GLU . 60.2 tttt -59.48 -25.15 64.18 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 116.604 2.076 . . . . 0.0 116.604 168.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.62 -45.69 64.76 Favored 'General case' 0 CA--C 1.568 1.648 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 166.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 11.2 tp -61.48 -43.73 98.34 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 171.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -59.51 -51.11 71.27 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 168.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 1.015 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 5.5 tp10 -43.96 -39.3 3.95 Favored 'General case' 0 CA--C 1.573 1.865 0 N-CA-C 115.548 1.684 . . . . 0.0 115.548 166.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 1.154 ' O ' ' HB2' ' A' ' 103' ' ' ARG . 66.5 mtt -83.05 -26.02 31.56 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 117.673 2.471 . . . . 0.0 117.673 174.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 41.1 tp -65.53 -54.94 20.95 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-N 120.681 1.582 . . . . 0.0 112.13 169.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -78.29 -51.04 10.73 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 119.269 0.941 . . . . 0.0 113.281 175.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 1.015 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 74.8 ttt180 -67.79 -46.43 71.98 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 177.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 1.154 ' HB2' ' O ' ' A' ' 99' ' ' MET . 58.1 mtt180 -65.09 -51.29 62.25 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 118.892 0.769 . . . . 0.0 111.97 165.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.38 42.66 1.14 Allowed Glycine 0 N--CA 1.482 1.758 0 N-CA-C 114.914 0.726 . . . . 0.0 114.914 167.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 41.4 p -97.5 142.65 29.08 Favored 'General case' 0 CA--C 1.559 1.315 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 169.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -66.73 131.92 46.98 Favored 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -170.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 4.8 tp -84.75 102.89 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 125.402 1.481 . . . . 0.0 108.144 175.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -99.33 -74.27 0.6 Allowed 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 115.369 -2.253 . . . . 0.0 108.412 167.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -137.93 124.94 21.37 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 122.34 2.336 . . . . 0.0 114.908 -176.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 44.2 t -92.42 109.82 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 1 N-CA-C 98.854 -4.498 . . . . 0.0 98.854 162.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.255 49.9 tp -118.17 111.6 19.05 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.446 -160.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -112.96 128.27 56.44 Favored 'General case' 0 CA--C 1.556 1.201 0 CA-C-O 122.39 1.09 . . . . 0.0 111.507 -171.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -96.45 122.43 39.34 Favored 'General case' 0 CA--C 1.558 1.288 0 CA-C-N 113.612 -1.631 . . . . 0.0 109.853 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.438 ' HB3' ' HA ' ' A' ' 163' ' ' ASP . 76.8 ttt180 -85.58 96.43 9.65 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 112.931 -1.941 . . . . 0.0 110.158 169.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.4 p . . . . . 0 CA--C 1.567 1.626 0 C-N-CA 125.849 1.659 . . . . 0.0 109.217 -167.923 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 . . . . . 0 N--CA 1.498 1.93 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -60.11 -35.5 75.37 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 166.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 64.1 mtt -68.63 -29.8 68.38 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 167.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -62.22 -51.42 67.82 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 120.424 1.466 . . . . 0.0 114.889 168.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.7 p -64.18 -32.58 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 170.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -54.7 -50.38 68.43 Favored 'General case' 0 CA--C 1.579 2.066 0 CA-C-N 119.678 1.127 . . . . 0.0 111.965 167.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.55 -38.05 76.99 Favored 'General case' 0 CA--C 1.563 1.454 0 N-CA-C 118.401 2.741 . . . . 0.0 118.401 174.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -50.67 -33.95 24.6 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 118.478 2.77 . . . . 0.0 118.478 172.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -130.3 -28.76 2.08 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 118.473 2.768 . . . . 0.0 118.473 -166.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 62.6 m -47.46 -33.61 6.37 Favored 'General case' 0 N--CA 1.504 2.225 0 N-CA-C 117.503 2.409 . . . . 0.0 117.503 -170.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -66.58 -61.93 4.56 Favored Pre-proline 0 CA--C 1.58 2.129 0 CA-C-O 115.97 -1.967 . . . . 0.0 112.207 171.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -55.17 -31.24 74.9 Favored 'Trans proline' 0 CA--C 1.578 2.718 0 N-CA-C 119.302 2.77 . . . . 0.0 119.302 169.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.99 -56.42 19.24 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 125.409 1.483 . . . . 0.0 111.842 169.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.982 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 42.3 tp -66.07 -23.12 66.46 Favored 'General case' 0 CA--C 1.562 1.435 0 CA-C-O 116.675 -1.631 . . . . 0.0 114.569 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -71.74 -47.36 54.28 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 121.976 2.171 . . . . 0.0 112.084 165.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -66.75 -54.99 17.03 Favored 'General case' 0 CA--C 1.564 1.495 0 CA-C-N 120.613 1.551 . . . . 0.0 112.047 -176.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . 0.262 21.4 m-30 -81.94 -19.74 40.07 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-O 114.69 -2.576 . . . . 0.0 112.456 178.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.982 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 43.5 ttt180 -66.24 -36.04 81.99 Favored 'General case' 0 N--CA 1.487 1.413 1 CA-C-N 126.28 4.127 . . . . 0.0 115.592 167.721 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -68.86 -38.2 79.58 Favored 'General case' 0 CA--C 1.576 1.962 0 CA-C-N 119.848 1.204 . . . . 0.0 113.917 166.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -90.45 -27.58 19.17 Favored 'General case' 0 CA--C 1.576 1.979 0 N-CA-C 119.14 3.015 . . . . 0.0 119.14 -176.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.0 pp -79.76 174.9 11.12 Favored 'General case' 0 N--CA 1.504 2.272 0 CA-C-N 122.773 2.533 . . . . 0.0 116.852 -164.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 37.8 tttp -127.38 131.56 50.32 Favored 'General case' 0 CA--C 1.559 1.298 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 168.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 31.5 m -94.93 148.86 21.87 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 122.224 1.012 . . . . 0.0 112.639 -167.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 36.2 t -132.09 134.34 59.73 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.523 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 166.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.438 ' HA ' ' HB3' ' A' ' 114' ' ' ARG . 13.6 t70 -96.88 131.45 43.63 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 167.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -163.61 118.93 1.64 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -163.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.257 -0.878 . . . . 0.0 109.345 173.969 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 . . . . . 0 N--CA 1.499 2.007 0 N-CA-C 116.013 1.857 . . . . 0.0 116.013 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -65.46 -45.35 84.06 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 171.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 69.0 t -56.49 -41.86 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.345 0 CA-C-N 120.622 1.555 . . . . 0.0 113.847 172.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.555 ' CE1' ' HB3' ' A' ' 19' ' ' LYS . 29.3 t80 -57.99 -36.16 72.24 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 115.783 1.771 . . . . 0.0 115.783 167.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -61.03 -53.29 59.07 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-O 118.141 -0.933 . . . . 0.0 113.459 176.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.409 ' NH1' ' HB3' ' A' ' 163' ' ' ASP . 93.6 mtt180 -63.96 -32.09 73.5 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 118.206 2.669 . . . . 0.0 118.206 171.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.95 -47.31 87.02 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 116.577 2.066 . . . . 0.0 116.577 170.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . 0.265 0.2 OUTLIER -71.06 -39.47 72.2 Favored 'General case' 0 N--CA 1.505 2.32 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 169.81 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -48.92 -39.46 26.23 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 168.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -69.51 -56.7 6.61 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 166.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -103.84 -56.18 2.25 Favored 'General case' 0 CA--C 1.563 1.462 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 -168.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.837 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -78.23 -37.08 29.27 Favored Glycine 0 CA--C 1.55 2.258 0 CA-C-N 121.308 1.867 . . . . 0.0 117.764 -169.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.837 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 86.1 tttt . . . . . 0 C--O 1.252 1.186 0 CA-C-N 118.073 0.936 . . . . 0.0 108.523 178.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 mmt . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 122.278 1.037 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.466 ' HG3' HH11 ' A' ' 2' ' ' ARG 0.324 16.0 ttm-85 -147.25 144.64 29.01 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 118.423 2.749 . . . . 0.0 118.423 -158.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.8 t -141.42 147.85 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 CA-C-O 123.951 1.834 . . . . 0.0 111.964 -171.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.6 mt -133.29 120.74 21.45 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 126.949 2.099 . . . . 0.0 108.995 -175.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 13.0 tp -105.88 122.51 46.27 Favored 'General case' 0 CA--C 1.577 2.005 0 CA-C-O 123.202 1.477 . . . . 0.0 111.066 -168.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.7 mt -120.93 164.67 16.34 Favored 'General case' 0 CA--C 1.563 1.478 0 CA-C-N 110.607 -2.997 . . . . 0.0 112.742 -171.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 142.08 170.67 12.66 Favored Glycine 0 CA--C 1.562 2.984 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.563 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo . . . . . 0 CA--C 1.579 2.761 0 CA-C-N 121.45 2.625 . . . . 0.0 110.145 170.035 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.7 mttt . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -46.39 -40.26 10.8 Favored Glycine 0 CA--C 1.555 2.571 0 N-CA-C 120.939 3.136 . . . . 0.0 120.939 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.7 m -52.82 -54.63 31.48 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-N 119.012 1.406 . . . . 0.0 114.359 169.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.25 0.0 OUTLIER -76.67 -17.12 59.32 Favored 'General case' 0 CA--C 1.575 1.927 0 CA-C-O 117.055 -1.45 . . . . 0.0 112.697 177.454 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.23 -44.18 65.83 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 122.068 2.213 . . . . 0.0 114.629 167.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.9 p -66.13 -46.81 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 172.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.699 ' HB3' ' CE1' ' A' ' 172' ' ' PHE . 45.0 mmtm -54.9 -46.74 74.87 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 169.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 12.5 tp -70.33 -27.76 64.62 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 175.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.15 -39.06 89.53 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 166.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -58.78 -43.35 90.41 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 117.31 -1.328 . . . . 0.0 114.131 166.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -68.12 -46.83 69.8 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 116.455 2.02 . . . . 0.0 116.455 173.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.0 mt -82.54 -26.63 32.27 Favored 'General case' 0 CA--C 1.574 1.893 0 N-CA-C 117.092 2.256 . . . . 0.0 117.092 -177.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.06 43.47 7.11 Favored Glycine 0 CA--C 1.555 2.557 0 N-CA-C 117.378 1.711 . . . . 0.0 117.378 -173.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.437 ' CG2' ' HA ' ' A' ' 81' ' ' PHE . 22.2 mm -114.62 157.98 41.43 Favored Pre-proline 0 CA--C 1.57 1.716 0 C-N-CA 124.551 1.14 . . . . 0.0 113.8 -168.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -76.3 103.18 1.7 Allowed 'Trans proline' 0 C--N 1.376 2.008 0 CA-C-N 121.582 1.601 . . . . 0.0 111.453 159.138 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.47 107.02 10.81 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.237 -0.914 . . . . 0.0 109.052 168.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.7 mm -99.17 112.0 30.21 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 -178.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.3 t -96.44 127.35 42.35 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 169.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 42.5 p -69.96 -10.55 58.98 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 116.802 2.149 . . . . 0.0 116.802 -175.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -83.76 -23.2 53.85 Favored Glycine 0 CA--C 1.545 1.912 0 N-CA-C 118.642 2.217 . . . . 0.0 118.642 166.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -80.52 -51.9 8.24 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 114.714 1.375 . . . . 0.0 114.714 -168.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -64.09 -39.21 93.57 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 174.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.4 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 13.5 m-85 -68.16 -42.19 80.42 Favored 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 172.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 29.2 ttp180 -57.33 -41.62 80.33 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 120.467 1.485 . . . . 0.0 114.073 167.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.2 ttt180 -58.88 -39.21 80.74 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 168.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -67.18 -27.8 67.57 Favored 'General case' 0 CA--C 1.577 1.988 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 167.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 97.4 mt -63.03 -45.51 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 CA-C-N 120.476 1.489 . . . . 0.0 111.403 168.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -66.86 -38.04 85.6 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 120.086 1.312 . . . . 0.0 114.285 173.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -67.85 -40.26 83.71 Favored 'General case' 0 CA--C 1.56 1.356 0 N-CA-C 116.339 1.977 . . . . 0.0 116.339 174.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.82 69.36 1.19 Allowed Glycine 0 CA--C 1.545 1.909 0 CA-C-O 118.379 -1.234 . . . . 0.0 114.645 -177.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.761 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 70.8 p -91.58 -49.1 6.48 Favored 'General case' 0 N--CA 1.5 2.025 0 CA-C-N 118.781 1.29 . . . . 0.0 114.341 176.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.761 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.255 74.2 mttt 105.96 -41.64 0.0 OUTLIER 'General case' 0 CA--C 1.569 1.705 0 CA-C-O 116.331 -1.795 . . . . 0.0 111.212 -172.181 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.3 -13.63 58.22 Favored 'General case' 0 CA--C 1.57 1.717 0 CA-C-N 123.117 2.689 . . . . 0.0 113.231 163.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.53 -55.03 32.26 Favored Glycine 0 C--N 1.354 1.529 0 CA-C-N 120.534 1.515 . . . . 0.0 115.2 169.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.28 8.7 p -76.42 -47.83 28.95 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.474 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -169.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -64.94 -47.42 77.73 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 121.291 1.859 . . . . 0.0 112.957 172.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.19 -31.03 69.35 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -179.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.4 ' HB2' ' HB3' ' A' ' 35' ' ' PHE . 2.0 tptm -69.7 -36.82 76.28 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 168.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.575 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 29.0 ttt180 -74.48 -52.5 11.78 Favored 'General case' 0 CA--C 1.59 2.487 1 CA-C-O 85.183 -16.627 . . . . 0.0 117.991 -178.378 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 18.5 m-30 -30.41 -55.55 0.19 Allowed 'General case' 0 N--CA 1.493 1.717 1 O-C-N 108.661 -8.774 . . . . 0.0 121.6 146.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 26.5 mt -61.43 -44.01 97.88 Favored 'General case' 0 CA--C 1.572 1.789 0 CA-C-N 123.455 2.843 . . . . 0.0 114.489 167.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -76.08 -41.68 49.71 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 116.297 1.962 . . . . 0.0 116.297 176.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.45 -33.49 20.38 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 175.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.66 38.12 3.77 Favored Glycine 0 CA--C 1.54 1.607 0 CA-C-N 121.112 1.778 . . . . 0.0 116.521 169.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -101.48 -132.44 0.27 Allowed 'General case' 0 CA--C 1.571 1.773 0 CA-C-O 118.589 -0.72 . . . . 0.0 109.374 169.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.8 pp -120.87 123.5 42.69 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 120.007 1.276 . . . . 0.0 111.491 -169.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.1 p -120.71 133.69 24.12 Favored Pre-proline 0 CA--C 1.574 1.893 0 CA-C-O 117.782 -1.104 . . . . 0.0 109.883 -176.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -59.47 148.56 86.45 Favored 'Trans proline' 0 CA--C 1.561 1.829 0 C-N-CA 123.447 2.764 . . . . 0.0 116.505 174.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 88.0 p -80.61 -35.81 33.57 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 117.314 2.338 . . . . 0.0 117.314 -175.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -71.76 -51.6 21.87 Favored 'General case' 0 N--CA 1.508 2.473 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -171.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.8 pp -54.51 -42.0 70.29 Favored 'General case' 0 CA--C 1.564 1.496 0 N-CA-C 117.521 2.415 . . . . 0.0 117.521 171.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.0 m -61.19 -48.31 82.12 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 123.905 0.882 . . . . 0.0 113.282 172.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -67.04 -19.76 65.73 Favored 'General case' 0 CA--C 1.572 1.817 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 169.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -75.17 -42.37 56.02 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 121.116 1.78 . . . . 0.0 115.128 170.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mt -61.53 -47.29 86.23 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 168.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -54.24 -48.42 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 169.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -61.94 -36.17 80.62 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 171.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -55.54 -42.03 74.04 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 117.95 -1.024 . . . . 0.0 113.611 169.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 88.2 mtt-85 -81.14 -21.82 39.49 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 118.112 2.634 . . . . 0.0 118.112 168.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.0 mp -89.3 7.69 34.32 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 118.331 2.715 . . . . 0.0 118.331 172.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 . . . . . 0 CA--C 1.585 2.317 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 163.166 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.46 ' HA2' ' NH1' ' A' ' 2' ' ' ARG . . . . . . . . 0 CA--C 1.544 1.847 0 CA-C-O 125.52 2.733 . . . . 0.0 113.776 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.437 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . 21.7 p90 -169.72 135.5 1.49 Allowed 'General case' 0 CA--C 1.56 1.362 0 CA-C-N 109.039 -3.581 . . . . 0.0 105.975 169.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 13.9 mt -106.79 106.32 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 173.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.3 mt -108.03 114.59 28.61 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.069 -176.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -106.77 125.28 50.8 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 119.467 1.031 . . . . 0.0 110.632 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 75.19 28.38 62.24 Favored Glycine 0 CA--C 1.551 2.293 0 N-CA-C 118.377 2.111 . . . . 0.0 118.377 177.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -88.81 -55.0 0.32 Allowed Pre-proline 0 N--CA 1.496 1.865 0 CA-C-O 115.234 -2.317 . . . . 0.0 107.264 168.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -67.56 66.51 0.79 Allowed 'Trans proline' 0 CA--C 1.574 2.475 0 N-CA-C 118.381 2.416 . . . . 0.0 118.381 166.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 8.0 tmm_? -76.41 -20.39 57.17 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 167.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.453 ' HA ' ' HG3' ' A' ' 147' ' ' GLU . 28.3 t -153.54 127.56 8.98 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 104.197 -2.52 . . . . 0.0 104.197 -167.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . 0.302 5.8 p -61.3 -27.18 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 CA-C-O 116.387 -1.768 . . . . 0.0 113.017 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.61 -32.6 70.01 Favored 'General case' 0 C--N 1.362 1.132 0 N-CA-C 119.631 3.197 . . . . 0.0 119.631 165.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -74.04 -49.95 21.93 Favored 'General case' 0 CA--C 1.588 2.405 0 CA-C-N 124.391 3.269 . . . . 0.0 111.493 166.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -53.99 -28.02 35.3 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 118.319 2.711 . . . . 0.0 118.319 178.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.2 tttp -57.18 -30.35 64.43 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 168.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.56 -44.79 81.35 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 168.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.9 tp -62.2 -35.57 79.28 Favored 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 169.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 13.3 t60 -64.45 -43.8 93.12 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 119.651 1.114 . . . . 0.0 113.175 167.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 1.152 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 0.5 OUTLIER -54.94 -30.61 59.18 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 166.696 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 1.341 ' O ' ' HB2' ' A' ' 103' ' ' ARG . 47.3 mtt -85.28 -33.71 22.08 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 118.946 2.943 . . . . 0.0 118.946 172.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.5 tt -69.51 -54.11 15.78 Favored 'General case' 0 N--CA 1.504 2.27 0 CA-C-N 121.372 1.897 . . . . 0.0 110.906 172.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -78.15 -49.41 13.9 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 117.662 -1.161 . . . . 0.0 114.065 175.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 1.152 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 93.0 mtt180 -75.08 -39.67 60.6 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 177.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 1.341 ' HB2' ' O ' ' A' ' 99' ' ' MET . 32.8 mmt180 -64.36 -54.36 34.07 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 120.123 1.329 . . . . 0.0 111.538 165.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.3 50.74 0.7 Allowed Glycine 0 N--CA 1.485 1.938 0 O-C-N 123.836 0.71 . . . . 0.0 113.957 168.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.0 p -92.65 169.05 10.81 Favored 'General case' 0 CA--C 1.566 1.562 0 CA-C-N 113.188 -1.506 . . . . 0.0 110.247 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -72.42 133.24 44.78 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.1 -1.0 . . . . 0.0 110.72 -174.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 7.8 tp -102.21 98.44 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 177.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -98.32 -77.45 0.51 Allowed 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 116.218 -1.849 . . . . 0.0 107.866 168.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.46 130.55 11.88 Favored 'General case' 0 C--N 1.362 1.149 0 CA-C-N 121.665 2.03 . . . . 0.0 113.94 -169.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 24.1 t -92.72 110.96 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 103.497 -2.779 . . . . 0.0 103.497 162.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.565 HD23 ' HB3' ' A' ' 160' ' ' LYS . 89.4 mt -96.6 95.65 8.11 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.478 -172.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -88.98 123.95 33.79 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.173 0.511 . . . . 0.0 111.608 177.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -90.93 124.07 34.91 Favored 'General case' 0 CA--C 1.559 1.289 0 CA-C-O 123.16 1.457 . . . . 0.0 110.915 -176.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -85.37 97.35 9.94 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 112.412 -2.177 . . . . 0.0 108.391 167.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.482 1.139 0 CA-C-N 113.477 -1.692 . . . . 0.0 107.455 -168.567 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 44.5 t30 . . . . . 0 N--CA 1.498 1.942 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -62.48 -37.31 85.48 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 168.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 57.8 mtt -67.93 -29.51 68.6 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 168.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -63.56 -50.69 68.53 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 120.412 1.46 . . . . 0.0 114.377 168.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.1 p -65.79 -33.08 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.221 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 170.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -57.2 -47.0 82.38 Favored 'General case' 0 CA--C 1.583 2.214 0 CA-C-N 119.994 1.27 . . . . 0.0 112.032 168.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -61.77 -54.08 47.18 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 117.445 2.387 . . . . 0.0 117.445 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.49 -43.81 62.32 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 116.922 2.193 . . . . 0.0 116.922 174.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.453 ' HG3' ' HA ' ' A' ' 89' ' ' SER . 32.9 mm-40 -98.84 -42.3 7.24 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 116.487 2.032 . . . . 0.0 116.487 -167.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 97.8 m -50.76 -33.38 22.95 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 117.427 2.38 . . . . 0.0 117.427 -167.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -71.04 -61.38 2.34 Favored Pre-proline 0 CA--C 1.583 2.212 0 CA-C-O 115.83 -2.033 . . . . 0.0 111.844 169.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -54.31 -37.02 88.56 Favored 'Trans proline' 0 CA--C 1.58 2.796 0 C-N-CA 123.625 2.883 . . . . 0.0 119.3 169.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -61.14 -53.27 59.11 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 126.193 1.797 . . . . 0.0 111.58 171.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 1.12 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 45.3 tp -64.32 -20.73 66.28 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 115.378 1.621 . . . . 0.0 115.378 174.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -71.6 -50.4 31.25 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 122.436 2.38 . . . . 0.0 112.667 164.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -65.05 -53.16 50.04 Favored 'General case' 0 CA--C 1.568 1.658 0 CA-C-N 120.106 1.321 . . . . 0.0 112.432 -179.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -74.87 -29.23 60.95 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-O 115.178 -2.344 . . . . 0.0 113.491 176.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 1.12 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 34.7 ttt180 -60.95 -36.42 79.33 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 124.535 3.334 . . . . 0.0 116.389 169.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -67.72 -36.49 80.7 Favored 'General case' 0 CA--C 1.575 1.935 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 166.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -86.87 -29.5 22.14 Favored 'General case' 0 CA--C 1.577 2.001 0 N-CA-C 119.43 3.122 . . . . 0.0 119.43 -178.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.1 pp -80.4 176.64 9.59 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 119.673 3.212 . . . . 0.0 119.673 -160.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.565 ' HB3' HD23 ' A' ' 111' ' ' LEU . 6.0 tmtt? -131.0 135.25 47.44 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 104.062 -2.57 . . . . 0.0 104.062 166.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 83.0 m -97.06 148.88 22.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.991 -1.068 . . . . 0.0 109.666 -174.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 34.3 t -130.38 138.18 54.44 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.442 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 168.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -91.14 136.8 32.84 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 169.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -160.26 99.89 1.34 Allowed 'General case' 0 N--CA 1.481 1.085 0 CA-C-O 121.711 0.767 . . . . 0.0 111.516 -163.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -176.989 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 . . . . . 0 N--CA 1.5 2.068 0 N-CA-C 116.112 1.893 . . . . 0.0 116.112 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.567 ' HB3' HH21 ' A' ' 174' ' ' ARG . 46.8 mt-10 -64.39 -47.7 78.25 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 119.491 1.041 . . . . 0.0 113.635 169.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 99.8 t -58.92 -36.65 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 CA-C-N 119.399 0.999 . . . . 0.0 113.543 173.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.699 ' CE1' ' HB3' ' A' ' 19' ' ' LYS . 43.0 t80 -57.34 -36.65 71.44 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 164.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.43 -54.43 32.72 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 175.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.567 HH21 ' HB3' ' A' ' 170' ' ' GLU . 9.7 ptp180 -66.36 -26.06 67.1 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 117.588 2.44 . . . . 0.0 117.588 170.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.93 -41.93 95.1 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 120.06 1.3 . . . . 0.0 114.211 167.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 4.5 mp -60.08 -46.14 90.56 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 118.265 -0.874 . . . . 0.0 113.035 166.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 26.3 mtp180 -51.52 -45.61 62.97 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 169.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.32 -49.05 79.3 Favored 'General case' 0 CA--C 1.558 1.27 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 171.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -84.19 -61.34 1.83 Allowed 'General case' 0 CA--C 1.564 1.515 0 CA-C-O 117.781 -1.104 . . . . 0.0 112.326 -177.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.974 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -101.45 -56.62 0.86 Allowed Glycine 0 CA--C 1.551 2.296 0 CA-C-N 120.523 1.51 . . . . 0.0 114.937 -177.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.974 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 57.5 tttp . . . . . 0 C--O 1.251 1.132 0 CA-C-N 120.003 1.902 . . . . 0.0 109.195 -176.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.3 mtt . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -149.68 172.97 14.2 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 116.613 2.079 . . . . 0.0 116.613 -168.024 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 54.7 t -134.25 156.04 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 CA-C-O 123.474 1.607 . . . . 0.0 112.802 -162.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . 0.259 0.0 OUTLIER -140.77 132.19 26.84 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 113.936 -1.484 . . . . 0.0 110.091 167.038 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 1.07 HD21 ' HB3' ' A' ' 13' ' ' LYS . 23.8 tp -99.56 126.37 45.52 Favored 'General case' 0 CA--C 1.573 1.849 0 CA-C-O 123.132 1.444 . . . . 0.0 112.121 -167.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.3 mt -116.51 153.03 32.89 Favored 'General case' 0 CA--C 1.559 1.305 0 CA-C-N 109.921 -3.309 . . . . 0.0 109.898 -177.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -179.38 108.26 0.24 Allowed Glycine 0 CA--C 1.547 2.036 0 CA-C-O 117.029 -1.984 . . . . 0.0 113.289 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo . . . . . 0 CA--C 1.579 2.725 0 CA-C-N 121.926 2.863 . . . . 0.0 115.689 168.422 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 1.07 ' HB3' HD21 ' A' ' 5' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.497 1.92 0 N-CA-C 118.826 2.898 . . . . 0.0 118.826 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.76 -24.46 40.87 Favored Glycine 0 CA--C 1.561 2.928 0 N-CA-C 118.972 2.349 . . . . 0.0 118.972 168.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 16.6 m -63.07 -56.22 18.8 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 119.378 1.589 . . . . 0.0 113.331 170.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.5 ' HA ' ' HB2' ' A' ' 19' ' ' LYS 0.286 1.8 mp0 -77.82 -12.29 59.96 Favored 'General case' 0 CA--C 1.571 1.78 0 CA-C-O 115.695 -2.098 . . . . 0.0 112.804 173.54 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.53 -46.83 45.29 Favored 'General case' 0 C--N 1.375 1.697 0 CA-C-N 123.831 3.014 . . . . 0.0 113.744 167.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.7 t -67.2 -38.24 80.68 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.995 0 CA-C-N 119.772 1.169 . . . . 0.0 111.893 173.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.5 ' HB2' ' HA ' ' A' ' 16' ' ' GLN . 18.9 mmmt -57.42 -54.34 47.88 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 116.38 1.993 . . . . 0.0 116.38 169.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.7 tp -65.09 -29.55 70.43 Favored 'General case' 0 CA--C 1.575 1.924 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 174.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.48 -39.13 91.59 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 167.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -61.03 -36.05 78.51 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 166.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.2 mmmt -65.21 -51.63 59.81 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 169.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.4 mt -85.15 -25.55 27.39 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 116.931 2.197 . . . . 0.0 116.931 -174.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.04 37.86 7.61 Favored Glycine 0 CA--C 1.554 2.525 0 N-CA-C 117.694 1.838 . . . . 0.0 117.694 -174.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.438 ' CG2' ' HA ' ' A' ' 81' ' ' PHE . 16.2 mm -105.21 155.95 36.98 Favored Pre-proline 0 CA--C 1.569 1.681 0 CA-C-N 119.26 1.53 . . . . 0.0 113.281 -168.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -80.64 99.06 1.11 Allowed 'Trans proline' 0 CA--C 1.567 2.125 0 CA-C-N 122.426 1.902 . . . . 0.0 109.549 162.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -72.18 112.47 8.29 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.923 -0.486 . . . . 0.0 110.108 177.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 12.8 mm -98.67 104.26 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 41.7 t -98.77 127.88 44.83 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 167.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 37.9 p -67.64 -18.73 65.06 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 117.41 2.374 . . . . 0.0 117.41 -168.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -82.88 -18.66 64.91 Favored Glycine 0 CA--C 1.548 2.126 0 N-CA-C 118.667 2.227 . . . . 0.0 118.667 167.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -78.96 -53.6 6.88 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 119.009 1.404 . . . . 0.0 114.189 -169.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -65.16 -38.02 89.23 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 174.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.466 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 15.3 m-85 -64.54 -38.53 91.32 Favored 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 168.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 49.0 ttp180 -58.6 -41.68 86.39 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 119.929 1.241 . . . . 0.0 114.273 167.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -60.65 -41.28 94.67 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 168.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -69.08 -24.31 64.13 Favored 'General case' 0 CA--C 1.579 2.059 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 169.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 65.6 mt -63.69 -47.98 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 CA-C-N 120.245 1.384 . . . . 0.0 110.97 167.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -65.63 -36.7 84.45 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 114.341 1.238 . . . . 0.0 114.341 174.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -66.46 -42.74 87.1 Favored 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 115.98 1.844 . . . . 0.0 115.98 173.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.79 69.44 1.06 Allowed Glycine 0 CA--C 1.543 1.829 0 CA-C-O 118.607 -1.107 . . . . 0.0 114.101 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.776 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 73.3 p -93.33 -48.74 6.28 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.776 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.253 74.6 mttt 106.17 -41.37 0.0 OUTLIER 'General case' 0 CA--C 1.572 1.818 0 CA-C-O 116.455 -1.736 . . . . 0.0 111.29 -172.607 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.88 -14.14 56.61 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 122.955 2.616 . . . . 0.0 112.895 163.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.54 -55.64 27.69 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-N 120.287 1.403 . . . . 0.0 114.864 170.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.297 7.4 p -76.32 -50.41 22.31 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.444 0 N-CA-C 115.883 1.808 . . . . 0.0 115.883 -168.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -66.71 -45.94 77.14 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 121.127 1.785 . . . . 0.0 112.922 173.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.47 -27.42 63.23 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -178.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.466 ' HB2' ' HB3' ' A' ' 35' ' ' PHE . 1.3 tmtp? -72.53 -41.97 65.26 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 117.302 -1.333 . . . . 0.0 112.946 166.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.594 ' CG ' ' O ' ' A' ' 51' ' ' ARG . 32.4 ttt180 -71.2 -51.77 22.86 Favored 'General case' 0 CA--C 1.586 2.342 1 CA-C-O 85.232 -16.604 . . . . 0.0 118.623 -174.139 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -34.58 -62.53 0.34 Allowed 'General case' 0 N--CA 1.494 1.732 1 O-C-N 108.992 -8.567 . . . . 0.0 121.129 146.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.5 tp -57.01 -29.47 63.36 Favored 'General case' 0 CA--C 1.582 2.206 0 CA-C-N 122.012 2.187 . . . . 0.0 116.223 171.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -92.58 -39.45 11.33 Favored 'General case' 0 CA--C 1.568 1.672 0 C-N-CA 126.738 2.015 . . . . 0.0 116.27 170.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -87.08 -27.88 22.88 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 116.874 2.176 . . . . 0.0 116.874 -176.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.75 22.01 6.87 Favored Glycine 0 CA--C 1.542 1.733 0 N-CA-C 118.588 2.195 . . . . 0.0 118.588 167.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -100.28 -132.23 0.25 Allowed 'General case' 0 CA--C 1.57 1.746 0 CA-C-N 118.935 1.367 . . . . 0.0 110.045 173.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 89.2 mt -116.17 119.31 35.39 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 119.916 1.235 . . . . 0.0 110.874 -168.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.2 p -121.37 136.48 25.88 Favored Pre-proline 0 CA--C 1.573 1.846 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.322 176.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -61.08 150.01 86.37 Favored 'Trans proline' 0 CA--C 1.561 1.857 0 C-N-CA 123.136 2.557 . . . . 0.0 115.275 169.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.1 t -83.85 -33.88 24.75 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -64.0 -44.91 91.22 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -174.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 pp -56.76 -43.63 80.98 Favored 'General case' 0 CA--C 1.562 1.425 0 N-CA-C 117.09 2.255 . . . . 0.0 117.09 169.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.5 m -61.77 -46.21 90.54 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 123.834 0.854 . . . . 0.0 113.013 174.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.543 HD21 ' HH ' ' A' ' 86' ' ' TYR . 0.7 OUTLIER -64.45 -23.63 67.35 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 167.202 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -74.26 -45.74 45.9 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 175.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.4 mt -65.79 -45.81 81.01 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 169.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 69.0 t -57.65 -53.8 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 117.645 -1.169 . . . . 0.0 111.688 172.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -62.14 -30.7 71.21 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 116.002 1.853 . . . . 0.0 116.002 174.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -57.94 -43.7 86.49 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 117.162 -1.399 . . . . 0.0 113.404 169.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.5 ttm-85 -81.64 -15.34 54.91 Favored 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 118.499 2.778 . . . . 0.0 118.499 168.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 74.7 mt -85.13 -6.62 59.29 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 166.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 . . . . . 0 N--CA 1.495 1.806 0 CA-C-O 126.237 2.922 . . . . 0.0 118.485 165.726 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.409 0 CA-C-O 123.856 1.809 . . . . 0.0 116.324 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.469 ' O ' ' HB2' ' A' ' 2' ' ' ARG . 17.2 p90 -177.6 132.14 0.16 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 112.958 -1.621 . . . . 0.0 109.278 169.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 16.7 mt -112.59 109.53 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 172.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 24.8 mt -104.01 114.33 28.51 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 117.52 -1.229 . . . . 0.0 109.87 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -104.5 125.71 50.92 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 121.32 1.873 . . . . 0.0 110.884 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 74.04 32.36 58.7 Favored Glycine 0 CA--C 1.548 2.147 0 N-CA-C 117.95 1.94 . . . . 0.0 117.95 174.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . 0.543 ' HH ' HD21 ' A' ' 65' ' ' ASN . 1.4 t80 -91.15 -55.8 0.26 Allowed Pre-proline 0 N--CA 1.496 1.853 0 CA-C-O 115.163 -2.351 . . . . 0.0 108.418 169.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -66.74 63.79 0.57 Allowed 'Trans proline' 0 CA--C 1.575 2.555 0 N-CA-C 120.192 3.112 . . . . 0.0 120.192 168.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . 0.331 29.6 ttt180 -69.59 -31.42 69.55 Favored 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 116.892 2.182 . . . . 0.0 116.892 165.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.9 t -151.72 129.32 11.49 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 104.742 -2.318 . . . . 0.0 104.742 -166.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . 0.33 12.8 p -61.86 -25.3 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 CA-C-O 116.726 -1.607 . . . . 0.0 113.718 -172.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.07 -38.21 75.92 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 119.506 3.15 . . . . 0.0 119.506 165.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -70.09 -47.95 59.72 Favored 'General case' 0 CA--C 1.592 2.589 0 CA-C-N 122.526 2.421 . . . . 0.0 111.939 165.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.07 -31.63 72.94 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 127.198 2.199 . . . . 0.0 116.279 -169.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -57.28 -32.61 66.8 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 166.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.62 -43.05 90.74 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 169.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 32.0 tp -64.22 -36.82 85.32 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 169.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 28.3 t-80 -60.26 -53.08 61.92 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 119.867 1.212 . . . . 0.0 113.042 169.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 1.243 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 35.6 mt-10 -49.01 -34.54 13.4 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 167.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 1.258 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 26.3 mmt -85.96 -30.56 22.68 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 118.182 2.66 . . . . 0.0 118.182 173.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 46.4 tp -67.48 -52.26 41.44 Favored 'General case' 0 N--CA 1.504 2.26 0 CA-C-N 121.281 1.855 . . . . 0.0 112.02 169.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -79.01 -51.37 9.68 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 123.512 0.725 . . . . 0.0 112.675 176.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 1.243 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 72.9 ttt180 -69.65 -44.94 69.53 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 176.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 1.258 ' HB3' ' O ' ' A' ' 99' ' ' MET . 72.0 ttt180 -59.8 -56.18 25.01 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 118.867 0.758 . . . . 0.0 110.953 164.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.27 43.78 1.05 Allowed Glycine 0 N--CA 1.48 1.588 0 O-C-N 124.282 0.989 . . . . 0.0 114.211 168.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 34.5 p -100.49 143.81 30.23 Favored 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 170.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -67.4 131.43 45.69 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -171.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 4.7 tp -82.91 103.19 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 C-N-CA 125.21 1.404 . . . . 0.0 108.257 175.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -97.95 -71.66 0.68 Allowed 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 114.925 -2.464 . . . . 0.0 108.237 168.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -144.96 125.5 14.06 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 122.852 2.569 . . . . 0.0 116.366 -174.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 69.2 t -92.3 109.14 21.06 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.626 0 N-CA-C 102.269 -3.234 . . . . 0.0 102.269 162.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.653 HD21 ' HB2' ' A' ' 160' ' ' LYS . 83.2 mt -102.18 107.04 17.98 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.083 0.553 . . . . 0.0 110.559 -173.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -99.3 122.15 42.05 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-O 122.387 1.089 . . . . 0.0 110.409 175.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -93.69 123.3 36.92 Favored 'General case' 0 CA--C 1.559 1.304 0 CA-C-N 113.661 -1.609 . . . . 0.0 108.709 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -82.68 98.27 8.96 Favored 'General case' 0 CA--C 1.555 1.163 0 CA-C-N 112.444 -2.162 . . . . 0.0 108.484 169.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.0 p . . . . . 0 CA--C 1.557 1.223 0 CA-C-N 112.977 -1.92 . . . . 0.0 107.187 -168.923 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . 0.418 ' HA ' ' HD3' ' A' ' 142' ' ' LYS . 7.5 t-20 . . . . . 0 N--CA 1.497 1.892 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -63.05 -36.52 83.85 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 167.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 13.2 tpt -67.09 -29.77 69.62 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 114.671 1.359 . . . . 0.0 114.671 168.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.418 ' HD3' ' HA ' ' A' ' 139' ' ' ASN . 62.1 mtpt -62.77 -50.71 69.96 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 168.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 10.1 p -64.56 -34.72 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 170.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -54.95 -49.36 71.57 Favored 'General case' 0 CA--C 1.578 2.046 0 CA-C-N 119.662 1.119 . . . . 0.0 112.335 167.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -57.19 -39.44 75.38 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 118.9 2.926 . . . . 0.0 118.9 173.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -57.21 -34.4 68.49 Favored 'General case' 0 N--CA 1.506 2.365 0 N-CA-C 117.011 2.226 . . . . 0.0 117.011 178.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -131.1 -26.59 2.12 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 119.225 3.046 . . . . 0.0 119.225 -166.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 73.2 m -45.4 -32.84 2.28 Favored 'General case' 0 N--CA 1.508 2.452 0 CA-C-N 122.667 2.485 . . . . 0.0 117.425 -171.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.53 -62.38 3.04 Favored Pre-proline 0 CA--C 1.584 2.261 0 CA-C-O 115.682 -2.104 . . . . 0.0 112.067 169.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -56.46 -31.73 86.83 Favored 'Trans proline' 0 CA--C 1.578 2.685 0 N-CA-C 120.083 3.07 . . . . 0.0 120.083 169.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -62.78 -53.17 58.39 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 125.719 1.608 . . . . 0.0 111.03 169.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.99 ' O ' ' HB2' ' A' ' 156' ' ' ARG 0.306 0.1 OUTLIER -62.03 -24.94 67.36 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 175.872 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -71.29 -50.73 29.62 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 120.366 1.439 . . . . 0.0 113.137 166.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -64.5 -53.54 46.45 Favored 'General case' 0 CA--C 1.568 1.666 0 CA-C-N 120.416 1.462 . . . . 0.0 112.728 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -80.86 -24.66 38.21 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 115.209 -2.329 . . . . 0.0 113.724 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.99 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 14.9 tpt180 -64.37 -37.49 87.68 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 124.144 3.156 . . . . 0.0 115.175 169.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -67.16 -38.09 84.86 Favored 'General case' 0 CA--C 1.574 1.87 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 167.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -80.47 -29.7 37.45 Favored 'General case' 0 CA--C 1.578 2.028 0 N-CA-C 119.713 3.227 . . . . 0.0 119.713 177.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.5 pp -79.21 175.76 10.3 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 119.933 3.309 . . . . 0.0 119.933 -161.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.653 ' HB2' HD21 ' A' ' 111' ' ' LEU . 95.1 mttt -128.55 133.38 48.38 Favored 'General case' 0 CA--C 1.561 1.392 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 166.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 62.4 m -96.07 148.4 22.71 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 122.261 1.029 . . . . 0.0 110.818 -172.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.99 HG11 ' HB3' ' A' ' 174' ' ' ARG . 58.6 t -130.35 136.14 59.18 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.48 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 167.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.561 ' O ' ' HG3' ' A' ' 174' ' ' ARG . 10.0 t0 -95.07 129.05 42.31 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 168.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -163.43 120.9 1.86 Allowed 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.447 -162.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.9 t . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.419 -0.801 . . . . 0.0 109.075 175.382 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 . . . . . 0 N--CA 1.5 2.063 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -64.03 -47.98 78.11 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 119.505 1.048 . . . . 0.0 113.653 169.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 99.3 t -56.7 -38.04 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-N 119.746 1.157 . . . . 0.0 113.647 172.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -59.0 -35.96 74.12 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 116.619 2.081 . . . . 0.0 116.619 167.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -60.37 -48.31 82.32 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 170.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.99 ' HB3' HG11 ' A' ' 162' ' ' VAL . 1.4 mmp_? -50.3 -57.2 8.41 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 117.337 2.347 . . . . 0.0 117.337 168.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -49.92 -44.5 50.33 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 116.752 2.13 . . . . 0.0 116.752 172.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.5 mp -62.69 -43.11 99.63 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 117.515 -1.231 . . . . 0.0 114.013 168.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -53.35 -47.81 69.07 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 171.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -67.87 -45.03 75.71 Favored 'General case' 0 CA--C 1.559 1.303 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 175.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -81.11 -56.6 3.98 Favored 'General case' 0 CA--C 1.564 1.513 0 CA-C-N 120.063 1.301 . . . . 0.0 112.878 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.65 ' O ' ' CB ' ' A' ' 181' ' ' LYS . . . -101.36 -57.87 0.83 Allowed Glycine 0 CA--C 1.552 2.389 0 CA-C-O 117.803 -1.554 . . . . 0.0 114.836 -177.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.65 ' CB ' ' O ' ' A' ' 180' ' ' GLY . 36.5 ttmt . . . . . 0 C--O 1.251 1.157 0 CA-C-N 120.296 2.048 . . . . 0.0 107.579 -177.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.0 tpp . . . . . 0 CA--C 1.56 1.344 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.75 166.95 27.82 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 119.65 3.204 . . . . 0.0 119.65 -166.434 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.8 p -123.49 145.0 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 123.237 1.494 . . . . 0.0 113.462 -167.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.2 mt -120.85 114.12 21.13 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 112.123 -2.308 . . . . 0.0 106.27 172.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.3 tt -102.67 126.77 49.88 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.806 1.243 . . . . 0.0 111.014 -165.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.1 mt -139.29 164.23 30.39 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 114.527 -1.215 . . . . 0.0 112.431 -166.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 151.68 171.22 19.31 Favored Glycine 0 CA--C 1.558 2.752 0 CA-C-O 119.088 -0.84 . . . . 0.0 114.728 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo . . . . . 0 CA--C 1.573 2.47 0 C-N-CA 123.576 2.851 . . . . 0.0 113.013 170.383 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -48.01 -31.09 7.84 Favored Glycine 0 CA--C 1.556 2.618 0 N-CA-C 120.96 3.144 . . . . 0.0 120.96 175.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.3 m -66.45 -55.64 14.74 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 119.558 1.679 . . . . 0.0 113.136 176.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.273 10.9 mm-40 -76.86 -12.16 59.93 Favored 'General case' 0 CA--C 1.573 1.848 0 CA-C-O 116.235 -1.841 . . . . 0.0 111.858 172.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.33 -47.65 60.09 Favored 'General case' 0 C--N 1.372 1.554 0 CA-C-N 123.346 2.794 . . . . 0.0 114.387 167.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.5 t -66.95 -44.72 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 CA-C-O 117.742 -1.123 . . . . 0.0 111.201 173.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -59.33 -41.41 89.07 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 116.596 2.073 . . . . 0.0 116.596 171.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.7 tp -66.35 -33.71 76.33 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 119.721 1.146 . . . . 0.0 113.82 171.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.68 -39.03 89.96 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 167.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -63.03 -38.54 91.6 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 166.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 42.1 tptt -64.84 -53.87 39.94 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 175.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.6 mt -83.34 -27.19 29.89 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 116.956 2.206 . . . . 0.0 116.956 178.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.06 40.02 5.95 Favored Glycine 0 CA--C 1.555 2.569 0 N-CA-C 117.516 1.766 . . . . 0.0 117.516 -174.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.468 ' CG2' ' HA ' ' A' ' 81' ' ' PHE . 19.2 mm -110.06 160.34 28.56 Favored Pre-proline 0 CA--C 1.567 1.634 0 CA-C-N 118.853 1.326 . . . . 0.0 114.103 -168.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -74.37 103.53 1.71 Allowed 'Trans proline' 0 CA--C 1.565 2.027 0 C-N-CA 121.766 1.644 . . . . 0.0 112.776 159.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.3 tm0? -69.5 104.96 2.46 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 165.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 35.2 mm -100.83 107.68 21.7 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 177.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.0 t -95.59 129.92 42.62 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 168.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.4 p -67.17 -19.48 65.58 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 117.037 2.236 . . . . 0.0 117.037 -170.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -84.92 -16.49 65.21 Favored Glycine 0 CA--C 1.544 1.895 0 N-CA-C 119.079 2.392 . . . . 0.0 119.079 168.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -80.34 -55.62 4.77 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 119.529 1.664 . . . . 0.0 114.519 -168.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -59.36 -40.15 85.55 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 172.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.557 ' HB3' ' CB ' ' A' ' 50' ' ' LYS . 6.4 m-85 -60.44 -46.79 88.75 Favored 'General case' 0 CA--C 1.558 1.26 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 170.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -55.22 -42.28 73.17 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 168.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -59.94 -38.14 81.57 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 167.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -68.97 -23.62 64.14 Favored 'General case' 0 CA--C 1.581 2.168 0 N-CA-C 115.024 1.491 . . . . 0.0 115.024 167.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 53.9 mt -62.91 -49.6 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.522 0 CA-C-N 120.927 1.694 . . . . 0.0 109.871 166.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -60.85 -40.34 92.51 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 176.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -67.19 -41.76 85.32 Favored 'General case' 0 CA--C 1.562 1.427 0 N-CA-C 116.268 1.951 . . . . 0.0 116.268 173.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.77 70.0 0.99 Allowed Glycine 0 CA--C 1.544 1.872 0 CA-C-O 118.349 -1.25 . . . . 0.0 114.425 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.776 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 68.5 p -94.0 -50.79 5.15 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 118.837 1.319 . . . . 0.0 114.407 178.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.776 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.251 37.6 mttp 106.24 -41.42 0.0 OUTLIER 'General case' 0 CA--C 1.571 1.755 0 CA-C-O 116.428 -1.749 . . . . 0.0 111.514 -172.234 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.98 -14.02 56.62 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 122.972 2.623 . . . . 0.0 113.013 163.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.23 -57.56 19.08 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 120.318 1.417 . . . . 0.0 114.494 170.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.304 4.2 p -75.52 -51.96 19.55 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.353 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -169.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -68.73 -44.07 74.58 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 120.703 1.592 . . . . 0.0 112.84 176.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.74 -29.16 62.07 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 117.267 -1.349 . . . . 0.0 114.282 -178.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.557 ' CB ' ' HB3' ' A' ' 35' ' ' PHE 0.273 0.0 OUTLIER -77.77 -33.94 52.55 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 117.084 -1.436 . . . . 0.0 113.689 169.832 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.55 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 29.1 ttt180 -76.06 -47.1 25.97 Favored 'General case' 0 CA--C 1.584 2.27 1 CA-C-O 84.928 -16.749 . . . . 0.0 118.477 -179.075 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -35.35 -56.71 0.62 Allowed 'General case' 0 N--CA 1.494 1.748 1 O-C-N 107.542 -9.474 . . . . 0.0 120.383 145.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 49.2 mt -54.33 -35.85 63.13 Favored 'General case' 0 N--CA 1.511 2.587 0 CA-C-N 123.869 3.031 . . . . 0.0 115.023 167.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -86.96 -42.17 13.35 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 116.139 1.904 . . . . 0.0 116.139 172.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.26 -42.79 54.24 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 1.057 ' HA2' HH12 ' A' ' 88' ' ' ARG . . . 107.61 40.99 1.66 Allowed Glycine 0 CA--C 1.537 1.463 0 N-CA-C 116.466 1.346 . . . . 0.0 116.466 168.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -118.75 -164.53 1.04 Allowed 'General case' 0 CA--C 1.569 1.692 0 C-N-CA 124.052 0.941 . . . . 0.0 111.076 168.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.5 mt -80.22 108.16 13.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.342 -0.849 . . . . 0.0 112.257 -169.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 p -103.57 132.3 21.2 Favored Pre-proline 0 CA--C 1.571 1.761 0 C-N-CA 124.708 1.203 . . . . 0.0 110.002 175.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -60.18 145.87 97.56 Favored 'Trans proline' 0 CA--C 1.558 1.724 0 C-N-CA 123.367 2.711 . . . . 0.0 116.238 171.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 73.7 m -82.8 178.64 8.08 Favored 'General case' 0 CA--C 1.571 1.767 0 CA-C-O 121.623 0.725 . . . . 0.0 111.591 170.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.0 t70 83.05 -52.81 0.17 Allowed 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 125.926 1.691 . . . . 0.0 113.583 176.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.9 pp -57.85 -42.35 84.26 Favored 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 116.547 2.055 . . . . 0.0 116.547 168.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.0 m -59.34 -49.5 77.57 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 124.354 1.062 . . . . 0.0 113.651 171.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -64.73 -21.04 66.66 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 167.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -77.67 -44.35 28.33 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 173.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.6 mt -66.37 -44.66 82.54 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 169.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 56.1 t -56.5 -52.53 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.954 170.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -63.57 -28.35 69.87 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 116.615 2.08 . . . . 0.0 116.615 173.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -60.44 -42.0 95.18 Favored 'General case' 0 CA--C 1.563 1.46 0 CA-C-O 117.743 -1.123 . . . . 0.0 113.081 168.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -81.31 -21.41 39.27 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 119.044 2.979 . . . . 0.0 119.044 168.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 88.4 mt -84.71 -20.08 31.74 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 117.156 2.28 . . . . 0.0 117.156 176.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 . . . . . 0 N--CA 1.498 1.972 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 169.418 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.55 0 CA-C-O 122.289 0.939 . . . . 0.0 114.493 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.468 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . 14.5 p90 -175.52 133.83 0.3 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 113.674 -1.263 . . . . 0.0 109.946 169.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.9 mm -102.45 106.21 19.49 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.736 0 N-CA-C 102.84 -3.022 . . . . 0.0 102.84 167.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.2 mt -103.22 134.5 46.53 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 123.728 0.811 . . . . 0.0 108.812 174.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -133.52 119.64 19.78 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 118.987 0.812 . . . . 0.0 111.099 -167.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 77.56 41.17 20.88 Favored Glycine 0 CA--C 1.55 2.223 0 CA-C-O 117.418 -1.768 . . . . 0.0 116.96 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . 0.275 0.9 OUTLIER -104.68 -66.84 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.833 0 CA-C-O 113.202 -3.285 . . . . 0.0 110.433 -175.375 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -63.13 60.38 0.17 Allowed 'Trans proline' 0 CA--C 1.57 2.311 0 CA-C-N 127.169 3.596 . . . . 0.0 121.212 170.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 1.057 HH12 ' HA2' ' A' ' 56' ' ' GLY . 16.4 ptt85 -62.79 -25.75 68.39 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 117.48 2.4 . . . . 0.0 117.48 167.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.41 ' HB2' ' HG3' ' A' ' 147' ' ' GLU . 77.9 p -151.18 138.99 19.83 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 125.824 1.65 . . . . 0.0 107.045 -167.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -55.95 -33.37 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-N 121.283 1.856 . . . . 0.0 113.462 172.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -61.92 -39.13 90.98 Favored 'General case' 0 C--N 1.362 1.115 0 N-CA-C 120.669 3.581 . . . . 0.0 120.669 172.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -74.87 -46.98 32.64 Favored 'General case' 0 CA--C 1.586 2.351 0 CA-C-N 123.51 2.868 . . . . 0.0 111.847 165.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.11 -29.96 68.95 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 118.412 2.745 . . . . 0.0 118.412 -175.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -58.65 -34.86 71.68 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 168.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.75 -42.71 90.6 Favored 'General case' 0 CA--C 1.566 1.592 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 170.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 26.6 tp -68.0 -33.93 75.56 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 171.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -63.12 -52.85 60.93 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 119.957 1.253 . . . . 0.0 112.816 169.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.97 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 35.6 mt-10 -47.05 -39.39 12.77 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 166.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.833 ' O ' ' HB2' ' A' ' 103' ' ' ARG . 1.7 tpt -83.12 -24.85 32.44 Favored 'General case' 0 CA--C 1.569 1.686 0 N-CA-C 117.756 2.502 . . . . 0.0 117.756 176.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.0 tt -73.8 -49.58 24.58 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-N 120.183 1.356 . . . . 0.0 111.68 171.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -74.78 -54.29 7.61 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 172.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.97 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 92.6 mtt180 -69.82 -40.23 76.04 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 177.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.833 ' HB2' ' O ' ' A' ' 99' ' ' MET . 6.9 ttt-85 -65.31 -53.6 41.54 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 119.831 1.196 . . . . 0.0 111.722 164.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 108.26 50.36 0.77 Allowed Glycine 0 N--CA 1.483 1.798 0 O-C-N 123.81 0.694 . . . . 0.0 114.096 167.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 68.5 p -88.96 146.2 25.04 Favored 'General case' 0 CA--C 1.558 1.285 0 CA-C-N 113.205 -1.498 . . . . 0.0 109.9 175.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -66.32 132.69 48.94 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.77 -0.581 . . . . 0.0 112.053 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 7.1 tp -95.26 100.74 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -175.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -94.27 -66.92 0.88 Allowed 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 117.074 -1.441 . . . . 0.0 108.847 168.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -153.91 123.11 6.49 Favored 'General case' 0 C--N 1.358 0.965 0 CA-C-N 120.605 1.548 . . . . 0.0 113.246 -169.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.3 t -91.8 109.07 20.8 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.583 0 N-CA-C 100.312 -3.958 . . . . 0.0 100.312 162.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.426 ' HA ' ' O ' ' A' ' 160' ' ' LYS 0.252 37.7 tp -112.97 104.07 12.03 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 114.957 -1.019 . . . . 0.0 112.369 -159.483 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -99.56 134.31 42.62 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-O 122.071 0.939 . . . . 0.0 110.987 -176.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -94.76 122.17 37.09 Favored 'General case' 0 CA--C 1.561 1.386 0 CA-C-O 122.903 1.335 . . . . 0.0 110.722 -173.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -85.62 95.05 9.22 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 113.018 -1.901 . . . . 0.0 109.637 169.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.483 1.204 0 C-N-CA 125.725 1.61 . . . . 0.0 107.226 -169.037 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 37.3 t30 . . . . . 0 N--CA 1.5 2.062 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 69.2 mtp180 -60.43 -40.66 91.88 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 167.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 25.8 ttt -65.7 -32.68 74.37 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 168.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -60.25 -50.04 75.22 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 169.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.0 p -65.57 -32.97 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 169.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -55.52 -53.44 56.37 Favored 'General case' 0 CA--C 1.58 2.112 0 CA-C-N 119.495 1.043 . . . . 0.0 111.716 169.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -62.96 -42.09 99.72 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 118.063 2.616 . . . . 0.0 118.063 175.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.26 -44.53 61.8 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 116.975 2.213 . . . . 0.0 116.975 174.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.41 ' HG3' ' HB2' ' A' ' 89' ' ' SER . 8.9 mm-40 -124.08 -30.43 3.48 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 118.54 2.792 . . . . 0.0 118.54 -166.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 63.7 m -55.07 -34.86 63.95 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 117.387 2.365 . . . . 0.0 117.387 -167.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -65.15 -60.4 7.98 Favored Pre-proline 0 CA--C 1.579 2.085 0 CA-C-O 116.305 -1.807 . . . . 0.0 111.751 171.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -51.59 -32.24 43.48 Favored 'Trans proline' 0 CA--C 1.579 2.754 0 C-N-CA 123.394 2.729 . . . . 0.0 118.549 166.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -66.77 -51.94 50.02 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 125.083 1.353 . . . . 0.0 111.305 175.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 1.219 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 38.2 tp -62.43 -22.04 65.87 Favored 'General case' 0 CA--C 1.571 1.752 0 N-CA-C 115.718 1.747 . . . . 0.0 115.718 170.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -70.82 -50.2 38.08 Favored 'General case' 0 CA--C 1.56 1.332 0 CA-C-N 122.681 2.491 . . . . 0.0 112.463 165.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -61.13 -56.48 20.37 Favored 'General case' 0 CA--C 1.574 1.895 0 CA-C-N 119.931 1.241 . . . . 0.0 113.488 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -77.75 -15.16 59.32 Favored 'General case' 0 CA--C 1.562 1.429 0 CA-C-O 116.647 -1.644 . . . . 0.0 114.268 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 1.219 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 0.1 OUTLIER -68.85 -40.3 79.46 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 121.723 2.056 . . . . 0.0 114.871 166.023 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -65.76 -38.97 90.54 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 167.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -75.47 -18.94 59.72 Favored 'General case' 0 CA--C 1.585 2.305 0 N-CA-C 118.386 2.735 . . . . 0.0 118.386 169.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.7 mt -39.26 143.04 0.21 Allowed 'General case' 0 CA--C 1.58 2.101 1 N-CA-C 123.741 4.719 . . . . 0.0 123.741 -164.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 111' ' ' LEU . 28.4 mttm -136.08 121.74 19.65 Favored 'General case' 0 CA--C 1.56 1.332 0 N-CA-C 103.435 -2.802 . . . . 0.0 103.435 160.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.0 t -103.76 156.42 17.83 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.531 -1.356 . . . . 0.0 113.126 -172.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 34.7 t -124.35 142.47 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 169.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -98.76 127.71 44.77 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 165.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.74 92.67 1.68 Allowed 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 122.68 1.229 . . . . 0.0 112.155 -163.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.2 t . . . . . 0 N--CA 1.486 1.346 0 CA-C-N 113.927 -1.488 . . . . 0.0 107.178 -175.905 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 . . . . . 0 N--CA 1.5 2.034 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -62.56 -49.98 73.14 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 117.855 -1.069 . . . . 0.0 113.602 170.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 97.7 t -60.41 -36.05 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 CA-C-N 120.029 1.286 . . . . 0.0 114.014 177.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -59.31 -38.21 79.68 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 166.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.07 -44.62 91.85 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 174.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -62.7 -40.6 97.66 Favored 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 116.512 2.042 . . . . 0.0 116.512 170.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.68 -42.98 94.12 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 169.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 4.9 mp -59.61 -42.61 93.0 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 167.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.586 ' HA ' ' HB3' ' A' ' 181' ' ' LYS . 45.1 mtt180 -55.41 -42.18 73.76 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 116.827 2.158 . . . . 0.0 116.827 169.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.91 -48.18 80.05 Favored 'General case' 0 CA--C 1.561 1.386 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 170.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.7 tt -83.08 -57.49 3.26 Favored 'General case' 0 CA--C 1.567 1.596 0 CA-C-N 120.778 1.627 . . . . 0.0 113.117 -178.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -104.6 -52.4 0.86 Allowed Glycine 0 CA--C 1.547 2.073 0 CA-C-O 117.456 -1.747 . . . . 0.0 114.64 -173.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.586 ' HB3' ' HA ' ' A' ' 177' ' ' ARG . 86.4 tttt . . . . . 0 C--O 1.251 1.184 0 CA-C-N 120.564 2.182 . . . . 0.0 112.735 -176.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.0 mtt . . . . . 0 CA--C 1.558 1.283 0 CA-C-O 123.095 1.426 . . . . 0.0 111.652 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.5 ttm-85 -141.39 149.46 41.12 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 116.736 2.125 . . . . 0.0 116.736 -161.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.7 p -143.84 146.16 21.25 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.861 0 CA-C-O 123.793 1.759 . . . . 0.0 114.797 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -131.86 111.57 11.7 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 112.417 -2.174 . . . . 0.0 108.009 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 14.5 tp -98.32 131.46 44.61 Favored 'General case' 0 CA--C 1.571 1.75 0 CA-C-O 122.706 1.241 . . . . 0.0 112.314 -167.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.7 mt -138.99 163.19 33.02 Favored 'General case' 0 CA--C 1.563 1.454 0 C-N-CA 127.607 2.363 . . . . 0.0 110.782 -166.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 141.89 129.22 2.41 Favored Glycine 0 CA--C 1.553 2.439 0 CA-C-O 116.975 -2.014 . . . . 0.0 111.657 -174.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo . . . . . 0 CA--C 1.573 2.429 0 CA-C-N 122.838 3.319 . . . . 0.0 116.024 172.969 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.7 mttt . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -50.81 -41.21 43.47 Favored Glycine 0 CA--C 1.558 2.72 0 N-CA-C 119.01 2.364 . . . . 0.0 119.01 175.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . 0.405 ' O ' ' HG2' ' A' ' 19' ' ' LYS . 85.5 m -58.82 -44.29 90.83 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 169.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . 0.583 ' HA ' ' HB2' ' A' ' 19' ' ' LYS 0.264 5.1 mm-40 -78.98 -14.05 59.43 Favored 'General case' 0 CA--C 1.576 1.958 0 CA-C-O 116.571 -1.68 . . . . 0.0 112.32 173.536 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.68 -45.22 62.58 Favored 'General case' 0 C--N 1.371 1.531 0 CA-C-N 123.062 2.665 . . . . 0.0 113.597 167.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 p -65.15 -41.53 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 169.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.696 ' HB3' ' CE1' ' A' ' 172' ' ' PHE . 31.1 mmtp -54.72 -42.13 71.16 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 116.11 1.892 . . . . 0.0 116.11 168.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 1.074 ' HA ' ' HB3' ' A' ' 23' ' ' LYS . 22.0 mt -68.67 -30.87 69.65 Favored 'General case' 0 CA--C 1.595 2.676 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 168.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.12 -29.58 70.7 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 118.394 -2.692 . . . . 0.0 115.707 167.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -64.06 -51.44 64.09 Favored 'General case' 0 CA--C 1.596 2.726 0 CA-C-N 120.324 1.42 . . . . 0.0 110.899 156.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 1.074 ' HB3' ' HA ' ' A' ' 20' ' ' LEU 0.29 4.5 tppt? -53.26 51.93 0.0 OUTLIER 'General case' 0 CA--C 1.576 1.944 2 C-N-CA 133.45 4.7 . . . . 0.0 122.424 166.647 . . . . . . . . 4 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 67.84 25.19 7.94 Favored 'General case' 0 N--CA 1.522 3.13 2 C-N-CA 144.854 9.262 . . . . 0.0 134.891 -152.331 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.44 29.98 28.73 Favored Glycine 0 N--CA 1.506 3.323 0 O-C-N 117.458 -3.276 . . . . 0.0 120.468 157.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 25.6 mm -90.25 149.23 40.88 Favored Pre-proline 0 CA--C 1.556 1.178 0 CA-C-N 112.381 -1.91 . . . . 0.0 110.969 -168.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -77.7 91.66 1.17 Allowed 'Trans proline' 0 CA--C 1.561 1.86 0 CA-C-N 122.082 1.779 . . . . 0.0 111.497 168.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.13 108.85 3.28 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.576 175.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 22.5 mm -105.65 114.94 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 82.8 p -96.25 132.36 41.78 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 169.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.7 p -68.37 -16.55 63.97 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 117.136 2.272 . . . . 0.0 117.136 -173.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -84.67 -19.83 59.24 Favored Glycine 0 CA--C 1.547 2.053 0 N-CA-C 118.736 2.254 . . . . 0.0 118.736 167.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -81.13 -49.67 10.56 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -169.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -65.4 -39.49 92.27 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 173.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.6 ' HB3' ' CB ' ' A' ' 50' ' ' LYS . 32.8 m-85 -64.59 -40.98 96.49 Favored 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 115.027 1.492 . . . . 0.0 115.027 169.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -57.28 -41.81 80.44 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 167.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.3 ttt180 -61.62 -37.98 85.97 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 168.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -68.09 -30.2 69.33 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 168.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 64.9 mt -62.75 -44.74 99.73 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 C-N-CA 124.893 1.277 . . . . 0.0 112.085 168.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -65.05 -42.09 94.58 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 173.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -76.31 -30.93 57.92 Favored 'General case' 0 CA--C 1.563 1.448 0 N-CA-C 116.784 2.142 . . . . 0.0 116.784 178.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.38 71.99 1.28 Allowed Glycine 0 CA--C 1.543 1.833 0 CA-C-O 118.083 -1.399 . . . . 0.0 115.282 178.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.773 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 70.8 p -93.69 -47.77 6.64 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 119.036 1.418 . . . . 0.0 114.571 174.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.773 ' HB2' ' O ' ' A' ' 43' ' ' THR . 74.8 mttt 103.62 -40.53 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.754 0 CA-C-O 116.247 -1.835 . . . . 0.0 111.527 -171.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.05 -12.33 58.33 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 123.053 2.66 . . . . 0.0 112.752 163.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.95 -56.07 23.0 Favored Glycine 0 C--N 1.353 1.525 0 CA-C-N 120.852 1.66 . . . . 0.0 114.743 170.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.286 7.1 p -74.57 -50.09 27.94 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.416 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 -169.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -66.49 -44.54 82.35 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 120.303 1.41 . . . . 0.0 112.691 174.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.34 -29.41 63.78 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 114.976 1.472 . . . . 0.0 114.976 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.6 ' CB ' ' HB3' ' A' ' 35' ' ' PHE 0.294 0.6 OUTLIER -75.34 -35.15 61.23 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 116.717 -1.611 . . . . 0.0 112.08 168.011 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.487 ' CG ' ' O ' ' A' ' 51' ' ' ARG . 18.8 ttt180 -74.2 -52.82 11.28 Favored 'General case' 0 CA--C 1.591 2.557 1 CA-C-O 87.026 -15.749 . . . . 0.0 118.197 -176.447 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 12.6 m-30 -26.28 -69.12 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.975 1 O-C-N 109.59 -8.193 . . . . 0.0 119.146 144.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 29.5 tp -54.12 -33.44 57.81 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 116.429 2.011 . . . . 0.0 116.429 175.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -91.56 -44.13 9.25 Favored 'General case' 0 CA--C 1.564 1.499 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 169.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -155.21 44.41 0.48 Allowed 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -166.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.54 50.44 0.32 Allowed Glycine 0 C--N 1.355 1.599 0 CA-C-N 121.628 2.013 . . . . 0.0 114.636 169.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . 0.294 5.6 t70 72.49 -112.94 0.05 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.608 1.163 . . . . 0.0 110.4 167.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.6 pp -105.8 144.35 32.66 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 122.691 1.234 . . . . 0.0 113.232 -169.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 p -129.76 140.27 38.13 Favored Pre-proline 0 CA--C 1.575 1.93 0 CA-C-N 113.307 -1.769 . . . . 0.0 109.139 -177.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -55.87 136.96 77.21 Favored 'Trans proline' 0 CA--C 1.56 1.805 0 C-N-CA 123.629 2.886 . . . . 0.0 116.679 173.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 98.6 p -72.42 -48.6 39.94 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 -178.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -62.38 -38.74 90.76 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 -178.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 17.3 mt -58.79 -48.2 82.09 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 172.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.0 m -61.36 -48.14 82.65 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 113.647 -1.615 . . . . 0.0 113.312 176.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -65.22 -22.04 66.83 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 168.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -73.03 -42.95 62.61 Favored 'General case' 0 CA--C 1.557 1.242 0 CA-C-N 120.975 1.716 . . . . 0.0 115.443 169.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.7 mt -61.31 -47.24 86.85 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 168.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -57.35 -49.87 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 172.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -60.71 -37.67 82.49 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 171.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -56.87 -43.78 81.56 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 117.818 -1.087 . . . . 0.0 113.643 170.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -81.4 -10.4 59.53 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 118.891 2.923 . . . . 0.0 118.891 168.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 87.7 mt -94.27 -8.71 38.32 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 116.669 2.1 . . . . 0.0 116.669 171.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 . . . . . 0 N--CA 1.503 2.201 0 N-CA-C 117.863 2.542 . . . . 0.0 117.863 172.73 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.593 0 CA-C-O 123.304 1.502 . . . . 0.0 113.944 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.4 p90 179.58 142.0 0.13 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 112.948 -1.626 . . . . 0.0 108.145 169.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 9.8 mt -110.11 108.79 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 103.301 -2.852 . . . . 0.0 103.301 169.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 44.6 mt -110.7 120.59 42.89 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 173.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -111.45 128.16 55.91 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 118.917 0.78 . . . . 0.0 110.779 -175.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 75.12 34.47 51.9 Favored Glycine 0 CA--C 1.553 2.413 0 N-CA-C 118.901 2.32 . . . . 0.0 118.901 176.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . 0.254 0.8 OUTLIER -93.37 -62.62 0.17 Allowed Pre-proline 0 CA--C 1.571 1.775 0 CA-C-O 114.126 -2.845 . . . . 0.0 109.538 175.519 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -63.6 56.99 0.19 Allowed 'Trans proline' 0 CA--C 1.57 2.309 0 N-CA-C 121.129 3.473 . . . . 0.0 121.129 169.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.25 -5.04 50.75 Favored 'General case' 0 CA--C 1.57 1.75 0 N-CA-C 117.057 2.243 . . . . 0.0 117.057 168.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.6 t -161.22 139.9 9.87 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 -171.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -58.33 -37.84 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-N 120.157 1.344 . . . . 0.0 112.778 -178.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.473 ' HB2' ' OE2' ' A' ' 147' ' ' GLU . 0.1 OUTLIER -65.6 -30.83 71.61 Favored 'General case' 0 C--N 1.36 1.035 0 N-CA-C 119.68 3.215 . . . . 0.0 119.68 175.825 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -80.43 -44.79 18.7 Favored 'General case' 0 CA--C 1.585 2.316 0 CA-C-N 122.008 2.185 . . . . 0.0 112.497 166.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.16 -35.0 72.75 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 118.428 2.751 . . . . 0.0 118.428 -176.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -58.66 -30.63 67.49 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 116.523 2.045 . . . . 0.0 116.523 169.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.51 -43.41 69.71 Favored 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 169.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.4 tp -67.89 -35.75 79.05 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 171.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 -58.58 -54.3 48.66 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 119.672 1.124 . . . . 0.0 112.809 168.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 1.174 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 32.3 tt0 -49.55 -32.81 13.28 Favored 'General case' 0 CA--C 1.575 1.906 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 166.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 1.085 ' O ' ' HB2' ' A' ' 103' ' ' ARG . 1.8 tpt -83.98 -40.54 18.33 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 117.619 2.452 . . . . 0.0 117.619 178.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.505 ' HA ' ' HG1' ' A' ' 105' ' ' THR . 0.1 OUTLIER -72.23 -45.21 61.2 Favored 'General case' 0 N--CA 1.505 2.317 0 CA-C-N 120.559 1.527 . . . . 0.0 112.504 172.525 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -76.93 -49.14 16.25 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 174.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 1.174 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 72.7 ttt180 -69.61 -43.57 72.46 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 177.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 1.085 ' HB2' ' O ' ' A' ' 99' ' ' MET . 42.5 mtp180 -63.88 -56.32 16.18 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 119.009 0.822 . . . . 0.0 111.895 165.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.02 48.75 0.76 Allowed Glycine 0 N--CA 1.48 1.592 0 O-C-N 124.049 0.843 . . . . 0.0 113.554 169.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.505 ' HG1' ' HA ' ' A' ' 100' ' ' LEU . 82.3 p -82.47 160.09 22.76 Favored 'General case' 0 CA--C 1.562 1.436 0 CA-C-N 113.909 -1.145 . . . . 0.0 110.019 169.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -69.38 128.16 35.58 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.827 -1.17 . . . . 0.0 110.356 -172.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 4.6 tp -94.57 93.56 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -177.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -98.44 -70.95 0.71 Allowed 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 116.043 -1.932 . . . . 0.0 109.176 168.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -151.83 133.93 15.09 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 121.698 2.044 . . . . 0.0 116.102 -168.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -92.35 122.08 43.5 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.163 0 N-CA-C 100.306 -3.961 . . . . 0.0 100.306 160.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.475 ' HA ' ' O ' ' A' ' 160' ' ' LYS . 44.0 mt -96.91 109.93 22.55 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 115.526 -2.178 . . . . 0.0 110.429 -176.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.439 ' N ' ' HB ' ' A' ' 161' ' ' THR . 9.5 tm-20 -101.46 113.75 27.14 Favored 'General case' 0 N--CA 1.536 3.831 0 N-CA-C 120.573 3.546 . . . . 0.0 120.573 170.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -86.04 114.63 23.07 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 119.268 -2.145 . . . . 0.0 110.815 170.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -106.18 110.26 22.45 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.39 169.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . 0.333 1.0 OUTLIER . . . . . 0 N--CA 1.506 2.332 0 CA-C-O 124.075 1.893 . . . . 0.0 108.836 160.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 . . . . . 0 N--CA 1.496 1.873 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -53.01 -48.46 67.53 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 125.231 1.412 . . . . 0.0 114.606 164.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 67.1 mtt -63.6 -35.52 80.8 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 168.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -60.75 -49.21 78.4 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 116.523 2.045 . . . . 0.0 116.523 169.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.4 p -64.45 -38.72 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 173.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -54.65 -48.48 72.28 Favored 'General case' 0 CA--C 1.579 2.063 0 C-N-CA 123.958 0.903 . . . . 0.0 112.604 167.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -56.26 -34.79 66.73 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 119.333 3.086 . . . . 0.0 119.333 174.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.65 -45.91 88.3 Favored 'General case' 0 N--CA 1.504 2.274 0 CA-C-N 120.44 1.473 . . . . 0.0 113.958 178.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.473 ' OE2' ' HB2' ' A' ' 91' ' ' GLU . 22.2 mt-10 -142.22 -4.76 1.01 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 120.952 3.686 . . . . 0.0 120.952 -166.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 38.0 m -69.12 -30.01 68.19 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 -171.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -63.76 -56.45 25.46 Favored Pre-proline 0 CA--C 1.579 2.086 0 CA-C-O 116.209 -1.853 . . . . 0.0 111.555 169.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -53.33 -32.88 63.45 Favored 'Trans proline' 0 CA--C 1.577 2.659 0 C-N-CA 123.454 2.769 . . . . 0.0 118.745 167.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -62.85 -53.96 46.16 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.877 1.271 . . . . 0.0 110.83 172.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 1.208 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 45.1 tp -60.99 -20.71 62.76 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 171.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -71.34 -51.58 23.47 Favored 'General case' 0 CA--C 1.562 1.42 0 CA-C-N 122.744 2.52 . . . . 0.0 113.251 164.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -63.04 -55.57 24.44 Favored 'General case' 0 CA--C 1.57 1.726 0 CA-C-N 120.559 1.527 . . . . 0.0 112.855 178.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -72.2 -31.88 66.28 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-O 114.591 -2.623 . . . . 0.0 112.106 177.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 1.208 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 36.7 ttt180 -59.32 -34.92 72.92 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 124.949 3.522 . . . . 0.0 116.864 169.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -66.32 -37.53 85.59 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 166.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -83.41 -39.99 19.9 Favored 'General case' 0 CA--C 1.581 2.16 0 N-CA-C 118.991 2.959 . . . . 0.0 118.991 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.0 pp -81.48 179.26 7.92 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 120.47 3.508 . . . . 0.0 120.47 -161.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 111' ' ' LEU 0.272 83.6 tttt -154.09 103.9 2.59 Favored 'General case' 0 C--N 1.361 1.08 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 166.018 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.451 HG23 ' H ' ' A' ' 162' ' ' VAL 1.149 24.3 m -124.44 -151.06 0.46 Allowed 'General case' 0 CA--C 1.568 1.673 1 O-C-N 114.839 -4.913 . . . . 0.0 108.339 149.507 . . . . . . . . 4 3 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.451 ' H ' HG23 ' A' ' 161' ' ' THR 0.388 2.5 t -121.39 176.49 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 CA-C-O 125.008 2.337 . . . . 0.0 113.731 -150.909 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -101.33 116.07 31.96 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 101.504 -3.517 . . . . 0.0 101.504 164.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . 0.346 . . -103.9 -120.39 0.2 Allowed 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 120.865 3.654 . . . . 0.0 120.865 -147.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 CA--C 1.568 1.666 0 N-CA-C 118.99 2.959 . . . . 0.0 118.99 -156.07 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 . . . . . 0 N--CA 1.501 2.081 0 N-CA-C 115.833 1.79 . . . . 0.0 115.833 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -62.73 -52.55 62.81 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 173.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -54.11 -38.57 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 173.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.696 ' CE1' ' HB3' ' A' ' 19' ' ' LYS . 5.8 t80 -60.74 -38.67 85.95 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 168.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -61.13 -54.14 48.25 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 174.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 55.9 mtt180 -62.31 -37.67 86.48 Favored 'General case' 0 CA--C 1.555 1.136 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 173.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.66 -45.31 85.72 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 115.761 1.763 . . . . 0.0 115.761 168.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.35 -40.83 87.64 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 168.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 40.6 mmt180 -71.8 -32.73 67.9 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 174.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.53 -48.39 75.25 Favored 'General case' 0 CA--C 1.561 1.378 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 170.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 65.9 tp -71.31 -42.57 68.45 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 119.859 1.209 . . . . 0.0 113.836 168.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.736 ' O ' ' CB ' ' A' ' 181' ' ' LYS . . . 97.47 52.61 1.42 Allowed Glycine 0 CA--C 1.554 2.491 0 CA-C-O 118.634 -1.092 . . . . 0.0 113.12 -169.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.736 ' CB ' ' O ' ' A' ' 180' ' ' GLY . 56.3 tttp . . . . . 0 C--O 1.251 1.135 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -170.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.2 mtt . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -158.96 166.45 31.76 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 117.416 2.376 . . . . 0.0 117.416 -167.909 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 51.6 t -132.06 150.59 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-O 123.924 1.821 . . . . 0.0 112.939 -164.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -130.4 115.9 17.52 Favored 'General case' 0 CA--C 1.559 1.317 0 CA-C-N 112.387 -2.188 . . . . 0.0 108.221 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.835 HD23 ' HB3' ' A' ' 13' ' ' LYS . 22.9 tp -96.91 127.5 42.95 Favored 'General case' 0 CA--C 1.567 1.629 0 CA-C-O 122.873 1.321 . . . . 0.0 110.314 -173.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.4 mt -122.28 148.9 44.45 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 112.048 -2.342 . . . . 0.0 111.658 -169.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 163.33 151.36 6.4 Favored Glycine 0 CA--C 1.558 2.754 0 CA-C-O 118.128 -1.373 . . . . 0.0 115.684 169.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo . . . . . 0 CA--C 1.575 2.544 0 C-N-CA 123.792 2.995 . . . . 0.0 117.542 174.911 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.835 ' HB3' HD23 ' A' ' 5' ' ' LEU . 13.6 mptt . . . . . 0 N--CA 1.496 1.829 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -51.66 -23.5 10.26 Favored Glycine 0 CA--C 1.553 2.457 0 N-CA-C 121.045 3.178 . . . . 0.0 121.045 177.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 65.1 m -66.83 -54.06 26.3 Favored 'General case' 0 CA--C 1.57 1.741 0 CA-C-N 120.119 1.96 . . . . 0.0 112.276 173.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.28 4.0 mm-40 -79.43 -14.39 58.95 Favored 'General case' 0 CA--C 1.579 2.083 0 CA-C-O 116.018 -1.944 . . . . 0.0 111.593 174.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.52 -43.18 63.92 Favored 'General case' 0 C--N 1.377 1.772 0 CA-C-N 123.75 2.977 . . . . 0.0 114.585 167.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.1 t -64.37 -41.92 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 CA-C-O 117.525 -1.226 . . . . 0.0 112.322 170.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.744 ' HB3' ' CE1' ' A' ' 172' ' ' PHE . 64.1 mmtt -65.45 -40.62 93.45 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 116.326 1.973 . . . . 0.0 116.326 171.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.6 tp -67.34 -34.67 77.81 Favored 'General case' 0 CA--C 1.572 1.824 0 CA-C-N 120.031 1.287 . . . . 0.0 113.522 173.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.02 94.14 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 166.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -56.58 -38.68 72.31 Favored 'General case' 0 CA--C 1.567 1.624 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 166.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -69.23 -53.78 18.1 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 120.306 1.412 . . . . 0.0 114.663 173.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.4 mt -84.4 -23.52 30.02 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 117.187 2.292 . . . . 0.0 117.187 -174.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.83 36.49 7.78 Favored Glycine 0 CA--C 1.555 2.555 0 N-CA-C 117.744 1.858 . . . . 0.0 117.744 -174.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.5 mm -104.46 153.67 38.94 Favored Pre-proline 0 CA--C 1.57 1.719 0 CA-C-N 118.899 1.349 . . . . 0.0 112.487 -169.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -82.65 98.13 0.88 Allowed 'Trans proline' 0 CA--C 1.566 2.118 0 CA-C-N 122.222 1.829 . . . . 0.0 109.586 163.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.01 114.82 12.76 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.811 0.815 . . . . 0.0 110.266 176.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 25.1 mm -101.99 112.32 34.75 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.6 t -95.08 134.59 37.61 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 170.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.0 p -68.97 -18.32 64.05 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 117.019 2.229 . . . . 0.0 117.019 -174.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.406 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -81.5 -21.23 62.52 Favored Glycine 0 CA--C 1.545 1.919 0 N-CA-C 118.619 2.207 . . . . 0.0 118.619 167.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -80.47 -51.75 8.44 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -169.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -63.61 -39.57 94.7 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 174.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.424 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 12.5 m-85 -70.28 -39.51 74.87 Favored 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 172.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 47.0 ttp180 -58.97 -40.64 85.39 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 120.182 1.355 . . . . 0.0 114.301 167.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.434 ' HD2' ' HA ' ' A' ' 37' ' ' ARG . 10.6 tpt180 -62.51 -39.46 93.59 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 169.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -68.53 -26.56 65.5 Favored 'General case' 0 CA--C 1.578 2.026 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 168.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 88.1 mt -63.89 -45.38 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 CA-C-N 120.267 1.394 . . . . 0.0 111.063 166.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -62.59 -40.86 98.24 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 173.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -64.64 -45.31 87.35 Favored 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 173.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.64 68.46 0.94 Allowed Glycine 0 CA--C 1.541 1.668 0 CA-C-O 118.452 -1.193 . . . . 0.0 113.555 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.721 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 63.9 p -97.48 -41.87 7.98 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -177.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.721 ' HB2' ' O ' ' A' ' 43' ' ' THR . 76.6 mttt 97.67 -38.75 0.01 OUTLIER 'General case' 0 CA--C 1.573 1.863 0 CA-C-O 116.904 -1.522 . . . . 0.0 111.869 -170.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.02 -18.66 55.62 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 122.246 2.293 . . . . 0.0 113.42 163.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.72 -53.4 46.25 Favored Glycine 0 C--N 1.356 1.657 0 CA-C-N 120.366 1.439 . . . . 0.0 115.332 172.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.64 ' O ' ' HB2' ' A' ' 51' ' ' ARG 0.27 11.8 p -77.91 -44.1 28.44 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.649 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 -169.673 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -59.35 -52.95 63.44 Favored 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 121.072 1.76 . . . . 0.0 113.315 169.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.69 -33.25 73.64 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -176.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.424 ' HB2' ' HB3' ' A' ' 35' ' ' PHE . 13.2 tmtt? -75.28 -19.93 59.41 Favored 'General case' 0 CA--C 1.562 1.442 0 CA-C-O 116.915 -1.517 . . . . 0.0 113.329 166.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . 0.64 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 34.5 ttt180 -76.81 -53.04 8.45 Favored 'General case' 0 CA--C 1.589 2.47 1 CA-C-O 86.371 -16.061 . . . . 0.0 118.169 -179.479 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . 0.405 ' HA ' ' H ' ' A' ' 57' ' ' ASP 0.34 0.0 OUTLIER -40.92 -61.7 0.93 Allowed 'General case' 0 N--CA 1.511 2.605 1 O-C-N 109.99 -7.944 . . . . 0.0 119.559 147.869 . . . . . . . . 5 4 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 61.0 mt -52.0 -31.67 30.58 Favored 'General case' 0 N--CA 1.52 3.067 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 178.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -93.46 -44.22 8.35 Favored 'General case' 0 CA--C 1.567 1.61 0 N-CA-C 116.912 2.19 . . . . 0.0 116.912 170.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.12 -10.56 14.66 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 119.041 2.978 . . . . 0.0 119.041 -168.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.51 42.62 9.04 Favored Glycine 0 CA--C 1.541 1.679 0 CA-C-N 122.094 2.225 . . . . 0.0 116.269 -177.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.405 ' H ' ' HA ' ' A' ' 52' ' ' TYR . 24.8 t70 -91.31 -175.52 4.28 Favored 'General case' 0 CA--C 1.568 1.636 0 CA-C-O 122.24 1.019 . . . . 0.0 110.739 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 65.4 mt -103.82 104.25 14.23 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 177.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.9 t -142.55 122.04 7.83 Favored Pre-proline 0 CA--C 1.584 2.259 0 CA-C-O 117.867 -1.063 . . . . 0.0 108.141 -170.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -57.63 170.1 2.08 Favored 'Trans proline' 0 CA--C 1.567 2.153 0 C-N-CA 124.278 3.319 . . . . 0.0 119.791 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.3 m -96.13 -169.4 1.92 Allowed 'General case' 0 CA--C 1.576 1.976 0 C-N-CA 124.444 1.098 . . . . 0.0 112.995 -178.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.278 19.1 m-20 80.55 -51.01 0.33 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 126.765 2.026 . . . . 0.0 115.144 172.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.44 -39.58 76.57 Favored 'General case' 0 N--CA 1.505 2.298 0 CA-C-N 120.359 1.436 . . . . 0.0 114.667 167.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.3 m -60.29 -47.51 85.71 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 114.669 -1.15 . . . . 0.0 112.688 172.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -62.92 -27.69 69.55 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 115.774 1.768 . . . . 0.0 115.774 168.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -68.36 -44.48 75.13 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 120.886 1.675 . . . . 0.0 114.523 171.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.9 mt -64.41 -38.57 91.5 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 168.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.0 t -57.58 -53.0 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-O 117.885 -1.055 . . . . 0.0 111.998 169.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -59.63 -37.32 78.33 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 116.436 2.013 . . . . 0.0 116.436 172.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -55.8 -49.02 74.36 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 116.715 -1.612 . . . . 0.0 113.084 170.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 61.3 mtp180 -88.94 7.85 32.45 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 120.515 3.524 . . . . 0.0 120.515 167.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 63.9 mt -66.19 -49.73 66.3 Favored 'General case' 0 CA--C 1.554 1.126 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 151.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 72.3 m-80 . . . . . 0 N--CA 1.503 2.2 0 CA-C-N 121.533 1.969 . . . . 0.0 110.981 -165.595 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.401 0 CA-C-O 122.732 1.184 . . . . 0.0 115.376 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.417 ' O ' ' HB2' ' A' ' 2' ' ' ARG . 23.2 p90 -173.98 135.74 0.5 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 112.585 -1.807 . . . . 0.0 109.827 168.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 33.6 mt -113.83 108.03 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 173.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.8 mt -110.96 122.4 47.79 Favored 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 123.33 0.652 . . . . 0.0 110.2 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -116.01 116.15 27.4 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 118.394 0.543 . . . . 0.0 110.746 -169.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.16 28.07 35.04 Favored Glycine 0 CA--C 1.548 2.138 0 N-CA-C 117.988 1.955 . . . . 0.0 117.988 176.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -86.68 -57.3 0.33 Allowed Pre-proline 0 CA--C 1.572 1.81 0 CA-C-O 114.297 -2.763 . . . . 0.0 110.791 175.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -61.88 50.25 0.1 OUTLIER 'Trans proline' 0 CA--C 1.578 2.719 0 N-CA-C 120.664 3.294 . . . . 0.0 120.664 167.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 1.25 ' NH2' HH12 ' A' ' 140' ' ' ARG . 0.0 OUTLIER -80.23 7.43 9.42 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 167.721 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.5 t -155.63 135.14 12.47 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 103.221 -2.881 . . . . 0.0 103.221 170.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.0 t -61.77 -34.21 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 CA-C-O 117.287 -1.34 . . . . 0.0 111.541 176.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.98 -35.39 64.27 Favored 'General case' 0 CA--C 1.564 1.505 0 N-CA-C 119.624 3.194 . . . . 0.0 119.624 165.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -72.26 -48.12 45.06 Favored 'General case' 0 CA--C 1.591 2.52 0 CA-C-N 121.679 2.036 . . . . 0.0 112.087 165.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.45 -33.18 75.29 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 116.677 2.103 . . . . 0.0 116.677 -169.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.2 tttp -61.25 -27.72 68.65 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 167.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.82 -42.45 63.8 Favored 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 168.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 36.8 tp -61.62 -40.83 96.23 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 169.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 43.7 t60 -64.09 -41.24 97.37 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 120.045 1.293 . . . . 0.0 113.986 169.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.714 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 29.7 tt0 -54.55 -40.84 69.09 Favored 'General case' 0 CA--C 1.567 1.61 0 CA-C-O 117.948 -1.025 . . . . 0.0 113.608 167.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 1.26 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 26.3 mmt -83.36 -21.26 33.16 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 117.553 2.427 . . . . 0.0 117.553 175.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.6 tt -73.06 -52.39 14.51 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-N 121.437 1.926 . . . . 0.0 110.39 172.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -75.37 -55.85 5.29 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 172.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.714 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 31.8 ttm180 -69.28 -39.81 78.14 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 178.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 1.26 ' HB3' ' O ' ' A' ' 99' ' ' MET . 76.5 ttt180 -63.45 -56.81 13.15 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 119.464 1.029 . . . . 0.0 111.036 165.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.27 50.0 0.74 Allowed Glycine 0 N--CA 1.483 1.794 0 O-C-N 124.184 0.927 . . . . 0.0 113.886 168.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 51.3 p -91.15 150.58 21.32 Favored 'General case' 0 CA--C 1.559 1.29 0 CA-C-N 113.481 -1.36 . . . . 0.0 109.797 176.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -67.94 132.55 47.53 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.899 -0.501 . . . . 0.0 112.053 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 6.3 tp -95.07 101.74 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -95.78 -69.45 0.75 Allowed 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 116.399 -1.763 . . . . 0.0 108.796 169.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -155.33 128.64 8.33 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 121.629 2.013 . . . . 0.0 113.929 177.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 33.3 t -93.72 108.37 20.46 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.726 0 N-CA-C 102.838 -3.023 . . . . 0.0 102.838 163.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.726 HD23 ' HB2' ' A' ' 160' ' ' LYS . 86.9 mt -101.43 110.8 22.87 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.776 0.83 . . . . 0.0 110.716 -169.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -89.57 121.23 31.58 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 121.638 0.732 . . . . 0.0 109.055 172.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -92.61 117.05 29.57 Favored 'General case' 0 CA--C 1.557 1.227 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 175.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.543 ' HB3' ' HA ' ' A' ' 163' ' ' ASP . 19.7 tpt180 -87.55 91.48 8.75 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 112.821 -1.99 . . . . 0.0 107.31 173.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.4 m . . . . . 0 CA--C 1.55 0.969 0 CA-C-N 112.839 -1.982 . . . . 0.0 106.038 -165.405 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.1 t30 . . . . . 0 N--CA 1.5 2.05 0 N-CA-C 114.849 1.425 . . . . 0.0 114.849 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 1.25 HH12 ' NH2' ' A' ' 88' ' ' ARG . 12.2 mmm180 -59.77 -42.13 92.64 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 169.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 58.9 mtt -66.49 -31.01 71.47 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 115.543 1.682 . . . . 0.0 115.543 169.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -63.64 -49.14 74.41 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 169.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . 0.64 HG12 HH22 ' A' ' 88' ' ' ARG . 7.8 p -64.57 -33.41 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 169.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -56.19 -52.36 64.68 Favored 'General case' 0 CA--C 1.581 2.168 0 CA-C-N 119.559 1.072 . . . . 0.0 111.779 167.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 31.1 ttp180 -52.19 -31.55 32.16 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 119.427 3.121 . . . . 0.0 119.427 170.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -48.47 -51.04 28.95 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 170.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -140.34 7.61 2.18 Favored 'General case' 0 CA--C 1.56 1.362 0 N-CA-C 119.944 3.312 . . . . 0.0 119.944 -167.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 23.9 m -55.27 -34.41 64.03 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 116.194 1.924 . . . . 0.0 116.194 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.14 -59.92 5.71 Favored Pre-proline 0 CA--C 1.578 2.054 0 CA-C-O 116.662 -1.637 . . . . 0.0 111.881 172.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -50.15 -31.3 28.12 Favored 'Trans proline' 0 CA--C 1.576 2.616 0 C-N-CA 123.365 2.71 . . . . 0.0 118.374 167.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.01 -55.58 18.13 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 125.391 1.476 . . . . 0.0 112.217 175.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 1.048 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 46.1 tp -65.32 -23.51 67.03 Favored 'General case' 0 CA--C 1.564 1.511 0 CA-C-O 116.504 -1.712 . . . . 0.0 114.704 176.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -71.55 -48.95 45.25 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 122.393 2.361 . . . . 0.0 113.444 165.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -67.16 -51.6 51.71 Favored 'General case' 0 CA--C 1.566 1.57 0 CA-C-N 120.042 1.292 . . . . 0.0 112.014 -177.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -80.81 -25.3 37.9 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-O 114.715 -2.564 . . . . 0.0 112.53 178.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 1.048 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 38.1 ttt180 -64.31 -35.63 81.48 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 124.893 3.497 . . . . 0.0 115.938 168.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -67.94 -37.74 81.97 Favored 'General case' 0 CA--C 1.574 1.89 0 CA-C-N 119.697 1.135 . . . . 0.0 113.949 167.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -80.71 -38.2 29.3 Favored 'General case' 0 CA--C 1.574 1.89 0 N-CA-C 119.351 3.093 . . . . 0.0 119.351 178.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.3 pp -78.08 173.69 11.94 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 119.675 3.213 . . . . 0.0 119.675 -160.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.726 ' HB2' HD23 ' A' ' 111' ' ' LEU . 91.0 mttt -124.83 134.35 52.77 Favored 'General case' 0 CA--C 1.561 1.399 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 166.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 60.4 m -98.1 148.95 23.03 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 122.79 1.281 . . . . 0.0 111.222 -170.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.526 HG12 ' HG3' ' A' ' 174' ' ' ARG . 44.8 t -127.84 138.67 54.05 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.871 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 167.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.543 ' HA ' ' HB3' ' A' ' 114' ' ' ARG . 14.7 t70 -114.95 127.32 55.62 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 170.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -151.53 -159.8 1.07 Allowed 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 -160.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . 0.511 5.7 p . . . . . 0 N--CA 1.497 1.905 0 C-N-CA 129.153 2.981 . . . . 0.0 114.498 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 . . . . . 0 N--CA 1.505 2.313 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . 0.938 ' HB3' HH21 ' A' ' 174' ' ' ARG . 47.6 mt-10 -59.42 -42.04 90.92 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 117.294 -1.336 . . . . 0.0 114.522 175.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 44.4 t -56.54 -38.65 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 CA-C-N 120.991 1.723 . . . . 0.0 113.419 172.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.744 ' CE1' ' HB3' ' A' ' 19' ' ' LYS . 22.8 t80 -57.95 -40.51 80.7 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 120.796 1.635 . . . . 0.0 115.103 166.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.578 ' O ' ' HB2' ' A' ' 177' ' ' ARG . . . -61.03 -50.85 71.64 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.938 HH21 ' HB3' ' A' ' 170' ' ' GLU . 11.7 ptp180 -73.32 -25.19 60.53 Favored 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 117.582 2.438 . . . . 0.0 117.582 171.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.11 -49.73 73.27 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 120.346 1.43 . . . . 0.0 114.715 169.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . 0.254 0.2 OUTLIER -66.77 -37.86 85.44 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 119.531 1.06 . . . . 0.0 113.429 167.471 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . 0.578 ' HB2' ' O ' ' A' ' 173' ' ' ALA . 17.3 ttt180 -43.55 -44.05 5.89 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 117.126 2.269 . . . . 0.0 117.126 167.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -71.13 -53.98 12.65 Favored 'General case' 0 CA--C 1.564 1.497 0 CA-C-O 118.204 -0.903 . . . . 0.0 113.208 166.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -99.05 -59.6 1.7 Allowed 'General case' 0 CA--C 1.565 1.528 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -169.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.892 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -79.39 -39.14 19.55 Favored Glycine 0 CA--C 1.55 2.276 0 CA-C-N 121.388 1.904 . . . . 0.0 117.737 -171.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.892 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 85.9 tttt . . . . . 0 C--O 1.251 1.142 0 CA-C-N 118.482 1.141 . . . . 0.0 108.623 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.6 mtt . . . . . 0 CA--C 1.555 1.171 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -160.96 162.79 32.03 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 -167.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.5 p -131.4 145.69 34.84 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.4 0 CA-C-O 123.299 1.523 . . . . 0.0 110.956 -170.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -118.12 157.07 27.57 Favored 'General case' 0 CA--C 1.562 1.442 0 CA-C-N 112.853 -1.976 . . . . 0.0 108.52 168.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . 0.475 HD21 ' HG2' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -128.23 117.07 20.87 Favored 'General case' 0 CA--C 1.569 1.69 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.201 -174.042 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.0 mt -116.17 158.48 23.2 Favored 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 127.669 2.387 . . . . 0.0 111.749 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.69 118.78 0.63 Allowed Glycine 0 CA--C 1.556 2.61 0 CA-C-O 116.996 -2.002 . . . . 0.0 114.029 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo . . . . . 0 CA--C 1.584 3.002 0 CA-C-N 122.572 3.186 . . . . 0.0 114.009 169.452 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.475 ' HG2' HD21 ' A' ' 5' ' ' LEU . 37.3 mtmm . . . . . 0 N--CA 1.485 1.325 0 N-CA-C 111.434 0.161 . . . . 0.0 111.434 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -54.04 -36.87 57.21 Favored Glycine 0 CA--C 1.552 2.346 0 N-CA-C 120.87 3.108 . . . . 0.0 120.87 -173.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 90.0 m -68.74 -49.09 61.61 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 119.397 1.598 . . . . 0.0 113.145 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.282 25.4 mp0 -77.57 -12.06 59.93 Favored 'General case' 0 CA--C 1.574 1.886 0 CA-C-O 115.325 -2.274 . . . . 0.0 112.071 169.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.07 -45.9 58.93 Favored 'General case' 0 C--N 1.373 1.61 0 CA-C-N 124.809 3.459 . . . . 0.0 114.389 167.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.2 t -67.01 -40.95 86.65 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.766 0 CA-C-O 117.523 -1.227 . . . . 0.0 111.793 171.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -62.62 -45.23 93.83 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 116.605 2.076 . . . . 0.0 116.605 171.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.26 -32.92 73.43 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-N 120.227 1.376 . . . . 0.0 113.85 173.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.03 -40.97 97.52 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 166.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -58.17 -40.25 80.97 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 166.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.9 tptt -68.62 -54.01 19.09 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 177.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.9 mt -83.31 -19.86 35.46 Favored 'General case' 0 CA--C 1.57 1.739 0 N-CA-C 116.972 2.212 . . . . 0.0 116.972 178.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.48 39.89 7.55 Favored Glycine 0 CA--C 1.554 2.482 0 N-CA-C 117.543 1.777 . . . . 0.0 117.543 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.505 ' CG2' ' HA ' ' A' ' 81' ' ' PHE . 18.8 mm -110.1 157.87 36.71 Favored Pre-proline 0 CA--C 1.572 1.827 0 CA-C-N 118.531 1.166 . . . . 0.0 113.457 -168.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -84.49 99.79 0.76 Allowed 'Trans proline' 0 CA--C 1.568 2.182 0 CA-C-N 122.146 1.802 . . . . 0.0 110.062 163.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.26 113.66 4.75 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.448 -0.783 . . . . 0.0 111.276 172.027 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 32.3 mm -98.12 108.14 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 N-CA-C 104.501 -2.407 . . . . 0.0 104.501 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 73.9 m -95.45 128.45 42.32 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 168.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.3 p -71.27 -8.28 52.6 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 116.94 2.2 . . . . 0.0 116.94 -172.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -87.12 -21.86 47.65 Favored Glycine 0 CA--C 1.551 2.288 0 N-CA-C 118.106 2.003 . . . . 0.0 118.106 165.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -79.79 -51.55 9.03 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -168.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -62.09 -41.85 98.61 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 172.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.443 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 26.0 m-85 -60.73 -37.08 80.54 Favored 'General case' 0 CA--C 1.564 1.513 0 N-CA-C 116.259 1.948 . . . . 0.0 116.259 168.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -60.09 -42.96 95.76 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 120.017 1.28 . . . . 0.0 114.035 167.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -60.33 -38.87 85.11 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 168.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -66.25 -28.14 68.49 Favored 'General case' 0 CA--C 1.575 1.923 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 168.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 73.9 mt -63.73 -46.74 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 CA-C-N 120.131 1.332 . . . . 0.0 111.434 168.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -65.35 -36.39 83.87 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 172.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -78.38 -32.08 48.71 Favored 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.14 73.69 1.28 Allowed Glycine 0 CA--C 1.544 1.855 0 CA-C-O 118.348 -1.251 . . . . 0.0 114.884 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.761 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 68.6 p -97.62 -44.53 6.75 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 178.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.761 ' HB2' ' O ' ' A' ' 43' ' ' THR . 76.9 mttt 102.35 -39.16 0.01 OUTLIER 'General case' 0 CA--C 1.579 2.072 0 CA-C-O 117.372 -1.299 . . . . 0.0 112.202 -171.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -89.01 1.8 54.98 Favored 'General case' 0 CA--C 1.58 2.103 0 CA-C-N 121.805 2.093 . . . . 0.0 113.251 163.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -81.9 -54.48 3.41 Favored Glycine 0 C--N 1.349 1.299 0 O-C-N 120.761 -1.212 . . . . 0.0 114.657 169.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.303 4.0 p -75.95 -52.38 18.02 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.441 0 N-CA-C 115.073 1.509 . . . . 0.0 115.073 -168.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -67.19 -48.93 66.42 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 120.586 1.539 . . . . 0.0 112.307 175.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.81 -19.32 62.01 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.443 ' HB2' ' HB3' ' A' ' 35' ' ' PHE . 14.2 tmtt? -74.64 -47.02 34.37 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 117.111 -1.423 . . . . 0.0 111.825 165.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -67.71 -53.55 26.66 Favored 'General case' 0 CA--C 1.591 2.539 1 CA-C-O 86.12 -16.181 . . . . 0.0 118.001 -173.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 15.9 m-30 -31.62 -64.41 0.16 Allowed 'General case' 0 N--CA 1.496 1.848 1 O-C-N 110.232 -7.793 . . . . 0.0 120.803 146.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.5 tp -60.8 -23.97 65.46 Favored 'General case' 0 CA--C 1.579 2.095 0 CA-C-N 122.201 2.273 . . . . 0.0 116.779 172.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -92.58 -43.27 9.22 Favored 'General case' 0 CA--C 1.569 1.68 0 C-N-CA 126.332 1.853 . . . . 0.0 114.737 168.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.41 -48.01 12.47 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 120.741 1.609 . . . . 0.0 115.318 -176.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . 0.438 ' HA2' HH12 ' A' ' 88' ' ' ARG . . . 116.99 41.42 0.71 Allowed Glycine 0 CA--C 1.539 1.542 0 N-CA-C 116.389 1.316 . . . . 0.0 116.389 169.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -105.73 -132.47 0.31 Allowed 'General case' 0 CA--C 1.572 1.802 0 CA-C-O 118.584 -0.722 . . . . 0.0 109.479 168.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.9 mt -108.23 109.95 21.44 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 120.163 1.347 . . . . 0.0 111.334 -168.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.9 p -117.11 129.49 25.29 Favored Pre-proline 0 CA--C 1.573 1.829 0 CA-C-O 117.796 -1.097 . . . . 0.0 110.225 178.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -60.73 145.2 99.31 Favored 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 123.475 2.783 . . . . 0.0 116.288 173.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 98.8 p -78.12 -45.07 24.32 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 178.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -66.82 -40.65 88.08 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 115.726 1.751 . . . . 0.0 115.726 -175.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.67 -43.88 97.13 Favored 'General case' 0 N--CA 1.506 2.341 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 172.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.3 m -61.46 -41.19 96.86 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.201 -1.363 . . . . 0.0 112.986 173.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -65.08 -26.58 68.29 Favored 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 166.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.41 -46.49 73.06 Favored 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 170.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.8 mt -60.64 -48.28 82.49 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 169.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 55.5 t -58.99 -52.17 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 124.024 0.93 . . . . 0.0 112.435 174.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -62.68 -31.16 72.0 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 116.344 1.979 . . . . 0.0 116.344 173.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -58.74 -42.99 90.08 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 117.558 -1.211 . . . . 0.0 113.462 169.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -81.35 -16.78 51.31 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 119.217 3.043 . . . . 0.0 119.217 168.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 88.7 mt -92.82 -17.88 23.57 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 117.067 2.247 . . . . 0.0 117.067 177.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 . . . . . 0 N--CA 1.498 1.95 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 169.17 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.445 0 CA-C-O 122.942 1.301 . . . . 0.0 114.298 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.505 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . 28.8 p90 -165.85 139.56 4.41 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 113.236 -1.482 . . . . 0.0 111.967 175.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.3 mm -101.39 110.39 28.12 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.764 0 N-CA-C 104.624 -2.361 . . . . 0.0 104.624 170.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.9 mt -106.09 130.22 54.03 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 174.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -128.99 117.85 21.62 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 119.206 0.912 . . . . 0.0 110.916 -166.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 76.06 36.72 40.02 Favored Glycine 0 CA--C 1.55 2.231 0 N-CA-C 118.051 1.981 . . . . 0.0 118.051 -176.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . 0.256 2.3 t80 -107.24 -66.14 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.921 0 CA-C-O 113.834 -2.984 . . . . 0.0 112.105 -176.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -61.79 47.97 0.09 OUTLIER 'Trans proline' 0 CA--C 1.576 2.602 0 N-CA-C 122.229 3.896 . . . . 0.0 122.229 171.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.438 HH12 ' HA2' ' A' ' 56' ' ' GLY . 0.8 OUTLIER -64.42 -21.76 66.74 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 116.821 2.156 . . . . 0.0 116.821 166.547 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 36.6 t -131.14 146.84 52.5 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 -172.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . 0.534 ' H ' ' HG2' ' A' ' 147' ' ' GLU . 1.0 OUTLIER -61.89 -35.78 70.02 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.724 0 CA-C-O 117.26 -1.352 . . . . 0.0 110.827 169.543 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.56 -45.66 81.14 Favored 'General case' 0 CA--C 1.559 1.323 0 N-CA-C 120.524 3.528 . . . . 0.0 120.524 168.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -67.32 -47.47 70.44 Favored 'General case' 0 CA--C 1.588 2.437 0 CA-C-N 122.264 2.302 . . . . 0.0 112.927 169.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.14 -33.1 73.86 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 116.405 2.002 . . . . 0.0 116.405 -169.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.44 ' HA ' ' HH ' ' A' ' 154' ' ' TYR . 84.8 mttt -63.46 -28.1 69.73 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 166.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.93 -46.31 62.7 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 169.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 22.6 tp -64.41 -37.96 89.34 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 173.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 56.6 t60 -68.43 -39.35 81.59 Favored 'General case' 0 CA--C 1.567 1.63 0 CA-C-N 119.695 1.134 . . . . 0.0 113.825 169.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.939 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 22.8 mt-10 -52.2 -41.44 62.69 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 166.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 1.126 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 3.3 tpt -84.09 -26.93 28.58 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 117.724 2.49 . . . . 0.0 117.724 175.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 30.9 tp -64.28 -55.33 22.11 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 120.214 1.37 . . . . 0.0 112.393 168.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -80.26 -51.68 8.62 Favored 'General case' 0 CA--C 1.562 1.42 0 CA-C-O 118.671 -0.68 . . . . 0.0 112.715 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.939 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 75.0 mtp180 -71.66 -41.06 69.19 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 176.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 1.126 ' HB3' ' O ' ' A' ' 99' ' ' MET . 0.8 OUTLIER -63.2 -55.14 27.5 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 119.759 1.163 . . . . 0.0 110.59 164.638 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.67 48.4 1.04 Allowed Glycine 0 N--CA 1.482 1.713 0 O-C-N 123.83 0.706 . . . . 0.0 113.274 169.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 29.7 p -99.91 163.61 12.38 Favored 'General case' 0 CA--C 1.56 1.343 0 O-C-N 124.594 0.82 . . . . 0.0 111.074 -178.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -75.56 134.78 40.64 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.64 -0.663 . . . . 0.0 111.748 -169.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 8.0 tp -109.64 106.05 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.42 -68.21 0.81 Allowed 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 117.446 -1.264 . . . . 0.0 107.701 167.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -159.87 136.83 9.34 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 120.601 1.546 . . . . 0.0 115.119 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 48.7 t -91.35 114.38 28.51 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.734 0 N-CA-C 103.733 -2.691 . . . . 0.0 103.733 162.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.439 HD21 ' HB2' ' A' ' 160' ' ' LYS . 84.3 mt -103.04 110.74 22.77 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.338 0.655 . . . . 0.0 111.959 -169.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -96.06 124.47 40.08 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.313 0.578 . . . . 0.0 110.849 175.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -92.68 123.87 36.28 Favored 'General case' 0 CA--C 1.561 1.388 0 CA-C-O 123.341 1.543 . . . . 0.0 110.147 -173.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.417 ' HB3' ' HA ' ' A' ' 163' ' ' ASP . 74.3 ttt180 -82.09 95.05 7.34 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 112.559 -2.109 . . . . 0.0 109.229 168.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.6 p . . . . . 0 CA--C 1.559 1.299 0 C-N-CA 125.864 1.666 . . . . 0.0 107.348 -168.579 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . 0.461 ' HA ' ' HD3' ' A' ' 142' ' ' LYS . 11.6 t-20 . . . . . 0 N--CA 1.499 2.018 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.01 -38.93 77.09 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 165.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 24.7 ttt -65.03 -33.12 75.28 Favored 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 168.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.461 ' HD3' ' HA ' ' A' ' 139' ' ' ASN . 60.5 mtpt -59.71 -52.23 66.4 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 168.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 14.8 p -62.67 -36.44 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.267 0 N-CA-C 114.109 1.152 . . . . 0.0 114.109 170.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -55.31 -50.29 69.95 Favored 'General case' 0 CA--C 1.581 2.161 0 CA-C-N 120.059 1.299 . . . . 0.0 112.974 169.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -61.55 -45.29 94.8 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 117.72 2.489 . . . . 0.0 117.72 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.01 -38.36 65.04 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 117.345 2.35 . . . . 0.0 117.345 175.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . 0.534 ' HG2' ' H ' ' A' ' 90' ' ' VAL . 2.3 mp0 -123.47 -35.91 2.87 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 119.534 3.161 . . . . 0.0 119.534 -165.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 86.0 m -49.31 -31.3 8.85 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 118.441 2.756 . . . . 0.0 118.441 -166.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.17 -63.04 2.66 Favored Pre-proline 0 CA--C 1.582 2.192 0 CA-C-N 121.157 1.799 . . . . 0.0 111.212 170.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -54.21 -32.1 69.21 Favored 'Trans proline' 0 CA--C 1.571 2.363 0 C-N-CA 123.4 2.734 . . . . 0.0 118.899 167.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.3 tp -71.74 -42.87 66.74 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 117.812 -1.09 . . . . 0.0 112.511 174.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 1.042 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 49.5 tp -63.56 -24.43 67.8 Favored 'General case' 0 CA--C 1.569 1.704 0 CA-C-N 120.656 1.571 . . . . 0.0 113.875 170.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -69.84 -49.69 50.0 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 121.829 2.104 . . . . 0.0 113.038 163.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.44 ' HH ' ' HA ' ' A' ' 94' ' ' LYS . 2.8 t80 -65.19 -52.31 55.68 Favored 'General case' 0 CA--C 1.564 1.49 0 CA-C-N 121.15 1.795 . . . . 0.0 112.69 -177.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -82.0 -22.52 36.48 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-O 115.128 -2.368 . . . . 0.0 112.804 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 1.042 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 40.3 ttt180 -66.07 -35.87 81.7 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 125.016 3.553 . . . . 0.0 115.653 168.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -68.41 -36.9 79.78 Favored 'General case' 0 CA--C 1.575 1.928 0 CA-C-N 119.673 1.124 . . . . 0.0 114.006 167.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -88.08 -31.98 18.97 Favored 'General case' 0 CA--C 1.575 1.914 0 N-CA-C 119.203 3.038 . . . . 0.0 119.203 -178.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.8 pp -79.87 174.33 11.69 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 118.412 2.745 . . . . 0.0 118.412 -162.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.439 ' HB2' HD21 ' A' ' 111' ' ' LEU . 61.7 mttp -133.24 137.27 46.02 Favored 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 166.041 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.0 t -96.34 154.28 17.35 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.341 1.067 . . . . 0.0 112.085 -175.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 59.5 t -127.75 142.82 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 171.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.417 ' HA ' ' HB3' ' A' ' 114' ' ' ARG . 35.4 t70 -95.3 132.28 40.48 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 168.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -159.49 99.26 1.44 Allowed 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 122.26 1.029 . . . . 0.0 113.317 -163.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.9 t . . . . . 0 N--CA 1.487 1.396 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 174.431 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 . . . . . 0 N--CA 1.5 2.05 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -61.55 -53.24 58.88 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 119.371 0.987 . . . . 0.0 113.28 169.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 61.6 t -57.73 -37.94 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 176.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -62.07 -33.53 74.57 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 116.45 2.019 . . . . 0.0 116.45 168.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -63.01 -47.28 83.77 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 171.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -61.8 -41.63 97.98 Favored 'General case' 0 CA--C 1.556 1.208 0 N-CA-C 116.676 2.102 . . . . 0.0 116.676 169.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.37 -42.39 91.5 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 116.212 1.931 . . . . 0.0 116.212 171.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.6 mp -65.99 -40.38 91.15 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 117.403 -1.284 . . . . 0.0 114.294 169.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 37.6 mtt180 -53.38 -43.27 67.7 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 116.442 2.015 . . . . 0.0 116.442 168.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -69.7 -41.82 74.89 Favored 'General case' 0 CA--C 1.562 1.438 0 N-CA-C 116.335 1.976 . . . . 0.0 116.335 172.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 6.8 tt -74.87 -57.14 4.09 Favored 'General case' 0 CA--C 1.566 1.566 0 CA-C-N 121.003 1.729 . . . . 0.0 111.729 177.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.651 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -117.36 -59.86 0.3 Allowed Glycine 0 CA--C 1.551 2.333 0 CA-C-O 117.621 -1.655 . . . . 0.0 114.898 -177.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.651 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 36.5 ttmt . . . . . 0 C--O 1.252 1.195 0 CA-C-N 120.608 2.204 . . . . 0.0 107.369 -174.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.1 mtt . . . . . 0 N--CA 1.483 1.213 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.38 165.94 31.58 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 117.744 2.498 . . . . 0.0 117.744 -165.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.65 155.56 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-O 124.044 1.878 . . . . 0.0 112.978 -165.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.7 pp -138.86 127.31 23.03 Favored 'General case' 0 CA--C 1.559 1.313 0 CA-C-N 112.618 -2.083 . . . . 0.0 108.718 168.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 tt -96.53 134.72 39.39 Favored 'General case' 0 CA--C 1.559 1.304 0 CA-C-O 122.879 1.324 . . . . 0.0 113.765 -165.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -135.26 157.41 46.97 Favored 'General case' 0 CA--C 1.56 1.335 0 CA-C-N 112.062 -2.335 . . . . 0.0 111.356 -169.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 156.67 135.98 2.05 Favored Glycine 0 CA--C 1.554 2.495 0 CA-C-O 117.412 -1.771 . . . . 0.0 111.905 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo . . . . . 0 CA--C 1.577 2.625 0 CA-C-N 122.789 3.294 . . . . 0.0 113.241 171.43 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.8 mptt . . . . . 0 N--CA 1.496 1.842 0 CA-C-O 120.746 0.308 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -40.94 -30.67 0.39 Allowed Glycine 0 CA--C 1.557 2.667 0 N-CA-C 121.254 3.262 . . . . 0.0 121.254 169.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.2 p -58.62 -63.04 1.43 Allowed 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 119.543 1.671 . . . . 0.0 114.507 171.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.264 5.7 mm-40 -75.28 -13.67 60.45 Favored 'General case' 0 CA--C 1.571 1.754 0 CA-C-O 116.536 -1.697 . . . . 0.0 111.432 175.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.83 -48.38 63.68 Favored 'General case' 0 C--N 1.373 1.609 0 CA-C-N 122.532 2.424 . . . . 0.0 113.946 166.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.6 t -66.43 -38.23 81.32 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.834 0 CA-C-O 117.89 -1.053 . . . . 0.0 111.931 176.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -63.09 -51.3 67.15 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 116.809 2.151 . . . . 0.0 116.809 169.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.401 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 0.9 OUTLIER -62.04 -35.24 78.0 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-N 119.969 1.259 . . . . 0.0 114.255 174.771 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.63 -45.21 94.92 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 116.405 2.002 . . . . 0.0 116.405 169.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.43 -28.64 63.48 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 164.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.401 ' HB3' ' O ' ' A' ' 20' ' ' LEU . 19.0 tptm -63.82 -62.8 1.41 Allowed 'General case' 0 CA--C 1.552 1.026 0 CA-C-O 116.653 -1.641 . . . . 0.0 114.745 170.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . 0.297 0.6 OUTLIER -83.28 -15.44 50.21 Favored 'General case' 0 N--CA 1.506 2.365 0 N-CA-C 117.006 2.225 . . . . 0.0 117.006 -178.445 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.08 42.32 4.09 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 117.024 1.57 . . . . 0.0 117.024 176.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.514 ' CD1' ' HA ' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -116.69 149.16 43.43 Favored Pre-proline 0 CA--C 1.573 1.865 0 C-N-CA 127.337 2.255 . . . . 0.0 110.776 -168.911 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -73.97 101.71 1.43 Allowed 'Trans proline' 0 CA--C 1.583 2.958 0 C-N-CA 121.794 1.663 . . . . 0.0 113.568 159.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -57.4 119.99 7.44 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.919 -1.113 . . . . 0.0 113.817 169.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 26.2 mm -101.8 109.34 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 169.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.7 p -95.17 125.05 39.55 Favored 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 103.928 -2.619 . . . . 0.0 103.928 163.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 47.4 p -67.48 -12.23 59.8 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 117.14 2.274 . . . . 0.0 117.14 -168.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.485 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -85.86 -19.57 57.55 Favored Glycine 0 CA--C 1.55 2.28 0 N-CA-C 118.347 2.099 . . . . 0.0 118.347 166.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -79.61 -53.44 6.85 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 118.756 1.278 . . . . 0.0 114.062 -168.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -59.18 -39.22 81.87 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 172.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.407 ' HB2' ' HB2' ' A' ' 50' ' ' LYS . 35.4 m-85 -70.14 -43.16 71.5 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 116.262 -1.828 . . . . 0.0 113.204 171.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 47.5 ttt180 -51.8 -39.84 59.4 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 116.541 2.052 . . . . 0.0 116.541 169.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.9 -43.49 98.74 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 113.736 1.014 . . . . 0.0 113.736 169.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -65.7 -24.63 67.04 Favored 'General case' 0 CA--C 1.585 2.304 0 N-CA-C 116.441 2.015 . . . . 0.0 116.441 167.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.9 mt -62.99 -48.96 85.51 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.381 0 CA-C-N 121.288 1.858 . . . . 0.0 109.468 166.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -61.52 -41.41 97.27 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 114.355 1.242 . . . . 0.0 114.355 175.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -65.95 -40.15 91.07 Favored 'General case' 0 CA--C 1.564 1.489 0 N-CA-C 116.571 2.063 . . . . 0.0 116.571 171.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.85 70.61 1.03 Allowed Glycine 0 CA--C 1.545 1.942 0 CA-C-O 117.901 -1.5 . . . . 0.0 114.789 -179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.775 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 64.1 p -95.67 -50.79 4.79 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-N 119.414 1.607 . . . . 0.0 114.502 177.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.775 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.251 73.5 mttt 103.99 -40.98 0.01 OUTLIER 'General case' 0 CA--C 1.573 1.846 0 CA-C-O 116.303 -1.808 . . . . 0.0 111.229 -171.257 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.91 -13.99 59.48 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 123.183 2.72 . . . . 0.0 112.901 163.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.502 ' O ' ' HB3' ' A' ' 50' ' ' LYS . . . -58.56 -60.45 8.92 Favored Glycine 0 C--N 1.355 1.587 0 CA-C-N 120.725 1.602 . . . . 0.0 115.032 170.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.281 7.6 p -73.68 -50.63 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.323 0 N-CA-C 116.21 1.93 . . . . 0.0 116.21 -168.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -66.3 -46.4 77.07 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 120.352 1.433 . . . . 0.0 112.384 175.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.58 -30.98 68.88 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -178.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.502 ' HB3' ' O ' ' A' ' 46' ' ' GLY 0.27 0.6 OUTLIER -78.03 -28.21 49.01 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-O 116.827 -1.559 . . . . 0.0 114.873 170.453 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -74.06 -56.52 4.83 Favored 'General case' 0 CA--C 1.595 2.682 1 CA-C-O 87.477 -15.535 . . . . 0.0 117.314 175.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . 0.259 11.4 m-30 -24.28 -66.53 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.836 1 O-C-N 109.279 -8.388 . . . . 0.0 119.929 145.522 . . . . . . . . 3 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 41.2 mt -53.66 -38.34 64.04 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-N 121.296 1.862 . . . . 0.0 115.735 171.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -80.37 -52.98 7.04 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-O 116.799 -1.572 . . . . 0.0 113.634 170.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -158.42 43.86 0.29 Allowed 'General case' 0 CA--C 1.574 1.87 0 CA-C-N 120.909 1.686 . . . . 0.0 115.463 -168.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -151.17 27.26 1.0 Allowed Glycine 0 CA--C 1.549 2.174 0 CA-C-N 121.942 2.155 . . . . 0.0 118.443 173.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . 0.318 9.1 t70 76.37 -118.46 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 120.034 1.917 . . . . 0.0 111.127 166.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 86.3 mt -75.6 114.48 14.22 Favored 'General case' 0 CA--C 1.559 1.317 0 N-CA-C 115.308 1.596 . . . . 0.0 115.308 -164.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.5 p -118.06 138.29 25.34 Favored Pre-proline 0 CA--C 1.573 1.845 0 C-N-CA 126.089 1.755 . . . . 0.0 108.529 174.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -56.46 135.46 70.39 Favored 'Trans proline' 0 CA--C 1.56 1.807 0 C-N-CA 123.373 2.715 . . . . 0.0 116.191 173.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.6 m -70.38 -48.11 57.77 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -60.5 -43.55 96.91 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 26.4 mt -56.59 -46.82 80.61 Favored 'General case' 0 N--CA 1.509 2.483 0 N-CA-C 116.393 1.998 . . . . 0.0 116.393 175.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.1 m -58.33 -44.54 88.72 Favored 'General case' 0 CA--C 1.565 1.529 0 CA-C-N 113.022 -1.899 . . . . 0.0 113.211 173.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -61.01 -33.25 72.97 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 166.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.35 -43.97 84.54 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 175.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.2 mt -64.24 -44.8 90.7 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 168.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 54.9 t -59.09 -50.24 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 CA-C-O 118.125 -0.94 . . . . 0.0 113.073 172.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -63.0 -35.46 80.29 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 174.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -56.4 -40.23 74.31 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 118.113 -0.946 . . . . 0.0 113.31 169.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.635 HH22 ' HG ' ' A' ' 83' ' ' LEU . 0.2 OUTLIER -67.62 -45.38 75.59 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 165.616 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 83.7 mt -68.83 -7.03 30.55 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 118.12 2.637 . . . . 0.0 118.12 -178.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 . . . . . 0 CA--C 1.582 2.193 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 165.455 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.567 0 N-CA-C 116.614 1.405 . . . . 0.0 116.614 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.514 ' HA ' ' CD1' ' A' ' 26' ' ' ILE 0.311 18.9 p90 -170.09 134.42 1.25 Allowed 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 114.747 -0.726 . . . . 0.0 112.064 168.53 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.1 mp -109.98 109.16 27.4 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.537 0 N-CA-C 104.134 -2.543 . . . . 0.0 104.134 168.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.635 ' HG ' HH22 ' A' ' 71' ' ' ARG . 10.2 mt -105.76 110.49 22.81 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.487 0.715 . . . . 0.0 109.752 169.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -103.73 130.65 51.26 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 118.511 0.596 . . . . 0.0 112.59 -173.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.58 40.32 98.55 Favored Glycine 0 CA--C 1.548 2.146 0 CA-C-O 116.867 -2.074 . . . . 0.0 116.274 -176.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -89.06 -54.27 0.33 Allowed Pre-proline 0 N--CA 1.502 2.172 0 CA-C-N 120.794 2.297 . . . . 0.0 108.205 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -61.18 60.03 0.1 Allowed 'Trans proline' 0 CA--C 1.576 2.588 0 N-CA-C 121.909 3.773 . . . . 0.0 121.909 167.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -56.36 -33.97 66.19 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 163.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.6 t -155.23 158.39 38.78 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -174.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 23.9 t -68.9 -31.57 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 CA-C-O 116.689 -1.624 . . . . 0.0 111.118 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.83 -39.16 76.99 Favored 'General case' 0 CA--C 1.56 1.363 0 N-CA-C 120.133 3.383 . . . . 0.0 120.133 167.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -72.25 -46.35 56.34 Favored 'General case' 0 CA--C 1.592 2.591 0 CA-C-N 122.505 2.411 . . . . 0.0 112.777 167.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.69 -34.79 78.64 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 127.2 2.2 . . . . 0.0 116.178 -168.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 57.9 tttt -61.41 -29.66 70.07 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 166.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.12 -36.77 72.25 Favored 'General case' 0 CA--C 1.568 1.651 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 168.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.7 tp -63.14 -38.29 90.59 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 168.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 31.5 t60 -63.67 -47.26 81.99 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 119.818 1.19 . . . . 0.0 112.973 168.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.939 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 34.4 mt-10 -52.02 -31.01 27.83 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 165.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 1.226 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 23.1 ttt -84.74 -31.58 23.93 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 117.578 2.436 . . . . 0.0 117.578 175.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.475 HD21 ' HG1' ' A' ' 105' ' ' THR . 16.6 mt -64.34 -55.88 18.19 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 121.948 2.158 . . . . 0.0 110.927 167.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -76.83 -51.62 10.98 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.939 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 36.5 ttm180 -74.06 -38.51 63.93 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 115.154 1.539 . . . . 0.0 115.154 176.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 1.226 ' HB3' ' O ' ' A' ' 99' ' ' MET . 25.4 tpt180 -62.74 -54.51 38.09 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 119.986 1.266 . . . . 0.0 112.081 166.359 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 114.07 44.64 0.73 Allowed Glycine 0 N--CA 1.479 1.51 0 O-C-N 123.971 0.794 . . . . 0.0 113.76 168.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.475 ' HG1' HD21 ' A' ' 100' ' ' LEU . 31.3 p -116.23 135.33 53.99 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 177.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -65.88 135.45 54.82 Favored 'General case' 0 N--CA 1.508 2.465 0 CA-C-O 122.601 1.191 . . . . 0.0 112.435 -170.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.5 tp -84.28 99.49 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 CA-C-N 113.262 -1.79 . . . . 0.0 107.04 178.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -97.75 -68.37 0.8 Allowed 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 116.947 -1.501 . . . . 0.0 110.175 169.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -138.02 116.06 11.68 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 120.44 1.473 . . . . 0.0 114.544 -167.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 72.8 t -91.53 117.64 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 101.176 -3.638 . . . . 0.0 101.176 163.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.444 ' HA ' ' O ' ' A' ' 160' ' ' LYS 0.259 6.8 tp -116.16 109.59 17.67 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 114.804 -2.522 . . . . 0.0 115.2 -159.545 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.428 ' N ' ' HB ' ' A' ' 161' ' ' THR . 3.0 tm-20 -110.23 109.5 20.0 Favored 'General case' 0 N--CA 1.517 2.908 0 CA-C-N 123.856 3.025 . . . . 0.0 117.998 -177.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -87.85 123.51 32.69 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 125.667 1.587 . . . . 0.0 110.647 170.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -92.76 101.03 13.41 Favored 'General case' 0 CA--C 1.558 1.271 0 CA-C-N 112.543 -2.117 . . . . 0.0 109.312 169.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.5 p . . . . . 0 CA--C 1.563 1.446 0 C-N-CA 127.279 2.232 . . . . 0.0 107.894 -167.985 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 . . . . . 0 N--CA 1.497 1.891 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 69.2 mtp180 -60.43 -41.86 94.89 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 169.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 62.5 mtt -65.53 -34.18 77.65 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 169.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -64.48 -46.35 83.41 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 170.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.6 p -65.74 -32.95 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 170.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -56.73 -53.13 61.25 Favored 'General case' 0 CA--C 1.581 2.158 0 CA-C-N 119.782 1.173 . . . . 0.0 111.71 167.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 41.3 ttt180 -53.34 -22.75 7.81 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 120.37 3.47 . . . . 0.0 120.37 169.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.37 -56.81 13.67 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-N 119.858 1.208 . . . . 0.0 113.308 169.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -141.99 23.08 2.07 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 118.639 2.829 . . . . 0.0 118.639 -171.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 20.9 m -56.25 -30.26 62.16 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 116.124 1.898 . . . . 0.0 116.124 170.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.0 -60.41 5.26 Favored Pre-proline 0 CA--C 1.583 2.234 0 CA-C-N 120.68 1.582 . . . . 0.0 111.227 169.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -53.03 -27.93 38.26 Favored 'Trans proline' 0 CA--C 1.568 2.194 0 N-CA-C 119.614 2.89 . . . . 0.0 119.614 168.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 8.2 tt -70.85 -55.58 8.19 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 116.876 -1.535 . . . . 0.0 109.751 172.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 0.948 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 39.5 tp -58.43 -26.47 63.34 Favored 'General case' 0 CA--C 1.564 1.515 0 CA-C-N 121.211 1.823 . . . . 0.0 113.962 -179.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -71.53 -48.02 51.41 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 121.635 2.016 . . . . 0.0 113.409 163.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -69.92 -49.37 52.7 Favored 'General case' 0 CA--C 1.571 1.764 0 CA-C-N 121.591 1.996 . . . . 0.0 112.548 -175.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -82.16 -27.06 32.9 Favored 'General case' 0 CA--C 1.557 1.234 0 CA-C-O 115.215 -2.326 . . . . 0.0 111.437 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 0.948 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 40.8 ttt180 -67.0 -32.66 74.04 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 124.926 3.512 . . . . 0.0 115.723 167.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -67.89 -41.57 82.53 Favored 'General case' 0 CA--C 1.573 1.833 0 CA-C-N 119.713 1.142 . . . . 0.0 113.458 167.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -90.96 -28.47 18.02 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 119.675 3.213 . . . . 0.0 119.675 -176.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.8 pp -80.54 159.36 25.51 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 118.297 2.703 . . . . 0.0 118.297 -162.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 111' ' ' LEU 0.296 97.6 mttt -145.48 101.1 3.54 Favored 'General case' 0 C--N 1.361 1.072 0 CA-C-O 117.748 -1.12 . . . . 0.0 110.791 162.915 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.428 ' HB ' ' N ' ' A' ' 112' ' ' GLU 1.254 24.4 m -131.44 -153.31 0.55 Allowed 'General case' 0 CA--C 1.573 1.856 1 O-C-N 115.74 -4.35 . . . . 0.0 110.059 149.926 . . . . . . . . 4 3 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.411 ' CG1' ' H ' ' A' ' 163' ' ' ASP 0.361 4.6 t -124.53 -177.81 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.413 0 CA-C-N 111.973 -2.376 . . . . 0.0 112.976 -151.047 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.411 ' H ' ' CG1' ' A' ' 162' ' ' VAL . 10.8 t70 -112.18 123.36 50.11 Favored 'General case' 0 CA--C 1.564 1.491 0 CA-C-N 111.324 -2.671 . . . . 0.0 104.47 166.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -160.5 122.59 3.19 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.295 0.638 . . . . 0.0 110.546 -161.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.1 t . . . . . 0 N--CA 1.487 1.378 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.754 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 . . . . . 0 N--CA 1.5 2.04 0 N-CA-C 116.126 1.898 . . . . 0.0 116.126 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -60.82 -51.82 67.71 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 170.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 87.5 t -58.81 -35.25 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 CA-C-O 117.311 -1.328 . . . . 0.0 113.949 176.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -60.07 -37.96 81.46 Favored 'General case' 0 N--CA 1.504 2.257 0 CA-C-N 121.262 1.846 . . . . 0.0 115.953 166.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -61.12 -53.55 55.69 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 175.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -56.42 -41.32 76.17 Favored 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 117.478 2.399 . . . . 0.0 117.478 169.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -53.28 -46.29 69.22 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 116.172 1.915 . . . . 0.0 116.172 169.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.7 mp -60.97 -44.99 96.54 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 117.388 -1.291 . . . . 0.0 113.962 168.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -50.66 -42.23 56.33 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 169.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -67.08 -45.17 78.11 Favored 'General case' 0 CA--C 1.561 1.369 0 N-CA-C 116.153 1.908 . . . . 0.0 116.153 171.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 6.6 tt -77.52 -55.15 5.62 Favored 'General case' 0 CA--C 1.568 1.665 0 CA-C-N 121.051 1.75 . . . . 0.0 112.38 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.835 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -130.7 -55.5 0.09 OUTLIER Glycine 0 CA--C 1.553 2.427 0 CA-C-O 117.628 -1.651 . . . . 0.0 115.807 -175.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.835 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 86.3 tttt . . . . . 0 C--O 1.251 1.153 0 CA-C-N 120.533 2.167 . . . . 0.0 108.874 -175.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.5 mtt . . . . . 0 CA--C 1.557 1.219 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.78 169.54 21.41 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 117.612 2.449 . . . . 0.0 117.612 -167.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.9 p -127.94 138.43 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 CA-C-N 115.116 -0.947 . . . . 0.0 113.532 -165.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -118.02 120.46 37.85 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 171.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -99.02 121.78 41.41 Favored 'General case' 0 CA--C 1.563 1.453 0 CA-C-O 122.376 1.084 . . . . 0.0 112.538 -167.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.4 mt -114.23 154.11 28.47 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 111.042 -2.799 . . . . 0.0 109.333 -172.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 175.24 107.9 0.21 Allowed Glycine 0 CA--C 1.549 2.178 0 CA-C-O 116.694 -2.17 . . . . 0.0 109.48 175.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo . . . . . 0 CA--C 1.574 2.525 0 CA-C-N 122.247 3.024 . . . . 0.0 117.863 -179.342 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt . . . . . 0 N--CA 1.488 1.454 0 N-CA-C 116.367 1.988 . . . . 0.0 116.367 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -32.59 -36.65 0.04 OUTLIER Glycine 0 CA--C 1.556 2.62 0 N-CA-C 122.877 3.911 . . . . 0.0 122.877 172.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.0 m -62.63 -56.26 19.48 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 120.069 1.934 . . . . 0.0 112.664 174.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.277 17.1 mp0 -74.55 -12.25 60.42 Favored 'General case' 0 CA--C 1.574 1.889 0 CA-C-O 115.427 -2.225 . . . . 0.0 112.655 170.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.67 -45.27 68.76 Favored 'General case' 0 C--N 1.374 1.664 0 CA-C-N 124.506 3.321 . . . . 0.0 114.513 167.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.7 t -69.95 -38.71 76.19 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.849 0 CA-C-O 117.672 -1.156 . . . . 0.0 111.569 174.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -61.33 -47.21 86.94 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 116.6 2.074 . . . . 0.0 116.6 169.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 mt -65.62 -31.08 71.92 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 172.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.97 -44.25 97.62 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 166.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -58.69 -37.69 76.63 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 168.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -67.1 -50.94 59.86 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 172.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.6 mt -83.69 -19.83 34.59 Favored 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 -177.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.97 36.11 10.52 Favored Glycine 0 CA--C 1.555 2.548 0 N-CA-C 117.889 1.915 . . . . 0.0 117.889 -177.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.425 ' CG2' ' HA ' ' A' ' 81' ' ' PHE . 16.4 mm -111.53 158.11 37.31 Favored Pre-proline 0 CA--C 1.572 1.796 0 CA-C-N 119.088 1.444 . . . . 0.0 113.811 -167.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -81.81 100.58 1.1 Allowed 'Trans proline' 0 CA--C 1.573 2.436 0 C-N-CA 122.115 1.876 . . . . 0.0 111.081 162.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -64.47 110.59 2.34 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 124.074 0.949 . . . . 0.0 111.887 171.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.7 mm -99.71 113.6 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 177.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 78.9 p -96.43 136.04 37.47 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 114.942 -1.026 . . . . 0.0 108.691 169.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.0 p -69.73 -7.88 43.23 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 117.585 2.439 . . . . 0.0 117.585 -175.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.436 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -90.43 -22.61 33.93 Favored Glycine 0 CA--C 1.545 1.937 0 N-CA-C 118.563 2.185 . . . . 0.0 118.563 165.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -80.74 -51.86 8.18 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -168.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -63.53 -41.44 98.48 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 173.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.482 ' HB3' ' CG ' ' A' ' 50' ' ' LYS . 29.6 m-85 -61.13 -43.4 98.94 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-O 116.431 -1.747 . . . . 0.0 115.136 168.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 72.8 ttt180 -54.97 -44.02 74.04 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 170.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 33.7 ttt180 -59.47 -40.98 88.67 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 114.668 1.358 . . . . 0.0 114.668 168.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -68.33 -24.19 64.8 Favored 'General case' 0 CA--C 1.582 2.188 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 169.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 82.5 mt -63.03 -49.49 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 CA-C-N 120.835 1.652 . . . . 0.0 110.299 167.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -65.26 -35.29 80.58 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 175.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -68.72 -42.8 77.17 Favored 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 174.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.45 69.4 1.27 Allowed Glycine 0 CA--C 1.545 1.947 0 CA-C-O 118.905 -0.942 . . . . 0.0 114.518 -174.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.796 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 64.8 p -91.52 -49.09 6.5 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 178.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.796 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.26 38.8 mttp 110.61 -42.37 0.0 OUTLIER 'General case' 0 CA--C 1.57 1.716 0 CA-C-O 116.135 -1.888 . . . . 0.0 110.876 -172.718 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -83.08 -10.86 58.48 Favored 'General case' 0 CA--C 1.574 1.872 0 CA-C-N 123.425 2.83 . . . . 0.0 113.106 162.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.37 -55.32 24.08 Favored Glycine 0 CA--C 1.544 1.853 0 CA-C-N 120.535 1.516 . . . . 0.0 114.276 169.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.267 1.0 OUTLIER -75.62 -50.21 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 116.729 2.122 . . . . 0.0 116.729 -168.556 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -67.16 -41.4 86.08 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 120.476 1.489 . . . . 0.0 112.565 174.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.88 -25.47 48.59 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -174.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.482 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -75.0 -41.01 60.34 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 117.064 -1.446 . . . . 0.0 111.871 166.699 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -71.63 -51.32 23.78 Favored 'General case' 0 CA--C 1.591 2.536 1 CA-C-O 85.298 -16.572 . . . . 0.0 118.444 -176.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 14.9 m-30 -35.25 -55.4 0.63 Allowed 'General case' 0 N--CA 1.496 1.844 2 O-C-N 108.913 -8.617 . . . . 0.0 121.85 147.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 71.6 mt -60.83 -32.77 72.14 Favored 'General case' 0 N--CA 1.51 2.571 0 CA-C-N 124.283 3.22 . . . . 0.0 114.799 167.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -83.09 -45.25 14.21 Favored 'General case' 0 CA--C 1.568 1.663 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 172.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.15 -28.23 25.67 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 116.81 2.152 . . . . 0.0 116.81 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.64 42.59 4.76 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-N 120.243 1.383 . . . . 0.0 115.952 170.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.423 ' O ' ' NH1' ' A' ' 88' ' ' ARG . 20.2 t70 -105.17 -132.53 0.31 Allowed 'General case' 0 CA--C 1.571 1.75 0 CA-C-O 118.532 -0.747 . . . . 0.0 109.548 169.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 88.8 mt -115.15 111.91 21.73 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 120.054 1.297 . . . . 0.0 110.192 -169.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.1 p -112.74 116.91 47.37 Favored Pre-proline 0 CA--C 1.568 1.651 0 CA-C-O 117.848 -1.072 . . . . 0.0 109.26 -178.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -59.64 144.24 99.48 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 123.477 2.785 . . . . 0.0 116.354 176.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 85.5 p -77.97 178.28 7.61 Favored 'General case' 0 CA--C 1.567 1.604 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 176.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.27 16.8 m-20 80.33 -51.53 0.35 Allowed 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 126.324 1.85 . . . . 0.0 113.998 175.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.9 pp -61.91 -42.46 99.1 Favored 'General case' 0 CA--C 1.563 1.459 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 167.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.2 m -61.43 -50.51 72.5 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.331 1.052 . . . . 0.0 112.805 174.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -64.41 -21.06 66.52 Favored 'General case' 0 CA--C 1.571 1.783 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 167.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -68.52 -47.11 67.8 Favored 'General case' 0 CA--C 1.557 1.234 0 CA-C-N 120.507 1.503 . . . . 0.0 114.0 168.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.9 mt -63.1 -37.74 88.42 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 168.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 56.7 t -58.39 -53.21 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-O 118.08 -0.962 . . . . 0.0 112.059 169.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -60.37 -36.17 77.42 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 172.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -56.61 -48.4 77.53 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 116.642 -1.646 . . . . 0.0 113.097 169.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -87.61 7.53 29.34 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 120.666 3.58 . . . . 0.0 120.666 167.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 69.9 mt -66.44 -49.38 66.92 Favored 'General case' 0 CA--C 1.559 1.296 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 150.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 . . . . . 0 N--CA 1.504 2.258 0 CA-C-N 121.267 1.848 . . . . 0.0 111.535 -167.409 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.551 0 CA-C-O 122.409 1.005 . . . . 0.0 114.061 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.425 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . 10.4 p90 -175.83 136.95 0.33 Allowed 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 114.205 -0.998 . . . . 0.0 110.849 -176.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 4.9 mm -108.97 107.89 23.97 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.489 0 N-CA-C 103.224 -2.88 . . . . 0.0 103.224 167.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 79.5 mt -114.62 118.02 32.52 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -178.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -114.54 132.34 56.35 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 118.927 0.785 . . . . 0.0 112.398 -169.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 75.56 36.06 44.78 Favored Glycine 0 CA--C 1.55 2.265 0 N-CA-C 118.803 2.281 . . . . 0.0 118.803 172.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -99.65 -58.52 0.13 Allowed Pre-proline 0 N--CA 1.495 1.787 0 CA-C-O 113.536 -3.126 . . . . 0.0 111.479 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -59.66 61.5 0.07 OUTLIER 'Trans proline' 0 CA--C 1.574 2.492 1 N-CA-C 123.141 4.247 . . . . 0.0 123.141 170.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 1.455 ' CG ' HH12 ' A' ' 140' ' ' ARG . 13.9 ttp180 -52.01 -39.68 59.83 Favored 'General case' 0 CA--C 1.573 1.859 0 N-CA-C 116.124 1.898 . . . . 0.0 116.124 163.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.3 t -154.97 153.7 31.45 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.156 1.383 . . . . 0.0 107.636 -168.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.2 t -60.16 -37.5 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 CA-C-O 117.167 -1.397 . . . . 0.0 112.188 177.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.96 -37.02 80.93 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 120.596 3.554 . . . . 0.0 120.596 172.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -77.81 -46.77 20.58 Favored 'General case' 0 CA--C 1.588 2.418 0 CA-C-N 123.468 2.849 . . . . 0.0 111.635 166.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.16 -32.87 72.6 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 117.999 2.592 . . . . 0.0 117.999 -172.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -57.54 -33.54 68.21 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 168.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.77 -39.88 88.01 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 170.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 39.2 tp -64.62 -40.11 94.9 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 169.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -60.24 -53.06 62.22 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-N 119.715 1.143 . . . . 0.0 113.37 170.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 0.9 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 35.6 mt-10 -48.01 -38.47 17.15 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 167.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 1.277 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 25.0 ttt -84.38 -25.21 29.28 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 117.825 2.528 . . . . 0.0 117.825 176.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 41.9 tp -68.38 -53.7 22.12 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-N 120.59 1.541 . . . . 0.0 110.912 169.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -76.33 -54.4 6.81 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 119.37 0.987 . . . . 0.0 113.416 175.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.9 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 75.9 mtp180 -71.6 -39.39 70.53 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 177.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 1.277 ' HB3' ' O ' ' A' ' 99' ' ' MET . 3.6 tmt_? -61.78 -56.02 23.95 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 119.699 1.136 . . . . 0.0 110.375 164.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 113.26 41.63 0.96 Allowed Glycine 0 N--CA 1.481 1.692 0 O-C-N 124.076 0.86 . . . . 0.0 114.96 167.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 36.5 p -102.13 137.6 40.19 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 169.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -71.14 135.28 47.54 Favored 'General case' 0 N--CA 1.51 2.55 0 CA-C-O 122.699 1.238 . . . . 0.0 112.293 -171.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.2 tp -79.68 102.25 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 CA-C-N 113.356 -1.747 . . . . 0.0 108.089 172.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -96.08 -61.8 1.38 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 117.301 -1.333 . . . . 0.0 110.428 167.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -150.55 112.3 4.5 Favored 'General case' 0 C--N 1.36 1.024 0 CA-C-N 120.309 1.413 . . . . 0.0 113.707 -166.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -97.17 104.67 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.678 0 CA-C-N 115.085 -0.962 . . . . 0.0 111.0 167.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.968 HD12 ' HB3' ' A' ' 160' ' ' LYS 0.311 6.9 tp -103.49 111.23 23.58 Favored 'General case' 0 CA--C 1.556 1.201 0 N-CA-C 118.446 2.758 . . . . 0.0 118.446 -157.073 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.518 ' H ' ' N ' ' A' ' 161' ' ' THR . 68.0 mt-10 -96.72 107.47 19.94 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 122.062 2.21 . . . . 0.0 115.528 -172.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -88.0 108.93 19.45 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 118.706 -2.496 . . . . 0.0 108.324 170.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.753 ' HB3' ' HA ' ' A' ' 163' ' ' ASP . 10.1 tpt180 -95.18 95.14 8.34 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 112.575 -2.102 . . . . 0.0 110.359 -172.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.564 1.483 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 -168.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 . . . . . 0 N--CA 1.496 1.86 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . 1.455 HH12 ' CG ' ' A' ' 88' ' ' ARG . 14.6 tpt180 -63.39 -43.7 96.81 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 169.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 67.4 mtt -66.04 -27.77 68.35 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 169.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -68.05 -44.56 76.11 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 169.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.5 p -66.06 -35.77 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 CA-C-N 120.514 1.507 . . . . 0.0 114.251 170.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -53.35 -56.33 17.61 Favored 'General case' 0 CA--C 1.581 2.151 0 CA-C-N 120.129 1.331 . . . . 0.0 111.522 167.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 49.9 ttt180 -53.88 -27.59 31.16 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 120.326 3.454 . . . . 0.0 120.326 173.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -54.61 -38.25 66.56 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 171.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -141.33 10.03 2.08 Favored 'General case' 0 CA--C 1.561 1.38 0 N-CA-C 119.389 3.107 . . . . 0.0 119.389 -168.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 80.3 m -47.49 -36.49 10.29 Favored 'General case' 0 N--CA 1.505 2.321 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 177.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.62 -60.95 4.13 Favored Pre-proline 0 CA--C 1.578 2.054 0 CA-C-O 116.254 -1.831 . . . . 0.0 112.021 173.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -51.07 -32.9 41.02 Favored 'Trans proline' 0 CA--C 1.578 2.689 0 C-N-CA 123.407 2.738 . . . . 0.0 118.351 167.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -67.08 -50.45 61.66 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 125.02 1.328 . . . . 0.0 111.797 176.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 1.173 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 58.3 tp -63.26 -23.53 67.46 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 170.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -70.41 -50.92 33.55 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 122.696 2.498 . . . . 0.0 113.108 165.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -61.27 -53.75 52.78 Favored 'General case' 0 CA--C 1.571 1.788 0 C-N-CA 124.141 0.976 . . . . 0.0 112.864 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -80.87 -17.62 50.05 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-O 116.006 -1.949 . . . . 0.0 113.82 177.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 1.173 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 31.7 ttt180 -69.66 -33.86 73.19 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 123.591 2.905 . . . . 0.0 115.733 167.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -73.11 -40.47 64.93 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 119.979 1.263 . . . . 0.0 113.659 167.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -82.14 -18.05 44.23 Favored 'General case' 0 CA--C 1.577 1.985 0 N-CA-C 119.142 3.016 . . . . 0.0 119.142 177.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.29 127.19 18.89 Favored 'General case' 0 CA--C 1.585 2.309 1 N-CA-C 123.692 4.701 . . . . 0.0 123.692 -159.754 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.968 ' HB3' HD12 ' A' ' 111' ' ' LEU 0.257 46.7 mmtm -92.88 -154.15 0.38 Allowed 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 123.716 1.722 . . . . 0.0 107.708 155.385 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.518 ' N ' ' H ' ' A' ' 112' ' ' GLU 0.763 0.4 OUTLIER -30.93 -164.83 0.0 OUTLIER 'General case' 0 CA--C 1.62 3.663 1 N-CA-C 128.041 6.312 . . . . 0.0 128.041 -146.103 . . . . . . . . 5 4 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . 0.601 ' O ' ' HB2' ' A' ' 114' ' ' ARG 0.475 2.1 t -88.4 -174.42 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.673 3 C-N-CA 139.219 7.008 . . . . 0.0 122.586 -146.687 . . . . . . . . 4 3 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.753 ' HA ' ' HB3' ' A' ' 114' ' ' ARG . 12.6 t70 -102.49 134.77 45.28 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 111.38 -2.645 . . . . 0.0 106.59 168.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -143.37 -146.03 0.18 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 117.057 2.243 . . . . 0.0 117.057 -155.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . 0.532 3.5 p . . . . . 0 N--CA 1.492 1.66 0 C-N-CA 128.503 2.721 . . . . 0.0 114.078 -174.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 . . . . . 0 N--CA 1.5 2.05 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -60.16 -53.4 58.22 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 173.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 18.2 t -66.71 -31.67 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 CA-C-N 119.778 1.172 . . . . 0.0 111.533 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -58.78 -38.17 77.92 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 164.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.46 -50.69 64.43 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . 0.512 ' HB3' HG22 ' A' ' 162' ' ' VAL . 72.9 mtt180 -61.15 -42.18 98.09 Favored 'General case' 0 CA--C 1.557 1.216 0 N-CA-C 117.305 2.335 . . . . 0.0 117.305 169.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.04 -46.87 82.09 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 116.512 2.042 . . . . 0.0 116.512 172.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 6.0 mp -63.5 -39.49 94.57 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 117.832 -1.08 . . . . 0.0 113.756 168.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -50.42 -45.81 56.02 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 169.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -74.57 -42.83 58.05 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 116.14 1.904 . . . . 0.0 116.14 172.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 8.7 tt -73.57 -51.47 16.81 Favored 'General case' 0 CA--C 1.568 1.645 0 CA-C-N 121.005 1.73 . . . . 0.0 113.213 -179.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.931 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -114.74 -59.52 0.37 Allowed Glycine 0 CA--C 1.552 2.385 0 CA-C-O 117.709 -1.606 . . . . 0.0 114.507 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.931 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 63.7 tttm . . . . . 0 C--O 1.25 1.112 0 CA-C-N 120.391 2.096 . . . . 0.0 109.144 -177.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 CA--C 1.554 1.119 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.441 ' HB2' ' O ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -154.35 171.06 19.9 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -167.548 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 77.8 t -133.9 147.86 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.66 0 CA-C-O 124.316 2.008 . . . . 0.0 111.883 -164.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -119.21 140.47 50.16 Favored 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 111.783 -2.462 . . . . 0.0 105.522 167.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -115.84 123.51 48.35 Favored 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 124.906 1.283 . . . . 0.0 109.81 -178.05 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.8 mp -126.17 157.07 39.11 Favored 'General case' 0 CA--C 1.559 1.304 0 CA-C-N 112.627 -2.079 . . . . 0.0 109.748 -166.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 167.96 154.31 8.64 Favored Glycine 0 CA--C 1.554 2.504 0 N-CA-C 115.494 0.957 . . . . 0.0 115.494 169.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo . . . . . 0 CA--C 1.576 2.576 0 C-N-CA 123.173 2.582 . . . . 0.0 114.195 173.484 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . 0.811 ' HB3' ' OD1' ' A' ' 84' ' ' ASP . 7.7 mptt . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 121.28 0.562 . . . . 0.0 111.1 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -53.01 -27.34 29.86 Favored Glycine 0 CA--C 1.556 2.612 0 N-CA-C 120.952 3.141 . . . . 0.0 120.952 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 51.7 m -63.64 -51.44 65.18 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 119.892 1.846 . . . . 0.0 112.964 171.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.34 2.7 mp0 -77.91 -12.92 60.02 Favored 'General case' 0 CA--C 1.57 1.713 0 CA-C-O 115.088 -2.387 . . . . 0.0 112.537 172.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.43 -43.76 63.37 Favored 'General case' 0 C--N 1.376 1.733 0 CA-C-N 124.598 3.363 . . . . 0.0 114.142 165.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 93.4 t -65.74 -42.7 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-O 117.677 -1.154 . . . . 0.0 112.655 173.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . 0.448 ' HB3' ' HE1' ' A' ' 172' ' ' PHE . 95.1 mttt -68.01 -44.35 76.75 Favored 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 115.797 1.777 . . . . 0.0 115.797 174.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.88 -29.08 68.89 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 120.58 1.536 . . . . 0.0 114.317 171.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.56 -41.3 98.42 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 167.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.97 -40.58 80.96 Favored 'General case' 0 CA--C 1.566 1.559 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 167.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -66.18 -50.86 62.44 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 172.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.2 mt -83.16 -22.72 33.2 Favored 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 116.807 2.151 . . . . 0.0 116.807 -177.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.23 34.6 8.61 Favored Glycine 0 CA--C 1.555 2.547 0 N-CA-C 117.742 1.857 . . . . 0.0 117.742 -174.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.433 ' CG2' ' HA ' ' A' ' 81' ' ' PHE . 18.1 mm -105.43 152.46 39.94 Favored Pre-proline 0 CA--C 1.568 1.651 0 CA-C-N 119.149 1.474 . . . . 0.0 112.205 -169.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -82.6 99.74 0.95 Allowed 'Trans proline' 0 CA--C 1.564 1.988 0 CA-C-N 122.06 1.771 . . . . 0.0 108.668 162.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.22 116.92 11.14 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.991 0.9 . . . . 0.0 110.226 176.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 38.6 mm -97.91 108.25 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 -176.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 70.0 p -96.2 129.56 43.48 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 172.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.6 p -71.36 -8.66 55.18 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 -170.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.547 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -92.12 -17.64 46.28 Favored Glycine 0 CA--C 1.55 2.23 0 N-CA-C 118.29 2.076 . . . . 0.0 118.29 165.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -79.37 -55.83 4.77 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 119.097 1.449 . . . . 0.0 113.683 -168.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -60.06 -38.02 81.59 Favored 'General case' 0 CA--C 1.565 1.522 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 173.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.479 ' HB2' ' HB2' ' A' ' 50' ' ' LYS . 41.8 m-85 -67.88 -41.81 82.21 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 116.676 -1.63 . . . . 0.0 113.719 169.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.547 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 35.2 ttt180 -54.05 -40.13 66.84 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 116.587 2.069 . . . . 0.0 116.587 169.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -63.29 -39.72 95.37 Favored 'General case' 0 CA--C 1.566 1.578 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 169.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -67.64 -23.63 65.36 Favored 'General case' 0 CA--C 1.587 2.398 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 167.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.5 mt -62.35 -50.46 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.485 0 CA-C-N 121.609 2.004 . . . . 0.0 109.239 166.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -60.3 -40.99 92.46 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 175.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -70.01 -37.2 75.58 Favored 'General case' 0 CA--C 1.563 1.462 0 N-CA-C 116.84 2.163 . . . . 0.0 116.84 173.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.65 75.07 1.29 Allowed Glycine 0 CA--C 1.544 1.895 0 CA-C-O 117.754 -1.581 . . . . 0.0 114.733 -175.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.886 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 82.2 p -96.45 -62.81 1.21 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 119.683 1.742 . . . . 0.0 111.29 170.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.886 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.302 13.0 mttt 115.83 -42.75 0.01 OUTLIER 'General case' 0 CA--C 1.573 1.861 0 CA-C-O 116.064 -1.922 . . . . 0.0 108.871 -173.423 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.41 -14.96 60.49 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 123.395 2.816 . . . . 0.0 112.891 161.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 50' ' ' LYS . . . -58.99 -62.9 5.7 Favored Glycine 0 C--N 1.355 1.598 0 CA-C-N 120.11 1.323 . . . . 0.0 114.148 169.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.295 7.7 p -69.23 -51.4 43.51 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.302 0 N-CA-C 116.862 2.171 . . . . 0.0 116.862 -168.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -67.09 -45.93 75.78 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 119.923 1.238 . . . . 0.0 112.397 176.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.27 -28.97 67.66 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.479 ' HB2' ' HB2' ' A' ' 35' ' ' PHE 0.278 4.2 tptt -76.02 -37.43 58.42 Favored 'General case' 0 CA--C 1.559 1.319 0 CA-C-O 116.21 -1.852 . . . . 0.0 113.11 170.986 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -78.31 -45.57 22.36 Favored 'General case' 0 CA--C 1.602 2.968 1 CA-C-O 86.548 -15.977 . . . . 0.0 118.565 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 17.2 m-30 -31.07 -54.18 0.21 Allowed 'General case' 0 N--CA 1.498 1.937 1 O-C-N 108.236 -9.04 . . . . 0.0 120.467 145.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.49 -49.96 63.68 Favored 'General case' 0 CA--C 1.576 1.949 0 CA-C-N 121.796 2.089 . . . . 0.0 114.462 166.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -77.0 -44.81 29.55 Favored 'General case' 0 CA--C 1.565 1.542 0 N-CA-C 115.948 1.832 . . . . 0.0 115.948 177.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -87.22 -24.84 24.28 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 116.148 1.906 . . . . 0.0 116.148 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.32 22.64 11.31 Favored Glycine 0 CA--C 1.544 1.856 0 N-CA-C 117.883 1.913 . . . . 0.0 117.883 168.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -95.62 177.96 5.63 Favored 'General case' 0 CA--C 1.573 1.865 0 CA-C-N 118.617 1.208 . . . . 0.0 110.504 168.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.3 pp -76.64 124.17 27.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.494 -1.378 . . . . 0.0 112.836 -168.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 p -113.4 122.47 35.31 Favored Pre-proline 0 CA--C 1.567 1.627 0 C-N-CA 124.656 1.182 . . . . 0.0 108.601 -177.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -55.51 141.62 82.43 Favored 'Trans proline' 0 C--N 1.37 1.666 0 C-N-CA 123.449 2.766 . . . . 0.0 116.135 174.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.6 m -85.46 177.55 7.73 Favored 'General case' 0 CA--C 1.569 1.707 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.712 177.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.9 t70 82.09 -52.03 0.23 Allowed 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 125.77 1.628 . . . . 0.0 113.64 178.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.2 pp -58.17 -41.75 84.52 Favored 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 116.335 1.976 . . . . 0.0 116.335 168.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.5 m -58.63 -51.96 67.72 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 124.914 1.286 . . . . 0.0 113.313 170.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -62.08 -21.97 65.39 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 167.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -76.95 -45.86 26.15 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 125.366 1.466 . . . . 0.0 114.841 172.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.4 mt -61.97 -45.77 92.21 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 169.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 52.7 t -56.42 -55.55 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-O 117.944 -1.027 . . . . 0.0 111.497 171.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -61.22 -31.08 70.86 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 116.836 2.162 . . . . 0.0 116.836 175.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -60.61 -40.46 91.93 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-O 117.937 -1.03 . . . . 0.0 113.288 167.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -80.92 -23.37 38.95 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 118.521 2.786 . . . . 0.0 118.521 169.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 66.4 mt -85.59 -22.14 28.17 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 116.832 2.16 . . . . 0.0 116.832 178.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 . . . . . 0 N--CA 1.498 1.969 0 N-CA-C 116.994 2.22 . . . . 0.0 116.994 169.434 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.434 0 CA-C-O 122.302 0.946 . . . . 0.0 113.472 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.441 ' O ' ' HB2' ' A' ' 2' ' ' ARG . 30.3 p90 -179.08 135.04 0.13 Allowed 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 113.862 -1.169 . . . . 0.0 111.121 176.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 22.1 mt -114.33 109.41 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 105.037 -2.208 . . . . 0.0 105.037 172.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.4 mt -101.21 120.95 40.99 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 118.643 -0.694 . . . . 0.0 109.638 174.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.811 ' OD1' ' HB3' ' A' ' 13' ' ' LYS . 25.1 t70 -110.13 129.21 55.74 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 119.006 0.821 . . . . 0.0 110.983 -177.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 74.27 39.62 43.35 Favored Glycine 0 CA--C 1.552 2.361 0 CA-C-O 117.361 -1.799 . . . . 0.0 117.258 -178.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . 0.256 1.0 OUTLIER -103.8 -58.05 0.08 OUTLIER Pre-proline 0 N--CA 1.496 1.834 0 CA-C-O 113.35 -3.214 . . . . 0.0 111.01 -174.439 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -63.22 70.89 0.14 Allowed 'Trans proline' 0 CA--C 1.571 2.35 0 CA-C-N 126.724 3.437 . . . . 0.0 119.29 167.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -67.53 -29.53 68.96 Favored 'General case' 0 CA--C 1.567 1.623 0 C-N-CA 125.907 1.683 . . . . 0.0 114.503 166.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 77.1 p -151.02 159.52 44.5 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.05 1.34 . . . . 0.0 108.78 -172.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.0 t -64.73 -41.69 92.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 CA-C-O 117.425 -1.274 . . . . 0.0 110.752 167.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.16 -37.79 86.58 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 120.672 3.582 . . . . 0.0 120.672 178.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -75.92 -48.29 21.88 Favored 'General case' 0 CA--C 1.583 2.225 0 CA-C-N 122.586 2.448 . . . . 0.0 111.94 167.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.14 -31.5 72.65 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 117.485 2.402 . . . . 0.0 117.485 -171.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 64.3 tttt -60.34 -30.48 69.55 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 168.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.53 -47.6 75.35 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 168.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.9 tp -58.48 -41.96 86.43 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 170.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -72.81 -41.52 64.83 Favored 'General case' 0 CA--C 1.567 1.596 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 176.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 1.319 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 37.7 mt-10 -56.18 -32.62 64.51 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 165.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 1.329 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 26.8 ttt -84.72 -28.5 26.26 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 118.152 2.649 . . . . 0.0 118.152 173.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . 0.652 HD13 ' HG1' ' A' ' 105' ' ' THR . 64.0 tp -66.88 -54.22 24.48 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-N 120.319 1.418 . . . . 0.0 112.855 169.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -79.7 -49.55 11.93 Favored 'General case' 0 CA--C 1.563 1.472 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 176.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 1.319 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 38.0 mmt180 -68.64 -45.39 71.96 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 175.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 1.329 ' HB3' ' O ' ' A' ' 99' ' ' MET . 74.8 ttt180 -61.4 -57.25 13.01 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 118.843 0.747 . . . . 0.0 111.398 165.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.82 43.16 1.05 Allowed Glycine 0 N--CA 1.479 1.536 0 O-C-N 124.41 1.069 . . . . 0.0 113.941 169.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.652 ' HG1' HD13 ' A' ' 100' ' ' LEU . 40.2 p -90.97 147.18 23.27 Favored 'General case' 0 CA--C 1.559 1.318 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 168.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -65.12 130.62 44.01 Favored 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -169.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.5 tp -90.43 99.17 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 125.344 1.458 . . . . 0.0 107.512 177.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -98.55 -75.15 0.56 Allowed 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 115.898 -2.001 . . . . 0.0 108.419 168.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -136.3 117.37 14.36 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 121.644 2.02 . . . . 0.0 113.459 -174.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.4 t -94.99 108.07 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 101.628 -3.471 . . . . 0.0 101.628 167.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.555 HD21 ' HB3' ' A' ' 160' ' ' LYS . 78.8 mt -109.19 105.33 14.73 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -164.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -90.55 130.9 36.54 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.93 0.871 . . . . 0.0 111.478 172.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -100.38 110.1 22.29 Favored 'General case' 0 CA--C 1.559 1.316 0 CA-C-N 114.227 -1.351 . . . . 0.0 109.426 -176.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . 0.25 71.8 ttt180 -73.11 101.12 3.21 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 126.835 2.054 . . . . 0.0 109.497 169.039 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.9 p . . . . . 0 CA--C 1.566 1.584 0 CA-C-N 112.416 -2.175 . . . . 0.0 110.491 -165.512 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 . . . . . 0 N--CA 1.494 1.767 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -57.28 -37.98 73.23 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 115.262 1.579 . . . . 0.0 115.262 165.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 24.9 ttt -67.2 -33.97 76.52 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 168.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 60.9 mttm -60.73 -50.73 72.32 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 169.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.4 p -64.08 -31.53 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 170.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -54.45 -49.5 69.92 Favored 'General case' 0 CA--C 1.583 2.226 0 CA-C-N 119.755 1.161 . . . . 0.0 112.104 167.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 66.9 ttt180 -60.04 -41.4 92.21 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 118.461 2.763 . . . . 0.0 118.461 174.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -51.38 -29.06 14.34 Favored 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 118.998 2.962 . . . . 0.0 118.998 172.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -132.9 -37.31 1.01 Allowed 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 119.635 3.198 . . . . 0.0 119.635 -163.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 86.0 m -46.51 -39.69 11.26 Favored 'General case' 0 N--CA 1.504 2.248 0 N-CA-C 118.654 2.835 . . . . 0.0 118.654 -167.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.72 -61.4 3.69 Favored Pre-proline 0 CA--C 1.579 2.087 0 CA-C-O 116.466 -1.731 . . . . 0.0 112.118 175.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -51.85 -31.16 41.45 Favored 'Trans proline' 0 CA--C 1.579 2.748 0 C-N-CA 123.387 2.725 . . . . 0.0 118.392 167.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.43 -54.38 33.62 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 125.515 1.526 . . . . 0.0 111.955 174.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 1.157 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 52.1 tp -65.47 -21.7 66.66 Favored 'General case' 0 CA--C 1.566 1.566 0 CA-C-O 116.803 -1.57 . . . . 0.0 114.801 175.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -71.44 -50.66 29.59 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 122.227 2.285 . . . . 0.0 113.307 164.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -65.86 -52.48 49.94 Favored 'General case' 0 CA--C 1.566 1.576 0 CA-C-N 120.466 1.484 . . . . 0.0 112.401 -178.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -76.59 -30.48 57.01 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-O 114.994 -2.431 . . . . 0.0 111.393 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 1.157 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 32.1 ttt180 -59.68 -34.05 72.36 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 124.955 3.525 . . . . 0.0 116.91 168.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -68.58 -41.88 79.04 Favored 'General case' 0 CA--C 1.573 1.83 0 CA-C-N 119.659 1.118 . . . . 0.0 113.519 167.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 38.9 mm-40 -90.63 -19.37 23.74 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 119.99 3.33 . . . . 0.0 119.99 -178.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.7 pp -77.97 179.72 6.59 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 119.506 3.15 . . . . 0.0 119.506 -161.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.555 ' HB3' HD21 ' A' ' 111' ' ' LEU . 50.9 mttt -135.59 135.88 40.62 Favored 'General case' 0 CA--C 1.564 1.493 0 N-CA-C 105.113 -2.18 . . . . 0.0 105.113 167.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 42.0 m -100.34 146.15 27.3 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 122.217 1.008 . . . . 0.0 110.269 -172.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 43.1 t -131.36 136.11 58.17 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.392 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 167.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -94.95 126.97 40.65 Favored 'General case' 0 CA--C 1.565 1.555 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 169.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -109.34 7.85 25.29 Favored 'General case' 0 N--CA 1.493 1.678 1 N-CA-C 126.339 5.681 . . . . 0.0 126.339 -159.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . 0.486 29.2 m . . . . . 0 CA--C 1.594 2.641 1 CA-C-O 109.954 -4.831 . . . . 0.0 107.597 -178.009 . . . . . . . . 2 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 . . . . . 0 N--CA 1.502 2.169 0 N-CA-C 115.925 1.824 . . . . 0.0 115.925 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -60.18 -52.79 63.8 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 169.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 2.7 t -59.27 -35.25 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . 0.448 ' HE1' ' HB3' ' A' ' 19' ' ' LYS . 8.4 t80 -61.16 -40.81 95.27 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 167.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.12 -43.49 95.12 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 115.089 1.515 . . . . 0.0 115.089 175.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 82.2 mtt-85 -71.73 -36.74 70.58 Favored 'General case' 0 CA--C 1.56 1.36 0 N-CA-C 116.265 1.95 . . . . 0.0 116.265 173.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.38 -44.16 92.21 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 171.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.7 mp -64.88 -42.08 95.11 Favored 'General case' 0 CA--C 1.567 1.612 0 CA-C-O 117.148 -1.406 . . . . 0.0 110.656 167.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -46.64 -41.61 14.99 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 117.567 2.432 . . . . 0.0 117.567 168.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -67.1 -48.51 67.95 Favored 'General case' 0 CA--C 1.562 1.431 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 168.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 5.8 tt -86.25 -58.13 2.75 Favored 'General case' 0 CA--C 1.57 1.72 0 CA-C-N 120.275 1.398 . . . . 0.0 113.575 -176.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 0.547 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -118.49 -56.88 0.27 Allowed Glycine 0 CA--C 1.553 2.438 0 CA-C-O 117.339 -1.811 . . . . 0.0 116.353 -174.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 0.547 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 38.9 ttmt . . . . . 0 C--O 1.251 1.166 0 CA-C-N 120.957 2.378 . . . . 0.0 108.207 -173.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.451 ' H2 ' HH11 ' A' ' 2' ' ' ARG . 41.5 ttm . . . . . 0 CA--C 1.56 1.328 0 CA-C-O 122.517 1.151 . . . . 0.0 109.631 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.451 HH11 ' H2 ' ' A' ' 1' ' ' MET 0.263 11.4 mpt_? -123.64 162.25 23.43 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 120.582 3.549 . . . . 0.0 120.582 -161.398 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.8 p -151.08 147.36 15.67 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.744 0 CA-C-O 123.931 1.825 . . . . 0.0 114.424 167.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.3 mt -131.83 133.44 44.68 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-N 111.42 -2.627 . . . . 0.0 108.375 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.48 120.26 41.03 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -169.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.8 mt -110.37 135.74 50.62 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 112.231 -2.258 . . . . 0.0 109.568 175.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 173.84 168.43 34.81 Favored Glycine 0 CA--C 1.56 2.869 0 N-CA-C 115.848 1.099 . . . . 0.0 115.848 171.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' PRO . . . . . 0.427 ' HA ' ' HH ' ' A' ' 144' ' ' TYR . 53.2 Cg_exo . . . . . 0 CA--C 1.572 2.378 0 C-N-CA 123.44 2.76 . . . . 0.0 116.725 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt . . . . . 0 N--CA 1.484 1.249 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -57.84 -30.66 63.31 Favored Glycine 0 CA--C 1.552 2.386 0 N-CA-C 120.053 2.781 . . . . 0.0 120.053 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 54.6 m -66.78 -53.82 29.09 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 119.852 1.826 . . . . 0.0 112.539 176.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -74.31 -16.79 60.92 Favored 'General case' 0 CA--C 1.573 1.84 0 CA-C-O 116.057 -1.925 . . . . 0.0 112.403 172.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.57 -41.31 63.09 Favored 'General case' 0 C--N 1.372 1.582 0 CA-C-N 123.288 2.767 . . . . 0.0 114.912 169.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.7 t -69.03 -39.26 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 CA-C-O 117.644 -1.169 . . . . 0.0 111.789 171.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -61.62 -46.39 90.01 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 116.353 1.983 . . . . 0.0 116.353 170.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.93 -33.49 75.94 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 172.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.06 -41.6 96.92 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 167.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -59.49 -38.12 80.03 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 166.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -66.09 -50.78 62.9 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 116.142 1.905 . . . . 0.0 116.142 171.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.5 mt -81.39 -24.49 36.95 Favored 'General case' 0 CA--C 1.571 1.78 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 -178.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.15 37.07 7.89 Favored Glycine 0 CA--C 1.555 2.542 0 N-CA-C 117.771 1.868 . . . . 0.0 117.771 -176.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.44 ' CG2' ' HA ' ' A' ' 81' ' ' PHE . 14.1 mm -109.24 159.2 32.17 Favored Pre-proline 0 CA--C 1.567 1.624 0 CA-C-N 118.833 1.317 . . . . 0.0 113.53 -168.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -71.67 100.6 1.07 Allowed 'Trans proline' 0 CA--C 1.563 1.969 0 C-N-CA 122.0 1.8 . . . . 0.0 114.224 160.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -73.41 109.85 7.25 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.383 -0.823 . . . . 0.0 111.044 167.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.3 mm -98.23 119.84 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 167.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 62.9 p -99.89 124.66 45.43 Favored 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 161.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.5 p -66.05 -18.61 65.45 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 117.306 2.335 . . . . 0.0 117.306 -169.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -80.29 -18.93 70.37 Favored Glycine 0 CA--C 1.548 2.098 0 N-CA-C 118.805 2.282 . . . . 0.0 118.805 168.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -80.24 -49.86 11.02 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -169.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -69.15 -36.35 77.33 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 174.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PHE . . . . . 0.458 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 42.5 m-85 -66.95 -38.48 86.21 Favored 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 125.379 1.472 . . . . 0.0 114.575 169.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ARG . . . . . 0.425 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 29.5 ttp180 -61.21 -40.67 94.85 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-N 120.109 1.322 . . . . 0.0 113.578 166.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -59.14 -37.15 76.58 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 168.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -66.36 -31.91 72.97 Favored 'General case' 0 CA--C 1.573 1.828 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 166.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.36 -45.68 97.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 CA-C-N 120.092 1.314 . . . . 0.0 112.65 170.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -68.17 -39.89 82.43 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 120.074 1.307 . . . . 0.0 113.814 174.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -77.05 -28.99 54.96 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 116.849 2.166 . . . . 0.0 116.849 178.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.08 74.17 1.28 Allowed Glycine 0 CA--C 1.542 1.757 0 CA-C-O 118.088 -1.395 . . . . 0.0 115.168 178.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.879 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 62.6 p -91.62 -60.24 1.93 Allowed 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 119.127 1.464 . . . . 0.0 111.285 169.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.879 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.287 13.4 mttt 114.44 -40.88 0.01 OUTLIER 'General case' 0 CA--C 1.567 1.604 0 CA-C-O 115.874 -2.012 . . . . 0.0 109.534 -173.103 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.14 -23.18 60.44 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 123.609 2.913 . . . . 0.0 111.729 161.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.55 -54.85 33.21 Favored Glycine 0 C--N 1.352 1.436 0 C-N-CA 125.673 1.606 . . . . 0.0 115.912 174.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.293 0.8 OUTLIER -65.62 -57.0 12.54 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.714 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -179.717 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -67.81 -51.01 53.69 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 120.033 1.288 . . . . 0.0 112.344 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.25 -19.51 65.52 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 176.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . 0.458 ' HB2' ' HB3' ' A' ' 35' ' ' PHE . 14.1 tmtt? -74.53 -45.52 45.15 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 120.577 1.535 . . . . 0.0 112.929 167.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -75.08 -48.37 24.24 Favored 'General case' 0 CA--C 1.583 2.227 1 CA-C-O 85.341 -16.552 . . . . 0.0 119.564 -176.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 12.9 m-30 -34.5 -54.33 0.53 Allowed 'General case' 0 N--CA 1.496 1.871 1 O-C-N 109.293 -8.38 . . . . 0.0 120.481 146.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.6 tp -59.41 -30.95 68.83 Favored 'General case' 0 CA--C 1.579 2.093 0 CA-C-N 122.366 2.348 . . . . 0.0 115.569 167.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -91.27 -41.79 10.75 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 115.964 1.838 . . . . 0.0 115.964 170.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.97 -35.29 26.05 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.42 34.04 5.18 Favored Glycine 0 N--CA 1.476 1.344 0 N-CA-C 118.146 2.018 . . . . 0.0 118.146 167.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -93.55 -129.69 0.13 Allowed 'General case' 0 CA--C 1.567 1.612 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 169.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 88.2 mt -103.12 97.58 7.65 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 119.971 1.259 . . . . 0.0 110.322 -169.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 p -104.03 118.2 57.66 Favored Pre-proline 0 CA--C 1.568 1.661 0 CA-C-O 117.603 -1.189 . . . . 0.0 108.786 176.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -57.26 141.4 94.57 Favored 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 123.491 2.794 . . . . 0.0 116.383 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 74.1 m -71.29 -49.91 38.01 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -65.79 -39.02 90.54 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 -177.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 28.4 mt -56.58 -50.57 71.54 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 117.54 2.422 . . . . 0.0 117.54 175.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 35.7 m -64.57 -46.46 82.64 Favored 'General case' 0 CA--C 1.566 1.593 0 CA-C-N 112.553 -2.112 . . . . 0.0 112.982 174.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -61.6 -21.5 64.4 Favored 'General case' 0 CA--C 1.577 2.003 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 165.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -75.11 -40.53 59.81 Favored 'General case' 0 CA--C 1.556 1.19 0 CA-C-N 121.026 1.739 . . . . 0.0 115.228 169.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 mt -59.89 -48.98 79.5 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-N 120.21 1.368 . . . . 0.0 114.129 167.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.532 HG23 HH21 ' A' ' 71' ' ' ARG . 0.4 OUTLIER -57.62 -44.64 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 172.667 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -67.17 -33.27 75.05 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.689 1.737 . . . . 0.0 115.689 169.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -58.62 -42.1 87.45 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 117.524 -1.227 . . . . 0.0 113.125 170.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ARG . . . . . 0.532 HH21 HG23 ' A' ' 68' ' ' VAL . 3.2 ppt_? -80.24 -16.99 53.5 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 118.582 2.808 . . . . 0.0 118.582 167.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.3 mt -103.96 3.41 33.49 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 119.192 3.034 . . . . 0.0 119.192 174.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 . . . . . 0 N--CA 1.505 2.285 0 CA-C-O 123.635 1.683 . . . . 0.0 112.558 162.543 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.551 0 CA-C-O 124.199 1.999 . . . . 0.0 115.933 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' PHE . . . . . 0.44 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . 32.0 p90 -167.48 138.59 3.03 Favored 'General case' 0 CA--C 1.551 1.019 0 CA-C-N 111.386 -2.407 . . . . 0.0 106.099 169.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -115.38 109.34 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 102.847 -3.02 . . . . 0.0 102.847 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.5 mt -109.82 141.96 41.75 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.518 0.727 . . . . 0.0 109.707 175.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -130.88 127.84 39.36 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 118.364 0.529 . . . . 0.0 111.928 169.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.56 39.04 86.98 Favored Glycine 0 CA--C 1.556 2.604 0 N-CA-C 117.378 1.711 . . . . 0.0 117.378 -178.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -99.63 -52.93 0.19 Allowed Pre-proline 0 N--CA 1.498 1.936 0 CA-C-O 115.139 -2.362 . . . . 0.0 108.807 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -66.41 72.06 0.41 Allowed 'Trans proline' 0 CA--C 1.568 2.199 0 CA-C-N 124.211 2.54 . . . . 0.0 117.932 165.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -65.32 -39.28 92.24 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 167.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.0 t -148.96 153.28 37.73 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -169.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.4 t -59.92 -38.49 76.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-O 117.298 -1.334 . . . . 0.0 112.355 178.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.66 -34.2 73.94 Favored 'General case' 0 C--N 1.361 1.074 0 N-CA-C 120.091 3.367 . . . . 0.0 120.091 173.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.04 -49.51 13.86 Favored 'General case' 0 CA--C 1.586 2.349 0 CA-C-N 122.326 2.33 . . . . 0.0 111.46 166.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.0 -31.43 71.81 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 117.102 2.26 . . . . 0.0 117.102 -170.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 58.5 tttt -61.97 -29.26 70.12 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 167.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.37 -39.55 74.55 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 167.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.3 tp -63.11 -36.5 83.79 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 168.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' HIS . . . . . 0.401 ' CG ' ' HH ' ' A' ' 154' ' ' TYR . 57.0 t60 -63.84 -43.77 95.15 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 120.261 1.391 . . . . 0.0 113.243 167.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' GLU . . . . . 1.229 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 32.2 mt-10 -54.38 -33.51 59.33 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 167.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' MET . . . . . 0.997 ' O ' ' CB ' ' A' ' 103' ' ' ARG . 1.7 tmt? -85.99 -31.41 22.06 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 118.451 2.759 . . . . 0.0 118.451 171.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 tt -70.89 -53.59 14.53 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-N 121.257 1.844 . . . . 0.0 111.067 172.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -76.56 -50.95 12.61 Favored 'General case' 0 CA--C 1.564 1.507 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 174.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 1.229 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 25.2 mmt85 -71.0 -43.04 68.8 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 177.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.997 ' CB ' ' O ' ' A' ' 99' ' ' MET . 0.2 OUTLIER -61.93 -57.15 12.82 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 118.842 0.747 . . . . 0.0 111.083 165.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 111.54 47.48 0.74 Allowed Glycine 0 N--CA 1.481 1.648 0 O-C-N 124.227 0.954 . . . . 0.0 114.46 167.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 61.9 p -85.48 155.84 21.06 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-N 113.85 -1.175 . . . . 0.0 109.538 168.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -71.34 132.04 44.3 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.343 -0.848 . . . . 0.0 110.982 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 6.5 tp -93.84 96.71 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 -175.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -98.97 -73.29 0.63 Allowed 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 115.796 -2.049 . . . . 0.0 109.062 170.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -149.54 124.89 10.21 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 117.564 2.431 . . . . 0.0 117.564 -167.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 62.0 t -92.84 113.55 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 102.66 -3.089 . . . . 0.0 102.66 160.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.457 HD21 ' HB3' ' A' ' 160' ' ' LYS . 71.5 mt -98.15 101.31 12.74 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.838 -178.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -89.01 115.65 26.73 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.849 169.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -92.91 112.23 24.12 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 124.446 1.098 . . . . 0.0 111.478 -175.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ARG . . . . . 0.51 ' HB3' ' HA ' ' A' ' 163' ' ' ASP . 13.5 tpt180 -81.21 97.38 7.59 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.582 1.553 . . . . 0.0 109.053 168.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 43.5 t . . . . . 0 CA--C 1.566 1.591 0 C-N-CA 126.142 1.777 . . . . 0.0 106.965 -170.724 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' ASN . . . . . 0.401 ' O ' ' HB2' ' A' ' 142' ' ' LYS . 5.9 t-20 . . . . . 0 N--CA 1.495 1.78 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 43.5 mmt-85 -64.3 -40.57 96.2 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 168.034 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 93.5 mmm -60.47 -26.97 67.18 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 165.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 139' ' ' ASN . 95.6 mttt -65.73 -40.08 91.82 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 120.249 1.386 . . . . 0.0 113.43 164.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.8 t -63.47 -27.22 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 CA-C-N 119.794 1.179 . . . . 0.0 112.958 168.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' TYR . . . . . 0.427 ' HH ' ' HA ' ' A' ' 8' ' ' PRO . 8.1 m-85 -66.14 -51.56 56.73 Favored 'General case' 0 CA--C 1.575 1.939 0 CA-C-N 120.748 1.613 . . . . 0.0 112.538 165.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 47.9 ttt180 -52.4 -26.59 12.94 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 120.238 3.421 . . . . 0.0 120.238 177.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.81 -67.58 0.3 Allowed 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 119.911 1.232 . . . . 0.0 112.432 169.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -148.84 22.82 0.99 Allowed 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 119.534 3.161 . . . . 0.0 119.534 -168.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 69.4 m -56.48 -29.06 61.3 Favored 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -71.49 -60.89 2.36 Favored Pre-proline 0 CA--C 1.58 2.099 0 CA-C-O 116.093 -1.908 . . . . 0.0 112.118 171.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -52.65 -33.19 57.97 Favored 'Trans proline' 0 CA--C 1.576 2.608 0 C-N-CA 123.458 2.772 . . . . 0.0 118.806 168.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.76 -52.14 53.44 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 125.259 1.423 . . . . 0.0 111.161 174.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' LEU . . . . . 1.16 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 49.1 tp -62.49 -21.78 65.75 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 171.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -72.01 -49.86 33.46 Favored 'General case' 0 CA--C 1.564 1.49 0 CA-C-N 122.759 2.527 . . . . 0.0 113.694 165.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.401 ' HH ' ' CG ' ' A' ' 97' ' ' HIS . 16.0 t80 -63.23 -54.06 43.37 Favored 'General case' 0 CA--C 1.567 1.629 0 CA-C-N 120.494 1.497 . . . . 0.0 112.676 178.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -74.06 -32.88 63.48 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-O 115.275 -2.298 . . . . 0.0 112.177 178.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ARG . . . . . 1.16 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 32.6 ttt180 -58.85 -34.91 72.11 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 124.187 3.176 . . . . 0.0 116.939 169.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -68.13 -38.84 82.64 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 167.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -89.3 -26.04 21.35 Favored 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 119.449 3.129 . . . . 0.0 119.449 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.4 pp -81.2 175.45 10.61 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 118.119 2.637 . . . . 0.0 118.119 -163.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' LYS . . . . . 0.457 ' HB3' HD21 ' A' ' 111' ' ' LEU . 35.9 tttp -123.49 128.99 50.57 Favored 'General case' 0 CA--C 1.561 1.376 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 164.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 11.0 t -101.96 144.63 30.34 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 122.536 1.16 . . . . 0.0 110.065 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 27.7 t -110.52 130.51 63.7 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.325 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 169.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' ASP . . . . . 0.51 ' HA ' ' HB3' ' A' ' 114' ' ' ARG . 16.5 t70 -103.7 117.46 34.42 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 102.593 -3.114 . . . . 0.0 102.593 168.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -121.77 -174.44 2.87 Favored 'General case' 0 CA--C 1.555 1.136 0 N-CA-C 117.831 2.53 . . . . 0.0 117.831 -157.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . 0.543 0.9 OUTLIER . . . . . 0 CA--C 1.559 1.296 0 CA-C-N 109.667 -3.424 . . . . 0.0 115.008 167.813 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 . . . . . 0 N--CA 1.512 2.644 0 N-CA-C 117.948 2.573 . . . . 0.0 117.948 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -46.51 -50.4 17.14 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 169.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 3.8 t -52.08 -38.77 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 175.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -63.14 -41.81 99.35 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 120.649 1.568 . . . . 0.0 114.829 168.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -57.38 -52.0 67.11 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 174.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 10.4 mtt-85 -66.02 -37.66 86.47 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 117.815 2.524 . . . . 0.0 117.815 174.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.67 -45.56 93.67 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 115.72 1.748 . . . . 0.0 115.72 172.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . 0.281 0.4 OUTLIER -72.27 -35.16 68.66 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 169.935 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -53.3 -41.83 66.02 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 167.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.86 -54.76 29.88 Favored 'General case' 0 CA--C 1.561 1.403 0 N-CA-C 114.73 1.382 . . . . 0.0 114.73 168.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 5.4 tt -81.68 -63.29 1.42 Allowed 'General case' 0 CA--C 1.565 1.558 0 CA-C-O 117.597 -1.192 . . . . 0.0 113.142 -176.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' GLY . . . . . 1.131 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -89.21 -48.72 3.7 Favored Glycine 0 CA--C 1.551 2.337 0 CA-C-N 120.915 1.689 . . . . 0.0 116.106 -174.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' LYS . . . . . 1.131 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.303 0 CA-C-N 119.259 1.529 . . . . 0.0 108.988 -175.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.5 mtt . . . . . 0 CA--C 1.558 1.276 0 CA-C-O 122.772 1.273 . . . . 0.0 111.881 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.469 ' HG3' HH11 ' A' ' 2' ' ' ARG 0.3 5.8 ttm-85 -150.27 152.99 35.37 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 116.612 2.079 . . . . 0.0 116.612 -162.777 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.5 t -141.59 145.04 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 CA-C-O 124.176 1.941 . . . . 0.0 111.098 -174.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -125.26 135.41 52.49 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 112.509 -2.132 . . . . 0.0 106.944 175.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.98 114.35 23.68 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-O 122.452 1.12 . . . . 0.0 110.533 -169.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.29 160.9 17.85 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 113.053 -1.885 . . . . 0.0 110.562 -168.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 151.8 149.36 5.06 Favored Glycine 0 CA--C 1.555 2.548 0 CA-C-O 118.2 -1.333 . . . . 0.0 114.129 169.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.28 168.27 2.13 Favored 'Trans proline' 0 CA--C 1.574 2.511 0 C-N-CA 123.375 2.717 . . . . 0.0 116.532 169.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -50.81 132.53 37.21 Favored 'Trans proline' 0 CA--C 1.561 1.869 0 C-N-CA 123.573 2.848 . . . . 0.0 114.615 170.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.3 110.36 0.48 Allowed Glycine 0 C--N 1.345 1.078 0 N-CA-C 107.58 -2.208 . . . . 0.0 107.58 -167.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -27.29 -46.27 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 121.751 3.982 . . . . 0.0 121.751 -177.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.437 ' O ' ' CG ' ' A' ' 13' ' ' LYS . . . -71.5 107.35 2.15 Favored Glycine 0 CA--C 1.549 2.204 0 CA-C-N 119.747 1.158 . . . . 0.0 115.362 -176.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.437 ' CG ' ' O ' ' A' ' 12' ' ' GLY . 23.1 mtmm -172.47 -78.09 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.741 0.817 . . . . 0.0 109.088 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -51.27 -27.45 16.11 Favored Glycine 0 CA--C 1.554 2.509 0 N-CA-C 120.416 2.926 . . . . 0.0 120.416 174.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.9 m -66.87 -52.29 45.24 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 119.663 1.731 . . . . 0.0 112.682 174.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.25 10.6 mm-40 -75.39 -15.63 60.44 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 115.904 -1.998 . . . . 0.0 112.455 171.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.85 -44.32 66.66 Favored 'General case' 0 C--N 1.374 1.637 0 CA-C-N 123.684 2.947 . . . . 0.0 114.319 168.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.78 -46.41 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 CA-C-N 119.282 0.946 . . . . 0.0 112.737 174.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -54.94 -44.25 74.14 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 116.623 2.083 . . . . 0.0 116.623 169.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.1 tp -67.24 -32.54 73.63 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 172.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.78 -38.89 92.42 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 167.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -59.33 -40.72 87.21 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 117.491 -1.243 . . . . 0.0 114.106 166.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -65.62 -49.09 70.0 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 172.465 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 65.8 mt -82.72 -25.0 33.33 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 117.383 2.364 . . . . 0.0 117.383 -177.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.56 41.31 7.37 Favored Glycine 0 CA--C 1.556 2.616 0 N-CA-C 117.521 1.768 . . . . 0.0 117.521 -172.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.441 ' CG2' ' HA ' ' A' ' 81' ' ' PHE . 22.8 mm -115.68 157.91 43.26 Favored Pre-proline 0 CA--C 1.57 1.738 0 CA-C-N 118.678 1.239 . . . . 0.0 113.748 -168.145 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -74.65 101.19 1.42 Allowed 'Trans proline' 0 CA--C 1.566 2.111 0 C-N-CA 121.885 1.723 . . . . 0.0 113.294 160.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -72.34 107.74 5.09 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.158 -0.964 . . . . 0.0 108.424 165.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.479 ' CD1' ' HB3' ' A' ' 71' ' ' ARG . 31.3 mm -104.25 109.38 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 176.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 74.1 p -96.45 128.96 43.86 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 168.585 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 18.4 p -68.36 -16.59 63.99 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 117.051 2.241 . . . . 0.0 117.051 -171.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.466 ' CA ' ' HZ3' ' A' ' 50' ' ' LYS . . . -80.37 -23.25 61.1 Favored Glycine 0 CA--C 1.543 1.809 0 N-CA-C 118.932 2.333 . . . . 0.0 118.932 167.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -80.38 -52.63 7.45 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 -168.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -62.88 -39.09 93.39 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 173.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.407 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 7.9 m-85 -65.2 -47.09 78.11 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 172.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -54.25 -42.06 69.47 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 168.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.8 ttt180 -59.11 -40.36 85.11 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 168.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -68.35 -23.83 64.74 Favored 'General case' 0 CA--C 1.579 2.07 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 168.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 63.6 mt -64.1 -48.69 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 CA-C-N 120.75 1.614 . . . . 0.0 110.448 167.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -64.42 -37.67 88.32 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -67.02 -40.93 87.37 Favored 'General case' 0 CA--C 1.561 1.391 0 N-CA-C 116.236 1.939 . . . . 0.0 116.236 173.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.28 69.26 1.04 Allowed Glycine 0 CA--C 1.543 1.844 0 CA-C-O 118.473 -1.182 . . . . 0.0 114.66 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.784 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 67.5 p -92.02 -49.86 6.0 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-N 118.737 1.268 . . . . 0.0 114.291 175.743 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.784 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.251 73.8 mttt 105.84 -41.49 0.0 OUTLIER 'General case' 0 CA--C 1.57 1.729 0 CA-C-O 116.376 -1.774 . . . . 0.0 111.307 -172.477 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.07 -14.13 58.1 Favored 'General case' 0 CA--C 1.569 1.711 0 CA-C-N 123.059 2.663 . . . . 0.0 112.988 163.788 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.694 ' O ' ' HB3' ' A' ' 50' ' ' LYS . . . -58.22 -56.48 24.97 Favored Glycine 0 C--N 1.355 1.605 0 CA-C-N 120.574 1.534 . . . . 0.0 114.825 169.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.289 6.2 p -76.44 -50.01 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.478 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 -169.859 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -64.91 -48.48 74.04 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 121.09 1.768 . . . . 0.0 112.582 174.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.12 -29.15 66.03 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 114.819 1.415 . . . . 0.0 114.819 -177.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.694 ' HB3' ' O ' ' A' ' 46' ' ' GLY . 35.8 tptt -72.78 -34.73 67.14 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 168.021 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.601 ' CG ' ' O ' ' A' ' 51' ' ' ARG . 42.9 ttt180 -74.64 -55.89 5.4 Favored 'General case' 0 CA--C 1.591 2.522 1 CA-C-O 85.878 -16.296 . . . . 0.0 117.639 -179.715 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -27.64 -66.22 0.07 Allowed 'General case' 0 N--CA 1.495 1.814 1 O-C-N 108.766 -8.709 . . . . 0.0 120.43 146.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.6 tp -59.32 -29.32 67.54 Favored 'General case' 0 CA--C 1.573 1.861 0 N-CA-C 116.388 1.996 . . . . 0.0 116.388 174.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -92.39 -41.6 10.24 Favored 'General case' 0 CA--C 1.566 1.588 0 CA-C-O 116.554 -1.689 . . . . 0.0 115.155 169.208 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -87.94 -41.15 13.36 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 121.976 2.171 . . . . 0.0 114.906 -174.561 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.511 ' HA2' HH12 ' A' ' 88' ' ' ARG . . . 128.83 5.35 4.91 Favored Glycine 0 CA--C 1.541 1.669 0 N-CA-C 119.095 2.398 . . . . 0.0 119.095 168.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -83.41 173.71 11.28 Favored 'General case' 0 CA--C 1.575 1.91 0 CA-C-N 119.86 1.83 . . . . 0.0 110.067 167.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.5 pp -76.18 128.77 35.62 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.205 -1.559 . . . . 0.0 114.398 -166.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.6 p -115.88 128.72 25.75 Favored Pre-proline 0 CA--C 1.571 1.779 0 CA-C-O 117.656 -1.164 . . . . 0.0 109.447 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -60.11 149.33 85.41 Favored 'Trans proline' 0 CA--C 1.559 1.77 0 C-N-CA 123.396 2.731 . . . . 0.0 116.275 173.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 64.0 m -76.87 -45.88 26.63 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -64.27 -46.56 83.17 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 -169.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.7 pp -57.86 -42.13 83.87 Favored 'General case' 0 CA--C 1.56 1.347 0 N-CA-C 116.709 2.114 . . . . 0.0 116.709 169.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.4 m -61.46 -48.79 79.53 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 174.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -66.94 -20.05 65.83 Favored 'General case' 0 CA--C 1.575 1.919 0 N-CA-C 115.443 1.645 . . . . 0.0 115.443 167.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.4 mm-40 -72.26 -47.56 49.31 Favored 'General case' 0 CA--C 1.556 1.203 0 CA-C-N 120.529 1.513 . . . . 0.0 114.197 169.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.9 mt -63.72 -38.46 91.2 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 169.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 51.9 t -56.55 -50.93 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 CA-C-O 117.582 -1.199 . . . . 0.0 111.55 167.676 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -60.05 -36.8 78.11 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 116.563 2.06 . . . . 0.0 116.563 172.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -58.16 -45.79 86.82 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 117.282 -1.342 . . . . 0.0 112.971 169.057 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.479 ' HB3' ' CD1' ' A' ' 29' ' ' ILE . 40.9 mmt180 -87.03 6.12 34.06 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 120.407 3.484 . . . . 0.0 120.407 167.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 50.7 mt -68.2 -49.94 57.5 Favored 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 105.473 -2.047 . . . . 0.0 105.473 153.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 49.51 39.15 16.2 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-N 121.375 1.898 . . . . 0.0 110.879 -163.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -32.26 -28.11 0.01 OUTLIER Pre-proline 0 CA--C 1.57 1.719 1 N-CA-C 127.822 6.23 . . . . 0.0 127.822 -161.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_exo -59.07 -13.98 21.48 Favored 'Trans proline' 0 N--CA 1.511 2.536 1 CA-C-N 130.521 4.793 . . . . 0.0 119.809 169.627 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -96.26 -28.49 14.5 Favored 'General case' 0 CA--C 1.573 1.848 0 CA-C-N 110.756 -2.929 . . . . 0.0 114.196 162.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -114.28 23.59 12.7 Favored 'General case' 0 CA--C 1.577 2.012 0 CA-C-N 123.537 2.881 . . . . 0.0 115.533 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.87 -38.3 73.11 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 120.863 1.665 . . . . 0.0 114.34 174.386 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -101.25 19.75 17.08 Favored 'General case' 0 CA--C 1.578 2.043 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 169.514 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -175.73 150.16 10.6 Favored Glycine 0 C--N 1.359 1.848 0 CA-C-N 122.262 2.301 . . . . 0.0 113.945 168.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.441 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . 45.2 p90 -176.18 138.93 0.34 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 112.018 -2.091 . . . . 0.0 109.58 173.261 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 44.6 mt -111.35 112.99 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 104.059 -2.571 . . . . 0.0 104.059 174.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.5 mt -96.7 147.42 23.93 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 168.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -134.11 131.72 39.05 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.8 0.81 . . . . 0.0 111.043 169.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 71.03 37.59 64.16 Favored Glycine 0 CA--C 1.551 2.297 0 CA-C-O 117.249 -1.862 . . . . 0.0 117.62 176.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -104.79 -56.02 0.09 OUTLIER Pre-proline 0 N--CA 1.496 1.834 0 CA-C-O 114.873 -2.489 . . . . 0.0 109.657 177.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.79 70.97 1.09 Allowed 'Trans proline' 0 CA--C 1.566 2.088 0 CA-C-N 124.921 2.793 . . . . 0.0 118.873 168.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.511 HH12 ' HA2' ' A' ' 56' ' ' GLY . 4.1 ptm180 -76.46 -31.57 57.88 Favored 'General case' 0 CA--C 1.567 1.602 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 167.205 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.485 ' HA ' ' HG3' ' A' ' 147' ' ' GLU . 77.6 p -141.59 134.62 29.06 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 -166.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -51.51 -38.29 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-N 120.298 1.408 . . . . 0.0 113.843 177.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.8 -38.62 91.61 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 120.753 3.612 . . . . 0.0 120.753 174.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -74.32 -47.81 32.26 Favored 'General case' 0 CA--C 1.587 2.401 0 CA-C-N 122.99 2.632 . . . . 0.0 111.802 166.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.33 -35.16 69.53 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 118.493 2.775 . . . . 0.0 118.493 -176.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.4 tttt -59.93 -26.6 66.09 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 116.571 2.063 . . . . 0.0 116.571 170.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.35 -43.86 84.87 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 168.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 23.6 tp -61.72 -37.93 86.01 Favored 'General case' 0 CA--C 1.569 1.695 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 169.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 28.9 t60 -67.85 -41.65 82.59 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 120.405 1.457 . . . . 0.0 113.749 169.081 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 1.363 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 0.5 OUTLIER -53.24 -35.05 59.56 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 167.414 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 1.2 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 63.3 mtt -85.39 -29.57 24.31 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 118.317 2.71 . . . . 0.0 118.317 171.014 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.662 ' HA ' ' HG1' ' A' ' 105' ' ' THR . 1.7 tt -69.35 -54.65 13.44 Favored 'General case' 0 N--CA 1.502 2.16 0 CA-C-N 122.076 2.216 . . . . 0.0 111.126 173.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -77.23 -50.37 13.06 Favored 'General case' 0 CA--C 1.563 1.48 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 174.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 1.363 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 23.3 tpp180 -71.93 -46.06 58.93 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 178.63 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 1.2 ' HB3' ' O ' ' A' ' 99' ' ' MET . 21.5 tpp180 -63.94 -49.66 71.71 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 119.036 0.835 . . . . 0.0 111.793 167.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 106.31 50.07 0.89 Allowed Glycine 0 N--CA 1.485 1.941 0 CA-C-O 121.767 0.648 . . . . 0.0 114.162 167.333 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.662 ' HG1' ' HA ' ' A' ' 100' ' ' LEU . 6.8 p -92.67 168.96 10.87 Favored 'General case' 0 CA--C 1.567 1.612 0 CA-C-N 113.207 -1.496 . . . . 0.0 110.712 179.354 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.47 132.14 45.11 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.034 -1.041 . . . . 0.0 110.919 -175.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 6.4 tp -105.79 96.99 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 174.512 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -100.25 -77.04 0.54 Allowed 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 115.391 -2.242 . . . . 0.0 107.69 166.62 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -140.71 126.14 18.82 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 122.25 2.295 . . . . 0.0 115.5 -171.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 72.8 t -88.92 116.58 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 101.406 -3.553 . . . . 0.0 101.406 160.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.294 20.7 tp -112.93 90.22 3.29 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 113.14 -1.846 . . . . 0.0 109.17 -165.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -89.71 132.22 35.29 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -177.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -97.73 123.87 41.84 Favored 'General case' 0 CA--C 1.566 1.584 0 CA-C-O 123.202 1.477 . . . . 0.0 110.594 -172.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -93.4 104.01 16.19 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 127.299 2.24 . . . . 0.0 108.868 173.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.2 m -133.3 143.0 40.43 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.594 0 CA-C-N 113.12 -1.855 . . . . 0.0 109.837 -165.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 19.6 m -91.72 155.42 18.29 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 123.417 0.687 . . . . 0.0 112.727 -176.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -45.31 -32.18 1.9 Allowed 'General case' 0 N--CA 1.506 2.366 0 N-CA-C 117.618 2.451 . . . . 0.0 117.618 171.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -48.98 -38.99 24.85 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 117.282 2.326 . . . . 0.0 117.282 171.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.6 m -60.11 -43.26 92.51 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.442 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 173.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 1.121 ' HA ' ' CB ' ' A' ' 123' ' ' ARG . 53.1 mt -58.25 -34.26 70.28 Favored 'General case' 0 N--CA 1.515 2.82 0 CA-C-O 123.315 1.531 . . . . 0.0 113.936 164.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.5 ' O ' ' HB3' ' A' ' 125' ' ' LYS . 15.9 mt -68.9 -21.36 64.24 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 175.072 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.493 ' C ' ' H ' ' A' ' 124' ' ' LEU . 9.5 mm-40 -68.59 -60.69 2.24 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 113.49 -3.148 . . . . 0.0 106.626 155.572 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 1.121 ' CB ' ' HA ' ' A' ' 120' ' ' LEU . 14.8 mmt180 -25.15 47.74 0.0 OUTLIER 'General case' 0 N--CA 1.531 3.608 3 O-C-N 131.316 5.385 . . . . 0.0 122.118 156.436 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . 0.493 ' H ' ' C ' ' A' ' 122' ' ' GLU 0.368 0.0 OUTLIER 36.04 27.13 0.01 OUTLIER 'General case' 0 C--N 1.277 -2.574 3 C-N-CA 140.19 7.396 . . . . 0.0 129.594 -150.735 . . . . . . . . 5 4 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.5 ' HB3' ' O ' ' A' ' 121' ' ' LEU . 77.2 tttt -62.86 -18.08 62.38 Favored 'General case' 0 CA--C 1.599 2.856 0 C-N-CA 114.896 -2.721 . . . . 0.0 112.648 150.281 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.894 ' O ' ' HB2' ' A' ' 127' ' ' ARG . . . -83.32 -44.3 7.05 Favored Glycine 0 C--N 1.386 3.33 0 CA-C-N 124.717 3.417 . . . . 0.0 115.615 173.68 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.894 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 76.0 ttt180 153.3 110.51 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.351 1.575 . . . . 0.0 109.056 -177.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -166.11 -32.53 0.02 OUTLIER Glycine 0 CA--C 1.547 2.076 0 N-CA-C 117.641 1.817 . . . . 0.0 117.641 -173.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.468 ' HB3' ' H ' ' A' ' 130' ' ' ALA . 94.7 mtt180 -146.24 -157.25 0.78 Allowed 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 120.12 1.96 . . . . 0.0 113.3 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.468 ' H ' ' HB3' ' A' ' 129' ' ' ARG . . . -149.88 56.92 0.97 Allowed 'General case' 0 CA--C 1.575 1.912 0 CA-C-N 113.521 -1.672 . . . . 0.0 111.353 -172.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.1 p30 45.66 49.23 11.26 Favored 'General case' 0 N--CA 1.507 2.388 0 N-CA-C 119.177 3.029 . . . . 0.0 119.177 -177.131 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -70.52 -40.24 73.61 Favored 'General case' 0 N--CA 1.508 2.454 0 CA-C-N 113.454 -1.703 . . . . 0.0 109.381 155.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 75.2 p -57.14 -165.72 0.0 OUTLIER 'General case' 0 CA--C 1.584 2.275 0 C-N-CA 128.431 2.692 . . . . 0.0 111.043 157.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.5 t70 70.64 -62.45 0.44 Allowed 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 128.819 2.848 . . . . 0.0 111.792 -167.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -69.27 -42.9 74.91 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 167.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.3 t -63.57 -40.32 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 CA-C-N 119.379 0.991 . . . . 0.0 113.248 169.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 47.2 mm -63.08 -35.62 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 CA-C-O 117.821 -1.085 . . . . 0.0 113.748 169.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 26.4 mt -65.45 -46.97 77.78 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 120.654 1.57 . . . . 0.0 114.464 171.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -65.4 -37.39 86.84 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 172.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -60.58 -42.65 97.14 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 167.872 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 13.6 tpt -61.5 -32.15 72.17 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 168.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -60.96 -49.1 78.81 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 166.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 29.1 t -65.13 -25.46 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 169.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -65.45 -49.43 69.17 Favored 'General case' 0 CA--C 1.577 1.982 0 CA-C-N 119.74 1.154 . . . . 0.0 111.864 169.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -61.34 -44.51 97.07 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 117.71 2.485 . . . . 0.0 117.71 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -56.18 -32.22 64.14 Favored 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 117.785 2.513 . . . . 0.0 117.785 177.048 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.485 ' HG3' ' HA ' ' A' ' 89' ' ' SER . 4.4 mm-40 -121.38 -40.5 2.57 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 118.684 2.846 . . . . 0.0 118.684 -163.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 95.7 m -46.64 -39.96 12.24 Favored 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 118.226 2.676 . . . . 0.0 118.226 -167.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.38 -61.16 4.12 Favored Pre-proline 0 CA--C 1.579 2.07 0 CA-C-O 116.17 -1.871 . . . . 0.0 112.05 173.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -52.01 -32.58 49.0 Favored 'Trans proline' 0 CA--C 1.578 2.692 0 C-N-CA 123.374 2.716 . . . . 0.0 118.568 167.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -66.57 -51.51 55.69 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 125.193 1.397 . . . . 0.0 111.462 176.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 1.186 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 47.7 tp -64.49 -21.23 66.61 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 171.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -71.92 -48.73 43.37 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 122.657 2.48 . . . . 0.0 112.944 164.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -61.03 -56.74 17.42 Favored 'General case' 0 CA--C 1.57 1.718 0 CA-C-N 120.191 1.359 . . . . 0.0 112.711 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -77.13 -28.04 54.17 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-O 115.348 -2.263 . . . . 0.0 112.774 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 1.186 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 38.3 ttt180 -60.35 -37.23 80.04 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 124.017 3.099 . . . . 0.0 116.259 169.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -67.76 -37.91 82.74 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 167.358 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -79.96 -33.22 39.7 Favored 'General case' 0 CA--C 1.579 2.09 0 N-CA-C 119.623 3.194 . . . . 0.0 119.623 177.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.1 pp -82.01 174.72 10.98 Favored 'General case' 0 CA--C 1.575 1.907 0 N-CA-C 121.324 3.824 . . . . 0.0 121.324 -159.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -128.64 139.66 52.15 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 164.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.1 t -102.77 152.56 21.1 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 122.515 1.15 . . . . 0.0 112.362 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 53.2 t -120.26 139.29 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 168.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -94.52 134.53 36.96 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 167.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -157.88 95.56 1.42 Allowed 'General case' 0 N--CA 1.484 1.243 0 CA-C-O 122.791 1.281 . . . . 0.0 110.886 -164.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.5 t -151.92 124.95 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-N 113.143 -1.844 . . . . 0.0 106.878 -171.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 78.62 -74.34 2.13 Favored Glycine 0 N--CA 1.483 1.798 0 N-CA-C 117.749 1.86 . . . . 0.0 117.749 168.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 42.9 p -79.59 147.52 32.06 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 112.008 -2.096 . . . . 0.0 112.527 -169.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 65.8 mtt -91.39 -65.31 1.02 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.259 0.623 . . . . 0.0 111.154 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -68.28 -37.88 81.13 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 -176.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -61.26 -48.71 80.16 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 169.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 69.9 t -55.74 -39.44 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 173.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -60.43 -35.62 76.26 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 168.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -58.81 -48.33 81.67 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 171.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 81.5 mtt-85 -60.8 -36.85 80.08 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 117.874 2.546 . . . . 0.0 117.874 168.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.85 -44.09 97.47 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 172.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . 0.272 0.2 OUTLIER -71.26 -38.7 71.87 Favored 'General case' 0 N--CA 1.507 2.383 0 CA-C-N 120.014 1.279 . . . . 0.0 114.332 169.031 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -49.57 -39.3 34.53 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 168.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -70.3 -52.53 22.16 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 166.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -102.29 -60.03 1.61 Allowed 'General case' 0 CA--C 1.564 1.515 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -169.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.633 ' O ' ' CB ' ' A' ' 181' ' ' LYS . . . -79.22 -37.0 25.88 Favored Glycine 0 CA--C 1.551 2.34 0 CA-C-N 121.554 1.979 . . . . 0.0 118.036 -170.141 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.633 ' CB ' ' O ' ' A' ' 180' ' ' GLY . 37.2 ttmt . . . . . 0 C--O 1.252 1.212 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -177.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.7 mtt . . . . . 0 N--CA 1.483 1.217 0 CA-C-O 121.76 0.791 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.566 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -160.42 155.36 24.37 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -166.8 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.6 t -135.07 150.67 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 114.34 -1.3 . . . . 0.0 111.607 -168.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.447 HD23 HH12 ' A' ' 2' ' ' ARG . 2.2 mm? -125.7 122.13 35.42 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 114.003 -1.453 . . . . 0.0 108.607 169.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.8 tt -95.91 119.54 34.59 Favored 'General case' 0 CA--C 1.572 1.8 0 CA-C-O 122.504 1.145 . . . . 0.0 111.94 -173.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 33.0 mt -104.8 160.03 15.32 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 111.074 -2.785 . . . . 0.0 110.97 175.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 165.68 129.46 1.05 Allowed Glycine 0 CA--C 1.549 2.19 0 CA-C-O 117.355 -1.803 . . . . 0.0 113.77 171.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -58.01 169.72 2.57 Favored 'Trans proline' 0 CA--C 1.581 2.855 0 CA-C-N 122.035 2.917 . . . . 0.0 114.881 168.061 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -50.76 121.51 8.16 Favored 'Trans proline' 0 CA--C 1.561 1.845 0 C-N-CA 123.749 2.966 . . . . 0.0 115.103 176.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.91 103.68 0.19 Allowed Glycine 0 CA--C 1.536 1.351 0 N-CA-C 108.133 -1.987 . . . . 0.0 108.133 -167.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.493 ' H ' ' HB2' ' A' ' 120' ' ' LEU . . . -57.46 112.94 1.57 Allowed 'General case' 0 CA--C 1.566 1.561 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 -178.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -173.13 -117.13 0.44 Allowed Glycine 0 N--CA 1.482 1.754 0 N-CA-C 107.058 -2.417 . . . . 0.0 107.058 173.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.6 mttt 64.8 -92.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 164.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -50.53 -22.03 5.12 Favored Glycine 0 CA--C 1.554 2.496 0 N-CA-C 120.955 3.142 . . . . 0.0 120.955 174.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 98.1 m -68.27 -53.0 27.54 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 120.036 1.918 . . . . 0.0 112.265 173.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.261 14.4 mm-40 -76.48 -15.43 59.9 Favored 'General case' 0 CA--C 1.574 1.87 0 CA-C-O 115.508 -2.187 . . . . 0.0 112.295 171.418 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.96 -41.49 67.66 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 124.211 3.187 . . . . 0.0 115.265 167.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.5 t -70.89 -40.66 76.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 CA-C-O 117.84 -1.076 . . . . 0.0 111.766 173.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -61.44 -42.11 98.24 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 169.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 23.6 mt -67.93 -32.4 72.82 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 170.841 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.02 -40.12 96.78 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 120.267 1.394 . . . . 0.0 114.446 167.473 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -59.77 -37.6 79.5 Favored 'General case' 0 CA--C 1.565 1.554 0 N-CA-C 114.889 1.441 . . . . 0.0 114.889 166.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -68.61 -53.99 19.22 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 120.561 1.528 . . . . 0.0 114.787 174.327 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.4 mp -81.73 -22.83 37.07 Favored 'General case' 0 CA--C 1.573 1.861 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 -177.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.68 38.64 7.46 Favored Glycine 0 CA--C 1.555 2.546 0 N-CA-C 117.507 1.763 . . . . 0.0 117.507 -174.29 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.458 ' CG2' ' HA ' ' A' ' 81' ' ' PHE . 23.6 mm -106.46 157.02 35.99 Favored Pre-proline 0 CA--C 1.565 1.551 0 CA-C-N 118.647 1.224 . . . . 0.0 112.876 -169.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -73.79 102.86 1.56 Allowed 'Trans proline' 0 CA--C 1.558 1.724 0 C-N-CA 121.49 1.46 . . . . 0.0 111.968 159.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.7 tm0? -69.48 106.54 3.02 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 166.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 34.2 mm -97.95 109.33 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 63.4 p -95.59 129.22 42.86 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 169.523 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.3 p -74.07 2.17 9.45 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 117.241 2.311 . . . . 0.0 117.241 -174.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -97.14 -22.17 18.16 Favored Glycine 0 CA--C 1.54 1.628 0 N-CA-C 118.703 2.241 . . . . 0.0 118.703 163.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -81.21 -54.27 5.65 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 119.37 1.585 . . . . 0.0 114.618 -168.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -65.44 -38.66 90.52 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 113.037 0.755 . . . . 0.0 113.037 175.117 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.449 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 56.8 m-85 -68.79 -42.48 77.3 Favored 'General case' 0 CA--C 1.56 1.332 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 173.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 73.9 ttt180 -58.76 -42.24 88.44 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 115.046 1.498 . . . . 0.0 115.046 169.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.411 ' HD2' ' HA ' ' A' ' 37' ' ' ARG . 10.4 tpt180 -61.51 -39.02 89.48 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 115.227 1.566 . . . . 0.0 115.227 169.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -68.82 -27.57 65.96 Favored 'General case' 0 CA--C 1.575 1.932 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 168.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . 0.696 HD11 ' HB3' ' A' ' 50' ' ' LYS . 86.1 mt -63.86 -43.94 97.96 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 CA-C-N 120.104 1.32 . . . . 0.0 111.251 167.251 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -64.02 -42.31 97.17 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 173.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -65.51 -41.74 92.82 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 173.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.4 70.83 1.17 Allowed Glycine 0 CA--C 1.539 1.593 0 CA-C-O 118.091 -1.394 . . . . 0.0 113.368 -177.036 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.545 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 67.0 p -92.16 -65.62 0.99 Allowed 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 119.187 1.494 . . . . 0.0 111.644 177.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.545 ' CB ' ' O ' ' A' ' 43' ' ' THR . 21.2 ptmt 128.81 -55.68 0.0 OUTLIER 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 123.934 0.894 . . . . 0.0 109.899 -166.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -75.76 -6.57 51.25 Favored 'General case' 0 CA--C 1.568 1.638 0 CA-C-O 118.136 -0.935 . . . . 0.0 113.021 167.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.22 -54.21 11.8 Favored Glycine 0 CA--C 1.544 1.905 0 CA-C-N 120.652 1.569 . . . . 0.0 113.254 166.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.292 11.9 p -76.22 -46.62 33.03 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.706 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 -169.122 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -56.38 -49.28 74.91 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 121.744 2.065 . . . . 0.0 113.339 169.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.03 -38.5 91.28 Favored 'General case' 0 C--N 1.348 0.527 0 CA-C-N 113.517 -1.674 . . . . 0.0 114.293 -176.063 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.696 ' HB3' HD11 ' A' ' 39' ' ' ILE . 5.1 tptt -80.14 -17.16 53.27 Favored 'General case' 0 CA--C 1.565 1.545 0 CA-C-O 116.809 -1.567 . . . . 0.0 113.855 173.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 62.6 mtp180 -76.59 -55.61 5.37 Favored 'General case' 0 CA--C 1.598 2.815 1 CA-C-O 86.227 -16.13 . . . . 0.0 118.297 172.572 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.425 ' HA ' ' H ' ' A' ' 57' ' ' ASP 0.346 0.1 OUTLIER -38.02 -61.57 0.64 Allowed 'General case' 0 N--CA 1.516 2.847 1 O-C-N 109.303 -8.373 . . . . 0.0 120.564 149.349 . . . . . . . . 5 4 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 60.3 mt -58.05 -23.66 55.31 Favored 'General case' 0 N--CA 1.518 2.948 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 177.769 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -93.32 -49.41 5.96 Favored 'General case' 0 CA--C 1.571 1.763 0 CA-C-O 116.486 -1.721 . . . . 0.0 114.56 166.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -104.28 -5.57 21.72 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 118.112 2.634 . . . . 0.0 118.112 -170.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.646 ' HA2' HH11 ' A' ' 88' ' ' ARG . . . 73.64 47.09 22.22 Favored Glycine 0 CA--C 1.544 1.847 0 CA-C-N 122.203 2.274 . . . . 0.0 115.241 -178.257 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.425 ' H ' ' HA ' ' A' ' 52' ' ' TYR . 78.9 m-20 -101.51 -175.3 2.82 Favored 'General case' 0 CA--C 1.568 1.642 0 C-N-CA 123.763 0.825 . . . . 0.0 110.807 -170.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 74.7 mt -100.56 99.6 10.2 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.4 t -148.26 130.93 7.86 Favored Pre-proline 0 CA--C 1.586 2.353 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -169.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -50.15 161.01 1.18 Allowed 'Trans proline' 0 CA--C 1.567 2.152 0 C-N-CA 124.446 3.43 . . . . 0.0 120.955 -177.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 58.4 m -91.25 -53.88 4.16 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -174.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -57.86 -36.35 72.2 Favored 'General case' 0 N--CA 1.506 2.366 0 N-CA-C 117.412 2.375 . . . . 0.0 117.412 -171.235 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 79.5 mt -46.54 -45.56 18.73 Favored 'General case' 0 N--CA 1.506 2.358 0 N-CA-C 118.137 2.643 . . . . 0.0 118.137 170.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.2 m -70.04 -48.88 56.1 Favored 'General case' 0 CA--C 1.562 1.422 0 CA-C-N 112.223 -2.262 . . . . 0.0 112.756 177.897 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.64 -22.86 62.47 Favored 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 167.031 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -75.85 -42.36 49.72 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 125.395 1.478 . . . . 0.0 114.908 171.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.8 mt -59.53 -50.39 74.1 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 168.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 87.7 t -63.07 -47.8 90.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 CA-C-O 118.023 -0.989 . . . . 0.0 111.72 177.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -64.4 -30.4 71.44 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 116.443 2.016 . . . . 0.0 116.443 172.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -60.85 -41.21 95.4 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 119.714 1.143 . . . . 0.0 113.255 168.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 20.5 ttm-85 -81.52 -13.94 57.5 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 119.021 2.971 . . . . 0.0 119.021 169.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.8 mt -95.08 -16.86 22.34 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 117.656 2.465 . . . . 0.0 117.656 175.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -66.81 8.64 0.24 Allowed 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 118.014 2.598 . . . . 0.0 118.014 176.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -68.32 136.82 91.23 Favored Pre-proline 0 CA--C 1.574 1.873 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 163.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -52.87 -35.94 72.32 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 N-CA-C 119.292 2.766 . . . . 0.0 119.292 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -70.08 -19.02 63.28 Favored 'General case' 0 CA--C 1.569 1.686 0 N-CA-C 116.485 2.032 . . . . 0.0 116.485 171.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -109.56 16.16 22.4 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 116.265 1.95 . . . . 0.0 116.265 176.335 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.2 -53.56 10.64 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 121.138 1.79 . . . . 0.0 114.535 169.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.566 ' O ' ' HG2' ' A' ' 2' ' ' ARG . 24.7 p30 -74.1 -34.97 64.14 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 172.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.51 ' HA2' ' HB3' ' A' ' 2' ' ' ARG . . . -112.4 148.83 18.34 Favored Glycine 0 N--CA 1.482 1.723 0 CA-C-N 120.095 1.316 . . . . 0.0 114.256 177.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.458 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . 37.6 p90 178.58 135.76 0.08 Allowed 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 112.208 -1.996 . . . . 0.0 111.88 -178.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 21.7 mt -115.23 109.55 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 174.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.7 mt -106.15 126.0 51.68 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 174.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -108.09 127.71 54.04 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 119.272 0.942 . . . . 0.0 110.36 176.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.39 37.93 80.05 Favored Glycine 0 CA--C 1.556 2.653 0 N-CA-C 117.202 1.641 . . . . 0.0 117.202 -176.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -92.87 -54.06 0.25 Allowed Pre-proline 0 N--CA 1.494 1.765 0 CA-C-O 114.935 -2.46 . . . . 0.0 108.223 175.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -65.3 70.87 0.29 Allowed 'Trans proline' 0 CA--C 1.571 2.344 0 CA-C-N 124.343 2.587 . . . . 0.0 117.289 165.252 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.646 HH11 ' HA2' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -71.67 -24.28 61.81 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 166.714 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.8 t -150.93 151.39 32.09 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 -176.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 36.7 t -62.07 -40.25 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 CA-C-O 117.924 -1.036 . . . . 0.0 112.173 174.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -68.66 -25.37 64.77 Favored 'General case' 0 CA--C 1.55 0.981 0 N-CA-C 119.656 3.206 . . . . 0.0 119.656 174.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.04 -51.34 12.52 Favored 'General case' 0 CA--C 1.589 2.462 0 CA-C-N 123.405 2.82 . . . . 0.0 110.078 163.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -54.58 -28.11 43.78 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 117.834 2.531 . . . . 0.0 117.834 -176.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -58.79 -32.71 69.58 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 166.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.67 -44.31 86.66 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 169.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.6 tp -60.63 -39.03 86.75 Favored 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 170.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 47.8 t60 -70.08 -42.86 72.22 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 120.021 1.282 . . . . 0.0 113.973 171.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 1.153 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 32.1 mt-10 -52.1 -36.46 51.0 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 166.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 1.136 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 25.2 ttt -84.37 -24.49 29.67 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 117.927 2.566 . . . . 0.0 117.927 171.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.468 ' HA ' ' HG1' ' A' ' 105' ' ' THR . 66.3 tp -65.77 -55.65 16.12 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 120.771 1.623 . . . . 0.0 112.572 169.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -79.79 -50.8 10.02 Favored 'General case' 0 CA--C 1.562 1.427 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 175.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 1.153 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 73.4 ttt180 -66.87 -45.69 77.29 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 176.612 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 1.136 ' HB3' ' O ' ' A' ' 99' ' ' MET . 1.2 tmt_? -63.24 -55.85 21.44 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.01 0.524 . . . . 0.0 111.168 165.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.34 46.83 1.04 Allowed Glycine 0 N--CA 1.48 1.603 0 O-C-N 124.013 0.82 . . . . 0.0 113.347 169.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.468 ' HG1' ' HA ' ' A' ' 100' ' ' LEU . 67.4 p -93.53 152.28 19.15 Favored 'General case' 0 CA--C 1.561 1.39 0 O-C-N 124.402 0.707 . . . . 0.0 109.666 175.013 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -82.73 129.1 34.92 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.444 -0.785 . . . . 0.0 111.557 -169.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 7.6 tp -89.99 107.68 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 -173.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -90.33 -68.04 0.81 Allowed 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 117.006 -1.473 . . . . 0.0 107.082 168.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -159.0 137.92 11.16 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 120.887 1.676 . . . . 0.0 114.513 177.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.6 t -91.91 109.71 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.676 0 N-CA-C 100.863 -3.755 . . . . 0.0 100.863 161.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.309 25.8 tp -111.68 103.61 11.92 Favored 'General case' 0 CA--C 1.558 1.288 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.858 -161.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -94.12 129.65 40.61 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.449 0.643 . . . . 0.0 112.248 -177.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -92.55 119.04 31.62 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-O 123.157 1.456 . . . . 0.0 110.164 -178.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -84.08 96.8 9.02 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 112.527 -2.124 . . . . 0.0 109.347 168.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.0 p -137.36 131.64 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 125.245 1.418 . . . . 0.0 107.922 -168.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 58.5 m -86.28 142.12 28.77 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 114.111 -1.404 . . . . 0.0 112.329 -169.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -63.1 -26.83 69.01 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 116.76 2.133 . . . . 0.0 116.76 -176.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -58.62 -44.48 90.0 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 170.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -49.79 -45.56 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 175.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.493 ' HB2' ' H ' ' A' ' 11' ' ' ALA . 2.9 tm? -64.05 -52.51 59.06 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 124.683 1.193 . . . . 0.0 112.308 171.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.1 mp -50.91 -41.45 58.66 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 170.392 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -60.23 -47.78 84.53 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 125.11 1.364 . . . . 0.0 114.367 169.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -52.22 -52.23 53.59 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 168.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 81.3 mt -56.54 -43.14 79.57 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 171.667 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -58.17 -53.45 58.09 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 173.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -88.49 38.44 3.19 Favored Glycine 0 CA--C 1.551 2.335 0 N-CA-C 117.135 1.614 . . . . 0.0 117.135 171.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -150.13 -115.61 0.05 Allowed 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 118.491 1.146 . . . . 0.0 109.909 169.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.884 ' O ' ' HB2' ' A' ' 129' ' ' ARG . . . 178.4 -175.83 47.65 Favored Glycine 0 CA--C 1.571 3.532 0 CA-C-N 115.04 -0.982 . . . . 0.0 113.784 -172.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.884 ' HB2' ' O ' ' A' ' 128' ' ' GLY . 18.2 tpt180 158.01 128.16 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 121.137 2.469 . . . . 0.0 110.387 176.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -91.01 65.82 5.69 Favored 'General case' 0 CA--C 1.575 1.929 0 C-N-CA 123.443 0.697 . . . . 0.0 112.082 -178.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 65.04 5.75 3.12 Favored 'General case' 0 N--CA 1.507 2.406 0 N-CA-C 119.271 3.063 . . . . 0.0 119.271 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -91.54 57.9 3.41 Favored 'General case' 0 N--CA 1.506 2.374 0 CA-C-O 123.662 1.696 . . . . 0.0 107.118 160.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . 0.306 3.0 m -129.32 -118.33 0.24 Allowed 'General case' 0 CA--C 1.558 1.27 0 CA-C-N 112.582 -2.099 . . . . 0.0 109.742 -160.342 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -80.9 -33.38 34.29 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -64.46 -48.65 74.45 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 176.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.0 p -58.46 -36.78 60.61 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.948 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 168.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 1.3 mp -66.27 -34.9 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 C-N-CA 124.456 1.102 . . . . 0.0 113.684 169.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 40.6 mt -66.69 -39.38 88.06 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 120.258 1.39 . . . . 0.0 114.131 170.554 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -64.73 -36.71 85.16 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-N 120.347 1.431 . . . . 0.0 114.043 168.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 70.0 mtp180 -57.96 -39.69 78.76 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 165.272 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 25.3 ttt -64.58 -30.96 71.99 Favored 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 168.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -62.85 -48.03 80.79 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 168.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.5 p -66.47 -35.61 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 171.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -53.94 -54.07 43.92 Favored 'General case' 0 CA--C 1.585 2.3 0 CA-C-N 120.073 1.306 . . . . 0.0 111.436 167.528 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 32.4 ttp180 -51.99 -32.97 35.98 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 119.296 3.073 . . . . 0.0 119.296 172.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -52.86 -38.56 61.69 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 173.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -140.34 26.73 2.15 Favored 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 117.534 2.42 . . . . 0.0 117.534 -177.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 39.5 m -47.69 -37.39 12.89 Favored 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 116.053 1.872 . . . . 0.0 116.053 173.296 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -69.73 -60.2 3.98 Favored Pre-proline 0 CA--C 1.578 2.026 0 CA-C-O 116.75 -1.595 . . . . 0.0 112.102 172.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -49.87 -30.79 24.62 Favored 'Trans proline' 0 CA--C 1.576 2.605 0 C-N-CA 123.375 2.716 . . . . 0.0 118.562 167.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -63.86 -55.39 23.15 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 125.515 1.526 . . . . 0.0 111.722 173.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.913 ' O ' ' HB2' ' A' ' 156' ' ' ARG 0.317 0.0 OUTLIER -63.41 -26.11 68.59 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 177.021 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -70.52 -50.92 32.7 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 120.68 1.582 . . . . 0.0 114.182 167.234 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -67.93 -53.91 22.75 Favored 'General case' 0 CA--C 1.557 1.225 0 CA-C-N 120.007 1.276 . . . . 0.0 111.398 -176.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . 0.256 67.5 m-85 -84.98 -19.69 31.69 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-O 114.959 -2.448 . . . . 0.0 113.387 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.913 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 40.6 ttt180 -70.73 -35.62 72.77 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 125.077 3.58 . . . . 0.0 115.073 168.386 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -69.01 -37.59 78.76 Favored 'General case' 0 CA--C 1.573 1.854 0 CA-C-N 120.08 1.309 . . . . 0.0 113.906 167.071 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -84.2 -33.03 24.24 Favored 'General case' 0 CA--C 1.572 1.791 0 N-CA-C 118.727 2.862 . . . . 0.0 118.727 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.8 pp -75.46 172.05 13.2 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 118.437 2.754 . . . . 0.0 118.437 -162.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -131.83 141.31 49.39 Favored 'General case' 0 CA--C 1.558 1.258 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 166.302 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 54.5 m -99.9 146.67 26.39 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 122.351 1.072 . . . . 0.0 110.731 -173.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 30.0 t -123.39 134.34 66.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 167.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -93.83 130.11 39.98 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 167.776 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -154.7 93.63 1.59 Allowed 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 122.623 1.201 . . . . 0.0 111.9 -163.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.1 t -150.85 126.92 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 CA-C-N 114.16 -1.382 . . . . 0.0 107.391 -176.207 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 78.9 -71.82 2.53 Favored Glycine 0 N--CA 1.483 1.786 0 N-CA-C 118.205 2.042 . . . . 0.0 118.205 167.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 42.7 p -78.09 142.8 37.89 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 112.163 -2.018 . . . . 0.0 112.453 -168.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 27.8 ttt -86.93 -68.35 0.75 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.456 0.702 . . . . 0.0 111.259 -177.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -70.16 -36.0 74.41 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 116.153 1.909 . . . . 0.0 116.153 -177.312 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -59.94 -49.61 77.0 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 170.023 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 94.5 t -56.69 -37.92 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 173.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -61.42 -34.55 75.57 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 167.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -61.0 -43.24 99.18 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 170.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 81.1 mtt-85 -66.65 -33.87 76.61 Favored 'General case' 0 CA--C 1.554 1.131 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 169.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.23 -47.1 85.91 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 171.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . 0.294 0.5 OUTLIER -69.3 -34.0 74.02 Favored 'General case' 0 N--CA 1.504 2.228 0 CA-C-N 120.196 1.362 . . . . 0.0 114.506 169.214 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 29.3 mtp180 -49.23 -45.26 44.33 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 166.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -67.39 -51.33 53.23 Favored 'General case' 0 CA--C 1.565 1.546 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 168.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.81 -62.88 1.39 Allowed 'General case' 0 CA--C 1.566 1.571 0 CA-C-O 117.981 -1.009 . . . . 0.0 112.84 -175.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.898 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -91.39 -54.92 1.89 Allowed Glycine 0 CA--C 1.552 2.402 0 CA-C-O 117.983 -1.454 . . . . 0.0 114.802 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.898 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 55.0 tttp . . . . . 0 C--O 1.251 1.169 0 CA-C-N 119.861 1.83 . . . . 0.0 109.612 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.0 mtt . . . . . 0 CA--C 1.561 1.371 0 CA-C-O 122.933 1.349 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . 0.309 11.7 mpt_? -122.67 167.48 13.38 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 120.747 3.61 . . . . 0.0 120.747 -164.787 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.1 p -148.25 141.24 18.74 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.656 0 CA-C-O 123.87 1.795 . . . . 0.0 112.568 166.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -116.55 136.99 52.52 Favored 'General case' 0 CA--C 1.56 1.341 0 CA-C-N 111.971 -2.377 . . . . 0.0 104.853 166.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.5 mt -111.85 128.81 56.24 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 122.693 1.235 . . . . 0.0 111.433 -176.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.8 mp -130.75 155.42 46.67 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 111.564 -2.562 . . . . 0.0 111.455 -164.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 144.5 168.87 12.84 Favored Glycine 0 CA--C 1.554 2.522 0 CA-C-O 119.134 -0.814 . . . . 0.0 114.701 169.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.53 122.52 11.91 Favored 'Trans proline' 0 CA--C 1.573 2.474 0 C-N-CA 123.462 2.774 . . . . 0.0 113.448 172.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -80.46 108.11 2.1 Favored 'Trans proline' 0 CA--C 1.558 1.7 0 C-N-CA 122.516 2.144 . . . . 0.0 116.007 -166.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -158.35 -93.33 0.1 OUTLIER Glycine 0 CA--C 1.537 1.439 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 168.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -72.13 -80.49 0.06 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 -169.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.697 ' O ' ' CG ' ' A' ' 13' ' ' LYS . . . -92.85 150.23 19.9 Favored Glycine 0 N--CA 1.486 1.997 0 CA-C-N 119.683 1.129 . . . . 0.0 114.717 -169.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.697 ' CG ' ' O ' ' A' ' 12' ' ' GLY . 0.2 OUTLIER 153.56 -84.71 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -172.585 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.12 -32.81 57.11 Favored Glycine 0 CA--C 1.553 2.469 0 N-CA-C 120.057 2.783 . . . . 0.0 120.057 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 78.5 m -63.21 -48.79 76.84 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 119.116 1.458 . . . . 0.0 113.294 172.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.252 6.7 mm-40 -75.57 -15.85 60.32 Favored 'General case' 0 CA--C 1.57 1.713 0 CA-C-O 115.749 -2.072 . . . . 0.0 111.972 172.23 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.31 -47.44 61.12 Favored 'General case' 0 C--N 1.374 1.642 0 CA-C-N 123.605 2.911 . . . . 0.0 114.249 168.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.7 p -66.36 -42.11 90.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 174.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -63.96 -41.7 97.48 Favored 'General case' 0 CA--C 1.565 1.54 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 171.022 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mt -66.35 -30.91 71.4 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-N 120.819 1.645 . . . . 0.0 114.724 170.756 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.9 -42.88 98.89 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 167.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -58.46 -39.95 81.28 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 167.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.4 tptt -63.47 -55.54 23.32 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 172.301 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.0 mt -82.53 -21.51 35.36 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 117.068 2.247 . . . . 0.0 117.068 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.65 34.87 8.16 Favored Glycine 0 CA--C 1.556 2.614 0 N-CA-C 118.06 1.984 . . . . 0.0 118.06 -177.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.459 ' CG2' ' HA ' ' A' ' 81' ' ' PHE . 16.9 mm -109.06 159.42 31.21 Favored Pre-proline 0 CA--C 1.572 1.824 0 CA-C-N 119.059 1.429 . . . . 0.0 113.275 -168.438 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -83.88 101.53 0.9 Allowed 'Trans proline' 0 CA--C 1.568 2.184 0 C-N-CA 121.996 1.797 . . . . 0.0 110.592 163.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -59.54 113.94 2.47 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.647 0.779 . . . . 0.0 111.67 168.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 22.0 mm -98.35 106.21 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.212 0 N-CA-C 103.891 -2.633 . . . . 0.0 103.891 173.95 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 66.0 p -95.81 131.93 41.59 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 169.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.6 p -68.59 -11.21 59.7 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 117.312 2.338 . . . . 0.0 117.312 -174.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -87.65 -20.68 50.35 Favored Glycine 0 CA--C 1.544 1.846 0 N-CA-C 118.769 2.268 . . . . 0.0 118.769 166.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -81.63 -50.99 8.67 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 118.92 1.36 . . . . 0.0 114.652 -169.365 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -65.36 -37.75 87.98 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 174.254 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.534 ' HB3' ' CB ' ' A' ' 50' ' ' LYS . 27.2 m-85 -67.49 -41.88 83.81 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 169.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.515 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 73.2 ttt180 -57.08 -36.65 70.84 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 165.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.5 ttm180 -62.15 -43.05 99.69 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.568 1.147 . . . . 0.0 113.956 168.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -60.41 -43.81 96.33 Favored 'General case' 0 CA--C 1.573 1.852 0 CA-C-N 119.149 0.886 . . . . 0.0 113.255 167.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 81.2 mt -51.27 -39.06 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.599 0 C-N-CA 125.93 1.692 . . . . 0.0 113.76 167.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -73.22 -32.62 64.88 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 115.786 1.772 . . . . 0.0 115.786 169.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -70.18 -50.43 40.28 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 175.855 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 166.33 -32.12 0.21 Allowed Glycine 0 CA--C 1.546 2.012 0 N-CA-C 117.818 1.887 . . . . 0.0 117.818 -169.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.641 ' O ' ' HG3' ' A' ' 44' ' ' LYS 0.322 44.7 p 49.45 125.29 0.0 OUTLIER 'General case' 0 N--CA 1.424 -1.749 1 N-CA-C 124.336 4.939 . . . . 0.0 124.336 -176.473 . . . . . . . . 4 3 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.641 ' HG3' ' O ' ' A' ' 43' ' ' THR 0.352 56.5 mtpt -142.46 -24.12 0.66 Allowed 'General case' 0 N--CA 1.507 2.406 0 CA-C-N 110.073 -3.239 . . . . 0.0 118.538 146.13 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -97.86 -24.93 15.21 Favored 'General case' 0 N--CA 1.514 2.726 0 CA-C-N 123.567 2.894 . . . . 0.0 112.332 161.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -40.52 -64.49 1.17 Allowed Glycine 0 CA--C 1.531 1.053 0 C-N-CA 130.583 3.944 . . . . 0.0 115.756 167.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.3 p -72.33 -48.65 47.19 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 N-CA-C 116.223 1.935 . . . . 0.0 116.223 -171.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -66.36 -44.85 82.05 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 120.359 1.436 . . . . 0.0 112.707 176.804 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.12 -38.43 85.57 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.534 ' CB ' ' HB3' ' A' ' 35' ' ' PHE 0.348 15.3 tptt -81.28 -19.79 42.27 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-O 116.943 -1.503 . . . . 0.0 113.238 174.613 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.596 ' CG ' ' O ' ' A' ' 51' ' ' ARG . 33.9 ttt180 -81.23 -57.76 3.36 Favored 'General case' 0 CA--C 1.59 2.501 1 CA-C-O 85.358 -16.544 . . . . 0.0 118.654 174.711 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 16.8 m-30 -28.28 -62.23 0.11 Allowed 'General case' 0 N--CA 1.497 1.91 1 O-C-N 107.744 -9.347 . . . . 0.0 120.853 147.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.5 tp -59.05 -33.8 71.19 Favored 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 116.415 2.006 . . . . 0.0 116.415 171.65 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -90.04 -39.99 12.58 Favored 'General case' 0 CA--C 1.567 1.603 0 N-CA-C 115.543 1.682 . . . . 0.0 115.543 174.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.53 -40.22 16.56 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 117.004 -1.474 . . . . 0.0 114.776 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 151.15 -38.91 0.83 Allowed Glycine 0 N--CA 1.476 1.333 0 CA-C-N 120.924 1.693 . . . . 0.0 116.729 170.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -67.31 171.72 5.59 Favored 'General case' 0 CA--C 1.57 1.741 0 CA-C-N 118.269 1.035 . . . . 0.0 111.626 -177.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 89.4 mt -92.76 135.93 33.69 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 121.383 -0.823 . . . . 0.0 112.12 -167.679 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.558 HG12 HE21 ' A' ' 92' ' ' GLN . 2.4 p -103.99 136.82 19.14 Favored Pre-proline 0 CA--C 1.58 2.12 0 CA-C-O 118.137 -0.935 . . . . 0.0 109.239 173.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -55.31 146.53 60.87 Favored 'Trans proline' 0 CA--C 1.562 1.911 0 C-N-CA 123.836 3.024 . . . . 0.0 116.671 169.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.8 m -73.97 -48.68 28.78 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 -168.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -61.52 -39.35 90.71 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 116.675 2.102 . . . . 0.0 116.675 -170.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 26.2 mt -57.3 -48.52 78.7 Favored 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 116.506 2.039 . . . . 0.0 116.506 172.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.4 m -61.31 -50.9 71.09 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 112.946 -1.934 . . . . 0.0 113.088 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 -64.08 -19.14 65.04 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 168.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -72.22 -44.12 63.41 Favored 'General case' 0 CA--C 1.558 1.273 0 CA-C-N 121.146 1.793 . . . . 0.0 114.18 168.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 mt -59.19 -49.96 75.86 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 120.207 1.367 . . . . 0.0 114.228 167.146 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 67.4 t -60.87 -46.79 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 123.811 0.844 . . . . 0.0 113.035 176.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -70.72 -27.16 63.76 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 175.136 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -64.47 -37.98 89.41 Favored 'General case' 0 CA--C 1.563 1.475 0 CA-C-N 119.808 1.186 . . . . 0.0 112.714 167.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -79.08 -24.0 43.79 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 118.414 2.746 . . . . 0.0 118.414 169.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.0 mp -81.7 -34.46 30.62 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 117.237 2.31 . . . . 0.0 117.237 176.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -71.53 15.96 0.12 Allowed 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 116.832 2.16 . . . . 0.0 116.832 169.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -75.77 144.35 76.46 Favored Pre-proline 0 CA--C 1.574 1.867 0 CA-C-O 118.024 -0.989 . . . . 0.0 108.947 165.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -47.72 -38.9 30.25 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 N-CA-C 119.156 2.714 . . . . 0.0 119.156 171.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.8 p30 -68.84 -16.03 63.66 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 117.043 2.238 . . . . 0.0 117.043 172.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -117.17 22.44 12.51 Favored 'General case' 0 CA--C 1.572 1.824 0 CA-C-N 121.567 1.985 . . . . 0.0 114.622 170.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.15 -46.29 67.95 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 121.65 2.023 . . . . 0.0 114.538 172.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -88.11 0.85 55.52 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 117.033 2.235 . . . . 0.0 117.033 172.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.61 167.51 38.53 Favored Glycine 0 N--CA 1.477 1.425 0 CA-C-N 121.998 2.181 . . . . 0.0 113.69 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.459 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . 19.7 p90 -172.63 132.53 0.58 Allowed 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 112.875 -1.662 . . . . 0.0 107.729 -174.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 4.3 mm -101.2 107.67 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.563 0 N-CA-C 102.729 -3.063 . . . . 0.0 102.729 168.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.4 mt -100.97 133.95 44.69 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 169.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -125.32 129.98 51.06 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 119.33 0.968 . . . . 0.0 111.778 177.149 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.02 41.73 80.4 Favored Glycine 0 CA--C 1.546 1.984 0 CA-C-O 116.198 -2.445 . . . . 0.0 116.717 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . 0.257 1.6 t80 -106.28 -55.22 0.08 OUTLIER Pre-proline 0 N--CA 1.502 2.151 0 CA-C-N 121.281 2.54 . . . . 0.0 108.771 174.236 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -67.53 72.64 0.63 Allowed 'Trans proline' 0 CA--C 1.572 2.382 0 CA-C-N 124.02 2.471 . . . . 0.0 117.688 165.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.99 17.34 17.93 Favored 'General case' 0 CA--C 1.572 1.827 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 168.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.7 t -167.55 120.15 0.91 Allowed 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 101.656 -3.461 . . . . 0.0 101.656 -177.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . 0.342 4.6 p -69.01 -21.13 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 CA-C-O 116.337 -1.792 . . . . 0.0 111.991 -176.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -64.38 -31.39 72.58 Favored 'General case' 0 CA--C 1.557 1.247 0 N-CA-C 117.896 2.554 . . . . 0.0 117.896 162.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.558 HE21 HG12 ' A' ' 59' ' ' VAL . 2.6 mm-40 -77.28 -51.57 10.67 Favored 'General case' 0 CA--C 1.585 2.32 0 CA-C-N 124.034 3.106 . . . . 0.0 111.412 164.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.27 -29.13 68.61 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 117.274 2.324 . . . . 0.0 117.274 -172.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 64.7 tttt -56.34 -35.32 67.49 Favored 'General case' 0 CA--C 1.557 1.213 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 167.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.32 -37.33 74.69 Favored 'General case' 0 CA--C 1.566 1.559 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 169.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 22.9 tp -65.55 -34.03 77.29 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 168.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.03 -42.28 89.78 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 121.549 1.977 . . . . 0.0 112.623 169.182 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 1.007 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 34.9 mt-10 -56.02 -34.92 66.3 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 115.154 1.539 . . . . 0.0 115.154 167.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 1.233 ' O ' ' HB2' ' A' ' 103' ' ' ARG . 20.7 ttt -85.78 -32.99 21.51 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 118.567 2.803 . . . . 0.0 118.567 178.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.8 -44.71 47.97 Favored 'General case' 0 N--CA 1.507 2.387 0 CA-C-N 121.375 1.898 . . . . 0.0 111.705 170.266 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -73.52 -53.5 10.42 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 119.221 0.919 . . . . 0.0 113.269 173.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 1.007 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 72.3 ttt180 -67.71 -40.75 84.24 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 116.013 1.857 . . . . 0.0 116.013 176.038 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 1.233 ' HB2' ' O ' ' A' ' 99' ' ' MET . 15.0 mmm180 -61.42 -60.18 4.11 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 118.622 0.646 . . . . 0.0 111.447 166.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 113.63 49.27 0.56 Allowed Glycine 0 N--CA 1.478 1.478 0 O-C-N 124.629 1.205 . . . . 0.0 113.632 169.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 73.2 p -86.92 146.16 26.27 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-N 114.388 -0.906 . . . . 0.0 109.399 171.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -69.13 132.15 46.11 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.526 -0.734 . . . . 0.0 111.394 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.9 tp -89.25 97.21 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -173.607 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -97.76 -65.58 0.95 Allowed 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 115.802 -2.046 . . . . 0.0 109.163 169.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -149.32 118.08 6.63 Favored 'General case' 0 C--N 1.366 1.295 0 CA-C-N 121.988 2.176 . . . . 0.0 114.88 -170.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -94.99 110.74 24.42 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.162 1 N-CA-C 98.888 -4.486 . . . . 0.0 98.888 161.042 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 40.9 tp -114.02 103.81 11.52 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.246 -162.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -100.2 123.39 44.38 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -176.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 6.8 m-30 -93.98 126.58 39.27 Favored 'General case' 0 CA--C 1.561 1.369 0 CA-C-O 122.471 1.129 . . . . 0.0 109.562 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.473 ' HB3' ' HA ' ' A' ' 163' ' ' ASP . 1.6 tmm_? -82.72 88.31 6.73 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 113.602 -1.635 . . . . 0.0 109.134 168.356 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.4 p -137.75 139.52 42.79 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.118 0 C-N-CA 125.758 1.623 . . . . 0.0 107.813 -169.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.5 m -86.41 127.09 34.79 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 113.526 -1.67 . . . . 0.0 111.023 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -64.09 -43.53 95.1 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 114.383 -1.281 . . . . 0.0 114.044 168.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -46.92 -40.64 14.6 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 117.384 2.365 . . . . 0.0 117.384 -176.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.2 t -59.1 -50.42 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.591 0 CA-C-N 120.337 1.426 . . . . 0.0 113.856 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.97 -35.13 79.67 Favored 'General case' 0 CA--C 1.565 1.536 0 CA-C-O 117.512 -1.232 . . . . 0.0 113.304 168.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.611 ' O ' ' HB2' ' A' ' 125' ' ' LYS . 35.2 mt -61.75 -29.4 70.1 Favored 'General case' 0 N--CA 1.505 2.297 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 169.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -66.42 -51.98 51.28 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.868 0.867 . . . . 0.0 112.634 167.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -47.42 -60.65 2.37 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 171.077 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.5 pp -68.57 -28.04 66.6 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 117.07 2.248 . . . . 0.0 117.07 174.75 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.611 ' HB2' ' O ' ' A' ' 121' ' ' LEU . 46.8 tttm -75.81 -57.27 3.98 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 115.864 1.801 . . . . 0.0 115.864 -177.391 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -92.12 42.07 2.76 Favored Glycine 0 CA--C 1.549 2.173 0 N-CA-C 116.646 1.418 . . . . 0.0 116.646 177.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.422 ' HB2' ' H ' ' A' ' 128' ' ' GLY . 91.2 mtt-85 -149.12 -94.92 0.07 Allowed 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 118.087 0.943 . . . . 0.0 109.739 176.147 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.652 ' O ' ' HG3' ' A' ' 129' ' ' ARG . . . -96.85 60.61 1.17 Allowed Glycine 0 CA--C 1.554 2.525 0 CA-C-O 117.047 -1.974 . . . . 0.0 115.736 -171.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.652 ' HG3' ' O ' ' A' ' 128' ' ' GLY . 79.3 mtp85 -163.49 151.94 13.74 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 121.507 2.654 . . . . 0.0 112.729 174.09 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -95.1 45.87 1.11 Allowed 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 174.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . 0.267 4.8 p-10 40.94 58.88 2.38 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 119.267 3.062 . . . . 0.0 119.267 -175.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . 0.537 ' HB3' ' NH2' ' A' ' 129' ' ' ARG . 23.7 t0 -79.93 -37.88 33.63 Favored 'General case' 0 N--CA 1.505 2.294 0 CA-C-N 112.592 -2.095 . . . . 0.0 111.633 160.03 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.77 ' HG1' ' H ' ' A' ' 134' ' ' ASP . 65.1 p -5.35 -79.5 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 129.651 3.18 . . . . 0.0 119.467 165.365 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.77 ' H ' ' HG1' ' A' ' 133' ' ' THR . 21.0 m-20 -59.73 -44.56 93.71 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 115.746 1.758 . . . . 0.0 115.746 -170.074 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -66.76 -39.45 87.89 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 169.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.8 t -57.38 -45.04 85.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 114.052 1.131 . . . . 0.0 114.052 169.389 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 48.9 mm -69.84 -28.7 37.85 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.787 0 CA-C-O 117.402 -1.285 . . . . 0.0 113.431 172.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 32.3 mt -65.43 -44.34 87.67 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 121.538 1.972 . . . . 0.0 114.262 169.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -67.61 -41.04 84.63 Favored 'General case' 0 N--CA 1.502 2.135 0 CA-C-N 120.654 1.57 . . . . 0.0 114.71 172.024 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 69.2 mtp180 -60.56 -38.68 85.34 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 169.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 56.1 mtt -71.62 -29.14 64.33 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 169.219 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -61.91 -50.35 72.53 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 120.459 1.482 . . . . 0.0 114.834 168.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.5 p -63.52 -33.83 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 169.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -54.21 -48.27 71.22 Favored 'General case' 0 CA--C 1.58 2.112 0 CA-C-N 119.983 1.265 . . . . 0.0 112.403 167.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -61.26 -45.57 93.98 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 117.859 2.54 . . . . 0.0 117.859 175.131 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -56.63 -32.1 64.99 Favored 'General case' 0 N--CA 1.507 2.385 0 N-CA-C 117.779 2.511 . . . . 0.0 117.779 177.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -114.61 -39.59 3.75 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 117.497 2.406 . . . . 0.0 117.497 -167.008 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 99.1 m -49.88 -34.2 19.44 Favored 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 117.525 2.417 . . . . 0.0 117.525 -168.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.8 -61.12 4.59 Favored Pre-proline 0 CA--C 1.581 2.168 0 CA-C-O 116.013 -1.946 . . . . 0.0 112.045 170.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_exo -55.74 -30.06 74.2 Favored 'Trans proline' 0 CA--C 1.582 2.919 0 N-CA-C 119.947 3.018 . . . . 0.0 119.947 169.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.3 -55.18 30.71 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 126.442 1.897 . . . . 0.0 111.524 169.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 1.31 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 28.9 tp -67.1 -22.52 65.81 Favored 'General case' 0 CA--C 1.562 1.409 0 CA-C-O 116.699 -1.619 . . . . 0.0 114.437 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -71.99 -49.35 37.91 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 122.008 2.185 . . . . 0.0 112.354 164.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -67.81 -54.4 19.42 Favored 'General case' 0 CA--C 1.562 1.438 0 CA-C-N 121.214 1.825 . . . . 0.0 112.158 -177.759 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -77.39 -23.27 50.73 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 114.49 -2.671 . . . . 0.0 112.337 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 1.31 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 0.1 OUTLIER -64.45 -40.25 95.38 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 125.878 3.945 . . . . 0.0 115.739 167.735 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -62.09 -37.0 83.4 Favored 'General case' 0 CA--C 1.576 1.947 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 167.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -90.48 -35.63 14.99 Favored 'General case' 0 CA--C 1.576 1.98 0 N-CA-C 118.653 2.834 . . . . 0.0 118.653 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.3 pp -71.87 171.81 11.04 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 119.843 3.275 . . . . 0.0 119.843 -163.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -129.72 126.3 37.92 Favored 'General case' 0 CA--C 1.566 1.585 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 166.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.3 t -101.64 160.45 14.44 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 122.798 1.285 . . . . 0.0 113.265 -169.724 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.566 HG12 ' HG3' ' A' ' 174' ' ' ARG . 91.9 t -131.74 150.41 33.94 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.887 0 CA-C-N 113.456 -1.702 . . . . 0.0 107.335 169.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.473 ' HA ' ' HB3' ' A' ' 114' ' ' ARG . 13.4 t70 -107.06 127.03 53.11 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 167.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -164.83 126.95 2.2 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -162.506 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.0 t -150.45 129.77 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.34 -0.85 . . . . 0.0 108.845 167.627 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 77.58 -60.3 3.68 Favored Glycine 0 N--CA 1.485 1.902 0 N-CA-C 120.705 3.042 . . . . 0.0 120.705 166.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 42.9 p -70.64 120.29 16.04 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 113.05 -1.575 . . . . 0.0 111.873 -168.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 27.9 ttt -73.4 -51.54 16.95 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -173.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -71.99 -44.25 63.78 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.862 ' HB3' ' NH2' ' A' ' 174' ' ' ARG . 45.1 mt-10 -58.99 -54.9 41.87 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 172.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 93.6 t -58.13 -37.8 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 176.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -60.48 -36.13 77.55 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 168.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -63.59 -56.05 18.91 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 175.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.862 ' NH2' ' HB3' ' A' ' 170' ' ' GLU . 9.8 ptp180 -66.07 -25.93 67.26 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 118.001 2.593 . . . . 0.0 118.001 171.736 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.5 -41.62 88.6 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 167.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.3 mp -62.82 -41.69 99.42 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 117.676 -1.154 . . . . 0.0 113.831 167.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -54.96 -45.18 74.89 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 168.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.64 -46.59 88.55 Favored 'General case' 0 CA--C 1.559 1.313 0 N-CA-C 116.655 2.095 . . . . 0.0 116.655 171.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 6.2 tt -83.74 -57.01 3.39 Favored 'General case' 0 CA--C 1.567 1.604 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.428 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.653 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -110.39 -58.89 0.49 Allowed Glycine 0 CA--C 1.552 2.366 0 CA-C-O 117.727 -1.596 . . . . 0.0 114.924 -176.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.653 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 37.0 ttmt . . . . . 0 C--O 1.251 1.151 0 CA-C-N 120.357 2.079 . . . . 0.0 107.328 -175.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 ptp . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 121.681 0.753 . . . . 0.0 111.551 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.764 ' HB3' ' HA2' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -160.42 159.0 30.47 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -168.782 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 99.4 t -136.7 150.2 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.543 0 CA-C-O 124.107 1.908 . . . . 0.0 110.262 -166.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.642 HD12 HH22 ' A' ' 2' ' ' ARG . 3.7 mt -117.46 134.04 55.29 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 127.234 2.214 . . . . 0.0 107.039 169.565 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 18.5 tp -116.65 119.35 35.23 Favored 'General case' 0 CA--C 1.571 1.769 0 CA-C-O 123.722 1.725 . . . . 0.0 108.716 -176.239 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -118.41 141.5 48.49 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 110.504 -3.044 . . . . 0.0 109.794 -166.815 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 171.2 167.85 32.05 Favored Glycine 0 CA--C 1.559 2.796 0 N-CA-C 116.04 1.176 . . . . 0.0 116.04 170.856 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -61.26 153.28 66.36 Favored 'Trans proline' 0 CA--C 1.574 2.5 0 C-N-CA 123.513 2.809 . . . . 0.0 116.002 174.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -84.99 90.35 0.79 Allowed 'Trans proline' 0 CA--C 1.562 1.902 0 C-N-CA 122.562 2.175 . . . . 0.0 114.684 -169.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -171.43 -87.64 0.07 OUTLIER Glycine 0 CA--C 1.536 1.377 0 N-CA-C 110.226 -1.149 . . . . 0.0 110.226 173.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -101.37 149.04 24.46 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -175.621 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.52 110.97 0.11 Allowed Glycine 0 N--CA 1.486 1.969 0 N-CA-C 116.956 1.542 . . . . 0.0 116.956 167.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm 170.56 -74.87 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.219 0.608 . . . . 0.0 110.158 173.756 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -51.06 -36.3 34.75 Favored Glycine 0 CA--C 1.554 2.509 0 N-CA-C 120.466 2.947 . . . . 0.0 120.466 -177.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 58.6 m -65.01 -52.45 56.07 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 119.151 1.475 . . . . 0.0 113.458 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.284 21.3 mp0 -76.51 -13.39 60.1 Favored 'General case' 0 CA--C 1.571 1.783 0 CA-C-O 115.545 -2.169 . . . . 0.0 112.329 171.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.39 -45.83 68.36 Favored 'General case' 0 C--N 1.373 1.619 0 CA-C-N 124.131 3.151 . . . . 0.0 114.389 166.901 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.9 p -66.22 -43.22 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-O 118.449 -0.786 . . . . 0.0 113.092 173.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.401 ' HB3' ' CE1' ' A' ' 172' ' ' PHE . 97.3 mttt -55.14 -48.61 73.46 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 116.6 2.074 . . . . 0.0 116.6 169.133 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 mt -66.16 -29.26 69.51 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 172.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.83 -39.83 94.21 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 167.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -59.32 -39.49 83.26 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 117.342 -1.313 . . . . 0.0 114.516 166.361 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -62.25 -58.89 6.08 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 120.901 1.682 . . . . 0.0 114.905 169.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.3 mt -82.31 -20.2 37.88 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 117.551 2.426 . . . . 0.0 117.551 -172.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.67 44.94 8.88 Favored Glycine 0 CA--C 1.553 2.432 0 CA-C-N 120.734 1.607 . . . . 0.0 117.071 -174.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.408 ' CG2' ' HA ' ' A' ' 81' ' ' PHE . 29.1 mm -112.32 156.02 42.74 Favored Pre-proline 0 CA--C 1.569 1.698 0 CA-C-N 118.219 1.01 . . . . 0.0 113.578 -168.227 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -73.04 100.65 1.24 Allowed 'Trans proline' 0 CA--C 1.562 1.894 0 C-N-CA 121.807 1.671 . . . . 0.0 112.685 160.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.23 105.34 4.61 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.302 -0.874 . . . . 0.0 108.809 167.446 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 44.6 mm -99.97 111.9 30.93 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 178.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.2 t -96.64 127.84 43.01 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 168.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 19.7 p -73.91 1.31 11.01 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 116.95 2.204 . . . . 0.0 116.95 -172.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.57 -18.67 29.71 Favored Glycine 0 CA--C 1.55 2.28 0 N-CA-C 118.014 1.966 . . . . 0.0 118.014 163.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -78.89 -55.87 4.82 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 119.494 1.647 . . . . 0.0 113.594 -168.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -57.0 -39.28 74.4 Favored 'General case' 0 CA--C 1.568 1.648 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 172.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.413 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 31.6 m-85 -69.84 -37.46 76.19 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 117.415 -1.279 . . . . 0.0 114.05 169.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -52.9 -39.95 63.16 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 115.478 1.658 . . . . 0.0 115.478 167.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.437 ' HD2' ' HA ' ' A' ' 37' ' ' ARG . 9.8 tpt180 -67.64 -39.99 84.59 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 172.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -64.99 -31.76 73.16 Favored 'General case' 0 CA--C 1.579 2.074 0 N-CA-C 115.634 1.716 . . . . 0.0 115.634 166.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 57.6 mt -59.89 -45.68 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 C-N-CA 126.023 1.729 . . . . 0.0 111.362 167.439 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -63.06 -41.48 99.47 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 172.017 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -71.74 -37.77 70.52 Favored 'General case' 0 CA--C 1.563 1.444 0 N-CA-C 116.823 2.157 . . . . 0.0 116.823 176.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.05 71.06 1.18 Allowed Glycine 0 CA--C 1.545 1.967 0 CA-C-O 117.782 -1.566 . . . . 0.0 115.179 -176.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.782 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 59.2 p -92.33 -51.26 5.24 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-N 119.684 1.742 . . . . 0.0 114.286 174.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.782 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.25 73.4 mttt 105.87 -40.52 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.777 0 CA-C-O 116.325 -1.798 . . . . 0.0 111.651 -171.549 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.06 -14.84 57.43 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 123.066 2.666 . . . . 0.0 112.968 164.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.3 -57.53 19.31 Favored Glycine 0 C--N 1.358 1.755 0 CA-C-N 120.299 1.409 . . . . 0.0 115.082 168.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.268 10.9 p -75.13 -47.5 35.8 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.394 0 N-CA-C 116.45 2.018 . . . . 0.0 116.45 -168.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -65.42 -46.86 78.3 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 120.783 1.629 . . . . 0.0 112.8 173.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.02 -33.81 75.29 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -178.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.413 ' HB2' ' HB3' ' A' ' 35' ' ' PHE . 13.6 tmtt? -66.68 -42.46 86.51 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 168.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.591 ' CG ' ' O ' ' A' ' 51' ' ' ARG . 31.6 ttt180 -73.0 -51.53 17.9 Favored 'General case' 0 CA--C 1.59 2.518 1 CA-C-O 85.079 -16.677 . . . . 0.0 118.318 -173.725 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 16.9 m-30 -31.57 -56.91 0.27 Allowed 'General case' 0 N--CA 1.495 1.793 1 O-C-N 109.216 -8.428 . . . . 0.0 121.693 146.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 35.8 mt -59.17 -44.68 92.16 Favored 'General case' 0 CA--C 1.578 2.039 0 CA-C-N 122.941 2.609 . . . . 0.0 114.411 166.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -80.79 -34.12 34.33 Favored 'General case' 0 CA--C 1.564 1.488 0 N-CA-C 116.941 2.2 . . . . 0.0 116.941 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -97.05 -33.77 11.41 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 175.159 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.47 20.19 6.69 Favored Glycine 0 CA--C 1.546 1.987 0 CA-C-N 122.452 2.387 . . . . 0.0 118.068 169.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -97.98 173.06 7.25 Favored 'General case' 0 CA--C 1.574 1.904 0 CA-C-N 118.998 1.399 . . . . 0.0 110.083 167.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.7 mt -72.71 130.31 40.22 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 119.828 -1.795 . . . . 0.0 114.923 -166.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.4 p -116.35 113.55 40.98 Favored Pre-proline 0 CA--C 1.57 1.745 0 C-N-CA 124.817 1.247 . . . . 0.0 108.936 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -60.6 153.06 64.22 Favored 'Trans proline' 0 CA--C 1.559 1.746 0 C-N-CA 123.425 2.75 . . . . 0.0 116.996 177.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 90.5 p -79.35 172.91 13.14 Favored 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 177.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . 0.453 ' O ' ' HB2' ' A' ' 66' ' ' GLU . 6.0 t70 81.89 -46.12 0.19 Allowed 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 125.839 1.656 . . . . 0.0 114.713 175.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 22.6 mt -60.83 -50.96 71.33 Favored 'General case' 0 N--CA 1.506 2.354 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 168.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.4 m -58.84 -50.83 72.53 Favored 'General case' 0 CA--C 1.566 1.591 0 CA-C-N 112.989 -1.914 . . . . 0.0 112.904 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -62.17 -28.44 69.66 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 115.216 1.561 . . . . 0.0 115.216 168.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -64.69 -44.37 90.52 Favored 'General case' 0 CA--C 1.555 1.171 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 171.997 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.3 mt -60.9 -48.99 79.29 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.214 1.191 . . . . 0.0 114.214 167.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 78.5 t -61.39 -51.82 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 CA-C-O 117.989 -1.005 . . . . 0.0 111.497 175.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -64.4 -28.38 69.65 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 174.082 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -64.05 -41.43 97.38 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 119.706 1.139 . . . . 0.0 112.806 168.423 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 27.8 ttm-85 -82.4 -9.2 59.54 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 119.001 2.963 . . . . 0.0 119.001 170.43 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 89.9 mt -99.49 -23.42 15.11 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 175.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 -75.8 23.43 0.13 Allowed 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 116.318 1.97 . . . . 0.0 116.318 172.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -81.04 145.67 57.28 Favored Pre-proline 0 CA--C 1.578 2.024 0 C-N-CA 124.276 1.03 . . . . 0.0 108.661 166.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -49.83 -32.7 30.53 Favored 'Trans proline' 0 N--CA 1.507 2.269 0 N-CA-C 119.447 2.826 . . . . 0.0 119.447 169.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -66.34 -12.71 58.25 Favored 'General case' 0 CA--C 1.564 1.492 0 CA-C-O 116.011 -1.947 . . . . 0.0 115.616 175.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.81 -38.75 76.71 Favored 'General case' 0 CA--C 1.565 1.541 0 CA-C-N 123.254 2.752 . . . . 0.0 111.389 165.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 52.34 37.1 21.49 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 122.355 2.343 . . . . 0.0 114.973 -173.055 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 64.33 26.23 13.6 Favored 'General case' 0 CA--C 1.59 2.509 0 C-N-CA 124.453 1.101 . . . . 0.0 113.855 -168.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.764 ' HA2' ' HB3' ' A' ' 2' ' ' ARG . . . -133.89 159.98 23.91 Favored Glycine 0 C--N 1.365 2.146 0 CA-C-N 121.077 1.762 . . . . 0.0 112.612 177.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.408 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . 31.5 p90 -178.39 135.32 0.15 Allowed 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 113.355 -1.422 . . . . 0.0 112.111 -168.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 31.3 mt -109.5 106.03 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.545 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 174.235 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.9 mt -99.98 129.84 46.09 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.35 1.06 . . . . 0.0 110.261 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -124.22 115.96 21.91 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 118.501 0.591 . . . . 0.0 110.235 -172.528 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 75.18 32.64 55.72 Favored Glycine 0 CA--C 1.551 2.343 0 CA-C-O 117.549 -1.695 . . . . 0.0 117.046 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -95.9 -52.77 0.23 Allowed Pre-proline 0 N--CA 1.496 1.863 0 CA-C-O 115.068 -2.396 . . . . 0.0 108.664 174.425 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -66.13 70.7 0.4 Allowed 'Trans proline' 0 CA--C 1.573 2.437 0 CA-C-N 124.57 2.668 . . . . 0.0 117.835 165.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . 0.33 39.2 ttt-85 -72.61 -35.41 67.85 Favored 'General case' 0 CA--C 1.56 1.333 0 N-CA-C 116.789 2.144 . . . . 0.0 116.789 167.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.434 ' HG ' ' HG3' ' A' ' 147' ' ' GLU . 38.6 t -147.29 135.4 21.45 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 -169.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . 0.329 4.9 p -69.02 -19.0 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 CA-C-O 116.364 -1.779 . . . . 0.0 112.597 -178.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -68.08 -32.7 73.22 Favored 'General case' 0 CA--C 1.558 1.254 0 N-CA-C 118.781 2.882 . . . . 0.0 118.781 165.168 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -75.83 -50.35 15.39 Favored 'General case' 0 CA--C 1.587 2.387 0 CA-C-N 124.372 3.26 . . . . 0.0 111.204 164.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.73 -27.43 66.47 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 117.984 2.587 . . . . 0.0 117.984 -175.673 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 41.9 tttt -57.32 -33.91 68.2 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 167.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.35 -38.23 88.69 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 167.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 47.3 mt -66.9 -33.19 75.05 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 170.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -63.19 -55.02 28.55 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 120.064 1.302 . . . . 0.0 112.755 169.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 1.171 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 0.7 OUTLIER -49.73 -36.58 26.09 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 115.761 1.763 . . . . 0.0 115.761 168.13 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 1.169 ' O ' ' HB2' ' A' ' 103' ' ' ARG . 65.6 mtt -84.37 -28.84 26.71 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 117.802 2.519 . . . . 0.0 117.802 175.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 35.9 tp -65.23 -55.05 20.67 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 120.747 1.612 . . . . 0.0 111.862 170.624 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -80.1 -50.74 9.9 Favored 'General case' 0 CA--C 1.562 1.42 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 176.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 1.171 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 94.4 mtt180 -71.86 -42.15 67.21 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 177.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 1.169 ' HB2' ' O ' ' A' ' 99' ' ' MET . 43.6 mtt180 -65.18 -51.52 60.59 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 119.928 1.24 . . . . 0.0 111.621 164.526 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.4 44.33 1.26 Allowed Glycine 0 N--CA 1.48 1.612 0 C-N-CA 121.052 -0.594 . . . . 0.0 114.153 167.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 31.1 p -95.18 145.02 25.33 Favored 'General case' 0 CA--C 1.557 1.217 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 169.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -69.44 128.19 35.65 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.438 -0.789 . . . . 0.0 112.604 -169.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 4.5 tp -81.0 102.78 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 173.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . 0.268 24.2 t70 -96.5 -76.23 0.51 Allowed 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 116.111 -1.899 . . . . 0.0 106.8 167.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -138.87 127.14 22.78 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 121.141 1.791 . . . . 0.0 114.794 -173.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.4 t -93.66 109.92 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 103.144 -2.91 . . . . 0.0 103.144 162.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 91.3 mt -107.09 120.48 42.2 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 122.918 0.487 . . . . 0.0 109.873 -172.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -103.95 128.18 51.48 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 118.033 0.379 . . . . 0.0 110.358 177.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -91.46 119.42 31.41 Favored 'General case' 0 CA--C 1.556 1.192 0 CA-C-O 122.946 1.355 . . . . 0.0 109.584 177.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.415 ' HB3' ' HA ' ' A' ' 163' ' ' ASP . 17.7 tpt180 -82.0 93.59 6.99 Favored 'General case' 0 CA--C 1.557 1.224 0 CA-C-N 112.843 -1.98 . . . . 0.0 108.314 166.497 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.7 p -137.82 141.44 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-N 113.605 -1.634 . . . . 0.0 108.286 -168.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.9 m -84.73 122.03 28.52 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.236 169.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -59.61 -32.8 70.75 Favored 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 170.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -50.03 -30.26 10.38 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 117.851 2.537 . . . . 0.0 117.851 174.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.8 t -61.9 -53.88 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 CA-C-N 121.896 2.134 . . . . 0.0 113.664 176.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 9.5 mp -73.25 -26.07 60.96 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 172.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 9.4 mp -69.26 -35.56 76.22 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 120.942 1.701 . . . . 0.0 114.576 169.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -72.88 -33.79 66.28 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 120.45 1.477 . . . . 0.0 114.764 170.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -58.48 -50.17 74.7 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 168.494 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 10.9 mp -64.52 -55.76 18.49 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 173.23 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -73.24 -19.19 61.13 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 118.882 2.919 . . . . 0.0 118.882 -177.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.13 -34.63 88.74 Favored Glycine 0 CA--C 1.552 2.363 0 N-CA-C 119.322 2.489 . . . . 0.0 119.322 -176.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -137.23 94.74 2.98 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 118.892 1.346 . . . . 0.0 109.126 176.136 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.475 ' O ' ' HG3' ' A' ' 129' ' ' ARG . . . 84.18 175.13 50.71 Favored Glycine 0 CA--C 1.573 3.702 0 CA-C-O 118.706 -1.052 . . . . 0.0 114.325 179.129 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.475 ' HG3' ' O ' ' A' ' 128' ' ' GLY . 79.0 mtp180 -164.4 112.03 1.09 Allowed 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 121.378 2.589 . . . . 0.0 110.292 176.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -83.7 99.49 10.27 Favored 'General case' 0 CA--C 1.578 2.055 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 166.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -84.7 74.83 10.39 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 123.376 2.807 . . . . 0.0 115.25 -166.473 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -116.62 62.0 0.72 Allowed 'General case' 0 CA--C 1.577 1.983 0 N-CA-C 102.813 -3.032 . . . . 0.0 102.813 157.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 73.2 p -140.45 -109.79 0.15 Allowed 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 113.917 -1.492 . . . . 0.0 109.886 -161.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -56.96 -31.27 64.83 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 117.105 2.261 . . . . 0.0 117.105 -169.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -70.65 -46.62 62.91 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.695 ' O ' ' HG3' ' A' ' 140' ' ' ARG . 18.9 m -62.79 -31.29 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.622 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 168.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 49.2 mm -64.92 -40.75 90.12 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.893 0 CA-C-O 117.175 -1.393 . . . . 0.0 112.102 167.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -60.61 -41.71 95.35 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 121.623 2.011 . . . . 0.0 115.68 169.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -60.99 -39.15 88.55 Favored 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 167.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.695 ' HG3' ' O ' ' A' ' 136' ' ' VAL . 27.7 mtp180 -59.78 -38.4 81.75 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 167.008 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 63.3 mtt -65.64 -31.87 73.13 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 169.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -64.12 -49.63 71.43 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 168.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.6 p -65.97 -33.33 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 169.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -54.19 -51.41 64.48 Favored 'General case' 0 CA--C 1.579 2.077 0 CA-C-N 120.175 1.352 . . . . 0.0 111.191 167.506 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -55.61 -37.09 67.67 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 119.529 3.159 . . . . 0.0 119.529 173.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -51.46 -29.37 15.99 Favored 'General case' 0 N--CA 1.513 2.685 0 N-CA-C 117.844 2.535 . . . . 0.0 117.844 170.625 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.434 ' HG3' ' HG ' ' A' ' 89' ' ' SER . 21.9 mm-40 -121.88 -28.94 4.38 Favored 'General case' 0 CA--C 1.559 1.309 0 N-CA-C 118.852 2.908 . . . . 0.0 118.852 -166.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 33.5 m -42.78 -37.08 1.66 Allowed 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 118.053 2.612 . . . . 0.0 118.053 -168.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.5 -62.46 2.99 Favored Pre-proline 0 CA--C 1.581 2.172 0 CA-C-O 116.175 -1.869 . . . . 0.0 111.822 172.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -52.08 -36.56 66.14 Favored 'Trans proline' 0 CA--C 1.58 2.819 0 C-N-CA 123.554 2.836 . . . . 0.0 118.546 167.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.68 -54.54 44.09 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 125.427 1.491 . . . . 0.0 111.973 171.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 1.003 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 44.2 tp -67.39 -23.55 65.58 Favored 'General case' 0 CA--C 1.561 1.396 0 CA-C-O 116.669 -1.634 . . . . 0.0 114.456 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -72.43 -46.01 57.02 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 122.022 2.192 . . . . 0.0 112.743 165.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -67.81 -52.07 41.37 Favored 'General case' 0 CA--C 1.565 1.534 0 CA-C-N 120.499 1.499 . . . . 0.0 112.245 -177.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -81.03 -24.3 38.01 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-O 115.119 -2.372 . . . . 0.0 113.405 178.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 1.003 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 39.8 ttt180 -65.04 -36.41 84.26 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 124.565 3.348 . . . . 0.0 115.581 168.29 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -68.17 -37.33 80.86 Favored 'General case' 0 CA--C 1.574 1.896 0 CA-C-N 119.806 1.185 . . . . 0.0 114.026 167.299 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -80.14 -35.93 35.94 Favored 'General case' 0 CA--C 1.575 1.91 0 N-CA-C 119.009 2.966 . . . . 0.0 119.009 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.2 pp -79.96 174.77 11.25 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 118.917 2.932 . . . . 0.0 118.917 -161.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 61.3 tttt -135.18 140.64 45.52 Favored 'General case' 0 CA--C 1.564 1.495 0 C-N-CA 125.249 1.42 . . . . 0.0 108.075 167.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 58.0 m -88.76 146.89 24.75 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.358 1.075 . . . . 0.0 112.14 -169.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 58.4 t -134.8 137.49 50.83 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.559 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 167.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.415 ' HA ' ' HB3' ' A' ' 114' ' ' ARG . 29.6 t70 -95.39 138.78 32.6 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 168.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -162.24 101.31 1.09 Allowed 'General case' 0 N--CA 1.482 1.13 0 O-C-N 121.466 -0.771 . . . . 0.0 112.323 -165.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.9 t -151.14 130.33 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 173.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 78.11 -68.45 2.86 Favored Glycine 0 N--CA 1.483 1.809 0 N-CA-C 119.092 2.397 . . . . 0.0 119.092 166.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 41.6 p -73.06 143.73 47.34 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 112.218 -1.991 . . . . 0.0 112.728 -168.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 27.8 ttt -85.37 -69.44 0.66 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.246 0.618 . . . . 0.0 111.044 -176.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -70.69 -36.02 73.08 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 -176.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.63 -51.95 67.62 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 171.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 79.5 t -55.47 -40.33 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 175.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.401 ' CE1' ' HB3' ' A' ' 19' ' ' LYS . 22.9 t80 -62.97 -33.2 74.89 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 169.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -62.02 -48.98 77.87 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 114.241 1.201 . . . . 0.0 114.241 171.452 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 80.0 mtt180 -58.93 -42.6 90.14 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 117.199 2.296 . . . . 0.0 117.199 169.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -58.93 -43.35 91.13 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 170.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.9 mp -64.84 -42.05 95.24 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 169.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -54.4 -41.25 69.06 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 116.412 2.004 . . . . 0.0 116.412 169.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -65.24 -51.67 59.36 Favored 'General case' 0 CA--C 1.561 1.37 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 169.815 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 7.4 tt -74.03 -57.65 3.83 Favored 'General case' 0 CA--C 1.566 1.574 0 CA-C-N 120.026 1.285 . . . . 0.0 112.636 -176.042 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.962 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -110.46 -57.66 0.5 Allowed Glycine 0 CA--C 1.552 2.362 0 CA-C-O 117.744 -1.587 . . . . 0.0 114.762 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.962 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 63.6 tttm . . . . . 0 C--O 1.251 1.173 0 CA-C-N 120.306 2.053 . . . . 0.0 109.212 -175.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.4 mmt . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 122.667 1.222 . . . . 0.0 111.444 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . 0.304 8.7 ttm-85 -148.59 147.07 28.57 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 118.162 2.652 . . . . 0.0 118.162 -158.429 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 37.7 t -142.76 148.83 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 124.624 2.154 . . . . 0.0 110.846 -172.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . 0.294 0.0 OUTLIER -135.56 122.03 20.63 Favored 'General case' 0 CA--C 1.564 1.513 0 CA-C-N 112.716 -2.038 . . . . 0.0 106.416 166.095 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.9 tt -97.98 133.31 42.63 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.823 1.649 . . . . 0.0 110.832 -166.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.6 mt -138.4 156.43 47.59 Favored 'General case' 0 CA--C 1.554 1.118 0 CA-C-N 113.98 -1.463 . . . . 0.0 111.174 -166.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 160.6 144.33 3.94 Favored Glycine 0 CA--C 1.555 2.544 0 CA-C-O 118.202 -1.332 . . . . 0.0 114.967 172.345 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -69.86 177.3 5.79 Favored 'Trans proline' 0 CA--C 1.579 2.733 0 CA-C-N 121.367 2.584 . . . . 0.0 114.847 169.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -47.78 132.07 21.06 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 124.057 3.171 . . . . 0.0 117.206 -177.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.22 98.76 0.25 Allowed Glycine 0 CA--C 1.533 1.211 0 N-CA-C 105.822 -2.911 . . . . 0.0 105.822 -167.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -72.78 100.64 2.91 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -168.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 179.1 85.49 0.06 OUTLIER Glycine 0 CA--C 1.539 1.563 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -159.61 -74.53 0.07 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.187 0.595 . . . . 0.0 109.519 -170.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -48.22 -33.07 10.33 Favored Glycine 0 CA--C 1.557 2.693 0 N-CA-C 120.175 2.83 . . . . 0.0 120.175 171.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 20.1 m -61.7 -52.18 65.34 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 118.872 1.336 . . . . 0.0 113.967 170.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.284 2.8 mp0 -75.09 -11.69 60.15 Favored 'General case' 0 CA--C 1.57 1.716 0 CA-C-O 115.719 -2.086 . . . . 0.0 112.683 171.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.91 -45.85 55.91 Favored 'General case' 0 C--N 1.372 1.581 0 CA-C-N 123.778 2.99 . . . . 0.0 113.929 166.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.3 p -65.22 -44.89 95.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 173.093 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.486 ' HB3' ' HE2' ' A' ' 172' ' ' PHE . 99.5 mttt -64.12 -46.06 85.84 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 116.325 1.972 . . . . 0.0 116.325 172.761 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.5 tp -65.26 -29.32 70.09 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 171.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.81 -45.15 93.97 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 168.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -52.71 -39.73 62.3 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 164.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -64.32 -48.2 76.52 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 170.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.7 mt -79.6 -19.01 50.33 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 116.505 2.039 . . . . 0.0 116.505 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.99 46.78 6.49 Favored Glycine 0 CA--C 1.554 2.513 0 CA-C-N 120.054 1.297 . . . . 0.0 116.14 -174.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.514 ' CD1' ' HA ' ' A' ' 81' ' ' PHE . 0.2 OUTLIER -130.86 147.93 68.17 Favored Pre-proline 0 CA--C 1.572 1.809 0 C-N-CA 125.855 1.662 . . . . 0.0 110.949 -165.773 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -75.55 106.73 2.32 Favored 'Trans proline' 0 CA--C 1.574 2.489 0 C-N-CA 121.85 1.7 . . . . 0.0 111.049 158.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.35 132.62 48.05 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 120.643 -1.286 . . . . 0.0 112.028 169.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -94.98 107.25 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 N-CA-C 103.478 -2.786 . . . . 0.0 103.478 174.077 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 76.3 p -98.24 125.06 43.16 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 168.669 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.9 p -68.76 -4.6 16.57 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 117.68 2.474 . . . . 0.0 117.68 -175.032 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.774 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -89.34 -26.06 26.71 Favored Glycine 0 CA--C 1.539 1.573 0 N-CA-C 118.898 2.319 . . . . 0.0 118.898 165.722 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -82.11 -55.61 4.45 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 -168.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -63.9 -40.1 95.72 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 175.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.421 ' HB3' ' CB ' ' A' ' 50' ' ' LYS . 20.1 m-85 -71.09 -44.97 64.6 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 116.35 -1.786 . . . . 0.0 114.612 173.006 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.774 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 72.5 ttt180 -52.46 -41.86 63.68 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 168.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -61.84 -41.25 97.58 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 168.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -67.61 -25.65 65.86 Favored 'General case' 0 CA--C 1.583 2.218 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 168.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 66.8 mt -61.64 -48.38 88.98 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.458 0 CA-C-N 121.054 1.752 . . . . 0.0 110.264 166.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -61.72 -40.91 96.71 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 175.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -65.94 -44.19 85.79 Favored 'General case' 0 CA--C 1.558 1.257 0 N-CA-C 116.069 1.878 . . . . 0.0 116.069 174.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.06 66.96 1.26 Allowed Glycine 0 CA--C 1.544 1.859 0 CA-C-O 118.784 -1.009 . . . . 0.0 114.301 -176.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.774 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 70.4 p -91.43 -48.45 6.88 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.774 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.274 38.9 mttp 107.77 -41.54 0.0 OUTLIER 'General case' 0 CA--C 1.571 1.752 0 CA-C-O 116.31 -1.805 . . . . 0.0 111.007 -172.431 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.4 pp -79.5 -18.66 51.47 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 123.108 2.686 . . . . 0.0 114.147 163.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.26 -55.77 28.64 Favored Glycine 0 CA--C 1.548 2.141 0 CA-C-O 122.419 1.011 . . . . 0.0 114.951 169.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 1.084 ' O ' ' HB2' ' A' ' 51' ' ' ARG . 1.0 OUTLIER -75.89 -43.73 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 N-CA-C 117.158 2.281 . . . . 0.0 117.158 -167.988 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -78.45 -24.79 45.86 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 122.369 2.349 . . . . 0.0 111.806 170.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.85 -47.76 70.96 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 123.163 2.71 . . . . 0.0 112.68 177.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.421 ' CB ' ' HB3' ' A' ' 35' ' ' PHE 0.356 38.5 tptt -81.56 -17.22 49.15 Favored 'General case' 0 CA--C 1.573 1.85 0 O-C-N 124.694 1.247 . . . . 0.0 114.339 173.111 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 1.084 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 21.5 ttt180 -83.61 -54.34 5.0 Favored 'General case' 0 CA--C 1.581 2.173 1 CA-C-O 85.034 -16.698 . . . . 0.0 118.562 175.691 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -37.99 -62.8 0.53 Allowed 'General case' 0 C--N 1.368 1.398 1 O-C-N 105.791 -10.568 . . . . 0.0 119.442 148.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . 0.271 1.2 tm? -41.18 -40.65 1.62 Allowed 'General case' 0 CA--C 1.58 2.123 0 CA-C-N 121.968 2.167 . . . . 0.0 116.845 170.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -90.72 -42.91 10.44 Favored 'General case' 0 CA--C 1.572 1.821 0 N-CA-C 117.045 2.239 . . . . 0.0 117.045 169.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -102.69 -23.45 13.83 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 118.31 2.707 . . . . 0.0 118.31 -169.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.48 32.45 7.32 Favored Glycine 0 CA--C 1.543 1.807 0 N-CA-C 118.58 2.192 . . . . 0.0 118.58 169.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -83.78 -127.09 0.03 OUTLIER 'General case' 0 CA--C 1.583 2.234 0 C-N-CA 123.833 0.853 . . . . 0.0 111.106 168.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 pp -128.81 179.08 5.91 Favored 'General case' 0 CA--C 1.573 1.835 0 C-N-CA 126.268 1.827 . . . . 0.0 110.462 169.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -163.9 138.84 4.76 Favored Pre-proline 0 CA--C 1.574 1.899 0 O-C-N 119.484 -2.01 . . . . 0.0 110.593 170.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -60.01 145.42 98.43 Favored 'Trans proline' 0 CA--C 1.562 1.919 0 C-N-CA 123.432 2.755 . . . . 0.0 115.999 169.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 95.3 p -78.61 173.15 12.72 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 77.27 -38.39 0.29 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 117.15 2.278 . . . . 0.0 117.15 173.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . 0.467 ' O ' ' HB2' ' A' ' 66' ' ' GLU . 4.4 pp -54.55 -43.07 71.69 Favored 'General case' 0 N--CA 1.507 2.416 0 N-CA-C 118.03 2.604 . . . . 0.0 118.03 170.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.4 m -60.91 -58.39 8.65 Favored 'General case' 0 CA--C 1.562 1.424 0 CA-C-N 111.5 -2.591 . . . . 0.0 112.082 176.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -62.38 -19.14 63.1 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 166.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 63' ' ' LEU . 6.1 mm-40 -65.52 -44.84 85.67 Favored 'General case' 0 CA--C 1.558 1.276 0 CA-C-N 120.729 1.604 . . . . 0.0 114.036 168.129 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.5 mt -63.66 -43.79 95.69 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 114.571 1.322 . . . . 0.0 114.571 167.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 81.8 t -59.82 -48.9 85.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 CA-C-O 117.967 -1.016 . . . . 0.0 112.45 170.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -57.6 -37.6 73.49 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 116.976 2.213 . . . . 0.0 116.976 169.739 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -60.19 -39.45 86.57 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 169.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 76.8 mtp85 -79.44 -12.41 59.89 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 117.805 2.52 . . . . 0.0 117.805 167.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.1 mp -91.65 -23.67 19.76 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 117.527 2.417 . . . . 0.0 117.527 176.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 30.3 p30 -58.9 0.4 0.09 Allowed 'General case' 0 CA--C 1.578 2.054 0 N-CA-C 118.187 2.662 . . . . 0.0 118.187 168.418 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -59.26 -144.9 0.0 OUTLIER Pre-proline 0 CA--C 1.607 3.156 0 N-CA-C 117.513 2.412 . . . . 0.0 117.513 168.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_exo -59.11 38.79 0.05 OUTLIER 'Trans proline' 0 N--CA 1.514 2.699 2 C-N-CA 125.505 4.136 . . . . 0.0 122.552 171.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 60.46 32.57 20.57 Favored 'General case' 0 CA--C 1.588 2.404 0 C-N-CA 125.877 1.671 . . . . 0.0 109.77 -160.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 69.42 16.54 8.24 Favored 'General case' 0 C--N 1.381 1.946 0 CA-C-O 117.081 -1.437 . . . . 0.0 114.346 -166.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 51.95 34.14 13.11 Favored 'General case' 0 CA--C 1.577 1.996 0 CA-C-N 122.39 2.359 . . . . 0.0 113.368 -164.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 19.1 m120 59.55 31.46 20.99 Favored 'General case' 0 CA--C 1.577 1.999 0 CA-C-O 116.834 -1.555 . . . . 0.0 113.66 -166.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -143.49 -168.44 12.14 Favored Glycine 0 C--N 1.375 2.698 0 CA-C-N 122.958 2.617 . . . . 0.0 113.337 -176.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.514 ' HA ' ' CD1' ' A' ' 26' ' ' ILE 0.38 1.6 p90 171.75 139.21 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 113.605 -1.297 . . . . 0.0 111.357 163.11 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.9 mp -115.45 109.26 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 165.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.9 mt -100.36 108.99 21.15 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 168.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -103.61 129.29 50.85 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-N 120.111 1.323 . . . . 0.0 109.961 -173.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 67.49 47.17 64.21 Favored Glycine 0 CA--C 1.548 2.098 0 CA-C-O 116.609 -2.217 . . . . 0.0 116.191 -173.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -132.77 73.17 76.45 Favored Pre-proline 0 CA--C 1.568 1.67 0 CA-C-N 121.104 2.452 . . . . 0.0 115.297 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -97.94 -28.27 0.05 OUTLIER 'Trans proline' 0 CA--C 1.561 1.87 0 C-N-CA 122.817 2.344 . . . . 0.0 112.857 156.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 50.1 mtt85 41.64 24.28 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 118.324 2.713 . . . . 0.0 118.324 -163.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.468 ' HA ' ' HG3' ' A' ' 147' ' ' GLU . 27.6 t 103.99 153.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 127.164 2.185 . . . . 0.0 106.519 -170.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.551 HG13 ' HB2' ' A' ' 147' ' ' GLU 0.307 7.7 p -57.77 -27.34 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 119.647 -1.908 . . . . 0.0 112.366 169.23 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -70.0 -25.76 63.76 Favored 'General case' 0 CA--C 1.557 1.218 0 N-CA-C 119.471 3.138 . . . . 0.0 119.471 166.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.3 tm0? -74.28 -49.96 20.91 Favored 'General case' 0 CA--C 1.59 2.505 0 CA-C-N 124.592 3.36 . . . . 0.0 108.961 162.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -53.09 -25.44 12.9 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 117.845 2.535 . . . . 0.0 117.845 -176.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -59.14 -33.05 70.43 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 166.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.12 -41.29 74.14 Favored 'General case' 0 CA--C 1.571 1.784 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 169.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 28.9 tp -63.16 -36.48 83.77 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 168.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -56.3 -53.6 55.36 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 125.219 1.408 . . . . 0.0 112.719 167.821 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.789 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 11.0 mm-40 -49.92 -36.55 28.08 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 115.694 1.738 . . . . 0.0 115.694 166.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 1.16 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 24.9 ttt -83.45 -31.75 26.41 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 118.117 2.636 . . . . 0.0 118.117 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.512 ' HA ' ' HG1' ' A' ' 105' ' ' THR . 0.1 OUTLIER -74.52 -44.28 51.96 Favored 'General case' 0 N--CA 1.508 2.449 0 CA-C-N 121.741 2.064 . . . . 0.0 111.486 169.987 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -71.91 -57.6 4.17 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 119.496 1.044 . . . . 0.0 113.694 173.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.789 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 76.8 mtp180 -71.76 -36.55 70.43 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 178.084 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 1.16 ' HB3' ' O ' ' A' ' 99' ' ' MET . 57.4 ttt85 -61.16 -56.59 19.0 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 119.462 1.028 . . . . 0.0 111.736 165.188 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 111.7 49.87 0.62 Allowed Glycine 0 N--CA 1.481 1.672 0 O-C-N 124.231 0.957 . . . . 0.0 114.09 167.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.512 ' HG1' ' HA ' ' A' ' 100' ' ' LEU . 62.0 p -97.88 163.74 12.66 Favored 'General case' 0 CA--C 1.561 1.387 0 CA-C-N 114.015 -1.093 . . . . 0.0 111.075 -179.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -84.63 134.57 34.38 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.158 -0.964 . . . . 0.0 109.128 177.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 8.9 tt -95.88 107.2 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 172.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -89.36 -60.44 1.95 Allowed 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 115.399 -2.239 . . . . 0.0 106.478 166.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -156.13 131.35 9.35 Favored 'General case' 0 C--N 1.369 1.419 0 CA-C-N 122.611 2.46 . . . . 0.0 116.463 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 39.2 t -88.66 107.86 18.21 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.629 0 N-CA-C 100.638 -3.838 . . . . 0.0 100.638 160.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.573 HD23 ' HB2' ' A' ' 160' ' ' LYS . 68.6 mt -104.27 108.83 20.42 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 118.318 -0.849 . . . . 0.0 109.616 -168.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -106.84 125.78 51.45 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.966 0.888 . . . . 0.0 109.857 -176.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -100.69 116.64 33.08 Favored 'General case' 0 CA--C 1.557 1.235 0 CA-C-O 122.568 1.175 . . . . 0.0 110.469 -169.37 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -79.64 97.81 6.68 Favored 'General case' 0 CA--C 1.556 1.191 0 CA-C-N 113.546 -1.661 . . . . 0.0 108.835 165.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.0 p -149.98 124.42 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 -169.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 95.1 p -87.59 136.4 32.96 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 113.298 -1.774 . . . . 0.0 111.506 -177.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.25 -44.28 92.4 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 113.691 -1.595 . . . . 0.0 114.409 170.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -63.49 -26.85 68.91 Favored 'General case' 0 CA--C 1.555 1.159 0 N-CA-C 117.879 2.548 . . . . 0.0 117.879 -174.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -74.97 -45.74 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 CA-C-N 120.673 1.579 . . . . 0.0 114.904 178.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -71.42 -35.55 71.01 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 116.865 -1.54 . . . . 0.0 113.436 169.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 25.9 mt -66.07 -39.4 90.05 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 121.781 2.082 . . . . 0.0 116.464 170.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.34 -35.62 78.04 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 170.222 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -56.34 -56.8 16.6 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 169.102 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.6 pp -68.46 -36.16 78.6 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 177.725 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -81.17 -60.15 2.39 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 121.211 1.823 . . . . 0.0 113.516 177.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 101.79 -40.62 2.36 Favored Glycine 0 CA--C 1.549 2.208 0 CA-C-N 120.501 1.501 . . . . 0.0 116.49 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 178.59 111.13 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 118.242 1.021 . . . . 0.0 108.647 -174.611 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.17 172.74 48.89 Favored Glycine 0 CA--C 1.57 3.472 0 CA-C-O 118.625 -1.097 . . . . 0.0 113.106 -172.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 1.284 ' HB2' ' OD2' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -160.92 100.32 1.25 Allowed 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 121.638 2.719 . . . . 0.0 114.219 -174.676 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -81.69 -37.7 26.98 Favored 'General case' 0 CA--C 1.576 1.96 0 CA-C-O 118.382 -0.818 . . . . 0.0 110.33 161.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 1.284 ' OD2' ' HB2' ' A' ' 129' ' ' ARG 0.29 20.9 m-20 66.89 -92.32 0.03 OUTLIER 'General case' 0 C--N 1.365 1.267 0 C-N-CA 126.846 2.059 . . . . 0.0 115.545 166.05 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . 0.302 17.9 t70 82.88 -58.16 0.17 Allowed 'General case' 0 N--CA 1.506 2.333 0 CA-C-N 113.704 -1.589 . . . . 0.0 109.165 -161.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.612 ' HG1' ' H ' ' A' ' 134' ' ' ASP . 73.0 p -27.78 -68.66 0.06 Allowed 'General case' 0 N--CA 1.504 2.247 0 C-N-CA 127.714 2.406 . . . . 0.0 117.483 164.576 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.612 ' H ' ' HG1' ' A' ' 133' ' ' THR . 12.3 t70 -52.03 -38.77 58.11 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 116.956 2.206 . . . . 0.0 116.956 171.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -67.5 -46.72 72.08 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 175.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.0 m -63.0 -32.81 57.45 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.805 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 169.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.5 -32.0 55.15 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.006 0 C-N-CA 125.037 1.335 . . . . 0.0 113.444 167.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 27.2 mt -67.75 -45.71 74.18 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 120.722 1.601 . . . . 0.0 113.551 170.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -61.4 -37.95 85.33 Favored 'General case' 0 N--CA 1.506 2.343 0 CA-C-N 120.228 1.376 . . . . 0.0 113.928 167.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -55.46 -39.11 69.95 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 166.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -67.6 -32.32 72.96 Favored 'General case' 0 CA--C 1.566 1.588 0 N-CA-C 114.97 1.471 . . . . 0.0 114.97 169.842 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -59.58 -54.18 49.44 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 120.561 1.528 . . . . 0.0 114.604 168.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . 0.253 7.3 p -63.67 -29.94 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 CA-C-O 117.085 -1.436 . . . . 0.0 114.054 170.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -56.65 -48.5 77.43 Favored 'General case' 0 CA--C 1.586 2.339 0 CA-C-N 121.441 1.928 . . . . 0.0 111.654 166.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.07 -21.2 11.74 Favored 'General case' 0 CA--C 1.564 1.493 0 N-CA-C 119.346 3.091 . . . . 0.0 119.346 170.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.31 -45.71 69.1 Favored 'General case' 0 N--CA 1.51 2.541 0 CA-C-N 121.339 1.882 . . . . 0.0 115.725 167.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.551 ' HB2' HG13 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -123.91 -18.57 5.95 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 120.742 3.608 . . . . 0.0 120.742 -167.31 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 53.7 m -43.72 -31.67 0.85 Allowed 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 117.899 2.555 . . . . 0.0 117.899 -169.081 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -71.48 -64.32 1.16 Allowed Pre-proline 0 CA--C 1.582 2.182 0 CA-C-O 116.123 -1.894 . . . . 0.0 112.21 172.259 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -56.53 -32.79 90.93 Favored 'Trans proline' 0 CA--C 1.579 2.772 0 CA-C-N 124.555 2.662 . . . . 0.0 118.905 168.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -63.2 -46.63 86.14 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 125.451 1.5 . . . . 0.0 112.711 171.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 1.065 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 54.2 tp -65.96 -21.91 66.45 Favored 'General case' 0 CA--C 1.57 1.719 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 169.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -70.62 -48.04 57.05 Favored 'General case' 0 CA--C 1.559 1.31 0 CA-C-N 122.362 2.346 . . . . 0.0 112.914 165.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -61.91 -54.31 43.72 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-N 120.271 1.396 . . . . 0.0 113.021 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 22.0 m-85 -76.43 -27.52 56.28 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-O 115.739 -2.076 . . . . 0.0 113.438 178.109 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 1.065 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 26.0 ttt180 -62.34 -33.81 75.43 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 124.166 3.166 . . . . 0.0 116.754 169.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -70.57 -40.9 73.06 Favored 'General case' 0 CA--C 1.575 1.922 0 CA-C-N 119.708 1.14 . . . . 0.0 113.64 166.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -90.66 -19.69 23.34 Favored 'General case' 0 CA--C 1.575 1.932 0 N-CA-C 119.877 3.288 . . . . 0.0 119.877 -176.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.5 pp -78.06 172.16 13.93 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 119.887 3.291 . . . . 0.0 119.887 -160.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.573 ' HB2' HD23 ' A' ' 111' ' ' LEU . 90.5 mttt -132.65 123.98 27.41 Favored 'General case' 0 CA--C 1.563 1.45 0 N-CA-C 104.349 -2.463 . . . . 0.0 104.349 163.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.9 t -95.94 151.01 19.82 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 122.034 0.921 . . . . 0.0 111.99 -171.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.549 HG11 ' HG3' ' A' ' 174' ' ' ARG . 15.2 t -129.76 129.49 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 178.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -97.22 111.61 23.77 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 104.121 -2.548 . . . . 0.0 104.121 169.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -128.14 42.28 3.35 Favored 'General case' 0 N--CA 1.484 1.272 1 N-CA-C 123.571 4.656 . . . . 0.0 123.571 -156.596 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . 0.501 32.5 m -101.9 -127.39 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.602 2.958 1 CA-C-O 109.702 -4.951 . . . . 0.0 106.98 169.031 . . . . . . . . 3 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 59.62 -17.31 0.03 OUTLIER Glycine 0 C--N 1.392 3.64 3 CA-C-N 134.441 7.837 . . . . 0.0 125.326 -168.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 67.2 p 60.5 94.71 0.04 OUTLIER 'General case' 0 CA--C 1.571 1.784 0 C-N-CA 127.254 2.221 . . . . 0.0 116.232 172.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . 0.271 43.4 tpp 86.94 -91.7 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 126.865 2.066 . . . . 0.0 112.244 166.12 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -63.83 -37.31 86.9 Favored 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -171.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.576 ' HB3' ' NH2' ' A' ' 174' ' ' ARG . 50.3 mt-10 -59.14 -51.95 67.82 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 174.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 4.0 t -59.14 -36.25 61.78 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.925 0 CA-C-O 117.426 -1.273 . . . . 0.0 113.462 177.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.486 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 21.4 t80 -58.75 -40.64 84.46 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 121.082 1.764 . . . . 0.0 114.84 166.806 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -61.83 -54.44 42.17 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 178.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.576 ' NH2' ' HB3' ' A' ' 170' ' ' GLU . 11.4 ptp180 -69.08 -25.28 64.36 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 117.841 2.534 . . . . 0.0 117.841 172.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.56 -46.61 85.15 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 120.637 1.562 . . . . 0.0 113.862 168.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.3 mp -58.79 -43.91 90.58 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 167.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -53.47 -43.07 67.85 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 168.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.09 -44.96 90.73 Favored 'General case' 0 CA--C 1.56 1.364 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 172.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.81 -61.56 1.72 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 120.538 1.517 . . . . 0.0 110.897 172.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.886 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . 164.6 52.57 0.02 OUTLIER Glycine 0 CA--C 1.545 1.942 0 N-CA-C 118.795 2.278 . . . . 0.0 118.795 168.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.886 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 85.2 tttt . . . . . 0 C--O 1.252 1.187 0 CA-C-N 120.794 2.297 . . . . 0.0 110.565 168.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.2 mtt . . . . . 0 CA--C 1.556 1.206 0 CA-C-O 122.812 1.292 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . 0.309 11.6 mpt_? -120.57 171.44 8.56 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 121.231 3.789 . . . . 0.0 121.231 -163.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.6 p -150.16 144.58 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.297 0 CA-C-O 123.044 1.402 . . . . 0.0 111.633 166.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.2 pp -138.62 134.16 33.37 Favored 'General case' 0 CA--C 1.563 1.448 0 CA-C-N 113.676 -1.602 . . . . 0.0 109.714 169.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.5 121.36 44.81 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 115.675 1.731 . . . . 0.0 115.675 -161.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 85.7 mt -99.58 144.96 28.07 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 111.443 -2.617 . . . . 0.0 110.358 175.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 163.93 162.26 14.53 Favored Glycine 0 CA--C 1.557 2.681 0 CA-C-O 118.801 -0.999 . . . . 0.0 115.553 169.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.3 118.61 5.77 Favored 'Trans proline' 0 CA--C 1.578 2.711 0 C-N-CA 123.475 2.783 . . . . 0.0 111.838 175.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -65.19 113.16 2.3 Favored 'Trans proline' 0 CA--C 1.559 1.761 0 C-N-CA 122.936 2.424 . . . . 0.0 118.2 -169.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.87 -87.41 0.07 OUTLIER Glycine 0 CA--C 1.538 1.472 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 168.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.433 ' H ' ' HB2' ' A' ' 120' ' ' LEU . . . -84.76 -71.17 0.53 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -172.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.435 ' O ' ' CG ' ' A' ' 13' ' ' LYS . . . -93.06 106.16 3.39 Favored Glycine 0 N--CA 1.484 1.886 0 CA-C-N 119.641 1.109 . . . . 0.0 114.991 -168.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.435 ' CG ' ' O ' ' A' ' 12' ' ' GLY . 3.6 mtmp? -175.48 -85.47 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 121.807 0.813 . . . . 0.0 110.347 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -53.8 -28.35 38.81 Favored Glycine 0 CA--C 1.554 2.48 0 N-CA-C 120.421 2.928 . . . . 0.0 120.421 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.1 m -65.76 -53.0 46.4 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 119.328 1.564 . . . . 0.0 113.265 176.011 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.28 20.0 mp0 -76.64 -13.32 60.07 Favored 'General case' 0 CA--C 1.569 1.698 0 CA-C-O 114.895 -2.479 . . . . 0.0 112.43 169.766 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.38 -47.08 68.3 Favored 'General case' 0 C--N 1.376 1.729 0 CA-C-N 125.145 3.611 . . . . 0.0 113.703 166.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.1 p -66.8 -39.94 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 174.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -62.13 -43.99 97.61 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 116.305 1.965 . . . . 0.0 116.305 169.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.84 -32.36 73.84 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 119.996 1.271 . . . . 0.0 114.152 171.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.38 -42.3 95.56 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 115.292 1.589 . . . . 0.0 115.292 167.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -58.2 -39.53 79.22 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 167.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.3 mmmt -65.9 -54.88 20.81 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 174.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.3 mt -83.51 -19.8 35.07 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 116.775 2.139 . . . . 0.0 116.775 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.02 38.6 7.83 Favored Glycine 0 CA--C 1.554 2.512 0 N-CA-C 117.62 1.808 . . . . 0.0 117.62 -176.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.45 ' CG2' ' HA ' ' A' ' 81' ' ' PHE . 11.9 mm -107.51 158.52 33.04 Favored Pre-proline 0 CA--C 1.57 1.724 0 CA-C-N 118.565 1.182 . . . . 0.0 113.419 -168.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -82.82 99.77 0.93 Allowed 'Trans proline' 0 CA--C 1.571 2.338 0 C-N-CA 121.867 1.712 . . . . 0.0 111.372 163.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -64.04 112.24 2.88 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 123.831 0.852 . . . . 0.0 112.117 170.635 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 21.5 mm -99.83 108.48 22.79 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.1 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 59.8 p -97.79 128.64 44.56 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 168.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.9 p -69.02 -19.34 64.11 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 117.066 2.247 . . . . 0.0 117.066 -169.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -81.67 -19.88 64.96 Favored Glycine 0 CA--C 1.543 1.839 0 N-CA-C 119.102 2.401 . . . . 0.0 119.102 167.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -80.84 -51.4 8.65 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -169.125 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -65.13 -41.07 95.15 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 174.346 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.41 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 25.2 m-85 -66.4 -41.1 89.82 Favored 'General case' 0 CA--C 1.559 1.298 0 N-CA-C 115.702 1.741 . . . . 0.0 115.702 172.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.424 ' HD2' ' HA ' ' A' ' 36' ' ' ARG . 22.5 tpt180 -59.3 -42.72 91.99 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 120.544 1.52 . . . . 0.0 114.203 168.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -59.21 -39.21 81.98 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 168.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -69.62 -24.47 63.65 Favored 'General case' 0 CA--C 1.581 2.14 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 168.315 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.0 mt -63.17 -49.46 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 CA-C-N 120.675 1.579 . . . . 0.0 110.96 167.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -67.95 -33.52 74.83 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 114.301 1.222 . . . . 0.0 114.301 175.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -73.7 -35.86 65.2 Favored 'General case' 0 CA--C 1.564 1.498 0 N-CA-C 116.299 1.962 . . . . 0.0 116.299 173.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.77 73.76 1.28 Allowed Glycine 0 CA--C 1.542 1.76 0 CA-C-O 118.065 -1.409 . . . . 0.0 114.482 -176.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.554 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 64.7 p -90.8 -65.59 1.0 Allowed 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 119.262 1.531 . . . . 0.0 111.911 173.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.554 ' CB ' ' O ' ' A' ' 43' ' ' THR . 21.3 ptmt 130.27 -57.13 0.0 OUTLIER 'General case' 0 CA--C 1.569 1.702 0 C-N-CA 123.661 0.784 . . . . 0.0 109.581 -166.814 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -80.03 6.83 10.39 Favored 'General case' 0 CA--C 1.575 1.913 0 C-N-CA 124.249 1.019 . . . . 0.0 113.454 166.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.467 ' O ' ' HB3' ' A' ' 50' ' ' LYS . . . -86.79 -52.77 3.05 Favored Glycine 0 CA--C 1.535 1.333 0 O-C-N 121.21 -0.931 . . . . 0.0 112.892 165.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.312 7.4 p -80.14 -52.03 15.22 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.581 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -167.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -66.94 -44.37 80.8 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 121.013 1.733 . . . . 0.0 112.686 172.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.79 -30.8 69.46 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.467 ' HB3' ' O ' ' A' ' 46' ' ' GLY . 2.4 tptm -71.97 -36.87 69.95 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 167.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.579 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 46.5 ttt180 -70.78 -58.71 3.35 Favored 'General case' 0 CA--C 1.591 2.534 1 CA-C-O 87.3 -15.619 . . . . 0.0 117.829 -178.531 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . 0.253 10.9 m-30 -26.47 -68.81 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.587 1 O-C-N 110.452 -7.655 . . . . 0.0 119.644 146.512 . . . . . . . . 3 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 26.6 tp -57.3 -32.07 66.29 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 116.517 2.043 . . . . 0.0 116.517 175.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -88.78 -47.25 8.35 Favored 'General case' 0 CA--C 1.559 1.311 0 CA-C-O 116.831 -1.557 . . . . 0.0 114.395 170.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -158.24 46.33 0.34 Allowed 'General case' 0 CA--C 1.573 1.837 0 CA-C-N 121.401 1.909 . . . . 0.0 113.32 -168.359 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -161.21 60.89 0.29 Allowed Glycine 0 C--N 1.358 1.785 0 CA-C-N 121.906 2.139 . . . . 0.0 111.727 169.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . 0.279 4.8 t70 75.56 -115.05 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 124.301 1.041 . . . . 0.0 110.423 168.619 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.555 ' HA ' HH22 ' A' ' 88' ' ' ARG . 74.7 mt -133.47 128.79 36.17 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 119.507 1.049 . . . . 0.0 110.628 -174.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.0 p -89.27 141.03 28.79 Favored Pre-proline 0 CA--C 1.578 2.031 0 CA-C-O 117.429 -1.272 . . . . 0.0 108.095 167.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -50.66 143.81 27.7 Favored 'Trans proline' 0 CA--C 1.565 2.03 0 C-N-CA 123.451 2.767 . . . . 0.0 116.696 169.765 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 59.6 m -65.71 -42.75 90.74 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 117.064 2.246 . . . . 0.0 117.064 -169.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -59.5 -37.71 79.01 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 116.832 2.16 . . . . 0.0 116.832 -175.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 35.5 mt -54.87 -51.82 64.75 Favored 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 169.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.7 m -64.99 -50.77 65.01 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 112.889 -1.96 . . . . 0.0 113.064 -178.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.83 -20.01 64.64 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 167.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -72.48 -46.87 52.79 Favored 'General case' 0 CA--C 1.556 1.185 0 CA-C-N 120.441 1.473 . . . . 0.0 114.588 170.02 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.1 mt -61.22 -46.0 92.26 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 169.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 97.3 t -61.77 -48.78 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 118.025 -0.988 . . . . 0.0 112.017 175.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -63.03 -35.78 81.36 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 115.993 1.849 . . . . 0.0 115.993 172.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -57.55 -42.83 83.73 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 117.695 -1.145 . . . . 0.0 113.779 170.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 83.2 mtt180 -80.26 -15.55 56.72 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 118.497 2.777 . . . . 0.0 118.497 168.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.6 mt -83.69 -14.69 51.14 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 116.527 2.047 . . . . 0.0 116.527 169.432 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -68.84 8.1 0.57 Allowed 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 117.17 2.285 . . . . 0.0 117.17 169.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -76.36 136.45 68.45 Favored Pre-proline 0 CA--C 1.574 1.885 0 CA-C-O 117.79 -1.1 . . . . 0.0 108.568 165.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -49.92 -24.42 10.46 Favored 'Trans proline' 0 N--CA 1.505 2.156 0 N-CA-C 122.25 3.904 . . . . 0.0 122.25 175.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -64.1 -10.73 24.18 Favored 'General case' 0 CA--C 1.573 1.845 0 CA-C-O 116.62 -1.657 . . . . 0.0 114.284 166.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.97 -19.14 57.68 Favored 'General case' 0 CA--C 1.564 1.516 0 CA-C-N 122.42 2.373 . . . . 0.0 115.68 168.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.82 -35.13 74.07 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 116.782 2.142 . . . . 0.0 116.782 174.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -106.14 16.72 24.55 Favored 'General case' 0 CA--C 1.574 1.884 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 172.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.26 178.6 38.56 Favored Glycine 0 C--N 1.358 1.782 0 CA-C-N 122.159 2.254 . . . . 0.0 115.266 173.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.45 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . 8.9 p90 -173.44 131.87 0.46 Allowed 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 169.091 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 4.7 mm -104.65 108.21 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.504 0 N-CA-C 103.412 -2.81 . . . . 0.0 103.412 170.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 79.8 mt -100.09 138.82 36.63 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 171.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -127.9 127.96 44.31 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 119.575 1.08 . . . . 0.0 111.859 172.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 67.63 34.02 82.57 Favored Glycine 0 CA--C 1.552 2.373 0 N-CA-C 118.008 1.963 . . . . 0.0 118.008 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -94.34 -54.27 0.23 Allowed Pre-proline 0 N--CA 1.496 1.826 0 CA-C-O 114.956 -2.45 . . . . 0.0 108.968 173.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.3 68.63 1.42 Allowed 'Trans proline' 0 CA--C 1.565 2.071 0 CA-C-N 124.75 2.732 . . . . 0.0 118.82 167.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.555 HH22 ' HA ' ' A' ' 58' ' ' LEU . 26.8 ptt180 -66.61 -35.57 80.5 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 116.056 1.873 . . . . 0.0 116.056 166.186 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 37.7 t -149.18 141.17 23.81 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -168.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . 0.274 8.4 p -61.7 -27.24 41.77 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.653 0 CA-C-O 115.941 -1.981 . . . . 0.0 113.322 178.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -38.22 88.26 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 120.155 3.391 . . . . 0.0 120.155 166.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -75.68 -47.91 24.26 Favored 'General case' 0 CA--C 1.586 2.34 0 CA-C-N 123.356 2.798 . . . . 0.0 112.299 166.746 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.5 -31.0 70.07 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 -175.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -57.31 -29.72 64.15 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 168.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.18 -40.54 86.58 Favored 'General case' 0 CA--C 1.571 1.758 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 167.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . 0.479 ' HA ' ' HG3' ' A' ' 99' ' ' MET . 40.1 tp -62.61 -38.3 89.66 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 169.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 55.8 t60 -64.89 -44.51 89.37 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 120.413 1.46 . . . . 0.0 113.313 168.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.863 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 32.0 mt-10 -51.58 -40.52 59.96 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 167.767 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 1.296 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -84.63 -19.95 32.14 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 117.934 2.568 . . . . 0.0 117.934 175.184 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 60.2 tp -72.45 -52.71 14.7 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 121.175 1.807 . . . . 0.0 111.47 170.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -74.85 -55.9 5.32 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 171.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.863 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 36.9 ttm180 -68.99 -39.22 79.51 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 178.076 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 1.296 ' HB3' ' O ' ' A' ' 99' ' ' MET . 66.1 ttt180 -62.37 -58.38 7.87 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 119.639 1.108 . . . . 0.0 110.365 164.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 111.47 46.66 0.78 Allowed Glycine 0 N--CA 1.479 1.529 0 O-C-N 124.366 1.041 . . . . 0.0 113.651 168.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 37.2 p -101.26 147.21 26.55 Favored 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 173.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -68.22 130.06 41.79 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.346 -0.846 . . . . 0.0 112.572 -170.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 4.4 tp -85.48 98.53 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 175.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -97.51 -67.77 0.83 Allowed 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 115.765 -2.064 . . . . 0.0 108.388 168.858 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -149.34 120.84 7.95 Favored 'General case' 0 C--N 1.367 1.367 0 CA-C-N 121.999 2.181 . . . . 0.0 115.114 -170.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 19.4 t -94.09 109.77 22.54 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.691 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 163.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.748 HD23 ' HB2' ' A' ' 160' ' ' LYS . 80.1 mt -105.07 117.97 35.35 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 123.423 0.689 . . . . 0.0 112.082 -172.556 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -88.68 136.19 33.12 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.398 0.618 . . . . 0.0 112.086 169.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -101.53 112.33 24.85 Favored 'General case' 0 CA--C 1.558 1.28 0 CA-C-O 122.998 1.38 . . . . 0.0 108.118 176.004 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.484 ' HB3' ' HA ' ' A' ' 163' ' ' ASP . 17.0 tpt180 -83.79 101.87 11.92 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 112.889 -1.959 . . . . 0.0 109.157 171.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.5 p -146.17 124.09 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 CA-C-N 113.128 -1.851 . . . . 0.0 106.717 -169.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 11.2 m -61.85 142.09 57.56 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 113.639 -1.619 . . . . 0.0 113.877 -169.444 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -54.32 -38.27 65.79 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 116.521 2.045 . . . . 0.0 116.521 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -70.66 -39.39 73.6 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 176.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.64 -47.58 92.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 CA-C-N 120.488 1.495 . . . . 0.0 114.318 175.685 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.433 ' HB2' ' H ' ' A' ' 11' ' ' ALA . 1.3 pp -67.12 -43.48 82.35 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 114.423 -1.262 . . . . 0.0 114.233 177.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.2 mp -60.37 -35.68 76.25 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 167.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -60.82 -43.09 98.7 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 168.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -57.6 -48.83 78.31 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 168.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -49.46 -48.12 47.89 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 169.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -62.57 -55.28 28.73 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 176.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.772 ' O ' ' HB2' ' A' ' 127' ' ' ARG . . . -112.16 60.81 0.33 Allowed Glycine 0 CA--C 1.543 1.81 0 C-N-CA 123.141 0.4 . . . . 0.0 114.002 178.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.772 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 66.3 ttt180 161.99 89.6 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 177.288 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.505 ' O ' ' HB2' ' A' ' 129' ' ' ARG . . . 174.49 -51.7 0.14 Allowed Glycine 0 CA--C 1.551 2.326 0 CA-C-O 118.244 -1.309 . . . . 0.0 114.301 -178.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.505 ' HB2' ' O ' ' A' ' 128' ' ' GLY . 37.8 ttm180 167.65 -97.0 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 119.483 1.641 . . . . 0.0 107.065 177.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -151.29 -44.92 0.11 Allowed 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 116.964 -1.493 . . . . 0.0 112.636 169.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -136.24 61.6 1.64 Allowed 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 121.772 2.078 . . . . 0.0 112.081 175.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -117.97 61.48 0.77 Allowed 'General case' 0 CA--C 1.572 1.824 0 N-CA-C 102.974 -2.972 . . . . 0.0 102.974 159.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 81.6 p -140.09 -112.5 0.15 Allowed 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 114.047 -1.433 . . . . 0.0 110.63 -160.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -55.88 -45.27 78.6 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 117.079 2.251 . . . . 0.0 117.079 -168.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -67.65 -38.16 83.41 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 172.349 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 44.4 t -66.2 -38.2 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-O 117.871 -1.061 . . . . 0.0 112.795 174.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.5 tp -75.17 -25.24 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 CA-C-O 117.26 -1.352 . . . . 0.0 114.276 170.355 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 28.8 mt -66.11 -51.07 61.39 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 121.824 2.102 . . . . 0.0 113.246 168.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -66.53 -38.69 87.7 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 114.692 1.368 . . . . 0.0 114.692 173.351 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 63.4 mtp180 -63.36 -32.61 74.08 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 116.363 1.986 . . . . 0.0 116.363 170.192 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 48.3 mtt -72.42 -33.0 66.8 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 168.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -61.84 -51.48 68.04 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 169.185 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.3 p -64.26 -34.22 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 CA-C-O 117.466 -1.254 . . . . 0.0 114.128 171.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -53.2 -48.08 68.38 Favored 'General case' 0 CA--C 1.591 2.55 0 CA-C-N 120.404 1.456 . . . . 0.0 112.349 167.391 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 63.1 ttt180 -57.42 -37.83 73.39 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 119.115 3.005 . . . . 0.0 119.115 174.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -52.91 -34.16 53.75 Favored 'General case' 0 N--CA 1.512 2.673 0 N-CA-C 117.205 2.298 . . . . 0.0 117.205 170.675 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -110.83 -28.43 8.4 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 120.298 3.444 . . . . 0.0 120.298 -165.336 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 56.8 m -63.5 -30.67 71.75 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 117.093 2.257 . . . . 0.0 117.093 -166.198 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.58 -61.55 4.33 Favored Pre-proline 0 CA--C 1.58 2.118 0 CA-C-O 116.583 -1.675 . . . . 0.0 112.616 168.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -65.29 -33.11 49.64 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 123.161 2.574 . . . . 0.0 117.471 176.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.2 tt -63.07 -55.06 28.7 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 117.344 -1.312 . . . . 0.0 110.542 168.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.979 ' O ' ' HB2' ' A' ' 156' ' ' ARG 0.335 0.1 OUTLIER -57.21 -27.12 61.71 Favored 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 177.931 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -73.5 -41.97 62.41 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 116.126 -1.892 . . . . 0.0 113.115 165.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -66.88 -55.82 13.01 Favored 'General case' 0 CA--C 1.564 1.494 0 CA-C-N 122.719 2.509 . . . . 0.0 112.583 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -80.46 -30.74 37.47 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-O 115.174 -2.346 . . . . 0.0 112.017 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.979 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 37.6 ttt180 -63.02 -32.63 74.03 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 124.418 3.281 . . . . 0.0 116.177 171.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -68.42 -41.12 80.86 Favored 'General case' 0 CA--C 1.574 1.888 0 CA-C-N 119.236 0.926 . . . . 0.0 113.182 165.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -90.81 -21.03 21.69 Favored 'General case' 0 CA--C 1.578 2.047 0 N-CA-C 120.331 3.456 . . . . 0.0 120.331 -176.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.7 pp -80.82 -178.37 6.79 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 119.053 2.983 . . . . 0.0 119.053 -163.119 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.748 ' HB2' HD23 ' A' ' 111' ' ' LEU . 90.5 mttt -130.89 141.52 50.31 Favored 'General case' 0 CA--C 1.564 1.491 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 166.752 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 34.0 m -100.01 145.49 27.82 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 122.408 1.099 . . . . 0.0 110.672 -171.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 38.4 t -133.04 132.39 58.87 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.487 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 169.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.484 ' HA ' ' HB3' ' A' ' 114' ' ' ARG . 20.4 t70 -96.14 138.47 33.7 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 167.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . 0.253 . . -125.61 -132.35 0.25 Allowed 'General case' 0 N--CA 1.483 1.212 0 O-C-N 121.64 -0.663 . . . . 0.0 111.433 -165.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 31.3 t 72.24 133.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 C-N-CA 127.173 2.189 . . . . 0.0 112.674 167.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 78.52 -73.43 2.23 Favored Glycine 0 N--CA 1.479 1.557 0 N-CA-C 117.566 1.787 . . . . 0.0 117.566 167.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 55.3 p -85.08 134.06 34.21 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 111.87 -2.165 . . . . 0.0 111.329 -169.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 65.3 mtt -85.8 -62.88 1.42 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.08 0.552 . . . . 0.0 111.468 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -69.89 -36.23 75.26 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 116.142 1.904 . . . . 0.0 116.142 -178.208 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.748 ' HB3' ' NH2' ' A' ' 174' ' ' ARG . 48.1 mt-10 -61.32 -52.45 64.65 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 118.023 -0.989 . . . . 0.0 113.507 169.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 99.5 t -57.51 -37.9 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 175.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -62.04 -33.9 75.24 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 116.424 2.009 . . . . 0.0 116.424 168.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.78 -53.23 43.11 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 174.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.748 ' NH2' ' HB3' ' A' ' 170' ' ' GLU . 10.5 ptp180 -65.66 -29.64 70.23 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 117.586 2.439 . . . . 0.0 117.586 170.85 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.71 -45.83 92.28 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 119.856 1.207 . . . . 0.0 114.172 167.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.92 -44.7 91.35 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-O 117.013 -1.47 . . . . 0.0 114.698 168.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 26.5 mmm180 -55.79 -43.1 76.49 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 170.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.74 -39.5 94.29 Favored 'General case' 0 CA--C 1.563 1.444 0 N-CA-C 116.477 2.028 . . . . 0.0 116.477 172.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 5.8 tt -75.0 -51.68 13.0 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 120.968 1.713 . . . . 0.0 112.077 170.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -149.5 -57.48 0.01 OUTLIER Glycine 0 CA--C 1.552 2.377 0 CA-C-O 117.486 -1.73 . . . . 0.0 115.801 -176.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt . . . . . 0 C--O 1.252 1.205 0 CA-C-N 120.774 2.287 . . . . 0.0 108.655 -172.777 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.9 ttm . . . . . 0 CA--C 1.56 1.334 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.47 166.77 32.1 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 118.414 2.746 . . . . 0.0 118.414 -166.249 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.4 p -126.71 146.07 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-O 122.923 1.344 . . . . 0.0 114.193 -166.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -119.89 113.34 20.43 Favored 'General case' 0 CA--C 1.559 1.307 0 N-CA-C 104.867 -2.271 . . . . 0.0 104.867 168.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.2 tt -101.73 131.24 48.12 Favored 'General case' 0 CA--C 1.562 1.408 0 C-N-CA 125.788 1.635 . . . . 0.0 111.348 -165.155 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.8 mt -135.48 165.8 24.66 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 125.378 1.471 . . . . 0.0 113.825 -167.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.43 124.7 0.94 Allowed Glycine 0 CA--C 1.557 2.665 0 CA-C-O 117.362 -1.799 . . . . 0.0 111.274 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -72.46 -176.68 2.34 Favored 'Trans proline' 0 CA--C 1.579 2.745 0 CA-C-N 122.522 3.161 . . . . 0.0 114.101 176.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -52.18 109.83 0.38 Allowed 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 123.748 2.965 . . . . 0.0 114.513 176.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.32 91.68 2.22 Favored Glycine 0 CA--C 1.542 1.731 0 N-CA-C 106.522 -2.631 . . . . 0.0 106.522 -165.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.58 164.32 13.81 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 115.637 1.717 . . . . 0.0 115.637 -165.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -159.87 99.32 0.18 Allowed Glycine 0 CA--C 1.539 1.538 0 N-CA-C 107.924 -2.07 . . . . 0.0 107.924 169.707 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -137.19 -73.13 0.43 Allowed 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -167.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -42.61 -42.15 4.55 Favored Glycine 0 CA--C 1.551 2.332 0 N-CA-C 121.207 3.243 . . . . 0.0 121.207 -175.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.1 m -61.97 -57.32 12.14 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 118.992 1.396 . . . . 0.0 113.835 178.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.259 3.7 mm-40 -76.49 -14.22 60.05 Favored 'General case' 0 CA--C 1.573 1.859 0 CA-C-O 116.175 -1.869 . . . . 0.0 111.528 175.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.63 -47.38 60.38 Favored 'General case' 0 C--N 1.373 1.608 0 CA-C-N 123.219 2.736 . . . . 0.0 114.476 168.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.2 p -66.12 -40.76 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 172.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -58.94 -44.22 91.36 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 116.321 1.971 . . . . 0.0 116.321 169.348 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.91 -35.46 80.69 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 172.332 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.21 -42.1 90.16 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 167.677 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -59.82 -36.23 76.35 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 167.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -64.87 -59.44 4.2 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 170.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.1 mt -80.28 -20.92 43.3 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 116.422 2.008 . . . . 0.0 116.422 -176.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.95 34.19 8.46 Favored Glycine 0 CA--C 1.554 2.501 0 N-CA-C 117.681 1.833 . . . . 0.0 117.681 -177.287 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.431 ' CG2' ' HA ' ' A' ' 81' ' ' PHE . 16.3 mm -104.64 156.07 36.47 Favored Pre-proline 0 CA--C 1.568 1.649 0 CA-C-N 118.987 1.394 . . . . 0.0 112.561 -169.208 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -80.72 100.69 1.24 Allowed 'Trans proline' 0 CA--C 1.569 2.257 0 C-N-CA 121.816 1.677 . . . . 0.0 110.099 162.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -58.81 109.11 0.75 Allowed 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 124.347 1.059 . . . . 0.0 112.002 170.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 35.7 mm -98.0 107.64 20.55 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 68.9 p -95.46 126.99 41.14 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 167.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.4 p -65.73 -22.1 66.58 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 -169.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.644 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -83.56 -13.02 76.92 Favored Glycine 0 CA--C 1.544 1.871 0 N-CA-C 119.168 2.427 . . . . 0.0 119.168 168.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -81.8 -51.21 8.37 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 119.197 1.498 . . . . 0.0 114.648 -171.144 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -66.2 -42.17 89.18 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 173.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.502 ' HB3' ' CB ' ' A' ' 50' ' ' LYS . 32.9 m-85 -59.56 -43.93 93.41 Favored 'General case' 0 CA--C 1.569 1.674 0 C-N-CA 125.403 1.481 . . . . 0.0 114.477 168.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.644 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 72.2 ttt180 -54.94 -42.56 72.45 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 168.25 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.3 ttt180 -60.36 -36.58 78.37 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 168.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -69.29 -26.54 64.79 Favored 'General case' 0 CA--C 1.581 2.168 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 167.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 58.7 mt -60.67 -52.18 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.376 0 CA-C-N 120.933 1.697 . . . . 0.0 110.235 167.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -65.4 -35.48 81.06 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -70.3 -38.44 75.0 Favored 'General case' 0 CA--C 1.562 1.426 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 174.1 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.35 68.84 1.24 Allowed Glycine 0 CA--C 1.543 1.842 0 CA-C-O 118.905 -0.941 . . . . 0.0 114.623 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.751 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 74.5 p -92.63 -47.25 7.2 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 177.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.751 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.254 75.5 mttt 104.84 -40.04 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.725 0 CA-C-O 116.227 -1.844 . . . . 0.0 111.694 -172.737 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -83.8 -12.41 55.69 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 123.09 2.677 . . . . 0.0 112.586 163.224 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.33 -56.23 26.29 Favored Glycine 0 CA--C 1.547 2.047 0 CA-C-N 120.905 1.684 . . . . 0.0 114.167 168.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.25 1.0 OUTLIER -74.33 -49.85 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 116.898 2.184 . . . . 0.0 116.898 -169.467 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -67.9 -38.59 83.19 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 119.907 1.23 . . . . 0.0 112.74 174.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.26 -35.85 66.29 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 117.969 -1.015 . . . . 0.0 113.594 -175.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.502 ' CB ' ' HB3' ' A' ' 35' ' ' PHE 0.33 1.7 tptt -81.14 -24.14 37.81 Favored 'General case' 0 CA--C 1.564 1.487 0 CA-C-O 116.961 -1.495 . . . . 0.0 113.36 173.022 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.587 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 40.6 ttt180 -75.56 -56.99 4.16 Favored 'General case' 0 CA--C 1.591 2.553 1 CA-C-O 86.613 -15.946 . . . . 0.0 117.686 176.815 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . 0.254 15.7 m-30 -27.38 -64.46 0.08 Allowed 'General case' 0 N--CA 1.499 1.979 1 O-C-N 108.837 -8.664 . . . . 0.0 120.192 146.491 . . . . . . . . 3 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.2 tp -53.89 -39.56 65.84 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 116.998 2.222 . . . . 0.0 116.998 172.858 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -90.18 -41.1 11.8 Favored 'General case' 0 CA--C 1.566 1.559 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 173.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -153.03 41.63 0.58 Allowed 'General case' 0 CA--C 1.571 1.757 0 CA-C-N 120.86 1.664 . . . . 0.0 114.887 -169.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -165.78 59.26 0.24 Allowed Glycine 0 C--N 1.354 1.559 0 O-C-N 119.419 -2.051 . . . . 0.0 111.779 168.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . 0.273 5.0 t70 71.51 -117.7 0.08 Allowed 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 124.018 0.927 . . . . 0.0 109.555 169.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.1 pp -124.93 143.65 50.76 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 123.637 0.775 . . . . 0.0 112.06 -176.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.1 p -96.93 130.92 28.86 Favored Pre-proline 0 CA--C 1.573 1.832 0 CA-C-O 117.676 -1.154 . . . . 0.0 107.924 167.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -49.34 134.89 31.91 Favored 'Trans proline' 0 CA--C 1.56 1.821 0 C-N-CA 123.537 2.825 . . . . 0.0 116.042 172.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.8 m -68.82 175.65 3.5 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -169.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.3 t70 86.09 -44.43 0.05 Allowed 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 126.339 1.856 . . . . 0.0 113.999 -176.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.8 mt -60.44 -47.37 86.39 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 168.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.8 m -57.6 -50.26 73.72 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 113.544 -1.662 . . . . 0.0 113.449 177.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -69.76 -21.25 63.45 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 168.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -65.59 -43.61 89.16 Favored 'General case' 0 CA--C 1.559 1.316 0 CA-C-N 120.557 1.526 . . . . 0.0 114.957 168.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 44.2 mt -65.56 -46.31 79.95 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 167.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -56.71 -50.99 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 172.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -65.09 -34.22 77.9 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 175.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -58.1 -43.34 87.06 Favored 'General case' 0 CA--C 1.559 1.31 0 CA-C-O 117.793 -1.098 . . . . 0.0 113.497 168.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -81.76 -9.82 59.52 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 119.256 3.058 . . . . 0.0 119.256 169.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 13.1 tp -87.66 -14.68 39.28 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 169.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -57.45 1.77 0.03 OUTLIER 'General case' 0 CA--C 1.583 2.218 0 N-CA-C 118.441 2.756 . . . . 0.0 118.441 168.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . 0.259 0.8 OUTLIER -48.1 -132.52 0.0 OUTLIER Pre-proline 0 CA--C 1.609 3.244 0 N-CA-C 118.93 2.937 . . . . 0.0 118.93 169.836 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -62.74 40.34 0.09 OUTLIER 'Trans proline' 0 C--N 1.387 2.563 0 C-N-CA 124.889 3.726 . . . . 0.0 121.221 169.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.7 t70 61.65 31.66 18.62 Favored 'General case' 0 CA--C 1.591 2.549 0 C-N-CA 124.434 1.093 . . . . 0.0 109.608 -161.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 82.32 -1.05 1.41 Allowed 'General case' 0 C--N 1.381 1.965 0 CA-C-O 116.347 -1.787 . . . . 0.0 114.638 -168.271 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 52.14 31.59 9.25 Favored 'General case' 0 CA--C 1.576 1.975 0 CA-C-N 123.873 3.033 . . . . 0.0 114.209 -165.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 60.02 32.99 21.31 Favored 'General case' 0 CA--C 1.586 2.328 0 CA-C-O 117.058 -1.449 . . . . 0.0 112.273 -166.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -179.72 173.64 45.34 Favored Glycine 0 C--N 1.374 2.673 0 CA-C-N 123.185 2.721 . . . . 0.0 117.883 -172.344 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.431 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . 15.1 p90 -170.46 132.63 0.99 Allowed 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 114.189 -1.005 . . . . 0.0 108.88 -175.173 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.1 mm -102.43 105.48 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.577 0 N-CA-C 102.745 -3.057 . . . . 0.0 102.745 166.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -110.5 122.76 48.51 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -176.65 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.25 119.67 32.94 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 119.048 0.84 . . . . 0.0 110.467 -165.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.39 43.68 68.67 Favored Glycine 0 CA--C 1.548 2.094 0 CA-C-O 116.098 -2.501 . . . . 0.0 116.345 -174.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . 0.257 2.9 t80 -95.97 -57.32 0.2 Allowed Pre-proline 0 N--CA 1.504 2.234 0 CA-C-N 121.737 2.768 . . . . 0.0 108.276 176.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -60.59 59.67 0.09 OUTLIER 'Trans proline' 0 CA--C 1.577 2.654 0 N-CA-C 121.547 3.633 . . . . 0.0 121.547 168.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.528 HH11 ' HB2' ' A' ' 89' ' ' SER . 7.0 tmm_? -69.55 -28.43 66.0 Favored 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 166.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.528 ' HB2' HH11 ' A' ' 88' ' ' ARG . 30.3 t -151.68 155.51 38.48 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 120.279 1.399 . . . . 0.0 107.913 -176.184 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.5 t -61.87 -37.0 77.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-O 116.981 -1.485 . . . . 0.0 111.793 173.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.34 -40.41 77.94 Favored 'General case' 0 CA--C 1.558 1.268 0 N-CA-C 119.882 3.29 . . . . 0.0 119.882 169.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 22.3 mm100 -71.41 -48.21 51.17 Favored 'General case' 0 CA--C 1.589 2.471 0 CA-C-N 122.279 2.308 . . . . 0.0 113.322 168.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.78 -29.49 66.82 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 126.894 2.078 . . . . 0.0 116.05 -168.184 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 57.6 tttt -63.68 -31.57 72.78 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 166.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.97 -39.08 69.58 Favored 'General case' 0 CA--C 1.569 1.688 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 169.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 16.8 tp -63.01 -40.88 99.09 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 168.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -58.5 -52.49 65.43 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 119.431 1.014 . . . . 0.0 113.463 169.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.946 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 21.5 mm-40 -48.63 -41.79 32.19 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 115.956 1.836 . . . . 0.0 115.956 168.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 1.189 ' O ' ' HB2' ' A' ' 103' ' ' ARG . 55.1 mtt -84.12 -20.73 32.03 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 117.956 2.576 . . . . 0.0 117.956 175.569 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.485 ' HA ' ' HG1' ' A' ' 105' ' ' THR . 2.1 tt -75.73 -48.93 19.8 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-N 121.301 1.864 . . . . 0.0 110.866 172.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -72.45 -56.28 5.67 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 119.57 1.077 . . . . 0.0 113.199 169.714 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.946 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 70.6 ttt180 -64.15 -44.63 91.54 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 116.353 1.983 . . . . 0.0 116.353 177.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 1.189 ' HB2' ' O ' ' A' ' 99' ' ' MET . 15.3 mtp-105 -65.13 -53.92 37.84 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 118.992 0.814 . . . . 0.0 111.196 165.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 111.02 48.62 0.71 Allowed Glycine 0 N--CA 1.483 1.831 0 C-N-CA 120.808 -0.71 . . . . 0.0 114.752 166.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.485 ' HG1' ' HA ' ' A' ' 100' ' ' LEU . 71.7 p -89.91 158.14 17.55 Favored 'General case' 0 CA--C 1.563 1.479 0 CA-C-N 113.22 -1.49 . . . . 0.0 110.307 169.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -72.55 138.69 47.07 Favored 'General case' 0 N--CA 1.507 2.381 0 CA-C-O 122.37 1.081 . . . . 0.0 111.38 172.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.6 tp -98.99 102.72 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -95.12 -70.32 0.72 Allowed 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 116.738 -1.601 . . . . 0.0 108.032 166.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.91 124.23 7.61 Favored 'General case' 0 C--N 1.36 1.05 0 CA-C-N 120.938 1.699 . . . . 0.0 113.818 -169.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 24.0 t -92.29 108.92 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.638 1 N-CA-C 99.97 -4.085 . . . . 0.0 99.97 162.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.255 52.2 tp -118.94 114.48 22.63 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.937 0.895 . . . . 0.0 112.607 -159.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -103.17 127.81 50.34 Favored 'General case' 0 CA--C 1.563 1.454 0 CA-C-O 121.448 0.642 . . . . 0.0 112.34 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -95.79 113.9 25.58 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.902 1.281 . . . . 0.0 109.796 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -86.33 96.06 9.85 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.214 170.614 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 56.1 t -132.63 146.66 32.45 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.565 0 C-N-CA 127.891 2.476 . . . . 0.0 106.016 -171.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.8 m -75.94 137.3 40.25 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 113.476 -1.693 . . . . 0.0 112.647 -175.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -65.17 -28.09 69.16 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 174.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -60.35 -35.86 76.66 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 122.102 2.228 . . . . 0.0 115.588 172.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -62.19 -46.55 96.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 169.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.18 -52.47 47.84 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 124.134 0.974 . . . . 0.0 113.505 175.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.0 mp -59.68 -34.98 73.56 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 116.137 1.902 . . . . 0.0 116.137 172.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.45 -33.87 69.75 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 120.813 1.642 . . . . 0.0 114.522 169.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -57.32 -52.6 64.69 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 168.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 72.4 mt -61.19 -48.41 81.65 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 171.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.486 ' HG3' ' NH1' ' A' ' 129' ' ' ARG . 24.0 ttmm -72.78 -54.91 7.62 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 116.769 2.137 . . . . 0.0 116.769 -173.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -67.2 -44.91 85.26 Favored Glycine 0 CA--C 1.552 2.404 0 N-CA-C 118.072 1.989 . . . . 0.0 118.072 -170.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -92.69 76.84 4.94 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 119.871 1.836 . . . . 0.0 111.428 178.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.562 ' O ' ' HB3' ' A' ' 129' ' ' ARG . . . 72.34 171.9 18.28 Favored Glycine 0 CA--C 1.573 3.661 0 CA-C-O 118.537 -1.146 . . . . 0.0 114.354 -172.587 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.562 ' HB3' ' O ' ' A' ' 128' ' ' GLY . 34.0 ptt180 170.72 163.4 0.08 Allowed 'General case' 0 C--N 1.363 1.171 0 CA-C-N 121.732 2.766 . . . . 0.0 115.848 174.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -157.69 -38.96 0.07 Allowed 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 111.582 -2.554 . . . . 0.0 110.739 166.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -59.94 -74.24 0.08 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 120.043 1.292 . . . . 0.0 112.402 166.112 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 38.47 40.7 0.39 Allowed 'General case' 0 N--CA 1.505 2.311 0 C-N-CA 124.603 1.161 . . . . 0.0 113.755 -162.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.405 ' HG1' ' HB ' ' A' ' 136' ' ' VAL 0.29 5.9 t 14.86 101.54 0.0 OUTLIER 'General case' 0 CA--C 1.566 1.57 0 C-N-CA 129.727 3.211 . . . . 0.0 118.18 -166.89 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -136.16 -67.69 0.52 Allowed 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 110.571 -3.013 . . . . 0.0 106.78 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -68.37 -35.22 77.4 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 117.897 -1.049 . . . . 0.0 113.306 165.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.823 ' O ' ' HG2' ' A' ' 140' ' ' ARG . 48.9 t -66.99 -34.39 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 CA-C-N 120.256 1.389 . . . . 0.0 112.807 169.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -71.94 -34.95 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 CA-C-N 119.729 1.149 . . . . 0.0 113.074 174.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 40.7 mt -69.38 -48.57 60.79 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 119.701 1.137 . . . . 0.0 113.834 173.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -66.43 -38.17 86.82 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 173.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.823 ' HG2' ' O ' ' A' ' 136' ' ' VAL . 47.8 mmm-85 -60.65 -43.94 97.01 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 169.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 37.0 mtt -64.26 -32.99 74.8 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 115.833 1.79 . . . . 0.0 115.833 169.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -64.44 -48.65 74.51 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 170.167 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.8 -31.26 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 172.195 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -57.8 -52.38 65.72 Favored 'General case' 0 CA--C 1.581 2.164 0 CA-C-N 119.492 1.042 . . . . 0.0 111.452 166.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -52.83 -25.38 11.3 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 120.2 3.408 . . . . 0.0 120.2 169.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.89 -55.48 19.89 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 170.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -145.43 13.84 1.4 Allowed 'General case' 0 CA--C 1.563 1.467 0 N-CA-C 119.497 3.147 . . . . 0.0 119.497 -169.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 17.7 m -51.9 -29.19 18.96 Favored 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -70.81 -61.33 2.49 Favored Pre-proline 0 CA--C 1.58 2.102 0 CA-C-O 116.148 -1.882 . . . . 0.0 112.142 171.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_exo -55.34 -27.8 59.64 Favored 'Trans proline' 0 CA--C 1.574 2.485 0 N-CA-C 119.492 2.843 . . . . 0.0 119.492 169.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -66.88 -53.01 36.54 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 125.156 1.383 . . . . 0.0 110.988 172.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.968 ' O ' ' HB2' ' A' ' 156' ' ' ARG 0.316 0.0 OUTLIER -61.32 -25.01 66.84 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 174.384 . . . . . . . . 4 4 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -71.3 -51.65 23.19 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 120.601 1.546 . . . . 0.0 113.667 166.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -62.66 -55.23 28.84 Favored 'General case' 0 CA--C 1.565 1.527 0 CA-C-N 120.045 1.293 . . . . 0.0 112.221 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -81.52 -25.94 35.53 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 115.153 -2.356 . . . . 0.0 113.399 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.968 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 43.9 ttt180 -67.3 -34.27 77.03 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 124.438 3.29 . . . . 0.0 115.919 170.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -69.5 -37.99 77.43 Favored 'General case' 0 CA--C 1.572 1.827 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 166.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -90.15 -24.37 21.08 Favored 'General case' 0 CA--C 1.575 1.926 0 N-CA-C 118.876 2.917 . . . . 0.0 118.876 -177.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.1 pp -76.06 178.75 6.09 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 117.478 2.399 . . . . 0.0 117.478 -165.446 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -128.91 129.31 45.33 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 169.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 27.1 m -100.38 149.95 23.11 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 122.079 0.943 . . . . 0.0 111.006 -171.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 4.1 t -128.14 134.74 64.42 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.663 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 167.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -110.86 121.43 45.32 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 104.435 -2.432 . . . . 0.0 104.435 166.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . 0.289 . . -165.58 162.03 18.8 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.095 0.958 . . . . 0.0 111.106 -161.034 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 4.5 t -139.36 119.47 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 160.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -79.45 72.93 2.45 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 119.866 2.706 . . . . 0.0 119.866 -165.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 6.6 t -158.52 60.66 0.44 Allowed 'General case' 0 CA--C 1.566 1.56 0 CA-C-N 111.293 -2.454 . . . . 0.0 108.437 -178.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 2.8 ttt -159.31 -35.39 0.06 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 -168.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 7.4 t70 80.79 -37.62 0.14 Allowed 'General case' 0 N--CA 1.508 2.451 0 CA-C-N 120.849 1.659 . . . . 0.0 111.869 -164.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -55.15 -39.04 69.03 Favored 'General case' 0 CA--C 1.559 1.295 0 CA-C-O 116.651 -1.642 . . . . 0.0 113.429 165.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 89.5 t -56.34 -39.26 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 CA-C-N 121.363 1.892 . . . . 0.0 114.309 171.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -57.77 -39.03 76.5 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-N 120.472 1.487 . . . . 0.0 114.86 166.381 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -60.53 -46.85 88.66 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 115.481 1.659 . . . . 0.0 115.481 173.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 12.2 mtt-85 -61.48 -43.14 99.4 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 169.403 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.11 -40.37 70.39 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 169.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 8.4 mp -64.18 -49.12 73.28 Favored 'General case' 0 CA--C 1.565 1.533 0 CA-C-O 118.413 -0.804 . . . . 0.0 112.608 168.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 36.4 mtt180 -51.24 -40.81 59.65 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 117.581 2.437 . . . . 0.0 117.581 171.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.11 -51.53 66.19 Favored 'General case' 0 CA--C 1.561 1.4 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 169.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -99.65 -60.46 1.53 Allowed 'General case' 0 CA--C 1.565 1.538 0 CA-C-O 117.993 -1.003 . . . . 0.0 113.469 -169.418 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.822 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -102.82 -50.52 1.08 Allowed Glycine 0 CA--C 1.551 2.34 0 CA-C-N 120.537 1.517 . . . . 0.0 116.885 -169.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.822 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 87.0 tttt . . . . . 0 C--O 1.252 1.201 0 CA-C-N 119.489 1.645 . . . . 0.0 108.356 -174.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.0 mtt . . . . . 0 N--CA 1.482 1.125 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.613 ' HE ' ' HA2' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -149.01 174.9 11.79 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 116.685 2.105 . . . . 0.0 116.685 -168.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 93.5 t -133.75 147.22 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-O 122.992 1.377 . . . . 0.0 113.319 -164.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -121.63 117.57 27.03 Favored 'General case' 0 CA--C 1.56 1.347 0 CA-C-N 113.491 -1.686 . . . . 0.0 107.284 169.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 17.5 tp -99.87 125.13 45.79 Favored 'General case' 0 CA--C 1.575 1.908 0 CA-C-O 123.706 1.717 . . . . 0.0 109.389 -170.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.1 mt -122.23 161.01 24.03 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 110.021 -3.263 . . . . 0.0 112.481 -165.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 148.39 -179.68 25.05 Favored Glycine 0 CA--C 1.559 2.809 0 CA-C-N 115.258 -0.883 . . . . 0.0 114.821 170.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -63.53 130.19 27.47 Favored 'Trans proline' 0 CA--C 1.574 2.508 0 C-N-CA 123.355 2.703 . . . . 0.0 113.765 176.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -82.01 131.98 7.16 Favored 'Trans proline' 0 CA--C 1.561 1.844 0 C-N-CA 122.648 2.232 . . . . 0.0 114.808 -169.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.2 -88.06 0.07 OUTLIER Glycine 0 CA--C 1.537 1.413 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 169.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.527 ' H ' ' HB2' ' A' ' 120' ' ' LEU . . . -151.65 106.63 3.27 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 175.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 175.11 -167.64 39.83 Favored Glycine 0 CA--C 1.546 2.018 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.9 -178.086 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.421 ' HB2' ' OD2' ' A' ' 84' ' ' ASP . 0.3 OUTLIER 78.26 -54.77 0.49 Allowed 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 175.577 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -49.48 -27.22 8.09 Favored Glycine 0 CA--C 1.553 2.465 0 N-CA-C 121.201 3.241 . . . . 0.0 121.201 177.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 52.0 m -66.99 -52.75 38.81 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 120.237 2.018 . . . . 0.0 112.598 173.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.291 0.6 OUTLIER -76.19 -13.88 60.17 Favored 'General case' 0 CA--C 1.568 1.667 0 CA-C-O 115.893 -2.003 . . . . 0.0 113.855 170.509 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.31 -47.17 36.37 Favored 'General case' 0 C--N 1.371 1.513 0 CA-C-N 123.421 2.828 . . . . 0.0 113.433 167.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.2 t -65.37 -36.74 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-N 120.06 1.3 . . . . 0.0 113.848 172.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -66.44 -45.78 78.67 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 171.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.0 tp -65.49 -30.65 71.45 Favored 'General case' 0 CA--C 1.574 1.902 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 170.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.22 -39.75 94.63 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 168.062 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -59.93 -37.7 80.25 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 166.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.3 tptt -64.3 -56.89 11.43 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 170.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 77.3 mt -83.23 -25.02 32.08 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 117.341 2.348 . . . . 0.0 117.341 -174.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.74 39.73 7.0 Favored Glycine 0 CA--C 1.556 2.612 0 N-CA-C 117.578 1.791 . . . . 0.0 117.578 -173.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 15.2 mm -104.56 154.69 38.27 Favored Pre-proline 0 CA--C 1.567 1.606 0 CA-C-O 117.567 -1.206 . . . . 0.0 113.11 -169.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -81.83 98.6 0.98 Allowed 'Trans proline' 0 CA--C 1.569 2.232 0 CA-C-N 122.219 1.828 . . . . 0.0 109.801 162.645 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -73.91 110.42 8.19 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.305 0.574 . . . . 0.0 110.189 176.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.0 mm -100.35 108.97 24.0 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 N-CA-C 105.515 -2.032 . . . . 0.0 105.515 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 72.7 p -96.98 127.74 43.25 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 171.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.0 p -67.29 -18.36 65.16 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 117.356 2.354 . . . . 0.0 117.356 -172.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.42 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -81.06 -20.24 65.49 Favored Glycine 0 CA--C 1.539 1.56 0 N-CA-C 119.242 2.457 . . . . 0.0 119.242 168.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -81.0 -51.47 8.48 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -169.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -64.3 -41.7 96.73 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 174.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.41 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 21.5 m-85 -68.92 -39.69 79.51 Favored 'General case' 0 CA--C 1.561 1.375 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 174.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.42 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 46.4 ttp180 -58.68 -41.71 86.81 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 120.473 1.488 . . . . 0.0 114.322 167.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -60.54 -38.71 85.36 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 168.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -67.55 -29.32 68.68 Favored 'General case' 0 CA--C 1.572 1.824 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 168.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 79.0 mt -62.7 -45.54 98.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 CA-C-N 120.111 1.323 . . . . 0.0 111.921 168.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -66.71 -38.96 87.77 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 120.25 1.387 . . . . 0.0 114.438 172.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -78.47 -27.85 46.38 Favored 'General case' 0 CA--C 1.562 1.413 0 N-CA-C 117.065 2.246 . . . . 0.0 117.065 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.11 72.99 1.23 Allowed Glycine 0 CA--C 1.545 1.935 0 CA-C-O 118.223 -1.321 . . . . 0.0 115.878 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.795 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 81.4 p -91.29 -45.92 8.34 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 172.106 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.795 ' HB2' ' O ' ' A' ' 43' ' ' THR . 75.6 mttt 104.56 -40.36 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.753 0 CA-C-O 116.493 -1.718 . . . . 0.0 111.633 -171.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -83.91 -10.32 58.06 Favored 'General case' 0 CA--C 1.574 1.894 0 CA-C-N 122.762 2.528 . . . . 0.0 113.222 163.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.21 -54.48 23.69 Favored Glycine 0 C--N 1.355 1.588 0 CA-C-N 120.385 1.448 . . . . 0.0 115.531 169.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.286 7.7 p -76.94 -47.5 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.514 0 N-CA-C 116.077 1.88 . . . . 0.0 116.077 -168.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -64.24 -48.31 76.29 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 121.111 1.778 . . . . 0.0 112.692 172.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.59 -28.04 64.57 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -178.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.41 ' HB2' ' HB3' ' A' ' 35' ' ' PHE . 10.8 tptt -74.91 -30.59 61.31 Favored 'General case' 0 CA--C 1.566 1.584 0 CA-C-O 115.909 -1.996 . . . . 0.0 113.762 168.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -57.02 -36.97 71.06 Favored 'General case' 0 CA--C 1.607 3.164 1 CA-C-O 90.989 -13.863 . . . . 0.0 119.424 164.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 9.5 m-30 -92.58 -49.65 6.0 Favored 'General case' 0 CA--C 1.591 2.538 2 O-C-N 110.588 -7.57 . . . . 0.0 100.415 -152.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.9 tp -51.38 -46.99 62.97 Favored 'General case' 0 CA--C 1.569 1.683 0 C-N-CA 126.209 1.803 . . . . 0.0 115.516 161.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -78.96 -41.9 28.14 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 176.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -95.38 -38.69 10.38 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -170.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.889 ' HA2' HH22 ' A' ' 88' ' ' ARG . . . 119.79 22.48 3.29 Favored Glycine 0 CA--C 1.541 1.685 0 N-CA-C 118.235 2.054 . . . . 0.0 118.235 168.511 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -97.3 -179.32 4.47 Favored 'General case' 0 CA--C 1.575 1.941 0 CA-C-N 118.805 1.303 . . . . 0.0 110.243 167.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.9 mt -82.34 127.97 33.76 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.184 -1.573 . . . . 0.0 114.382 -166.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.4 p -118.3 124.08 28.87 Favored Pre-proline 0 CA--C 1.572 1.806 0 C-N-CA 124.935 1.294 . . . . 0.0 110.485 -174.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -60.72 153.1 64.69 Favored 'Trans proline' 0 CA--C 1.56 1.81 0 C-N-CA 123.425 2.75 . . . . 0.0 116.337 172.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 97.2 p -80.24 -49.62 11.36 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 -177.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -63.61 -45.69 89.15 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 -169.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 pp -57.76 -43.1 85.23 Favored 'General case' 0 CA--C 1.562 1.421 0 N-CA-C 117.266 2.321 . . . . 0.0 117.266 169.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.0 m -62.24 -42.32 99.21 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 123.93 0.892 . . . . 0.0 112.578 174.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -62.77 -30.57 71.55 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 166.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.48 -42.35 83.1 Favored 'General case' 0 CA--C 1.555 1.138 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 174.497 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mt -64.75 -46.15 83.42 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 168.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -56.08 -51.13 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 169.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -60.83 -38.38 85.27 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 115.794 1.775 . . . . 0.0 115.794 174.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -57.23 -44.18 83.53 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 117.592 -1.194 . . . . 0.0 113.421 170.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -84.3 1.84 43.03 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 119.51 3.152 . . . . 0.0 119.51 168.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 21.7 tp -115.64 -5.91 12.18 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 117.813 2.524 . . . . 0.0 117.813 172.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -54.61 -32.39 58.72 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 169.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.409 ' C ' ' H ' ' A' ' 76' ' ' ASP 0.38 2.4 m-20 -8.87 -120.54 0.0 OUTLIER Pre-proline 0 CA--C 1.604 3.022 0 N-CA-C 120.752 3.612 . . . . 0.0 120.752 168.521 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_exo -64.94 27.29 0.08 OUTLIER 'Trans proline' 0 N--CA 1.52 3.031 1 CA-C-N 128.376 4.027 . . . . 0.0 120.589 167.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.409 ' H ' ' C ' ' A' ' 74' ' ' ASN . 9.0 t70 62.15 28.92 17.38 Favored 'General case' 0 CA--C 1.577 2.014 0 C-N-CA 126.311 1.844 . . . . 0.0 109.142 -158.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 56.67 27.87 13.25 Favored 'General case' 0 CA--C 1.583 2.214 0 CA-C-N 120.694 1.588 . . . . 0.0 113.036 -163.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.08 -40.33 60.19 Favored 'General case' 0 C--N 1.378 1.847 0 CA-C-N 121.746 2.066 . . . . 0.0 114.779 -177.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -73.45 -18.85 61.08 Favored 'General case' 0 CA--C 1.566 1.561 0 CA-C-O 115.621 -2.133 . . . . 0.0 115.325 172.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.613 ' HA2' ' HE ' ' A' ' 2' ' ' ARG . . . 137.17 -176.7 20.33 Favored Glycine 0 C--N 1.363 2.072 0 CA-C-N 123.332 2.787 . . . . 0.0 113.639 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.473 ' O ' ' HB2' ' A' ' 2' ' ' ARG . 21.9 p90 -167.41 131.52 1.84 Allowed 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 111.719 -2.241 . . . . 0.0 109.092 172.593 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 17.5 mt -110.47 106.56 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 104.099 -2.556 . . . . 0.0 104.099 170.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.7 mt -110.35 112.75 24.9 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.718 0.807 . . . . 0.0 108.832 -176.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.421 ' OD2' ' HB2' ' A' ' 13' ' ' LYS . 35.4 t0 -109.46 128.65 55.31 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 118.732 0.696 . . . . 0.0 111.688 -175.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 73.54 35.39 55.77 Favored Glycine 0 CA--C 1.552 2.373 0 CA-C-O 117.563 -1.687 . . . . 0.0 117.279 176.258 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -103.56 -51.89 0.13 Allowed Pre-proline 0 N--CA 1.497 1.906 0 CA-C-O 114.761 -2.542 . . . . 0.0 109.333 173.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -62.08 71.61 0.1 Allowed 'Trans proline' 0 CA--C 1.568 2.22 0 CA-C-N 124.874 2.776 . . . . 0.0 118.838 165.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.889 HH22 ' HA2' ' A' ' 56' ' ' GLY . 1.4 ptm180 -78.05 -36.95 47.83 Favored 'General case' 0 CA--C 1.56 1.342 0 N-CA-C 115.54 1.681 . . . . 0.0 115.54 167.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 69.1 p -137.18 151.42 48.77 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 -168.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.2 t -71.01 -31.03 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-O 116.884 -1.532 . . . . 0.0 111.153 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.71 -40.21 94.23 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 120.149 3.388 . . . . 0.0 120.149 168.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -71.25 -49.29 44.7 Favored 'General case' 0 CA--C 1.589 2.456 0 CA-C-N 122.413 2.37 . . . . 0.0 112.462 168.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.6 -28.87 66.32 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 126.756 2.023 . . . . 0.0 115.646 -170.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.6 ttpm? -58.54 -31.95 68.42 Favored 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 166.321 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.05 -43.81 94.35 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 114.668 1.358 . . . . 0.0 114.668 168.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.0 mt -66.69 -33.82 76.49 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 172.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -66.22 -58.38 5.51 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 125.349 1.46 . . . . 0.0 112.646 173.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.964 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 47.8 mt-10 -54.66 -36.48 64.64 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 171.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 24.7 ttt -82.72 -40.62 20.33 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 176.467 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 24.6 tp -57.12 -61.79 2.21 Favored 'General case' 0 N--CA 1.508 2.431 0 CA-C-N 121.503 1.956 . . . . 0.0 110.499 174.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -81.74 -37.27 27.51 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 -177.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.964 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 52.8 ttt85 -60.29 -41.34 93.15 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 176.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.574 ' HB2' ' O ' ' A' ' 102' ' ' ARG . 54.9 ttt180 -174.92 41.72 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 114.464 -2.684 . . . . 0.0 115.851 168.057 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -114.77 -61.25 0.38 Allowed Glycine 0 C--N 1.362 2.021 0 CA-C-N 123.565 2.893 . . . . 0.0 113.441 174.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 23.5 p -148.28 159.4 44.02 Favored 'General case' 0 CA--C 1.554 1.13 0 CA-C-O 122.957 1.361 . . . . 0.0 112.894 -159.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -74.68 134.74 41.93 Favored 'General case' 0 N--CA 1.503 2.198 0 CA-C-N 114.379 -1.282 . . . . 0.0 113.439 176.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 4.7 tp -86.65 105.82 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.516 0 C-N-CA 125.06 1.344 . . . . 0.0 107.714 175.488 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -96.92 -70.4 0.72 Allowed 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 115.136 -2.364 . . . . 0.0 108.115 168.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -140.28 122.65 16.0 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 122.503 2.41 . . . . 0.0 115.015 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -92.83 107.81 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.417 0 N-CA-C 100.974 -3.713 . . . . 0.0 100.974 161.768 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.288 59.5 tp -114.5 105.24 12.87 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.753 -161.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -96.04 126.12 41.06 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.16 0.584 . . . . 0.0 111.541 -176.297 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -95.06 114.17 25.95 Favored 'General case' 0 CA--C 1.56 1.355 0 CA-C-O 122.537 1.16 . . . . 0.0 110.185 177.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -89.03 100.38 13.16 Favored 'General case' 0 CA--C 1.556 1.187 0 CA-C-N 113.597 -1.638 . . . . 0.0 109.459 168.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.4 p -137.97 143.09 34.21 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.387 0 C-N-CA 125.921 1.688 . . . . 0.0 108.376 -168.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.8 m -62.29 141.85 58.05 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.568 175.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -55.61 -46.05 77.39 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 172.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -46.82 -35.44 6.3 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 117.962 2.579 . . . . 0.0 117.962 177.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.6 t -69.42 -49.66 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 CA-C-N 120.032 1.287 . . . . 0.0 113.141 176.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.527 ' HB2' ' H ' ' A' ' 11' ' ' ALA . 3.8 pp -65.09 -34.95 79.63 Favored 'General case' 0 CA--C 1.561 1.391 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 169.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . 0.576 ' O ' ' HB2' ' A' ' 125' ' ' LYS . 49.8 mt -71.72 -34.82 69.9 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 117.121 2.267 . . . . 0.0 117.121 172.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . 0.585 ' OE2' ' HG3' ' A' ' 123' ' ' ARG . 1.1 pp20? -71.39 -38.66 71.47 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 170.924 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.585 ' HG3' ' OE2' ' A' ' 122' ' ' GLU . 51.4 mtp180 -60.98 -52.13 66.31 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 171.123 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.5 pp -68.87 -34.65 75.8 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 115.872 1.805 . . . . 0.0 115.872 171.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . 0.576 ' HB2' ' O ' ' A' ' 121' ' ' LEU . 82.6 tttt -61.06 -46.82 89.12 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 116.847 2.165 . . . . 0.0 116.847 176.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -53.34 -33.43 46.43 Favored Glycine 0 CA--C 1.558 2.722 0 N-CA-C 118.876 2.31 . . . . 0.0 118.876 173.1 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -154.46 102.17 2.4 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 118.837 1.319 . . . . 0.0 108.79 171.006 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -171.86 39.88 0.17 Allowed Glycine 0 CA--C 1.549 2.207 0 N-CA-C 117.271 1.668 . . . . 0.0 117.271 174.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 73.43 -162.11 0.09 Allowed 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 119.616 1.708 . . . . 0.0 114.878 169.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -72.53 -30.22 64.26 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 169.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -89.74 86.44 6.68 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 122.778 1.275 . . . . 0.0 108.763 168.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -99.18 67.55 1.6 Allowed 'General case' 0 CA--C 1.564 1.486 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 163.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 23.9 p 36.69 108.57 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 118.839 2.903 . . . . 0.0 118.839 -168.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -151.51 -72.85 0.15 Allowed 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 112.432 -2.167 . . . . 0.0 107.38 167.02 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -66.18 -33.04 74.86 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 167.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.654 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 95.0 t -66.85 -40.15 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 CA-C-O 117.468 -1.253 . . . . 0.0 112.701 171.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.9 tp -74.61 -27.26 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 CA-C-N 120.261 1.391 . . . . 0.0 114.326 172.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 43.7 mt -72.59 -48.01 43.3 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 121.503 1.956 . . . . 0.0 113.874 171.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -70.32 -36.45 74.28 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 175.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.654 ' HB2' ' O ' ' A' ' 136' ' ' VAL . 14.8 tpt85 -63.42 -45.98 88.5 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 169.201 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 46.3 mtt -61.31 -29.51 69.92 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 167.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -63.31 -43.76 96.9 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 167.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 20.5 t -70.49 -26.69 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.533 0 CA-C-N 120.088 1.313 . . . . 0.0 113.521 171.202 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -65.34 -56.75 10.89 Favored 'General case' 0 CA--C 1.583 2.242 0 CA-C-N 120.68 1.582 . . . . 0.0 110.766 167.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 54.3 ttt180 -52.78 -26.8 15.42 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 119.711 3.226 . . . . 0.0 119.711 172.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -47.46 -51.42 20.32 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 169.33 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -142.55 42.33 1.61 Allowed 'General case' 0 CA--C 1.563 1.461 0 N-CA-C 117.084 2.253 . . . . 0.0 117.084 176.228 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 36.7 m -49.25 -36.65 20.97 Favored 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 166.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.09 -59.28 6.53 Favored Pre-proline 0 CA--C 1.577 2.014 0 CA-C-O 116.556 -1.688 . . . . 0.0 111.891 172.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_exo -53.03 -26.95 34.09 Favored 'Trans proline' 0 CA--C 1.577 2.666 0 N-CA-C 119.608 2.888 . . . . 0.0 119.608 168.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -65.25 -56.31 13.51 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 125.764 1.625 . . . . 0.0 111.371 172.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.873 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 44.4 tp -62.48 -24.19 67.33 Favored 'General case' 0 CA--C 1.571 1.776 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 175.042 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -71.23 -47.81 55.06 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 122.247 2.294 . . . . 0.0 113.745 166.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -60.77 -57.02 14.45 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 119.846 1.203 . . . . 0.0 111.966 177.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -80.2 -19.45 46.99 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 115.409 -2.234 . . . . 0.0 113.803 -178.242 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.873 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 33.2 ttt180 -74.21 -31.09 62.48 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 124.436 3.289 . . . . 0.0 116.202 168.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -68.77 -44.28 74.02 Favored 'General case' 0 CA--C 1.57 1.738 0 CA-C-N 119.688 1.131 . . . . 0.0 113.126 167.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -91.43 -30.21 16.62 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 119.164 3.024 . . . . 0.0 119.164 -176.542 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.5 pp -39.73 156.81 0.02 OUTLIER 'General case' 0 CA--C 1.582 2.183 1 N-CA-C 122.37 4.211 . . . . 0.0 122.37 -164.304 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -133.43 113.1 12.15 Favored 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 101.71 -3.441 . . . . 0.0 101.71 164.778 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 60.4 m -94.7 146.58 24.06 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 122.499 1.142 . . . . 0.0 110.349 -168.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 47.3 t -130.8 130.67 64.52 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.259 0 CA-C-N 113.654 -1.612 . . . . 0.0 106.721 169.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -98.48 117.9 33.96 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 100.892 -3.744 . . . . 0.0 100.892 163.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . 0.293 . . -105.41 -138.01 0.36 Allowed 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 -154.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . 0.252 14.6 m 9.76 92.26 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.573 1.849 1 N-CA-C 123.812 4.745 . . . . 0.0 123.812 -171.559 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -136.31 75.21 0.4 Allowed Glycine 0 N--CA 1.48 1.621 0 CA-C-O 122.966 1.315 . . . . 0.0 112.741 163.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 69.7 p 46.19 53.76 9.04 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 175.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 61.7 mtt 74.62 -68.08 0.23 Allowed 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 125.627 1.571 . . . . 0.0 113.87 175.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -63.06 -39.43 94.71 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 -174.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -61.69 -49.11 77.81 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 117.737 -1.125 . . . . 0.0 112.535 169.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 3.0 t -54.43 -37.87 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 174.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -62.61 -38.16 89.07 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 116.119 1.896 . . . . 0.0 116.119 169.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -61.83 -48.02 82.46 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 175.552 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.553 ' HA ' ' HB2' ' A' ' 177' ' ' ARG . 1.2 ptt-85 -70.36 -29.14 65.74 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 117.036 2.235 . . . . 0.0 117.036 170.331 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.77 -46.63 88.75 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 169.082 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 10.9 mp -64.4 -43.33 94.75 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 117.411 -1.281 . . . . 0.0 111.402 167.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.553 ' HB2' ' HA ' ' A' ' 174' ' ' ARG . 41.1 mtt180 -46.64 -40.87 13.84 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 117.883 2.549 . . . . 0.0 117.883 169.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -69.0 -48.72 62.39 Favored 'General case' 0 CA--C 1.562 1.423 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 169.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.7 tt -83.13 -52.3 6.75 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 120.583 1.538 . . . . 0.0 114.336 -176.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -135.18 -60.18 0.06 OUTLIER Glycine 0 CA--C 1.551 2.284 0 CA-C-O 116.952 -2.027 . . . . 0.0 115.594 -170.092 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.471 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 39.7 ttmt . . . . . 0 C--O 1.251 1.17 0 CA-C-N 121.548 2.674 . . . . 0.0 109.595 -175.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.8 ttp . . . . . 0 CA--C 1.56 1.333 0 CA-C-O 122.382 1.086 . . . . 0.0 109.25 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . 0.275 11.4 mpt_? -124.5 167.73 14.05 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 120.878 3.659 . . . . 0.0 120.878 -162.621 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.3 p -148.11 151.18 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.695 0 CA-C-O 123.611 1.672 . . . . 0.0 113.067 167.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . 0.285 0.0 OUTLIER -143.56 133.87 24.58 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 113.922 -1.49 . . . . 0.0 110.99 166.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.759 ' CD1' ' HB2' ' A' ' 13' ' ' LYS . 3.7 tt -95.64 125.51 40.28 Favored 'General case' 0 CA--C 1.572 1.795 0 C-N-CA 125.188 1.395 . . . . 0.0 114.649 -165.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.6 mt -109.78 155.49 21.54 Favored 'General case' 0 CA--C 1.567 1.607 0 CA-C-N 110.559 -3.019 . . . . 0.0 109.847 169.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -174.36 99.49 0.14 Allowed Glycine 0 CA--C 1.55 2.24 0 CA-C-O 116.729 -2.15 . . . . 0.0 113.468 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.281 33.3 Cg_endo -66.13 -69.97 0.03 OUTLIER 'Trans proline' 0 CA--C 1.58 2.778 0 CA-C-N 122.277 3.039 . . . . 0.0 111.853 175.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -74.94 102.14 1.55 Allowed 'Trans proline' 0 C--N 1.378 2.12 0 CA-C-N 127.247 3.624 . . . . 0.0 111.032 167.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.89 99.94 0.78 Allowed Glycine 0 N--CA 1.476 1.302 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -172.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.35 -27.75 67.62 Favored 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 118.185 2.661 . . . . 0.0 118.185 176.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -167.65 134.29 3.2 Favored Glycine 0 CA--C 1.545 1.933 0 CA-C-N 120.327 1.421 . . . . 0.0 112.515 173.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.759 ' HB2' ' CD1' ' A' ' 5' ' ' LEU . 32.1 mmtt -94.73 59.26 2.39 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 176.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.91 -35.74 92.4 Favored Glycine 0 CA--C 1.552 2.362 0 N-CA-C 118.609 2.204 . . . . 0.0 118.609 173.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 40.3 m -61.65 -53.48 55.6 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 119.324 1.562 . . . . 0.0 113.416 174.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.259 0.1 OUTLIER -79.59 -17.45 53.85 Favored 'General case' 0 CA--C 1.58 2.106 0 CA-C-O 116.639 -1.648 . . . . 0.0 111.491 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.28 -43.7 55.79 Favored 'General case' 0 C--N 1.374 1.633 0 CA-C-N 122.712 2.506 . . . . 0.0 115.337 168.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.5 t -65.77 -37.99 81.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 CA-C-O 117.691 -1.147 . . . . 0.0 112.335 170.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -59.68 -51.61 69.05 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 169.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.5 tp -64.37 -31.5 72.73 Favored 'General case' 0 CA--C 1.575 1.937 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 174.253 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.29 -39.46 93.97 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 168.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -63.73 -35.13 79.55 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 166.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 43.7 tptt -68.28 -55.49 11.98 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 174.584 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 65.0 mt -83.83 -26.51 29.46 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 116.648 2.092 . . . . 0.0 116.648 -178.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.27 39.28 6.44 Favored Glycine 0 CA--C 1.555 2.534 0 N-CA-C 117.313 1.685 . . . . 0.0 117.313 -172.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.463 ' CG2' ' HA ' ' A' ' 81' ' ' PHE . 20.4 mm -104.22 153.91 38.63 Favored Pre-proline 0 CA--C 1.567 1.605 0 CA-C-N 119.029 1.414 . . . . 0.0 112.271 -170.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -81.3 101.52 1.25 Allowed 'Trans proline' 0 CA--C 1.568 2.22 0 CA-C-N 121.65 1.625 . . . . 0.0 108.667 161.028 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.96 119.24 17.9 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 122.088 0.947 . . . . 0.0 110.197 173.558 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.449 HD11 ' HB3' ' A' ' 71' ' ' ARG . 1.8 mp -95.28 109.06 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 N-CA-C 104.089 -2.56 . . . . 0.0 104.089 176.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 78.0 p -97.41 128.15 43.96 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 166.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.8 p -67.33 -10.89 55.39 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 117.822 2.526 . . . . 0.0 117.822 -169.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -82.41 -27.85 42.08 Favored Glycine 0 CA--C 1.553 2.409 0 N-CA-C 117.951 1.94 . . . . 0.0 117.951 165.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -81.3 -46.14 15.17 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -168.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -69.68 -37.32 76.61 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 173.181 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.502 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 42.4 m-85 -65.67 -46.85 77.55 Favored 'General case' 0 CA--C 1.557 1.234 0 CA-C-O 116.538 -1.696 . . . . 0.0 112.855 170.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -54.84 -40.65 69.84 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 168.716 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -59.44 -40.47 86.9 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 169.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -68.39 -25.47 65.07 Favored 'General case' 0 CA--C 1.583 2.238 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 167.703 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.5 mt -62.91 -50.16 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 CA-C-N 120.383 1.447 . . . . 0.0 110.768 167.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.53 -31.55 69.83 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -67.76 -39.92 84.11 Favored 'General case' 0 CA--C 1.565 1.524 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 169.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.98 70.73 1.0 Allowed Glycine 0 CA--C 1.536 1.394 0 CA-C-O 118.577 -1.124 . . . . 0.0 112.886 175.172 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.566 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 56.9 p -96.18 -66.4 0.91 Allowed 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 118.291 1.046 . . . . 0.0 110.609 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.566 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.0 OUTLIER 124.88 -54.97 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 119.436 1.016 . . . . 0.0 110.117 -167.061 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -71.8 -15.04 62.14 Favored 'General case' 0 CA--C 1.57 1.747 0 CA-C-O 118.48 -0.771 . . . . 0.0 112.54 167.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.89 -53.66 44.03 Favored Glycine 0 CA--C 1.555 2.586 0 CA-C-N 120.102 1.319 . . . . 0.0 114.009 166.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -75.05 -50.88 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 -170.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -65.4 -41.8 93.25 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 120.908 1.685 . . . . 0.0 113.196 172.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -75.57 -24.26 56.61 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -176.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.502 ' HB2' ' HB3' ' A' ' 35' ' ' PHE . 9.6 tmtm? -76.18 -38.82 56.09 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 117.127 -1.416 . . . . 0.0 112.978 166.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.603 ' CG ' ' O ' ' A' ' 51' ' ' ARG . 51.1 ttt180 -70.58 -55.45 8.82 Favored 'General case' 0 CA--C 1.591 2.543 1 CA-C-O 86.101 -16.19 . . . . 0.0 118.413 -178.013 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 12.6 m-30 -33.15 -60.32 0.34 Allowed 'General case' 0 N--CA 1.496 1.858 1 O-C-N 109.089 -8.507 . . . . 0.0 121.273 146.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.7 tp -60.75 -23.67 65.14 Favored 'General case' 0 CA--C 1.576 1.966 0 CA-C-N 122.58 2.446 . . . . 0.0 117.226 169.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -93.09 -44.52 8.34 Favored 'General case' 0 CA--C 1.569 1.688 0 C-N-CA 126.112 1.765 . . . . 0.0 114.376 168.344 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.23 -36.27 24.74 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 116.669 2.1 . . . . 0.0 116.669 -177.155 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.97 40.04 2.55 Favored Glycine 0 CA--C 1.537 1.412 0 N-CA-C 116.157 1.223 . . . . 0.0 116.157 169.555 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -103.29 -135.94 0.34 Allowed 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 169.169 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.6 mt -105.56 108.57 20.16 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 120.857 1.662 . . . . 0.0 110.304 -170.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.3 p -112.05 109.58 54.6 Favored Pre-proline 0 CA--C 1.565 1.551 0 CA-C-O 117.483 -1.246 . . . . 0.0 108.23 175.46 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -64.28 154.82 69.01 Favored 'Trans proline' 0 CA--C 1.558 1.705 0 C-N-CA 123.094 2.529 . . . . 0.0 116.567 178.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 71.9 m -78.03 174.98 10.53 Favored 'General case' 0 CA--C 1.571 1.762 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.969 169.75 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.7 t70 83.17 -47.11 0.13 Allowed 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 125.884 1.674 . . . . 0.0 114.075 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 24.9 mt -65.47 -53.98 34.87 Favored 'General case' 0 N--CA 1.505 2.276 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 168.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 53.7 m -53.68 -49.85 67.1 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 113.112 -1.858 . . . . 0.0 113.678 169.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -59.63 -27.24 66.16 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 116.534 2.05 . . . . 0.0 116.534 167.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.57 -47.56 54.16 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 173.082 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.381 4.5 pp -74.59 -25.73 59.46 Favored 'General case' 0 CA--C 1.588 2.439 0 CA-C-N 119.743 1.156 . . . . 0.0 112.952 174.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.0 -48.01 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 CA-C-N 121.78 2.082 . . . . 0.0 112.816 165.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -58.57 -32.82 69.28 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 171.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -59.58 -45.84 90.68 Favored 'General case' 0 CA--C 1.566 1.585 0 CA-C-O 117.555 -1.212 . . . . 0.0 112.697 166.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.449 ' HB3' HD11 ' A' ' 29' ' ' ILE . 83.0 mtt180 -82.93 7.9 14.11 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 118.59 2.811 . . . . 0.0 118.59 167.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.8 mt -123.69 -5.87 8.06 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 118.294 2.701 . . . . 0.0 118.294 170.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 55.9 p30 -73.06 13.32 0.42 Allowed 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 171.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . 0.352 6.1 m120 -73.17 -129.05 0.0 OUTLIER Pre-proline 0 CA--C 1.592 2.58 0 CA-C-O 115.362 -2.256 . . . . 0.0 116.724 -169.367 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 68.2 Cg_exo -60.71 40.06 0.06 OUTLIER 'Trans proline' 0 C--N 1.386 2.552 0 N-CA-C 121.973 3.797 . . . . 0.0 121.973 168.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 59.78 33.61 21.77 Favored 'General case' 0 CA--C 1.583 2.246 0 C-N-CA 125.97 1.708 . . . . 0.0 109.848 -161.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 84.24 -3.35 1.05 Allowed 'General case' 0 C--N 1.385 2.133 0 CA-C-O 116.584 -1.674 . . . . 0.0 114.246 -168.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 51.18 34.6 11.54 Favored 'General case' 0 CA--C 1.573 1.861 0 CA-C-N 124.11 3.141 . . . . 0.0 114.701 -166.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 62.42 37.97 13.19 Favored 'General case' 0 CA--C 1.584 2.264 0 CA-C-O 117.057 -1.449 . . . . 0.0 111.928 -167.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.42 171.49 31.7 Favored Glycine 0 C--N 1.375 2.697 0 CA-C-N 123.21 2.732 . . . . 0.0 117.325 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.463 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . 13.9 p90 -171.39 135.84 0.97 Allowed 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 113.344 -1.428 . . . . 0.0 107.675 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 9.1 mt -111.56 108.92 26.69 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.542 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 172.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 26.2 mt -107.24 121.06 43.78 Favored 'General case' 0 N--CA 1.504 2.235 0 CA-C-O 117.402 -1.285 . . . . 0.0 110.009 177.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -117.74 118.17 31.34 Favored 'General case' 0 N--CA 1.506 2.369 0 CA-C-N 121.566 1.985 . . . . 0.0 111.588 -169.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 74.63 35.8 50.37 Favored Glycine 0 CA--C 1.555 2.537 0 CA-C-O 117.986 -1.452 . . . . 0.0 116.653 -174.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -94.64 -52.67 0.24 Allowed Pre-proline 0 N--CA 1.493 1.709 0 CA-C-O 115.361 -2.257 . . . . 0.0 108.672 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -68.41 68.71 1.04 Allowed 'Trans proline' 0 CA--C 1.57 2.321 0 CA-C-N 124.071 2.49 . . . . 0.0 117.623 164.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -20.99 61.47 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 165.711 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.2 m -147.19 143.38 28.16 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 -173.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . 0.313 9.8 p -69.54 -23.2 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 CA-C-O 116.158 -1.877 . . . . 0.0 112.337 175.223 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -63.43 -31.89 73.17 Favored 'General case' 0 CA--C 1.563 1.449 0 N-CA-C 118.943 2.942 . . . . 0.0 118.943 166.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -76.84 -48.16 19.26 Favored 'General case' 0 CA--C 1.588 2.409 0 CA-C-N 122.281 2.31 . . . . 0.0 112.159 165.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.36 -35.47 80.97 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 126.932 2.093 . . . . 0.0 116.003 -169.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.0 tttt -57.71 -29.48 64.74 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 115.683 1.735 . . . . 0.0 115.683 167.036 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.74 -41.0 72.39 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 168.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 23.6 tp -60.41 -40.36 90.69 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 168.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -56.12 -53.08 61.35 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 124.003 0.921 . . . . 0.0 113.147 168.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.904 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 14.3 mm-40 -46.88 -42.71 17.91 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 116.012 1.856 . . . . 0.0 116.012 167.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 1.306 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 58.7 mtt -83.87 -19.66 34.45 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 117.793 2.516 . . . . 0.0 117.793 177.381 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.655 HD12 ' HG1' ' A' ' 105' ' ' THR . 60.6 tp -73.81 -50.36 20.83 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 120.835 1.652 . . . . 0.0 111.741 169.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -74.2 -56.78 4.5 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 171.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.904 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 96.4 mtt180 -68.58 -37.98 80.29 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 177.078 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 1.306 ' HB3' ' O ' ' A' ' 99' ' ' MET . 70.7 ttt180 -62.25 -59.31 5.21 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 119.857 1.208 . . . . 0.0 110.193 164.083 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 113.11 46.22 0.71 Allowed Glycine 0 N--CA 1.48 1.632 0 O-C-N 124.435 1.085 . . . . 0.0 114.011 167.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.655 ' HG1' HD12 ' A' ' 100' ' ' LEU . 28.2 p -103.61 146.63 28.28 Favored 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 172.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -68.81 128.96 38.55 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.183 -0.948 . . . . 0.0 112.894 -170.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.8 tp -82.23 101.15 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -103.32 -72.0 0.71 Allowed 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 115.737 -2.078 . . . . 0.0 109.21 167.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -142.6 119.76 11.45 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 116.543 2.053 . . . . 0.0 116.543 -166.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 93.8 t -92.87 114.28 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 100.532 -3.877 . . . . 0.0 100.532 161.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 32.9 tp -117.96 109.47 16.54 Favored 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 122.778 0.431 . . . . 0.0 111.454 -165.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -96.64 115.91 28.23 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 122.986 0.514 . . . . 0.0 112.062 -178.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -93.09 108.86 20.36 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 175.448 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 80.0 ttt180 -103.13 110.89 23.0 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.949 0.899 . . . . 0.0 108.745 172.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . 0.31 1.3 t 179.35 141.1 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 CA-C-O 123.925 1.821 . . . . 0.0 108.252 159.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 92.2 p 59.34 133.11 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.359 0 N-CA-C 119.022 2.971 . . . . 0.0 119.022 169.637 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -72.7 -31.86 65.32 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 116.366 1.988 . . . . 0.0 116.366 171.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -45.18 -44.89 11.2 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 115.664 1.727 . . . . 0.0 115.664 173.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.2 t -46.96 -48.97 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.455 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 174.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 5.9 tt -67.17 -40.46 86.61 Favored 'General case' 0 CA--C 1.559 1.289 0 CA-C-O 116.572 -1.68 . . . . 0.0 113.015 173.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . 0.389 0.0 OUTLIER -76.96 -12.89 60.01 Favored 'General case' 0 N--CA 1.51 2.572 0 CA-C-N 121.191 1.814 . . . . 0.0 114.974 173.52 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -73.32 -46.71 47.87 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 121.18 1.809 . . . . 0.0 111.895 166.241 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 1.028 ' O ' ' HB2' ' A' ' 127' ' ' ARG . 18.8 mmt180 -53.52 -48.64 68.85 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 167.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 75.9 mt -58.95 -58.95 6.39 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 169.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -81.02 -59.59 2.6 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 -171.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -91.08 44.83 2.83 Favored Glycine 0 CA--C 1.55 2.277 0 N-CA-C 115.92 1.128 . . . . 0.0 115.92 173.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 1.028 ' HB2' ' O ' ' A' ' 123' ' ' ARG . 18.3 mmm180 -150.5 -73.03 0.17 Allowed 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 173.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -90.16 38.05 3.27 Favored Glycine 0 CA--C 1.555 2.586 0 N-CA-C 118.024 1.97 . . . . 0.0 118.024 172.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.464 ' HB3' ' H ' ' A' ' 130' ' ' ALA . 98.3 mtt180 71.33 -143.51 0.06 Allowed 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 169.256 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.464 ' H ' ' HB3' ' A' ' 129' ' ' ARG . . . -90.29 64.57 6.04 Favored 'General case' 0 CA--C 1.564 1.517 0 CA-C-N 113.358 -1.746 . . . . 0.0 111.573 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . 0.3 8.0 m-20 75.94 -90.97 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 119.894 1.224 . . . . 0.0 108.469 -169.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . 0.274 16.0 t70 74.3 -56.19 0.65 Allowed 'General case' 0 N--CA 1.508 2.432 0 C-N-CA 125.234 1.413 . . . . 0.0 111.022 -162.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' THR . . . . . 0.552 ' HG1' ' H ' ' A' ' 134' ' ' ASP . 70.9 p -55.26 -113.17 0.0 OUTLIER 'General case' 0 CA--C 1.57 1.735 0 C-N-CA 130.239 3.415 . . . . 0.0 111.263 164.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . 0.552 ' H ' ' HG1' ' A' ' 133' ' ' THR . 8.3 t70 72.49 -64.05 0.41 Allowed 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 127.197 2.199 . . . . 0.0 110.708 -168.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -68.05 -36.09 79.31 Favored 'General case' 0 CA--C 1.559 1.291 0 CA-C-O 117.662 -1.161 . . . . 0.0 113.863 165.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.8 t -70.89 -37.04 66.63 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.717 0 CA-C-N 120.79 1.632 . . . . 0.0 112.683 174.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.479 ' O ' ' HB3' ' A' ' 140' ' ' ARG . 10.6 tp -69.46 -33.08 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 CA-C-N 119.869 1.213 . . . . 0.0 113.278 169.107 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 30.5 mt -62.94 -42.82 99.93 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 120.768 1.622 . . . . 0.0 114.075 167.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -62.76 -33.29 74.85 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 168.372 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.479 ' HB3' ' O ' ' A' ' 137' ' ' ILE . 9.5 tpt180 -57.69 -45.45 85.65 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 166.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 25.1 ttt -64.18 -33.02 74.84 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 169.049 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -60.89 -48.92 79.61 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 169.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 12.4 p -65.32 -33.09 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 169.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -55.02 -49.57 71.2 Favored 'General case' 0 CA--C 1.581 2.162 0 CA-C-N 119.922 1.237 . . . . 0.0 111.652 167.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -56.74 -41.63 77.85 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 118.878 2.918 . . . . 0.0 118.878 171.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -46.71 -42.45 16.65 Favored 'General case' 0 N--CA 1.506 2.342 0 N-CA-C 117.969 2.581 . . . . 0.0 117.969 174.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -125.69 -29.3 3.17 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 117.597 2.443 . . . . 0.0 117.597 -166.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 51.7 m -45.97 -34.29 3.88 Favored 'General case' 0 N--CA 1.505 2.29 0 N-CA-C 117.543 2.423 . . . . 0.0 117.543 -171.097 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -66.86 -62.49 3.77 Favored Pre-proline 0 CA--C 1.583 2.247 0 CA-C-O 116.144 -1.884 . . . . 0.0 112.09 170.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -53.15 -35.86 74.78 Favored 'Trans proline' 0 CA--C 1.584 3.004 0 C-N-CA 123.632 2.888 . . . . 0.0 118.945 168.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.97 -53.75 54.86 Favored 'General case' 0 N--CA 1.496 1.875 0 C-N-CA 126.165 1.786 . . . . 0.0 112.174 169.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 1.299 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 28.8 tp -68.09 -21.57 64.96 Favored 'General case' 0 CA--C 1.563 1.467 0 CA-C-O 116.749 -1.596 . . . . 0.0 114.214 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -71.98 -49.02 40.76 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 121.961 2.164 . . . . 0.0 112.618 164.607 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -68.63 -51.75 38.8 Favored 'General case' 0 CA--C 1.567 1.613 0 CA-C-N 120.569 1.531 . . . . 0.0 112.302 -176.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -78.56 -26.23 45.59 Favored 'General case' 0 CA--C 1.554 1.109 0 CA-C-O 114.854 -2.498 . . . . 0.0 113.072 176.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 1.299 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 0.1 OUTLIER -60.96 -41.97 97.37 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 125.24 3.655 . . . . 0.0 115.543 168.393 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -62.87 -36.0 81.86 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 167.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -88.3 -34.42 17.68 Favored 'General case' 0 CA--C 1.576 1.977 0 N-CA-C 119.336 3.088 . . . . 0.0 119.336 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.1 pp -80.35 173.71 12.32 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 117.803 2.52 . . . . 0.0 117.803 -162.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -122.78 123.53 41.25 Favored 'General case' 0 CA--C 1.557 1.221 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 166.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 1.4 t -100.2 156.9 16.96 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 123.195 1.474 . . . . 0.0 110.241 -178.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 40.0 t -132.61 143.99 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.367 0 CA-C-N 113.096 -1.865 . . . . 0.0 106.651 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -95.05 120.25 34.94 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 100.32 -3.955 . . . . 0.0 100.32 164.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . 0.307 . . -99.34 -101.74 0.22 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 119.489 3.144 . . . . 0.0 119.489 -150.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.3 t -57.54 95.22 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.564 1.492 0 N-CA-C 117.492 2.405 . . . . 0.0 117.492 -158.005 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -112.77 65.76 0.26 Allowed Glycine 0 N--CA 1.48 1.611 0 CA-C-O 122.211 0.895 . . . . 0.0 112.953 163.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 61.6 p 43.38 65.8 0.92 Allowed 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 116.257 1.947 . . . . 0.0 116.257 177.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 55.2 mtt 80.02 -57.77 0.35 Allowed 'General case' 0 N--CA 1.501 2.082 0 C-N-CA 125.59 1.556 . . . . 0.0 114.917 170.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -75.4 -42.38 53.9 Favored 'General case' 0 N--CA 1.506 2.346 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -175.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -63.99 -44.76 91.7 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 174.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -40.58 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-O 117.947 -1.025 . . . . 0.0 113.667 172.122 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -54.7 -38.81 67.49 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 116.656 2.095 . . . . 0.0 116.656 166.19 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -62.57 -53.46 54.28 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 74.7 mtt85 -70.94 -28.38 64.44 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 117.91 2.559 . . . . 0.0 117.91 174.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.14 -45.42 94.74 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 167.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.5 mp -62.76 -43.17 99.51 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 117.852 -1.07 . . . . 0.0 113.641 168.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 39.6 mtt180 -52.56 -42.65 64.64 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 117.034 2.235 . . . . 0.0 117.034 169.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -66.8 -50.86 61.28 Favored 'General case' 0 CA--C 1.558 1.264 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 172.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.86 -59.59 2.67 Favored 'General case' 0 CA--C 1.569 1.688 0 CA-C-N 119.833 1.197 . . . . 0.0 112.565 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.638 ' O ' ' CB ' ' A' ' 181' ' ' LYS . . . -106.59 -55.68 0.66 Allowed Glycine 0 CA--C 1.55 2.249 0 CA-C-O 117.902 -1.499 . . . . 0.0 115.095 -175.441 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.638 ' CB ' ' O ' ' A' ' 180' ' ' GLY . 36.5 ttmt . . . . . 0 C--O 1.251 1.139 0 CA-C-N 120.13 1.965 . . . . 0.0 107.507 -175.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.9 mmt . . . . . 0 CA--C 1.555 1.154 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.98 169.74 21.03 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 115.837 1.791 . . . . 0.0 115.837 -165.408 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.9 t -131.51 148.57 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 123.66 1.695 . . . . 0.0 113.135 -162.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -119.47 113.54 20.92 Favored 'General case' 0 CA--C 1.558 1.262 0 CA-C-N 112.576 -2.102 . . . . 0.0 105.331 169.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.8 tp -99.67 127.03 45.78 Favored 'General case' 0 CA--C 1.562 1.424 0 CA-C-O 123.44 1.59 . . . . 0.0 108.399 -168.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.3 mt -134.67 163.73 29.11 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 111.695 -2.502 . . . . 0.0 113.277 -164.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 172.96 115.6 0.38 Allowed Glycine 0 CA--C 1.546 2.007 0 CA-C-O 117.015 -1.991 . . . . 0.0 110.953 -171.07 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.91 -177.68 0.09 OUTLIER 'Trans proline' 0 CA--C 1.577 2.656 0 CA-C-N 122.147 2.973 . . . . 0.0 115.196 168.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.78 112.32 0.74 Allowed 'Trans proline' 0 CA--C 1.56 1.795 0 C-N-CA 123.469 2.779 . . . . 0.0 113.822 172.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.06 90.19 0.08 OUTLIER Glycine 0 CA--C 1.533 1.216 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 -168.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 53.48 -98.18 0.07 Allowed 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 171.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -167.22 -169.37 30.7 Favored Glycine 0 CA--C 1.548 2.126 0 CA-C-N 120.585 1.539 . . . . 0.0 115.934 -174.026 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -152.17 -33.28 0.14 Allowed 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -169.646 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -44.61 -33.49 3.31 Favored Glycine 0 CA--C 1.551 2.332 0 N-CA-C 120.887 3.115 . . . . 0.0 120.887 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.8 p -57.92 -61.12 2.76 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 119.322 1.561 . . . . 0.0 115.21 173.225 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.259 5.2 mm-40 -75.95 -12.53 60.16 Favored 'General case' 0 CA--C 1.567 1.598 0 CA-C-O 116.539 -1.696 . . . . 0.0 111.59 175.09 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.68 -50.56 42.73 Favored 'General case' 0 C--N 1.37 1.458 0 CA-C-N 122.57 2.441 . . . . 0.0 113.639 167.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.8 p -66.9 -39.83 84.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 173.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.555 ' HB3' ' CE1' ' A' ' 172' ' ' PHE . 58.5 mmtt -62.89 -42.48 99.79 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 116.21 1.929 . . . . 0.0 116.21 170.885 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 20.0 tp -66.67 -36.81 83.42 Favored 'General case' 0 CA--C 1.571 1.766 0 CA-C-N 120.04 1.291 . . . . 0.0 113.53 172.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.24 -39.29 86.21 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 166.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -56.59 -39.88 74.32 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 166.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -68.71 -53.44 22.16 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 174.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.1 mt -83.87 -23.81 31.12 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 117.274 2.324 . . . . 0.0 117.274 -176.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.91 35.42 7.72 Favored Glycine 0 CA--C 1.555 2.582 0 N-CA-C 117.8 1.88 . . . . 0.0 117.8 -174.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.0 mm -105.39 155.21 38.3 Favored Pre-proline 0 CA--C 1.57 1.722 0 CA-C-N 119.136 1.468 . . . . 0.0 112.434 -169.345 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -81.95 99.72 1.03 Allowed 'Trans proline' 0 CA--C 1.569 2.23 0 C-N-CA 121.695 1.596 . . . . 0.0 109.953 162.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.85 112.69 3.38 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 123.511 0.724 . . . . 0.0 110.539 170.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 27.3 mm -104.11 108.92 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 175.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.0 t -94.77 136.51 34.99 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 169.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.1 p -70.35 -6.53 35.98 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 117.531 2.419 . . . . 0.0 117.531 -177.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.481 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -89.72 -24.05 31.51 Favored Glycine 0 CA--C 1.544 1.886 0 N-CA-C 118.324 2.09 . . . . 0.0 118.324 165.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -81.18 -51.23 8.65 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -168.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -64.71 -39.08 93.04 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 174.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.513 ' HB3' ' CG ' ' A' ' 50' ' ' LYS . 41.6 m-85 -66.3 -37.6 85.78 Favored 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 116.183 1.92 . . . . 0.0 116.183 169.184 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.481 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 74.4 ttt180 -58.59 -41.05 84.91 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 166.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.409 ' HD2' ' HA ' ' A' ' 37' ' ' ARG . 10.1 tpt180 -63.81 -38.88 92.76 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 114.746 1.388 . . . . 0.0 114.746 169.307 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -64.28 -34.34 77.9 Favored 'General case' 0 CA--C 1.573 1.862 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 167.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 51.8 mt -59.35 -43.53 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 C-N-CA 124.994 1.318 . . . . 0.0 111.933 168.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -63.88 -40.62 96.95 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 170.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -72.68 -40.34 66.33 Favored 'General case' 0 CA--C 1.558 1.257 0 N-CA-C 116.266 1.95 . . . . 0.0 116.266 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.01 72.12 1.29 Allowed Glycine 0 CA--C 1.542 1.774 0 CA-C-O 118.383 -1.232 . . . . 0.0 113.965 -171.368 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.562 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 76.4 p -91.55 -65.47 1.01 Allowed 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 118.887 1.343 . . . . 0.0 111.267 177.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.562 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.0 OUTLIER 128.3 -55.76 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.942 0.897 . . . . 0.0 110.349 -167.422 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -74.67 -11.17 60.11 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 166.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.08 -54.31 25.06 Favored Glycine 0 CA--C 1.546 2.028 0 CA-C-N 119.324 0.965 . . . . 0.0 114.393 167.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.409 ' O ' ' HB2' ' A' ' 51' ' ' ARG 0.268 1.0 OUTLIER -76.44 -47.37 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 116.593 2.072 . . . . 0.0 116.593 -168.624 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -67.05 -36.81 82.89 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 120.985 1.72 . . . . 0.0 113.363 171.156 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -74.77 -34.24 62.43 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -177.32 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.513 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -73.92 -34.06 64.21 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 117.736 -1.126 . . . . 0.0 112.503 169.573 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.527 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 22.0 ttt180 -74.12 -51.12 16.62 Favored 'General case' 0 CA--C 1.586 2.359 1 CA-C-O 84.252 -17.07 . . . . 0.0 118.583 -178.761 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . 0.251 21.4 m-85 -36.83 -57.42 0.81 Allowed 'General case' 0 N--CA 1.494 1.769 2 O-C-N 107.666 -9.396 . . . . 0.0 122.029 147.869 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 38.4 mt -57.43 -33.92 68.4 Favored 'General case' 0 N--CA 1.511 2.597 0 CA-C-N 123.241 2.746 . . . . 0.0 115.501 168.625 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -90.71 -38.38 13.09 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 175.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.96 -37.78 38.71 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 178.203 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.89 40.41 1.44 Allowed Glycine 0 CA--C 1.536 1.403 0 N-CA-C 116.475 1.35 . . . . 0.0 116.475 171.213 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -119.31 -142.94 0.36 Allowed 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 165.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 79.9 mt -129.92 133.77 47.06 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.307 -0.87 . . . . 0.0 109.77 -170.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.608 HG13 HH22 ' A' ' 88' ' ' ARG . 7.0 p -109.01 133.03 20.85 Favored Pre-proline 0 CA--C 1.573 1.863 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 172.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -54.95 146.72 55.85 Favored 'Trans proline' 0 CA--C 1.561 1.838 0 C-N-CA 123.33 2.687 . . . . 0.0 116.839 173.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 96.4 p -72.64 175.6 6.24 Favored 'General case' 0 CA--C 1.57 1.739 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 176.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.6 t70 81.04 -45.18 0.22 Allowed 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 125.822 1.649 . . . . 0.0 114.29 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 34.8 mt -62.3 -54.51 39.55 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 168.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.8 m -56.65 -48.72 76.95 Favored 'General case' 0 CA--C 1.571 1.765 0 CA-C-N 113.051 -1.886 . . . . 0.0 113.07 173.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -58.04 -35.28 71.09 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 168.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -64.95 -44.6 88.9 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 173.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.8 mt -62.93 -44.27 96.53 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 170.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 82.7 t -58.29 -46.77 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-O 117.799 -1.096 . . . . 0.0 112.463 170.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -60.0 -39.21 84.98 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 116.013 1.857 . . . . 0.0 116.013 172.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -58.67 -41.83 87.07 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 120.331 1.423 . . . . 0.0 113.44 169.009 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -82.11 2.01 33.37 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 119.198 3.036 . . . . 0.0 119.198 167.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 23.3 tp -121.68 -7.94 9.04 Favored 'General case' 0 CA--C 1.564 1.49 0 N-CA-C 118.407 2.743 . . . . 0.0 118.407 175.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -57.78 -34.13 69.28 Favored 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 174.494 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . 0.299 1.6 m-20 -5.35 -127.58 0.0 OUTLIER Pre-proline 0 CA--C 1.6 2.9 1 N-CA-C 121.97 4.063 . . . . 0.0 121.97 169.668 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 85.9 Cg_exo -68.38 36.77 0.19 Allowed 'Trans proline' 0 N--CA 1.513 2.676 0 CA-C-N 126.727 3.438 . . . . 0.0 119.893 168.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.4 t70 62.5 31.88 16.84 Favored 'General case' 0 CA--C 1.587 2.388 0 C-N-CA 124.623 1.169 . . . . 0.0 109.235 -158.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 76.53 5.25 3.55 Favored 'General case' 0 C--N 1.383 2.022 0 CA-C-O 116.787 -1.578 . . . . 0.0 115.078 -168.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 50.83 31.7 6.37 Favored 'General case' 0 CA--C 1.575 1.933 0 CA-C-N 123.144 2.702 . . . . 0.0 114.281 -165.352 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 60.02 34.17 21.4 Favored 'General case' 0 CA--C 1.585 2.32 0 CA-C-O 116.907 -1.521 . . . . 0.0 112.193 -166.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 179.02 171.12 41.86 Favored Glycine 0 C--N 1.377 2.84 0 CA-C-N 123.398 2.817 . . . . 0.0 118.874 -175.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -175.89 136.75 0.32 Allowed 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 113.731 -1.234 . . . . 0.0 110.438 -169.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 22.6 mt -113.32 106.27 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 169.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 58.8 mt -105.72 120.52 41.89 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 123.151 0.58 . . . . 0.0 109.454 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -113.49 122.09 46.22 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 118.645 0.657 . . . . 0.0 110.621 -167.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 72.73 38.87 56.61 Favored Glycine 0 CA--C 1.548 2.114 0 CA-C-O 117.287 -1.841 . . . . 0.0 115.801 -178.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -99.66 -54.16 0.18 Allowed Pre-proline 0 N--CA 1.498 1.967 0 CA-C-O 115.359 -2.257 . . . . 0.0 107.536 176.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -60.87 70.04 0.08 OUTLIER 'Trans proline' 0 CA--C 1.575 2.555 0 N-CA-C 118.784 2.571 . . . . 0.0 118.784 164.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.608 HH22 HG13 ' A' ' 59' ' ' VAL . 4.5 ttm105 -69.94 -37.56 75.92 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 168.107 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.0 p -151.56 126.95 9.99 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 104.316 -2.475 . . . . 0.0 104.316 -164.855 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . 0.317 5.8 p -62.28 -21.3 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-O 116.089 -1.91 . . . . 0.0 113.6 -173.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.09 -36.92 85.61 Favored 'General case' 0 CA--C 1.557 1.221 0 N-CA-C 119.435 3.124 . . . . 0.0 119.435 165.193 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -73.04 -48.54 35.28 Favored 'General case' 0 CA--C 1.586 2.361 0 CA-C-N 124.422 3.283 . . . . 0.0 111.088 165.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.16 -32.03 67.8 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 118.078 2.621 . . . . 0.0 118.078 -174.212 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.537 ' O ' ' HB2' ' A' ' 98' ' ' GLU . 60.2 tttt -59.48 -25.15 64.18 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 116.604 2.076 . . . . 0.0 116.604 168.706 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.62 -45.69 64.76 Favored 'General case' 0 CA--C 1.568 1.648 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 166.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 11.2 tp -61.48 -43.73 98.34 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 171.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -59.51 -51.11 71.27 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 168.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 1.015 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 5.5 tp10 -43.96 -39.3 3.95 Favored 'General case' 0 CA--C 1.573 1.865 0 N-CA-C 115.548 1.684 . . . . 0.0 115.548 166.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 1.154 ' O ' ' HB2' ' A' ' 103' ' ' ARG . 66.5 mtt -83.05 -26.02 31.56 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 117.673 2.471 . . . . 0.0 117.673 174.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 41.1 tp -65.53 -54.94 20.95 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-N 120.681 1.582 . . . . 0.0 112.13 169.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -78.29 -51.04 10.73 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 119.269 0.941 . . . . 0.0 113.281 175.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 1.015 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 74.8 ttt180 -67.79 -46.43 71.98 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 177.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 1.154 ' HB2' ' O ' ' A' ' 99' ' ' MET . 58.1 mtt180 -65.09 -51.29 62.25 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 118.892 0.769 . . . . 0.0 111.97 165.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.38 42.66 1.14 Allowed Glycine 0 N--CA 1.482 1.758 0 N-CA-C 114.914 0.726 . . . . 0.0 114.914 167.102 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 41.4 p -97.5 142.65 29.08 Favored 'General case' 0 CA--C 1.559 1.315 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 169.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -66.73 131.92 46.98 Favored 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -170.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 4.8 tp -84.75 102.89 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 125.402 1.481 . . . . 0.0 108.144 175.563 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -99.33 -74.27 0.6 Allowed 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 115.369 -2.253 . . . . 0.0 108.412 167.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -137.93 124.94 21.37 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 122.34 2.336 . . . . 0.0 114.908 -176.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 44.2 t -92.42 109.82 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 1 N-CA-C 98.854 -4.498 . . . . 0.0 98.854 162.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.255 49.9 tp -118.17 111.6 19.05 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.446 -160.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -112.96 128.27 56.44 Favored 'General case' 0 CA--C 1.556 1.201 0 CA-C-O 122.39 1.09 . . . . 0.0 111.507 -171.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -96.45 122.43 39.34 Favored 'General case' 0 CA--C 1.558 1.288 0 CA-C-N 113.612 -1.631 . . . . 0.0 109.853 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.438 ' HB3' ' HA ' ' A' ' 163' ' ' ASP . 76.8 ttt180 -85.58 96.43 9.65 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 112.931 -1.941 . . . . 0.0 110.158 169.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.4 p -137.74 147.11 26.45 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.626 0 C-N-CA 125.849 1.659 . . . . 0.0 109.217 -167.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 50.8 m -95.93 139.51 32.02 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 122.957 1.361 . . . . 0.0 113.883 -168.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -61.21 -37.64 83.74 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 112.794 -2.003 . . . . 0.0 115.883 173.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -49.5 -33.59 14.9 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 117.507 2.41 . . . . 0.0 117.507 177.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.1 t -63.45 -48.46 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 CA-C-N 119.883 1.219 . . . . 0.0 113.725 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 5.2 tp -64.97 -38.22 90.23 Favored 'General case' 0 CA--C 1.555 1.142 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 168.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 9.7 mp -64.09 -42.29 96.98 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 175.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -68.3 -35.31 77.63 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 114.76 1.392 . . . . 0.0 114.76 169.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.965 ' O ' ' HB3' ' A' ' 127' ' ' ARG . 32.2 ttm180 -56.0 -54.92 39.03 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 168.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.9 pp -70.31 -37.34 74.72 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 178.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -63.9 -48.87 74.91 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 116.352 1.982 . . . . 0.0 116.352 170.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -107.71 63.99 0.27 Allowed Glycine 0 CA--C 1.542 1.754 0 CA-C-N 118.888 0.767 . . . . 0.0 112.405 172.254 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.965 ' HB3' ' O ' ' A' ' 123' ' ' ARG . 24.3 tpt180 -172.56 -85.19 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -178.592 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -166.99 175.47 42.2 Favored Glycine 0 CA--C 1.57 3.502 0 CA-C-O 118.619 -1.1 . . . . 0.0 113.075 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.445 ' HB3' ' H ' ' A' ' 130' ' ' ALA . 88.8 mtt180 -154.09 -144.37 0.14 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 121.723 2.761 . . . . 0.0 112.6 -177.411 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.445 ' H ' ' HB3' ' A' ' 129' ' ' ARG . . . -151.31 -25.74 0.2 Allowed 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 111.934 -2.394 . . . . 0.0 114.625 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.5 t70 81.1 -43.6 0.19 Allowed 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 117.225 2.306 . . . . 0.0 117.225 -176.069 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -61.7 -30.09 70.53 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 162.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . 0.293 10.0 t -33.68 -51.3 0.38 Allowed 'General case' 0 N--CA 1.493 1.7 1 N-CA-C 122.045 4.091 . . . . 0.0 122.045 176.561 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -65.98 -51.34 59.33 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -64.72 -34.29 77.97 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 169.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 17.5 t -61.37 -41.45 89.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 C-N-CA 124.875 1.27 . . . . 0.0 113.605 169.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 34.5 mm -69.91 -35.96 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-O 117.658 -1.163 . . . . 0.0 113.17 171.099 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 41.7 mt -62.34 -42.6 99.52 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 120.811 1.642 . . . . 0.0 114.313 169.307 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -63.15 -38.49 91.38 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 169.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -60.11 -35.5 75.37 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 166.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 64.1 mtt -68.63 -29.8 68.38 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 167.778 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -62.22 -51.42 67.82 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 120.424 1.466 . . . . 0.0 114.889 168.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.7 p -64.18 -32.58 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 170.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -54.7 -50.38 68.43 Favored 'General case' 0 CA--C 1.579 2.066 0 CA-C-N 119.678 1.127 . . . . 0.0 111.965 167.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.55 -38.05 76.99 Favored 'General case' 0 CA--C 1.563 1.454 0 N-CA-C 118.401 2.741 . . . . 0.0 118.401 174.203 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -50.67 -33.95 24.6 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 118.478 2.77 . . . . 0.0 118.478 172.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -130.3 -28.76 2.08 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 118.473 2.768 . . . . 0.0 118.473 -166.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 62.6 m -47.46 -33.61 6.37 Favored 'General case' 0 N--CA 1.504 2.225 0 N-CA-C 117.503 2.409 . . . . 0.0 117.503 -170.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -66.58 -61.93 4.56 Favored Pre-proline 0 CA--C 1.58 2.129 0 CA-C-O 115.97 -1.967 . . . . 0.0 112.207 171.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -55.17 -31.24 74.9 Favored 'Trans proline' 0 CA--C 1.578 2.718 0 N-CA-C 119.302 2.77 . . . . 0.0 119.302 169.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.99 -56.42 19.24 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 125.409 1.483 . . . . 0.0 111.842 169.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.982 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 42.3 tp -66.07 -23.12 66.46 Favored 'General case' 0 CA--C 1.562 1.435 0 CA-C-O 116.675 -1.631 . . . . 0.0 114.569 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -71.74 -47.36 54.28 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 121.976 2.171 . . . . 0.0 112.084 165.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -66.75 -54.99 17.03 Favored 'General case' 0 CA--C 1.564 1.495 0 CA-C-N 120.613 1.551 . . . . 0.0 112.047 -176.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . 0.262 21.4 m-30 -81.94 -19.74 40.07 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-O 114.69 -2.576 . . . . 0.0 112.456 178.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.982 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 43.5 ttt180 -66.24 -36.04 81.99 Favored 'General case' 0 N--CA 1.487 1.413 1 CA-C-N 126.28 4.127 . . . . 0.0 115.592 167.721 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -68.86 -38.2 79.58 Favored 'General case' 0 CA--C 1.576 1.962 0 CA-C-N 119.848 1.204 . . . . 0.0 113.917 166.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -90.45 -27.58 19.17 Favored 'General case' 0 CA--C 1.576 1.979 0 N-CA-C 119.14 3.015 . . . . 0.0 119.14 -176.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.0 pp -79.76 174.9 11.12 Favored 'General case' 0 N--CA 1.504 2.272 0 CA-C-N 122.773 2.533 . . . . 0.0 116.852 -164.727 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 37.8 tttp -127.38 131.56 50.32 Favored 'General case' 0 CA--C 1.559 1.298 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 168.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 31.5 m -94.93 148.86 21.87 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 122.224 1.012 . . . . 0.0 112.639 -167.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 36.2 t -132.09 134.34 59.73 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.523 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 166.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.438 ' HA ' ' HB3' ' A' ' 114' ' ' ARG . 13.6 t70 -96.88 131.45 43.63 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 167.778 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -163.61 118.93 1.64 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -163.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.6 t -150.05 127.53 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-O 118.257 -0.878 . . . . 0.0 109.345 173.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 77.84 -65.24 3.24 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 119.963 2.745 . . . . 0.0 119.963 166.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 5.8 t -72.79 118.83 16.2 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 112.419 -1.89 . . . . 0.0 111.59 -169.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 64.8 mtt -69.91 -59.61 2.82 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -170.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -66.93 -37.47 84.4 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 116.013 1.857 . . . . 0.0 116.013 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -65.46 -45.35 84.06 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 171.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 69.0 t -56.49 -41.86 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.345 0 CA-C-N 120.622 1.555 . . . . 0.0 113.847 172.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.555 ' CE1' ' HB3' ' A' ' 19' ' ' LYS . 29.3 t80 -57.99 -36.16 72.24 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 115.783 1.771 . . . . 0.0 115.783 167.204 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -61.03 -53.29 59.07 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-O 118.141 -0.933 . . . . 0.0 113.459 176.169 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.409 ' NH1' ' HB3' ' A' ' 163' ' ' ASP . 93.6 mtt180 -63.96 -32.09 73.5 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 118.206 2.669 . . . . 0.0 118.206 171.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.95 -47.31 87.02 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 116.577 2.066 . . . . 0.0 116.577 170.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . 0.265 0.2 OUTLIER -71.06 -39.47 72.2 Favored 'General case' 0 N--CA 1.505 2.32 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 169.81 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -48.92 -39.46 26.23 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 168.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -69.51 -56.7 6.61 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 166.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -103.84 -56.18 2.25 Favored 'General case' 0 CA--C 1.563 1.462 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 -168.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.837 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -78.23 -37.08 29.27 Favored Glycine 0 CA--C 1.55 2.258 0 CA-C-N 121.308 1.867 . . . . 0.0 117.764 -169.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.837 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 86.1 tttt . . . . . 0 C--O 1.252 1.186 0 CA-C-N 118.073 0.936 . . . . 0.0 108.523 178.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 mmt . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 122.278 1.037 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.466 ' HG3' HH11 ' A' ' 2' ' ' ARG 0.324 16.0 ttm-85 -147.25 144.64 29.01 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 118.423 2.749 . . . . 0.0 118.423 -158.985 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.8 t -141.42 147.85 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 CA-C-O 123.951 1.834 . . . . 0.0 111.964 -171.355 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.6 mt -133.29 120.74 21.45 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 126.949 2.099 . . . . 0.0 108.995 -175.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 13.0 tp -105.88 122.51 46.27 Favored 'General case' 0 CA--C 1.577 2.005 0 CA-C-O 123.202 1.477 . . . . 0.0 111.066 -168.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.7 mt -120.93 164.67 16.34 Favored 'General case' 0 CA--C 1.563 1.478 0 CA-C-N 110.607 -2.997 . . . . 0.0 112.742 -171.598 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 142.08 170.67 12.66 Favored Glycine 0 CA--C 1.562 2.984 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.563 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.81 119.45 6.45 Favored 'Trans proline' 0 CA--C 1.579 2.761 0 CA-C-N 121.45 2.625 . . . . 0.0 110.145 170.035 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -79.57 112.26 2.92 Favored 'Trans proline' 0 CA--C 1.56 1.809 0 C-N-CA 122.511 2.141 . . . . 0.0 116.902 -165.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -172.69 -84.21 0.06 OUTLIER Glycine 0 CA--C 1.534 1.229 0 N-CA-C 107.96 -2.056 . . . . 0.0 107.96 168.087 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.15 143.47 35.41 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 175.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 1.063 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . 81.69 -176.04 54.17 Favored Glycine 0 CA--C 1.547 2.045 0 N-CA-C 115.297 0.879 . . . . 0.0 115.297 177.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 1.063 ' HB2' ' O ' ' A' ' 12' ' ' GLY . 45.7 mttt 94.59 -90.2 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 170.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -46.39 -40.26 10.8 Favored Glycine 0 CA--C 1.555 2.571 0 N-CA-C 120.939 3.136 . . . . 0.0 120.939 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.7 m -52.82 -54.63 31.48 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-N 119.012 1.406 . . . . 0.0 114.359 169.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.25 0.0 OUTLIER -76.67 -17.12 59.32 Favored 'General case' 0 CA--C 1.575 1.927 0 CA-C-O 117.055 -1.45 . . . . 0.0 112.697 177.454 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.23 -44.18 65.83 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 122.068 2.213 . . . . 0.0 114.629 167.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.9 p -66.13 -46.81 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 172.289 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.699 ' HB3' ' CE1' ' A' ' 172' ' ' PHE . 45.0 mmtm -54.9 -46.74 74.87 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 169.574 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 12.5 tp -70.33 -27.76 64.62 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 175.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.15 -39.06 89.53 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 166.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -58.78 -43.35 90.41 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 117.31 -1.328 . . . . 0.0 114.131 166.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -68.12 -46.83 69.8 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 116.455 2.02 . . . . 0.0 116.455 173.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.0 mt -82.54 -26.63 32.27 Favored 'General case' 0 CA--C 1.574 1.893 0 N-CA-C 117.092 2.256 . . . . 0.0 117.092 -177.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.06 43.47 7.11 Favored Glycine 0 CA--C 1.555 2.557 0 N-CA-C 117.378 1.711 . . . . 0.0 117.378 -173.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.437 ' CG2' ' HA ' ' A' ' 81' ' ' PHE . 22.2 mm -114.62 157.98 41.43 Favored Pre-proline 0 CA--C 1.57 1.716 0 C-N-CA 124.551 1.14 . . . . 0.0 113.8 -168.081 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.425 ' HG2' HD21 ' A' ' 74' ' ' ASN . 34.9 Cg_exo -76.3 103.18 1.7 Allowed 'Trans proline' 0 C--N 1.376 2.008 0 CA-C-N 121.582 1.601 . . . . 0.0 111.453 159.138 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.47 107.02 10.81 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.237 -0.914 . . . . 0.0 109.052 168.156 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.7 mm -99.17 112.0 30.21 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 -178.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.3 t -96.44 127.35 42.35 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 169.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 42.5 p -69.96 -10.55 58.98 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 116.802 2.149 . . . . 0.0 116.802 -175.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -83.76 -23.2 53.85 Favored Glycine 0 CA--C 1.545 1.912 0 N-CA-C 118.642 2.217 . . . . 0.0 118.642 166.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -80.52 -51.9 8.24 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 114.714 1.375 . . . . 0.0 114.714 -168.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -64.09 -39.21 93.57 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 174.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.4 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 13.5 m-85 -68.16 -42.19 80.42 Favored 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 172.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 29.2 ttp180 -57.33 -41.62 80.33 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 120.467 1.485 . . . . 0.0 114.073 167.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.2 ttt180 -58.88 -39.21 80.74 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 168.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -67.18 -27.8 67.57 Favored 'General case' 0 CA--C 1.577 1.988 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 167.198 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 97.4 mt -63.03 -45.51 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 CA-C-N 120.476 1.489 . . . . 0.0 111.403 168.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -66.86 -38.04 85.6 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 120.086 1.312 . . . . 0.0 114.285 173.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -67.85 -40.26 83.71 Favored 'General case' 0 CA--C 1.56 1.356 0 N-CA-C 116.339 1.977 . . . . 0.0 116.339 174.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.82 69.36 1.19 Allowed Glycine 0 CA--C 1.545 1.909 0 CA-C-O 118.379 -1.234 . . . . 0.0 114.645 -177.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.761 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 70.8 p -91.58 -49.1 6.48 Favored 'General case' 0 N--CA 1.5 2.025 0 CA-C-N 118.781 1.29 . . . . 0.0 114.341 176.21 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.761 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.255 74.2 mttt 105.96 -41.64 0.0 OUTLIER 'General case' 0 CA--C 1.569 1.705 0 CA-C-O 116.331 -1.795 . . . . 0.0 111.212 -172.181 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.3 -13.63 58.22 Favored 'General case' 0 CA--C 1.57 1.717 0 CA-C-N 123.117 2.689 . . . . 0.0 113.231 163.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.53 -55.03 32.26 Favored Glycine 0 C--N 1.354 1.529 0 CA-C-N 120.534 1.515 . . . . 0.0 115.2 169.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.28 8.7 p -76.42 -47.83 28.95 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.474 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -169.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -64.94 -47.42 77.73 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 121.291 1.859 . . . . 0.0 112.957 172.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.19 -31.03 69.35 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -179.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.4 ' HB2' ' HB3' ' A' ' 35' ' ' PHE . 2.0 tptm -69.7 -36.82 76.28 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 168.045 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.575 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 29.0 ttt180 -74.48 -52.5 11.78 Favored 'General case' 0 CA--C 1.59 2.487 1 CA-C-O 85.183 -16.627 . . . . 0.0 117.991 -178.378 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 18.5 m-30 -30.41 -55.55 0.19 Allowed 'General case' 0 N--CA 1.493 1.717 1 O-C-N 108.661 -8.774 . . . . 0.0 121.6 146.736 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 26.5 mt -61.43 -44.01 97.88 Favored 'General case' 0 CA--C 1.572 1.789 0 CA-C-N 123.455 2.843 . . . . 0.0 114.489 167.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -76.08 -41.68 49.71 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 116.297 1.962 . . . . 0.0 116.297 176.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.45 -33.49 20.38 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 175.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.66 38.12 3.77 Favored Glycine 0 CA--C 1.54 1.607 0 CA-C-N 121.112 1.778 . . . . 0.0 116.521 169.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -101.48 -132.44 0.27 Allowed 'General case' 0 CA--C 1.571 1.773 0 CA-C-O 118.589 -0.72 . . . . 0.0 109.374 169.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.8 pp -120.87 123.5 42.69 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 120.007 1.276 . . . . 0.0 111.491 -169.517 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.1 p -120.71 133.69 24.12 Favored Pre-proline 0 CA--C 1.574 1.893 0 CA-C-O 117.782 -1.104 . . . . 0.0 109.883 -176.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -59.47 148.56 86.45 Favored 'Trans proline' 0 CA--C 1.561 1.829 0 C-N-CA 123.447 2.764 . . . . 0.0 116.505 174.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 88.0 p -80.61 -35.81 33.57 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 117.314 2.338 . . . . 0.0 117.314 -175.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -71.76 -51.6 21.87 Favored 'General case' 0 N--CA 1.508 2.473 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -171.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.8 pp -54.51 -42.0 70.29 Favored 'General case' 0 CA--C 1.564 1.496 0 N-CA-C 117.521 2.415 . . . . 0.0 117.521 171.252 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.0 m -61.19 -48.31 82.12 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 123.905 0.882 . . . . 0.0 113.282 172.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -67.04 -19.76 65.73 Favored 'General case' 0 CA--C 1.572 1.817 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 169.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -75.17 -42.37 56.02 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 121.116 1.78 . . . . 0.0 115.128 170.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mt -61.53 -47.29 86.23 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 168.247 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -54.24 -48.42 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 169.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -61.94 -36.17 80.62 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 171.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -55.54 -42.03 74.04 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 117.95 -1.024 . . . . 0.0 113.611 169.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 88.2 mtt-85 -81.14 -21.82 39.49 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 118.112 2.634 . . . . 0.0 118.112 168.395 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.0 mp -89.3 7.69 34.32 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 118.331 2.715 . . . . 0.0 118.331 172.095 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -68.67 4.76 1.28 Allowed 'General case' 0 CA--C 1.585 2.317 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 163.166 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.469 ' C ' ' H ' ' A' ' 76' ' ' ASP 0.293 49.7 p30 -44.33 -156.67 0.0 OUTLIER Pre-proline 0 CA--C 1.594 2.639 0 N-CA-C 120.842 3.645 . . . . 0.0 120.842 164.192 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 15.2 Cg_exo -40.2 25.74 0.0 OUTLIER 'Trans proline' 0 N--CA 1.515 2.747 2 C-N-CA 127.699 5.599 . . . . 0.0 125.586 163.193 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.469 ' H ' ' C ' ' A' ' 74' ' ' ASN . 15.6 t70 61.85 27.69 16.89 Favored 'General case' 0 CA--C 1.582 2.197 0 C-N-CA 125.538 1.535 . . . . 0.0 109.154 -160.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 58.61 33.61 23.22 Favored 'General case' 0 CA--C 1.578 2.028 0 CA-C-N 120.952 1.705 . . . . 0.0 112.452 -165.75 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.83 -39.52 92.11 Favored 'General case' 0 C--N 1.38 1.899 0 CA-C-N 121.689 2.041 . . . . 0.0 115.73 176.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -74.24 -25.11 59.45 Favored 'General case' 0 CA--C 1.566 1.576 0 N-CA-C 116.488 2.033 . . . . 0.0 116.488 169.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.46 ' HA2' ' NH1' ' A' ' 2' ' ' ARG . . . 130.95 -167.71 22.21 Favored Glycine 0 C--N 1.36 1.884 0 CA-C-O 125.52 2.733 . . . . 0.0 113.776 -168.408 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.437 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . 21.7 p90 -169.72 135.5 1.49 Allowed 'General case' 0 CA--C 1.56 1.362 0 CA-C-N 109.039 -3.581 . . . . 0.0 105.975 169.382 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 13.9 mt -106.79 106.32 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 173.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.3 mt -108.03 114.59 28.61 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.069 -176.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -106.77 125.28 50.8 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 119.467 1.031 . . . . 0.0 110.632 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 75.19 28.38 62.24 Favored Glycine 0 CA--C 1.551 2.293 0 N-CA-C 118.377 2.111 . . . . 0.0 118.377 177.37 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -88.81 -55.0 0.32 Allowed Pre-proline 0 N--CA 1.496 1.865 0 CA-C-O 115.234 -2.317 . . . . 0.0 107.264 168.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -67.56 66.51 0.79 Allowed 'Trans proline' 0 CA--C 1.574 2.475 0 N-CA-C 118.381 2.416 . . . . 0.0 118.381 166.349 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 8.0 tmm_? -76.41 -20.39 57.17 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 167.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.453 ' HA ' ' HG3' ' A' ' 147' ' ' GLU . 28.3 t -153.54 127.56 8.98 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 104.197 -2.52 . . . . 0.0 104.197 -167.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . 0.302 5.8 p -61.3 -27.18 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 CA-C-O 116.387 -1.768 . . . . 0.0 113.017 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.61 -32.6 70.01 Favored 'General case' 0 C--N 1.362 1.132 0 N-CA-C 119.631 3.197 . . . . 0.0 119.631 165.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -74.04 -49.95 21.93 Favored 'General case' 0 CA--C 1.588 2.405 0 CA-C-N 124.391 3.269 . . . . 0.0 111.493 166.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -53.99 -28.02 35.3 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 118.319 2.711 . . . . 0.0 118.319 178.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.2 tttp -57.18 -30.35 64.43 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 168.74 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.56 -44.79 81.35 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 168.218 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.9 tp -62.2 -35.57 79.28 Favored 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 169.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 13.3 t60 -64.45 -43.8 93.12 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 119.651 1.114 . . . . 0.0 113.175 167.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 1.152 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 0.5 OUTLIER -54.94 -30.61 59.18 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 166.696 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 1.341 ' O ' ' HB2' ' A' ' 103' ' ' ARG . 47.3 mtt -85.28 -33.71 22.08 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 118.946 2.943 . . . . 0.0 118.946 172.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.5 tt -69.51 -54.11 15.78 Favored 'General case' 0 N--CA 1.504 2.27 0 CA-C-N 121.372 1.897 . . . . 0.0 110.906 172.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -78.15 -49.41 13.9 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 117.662 -1.161 . . . . 0.0 114.065 175.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 1.152 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 93.0 mtt180 -75.08 -39.67 60.6 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 177.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 1.341 ' HB2' ' O ' ' A' ' 99' ' ' MET . 32.8 mmt180 -64.36 -54.36 34.07 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 120.123 1.329 . . . . 0.0 111.538 165.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.3 50.74 0.7 Allowed Glycine 0 N--CA 1.485 1.938 0 O-C-N 123.836 0.71 . . . . 0.0 113.957 168.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.0 p -92.65 169.05 10.81 Favored 'General case' 0 CA--C 1.566 1.562 0 CA-C-N 113.188 -1.506 . . . . 0.0 110.247 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -72.42 133.24 44.78 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.1 -1.0 . . . . 0.0 110.72 -174.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 7.8 tp -102.21 98.44 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 177.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -98.32 -77.45 0.51 Allowed 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 116.218 -1.849 . . . . 0.0 107.866 168.055 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.46 130.55 11.88 Favored 'General case' 0 C--N 1.362 1.149 0 CA-C-N 121.665 2.03 . . . . 0.0 113.94 -169.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 24.1 t -92.72 110.96 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 103.497 -2.779 . . . . 0.0 103.497 162.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.565 HD23 ' HB3' ' A' ' 160' ' ' LYS . 89.4 mt -96.6 95.65 8.11 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.478 -172.978 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -88.98 123.95 33.79 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.173 0.511 . . . . 0.0 111.608 177.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -90.93 124.07 34.91 Favored 'General case' 0 CA--C 1.559 1.289 0 CA-C-O 123.16 1.457 . . . . 0.0 110.915 -176.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -85.37 97.35 9.94 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 112.412 -2.177 . . . . 0.0 108.391 167.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.1 p -134.46 133.49 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 CA-C-N 113.477 -1.692 . . . . 0.0 107.455 -168.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.1 m -74.92 138.98 42.75 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.432 -175.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -64.97 -26.63 68.38 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 175.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -52.46 -45.69 66.2 Favored 'General case' 0 CA--C 1.563 1.469 0 CA-C-N 121.704 2.047 . . . . 0.0 114.998 167.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.5 t -65.22 -44.89 95.1 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 173.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -51.25 -45.14 61.91 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 124.792 1.237 . . . . 0.0 114.123 168.002 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.1 mp -61.58 -37.58 84.39 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 169.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -56.61 -43.66 80.38 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 167.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 86.5 mmt-85 -56.35 -50.75 70.6 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 168.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -52.56 -48.38 66.2 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 169.533 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -59.07 -43.64 91.77 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 117.249 2.315 . . . . 0.0 117.249 173.685 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -96.26 54.13 1.55 Allowed Glycine 0 CA--C 1.547 2.036 0 N-CA-C 114.979 0.752 . . . . 0.0 114.979 172.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 75.4 mtp85 -150.35 115.14 5.28 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 171.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.597 ' O ' ' CB ' ' A' ' 129' ' ' ARG . . . -78.23 -178.86 49.94 Favored Glycine 0 CA--C 1.572 3.62 0 N-CA-C 116.072 1.189 . . . . 0.0 116.072 -169.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.597 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 33.4 ttm180 101.9 126.48 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 120.93 2.365 . . . . 0.0 109.54 -173.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -68.08 -35.4 78.12 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 117.0 2.222 . . . . 0.0 117.0 -175.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -136.67 58.94 1.71 Allowed 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 120.833 1.652 . . . . 0.0 113.653 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -122.67 61.3 1.0 Allowed 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 103.241 -2.874 . . . . 0.0 103.241 158.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 82.7 p -143.0 -115.39 0.1 Allowed 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 113.707 -1.588 . . . . 0.0 110.103 -160.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -59.13 -41.38 88.1 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 117.125 2.268 . . . . 0.0 117.125 -169.165 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -75.07 -36.06 61.79 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 115.518 1.673 . . . . 0.0 115.518 177.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.4 t -64.38 -40.59 89.61 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.68 0 CA-C-O 117.582 -1.199 . . . . 0.0 111.571 169.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.7 tp -74.29 -30.06 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 CA-C-N 120.503 1.501 . . . . 0.0 113.879 174.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 31.3 mt -63.88 -46.46 84.83 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 121.139 1.79 . . . . 0.0 113.332 168.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -61.96 -40.32 95.16 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 172.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -62.48 -37.31 85.48 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 168.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 57.8 mtt -67.93 -29.51 68.6 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 168.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -63.56 -50.69 68.53 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 120.412 1.46 . . . . 0.0 114.377 168.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.1 p -65.79 -33.08 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.221 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 170.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -57.2 -47.0 82.38 Favored 'General case' 0 CA--C 1.583 2.214 0 CA-C-N 119.994 1.27 . . . . 0.0 112.032 168.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -61.77 -54.08 47.18 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 117.445 2.387 . . . . 0.0 117.445 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.49 -43.81 62.32 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 116.922 2.193 . . . . 0.0 116.922 174.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.453 ' HG3' ' HA ' ' A' ' 89' ' ' SER . 32.9 mm-40 -98.84 -42.3 7.24 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 116.487 2.032 . . . . 0.0 116.487 -167.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 97.8 m -50.76 -33.38 22.95 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 117.427 2.38 . . . . 0.0 117.427 -167.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -71.04 -61.38 2.34 Favored Pre-proline 0 CA--C 1.583 2.212 0 CA-C-O 115.83 -2.033 . . . . 0.0 111.844 169.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_exo -54.31 -37.02 88.56 Favored 'Trans proline' 0 CA--C 1.58 2.796 0 C-N-CA 123.625 2.883 . . . . 0.0 119.3 169.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -61.14 -53.27 59.11 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 126.193 1.797 . . . . 0.0 111.58 171.536 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 1.12 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 45.3 tp -64.32 -20.73 66.28 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 115.378 1.621 . . . . 0.0 115.378 174.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -71.6 -50.4 31.25 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 122.436 2.38 . . . . 0.0 112.667 164.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -65.05 -53.16 50.04 Favored 'General case' 0 CA--C 1.568 1.658 0 CA-C-N 120.106 1.321 . . . . 0.0 112.432 -179.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -74.87 -29.23 60.95 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-O 115.178 -2.344 . . . . 0.0 113.491 176.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 1.12 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 34.7 ttt180 -60.95 -36.42 79.33 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 124.535 3.334 . . . . 0.0 116.389 169.501 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -67.72 -36.49 80.7 Favored 'General case' 0 CA--C 1.575 1.935 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 166.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -86.87 -29.5 22.14 Favored 'General case' 0 CA--C 1.577 2.001 0 N-CA-C 119.43 3.122 . . . . 0.0 119.43 -178.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.1 pp -80.4 176.64 9.59 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 119.673 3.212 . . . . 0.0 119.673 -160.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.565 ' HB3' HD23 ' A' ' 111' ' ' LEU . 6.0 tmtt? -131.0 135.25 47.44 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 104.062 -2.57 . . . . 0.0 104.062 166.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 83.0 m -97.06 148.88 22.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.991 -1.068 . . . . 0.0 109.666 -174.745 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 34.3 t -130.38 138.18 54.44 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.442 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 168.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -91.14 136.8 32.84 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 169.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -160.26 99.89 1.34 Allowed 'General case' 0 N--CA 1.481 1.085 0 CA-C-O 121.711 0.767 . . . . 0.0 111.516 -163.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.3 t -149.92 126.77 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -176.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.14 -69.83 3.04 Favored Glycine 0 N--CA 1.482 1.731 0 N-CA-C 117.471 1.748 . . . . 0.0 117.471 168.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 44.5 p -81.23 138.28 35.79 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 112.139 -2.03 . . . . 0.0 111.628 -169.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 53.9 mtt -88.39 -58.05 2.7 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 118.742 -0.647 . . . . 0.0 111.807 175.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -69.57 -37.48 76.99 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 116.112 1.893 . . . . 0.0 116.112 -177.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.567 ' HB3' HH21 ' A' ' 174' ' ' ARG . 46.8 mt-10 -64.39 -47.7 78.25 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 119.491 1.041 . . . . 0.0 113.635 169.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 99.8 t -58.92 -36.65 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 CA-C-N 119.399 0.999 . . . . 0.0 113.543 173.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.699 ' CE1' ' HB3' ' A' ' 19' ' ' LYS . 43.0 t80 -57.34 -36.65 71.44 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 164.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.43 -54.43 32.72 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 175.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.567 HH21 ' HB3' ' A' ' 170' ' ' GLU . 9.7 ptp180 -66.36 -26.06 67.1 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 117.588 2.44 . . . . 0.0 117.588 170.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.93 -41.93 95.1 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 120.06 1.3 . . . . 0.0 114.211 167.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 4.5 mp -60.08 -46.14 90.56 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 118.265 -0.874 . . . . 0.0 113.035 166.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 26.3 mtp180 -51.52 -45.61 62.97 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 169.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.32 -49.05 79.3 Favored 'General case' 0 CA--C 1.558 1.27 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 171.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -84.19 -61.34 1.83 Allowed 'General case' 0 CA--C 1.564 1.515 0 CA-C-O 117.781 -1.104 . . . . 0.0 112.326 -177.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.974 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -101.45 -56.62 0.86 Allowed Glycine 0 CA--C 1.551 2.296 0 CA-C-N 120.523 1.51 . . . . 0.0 114.937 -177.092 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.974 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 57.5 tttp . . . . . 0 C--O 1.251 1.132 0 CA-C-N 120.003 1.902 . . . . 0.0 109.195 -176.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.3 mtt . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -149.68 172.97 14.2 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 116.613 2.079 . . . . 0.0 116.613 -168.024 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 54.7 t -134.25 156.04 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 CA-C-O 123.474 1.607 . . . . 0.0 112.802 -162.558 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . 0.259 0.0 OUTLIER -140.77 132.19 26.84 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 113.936 -1.484 . . . . 0.0 110.091 167.038 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 1.07 HD21 ' HB3' ' A' ' 13' ' ' LYS . 23.8 tp -99.56 126.37 45.52 Favored 'General case' 0 CA--C 1.573 1.849 0 CA-C-O 123.132 1.444 . . . . 0.0 112.121 -167.666 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.3 mt -116.51 153.03 32.89 Favored 'General case' 0 CA--C 1.559 1.305 0 CA-C-N 109.921 -3.309 . . . . 0.0 109.898 -177.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -179.38 108.26 0.24 Allowed Glycine 0 CA--C 1.547 2.036 0 CA-C-O 117.029 -1.984 . . . . 0.0 113.289 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.45 175.41 0.39 Allowed 'Trans proline' 0 CA--C 1.579 2.725 0 CA-C-N 121.926 2.863 . . . . 0.0 115.689 168.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -47.97 114.76 1.21 Allowed 'Trans proline' 0 CA--C 1.561 1.862 0 C-N-CA 123.94 3.093 . . . . 0.0 116.905 -174.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.21 89.86 0.07 OUTLIER Glycine 0 CA--C 1.539 1.57 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -169.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 64.02 -111.6 0.31 Allowed 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 124.951 1.3 . . . . 0.0 114.068 173.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 165.55 118.98 0.46 Allowed Glycine 0 CA--C 1.543 1.803 0 CA-C-N 120.065 1.302 . . . . 0.0 110.438 -171.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 1.07 ' HB3' HD21 ' A' ' 5' ' ' LEU . 0.5 OUTLIER -86.43 10.34 15.43 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 118.826 2.898 . . . . 0.0 118.826 -169.02 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.76 -24.46 40.87 Favored Glycine 0 CA--C 1.561 2.928 0 N-CA-C 118.972 2.349 . . . . 0.0 118.972 168.029 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 16.6 m -63.07 -56.22 18.8 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 119.378 1.589 . . . . 0.0 113.331 170.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.5 ' HA ' ' HB2' ' A' ' 19' ' ' LYS 0.286 1.8 mp0 -77.82 -12.29 59.96 Favored 'General case' 0 CA--C 1.571 1.78 0 CA-C-O 115.695 -2.098 . . . . 0.0 112.804 173.54 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.53 -46.83 45.29 Favored 'General case' 0 C--N 1.375 1.697 0 CA-C-N 123.831 3.014 . . . . 0.0 113.744 167.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.7 t -67.2 -38.24 80.68 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.995 0 CA-C-N 119.772 1.169 . . . . 0.0 111.893 173.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.5 ' HB2' ' HA ' ' A' ' 16' ' ' GLN . 18.9 mmmt -57.42 -54.34 47.88 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 116.38 1.993 . . . . 0.0 116.38 169.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.7 tp -65.09 -29.55 70.43 Favored 'General case' 0 CA--C 1.575 1.924 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 174.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.48 -39.13 91.59 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 167.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -61.03 -36.05 78.51 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 166.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.2 mmmt -65.21 -51.63 59.81 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 169.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.4 mt -85.15 -25.55 27.39 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 116.931 2.197 . . . . 0.0 116.931 -174.445 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.04 37.86 7.61 Favored Glycine 0 CA--C 1.554 2.525 0 N-CA-C 117.694 1.838 . . . . 0.0 117.694 -174.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.438 ' CG2' ' HA ' ' A' ' 81' ' ' PHE . 16.2 mm -105.21 155.95 36.98 Favored Pre-proline 0 CA--C 1.569 1.681 0 CA-C-N 119.26 1.53 . . . . 0.0 113.281 -168.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -80.64 99.06 1.11 Allowed 'Trans proline' 0 CA--C 1.567 2.125 0 CA-C-N 122.426 1.902 . . . . 0.0 109.549 162.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -72.18 112.47 8.29 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.923 -0.486 . . . . 0.0 110.108 177.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 12.8 mm -98.67 104.26 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 41.7 t -98.77 127.88 44.83 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 167.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 37.9 p -67.64 -18.73 65.06 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 117.41 2.374 . . . . 0.0 117.41 -168.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -82.88 -18.66 64.91 Favored Glycine 0 CA--C 1.548 2.126 0 N-CA-C 118.667 2.227 . . . . 0.0 118.667 167.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -78.96 -53.6 6.88 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 119.009 1.404 . . . . 0.0 114.189 -169.497 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -65.16 -38.02 89.23 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 174.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.466 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 15.3 m-85 -64.54 -38.53 91.32 Favored 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 168.325 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 49.0 ttp180 -58.6 -41.68 86.39 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 119.929 1.241 . . . . 0.0 114.273 167.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -60.65 -41.28 94.67 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 168.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -69.08 -24.31 64.13 Favored 'General case' 0 CA--C 1.579 2.059 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 169.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 65.6 mt -63.69 -47.98 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 CA-C-N 120.245 1.384 . . . . 0.0 110.97 167.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -65.63 -36.7 84.45 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 114.341 1.238 . . . . 0.0 114.341 174.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -66.46 -42.74 87.1 Favored 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 115.98 1.844 . . . . 0.0 115.98 173.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.79 69.44 1.06 Allowed Glycine 0 CA--C 1.543 1.829 0 CA-C-O 118.607 -1.107 . . . . 0.0 114.101 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.776 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 73.3 p -93.33 -48.74 6.28 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.776 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.253 74.6 mttt 106.17 -41.37 0.0 OUTLIER 'General case' 0 CA--C 1.572 1.818 0 CA-C-O 116.455 -1.736 . . . . 0.0 111.29 -172.607 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.88 -14.14 56.61 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 122.955 2.616 . . . . 0.0 112.895 163.789 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.54 -55.64 27.69 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-N 120.287 1.403 . . . . 0.0 114.864 170.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.297 7.4 p -76.32 -50.41 22.31 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.444 0 N-CA-C 115.883 1.808 . . . . 0.0 115.883 -168.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -66.71 -45.94 77.14 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 121.127 1.785 . . . . 0.0 112.922 173.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.47 -27.42 63.23 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -178.031 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.466 ' HB2' ' HB3' ' A' ' 35' ' ' PHE . 1.3 tmtp? -72.53 -41.97 65.26 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 117.302 -1.333 . . . . 0.0 112.946 166.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.594 ' CG ' ' O ' ' A' ' 51' ' ' ARG . 32.4 ttt180 -71.2 -51.77 22.86 Favored 'General case' 0 CA--C 1.586 2.342 1 CA-C-O 85.232 -16.604 . . . . 0.0 118.623 -174.139 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -34.58 -62.53 0.34 Allowed 'General case' 0 N--CA 1.494 1.732 1 O-C-N 108.992 -8.567 . . . . 0.0 121.129 146.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.5 tp -57.01 -29.47 63.36 Favored 'General case' 0 CA--C 1.582 2.206 0 CA-C-N 122.012 2.187 . . . . 0.0 116.223 171.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -92.58 -39.45 11.33 Favored 'General case' 0 CA--C 1.568 1.672 0 C-N-CA 126.738 2.015 . . . . 0.0 116.27 170.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -87.08 -27.88 22.88 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 116.874 2.176 . . . . 0.0 116.874 -176.425 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.75 22.01 6.87 Favored Glycine 0 CA--C 1.542 1.733 0 N-CA-C 118.588 2.195 . . . . 0.0 118.588 167.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -100.28 -132.23 0.25 Allowed 'General case' 0 CA--C 1.57 1.746 0 CA-C-N 118.935 1.367 . . . . 0.0 110.045 173.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 89.2 mt -116.17 119.31 35.39 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 119.916 1.235 . . . . 0.0 110.874 -168.748 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.2 p -121.37 136.48 25.88 Favored Pre-proline 0 CA--C 1.573 1.846 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.322 176.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -61.08 150.01 86.37 Favored 'Trans proline' 0 CA--C 1.561 1.857 0 C-N-CA 123.136 2.557 . . . . 0.0 115.275 169.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.1 t -83.85 -33.88 24.75 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -64.0 -44.91 91.22 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -174.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 pp -56.76 -43.63 80.98 Favored 'General case' 0 CA--C 1.562 1.425 0 N-CA-C 117.09 2.255 . . . . 0.0 117.09 169.573 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.5 m -61.77 -46.21 90.54 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 123.834 0.854 . . . . 0.0 113.013 174.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.543 HD21 ' HH ' ' A' ' 86' ' ' TYR . 0.7 OUTLIER -64.45 -23.63 67.35 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 167.202 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -74.26 -45.74 45.9 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 175.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.4 mt -65.79 -45.81 81.01 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 169.371 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 69.0 t -57.65 -53.8 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 117.645 -1.169 . . . . 0.0 111.688 172.644 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -62.14 -30.7 71.21 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 116.002 1.853 . . . . 0.0 116.002 174.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -57.94 -43.7 86.49 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 117.162 -1.399 . . . . 0.0 113.404 169.733 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.5 ttm-85 -81.64 -15.34 54.91 Favored 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 118.499 2.778 . . . . 0.0 118.499 168.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.52 ' C ' ' H ' ' A' ' 74' ' ' ASN . 74.7 mt -85.13 -6.62 59.29 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 166.804 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -72.02 45.42 0.12 Allowed 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 126.237 2.922 . . . . 0.0 118.485 165.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.52 ' H ' ' C ' ' A' ' 72' ' ' LEU 0.362 0.7 OUTLIER 74.33 90.71 0.06 OUTLIER Pre-proline 0 CA--C 1.556 1.183 2 N-CA-C 123.532 4.642 . . . . 0.0 123.532 146.568 . . . . . . . . 5 4 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -80.92 37.04 0.65 Allowed 'Trans proline' 0 CA--C 1.578 2.687 0 C-N-CA 121.985 1.79 . . . . 0.0 113.002 149.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 63.61 30.43 14.96 Favored 'General case' 0 CA--C 1.594 2.656 0 C-N-CA 125.97 1.708 . . . . 0.0 107.684 -151.578 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 61.41 5.33 1.14 Allowed 'General case' 0 C--N 1.398 2.681 0 CA-C-N 123.027 2.649 . . . . 0.0 114.2 -162.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 47.87 34.18 3.79 Favored 'General case' 0 CA--C 1.583 2.217 0 CA-C-N 122.542 2.428 . . . . 0.0 113.829 -158.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 18.3 m120 59.67 28.96 18.5 Favored 'General case' 0 CA--C 1.582 2.183 0 C-N-CA 125.576 1.55 . . . . 0.0 113.828 -166.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.89 -169.64 42.27 Favored Glycine 0 C--N 1.373 2.593 0 CA-C-N 123.226 2.739 . . . . 0.0 116.324 -169.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.469 ' O ' ' HB2' ' A' ' 2' ' ' ARG . 17.2 p90 -177.6 132.14 0.16 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 112.958 -1.621 . . . . 0.0 109.278 169.675 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 16.7 mt -112.59 109.53 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 172.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 24.8 mt -104.01 114.33 28.51 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 117.52 -1.229 . . . . 0.0 109.87 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -104.5 125.71 50.92 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 121.32 1.873 . . . . 0.0 110.884 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 74.04 32.36 58.7 Favored Glycine 0 CA--C 1.548 2.147 0 N-CA-C 117.95 1.94 . . . . 0.0 117.95 174.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . 0.543 ' HH ' HD21 ' A' ' 65' ' ' ASN . 1.4 t80 -91.15 -55.8 0.26 Allowed Pre-proline 0 N--CA 1.496 1.853 0 CA-C-O 115.163 -2.351 . . . . 0.0 108.418 169.133 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -66.74 63.79 0.57 Allowed 'Trans proline' 0 CA--C 1.575 2.555 0 N-CA-C 120.192 3.112 . . . . 0.0 120.192 168.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . 0.331 29.6 ttt180 -69.59 -31.42 69.55 Favored 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 116.892 2.182 . . . . 0.0 116.892 165.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.9 t -151.72 129.32 11.49 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 104.742 -2.318 . . . . 0.0 104.742 -166.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . 0.33 12.8 p -61.86 -25.3 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 CA-C-O 116.726 -1.607 . . . . 0.0 113.718 -172.397 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.07 -38.21 75.92 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 119.506 3.15 . . . . 0.0 119.506 165.185 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -70.09 -47.95 59.72 Favored 'General case' 0 CA--C 1.592 2.589 0 CA-C-N 122.526 2.421 . . . . 0.0 111.939 165.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.07 -31.63 72.94 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 127.198 2.199 . . . . 0.0 116.279 -169.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -57.28 -32.61 66.8 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 166.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.62 -43.05 90.74 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 169.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 32.0 tp -64.22 -36.82 85.32 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 169.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 28.3 t-80 -60.26 -53.08 61.92 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 119.867 1.212 . . . . 0.0 113.042 169.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 1.243 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 35.6 mt-10 -49.01 -34.54 13.4 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 167.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 1.258 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 26.3 mmt -85.96 -30.56 22.68 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 118.182 2.66 . . . . 0.0 118.182 173.917 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 46.4 tp -67.48 -52.26 41.44 Favored 'General case' 0 N--CA 1.504 2.26 0 CA-C-N 121.281 1.855 . . . . 0.0 112.02 169.81 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -79.01 -51.37 9.68 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 123.512 0.725 . . . . 0.0 112.675 176.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 1.243 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 72.9 ttt180 -69.65 -44.94 69.53 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 176.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 1.258 ' HB3' ' O ' ' A' ' 99' ' ' MET . 72.0 ttt180 -59.8 -56.18 25.01 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 118.867 0.758 . . . . 0.0 110.953 164.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.27 43.78 1.05 Allowed Glycine 0 N--CA 1.48 1.588 0 O-C-N 124.282 0.989 . . . . 0.0 114.211 168.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 34.5 p -100.49 143.81 30.23 Favored 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 170.459 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -67.4 131.43 45.69 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -171.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 4.7 tp -82.91 103.19 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 C-N-CA 125.21 1.404 . . . . 0.0 108.257 175.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -97.95 -71.66 0.68 Allowed 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 114.925 -2.464 . . . . 0.0 108.237 168.049 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -144.96 125.5 14.06 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 122.852 2.569 . . . . 0.0 116.366 -174.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 69.2 t -92.3 109.14 21.06 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.626 0 N-CA-C 102.269 -3.234 . . . . 0.0 102.269 162.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.653 HD21 ' HB2' ' A' ' 160' ' ' LYS . 83.2 mt -102.18 107.04 17.98 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.083 0.553 . . . . 0.0 110.559 -173.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -99.3 122.15 42.05 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-O 122.387 1.089 . . . . 0.0 110.409 175.195 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -93.69 123.3 36.92 Favored 'General case' 0 CA--C 1.559 1.304 0 CA-C-N 113.661 -1.609 . . . . 0.0 108.709 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -82.68 98.27 8.96 Favored 'General case' 0 CA--C 1.555 1.163 0 CA-C-N 112.444 -2.162 . . . . 0.0 108.484 169.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.0 p -137.97 136.26 45.2 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.223 0 CA-C-N 112.977 -1.92 . . . . 0.0 107.187 -168.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 65.1 m -88.18 134.03 33.88 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 113.338 -1.756 . . . . 0.0 113.039 -169.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -63.94 -27.1 68.91 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 175.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -62.02 -30.36 70.9 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 115.691 1.737 . . . . 0.0 115.691 175.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -59.01 -51.19 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 177.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.8 tt -72.55 -39.74 67.26 Favored 'General case' 0 CA--C 1.569 1.693 0 CA-C-N 114.543 -1.208 . . . . 0.0 113.185 174.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.7 mp -58.31 -35.15 71.42 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 167.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -67.77 -43.06 80.67 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 119.387 0.994 . . . . 0.0 113.607 168.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -51.61 -49.78 61.51 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 168.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 10.7 mt -59.16 -60.72 3.42 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 114.525 1.305 . . . . 0.0 114.525 170.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.7 tmtp? -75.87 -56.9 4.23 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 -170.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -59.0 -33.55 74.68 Favored Glycine 0 CA--C 1.552 2.39 0 N-CA-C 119.16 2.424 . . . . 0.0 119.16 -175.838 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.77 -73.42 0.29 Allowed 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 118.965 1.382 . . . . 0.0 111.388 174.056 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.717 ' O ' ' HB2' ' A' ' 129' ' ' ARG . . . -162.0 -48.53 0.02 OUTLIER Glycine 0 CA--C 1.549 2.179 0 CA-C-O 118.194 -1.337 . . . . 0.0 115.519 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.717 ' HB2' ' O ' ' A' ' 128' ' ' GLY . 6.4 mmm180 108.41 101.35 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 119.721 1.76 . . . . 0.0 108.74 -174.898 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -98.25 30.92 2.95 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 178.704 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 47.58 55.41 8.41 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 116.862 2.171 . . . . 0.0 116.862 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -91.68 84.91 5.52 Favored 'General case' 0 N--CA 1.489 1.505 1 N-CA-C 97.279 -5.082 . . . . 0.0 97.279 156.972 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 6.8 t -61.24 138.35 58.23 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 116.718 2.118 . . . . 0.0 116.718 -155.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -48.58 -34.82 12.2 Favored 'General case' 0 CA--C 1.575 1.911 0 CA-C-N 111.509 -2.587 . . . . 0.0 117.271 172.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -67.43 -37.12 82.51 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 172.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.2 t -65.28 -35.94 76.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 CA-C-N 119.073 0.851 . . . . 0.0 113.113 168.012 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 2.2 mp -64.31 -40.83 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 CA-C-O 118.522 -0.752 . . . . 0.0 112.4 169.638 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . 0.4 ' O ' ' HG3' ' A' ' 142' ' ' LYS . 32.5 mt -63.9 -36.37 83.72 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 115.043 1.498 . . . . 0.0 115.043 169.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.418 ' HA ' ' HD3' ' A' ' 142' ' ' LYS . 7.5 t-20 -64.64 -39.95 94.59 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 169.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -63.05 -36.52 83.85 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 167.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 13.2 tpt -67.09 -29.77 69.62 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 114.671 1.359 . . . . 0.0 114.671 168.078 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.418 ' HD3' ' HA ' ' A' ' 139' ' ' ASN . 62.1 mtpt -62.77 -50.71 69.96 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 168.714 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 10.1 p -64.56 -34.72 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 170.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -54.95 -49.36 71.57 Favored 'General case' 0 CA--C 1.578 2.046 0 CA-C-N 119.662 1.119 . . . . 0.0 112.335 167.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -57.19 -39.44 75.38 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 118.9 2.926 . . . . 0.0 118.9 173.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -57.21 -34.4 68.49 Favored 'General case' 0 N--CA 1.506 2.365 0 N-CA-C 117.011 2.226 . . . . 0.0 117.011 178.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -131.1 -26.59 2.12 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 119.225 3.046 . . . . 0.0 119.225 -166.241 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 73.2 m -45.4 -32.84 2.28 Favored 'General case' 0 N--CA 1.508 2.452 0 CA-C-N 122.667 2.485 . . . . 0.0 117.425 -171.552 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.53 -62.38 3.04 Favored Pre-proline 0 CA--C 1.584 2.261 0 CA-C-O 115.682 -2.104 . . . . 0.0 112.067 169.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -56.46 -31.73 86.83 Favored 'Trans proline' 0 CA--C 1.578 2.685 0 N-CA-C 120.083 3.07 . . . . 0.0 120.083 169.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -62.78 -53.17 58.39 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 125.719 1.608 . . . . 0.0 111.03 169.516 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.99 ' O ' ' HB2' ' A' ' 156' ' ' ARG 0.306 0.1 OUTLIER -62.03 -24.94 67.36 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 175.872 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -71.29 -50.73 29.62 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 120.366 1.439 . . . . 0.0 113.137 166.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -64.5 -53.54 46.45 Favored 'General case' 0 CA--C 1.568 1.666 0 CA-C-N 120.416 1.462 . . . . 0.0 112.728 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -80.86 -24.66 38.21 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 115.209 -2.329 . . . . 0.0 113.724 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.99 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 14.9 tpt180 -64.37 -37.49 87.68 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 124.144 3.156 . . . . 0.0 115.175 169.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -67.16 -38.09 84.86 Favored 'General case' 0 CA--C 1.574 1.87 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 167.359 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -80.47 -29.7 37.45 Favored 'General case' 0 CA--C 1.578 2.028 0 N-CA-C 119.713 3.227 . . . . 0.0 119.713 177.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.5 pp -79.21 175.76 10.3 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 119.933 3.309 . . . . 0.0 119.933 -161.17 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.653 ' HB2' HD21 ' A' ' 111' ' ' LEU . 95.1 mttt -128.55 133.38 48.38 Favored 'General case' 0 CA--C 1.561 1.392 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 166.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 62.4 m -96.07 148.4 22.71 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 122.261 1.029 . . . . 0.0 110.818 -172.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.99 HG11 ' HB3' ' A' ' 174' ' ' ARG . 58.6 t -130.35 136.14 59.18 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.48 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 167.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.561 ' O ' ' HG3' ' A' ' 174' ' ' ARG . 10.0 t0 -95.07 129.05 42.31 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 168.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -163.43 120.9 1.86 Allowed 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.447 -162.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.9 t -149.32 130.23 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-O 118.419 -0.801 . . . . 0.0 109.075 175.382 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 78.52 -65.98 3.34 Favored Glycine 0 N--CA 1.484 1.845 0 N-CA-C 118.785 2.274 . . . . 0.0 118.785 167.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 40.9 p -70.34 149.95 46.83 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 112.068 -2.066 . . . . 0.0 113.072 -169.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 61.1 mtt -91.97 -60.17 1.92 Allowed 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 118.722 -0.656 . . . . 0.0 111.549 176.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -69.42 -38.67 77.97 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 -176.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -64.03 -47.98 78.11 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 119.505 1.048 . . . . 0.0 113.653 169.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 99.3 t -56.7 -38.04 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-N 119.746 1.157 . . . . 0.0 113.647 172.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -59.0 -35.96 74.12 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 116.619 2.081 . . . . 0.0 116.619 167.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -60.37 -48.31 82.32 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 170.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.99 ' HB3' HG11 ' A' ' 162' ' ' VAL . 1.4 mmp_? -50.3 -57.2 8.41 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 117.337 2.347 . . . . 0.0 117.337 168.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -49.92 -44.5 50.33 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 116.752 2.13 . . . . 0.0 116.752 172.673 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.5 mp -62.69 -43.11 99.63 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 117.515 -1.231 . . . . 0.0 114.013 168.181 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -53.35 -47.81 69.07 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 171.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -67.87 -45.03 75.71 Favored 'General case' 0 CA--C 1.559 1.303 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 175.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -81.11 -56.6 3.98 Favored 'General case' 0 CA--C 1.564 1.513 0 CA-C-N 120.063 1.301 . . . . 0.0 112.878 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.65 ' O ' ' CB ' ' A' ' 181' ' ' LYS . . . -101.36 -57.87 0.83 Allowed Glycine 0 CA--C 1.552 2.389 0 CA-C-O 117.803 -1.554 . . . . 0.0 114.836 -177.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.65 ' CB ' ' O ' ' A' ' 180' ' ' GLY . 36.5 ttmt . . . . . 0 C--O 1.251 1.157 0 CA-C-N 120.296 2.048 . . . . 0.0 107.579 -177.314 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.0 tpp . . . . . 0 CA--C 1.56 1.344 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.474 ' NH1' ' HA ' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -160.75 166.95 27.82 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 119.65 3.204 . . . . 0.0 119.65 -166.434 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.8 p -123.49 145.0 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 123.237 1.494 . . . . 0.0 113.462 -167.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.2 mt -120.85 114.12 21.13 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 112.123 -2.308 . . . . 0.0 106.27 172.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.3 tt -102.67 126.77 49.88 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.806 1.243 . . . . 0.0 111.014 -165.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.1 mt -139.29 164.23 30.39 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 114.527 -1.215 . . . . 0.0 112.431 -166.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 151.68 171.22 19.31 Favored Glycine 0 CA--C 1.558 2.752 0 CA-C-O 119.088 -0.84 . . . . 0.0 114.728 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.75 123.24 12.86 Favored 'Trans proline' 0 CA--C 1.573 2.47 0 C-N-CA 123.576 2.851 . . . . 0.0 113.013 170.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -81.45 104.44 1.49 Allowed 'Trans proline' 0 CA--C 1.56 1.775 0 C-N-CA 122.413 2.076 . . . . 0.0 114.911 -168.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -162.38 -93.43 0.09 OUTLIER Glycine 0 CA--C 1.534 1.233 0 N-CA-C 107.769 -2.132 . . . . 0.0 107.769 169.027 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.65 151.41 21.29 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 175.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.01 -168.86 35.91 Favored Glycine 0 CA--C 1.546 2.001 0 CA-C-N 115.729 -0.669 . . . . 0.0 114.556 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? 80.36 -82.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 174.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -48.01 -31.09 7.84 Favored Glycine 0 CA--C 1.556 2.618 0 N-CA-C 120.96 3.144 . . . . 0.0 120.96 175.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.3 m -66.45 -55.64 14.74 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 119.558 1.679 . . . . 0.0 113.136 176.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.273 10.9 mm-40 -76.86 -12.16 59.93 Favored 'General case' 0 CA--C 1.573 1.848 0 CA-C-O 116.235 -1.841 . . . . 0.0 111.858 172.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.33 -47.65 60.09 Favored 'General case' 0 C--N 1.372 1.554 0 CA-C-N 123.346 2.794 . . . . 0.0 114.387 167.695 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.5 t -66.95 -44.72 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 CA-C-O 117.742 -1.123 . . . . 0.0 111.201 173.346 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -59.33 -41.41 89.07 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 116.596 2.073 . . . . 0.0 116.596 171.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.7 tp -66.35 -33.71 76.33 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 119.721 1.146 . . . . 0.0 113.82 171.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.68 -39.03 89.96 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 167.702 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -63.03 -38.54 91.6 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 166.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 42.1 tptt -64.84 -53.87 39.94 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 175.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.6 mt -83.34 -27.19 29.89 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 116.956 2.206 . . . . 0.0 116.956 178.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.06 40.02 5.95 Favored Glycine 0 CA--C 1.555 2.569 0 N-CA-C 117.516 1.766 . . . . 0.0 117.516 -174.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.468 ' CG2' ' HA ' ' A' ' 81' ' ' PHE . 19.2 mm -110.06 160.34 28.56 Favored Pre-proline 0 CA--C 1.567 1.634 0 CA-C-N 118.853 1.326 . . . . 0.0 114.103 -168.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -74.37 103.53 1.71 Allowed 'Trans proline' 0 CA--C 1.565 2.027 0 C-N-CA 121.766 1.644 . . . . 0.0 112.776 159.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.3 tm0? -69.5 104.96 2.46 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 165.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 35.2 mm -100.83 107.68 21.7 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 177.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.0 t -95.59 129.92 42.62 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 168.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.4 p -67.17 -19.48 65.58 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 117.037 2.236 . . . . 0.0 117.037 -170.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -84.92 -16.49 65.21 Favored Glycine 0 CA--C 1.544 1.895 0 N-CA-C 119.079 2.392 . . . . 0.0 119.079 168.031 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -80.34 -55.62 4.77 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 119.529 1.664 . . . . 0.0 114.519 -168.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -59.36 -40.15 85.55 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 172.267 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.557 ' HB3' ' CB ' ' A' ' 50' ' ' LYS . 6.4 m-85 -60.44 -46.79 88.75 Favored 'General case' 0 CA--C 1.558 1.26 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 170.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -55.22 -42.28 73.17 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 168.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -59.94 -38.14 81.57 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 167.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -68.97 -23.62 64.14 Favored 'General case' 0 CA--C 1.581 2.168 0 N-CA-C 115.024 1.491 . . . . 0.0 115.024 167.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 53.9 mt -62.91 -49.6 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.522 0 CA-C-N 120.927 1.694 . . . . 0.0 109.871 166.303 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -60.85 -40.34 92.51 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 176.072 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -67.19 -41.76 85.32 Favored 'General case' 0 CA--C 1.562 1.427 0 N-CA-C 116.268 1.951 . . . . 0.0 116.268 173.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.77 70.0 0.99 Allowed Glycine 0 CA--C 1.544 1.872 0 CA-C-O 118.349 -1.25 . . . . 0.0 114.425 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.776 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 68.5 p -94.0 -50.79 5.15 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 118.837 1.319 . . . . 0.0 114.407 178.032 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.776 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.251 37.6 mttp 106.24 -41.42 0.0 OUTLIER 'General case' 0 CA--C 1.571 1.755 0 CA-C-O 116.428 -1.749 . . . . 0.0 111.514 -172.234 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.98 -14.02 56.62 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 122.972 2.623 . . . . 0.0 113.013 163.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.23 -57.56 19.08 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 120.318 1.417 . . . . 0.0 114.494 170.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.304 4.2 p -75.52 -51.96 19.55 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.353 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -169.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -68.73 -44.07 74.58 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 120.703 1.592 . . . . 0.0 112.84 176.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.74 -29.16 62.07 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 117.267 -1.349 . . . . 0.0 114.282 -178.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.557 ' CB ' ' HB3' ' A' ' 35' ' ' PHE 0.273 0.0 OUTLIER -77.77 -33.94 52.55 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 117.084 -1.436 . . . . 0.0 113.689 169.832 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.55 ' O ' ' HG2' ' A' ' 51' ' ' ARG . 29.1 ttt180 -76.06 -47.1 25.97 Favored 'General case' 0 CA--C 1.584 2.27 1 CA-C-O 84.928 -16.749 . . . . 0.0 118.477 -179.075 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -35.35 -56.71 0.62 Allowed 'General case' 0 N--CA 1.494 1.748 1 O-C-N 107.542 -9.474 . . . . 0.0 120.383 145.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 49.2 mt -54.33 -35.85 63.13 Favored 'General case' 0 N--CA 1.511 2.587 0 CA-C-N 123.869 3.031 . . . . 0.0 115.023 167.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -86.96 -42.17 13.35 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 116.139 1.904 . . . . 0.0 116.139 172.805 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.26 -42.79 54.24 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 1.057 ' HA2' HH12 ' A' ' 88' ' ' ARG . . . 107.61 40.99 1.66 Allowed Glycine 0 CA--C 1.537 1.463 0 N-CA-C 116.466 1.346 . . . . 0.0 116.466 168.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -118.75 -164.53 1.04 Allowed 'General case' 0 CA--C 1.569 1.692 0 C-N-CA 124.052 0.941 . . . . 0.0 111.076 168.049 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.5 mt -80.22 108.16 13.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.342 -0.849 . . . . 0.0 112.257 -169.273 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 p -103.57 132.3 21.2 Favored Pre-proline 0 CA--C 1.571 1.761 0 C-N-CA 124.708 1.203 . . . . 0.0 110.002 175.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -60.18 145.87 97.56 Favored 'Trans proline' 0 CA--C 1.558 1.724 0 C-N-CA 123.367 2.711 . . . . 0.0 116.238 171.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 73.7 m -82.8 178.64 8.08 Favored 'General case' 0 CA--C 1.571 1.767 0 CA-C-O 121.623 0.725 . . . . 0.0 111.591 170.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.0 t70 83.05 -52.81 0.17 Allowed 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 125.926 1.691 . . . . 0.0 113.583 176.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.9 pp -57.85 -42.35 84.26 Favored 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 116.547 2.055 . . . . 0.0 116.547 168.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.0 m -59.34 -49.5 77.57 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 124.354 1.062 . . . . 0.0 113.651 171.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -64.73 -21.04 66.66 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 167.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -77.67 -44.35 28.33 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 173.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.6 mt -66.37 -44.66 82.54 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 169.564 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 56.1 t -56.5 -52.53 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.954 170.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -63.57 -28.35 69.87 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 116.615 2.08 . . . . 0.0 116.615 173.177 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -60.44 -42.0 95.18 Favored 'General case' 0 CA--C 1.563 1.46 0 CA-C-O 117.743 -1.123 . . . . 0.0 113.081 168.461 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -81.31 -21.41 39.27 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 119.044 2.979 . . . . 0.0 119.044 168.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 88.4 mt -84.71 -20.08 31.74 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 117.156 2.28 . . . . 0.0 117.156 176.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -70.0 9.02 0.61 Allowed 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 169.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -68.94 139.55 90.71 Favored Pre-proline 0 CA--C 1.575 1.906 0 CA-C-O 118.016 -0.992 . . . . 0.0 108.776 164.497 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -55.03 -33.04 81.87 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 N-CA-C 119.395 2.806 . . . . 0.0 119.395 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -66.92 -12.73 60.42 Favored 'General case' 0 CA--C 1.569 1.677 0 CA-C-O 116.517 -1.706 . . . . 0.0 115.47 170.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -107.11 18.87 21.18 Favored 'General case' 0 CA--C 1.574 1.896 0 CA-C-N 122.197 2.271 . . . . 0.0 114.437 168.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.57 -42.48 82.49 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 121.248 1.84 . . . . 0.0 115.16 174.416 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . 0.474 ' HA ' ' NH1' ' A' ' 2' ' ' ARG . 25.3 m120 -111.02 38.01 2.65 Favored 'General case' 0 CA--C 1.58 2.101 0 C-N-CA 123.696 0.798 . . . . 0.0 111.504 168.878 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -172.32 160.23 31.51 Favored Glycine 0 C--N 1.364 2.127 0 CA-C-N 121.897 2.135 . . . . 0.0 114.493 169.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.468 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . 14.5 p90 -175.52 133.83 0.3 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 113.674 -1.263 . . . . 0.0 109.946 169.709 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.9 mm -102.45 106.21 19.49 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.736 0 N-CA-C 102.84 -3.022 . . . . 0.0 102.84 167.383 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.2 mt -103.22 134.5 46.53 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 123.728 0.811 . . . . 0.0 108.812 174.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -133.52 119.64 19.78 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 118.987 0.812 . . . . 0.0 111.099 -167.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 77.56 41.17 20.88 Favored Glycine 0 CA--C 1.55 2.223 0 CA-C-O 117.418 -1.768 . . . . 0.0 116.96 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . 0.275 0.9 OUTLIER -104.68 -66.84 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.833 0 CA-C-O 113.202 -3.285 . . . . 0.0 110.433 -175.375 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -63.13 60.38 0.17 Allowed 'Trans proline' 0 CA--C 1.57 2.311 0 CA-C-N 127.169 3.596 . . . . 0.0 121.212 170.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 1.057 HH12 ' HA2' ' A' ' 56' ' ' GLY . 16.4 ptt85 -62.79 -25.75 68.39 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 117.48 2.4 . . . . 0.0 117.48 167.129 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.41 ' HB2' ' HG3' ' A' ' 147' ' ' GLU . 77.9 p -151.18 138.99 19.83 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 125.824 1.65 . . . . 0.0 107.045 -167.369 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -55.95 -33.37 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-N 121.283 1.856 . . . . 0.0 113.462 172.82 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -61.92 -39.13 90.98 Favored 'General case' 0 C--N 1.362 1.115 0 N-CA-C 120.669 3.581 . . . . 0.0 120.669 172.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -74.87 -46.98 32.64 Favored 'General case' 0 CA--C 1.586 2.351 0 CA-C-N 123.51 2.868 . . . . 0.0 111.847 165.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.11 -29.96 68.95 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 118.412 2.745 . . . . 0.0 118.412 -175.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -58.65 -34.86 71.68 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 168.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.75 -42.71 90.6 Favored 'General case' 0 CA--C 1.566 1.592 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 170.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 26.6 tp -68.0 -33.93 75.56 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 171.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -63.12 -52.85 60.93 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 119.957 1.253 . . . . 0.0 112.816 169.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.97 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 35.6 mt-10 -47.05 -39.39 12.77 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 166.484 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.833 ' O ' ' HB2' ' A' ' 103' ' ' ARG . 1.7 tpt -83.12 -24.85 32.44 Favored 'General case' 0 CA--C 1.569 1.686 0 N-CA-C 117.756 2.502 . . . . 0.0 117.756 176.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.0 tt -73.8 -49.58 24.58 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-N 120.183 1.356 . . . . 0.0 111.68 171.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -74.78 -54.29 7.61 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 172.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.97 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 92.6 mtt180 -69.82 -40.23 76.04 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 177.927 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.833 ' HB2' ' O ' ' A' ' 99' ' ' MET . 6.9 ttt-85 -65.31 -53.6 41.54 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 119.831 1.196 . . . . 0.0 111.722 164.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 108.26 50.36 0.77 Allowed Glycine 0 N--CA 1.483 1.798 0 O-C-N 123.81 0.694 . . . . 0.0 114.096 167.475 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 68.5 p -88.96 146.2 25.04 Favored 'General case' 0 CA--C 1.558 1.285 0 CA-C-N 113.205 -1.498 . . . . 0.0 109.9 175.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -66.32 132.69 48.94 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.77 -0.581 . . . . 0.0 112.053 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 7.1 tp -95.26 100.74 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -175.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -94.27 -66.92 0.88 Allowed 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 117.074 -1.441 . . . . 0.0 108.847 168.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -153.91 123.11 6.49 Favored 'General case' 0 C--N 1.358 0.965 0 CA-C-N 120.605 1.548 . . . . 0.0 113.246 -169.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.3 t -91.8 109.07 20.8 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.583 0 N-CA-C 100.312 -3.958 . . . . 0.0 100.312 162.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.426 ' HA ' ' O ' ' A' ' 160' ' ' LYS 0.252 37.7 tp -112.97 104.07 12.03 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 114.957 -1.019 . . . . 0.0 112.369 -159.483 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -99.56 134.31 42.62 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-O 122.071 0.939 . . . . 0.0 110.987 -176.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -94.76 122.17 37.09 Favored 'General case' 0 CA--C 1.561 1.386 0 CA-C-O 122.903 1.335 . . . . 0.0 110.722 -173.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -85.62 95.05 9.22 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 113.018 -1.901 . . . . 0.0 109.637 169.319 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.1 p -133.92 132.34 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 125.725 1.61 . . . . 0.0 107.226 -169.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 44.3 t -80.23 147.12 31.37 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 114.465 -1.243 . . . . 0.0 112.432 -169.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -59.59 -27.6 66.43 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 116.895 2.183 . . . . 0.0 116.895 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -63.02 -42.37 99.79 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 171.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.6 t -63.57 -48.1 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 CA-C-N 120.311 1.414 . . . . 0.0 113.515 -177.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.0 pp -60.32 -37.61 81.13 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 169.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.0 mp -58.46 -41.62 85.58 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 167.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -56.35 -49.29 74.79 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 170.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 55.6 ttm-85 -55.13 -47.89 74.42 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 116.335 1.976 . . . . 0.0 116.335 171.426 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -59.49 -45.11 92.62 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 169.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -59.74 -38.92 83.06 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 117.423 2.379 . . . . 0.0 117.423 175.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.511 ' O ' ' HB2' ' A' ' 127' ' ' ARG . . . -80.65 24.3 3.82 Favored Glycine 0 CA--C 1.556 2.633 0 N-CA-C 118.639 2.215 . . . . 0.0 118.639 171.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.511 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 98.7 mtt180 80.59 -148.24 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 169.679 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.422 ' H ' ' HB3' ' A' ' 127' ' ' ARG . . . 154.85 -51.67 0.46 Allowed Glycine 0 CA--C 1.552 2.355 0 CA-C-N 112.972 -1.922 . . . . 0.0 113.807 -173.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -155.99 -101.57 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 119.562 1.681 . . . . 0.0 107.679 175.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -148.24 -45.07 0.16 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 116.99 -1.481 . . . . 0.0 112.529 170.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -136.28 61.49 1.64 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-N 121.868 2.122 . . . . 0.0 112.078 174.036 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -116.72 62.53 0.72 Allowed 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 102.5 -3.148 . . . . 0.0 102.5 158.681 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 82.6 p -138.29 -114.97 0.16 Allowed 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 113.916 -1.493 . . . . 0.0 110.183 -160.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -59.24 -43.14 92.4 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 116.695 2.109 . . . . 0.0 116.695 -169.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -73.63 -38.27 65.09 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 177.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 20.4 t -64.25 -39.87 87.06 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.508 0 CA-C-O 117.317 -1.325 . . . . 0.0 112.124 170.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 8.3 tp -75.32 -25.6 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 CA-C-N 120.463 1.483 . . . . 0.0 114.333 173.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 30.0 mt -67.63 -46.67 71.8 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 120.92 1.691 . . . . 0.0 113.676 169.115 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -68.99 -34.55 75.47 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 172.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 69.2 mtp180 -60.43 -40.66 91.88 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 167.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 25.8 ttt -65.7 -32.68 74.37 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 168.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -60.25 -50.04 75.22 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 169.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.0 p -65.57 -32.97 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 169.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -55.52 -53.44 56.37 Favored 'General case' 0 CA--C 1.58 2.112 0 CA-C-N 119.495 1.043 . . . . 0.0 111.716 169.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -62.96 -42.09 99.72 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 118.063 2.616 . . . . 0.0 118.063 175.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.26 -44.53 61.8 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 116.975 2.213 . . . . 0.0 116.975 174.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.41 ' HG3' ' HB2' ' A' ' 89' ' ' SER . 8.9 mm-40 -124.08 -30.43 3.48 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 118.54 2.792 . . . . 0.0 118.54 -166.611 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 63.7 m -55.07 -34.86 63.95 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 117.387 2.365 . . . . 0.0 117.387 -167.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -65.15 -60.4 7.98 Favored Pre-proline 0 CA--C 1.579 2.085 0 CA-C-O 116.305 -1.807 . . . . 0.0 111.751 171.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -51.59 -32.24 43.48 Favored 'Trans proline' 0 CA--C 1.579 2.754 0 C-N-CA 123.394 2.729 . . . . 0.0 118.549 166.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -66.77 -51.94 50.02 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 125.083 1.353 . . . . 0.0 111.305 175.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 1.219 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 38.2 tp -62.43 -22.04 65.87 Favored 'General case' 0 CA--C 1.571 1.752 0 N-CA-C 115.718 1.747 . . . . 0.0 115.718 170.65 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -70.82 -50.2 38.08 Favored 'General case' 0 CA--C 1.56 1.332 0 CA-C-N 122.681 2.491 . . . . 0.0 112.463 165.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -61.13 -56.48 20.37 Favored 'General case' 0 CA--C 1.574 1.895 0 CA-C-N 119.931 1.241 . . . . 0.0 113.488 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -77.75 -15.16 59.32 Favored 'General case' 0 CA--C 1.562 1.429 0 CA-C-O 116.647 -1.644 . . . . 0.0 114.268 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 1.219 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 0.1 OUTLIER -68.85 -40.3 79.46 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 121.723 2.056 . . . . 0.0 114.871 166.023 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -65.76 -38.97 90.54 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 167.424 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -75.47 -18.94 59.72 Favored 'General case' 0 CA--C 1.585 2.305 0 N-CA-C 118.386 2.735 . . . . 0.0 118.386 169.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.7 mt -39.26 143.04 0.21 Allowed 'General case' 0 CA--C 1.58 2.101 1 N-CA-C 123.741 4.719 . . . . 0.0 123.741 -164.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 111' ' ' LEU . 28.4 mttm -136.08 121.74 19.65 Favored 'General case' 0 CA--C 1.56 1.332 0 N-CA-C 103.435 -2.802 . . . . 0.0 103.435 160.187 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.0 t -103.76 156.42 17.83 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.531 -1.356 . . . . 0.0 113.126 -172.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 34.7 t -124.35 142.47 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 169.517 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -98.76 127.71 44.77 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 165.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.74 92.67 1.68 Allowed 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 122.68 1.229 . . . . 0.0 112.155 -163.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.2 t -150.7 125.73 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 CA-C-N 113.927 -1.488 . . . . 0.0 107.178 -175.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 79.01 -72.46 2.46 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 118.349 2.1 . . . . 0.0 118.349 168.337 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 40.8 p -79.09 144.14 34.86 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 112.124 -2.038 . . . . 0.0 112.371 -169.092 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.98 -46.22 6.29 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 178.181 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -72.73 -42.02 64.54 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 177.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -62.56 -49.98 73.14 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 117.855 -1.069 . . . . 0.0 113.602 170.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 97.7 t -60.41 -36.05 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 CA-C-N 120.029 1.286 . . . . 0.0 114.014 177.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -59.31 -38.21 79.68 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 166.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.07 -44.62 91.85 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 174.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -62.7 -40.6 97.66 Favored 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 116.512 2.042 . . . . 0.0 116.512 170.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.68 -42.98 94.12 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 169.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 4.9 mp -59.61 -42.61 93.0 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 167.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.586 ' HA ' ' HB3' ' A' ' 181' ' ' LYS . 45.1 mtt180 -55.41 -42.18 73.76 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 116.827 2.158 . . . . 0.0 116.827 169.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.91 -48.18 80.05 Favored 'General case' 0 CA--C 1.561 1.386 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 170.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.7 tt -83.08 -57.49 3.26 Favored 'General case' 0 CA--C 1.567 1.596 0 CA-C-N 120.778 1.627 . . . . 0.0 113.117 -178.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -104.6 -52.4 0.86 Allowed Glycine 0 CA--C 1.547 2.073 0 CA-C-O 117.456 -1.747 . . . . 0.0 114.64 -173.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.586 ' HB3' ' HA ' ' A' ' 177' ' ' ARG . 86.4 tttt . . . . . 0 C--O 1.251 1.184 0 CA-C-N 120.564 2.182 . . . . 0.0 112.735 -176.149 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.0 mtt . . . . . 0 CA--C 1.558 1.283 0 CA-C-O 123.095 1.426 . . . . 0.0 111.652 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.5 ttm-85 -141.39 149.46 41.12 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 116.736 2.125 . . . . 0.0 116.736 -161.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.7 p -143.84 146.16 21.25 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.861 0 CA-C-O 123.793 1.759 . . . . 0.0 114.797 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -131.86 111.57 11.7 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 112.417 -2.174 . . . . 0.0 108.009 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 14.5 tp -98.32 131.46 44.61 Favored 'General case' 0 CA--C 1.571 1.75 0 CA-C-O 122.706 1.241 . . . . 0.0 112.314 -167.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.7 mt -138.99 163.19 33.02 Favored 'General case' 0 CA--C 1.563 1.454 0 C-N-CA 127.607 2.363 . . . . 0.0 110.782 -166.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 141.89 129.22 2.41 Favored Glycine 0 CA--C 1.553 2.439 0 CA-C-O 116.975 -2.014 . . . . 0.0 111.657 -174.348 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -51.42 143.59 34.53 Favored 'Trans proline' 0 CA--C 1.573 2.429 0 CA-C-N 122.838 3.319 . . . . 0.0 116.024 172.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -54.45 106.81 0.18 Allowed 'Trans proline' 0 CA--C 1.56 1.796 0 C-N-CA 123.471 2.781 . . . . 0.0 116.75 -169.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.72 73.76 0.08 OUTLIER Glycine 0 N--CA 1.479 1.545 0 CA-C-O 119.65 -0.528 . . . . 0.0 114.393 -169.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 39.88 76.59 0.06 Allowed 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 117.468 2.396 . . . . 0.0 117.468 170.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.428 ' O ' ' HG3' ' A' ' 13' ' ' LYS . . . 156.28 107.54 0.27 Allowed Glycine 0 N--CA 1.479 1.536 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -176.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.428 ' HG3' ' O ' ' A' ' 12' ' ' GLY . 19.7 mttt 164.44 -92.29 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.851 0.325 . . . . 0.0 110.351 -172.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -50.81 -41.21 43.47 Favored Glycine 0 CA--C 1.558 2.72 0 N-CA-C 119.01 2.364 . . . . 0.0 119.01 175.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.405 ' O ' ' HG2' ' A' ' 19' ' ' LYS . 85.5 m -58.82 -44.29 90.83 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 169.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . 0.583 ' HA ' ' HB2' ' A' ' 19' ' ' LYS 0.264 5.1 mm-40 -78.98 -14.05 59.43 Favored 'General case' 0 CA--C 1.576 1.958 0 CA-C-O 116.571 -1.68 . . . . 0.0 112.32 173.536 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.68 -45.22 62.58 Favored 'General case' 0 C--N 1.371 1.531 0 CA-C-N 123.062 2.665 . . . . 0.0 113.597 167.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 p -65.15 -41.53 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 169.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.696 ' HB3' ' CE1' ' A' ' 172' ' ' PHE . 31.1 mmtp -54.72 -42.13 71.16 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 116.11 1.892 . . . . 0.0 116.11 168.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 1.074 ' HA ' ' HB3' ' A' ' 23' ' ' LYS . 22.0 mt -68.67 -30.87 69.65 Favored 'General case' 0 CA--C 1.595 2.676 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 168.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.12 -29.58 70.7 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 118.394 -2.692 . . . . 0.0 115.707 167.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -64.06 -51.44 64.09 Favored 'General case' 0 CA--C 1.596 2.726 0 CA-C-N 120.324 1.42 . . . . 0.0 110.899 156.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 1.074 ' HB3' ' HA ' ' A' ' 20' ' ' LEU 0.29 4.5 tppt? -53.26 51.93 0.0 OUTLIER 'General case' 0 CA--C 1.576 1.944 2 C-N-CA 133.45 4.7 . . . . 0.0 122.424 166.647 . . . . . . . . 4 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 67.84 25.19 7.94 Favored 'General case' 0 N--CA 1.522 3.13 2 C-N-CA 144.854 9.262 . . . . 0.0 134.891 -152.331 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.44 29.98 28.73 Favored Glycine 0 N--CA 1.506 3.323 0 O-C-N 117.458 -3.276 . . . . 0.0 120.468 157.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 25.6 mm -90.25 149.23 40.88 Favored Pre-proline 0 CA--C 1.556 1.178 0 CA-C-N 112.381 -1.91 . . . . 0.0 110.969 -168.172 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -77.7 91.66 1.17 Allowed 'Trans proline' 0 CA--C 1.561 1.86 0 CA-C-N 122.082 1.779 . . . . 0.0 111.497 168.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.13 108.85 3.28 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.576 175.154 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 22.5 mm -105.65 114.94 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 82.8 p -96.25 132.36 41.78 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 169.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.7 p -68.37 -16.55 63.97 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 117.136 2.272 . . . . 0.0 117.136 -173.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -84.67 -19.83 59.24 Favored Glycine 0 CA--C 1.547 2.053 0 N-CA-C 118.736 2.254 . . . . 0.0 118.736 167.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -81.13 -49.67 10.56 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -169.174 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -65.4 -39.49 92.27 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 173.886 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.6 ' HB3' ' CB ' ' A' ' 50' ' ' LYS . 32.8 m-85 -64.59 -40.98 96.49 Favored 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 115.027 1.492 . . . . 0.0 115.027 169.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -57.28 -41.81 80.44 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 167.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.3 ttt180 -61.62 -37.98 85.97 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 168.89 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -68.09 -30.2 69.33 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 168.307 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 64.9 mt -62.75 -44.74 99.73 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 C-N-CA 124.893 1.277 . . . . 0.0 112.085 168.38 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -65.05 -42.09 94.58 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 173.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -76.31 -30.93 57.92 Favored 'General case' 0 CA--C 1.563 1.448 0 N-CA-C 116.784 2.142 . . . . 0.0 116.784 178.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.38 71.99 1.28 Allowed Glycine 0 CA--C 1.543 1.833 0 CA-C-O 118.083 -1.399 . . . . 0.0 115.282 178.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.773 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 70.8 p -93.69 -47.77 6.64 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 119.036 1.418 . . . . 0.0 114.571 174.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.773 ' HB2' ' O ' ' A' ' 43' ' ' THR . 74.8 mttt 103.62 -40.53 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.754 0 CA-C-O 116.247 -1.835 . . . . 0.0 111.527 -171.316 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.05 -12.33 58.33 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 123.053 2.66 . . . . 0.0 112.752 163.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.95 -56.07 23.0 Favored Glycine 0 C--N 1.353 1.525 0 CA-C-N 120.852 1.66 . . . . 0.0 114.743 170.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.286 7.1 p -74.57 -50.09 27.94 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.416 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 -169.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -66.49 -44.54 82.35 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 120.303 1.41 . . . . 0.0 112.691 174.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.34 -29.41 63.78 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 114.976 1.472 . . . . 0.0 114.976 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.6 ' CB ' ' HB3' ' A' ' 35' ' ' PHE 0.294 0.6 OUTLIER -75.34 -35.15 61.23 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 116.717 -1.611 . . . . 0.0 112.08 168.011 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.487 ' CG ' ' O ' ' A' ' 51' ' ' ARG . 18.8 ttt180 -74.2 -52.82 11.28 Favored 'General case' 0 CA--C 1.591 2.557 1 CA-C-O 87.026 -15.749 . . . . 0.0 118.197 -176.447 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 12.6 m-30 -26.28 -69.12 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.975 1 O-C-N 109.59 -8.193 . . . . 0.0 119.146 144.03 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 29.5 tp -54.12 -33.44 57.81 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 116.429 2.011 . . . . 0.0 116.429 175.253 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -91.56 -44.13 9.25 Favored 'General case' 0 CA--C 1.564 1.499 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 169.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -155.21 44.41 0.48 Allowed 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -166.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.54 50.44 0.32 Allowed Glycine 0 C--N 1.355 1.599 0 CA-C-N 121.628 2.013 . . . . 0.0 114.636 169.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . 0.294 5.6 t70 72.49 -112.94 0.05 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.608 1.163 . . . . 0.0 110.4 167.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.6 pp -105.8 144.35 32.66 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 122.691 1.234 . . . . 0.0 113.232 -169.512 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 p -129.76 140.27 38.13 Favored Pre-proline 0 CA--C 1.575 1.93 0 CA-C-N 113.307 -1.769 . . . . 0.0 109.139 -177.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -55.87 136.96 77.21 Favored 'Trans proline' 0 CA--C 1.56 1.805 0 C-N-CA 123.629 2.886 . . . . 0.0 116.679 173.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 98.6 p -72.42 -48.6 39.94 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 -178.32 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -62.38 -38.74 90.76 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 -178.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 17.3 mt -58.79 -48.2 82.09 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 172.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.0 m -61.36 -48.14 82.65 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 113.647 -1.615 . . . . 0.0 113.312 176.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -65.22 -22.04 66.83 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 168.518 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -73.03 -42.95 62.61 Favored 'General case' 0 CA--C 1.557 1.242 0 CA-C-N 120.975 1.716 . . . . 0.0 115.443 169.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.7 mt -61.31 -47.24 86.85 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 168.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -57.35 -49.87 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 172.393 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -60.71 -37.67 82.49 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 171.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -56.87 -43.78 81.56 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 117.818 -1.087 . . . . 0.0 113.643 170.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -81.4 -10.4 59.53 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 118.891 2.923 . . . . 0.0 118.891 168.038 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 87.7 mt -94.27 -8.71 38.32 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 116.669 2.1 . . . . 0.0 116.669 171.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -66.06 8.07 0.24 Allowed 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 117.863 2.542 . . . . 0.0 117.863 172.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -71.56 143.74 87.91 Favored Pre-proline 0 CA--C 1.579 2.078 0 C-N-CA 124.511 1.124 . . . . 0.0 109.357 164.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -56.6 -27.56 70.34 Favored 'Trans proline' 0 N--CA 1.504 2.113 0 N-CA-C 120.537 3.245 . . . . 0.0 120.537 176.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -63.71 -14.2 50.15 Favored 'General case' 0 CA--C 1.579 2.071 0 CA-C-O 116.689 -1.624 . . . . 0.0 114.739 169.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.45 -20.38 61.41 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 122.804 2.547 . . . . 0.0 115.954 168.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.66 -38.38 87.52 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 169.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -86.12 -7.05 58.86 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 117.281 2.326 . . . . 0.0 117.281 172.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.35 -178.38 43.74 Favored Glycine 0 CA--C 1.539 1.593 0 CA-C-N 121.406 1.912 . . . . 0.0 113.944 -175.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.4 p90 179.58 142.0 0.13 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 112.948 -1.626 . . . . 0.0 108.145 169.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 9.8 mt -110.11 108.79 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 103.301 -2.852 . . . . 0.0 103.301 169.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 44.6 mt -110.7 120.59 42.89 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 173.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -111.45 128.16 55.91 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 118.917 0.78 . . . . 0.0 110.779 -175.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 75.12 34.47 51.9 Favored Glycine 0 CA--C 1.553 2.413 0 N-CA-C 118.901 2.32 . . . . 0.0 118.901 176.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . 0.254 0.8 OUTLIER -93.37 -62.62 0.17 Allowed Pre-proline 0 CA--C 1.571 1.775 0 CA-C-O 114.126 -2.845 . . . . 0.0 109.538 175.519 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -63.6 56.99 0.19 Allowed 'Trans proline' 0 CA--C 1.57 2.309 0 N-CA-C 121.129 3.473 . . . . 0.0 121.129 169.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.25 -5.04 50.75 Favored 'General case' 0 CA--C 1.57 1.75 0 N-CA-C 117.057 2.243 . . . . 0.0 117.057 168.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.6 t -161.22 139.9 9.87 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 -171.513 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -58.33 -37.84 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-N 120.157 1.344 . . . . 0.0 112.778 -178.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.473 ' HB2' ' OE2' ' A' ' 147' ' ' GLU . 0.1 OUTLIER -65.6 -30.83 71.61 Favored 'General case' 0 C--N 1.36 1.035 0 N-CA-C 119.68 3.215 . . . . 0.0 119.68 175.825 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -80.43 -44.79 18.7 Favored 'General case' 0 CA--C 1.585 2.316 0 CA-C-N 122.008 2.185 . . . . 0.0 112.497 166.257 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.16 -35.0 72.75 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 118.428 2.751 . . . . 0.0 118.428 -176.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -58.66 -30.63 67.49 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 116.523 2.045 . . . . 0.0 116.523 169.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.51 -43.41 69.71 Favored 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 169.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.4 tp -67.89 -35.75 79.05 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 171.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 -58.58 -54.3 48.66 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 119.672 1.124 . . . . 0.0 112.809 168.66 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 1.174 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 32.3 tt0 -49.55 -32.81 13.28 Favored 'General case' 0 CA--C 1.575 1.906 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 166.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 1.085 ' O ' ' HB2' ' A' ' 103' ' ' ARG . 1.8 tpt -83.98 -40.54 18.33 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 117.619 2.452 . . . . 0.0 117.619 178.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.505 ' HA ' ' HG1' ' A' ' 105' ' ' THR . 0.1 OUTLIER -72.23 -45.21 61.2 Favored 'General case' 0 N--CA 1.505 2.317 0 CA-C-N 120.559 1.527 . . . . 0.0 112.504 172.525 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -76.93 -49.14 16.25 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 174.2 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 1.174 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 72.7 ttt180 -69.61 -43.57 72.46 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 177.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 1.085 ' HB2' ' O ' ' A' ' 99' ' ' MET . 42.5 mtp180 -63.88 -56.32 16.18 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 119.009 0.822 . . . . 0.0 111.895 165.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.02 48.75 0.76 Allowed Glycine 0 N--CA 1.48 1.592 0 O-C-N 124.049 0.843 . . . . 0.0 113.554 169.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.505 ' HG1' ' HA ' ' A' ' 100' ' ' LEU . 82.3 p -82.47 160.09 22.76 Favored 'General case' 0 CA--C 1.562 1.436 0 CA-C-N 113.909 -1.145 . . . . 0.0 110.019 169.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -69.38 128.16 35.58 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.827 -1.17 . . . . 0.0 110.356 -172.671 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 4.6 tp -94.57 93.56 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -177.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -98.44 -70.95 0.71 Allowed 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 116.043 -1.932 . . . . 0.0 109.176 168.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -151.83 133.93 15.09 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 121.698 2.044 . . . . 0.0 116.102 -168.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -92.35 122.08 43.5 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.163 0 N-CA-C 100.306 -3.961 . . . . 0.0 100.306 160.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.475 ' HA ' ' O ' ' A' ' 160' ' ' LYS . 44.0 mt -96.91 109.93 22.55 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 115.526 -2.178 . . . . 0.0 110.429 -176.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.439 ' N ' ' HB ' ' A' ' 161' ' ' THR . 9.5 tm-20 -101.46 113.75 27.14 Favored 'General case' 0 N--CA 1.536 3.831 0 N-CA-C 120.573 3.546 . . . . 0.0 120.573 170.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -86.04 114.63 23.07 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 119.268 -2.145 . . . . 0.0 110.815 170.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 79.4 ttt180 -106.18 110.26 22.45 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.39 169.343 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . 0.333 1.0 OUTLIER -179.0 146.41 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.332 0 CA-C-O 124.075 1.893 . . . . 0.0 108.836 160.021 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . 0.374 75.1 m 56.5 -79.98 0.01 OUTLIER 'General case' 0 CA--C 1.568 1.673 1 N-CA-C 123.223 4.527 . . . . 0.0 123.223 174.391 . . . . . . . . 3 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 78.02 -34.55 0.19 Allowed 'General case' 0 CA--C 1.566 1.563 0 C-N-CA 126.684 1.994 . . . . 0.0 116.019 -166.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -63.37 -31.43 72.58 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 115.359 1.614 . . . . 0.0 115.359 176.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.5 t -52.61 -50.68 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 C-N-CA 125.231 1.413 . . . . 0.0 114.398 173.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 39.8 tp -64.9 -38.75 92.0 Favored 'General case' 0 CA--C 1.561 1.384 0 C-N-CA 124.179 0.991 . . . . 0.0 113.658 168.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 46.8 mt -57.86 -34.23 69.52 Favored 'General case' 0 N--CA 1.508 2.444 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 168.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -63.81 -49.79 71.52 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 124.526 1.131 . . . . 0.0 113.825 168.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 -51.64 -53.44 38.67 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 170.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.0 mt -56.42 -45.67 80.58 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 115.927 1.825 . . . . 0.0 115.927 170.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -60.96 -44.24 97.6 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 117.318 2.34 . . . . 0.0 117.318 175.302 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.723 ' O ' ' HB2' ' A' ' 127' ' ' ARG . . . -95.9 57.74 1.53 Allowed Glycine 0 CA--C 1.544 1.899 0 CA-C-N 118.473 0.579 . . . . 0.0 113.874 170.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.723 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 89.6 mtt180 92.71 91.58 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.582 0.753 . . . . 0.0 111.768 175.274 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -97.05 -57.24 1.09 Allowed Glycine 0 CA--C 1.55 2.27 0 CA-C-O 117.452 -1.749 . . . . 0.0 114.489 176.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 48.9 mtm180 -156.23 -118.11 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 120.36 2.08 . . . . 0.0 109.568 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -145.79 62.37 1.26 Allowed 'General case' 0 CA--C 1.574 1.896 0 C-N-CA 123.715 0.806 . . . . 0.0 109.935 -174.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 65.49 2.43 2.01 Favored 'General case' 0 N--CA 1.511 2.59 0 N-CA-C 119.27 3.063 . . . . 0.0 119.27 -176.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -92.05 62.73 4.27 Favored 'General case' 0 CA--C 1.581 2.139 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 159.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 80.8 p -135.26 -110.08 0.21 Allowed 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 114.33 -1.305 . . . . 0.0 110.722 -162.381 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -53.2 -41.35 65.2 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 117.028 2.233 . . . . 0.0 117.028 -170.571 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -67.6 -40.06 84.75 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 172.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.735 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 17.0 t -63.85 -31.14 51.99 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.816 0 C-N-CA 125.317 1.447 . . . . 0.0 114.395 168.779 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.654 ' O ' ' HB3' ' A' ' 140' ' ' ARG . 1.7 mp -71.6 -38.39 67.03 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.998 0 C-N-CA 124.536 1.134 . . . . 0.0 112.337 169.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 37.1 mt -64.55 -50.91 65.45 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 120.535 1.516 . . . . 0.0 113.434 173.297 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -65.54 -27.61 68.57 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 168.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.735 ' HB2' ' O ' ' A' ' 136' ' ' VAL . 14.6 tpt180 -53.01 -48.46 67.53 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 125.231 1.412 . . . . 0.0 114.606 164.713 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 67.1 mtt -63.6 -35.52 80.8 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 168.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -60.75 -49.21 78.4 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 116.523 2.045 . . . . 0.0 116.523 169.483 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.4 p -64.45 -38.72 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 173.648 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -54.65 -48.48 72.28 Favored 'General case' 0 CA--C 1.579 2.063 0 C-N-CA 123.958 0.903 . . . . 0.0 112.604 167.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -56.26 -34.79 66.73 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 119.333 3.086 . . . . 0.0 119.333 174.119 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.65 -45.91 88.3 Favored 'General case' 0 N--CA 1.504 2.274 0 CA-C-N 120.44 1.473 . . . . 0.0 113.958 178.384 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.473 ' OE2' ' HB2' ' A' ' 91' ' ' GLU . 22.2 mt-10 -142.22 -4.76 1.01 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 120.952 3.686 . . . . 0.0 120.952 -166.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 38.0 m -69.12 -30.01 68.19 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 -171.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -63.76 -56.45 25.46 Favored Pre-proline 0 CA--C 1.579 2.086 0 CA-C-O 116.209 -1.853 . . . . 0.0 111.555 169.026 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -53.33 -32.88 63.45 Favored 'Trans proline' 0 CA--C 1.577 2.659 0 C-N-CA 123.454 2.769 . . . . 0.0 118.745 167.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -62.85 -53.96 46.16 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.877 1.271 . . . . 0.0 110.83 172.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 1.208 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 45.1 tp -60.99 -20.71 62.76 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 171.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -71.34 -51.58 23.47 Favored 'General case' 0 CA--C 1.562 1.42 0 CA-C-N 122.744 2.52 . . . . 0.0 113.251 164.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -63.04 -55.57 24.44 Favored 'General case' 0 CA--C 1.57 1.726 0 CA-C-N 120.559 1.527 . . . . 0.0 112.855 178.275 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -72.2 -31.88 66.28 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-O 114.591 -2.623 . . . . 0.0 112.106 177.821 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 1.208 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 36.7 ttt180 -59.32 -34.92 72.92 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 124.949 3.522 . . . . 0.0 116.864 169.544 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -66.32 -37.53 85.59 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 166.765 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -83.41 -39.99 19.9 Favored 'General case' 0 CA--C 1.581 2.16 0 N-CA-C 118.991 2.959 . . . . 0.0 118.991 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.0 pp -81.48 179.26 7.92 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 120.47 3.508 . . . . 0.0 120.47 -161.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 111' ' ' LEU 0.272 83.6 tttt -154.09 103.9 2.59 Favored 'General case' 0 C--N 1.361 1.08 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 166.018 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.451 HG23 ' H ' ' A' ' 162' ' ' VAL 1.149 24.3 m -124.44 -151.06 0.46 Allowed 'General case' 0 CA--C 1.568 1.673 1 O-C-N 114.839 -4.913 . . . . 0.0 108.339 149.507 . . . . . . . . 4 3 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.451 ' H ' HG23 ' A' ' 161' ' ' THR 0.388 2.5 t -121.39 176.49 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 CA-C-O 125.008 2.337 . . . . 0.0 113.731 -150.909 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -101.33 116.07 31.96 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 101.504 -3.517 . . . . 0.0 101.504 164.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . 0.346 . . -103.9 -120.39 0.2 Allowed 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 120.865 3.654 . . . . 0.0 120.865 -147.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.7 t -29.01 91.07 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.666 0 N-CA-C 118.99 2.959 . . . . 0.0 118.99 -156.07 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -110.1 63.79 0.27 Allowed Glycine 0 C--N 1.355 1.634 0 CA-C-O 121.879 0.711 . . . . 0.0 113.551 164.554 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 62.0 p 41.11 64.57 0.97 Allowed 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 178.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . 0.253 58.2 mtt 80.57 -64.48 0.18 Allowed 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 125.774 1.63 . . . . 0.0 114.081 171.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -71.8 -41.61 68.07 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 115.833 1.79 . . . . 0.0 115.833 -172.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -62.73 -52.55 62.81 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 173.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -54.11 -38.57 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 173.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.696 ' CE1' ' HB3' ' A' ' 19' ' ' LYS . 5.8 t80 -60.74 -38.67 85.95 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 168.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -61.13 -54.14 48.25 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 174.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 55.9 mtt180 -62.31 -37.67 86.48 Favored 'General case' 0 CA--C 1.555 1.136 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 173.724 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.66 -45.31 85.72 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 115.761 1.763 . . . . 0.0 115.761 168.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.35 -40.83 87.64 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 168.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 40.6 mmt180 -71.8 -32.73 67.9 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 174.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.53 -48.39 75.25 Favored 'General case' 0 CA--C 1.561 1.378 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 170.21 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 65.9 tp -71.31 -42.57 68.45 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 119.859 1.209 . . . . 0.0 113.836 168.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.736 ' O ' ' CB ' ' A' ' 181' ' ' LYS . . . 97.47 52.61 1.42 Allowed Glycine 0 CA--C 1.554 2.491 0 CA-C-O 118.634 -1.092 . . . . 0.0 113.12 -169.152 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.736 ' CB ' ' O ' ' A' ' 180' ' ' GLY . 56.3 tttp . . . . . 0 C--O 1.251 1.135 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -170.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.2 mtt . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.417 ' HB2' ' O ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -158.96 166.45 31.76 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 117.416 2.376 . . . . 0.0 117.416 -167.909 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 51.6 t -132.06 150.59 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-O 123.924 1.821 . . . . 0.0 112.939 -164.479 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -130.4 115.9 17.52 Favored 'General case' 0 CA--C 1.559 1.317 0 CA-C-N 112.387 -2.188 . . . . 0.0 108.221 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.835 HD23 ' HB3' ' A' ' 13' ' ' LYS . 22.9 tp -96.91 127.5 42.95 Favored 'General case' 0 CA--C 1.567 1.629 0 CA-C-O 122.873 1.321 . . . . 0.0 110.314 -173.216 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.4 mt -122.28 148.9 44.45 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 112.048 -2.342 . . . . 0.0 111.658 -169.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 163.33 151.36 6.4 Favored Glycine 0 CA--C 1.558 2.754 0 CA-C-O 118.128 -1.373 . . . . 0.0 115.684 169.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -55.75 155.04 23.57 Favored 'Trans proline' 0 CA--C 1.575 2.544 0 C-N-CA 123.792 2.995 . . . . 0.0 117.542 174.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -81.79 97.11 0.92 Allowed 'Trans proline' 0 CA--C 1.562 1.922 0 C-N-CA 122.828 2.352 . . . . 0.0 115.024 -169.469 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -168.17 -86.1 0.06 OUTLIER Glycine 0 N--CA 1.476 1.328 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 172.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.76 149.81 45.98 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 115.042 1.497 . . . . 0.0 115.042 179.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.29 148.02 29.22 Favored Glycine 0 CA--C 1.548 2.096 0 N-CA-C 117.254 1.662 . . . . 0.0 117.254 -168.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.835 ' HB3' HD23 ' A' ' 5' ' ' LEU . 13.6 mptt -119.8 -33.68 3.94 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 124.626 1.171 . . . . 0.0 114.063 176.451 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -51.66 -23.5 10.26 Favored Glycine 0 CA--C 1.553 2.457 0 N-CA-C 121.045 3.178 . . . . 0.0 121.045 177.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 65.1 m -66.83 -54.06 26.3 Favored 'General case' 0 CA--C 1.57 1.741 0 CA-C-N 120.119 1.96 . . . . 0.0 112.276 173.136 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.28 4.0 mm-40 -79.43 -14.39 58.95 Favored 'General case' 0 CA--C 1.579 2.083 0 CA-C-O 116.018 -1.944 . . . . 0.0 111.593 174.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.52 -43.18 63.92 Favored 'General case' 0 C--N 1.377 1.772 0 CA-C-N 123.75 2.977 . . . . 0.0 114.585 167.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.1 t -64.37 -41.92 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 CA-C-O 117.525 -1.226 . . . . 0.0 112.322 170.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.744 ' HB3' ' CE1' ' A' ' 172' ' ' PHE . 64.1 mmtt -65.45 -40.62 93.45 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 116.326 1.973 . . . . 0.0 116.326 171.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.6 tp -67.34 -34.67 77.81 Favored 'General case' 0 CA--C 1.572 1.824 0 CA-C-N 120.031 1.287 . . . . 0.0 113.522 173.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.02 94.14 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 166.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -56.58 -38.68 72.31 Favored 'General case' 0 CA--C 1.567 1.624 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 166.412 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -69.23 -53.78 18.1 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 120.306 1.412 . . . . 0.0 114.663 173.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.4 mt -84.4 -23.52 30.02 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 117.187 2.292 . . . . 0.0 117.187 -174.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.83 36.49 7.78 Favored Glycine 0 CA--C 1.555 2.555 0 N-CA-C 117.744 1.858 . . . . 0.0 117.744 -174.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.5 mm -104.46 153.67 38.94 Favored Pre-proline 0 CA--C 1.57 1.719 0 CA-C-N 118.899 1.349 . . . . 0.0 112.487 -169.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -82.65 98.13 0.88 Allowed 'Trans proline' 0 CA--C 1.566 2.118 0 CA-C-N 122.222 1.829 . . . . 0.0 109.586 163.383 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.01 114.82 12.76 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.811 0.815 . . . . 0.0 110.266 176.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 25.1 mm -101.99 112.32 34.75 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.6 t -95.08 134.59 37.61 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 170.447 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.0 p -68.97 -18.32 64.05 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 117.019 2.229 . . . . 0.0 117.019 -174.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.406 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -81.5 -21.23 62.52 Favored Glycine 0 CA--C 1.545 1.919 0 N-CA-C 118.619 2.207 . . . . 0.0 118.619 167.393 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -80.47 -51.75 8.44 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -169.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -63.61 -39.57 94.7 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 174.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.424 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 12.5 m-85 -70.28 -39.51 74.87 Favored 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 172.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.406 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 47.0 ttp180 -58.97 -40.64 85.39 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 120.182 1.355 . . . . 0.0 114.301 167.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.434 ' HD2' ' HA ' ' A' ' 37' ' ' ARG . 10.6 tpt180 -62.51 -39.46 93.59 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 169.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -68.53 -26.56 65.5 Favored 'General case' 0 CA--C 1.578 2.026 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 168.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 88.1 mt -63.89 -45.38 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 CA-C-N 120.267 1.394 . . . . 0.0 111.063 166.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -62.59 -40.86 98.24 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 173.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -64.64 -45.31 87.35 Favored 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 173.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.64 68.46 0.94 Allowed Glycine 0 CA--C 1.541 1.668 0 CA-C-O 118.452 -1.193 . . . . 0.0 113.555 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.721 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 63.9 p -97.48 -41.87 7.98 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -177.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.721 ' HB2' ' O ' ' A' ' 43' ' ' THR . 76.6 mttt 97.67 -38.75 0.01 OUTLIER 'General case' 0 CA--C 1.573 1.863 0 CA-C-O 116.904 -1.522 . . . . 0.0 111.869 -170.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.02 -18.66 55.62 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 122.246 2.293 . . . . 0.0 113.42 163.497 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.72 -53.4 46.25 Favored Glycine 0 C--N 1.356 1.657 0 CA-C-N 120.366 1.439 . . . . 0.0 115.332 172.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.64 ' O ' ' HB2' ' A' ' 51' ' ' ARG 0.27 11.8 p -77.91 -44.1 28.44 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.649 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 -169.673 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -59.35 -52.95 63.44 Favored 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 121.072 1.76 . . . . 0.0 113.315 169.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.69 -33.25 73.64 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -176.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.424 ' HB2' ' HB3' ' A' ' 35' ' ' PHE . 13.2 tmtt? -75.28 -19.93 59.41 Favored 'General case' 0 CA--C 1.562 1.442 0 CA-C-O 116.915 -1.517 . . . . 0.0 113.329 166.674 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . 0.64 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 34.5 ttt180 -76.81 -53.04 8.45 Favored 'General case' 0 CA--C 1.589 2.47 1 CA-C-O 86.371 -16.061 . . . . 0.0 118.169 -179.479 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . 0.405 ' HA ' ' H ' ' A' ' 57' ' ' ASP 0.34 0.0 OUTLIER -40.92 -61.7 0.93 Allowed 'General case' 0 N--CA 1.511 2.605 1 O-C-N 109.99 -7.944 . . . . 0.0 119.559 147.869 . . . . . . . . 5 4 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 61.0 mt -52.0 -31.67 30.58 Favored 'General case' 0 N--CA 1.52 3.067 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 178.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -93.46 -44.22 8.35 Favored 'General case' 0 CA--C 1.567 1.61 0 N-CA-C 116.912 2.19 . . . . 0.0 116.912 170.154 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.12 -10.56 14.66 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 119.041 2.978 . . . . 0.0 119.041 -168.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.51 42.62 9.04 Favored Glycine 0 CA--C 1.541 1.679 0 CA-C-N 122.094 2.225 . . . . 0.0 116.269 -177.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.405 ' H ' ' HA ' ' A' ' 52' ' ' TYR . 24.8 t70 -91.31 -175.52 4.28 Favored 'General case' 0 CA--C 1.568 1.636 0 CA-C-O 122.24 1.019 . . . . 0.0 110.739 179.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 65.4 mt -103.82 104.25 14.23 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 177.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.9 t -142.55 122.04 7.83 Favored Pre-proline 0 CA--C 1.584 2.259 0 CA-C-O 117.867 -1.063 . . . . 0.0 108.141 -170.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -57.63 170.1 2.08 Favored 'Trans proline' 0 CA--C 1.567 2.153 0 C-N-CA 124.278 3.319 . . . . 0.0 119.791 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.3 m -96.13 -169.4 1.92 Allowed 'General case' 0 CA--C 1.576 1.976 0 C-N-CA 124.444 1.098 . . . . 0.0 112.995 -178.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.278 19.1 m-20 80.55 -51.01 0.33 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 126.765 2.026 . . . . 0.0 115.144 172.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.44 -39.58 76.57 Favored 'General case' 0 N--CA 1.505 2.298 0 CA-C-N 120.359 1.436 . . . . 0.0 114.667 167.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.3 m -60.29 -47.51 85.71 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 114.669 -1.15 . . . . 0.0 112.688 172.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -62.92 -27.69 69.55 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 115.774 1.768 . . . . 0.0 115.774 168.051 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -68.36 -44.48 75.13 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 120.886 1.675 . . . . 0.0 114.523 171.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.9 mt -64.41 -38.57 91.5 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 168.637 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.0 t -57.58 -53.0 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-O 117.885 -1.055 . . . . 0.0 111.998 169.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -59.63 -37.32 78.33 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 116.436 2.013 . . . . 0.0 116.436 172.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -55.8 -49.02 74.36 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 116.715 -1.612 . . . . 0.0 113.084 170.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 61.3 mtp180 -88.94 7.85 32.45 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 120.515 3.524 . . . . 0.0 120.515 167.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 63.9 mt -66.19 -49.73 66.3 Favored 'General case' 0 CA--C 1.554 1.126 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 151.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 72.3 m-80 48.81 40.07 15.46 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-N 121.533 1.969 . . . . 0.0 110.981 -165.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -30.53 -32.91 0.03 OUTLIER Pre-proline 0 CA--C 1.573 1.84 1 N-CA-C 127.349 6.055 . . . . 0.0 127.349 -161.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_exo -58.61 -16.24 29.31 Favored 'Trans proline' 0 N--CA 1.511 2.504 1 CA-C-N 129.85 4.553 . . . . 0.0 118.963 168.012 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -96.88 -18.83 19.26 Favored 'General case' 0 CA--C 1.577 2.01 0 CA-C-N 110.82 -2.9 . . . . 0.0 113.587 164.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -109.17 25.04 12.27 Favored 'General case' 0 CA--C 1.58 2.112 0 CA-C-N 125.146 3.612 . . . . 0.0 114.221 168.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.6 -36.78 73.71 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 120.989 1.722 . . . . 0.0 115.148 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -105.89 18.99 21.27 Favored 'General case' 0 CA--C 1.576 1.957 0 CA-C-O 117.555 -1.212 . . . . 0.0 113.747 168.779 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.56 153.42 13.38 Favored Glycine 0 C--N 1.361 1.957 0 CA-C-N 122.344 2.338 . . . . 0.0 115.376 169.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.417 ' O ' ' HB2' ' A' ' 2' ' ' ARG . 23.2 p90 -173.98 135.74 0.5 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 112.585 -1.807 . . . . 0.0 109.827 168.944 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 33.6 mt -113.83 108.03 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 173.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.8 mt -110.96 122.4 47.79 Favored 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 123.33 0.652 . . . . 0.0 110.2 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -116.01 116.15 27.4 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 118.394 0.543 . . . . 0.0 110.746 -169.244 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.16 28.07 35.04 Favored Glycine 0 CA--C 1.548 2.138 0 N-CA-C 117.988 1.955 . . . . 0.0 117.988 176.146 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -86.68 -57.3 0.33 Allowed Pre-proline 0 CA--C 1.572 1.81 0 CA-C-O 114.297 -2.763 . . . . 0.0 110.791 175.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -61.88 50.25 0.1 OUTLIER 'Trans proline' 0 CA--C 1.578 2.719 0 N-CA-C 120.664 3.294 . . . . 0.0 120.664 167.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 1.25 ' NH2' HH12 ' A' ' 140' ' ' ARG . 0.0 OUTLIER -80.23 7.43 9.42 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 167.721 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.5 t -155.63 135.14 12.47 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 103.221 -2.881 . . . . 0.0 103.221 170.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.0 t -61.77 -34.21 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 CA-C-O 117.287 -1.34 . . . . 0.0 111.541 176.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.98 -35.39 64.27 Favored 'General case' 0 CA--C 1.564 1.505 0 N-CA-C 119.624 3.194 . . . . 0.0 119.624 165.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -72.26 -48.12 45.06 Favored 'General case' 0 CA--C 1.591 2.52 0 CA-C-N 121.679 2.036 . . . . 0.0 112.087 165.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.45 -33.18 75.29 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 116.677 2.103 . . . . 0.0 116.677 -169.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.2 tttp -61.25 -27.72 68.65 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 167.043 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.82 -42.45 63.8 Favored 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 168.295 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 36.8 tp -61.62 -40.83 96.23 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 169.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 43.7 t60 -64.09 -41.24 97.37 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 120.045 1.293 . . . . 0.0 113.986 169.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.714 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 29.7 tt0 -54.55 -40.84 69.09 Favored 'General case' 0 CA--C 1.567 1.61 0 CA-C-O 117.948 -1.025 . . . . 0.0 113.608 167.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 1.26 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 26.3 mmt -83.36 -21.26 33.16 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 117.553 2.427 . . . . 0.0 117.553 175.637 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.6 tt -73.06 -52.39 14.51 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-N 121.437 1.926 . . . . 0.0 110.39 172.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -75.37 -55.85 5.29 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 172.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.714 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 31.8 ttm180 -69.28 -39.81 78.14 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 178.063 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 1.26 ' HB3' ' O ' ' A' ' 99' ' ' MET . 76.5 ttt180 -63.45 -56.81 13.15 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 119.464 1.029 . . . . 0.0 111.036 165.159 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.27 50.0 0.74 Allowed Glycine 0 N--CA 1.483 1.794 0 O-C-N 124.184 0.927 . . . . 0.0 113.886 168.267 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 51.3 p -91.15 150.58 21.32 Favored 'General case' 0 CA--C 1.559 1.29 0 CA-C-N 113.481 -1.36 . . . . 0.0 109.797 176.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -67.94 132.55 47.53 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.899 -0.501 . . . . 0.0 112.053 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 6.3 tp -95.07 101.74 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -95.78 -69.45 0.75 Allowed 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 116.399 -1.763 . . . . 0.0 108.796 169.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -155.33 128.64 8.33 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 121.629 2.013 . . . . 0.0 113.929 177.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 33.3 t -93.72 108.37 20.46 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.726 0 N-CA-C 102.838 -3.023 . . . . 0.0 102.838 163.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.726 HD23 ' HB2' ' A' ' 160' ' ' LYS . 86.9 mt -101.43 110.8 22.87 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.776 0.83 . . . . 0.0 110.716 -169.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -89.57 121.23 31.58 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 121.638 0.732 . . . . 0.0 109.055 172.199 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -92.61 117.05 29.57 Favored 'General case' 0 CA--C 1.557 1.227 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 175.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.543 ' HB3' ' HA ' ' A' ' 163' ' ' ASP . 19.7 tpt180 -87.55 91.48 8.75 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 112.821 -1.99 . . . . 0.0 107.31 173.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.4 m -142.16 116.21 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 CA-C-N 112.839 -1.982 . . . . 0.0 106.038 -165.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 18.9 p -66.86 120.7 14.0 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.997 0.903 . . . . 0.0 113.01 -172.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -54.89 -45.93 74.73 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -49.2 -29.5 5.69 Favored 'General case' 0 CA--C 1.558 1.255 0 N-CA-C 118.217 2.673 . . . . 0.0 118.217 176.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.5 t -63.5 -48.26 87.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 CA-C-N 120.625 1.557 . . . . 0.0 113.865 178.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 9.0 mp -73.24 -23.32 60.33 Favored 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 116.74 -1.6 . . . . 0.0 113.992 168.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 48.0 mt -66.07 -45.88 79.72 Favored 'General case' 0 N--CA 1.502 2.125 0 CA-C-N 121.996 2.18 . . . . 0.0 115.143 169.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -65.09 -36.8 85.45 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 170.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -55.35 -55.92 26.0 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 168.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.7 pp -66.76 -34.21 77.34 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 177.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -77.33 -64.83 1.05 Allowed 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 120.91 1.686 . . . . 0.0 113.335 173.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.556 ' O ' ' HB2' ' A' ' 127' ' ' ARG . . . 60.01 43.94 97.71 Favored Glycine 0 CA--C 1.548 2.148 0 N-CA-C 118.616 2.206 . . . . 0.0 118.616 170.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.556 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 76.6 mtp85 76.14 93.38 0.07 Allowed 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 118.028 0.914 . . . . 0.0 111.104 -174.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 96.02 -176.43 33.18 Favored Glycine 0 CA--C 1.572 3.606 0 CA-C-O 118.854 -0.97 . . . . 0.0 113.278 -172.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -171.37 177.39 3.55 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 121.316 2.558 . . . . 0.0 114.428 -176.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -127.91 30.18 5.31 Favored 'General case' 0 CA--C 1.571 1.758 0 CA-C-N 113.233 -1.803 . . . . 0.0 113.806 168.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 57.72 12.09 1.53 Allowed 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 119.138 3.014 . . . . 0.0 119.138 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -87.19 52.08 2.42 Favored 'General case' 0 CA--C 1.58 2.106 0 CA-C-O 122.988 1.375 . . . . 0.0 109.176 162.24 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 73.3 p -140.55 -118.83 0.12 Allowed 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 113.998 -1.455 . . . . 0.0 109.494 -162.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -56.85 -41.28 77.66 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 116.728 2.121 . . . . 0.0 116.728 -169.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -71.64 -38.91 70.68 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 177.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 1.013 ' O ' ' HG2' ' A' ' 140' ' ' ARG . 50.8 t -62.72 -38.58 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 C-N-CA 124.122 0.969 . . . . 0.0 112.539 168.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 1.7 mp -72.35 -29.81 32.89 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.962 0 CA-C-O 117.546 -1.216 . . . . 0.0 113.205 173.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 31.2 mt -66.66 -46.38 75.9 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 121.382 1.901 . . . . 0.0 113.881 170.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -65.94 -37.52 86.26 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 114.849 1.425 . . . . 0.0 114.849 171.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 1.25 HH12 ' NH2' ' A' ' 88' ' ' ARG . 12.2 mmm180 -59.77 -42.13 92.64 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 169.484 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 58.9 mtt -66.49 -31.01 71.47 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 115.543 1.682 . . . . 0.0 115.543 169.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -63.64 -49.14 74.41 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 169.411 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . 0.64 HG12 HH22 ' A' ' 88' ' ' ARG . 7.8 p -64.57 -33.41 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 169.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -56.19 -52.36 64.68 Favored 'General case' 0 CA--C 1.581 2.168 0 CA-C-N 119.559 1.072 . . . . 0.0 111.779 167.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 31.1 ttp180 -52.19 -31.55 32.16 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 119.427 3.121 . . . . 0.0 119.427 170.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -48.47 -51.04 28.95 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 170.75 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -140.34 7.61 2.18 Favored 'General case' 0 CA--C 1.56 1.362 0 N-CA-C 119.944 3.312 . . . . 0.0 119.944 -167.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 23.9 m -55.27 -34.41 64.03 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 116.194 1.924 . . . . 0.0 116.194 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.14 -59.92 5.71 Favored Pre-proline 0 CA--C 1.578 2.054 0 CA-C-O 116.662 -1.637 . . . . 0.0 111.881 172.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -50.15 -31.3 28.12 Favored 'Trans proline' 0 CA--C 1.576 2.616 0 C-N-CA 123.365 2.71 . . . . 0.0 118.374 167.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.01 -55.58 18.13 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 125.391 1.476 . . . . 0.0 112.217 175.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 1.048 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 46.1 tp -65.32 -23.51 67.03 Favored 'General case' 0 CA--C 1.564 1.511 0 CA-C-O 116.504 -1.712 . . . . 0.0 114.704 176.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -71.55 -48.95 45.25 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 122.393 2.361 . . . . 0.0 113.444 165.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -67.16 -51.6 51.71 Favored 'General case' 0 CA--C 1.566 1.57 0 CA-C-N 120.042 1.292 . . . . 0.0 112.014 -177.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -80.81 -25.3 37.9 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-O 114.715 -2.564 . . . . 0.0 112.53 178.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 1.048 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 38.1 ttt180 -64.31 -35.63 81.48 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 124.893 3.497 . . . . 0.0 115.938 168.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -67.94 -37.74 81.97 Favored 'General case' 0 CA--C 1.574 1.89 0 CA-C-N 119.697 1.135 . . . . 0.0 113.949 167.303 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -80.71 -38.2 29.3 Favored 'General case' 0 CA--C 1.574 1.89 0 N-CA-C 119.351 3.093 . . . . 0.0 119.351 178.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.3 pp -78.08 173.69 11.94 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 119.675 3.213 . . . . 0.0 119.675 -160.271 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.726 ' HB2' HD23 ' A' ' 111' ' ' LEU . 91.0 mttt -124.83 134.35 52.77 Favored 'General case' 0 CA--C 1.561 1.399 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 166.027 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 60.4 m -98.1 148.95 23.03 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 122.79 1.281 . . . . 0.0 111.222 -170.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.526 HG12 ' HG3' ' A' ' 174' ' ' ARG . 44.8 t -127.84 138.67 54.05 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.871 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 167.024 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.543 ' HA ' ' HB3' ' A' ' 114' ' ' ARG . 14.7 t70 -114.95 127.32 55.62 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 170.308 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -151.53 -159.8 1.07 Allowed 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 -160.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . 0.511 5.7 p 58.28 178.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 C-N-CA 129.153 2.981 . . . . 0.0 114.498 -179.376 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 72.52 -17.41 1.52 Allowed Glycine 0 CA--C 1.559 2.843 0 N-CA-C 117.821 1.888 . . . . 0.0 117.821 -151.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 82.7 p -141.28 145.38 35.44 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 118.735 1.267 . . . . 0.0 110.91 -168.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -88.88 -67.62 0.82 Allowed 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 118.751 -0.642 . . . . 0.0 112.143 174.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -70.03 -37.04 75.49 Favored 'General case' 0 N--CA 1.505 2.313 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 -176.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . 0.938 ' HB3' HH21 ' A' ' 174' ' ' ARG . 47.6 mt-10 -59.42 -42.04 90.92 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 117.294 -1.336 . . . . 0.0 114.522 175.305 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 44.4 t -56.54 -38.65 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 CA-C-N 120.991 1.723 . . . . 0.0 113.419 172.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.744 ' CE1' ' HB3' ' A' ' 19' ' ' LYS . 22.8 t80 -57.95 -40.51 80.7 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 120.796 1.635 . . . . 0.0 115.103 166.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.578 ' O ' ' HB2' ' A' ' 177' ' ' ARG . . . -61.03 -50.85 71.64 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.938 HH21 ' HB3' ' A' ' 170' ' ' GLU . 11.7 ptp180 -73.32 -25.19 60.53 Favored 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 117.582 2.438 . . . . 0.0 117.582 171.056 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.11 -49.73 73.27 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 120.346 1.43 . . . . 0.0 114.715 169.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . 0.254 0.2 OUTLIER -66.77 -37.86 85.44 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 119.531 1.06 . . . . 0.0 113.429 167.471 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . 0.578 ' HB2' ' O ' ' A' ' 173' ' ' ALA . 17.3 ttt180 -43.55 -44.05 5.89 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 117.126 2.269 . . . . 0.0 117.126 167.594 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -71.13 -53.98 12.65 Favored 'General case' 0 CA--C 1.564 1.497 0 CA-C-O 118.204 -0.903 . . . . 0.0 113.208 166.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -99.05 -59.6 1.7 Allowed 'General case' 0 CA--C 1.565 1.528 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -169.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.892 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -79.39 -39.14 19.55 Favored Glycine 0 CA--C 1.55 2.276 0 CA-C-N 121.388 1.904 . . . . 0.0 117.737 -171.46 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.892 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 85.9 tttt . . . . . 0 C--O 1.251 1.142 0 CA-C-N 118.482 1.141 . . . . 0.0 108.623 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.6 mtt . . . . . 0 CA--C 1.555 1.171 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 2.4 ptm180 -160.96 162.79 32.03 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 -167.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.5 p -131.4 145.69 34.84 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.4 0 CA-C-O 123.299 1.523 . . . . 0.0 110.956 -170.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.2 mm? -118.12 157.07 27.57 Favored 'General case' 0 CA--C 1.562 1.442 0 CA-C-N 112.853 -1.976 . . . . 0.0 108.52 168.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . 0.475 HD21 ' HG2' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -128.23 117.07 20.87 Favored 'General case' 0 CA--C 1.569 1.69 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.201 -174.042 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.0 mt -116.17 158.48 23.2 Favored 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 127.669 2.387 . . . . 0.0 111.749 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.69 118.78 0.63 Allowed Glycine 0 CA--C 1.556 2.61 0 CA-C-O 116.996 -2.002 . . . . 0.0 114.029 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -70.83 -178.07 2.56 Favored 'Trans proline' 0 CA--C 1.584 3.002 0 CA-C-N 122.572 3.186 . . . . 0.0 114.009 169.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -48.03 125.98 12.52 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 124.132 3.221 . . . . 0.0 116.111 -178.652 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.57 101.74 2.41 Favored Glycine 0 CA--C 1.538 1.476 0 N-CA-C 106.093 -2.803 . . . . 0.0 106.093 -165.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.02 129.58 34.61 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -169.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -166.57 98.94 0.15 Allowed Glycine 0 N--CA 1.48 1.598 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.475 ' HG2' HD21 ' A' ' 5' ' ' LEU . 37.3 mtmm -158.34 -65.63 0.09 Allowed 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 122.896 0.478 . . . . 0.0 111.434 -172.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -54.04 -36.87 57.21 Favored Glycine 0 CA--C 1.552 2.346 0 N-CA-C 120.87 3.108 . . . . 0.0 120.87 -173.096 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 90.0 m -68.74 -49.09 61.61 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 119.397 1.598 . . . . 0.0 113.145 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.282 25.4 mp0 -77.57 -12.06 59.93 Favored 'General case' 0 CA--C 1.574 1.886 0 CA-C-O 115.325 -2.274 . . . . 0.0 112.071 169.629 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.07 -45.9 58.93 Favored 'General case' 0 C--N 1.373 1.61 0 CA-C-N 124.809 3.459 . . . . 0.0 114.389 167.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.2 t -67.01 -40.95 86.65 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.766 0 CA-C-O 117.523 -1.227 . . . . 0.0 111.793 171.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -62.62 -45.23 93.83 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 116.605 2.076 . . . . 0.0 116.605 171.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.26 -32.92 73.43 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-N 120.227 1.376 . . . . 0.0 113.85 173.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.03 -40.97 97.52 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 166.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -58.17 -40.25 80.97 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 166.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.9 tptt -68.62 -54.01 19.09 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 177.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.9 mt -83.31 -19.86 35.46 Favored 'General case' 0 CA--C 1.57 1.739 0 N-CA-C 116.972 2.212 . . . . 0.0 116.972 178.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.48 39.89 7.55 Favored Glycine 0 CA--C 1.554 2.482 0 N-CA-C 117.543 1.777 . . . . 0.0 117.543 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.505 ' CG2' ' HA ' ' A' ' 81' ' ' PHE . 18.8 mm -110.1 157.87 36.71 Favored Pre-proline 0 CA--C 1.572 1.827 0 CA-C-N 118.531 1.166 . . . . 0.0 113.457 -168.261 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -84.49 99.79 0.76 Allowed 'Trans proline' 0 CA--C 1.568 2.182 0 CA-C-N 122.146 1.802 . . . . 0.0 110.062 163.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.26 113.66 4.75 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.448 -0.783 . . . . 0.0 111.276 172.027 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 32.3 mm -98.12 108.14 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 N-CA-C 104.501 -2.407 . . . . 0.0 104.501 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 73.9 m -95.45 128.45 42.32 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 168.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.3 p -71.27 -8.28 52.6 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 116.94 2.2 . . . . 0.0 116.94 -172.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -87.12 -21.86 47.65 Favored Glycine 0 CA--C 1.551 2.288 0 N-CA-C 118.106 2.003 . . . . 0.0 118.106 165.361 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -79.79 -51.55 9.03 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -168.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -62.09 -41.85 98.61 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 172.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.443 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 26.0 m-85 -60.73 -37.08 80.54 Favored 'General case' 0 CA--C 1.564 1.513 0 N-CA-C 116.259 1.948 . . . . 0.0 116.259 168.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -60.09 -42.96 95.76 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 120.017 1.28 . . . . 0.0 114.035 167.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -60.33 -38.87 85.11 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 168.105 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -66.25 -28.14 68.49 Favored 'General case' 0 CA--C 1.575 1.923 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 168.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 73.9 mt -63.73 -46.74 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 CA-C-N 120.131 1.332 . . . . 0.0 111.434 168.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -65.35 -36.39 83.87 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 172.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -78.38 -32.08 48.71 Favored 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.14 73.69 1.28 Allowed Glycine 0 CA--C 1.544 1.855 0 CA-C-O 118.348 -1.251 . . . . 0.0 114.884 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.761 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 68.6 p -97.62 -44.53 6.75 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 178.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.761 ' HB2' ' O ' ' A' ' 43' ' ' THR . 76.9 mttt 102.35 -39.16 0.01 OUTLIER 'General case' 0 CA--C 1.579 2.072 0 CA-C-O 117.372 -1.299 . . . . 0.0 112.202 -171.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -89.01 1.8 54.98 Favored 'General case' 0 CA--C 1.58 2.103 0 CA-C-N 121.805 2.093 . . . . 0.0 113.251 163.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -81.9 -54.48 3.41 Favored Glycine 0 C--N 1.349 1.299 0 O-C-N 120.761 -1.212 . . . . 0.0 114.657 169.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.303 4.0 p -75.95 -52.38 18.02 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.441 0 N-CA-C 115.073 1.509 . . . . 0.0 115.073 -168.387 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -67.19 -48.93 66.42 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 120.586 1.539 . . . . 0.0 112.307 175.235 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.81 -19.32 62.01 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.443 ' HB2' ' HB3' ' A' ' 35' ' ' PHE . 14.2 tmtt? -74.64 -47.02 34.37 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 117.111 -1.423 . . . . 0.0 111.825 165.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -67.71 -53.55 26.66 Favored 'General case' 0 CA--C 1.591 2.539 1 CA-C-O 86.12 -16.181 . . . . 0.0 118.001 -173.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 15.9 m-30 -31.62 -64.41 0.16 Allowed 'General case' 0 N--CA 1.496 1.848 1 O-C-N 110.232 -7.793 . . . . 0.0 120.803 146.216 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.5 tp -60.8 -23.97 65.46 Favored 'General case' 0 CA--C 1.579 2.095 0 CA-C-N 122.201 2.273 . . . . 0.0 116.779 172.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -92.58 -43.27 9.22 Favored 'General case' 0 CA--C 1.569 1.68 0 C-N-CA 126.332 1.853 . . . . 0.0 114.737 168.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.41 -48.01 12.47 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 120.741 1.609 . . . . 0.0 115.318 -176.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . 0.438 ' HA2' HH12 ' A' ' 88' ' ' ARG . . . 116.99 41.42 0.71 Allowed Glycine 0 CA--C 1.539 1.542 0 N-CA-C 116.389 1.316 . . . . 0.0 116.389 169.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -105.73 -132.47 0.31 Allowed 'General case' 0 CA--C 1.572 1.802 0 CA-C-O 118.584 -0.722 . . . . 0.0 109.479 168.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.9 mt -108.23 109.95 21.44 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 120.163 1.347 . . . . 0.0 111.334 -168.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.9 p -117.11 129.49 25.29 Favored Pre-proline 0 CA--C 1.573 1.829 0 CA-C-O 117.796 -1.097 . . . . 0.0 110.225 178.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -60.73 145.2 99.31 Favored 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 123.475 2.783 . . . . 0.0 116.288 173.722 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 98.8 p -78.12 -45.07 24.32 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 178.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -66.82 -40.65 88.08 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 115.726 1.751 . . . . 0.0 115.726 -175.713 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.67 -43.88 97.13 Favored 'General case' 0 N--CA 1.506 2.341 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 172.219 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.3 m -61.46 -41.19 96.86 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.201 -1.363 . . . . 0.0 112.986 173.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -65.08 -26.58 68.29 Favored 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 166.74 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.41 -46.49 73.06 Favored 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 170.392 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.8 mt -60.64 -48.28 82.49 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 169.129 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 55.5 t -58.99 -52.17 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 124.024 0.93 . . . . 0.0 112.435 174.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -62.68 -31.16 72.0 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 116.344 1.979 . . . . 0.0 116.344 173.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -58.74 -42.99 90.08 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 117.558 -1.211 . . . . 0.0 113.462 169.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -81.35 -16.78 51.31 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 119.217 3.043 . . . . 0.0 119.217 168.612 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 88.7 mt -92.82 -17.88 23.57 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 117.067 2.247 . . . . 0.0 117.067 177.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -71.95 9.03 1.02 Allowed 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 169.17 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -67.95 141.77 94.78 Favored Pre-proline 0 CA--C 1.574 1.896 0 CA-C-O 117.816 -1.088 . . . . 0.0 109.837 166.116 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -48.59 -36.69 32.56 Favored 'Trans proline' 0 N--CA 1.5 1.898 0 N-CA-C 119.419 2.815 . . . . 0.0 119.419 174.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.8 p30 -65.65 -19.54 65.95 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 116.824 2.157 . . . . 0.0 116.824 172.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -100.7 9.19 42.75 Favored 'General case' 0 CA--C 1.572 1.811 0 CA-C-N 121.696 2.044 . . . . 0.0 115.897 171.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.62 -45.23 83.87 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 121.148 1.794 . . . . 0.0 114.51 169.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -93.17 16.18 13.62 Favored 'General case' 0 CA--C 1.577 1.998 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 173.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.82 163.95 21.55 Favored Glycine 0 C--N 1.354 1.552 0 CA-C-N 121.336 1.88 . . . . 0.0 114.298 169.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.505 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . 28.8 p90 -165.85 139.56 4.41 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 113.236 -1.482 . . . . 0.0 111.967 175.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.3 mm -101.39 110.39 28.12 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.764 0 N-CA-C 104.624 -2.361 . . . . 0.0 104.624 170.383 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.9 mt -106.09 130.22 54.03 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 174.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -128.99 117.85 21.62 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 119.206 0.912 . . . . 0.0 110.916 -166.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 76.06 36.72 40.02 Favored Glycine 0 CA--C 1.55 2.231 0 N-CA-C 118.051 1.981 . . . . 0.0 118.051 -176.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . 0.256 2.3 t80 -107.24 -66.14 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.921 0 CA-C-O 113.834 -2.984 . . . . 0.0 112.105 -176.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -61.79 47.97 0.09 OUTLIER 'Trans proline' 0 CA--C 1.576 2.602 0 N-CA-C 122.229 3.896 . . . . 0.0 122.229 171.155 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.438 HH12 ' HA2' ' A' ' 56' ' ' GLY . 0.8 OUTLIER -64.42 -21.76 66.74 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 116.821 2.156 . . . . 0.0 116.821 166.547 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 36.6 t -131.14 146.84 52.5 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 -172.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . 0.534 ' H ' ' HG2' ' A' ' 147' ' ' GLU . 1.0 OUTLIER -61.89 -35.78 70.02 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.724 0 CA-C-O 117.26 -1.352 . . . . 0.0 110.827 169.543 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.56 -45.66 81.14 Favored 'General case' 0 CA--C 1.559 1.323 0 N-CA-C 120.524 3.528 . . . . 0.0 120.524 168.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -67.32 -47.47 70.44 Favored 'General case' 0 CA--C 1.588 2.437 0 CA-C-N 122.264 2.302 . . . . 0.0 112.927 169.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.14 -33.1 73.86 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 116.405 2.002 . . . . 0.0 116.405 -169.179 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.44 ' HA ' ' HH ' ' A' ' 154' ' ' TYR . 84.8 mttt -63.46 -28.1 69.73 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 166.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.93 -46.31 62.7 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 169.013 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 22.6 tp -64.41 -37.96 89.34 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 173.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 56.6 t60 -68.43 -39.35 81.59 Favored 'General case' 0 CA--C 1.567 1.63 0 CA-C-N 119.695 1.134 . . . . 0.0 113.825 169.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.939 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 22.8 mt-10 -52.2 -41.44 62.69 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 166.654 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 1.126 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 3.3 tpt -84.09 -26.93 28.58 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 117.724 2.49 . . . . 0.0 117.724 175.478 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 30.9 tp -64.28 -55.33 22.11 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 120.214 1.37 . . . . 0.0 112.393 168.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -80.26 -51.68 8.62 Favored 'General case' 0 CA--C 1.562 1.42 0 CA-C-O 118.671 -0.68 . . . . 0.0 112.715 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.939 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 75.0 mtp180 -71.66 -41.06 69.19 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 176.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 1.126 ' HB3' ' O ' ' A' ' 99' ' ' MET . 0.8 OUTLIER -63.2 -55.14 27.5 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 119.759 1.163 . . . . 0.0 110.59 164.638 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.67 48.4 1.04 Allowed Glycine 0 N--CA 1.482 1.713 0 O-C-N 123.83 0.706 . . . . 0.0 113.274 169.246 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 29.7 p -99.91 163.61 12.38 Favored 'General case' 0 CA--C 1.56 1.343 0 O-C-N 124.594 0.82 . . . . 0.0 111.074 -178.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -75.56 134.78 40.64 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.64 -0.663 . . . . 0.0 111.748 -169.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 8.0 tp -109.64 106.05 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 179.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.42 -68.21 0.81 Allowed 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 117.446 -1.264 . . . . 0.0 107.701 167.239 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -159.87 136.83 9.34 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 120.601 1.546 . . . . 0.0 115.119 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 48.7 t -91.35 114.38 28.51 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.734 0 N-CA-C 103.733 -2.691 . . . . 0.0 103.733 162.78 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.439 HD21 ' HB2' ' A' ' 160' ' ' LYS . 84.3 mt -103.04 110.74 22.77 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.338 0.655 . . . . 0.0 111.959 -169.249 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -96.06 124.47 40.08 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.313 0.578 . . . . 0.0 110.849 175.581 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -92.68 123.87 36.28 Favored 'General case' 0 CA--C 1.561 1.388 0 CA-C-O 123.341 1.543 . . . . 0.0 110.147 -173.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.417 ' HB3' ' HA ' ' A' ' 163' ' ' ASP . 74.3 ttt180 -82.09 95.05 7.34 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 112.559 -2.109 . . . . 0.0 109.229 168.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.6 p -138.55 139.3 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.299 0 C-N-CA 125.864 1.666 . . . . 0.0 107.348 -168.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.4 m -76.94 140.35 40.45 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 114.341 -1.299 . . . . 0.0 112.699 -169.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -57.16 -41.78 79.83 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 169.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -47.41 -36.91 10.48 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 117.992 2.59 . . . . 0.0 117.992 174.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.3 t -61.14 -51.24 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.329 0 CA-C-N 119.856 1.207 . . . . 0.0 113.714 176.423 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 14.0 tp -61.08 -39.93 91.78 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 168.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 9.0 mp -62.45 -43.88 97.75 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 174.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -66.61 -35.92 81.35 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 171.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.457 ' O ' ' HB3' ' A' ' 127' ' ' ARG . 98.9 mtt180 -57.28 -52.85 63.69 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 168.324 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 10.5 mp -60.81 -48.96 79.43 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 174.009 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -60.15 -46.98 87.84 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 116.406 2.002 . . . . 0.0 116.406 176.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.598 ' O ' ' HB2' ' A' ' 127' ' ' ARG . . . -102.3 56.35 0.66 Allowed Glycine 0 CA--C 1.546 1.979 0 CA-C-N 118.746 0.703 . . . . 0.0 113.978 169.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.598 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 35.9 ttm180 154.25 91.76 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.224 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.73 ' O ' ' HB2' ' A' ' 129' ' ' ARG . . . -174.42 -44.71 0.05 OUTLIER Glycine 0 CA--C 1.548 2.151 0 N-CA-C 116.639 1.416 . . . . 0.0 116.639 -175.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.73 ' HB2' ' O ' ' A' ' 128' ' ' GLY . 94.2 mtt180 89.6 -128.99 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 119.626 1.713 . . . . 0.0 112.319 -175.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.477 ' H ' ' HB3' ' A' ' 129' ' ' ARG . . . -93.68 -41.08 9.9 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 115.127 1.529 . . . . 0.0 115.127 -175.343 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -138.05 62.64 1.56 Allowed 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 121.426 1.921 . . . . 0.0 113.131 177.343 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -121.83 62.96 0.92 Allowed 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 102.445 -3.168 . . . . 0.0 102.445 159.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 76.2 p -143.7 -117.55 0.09 Allowed 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 113.98 -1.464 . . . . 0.0 110.374 -160.385 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -84.87 -33.5 22.79 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 115.513 1.671 . . . . 0.0 115.513 -171.061 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -68.22 -40.03 82.2 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 177.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 5.0 p -59.97 -46.45 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 172.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.8 tp -70.88 -26.81 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 174.452 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 33.7 mt -66.66 -40.7 88.76 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 120.51 1.505 . . . . 0.0 114.175 168.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.461 ' HA ' ' HD3' ' A' ' 142' ' ' LYS . 11.6 t-20 -68.62 -37.12 79.49 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 120.495 1.498 . . . . 0.0 114.316 170.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.01 -38.93 77.09 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 165.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 24.7 ttt -65.03 -33.12 75.28 Favored 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 168.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.461 ' HD3' ' HA ' ' A' ' 139' ' ' ASN . 60.5 mtpt -59.71 -52.23 66.4 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 168.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 14.8 p -62.67 -36.44 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.267 0 N-CA-C 114.109 1.152 . . . . 0.0 114.109 170.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -55.31 -50.29 69.95 Favored 'General case' 0 CA--C 1.581 2.161 0 CA-C-N 120.059 1.299 . . . . 0.0 112.974 169.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -61.55 -45.29 94.8 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 117.72 2.489 . . . . 0.0 117.72 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.01 -38.36 65.04 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 117.345 2.35 . . . . 0.0 117.345 175.663 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . 0.534 ' HG2' ' H ' ' A' ' 90' ' ' VAL . 2.3 mp0 -123.47 -35.91 2.87 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 119.534 3.161 . . . . 0.0 119.534 -165.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 86.0 m -49.31 -31.3 8.85 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 118.441 2.756 . . . . 0.0 118.441 -166.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.17 -63.04 2.66 Favored Pre-proline 0 CA--C 1.582 2.192 0 CA-C-N 121.157 1.799 . . . . 0.0 111.212 170.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -54.21 -32.1 69.21 Favored 'Trans proline' 0 CA--C 1.571 2.363 0 C-N-CA 123.4 2.734 . . . . 0.0 118.899 167.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.3 tp -71.74 -42.87 66.74 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 117.812 -1.09 . . . . 0.0 112.511 174.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 1.042 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 49.5 tp -63.56 -24.43 67.8 Favored 'General case' 0 CA--C 1.569 1.704 0 CA-C-N 120.656 1.571 . . . . 0.0 113.875 170.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -69.84 -49.69 50.0 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 121.829 2.104 . . . . 0.0 113.038 163.3 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.44 ' HH ' ' HA ' ' A' ' 94' ' ' LYS . 2.8 t80 -65.19 -52.31 55.68 Favored 'General case' 0 CA--C 1.564 1.49 0 CA-C-N 121.15 1.795 . . . . 0.0 112.69 -177.876 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -82.0 -22.52 36.48 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-O 115.128 -2.368 . . . . 0.0 112.804 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 1.042 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 40.3 ttt180 -66.07 -35.87 81.7 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 125.016 3.553 . . . . 0.0 115.653 168.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -68.41 -36.9 79.78 Favored 'General case' 0 CA--C 1.575 1.928 0 CA-C-N 119.673 1.124 . . . . 0.0 114.006 167.043 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -88.08 -31.98 18.97 Favored 'General case' 0 CA--C 1.575 1.914 0 N-CA-C 119.203 3.038 . . . . 0.0 119.203 -178.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.8 pp -79.87 174.33 11.69 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 118.412 2.745 . . . . 0.0 118.412 -162.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.439 ' HB2' HD21 ' A' ' 111' ' ' LEU . 61.7 mttp -133.24 137.27 46.02 Favored 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 166.041 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.0 t -96.34 154.28 17.35 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.341 1.067 . . . . 0.0 112.085 -175.429 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 59.5 t -127.75 142.82 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 171.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.417 ' HA ' ' HB3' ' A' ' 114' ' ' ARG . 35.4 t70 -95.3 132.28 40.48 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 168.68 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -159.49 99.26 1.44 Allowed 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 122.26 1.029 . . . . 0.0 113.317 -163.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.9 t -150.92 130.81 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 174.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 79.58 -70.99 2.76 Favored Glycine 0 N--CA 1.482 1.735 0 N-CA-C 118.314 2.086 . . . . 0.0 118.314 167.375 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 40.6 p -76.98 142.36 40.01 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 112.215 -1.992 . . . . 0.0 112.26 -169.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 61.3 mtt -88.35 -61.65 1.66 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 118.699 -0.667 . . . . 0.0 111.579 178.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -69.64 -37.63 76.84 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 -176.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -61.55 -53.24 58.88 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 119.371 0.987 . . . . 0.0 113.28 169.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 61.6 t -57.73 -37.94 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 176.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -62.07 -33.53 74.57 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 116.45 2.019 . . . . 0.0 116.45 168.609 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -63.01 -47.28 83.77 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 171.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -61.8 -41.63 97.98 Favored 'General case' 0 CA--C 1.556 1.208 0 N-CA-C 116.676 2.102 . . . . 0.0 116.676 169.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.37 -42.39 91.5 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 116.212 1.931 . . . . 0.0 116.212 171.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.6 mp -65.99 -40.38 91.15 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 117.403 -1.284 . . . . 0.0 114.294 169.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 37.6 mtt180 -53.38 -43.27 67.7 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 116.442 2.015 . . . . 0.0 116.442 168.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -69.7 -41.82 74.89 Favored 'General case' 0 CA--C 1.562 1.438 0 N-CA-C 116.335 1.976 . . . . 0.0 116.335 172.858 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 6.8 tt -74.87 -57.14 4.09 Favored 'General case' 0 CA--C 1.566 1.566 0 CA-C-N 121.003 1.729 . . . . 0.0 111.729 177.044 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.651 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -117.36 -59.86 0.3 Allowed Glycine 0 CA--C 1.551 2.333 0 CA-C-O 117.621 -1.655 . . . . 0.0 114.898 -177.099 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.651 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 36.5 ttmt . . . . . 0 C--O 1.252 1.195 0 CA-C-N 120.608 2.204 . . . . 0.0 107.369 -174.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.1 mtt . . . . . 0 N--CA 1.483 1.213 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.38 165.94 31.58 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 117.744 2.498 . . . . 0.0 117.744 -165.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.65 155.56 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-O 124.044 1.878 . . . . 0.0 112.978 -165.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.7 pp -138.86 127.31 23.03 Favored 'General case' 0 CA--C 1.559 1.313 0 CA-C-N 112.618 -2.083 . . . . 0.0 108.718 168.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 tt -96.53 134.72 39.39 Favored 'General case' 0 CA--C 1.559 1.304 0 CA-C-O 122.879 1.324 . . . . 0.0 113.765 -165.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -135.26 157.41 46.97 Favored 'General case' 0 CA--C 1.56 1.335 0 CA-C-N 112.062 -2.335 . . . . 0.0 111.356 -169.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 156.67 135.98 2.05 Favored Glycine 0 CA--C 1.554 2.495 0 CA-C-O 117.412 -1.771 . . . . 0.0 111.905 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.21 154.1 75.3 Favored 'Trans proline' 0 CA--C 1.577 2.625 0 CA-C-N 122.789 3.294 . . . . 0.0 113.241 171.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -43.28 132.02 6.62 Favored 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 124.359 3.373 . . . . 0.0 118.519 -169.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 164.24 89.98 0.08 OUTLIER Glycine 0 CA--C 1.536 1.384 0 CA-C-N 116.343 -0.389 . . . . 0.0 112.658 -170.161 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 48.45 -83.47 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 120.602 3.556 . . . . 0.0 120.602 167.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.92 -115.22 0.09 OUTLIER Glycine 0 CA--C 1.544 1.901 0 N-CA-C 117.247 1.659 . . . . 0.0 117.247 -167.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.8 mptt 78.28 -83.8 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 124.503 1.121 . . . . 0.0 111.191 -169.366 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -40.94 -30.67 0.39 Allowed Glycine 0 CA--C 1.557 2.667 0 N-CA-C 121.254 3.262 . . . . 0.0 121.254 169.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.2 p -58.62 -63.04 1.43 Allowed 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 119.543 1.671 . . . . 0.0 114.507 171.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.264 5.7 mm-40 -75.28 -13.67 60.45 Favored 'General case' 0 CA--C 1.571 1.754 0 CA-C-O 116.536 -1.697 . . . . 0.0 111.432 175.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.83 -48.38 63.68 Favored 'General case' 0 C--N 1.373 1.609 0 CA-C-N 122.532 2.424 . . . . 0.0 113.946 166.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.6 t -66.43 -38.23 81.32 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.834 0 CA-C-O 117.89 -1.053 . . . . 0.0 111.931 176.32 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -63.09 -51.3 67.15 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 116.809 2.151 . . . . 0.0 116.809 169.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.401 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 0.9 OUTLIER -62.04 -35.24 78.0 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-N 119.969 1.259 . . . . 0.0 114.255 174.771 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.63 -45.21 94.92 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 116.405 2.002 . . . . 0.0 116.405 169.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.43 -28.64 63.48 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 164.3 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.401 ' HB3' ' O ' ' A' ' 20' ' ' LEU . 19.0 tptm -63.82 -62.8 1.41 Allowed 'General case' 0 CA--C 1.552 1.026 0 CA-C-O 116.653 -1.641 . . . . 0.0 114.745 170.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . 0.297 0.6 OUTLIER -83.28 -15.44 50.21 Favored 'General case' 0 N--CA 1.506 2.365 0 N-CA-C 117.006 2.225 . . . . 0.0 117.006 -178.445 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.08 42.32 4.09 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 117.024 1.57 . . . . 0.0 117.024 176.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.514 ' CD1' ' HA ' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -116.69 149.16 43.43 Favored Pre-proline 0 CA--C 1.573 1.865 0 C-N-CA 127.337 2.255 . . . . 0.0 110.776 -168.911 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -73.97 101.71 1.43 Allowed 'Trans proline' 0 CA--C 1.583 2.958 0 C-N-CA 121.794 1.663 . . . . 0.0 113.568 159.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -57.4 119.99 7.44 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.919 -1.113 . . . . 0.0 113.817 169.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 26.2 mm -101.8 109.34 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 169.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.7 p -95.17 125.05 39.55 Favored 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 103.928 -2.619 . . . . 0.0 103.928 163.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 47.4 p -67.48 -12.23 59.8 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 117.14 2.274 . . . . 0.0 117.14 -168.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.485 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -85.86 -19.57 57.55 Favored Glycine 0 CA--C 1.55 2.28 0 N-CA-C 118.347 2.099 . . . . 0.0 118.347 166.376 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -79.61 -53.44 6.85 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 118.756 1.278 . . . . 0.0 114.062 -168.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -59.18 -39.22 81.87 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 172.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.407 ' HB2' ' HB2' ' A' ' 50' ' ' LYS . 35.4 m-85 -70.14 -43.16 71.5 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 116.262 -1.828 . . . . 0.0 113.204 171.855 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 47.5 ttt180 -51.8 -39.84 59.4 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 116.541 2.052 . . . . 0.0 116.541 169.216 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.9 -43.49 98.74 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 113.736 1.014 . . . . 0.0 113.736 169.382 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -65.7 -24.63 67.04 Favored 'General case' 0 CA--C 1.585 2.304 0 N-CA-C 116.441 2.015 . . . . 0.0 116.441 167.397 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.9 mt -62.99 -48.96 85.51 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.381 0 CA-C-N 121.288 1.858 . . . . 0.0 109.468 166.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -61.52 -41.41 97.27 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 114.355 1.242 . . . . 0.0 114.355 175.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -65.95 -40.15 91.07 Favored 'General case' 0 CA--C 1.564 1.489 0 N-CA-C 116.571 2.063 . . . . 0.0 116.571 171.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.85 70.61 1.03 Allowed Glycine 0 CA--C 1.545 1.942 0 CA-C-O 117.901 -1.5 . . . . 0.0 114.789 -179.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.775 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 64.1 p -95.67 -50.79 4.79 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-N 119.414 1.607 . . . . 0.0 114.502 177.42 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.775 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.251 73.5 mttt 103.99 -40.98 0.01 OUTLIER 'General case' 0 CA--C 1.573 1.846 0 CA-C-O 116.303 -1.808 . . . . 0.0 111.229 -171.257 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.91 -13.99 59.48 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 123.183 2.72 . . . . 0.0 112.901 163.818 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.502 ' O ' ' HB3' ' A' ' 50' ' ' LYS . . . -58.56 -60.45 8.92 Favored Glycine 0 C--N 1.355 1.587 0 CA-C-N 120.725 1.602 . . . . 0.0 115.032 170.063 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.281 7.6 p -73.68 -50.63 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.323 0 N-CA-C 116.21 1.93 . . . . 0.0 116.21 -168.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -66.3 -46.4 77.07 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 120.352 1.433 . . . . 0.0 112.384 175.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.58 -30.98 68.88 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -178.092 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.502 ' HB3' ' O ' ' A' ' 46' ' ' GLY 0.27 0.6 OUTLIER -78.03 -28.21 49.01 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-O 116.827 -1.559 . . . . 0.0 114.873 170.453 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -74.06 -56.52 4.83 Favored 'General case' 0 CA--C 1.595 2.682 1 CA-C-O 87.477 -15.535 . . . . 0.0 117.314 175.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . 0.259 11.4 m-30 -24.28 -66.53 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.836 1 O-C-N 109.279 -8.388 . . . . 0.0 119.929 145.522 . . . . . . . . 3 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 41.2 mt -53.66 -38.34 64.04 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-N 121.296 1.862 . . . . 0.0 115.735 171.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -80.37 -52.98 7.04 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-O 116.799 -1.572 . . . . 0.0 113.634 170.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -158.42 43.86 0.29 Allowed 'General case' 0 CA--C 1.574 1.87 0 CA-C-N 120.909 1.686 . . . . 0.0 115.463 -168.714 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -151.17 27.26 1.0 Allowed Glycine 0 CA--C 1.549 2.174 0 CA-C-N 121.942 2.155 . . . . 0.0 118.443 173.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . 0.318 9.1 t70 76.37 -118.46 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 120.034 1.917 . . . . 0.0 111.127 166.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 86.3 mt -75.6 114.48 14.22 Favored 'General case' 0 CA--C 1.559 1.317 0 N-CA-C 115.308 1.596 . . . . 0.0 115.308 -164.736 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.5 p -118.06 138.29 25.34 Favored Pre-proline 0 CA--C 1.573 1.845 0 C-N-CA 126.089 1.755 . . . . 0.0 108.529 174.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -56.46 135.46 70.39 Favored 'Trans proline' 0 CA--C 1.56 1.807 0 C-N-CA 123.373 2.715 . . . . 0.0 116.191 173.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.6 m -70.38 -48.11 57.77 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -60.5 -43.55 96.91 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 26.4 mt -56.59 -46.82 80.61 Favored 'General case' 0 N--CA 1.509 2.483 0 N-CA-C 116.393 1.998 . . . . 0.0 116.393 175.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.1 m -58.33 -44.54 88.72 Favored 'General case' 0 CA--C 1.565 1.529 0 CA-C-N 113.022 -1.899 . . . . 0.0 113.211 173.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -61.01 -33.25 72.97 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 166.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.35 -43.97 84.54 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 175.586 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.2 mt -64.24 -44.8 90.7 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 168.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 54.9 t -59.09 -50.24 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 CA-C-O 118.125 -0.94 . . . . 0.0 113.073 172.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -63.0 -35.46 80.29 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 174.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -56.4 -40.23 74.31 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 118.113 -0.946 . . . . 0.0 113.31 169.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.635 HH22 ' HG ' ' A' ' 83' ' ' LEU . 0.2 OUTLIER -67.62 -45.38 75.59 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 165.616 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 83.7 mt -68.83 -7.03 30.55 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 118.12 2.637 . . . . 0.0 118.12 -178.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -73.06 6.63 2.57 Favored 'General case' 0 CA--C 1.582 2.193 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 165.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 15.6 p30 -52.58 -170.44 0.0 OUTLIER Pre-proline 0 CA--C 1.574 1.871 0 N-CA-C 120.688 3.588 . . . . 0.0 120.688 167.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -35.6 39.86 0.0 OUTLIER 'Trans proline' 0 C--N 1.385 2.495 2 C-N-CA 127.666 5.578 . . . . 0.0 125.331 163.086 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.8 t70 59.66 34.1 22.09 Favored 'General case' 0 CA--C 1.582 2.183 0 C-N-CA 124.307 1.043 . . . . 0.0 110.366 -164.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . 0.258 . . 78.92 4.4 2.4 Favored 'General case' 0 C--N 1.376 1.73 0 CA-C-O 116.269 -1.824 . . . . 0.0 114.996 -169.47 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 51.06 30.6 5.59 Favored 'General case' 0 CA--C 1.58 2.129 0 CA-C-N 123.441 2.837 . . . . 0.0 113.719 -164.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 59.58 32.98 21.93 Favored 'General case' 0 CA--C 1.581 2.163 0 CA-C-O 116.765 -1.588 . . . . 0.0 113.101 -165.882 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -170.68 174.28 44.55 Favored Glycine 0 C--N 1.376 2.759 0 CA-C-N 123.508 2.867 . . . . 0.0 116.614 -178.048 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.514 ' HA ' ' CD1' ' A' ' 26' ' ' ILE 0.311 18.9 p90 -170.09 134.42 1.25 Allowed 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 114.747 -0.726 . . . . 0.0 112.064 168.53 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.1 mp -109.98 109.16 27.4 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.537 0 N-CA-C 104.134 -2.543 . . . . 0.0 104.134 168.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.635 ' HG ' HH22 ' A' ' 71' ' ' ARG . 10.2 mt -105.76 110.49 22.81 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.487 0.715 . . . . 0.0 109.752 169.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -103.73 130.65 51.26 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 118.511 0.596 . . . . 0.0 112.59 -173.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.58 40.32 98.55 Favored Glycine 0 CA--C 1.548 2.146 0 CA-C-O 116.867 -2.074 . . . . 0.0 116.274 -176.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -89.06 -54.27 0.33 Allowed Pre-proline 0 N--CA 1.502 2.172 0 CA-C-N 120.794 2.297 . . . . 0.0 108.205 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -61.18 60.03 0.1 Allowed 'Trans proline' 0 CA--C 1.576 2.588 0 N-CA-C 121.909 3.773 . . . . 0.0 121.909 167.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -56.36 -33.97 66.19 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 163.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.6 t -155.23 158.39 38.78 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -174.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 23.9 t -68.9 -31.57 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 CA-C-O 116.689 -1.624 . . . . 0.0 111.118 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.83 -39.16 76.99 Favored 'General case' 0 CA--C 1.56 1.363 0 N-CA-C 120.133 3.383 . . . . 0.0 120.133 167.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -72.25 -46.35 56.34 Favored 'General case' 0 CA--C 1.592 2.591 0 CA-C-N 122.505 2.411 . . . . 0.0 112.777 167.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.69 -34.79 78.64 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 127.2 2.2 . . . . 0.0 116.178 -168.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 57.9 tttt -61.41 -29.66 70.07 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 166.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.12 -36.77 72.25 Favored 'General case' 0 CA--C 1.568 1.651 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 168.288 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.7 tp -63.14 -38.29 90.59 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 168.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 31.5 t60 -63.67 -47.26 81.99 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 119.818 1.19 . . . . 0.0 112.973 168.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.939 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 34.4 mt-10 -52.02 -31.01 27.83 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 165.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 1.226 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 23.1 ttt -84.74 -31.58 23.93 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 117.578 2.436 . . . . 0.0 117.578 175.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.475 HD21 ' HG1' ' A' ' 105' ' ' THR . 16.6 mt -64.34 -55.88 18.19 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 121.948 2.158 . . . . 0.0 110.927 167.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -76.83 -51.62 10.98 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.939 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 36.5 ttm180 -74.06 -38.51 63.93 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 115.154 1.539 . . . . 0.0 115.154 176.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 1.226 ' HB3' ' O ' ' A' ' 99' ' ' MET . 25.4 tpt180 -62.74 -54.51 38.09 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 119.986 1.266 . . . . 0.0 112.081 166.359 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 114.07 44.64 0.73 Allowed Glycine 0 N--CA 1.479 1.51 0 O-C-N 123.971 0.794 . . . . 0.0 113.76 168.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.475 ' HG1' HD21 ' A' ' 100' ' ' LEU . 31.3 p -116.23 135.33 53.99 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 177.432 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -65.88 135.45 54.82 Favored 'General case' 0 N--CA 1.508 2.465 0 CA-C-O 122.601 1.191 . . . . 0.0 112.435 -170.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.5 tp -84.28 99.49 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 CA-C-N 113.262 -1.79 . . . . 0.0 107.04 178.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -97.75 -68.37 0.8 Allowed 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 116.947 -1.501 . . . . 0.0 110.175 169.053 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -138.02 116.06 11.68 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 120.44 1.473 . . . . 0.0 114.544 -167.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 72.8 t -91.53 117.64 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 101.176 -3.638 . . . . 0.0 101.176 163.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.444 ' HA ' ' O ' ' A' ' 160' ' ' LYS 0.259 6.8 tp -116.16 109.59 17.67 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 114.804 -2.522 . . . . 0.0 115.2 -159.545 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.428 ' N ' ' HB ' ' A' ' 161' ' ' THR . 3.0 tm-20 -110.23 109.5 20.0 Favored 'General case' 0 N--CA 1.517 2.908 0 CA-C-N 123.856 3.025 . . . . 0.0 117.998 -177.14 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -87.85 123.51 32.69 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 125.667 1.587 . . . . 0.0 110.647 170.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -92.76 101.03 13.41 Favored 'General case' 0 CA--C 1.558 1.271 0 CA-C-N 112.543 -2.117 . . . . 0.0 109.312 169.47 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.5 p -135.89 141.94 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.446 0 C-N-CA 127.279 2.232 . . . . 0.0 107.894 -167.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.6 m -83.9 137.49 33.63 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 114.071 -1.422 . . . . 0.0 114.423 -167.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -58.32 -46.57 85.92 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 168.984 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -45.56 -36.47 4.67 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 117.995 2.591 . . . . 0.0 117.995 177.824 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.2 t -59.84 -52.78 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 177.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 5.3 tt -67.41 -36.65 81.7 Favored 'General case' 0 CA--C 1.56 1.357 0 CA-C-O 117.255 -1.355 . . . . 0.0 113.0 171.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.3 mp -59.46 -32.3 70.11 Favored 'General case' 0 N--CA 1.503 2.202 0 CA-C-N 120.852 1.66 . . . . 0.0 115.18 168.851 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -66.6 -47.3 73.12 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 119.231 0.923 . . . . 0.0 113.436 168.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -51.63 -54.99 21.9 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 116.316 1.969 . . . . 0.0 116.316 169.134 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 79.8 mt -52.95 -48.37 67.4 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 169.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 38.1 tptt -61.72 -42.64 99.22 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 116.949 2.203 . . . . 0.0 116.949 177.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.557 ' O ' ' HB2' ' A' ' 127' ' ' ARG . . . -96.74 57.79 1.3 Allowed Glycine 0 CA--C 1.545 1.908 0 CA-C-N 118.642 0.656 . . . . 0.0 113.983 170.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.557 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 74.3 mtp180 107.13 96.07 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.873 0.869 . . . . 0.0 110.481 174.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 139.37 64.19 0.04 OUTLIER Glycine 0 CA--C 1.549 2.186 0 CA-C-O 117.069 -1.962 . . . . 0.0 112.906 177.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 41.7 ptt85 -165.3 95.88 0.67 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 121.751 2.776 . . . . 0.0 112.01 -179.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -122.21 58.77 1.03 Allowed 'General case' 0 CA--C 1.573 1.863 0 C-N-CA 123.729 0.812 . . . . 0.0 109.809 171.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 63.89 8.09 3.66 Favored 'General case' 0 N--CA 1.506 2.341 0 N-CA-C 119.289 3.07 . . . . 0.0 119.289 -176.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -91.75 60.22 3.9 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 160.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 82.6 p -139.05 -113.24 0.15 Allowed 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 114.146 -1.388 . . . . 0.0 110.284 -162.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -58.63 -42.09 87.46 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -170.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -66.93 -35.77 80.74 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 172.051 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.642 ' O ' ' HG3' ' A' ' 140' ' ' ARG . 60.7 t -64.58 -42.54 95.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 C-N-CA 124.293 1.037 . . . . 0.0 112.3 173.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.1 tp -72.64 -28.58 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 171.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 32.3 mt -64.67 -44.33 90.7 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-N 121.152 1.796 . . . . 0.0 113.887 168.672 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -65.27 -36.95 85.7 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 170.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.642 ' HG3' ' O ' ' A' ' 136' ' ' VAL . 69.2 mtp180 -60.43 -41.86 94.89 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 169.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 62.5 mtt -65.53 -34.18 77.65 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 169.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -64.48 -46.35 83.41 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 170.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.6 p -65.74 -32.95 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 170.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -56.73 -53.13 61.25 Favored 'General case' 0 CA--C 1.581 2.158 0 CA-C-N 119.782 1.173 . . . . 0.0 111.71 167.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 41.3 ttt180 -53.34 -22.75 7.81 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 120.37 3.47 . . . . 0.0 120.37 169.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.37 -56.81 13.67 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-N 119.858 1.208 . . . . 0.0 113.308 169.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -141.99 23.08 2.07 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 118.639 2.829 . . . . 0.0 118.639 -171.679 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 20.9 m -56.25 -30.26 62.16 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 116.124 1.898 . . . . 0.0 116.124 170.719 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.0 -60.41 5.26 Favored Pre-proline 0 CA--C 1.583 2.234 0 CA-C-N 120.68 1.582 . . . . 0.0 111.227 169.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -53.03 -27.93 38.26 Favored 'Trans proline' 0 CA--C 1.568 2.194 0 N-CA-C 119.614 2.89 . . . . 0.0 119.614 168.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 8.2 tt -70.85 -55.58 8.19 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 116.876 -1.535 . . . . 0.0 109.751 172.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 0.948 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 39.5 tp -58.43 -26.47 63.34 Favored 'General case' 0 CA--C 1.564 1.515 0 CA-C-N 121.211 1.823 . . . . 0.0 113.962 -179.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -71.53 -48.02 51.41 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 121.635 2.016 . . . . 0.0 113.409 163.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -69.92 -49.37 52.7 Favored 'General case' 0 CA--C 1.571 1.764 0 CA-C-N 121.591 1.996 . . . . 0.0 112.548 -175.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -82.16 -27.06 32.9 Favored 'General case' 0 CA--C 1.557 1.234 0 CA-C-O 115.215 -2.326 . . . . 0.0 111.437 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 0.948 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 40.8 ttt180 -67.0 -32.66 74.04 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 124.926 3.512 . . . . 0.0 115.723 167.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -67.89 -41.57 82.53 Favored 'General case' 0 CA--C 1.573 1.833 0 CA-C-N 119.713 1.142 . . . . 0.0 113.458 167.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -90.96 -28.47 18.02 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 119.675 3.213 . . . . 0.0 119.675 -176.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.8 pp -80.54 159.36 25.51 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 118.297 2.703 . . . . 0.0 118.297 -162.319 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.444 ' O ' ' HA ' ' A' ' 111' ' ' LEU 0.296 97.6 mttt -145.48 101.1 3.54 Favored 'General case' 0 C--N 1.361 1.072 0 CA-C-O 117.748 -1.12 . . . . 0.0 110.791 162.915 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.428 ' HB ' ' N ' ' A' ' 112' ' ' GLU 1.254 24.4 m -131.44 -153.31 0.55 Allowed 'General case' 0 CA--C 1.573 1.856 1 O-C-N 115.74 -4.35 . . . . 0.0 110.059 149.926 . . . . . . . . 4 3 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.411 ' CG1' ' H ' ' A' ' 163' ' ' ASP 0.361 4.6 t -124.53 -177.81 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.413 0 CA-C-N 111.973 -2.376 . . . . 0.0 112.976 -151.047 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.411 ' H ' ' CG1' ' A' ' 162' ' ' VAL . 10.8 t70 -112.18 123.36 50.11 Favored 'General case' 0 CA--C 1.564 1.491 0 CA-C-N 111.324 -2.671 . . . . 0.0 104.47 166.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -160.5 122.59 3.19 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.295 0.638 . . . . 0.0 110.546 -161.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.1 t -149.76 128.63 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 78.02 -55.12 3.9 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 120.258 2.863 . . . . 0.0 120.258 168.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 52.9 p -74.41 119.41 18.58 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 114.051 -1.074 . . . . 0.0 111.062 -169.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 64.7 mtt -73.76 -63.66 1.16 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -172.256 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -67.58 -36.03 80.13 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 116.126 1.898 . . . . 0.0 116.126 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -60.82 -51.82 67.71 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 170.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 87.5 t -58.81 -35.25 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 CA-C-O 117.311 -1.328 . . . . 0.0 113.949 176.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -60.07 -37.96 81.46 Favored 'General case' 0 N--CA 1.504 2.257 0 CA-C-N 121.262 1.846 . . . . 0.0 115.953 166.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -61.12 -53.55 55.69 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 175.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -56.42 -41.32 76.17 Favored 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 117.478 2.399 . . . . 0.0 117.478 169.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -53.28 -46.29 69.22 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 116.172 1.915 . . . . 0.0 116.172 169.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.7 mp -60.97 -44.99 96.54 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 117.388 -1.291 . . . . 0.0 113.962 168.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -50.66 -42.23 56.33 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 169.909 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -67.08 -45.17 78.11 Favored 'General case' 0 CA--C 1.561 1.369 0 N-CA-C 116.153 1.908 . . . . 0.0 116.153 171.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 6.6 tt -77.52 -55.15 5.62 Favored 'General case' 0 CA--C 1.568 1.665 0 CA-C-N 121.051 1.75 . . . . 0.0 112.38 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.835 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -130.7 -55.5 0.09 OUTLIER Glycine 0 CA--C 1.553 2.427 0 CA-C-O 117.628 -1.651 . . . . 0.0 115.807 -175.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.835 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 86.3 tttt . . . . . 0 C--O 1.251 1.153 0 CA-C-N 120.533 2.167 . . . . 0.0 108.874 -175.318 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.5 mtt . . . . . 0 CA--C 1.557 1.219 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.78 169.54 21.41 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 117.612 2.449 . . . . 0.0 117.612 -167.224 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.9 p -127.94 138.43 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 CA-C-N 115.116 -0.947 . . . . 0.0 113.532 -165.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -118.02 120.46 37.85 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 171.008 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -99.02 121.78 41.41 Favored 'General case' 0 CA--C 1.563 1.453 0 CA-C-O 122.376 1.084 . . . . 0.0 112.538 -167.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.4 mt -114.23 154.11 28.47 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 111.042 -2.799 . . . . 0.0 109.333 -172.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 175.24 107.9 0.21 Allowed Glycine 0 CA--C 1.549 2.178 0 CA-C-O 116.694 -2.17 . . . . 0.0 109.48 175.203 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -55.39 173.95 0.29 Allowed 'Trans proline' 0 CA--C 1.574 2.525 0 CA-C-N 122.247 3.024 . . . . 0.0 117.863 -179.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -46.7 116.17 1.52 Allowed 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 124.248 3.299 . . . . 0.0 115.642 -177.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.79 101.94 0.92 Allowed Glycine 0 CA--C 1.534 1.273 0 N-CA-C 106.523 -2.631 . . . . 0.0 106.523 -166.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.17 132.96 36.72 Favored 'General case' 0 CA--C 1.557 1.25 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 -167.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -153.37 -115.96 0.61 Allowed Glycine 0 CA--C 1.542 1.72 0 N-CA-C 105.882 -2.887 . . . . 0.0 105.882 167.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 12' ' ' GLY . 48.3 mtpt 79.35 -88.03 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 116.367 1.988 . . . . 0.0 116.367 164.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -32.59 -36.65 0.04 OUTLIER Glycine 0 CA--C 1.556 2.62 0 N-CA-C 122.877 3.911 . . . . 0.0 122.877 172.459 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.0 m -62.63 -56.26 19.48 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 120.069 1.934 . . . . 0.0 112.664 174.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.277 17.1 mp0 -74.55 -12.25 60.42 Favored 'General case' 0 CA--C 1.574 1.889 0 CA-C-O 115.427 -2.225 . . . . 0.0 112.655 170.194 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.67 -45.27 68.76 Favored 'General case' 0 C--N 1.374 1.664 0 CA-C-N 124.506 3.321 . . . . 0.0 114.513 167.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.7 t -69.95 -38.71 76.19 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.849 0 CA-C-O 117.672 -1.156 . . . . 0.0 111.569 174.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -61.33 -47.21 86.94 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 116.6 2.074 . . . . 0.0 116.6 169.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 mt -65.62 -31.08 71.92 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 172.408 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.97 -44.25 97.62 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 166.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -58.69 -37.69 76.63 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 168.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -67.1 -50.94 59.86 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 172.223 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.6 mt -83.69 -19.83 34.59 Favored 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 -177.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.97 36.11 10.52 Favored Glycine 0 CA--C 1.555 2.548 0 N-CA-C 117.889 1.915 . . . . 0.0 117.889 -177.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.425 ' CG2' ' HA ' ' A' ' 81' ' ' PHE . 16.4 mm -111.53 158.11 37.31 Favored Pre-proline 0 CA--C 1.572 1.796 0 CA-C-N 119.088 1.444 . . . . 0.0 113.811 -167.628 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -81.81 100.58 1.1 Allowed 'Trans proline' 0 CA--C 1.573 2.436 0 C-N-CA 122.115 1.876 . . . . 0.0 111.081 162.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -64.47 110.59 2.34 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 124.074 0.949 . . . . 0.0 111.887 171.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.7 mm -99.71 113.6 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 177.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 78.9 p -96.43 136.04 37.47 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 114.942 -1.026 . . . . 0.0 108.691 169.247 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.0 p -69.73 -7.88 43.23 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 117.585 2.439 . . . . 0.0 117.585 -175.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.436 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -90.43 -22.61 33.93 Favored Glycine 0 CA--C 1.545 1.937 0 N-CA-C 118.563 2.185 . . . . 0.0 118.563 165.828 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -80.74 -51.86 8.18 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -168.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -63.53 -41.44 98.48 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 173.57 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.482 ' HB3' ' CG ' ' A' ' 50' ' ' LYS . 29.6 m-85 -61.13 -43.4 98.94 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-O 116.431 -1.747 . . . . 0.0 115.136 168.516 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.436 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 72.8 ttt180 -54.97 -44.02 74.04 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 170.331 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 33.7 ttt180 -59.47 -40.98 88.67 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 114.668 1.358 . . . . 0.0 114.668 168.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -68.33 -24.19 64.8 Favored 'General case' 0 CA--C 1.582 2.188 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 169.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 82.5 mt -63.03 -49.49 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 CA-C-N 120.835 1.652 . . . . 0.0 110.299 167.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -65.26 -35.29 80.58 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 175.035 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -68.72 -42.8 77.17 Favored 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 174.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.45 69.4 1.27 Allowed Glycine 0 CA--C 1.545 1.947 0 CA-C-O 118.905 -0.942 . . . . 0.0 114.518 -174.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.796 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 64.8 p -91.52 -49.09 6.5 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 178.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.796 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.26 38.8 mttp 110.61 -42.37 0.0 OUTLIER 'General case' 0 CA--C 1.57 1.716 0 CA-C-O 116.135 -1.888 . . . . 0.0 110.876 -172.718 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -83.08 -10.86 58.48 Favored 'General case' 0 CA--C 1.574 1.872 0 CA-C-N 123.425 2.83 . . . . 0.0 113.106 162.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.37 -55.32 24.08 Favored Glycine 0 CA--C 1.544 1.853 0 CA-C-N 120.535 1.516 . . . . 0.0 114.276 169.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.267 1.0 OUTLIER -75.62 -50.21 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 116.729 2.122 . . . . 0.0 116.729 -168.556 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -67.16 -41.4 86.08 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 120.476 1.489 . . . . 0.0 112.565 174.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.88 -25.47 48.59 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -174.505 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.482 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -75.0 -41.01 60.34 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 117.064 -1.446 . . . . 0.0 111.871 166.699 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -71.63 -51.32 23.78 Favored 'General case' 0 CA--C 1.591 2.536 1 CA-C-O 85.298 -16.572 . . . . 0.0 118.444 -176.282 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 14.9 m-30 -35.25 -55.4 0.63 Allowed 'General case' 0 N--CA 1.496 1.844 2 O-C-N 108.913 -8.617 . . . . 0.0 121.85 147.209 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 71.6 mt -60.83 -32.77 72.14 Favored 'General case' 0 N--CA 1.51 2.571 0 CA-C-N 124.283 3.22 . . . . 0.0 114.799 167.917 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -83.09 -45.25 14.21 Favored 'General case' 0 CA--C 1.568 1.663 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 172.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.15 -28.23 25.67 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 116.81 2.152 . . . . 0.0 116.81 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.64 42.59 4.76 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-N 120.243 1.383 . . . . 0.0 115.952 170.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.423 ' O ' ' NH1' ' A' ' 88' ' ' ARG . 20.2 t70 -105.17 -132.53 0.31 Allowed 'General case' 0 CA--C 1.571 1.75 0 CA-C-O 118.532 -0.747 . . . . 0.0 109.548 169.328 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 88.8 mt -115.15 111.91 21.73 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 120.054 1.297 . . . . 0.0 110.192 -169.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.1 p -112.74 116.91 47.37 Favored Pre-proline 0 CA--C 1.568 1.651 0 CA-C-O 117.848 -1.072 . . . . 0.0 109.26 -178.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -59.64 144.24 99.48 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 123.477 2.785 . . . . 0.0 116.354 176.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 85.5 p -77.97 178.28 7.61 Favored 'General case' 0 CA--C 1.567 1.604 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 176.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.27 16.8 m-20 80.33 -51.53 0.35 Allowed 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 126.324 1.85 . . . . 0.0 113.998 175.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.9 pp -61.91 -42.46 99.1 Favored 'General case' 0 CA--C 1.563 1.459 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 167.249 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.2 m -61.43 -50.51 72.5 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.331 1.052 . . . . 0.0 112.805 174.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -64.41 -21.06 66.52 Favored 'General case' 0 CA--C 1.571 1.783 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 167.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -68.52 -47.11 67.8 Favored 'General case' 0 CA--C 1.557 1.234 0 CA-C-N 120.507 1.503 . . . . 0.0 114.0 168.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.9 mt -63.1 -37.74 88.42 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 168.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 56.7 t -58.39 -53.21 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-O 118.08 -0.962 . . . . 0.0 112.059 169.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -60.37 -36.17 77.42 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 172.82 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -56.61 -48.4 77.53 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 116.642 -1.646 . . . . 0.0 113.097 169.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -87.61 7.53 29.34 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 120.666 3.58 . . . . 0.0 120.666 167.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 69.9 mt -66.44 -49.38 66.92 Favored 'General case' 0 CA--C 1.559 1.296 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 150.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 50.39 33.96 8.41 Favored 'General case' 0 N--CA 1.504 2.258 0 CA-C-N 121.267 1.848 . . . . 0.0 111.535 -167.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . 0.277 16.4 p-10 -15.57 -48.47 0.03 OUTLIER Pre-proline 0 CA--C 1.587 2.387 1 N-CA-C 127.815 6.228 . . . . 0.0 127.815 -162.604 . . . . . . . . 3 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -57.51 -22.67 52.19 Favored 'Trans proline' 0 N--CA 1.512 2.6 1 CA-C-N 130.288 4.71 . . . . 0.0 117.419 166.763 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -81.81 -18.21 44.8 Favored 'General case' 0 CA--C 1.58 2.098 0 CA-C-N 110.426 -3.079 . . . . 0.0 113.231 163.388 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.01 -27.42 68.81 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 124.134 3.152 . . . . 0.0 114.48 165.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 57.21 37.8 28.52 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 121.595 1.998 . . . . 0.0 114.273 -174.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 66.1 m-80 57.53 38.87 28.13 Favored 'General case' 0 CA--C 1.582 2.191 0 CA-C-O 117.554 -1.213 . . . . 0.0 112.023 -167.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -157.29 163.86 32.65 Favored Glycine 0 C--N 1.372 2.53 0 CA-C-N 122.28 2.309 . . . . 0.0 114.061 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.425 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . 10.4 p90 -175.83 136.95 0.33 Allowed 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 114.205 -0.998 . . . . 0.0 110.849 -176.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 4.9 mm -108.97 107.89 23.97 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.489 0 N-CA-C 103.224 -2.88 . . . . 0.0 103.224 167.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 79.5 mt -114.62 118.02 32.52 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -178.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -114.54 132.34 56.35 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 118.927 0.785 . . . . 0.0 112.398 -169.604 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 75.56 36.06 44.78 Favored Glycine 0 CA--C 1.55 2.265 0 N-CA-C 118.803 2.281 . . . . 0.0 118.803 172.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -99.65 -58.52 0.13 Allowed Pre-proline 0 N--CA 1.495 1.787 0 CA-C-O 113.536 -3.126 . . . . 0.0 111.479 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -59.66 61.5 0.07 OUTLIER 'Trans proline' 0 CA--C 1.574 2.492 1 N-CA-C 123.141 4.247 . . . . 0.0 123.141 170.487 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 1.455 ' CG ' HH12 ' A' ' 140' ' ' ARG . 13.9 ttp180 -52.01 -39.68 59.83 Favored 'General case' 0 CA--C 1.573 1.859 0 N-CA-C 116.124 1.898 . . . . 0.0 116.124 163.418 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.3 t -154.97 153.7 31.45 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.156 1.383 . . . . 0.0 107.636 -168.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.2 t -60.16 -37.5 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 CA-C-O 117.167 -1.397 . . . . 0.0 112.188 177.609 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.96 -37.02 80.93 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 120.596 3.554 . . . . 0.0 120.596 172.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -77.81 -46.77 20.58 Favored 'General case' 0 CA--C 1.588 2.418 0 CA-C-N 123.468 2.849 . . . . 0.0 111.635 166.397 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.16 -32.87 72.6 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 117.999 2.592 . . . . 0.0 117.999 -172.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -57.54 -33.54 68.21 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 168.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.77 -39.88 88.01 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 170.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 39.2 tp -64.62 -40.11 94.9 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 169.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -60.24 -53.06 62.22 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-N 119.715 1.143 . . . . 0.0 113.37 170.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 0.9 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 35.6 mt-10 -48.01 -38.47 17.15 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 167.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 1.277 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 25.0 ttt -84.38 -25.21 29.28 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 117.825 2.528 . . . . 0.0 117.825 176.737 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 41.9 tp -68.38 -53.7 22.12 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-N 120.59 1.541 . . . . 0.0 110.912 169.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -76.33 -54.4 6.81 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 119.37 0.987 . . . . 0.0 113.416 175.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.9 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 75.9 mtp180 -71.6 -39.39 70.53 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 177.473 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 1.277 ' HB3' ' O ' ' A' ' 99' ' ' MET . 3.6 tmt_? -61.78 -56.02 23.95 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 119.699 1.136 . . . . 0.0 110.375 164.787 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 113.26 41.63 0.96 Allowed Glycine 0 N--CA 1.481 1.692 0 O-C-N 124.076 0.86 . . . . 0.0 114.96 167.546 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 36.5 p -102.13 137.6 40.19 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 169.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -71.14 135.28 47.54 Favored 'General case' 0 N--CA 1.51 2.55 0 CA-C-O 122.699 1.238 . . . . 0.0 112.293 -171.252 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.2 tp -79.68 102.25 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 CA-C-N 113.356 -1.747 . . . . 0.0 108.089 172.773 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -96.08 -61.8 1.38 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 117.301 -1.333 . . . . 0.0 110.428 167.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -150.55 112.3 4.5 Favored 'General case' 0 C--N 1.36 1.024 0 CA-C-N 120.309 1.413 . . . . 0.0 113.707 -166.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -97.17 104.67 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.678 0 CA-C-N 115.085 -0.962 . . . . 0.0 111.0 167.805 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.968 HD12 ' HB3' ' A' ' 160' ' ' LYS 0.311 6.9 tp -103.49 111.23 23.58 Favored 'General case' 0 CA--C 1.556 1.201 0 N-CA-C 118.446 2.758 . . . . 0.0 118.446 -157.073 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.518 ' H ' ' N ' ' A' ' 161' ' ' THR . 68.0 mt-10 -96.72 107.47 19.94 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 122.062 2.21 . . . . 0.0 115.528 -172.161 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -88.0 108.93 19.45 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 118.706 -2.496 . . . . 0.0 108.324 170.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.753 ' HB3' ' HA ' ' A' ' 163' ' ' ASP . 10.1 tpt180 -95.18 95.14 8.34 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 112.575 -2.102 . . . . 0.0 110.359 -172.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.19 122.47 60.0 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.483 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 -168.453 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 52.0 p -59.24 140.12 56.29 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -172.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -52.94 -36.08 59.41 Favored 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 116.628 2.085 . . . . 0.0 116.628 177.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -52.53 -32.82 42.43 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 116.956 2.206 . . . . 0.0 116.956 174.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -59.48 -47.25 91.48 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 N-CA-C 115.848 1.796 . . . . 0.0 115.848 170.176 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 34.5 tp -65.02 -40.13 94.41 Favored 'General case' 0 CA--C 1.563 1.464 0 CA-C-N 114.506 -1.225 . . . . 0.0 114.059 170.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 69.1 mt -59.1 -47.53 84.92 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 115.732 1.752 . . . . 0.0 115.732 171.463 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -63.64 -40.53 97.12 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 173.436 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -58.69 -47.45 84.47 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 168.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.6 mp -52.85 -51.86 59.42 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 115.376 1.621 . . . . 0.0 115.376 171.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -74.84 -61.65 1.81 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 85.62 -41.01 3.04 Favored Glycine 0 CA--C 1.555 2.553 0 N-CA-C 116.128 1.211 . . . . 0.0 116.128 -175.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.405 ' HB2' ' H ' ' A' ' 128' ' ' GLY . 99.2 mtt180 -151.98 -93.04 0.05 Allowed 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 178.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.569 ' O ' ' HB2' ' A' ' 129' ' ' ARG . . . -113.07 50.47 0.77 Allowed Glycine 0 CA--C 1.551 2.319 0 CA-C-O 118.095 -1.392 . . . . 0.0 114.873 171.434 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.569 ' HB2' ' O ' ' A' ' 128' ' ' GLY . 78.5 mtp180 82.45 101.34 0.05 Allowed 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 119.893 1.847 . . . . 0.0 112.323 175.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -101.53 32.1 3.49 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 176.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 46.66 50.76 12.82 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 118.194 2.664 . . . . 0.0 118.194 -177.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -100.15 86.74 3.29 Favored 'General case' 0 N--CA 1.487 1.404 1 N-CA-C 96.837 -5.246 . . . . 0.0 96.837 158.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 33.6 p -49.34 134.31 18.76 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 118.408 2.744 . . . . 0.0 118.408 -156.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -58.48 -36.83 74.36 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 111.116 -2.765 . . . . 0.0 115.259 169.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -64.15 -37.28 86.9 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 115.984 1.846 . . . . 0.0 115.984 169.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.4 t -64.67 -44.0 96.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 CA-C-N 120.718 1.599 . . . . 0.0 113.026 174.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.1 tp -69.5 -33.2 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 172.221 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 42.6 mt -64.95 -40.76 95.51 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 120.37 1.441 . . . . 0.0 114.107 168.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -65.47 -38.23 89.18 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 172.29 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 1.455 HH12 ' CG ' ' A' ' 88' ' ' ARG . 14.6 tpt180 -63.39 -43.7 96.81 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 169.686 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 67.4 mtt -66.04 -27.77 68.35 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 169.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -68.05 -44.56 76.11 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 169.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.5 p -66.06 -35.77 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 CA-C-N 120.514 1.507 . . . . 0.0 114.251 170.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -53.35 -56.33 17.61 Favored 'General case' 0 CA--C 1.581 2.151 0 CA-C-N 120.129 1.331 . . . . 0.0 111.522 167.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 49.9 ttt180 -53.88 -27.59 31.16 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 120.326 3.454 . . . . 0.0 120.326 173.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -54.61 -38.25 66.56 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 171.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -141.33 10.03 2.08 Favored 'General case' 0 CA--C 1.561 1.38 0 N-CA-C 119.389 3.107 . . . . 0.0 119.389 -168.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 80.3 m -47.49 -36.49 10.29 Favored 'General case' 0 N--CA 1.505 2.321 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 177.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.62 -60.95 4.13 Favored Pre-proline 0 CA--C 1.578 2.054 0 CA-C-O 116.254 -1.831 . . . . 0.0 112.021 173.39 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -51.07 -32.9 41.02 Favored 'Trans proline' 0 CA--C 1.578 2.689 0 C-N-CA 123.407 2.738 . . . . 0.0 118.351 167.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -67.08 -50.45 61.66 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 125.02 1.328 . . . . 0.0 111.797 176.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 1.173 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 58.3 tp -63.26 -23.53 67.46 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 170.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -70.41 -50.92 33.55 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 122.696 2.498 . . . . 0.0 113.108 165.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -61.27 -53.75 52.78 Favored 'General case' 0 CA--C 1.571 1.788 0 C-N-CA 124.141 0.976 . . . . 0.0 112.864 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -80.87 -17.62 50.05 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-O 116.006 -1.949 . . . . 0.0 113.82 177.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 1.173 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 31.7 ttt180 -69.66 -33.86 73.19 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 123.591 2.905 . . . . 0.0 115.733 167.212 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -73.11 -40.47 64.93 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 119.979 1.263 . . . . 0.0 113.659 167.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -82.14 -18.05 44.23 Favored 'General case' 0 CA--C 1.577 1.985 0 N-CA-C 119.142 3.016 . . . . 0.0 119.142 177.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.29 127.19 18.89 Favored 'General case' 0 CA--C 1.585 2.309 1 N-CA-C 123.692 4.701 . . . . 0.0 123.692 -159.754 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.968 ' HB3' HD12 ' A' ' 111' ' ' LEU 0.257 46.7 mmtm -92.88 -154.15 0.38 Allowed 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 123.716 1.722 . . . . 0.0 107.708 155.385 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.518 ' N ' ' H ' ' A' ' 112' ' ' GLU 0.763 0.4 OUTLIER -30.93 -164.83 0.0 OUTLIER 'General case' 0 CA--C 1.62 3.663 1 N-CA-C 128.041 6.312 . . . . 0.0 128.041 -146.103 . . . . . . . . 5 4 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . 0.601 ' O ' ' HB2' ' A' ' 114' ' ' ARG 0.475 2.1 t -88.4 -174.42 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.673 3 C-N-CA 139.219 7.008 . . . . 0.0 122.586 -146.687 . . . . . . . . 4 3 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.753 ' HA ' ' HB3' ' A' ' 114' ' ' ARG . 12.6 t70 -102.49 134.77 45.28 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 111.38 -2.645 . . . . 0.0 106.59 168.455 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -143.37 -146.03 0.18 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 117.057 2.243 . . . . 0.0 117.057 -155.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . 0.532 3.5 p 59.14 170.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 C-N-CA 128.503 2.721 . . . . 0.0 114.078 -174.548 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.81 -36.74 2.3 Favored Glycine 0 CA--C 1.568 3.362 0 C-N-CA 119.051 -1.547 . . . . 0.0 114.689 -149.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 72.0 p 36.31 86.82 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 117.69 2.478 . . . . 0.0 117.69 170.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 21.5 ptt? -159.24 -114.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 117.618 -1.182 . . . . 0.0 108.749 168.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -79.44 -36.82 38.32 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 121.236 1.835 . . . . 0.0 114.479 -179.344 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -60.16 -53.4 58.22 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 173.197 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 18.2 t -66.71 -31.67 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 CA-C-N 119.778 1.172 . . . . 0.0 111.533 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -58.78 -38.17 77.92 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 164.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.46 -50.69 64.43 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . 0.512 ' HB3' HG22 ' A' ' 162' ' ' VAL . 72.9 mtt180 -61.15 -42.18 98.09 Favored 'General case' 0 CA--C 1.557 1.216 0 N-CA-C 117.305 2.335 . . . . 0.0 117.305 169.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.04 -46.87 82.09 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 116.512 2.042 . . . . 0.0 116.512 172.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 6.0 mp -63.5 -39.49 94.57 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 117.832 -1.08 . . . . 0.0 113.756 168.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -50.42 -45.81 56.02 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 169.267 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -74.57 -42.83 58.05 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 116.14 1.904 . . . . 0.0 116.14 172.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 8.7 tt -73.57 -51.47 16.81 Favored 'General case' 0 CA--C 1.568 1.645 0 CA-C-N 121.005 1.73 . . . . 0.0 113.213 -179.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.931 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -114.74 -59.52 0.37 Allowed Glycine 0 CA--C 1.552 2.385 0 CA-C-O 117.709 -1.606 . . . . 0.0 114.507 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.931 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 63.7 tttm . . . . . 0 C--O 1.25 1.112 0 CA-C-N 120.391 2.096 . . . . 0.0 109.144 -177.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 CA--C 1.554 1.119 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.441 ' HB2' ' O ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -154.35 171.06 19.9 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -167.548 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 77.8 t -133.9 147.86 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.66 0 CA-C-O 124.316 2.008 . . . . 0.0 111.883 -164.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -119.21 140.47 50.16 Favored 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 111.783 -2.462 . . . . 0.0 105.522 167.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -115.84 123.51 48.35 Favored 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 124.906 1.283 . . . . 0.0 109.81 -178.05 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.8 mp -126.17 157.07 39.11 Favored 'General case' 0 CA--C 1.559 1.304 0 CA-C-N 112.627 -2.079 . . . . 0.0 109.748 -166.182 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 167.96 154.31 8.64 Favored Glycine 0 CA--C 1.554 2.504 0 N-CA-C 115.494 0.957 . . . . 0.0 115.494 169.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -73.85 177.42 8.13 Favored 'Trans proline' 0 CA--C 1.576 2.576 0 C-N-CA 123.173 2.582 . . . . 0.0 114.195 173.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -55.02 111.16 0.66 Allowed 'Trans proline' 0 CA--C 1.561 1.854 0 C-N-CA 123.44 2.76 . . . . 0.0 113.831 173.117 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 161.43 95.02 0.1 Allowed Glycine 0 CA--C 1.535 1.301 0 N-CA-C 107.532 -2.227 . . . . 0.0 107.532 -167.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.38 120.36 10.3 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 115.489 1.662 . . . . 0.0 115.489 -170.404 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 165.56 84.99 0.06 OUTLIER Glycine 0 CA--C 1.543 1.821 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 177.09 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . 0.811 ' HB3' ' OD1' ' A' ' 84' ' ' ASP . 7.7 mptt -153.1 -69.58 0.15 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.576 0.75 . . . . 0.0 111.1 -174.37 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -53.01 -27.34 29.86 Favored Glycine 0 CA--C 1.556 2.612 0 N-CA-C 120.952 3.141 . . . . 0.0 120.952 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 51.7 m -63.64 -51.44 65.18 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 119.892 1.846 . . . . 0.0 112.964 171.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.34 2.7 mp0 -77.91 -12.92 60.02 Favored 'General case' 0 CA--C 1.57 1.713 0 CA-C-O 115.088 -2.387 . . . . 0.0 112.537 172.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.43 -43.76 63.37 Favored 'General case' 0 C--N 1.376 1.733 0 CA-C-N 124.598 3.363 . . . . 0.0 114.142 165.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 93.4 t -65.74 -42.7 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-O 117.677 -1.154 . . . . 0.0 112.655 173.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . 0.448 ' HB3' ' HE1' ' A' ' 172' ' ' PHE . 95.1 mttt -68.01 -44.35 76.75 Favored 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 115.797 1.777 . . . . 0.0 115.797 174.906 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.88 -29.08 68.89 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 120.58 1.536 . . . . 0.0 114.317 171.756 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.56 -41.3 98.42 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 167.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.97 -40.58 80.96 Favored 'General case' 0 CA--C 1.566 1.559 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 167.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -66.18 -50.86 62.44 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 172.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.2 mt -83.16 -22.72 33.2 Favored 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 116.807 2.151 . . . . 0.0 116.807 -177.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.23 34.6 8.61 Favored Glycine 0 CA--C 1.555 2.547 0 N-CA-C 117.742 1.857 . . . . 0.0 117.742 -174.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.433 ' CG2' ' HA ' ' A' ' 81' ' ' PHE . 18.1 mm -105.43 152.46 39.94 Favored Pre-proline 0 CA--C 1.568 1.651 0 CA-C-N 119.149 1.474 . . . . 0.0 112.205 -169.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -82.6 99.74 0.95 Allowed 'Trans proline' 0 CA--C 1.564 1.988 0 CA-C-N 122.06 1.771 . . . . 0.0 108.668 162.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.22 116.92 11.14 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.991 0.9 . . . . 0.0 110.226 176.262 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 38.6 mm -97.91 108.25 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 -176.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 70.0 p -96.2 129.56 43.48 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 172.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.6 p -71.36 -8.66 55.18 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 -170.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.547 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -92.12 -17.64 46.28 Favored Glycine 0 CA--C 1.55 2.23 0 N-CA-C 118.29 2.076 . . . . 0.0 118.29 165.486 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -79.37 -55.83 4.77 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 119.097 1.449 . . . . 0.0 113.683 -168.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -60.06 -38.02 81.59 Favored 'General case' 0 CA--C 1.565 1.522 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 173.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.479 ' HB2' ' HB2' ' A' ' 50' ' ' LYS . 41.8 m-85 -67.88 -41.81 82.21 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 116.676 -1.63 . . . . 0.0 113.719 169.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.547 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 35.2 ttt180 -54.05 -40.13 66.84 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 116.587 2.069 . . . . 0.0 116.587 169.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -63.29 -39.72 95.37 Favored 'General case' 0 CA--C 1.566 1.578 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 169.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -67.64 -23.63 65.36 Favored 'General case' 0 CA--C 1.587 2.398 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 167.171 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.5 mt -62.35 -50.46 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.485 0 CA-C-N 121.609 2.004 . . . . 0.0 109.239 166.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -60.3 -40.99 92.46 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 175.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -70.01 -37.2 75.58 Favored 'General case' 0 CA--C 1.563 1.462 0 N-CA-C 116.84 2.163 . . . . 0.0 116.84 173.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.65 75.07 1.29 Allowed Glycine 0 CA--C 1.544 1.895 0 CA-C-O 117.754 -1.581 . . . . 0.0 114.733 -175.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.886 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 82.2 p -96.45 -62.81 1.21 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 119.683 1.742 . . . . 0.0 111.29 170.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.886 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.302 13.0 mttt 115.83 -42.75 0.01 OUTLIER 'General case' 0 CA--C 1.573 1.861 0 CA-C-O 116.064 -1.922 . . . . 0.0 108.871 -173.423 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.41 -14.96 60.49 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 123.395 2.816 . . . . 0.0 112.891 161.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.464 ' O ' ' HB3' ' A' ' 50' ' ' LYS . . . -58.99 -62.9 5.7 Favored Glycine 0 C--N 1.355 1.598 0 CA-C-N 120.11 1.323 . . . . 0.0 114.148 169.455 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.295 7.7 p -69.23 -51.4 43.51 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.302 0 N-CA-C 116.862 2.171 . . . . 0.0 116.862 -168.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -67.09 -45.93 75.78 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 119.923 1.238 . . . . 0.0 112.397 176.86 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.27 -28.97 67.66 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.479 ' HB2' ' HB2' ' A' ' 35' ' ' PHE 0.278 4.2 tptt -76.02 -37.43 58.42 Favored 'General case' 0 CA--C 1.559 1.319 0 CA-C-O 116.21 -1.852 . . . . 0.0 113.11 170.986 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -78.31 -45.57 22.36 Favored 'General case' 0 CA--C 1.602 2.968 1 CA-C-O 86.548 -15.977 . . . . 0.0 118.565 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 17.2 m-30 -31.07 -54.18 0.21 Allowed 'General case' 0 N--CA 1.498 1.937 1 O-C-N 108.236 -9.04 . . . . 0.0 120.467 145.215 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.49 -49.96 63.68 Favored 'General case' 0 CA--C 1.576 1.949 0 CA-C-N 121.796 2.089 . . . . 0.0 114.462 166.066 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -77.0 -44.81 29.55 Favored 'General case' 0 CA--C 1.565 1.542 0 N-CA-C 115.948 1.832 . . . . 0.0 115.948 177.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -87.22 -24.84 24.28 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 116.148 1.906 . . . . 0.0 116.148 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.32 22.64 11.31 Favored Glycine 0 CA--C 1.544 1.856 0 N-CA-C 117.883 1.913 . . . . 0.0 117.883 168.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -95.62 177.96 5.63 Favored 'General case' 0 CA--C 1.573 1.865 0 CA-C-N 118.617 1.208 . . . . 0.0 110.504 168.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.3 pp -76.64 124.17 27.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.494 -1.378 . . . . 0.0 112.836 -168.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 p -113.4 122.47 35.31 Favored Pre-proline 0 CA--C 1.567 1.627 0 C-N-CA 124.656 1.182 . . . . 0.0 108.601 -177.325 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -55.51 141.62 82.43 Favored 'Trans proline' 0 C--N 1.37 1.666 0 C-N-CA 123.449 2.766 . . . . 0.0 116.135 174.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.6 m -85.46 177.55 7.73 Favored 'General case' 0 CA--C 1.569 1.707 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.712 177.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.9 t70 82.09 -52.03 0.23 Allowed 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 125.77 1.628 . . . . 0.0 113.64 178.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.2 pp -58.17 -41.75 84.52 Favored 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 116.335 1.976 . . . . 0.0 116.335 168.387 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.5 m -58.63 -51.96 67.72 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 124.914 1.286 . . . . 0.0 113.313 170.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -62.08 -21.97 65.39 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 167.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -76.95 -45.86 26.15 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 125.366 1.466 . . . . 0.0 114.841 172.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.4 mt -61.97 -45.77 92.21 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 169.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 52.7 t -56.42 -55.55 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-O 117.944 -1.027 . . . . 0.0 111.497 171.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -61.22 -31.08 70.86 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 116.836 2.162 . . . . 0.0 116.836 175.485 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -60.61 -40.46 91.93 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-O 117.937 -1.03 . . . . 0.0 113.288 167.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -80.92 -23.37 38.95 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 118.521 2.786 . . . . 0.0 118.521 169.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 66.4 mt -85.59 -22.14 28.17 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 116.832 2.16 . . . . 0.0 116.832 178.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -68.77 8.37 0.52 Allowed 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 116.994 2.22 . . . . 0.0 116.994 169.434 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -66.45 144.0 98.47 Favored Pre-proline 0 CA--C 1.576 1.957 0 C-N-CA 124.261 1.025 . . . . 0.0 109.957 165.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -50.44 -37.37 51.18 Favored 'Trans proline' 0 N--CA 1.5 1.875 0 N-CA-C 118.412 2.428 . . . . 0.0 118.412 171.386 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -68.85 -15.03 63.39 Favored 'General case' 0 CA--C 1.57 1.72 0 CA-C-O 116.367 -1.778 . . . . 0.0 115.674 174.264 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -111.67 20.71 16.84 Favored 'General case' 0 CA--C 1.574 1.887 0 CA-C-N 122.566 2.439 . . . . 0.0 114.401 168.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.54 -52.4 32.41 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 121.453 1.933 . . . . 0.0 113.664 171.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -93.99 20.88 7.27 Favored 'General case' 0 CA--C 1.577 1.985 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 171.262 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -173.29 159.49 29.63 Favored Glycine 0 C--N 1.358 1.77 0 CA-C-N 122.028 2.195 . . . . 0.0 113.472 176.305 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.441 ' O ' ' HB2' ' A' ' 2' ' ' ARG . 30.3 p90 -179.08 135.04 0.13 Allowed 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 113.862 -1.169 . . . . 0.0 111.121 176.073 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 22.1 mt -114.33 109.41 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 105.037 -2.208 . . . . 0.0 105.037 172.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.4 mt -101.21 120.95 40.99 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 118.643 -0.694 . . . . 0.0 109.638 174.184 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.811 ' OD1' ' HB3' ' A' ' 13' ' ' LYS . 25.1 t70 -110.13 129.21 55.74 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 119.006 0.821 . . . . 0.0 110.983 -177.138 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 74.27 39.62 43.35 Favored Glycine 0 CA--C 1.552 2.361 0 CA-C-O 117.361 -1.799 . . . . 0.0 117.258 -178.5 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . 0.256 1.0 OUTLIER -103.8 -58.05 0.08 OUTLIER Pre-proline 0 N--CA 1.496 1.834 0 CA-C-O 113.35 -3.214 . . . . 0.0 111.01 -174.439 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -63.22 70.89 0.14 Allowed 'Trans proline' 0 CA--C 1.571 2.35 0 CA-C-N 126.724 3.437 . . . . 0.0 119.29 167.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -67.53 -29.53 68.96 Favored 'General case' 0 CA--C 1.567 1.623 0 C-N-CA 125.907 1.683 . . . . 0.0 114.503 166.359 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 77.1 p -151.02 159.52 44.5 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.05 1.34 . . . . 0.0 108.78 -172.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.0 t -64.73 -41.69 92.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 CA-C-O 117.425 -1.274 . . . . 0.0 110.752 167.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.16 -37.79 86.58 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 120.672 3.582 . . . . 0.0 120.672 178.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -75.92 -48.29 21.88 Favored 'General case' 0 CA--C 1.583 2.225 0 CA-C-N 122.586 2.448 . . . . 0.0 111.94 167.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.14 -31.5 72.65 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 117.485 2.402 . . . . 0.0 117.485 -171.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 64.3 tttt -60.34 -30.48 69.55 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 168.557 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.53 -47.6 75.35 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 168.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.9 tp -58.48 -41.96 86.43 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 170.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -72.81 -41.52 64.83 Favored 'General case' 0 CA--C 1.567 1.596 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 176.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 1.319 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 37.7 mt-10 -56.18 -32.62 64.51 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 165.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 1.329 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 26.8 ttt -84.72 -28.5 26.26 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 118.152 2.649 . . . . 0.0 118.152 173.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . 0.652 HD13 ' HG1' ' A' ' 105' ' ' THR . 64.0 tp -66.88 -54.22 24.48 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-N 120.319 1.418 . . . . 0.0 112.855 169.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -79.7 -49.55 11.93 Favored 'General case' 0 CA--C 1.563 1.472 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 176.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 1.319 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 38.0 mmt180 -68.64 -45.39 71.96 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 175.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 1.329 ' HB3' ' O ' ' A' ' 99' ' ' MET . 74.8 ttt180 -61.4 -57.25 13.01 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 118.843 0.747 . . . . 0.0 111.398 165.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.82 43.16 1.05 Allowed Glycine 0 N--CA 1.479 1.536 0 O-C-N 124.41 1.069 . . . . 0.0 113.941 169.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.652 ' HG1' HD13 ' A' ' 100' ' ' LEU . 40.2 p -90.97 147.18 23.27 Favored 'General case' 0 CA--C 1.559 1.318 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 168.831 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -65.12 130.62 44.01 Favored 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -169.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.5 tp -90.43 99.17 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 125.344 1.458 . . . . 0.0 107.512 177.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -98.55 -75.15 0.56 Allowed 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 115.898 -2.001 . . . . 0.0 108.419 168.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -136.3 117.37 14.36 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 121.644 2.02 . . . . 0.0 113.459 -174.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.4 t -94.99 108.07 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 101.628 -3.471 . . . . 0.0 101.628 167.796 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.555 HD21 ' HB3' ' A' ' 160' ' ' LYS . 78.8 mt -109.19 105.33 14.73 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -164.114 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -90.55 130.9 36.54 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.93 0.871 . . . . 0.0 111.478 172.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -100.38 110.1 22.29 Favored 'General case' 0 CA--C 1.559 1.316 0 CA-C-N 114.227 -1.351 . . . . 0.0 109.426 -176.603 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . 0.25 71.8 ttt180 -73.11 101.12 3.21 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 126.835 2.054 . . . . 0.0 109.497 169.039 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.9 p -130.4 161.79 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.584 0 CA-C-N 112.416 -2.175 . . . . 0.0 110.491 -165.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.1 m -103.81 151.86 22.57 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.164 -168.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -59.77 -45.82 91.09 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 168.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -51.65 -39.24 57.79 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 117.343 2.349 . . . . 0.0 117.343 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.4 m -61.36 -46.3 96.88 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.405 0 N-CA-C 117.011 2.226 . . . . 0.0 117.011 172.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.498 ' O ' ' HB2' ' A' ' 123' ' ' ARG . 8.6 tt -55.47 -39.39 70.32 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 115.039 -0.982 . . . . 0.0 113.547 166.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 25.4 mt -60.26 -38.12 82.56 Favored 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 170.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -57.01 -47.32 81.14 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 167.176 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.498 ' HB2' ' O ' ' A' ' 120' ' ' LEU . 31.2 mmt180 -51.61 -45.37 63.21 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 116.702 2.112 . . . . 0.0 116.702 167.409 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 70.6 mt -60.82 -48.12 83.23 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.042 1.497 . . . . 0.0 115.042 171.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -56.72 -45.9 81.63 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 172.753 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -102.77 70.54 0.31 Allowed Glycine 0 CA--C 1.543 1.81 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 167.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -38.66 134.46 0.94 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 119.032 2.975 . . . . 0.0 119.032 -168.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 129' ' ' ARG . . . -162.16 -164.35 16.94 Favored Glycine 0 CA--C 1.569 3.416 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.421 -174.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . 0.467 ' HB2' ' O ' ' A' ' 128' ' ' GLY . 2.2 mpt_? 73.53 -138.31 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 120.988 2.394 . . . . 0.0 113.484 176.218 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.467 ' H ' ' HB3' ' A' ' 129' ' ' ARG . . . -121.47 36.37 4.63 Favored 'General case' 0 CA--C 1.572 1.803 0 CA-C-N 111.452 -2.613 . . . . 0.0 112.164 167.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -73.61 92.28 1.93 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 126.05 1.74 . . . . 0.0 110.34 -178.137 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -88.09 63.73 7.42 Favored 'General case' 0 CA--C 1.574 1.891 0 CA-C-N 111.664 -2.516 . . . . 0.0 106.98 163.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 32.0 p -0.35 117.92 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 120.937 3.68 . . . . 0.0 120.937 -165.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.293 1.2 p30 76.69 -42.45 0.43 Allowed 'General case' 0 N--CA 1.502 2.146 0 CA-C-N 111.013 -2.812 . . . . 0.0 116.011 168.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -69.43 -35.29 75.56 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 172.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.6 t -59.15 -46.31 92.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 169.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.4 tp -73.6 -31.25 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 175.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 38.5 tp -66.95 -37.5 84.39 Favored 'General case' 0 CA--C 1.571 1.781 0 CA-C-N 120.962 1.71 . . . . 0.0 113.381 168.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -68.79 -36.1 77.85 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 120.797 1.635 . . . . 0.0 113.96 169.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -57.28 -37.98 73.23 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 115.262 1.579 . . . . 0.0 115.262 165.297 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 24.9 ttt -67.2 -33.97 76.52 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 168.678 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 60.9 mttm -60.73 -50.73 72.32 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 169.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.4 p -64.08 -31.53 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 170.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -54.45 -49.5 69.92 Favored 'General case' 0 CA--C 1.583 2.226 0 CA-C-N 119.755 1.161 . . . . 0.0 112.104 167.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 66.9 ttt180 -60.04 -41.4 92.21 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 118.461 2.763 . . . . 0.0 118.461 174.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -51.38 -29.06 14.34 Favored 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 118.998 2.962 . . . . 0.0 118.998 172.702 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -132.9 -37.31 1.01 Allowed 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 119.635 3.198 . . . . 0.0 119.635 -163.243 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 86.0 m -46.51 -39.69 11.26 Favored 'General case' 0 N--CA 1.504 2.248 0 N-CA-C 118.654 2.835 . . . . 0.0 118.654 -167.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.72 -61.4 3.69 Favored Pre-proline 0 CA--C 1.579 2.087 0 CA-C-O 116.466 -1.731 . . . . 0.0 112.118 175.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_exo -51.85 -31.16 41.45 Favored 'Trans proline' 0 CA--C 1.579 2.748 0 C-N-CA 123.387 2.725 . . . . 0.0 118.392 167.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.43 -54.38 33.62 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 125.515 1.526 . . . . 0.0 111.955 174.153 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 1.157 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 52.1 tp -65.47 -21.7 66.66 Favored 'General case' 0 CA--C 1.566 1.566 0 CA-C-O 116.803 -1.57 . . . . 0.0 114.801 175.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -71.44 -50.66 29.59 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 122.227 2.285 . . . . 0.0 113.307 164.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -65.86 -52.48 49.94 Favored 'General case' 0 CA--C 1.566 1.576 0 CA-C-N 120.466 1.484 . . . . 0.0 112.401 -178.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -76.59 -30.48 57.01 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-O 114.994 -2.431 . . . . 0.0 111.393 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 1.157 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 32.1 ttt180 -59.68 -34.05 72.36 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 124.955 3.525 . . . . 0.0 116.91 168.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -68.58 -41.88 79.04 Favored 'General case' 0 CA--C 1.573 1.83 0 CA-C-N 119.659 1.118 . . . . 0.0 113.519 167.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 38.9 mm-40 -90.63 -19.37 23.74 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 119.99 3.33 . . . . 0.0 119.99 -178.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.7 pp -77.97 179.72 6.59 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 119.506 3.15 . . . . 0.0 119.506 -161.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.555 ' HB3' HD21 ' A' ' 111' ' ' LEU . 50.9 mttt -135.59 135.88 40.62 Favored 'General case' 0 CA--C 1.564 1.493 0 N-CA-C 105.113 -2.18 . . . . 0.0 105.113 167.934 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 42.0 m -100.34 146.15 27.3 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 122.217 1.008 . . . . 0.0 110.269 -172.127 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 43.1 t -131.36 136.11 58.17 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.392 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 167.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -94.95 126.97 40.65 Favored 'General case' 0 CA--C 1.565 1.555 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 169.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -109.34 7.85 25.29 Favored 'General case' 0 N--CA 1.493 1.678 1 N-CA-C 126.339 5.681 . . . . 0.0 126.339 -159.596 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . 0.486 29.2 m -111.17 -127.79 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.594 2.641 1 CA-C-O 109.954 -4.831 . . . . 0.0 107.597 -178.009 . . . . . . . . 3 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 53.38 -3.11 0.01 OUTLIER Glycine 0 C--N 1.391 3.591 3 CA-C-N 133.611 7.459 . . . . 0.0 126.235 -168.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 69.0 p 59.51 80.12 0.21 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 127.377 2.271 . . . . 0.0 115.501 173.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . 0.25 59.2 mtt 78.01 -75.51 0.05 Allowed 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 126.202 1.801 . . . . 0.0 114.119 167.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -61.51 -39.48 91.13 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 115.925 1.824 . . . . 0.0 115.925 -174.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -60.18 -52.79 63.8 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 169.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 2.7 t -59.27 -35.25 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . 0.448 ' HE1' ' HB3' ' A' ' 19' ' ' LYS . 8.4 t80 -61.16 -40.81 95.27 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 167.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.12 -43.49 95.12 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 115.089 1.515 . . . . 0.0 115.089 175.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 82.2 mtt-85 -71.73 -36.74 70.58 Favored 'General case' 0 CA--C 1.56 1.36 0 N-CA-C 116.265 1.95 . . . . 0.0 116.265 173.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.38 -44.16 92.21 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 171.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.7 mp -64.88 -42.08 95.11 Favored 'General case' 0 CA--C 1.567 1.612 0 CA-C-O 117.148 -1.406 . . . . 0.0 110.656 167.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -46.64 -41.61 14.99 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 117.567 2.432 . . . . 0.0 117.567 168.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -67.1 -48.51 67.95 Favored 'General case' 0 CA--C 1.562 1.431 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 168.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 5.8 tt -86.25 -58.13 2.75 Favored 'General case' 0 CA--C 1.57 1.72 0 CA-C-N 120.275 1.398 . . . . 0.0 113.575 -176.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 0.547 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -118.49 -56.88 0.27 Allowed Glycine 0 CA--C 1.553 2.438 0 CA-C-O 117.339 -1.811 . . . . 0.0 116.353 -174.811 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 0.547 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 38.9 ttmt . . . . . 0 C--O 1.251 1.166 0 CA-C-N 120.957 2.378 . . . . 0.0 108.207 -173.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.451 ' H2 ' HH11 ' A' ' 2' ' ' ARG . 41.5 ttm . . . . . 0 CA--C 1.56 1.328 0 CA-C-O 122.517 1.151 . . . . 0.0 109.631 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.451 HH11 ' H2 ' ' A' ' 1' ' ' MET 0.263 11.4 mpt_? -123.64 162.25 23.43 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 120.582 3.549 . . . . 0.0 120.582 -161.398 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.8 p -151.08 147.36 15.67 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.744 0 CA-C-O 123.931 1.825 . . . . 0.0 114.424 167.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.3 mt -131.83 133.44 44.68 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-N 111.42 -2.627 . . . . 0.0 108.375 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.48 120.26 41.03 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -169.062 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.8 mt -110.37 135.74 50.62 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 112.231 -2.258 . . . . 0.0 109.568 175.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 173.84 168.43 34.81 Favored Glycine 0 CA--C 1.56 2.869 0 N-CA-C 115.848 1.099 . . . . 0.0 115.848 171.591 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' PRO . . . . . 0.427 ' HA ' ' HH ' ' A' ' 144' ' ' TYR . 53.2 Cg_exo -62.44 152.59 76.27 Favored 'Trans proline' 0 CA--C 1.572 2.378 0 C-N-CA 123.44 2.76 . . . . 0.0 116.725 179.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.509 ' HG3' ' HB3' ' A' ' 140' ' ' ARG . 74.4 Cg_endo -77.47 98.93 1.25 Allowed 'Trans proline' 0 CA--C 1.56 1.815 0 C-N-CA 123.296 2.664 . . . . 0.0 113.589 -173.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.726 ' HA2' ' HG2' ' A' ' 123' ' ' ARG . . . 137.81 -64.43 0.56 Allowed Glycine 0 N--CA 1.485 1.925 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 -169.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -33.11 159.29 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.539 0 N-CA-C 119.839 3.274 . . . . 0.0 119.839 173.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.86 116.3 9.02 Favored Glycine 0 CA--C 1.546 2.003 0 N-CA-C 115.293 0.877 . . . . 0.0 115.293 -174.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -152.3 -75.09 0.14 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.261 0.624 . . . . 0.0 109.761 -169.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -57.84 -30.66 63.31 Favored Glycine 0 CA--C 1.552 2.386 0 N-CA-C 120.053 2.781 . . . . 0.0 120.053 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 54.6 m -66.78 -53.82 29.09 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 119.852 1.826 . . . . 0.0 112.539 176.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -74.31 -16.79 60.92 Favored 'General case' 0 CA--C 1.573 1.84 0 CA-C-O 116.057 -1.925 . . . . 0.0 112.403 172.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.57 -41.31 63.09 Favored 'General case' 0 C--N 1.372 1.582 0 CA-C-N 123.288 2.767 . . . . 0.0 114.912 169.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.7 t -69.03 -39.26 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 CA-C-O 117.644 -1.169 . . . . 0.0 111.789 171.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -61.62 -46.39 90.01 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 116.353 1.983 . . . . 0.0 116.353 170.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.93 -33.49 75.94 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 172.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.06 -41.6 96.92 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 167.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -59.49 -38.12 80.03 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 166.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -66.09 -50.78 62.9 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 116.142 1.905 . . . . 0.0 116.142 171.169 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.5 mt -81.39 -24.49 36.95 Favored 'General case' 0 CA--C 1.571 1.78 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 -178.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.15 37.07 7.89 Favored Glycine 0 CA--C 1.555 2.542 0 N-CA-C 117.771 1.868 . . . . 0.0 117.771 -176.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.44 ' CG2' ' HA ' ' A' ' 81' ' ' PHE . 14.1 mm -109.24 159.2 32.17 Favored Pre-proline 0 CA--C 1.567 1.624 0 CA-C-N 118.833 1.317 . . . . 0.0 113.53 -168.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -71.67 100.6 1.07 Allowed 'Trans proline' 0 CA--C 1.563 1.969 0 C-N-CA 122.0 1.8 . . . . 0.0 114.224 160.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -73.41 109.85 7.25 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.383 -0.823 . . . . 0.0 111.044 167.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.3 mm -98.23 119.84 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 167.419 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 62.9 p -99.89 124.66 45.43 Favored 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 161.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.5 p -66.05 -18.61 65.45 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 117.306 2.335 . . . . 0.0 117.306 -169.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.425 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -80.29 -18.93 70.37 Favored Glycine 0 CA--C 1.548 2.098 0 N-CA-C 118.805 2.282 . . . . 0.0 118.805 168.187 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -80.24 -49.86 11.02 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -169.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -69.15 -36.35 77.33 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 174.439 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PHE . . . . . 0.458 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 42.5 m-85 -66.95 -38.48 86.21 Favored 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 125.379 1.472 . . . . 0.0 114.575 169.539 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.425 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 29.5 ttp180 -61.21 -40.67 94.85 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-N 120.109 1.322 . . . . 0.0 113.578 166.779 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -59.14 -37.15 76.58 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 168.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -66.36 -31.91 72.97 Favored 'General case' 0 CA--C 1.573 1.828 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 166.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.36 -45.68 97.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 CA-C-N 120.092 1.314 . . . . 0.0 112.65 170.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -68.17 -39.89 82.43 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 120.074 1.307 . . . . 0.0 113.814 174.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -77.05 -28.99 54.96 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 116.849 2.166 . . . . 0.0 116.849 178.143 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.08 74.17 1.28 Allowed Glycine 0 CA--C 1.542 1.757 0 CA-C-O 118.088 -1.395 . . . . 0.0 115.168 178.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.879 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 62.6 p -91.62 -60.24 1.93 Allowed 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 119.127 1.464 . . . . 0.0 111.285 169.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.879 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.287 13.4 mttt 114.44 -40.88 0.01 OUTLIER 'General case' 0 CA--C 1.567 1.604 0 CA-C-O 115.874 -2.012 . . . . 0.0 109.534 -173.103 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.14 -23.18 60.44 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 123.609 2.913 . . . . 0.0 111.729 161.146 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.55 -54.85 33.21 Favored Glycine 0 C--N 1.352 1.436 0 C-N-CA 125.673 1.606 . . . . 0.0 115.912 174.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.293 0.8 OUTLIER -65.62 -57.0 12.54 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.714 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -179.717 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -67.81 -51.01 53.69 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 120.033 1.288 . . . . 0.0 112.344 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.25 -19.51 65.52 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 176.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . 0.458 ' HB2' ' HB3' ' A' ' 35' ' ' PHE . 14.1 tmtt? -74.53 -45.52 45.15 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 120.577 1.535 . . . . 0.0 112.929 167.911 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -75.08 -48.37 24.24 Favored 'General case' 0 CA--C 1.583 2.227 1 CA-C-O 85.341 -16.552 . . . . 0.0 119.564 -176.066 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 12.9 m-30 -34.5 -54.33 0.53 Allowed 'General case' 0 N--CA 1.496 1.871 1 O-C-N 109.293 -8.38 . . . . 0.0 120.481 146.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.6 tp -59.41 -30.95 68.83 Favored 'General case' 0 CA--C 1.579 2.093 0 CA-C-N 122.366 2.348 . . . . 0.0 115.569 167.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -91.27 -41.79 10.75 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 115.964 1.838 . . . . 0.0 115.964 170.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.97 -35.29 26.05 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.42 34.04 5.18 Favored Glycine 0 N--CA 1.476 1.344 0 N-CA-C 118.146 2.018 . . . . 0.0 118.146 167.358 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -93.55 -129.69 0.13 Allowed 'General case' 0 CA--C 1.567 1.612 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 169.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 88.2 mt -103.12 97.58 7.65 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 119.971 1.259 . . . . 0.0 110.322 -169.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 p -104.03 118.2 57.66 Favored Pre-proline 0 CA--C 1.568 1.661 0 CA-C-O 117.603 -1.189 . . . . 0.0 108.786 176.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -57.26 141.4 94.57 Favored 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 123.491 2.794 . . . . 0.0 116.383 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 74.1 m -71.29 -49.91 38.01 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -65.79 -39.02 90.54 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 -177.083 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 28.4 mt -56.58 -50.57 71.54 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 117.54 2.422 . . . . 0.0 117.54 175.029 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 35.7 m -64.57 -46.46 82.64 Favored 'General case' 0 CA--C 1.566 1.593 0 CA-C-N 112.553 -2.112 . . . . 0.0 112.982 174.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -61.6 -21.5 64.4 Favored 'General case' 0 CA--C 1.577 2.003 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 165.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -75.11 -40.53 59.81 Favored 'General case' 0 CA--C 1.556 1.19 0 CA-C-N 121.026 1.739 . . . . 0.0 115.228 169.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 mt -59.89 -48.98 79.5 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-N 120.21 1.368 . . . . 0.0 114.129 167.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.532 HG23 HH21 ' A' ' 71' ' ' ARG . 0.4 OUTLIER -57.62 -44.64 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 172.667 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -67.17 -33.27 75.05 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.689 1.737 . . . . 0.0 115.689 169.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -58.62 -42.1 87.45 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 117.524 -1.227 . . . . 0.0 113.125 170.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ARG . . . . . 0.532 HH21 HG23 ' A' ' 68' ' ' VAL . 3.2 ppt_? -80.24 -16.99 53.5 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 118.582 2.808 . . . . 0.0 118.582 167.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.518 ' C ' ' H ' ' A' ' 74' ' ' ASN . 12.3 mt -103.96 3.41 33.49 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 119.192 3.034 . . . . 0.0 119.192 174.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -77.95 37.06 0.24 Allowed 'General case' 0 N--CA 1.505 2.285 0 CA-C-O 123.635 1.683 . . . . 0.0 112.558 162.543 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.518 ' H ' ' C ' ' A' ' 72' ' ' LEU 0.336 7.3 m120 -122.64 146.02 46.66 Favored Pre-proline 0 CA--C 1.569 1.677 0 C-N-CA 128.272 2.629 . . . . 0.0 106.835 -172.564 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -49.45 -23.25 7.19 Favored 'Trans proline' 0 N--CA 1.507 2.293 0 N-CA-C 122.091 3.843 . . . . 0.0 122.091 175.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -63.53 -12.28 31.01 Favored 'General case' 0 CA--C 1.571 1.788 0 CA-C-O 115.558 -2.163 . . . . 0.0 114.344 166.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.89 -21.78 62.36 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 123.795 2.998 . . . . 0.0 114.867 167.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.47 -38.37 89.59 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 120.711 1.596 . . . . 0.0 115.079 167.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -92.18 -9.39 42.51 Favored 'General case' 0 CA--C 1.568 1.644 0 N-CA-C 117.533 2.42 . . . . 0.0 117.533 178.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.76 -178.2 30.03 Favored Glycine 0 C--N 1.357 1.726 0 CA-C-N 122.794 2.543 . . . . 0.0 115.933 -176.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' PHE . . . . . 0.44 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . 32.0 p90 -167.48 138.59 3.03 Favored 'General case' 0 CA--C 1.551 1.019 0 CA-C-N 111.386 -2.407 . . . . 0.0 106.099 169.432 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -115.38 109.34 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 102.847 -3.02 . . . . 0.0 102.847 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.5 mt -109.82 141.96 41.75 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.518 0.727 . . . . 0.0 109.707 175.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -130.88 127.84 39.36 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 118.364 0.529 . . . . 0.0 111.928 169.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.56 39.04 86.98 Favored Glycine 0 CA--C 1.556 2.604 0 N-CA-C 117.378 1.711 . . . . 0.0 117.378 -178.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -99.63 -52.93 0.19 Allowed Pre-proline 0 N--CA 1.498 1.936 0 CA-C-O 115.139 -2.362 . . . . 0.0 108.807 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -66.41 72.06 0.41 Allowed 'Trans proline' 0 CA--C 1.568 2.199 0 CA-C-N 124.211 2.54 . . . . 0.0 117.932 165.26 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -65.32 -39.28 92.24 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 167.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.0 t -148.96 153.28 37.73 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -169.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.4 t -59.92 -38.49 76.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-O 117.298 -1.334 . . . . 0.0 112.355 178.414 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.66 -34.2 73.94 Favored 'General case' 0 C--N 1.361 1.074 0 N-CA-C 120.091 3.367 . . . . 0.0 120.091 173.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.04 -49.51 13.86 Favored 'General case' 0 CA--C 1.586 2.349 0 CA-C-N 122.326 2.33 . . . . 0.0 111.46 166.295 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.0 -31.43 71.81 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 117.102 2.26 . . . . 0.0 117.102 -170.113 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 58.5 tttt -61.97 -29.26 70.12 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 167.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.37 -39.55 74.55 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 167.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.3 tp -63.11 -36.5 83.79 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 168.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' HIS . . . . . 0.401 ' CG ' ' HH ' ' A' ' 154' ' ' TYR . 57.0 t60 -63.84 -43.77 95.15 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 120.261 1.391 . . . . 0.0 113.243 167.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' GLU . . . . . 1.229 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 32.2 mt-10 -54.38 -33.51 59.33 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 167.574 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' MET . . . . . 0.997 ' O ' ' CB ' ' A' ' 103' ' ' ARG . 1.7 tmt? -85.99 -31.41 22.06 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 118.451 2.759 . . . . 0.0 118.451 171.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 tt -70.89 -53.59 14.53 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-N 121.257 1.844 . . . . 0.0 111.067 172.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -76.56 -50.95 12.61 Favored 'General case' 0 CA--C 1.564 1.507 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 174.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 1.229 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 25.2 mmt85 -71.0 -43.04 68.8 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 177.494 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.997 ' CB ' ' O ' ' A' ' 99' ' ' MET . 0.2 OUTLIER -61.93 -57.15 12.82 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 118.842 0.747 . . . . 0.0 111.083 165.995 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 111.54 47.48 0.74 Allowed Glycine 0 N--CA 1.481 1.648 0 O-C-N 124.227 0.954 . . . . 0.0 114.46 167.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 61.9 p -85.48 155.84 21.06 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-N 113.85 -1.175 . . . . 0.0 109.538 168.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -71.34 132.04 44.3 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.343 -0.848 . . . . 0.0 110.982 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 6.5 tp -93.84 96.71 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 -175.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -98.97 -73.29 0.63 Allowed 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 115.796 -2.049 . . . . 0.0 109.062 170.734 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -149.54 124.89 10.21 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 117.564 2.431 . . . . 0.0 117.564 -167.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 62.0 t -92.84 113.55 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 102.66 -3.089 . . . . 0.0 102.66 160.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.457 HD21 ' HB3' ' A' ' 160' ' ' LYS . 71.5 mt -98.15 101.31 12.74 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.838 -178.072 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -89.01 115.65 26.73 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.849 169.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -92.91 112.23 24.12 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 124.446 1.098 . . . . 0.0 111.478 -175.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ARG . . . . . 0.51 ' HB3' ' HA ' ' A' ' 163' ' ' ASP . 13.5 tpt180 -81.21 97.38 7.59 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.582 1.553 . . . . 0.0 109.053 168.616 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 43.5 t -125.58 150.11 30.69 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.591 0 C-N-CA 126.142 1.777 . . . . 0.0 106.965 -170.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 63.5 p -70.63 143.0 51.59 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 114.58 -1.191 . . . . 0.0 113.014 178.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.95 -30.05 65.66 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 116.023 1.86 . . . . 0.0 116.023 176.808 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -54.5 -35.77 63.47 Favored 'General case' 0 CA--C 1.565 1.543 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 169.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.3 t -64.16 -42.64 96.19 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 CA-C-N 119.542 1.065 . . . . 0.0 113.016 170.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . 0.406 ' HA ' ' HA3' ' A' ' 10' ' ' GLY . 0.9 OUTLIER -60.32 -32.44 71.24 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 167.364 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.7 mp -65.39 -40.2 93.15 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 169.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -62.58 -46.45 88.26 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 171.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.726 ' HG2' ' HA2' ' A' ' 10' ' ' GLY . 21.9 tpt180 -56.62 -43.96 80.71 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 169.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 8.7 mt -53.95 -59.51 4.54 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 167.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -77.28 -65.83 0.9 Allowed 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 -174.336 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.745 ' O ' ' CB ' ' A' ' 127' ' ' ARG . . . 68.34 63.9 3.36 Favored Glycine 0 CA--C 1.548 2.107 0 N-CA-C 115.438 0.935 . . . . 0.0 115.438 -173.379 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . 0.745 ' CB ' ' O ' ' A' ' 126' ' ' GLY . 11.3 tpt180 108.76 -86.71 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 175.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.431 ' H ' ' HB3' ' A' ' 127' ' ' ARG . . . -148.45 70.13 0.33 Allowed Glycine 0 CA--C 1.554 2.487 0 CA-C-O 116.858 -2.079 . . . . 0.0 111.546 -169.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 26.3 mtt180 -149.06 94.72 2.28 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 121.58 2.69 . . . . 0.0 108.17 -173.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -72.04 -29.54 64.27 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 118.106 2.632 . . . . 0.0 118.106 -170.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -56.42 -76.92 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 120.567 1.531 . . . . 0.0 111.965 168.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.7 p30 35.51 42.57 0.13 Allowed 'General case' 0 N--CA 1.51 2.551 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -166.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' THR . . . . . . . . . . . . 0.285 0.6 OUTLIER 8.7 116.67 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 119.695 3.22 . . . . 0.0 119.695 -159.347 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -55.54 -38.69 69.61 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 112.641 -2.072 . . . . 0.0 113.695 165.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -63.95 -33.54 75.95 Favored 'General case' 0 CA--C 1.561 1.378 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 166.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -58.18 -50.23 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-N 121.902 2.137 . . . . 0.0 113.338 169.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.0 tp -69.6 -32.01 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 176.205 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 47.9 mt -65.86 -36.49 83.58 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 119.834 1.197 . . . . 0.0 113.977 167.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' ASN . . . . . 0.401 ' O ' ' HB2' ' A' ' 142' ' ' LYS . 5.9 t-20 -64.61 -37.18 86.67 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 170.001 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' ARG . . . . . 0.509 ' HB3' ' HG3' ' A' ' 9' ' ' PRO . 43.5 mmt-85 -64.3 -40.57 96.2 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 168.034 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 93.5 mmm -60.47 -26.97 67.18 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 165.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' LYS . . . . . 0.401 ' HB2' ' O ' ' A' ' 139' ' ' ASN . 95.6 mttt -65.73 -40.08 91.82 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 120.249 1.386 . . . . 0.0 113.43 164.137 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.8 t -63.47 -27.22 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 CA-C-N 119.794 1.179 . . . . 0.0 112.958 168.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' TYR . . . . . 0.427 ' HH ' ' HA ' ' A' ' 8' ' ' PRO . 8.1 m-85 -66.14 -51.56 56.73 Favored 'General case' 0 CA--C 1.575 1.939 0 CA-C-N 120.748 1.613 . . . . 0.0 112.538 165.644 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 47.9 ttt180 -52.4 -26.59 12.94 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 120.238 3.421 . . . . 0.0 120.238 177.309 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.81 -67.58 0.3 Allowed 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 119.911 1.232 . . . . 0.0 112.432 169.441 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -148.84 22.82 0.99 Allowed 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 119.534 3.161 . . . . 0.0 119.534 -168.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 69.4 m -56.48 -29.06 61.3 Favored 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -71.49 -60.89 2.36 Favored Pre-proline 0 CA--C 1.58 2.099 0 CA-C-O 116.093 -1.908 . . . . 0.0 112.118 171.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -52.65 -33.19 57.97 Favored 'Trans proline' 0 CA--C 1.576 2.608 0 C-N-CA 123.458 2.772 . . . . 0.0 118.806 168.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.76 -52.14 53.44 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 125.259 1.423 . . . . 0.0 111.161 174.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' LEU . . . . . 1.16 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 49.1 tp -62.49 -21.78 65.75 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 171.352 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -72.01 -49.86 33.46 Favored 'General case' 0 CA--C 1.564 1.49 0 CA-C-N 122.759 2.527 . . . . 0.0 113.694 165.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.401 ' HH ' ' CG ' ' A' ' 97' ' ' HIS . 16.0 t80 -63.23 -54.06 43.37 Favored 'General case' 0 CA--C 1.567 1.629 0 CA-C-N 120.494 1.497 . . . . 0.0 112.676 178.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -74.06 -32.88 63.48 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-O 115.275 -2.298 . . . . 0.0 112.177 178.067 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ARG . . . . . 1.16 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 32.6 ttt180 -58.85 -34.91 72.11 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 124.187 3.176 . . . . 0.0 116.939 169.839 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -68.13 -38.84 82.64 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 167.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -89.3 -26.04 21.35 Favored 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 119.449 3.129 . . . . 0.0 119.449 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.4 pp -81.2 175.45 10.61 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 118.119 2.637 . . . . 0.0 118.119 -163.103 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' LYS . . . . . 0.457 ' HB3' HD21 ' A' ' 111' ' ' LEU . 35.9 tttp -123.49 128.99 50.57 Favored 'General case' 0 CA--C 1.561 1.376 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 164.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 11.0 t -101.96 144.63 30.34 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 122.536 1.16 . . . . 0.0 110.065 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 27.7 t -110.52 130.51 63.7 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.325 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 169.794 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' ASP . . . . . 0.51 ' HA ' ' HB3' ' A' ' 114' ' ' ARG . 16.5 t70 -103.7 117.46 34.42 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 102.593 -3.114 . . . . 0.0 102.593 168.129 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -121.77 -174.44 2.87 Favored 'General case' 0 CA--C 1.555 1.136 0 N-CA-C 117.831 2.53 . . . . 0.0 117.831 -157.042 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . 0.543 0.9 OUTLIER 69.5 -115.31 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.296 0 CA-C-N 109.667 -3.424 . . . . 0.0 115.008 167.813 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 78.61 -68.9 2.91 Favored Glycine 0 CA--C 1.556 2.639 1 CA-C-N 126.201 4.092 . . . . 0.0 112.709 -159.189 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 35.5 p -129.4 -153.05 0.54 Allowed 'General case' 0 CA--C 1.582 2.19 0 C-N-CA 127.601 2.36 . . . . 0.0 108.915 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 14.8 tpt -98.97 -59.43 1.73 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.83 -1.169 . . . . 0.0 112.835 174.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -57.41 -31.75 66.16 Favored 'General case' 0 N--CA 1.512 2.644 0 N-CA-C 117.948 2.573 . . . . 0.0 117.948 -177.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -46.51 -50.4 17.14 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 169.41 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 3.8 t -52.08 -38.77 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 175.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -63.14 -41.81 99.35 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 120.649 1.568 . . . . 0.0 114.829 168.455 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -57.38 -52.0 67.11 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 174.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 10.4 mtt-85 -66.02 -37.66 86.47 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 117.815 2.524 . . . . 0.0 117.815 174.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.67 -45.56 93.67 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 115.72 1.748 . . . . 0.0 115.72 172.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . 0.281 0.4 OUTLIER -72.27 -35.16 68.66 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 169.935 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -53.3 -41.83 66.02 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 167.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.86 -54.76 29.88 Favored 'General case' 0 CA--C 1.561 1.403 0 N-CA-C 114.73 1.382 . . . . 0.0 114.73 168.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 5.4 tt -81.68 -63.29 1.42 Allowed 'General case' 0 CA--C 1.565 1.558 0 CA-C-O 117.597 -1.192 . . . . 0.0 113.142 -176.112 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' GLY . . . . . 1.131 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -89.21 -48.72 3.7 Favored Glycine 0 CA--C 1.551 2.337 0 CA-C-N 120.915 1.689 . . . . 0.0 116.106 -174.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' LYS . . . . . 1.131 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.303 0 CA-C-N 119.259 1.529 . . . . 0.0 108.988 -175.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.5 mtt . . . . . 0 CA--C 1.558 1.276 0 CA-C-O 122.772 1.273 . . . . 0.0 111.881 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.439 ' HG3' HH11 ' A' ' 2' ' ' ARG 0.3 5.8 ttm-85 -150.27 152.99 35.37 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 116.612 2.079 . . . . 0.0 116.612 -162.777 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.5 t -141.59 145.04 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 CA-C-O 124.176 1.941 . . . . 0.0 111.098 -174.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -125.26 135.41 52.49 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 112.509 -2.132 . . . . 0.0 106.944 175.102 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.98 114.35 23.68 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-O 122.452 1.12 . . . . 0.0 110.533 -169.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.29 160.9 17.85 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 113.053 -1.885 . . . . 0.0 110.562 -168.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 151.8 149.36 5.06 Favored Glycine 0 CA--C 1.555 2.548 0 CA-C-O 118.2 -1.333 . . . . 0.0 114.129 169.789 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo . . . . . 0 CA--C 1.574 2.511 0 C-N-CA 123.375 2.717 . . . . 0.0 116.532 169.576 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.1 mtmm . . . . . 0 N--CA 1.485 1.294 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -51.27 -27.45 16.11 Favored Glycine 0 CA--C 1.554 2.509 0 N-CA-C 120.416 2.926 . . . . 0.0 120.416 174.8 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.9 m -66.87 -52.29 45.24 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 119.663 1.731 . . . . 0.0 112.682 174.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.25 10.6 mm-40 -75.39 -15.63 60.44 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 115.904 -1.998 . . . . 0.0 112.455 171.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.85 -44.32 66.66 Favored 'General case' 0 C--N 1.374 1.637 0 CA-C-N 123.684 2.947 . . . . 0.0 114.319 168.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.78 -46.41 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 CA-C-N 119.282 0.946 . . . . 0.0 112.737 174.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -54.94 -44.25 74.14 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 116.623 2.083 . . . . 0.0 116.623 169.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.1 tp -67.24 -32.54 73.63 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 172.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.78 -38.89 92.42 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 167.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -59.33 -40.72 87.21 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 117.491 -1.243 . . . . 0.0 114.106 166.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -65.62 -49.09 70.0 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 172.465 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 65.8 mt -82.72 -25.0 33.33 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 117.383 2.364 . . . . 0.0 117.383 -177.017 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.56 41.31 7.37 Favored Glycine 0 CA--C 1.556 2.616 0 N-CA-C 117.521 1.768 . . . . 0.0 117.521 -172.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 22.8 mm -115.68 157.91 43.26 Favored Pre-proline 0 CA--C 1.57 1.738 0 CA-C-N 118.678 1.239 . . . . 0.0 113.748 -168.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -74.65 101.19 1.42 Allowed 'Trans proline' 0 CA--C 1.566 2.111 0 C-N-CA 121.885 1.723 . . . . 0.0 113.294 160.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -72.34 107.74 5.09 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.158 -0.964 . . . . 0.0 108.424 165.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.457 ' CD1' ' HB3' ' A' ' 71' ' ' ARG . 31.3 mm -104.25 109.38 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 176.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 74.1 p -96.45 128.96 43.86 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 168.585 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 18.4 p -68.36 -16.59 63.99 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 117.051 2.241 . . . . 0.0 117.051 -171.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -80.37 -23.25 61.1 Favored Glycine 0 CA--C 1.543 1.809 0 N-CA-C 118.932 2.333 . . . . 0.0 118.932 167.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -80.38 -52.63 7.45 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 -168.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -62.88 -39.09 93.39 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 173.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.479 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 7.9 m-85 -65.2 -47.09 78.11 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 172.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -54.25 -42.06 69.47 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 168.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.8 ttt180 -59.11 -40.36 85.11 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 168.251 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -68.35 -23.83 64.74 Favored 'General case' 0 CA--C 1.579 2.07 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 168.332 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 63.6 mt -64.1 -48.69 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 CA-C-N 120.75 1.614 . . . . 0.0 110.448 167.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -64.42 -37.67 88.32 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -67.02 -40.93 87.37 Favored 'General case' 0 CA--C 1.561 1.391 0 N-CA-C 116.236 1.939 . . . . 0.0 116.236 173.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.28 69.26 1.04 Allowed Glycine 0 CA--C 1.543 1.844 0 CA-C-O 118.473 -1.182 . . . . 0.0 114.66 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.835 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 67.5 p -92.02 -49.86 6.0 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-N 118.737 1.268 . . . . 0.0 114.291 175.743 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.835 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.251 73.8 mttt 105.84 -41.49 0.0 OUTLIER 'General case' 0 CA--C 1.57 1.729 0 CA-C-O 116.376 -1.774 . . . . 0.0 111.307 -172.477 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.07 -14.13 58.1 Favored 'General case' 0 CA--C 1.569 1.711 0 CA-C-N 123.059 2.663 . . . . 0.0 112.988 163.788 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.673 ' O ' ' HB3' ' A' ' 50' ' ' LYS . . . -58.22 -56.48 24.97 Favored Glycine 0 C--N 1.355 1.605 0 CA-C-N 120.574 1.534 . . . . 0.0 114.825 169.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.289 6.2 p -76.44 -50.01 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.478 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 -169.859 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -64.91 -48.48 74.04 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 121.09 1.768 . . . . 0.0 112.582 174.191 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.12 -29.15 66.03 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 114.819 1.415 . . . . 0.0 114.819 -177.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.673 ' HB3' ' O ' ' A' ' 46' ' ' GLY . 35.8 tptt -72.78 -34.73 67.14 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 168.021 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.601 ' CG ' ' O ' ' A' ' 51' ' ' ARG . 42.9 ttt180 -74.64 -55.89 5.4 Favored 'General case' 0 CA--C 1.591 2.522 1 CA-C-O 85.878 -16.296 . . . . 0.0 117.639 -179.715 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -27.64 -66.22 0.07 Allowed 'General case' 0 N--CA 1.495 1.814 1 O-C-N 108.766 -8.709 . . . . 0.0 120.43 146.001 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.6 tp -59.32 -29.32 67.54 Favored 'General case' 0 CA--C 1.573 1.861 0 N-CA-C 116.388 1.996 . . . . 0.0 116.388 174.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -92.39 -41.6 10.24 Favored 'General case' 0 CA--C 1.566 1.588 0 CA-C-O 116.554 -1.689 . . . . 0.0 115.155 169.208 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -87.94 -41.15 13.36 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 121.976 2.171 . . . . 0.0 114.906 -174.561 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.449 ' HA2' HH12 ' A' ' 88' ' ' ARG . . . 128.83 5.35 4.91 Favored Glycine 0 CA--C 1.541 1.669 0 N-CA-C 119.095 2.398 . . . . 0.0 119.095 168.18 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -83.41 173.71 11.28 Favored 'General case' 0 CA--C 1.575 1.91 0 CA-C-N 119.86 1.83 . . . . 0.0 110.067 167.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.5 pp -76.18 128.77 35.62 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.205 -1.559 . . . . 0.0 114.398 -166.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.6 p -115.88 128.72 25.75 Favored Pre-proline 0 CA--C 1.571 1.779 0 CA-C-O 117.656 -1.164 . . . . 0.0 109.447 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -60.11 149.33 85.41 Favored 'Trans proline' 0 CA--C 1.559 1.77 0 C-N-CA 123.396 2.731 . . . . 0.0 116.275 173.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 64.0 m -76.87 -45.88 26.63 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -64.27 -46.56 83.17 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 -169.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.407 ' HA ' ' HB2' ' A' ' 66' ' ' GLU . 1.7 pp -57.86 -42.13 83.87 Favored 'General case' 0 CA--C 1.56 1.347 0 N-CA-C 116.709 2.114 . . . . 0.0 116.709 169.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.4 m -61.46 -48.79 79.53 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 174.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -66.94 -20.05 65.83 Favored 'General case' 0 CA--C 1.575 1.919 0 N-CA-C 115.443 1.645 . . . . 0.0 115.443 167.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.407 ' HB2' ' HA ' ' A' ' 63' ' ' LEU . 9.4 mm-40 -72.26 -47.56 49.31 Favored 'General case' 0 CA--C 1.556 1.203 0 CA-C-N 120.529 1.513 . . . . 0.0 114.197 169.771 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.9 mt -63.72 -38.46 91.2 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 169.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 51.9 t -56.55 -50.93 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 CA-C-O 117.582 -1.199 . . . . 0.0 111.55 167.676 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -60.05 -36.8 78.11 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 116.563 2.06 . . . . 0.0 116.563 172.617 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -58.16 -45.79 86.82 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 117.282 -1.342 . . . . 0.0 112.971 169.057 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.457 ' HB3' ' CD1' ' A' ' 29' ' ' ILE . 40.9 mmt180 -87.03 6.12 34.06 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 120.407 3.484 . . . . 0.0 120.407 167.385 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 50.7 mt -68.2 -49.94 57.5 Favored 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 105.473 -2.047 . . . . 0.0 105.473 153.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 . . . . . 0 N--CA 1.503 2.176 0 CA-C-N 121.375 1.898 . . . . 0.0 110.879 -163.81 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.56 0 CA-C-O 123.156 1.42 . . . . 0.0 113.945 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -176.18 138.93 0.34 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 112.018 -2.091 . . . . 0.0 109.58 173.261 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 44.6 mt -111.35 112.99 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 104.059 -2.571 . . . . 0.0 104.059 174.326 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.5 mt -96.7 147.42 23.93 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 168.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -134.11 131.72 39.05 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.8 0.81 . . . . 0.0 111.043 169.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 71.03 37.59 64.16 Favored Glycine 0 CA--C 1.551 2.297 0 CA-C-O 117.249 -1.862 . . . . 0.0 117.62 176.343 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -104.79 -56.02 0.09 OUTLIER Pre-proline 0 N--CA 1.496 1.834 0 CA-C-O 114.873 -2.489 . . . . 0.0 109.657 177.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.79 70.97 1.09 Allowed 'Trans proline' 0 CA--C 1.566 2.088 0 CA-C-N 124.921 2.793 . . . . 0.0 118.873 168.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.449 HH12 ' HA2' ' A' ' 56' ' ' GLY . 4.1 ptm180 -76.46 -31.57 57.88 Favored 'General case' 0 CA--C 1.567 1.602 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 167.205 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.492 ' HA ' ' HG3' ' A' ' 147' ' ' GLU . 77.6 p -141.59 134.62 29.06 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 -166.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -51.51 -38.29 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-N 120.298 1.408 . . . . 0.0 113.843 177.294 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.8 -38.62 91.61 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 120.753 3.612 . . . . 0.0 120.753 174.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -74.32 -47.81 32.26 Favored 'General case' 0 CA--C 1.587 2.401 0 CA-C-N 122.99 2.632 . . . . 0.0 111.802 166.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.33 -35.16 69.53 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 118.493 2.775 . . . . 0.0 118.493 -176.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.4 tttt -59.93 -26.6 66.09 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 116.571 2.063 . . . . 0.0 116.571 170.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.35 -43.86 84.87 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 168.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 23.6 tp -61.72 -37.93 86.01 Favored 'General case' 0 CA--C 1.569 1.695 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 169.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 28.9 t60 -67.85 -41.65 82.59 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 120.405 1.457 . . . . 0.0 113.749 169.081 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 1.35 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 0.5 OUTLIER -53.24 -35.05 59.56 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 167.414 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 99' ' ' MET . . . . . 1.183 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 63.3 mtt -85.39 -29.57 24.31 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 118.317 2.71 . . . . 0.0 118.317 171.014 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 tt -69.35 -54.65 13.44 Favored 'General case' 0 N--CA 1.502 2.16 0 CA-C-N 122.076 2.216 . . . . 0.0 111.126 173.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -77.23 -50.37 13.06 Favored 'General case' 0 CA--C 1.563 1.48 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 174.768 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 1.35 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 23.3 tpp180 -71.93 -46.06 58.93 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 178.63 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 1.183 ' HB3' ' O ' ' A' ' 99' ' ' MET . 21.5 tpp180 -63.94 -49.66 71.71 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 119.036 0.835 . . . . 0.0 111.793 167.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 106.31 50.07 0.89 Allowed Glycine 0 N--CA 1.485 1.941 0 CA-C-O 121.767 0.648 . . . . 0.0 114.162 167.333 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.8 p -92.67 168.96 10.87 Favored 'General case' 0 CA--C 1.567 1.612 0 CA-C-N 113.207 -1.496 . . . . 0.0 110.712 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.47 132.14 45.11 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.034 -1.041 . . . . 0.0 110.919 -175.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 6.4 tp -105.79 96.99 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 174.512 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -100.25 -77.04 0.54 Allowed 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 115.391 -2.242 . . . . 0.0 107.69 166.62 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -140.71 126.14 18.82 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 122.25 2.295 . . . . 0.0 115.5 -171.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 72.8 t -88.92 116.58 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 101.406 -3.553 . . . . 0.0 101.406 160.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.294 20.7 tp -112.93 90.22 3.29 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 113.14 -1.846 . . . . 0.0 109.17 -165.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -89.71 132.22 35.29 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -177.394 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -97.73 123.87 41.84 Favored 'General case' 0 CA--C 1.566 1.584 0 CA-C-O 123.202 1.477 . . . . 0.0 110.594 -172.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -93.4 104.01 16.19 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 127.299 2.24 . . . . 0.0 108.868 173.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.2 m . . . . . 0 CA--C 1.566 1.594 0 CA-C-N 113.12 -1.855 . . . . 0.0 109.837 -165.6 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 . . . . . 0 N--CA 1.501 2.11 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -60.58 -42.65 97.14 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 167.872 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 13.6 tpt -61.5 -32.15 72.17 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 168.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -60.96 -49.1 78.81 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 166.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 29.1 t -65.13 -25.46 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 169.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -65.45 -49.43 69.17 Favored 'General case' 0 CA--C 1.577 1.982 0 CA-C-N 119.74 1.154 . . . . 0.0 111.864 169.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -61.34 -44.51 97.07 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 117.71 2.485 . . . . 0.0 117.71 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -56.18 -32.22 64.14 Favored 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 117.785 2.513 . . . . 0.0 117.785 177.048 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.492 ' HG3' ' HA ' ' A' ' 89' ' ' SER . 4.4 mm-40 -121.38 -40.5 2.57 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 118.684 2.846 . . . . 0.0 118.684 -163.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 95.7 m -46.64 -39.96 12.24 Favored 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 118.226 2.676 . . . . 0.0 118.226 -167.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.38 -61.16 4.12 Favored Pre-proline 0 CA--C 1.579 2.07 0 CA-C-O 116.17 -1.871 . . . . 0.0 112.05 173.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -52.01 -32.58 49.0 Favored 'Trans proline' 0 CA--C 1.578 2.692 0 C-N-CA 123.374 2.716 . . . . 0.0 118.568 167.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -66.57 -51.51 55.69 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 125.193 1.397 . . . . 0.0 111.462 176.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 1.187 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 47.7 tp -64.49 -21.23 66.61 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 171.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -71.92 -48.73 43.37 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 122.657 2.48 . . . . 0.0 112.944 164.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -61.03 -56.74 17.42 Favored 'General case' 0 CA--C 1.57 1.718 0 CA-C-N 120.191 1.359 . . . . 0.0 112.711 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -77.13 -28.04 54.17 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-O 115.348 -2.263 . . . . 0.0 112.774 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 1.187 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 38.3 ttt180 -60.35 -37.23 80.04 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 124.017 3.099 . . . . 0.0 116.259 169.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -67.76 -37.91 82.74 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 167.358 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -79.96 -33.22 39.7 Favored 'General case' 0 CA--C 1.579 2.09 0 N-CA-C 119.623 3.194 . . . . 0.0 119.623 177.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.1 pp -82.01 174.72 10.98 Favored 'General case' 0 CA--C 1.575 1.907 0 N-CA-C 121.324 3.824 . . . . 0.0 121.324 -159.673 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -128.64 139.66 52.15 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 164.215 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.1 t -102.77 152.56 21.1 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 122.515 1.15 . . . . 0.0 112.362 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 53.2 t -120.26 139.29 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 168.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -94.52 134.53 36.96 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 167.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -157.88 95.56 1.42 Allowed 'General case' 0 N--CA 1.484 1.243 0 CA-C-O 122.791 1.281 . . . . 0.0 110.886 -164.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.482 1.126 0 CA-C-N 113.143 -1.844 . . . . 0.0 106.878 -171.483 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 . . . . . 0 N--CA 1.501 2.078 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -61.26 -48.71 80.16 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 169.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 69.9 t -55.74 -39.44 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 173.476 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -60.43 -35.62 76.26 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 168.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -58.81 -48.33 81.67 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 171.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 81.5 mtt-85 -60.8 -36.85 80.08 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 117.874 2.546 . . . . 0.0 117.874 168.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.85 -44.09 97.47 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 172.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . 0.272 0.2 OUTLIER -71.26 -38.7 71.87 Favored 'General case' 0 N--CA 1.507 2.383 0 CA-C-N 120.014 1.279 . . . . 0.0 114.332 169.031 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -49.57 -39.3 34.53 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 168.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -70.3 -52.53 22.16 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 166.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -102.29 -60.03 1.61 Allowed 'General case' 0 CA--C 1.564 1.515 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -169.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.633 ' O ' ' CB ' ' A' ' 181' ' ' LYS . . . -79.22 -37.0 25.88 Favored Glycine 0 CA--C 1.551 2.34 0 CA-C-N 121.554 1.979 . . . . 0.0 118.036 -170.141 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.633 ' CB ' ' O ' ' A' ' 180' ' ' GLY . 37.2 ttmt . . . . . 0 C--O 1.252 1.212 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -177.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.7 mtt . . . . . 0 N--CA 1.483 1.217 0 CA-C-O 121.76 0.791 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.549 ' HB3' ' H ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -160.42 155.36 24.37 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -166.8 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.6 t -135.07 150.67 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 114.34 -1.3 . . . . 0.0 111.607 -168.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.405 HD22 HH12 ' A' ' 2' ' ' ARG . 2.2 mm? -125.7 122.13 35.42 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 114.003 -1.453 . . . . 0.0 108.607 169.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.8 tt -95.91 119.54 34.59 Favored 'General case' 0 CA--C 1.572 1.8 0 CA-C-O 122.504 1.145 . . . . 0.0 111.94 -173.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 33.0 mt -104.8 160.03 15.32 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 111.074 -2.785 . . . . 0.0 110.97 175.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 165.68 129.46 1.05 Allowed Glycine 0 CA--C 1.549 2.19 0 CA-C-O 117.355 -1.803 . . . . 0.0 113.77 171.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo . . . . . 0 CA--C 1.581 2.855 0 CA-C-N 122.035 2.917 . . . . 0.0 114.881 168.061 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.6 mttt . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -50.53 -22.03 5.12 Favored Glycine 0 CA--C 1.554 2.496 0 N-CA-C 120.955 3.142 . . . . 0.0 120.955 174.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 98.1 m -68.27 -53.0 27.54 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 120.036 1.918 . . . . 0.0 112.265 173.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.261 14.4 mm-40 -76.48 -15.43 59.9 Favored 'General case' 0 CA--C 1.574 1.87 0 CA-C-O 115.508 -2.187 . . . . 0.0 112.295 171.418 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.96 -41.49 67.66 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 124.211 3.187 . . . . 0.0 115.265 167.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.5 t -70.89 -40.66 76.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 CA-C-O 117.84 -1.076 . . . . 0.0 111.766 173.201 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -61.44 -42.11 98.24 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 169.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 23.6 mt -67.93 -32.4 72.82 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 170.841 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.02 -40.12 96.78 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 120.267 1.394 . . . . 0.0 114.446 167.473 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -59.77 -37.6 79.5 Favored 'General case' 0 CA--C 1.565 1.554 0 N-CA-C 114.889 1.441 . . . . 0.0 114.889 166.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -68.61 -53.99 19.22 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 120.561 1.528 . . . . 0.0 114.787 174.327 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.4 mp -81.73 -22.83 37.07 Favored 'General case' 0 CA--C 1.573 1.861 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 -177.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.68 38.64 7.46 Favored Glycine 0 CA--C 1.555 2.546 0 N-CA-C 117.507 1.763 . . . . 0.0 117.507 -174.29 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.454 ' CG2' ' HA ' ' A' ' 81' ' ' PHE . 23.6 mm -106.46 157.02 35.99 Favored Pre-proline 0 CA--C 1.565 1.551 0 CA-C-N 118.647 1.224 . . . . 0.0 112.876 -169.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -73.79 102.86 1.56 Allowed 'Trans proline' 0 CA--C 1.558 1.724 0 C-N-CA 121.49 1.46 . . . . 0.0 111.968 159.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.7 tm0? -69.48 106.54 3.02 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 166.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 34.2 mm -97.95 109.33 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 63.4 p -95.59 129.22 42.86 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 169.523 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.3 p -74.07 2.17 9.45 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 117.241 2.311 . . . . 0.0 117.241 -174.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.477 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -97.14 -22.17 18.16 Favored Glycine 0 CA--C 1.54 1.628 0 N-CA-C 118.703 2.241 . . . . 0.0 118.703 163.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -81.21 -54.27 5.65 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 119.37 1.585 . . . . 0.0 114.618 -168.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -65.44 -38.66 90.52 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 113.037 0.755 . . . . 0.0 113.037 175.117 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.467 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 56.8 m-85 -68.79 -42.48 77.3 Favored 'General case' 0 CA--C 1.56 1.332 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 173.166 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 73.9 ttt180 -58.76 -42.24 88.44 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 115.046 1.498 . . . . 0.0 115.046 169.034 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -61.51 -39.02 89.48 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 115.227 1.566 . . . . 0.0 115.227 169.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -68.82 -27.57 65.96 Favored 'General case' 0 CA--C 1.575 1.932 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 168.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.644 HD11 ' HB3' ' A' ' 50' ' ' LYS . 86.1 mt -63.86 -43.94 97.96 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 CA-C-N 120.104 1.32 . . . . 0.0 111.251 167.251 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -64.02 -42.31 97.17 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 173.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -65.51 -41.74 92.82 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 173.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.4 70.83 1.17 Allowed Glycine 0 CA--C 1.539 1.593 0 CA-C-O 118.091 -1.394 . . . . 0.0 113.368 -177.036 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.545 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 67.0 p -92.16 -65.62 0.99 Allowed 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 119.187 1.494 . . . . 0.0 111.644 177.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.545 ' CB ' ' O ' ' A' ' 43' ' ' THR . 21.2 ptmt 128.81 -55.68 0.0 OUTLIER 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 123.934 0.894 . . . . 0.0 109.899 -166.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -75.76 -6.57 51.25 Favored 'General case' 0 CA--C 1.568 1.638 0 CA-C-O 118.136 -0.935 . . . . 0.0 113.021 167.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.22 -54.21 11.8 Favored Glycine 0 CA--C 1.544 1.905 0 CA-C-N 120.652 1.569 . . . . 0.0 113.254 166.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.292 11.9 p -76.22 -46.62 33.03 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.706 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 -169.122 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -56.38 -49.28 74.91 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 121.744 2.065 . . . . 0.0 113.339 169.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.03 -38.5 91.28 Favored 'General case' 0 C--N 1.348 0.527 0 CA-C-N 113.517 -1.674 . . . . 0.0 114.293 -176.063 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.644 ' HB3' HD11 ' A' ' 39' ' ' ILE . 5.1 tptt -80.14 -17.16 53.27 Favored 'General case' 0 CA--C 1.565 1.545 0 CA-C-O 116.809 -1.567 . . . . 0.0 113.855 173.026 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 62.6 mtp180 -76.59 -55.61 5.37 Favored 'General case' 0 CA--C 1.598 2.815 1 CA-C-O 86.227 -16.13 . . . . 0.0 118.297 172.572 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . 0.346 0.1 OUTLIER -38.02 -61.57 0.64 Allowed 'General case' 0 N--CA 1.516 2.847 1 O-C-N 109.303 -8.373 . . . . 0.0 120.564 149.349 . . . . . . . . 4 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 60.3 mt -58.05 -23.66 55.31 Favored 'General case' 0 N--CA 1.518 2.948 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 177.769 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -93.32 -49.41 5.96 Favored 'General case' 0 CA--C 1.571 1.763 0 CA-C-O 116.486 -1.721 . . . . 0.0 114.56 166.685 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -104.28 -5.57 21.72 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 118.112 2.634 . . . . 0.0 118.112 -170.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.673 ' HA2' HH11 ' A' ' 88' ' ' ARG . . . 73.64 47.09 22.22 Favored Glycine 0 CA--C 1.544 1.847 0 CA-C-N 122.203 2.274 . . . . 0.0 115.241 -178.257 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -101.51 -175.3 2.82 Favored 'General case' 0 CA--C 1.568 1.642 0 C-N-CA 123.763 0.825 . . . . 0.0 110.807 -170.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 74.7 mt -100.56 99.6 10.2 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.4 t -148.26 130.93 7.86 Favored Pre-proline 0 CA--C 1.586 2.353 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -169.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -50.15 161.01 1.18 Allowed 'Trans proline' 0 CA--C 1.567 2.152 0 C-N-CA 124.446 3.43 . . . . 0.0 120.955 -177.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 58.4 m -91.25 -53.88 4.16 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -174.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -57.86 -36.35 72.2 Favored 'General case' 0 N--CA 1.506 2.366 0 N-CA-C 117.412 2.375 . . . . 0.0 117.412 -171.235 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 79.5 mt -46.54 -45.56 18.73 Favored 'General case' 0 N--CA 1.506 2.358 0 N-CA-C 118.137 2.643 . . . . 0.0 118.137 170.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.2 m -70.04 -48.88 56.1 Favored 'General case' 0 CA--C 1.562 1.422 0 CA-C-N 112.223 -2.262 . . . . 0.0 112.756 177.897 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.64 -22.86 62.47 Favored 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 167.031 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -75.85 -42.36 49.72 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 125.395 1.478 . . . . 0.0 114.908 171.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.8 mt -59.53 -50.39 74.1 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 168.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 87.7 t -63.07 -47.8 90.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 CA-C-O 118.023 -0.989 . . . . 0.0 111.72 177.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -64.4 -30.4 71.44 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 116.443 2.016 . . . . 0.0 116.443 172.172 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -60.85 -41.21 95.4 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 119.714 1.143 . . . . 0.0 113.255 168.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 20.5 ttm-85 -81.52 -13.94 57.5 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 119.021 2.971 . . . . 0.0 119.021 169.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.8 mt -95.08 -16.86 22.34 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 117.656 2.465 . . . . 0.0 117.656 175.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 . . . . . 0 N--CA 1.5 2.048 0 N-CA-C 118.014 2.598 . . . . 0.0 118.014 176.197 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.508 ' HA2' ' HB3' ' A' ' 2' ' ' ARG . . . . . . . . 0 N--CA 1.482 1.723 0 CA-C-O 122.9 1.278 . . . . 0.0 114.256 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.549 ' H ' ' HB3' ' A' ' 2' ' ' ARG . 37.6 p90 178.58 135.76 0.08 Allowed 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 112.208 -1.996 . . . . 0.0 111.88 -178.127 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 21.7 mt -115.23 109.55 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 174.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.7 mt -106.15 126.0 51.68 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 174.184 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -108.09 127.71 54.04 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 119.272 0.942 . . . . 0.0 110.36 176.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.39 37.93 80.05 Favored Glycine 0 CA--C 1.556 2.653 0 N-CA-C 117.202 1.641 . . . . 0.0 117.202 -176.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -92.87 -54.06 0.25 Allowed Pre-proline 0 N--CA 1.494 1.765 0 CA-C-O 114.935 -2.46 . . . . 0.0 108.223 175.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -65.3 70.87 0.29 Allowed 'Trans proline' 0 CA--C 1.571 2.344 0 CA-C-N 124.343 2.587 . . . . 0.0 117.289 165.252 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.673 HH11 ' HA2' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -71.67 -24.28 61.81 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 166.714 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.8 t -150.93 151.39 32.09 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 -176.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 36.7 t -62.07 -40.25 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 CA-C-O 117.924 -1.036 . . . . 0.0 112.173 174.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -68.66 -25.37 64.77 Favored 'General case' 0 CA--C 1.55 0.981 0 N-CA-C 119.656 3.206 . . . . 0.0 119.656 174.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.04 -51.34 12.52 Favored 'General case' 0 CA--C 1.589 2.462 0 CA-C-N 123.405 2.82 . . . . 0.0 110.078 163.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -54.58 -28.11 43.78 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 117.834 2.531 . . . . 0.0 117.834 -176.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -58.79 -32.71 69.58 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 166.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.67 -44.31 86.66 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 169.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.6 tp -60.63 -39.03 86.75 Favored 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 170.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -70.08 -42.86 72.22 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 120.021 1.282 . . . . 0.0 113.973 171.095 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 1.114 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 32.1 mt-10 -52.1 -36.46 51.0 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 166.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' MET . . . . . 1.061 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 25.2 ttt -84.37 -24.49 29.67 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 117.927 2.566 . . . . 0.0 117.927 171.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.607 HD21 HD13 ' A' ' 107' ' ' ILE . 66.3 tp -65.77 -55.65 16.12 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 120.771 1.623 . . . . 0.0 112.572 169.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -79.79 -50.8 10.02 Favored 'General case' 0 CA--C 1.562 1.427 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 175.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 1.114 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 73.4 ttt180 -66.87 -45.69 77.29 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 176.612 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 1.061 ' HB3' ' O ' ' A' ' 99' ' ' MET . 1.2 tmt_? -63.24 -55.85 21.44 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.01 0.524 . . . . 0.0 111.168 165.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.34 46.83 1.04 Allowed Glycine 0 N--CA 1.48 1.603 0 O-C-N 124.013 0.82 . . . . 0.0 113.347 169.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 67.4 p -93.53 152.28 19.15 Favored 'General case' 0 CA--C 1.561 1.39 0 O-C-N 124.402 0.707 . . . . 0.0 109.666 175.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -82.73 129.1 34.92 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.444 -0.785 . . . . 0.0 111.557 -169.091 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.607 HD13 HD21 ' A' ' 100' ' ' LEU . 7.6 tp -89.99 107.68 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 -173.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -90.33 -68.04 0.81 Allowed 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 117.006 -1.473 . . . . 0.0 107.082 168.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -159.0 137.92 11.16 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 120.887 1.676 . . . . 0.0 114.513 177.978 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.6 t -91.91 109.71 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.676 0 N-CA-C 100.863 -3.755 . . . . 0.0 100.863 161.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.309 25.8 tp -111.68 103.61 11.92 Favored 'General case' 0 CA--C 1.558 1.288 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.858 -161.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -94.12 129.65 40.61 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.449 0.643 . . . . 0.0 112.248 -177.312 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -92.55 119.04 31.62 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-O 123.157 1.456 . . . . 0.0 110.164 -178.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -84.08 96.8 9.02 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 112.527 -2.124 . . . . 0.0 109.347 168.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.0 p . . . . . 0 N--CA 1.485 1.276 0 C-N-CA 125.245 1.418 . . . . 0.0 107.922 -168.453 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 . . . . . 0 N--CA 1.501 2.104 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 70.0 mtp180 -57.96 -39.69 78.76 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 165.272 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 25.3 ttt -64.58 -30.96 71.99 Favored 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 168.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -62.85 -48.03 80.79 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 168.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.5 p -66.47 -35.61 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 171.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -53.94 -54.07 43.92 Favored 'General case' 0 CA--C 1.585 2.3 0 CA-C-N 120.073 1.306 . . . . 0.0 111.436 167.528 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 32.4 ttp180 -51.99 -32.97 35.98 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 119.296 3.073 . . . . 0.0 119.296 172.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -52.86 -38.56 61.69 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 173.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -140.34 26.73 2.15 Favored 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 117.534 2.42 . . . . 0.0 117.534 -177.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 39.5 m -47.69 -37.39 12.89 Favored 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 116.053 1.872 . . . . 0.0 116.053 173.296 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -69.73 -60.2 3.98 Favored Pre-proline 0 CA--C 1.578 2.026 0 CA-C-O 116.75 -1.595 . . . . 0.0 112.102 172.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -49.87 -30.79 24.62 Favored 'Trans proline' 0 CA--C 1.576 2.605 0 C-N-CA 123.375 2.716 . . . . 0.0 118.562 167.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -63.86 -55.39 23.15 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 125.515 1.526 . . . . 0.0 111.722 173.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.917 ' O ' ' HB2' ' A' ' 156' ' ' ARG 0.317 0.0 OUTLIER -63.41 -26.11 68.59 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 177.021 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -70.52 -50.92 32.7 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 120.68 1.582 . . . . 0.0 114.182 167.234 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -67.93 -53.91 22.75 Favored 'General case' 0 CA--C 1.557 1.225 0 CA-C-N 120.007 1.276 . . . . 0.0 111.398 -176.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . 0.256 67.5 m-85 -84.98 -19.69 31.69 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-O 114.959 -2.448 . . . . 0.0 113.387 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.917 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 40.6 ttt180 -70.73 -35.62 72.77 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 125.077 3.58 . . . . 0.0 115.073 168.386 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -69.01 -37.59 78.76 Favored 'General case' 0 CA--C 1.573 1.854 0 CA-C-N 120.08 1.309 . . . . 0.0 113.906 167.071 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -84.2 -33.03 24.24 Favored 'General case' 0 CA--C 1.572 1.791 0 N-CA-C 118.727 2.862 . . . . 0.0 118.727 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.8 pp -75.46 172.05 13.2 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 118.437 2.754 . . . . 0.0 118.437 -162.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -131.83 141.31 49.39 Favored 'General case' 0 CA--C 1.558 1.258 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 166.302 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 54.5 m -99.9 146.67 26.39 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 122.351 1.072 . . . . 0.0 110.731 -173.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 30.0 t -123.39 134.34 66.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 167.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -93.83 130.11 39.98 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 167.776 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -154.7 93.63 1.59 Allowed 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 122.623 1.201 . . . . 0.0 111.9 -163.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.1 t . . . . . 0 N--CA 1.484 1.251 0 CA-C-N 114.16 -1.382 . . . . 0.0 107.391 -176.207 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 . . . . . 0 N--CA 1.5 2.056 0 N-CA-C 116.153 1.909 . . . . 0.0 116.153 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -59.94 -49.61 77.0 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 170.023 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 94.5 t -56.69 -37.92 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 173.074 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -61.42 -34.55 75.57 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 167.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -61.0 -43.24 99.18 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 170.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 81.1 mtt-85 -66.65 -33.87 76.61 Favored 'General case' 0 CA--C 1.554 1.131 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 169.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.23 -47.1 85.91 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 171.319 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . 0.294 0.5 OUTLIER -69.3 -34.0 74.02 Favored 'General case' 0 N--CA 1.504 2.228 0 CA-C-N 120.196 1.362 . . . . 0.0 114.506 169.214 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 29.3 mtp180 -49.23 -45.26 44.33 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 166.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -67.39 -51.33 53.23 Favored 'General case' 0 CA--C 1.565 1.546 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 168.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.81 -62.88 1.39 Allowed 'General case' 0 CA--C 1.566 1.571 0 CA-C-O 117.981 -1.009 . . . . 0.0 112.84 -175.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.89 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -91.39 -54.92 1.89 Allowed Glycine 0 CA--C 1.552 2.402 0 CA-C-O 117.983 -1.454 . . . . 0.0 114.802 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.89 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 55.0 tttp . . . . . 0 C--O 1.251 1.169 0 CA-C-N 119.861 1.83 . . . . 0.0 109.612 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.0 mtt . . . . . 0 CA--C 1.561 1.371 0 CA-C-O 122.933 1.349 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . 0.309 11.7 mpt_? -122.67 167.48 13.38 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 120.747 3.61 . . . . 0.0 120.747 -164.787 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.1 p -148.25 141.24 18.74 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.656 0 CA-C-O 123.87 1.795 . . . . 0.0 112.568 166.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -116.55 136.99 52.52 Favored 'General case' 0 CA--C 1.56 1.341 0 CA-C-N 111.971 -2.377 . . . . 0.0 104.853 166.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.5 mt -111.85 128.81 56.24 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 122.693 1.235 . . . . 0.0 111.433 -176.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.545 HD11 HG12 ' A' ' 110' ' ' VAL . 5.8 mp -130.75 155.42 46.67 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 111.564 -2.562 . . . . 0.0 111.455 -164.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 144.5 168.87 12.84 Favored Glycine 0 CA--C 1.554 2.522 0 CA-C-O 119.134 -0.814 . . . . 0.0 114.701 169.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo . . . . . 0 CA--C 1.573 2.474 0 C-N-CA 123.462 2.774 . . . . 0.0 113.448 172.195 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.484 1.232 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.12 -32.81 57.11 Favored Glycine 0 CA--C 1.553 2.469 0 N-CA-C 120.057 2.783 . . . . 0.0 120.057 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 78.5 m -63.21 -48.79 76.84 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 119.116 1.458 . . . . 0.0 113.294 172.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.252 6.7 mm-40 -75.57 -15.85 60.32 Favored 'General case' 0 CA--C 1.57 1.713 0 CA-C-O 115.749 -2.072 . . . . 0.0 111.972 172.23 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.31 -47.44 61.12 Favored 'General case' 0 C--N 1.374 1.642 0 CA-C-N 123.605 2.911 . . . . 0.0 114.249 168.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.7 p -66.36 -42.11 90.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 174.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -63.96 -41.7 97.48 Favored 'General case' 0 CA--C 1.565 1.54 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 171.022 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mt -66.35 -30.91 71.4 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-N 120.819 1.645 . . . . 0.0 114.724 170.756 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.9 -42.88 98.89 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 167.555 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -58.46 -39.95 81.28 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 167.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.4 tptt -63.47 -55.54 23.32 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 172.301 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.0 mt -82.53 -21.51 35.36 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 117.068 2.247 . . . . 0.0 117.068 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.65 34.87 8.16 Favored Glycine 0 CA--C 1.556 2.614 0 N-CA-C 118.06 1.984 . . . . 0.0 118.06 -177.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.9 mm -109.06 159.42 31.21 Favored Pre-proline 0 CA--C 1.572 1.824 0 CA-C-N 119.059 1.429 . . . . 0.0 113.275 -168.438 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -83.88 101.53 0.9 Allowed 'Trans proline' 0 CA--C 1.568 2.184 0 C-N-CA 121.996 1.797 . . . . 0.0 110.592 163.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -59.54 113.94 2.47 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.647 0.779 . . . . 0.0 111.67 168.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 22.0 mm -98.35 106.21 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.212 0 N-CA-C 103.891 -2.633 . . . . 0.0 103.891 173.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 66.0 p -95.81 131.93 41.59 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 169.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.6 p -68.59 -11.21 59.7 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 117.312 2.338 . . . . 0.0 117.312 -174.331 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.512 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -87.65 -20.68 50.35 Favored Glycine 0 CA--C 1.544 1.846 0 N-CA-C 118.769 2.268 . . . . 0.0 118.769 166.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -81.63 -50.99 8.67 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 118.92 1.36 . . . . 0.0 114.652 -169.365 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -65.36 -37.75 87.98 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 174.254 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.598 ' HB3' ' CB ' ' A' ' 50' ' ' LYS . 27.2 m-85 -67.49 -41.88 83.81 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 169.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.512 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 73.2 ttt180 -57.08 -36.65 70.84 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 165.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.5 ttm180 -62.15 -43.05 99.69 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.568 1.147 . . . . 0.0 113.956 168.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -60.41 -43.81 96.33 Favored 'General case' 0 CA--C 1.573 1.852 0 CA-C-N 119.149 0.886 . . . . 0.0 113.255 167.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.473 ' HA ' HG23 ' A' ' 43' ' ' THR . 81.2 mt -51.27 -39.06 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.599 0 C-N-CA 125.93 1.692 . . . . 0.0 113.76 167.762 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -73.22 -32.62 64.88 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 115.786 1.772 . . . . 0.0 115.786 169.389 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -70.18 -50.43 40.28 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 175.855 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 166.33 -32.12 0.21 Allowed Glycine 0 CA--C 1.546 2.012 0 N-CA-C 117.818 1.887 . . . . 0.0 117.818 -169.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.618 ' O ' ' HG3' ' A' ' 44' ' ' LYS 0.322 44.7 p 49.45 125.29 0.0 OUTLIER 'General case' 0 N--CA 1.424 -1.749 1 N-CA-C 124.336 4.939 . . . . 0.0 124.336 -176.473 . . . . . . . . 4 3 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.618 ' HG3' ' O ' ' A' ' 43' ' ' THR 0.352 56.5 mtpt -142.46 -24.12 0.66 Allowed 'General case' 0 N--CA 1.507 2.406 0 CA-C-N 110.073 -3.239 . . . . 0.0 118.538 146.13 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -97.86 -24.93 15.21 Favored 'General case' 0 N--CA 1.514 2.726 0 CA-C-N 123.567 2.894 . . . . 0.0 112.332 161.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -40.52 -64.49 1.17 Allowed Glycine 0 CA--C 1.531 1.053 0 C-N-CA 130.583 3.944 . . . . 0.0 115.756 167.193 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.3 p -72.33 -48.65 47.19 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 N-CA-C 116.223 1.935 . . . . 0.0 116.223 -171.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -66.36 -44.85 82.05 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 120.359 1.436 . . . . 0.0 112.707 176.804 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.12 -38.43 85.57 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.598 ' CB ' ' HB3' ' A' ' 35' ' ' PHE 0.348 15.3 tptt -81.28 -19.79 42.27 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-O 116.943 -1.503 . . . . 0.0 113.238 174.613 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.596 ' O ' ' CG ' ' A' ' 51' ' ' ARG . 33.9 ttt180 -81.23 -57.76 3.36 Favored 'General case' 0 CA--C 1.59 2.501 1 CA-C-O 85.358 -16.544 . . . . 0.0 118.654 174.711 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 16.8 m-30 -28.28 -62.23 0.11 Allowed 'General case' 0 N--CA 1.497 1.91 1 O-C-N 107.744 -9.347 . . . . 0.0 120.853 147.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.5 tp -59.05 -33.8 71.19 Favored 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 116.415 2.006 . . . . 0.0 116.415 171.65 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -90.04 -39.99 12.58 Favored 'General case' 0 CA--C 1.567 1.603 0 N-CA-C 115.543 1.682 . . . . 0.0 115.543 174.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.53 -40.22 16.56 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 117.004 -1.474 . . . . 0.0 114.776 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 151.15 -38.91 0.83 Allowed Glycine 0 N--CA 1.476 1.333 0 CA-C-N 120.924 1.693 . . . . 0.0 116.729 170.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -67.31 171.72 5.59 Favored 'General case' 0 CA--C 1.57 1.741 0 CA-C-N 118.269 1.035 . . . . 0.0 111.626 -177.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 89.4 mt -92.76 135.93 33.69 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 121.383 -0.823 . . . . 0.0 112.12 -167.679 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 p -103.99 136.82 19.14 Favored Pre-proline 0 CA--C 1.58 2.12 0 CA-C-O 118.137 -0.935 . . . . 0.0 109.239 173.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -55.31 146.53 60.87 Favored 'Trans proline' 0 CA--C 1.562 1.911 0 C-N-CA 123.836 3.024 . . . . 0.0 116.671 169.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.8 m -73.97 -48.68 28.78 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 -168.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -61.52 -39.35 90.71 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 116.675 2.102 . . . . 0.0 116.675 -170.755 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 26.2 mt -57.3 -48.52 78.7 Favored 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 116.506 2.039 . . . . 0.0 116.506 172.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.4 m -61.31 -50.9 71.09 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 112.946 -1.934 . . . . 0.0 113.088 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 -64.08 -19.14 65.04 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 168.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -72.22 -44.12 63.41 Favored 'General case' 0 CA--C 1.558 1.273 0 CA-C-N 121.146 1.793 . . . . 0.0 114.18 168.573 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 mt -59.19 -49.96 75.86 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 120.207 1.367 . . . . 0.0 114.228 167.146 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 67.4 t -60.87 -46.79 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 123.811 0.844 . . . . 0.0 113.035 176.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -70.72 -27.16 63.76 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 175.136 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -64.47 -37.98 89.41 Favored 'General case' 0 CA--C 1.563 1.475 0 CA-C-N 119.808 1.186 . . . . 0.0 112.714 167.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -79.08 -24.0 43.79 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 118.414 2.746 . . . . 0.0 118.414 169.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.0 mp -81.7 -34.46 30.62 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 117.237 2.31 . . . . 0.0 117.237 176.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 . . . . . 0 N--CA 1.5 2.036 0 N-CA-C 116.832 2.16 . . . . 0.0 116.832 169.462 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.425 0 CA-C-O 123.413 1.563 . . . . 0.0 113.69 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -172.63 132.53 0.58 Allowed 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 112.875 -1.662 . . . . 0.0 107.729 -174.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 4.3 mm -101.2 107.67 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.563 0 N-CA-C 102.729 -3.063 . . . . 0.0 102.729 168.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.4 mt -100.97 133.95 44.69 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 169.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -125.32 129.98 51.06 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 119.33 0.968 . . . . 0.0 111.778 177.149 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.02 41.73 80.4 Favored Glycine 0 CA--C 1.546 1.984 0 CA-C-O 116.198 -2.445 . . . . 0.0 116.717 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . 0.257 1.6 t80 -106.28 -55.22 0.08 OUTLIER Pre-proline 0 N--CA 1.502 2.151 0 CA-C-N 121.281 2.54 . . . . 0.0 108.771 174.236 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -67.53 72.64 0.63 Allowed 'Trans proline' 0 CA--C 1.572 2.382 0 CA-C-N 124.02 2.471 . . . . 0.0 117.688 165.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.99 17.34 17.93 Favored 'General case' 0 CA--C 1.572 1.827 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 168.069 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.7 t -167.55 120.15 0.91 Allowed 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 101.656 -3.461 . . . . 0.0 101.656 -177.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . 0.342 4.6 p -69.01 -21.13 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 CA-C-O 116.337 -1.792 . . . . 0.0 111.991 -176.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -64.38 -31.39 72.58 Favored 'General case' 0 CA--C 1.557 1.247 0 N-CA-C 117.896 2.554 . . . . 0.0 117.896 162.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.28 -51.57 10.67 Favored 'General case' 0 CA--C 1.585 2.32 0 CA-C-N 124.034 3.106 . . . . 0.0 111.412 164.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.27 -29.13 68.61 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 117.274 2.324 . . . . 0.0 117.274 -172.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 64.7 tttt -56.34 -35.32 67.49 Favored 'General case' 0 CA--C 1.557 1.213 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 167.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.32 -37.33 74.69 Favored 'General case' 0 CA--C 1.566 1.559 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 169.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 22.9 tp -65.55 -34.03 77.29 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 168.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.03 -42.28 89.78 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 121.549 1.977 . . . . 0.0 112.623 169.182 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.971 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 34.9 mt-10 -56.02 -34.92 66.3 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 115.154 1.539 . . . . 0.0 115.154 167.066 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' MET . . . . . 1.226 ' O ' ' HB2' ' A' ' 103' ' ' ARG . 20.7 ttt -85.78 -32.99 21.51 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 118.567 2.803 . . . . 0.0 118.567 178.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.8 -44.71 47.97 Favored 'General case' 0 N--CA 1.507 2.387 0 CA-C-N 121.375 1.898 . . . . 0.0 111.705 170.266 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -73.52 -53.5 10.42 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 119.221 0.919 . . . . 0.0 113.269 173.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.971 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 72.3 ttt180 -67.71 -40.75 84.24 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 116.013 1.857 . . . . 0.0 116.013 176.038 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 1.226 ' HB2' ' O ' ' A' ' 99' ' ' MET . 15.0 mmm180 -61.42 -60.18 4.11 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 118.622 0.646 . . . . 0.0 111.447 166.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 113.63 49.27 0.56 Allowed Glycine 0 N--CA 1.478 1.478 0 O-C-N 124.629 1.205 . . . . 0.0 113.632 169.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 73.2 p -86.92 146.16 26.27 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-N 114.388 -0.906 . . . . 0.0 109.399 171.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -69.13 132.15 46.11 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.526 -0.734 . . . . 0.0 111.394 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.9 tp -89.25 97.21 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -173.607 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -97.76 -65.58 0.95 Allowed 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 115.802 -2.046 . . . . 0.0 109.163 169.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -149.32 118.08 6.63 Favored 'General case' 0 C--N 1.366 1.295 0 CA-C-N 121.988 2.176 . . . . 0.0 114.88 -170.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.545 HG12 HD11 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -94.99 110.74 24.42 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.162 1 N-CA-C 98.888 -4.486 . . . . 0.0 98.888 161.042 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 40.9 tp -114.02 103.81 11.52 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.246 -162.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -100.2 123.39 44.38 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -176.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 6.8 m-30 -93.98 126.58 39.27 Favored 'General case' 0 CA--C 1.561 1.369 0 CA-C-O 122.471 1.129 . . . . 0.0 109.562 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.405 ' HB3' ' HA ' ' A' ' 163' ' ' ASP . 1.6 tmm_? -82.72 88.31 6.73 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 113.602 -1.635 . . . . 0.0 109.134 168.356 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.4 p . . . . . 0 CA--C 1.554 1.118 0 C-N-CA 125.758 1.623 . . . . 0.0 107.813 -169.496 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 . . . . . 0 N--CA 1.502 2.135 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 69.2 mtp180 -60.56 -38.68 85.34 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 169.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 56.1 mtt -71.62 -29.14 64.33 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 169.219 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -61.91 -50.35 72.53 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 120.459 1.482 . . . . 0.0 114.834 168.882 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.5 p -63.52 -33.83 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 169.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -54.21 -48.27 71.22 Favored 'General case' 0 CA--C 1.58 2.112 0 CA-C-N 119.983 1.265 . . . . 0.0 112.403 167.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -61.26 -45.57 93.98 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 117.859 2.54 . . . . 0.0 117.859 175.131 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -56.63 -32.1 64.99 Favored 'General case' 0 N--CA 1.507 2.385 0 N-CA-C 117.779 2.511 . . . . 0.0 117.779 177.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -114.61 -39.59 3.75 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 117.497 2.406 . . . . 0.0 117.497 -167.008 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 99.1 m -49.88 -34.2 19.44 Favored 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 117.525 2.417 . . . . 0.0 117.525 -168.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.442 ' HB3' ' HD3' ' A' ' 150' ' ' PRO . . . -67.8 -61.12 4.59 Favored Pre-proline 0 CA--C 1.581 2.168 0 CA-C-O 116.013 -1.946 . . . . 0.0 112.045 170.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.442 ' HD3' ' HB3' ' A' ' 149' ' ' ALA . 84.8 Cg_exo -55.74 -30.06 74.2 Favored 'Trans proline' 0 CA--C 1.582 2.919 0 N-CA-C 119.947 3.018 . . . . 0.0 119.947 169.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.3 -55.18 30.71 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 126.442 1.897 . . . . 0.0 111.524 169.233 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 1.3 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 28.9 tp -67.1 -22.52 65.81 Favored 'General case' 0 CA--C 1.562 1.409 0 CA-C-O 116.699 -1.619 . . . . 0.0 114.437 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -71.99 -49.35 37.91 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 122.008 2.185 . . . . 0.0 112.354 164.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -67.81 -54.4 19.42 Favored 'General case' 0 CA--C 1.562 1.438 0 CA-C-N 121.214 1.825 . . . . 0.0 112.158 -177.759 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -77.39 -23.27 50.73 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 114.49 -2.671 . . . . 0.0 112.337 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 1.3 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 0.1 OUTLIER -64.45 -40.25 95.38 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 125.878 3.945 . . . . 0.0 115.739 167.735 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -62.09 -37.0 83.4 Favored 'General case' 0 CA--C 1.576 1.947 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 167.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -90.48 -35.63 14.99 Favored 'General case' 0 CA--C 1.576 1.98 0 N-CA-C 118.653 2.834 . . . . 0.0 118.653 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.418 ' HA ' HG23 ' A' ' 110' ' ' VAL . 3.3 pp -71.87 171.81 11.04 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 119.843 3.275 . . . . 0.0 119.843 -163.449 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -129.72 126.3 37.92 Favored 'General case' 0 CA--C 1.566 1.585 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 166.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.3 t -101.64 160.45 14.44 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 122.798 1.285 . . . . 0.0 113.265 -169.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.525 HG13 ' HG3' ' A' ' 174' ' ' ARG . 91.9 t -131.74 150.41 33.94 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.887 0 CA-C-N 113.456 -1.702 . . . . 0.0 107.335 169.578 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.405 ' HA ' ' HB3' ' A' ' 114' ' ' ARG . 13.4 t70 -107.06 127.03 53.11 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 167.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -164.83 126.95 2.2 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -162.506 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.0 t . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.34 -0.85 . . . . 0.0 108.845 167.627 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 . . . . . 0 N--CA 1.496 1.87 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.844 ' HB3' ' NH2' ' A' ' 174' ' ' ARG . 45.1 mt-10 -58.99 -54.9 41.87 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 172.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 93.6 t -58.13 -37.8 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 176.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -60.48 -36.13 77.55 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 168.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -63.59 -56.05 18.91 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 175.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.844 ' NH2' ' HB3' ' A' ' 170' ' ' GLU . 9.8 ptp180 -66.07 -25.93 67.26 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 118.001 2.593 . . . . 0.0 118.001 171.736 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.5 -41.62 88.6 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 167.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.3 mp -62.82 -41.69 99.42 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 117.676 -1.154 . . . . 0.0 113.831 167.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -54.96 -45.18 74.89 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 168.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.64 -46.59 88.55 Favored 'General case' 0 CA--C 1.559 1.313 0 N-CA-C 116.655 2.095 . . . . 0.0 116.655 171.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 6.2 tt -83.74 -57.01 3.39 Favored 'General case' 0 CA--C 1.567 1.604 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.428 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.646 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -110.39 -58.89 0.49 Allowed Glycine 0 CA--C 1.552 2.366 0 CA-C-O 117.727 -1.596 . . . . 0.0 114.924 -176.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.646 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 37.0 ttmt . . . . . 0 C--O 1.251 1.151 0 CA-C-N 120.357 2.079 . . . . 0.0 107.328 -175.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 ptp . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 121.681 0.753 . . . . 0.0 111.551 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.729 ' HB3' ' HA2' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -160.42 159.0 30.47 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -168.782 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 99.4 t -136.7 150.2 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.543 0 CA-C-O 124.107 1.908 . . . . 0.0 110.262 -166.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.638 HD12 HH22 ' A' ' 2' ' ' ARG . 3.7 mt -117.46 134.04 55.29 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 127.234 2.214 . . . . 0.0 107.039 169.565 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 18.5 tp -116.65 119.35 35.23 Favored 'General case' 0 CA--C 1.571 1.769 0 CA-C-O 123.722 1.725 . . . . 0.0 108.716 -176.239 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -118.41 141.5 48.49 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 110.504 -3.044 . . . . 0.0 109.794 -166.815 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 171.2 167.85 32.05 Favored Glycine 0 CA--C 1.559 2.796 0 N-CA-C 116.04 1.176 . . . . 0.0 116.04 170.856 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo . . . . . 0 CA--C 1.574 2.5 0 C-N-CA 123.513 2.809 . . . . 0.0 116.002 174.906 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.853 0.359 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -51.06 -36.3 34.75 Favored Glycine 0 CA--C 1.554 2.509 0 N-CA-C 120.466 2.947 . . . . 0.0 120.466 -177.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 58.6 m -65.01 -52.45 56.07 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 119.151 1.475 . . . . 0.0 113.458 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.284 21.3 mp0 -76.51 -13.39 60.1 Favored 'General case' 0 CA--C 1.571 1.783 0 CA-C-O 115.545 -2.169 . . . . 0.0 112.329 171.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.39 -45.83 68.36 Favored 'General case' 0 C--N 1.373 1.619 0 CA-C-N 124.131 3.151 . . . . 0.0 114.389 166.901 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.9 p -66.22 -43.22 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-O 118.449 -0.786 . . . . 0.0 113.092 173.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.4 ' HB3' ' CE1' ' A' ' 172' ' ' PHE . 97.3 mttt -55.14 -48.61 73.46 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 116.6 2.074 . . . . 0.0 116.6 169.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 mt -66.16 -29.26 69.51 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 172.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.83 -39.83 94.21 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 167.313 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -59.32 -39.49 83.26 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 117.342 -1.313 . . . . 0.0 114.516 166.361 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -62.25 -58.89 6.08 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 120.901 1.682 . . . . 0.0 114.905 169.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.3 mt -82.31 -20.2 37.88 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 117.551 2.426 . . . . 0.0 117.551 -172.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.67 44.94 8.88 Favored Glycine 0 CA--C 1.553 2.432 0 CA-C-N 120.734 1.607 . . . . 0.0 117.071 -174.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.402 ' CG2' ' HA ' ' A' ' 81' ' ' PHE . 29.1 mm -112.32 156.02 42.74 Favored Pre-proline 0 CA--C 1.569 1.698 0 CA-C-N 118.219 1.01 . . . . 0.0 113.578 -168.227 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -73.04 100.65 1.24 Allowed 'Trans proline' 0 CA--C 1.562 1.894 0 C-N-CA 121.807 1.671 . . . . 0.0 112.685 160.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.23 105.34 4.61 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.302 -0.874 . . . . 0.0 108.809 167.446 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 44.6 mm -99.97 111.9 30.93 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 178.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.2 t -96.64 127.84 43.01 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 168.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 19.7 p -73.91 1.31 11.01 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 116.95 2.204 . . . . 0.0 116.95 -172.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.57 -18.67 29.71 Favored Glycine 0 CA--C 1.55 2.28 0 N-CA-C 118.014 1.966 . . . . 0.0 118.014 163.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -78.89 -55.87 4.82 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 119.494 1.647 . . . . 0.0 113.594 -168.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -57.0 -39.28 74.4 Favored 'General case' 0 CA--C 1.568 1.648 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 172.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -69.84 -37.46 76.19 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 117.415 -1.279 . . . . 0.0 114.05 169.329 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -52.9 -39.95 63.16 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 115.478 1.658 . . . . 0.0 115.478 167.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.43 ' HD2' ' HA ' ' A' ' 37' ' ' ARG . 9.8 tpt180 -67.64 -39.99 84.59 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 172.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -64.99 -31.76 73.16 Favored 'General case' 0 CA--C 1.579 2.074 0 N-CA-C 115.634 1.716 . . . . 0.0 115.634 166.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 57.6 mt -59.89 -45.68 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 C-N-CA 126.023 1.729 . . . . 0.0 111.362 167.439 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -63.06 -41.48 99.47 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 172.017 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -71.74 -37.77 70.52 Favored 'General case' 0 CA--C 1.563 1.444 0 N-CA-C 116.823 2.157 . . . . 0.0 116.823 176.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.05 71.06 1.18 Allowed Glycine 0 CA--C 1.545 1.967 0 CA-C-O 117.782 -1.566 . . . . 0.0 115.179 -176.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.874 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 59.2 p -92.33 -51.26 5.24 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-N 119.684 1.742 . . . . 0.0 114.286 174.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.874 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.25 73.4 mttt 105.87 -40.52 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.777 0 CA-C-O 116.325 -1.798 . . . . 0.0 111.651 -171.549 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.06 -14.84 57.43 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 123.066 2.666 . . . . 0.0 112.968 164.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.3 -57.53 19.31 Favored Glycine 0 C--N 1.358 1.755 0 CA-C-N 120.299 1.409 . . . . 0.0 115.082 168.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.268 10.9 p -75.13 -47.5 35.8 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.394 0 N-CA-C 116.45 2.018 . . . . 0.0 116.45 -168.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -65.42 -46.86 78.3 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 120.783 1.629 . . . . 0.0 112.8 173.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.02 -33.81 75.29 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -178.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -66.68 -42.46 86.51 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 168.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.591 ' CG ' ' O ' ' A' ' 51' ' ' ARG . 31.6 ttt180 -73.0 -51.53 17.9 Favored 'General case' 0 CA--C 1.59 2.518 1 CA-C-O 85.079 -16.677 . . . . 0.0 118.318 -173.725 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 16.9 m-30 -31.57 -56.91 0.27 Allowed 'General case' 0 N--CA 1.495 1.793 1 O-C-N 109.216 -8.428 . . . . 0.0 121.693 146.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 35.8 mt -59.17 -44.68 92.16 Favored 'General case' 0 CA--C 1.578 2.039 0 CA-C-N 122.941 2.609 . . . . 0.0 114.411 166.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -80.79 -34.12 34.33 Favored 'General case' 0 CA--C 1.564 1.488 0 N-CA-C 116.941 2.2 . . . . 0.0 116.941 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -97.05 -33.77 11.41 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 175.159 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.47 20.19 6.69 Favored Glycine 0 CA--C 1.546 1.987 0 CA-C-N 122.452 2.387 . . . . 0.0 118.068 169.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -97.98 173.06 7.25 Favored 'General case' 0 CA--C 1.574 1.904 0 CA-C-N 118.998 1.399 . . . . 0.0 110.083 167.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.7 mt -72.71 130.31 40.22 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 119.828 -1.795 . . . . 0.0 114.923 -166.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.4 p -116.35 113.55 40.98 Favored Pre-proline 0 CA--C 1.57 1.745 0 C-N-CA 124.817 1.247 . . . . 0.0 108.936 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -60.6 153.06 64.22 Favored 'Trans proline' 0 CA--C 1.559 1.746 0 C-N-CA 123.425 2.75 . . . . 0.0 116.996 177.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 90.5 p -79.35 172.91 13.14 Favored 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 177.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASP . . . . . 0.427 ' O ' ' HB2' ' A' ' 66' ' ' GLU . 6.0 t70 81.89 -46.12 0.19 Allowed 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 125.839 1.656 . . . . 0.0 114.713 175.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 22.6 mt -60.83 -50.96 71.33 Favored 'General case' 0 N--CA 1.506 2.354 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 168.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.4 m -58.84 -50.83 72.53 Favored 'General case' 0 CA--C 1.566 1.591 0 CA-C-N 112.989 -1.914 . . . . 0.0 112.904 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -62.17 -28.44 69.66 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 115.216 1.561 . . . . 0.0 115.216 168.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -64.69 -44.37 90.52 Favored 'General case' 0 CA--C 1.555 1.171 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 171.997 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.3 mt -60.9 -48.99 79.29 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.214 1.191 . . . . 0.0 114.214 167.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 78.5 t -61.39 -51.82 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 CA-C-O 117.989 -1.005 . . . . 0.0 111.497 175.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -64.4 -28.38 69.65 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 174.082 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -64.05 -41.43 97.38 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 119.706 1.139 . . . . 0.0 112.806 168.423 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 27.8 ttm-85 -82.4 -9.2 59.54 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 119.001 2.963 . . . . 0.0 119.001 170.43 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 89.9 mt -99.49 -23.42 15.11 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 175.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 . . . . . 0 N--CA 1.5 2.028 0 N-CA-C 116.318 1.97 . . . . 0.0 116.318 172.168 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.729 ' HA2' ' HB3' ' A' ' 2' ' ' ARG . . . . . . . . 0 N--CA 1.483 1.786 0 CA-C-O 122.969 1.316 . . . . 0.0 112.612 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.402 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . 31.5 p90 -178.39 135.32 0.15 Allowed 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 113.355 -1.422 . . . . 0.0 112.111 -168.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 31.3 mt -109.5 106.03 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.545 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 174.235 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.9 mt -99.98 129.84 46.09 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.35 1.06 . . . . 0.0 110.261 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -124.22 115.96 21.91 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 118.501 0.591 . . . . 0.0 110.235 -172.528 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 75.18 32.64 55.72 Favored Glycine 0 CA--C 1.551 2.343 0 CA-C-O 117.549 -1.695 . . . . 0.0 117.046 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -95.9 -52.77 0.23 Allowed Pre-proline 0 N--CA 1.496 1.863 0 CA-C-O 115.068 -2.396 . . . . 0.0 108.664 174.425 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -66.13 70.7 0.4 Allowed 'Trans proline' 0 CA--C 1.573 2.437 0 CA-C-N 124.57 2.668 . . . . 0.0 117.835 165.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . 0.33 39.2 ttt-85 -72.61 -35.41 67.85 Favored 'General case' 0 CA--C 1.56 1.333 0 N-CA-C 116.789 2.144 . . . . 0.0 116.789 167.629 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.6 t -147.29 135.4 21.45 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 -169.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . 0.329 4.9 p -69.02 -19.0 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 CA-C-O 116.364 -1.779 . . . . 0.0 112.597 -178.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -68.08 -32.7 73.22 Favored 'General case' 0 CA--C 1.558 1.254 0 N-CA-C 118.781 2.882 . . . . 0.0 118.781 165.168 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -75.83 -50.35 15.39 Favored 'General case' 0 CA--C 1.587 2.387 0 CA-C-N 124.372 3.26 . . . . 0.0 111.204 164.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.73 -27.43 66.47 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 117.984 2.587 . . . . 0.0 117.984 -175.673 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 41.9 tttt -57.32 -33.91 68.2 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 167.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.35 -38.23 88.69 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 167.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 47.3 mt -66.9 -33.19 75.05 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 170.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -63.19 -55.02 28.55 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 120.064 1.302 . . . . 0.0 112.755 169.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 1.157 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 0.7 OUTLIER -49.73 -36.58 26.09 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 115.761 1.763 . . . . 0.0 115.761 168.13 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 99' ' ' MET . . . . . 1.125 ' O ' ' HB2' ' A' ' 103' ' ' ARG . 65.6 mtt -84.37 -28.84 26.71 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 117.802 2.519 . . . . 0.0 117.802 175.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 35.9 tp -65.23 -55.05 20.67 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 120.747 1.612 . . . . 0.0 111.862 170.624 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -80.1 -50.74 9.9 Favored 'General case' 0 CA--C 1.562 1.42 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 176.849 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 1.157 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 94.4 mtt180 -71.86 -42.15 67.21 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 177.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 1.125 ' HB2' ' O ' ' A' ' 99' ' ' MET . 43.6 mtt180 -65.18 -51.52 60.59 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 119.928 1.24 . . . . 0.0 111.621 164.526 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.4 44.33 1.26 Allowed Glycine 0 N--CA 1.48 1.612 0 C-N-CA 121.052 -0.594 . . . . 0.0 114.153 167.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 31.1 p -95.18 145.02 25.33 Favored 'General case' 0 CA--C 1.557 1.217 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 169.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -69.44 128.19 35.65 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.438 -0.789 . . . . 0.0 112.604 -169.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 4.5 tp -81.0 102.78 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 173.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . 0.268 24.2 t70 -96.5 -76.23 0.51 Allowed 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 116.111 -1.899 . . . . 0.0 106.8 167.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -138.87 127.14 22.78 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 121.141 1.791 . . . . 0.0 114.794 -173.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.4 t -93.66 109.92 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 103.144 -2.91 . . . . 0.0 103.144 162.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 91.3 mt -107.09 120.48 42.2 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 122.918 0.487 . . . . 0.0 109.873 -172.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -103.95 128.18 51.48 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 118.033 0.379 . . . . 0.0 110.358 177.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -91.46 119.42 31.41 Favored 'General case' 0 CA--C 1.556 1.192 0 CA-C-O 122.946 1.355 . . . . 0.0 109.584 177.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -82.0 93.59 6.99 Favored 'General case' 0 CA--C 1.557 1.224 0 CA-C-N 112.843 -1.98 . . . . 0.0 108.314 166.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.481 1.076 0 CA-C-N 113.605 -1.634 . . . . 0.0 108.286 -168.499 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 48.3 t30 . . . . . 0 N--CA 1.503 2.211 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 27.7 mtp180 -59.78 -38.4 81.75 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 167.008 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 63.3 mtt -65.64 -31.87 73.13 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 169.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -64.12 -49.63 71.43 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 168.954 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.6 p -65.97 -33.33 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 169.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -54.19 -51.41 64.48 Favored 'General case' 0 CA--C 1.579 2.077 0 CA-C-N 120.175 1.352 . . . . 0.0 111.191 167.506 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -55.61 -37.09 67.67 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 119.529 3.159 . . . . 0.0 119.529 173.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -51.46 -29.37 15.99 Favored 'General case' 0 N--CA 1.513 2.685 0 N-CA-C 117.844 2.535 . . . . 0.0 117.844 170.625 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -121.88 -28.94 4.38 Favored 'General case' 0 CA--C 1.559 1.309 0 N-CA-C 118.852 2.908 . . . . 0.0 118.852 -166.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 33.5 m -42.78 -37.08 1.66 Allowed 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 118.053 2.612 . . . . 0.0 118.053 -168.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.5 -62.46 2.99 Favored Pre-proline 0 CA--C 1.581 2.172 0 CA-C-O 116.175 -1.869 . . . . 0.0 111.822 172.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -52.08 -36.56 66.14 Favored 'Trans proline' 0 CA--C 1.58 2.819 0 C-N-CA 123.554 2.836 . . . . 0.0 118.546 167.993 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.68 -54.54 44.09 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 125.427 1.491 . . . . 0.0 111.973 171.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 1.004 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 44.2 tp -67.39 -23.55 65.58 Favored 'General case' 0 CA--C 1.561 1.396 0 CA-C-O 116.669 -1.634 . . . . 0.0 114.456 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -72.43 -46.01 57.02 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 122.022 2.192 . . . . 0.0 112.743 165.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -67.81 -52.07 41.37 Favored 'General case' 0 CA--C 1.565 1.534 0 CA-C-N 120.499 1.499 . . . . 0.0 112.245 -177.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -81.03 -24.3 38.01 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-O 115.119 -2.372 . . . . 0.0 113.405 178.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 1.004 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 39.8 ttt180 -65.04 -36.41 84.26 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 124.565 3.348 . . . . 0.0 115.581 168.29 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -68.17 -37.33 80.86 Favored 'General case' 0 CA--C 1.574 1.896 0 CA-C-N 119.806 1.185 . . . . 0.0 114.026 167.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -80.14 -35.93 35.94 Favored 'General case' 0 CA--C 1.575 1.91 0 N-CA-C 119.009 2.966 . . . . 0.0 119.009 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.2 pp -79.96 174.77 11.25 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 118.917 2.932 . . . . 0.0 118.917 -161.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 61.3 tttt -135.18 140.64 45.52 Favored 'General case' 0 CA--C 1.564 1.495 0 C-N-CA 125.249 1.42 . . . . 0.0 108.075 167.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 58.0 m -88.76 146.89 24.75 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.358 1.075 . . . . 0.0 112.14 -169.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 58.4 t -134.8 137.49 50.83 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.559 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 167.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -95.39 138.78 32.6 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 168.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -162.24 101.31 1.09 Allowed 'General case' 0 N--CA 1.482 1.13 0 O-C-N 121.466 -0.771 . . . . 0.0 112.323 -165.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.9 t . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 173.775 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 . . . . . 0 N--CA 1.499 2.003 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.63 -51.95 67.62 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 171.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 79.5 t -55.47 -40.33 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 175.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.4 ' CE1' ' HB3' ' A' ' 19' ' ' LYS . 22.9 t80 -62.97 -33.2 74.89 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 169.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -62.02 -48.98 77.87 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 114.241 1.201 . . . . 0.0 114.241 171.452 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 80.0 mtt180 -58.93 -42.6 90.14 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 117.199 2.296 . . . . 0.0 117.199 169.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -58.93 -43.35 91.13 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 170.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.9 mp -64.84 -42.05 95.24 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 169.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -54.4 -41.25 69.06 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 116.412 2.004 . . . . 0.0 116.412 169.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -65.24 -51.67 59.36 Favored 'General case' 0 CA--C 1.561 1.37 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 169.815 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 7.4 tt -74.03 -57.65 3.83 Favored 'General case' 0 CA--C 1.566 1.574 0 CA-C-N 120.026 1.285 . . . . 0.0 112.636 -176.042 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.945 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -110.46 -57.66 0.5 Allowed Glycine 0 CA--C 1.552 2.362 0 CA-C-O 117.744 -1.587 . . . . 0.0 114.762 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.945 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 63.6 tttm . . . . . 0 C--O 1.251 1.173 0 CA-C-N 120.306 2.053 . . . . 0.0 109.212 -175.864 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.4 mmt . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 122.667 1.222 . . . . 0.0 111.444 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . 0.304 8.7 ttm-85 -148.59 147.07 28.57 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 118.162 2.652 . . . . 0.0 118.162 -158.429 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 37.7 t -142.76 148.83 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 124.624 2.154 . . . . 0.0 110.846 -172.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.4 HD11 HG22 ' A' ' 110' ' ' VAL 0.294 0.0 OUTLIER -135.56 122.03 20.63 Favored 'General case' 0 CA--C 1.564 1.513 0 CA-C-N 112.716 -2.038 . . . . 0.0 106.416 166.095 . . . . . . . . 4 4 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.9 tt -97.98 133.31 42.63 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.823 1.649 . . . . 0.0 110.832 -166.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.6 mt -138.4 156.43 47.59 Favored 'General case' 0 CA--C 1.554 1.118 0 CA-C-N 113.98 -1.463 . . . . 0.0 111.174 -166.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 160.6 144.33 3.94 Favored Glycine 0 CA--C 1.555 2.544 0 CA-C-O 118.202 -1.332 . . . . 0.0 114.967 172.345 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo . . . . . 0 CA--C 1.579 2.733 0 CA-C-N 121.367 2.584 . . . . 0.0 114.847 169.966 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm . . . . . 0 N--CA 1.484 1.274 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -48.22 -33.07 10.33 Favored Glycine 0 CA--C 1.557 2.693 0 N-CA-C 120.175 2.83 . . . . 0.0 120.175 171.792 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 20.1 m -61.7 -52.18 65.34 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 118.872 1.336 . . . . 0.0 113.967 170.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.284 2.8 mp0 -75.09 -11.69 60.15 Favored 'General case' 0 CA--C 1.57 1.716 0 CA-C-O 115.719 -2.086 . . . . 0.0 112.683 171.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.91 -45.85 55.91 Favored 'General case' 0 C--N 1.372 1.581 0 CA-C-N 123.778 2.99 . . . . 0.0 113.929 166.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.3 p -65.22 -44.89 95.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 173.093 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.481 ' HB3' ' HE2' ' A' ' 172' ' ' PHE . 99.5 mttt -64.12 -46.06 85.84 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 116.325 1.972 . . . . 0.0 116.325 172.761 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.5 tp -65.26 -29.32 70.09 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 171.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.81 -45.15 93.97 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 168.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -52.71 -39.73 62.3 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 164.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -64.32 -48.2 76.52 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 170.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.7 mt -79.6 -19.01 50.33 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 116.505 2.039 . . . . 0.0 116.505 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.99 46.78 6.49 Favored Glycine 0 CA--C 1.554 2.513 0 CA-C-N 120.054 1.297 . . . . 0.0 116.14 -174.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.555 ' CD1' ' HA ' ' A' ' 81' ' ' PHE . 0.2 OUTLIER -130.86 147.93 68.17 Favored Pre-proline 0 CA--C 1.572 1.809 0 C-N-CA 125.855 1.662 . . . . 0.0 110.949 -165.773 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.476 ' HD2' HD12 ' A' ' 26' ' ' ILE . 19.2 Cg_endo -75.55 106.73 2.32 Favored 'Trans proline' 0 CA--C 1.574 2.489 0 C-N-CA 121.85 1.7 . . . . 0.0 111.049 158.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.35 132.62 48.05 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 120.643 -1.286 . . . . 0.0 112.028 169.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -94.98 107.25 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 N-CA-C 103.478 -2.786 . . . . 0.0 103.478 174.077 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 76.3 p -98.24 125.06 43.16 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 168.669 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.9 p -68.76 -4.6 16.57 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 117.68 2.474 . . . . 0.0 117.68 -175.032 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.77 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -89.34 -26.06 26.71 Favored Glycine 0 CA--C 1.539 1.573 0 N-CA-C 118.898 2.319 . . . . 0.0 118.898 165.722 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -82.11 -55.61 4.45 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 -168.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -63.9 -40.1 95.72 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 175.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.481 ' HB3' ' CB ' ' A' ' 50' ' ' LYS . 20.1 m-85 -71.09 -44.97 64.6 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 116.35 -1.786 . . . . 0.0 114.612 173.006 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.77 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 72.5 ttt180 -52.46 -41.86 63.68 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 168.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -61.84 -41.25 97.58 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 168.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -67.61 -25.65 65.86 Favored 'General case' 0 CA--C 1.583 2.218 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 168.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 66.8 mt -61.64 -48.38 88.98 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.458 0 CA-C-N 121.054 1.752 . . . . 0.0 110.264 166.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -61.72 -40.91 96.71 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 175.469 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -65.94 -44.19 85.79 Favored 'General case' 0 CA--C 1.558 1.257 0 N-CA-C 116.069 1.878 . . . . 0.0 116.069 174.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.06 66.96 1.26 Allowed Glycine 0 CA--C 1.544 1.859 0 CA-C-O 118.784 -1.009 . . . . 0.0 114.301 -176.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.837 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 70.4 p -91.43 -48.45 6.88 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.837 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.274 38.9 mttp 107.77 -41.54 0.0 OUTLIER 'General case' 0 CA--C 1.571 1.752 0 CA-C-O 116.31 -1.805 . . . . 0.0 111.007 -172.431 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.4 pp -79.5 -18.66 51.47 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 123.108 2.686 . . . . 0.0 114.147 163.029 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.26 -55.77 28.64 Favored Glycine 0 CA--C 1.548 2.141 0 CA-C-O 122.419 1.011 . . . . 0.0 114.951 169.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 1.082 ' O ' ' HB2' ' A' ' 51' ' ' ARG . 1.0 OUTLIER -75.89 -43.73 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 N-CA-C 117.158 2.281 . . . . 0.0 117.158 -167.988 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.48 ' HG2' HG23 ' A' ' 59' ' ' VAL . 29.7 tt0 -78.45 -24.79 45.86 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 122.369 2.349 . . . . 0.0 111.806 170.318 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.85 -47.76 70.96 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 123.163 2.71 . . . . 0.0 112.68 177.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.481 ' CB ' ' HB3' ' A' ' 35' ' ' PHE 0.356 38.5 tptt -81.56 -17.22 49.15 Favored 'General case' 0 CA--C 1.573 1.85 0 O-C-N 124.694 1.247 . . . . 0.0 114.339 173.111 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 1.082 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 21.5 ttt180 -83.61 -54.34 5.0 Favored 'General case' 0 CA--C 1.581 2.173 1 CA-C-O 85.034 -16.698 . . . . 0.0 118.562 175.691 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -37.99 -62.8 0.53 Allowed 'General case' 0 C--N 1.368 1.398 1 O-C-N 105.791 -10.568 . . . . 0.0 119.442 148.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . 0.271 1.2 tm? -41.18 -40.65 1.62 Allowed 'General case' 0 CA--C 1.58 2.123 0 CA-C-N 121.968 2.167 . . . . 0.0 116.845 170.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -90.72 -42.91 10.44 Favored 'General case' 0 CA--C 1.572 1.821 0 N-CA-C 117.045 2.239 . . . . 0.0 117.045 169.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -102.69 -23.45 13.83 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 118.31 2.707 . . . . 0.0 118.31 -169.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.48 32.45 7.32 Favored Glycine 0 CA--C 1.543 1.807 0 N-CA-C 118.58 2.192 . . . . 0.0 118.58 169.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -83.78 -127.09 0.03 OUTLIER 'General case' 0 CA--C 1.583 2.234 0 C-N-CA 123.833 0.853 . . . . 0.0 111.106 168.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 pp -128.81 179.08 5.91 Favored 'General case' 0 CA--C 1.573 1.835 0 C-N-CA 126.268 1.827 . . . . 0.0 110.462 169.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.48 HG23 ' HG2' ' A' ' 48' ' ' GLU . 0.3 OUTLIER -163.9 138.84 4.76 Favored Pre-proline 0 CA--C 1.574 1.899 0 O-C-N 119.484 -2.01 . . . . 0.0 110.593 170.927 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -60.01 145.42 98.43 Favored 'Trans proline' 0 CA--C 1.562 1.919 0 C-N-CA 123.432 2.755 . . . . 0.0 115.999 169.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 95.3 p -78.61 173.15 12.72 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 77.27 -38.39 0.29 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 117.15 2.278 . . . . 0.0 117.15 173.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' LEU . . . . . 0.452 ' O ' ' HB2' ' A' ' 66' ' ' GLU . 4.4 pp -54.55 -43.07 71.69 Favored 'General case' 0 N--CA 1.507 2.416 0 N-CA-C 118.03 2.604 . . . . 0.0 118.03 170.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.4 m -60.91 -58.39 8.65 Favored 'General case' 0 CA--C 1.562 1.424 0 CA-C-N 111.5 -2.591 . . . . 0.0 112.082 176.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -62.38 -19.14 63.1 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 166.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 63' ' ' LEU . 6.1 mm-40 -65.52 -44.84 85.67 Favored 'General case' 0 CA--C 1.558 1.276 0 CA-C-N 120.729 1.604 . . . . 0.0 114.036 168.129 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.5 mt -63.66 -43.79 95.69 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 114.571 1.322 . . . . 0.0 114.571 167.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 81.8 t -59.82 -48.9 85.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 CA-C-O 117.967 -1.016 . . . . 0.0 112.45 170.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -57.6 -37.6 73.49 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 116.976 2.213 . . . . 0.0 116.976 169.739 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -60.19 -39.45 86.57 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 169.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 76.8 mtp85 -79.44 -12.41 59.89 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 117.805 2.52 . . . . 0.0 117.805 167.578 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.1 mp -91.65 -23.67 19.76 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 117.527 2.417 . . . . 0.0 117.527 176.61 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 30.3 p30 . . . . . 0 CA--C 1.578 2.054 0 N-CA-C 118.187 2.662 . . . . 0.0 118.187 168.418 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.502 0 CA-C-O 122.5 1.056 . . . . 0.0 113.337 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.555 ' HA ' ' CD1' ' A' ' 26' ' ' ILE 0.38 1.6 p90 171.75 139.21 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 113.605 -1.297 . . . . 0.0 111.357 163.11 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.9 mp -115.45 109.26 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 165.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.9 mt -100.36 108.99 21.15 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 168.765 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -103.61 129.29 50.85 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-N 120.111 1.323 . . . . 0.0 109.961 -173.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 67.49 47.17 64.21 Favored Glycine 0 CA--C 1.548 2.098 0 CA-C-O 116.609 -2.217 . . . . 0.0 116.191 -173.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -132.77 73.17 76.45 Favored Pre-proline 0 CA--C 1.568 1.67 0 CA-C-N 121.104 2.452 . . . . 0.0 115.297 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -97.94 -28.27 0.05 OUTLIER 'Trans proline' 0 CA--C 1.561 1.87 0 C-N-CA 122.817 2.344 . . . . 0.0 112.857 156.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 50.1 mtt85 41.64 24.28 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 118.324 2.713 . . . . 0.0 118.324 -163.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.521 ' HA ' ' HG3' ' A' ' 147' ' ' GLU . 27.6 t 103.99 153.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 127.164 2.185 . . . . 0.0 106.519 -170.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' VAL . . . . . 0.531 HG12 ' HB2' ' A' ' 147' ' ' GLU 0.307 7.7 p -57.77 -27.34 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 119.647 -1.908 . . . . 0.0 112.366 169.23 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -70.0 -25.76 63.76 Favored 'General case' 0 CA--C 1.557 1.218 0 N-CA-C 119.471 3.138 . . . . 0.0 119.471 166.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.3 tm0? -74.28 -49.96 20.91 Favored 'General case' 0 CA--C 1.59 2.505 0 CA-C-N 124.592 3.36 . . . . 0.0 108.961 162.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -53.09 -25.44 12.9 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 117.845 2.535 . . . . 0.0 117.845 -176.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -59.14 -33.05 70.43 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 166.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.12 -41.29 74.14 Favored 'General case' 0 CA--C 1.571 1.784 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 169.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 28.9 tp -63.16 -36.48 83.77 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 168.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 21.7 t60 -56.3 -53.6 55.36 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 125.219 1.408 . . . . 0.0 112.719 167.821 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.806 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 11.0 mm-40 -49.92 -36.55 28.08 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 115.694 1.738 . . . . 0.0 115.694 166.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' MET . . . . . 1.13 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 24.9 ttt -83.45 -31.75 26.41 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 118.117 2.636 . . . . 0.0 118.117 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.52 -44.28 51.96 Favored 'General case' 0 N--CA 1.508 2.449 0 CA-C-N 121.741 2.064 . . . . 0.0 111.486 169.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -71.91 -57.6 4.17 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 119.496 1.044 . . . . 0.0 113.694 173.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.806 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 76.8 mtp180 -71.76 -36.55 70.43 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 178.084 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 1.13 ' HB3' ' O ' ' A' ' 99' ' ' MET . 57.4 ttt85 -61.16 -56.59 19.0 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 119.462 1.028 . . . . 0.0 111.736 165.188 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 111.7 49.87 0.62 Allowed Glycine 0 N--CA 1.481 1.672 0 O-C-N 124.231 0.957 . . . . 0.0 114.09 167.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 62.0 p -97.88 163.74 12.66 Favored 'General case' 0 CA--C 1.561 1.387 0 CA-C-N 114.015 -1.093 . . . . 0.0 111.075 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -84.63 134.57 34.38 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.158 -0.964 . . . . 0.0 109.128 177.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.502 HD11 HG23 ' A' ' 110' ' ' VAL . 8.9 tt -95.88 107.2 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 172.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -89.36 -60.44 1.95 Allowed 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 115.399 -2.239 . . . . 0.0 106.478 166.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -156.13 131.35 9.35 Favored 'General case' 0 C--N 1.369 1.419 0 CA-C-N 122.611 2.46 . . . . 0.0 116.463 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.502 HG23 HD11 ' A' ' 107' ' ' ILE . 39.2 t -88.66 107.86 18.21 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.629 0 N-CA-C 100.638 -3.838 . . . . 0.0 100.638 160.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.5 HD23 ' HB2' ' A' ' 160' ' ' LYS . 68.6 mt -104.27 108.83 20.42 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 118.318 -0.849 . . . . 0.0 109.616 -168.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -106.84 125.78 51.45 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.966 0.888 . . . . 0.0 109.857 -176.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -100.69 116.64 33.08 Favored 'General case' 0 CA--C 1.557 1.235 0 CA-C-O 122.568 1.175 . . . . 0.0 110.469 -169.37 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -79.64 97.81 6.68 Favored 'General case' 0 CA--C 1.556 1.191 0 CA-C-N 113.546 -1.661 . . . . 0.0 108.835 165.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.0 p . . . . . 0 CA--C 1.553 1.063 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 -169.265 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 . . . . . 0 N--CA 1.506 2.343 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -55.46 -39.11 69.95 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 166.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -67.6 -32.32 72.96 Favored 'General case' 0 CA--C 1.566 1.588 0 N-CA-C 114.97 1.471 . . . . 0.0 114.97 169.842 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -59.58 -54.18 49.44 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 120.561 1.528 . . . . 0.0 114.604 168.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . 0.253 7.3 p -63.67 -29.94 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 CA-C-O 117.085 -1.436 . . . . 0.0 114.054 170.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -56.65 -48.5 77.43 Favored 'General case' 0 CA--C 1.586 2.339 0 CA-C-N 121.441 1.928 . . . . 0.0 111.654 166.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.07 -21.2 11.74 Favored 'General case' 0 CA--C 1.564 1.493 0 N-CA-C 119.346 3.091 . . . . 0.0 119.346 170.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.31 -45.71 69.1 Favored 'General case' 0 N--CA 1.51 2.541 0 CA-C-N 121.339 1.882 . . . . 0.0 115.725 167.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.531 ' HB2' HG12 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -123.91 -18.57 5.95 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 120.742 3.608 . . . . 0.0 120.742 -167.31 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 53.7 m -43.72 -31.67 0.85 Allowed 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 117.899 2.555 . . . . 0.0 117.899 -169.081 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -71.48 -64.32 1.16 Allowed Pre-proline 0 CA--C 1.582 2.182 0 CA-C-O 116.123 -1.894 . . . . 0.0 112.21 172.259 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -56.53 -32.79 90.93 Favored 'Trans proline' 0 CA--C 1.579 2.772 0 CA-C-N 124.555 2.662 . . . . 0.0 118.905 168.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -63.2 -46.63 86.14 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 125.451 1.5 . . . . 0.0 112.711 171.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 1.075 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 54.2 tp -65.96 -21.91 66.45 Favored 'General case' 0 CA--C 1.57 1.719 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 169.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -70.62 -48.04 57.05 Favored 'General case' 0 CA--C 1.559 1.31 0 CA-C-N 122.362 2.346 . . . . 0.0 112.914 165.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -61.91 -54.31 43.72 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-N 120.271 1.396 . . . . 0.0 113.021 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' TYR . . . . . 0.422 ' CD1' HG11 ' A' ' 110' ' ' VAL . 22.0 m-85 -76.43 -27.52 56.28 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-O 115.739 -2.076 . . . . 0.0 113.438 178.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 1.075 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 26.0 ttt180 -62.34 -33.81 75.43 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 124.166 3.166 . . . . 0.0 116.754 169.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -70.57 -40.9 73.06 Favored 'General case' 0 CA--C 1.575 1.922 0 CA-C-N 119.708 1.14 . . . . 0.0 113.64 166.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -90.66 -19.69 23.34 Favored 'General case' 0 CA--C 1.575 1.932 0 N-CA-C 119.877 3.288 . . . . 0.0 119.877 -176.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.5 pp -78.06 172.16 13.93 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 119.887 3.291 . . . . 0.0 119.887 -160.938 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.5 ' HB2' HD23 ' A' ' 111' ' ' LEU . 90.5 mttt -132.65 123.98 27.41 Favored 'General case' 0 CA--C 1.563 1.45 0 N-CA-C 104.349 -2.463 . . . . 0.0 104.349 163.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.9 t -95.94 151.01 19.82 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 122.034 0.921 . . . . 0.0 111.99 -171.151 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.511 HG13 ' HG3' ' A' ' 174' ' ' ARG . 15.2 t -129.76 129.49 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 178.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -97.22 111.61 23.77 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 104.121 -2.548 . . . . 0.0 104.121 169.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -128.14 42.28 3.35 Favored 'General case' 0 N--CA 1.484 1.272 1 N-CA-C 123.571 4.656 . . . . 0.0 123.571 -156.596 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . 0.501 32.5 m . . . . . 0 CA--C 1.602 2.958 1 CA-C-O 109.702 -4.951 . . . . 0.0 106.98 169.031 . . . . . . . . 2 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 . . . . . 0 N--CA 1.504 2.261 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.557 ' HB3' ' NH2' ' A' ' 174' ' ' ARG . 50.3 mt-10 -59.14 -51.95 67.82 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 174.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 4.0 t -59.14 -36.25 61.78 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.925 0 CA-C-O 117.426 -1.273 . . . . 0.0 113.462 177.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.481 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 21.4 t80 -58.75 -40.64 84.46 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 121.082 1.764 . . . . 0.0 114.84 166.806 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -61.83 -54.44 42.17 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 178.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.557 ' NH2' ' HB3' ' A' ' 170' ' ' GLU . 11.4 ptp180 -69.08 -25.28 64.36 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 117.841 2.534 . . . . 0.0 117.841 172.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.56 -46.61 85.15 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 120.637 1.562 . . . . 0.0 113.862 168.013 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.3 mp -58.79 -43.91 90.58 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 167.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -53.47 -43.07 67.85 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 168.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.09 -44.96 90.73 Favored 'General case' 0 CA--C 1.56 1.364 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 172.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.81 -61.56 1.72 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 120.538 1.517 . . . . 0.0 110.897 172.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.885 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . 164.6 52.57 0.02 OUTLIER Glycine 0 CA--C 1.545 1.942 0 N-CA-C 118.795 2.278 . . . . 0.0 118.795 168.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.885 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 85.2 tttt . . . . . 0 C--O 1.252 1.187 0 CA-C-N 120.794 2.297 . . . . 0.0 110.565 168.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.2 mtt . . . . . 0 CA--C 1.556 1.206 0 CA-C-O 122.812 1.292 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . 0.309 11.6 mpt_? -120.57 171.44 8.56 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 121.231 3.789 . . . . 0.0 121.231 -163.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.6 p -150.16 144.58 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.297 0 CA-C-O 123.044 1.402 . . . . 0.0 111.633 166.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.2 pp -138.62 134.16 33.37 Favored 'General case' 0 CA--C 1.563 1.448 0 CA-C-N 113.676 -1.602 . . . . 0.0 109.714 169.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.5 121.36 44.81 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 115.675 1.731 . . . . 0.0 115.675 -161.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 85.7 mt -99.58 144.96 28.07 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 111.443 -2.617 . . . . 0.0 110.358 175.212 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 163.93 162.26 14.53 Favored Glycine 0 CA--C 1.557 2.681 0 CA-C-O 118.801 -0.999 . . . . 0.0 115.553 169.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo . . . . . 0 CA--C 1.578 2.711 0 C-N-CA 123.475 2.783 . . . . 0.0 111.838 175.597 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.6 mtmp? . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 121.807 0.813 . . . . 0.0 110.347 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -53.8 -28.35 38.81 Favored Glycine 0 CA--C 1.554 2.48 0 N-CA-C 120.421 2.928 . . . . 0.0 120.421 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.1 m -65.76 -53.0 46.4 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 119.328 1.564 . . . . 0.0 113.265 176.011 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.28 20.0 mp0 -76.64 -13.32 60.07 Favored 'General case' 0 CA--C 1.569 1.698 0 CA-C-O 114.895 -2.479 . . . . 0.0 112.43 169.766 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.38 -47.08 68.3 Favored 'General case' 0 C--N 1.376 1.729 0 CA-C-N 125.145 3.611 . . . . 0.0 113.703 166.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.1 p -66.8 -39.94 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 174.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -62.13 -43.99 97.61 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 116.305 1.965 . . . . 0.0 116.305 169.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.84 -32.36 73.84 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 119.996 1.271 . . . . 0.0 114.152 171.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.38 -42.3 95.56 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 115.292 1.589 . . . . 0.0 115.292 167.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -58.2 -39.53 79.22 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 167.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.3 mmmt -65.9 -54.88 20.81 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 174.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.3 mt -83.51 -19.8 35.07 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 116.775 2.139 . . . . 0.0 116.775 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.02 38.6 7.83 Favored Glycine 0 CA--C 1.554 2.512 0 N-CA-C 117.62 1.808 . . . . 0.0 117.62 -176.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.9 mm -107.51 158.52 33.04 Favored Pre-proline 0 CA--C 1.57 1.724 0 CA-C-N 118.565 1.182 . . . . 0.0 113.419 -168.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -82.82 99.77 0.93 Allowed 'Trans proline' 0 CA--C 1.571 2.338 0 C-N-CA 121.867 1.712 . . . . 0.0 111.372 163.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -64.04 112.24 2.88 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 123.831 0.852 . . . . 0.0 112.117 170.635 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 21.5 mm -99.83 108.48 22.79 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.1 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 59.8 p -97.79 128.64 44.56 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 168.484 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.9 p -69.02 -19.34 64.11 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 117.066 2.247 . . . . 0.0 117.066 -169.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -81.67 -19.88 64.96 Favored Glycine 0 CA--C 1.543 1.839 0 N-CA-C 119.102 2.401 . . . . 0.0 119.102 167.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -80.84 -51.4 8.65 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -169.125 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -65.13 -41.07 95.15 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 174.346 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.452 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 25.2 m-85 -66.4 -41.1 89.82 Favored 'General case' 0 CA--C 1.559 1.298 0 N-CA-C 115.702 1.741 . . . . 0.0 115.702 172.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -59.3 -42.72 91.99 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 120.544 1.52 . . . . 0.0 114.203 168.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -59.21 -39.21 81.98 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 168.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -69.62 -24.47 63.65 Favored 'General case' 0 CA--C 1.581 2.14 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 168.315 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.0 mt -63.17 -49.46 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 CA-C-N 120.675 1.579 . . . . 0.0 110.96 167.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -67.95 -33.52 74.83 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 114.301 1.222 . . . . 0.0 114.301 175.254 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -73.7 -35.86 65.2 Favored 'General case' 0 CA--C 1.564 1.498 0 N-CA-C 116.299 1.962 . . . . 0.0 116.299 173.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.77 73.76 1.28 Allowed Glycine 0 CA--C 1.542 1.76 0 CA-C-O 118.065 -1.409 . . . . 0.0 114.482 -176.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.554 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 64.7 p -90.8 -65.59 1.0 Allowed 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 119.262 1.531 . . . . 0.0 111.911 173.123 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.554 ' CB ' ' O ' ' A' ' 43' ' ' THR . 21.3 ptmt 130.27 -57.13 0.0 OUTLIER 'General case' 0 CA--C 1.569 1.702 0 C-N-CA 123.661 0.784 . . . . 0.0 109.581 -166.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -80.03 6.83 10.39 Favored 'General case' 0 CA--C 1.575 1.913 0 C-N-CA 124.249 1.019 . . . . 0.0 113.454 166.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 50' ' ' LYS . . . -86.79 -52.77 3.05 Favored Glycine 0 CA--C 1.535 1.333 0 O-C-N 121.21 -0.931 . . . . 0.0 112.892 165.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.312 7.4 p -80.14 -52.03 15.22 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.581 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -167.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -66.94 -44.37 80.8 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 121.013 1.733 . . . . 0.0 112.686 172.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.79 -30.8 69.46 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.452 ' HB2' ' HB3' ' A' ' 35' ' ' PHE . 2.4 tptm -71.97 -36.87 69.95 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 167.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.571 ' HG2' ' O ' ' A' ' 51' ' ' ARG . 46.5 ttt180 -70.78 -58.71 3.35 Favored 'General case' 0 CA--C 1.591 2.534 1 CA-C-O 87.3 -15.619 . . . . 0.0 117.829 -178.531 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . 0.253 10.9 m-30 -26.47 -68.81 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.587 1 O-C-N 110.452 -7.655 . . . . 0.0 119.644 146.512 . . . . . . . . 3 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 26.6 tp -57.3 -32.07 66.29 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 116.517 2.043 . . . . 0.0 116.517 175.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -88.78 -47.25 8.35 Favored 'General case' 0 CA--C 1.559 1.311 0 CA-C-O 116.831 -1.557 . . . . 0.0 114.395 170.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -158.24 46.33 0.34 Allowed 'General case' 0 CA--C 1.573 1.837 0 CA-C-N 121.401 1.909 . . . . 0.0 113.32 -168.359 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -161.21 60.89 0.29 Allowed Glycine 0 C--N 1.358 1.785 0 CA-C-N 121.906 2.139 . . . . 0.0 111.727 169.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . 0.279 4.8 t70 75.56 -115.05 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 124.301 1.041 . . . . 0.0 110.423 168.619 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.568 ' HA ' HH22 ' A' ' 88' ' ' ARG . 74.7 mt -133.47 128.79 36.17 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 119.507 1.049 . . . . 0.0 110.628 -174.121 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.0 p -89.27 141.03 28.79 Favored Pre-proline 0 CA--C 1.578 2.031 0 CA-C-O 117.429 -1.272 . . . . 0.0 108.095 167.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -50.66 143.81 27.7 Favored 'Trans proline' 0 CA--C 1.565 2.03 0 C-N-CA 123.451 2.767 . . . . 0.0 116.696 169.765 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 59.6 m -65.71 -42.75 90.74 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 117.064 2.246 . . . . 0.0 117.064 -169.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -59.5 -37.71 79.01 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 116.832 2.16 . . . . 0.0 116.832 -175.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 35.5 mt -54.87 -51.82 64.75 Favored 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 169.865 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.7 m -64.99 -50.77 65.01 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 112.889 -1.96 . . . . 0.0 113.064 -178.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.83 -20.01 64.64 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 167.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -72.48 -46.87 52.79 Favored 'General case' 0 CA--C 1.556 1.185 0 CA-C-N 120.441 1.473 . . . . 0.0 114.588 170.02 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.1 mt -61.22 -46.0 92.26 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 169.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 97.3 t -61.77 -48.78 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 118.025 -0.988 . . . . 0.0 112.017 175.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -63.03 -35.78 81.36 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 115.993 1.849 . . . . 0.0 115.993 172.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -57.55 -42.83 83.73 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 117.695 -1.145 . . . . 0.0 113.779 170.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 83.2 mtt180 -80.26 -15.55 56.72 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 118.497 2.777 . . . . 0.0 118.497 168.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.419 HD13 HH12 ' A' ' 103' ' ' ARG . 96.6 mt -83.69 -14.69 51.14 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 116.527 2.047 . . . . 0.0 116.527 169.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 . . . . . 0 N--CA 1.5 2.03 0 N-CA-C 117.17 2.285 . . . . 0.0 117.17 169.917 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.451 0 CA-C-O 123.495 1.608 . . . . 0.0 115.266 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -173.44 131.87 0.46 Allowed 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 169.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 4.7 mm -104.65 108.21 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.504 0 N-CA-C 103.412 -2.81 . . . . 0.0 103.412 170.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 79.8 mt -100.09 138.82 36.63 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 171.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -127.9 127.96 44.31 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 119.575 1.08 . . . . 0.0 111.859 172.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 67.63 34.02 82.57 Favored Glycine 0 CA--C 1.552 2.373 0 N-CA-C 118.008 1.963 . . . . 0.0 118.008 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -94.34 -54.27 0.23 Allowed Pre-proline 0 N--CA 1.496 1.826 0 CA-C-O 114.956 -2.45 . . . . 0.0 108.968 173.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.3 68.63 1.42 Allowed 'Trans proline' 0 CA--C 1.565 2.071 0 CA-C-N 124.75 2.732 . . . . 0.0 118.82 167.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.568 HH22 ' HA ' ' A' ' 58' ' ' LEU . 26.8 ptt180 -66.61 -35.57 80.5 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 116.056 1.873 . . . . 0.0 116.056 166.186 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 37.7 t -149.18 141.17 23.81 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -168.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . 0.274 8.4 p -61.7 -27.24 41.77 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.653 0 CA-C-O 115.941 -1.981 . . . . 0.0 113.322 178.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -38.22 88.26 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 120.155 3.391 . . . . 0.0 120.155 166.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -75.68 -47.91 24.26 Favored 'General case' 0 CA--C 1.586 2.34 0 CA-C-N 123.356 2.798 . . . . 0.0 112.299 166.746 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.5 -31.0 70.07 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 -175.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -57.31 -29.72 64.15 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 168.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.18 -40.54 86.58 Favored 'General case' 0 CA--C 1.571 1.758 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 167.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LEU . . . . . 0.484 ' HA ' ' HG3' ' A' ' 99' ' ' MET . 40.1 tp -62.61 -38.3 89.66 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 169.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 55.8 t60 -64.89 -44.51 89.37 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 120.413 1.46 . . . . 0.0 113.313 168.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.839 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 32.0 mt-10 -51.58 -40.52 59.96 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 167.767 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' MET . . . . . 1.287 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -84.63 -19.95 32.14 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 117.934 2.568 . . . . 0.0 117.934 175.184 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 60.2 tp -72.45 -52.71 14.7 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 121.175 1.807 . . . . 0.0 111.47 170.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -74.85 -55.9 5.32 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 171.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.839 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 36.9 ttm180 -68.99 -39.22 79.51 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 178.076 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 1.287 ' HB3' ' O ' ' A' ' 99' ' ' MET . 66.1 ttt180 -62.37 -58.38 7.87 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 119.639 1.108 . . . . 0.0 110.365 164.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 111.47 46.66 0.78 Allowed Glycine 0 N--CA 1.479 1.529 0 O-C-N 124.366 1.041 . . . . 0.0 113.651 168.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 37.2 p -101.26 147.21 26.55 Favored 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 173.506 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -68.22 130.06 41.79 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.346 -0.846 . . . . 0.0 112.572 -170.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 4.4 tp -85.48 98.53 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 175.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -97.51 -67.77 0.83 Allowed 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 115.765 -2.064 . . . . 0.0 108.388 168.858 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -149.34 120.84 7.95 Favored 'General case' 0 C--N 1.367 1.367 0 CA-C-N 121.999 2.181 . . . . 0.0 115.114 -170.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 19.4 t -94.09 109.77 22.54 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.691 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 163.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.673 HD23 ' HB2' ' A' ' 160' ' ' LYS . 80.1 mt -105.07 117.97 35.35 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 123.423 0.689 . . . . 0.0 112.082 -172.556 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -88.68 136.19 33.12 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.398 0.618 . . . . 0.0 112.086 169.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -101.53 112.33 24.85 Favored 'General case' 0 CA--C 1.558 1.28 0 CA-C-O 122.998 1.38 . . . . 0.0 108.118 176.004 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.431 ' HB3' ' HA ' ' A' ' 163' ' ' ASP . 17.0 tpt180 -83.79 101.87 11.92 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 112.889 -1.959 . . . . 0.0 109.157 171.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.5 p . . . . . 0 CA--C 1.556 1.185 0 CA-C-N 113.128 -1.851 . . . . 0.0 106.717 -169.349 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.9 t30 . . . . . 0 N--CA 1.497 1.904 0 N-CA-C 114.692 1.368 . . . . 0.0 114.692 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 63.4 mtp180 -63.36 -32.61 74.08 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 116.363 1.986 . . . . 0.0 116.363 170.192 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 48.3 mtt -72.42 -33.0 66.8 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 168.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -61.84 -51.48 68.04 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 169.185 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.3 p -64.26 -34.22 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 CA-C-O 117.466 -1.254 . . . . 0.0 114.128 171.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -53.2 -48.08 68.38 Favored 'General case' 0 CA--C 1.591 2.55 0 CA-C-N 120.404 1.456 . . . . 0.0 112.349 167.391 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 63.1 ttt180 -57.42 -37.83 73.39 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 119.115 3.005 . . . . 0.0 119.115 174.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -52.91 -34.16 53.75 Favored 'General case' 0 N--CA 1.512 2.673 0 N-CA-C 117.205 2.298 . . . . 0.0 117.205 170.675 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -110.83 -28.43 8.4 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 120.298 3.444 . . . . 0.0 120.298 -165.336 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 56.8 m -63.5 -30.67 71.75 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 117.093 2.257 . . . . 0.0 117.093 -166.198 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.58 -61.55 4.33 Favored Pre-proline 0 CA--C 1.58 2.118 0 CA-C-O 116.583 -1.675 . . . . 0.0 112.616 168.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -65.29 -33.11 49.64 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 123.161 2.574 . . . . 0.0 117.471 176.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.2 tt -63.07 -55.06 28.7 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 117.344 -1.312 . . . . 0.0 110.542 168.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.997 ' O ' ' HB2' ' A' ' 156' ' ' ARG 0.335 0.1 OUTLIER -57.21 -27.12 61.71 Favored 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 177.931 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -73.5 -41.97 62.41 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 116.126 -1.892 . . . . 0.0 113.115 165.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -66.88 -55.82 13.01 Favored 'General case' 0 CA--C 1.564 1.494 0 CA-C-N 122.719 2.509 . . . . 0.0 112.583 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -80.46 -30.74 37.47 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-O 115.174 -2.346 . . . . 0.0 112.017 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.997 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 37.6 ttt180 -63.02 -32.63 74.03 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 124.418 3.281 . . . . 0.0 116.177 171.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -68.42 -41.12 80.86 Favored 'General case' 0 CA--C 1.574 1.888 0 CA-C-N 119.236 0.926 . . . . 0.0 113.182 165.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -90.81 -21.03 21.69 Favored 'General case' 0 CA--C 1.578 2.047 0 N-CA-C 120.331 3.456 . . . . 0.0 120.331 -176.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.7 pp -80.82 -178.37 6.79 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 119.053 2.983 . . . . 0.0 119.053 -163.119 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.673 ' HB2' HD23 ' A' ' 111' ' ' LEU . 90.5 mttt -130.89 141.52 50.31 Favored 'General case' 0 CA--C 1.564 1.491 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 166.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 34.0 m -100.01 145.49 27.82 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 122.408 1.099 . . . . 0.0 110.672 -171.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 38.4 t -133.04 132.39 58.87 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.487 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 169.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.431 ' HA ' ' HB3' ' A' ' 114' ' ' ARG . 20.4 t70 -96.14 138.47 33.7 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 167.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . 0.253 . . -125.61 -132.35 0.25 Allowed 'General case' 0 N--CA 1.483 1.212 0 O-C-N 121.64 -0.663 . . . . 0.0 111.433 -165.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 31.3 t . . . . . 0 N--CA 1.497 1.886 0 C-N-CA 127.173 2.189 . . . . 0.0 112.674 167.275 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 . . . . . 0 N--CA 1.498 1.971 0 N-CA-C 116.142 1.904 . . . . 0.0 116.142 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.734 ' HB3' ' NH2' ' A' ' 174' ' ' ARG . 48.1 mt-10 -61.32 -52.45 64.65 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 118.023 -0.989 . . . . 0.0 113.507 169.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 99.5 t -57.51 -37.9 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 175.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -62.04 -33.9 75.24 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 116.424 2.009 . . . . 0.0 116.424 168.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.78 -53.23 43.11 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 174.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.734 ' NH2' ' HB3' ' A' ' 170' ' ' GLU . 10.5 ptp180 -65.66 -29.64 70.23 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 117.586 2.439 . . . . 0.0 117.586 170.85 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.71 -45.83 92.28 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 119.856 1.207 . . . . 0.0 114.172 167.729 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.92 -44.7 91.35 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-O 117.013 -1.47 . . . . 0.0 114.698 168.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 26.5 mmm180 -55.79 -43.1 76.49 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 170.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.74 -39.5 94.29 Favored 'General case' 0 CA--C 1.563 1.444 0 N-CA-C 116.477 2.028 . . . . 0.0 116.477 172.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 5.8 tt -75.0 -51.68 13.0 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 120.968 1.713 . . . . 0.0 112.077 170.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -149.5 -57.48 0.01 OUTLIER Glycine 0 CA--C 1.552 2.377 0 CA-C-O 117.486 -1.73 . . . . 0.0 115.801 -176.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt . . . . . 0 C--O 1.252 1.205 0 CA-C-N 120.774 2.287 . . . . 0.0 108.655 -172.777 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.9 ttm . . . . . 0 CA--C 1.56 1.334 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.47 166.77 32.1 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 118.414 2.746 . . . . 0.0 118.414 -166.249 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.4 p -126.71 146.07 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-O 122.923 1.344 . . . . 0.0 114.193 -166.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -119.89 113.34 20.43 Favored 'General case' 0 CA--C 1.559 1.307 0 N-CA-C 104.867 -2.271 . . . . 0.0 104.867 168.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.2 tt -101.73 131.24 48.12 Favored 'General case' 0 CA--C 1.562 1.408 0 C-N-CA 125.788 1.635 . . . . 0.0 111.348 -165.155 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.8 mt -135.48 165.8 24.66 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 125.378 1.471 . . . . 0.0 113.825 -167.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.43 124.7 0.94 Allowed Glycine 0 CA--C 1.557 2.665 0 CA-C-O 117.362 -1.799 . . . . 0.0 111.274 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo . . . . . 0 CA--C 1.579 2.745 0 CA-C-N 122.522 3.161 . . . . 0.0 114.101 176.939 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt . . . . . 0 N--CA 1.487 1.383 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -42.61 -42.15 4.55 Favored Glycine 0 CA--C 1.551 2.332 0 N-CA-C 121.207 3.243 . . . . 0.0 121.207 -175.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.1 m -61.97 -57.32 12.14 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 118.992 1.396 . . . . 0.0 113.835 178.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.259 3.7 mm-40 -76.49 -14.22 60.05 Favored 'General case' 0 CA--C 1.573 1.859 0 CA-C-O 116.175 -1.869 . . . . 0.0 111.528 175.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.63 -47.38 60.38 Favored 'General case' 0 C--N 1.373 1.608 0 CA-C-N 123.219 2.736 . . . . 0.0 114.476 168.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.2 p -66.12 -40.76 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 172.404 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -58.94 -44.22 91.36 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 116.321 1.971 . . . . 0.0 116.321 169.348 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.91 -35.46 80.69 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 172.332 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.21 -42.1 90.16 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 167.677 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -59.82 -36.23 76.35 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 167.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -64.87 -59.44 4.2 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 170.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.1 mt -80.28 -20.92 43.3 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 116.422 2.008 . . . . 0.0 116.422 -176.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.95 34.19 8.46 Favored Glycine 0 CA--C 1.554 2.501 0 N-CA-C 117.681 1.833 . . . . 0.0 117.681 -177.287 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.3 mm -104.64 156.07 36.47 Favored Pre-proline 0 CA--C 1.568 1.649 0 CA-C-N 118.987 1.394 . . . . 0.0 112.561 -169.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -80.72 100.69 1.24 Allowed 'Trans proline' 0 CA--C 1.569 2.257 0 C-N-CA 121.816 1.677 . . . . 0.0 110.099 162.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -58.81 109.11 0.75 Allowed 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 124.347 1.059 . . . . 0.0 112.002 170.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 35.7 mm -98.0 107.64 20.55 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 68.9 p -95.46 126.99 41.14 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 167.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.4 p -65.73 -22.1 66.58 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 -169.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.638 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -83.56 -13.02 76.92 Favored Glycine 0 CA--C 1.544 1.871 0 N-CA-C 119.168 2.427 . . . . 0.0 119.168 168.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -81.8 -51.21 8.37 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 119.197 1.498 . . . . 0.0 114.648 -171.144 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -66.2 -42.17 89.18 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 173.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.54 ' HB3' ' CB ' ' A' ' 50' ' ' LYS . 32.9 m-85 -59.56 -43.93 93.41 Favored 'General case' 0 CA--C 1.569 1.674 0 C-N-CA 125.403 1.481 . . . . 0.0 114.477 168.126 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.638 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 72.2 ttt180 -54.94 -42.56 72.45 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 168.25 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.3 ttt180 -60.36 -36.58 78.37 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 168.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -69.29 -26.54 64.79 Favored 'General case' 0 CA--C 1.581 2.168 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 167.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.408 HG12 HG23 ' A' ' 47' ' ' VAL . 58.7 mt -60.67 -52.18 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.376 0 CA-C-N 120.933 1.697 . . . . 0.0 110.235 167.124 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -65.4 -35.48 81.06 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -70.3 -38.44 75.0 Favored 'General case' 0 CA--C 1.562 1.426 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 174.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.35 68.84 1.24 Allowed Glycine 0 CA--C 1.543 1.842 0 CA-C-O 118.905 -0.941 . . . . 0.0 114.623 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.822 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 74.5 p -92.63 -47.25 7.2 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 177.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.822 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.254 75.5 mttt 104.84 -40.04 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.725 0 CA-C-O 116.227 -1.844 . . . . 0.0 111.694 -172.737 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -83.8 -12.41 55.69 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 123.09 2.677 . . . . 0.0 112.586 163.224 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.33 -56.23 26.29 Favored Glycine 0 CA--C 1.547 2.047 0 CA-C-N 120.905 1.684 . . . . 0.0 114.167 168.302 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.408 HG23 HG12 ' A' ' 39' ' ' ILE 0.25 1.0 OUTLIER -74.33 -49.85 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 116.898 2.184 . . . . 0.0 116.898 -169.467 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -67.9 -38.59 83.19 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 119.907 1.23 . . . . 0.0 112.74 174.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.26 -35.85 66.29 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 117.969 -1.015 . . . . 0.0 113.594 -175.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.54 ' CB ' ' HB3' ' A' ' 35' ' ' PHE 0.33 1.7 tptt -81.14 -24.14 37.81 Favored 'General case' 0 CA--C 1.564 1.487 0 CA-C-O 116.961 -1.495 . . . . 0.0 113.36 173.022 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.585 ' HG2' ' O ' ' A' ' 51' ' ' ARG . 40.6 ttt180 -75.56 -56.99 4.16 Favored 'General case' 0 CA--C 1.591 2.553 1 CA-C-O 86.613 -15.946 . . . . 0.0 117.686 176.815 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . 0.254 15.7 m-30 -27.38 -64.46 0.08 Allowed 'General case' 0 N--CA 1.499 1.979 1 O-C-N 108.837 -8.664 . . . . 0.0 120.192 146.491 . . . . . . . . 3 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.2 tp -53.89 -39.56 65.84 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 116.998 2.222 . . . . 0.0 116.998 172.858 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -90.18 -41.1 11.8 Favored 'General case' 0 CA--C 1.566 1.559 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 173.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -153.03 41.63 0.58 Allowed 'General case' 0 CA--C 1.571 1.757 0 CA-C-N 120.86 1.664 . . . . 0.0 114.887 -169.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -165.78 59.26 0.24 Allowed Glycine 0 C--N 1.354 1.559 0 O-C-N 119.419 -2.051 . . . . 0.0 111.779 168.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . 0.273 5.0 t70 71.51 -117.7 0.08 Allowed 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 124.018 0.927 . . . . 0.0 109.555 169.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.1 pp -124.93 143.65 50.76 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 123.637 0.775 . . . . 0.0 112.06 -176.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.1 p -96.93 130.92 28.86 Favored Pre-proline 0 CA--C 1.573 1.832 0 CA-C-O 117.676 -1.154 . . . . 0.0 107.924 167.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -49.34 134.89 31.91 Favored 'Trans proline' 0 CA--C 1.56 1.821 0 C-N-CA 123.537 2.825 . . . . 0.0 116.042 172.641 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.8 m -68.82 175.65 3.5 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -169.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.3 t70 86.09 -44.43 0.05 Allowed 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 126.339 1.856 . . . . 0.0 113.999 -176.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.8 mt -60.44 -47.37 86.39 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 168.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.8 m -57.6 -50.26 73.72 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 113.544 -1.662 . . . . 0.0 113.449 177.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -69.76 -21.25 63.45 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 168.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -65.59 -43.61 89.16 Favored 'General case' 0 CA--C 1.559 1.316 0 CA-C-N 120.557 1.526 . . . . 0.0 114.957 168.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 44.2 mt -65.56 -46.31 79.95 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 167.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -56.71 -50.99 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 172.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -65.09 -34.22 77.9 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 175.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -58.1 -43.34 87.06 Favored 'General case' 0 CA--C 1.559 1.31 0 CA-C-O 117.793 -1.098 . . . . 0.0 113.497 168.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -81.76 -9.82 59.52 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 119.256 3.058 . . . . 0.0 119.256 169.08 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 13.1 tp -87.66 -14.68 39.28 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 169.256 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 . . . . . 0 CA--C 1.583 2.218 0 N-CA-C 118.441 2.756 . . . . 0.0 118.441 168.491 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.784 0 N-CA-C 117.883 1.913 . . . . 0.0 117.883 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -170.46 132.63 0.99 Allowed 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 114.189 -1.005 . . . . 0.0 108.88 -175.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.1 mm -102.43 105.48 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.577 0 N-CA-C 102.745 -3.057 . . . . 0.0 102.745 166.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -110.5 122.76 48.51 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -176.65 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.25 119.67 32.94 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 119.048 0.84 . . . . 0.0 110.467 -165.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.39 43.68 68.67 Favored Glycine 0 CA--C 1.548 2.094 0 CA-C-O 116.098 -2.501 . . . . 0.0 116.345 -174.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . 0.257 2.9 t80 -95.97 -57.32 0.2 Allowed Pre-proline 0 N--CA 1.504 2.234 0 CA-C-N 121.737 2.768 . . . . 0.0 108.276 176.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -60.59 59.67 0.09 OUTLIER 'Trans proline' 0 CA--C 1.577 2.654 0 N-CA-C 121.547 3.633 . . . . 0.0 121.547 168.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.533 HH11 ' HB2' ' A' ' 89' ' ' SER . 7.0 tmm_? -69.55 -28.43 66.0 Favored 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 166.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.533 ' HB2' HH11 ' A' ' 88' ' ' ARG . 30.3 t -151.68 155.51 38.48 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 120.279 1.399 . . . . 0.0 107.913 -176.184 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.5 t -61.87 -37.0 77.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-O 116.981 -1.485 . . . . 0.0 111.793 173.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.34 -40.41 77.94 Favored 'General case' 0 CA--C 1.558 1.268 0 N-CA-C 119.882 3.29 . . . . 0.0 119.882 169.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 22.3 mm100 -71.41 -48.21 51.17 Favored 'General case' 0 CA--C 1.589 2.471 0 CA-C-N 122.279 2.308 . . . . 0.0 113.322 168.42 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.78 -29.49 66.82 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 126.894 2.078 . . . . 0.0 116.05 -168.184 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 57.6 tttt -63.68 -31.57 72.78 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 166.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.97 -39.08 69.58 Favored 'General case' 0 CA--C 1.569 1.688 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 169.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 16.8 tp -63.01 -40.88 99.09 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 168.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -58.5 -52.49 65.43 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 119.431 1.014 . . . . 0.0 113.463 169.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.904 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 21.5 mm-40 -48.63 -41.79 32.19 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 115.956 1.836 . . . . 0.0 115.956 168.067 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' MET . . . . . 1.184 ' O ' ' HB2' ' A' ' 103' ' ' ARG . 55.1 mtt -84.12 -20.73 32.03 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 117.956 2.576 . . . . 0.0 117.956 175.569 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.1 tt -75.73 -48.93 19.8 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-N 121.301 1.864 . . . . 0.0 110.866 172.556 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -72.45 -56.28 5.67 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 119.57 1.077 . . . . 0.0 113.199 169.714 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.904 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 70.6 ttt180 -64.15 -44.63 91.54 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 116.353 1.983 . . . . 0.0 116.353 177.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 1.184 ' HB2' ' O ' ' A' ' 99' ' ' MET . 15.3 mtp-105 -65.13 -53.92 37.84 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 118.992 0.814 . . . . 0.0 111.196 165.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 111.02 48.62 0.71 Allowed Glycine 0 N--CA 1.483 1.831 0 C-N-CA 120.808 -0.71 . . . . 0.0 114.752 166.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 71.7 p -89.91 158.14 17.55 Favored 'General case' 0 CA--C 1.563 1.479 0 CA-C-N 113.22 -1.49 . . . . 0.0 110.307 169.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -72.55 138.69 47.07 Favored 'General case' 0 N--CA 1.507 2.381 0 CA-C-O 122.37 1.081 . . . . 0.0 111.38 172.835 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.6 tp -98.99 102.72 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -95.12 -70.32 0.72 Allowed 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 116.738 -1.601 . . . . 0.0 108.032 166.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.91 124.23 7.61 Favored 'General case' 0 C--N 1.36 1.05 0 CA-C-N 120.938 1.699 . . . . 0.0 113.818 -169.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 24.0 t -92.29 108.92 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.638 1 N-CA-C 99.97 -4.085 . . . . 0.0 99.97 162.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.255 52.2 tp -118.94 114.48 22.63 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.937 0.895 . . . . 0.0 112.607 -159.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -103.17 127.81 50.34 Favored 'General case' 0 CA--C 1.563 1.454 0 CA-C-O 121.448 0.642 . . . . 0.0 112.34 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -95.79 113.9 25.58 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.902 1.281 . . . . 0.0 109.796 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -86.33 96.06 9.85 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.214 170.614 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 56.1 t . . . . . 0 CA--C 1.566 1.565 0 C-N-CA 127.891 2.476 . . . . 0.0 106.016 -171.734 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 . . . . . 0 N--CA 1.496 1.829 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 47.8 mmm-85 -60.65 -43.94 97.01 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 169.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 37.0 mtt -64.26 -32.99 74.8 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 115.833 1.79 . . . . 0.0 115.833 169.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -64.44 -48.65 74.51 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 170.167 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.8 -31.26 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 172.195 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -57.8 -52.38 65.72 Favored 'General case' 0 CA--C 1.581 2.164 0 CA-C-N 119.492 1.042 . . . . 0.0 111.452 166.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -52.83 -25.38 11.3 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 120.2 3.408 . . . . 0.0 120.2 169.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.89 -55.48 19.89 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 170.079 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -145.43 13.84 1.4 Allowed 'General case' 0 CA--C 1.563 1.467 0 N-CA-C 119.497 3.147 . . . . 0.0 119.497 -169.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 17.7 m -51.9 -29.19 18.96 Favored 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.432 ' HB3' ' HD3' ' A' ' 150' ' ' PRO . . . -70.81 -61.33 2.49 Favored Pre-proline 0 CA--C 1.58 2.102 0 CA-C-O 116.148 -1.882 . . . . 0.0 112.142 171.692 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.432 ' HD3' ' HB3' ' A' ' 149' ' ' ALA . 46.8 Cg_exo -55.34 -27.8 59.64 Favored 'Trans proline' 0 CA--C 1.574 2.485 0 N-CA-C 119.492 2.843 . . . . 0.0 119.492 169.207 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -66.88 -53.01 36.54 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 125.156 1.383 . . . . 0.0 110.988 172.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.989 ' O ' ' HB2' ' A' ' 156' ' ' ARG 0.316 0.0 OUTLIER -61.32 -25.01 66.84 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 174.384 . . . . . . . . 4 4 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -71.3 -51.65 23.19 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 120.601 1.546 . . . . 0.0 113.667 166.474 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -62.66 -55.23 28.84 Favored 'General case' 0 CA--C 1.565 1.527 0 CA-C-N 120.045 1.293 . . . . 0.0 112.221 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -81.52 -25.94 35.53 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 115.153 -2.356 . . . . 0.0 113.399 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.989 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 43.9 ttt180 -67.3 -34.27 77.03 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 124.438 3.29 . . . . 0.0 115.919 170.785 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -69.5 -37.99 77.43 Favored 'General case' 0 CA--C 1.572 1.827 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 166.642 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -90.15 -24.37 21.08 Favored 'General case' 0 CA--C 1.575 1.926 0 N-CA-C 118.876 2.917 . . . . 0.0 118.876 -177.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.1 pp -76.06 178.75 6.09 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 117.478 2.399 . . . . 0.0 117.478 -165.446 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -128.91 129.31 45.33 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 169.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 27.1 m -100.38 149.95 23.11 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 122.079 0.943 . . . . 0.0 111.006 -171.04 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 4.1 t -128.14 134.74 64.42 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.663 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 167.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -110.86 121.43 45.32 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 104.435 -2.432 . . . . 0.0 104.435 166.726 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . 0.289 . . -165.58 162.03 18.8 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.095 0.958 . . . . 0.0 111.106 -161.034 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 4.5 t . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 160.574 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 7.4 t70 . . . . . 0 N--CA 1.508 2.451 0 CA-C-O 121.127 0.489 . . . . 0.0 111.869 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -55.15 -39.04 69.03 Favored 'General case' 0 CA--C 1.559 1.295 0 CA-C-O 116.651 -1.642 . . . . 0.0 113.429 165.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 89.5 t -56.34 -39.26 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 CA-C-N 121.363 1.892 . . . . 0.0 114.309 171.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -57.77 -39.03 76.5 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-N 120.472 1.487 . . . . 0.0 114.86 166.381 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -60.53 -46.85 88.66 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 115.481 1.659 . . . . 0.0 115.481 173.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 12.2 mtt-85 -61.48 -43.14 99.4 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 169.403 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.11 -40.37 70.39 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 169.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 8.4 mp -64.18 -49.12 73.28 Favored 'General case' 0 CA--C 1.565 1.533 0 CA-C-O 118.413 -0.804 . . . . 0.0 112.608 168.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 36.4 mtt180 -51.24 -40.81 59.65 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 117.581 2.437 . . . . 0.0 117.581 171.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.11 -51.53 66.19 Favored 'General case' 0 CA--C 1.561 1.4 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 169.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -99.65 -60.46 1.53 Allowed 'General case' 0 CA--C 1.565 1.538 0 CA-C-O 117.993 -1.003 . . . . 0.0 113.469 -169.418 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.803 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -102.82 -50.52 1.08 Allowed Glycine 0 CA--C 1.551 2.34 0 CA-C-N 120.537 1.517 . . . . 0.0 116.885 -169.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.803 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 87.0 tttt . . . . . 0 C--O 1.252 1.201 0 CA-C-N 119.489 1.645 . . . . 0.0 108.356 -174.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.0 mtt . . . . . 0 N--CA 1.482 1.125 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.578 ' HE ' ' HA2' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -149.01 174.9 11.79 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 116.685 2.105 . . . . 0.0 116.685 -168.967 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 93.5 t -133.75 147.22 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-O 122.992 1.377 . . . . 0.0 113.319 -164.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -121.63 117.57 27.03 Favored 'General case' 0 CA--C 1.56 1.347 0 CA-C-N 113.491 -1.686 . . . . 0.0 107.284 169.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 17.5 tp -99.87 125.13 45.79 Favored 'General case' 0 CA--C 1.575 1.908 0 CA-C-O 123.706 1.717 . . . . 0.0 109.389 -170.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.1 mt -122.23 161.01 24.03 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 110.021 -3.263 . . . . 0.0 112.481 -165.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 148.39 -179.68 25.05 Favored Glycine 0 CA--C 1.559 2.809 0 CA-C-N 115.258 -0.883 . . . . 0.0 114.821 170.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo . . . . . 0 CA--C 1.574 2.508 0 C-N-CA 123.355 2.703 . . . . 0.0 113.765 176.22 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.41 ' CB ' ' OD2' ' A' ' 84' ' ' ASP . 0.3 OUTLIER . . . . . 0 N--CA 1.501 2.085 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -49.48 -27.22 8.09 Favored Glycine 0 CA--C 1.553 2.465 0 N-CA-C 121.201 3.241 . . . . 0.0 121.201 177.144 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 52.0 m -66.99 -52.75 38.81 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 120.237 2.018 . . . . 0.0 112.598 173.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.291 0.6 OUTLIER -76.19 -13.88 60.17 Favored 'General case' 0 CA--C 1.568 1.667 0 CA-C-O 115.893 -2.003 . . . . 0.0 113.855 170.509 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.31 -47.17 36.37 Favored 'General case' 0 C--N 1.371 1.513 0 CA-C-N 123.421 2.828 . . . . 0.0 113.433 167.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.2 t -65.37 -36.74 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-N 120.06 1.3 . . . . 0.0 113.848 172.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -66.44 -45.78 78.67 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 171.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.0 tp -65.49 -30.65 71.45 Favored 'General case' 0 CA--C 1.574 1.902 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 170.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.22 -39.75 94.63 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 168.062 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -59.93 -37.7 80.25 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 166.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.3 tptt -64.3 -56.89 11.43 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 170.376 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 77.3 mt -83.23 -25.02 32.08 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 117.341 2.348 . . . . 0.0 117.341 -174.199 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.74 39.73 7.0 Favored Glycine 0 CA--C 1.556 2.612 0 N-CA-C 117.578 1.791 . . . . 0.0 117.578 -173.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 15.2 mm -104.56 154.69 38.27 Favored Pre-proline 0 CA--C 1.567 1.606 0 CA-C-O 117.567 -1.206 . . . . 0.0 113.11 -169.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -81.83 98.6 0.98 Allowed 'Trans proline' 0 CA--C 1.569 2.232 0 CA-C-N 122.219 1.828 . . . . 0.0 109.801 162.645 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -73.91 110.42 8.19 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.305 0.574 . . . . 0.0 110.189 176.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.0 mm -100.35 108.97 24.0 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 N-CA-C 105.515 -2.032 . . . . 0.0 105.515 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 72.7 p -96.98 127.74 43.25 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 171.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.0 p -67.29 -18.36 65.16 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 117.356 2.354 . . . . 0.0 117.356 -172.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.429 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -81.06 -20.24 65.49 Favored Glycine 0 CA--C 1.539 1.56 0 N-CA-C 119.242 2.457 . . . . 0.0 119.242 168.103 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -81.0 -51.47 8.48 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -169.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -64.3 -41.7 96.73 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 174.846 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.439 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 21.5 m-85 -68.92 -39.69 79.51 Favored 'General case' 0 CA--C 1.561 1.375 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 174.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 46.4 ttp180 -58.68 -41.71 86.81 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 120.473 1.488 . . . . 0.0 114.322 167.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -60.54 -38.71 85.36 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 168.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -67.55 -29.32 68.68 Favored 'General case' 0 CA--C 1.572 1.824 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 168.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 79.0 mt -62.7 -45.54 98.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 CA-C-N 120.111 1.323 . . . . 0.0 111.921 168.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -66.71 -38.96 87.77 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 120.25 1.387 . . . . 0.0 114.438 172.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -78.47 -27.85 46.38 Favored 'General case' 0 CA--C 1.562 1.413 0 N-CA-C 117.065 2.246 . . . . 0.0 117.065 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.11 72.99 1.23 Allowed Glycine 0 CA--C 1.545 1.935 0 CA-C-O 118.223 -1.321 . . . . 0.0 115.878 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.855 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 81.4 p -91.29 -45.92 8.34 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 172.106 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.855 ' HB2' ' O ' ' A' ' 43' ' ' THR . 75.6 mttt 104.56 -40.36 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.753 0 CA-C-O 116.493 -1.718 . . . . 0.0 111.633 -171.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -83.91 -10.32 58.06 Favored 'General case' 0 CA--C 1.574 1.894 0 CA-C-N 122.762 2.528 . . . . 0.0 113.222 163.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.21 -54.48 23.69 Favored Glycine 0 C--N 1.355 1.588 0 CA-C-N 120.385 1.448 . . . . 0.0 115.531 169.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.286 7.7 p -76.94 -47.5 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.514 0 N-CA-C 116.077 1.88 . . . . 0.0 116.077 -168.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -64.24 -48.31 76.29 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 121.111 1.778 . . . . 0.0 112.692 172.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.59 -28.04 64.57 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -178.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.447 ' HA ' ' HD2' ' A' ' 50' ' ' LYS . 10.8 tptt -74.91 -30.59 61.31 Favored 'General case' 0 CA--C 1.566 1.584 0 CA-C-O 115.909 -1.996 . . . . 0.0 113.762 168.02 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -57.02 -36.97 71.06 Favored 'General case' 0 CA--C 1.607 3.164 1 CA-C-O 90.989 -13.863 . . . . 0.0 119.424 164.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 9.5 m-30 -92.58 -49.65 6.0 Favored 'General case' 0 CA--C 1.591 2.538 2 O-C-N 110.588 -7.57 . . . . 0.0 100.415 -152.014 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.9 tp -51.38 -46.99 62.97 Favored 'General case' 0 CA--C 1.569 1.683 0 C-N-CA 126.209 1.803 . . . . 0.0 115.516 161.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -78.96 -41.9 28.14 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 176.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -95.38 -38.69 10.38 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -170.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 0.901 ' HA2' HH22 ' A' ' 88' ' ' ARG . . . 119.79 22.48 3.29 Favored Glycine 0 CA--C 1.541 1.685 0 N-CA-C 118.235 2.054 . . . . 0.0 118.235 168.511 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -97.3 -179.32 4.47 Favored 'General case' 0 CA--C 1.575 1.941 0 CA-C-N 118.805 1.303 . . . . 0.0 110.243 167.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.9 mt -82.34 127.97 33.76 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.184 -1.573 . . . . 0.0 114.382 -166.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.4 p -118.3 124.08 28.87 Favored Pre-proline 0 CA--C 1.572 1.806 0 C-N-CA 124.935 1.294 . . . . 0.0 110.485 -174.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -60.72 153.1 64.69 Favored 'Trans proline' 0 CA--C 1.56 1.81 0 C-N-CA 123.425 2.75 . . . . 0.0 116.337 172.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 97.2 p -80.24 -49.62 11.36 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 -177.275 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -63.61 -45.69 89.15 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 -169.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 pp -57.76 -43.1 85.23 Favored 'General case' 0 CA--C 1.562 1.421 0 N-CA-C 117.266 2.321 . . . . 0.0 117.266 169.694 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.0 m -62.24 -42.32 99.21 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 123.93 0.892 . . . . 0.0 112.578 174.155 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -62.77 -30.57 71.55 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 166.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.48 -42.35 83.1 Favored 'General case' 0 CA--C 1.555 1.138 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 174.497 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mt -64.75 -46.15 83.42 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 168.233 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -56.08 -51.13 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 169.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -60.83 -38.38 85.27 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 115.794 1.775 . . . . 0.0 115.794 174.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -57.23 -44.18 83.53 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 117.592 -1.194 . . . . 0.0 113.421 170.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -84.3 1.84 43.03 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 119.51 3.152 . . . . 0.0 119.51 168.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 21.7 tp -115.64 -5.91 12.18 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 117.813 2.524 . . . . 0.0 117.813 172.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 . . . . . 0 N--CA 1.503 2.204 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 169.737 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.578 ' HA2' ' HE ' ' A' ' 2' ' ' ARG . . . . . . . . 0 CA--C 1.531 1.083 0 CA-C-O 124.011 1.895 . . . . 0.0 113.639 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.463 ' O ' ' HB2' ' A' ' 2' ' ' ARG . 21.9 p90 -167.41 131.52 1.84 Allowed 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 111.719 -2.241 . . . . 0.0 109.092 172.593 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 17.5 mt -110.47 106.56 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 104.099 -2.556 . . . . 0.0 104.099 170.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.7 mt -110.35 112.75 24.9 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.718 0.807 . . . . 0.0 108.832 -176.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.41 ' OD2' ' CB ' ' A' ' 13' ' ' LYS . 35.4 t0 -109.46 128.65 55.31 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 118.732 0.696 . . . . 0.0 111.688 -175.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 73.54 35.39 55.77 Favored Glycine 0 CA--C 1.552 2.373 0 CA-C-O 117.563 -1.687 . . . . 0.0 117.279 176.258 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -103.56 -51.89 0.13 Allowed Pre-proline 0 N--CA 1.497 1.906 0 CA-C-O 114.761 -2.542 . . . . 0.0 109.333 173.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -62.08 71.61 0.1 Allowed 'Trans proline' 0 CA--C 1.568 2.22 0 CA-C-N 124.874 2.776 . . . . 0.0 118.838 165.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.901 HH22 ' HA2' ' A' ' 56' ' ' GLY . 1.4 ptm180 -78.05 -36.95 47.83 Favored 'General case' 0 CA--C 1.56 1.342 0 N-CA-C 115.54 1.681 . . . . 0.0 115.54 167.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 69.1 p -137.18 151.42 48.77 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 -168.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.2 t -71.01 -31.03 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-O 116.884 -1.532 . . . . 0.0 111.153 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.71 -40.21 94.23 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 120.149 3.388 . . . . 0.0 120.149 168.143 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -71.25 -49.29 44.7 Favored 'General case' 0 CA--C 1.589 2.456 0 CA-C-N 122.413 2.37 . . . . 0.0 112.462 168.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.6 -28.87 66.32 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 126.756 2.023 . . . . 0.0 115.646 -170.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.6 ttpm? -58.54 -31.95 68.42 Favored 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 166.321 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.05 -43.81 94.35 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 114.668 1.358 . . . . 0.0 114.668 168.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.0 mt -66.69 -33.82 76.49 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 172.633 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -66.22 -58.38 5.51 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 125.349 1.46 . . . . 0.0 112.646 173.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.933 ' O ' ' CB ' ' A' ' 102' ' ' ARG . 47.8 mt-10 -54.66 -36.48 64.64 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 171.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 24.7 ttt -82.72 -40.62 20.33 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 176.467 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 24.6 tp -57.12 -61.79 2.21 Favored 'General case' 0 N--CA 1.508 2.431 0 CA-C-N 121.503 1.956 . . . . 0.0 110.499 174.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -81.74 -37.27 27.51 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 -177.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.933 ' CB ' ' O ' ' A' ' 98' ' ' GLU . 52.8 ttt85 -60.29 -41.34 93.15 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 176.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.544 ' HB2' ' O ' ' A' ' 102' ' ' ARG . 54.9 ttt180 -174.92 41.72 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 114.464 -2.684 . . . . 0.0 115.851 168.057 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -114.77 -61.25 0.38 Allowed Glycine 0 C--N 1.362 2.021 0 CA-C-N 123.565 2.893 . . . . 0.0 113.441 174.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 23.5 p -148.28 159.4 44.02 Favored 'General case' 0 CA--C 1.554 1.13 0 CA-C-O 122.957 1.361 . . . . 0.0 112.894 -159.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -74.68 134.74 41.93 Favored 'General case' 0 N--CA 1.503 2.198 0 CA-C-N 114.379 -1.282 . . . . 0.0 113.439 176.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 4.7 tp -86.65 105.82 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.516 0 C-N-CA 125.06 1.344 . . . . 0.0 107.714 175.488 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -96.92 -70.4 0.72 Allowed 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 115.136 -2.364 . . . . 0.0 108.115 168.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -140.28 122.65 16.0 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 122.503 2.41 . . . . 0.0 115.015 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -92.83 107.81 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.417 0 N-CA-C 100.974 -3.713 . . . . 0.0 100.974 161.768 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.288 59.5 tp -114.5 105.24 12.87 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.753 -161.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -96.04 126.12 41.06 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.16 0.584 . . . . 0.0 111.541 -176.297 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -95.06 114.17 25.95 Favored 'General case' 0 CA--C 1.56 1.355 0 CA-C-O 122.537 1.16 . . . . 0.0 110.185 177.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -89.03 100.38 13.16 Favored 'General case' 0 CA--C 1.556 1.187 0 CA-C-N 113.597 -1.638 . . . . 0.0 109.459 168.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.4 p . . . . . 0 CA--C 1.561 1.387 0 C-N-CA 125.921 1.688 . . . . 0.0 108.376 -168.874 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 36.1 t30 . . . . . 0 N--CA 1.496 1.84 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.8 tpt85 -63.42 -45.98 88.5 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 169.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 46.3 mtt -61.31 -29.51 69.92 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 167.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -63.31 -43.76 96.9 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 167.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 20.5 t -70.49 -26.69 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.533 0 CA-C-N 120.088 1.313 . . . . 0.0 113.521 171.202 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -65.34 -56.75 10.89 Favored 'General case' 0 CA--C 1.583 2.242 0 CA-C-N 120.68 1.582 . . . . 0.0 110.766 167.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 54.3 ttt180 -52.78 -26.8 15.42 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 119.711 3.226 . . . . 0.0 119.711 172.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -47.46 -51.42 20.32 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 169.33 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -142.55 42.33 1.61 Allowed 'General case' 0 CA--C 1.563 1.461 0 N-CA-C 117.084 2.253 . . . . 0.0 117.084 176.228 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 36.7 m -49.25 -36.65 20.97 Favored 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 166.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.414 ' HB3' ' HD3' ' A' ' 150' ' ' PRO . . . -68.09 -59.28 6.53 Favored Pre-proline 0 CA--C 1.577 2.014 0 CA-C-O 116.556 -1.688 . . . . 0.0 111.891 172.111 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.414 ' HD3' ' HB3' ' A' ' 149' ' ' ALA . 71.8 Cg_exo -53.03 -26.95 34.09 Favored 'Trans proline' 0 CA--C 1.577 2.666 0 N-CA-C 119.608 2.888 . . . . 0.0 119.608 168.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -65.25 -56.31 13.51 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 125.764 1.625 . . . . 0.0 111.371 172.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.868 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 44.4 tp -62.48 -24.19 67.33 Favored 'General case' 0 CA--C 1.571 1.776 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 175.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -71.23 -47.81 55.06 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 122.247 2.294 . . . . 0.0 113.745 166.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -60.77 -57.02 14.45 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 119.846 1.203 . . . . 0.0 111.966 177.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -80.2 -19.45 46.99 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 115.409 -2.234 . . . . 0.0 113.803 -178.242 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.868 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 33.2 ttt180 -74.21 -31.09 62.48 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 124.436 3.289 . . . . 0.0 116.202 168.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -68.77 -44.28 74.02 Favored 'General case' 0 CA--C 1.57 1.738 0 CA-C-N 119.688 1.131 . . . . 0.0 113.126 167.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -91.43 -30.21 16.62 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 119.164 3.024 . . . . 0.0 119.164 -176.542 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.5 pp -39.73 156.81 0.02 OUTLIER 'General case' 0 CA--C 1.582 2.183 1 N-CA-C 122.37 4.211 . . . . 0.0 122.37 -164.304 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -133.43 113.1 12.15 Favored 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 101.71 -3.441 . . . . 0.0 101.71 164.778 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 60.4 m -94.7 146.58 24.06 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 122.499 1.142 . . . . 0.0 110.349 -168.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 47.3 t -130.8 130.67 64.52 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.259 0 CA-C-N 113.654 -1.612 . . . . 0.0 106.721 169.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -98.48 117.9 33.96 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 100.892 -3.744 . . . . 0.0 100.892 163.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . 0.293 . . -105.41 -138.01 0.36 Allowed 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 -154.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . 0.252 14.6 m . . . . . 0 CA--C 1.573 1.849 1 N-CA-C 123.812 4.745 . . . . 0.0 123.812 -171.559 . . . . . . . . 2 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 . . . . . 0 N--CA 1.5 2.073 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -61.69 -49.11 77.81 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 117.737 -1.125 . . . . 0.0 112.535 169.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 3.0 t -54.43 -37.87 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 174.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -62.61 -38.16 89.07 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 116.119 1.896 . . . . 0.0 116.119 169.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -61.83 -48.02 82.46 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 175.552 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.577 ' HA ' ' HB2' ' A' ' 177' ' ' ARG . 1.2 ptt-85 -70.36 -29.14 65.74 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 117.036 2.235 . . . . 0.0 117.036 170.331 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.77 -46.63 88.75 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 169.082 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 10.9 mp -64.4 -43.33 94.75 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 117.411 -1.281 . . . . 0.0 111.402 167.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.577 ' HB2' ' HA ' ' A' ' 174' ' ' ARG . 41.1 mtt180 -46.64 -40.87 13.84 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 117.883 2.549 . . . . 0.0 117.883 169.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -69.0 -48.72 62.39 Favored 'General case' 0 CA--C 1.562 1.423 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 169.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.7 tt -83.13 -52.3 6.75 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 120.583 1.538 . . . . 0.0 114.336 -176.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -135.18 -60.18 0.06 OUTLIER Glycine 0 CA--C 1.551 2.284 0 CA-C-O 116.952 -2.027 . . . . 0.0 115.594 -170.092 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 39.7 ttmt . . . . . 0 C--O 1.251 1.17 0 CA-C-N 121.548 2.674 . . . . 0.0 109.595 -175.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.8 ttp . . . . . 0 CA--C 1.56 1.333 0 CA-C-O 122.382 1.086 . . . . 0.0 109.25 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . 0.275 11.4 mpt_? -124.5 167.73 14.05 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 120.878 3.659 . . . . 0.0 120.878 -162.621 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.3 p -148.11 151.18 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.695 0 CA-C-O 123.611 1.672 . . . . 0.0 113.067 167.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . 0.285 0.0 OUTLIER -143.56 133.87 24.58 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 113.922 -1.49 . . . . 0.0 110.99 166.965 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.729 HD11 ' CB ' ' A' ' 13' ' ' LYS . 3.7 tt -95.64 125.51 40.28 Favored 'General case' 0 CA--C 1.572 1.795 0 C-N-CA 125.188 1.395 . . . . 0.0 114.649 -165.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.6 mt -109.78 155.49 21.54 Favored 'General case' 0 CA--C 1.567 1.607 0 CA-C-N 110.559 -3.019 . . . . 0.0 109.847 169.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -174.36 99.49 0.14 Allowed Glycine 0 CA--C 1.55 2.24 0 CA-C-O 116.729 -2.15 . . . . 0.0 113.468 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.281 33.3 Cg_endo . . . . . 0 CA--C 1.58 2.778 0 CA-C-N 122.277 3.039 . . . . 0.0 111.853 175.25 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.729 ' CB ' HD11 ' A' ' 5' ' ' LEU . 32.1 mmtt . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.91 -35.74 92.4 Favored Glycine 0 CA--C 1.552 2.362 0 N-CA-C 118.609 2.204 . . . . 0.0 118.609 173.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 40.3 m -61.65 -53.48 55.6 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 119.324 1.562 . . . . 0.0 113.416 174.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.259 0.1 OUTLIER -79.59 -17.45 53.85 Favored 'General case' 0 CA--C 1.58 2.106 0 CA-C-O 116.639 -1.648 . . . . 0.0 111.491 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.28 -43.7 55.79 Favored 'General case' 0 C--N 1.374 1.633 0 CA-C-N 122.712 2.506 . . . . 0.0 115.337 168.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.5 t -65.77 -37.99 81.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 CA-C-O 117.691 -1.147 . . . . 0.0 112.335 170.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -59.68 -51.61 69.05 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 169.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.5 tp -64.37 -31.5 72.73 Favored 'General case' 0 CA--C 1.575 1.937 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 174.253 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.29 -39.46 93.97 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 168.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -63.73 -35.13 79.55 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 166.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 43.7 tptt -68.28 -55.49 11.98 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 174.584 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 65.0 mt -83.83 -26.51 29.46 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 116.648 2.092 . . . . 0.0 116.648 -178.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.27 39.28 6.44 Favored Glycine 0 CA--C 1.555 2.534 0 N-CA-C 117.313 1.685 . . . . 0.0 117.313 -172.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.404 ' CG2' ' HA ' ' A' ' 81' ' ' PHE . 20.4 mm -104.22 153.91 38.63 Favored Pre-proline 0 CA--C 1.567 1.605 0 CA-C-N 119.029 1.414 . . . . 0.0 112.271 -170.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -81.3 101.52 1.25 Allowed 'Trans proline' 0 CA--C 1.568 2.22 0 CA-C-N 121.65 1.625 . . . . 0.0 108.667 161.028 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.96 119.24 17.9 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 122.088 0.947 . . . . 0.0 110.197 173.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.477 HD11 ' HB3' ' A' ' 71' ' ' ARG . 1.8 mp -95.28 109.06 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 N-CA-C 104.089 -2.56 . . . . 0.0 104.089 176.142 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 78.0 p -97.41 128.15 43.96 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 166.099 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.8 p -67.33 -10.89 55.39 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 117.822 2.526 . . . . 0.0 117.822 -169.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -82.41 -27.85 42.08 Favored Glycine 0 CA--C 1.553 2.409 0 N-CA-C 117.951 1.94 . . . . 0.0 117.951 165.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -81.3 -46.14 15.17 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -168.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -69.68 -37.32 76.61 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 173.181 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.485 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 42.4 m-85 -65.67 -46.85 77.55 Favored 'General case' 0 CA--C 1.557 1.234 0 CA-C-O 116.538 -1.696 . . . . 0.0 112.855 170.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -54.84 -40.65 69.84 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 168.716 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -59.44 -40.47 86.9 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 169.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -68.39 -25.47 65.07 Favored 'General case' 0 CA--C 1.583 2.238 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 167.703 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ILE . . . . . 0.42 HG12 HG23 ' A' ' 47' ' ' VAL . 50.5 mt -62.91 -50.16 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 CA-C-N 120.383 1.447 . . . . 0.0 110.768 167.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.53 -31.55 69.83 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -67.76 -39.92 84.11 Favored 'General case' 0 CA--C 1.565 1.524 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 169.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.98 70.73 1.0 Allowed Glycine 0 CA--C 1.536 1.394 0 CA-C-O 118.577 -1.124 . . . . 0.0 112.886 175.172 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.566 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 56.9 p -96.18 -66.4 0.91 Allowed 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 118.291 1.046 . . . . 0.0 110.609 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.566 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.0 OUTLIER 124.88 -54.97 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 119.436 1.016 . . . . 0.0 110.117 -167.061 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.462 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.8 OUTLIER -71.8 -15.04 62.14 Favored 'General case' 0 CA--C 1.57 1.747 0 CA-C-O 118.48 -0.771 . . . . 0.0 112.54 167.058 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.89 -53.66 44.03 Favored Glycine 0 CA--C 1.555 2.586 0 CA-C-N 120.102 1.319 . . . . 0.0 114.009 166.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.42 HG23 HG12 ' A' ' 39' ' ' ILE . 1.0 OUTLIER -75.05 -50.88 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 -170.984 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -65.4 -41.8 93.25 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 120.908 1.685 . . . . 0.0 113.196 172.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 45' ' ' LEU . . . -75.57 -24.26 56.61 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -176.105 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.485 ' HB2' ' HB3' ' A' ' 35' ' ' PHE . 9.6 tmtm? -76.18 -38.82 56.09 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 117.127 -1.416 . . . . 0.0 112.978 166.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.603 ' O ' ' CG ' ' A' ' 51' ' ' ARG . 51.1 ttt180 -70.58 -55.45 8.82 Favored 'General case' 0 CA--C 1.591 2.543 1 CA-C-O 86.101 -16.19 . . . . 0.0 118.413 -178.013 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 12.6 m-30 -33.15 -60.32 0.34 Allowed 'General case' 0 N--CA 1.496 1.858 1 O-C-N 109.089 -8.507 . . . . 0.0 121.273 146.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.7 tp -60.75 -23.67 65.14 Favored 'General case' 0 CA--C 1.576 1.966 0 CA-C-N 122.58 2.446 . . . . 0.0 117.226 169.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -93.09 -44.52 8.34 Favored 'General case' 0 CA--C 1.569 1.688 0 C-N-CA 126.112 1.765 . . . . 0.0 114.376 168.344 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.23 -36.27 24.74 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 116.669 2.1 . . . . 0.0 116.669 -177.155 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.97 40.04 2.55 Favored Glycine 0 CA--C 1.537 1.412 0 N-CA-C 116.157 1.223 . . . . 0.0 116.157 169.555 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -103.29 -135.94 0.34 Allowed 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 169.169 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.6 mt -105.56 108.57 20.16 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 120.857 1.662 . . . . 0.0 110.304 -170.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.3 p -112.05 109.58 54.6 Favored Pre-proline 0 CA--C 1.565 1.551 0 CA-C-O 117.483 -1.246 . . . . 0.0 108.23 175.46 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -64.28 154.82 69.01 Favored 'Trans proline' 0 CA--C 1.558 1.705 0 C-N-CA 123.094 2.529 . . . . 0.0 116.567 178.627 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 71.9 m -78.03 174.98 10.53 Favored 'General case' 0 CA--C 1.571 1.762 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.969 169.75 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.7 t70 83.17 -47.11 0.13 Allowed 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 125.884 1.674 . . . . 0.0 114.075 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 24.9 mt -65.47 -53.98 34.87 Favored 'General case' 0 N--CA 1.505 2.276 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 168.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 53.7 m -53.68 -49.85 67.1 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 113.112 -1.858 . . . . 0.0 113.678 169.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -59.63 -27.24 66.16 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 116.534 2.05 . . . . 0.0 116.534 167.972 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.57 -47.56 54.16 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 173.082 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.381 4.5 pp -74.59 -25.73 59.46 Favored 'General case' 0 CA--C 1.588 2.439 0 CA-C-N 119.743 1.156 . . . . 0.0 112.952 174.51 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.0 -48.01 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 CA-C-N 121.78 2.082 . . . . 0.0 112.816 165.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -58.57 -32.82 69.28 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 171.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -59.58 -45.84 90.68 Favored 'General case' 0 CA--C 1.566 1.585 0 CA-C-O 117.555 -1.212 . . . . 0.0 112.697 166.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.477 ' HB3' HD11 ' A' ' 29' ' ' ILE . 83.0 mtt180 -82.93 7.9 14.11 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 118.59 2.811 . . . . 0.0 118.59 167.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.8 mt -123.69 -5.87 8.06 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 118.294 2.701 . . . . 0.0 118.294 170.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 55.9 p30 . . . . . 0 N--CA 1.5 2.052 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 171.921 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.838 0 CA-C-O 123.993 1.885 . . . . 0.0 117.325 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.404 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . 13.9 p90 -171.39 135.84 0.97 Allowed 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 113.344 -1.428 . . . . 0.0 107.675 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 9.1 mt -111.56 108.92 26.69 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.542 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 172.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 26.2 mt -107.24 121.06 43.78 Favored 'General case' 0 N--CA 1.504 2.235 0 CA-C-O 117.402 -1.285 . . . . 0.0 110.009 177.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -117.74 118.17 31.34 Favored 'General case' 0 N--CA 1.506 2.369 0 CA-C-N 121.566 1.985 . . . . 0.0 111.588 -169.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 74.63 35.8 50.37 Favored Glycine 0 CA--C 1.555 2.537 0 CA-C-O 117.986 -1.452 . . . . 0.0 116.653 -174.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -94.64 -52.67 0.24 Allowed Pre-proline 0 N--CA 1.493 1.709 0 CA-C-O 115.361 -2.257 . . . . 0.0 108.672 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -68.41 68.71 1.04 Allowed 'Trans proline' 0 CA--C 1.57 2.321 0 CA-C-N 124.071 2.49 . . . . 0.0 117.623 164.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -20.99 61.47 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 165.711 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.2 m -147.19 143.38 28.16 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 -173.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . 0.313 9.8 p -69.54 -23.2 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 CA-C-O 116.158 -1.877 . . . . 0.0 112.337 175.223 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -63.43 -31.89 73.17 Favored 'General case' 0 CA--C 1.563 1.449 0 N-CA-C 118.943 2.942 . . . . 0.0 118.943 166.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -76.84 -48.16 19.26 Favored 'General case' 0 CA--C 1.588 2.409 0 CA-C-N 122.281 2.31 . . . . 0.0 112.159 165.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.36 -35.47 80.97 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 126.932 2.093 . . . . 0.0 116.003 -169.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.0 tttt -57.71 -29.48 64.74 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 115.683 1.735 . . . . 0.0 115.683 167.036 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.74 -41.0 72.39 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 168.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 23.6 tp -60.41 -40.36 90.69 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 168.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -56.12 -53.08 61.35 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 124.003 0.921 . . . . 0.0 113.147 168.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.902 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 14.3 mm-40 -46.88 -42.71 17.91 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 116.012 1.856 . . . . 0.0 116.012 167.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' MET . . . . . 1.284 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 58.7 mtt -83.87 -19.66 34.45 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 117.793 2.516 . . . . 0.0 117.793 177.381 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 60.6 tp -73.81 -50.36 20.83 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 120.835 1.652 . . . . 0.0 111.741 169.839 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -74.2 -56.78 4.5 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 171.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.902 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 96.4 mtt180 -68.58 -37.98 80.29 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 177.078 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 1.284 ' HB3' ' O ' ' A' ' 99' ' ' MET . 70.7 ttt180 -62.25 -59.31 5.21 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 119.857 1.208 . . . . 0.0 110.193 164.083 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 113.11 46.22 0.71 Allowed Glycine 0 N--CA 1.48 1.632 0 O-C-N 124.435 1.085 . . . . 0.0 114.011 167.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.2 p -103.61 146.63 28.28 Favored 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 172.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -68.81 128.96 38.55 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.183 -0.948 . . . . 0.0 112.894 -170.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.8 tp -82.23 101.15 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -103.32 -72.0 0.71 Allowed 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 115.737 -2.078 . . . . 0.0 109.21 167.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -142.6 119.76 11.45 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 116.543 2.053 . . . . 0.0 116.543 -166.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 93.8 t -92.87 114.28 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 100.532 -3.877 . . . . 0.0 100.532 161.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 32.9 tp -117.96 109.47 16.54 Favored 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 122.778 0.431 . . . . 0.0 111.454 -165.078 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -96.64 115.91 28.23 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 122.986 0.514 . . . . 0.0 112.062 -178.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -93.09 108.86 20.36 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 175.448 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.5 ' O ' HG23 ' A' ' 115' ' ' VAL . 80.0 ttt180 -103.13 110.89 23.0 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.949 0.899 . . . . 0.0 108.745 172.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 114' ' ' ARG 0.31 1.3 t . . . . . 0 N--CA 1.499 1.984 0 CA-C-O 123.925 1.821 . . . . 0.0 108.252 159.688 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 . . . . . 0 N--CA 1.5 2.075 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -57.69 -45.45 85.65 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 166.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 25.1 ttt -64.18 -33.02 74.84 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 169.049 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -60.89 -48.92 79.61 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 169.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 12.4 p -65.32 -33.09 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 169.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -55.02 -49.57 71.2 Favored 'General case' 0 CA--C 1.581 2.162 0 CA-C-N 119.922 1.237 . . . . 0.0 111.652 167.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -56.74 -41.63 77.85 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 118.878 2.918 . . . . 0.0 118.878 171.857 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -46.71 -42.45 16.65 Favored 'General case' 0 N--CA 1.506 2.342 0 N-CA-C 117.969 2.581 . . . . 0.0 117.969 174.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -125.69 -29.3 3.17 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 117.597 2.443 . . . . 0.0 117.597 -166.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 51.7 m -45.97 -34.29 3.88 Favored 'General case' 0 N--CA 1.505 2.29 0 N-CA-C 117.543 2.423 . . . . 0.0 117.543 -171.097 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -66.86 -62.49 3.77 Favored Pre-proline 0 CA--C 1.583 2.247 0 CA-C-O 116.144 -1.884 . . . . 0.0 112.09 170.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -53.15 -35.86 74.78 Favored 'Trans proline' 0 CA--C 1.584 3.004 0 C-N-CA 123.632 2.888 . . . . 0.0 118.945 168.12 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.97 -53.75 54.86 Favored 'General case' 0 N--CA 1.496 1.875 0 C-N-CA 126.165 1.786 . . . . 0.0 112.174 169.458 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 1.27 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 28.8 tp -68.09 -21.57 64.96 Favored 'General case' 0 CA--C 1.563 1.467 0 CA-C-O 116.749 -1.596 . . . . 0.0 114.214 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -71.98 -49.02 40.76 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 121.961 2.164 . . . . 0.0 112.618 164.607 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -68.63 -51.75 38.8 Favored 'General case' 0 CA--C 1.567 1.613 0 CA-C-N 120.569 1.531 . . . . 0.0 112.302 -176.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -78.56 -26.23 45.59 Favored 'General case' 0 CA--C 1.554 1.109 0 CA-C-O 114.854 -2.498 . . . . 0.0 113.072 176.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 1.27 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 0.1 OUTLIER -60.96 -41.97 97.37 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 125.24 3.655 . . . . 0.0 115.543 168.393 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -62.87 -36.0 81.86 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 167.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -88.3 -34.42 17.68 Favored 'General case' 0 CA--C 1.576 1.977 0 N-CA-C 119.336 3.088 . . . . 0.0 119.336 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.1 pp -80.35 173.71 12.32 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 117.803 2.52 . . . . 0.0 117.803 -162.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -122.78 123.53 41.25 Favored 'General case' 0 CA--C 1.557 1.221 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 166.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 1.4 t -100.2 156.9 16.96 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 123.195 1.474 . . . . 0.0 110.241 -178.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 40.0 t -132.61 143.99 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.367 0 CA-C-N 113.096 -1.865 . . . . 0.0 106.651 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -95.05 120.25 34.94 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 100.32 -3.955 . . . . 0.0 100.32 164.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . 0.307 . . -99.34 -101.74 0.22 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 119.489 3.144 . . . . 0.0 119.489 -150.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 CA--C 1.564 1.492 0 N-CA-C 117.492 2.405 . . . . 0.0 117.492 -158.005 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 8.9 t70 . . . . . 0 N--CA 1.506 2.346 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -63.99 -44.76 91.7 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 174.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -40.58 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-O 117.947 -1.025 . . . . 0.0 113.667 172.122 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -54.7 -38.81 67.49 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 116.656 2.095 . . . . 0.0 116.656 166.19 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -62.57 -53.46 54.28 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.449 ' HA ' ' HB2' ' A' ' 177' ' ' ARG . 74.7 mtt85 -70.94 -28.38 64.44 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 117.91 2.559 . . . . 0.0 117.91 174.187 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.14 -45.42 94.74 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 167.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.5 mp -62.76 -43.17 99.51 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 117.852 -1.07 . . . . 0.0 113.641 168.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.449 ' HB2' ' HA ' ' A' ' 174' ' ' ARG . 39.6 mtt180 -52.56 -42.65 64.64 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 117.034 2.235 . . . . 0.0 117.034 169.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -66.8 -50.86 61.28 Favored 'General case' 0 CA--C 1.558 1.264 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 172.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.86 -59.59 2.67 Favored 'General case' 0 CA--C 1.569 1.688 0 CA-C-N 119.833 1.197 . . . . 0.0 112.565 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.638 ' O ' ' CB ' ' A' ' 181' ' ' LYS . . . -106.59 -55.68 0.66 Allowed Glycine 0 CA--C 1.55 2.249 0 CA-C-O 117.902 -1.499 . . . . 0.0 115.095 -175.441 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.638 ' CB ' ' O ' ' A' ' 180' ' ' GLY . 36.5 ttmt . . . . . 0 C--O 1.251 1.139 0 CA-C-N 120.13 1.965 . . . . 0.0 107.507 -175.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.9 mmt . . . . . 0 CA--C 1.555 1.154 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.98 169.74 21.03 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 115.837 1.791 . . . . 0.0 115.837 -165.408 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.9 t -131.51 148.57 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 123.66 1.695 . . . . 0.0 113.135 -162.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -119.47 113.54 20.92 Favored 'General case' 0 CA--C 1.558 1.262 0 CA-C-N 112.576 -2.102 . . . . 0.0 105.331 169.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.8 tp -99.67 127.03 45.78 Favored 'General case' 0 CA--C 1.562 1.424 0 CA-C-O 123.44 1.59 . . . . 0.0 108.399 -168.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.3 mt -134.67 163.73 29.11 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 111.695 -2.502 . . . . 0.0 113.277 -164.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 172.96 115.6 0.38 Allowed Glycine 0 CA--C 1.546 2.007 0 CA-C-O 117.015 -1.991 . . . . 0.0 110.953 -171.07 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 CA--C 1.577 2.656 0 CA-C-N 122.147 2.973 . . . . 0.0 115.196 168.751 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt . . . . . 0 N--CA 1.497 1.913 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -44.61 -33.49 3.31 Favored Glycine 0 CA--C 1.551 2.332 0 N-CA-C 120.887 3.115 . . . . 0.0 120.887 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.8 p -57.92 -61.12 2.76 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 119.322 1.561 . . . . 0.0 115.21 173.225 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.259 5.2 mm-40 -75.95 -12.53 60.16 Favored 'General case' 0 CA--C 1.567 1.598 0 CA-C-O 116.539 -1.696 . . . . 0.0 111.59 175.09 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.68 -50.56 42.73 Favored 'General case' 0 C--N 1.37 1.458 0 CA-C-N 122.57 2.441 . . . . 0.0 113.639 167.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.8 p -66.9 -39.83 84.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 173.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.539 ' HB3' ' CE1' ' A' ' 172' ' ' PHE . 58.5 mmtt -62.89 -42.48 99.79 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 116.21 1.929 . . . . 0.0 116.21 170.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 20.0 tp -66.67 -36.81 83.42 Favored 'General case' 0 CA--C 1.571 1.766 0 CA-C-N 120.04 1.291 . . . . 0.0 113.53 172.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.24 -39.29 86.21 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 166.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -56.59 -39.88 74.32 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 166.168 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -68.71 -53.44 22.16 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 174.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.1 mt -83.87 -23.81 31.12 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 117.274 2.324 . . . . 0.0 117.274 -176.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.91 35.42 7.72 Favored Glycine 0 CA--C 1.555 2.582 0 N-CA-C 117.8 1.88 . . . . 0.0 117.8 -174.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.0 mm -105.39 155.21 38.3 Favored Pre-proline 0 CA--C 1.57 1.722 0 CA-C-N 119.136 1.468 . . . . 0.0 112.434 -169.345 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -81.95 99.72 1.03 Allowed 'Trans proline' 0 CA--C 1.569 2.23 0 C-N-CA 121.695 1.596 . . . . 0.0 109.953 162.776 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.85 112.69 3.38 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 123.511 0.724 . . . . 0.0 110.539 170.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 27.3 mm -104.11 108.92 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 175.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.0 t -94.77 136.51 34.99 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 169.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.1 p -70.35 -6.53 35.98 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 117.531 2.419 . . . . 0.0 117.531 -177.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -89.72 -24.05 31.51 Favored Glycine 0 CA--C 1.544 1.886 0 N-CA-C 118.324 2.09 . . . . 0.0 118.324 165.194 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -81.18 -51.23 8.65 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -168.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -64.71 -39.08 93.04 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 174.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.544 ' HB3' ' CG ' ' A' ' 50' ' ' LYS . 41.6 m-85 -66.3 -37.6 85.78 Favored 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 116.183 1.92 . . . . 0.0 116.183 169.184 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 74.4 ttt180 -58.59 -41.05 84.91 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 166.084 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -63.81 -38.88 92.76 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 114.746 1.388 . . . . 0.0 114.746 169.307 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -64.28 -34.34 77.9 Favored 'General case' 0 CA--C 1.573 1.862 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 167.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 51.8 mt -59.35 -43.53 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 C-N-CA 124.994 1.318 . . . . 0.0 111.933 168.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -63.88 -40.62 96.95 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 170.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -72.68 -40.34 66.33 Favored 'General case' 0 CA--C 1.558 1.257 0 N-CA-C 116.266 1.95 . . . . 0.0 116.266 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.01 72.12 1.29 Allowed Glycine 0 CA--C 1.542 1.774 0 CA-C-O 118.383 -1.232 . . . . 0.0 113.965 -171.368 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.562 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 76.4 p -91.55 -65.47 1.01 Allowed 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 118.887 1.343 . . . . 0.0 111.267 177.626 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.562 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.0 OUTLIER 128.3 -55.76 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.942 0.897 . . . . 0.0 110.349 -167.422 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -74.67 -11.17 60.11 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 166.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.08 -54.31 25.06 Favored Glycine 0 CA--C 1.546 2.028 0 CA-C-N 119.324 0.965 . . . . 0.0 114.393 167.273 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.414 ' O ' ' HB2' ' A' ' 51' ' ' ARG 0.268 1.0 OUTLIER -76.44 -47.37 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 116.593 2.072 . . . . 0.0 116.593 -168.624 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -67.05 -36.81 82.89 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 120.985 1.72 . . . . 0.0 113.363 171.156 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -74.77 -34.24 62.43 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -177.32 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.544 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -73.92 -34.06 64.21 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 117.736 -1.126 . . . . 0.0 112.503 169.573 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 51' ' ' ARG . 22.0 ttt180 -74.12 -51.12 16.62 Favored 'General case' 0 CA--C 1.586 2.359 1 CA-C-O 84.252 -17.07 . . . . 0.0 118.583 -178.761 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . 0.251 21.4 m-85 -36.83 -57.42 0.81 Allowed 'General case' 0 N--CA 1.494 1.769 2 O-C-N 107.666 -9.396 . . . . 0.0 122.029 147.869 . . . . . . . . 3 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 38.4 mt -57.43 -33.92 68.4 Favored 'General case' 0 N--CA 1.511 2.597 0 CA-C-N 123.241 2.746 . . . . 0.0 115.501 168.625 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -90.71 -38.38 13.09 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 175.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.96 -37.78 38.71 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 178.203 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.89 40.41 1.44 Allowed Glycine 0 CA--C 1.536 1.403 0 N-CA-C 116.475 1.35 . . . . 0.0 116.475 171.213 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -119.31 -142.94 0.36 Allowed 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 165.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 79.9 mt -129.92 133.77 47.06 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.307 -0.87 . . . . 0.0 109.77 -170.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.609 HG12 HH22 ' A' ' 88' ' ' ARG . 7.0 p -109.01 133.03 20.85 Favored Pre-proline 0 CA--C 1.573 1.863 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 172.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -54.95 146.72 55.85 Favored 'Trans proline' 0 CA--C 1.561 1.838 0 C-N-CA 123.33 2.687 . . . . 0.0 116.839 173.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 96.4 p -72.64 175.6 6.24 Favored 'General case' 0 CA--C 1.57 1.739 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 176.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.6 t70 81.04 -45.18 0.22 Allowed 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 125.822 1.649 . . . . 0.0 114.29 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 34.8 mt -62.3 -54.51 39.55 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 168.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.8 m -56.65 -48.72 76.95 Favored 'General case' 0 CA--C 1.571 1.765 0 CA-C-N 113.051 -1.886 . . . . 0.0 113.07 173.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -58.04 -35.28 71.09 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 168.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -64.95 -44.6 88.9 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 173.426 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.8 mt -62.93 -44.27 96.53 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 170.28 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 82.7 t -58.29 -46.77 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-O 117.799 -1.096 . . . . 0.0 112.463 170.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -60.0 -39.21 84.98 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 116.013 1.857 . . . . 0.0 116.013 172.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -58.67 -41.83 87.07 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 120.331 1.423 . . . . 0.0 113.44 169.009 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -82.11 2.01 33.37 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 119.198 3.036 . . . . 0.0 119.198 167.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 23.3 tp -121.68 -7.94 9.04 Favored 'General case' 0 CA--C 1.564 1.49 0 N-CA-C 118.407 2.743 . . . . 0.0 118.407 175.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 . . . . . 0 N--CA 1.504 2.251 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 174.494 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.687 0 N-CA-C 118.874 2.31 . . . . 0.0 118.874 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -175.89 136.75 0.32 Allowed 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 113.731 -1.234 . . . . 0.0 110.438 -169.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 22.6 mt -113.32 106.27 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 169.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 58.8 mt -105.72 120.52 41.89 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 123.151 0.58 . . . . 0.0 109.454 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -113.49 122.09 46.22 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 118.645 0.657 . . . . 0.0 110.621 -167.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 72.73 38.87 56.61 Favored Glycine 0 CA--C 1.548 2.114 0 CA-C-O 117.287 -1.841 . . . . 0.0 115.801 -178.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -99.66 -54.16 0.18 Allowed Pre-proline 0 N--CA 1.498 1.967 0 CA-C-O 115.359 -2.257 . . . . 0.0 107.536 176.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -60.87 70.04 0.08 OUTLIER 'Trans proline' 0 CA--C 1.575 2.555 0 N-CA-C 118.784 2.571 . . . . 0.0 118.784 164.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.609 HH22 HG12 ' A' ' 59' ' ' VAL . 4.5 ttm105 -69.94 -37.56 75.92 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 168.107 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.0 p -151.56 126.95 9.99 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 104.316 -2.475 . . . . 0.0 104.316 -164.855 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . 0.317 5.8 p -62.28 -21.3 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-O 116.089 -1.91 . . . . 0.0 113.6 -173.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.09 -36.92 85.61 Favored 'General case' 0 CA--C 1.557 1.221 0 N-CA-C 119.435 3.124 . . . . 0.0 119.435 165.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -73.04 -48.54 35.28 Favored 'General case' 0 CA--C 1.586 2.361 0 CA-C-N 124.422 3.283 . . . . 0.0 111.088 165.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.16 -32.03 67.8 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 118.078 2.621 . . . . 0.0 118.078 -174.212 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.519 ' O ' ' HB2' ' A' ' 98' ' ' GLU . 60.2 tttt -59.48 -25.15 64.18 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 116.604 2.076 . . . . 0.0 116.604 168.706 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.62 -45.69 64.76 Favored 'General case' 0 CA--C 1.568 1.648 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 166.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 11.2 tp -61.48 -43.73 98.34 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 171.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -59.51 -51.11 71.27 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 168.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.984 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 5.5 tp10 -43.96 -39.3 3.95 Favored 'General case' 0 CA--C 1.573 1.865 0 N-CA-C 115.548 1.684 . . . . 0.0 115.548 166.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' MET . . . . . 1.122 ' O ' ' HB2' ' A' ' 103' ' ' ARG . 66.5 mtt -83.05 -26.02 31.56 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 117.673 2.471 . . . . 0.0 117.673 174.166 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 41.1 tp -65.53 -54.94 20.95 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-N 120.681 1.582 . . . . 0.0 112.13 169.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -78.29 -51.04 10.73 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 119.269 0.941 . . . . 0.0 113.281 175.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.984 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 74.8 ttt180 -67.79 -46.43 71.98 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 177.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 1.122 ' HB2' ' O ' ' A' ' 99' ' ' MET . 58.1 mtt180 -65.09 -51.29 62.25 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 118.892 0.769 . . . . 0.0 111.97 165.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.38 42.66 1.14 Allowed Glycine 0 N--CA 1.482 1.758 0 N-CA-C 114.914 0.726 . . . . 0.0 114.914 167.102 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 41.4 p -97.5 142.65 29.08 Favored 'General case' 0 CA--C 1.559 1.315 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 169.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -66.73 131.92 46.98 Favored 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -170.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 4.8 tp -84.75 102.89 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 125.402 1.481 . . . . 0.0 108.144 175.563 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -99.33 -74.27 0.6 Allowed 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 115.369 -2.253 . . . . 0.0 108.412 167.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -137.93 124.94 21.37 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 122.34 2.336 . . . . 0.0 114.908 -176.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 44.2 t -92.42 109.82 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 1 N-CA-C 98.854 -4.498 . . . . 0.0 98.854 162.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.255 49.9 tp -118.17 111.6 19.05 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.446 -160.153 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -112.96 128.27 56.44 Favored 'General case' 0 CA--C 1.556 1.201 0 CA-C-O 122.39 1.09 . . . . 0.0 111.507 -171.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -96.45 122.43 39.34 Favored 'General case' 0 CA--C 1.558 1.288 0 CA-C-N 113.612 -1.631 . . . . 0.0 109.853 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -85.58 96.43 9.65 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 112.931 -1.941 . . . . 0.0 110.158 169.394 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.4 p . . . . . 0 CA--C 1.567 1.626 0 C-N-CA 125.849 1.659 . . . . 0.0 109.217 -167.923 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 . . . . . 0 N--CA 1.498 1.93 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -60.11 -35.5 75.37 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 166.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 64.1 mtt -68.63 -29.8 68.38 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 167.778 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -62.22 -51.42 67.82 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 120.424 1.466 . . . . 0.0 114.889 168.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.7 p -64.18 -32.58 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 170.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -54.7 -50.38 68.43 Favored 'General case' 0 CA--C 1.579 2.066 0 CA-C-N 119.678 1.127 . . . . 0.0 111.965 167.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.55 -38.05 76.99 Favored 'General case' 0 CA--C 1.563 1.454 0 N-CA-C 118.401 2.741 . . . . 0.0 118.401 174.203 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -50.67 -33.95 24.6 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 118.478 2.77 . . . . 0.0 118.478 172.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -130.3 -28.76 2.08 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 118.473 2.768 . . . . 0.0 118.473 -166.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 62.6 m -47.46 -33.61 6.37 Favored 'General case' 0 N--CA 1.504 2.225 0 N-CA-C 117.503 2.409 . . . . 0.0 117.503 -170.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -66.58 -61.93 4.56 Favored Pre-proline 0 CA--C 1.58 2.129 0 CA-C-O 115.97 -1.967 . . . . 0.0 112.207 171.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -55.17 -31.24 74.9 Favored 'Trans proline' 0 CA--C 1.578 2.718 0 N-CA-C 119.302 2.77 . . . . 0.0 119.302 169.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.99 -56.42 19.24 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 125.409 1.483 . . . . 0.0 111.842 169.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.981 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 42.3 tp -66.07 -23.12 66.46 Favored 'General case' 0 CA--C 1.562 1.435 0 CA-C-O 116.675 -1.631 . . . . 0.0 114.569 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -71.74 -47.36 54.28 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 121.976 2.171 . . . . 0.0 112.084 165.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -66.75 -54.99 17.03 Favored 'General case' 0 CA--C 1.564 1.495 0 CA-C-N 120.613 1.551 . . . . 0.0 112.047 -176.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . 0.262 21.4 m-30 -81.94 -19.74 40.07 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-O 114.69 -2.576 . . . . 0.0 112.456 178.566 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.981 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 43.5 ttt180 -66.24 -36.04 81.99 Favored 'General case' 0 N--CA 1.487 1.413 1 CA-C-N 126.28 4.127 . . . . 0.0 115.592 167.721 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -68.86 -38.2 79.58 Favored 'General case' 0 CA--C 1.576 1.962 0 CA-C-N 119.848 1.204 . . . . 0.0 113.917 166.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -90.45 -27.58 19.17 Favored 'General case' 0 CA--C 1.576 1.979 0 N-CA-C 119.14 3.015 . . . . 0.0 119.14 -176.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.0 pp -79.76 174.9 11.12 Favored 'General case' 0 N--CA 1.504 2.272 0 CA-C-N 122.773 2.533 . . . . 0.0 116.852 -164.727 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 37.8 tttp -127.38 131.56 50.32 Favored 'General case' 0 CA--C 1.559 1.298 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 168.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 31.5 m -94.93 148.86 21.87 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 122.224 1.012 . . . . 0.0 112.639 -167.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 36.2 t -132.09 134.34 59.73 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.523 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 166.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.412 ' HB3' ' NH1' ' A' ' 174' ' ' ARG . 13.6 t70 -96.88 131.45 43.63 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 167.778 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -163.61 118.93 1.64 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -163.118 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.257 -0.878 . . . . 0.0 109.345 173.969 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 . . . . . 0 N--CA 1.499 2.007 0 N-CA-C 116.013 1.857 . . . . 0.0 116.013 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -65.46 -45.35 84.06 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 171.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 69.0 t -56.49 -41.86 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.345 0 CA-C-N 120.622 1.555 . . . . 0.0 113.847 172.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.539 ' CE1' ' HB3' ' A' ' 19' ' ' LYS . 29.3 t80 -57.99 -36.16 72.24 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 115.783 1.771 . . . . 0.0 115.783 167.204 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -61.03 -53.29 59.07 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-O 118.141 -0.933 . . . . 0.0 113.459 176.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.412 ' NH1' ' HB3' ' A' ' 163' ' ' ASP . 93.6 mtt180 -63.96 -32.09 73.5 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 118.206 2.669 . . . . 0.0 118.206 171.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.95 -47.31 87.02 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 116.577 2.066 . . . . 0.0 116.577 170.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . 0.265 0.2 OUTLIER -71.06 -39.47 72.2 Favored 'General case' 0 N--CA 1.505 2.32 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 169.81 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -48.92 -39.46 26.23 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 168.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -69.51 -56.7 6.61 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 166.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -103.84 -56.18 2.25 Favored 'General case' 0 CA--C 1.563 1.462 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 -168.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.824 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -78.23 -37.08 29.27 Favored Glycine 0 CA--C 1.55 2.258 0 CA-C-N 121.308 1.867 . . . . 0.0 117.764 -169.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.824 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 86.1 tttt . . . . . 0 C--O 1.252 1.186 0 CA-C-N 118.073 0.936 . . . . 0.0 108.523 178.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 mmt . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 122.278 1.037 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.457 ' NH1' ' HA2' ' A' ' 80' ' ' GLY 0.324 16.0 ttm-85 -147.25 144.64 29.01 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 118.423 2.749 . . . . 0.0 118.423 -158.985 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.8 t -141.42 147.85 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 CA-C-O 123.951 1.834 . . . . 0.0 111.964 -171.355 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.6 mt -133.29 120.74 21.45 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 126.949 2.099 . . . . 0.0 108.995 -175.989 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 13.0 tp -105.88 122.51 46.27 Favored 'General case' 0 CA--C 1.577 2.005 0 CA-C-O 123.202 1.477 . . . . 0.0 111.066 -168.166 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.7 mt -120.93 164.67 16.34 Favored 'General case' 0 CA--C 1.563 1.478 0 CA-C-N 110.607 -2.997 . . . . 0.0 112.742 -171.598 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 142.08 170.67 12.66 Favored Glycine 0 CA--C 1.562 2.984 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.563 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo . . . . . 0 CA--C 1.579 2.761 0 CA-C-N 121.45 2.625 . . . . 0.0 110.145 170.035 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.7 mttt . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -46.39 -40.26 10.8 Favored Glycine 0 CA--C 1.555 2.571 0 N-CA-C 120.939 3.136 . . . . 0.0 120.939 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.7 m -52.82 -54.63 31.48 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-N 119.012 1.406 . . . . 0.0 114.359 169.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.25 0.0 OUTLIER -76.67 -17.12 59.32 Favored 'General case' 0 CA--C 1.575 1.927 0 CA-C-O 117.055 -1.45 . . . . 0.0 112.697 177.454 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.23 -44.18 65.83 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 122.068 2.213 . . . . 0.0 114.629 167.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.9 p -66.13 -46.81 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 172.289 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.675 ' HB3' ' CE1' ' A' ' 172' ' ' PHE . 45.0 mmtm -54.9 -46.74 74.87 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 169.574 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 12.5 tp -70.33 -27.76 64.62 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 175.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.15 -39.06 89.53 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 166.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -58.78 -43.35 90.41 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 117.31 -1.328 . . . . 0.0 114.131 166.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -68.12 -46.83 69.8 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 116.455 2.02 . . . . 0.0 116.455 173.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.0 mt -82.54 -26.63 32.27 Favored 'General case' 0 CA--C 1.574 1.893 0 N-CA-C 117.092 2.256 . . . . 0.0 117.092 -177.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.06 43.47 7.11 Favored Glycine 0 CA--C 1.555 2.557 0 N-CA-C 117.378 1.711 . . . . 0.0 117.378 -173.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 22.2 mm -114.62 157.98 41.43 Favored Pre-proline 0 CA--C 1.57 1.716 0 C-N-CA 124.551 1.14 . . . . 0.0 113.8 -168.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -76.3 103.18 1.7 Allowed 'Trans proline' 0 C--N 1.376 2.008 0 CA-C-N 121.582 1.601 . . . . 0.0 111.453 159.138 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.47 107.02 10.81 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.237 -0.914 . . . . 0.0 109.052 168.156 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.7 mm -99.17 112.0 30.21 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 -178.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.3 t -96.44 127.35 42.35 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 169.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 42.5 p -69.96 -10.55 58.98 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 116.802 2.149 . . . . 0.0 116.802 -175.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -83.76 -23.2 53.85 Favored Glycine 0 CA--C 1.545 1.912 0 N-CA-C 118.642 2.217 . . . . 0.0 118.642 166.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -80.52 -51.9 8.24 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 114.714 1.375 . . . . 0.0 114.714 -168.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -64.09 -39.21 93.57 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 174.359 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.447 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 13.5 m-85 -68.16 -42.19 80.42 Favored 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 172.397 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 29.2 ttp180 -57.33 -41.62 80.33 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 120.467 1.485 . . . . 0.0 114.073 167.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.2 ttt180 -58.88 -39.21 80.74 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 168.89 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -67.18 -27.8 67.57 Favored 'General case' 0 CA--C 1.577 1.988 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 167.198 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 97.4 mt -63.03 -45.51 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 CA-C-N 120.476 1.489 . . . . 0.0 111.403 168.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -66.86 -38.04 85.6 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 120.086 1.312 . . . . 0.0 114.285 173.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -67.85 -40.26 83.71 Favored 'General case' 0 CA--C 1.56 1.356 0 N-CA-C 116.339 1.977 . . . . 0.0 116.339 174.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.82 69.36 1.19 Allowed Glycine 0 CA--C 1.545 1.909 0 CA-C-O 118.379 -1.234 . . . . 0.0 114.645 -177.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.855 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 70.8 p -91.58 -49.1 6.48 Favored 'General case' 0 N--CA 1.5 2.025 0 CA-C-N 118.781 1.29 . . . . 0.0 114.341 176.21 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.855 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.255 74.2 mttt 105.96 -41.64 0.0 OUTLIER 'General case' 0 CA--C 1.569 1.705 0 CA-C-O 116.331 -1.795 . . . . 0.0 111.212 -172.181 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.3 -13.63 58.22 Favored 'General case' 0 CA--C 1.57 1.717 0 CA-C-N 123.117 2.689 . . . . 0.0 113.231 163.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.53 -55.03 32.26 Favored Glycine 0 C--N 1.354 1.529 0 CA-C-N 120.534 1.515 . . . . 0.0 115.2 169.318 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.28 8.7 p -76.42 -47.83 28.95 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.474 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -169.165 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -64.94 -47.42 77.73 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 121.291 1.859 . . . . 0.0 112.957 172.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.19 -31.03 69.35 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -179.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.447 ' HB2' ' HB3' ' A' ' 35' ' ' PHE . 2.0 tptm -69.7 -36.82 76.28 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 168.045 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.572 ' HG2' ' O ' ' A' ' 51' ' ' ARG . 29.0 ttt180 -74.48 -52.5 11.78 Favored 'General case' 0 CA--C 1.59 2.487 1 CA-C-O 85.183 -16.627 . . . . 0.0 117.991 -178.378 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 18.5 m-30 -30.41 -55.55 0.19 Allowed 'General case' 0 N--CA 1.493 1.717 1 O-C-N 108.661 -8.774 . . . . 0.0 121.6 146.736 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 26.5 mt -61.43 -44.01 97.88 Favored 'General case' 0 CA--C 1.572 1.789 0 CA-C-N 123.455 2.843 . . . . 0.0 114.489 167.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -76.08 -41.68 49.71 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 116.297 1.962 . . . . 0.0 116.297 176.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.45 -33.49 20.38 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 175.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.66 38.12 3.77 Favored Glycine 0 CA--C 1.54 1.607 0 CA-C-N 121.112 1.778 . . . . 0.0 116.521 169.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -101.48 -132.44 0.27 Allowed 'General case' 0 CA--C 1.571 1.773 0 CA-C-O 118.589 -0.72 . . . . 0.0 109.374 169.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.8 pp -120.87 123.5 42.69 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 120.007 1.276 . . . . 0.0 111.491 -169.517 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.49 HG12 HH22 ' A' ' 88' ' ' ARG . 6.1 p -120.71 133.69 24.12 Favored Pre-proline 0 CA--C 1.574 1.893 0 CA-C-O 117.782 -1.104 . . . . 0.0 109.883 -176.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -59.47 148.56 86.45 Favored 'Trans proline' 0 CA--C 1.561 1.829 0 C-N-CA 123.447 2.764 . . . . 0.0 116.505 174.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 88.0 p -80.61 -35.81 33.57 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 117.314 2.338 . . . . 0.0 117.314 -175.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -71.76 -51.6 21.87 Favored 'General case' 0 N--CA 1.508 2.473 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -171.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.8 pp -54.51 -42.0 70.29 Favored 'General case' 0 CA--C 1.564 1.496 0 N-CA-C 117.521 2.415 . . . . 0.0 117.521 171.252 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.0 m -61.19 -48.31 82.12 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 123.905 0.882 . . . . 0.0 113.282 172.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -67.04 -19.76 65.73 Favored 'General case' 0 CA--C 1.572 1.817 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 169.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -75.17 -42.37 56.02 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 121.116 1.78 . . . . 0.0 115.128 170.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mt -61.53 -47.29 86.23 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 168.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -54.24 -48.42 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 169.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -61.94 -36.17 80.62 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 171.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -55.54 -42.03 74.04 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 117.95 -1.024 . . . . 0.0 113.611 169.28 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 88.2 mtt-85 -81.14 -21.82 39.49 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 118.112 2.634 . . . . 0.0 118.112 168.395 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.0 mp -89.3 7.69 34.32 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 118.331 2.715 . . . . 0.0 118.331 172.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 . . . . . 0 CA--C 1.585 2.317 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 163.166 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.457 ' HA2' ' NH1' ' A' ' 2' ' ' ARG . . . . . . . . 0 CA--C 1.544 1.847 0 CA-C-O 125.52 2.733 . . . . 0.0 113.776 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.405 ' CZ ' ' HD3' ' A' ' 2' ' ' ARG . 21.7 p90 -169.72 135.5 1.49 Allowed 'General case' 0 CA--C 1.56 1.362 0 CA-C-N 109.039 -3.581 . . . . 0.0 105.975 169.382 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 13.9 mt -106.79 106.32 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 173.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.3 mt -108.03 114.59 28.61 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.069 -176.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -106.77 125.28 50.8 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 119.467 1.031 . . . . 0.0 110.632 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 75.19 28.38 62.24 Favored Glycine 0 CA--C 1.551 2.293 0 N-CA-C 118.377 2.111 . . . . 0.0 118.377 177.37 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -88.81 -55.0 0.32 Allowed Pre-proline 0 N--CA 1.496 1.865 0 CA-C-O 115.234 -2.317 . . . . 0.0 107.264 168.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -67.56 66.51 0.79 Allowed 'Trans proline' 0 CA--C 1.574 2.475 0 N-CA-C 118.381 2.416 . . . . 0.0 118.381 166.349 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.49 HH22 HG12 ' A' ' 59' ' ' VAL . 8.0 tmm_? -76.41 -20.39 57.17 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 167.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.491 ' HA ' ' HG3' ' A' ' 147' ' ' GLU . 28.3 t -153.54 127.56 8.98 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 104.197 -2.52 . . . . 0.0 104.197 -167.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . 0.302 5.8 p -61.3 -27.18 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 CA-C-O 116.387 -1.768 . . . . 0.0 113.017 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.61 -32.6 70.01 Favored 'General case' 0 C--N 1.362 1.132 0 N-CA-C 119.631 3.197 . . . . 0.0 119.631 165.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -74.04 -49.95 21.93 Favored 'General case' 0 CA--C 1.588 2.405 0 CA-C-N 124.391 3.269 . . . . 0.0 111.493 166.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -53.99 -28.02 35.3 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 118.319 2.711 . . . . 0.0 118.319 178.102 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.2 tttp -57.18 -30.35 64.43 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 168.74 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.56 -44.79 81.35 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 168.218 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.9 tp -62.2 -35.57 79.28 Favored 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 169.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -64.45 -43.8 93.12 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 119.651 1.114 . . . . 0.0 113.175 167.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 1.156 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 0.5 OUTLIER -54.94 -30.61 59.18 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 166.696 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 99' ' ' MET . . . . . 1.346 ' O ' ' HB2' ' A' ' 103' ' ' ARG . 47.3 mtt -85.28 -33.71 22.08 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 118.946 2.943 . . . . 0.0 118.946 172.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.5 tt -69.51 -54.11 15.78 Favored 'General case' 0 N--CA 1.504 2.27 0 CA-C-N 121.372 1.897 . . . . 0.0 110.906 172.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -78.15 -49.41 13.9 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 117.662 -1.161 . . . . 0.0 114.065 175.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 1.156 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 93.0 mtt180 -75.08 -39.67 60.6 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 177.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 1.346 ' HB2' ' O ' ' A' ' 99' ' ' MET . 32.8 mmt180 -64.36 -54.36 34.07 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 120.123 1.329 . . . . 0.0 111.538 165.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.3 50.74 0.7 Allowed Glycine 0 N--CA 1.485 1.938 0 O-C-N 123.836 0.71 . . . . 0.0 113.957 168.223 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.0 p -92.65 169.05 10.81 Favored 'General case' 0 CA--C 1.566 1.562 0 CA-C-N 113.188 -1.506 . . . . 0.0 110.247 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -72.42 133.24 44.78 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.1 -1.0 . . . . 0.0 110.72 -174.923 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 7.8 tp -102.21 98.44 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 177.474 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -98.32 -77.45 0.51 Allowed 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 116.218 -1.849 . . . . 0.0 107.866 168.055 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.46 130.55 11.88 Favored 'General case' 0 C--N 1.362 1.149 0 CA-C-N 121.665 2.03 . . . . 0.0 113.94 -169.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 24.1 t -92.72 110.96 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 103.497 -2.779 . . . . 0.0 103.497 162.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.455 HD23 ' HB3' ' A' ' 160' ' ' LYS . 89.4 mt -96.6 95.65 8.11 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.478 -172.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -88.98 123.95 33.79 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.173 0.511 . . . . 0.0 111.608 177.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -90.93 124.07 34.91 Favored 'General case' 0 CA--C 1.559 1.289 0 CA-C-O 123.16 1.457 . . . . 0.0 110.915 -176.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -85.37 97.35 9.94 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 112.412 -2.177 . . . . 0.0 108.391 167.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.482 1.139 0 CA-C-N 113.477 -1.692 . . . . 0.0 107.455 -168.567 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 44.5 t30 . . . . . 0 N--CA 1.498 1.942 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -62.48 -37.31 85.48 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 168.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 57.8 mtt -67.93 -29.51 68.6 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 168.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -63.56 -50.69 68.53 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 120.412 1.46 . . . . 0.0 114.377 168.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.1 p -65.79 -33.08 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.221 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 170.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -57.2 -47.0 82.38 Favored 'General case' 0 CA--C 1.583 2.214 0 CA-C-N 119.994 1.27 . . . . 0.0 112.032 168.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -61.77 -54.08 47.18 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 117.445 2.387 . . . . 0.0 117.445 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.49 -43.81 62.32 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 116.922 2.193 . . . . 0.0 116.922 174.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.491 ' HG3' ' HA ' ' A' ' 89' ' ' SER . 32.9 mm-40 -98.84 -42.3 7.24 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 116.487 2.032 . . . . 0.0 116.487 -167.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 97.8 m -50.76 -33.38 22.95 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 117.427 2.38 . . . . 0.0 117.427 -167.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.444 ' HB3' ' HD3' ' A' ' 150' ' ' PRO . . . -71.04 -61.38 2.34 Favored Pre-proline 0 CA--C 1.583 2.212 0 CA-C-O 115.83 -2.033 . . . . 0.0 111.844 169.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.444 ' HD3' ' HB3' ' A' ' 149' ' ' ALA . 75.7 Cg_exo -54.31 -37.02 88.56 Favored 'Trans proline' 0 CA--C 1.58 2.796 0 C-N-CA 123.625 2.883 . . . . 0.0 119.3 169.668 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -61.14 -53.27 59.11 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 126.193 1.797 . . . . 0.0 111.58 171.536 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 1.113 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 45.3 tp -64.32 -20.73 66.28 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 115.378 1.621 . . . . 0.0 115.378 174.247 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -71.6 -50.4 31.25 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 122.436 2.38 . . . . 0.0 112.667 164.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -65.05 -53.16 50.04 Favored 'General case' 0 CA--C 1.568 1.658 0 CA-C-N 120.106 1.321 . . . . 0.0 112.432 -179.01 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -74.87 -29.23 60.95 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-O 115.178 -2.344 . . . . 0.0 113.491 176.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 1.113 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 34.7 ttt180 -60.95 -36.42 79.33 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 124.535 3.334 . . . . 0.0 116.389 169.501 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -67.72 -36.49 80.7 Favored 'General case' 0 CA--C 1.575 1.935 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 166.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -86.87 -29.5 22.14 Favored 'General case' 0 CA--C 1.577 2.001 0 N-CA-C 119.43 3.122 . . . . 0.0 119.43 -178.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.1 pp -80.4 176.64 9.59 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 119.673 3.212 . . . . 0.0 119.673 -160.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.455 ' HB3' HD23 ' A' ' 111' ' ' LEU . 6.0 tmtt? -131.0 135.25 47.44 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 104.062 -2.57 . . . . 0.0 104.062 166.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 83.0 m -97.06 148.88 22.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.991 -1.068 . . . . 0.0 109.666 -174.745 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 34.3 t -130.38 138.18 54.44 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.442 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 168.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -91.14 136.8 32.84 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 169.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -160.26 99.89 1.34 Allowed 'General case' 0 N--CA 1.481 1.085 0 CA-C-O 121.711 0.767 . . . . 0.0 111.516 -163.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -176.989 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 . . . . . 0 N--CA 1.5 2.068 0 N-CA-C 116.112 1.893 . . . . 0.0 116.112 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.576 ' HB3' HH21 ' A' ' 174' ' ' ARG . 46.8 mt-10 -64.39 -47.7 78.25 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 119.491 1.041 . . . . 0.0 113.635 169.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 99.8 t -58.92 -36.65 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 CA-C-N 119.399 0.999 . . . . 0.0 113.543 173.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.675 ' CE1' ' HB3' ' A' ' 19' ' ' LYS . 43.0 t80 -57.34 -36.65 71.44 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 164.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.43 -54.43 32.72 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 175.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.576 HH21 ' HB3' ' A' ' 170' ' ' GLU . 9.7 ptp180 -66.36 -26.06 67.1 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 117.588 2.44 . . . . 0.0 117.588 170.504 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.93 -41.93 95.1 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 120.06 1.3 . . . . 0.0 114.211 167.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 4.5 mp -60.08 -46.14 90.56 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 118.265 -0.874 . . . . 0.0 113.035 166.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.433 ' HB2' ' HA ' ' A' ' 174' ' ' ARG . 26.3 mtp180 -51.52 -45.61 62.97 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 169.182 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.32 -49.05 79.3 Favored 'General case' 0 CA--C 1.558 1.27 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 171.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -84.19 -61.34 1.83 Allowed 'General case' 0 CA--C 1.564 1.515 0 CA-C-O 117.781 -1.104 . . . . 0.0 112.326 -177.537 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.958 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -101.45 -56.62 0.86 Allowed Glycine 0 CA--C 1.551 2.296 0 CA-C-N 120.523 1.51 . . . . 0.0 114.937 -177.092 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.958 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 57.5 tttp . . . . . 0 C--O 1.251 1.132 0 CA-C-N 120.003 1.902 . . . . 0.0 109.195 -176.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.3 mtt . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.456 ' HB2' ' O ' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -149.68 172.97 14.2 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 116.613 2.079 . . . . 0.0 116.613 -168.024 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 54.7 t -134.25 156.04 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 CA-C-O 123.474 1.607 . . . . 0.0 112.802 -162.558 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . 0.259 0.0 OUTLIER -140.77 132.19 26.84 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 113.936 -1.484 . . . . 0.0 110.091 167.038 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 1.099 HD21 ' HB3' ' A' ' 13' ' ' LYS . 23.8 tp -99.56 126.37 45.52 Favored 'General case' 0 CA--C 1.573 1.849 0 CA-C-O 123.132 1.444 . . . . 0.0 112.121 -167.666 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.3 mt -116.51 153.03 32.89 Favored 'General case' 0 CA--C 1.559 1.305 0 CA-C-N 109.921 -3.309 . . . . 0.0 109.898 -177.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -179.38 108.26 0.24 Allowed Glycine 0 CA--C 1.547 2.036 0 CA-C-O 117.029 -1.984 . . . . 0.0 113.289 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo . . . . . 0 CA--C 1.579 2.725 0 CA-C-N 121.926 2.863 . . . . 0.0 115.689 168.422 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 1.099 ' HB3' HD21 ' A' ' 5' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.497 1.92 0 N-CA-C 118.826 2.898 . . . . 0.0 118.826 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.76 -24.46 40.87 Favored Glycine 0 CA--C 1.561 2.928 0 N-CA-C 118.972 2.349 . . . . 0.0 118.972 168.029 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 16.6 m -63.07 -56.22 18.8 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 119.378 1.589 . . . . 0.0 113.331 170.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.48 ' HA ' ' HB2' ' A' ' 19' ' ' LYS 0.286 1.8 mp0 -77.82 -12.29 59.96 Favored 'General case' 0 CA--C 1.571 1.78 0 CA-C-O 115.695 -2.098 . . . . 0.0 112.804 173.54 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.53 -46.83 45.29 Favored 'General case' 0 C--N 1.375 1.697 0 CA-C-N 123.831 3.014 . . . . 0.0 113.744 167.477 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.7 t -67.2 -38.24 80.68 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.995 0 CA-C-N 119.772 1.169 . . . . 0.0 111.893 173.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.48 ' HB2' ' HA ' ' A' ' 16' ' ' GLN . 18.9 mmmt -57.42 -54.34 47.88 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 116.38 1.993 . . . . 0.0 116.38 169.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.7 tp -65.09 -29.55 70.43 Favored 'General case' 0 CA--C 1.575 1.924 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 174.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.48 -39.13 91.59 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 167.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -61.03 -36.05 78.51 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 166.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.2 mmmt -65.21 -51.63 59.81 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 169.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.4 mt -85.15 -25.55 27.39 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 116.931 2.197 . . . . 0.0 116.931 -174.445 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.04 37.86 7.61 Favored Glycine 0 CA--C 1.554 2.525 0 N-CA-C 117.694 1.838 . . . . 0.0 117.694 -174.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.2 mm -105.21 155.95 36.98 Favored Pre-proline 0 CA--C 1.569 1.681 0 CA-C-N 119.26 1.53 . . . . 0.0 113.281 -168.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -80.64 99.06 1.11 Allowed 'Trans proline' 0 CA--C 1.567 2.125 0 CA-C-N 122.426 1.902 . . . . 0.0 109.549 162.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -72.18 112.47 8.29 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.923 -0.486 . . . . 0.0 110.108 177.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 12.8 mm -98.67 104.26 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 41.7 t -98.77 127.88 44.83 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 167.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 37.9 p -67.64 -18.73 65.06 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 117.41 2.374 . . . . 0.0 117.41 -168.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -82.88 -18.66 64.91 Favored Glycine 0 CA--C 1.548 2.126 0 N-CA-C 118.667 2.227 . . . . 0.0 118.667 167.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -78.96 -53.6 6.88 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 119.009 1.404 . . . . 0.0 114.189 -169.497 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -65.16 -38.02 89.23 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 174.172 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.47 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 15.3 m-85 -64.54 -38.53 91.32 Favored 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 168.325 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 49.0 ttp180 -58.6 -41.68 86.39 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 119.929 1.241 . . . . 0.0 114.273 167.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -60.65 -41.28 94.67 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 168.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -69.08 -24.31 64.13 Favored 'General case' 0 CA--C 1.579 2.059 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 169.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 65.6 mt -63.69 -47.98 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 CA-C-N 120.245 1.384 . . . . 0.0 110.97 167.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -65.63 -36.7 84.45 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 114.341 1.238 . . . . 0.0 114.341 174.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -66.46 -42.74 87.1 Favored 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 115.98 1.844 . . . . 0.0 115.98 173.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.79 69.44 1.06 Allowed Glycine 0 CA--C 1.543 1.829 0 CA-C-O 118.607 -1.107 . . . . 0.0 114.101 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.86 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 73.3 p -93.33 -48.74 6.28 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.86 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.253 74.6 mttt 106.17 -41.37 0.0 OUTLIER 'General case' 0 CA--C 1.572 1.818 0 CA-C-O 116.455 -1.736 . . . . 0.0 111.29 -172.607 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.401 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -81.88 -14.14 56.61 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 122.955 2.616 . . . . 0.0 112.895 163.789 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.54 -55.64 27.69 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-N 120.287 1.403 . . . . 0.0 114.864 170.654 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.297 7.4 p -76.32 -50.41 22.31 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.444 0 N-CA-C 115.883 1.808 . . . . 0.0 115.883 -168.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -66.71 -45.94 77.14 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 121.127 1.785 . . . . 0.0 112.922 173.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 45' ' ' LEU . . . -71.47 -27.42 63.23 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -178.031 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.47 ' HB2' ' HB3' ' A' ' 35' ' ' PHE . 1.3 tmtp? -72.53 -41.97 65.26 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 117.302 -1.333 . . . . 0.0 112.946 166.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.594 ' O ' ' CG ' ' A' ' 51' ' ' ARG . 32.4 ttt180 -71.2 -51.77 22.86 Favored 'General case' 0 CA--C 1.586 2.342 1 CA-C-O 85.232 -16.604 . . . . 0.0 118.623 -174.139 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -34.58 -62.53 0.34 Allowed 'General case' 0 N--CA 1.494 1.732 1 O-C-N 108.992 -8.567 . . . . 0.0 121.129 146.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.5 tp -57.01 -29.47 63.36 Favored 'General case' 0 CA--C 1.582 2.206 0 CA-C-N 122.012 2.187 . . . . 0.0 116.223 171.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -92.58 -39.45 11.33 Favored 'General case' 0 CA--C 1.568 1.672 0 C-N-CA 126.738 2.015 . . . . 0.0 116.27 170.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -87.08 -27.88 22.88 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 116.874 2.176 . . . . 0.0 116.874 -176.425 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.75 22.01 6.87 Favored Glycine 0 CA--C 1.542 1.733 0 N-CA-C 118.588 2.195 . . . . 0.0 118.588 167.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -100.28 -132.23 0.25 Allowed 'General case' 0 CA--C 1.57 1.746 0 CA-C-N 118.935 1.367 . . . . 0.0 110.045 173.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 89.2 mt -116.17 119.31 35.39 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 119.916 1.235 . . . . 0.0 110.874 -168.748 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.491 HG12 HH12 ' A' ' 88' ' ' ARG . 13.2 p -121.37 136.48 25.88 Favored Pre-proline 0 CA--C 1.573 1.846 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.322 176.534 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -61.08 150.01 86.37 Favored 'Trans proline' 0 CA--C 1.561 1.857 0 C-N-CA 123.136 2.557 . . . . 0.0 115.275 169.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.1 t -83.85 -33.88 24.75 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -64.0 -44.91 91.22 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -174.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 pp -56.76 -43.63 80.98 Favored 'General case' 0 CA--C 1.562 1.425 0 N-CA-C 117.09 2.255 . . . . 0.0 117.09 169.573 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.5 m -61.77 -46.21 90.54 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 123.834 0.854 . . . . 0.0 113.013 174.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.45 -23.63 67.35 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 167.202 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -74.26 -45.74 45.9 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 175.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.4 mt -65.79 -45.81 81.01 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 169.371 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 69.0 t -57.65 -53.8 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 117.645 -1.169 . . . . 0.0 111.688 172.644 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -62.14 -30.7 71.21 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 116.002 1.853 . . . . 0.0 116.002 174.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -57.94 -43.7 86.49 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 117.162 -1.399 . . . . 0.0 113.404 169.733 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.5 ttm-85 -81.64 -15.34 54.91 Favored 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 118.499 2.778 . . . . 0.0 118.499 168.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 74.7 mt -85.13 -6.62 59.29 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 166.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 . . . . . 0 N--CA 1.495 1.806 0 CA-C-O 126.237 2.922 . . . . 0.0 118.485 165.726 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.409 0 CA-C-O 123.856 1.809 . . . . 0.0 116.324 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.456 ' O ' ' HB2' ' A' ' 2' ' ' ARG . 17.2 p90 -177.6 132.14 0.16 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 112.958 -1.621 . . . . 0.0 109.278 169.675 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 16.7 mt -112.59 109.53 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 172.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 24.8 mt -104.01 114.33 28.51 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 117.52 -1.229 . . . . 0.0 109.87 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -104.5 125.71 50.92 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 121.32 1.873 . . . . 0.0 110.884 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 74.04 32.36 58.7 Favored Glycine 0 CA--C 1.548 2.147 0 N-CA-C 117.95 1.94 . . . . 0.0 117.95 174.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -91.15 -55.8 0.26 Allowed Pre-proline 0 N--CA 1.496 1.853 0 CA-C-O 115.163 -2.351 . . . . 0.0 108.418 169.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -66.74 63.79 0.57 Allowed 'Trans proline' 0 CA--C 1.575 2.555 0 N-CA-C 120.192 3.112 . . . . 0.0 120.192 168.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.491 HH12 HG12 ' A' ' 59' ' ' VAL 0.331 29.6 ttt180 -69.59 -31.42 69.55 Favored 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 116.892 2.182 . . . . 0.0 116.892 165.877 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.9 t -151.72 129.32 11.49 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 104.742 -2.318 . . . . 0.0 104.742 -166.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . 0.33 12.8 p -61.86 -25.3 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 CA-C-O 116.726 -1.607 . . . . 0.0 113.718 -172.397 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.07 -38.21 75.92 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 119.506 3.15 . . . . 0.0 119.506 165.185 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -70.09 -47.95 59.72 Favored 'General case' 0 CA--C 1.592 2.589 0 CA-C-N 122.526 2.421 . . . . 0.0 111.939 165.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.07 -31.63 72.94 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 127.198 2.199 . . . . 0.0 116.279 -169.867 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -57.28 -32.61 66.8 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 166.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.62 -43.05 90.74 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 169.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 32.0 tp -64.22 -36.82 85.32 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 169.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 28.3 t-80 -60.26 -53.08 61.92 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 119.867 1.212 . . . . 0.0 113.042 169.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 1.222 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 35.6 mt-10 -49.01 -34.54 13.4 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 167.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' MET . . . . . 1.248 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 26.3 mmt -85.96 -30.56 22.68 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 118.182 2.66 . . . . 0.0 118.182 173.917 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 46.4 tp -67.48 -52.26 41.44 Favored 'General case' 0 N--CA 1.504 2.26 0 CA-C-N 121.281 1.855 . . . . 0.0 112.02 169.81 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -79.01 -51.37 9.68 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 123.512 0.725 . . . . 0.0 112.675 176.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 1.222 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 72.9 ttt180 -69.65 -44.94 69.53 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 176.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 1.248 ' HB3' ' O ' ' A' ' 99' ' ' MET . 72.0 ttt180 -59.8 -56.18 25.01 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 118.867 0.758 . . . . 0.0 110.953 164.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.27 43.78 1.05 Allowed Glycine 0 N--CA 1.48 1.588 0 O-C-N 124.282 0.989 . . . . 0.0 114.211 168.283 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 34.5 p -100.49 143.81 30.23 Favored 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 170.459 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -67.4 131.43 45.69 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -171.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 4.7 tp -82.91 103.19 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 C-N-CA 125.21 1.404 . . . . 0.0 108.257 175.258 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -97.95 -71.66 0.68 Allowed 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 114.925 -2.464 . . . . 0.0 108.237 168.049 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -144.96 125.5 14.06 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 122.852 2.569 . . . . 0.0 116.366 -174.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 69.2 t -92.3 109.14 21.06 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.626 0 N-CA-C 102.269 -3.234 . . . . 0.0 102.269 162.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.585 HD23 ' HB2' ' A' ' 160' ' ' LYS . 83.2 mt -102.18 107.04 17.98 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.083 0.553 . . . . 0.0 110.559 -173.144 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -99.3 122.15 42.05 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-O 122.387 1.089 . . . . 0.0 110.409 175.195 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -93.69 123.3 36.92 Favored 'General case' 0 CA--C 1.559 1.304 0 CA-C-N 113.661 -1.609 . . . . 0.0 108.709 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -82.68 98.27 8.96 Favored 'General case' 0 CA--C 1.555 1.163 0 CA-C-N 112.444 -2.162 . . . . 0.0 108.484 169.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.0 p . . . . . 0 CA--C 1.557 1.223 0 CA-C-N 112.977 -1.92 . . . . 0.0 107.187 -168.923 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 . . . . . 0 N--CA 1.497 1.892 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -63.05 -36.52 83.85 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 167.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 13.2 tpt -67.09 -29.77 69.62 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 114.671 1.359 . . . . 0.0 114.671 168.078 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -62.77 -50.71 69.96 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 168.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 10.1 p -64.56 -34.72 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 170.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -54.95 -49.36 71.57 Favored 'General case' 0 CA--C 1.578 2.046 0 CA-C-N 119.662 1.119 . . . . 0.0 112.335 167.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -57.19 -39.44 75.38 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 118.9 2.926 . . . . 0.0 118.9 173.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -57.21 -34.4 68.49 Favored 'General case' 0 N--CA 1.506 2.365 0 N-CA-C 117.011 2.226 . . . . 0.0 117.011 178.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -131.1 -26.59 2.12 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 119.225 3.046 . . . . 0.0 119.225 -166.241 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 73.2 m -45.4 -32.84 2.28 Favored 'General case' 0 N--CA 1.508 2.452 0 CA-C-N 122.667 2.485 . . . . 0.0 117.425 -171.552 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.403 ' HB3' ' HD3' ' A' ' 150' ' ' PRO . . . -68.53 -62.38 3.04 Favored Pre-proline 0 CA--C 1.584 2.261 0 CA-C-O 115.682 -2.104 . . . . 0.0 112.067 169.201 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.403 ' HD3' ' HB3' ' A' ' 149' ' ' ALA . 75.3 Cg_exo -56.46 -31.73 86.83 Favored 'Trans proline' 0 CA--C 1.578 2.685 0 N-CA-C 120.083 3.07 . . . . 0.0 120.083 169.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -62.78 -53.17 58.39 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 125.719 1.608 . . . . 0.0 111.03 169.516 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.987 ' O ' ' HB2' ' A' ' 156' ' ' ARG 0.306 0.1 OUTLIER -62.03 -24.94 67.36 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 175.872 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -71.29 -50.73 29.62 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 120.366 1.439 . . . . 0.0 113.137 166.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -64.5 -53.54 46.45 Favored 'General case' 0 CA--C 1.568 1.666 0 CA-C-N 120.416 1.462 . . . . 0.0 112.728 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -80.86 -24.66 38.21 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 115.209 -2.329 . . . . 0.0 113.724 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.987 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 14.9 tpt180 -64.37 -37.49 87.68 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 124.144 3.156 . . . . 0.0 115.175 169.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -67.16 -38.09 84.86 Favored 'General case' 0 CA--C 1.574 1.87 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 167.359 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -80.47 -29.7 37.45 Favored 'General case' 0 CA--C 1.578 2.028 0 N-CA-C 119.713 3.227 . . . . 0.0 119.713 177.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.5 pp -79.21 175.76 10.3 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 119.933 3.309 . . . . 0.0 119.933 -161.17 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.585 ' HB2' HD23 ' A' ' 111' ' ' LEU . 95.1 mttt -128.55 133.38 48.38 Favored 'General case' 0 CA--C 1.561 1.392 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 166.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 62.4 m -96.07 148.4 22.71 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 122.261 1.029 . . . . 0.0 110.818 -172.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 1.018 HG13 ' HB3' ' A' ' 174' ' ' ARG . 58.6 t -130.35 136.14 59.18 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.48 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 167.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.549 ' O ' ' HG3' ' A' ' 174' ' ' ARG . 10.0 t0 -95.07 129.05 42.31 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 168.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -163.43 120.9 1.86 Allowed 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.447 -162.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.9 t . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.419 -0.801 . . . . 0.0 109.075 175.382 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 . . . . . 0 N--CA 1.5 2.063 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -64.03 -47.98 78.11 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 119.505 1.048 . . . . 0.0 113.653 169.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 99.3 t -56.7 -38.04 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-N 119.746 1.157 . . . . 0.0 113.647 172.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -59.0 -35.96 74.12 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 116.619 2.081 . . . . 0.0 116.619 167.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -60.37 -48.31 82.32 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 170.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 1.018 ' HB3' HG13 ' A' ' 162' ' ' VAL . 1.4 mmp_? -50.3 -57.2 8.41 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 117.337 2.347 . . . . 0.0 117.337 168.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -49.92 -44.5 50.33 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 116.752 2.13 . . . . 0.0 116.752 172.673 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.5 mp -62.69 -43.11 99.63 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 117.515 -1.231 . . . . 0.0 114.013 168.181 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -53.35 -47.81 69.07 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 171.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -67.87 -45.03 75.71 Favored 'General case' 0 CA--C 1.559 1.303 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 175.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -81.11 -56.6 3.98 Favored 'General case' 0 CA--C 1.564 1.513 0 CA-C-N 120.063 1.301 . . . . 0.0 112.878 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.65 ' O ' ' CB ' ' A' ' 181' ' ' LYS . . . -101.36 -57.87 0.83 Allowed Glycine 0 CA--C 1.552 2.389 0 CA-C-O 117.803 -1.554 . . . . 0.0 114.836 -177.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.65 ' CB ' ' O ' ' A' ' 180' ' ' GLY . 36.5 ttmt . . . . . 0 C--O 1.251 1.157 0 CA-C-N 120.296 2.048 . . . . 0.0 107.579 -177.314 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.0 tpp . . . . . 0 CA--C 1.56 1.344 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.75 166.95 27.82 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 119.65 3.204 . . . . 0.0 119.65 -166.434 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.8 p -123.49 145.0 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 123.237 1.494 . . . . 0.0 113.462 -167.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.2 mt -120.85 114.12 21.13 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 112.123 -2.308 . . . . 0.0 106.27 172.871 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.3 tt -102.67 126.77 49.88 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.806 1.243 . . . . 0.0 111.014 -165.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.1 mt -139.29 164.23 30.39 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 114.527 -1.215 . . . . 0.0 112.431 -166.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 151.68 171.22 19.31 Favored Glycine 0 CA--C 1.558 2.752 0 CA-C-O 119.088 -0.84 . . . . 0.0 114.728 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo . . . . . 0 CA--C 1.573 2.47 0 C-N-CA 123.576 2.851 . . . . 0.0 113.013 170.383 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -48.01 -31.09 7.84 Favored Glycine 0 CA--C 1.556 2.618 0 N-CA-C 120.96 3.144 . . . . 0.0 120.96 175.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.3 m -66.45 -55.64 14.74 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 119.558 1.679 . . . . 0.0 113.136 176.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.273 10.9 mm-40 -76.86 -12.16 59.93 Favored 'General case' 0 CA--C 1.573 1.848 0 CA-C-O 116.235 -1.841 . . . . 0.0 111.858 172.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.33 -47.65 60.09 Favored 'General case' 0 C--N 1.372 1.554 0 CA-C-N 123.346 2.794 . . . . 0.0 114.387 167.695 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.5 t -66.95 -44.72 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 CA-C-O 117.742 -1.123 . . . . 0.0 111.201 173.346 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -59.33 -41.41 89.07 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 116.596 2.073 . . . . 0.0 116.596 171.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.7 tp -66.35 -33.71 76.33 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 119.721 1.146 . . . . 0.0 113.82 171.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.68 -39.03 89.96 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 167.702 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -63.03 -38.54 91.6 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 166.113 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 42.1 tptt -64.84 -53.87 39.94 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 175.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.6 mt -83.34 -27.19 29.89 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 116.956 2.206 . . . . 0.0 116.956 178.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.06 40.02 5.95 Favored Glycine 0 CA--C 1.555 2.569 0 N-CA-C 117.516 1.766 . . . . 0.0 117.516 -174.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.429 ' CG2' ' HA ' ' A' ' 81' ' ' PHE . 19.2 mm -110.06 160.34 28.56 Favored Pre-proline 0 CA--C 1.567 1.634 0 CA-C-N 118.853 1.326 . . . . 0.0 114.103 -168.28 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -74.37 103.53 1.71 Allowed 'Trans proline' 0 CA--C 1.565 2.027 0 C-N-CA 121.766 1.644 . . . . 0.0 112.776 159.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.3 tm0? -69.5 104.96 2.46 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 165.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 35.2 mm -100.83 107.68 21.7 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 177.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.0 t -95.59 129.92 42.62 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 168.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.4 p -67.17 -19.48 65.58 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 117.037 2.236 . . . . 0.0 117.037 -170.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -84.92 -16.49 65.21 Favored Glycine 0 CA--C 1.544 1.895 0 N-CA-C 119.079 2.392 . . . . 0.0 119.079 168.031 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -80.34 -55.62 4.77 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 119.529 1.664 . . . . 0.0 114.519 -168.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -59.36 -40.15 85.55 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 172.267 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.586 ' HB3' ' CB ' ' A' ' 50' ' ' LYS . 6.4 m-85 -60.44 -46.79 88.75 Favored 'General case' 0 CA--C 1.558 1.26 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 170.086 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -55.22 -42.28 73.17 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 168.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -59.94 -38.14 81.57 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 167.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -68.97 -23.62 64.14 Favored 'General case' 0 CA--C 1.581 2.168 0 N-CA-C 115.024 1.491 . . . . 0.0 115.024 167.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 53.9 mt -62.91 -49.6 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.522 0 CA-C-N 120.927 1.694 . . . . 0.0 109.871 166.303 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -60.85 -40.34 92.51 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 176.072 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -67.19 -41.76 85.32 Favored 'General case' 0 CA--C 1.562 1.427 0 N-CA-C 116.268 1.951 . . . . 0.0 116.268 173.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.77 70.0 0.99 Allowed Glycine 0 CA--C 1.544 1.872 0 CA-C-O 118.349 -1.25 . . . . 0.0 114.425 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.855 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 68.5 p -94.0 -50.79 5.15 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 118.837 1.319 . . . . 0.0 114.407 178.032 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.855 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.251 37.6 mttp 106.24 -41.42 0.0 OUTLIER 'General case' 0 CA--C 1.571 1.755 0 CA-C-O 116.428 -1.749 . . . . 0.0 111.514 -172.234 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.403 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.6 OUTLIER -81.98 -14.02 56.62 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 122.972 2.623 . . . . 0.0 113.013 163.682 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.23 -57.56 19.08 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 120.318 1.417 . . . . 0.0 114.494 170.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.304 4.2 p -75.52 -51.96 19.55 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.353 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -169.304 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -68.73 -44.07 74.58 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 120.703 1.592 . . . . 0.0 112.84 176.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 45' ' ' LEU . . . -73.74 -29.16 62.07 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 117.267 -1.349 . . . . 0.0 114.282 -178.01 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.586 ' CB ' ' HB3' ' A' ' 35' ' ' PHE 0.273 0.0 OUTLIER -77.77 -33.94 52.55 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 117.084 -1.436 . . . . 0.0 113.689 169.832 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.543 ' HG2' ' O ' ' A' ' 51' ' ' ARG . 29.1 ttt180 -76.06 -47.1 25.97 Favored 'General case' 0 CA--C 1.584 2.27 1 CA-C-O 84.928 -16.749 . . . . 0.0 118.477 -179.075 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -35.35 -56.71 0.62 Allowed 'General case' 0 N--CA 1.494 1.748 1 O-C-N 107.542 -9.474 . . . . 0.0 120.383 145.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 49.2 mt -54.33 -35.85 63.13 Favored 'General case' 0 N--CA 1.511 2.587 0 CA-C-N 123.869 3.031 . . . . 0.0 115.023 167.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -86.96 -42.17 13.35 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 116.139 1.904 . . . . 0.0 116.139 172.805 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.26 -42.79 54.24 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . 1.04 ' HA2' HH12 ' A' ' 88' ' ' ARG . . . 107.61 40.99 1.66 Allowed Glycine 0 CA--C 1.537 1.463 0 N-CA-C 116.466 1.346 . . . . 0.0 116.466 168.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -118.75 -164.53 1.04 Allowed 'General case' 0 CA--C 1.569 1.692 0 C-N-CA 124.052 0.941 . . . . 0.0 111.076 168.049 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.5 mt -80.22 108.16 13.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.342 -0.849 . . . . 0.0 112.257 -169.273 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 p -103.57 132.3 21.2 Favored Pre-proline 0 CA--C 1.571 1.761 0 C-N-CA 124.708 1.203 . . . . 0.0 110.002 175.108 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -60.18 145.87 97.56 Favored 'Trans proline' 0 CA--C 1.558 1.724 0 C-N-CA 123.367 2.711 . . . . 0.0 116.238 171.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 73.7 m -82.8 178.64 8.08 Favored 'General case' 0 CA--C 1.571 1.767 0 CA-C-O 121.623 0.725 . . . . 0.0 111.591 170.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.0 t70 83.05 -52.81 0.17 Allowed 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 125.926 1.691 . . . . 0.0 113.583 176.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.9 pp -57.85 -42.35 84.26 Favored 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 116.547 2.055 . . . . 0.0 116.547 168.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.0 m -59.34 -49.5 77.57 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 124.354 1.062 . . . . 0.0 113.651 171.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -64.73 -21.04 66.66 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 167.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -77.67 -44.35 28.33 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 173.538 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.6 mt -66.37 -44.66 82.54 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 169.564 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 56.1 t -56.5 -52.53 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.954 170.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -63.57 -28.35 69.87 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 116.615 2.08 . . . . 0.0 116.615 173.177 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -60.44 -42.0 95.18 Favored 'General case' 0 CA--C 1.563 1.46 0 CA-C-O 117.743 -1.123 . . . . 0.0 113.081 168.461 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -81.31 -21.41 39.27 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 119.044 2.979 . . . . 0.0 119.044 168.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 88.4 mt -84.71 -20.08 31.74 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 117.156 2.28 . . . . 0.0 117.156 176.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 . . . . . 0 N--CA 1.498 1.972 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 169.418 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.55 0 CA-C-O 122.289 0.939 . . . . 0.0 114.493 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.429 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . 14.5 p90 -175.52 133.83 0.3 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 113.674 -1.263 . . . . 0.0 109.946 169.709 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.9 mm -102.45 106.21 19.49 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.736 0 N-CA-C 102.84 -3.022 . . . . 0.0 102.84 167.383 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.2 mt -103.22 134.5 46.53 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 123.728 0.811 . . . . 0.0 108.812 174.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -133.52 119.64 19.78 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 118.987 0.812 . . . . 0.0 111.099 -167.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 77.56 41.17 20.88 Favored Glycine 0 CA--C 1.55 2.223 0 CA-C-O 117.418 -1.768 . . . . 0.0 116.96 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . 0.275 0.9 OUTLIER -104.68 -66.84 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.833 0 CA-C-O 113.202 -3.285 . . . . 0.0 110.433 -175.375 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -63.13 60.38 0.17 Allowed 'Trans proline' 0 CA--C 1.57 2.311 0 CA-C-N 127.169 3.596 . . . . 0.0 121.212 170.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 1.04 HH12 ' HA2' ' A' ' 56' ' ' GLY . 16.4 ptt85 -62.79 -25.75 68.39 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 117.48 2.4 . . . . 0.0 117.48 167.129 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.467 ' HB2' ' HG3' ' A' ' 147' ' ' GLU . 77.9 p -151.18 138.99 19.83 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 125.824 1.65 . . . . 0.0 107.045 -167.369 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -55.95 -33.37 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-N 121.283 1.856 . . . . 0.0 113.462 172.82 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -61.92 -39.13 90.98 Favored 'General case' 0 C--N 1.362 1.115 0 N-CA-C 120.669 3.581 . . . . 0.0 120.669 172.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -74.87 -46.98 32.64 Favored 'General case' 0 CA--C 1.586 2.351 0 CA-C-N 123.51 2.868 . . . . 0.0 111.847 165.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.11 -29.96 68.95 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 118.412 2.745 . . . . 0.0 118.412 -175.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -58.65 -34.86 71.68 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 168.426 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.75 -42.71 90.6 Favored 'General case' 0 CA--C 1.566 1.592 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 170.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 26.6 tp -68.0 -33.93 75.56 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 171.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -63.12 -52.85 60.93 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 119.957 1.253 . . . . 0.0 112.816 169.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.982 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 35.6 mt-10 -47.05 -39.39 12.77 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 166.484 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.83 ' O ' ' HB2' ' A' ' 103' ' ' ARG . 1.7 tpt -83.12 -24.85 32.44 Favored 'General case' 0 CA--C 1.569 1.686 0 N-CA-C 117.756 2.502 . . . . 0.0 117.756 176.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.0 tt -73.8 -49.58 24.58 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-N 120.183 1.356 . . . . 0.0 111.68 171.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -74.78 -54.29 7.61 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 172.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.982 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 92.6 mtt180 -69.82 -40.23 76.04 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 177.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.83 ' HB2' ' O ' ' A' ' 99' ' ' MET . 6.9 ttt-85 -65.31 -53.6 41.54 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 119.831 1.196 . . . . 0.0 111.722 164.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 108.26 50.36 0.77 Allowed Glycine 0 N--CA 1.483 1.798 0 O-C-N 123.81 0.694 . . . . 0.0 114.096 167.475 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 68.5 p -88.96 146.2 25.04 Favored 'General case' 0 CA--C 1.558 1.285 0 CA-C-N 113.205 -1.498 . . . . 0.0 109.9 175.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -66.32 132.69 48.94 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.77 -0.581 . . . . 0.0 112.053 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 7.1 tp -95.26 100.74 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -175.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -94.27 -66.92 0.88 Allowed 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 117.074 -1.441 . . . . 0.0 108.847 168.109 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -153.91 123.11 6.49 Favored 'General case' 0 C--N 1.358 0.965 0 CA-C-N 120.605 1.548 . . . . 0.0 113.246 -169.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.3 t -91.8 109.07 20.8 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.583 0 N-CA-C 100.312 -3.958 . . . . 0.0 100.312 162.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.475 ' HA ' ' O ' ' A' ' 160' ' ' LYS 0.252 37.7 tp -112.97 104.07 12.03 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 114.957 -1.019 . . . . 0.0 112.369 -159.483 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -99.56 134.31 42.62 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-O 122.071 0.939 . . . . 0.0 110.987 -176.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -94.76 122.17 37.09 Favored 'General case' 0 CA--C 1.561 1.386 0 CA-C-O 122.903 1.335 . . . . 0.0 110.722 -173.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -85.62 95.05 9.22 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 113.018 -1.901 . . . . 0.0 109.637 169.319 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.483 1.204 0 C-N-CA 125.725 1.61 . . . . 0.0 107.226 -169.037 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 37.3 t30 . . . . . 0 N--CA 1.5 2.062 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 69.2 mtp180 -60.43 -40.66 91.88 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 167.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 25.8 ttt -65.7 -32.68 74.37 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 168.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -60.25 -50.04 75.22 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 169.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.0 p -65.57 -32.97 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 169.349 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -55.52 -53.44 56.37 Favored 'General case' 0 CA--C 1.58 2.112 0 CA-C-N 119.495 1.043 . . . . 0.0 111.716 169.567 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -62.96 -42.09 99.72 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 118.063 2.616 . . . . 0.0 118.063 175.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.26 -44.53 61.8 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 116.975 2.213 . . . . 0.0 116.975 174.961 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.467 ' HG3' ' HB2' ' A' ' 89' ' ' SER . 8.9 mm-40 -124.08 -30.43 3.48 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 118.54 2.792 . . . . 0.0 118.54 -166.611 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 63.7 m -55.07 -34.86 63.95 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 117.387 2.365 . . . . 0.0 117.387 -167.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -65.15 -60.4 7.98 Favored Pre-proline 0 CA--C 1.579 2.085 0 CA-C-O 116.305 -1.807 . . . . 0.0 111.751 171.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -51.59 -32.24 43.48 Favored 'Trans proline' 0 CA--C 1.579 2.754 0 C-N-CA 123.394 2.729 . . . . 0.0 118.549 166.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -66.77 -51.94 50.02 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 125.083 1.353 . . . . 0.0 111.305 175.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 1.215 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 38.2 tp -62.43 -22.04 65.87 Favored 'General case' 0 CA--C 1.571 1.752 0 N-CA-C 115.718 1.747 . . . . 0.0 115.718 170.65 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -70.82 -50.2 38.08 Favored 'General case' 0 CA--C 1.56 1.332 0 CA-C-N 122.681 2.491 . . . . 0.0 112.463 165.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -61.13 -56.48 20.37 Favored 'General case' 0 CA--C 1.574 1.895 0 CA-C-N 119.931 1.241 . . . . 0.0 113.488 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -77.75 -15.16 59.32 Favored 'General case' 0 CA--C 1.562 1.429 0 CA-C-O 116.647 -1.644 . . . . 0.0 114.268 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 1.215 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 0.1 OUTLIER -68.85 -40.3 79.46 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 121.723 2.056 . . . . 0.0 114.871 166.023 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -65.76 -38.97 90.54 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 167.424 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -75.47 -18.94 59.72 Favored 'General case' 0 CA--C 1.585 2.305 0 N-CA-C 118.386 2.735 . . . . 0.0 118.386 169.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.7 mt -39.26 143.04 0.21 Allowed 'General case' 0 CA--C 1.58 2.101 1 N-CA-C 123.741 4.719 . . . . 0.0 123.741 -164.191 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 111' ' ' LEU . 28.4 mttm -136.08 121.74 19.65 Favored 'General case' 0 CA--C 1.56 1.332 0 N-CA-C 103.435 -2.802 . . . . 0.0 103.435 160.187 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.0 t -103.76 156.42 17.83 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.531 -1.356 . . . . 0.0 113.126 -172.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 34.7 t -124.35 142.47 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 169.517 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -98.76 127.71 44.77 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 165.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.74 92.67 1.68 Allowed 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 122.68 1.229 . . . . 0.0 112.155 -163.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.2 t . . . . . 0 N--CA 1.486 1.346 0 CA-C-N 113.927 -1.488 . . . . 0.0 107.178 -175.905 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 . . . . . 0 N--CA 1.5 2.034 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -62.56 -49.98 73.14 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 117.855 -1.069 . . . . 0.0 113.602 170.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 97.7 t -60.41 -36.05 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 CA-C-N 120.029 1.286 . . . . 0.0 114.014 177.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -59.31 -38.21 79.68 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 166.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.07 -44.62 91.85 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 174.119 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -62.7 -40.6 97.66 Favored 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 116.512 2.042 . . . . 0.0 116.512 170.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.68 -42.98 94.12 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 169.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 4.9 mp -59.61 -42.61 93.0 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 167.718 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.57 ' HA ' ' HB3' ' A' ' 181' ' ' LYS . 45.1 mtt180 -55.41 -42.18 73.76 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 116.827 2.158 . . . . 0.0 116.827 169.792 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.91 -48.18 80.05 Favored 'General case' 0 CA--C 1.561 1.386 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 170.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.7 tt -83.08 -57.49 3.26 Favored 'General case' 0 CA--C 1.567 1.596 0 CA-C-N 120.778 1.627 . . . . 0.0 113.117 -178.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -104.6 -52.4 0.86 Allowed Glycine 0 CA--C 1.547 2.073 0 CA-C-O 117.456 -1.747 . . . . 0.0 114.64 -173.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.57 ' HB3' ' HA ' ' A' ' 177' ' ' ARG . 86.4 tttt . . . . . 0 C--O 1.251 1.184 0 CA-C-N 120.564 2.182 . . . . 0.0 112.735 -176.149 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.0 mtt . . . . . 0 CA--C 1.558 1.283 0 CA-C-O 123.095 1.426 . . . . 0.0 111.652 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.5 ttm-85 -141.39 149.46 41.12 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 116.736 2.125 . . . . 0.0 116.736 -161.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.7 p -143.84 146.16 21.25 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.861 0 CA-C-O 123.793 1.759 . . . . 0.0 114.797 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -131.86 111.57 11.7 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 112.417 -2.174 . . . . 0.0 108.009 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 14.5 tp -98.32 131.46 44.61 Favored 'General case' 0 CA--C 1.571 1.75 0 CA-C-O 122.706 1.241 . . . . 0.0 112.314 -167.017 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.7 mt -138.99 163.19 33.02 Favored 'General case' 0 CA--C 1.563 1.454 0 C-N-CA 127.607 2.363 . . . . 0.0 110.782 -166.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 141.89 129.22 2.41 Favored Glycine 0 CA--C 1.553 2.439 0 CA-C-O 116.975 -2.014 . . . . 0.0 111.657 -174.348 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo . . . . . 0 CA--C 1.573 2.429 0 CA-C-N 122.838 3.319 . . . . 0.0 116.024 172.969 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.7 mttt . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -50.81 -41.21 43.47 Favored Glycine 0 CA--C 1.558 2.72 0 N-CA-C 119.01 2.364 . . . . 0.0 119.01 175.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.5 m -58.82 -44.29 90.83 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 169.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLN . . . . . 0.569 ' HA ' ' HB2' ' A' ' 19' ' ' LYS 0.264 5.1 mm-40 -78.98 -14.05 59.43 Favored 'General case' 0 CA--C 1.576 1.958 0 CA-C-O 116.571 -1.68 . . . . 0.0 112.32 173.536 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.68 -45.22 62.58 Favored 'General case' 0 C--N 1.371 1.531 0 CA-C-N 123.062 2.665 . . . . 0.0 113.597 167.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 p -65.15 -41.53 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 169.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.679 ' HB3' ' CE1' ' A' ' 172' ' ' PHE . 31.1 mmtp -54.72 -42.13 71.16 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 116.11 1.892 . . . . 0.0 116.11 168.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 1.09 ' HA ' ' HB3' ' A' ' 23' ' ' LYS . 22.0 mt -68.67 -30.87 69.65 Favored 'General case' 0 CA--C 1.595 2.676 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 168.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.12 -29.58 70.7 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 118.394 -2.692 . . . . 0.0 115.707 167.723 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -64.06 -51.44 64.09 Favored 'General case' 0 CA--C 1.596 2.726 0 CA-C-N 120.324 1.42 . . . . 0.0 110.899 156.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 1.09 ' HB3' ' HA ' ' A' ' 20' ' ' LEU 0.29 4.5 tppt? -53.26 51.93 0.0 OUTLIER 'General case' 0 CA--C 1.576 1.944 2 C-N-CA 133.45 4.7 . . . . 0.0 122.424 166.647 . . . . . . . . 4 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.709 HD13 HD11 ' A' ' 26' ' ' ILE . 0.2 OUTLIER 67.84 25.19 7.94 Favored 'General case' 0 N--CA 1.522 3.13 2 C-N-CA 144.854 9.262 . . . . 0.0 134.891 -152.331 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.44 29.98 28.73 Favored Glycine 0 N--CA 1.506 3.323 0 O-C-N 117.458 -3.276 . . . . 0.0 120.468 157.538 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.709 HD11 HD13 ' A' ' 24' ' ' LEU . 25.6 mm -90.25 149.23 40.88 Favored Pre-proline 0 CA--C 1.556 1.178 0 CA-C-N 112.381 -1.91 . . . . 0.0 110.969 -168.172 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -77.7 91.66 1.17 Allowed 'Trans proline' 0 CA--C 1.561 1.86 0 CA-C-N 122.082 1.779 . . . . 0.0 111.497 168.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.13 108.85 3.28 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.576 175.154 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 22.5 mm -105.65 114.94 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 82.8 p -96.25 132.36 41.78 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 169.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.7 p -68.37 -16.55 63.97 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 117.136 2.272 . . . . 0.0 117.136 -173.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -84.67 -19.83 59.24 Favored Glycine 0 CA--C 1.547 2.053 0 N-CA-C 118.736 2.254 . . . . 0.0 118.736 167.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -81.13 -49.67 10.56 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -169.174 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -65.4 -39.49 92.27 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 173.886 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.712 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 32.8 m-85 -64.59 -40.98 96.49 Favored 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 115.027 1.492 . . . . 0.0 115.027 169.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -57.28 -41.81 80.44 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 167.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.3 ttt180 -61.62 -37.98 85.97 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 168.89 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -68.09 -30.2 69.33 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 168.307 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 64.9 mt -62.75 -44.74 99.73 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 C-N-CA 124.893 1.277 . . . . 0.0 112.085 168.38 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -65.05 -42.09 94.58 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 173.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -76.31 -30.93 57.92 Favored 'General case' 0 CA--C 1.563 1.448 0 N-CA-C 116.784 2.142 . . . . 0.0 116.784 178.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.38 71.99 1.28 Allowed Glycine 0 CA--C 1.543 1.833 0 CA-C-O 118.083 -1.399 . . . . 0.0 115.282 178.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.847 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 70.8 p -93.69 -47.77 6.64 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 119.036 1.418 . . . . 0.0 114.571 174.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.847 ' HB2' ' O ' ' A' ' 43' ' ' THR . 74.8 mttt 103.62 -40.53 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.754 0 CA-C-O 116.247 -1.835 . . . . 0.0 111.527 -171.316 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.05 -12.33 58.33 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 123.053 2.66 . . . . 0.0 112.752 163.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.95 -56.07 23.0 Favored Glycine 0 C--N 1.353 1.525 0 CA-C-N 120.852 1.66 . . . . 0.0 114.743 170.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.286 7.1 p -74.57 -50.09 27.94 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.416 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 -169.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -66.49 -44.54 82.35 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 120.303 1.41 . . . . 0.0 112.691 174.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.34 -29.41 63.78 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 114.976 1.472 . . . . 0.0 114.976 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.712 ' HB2' ' HB3' ' A' ' 35' ' ' PHE 0.294 0.6 OUTLIER -75.34 -35.15 61.23 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 116.717 -1.611 . . . . 0.0 112.08 168.011 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.487 ' O ' ' CG ' ' A' ' 51' ' ' ARG . 18.8 ttt180 -74.2 -52.82 11.28 Favored 'General case' 0 CA--C 1.591 2.557 1 CA-C-O 87.026 -15.749 . . . . 0.0 118.197 -176.447 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 12.6 m-30 -26.28 -69.12 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.975 1 O-C-N 109.59 -8.193 . . . . 0.0 119.146 144.03 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 29.5 tp -54.12 -33.44 57.81 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 116.429 2.011 . . . . 0.0 116.429 175.253 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -91.56 -44.13 9.25 Favored 'General case' 0 CA--C 1.564 1.499 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 169.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -155.21 44.41 0.48 Allowed 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -166.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.54 50.44 0.32 Allowed Glycine 0 C--N 1.355 1.599 0 CA-C-N 121.628 2.013 . . . . 0.0 114.636 169.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . 0.294 5.6 t70 72.49 -112.94 0.05 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.608 1.163 . . . . 0.0 110.4 167.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.6 pp -105.8 144.35 32.66 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 122.691 1.234 . . . . 0.0 113.232 -169.512 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 p -129.76 140.27 38.13 Favored Pre-proline 0 CA--C 1.575 1.93 0 CA-C-N 113.307 -1.769 . . . . 0.0 109.139 -177.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -55.87 136.96 77.21 Favored 'Trans proline' 0 CA--C 1.56 1.805 0 C-N-CA 123.629 2.886 . . . . 0.0 116.679 173.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 98.6 p -72.42 -48.6 39.94 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 -178.32 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -62.38 -38.74 90.76 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 -178.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 17.3 mt -58.79 -48.2 82.09 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 172.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.0 m -61.36 -48.14 82.65 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 113.647 -1.615 . . . . 0.0 113.312 176.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -65.22 -22.04 66.83 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 168.518 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -73.03 -42.95 62.61 Favored 'General case' 0 CA--C 1.557 1.242 0 CA-C-N 120.975 1.716 . . . . 0.0 115.443 169.528 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.7 mt -61.31 -47.24 86.85 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 168.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -57.35 -49.87 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 172.393 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -60.71 -37.67 82.49 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 171.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -56.87 -43.78 81.56 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 117.818 -1.087 . . . . 0.0 113.643 170.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -81.4 -10.4 59.53 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 118.891 2.923 . . . . 0.0 118.891 168.038 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 87.7 mt -94.27 -8.71 38.32 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 116.669 2.1 . . . . 0.0 116.669 171.369 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 . . . . . 0 N--CA 1.503 2.201 0 N-CA-C 117.863 2.542 . . . . 0.0 117.863 172.73 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.593 0 CA-C-O 123.304 1.502 . . . . 0.0 113.944 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.4 p90 179.58 142.0 0.13 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 112.948 -1.626 . . . . 0.0 108.145 169.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 9.8 mt -110.11 108.79 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 103.301 -2.852 . . . . 0.0 103.301 169.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 44.6 mt -110.7 120.59 42.89 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 173.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -111.45 128.16 55.91 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 118.917 0.78 . . . . 0.0 110.779 -175.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 75.12 34.47 51.9 Favored Glycine 0 CA--C 1.553 2.413 0 N-CA-C 118.901 2.32 . . . . 0.0 118.901 176.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . 0.254 0.8 OUTLIER -93.37 -62.62 0.17 Allowed Pre-proline 0 CA--C 1.571 1.775 0 CA-C-O 114.126 -2.845 . . . . 0.0 109.538 175.519 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -63.6 56.99 0.19 Allowed 'Trans proline' 0 CA--C 1.57 2.309 0 N-CA-C 121.129 3.473 . . . . 0.0 121.129 169.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.25 -5.04 50.75 Favored 'General case' 0 CA--C 1.57 1.75 0 N-CA-C 117.057 2.243 . . . . 0.0 117.057 168.287 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.6 t -161.22 139.9 9.87 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 -171.513 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -58.33 -37.84 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-N 120.157 1.344 . . . . 0.0 112.778 -178.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.467 ' HB2' ' OE2' ' A' ' 147' ' ' GLU . 0.1 OUTLIER -65.6 -30.83 71.61 Favored 'General case' 0 C--N 1.36 1.035 0 N-CA-C 119.68 3.215 . . . . 0.0 119.68 175.825 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -80.43 -44.79 18.7 Favored 'General case' 0 CA--C 1.585 2.316 0 CA-C-N 122.008 2.185 . . . . 0.0 112.497 166.257 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.16 -35.0 72.75 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 118.428 2.751 . . . . 0.0 118.428 -176.876 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -58.66 -30.63 67.49 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 116.523 2.045 . . . . 0.0 116.523 169.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.51 -43.41 69.71 Favored 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 169.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.4 tp -67.89 -35.75 79.05 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 171.554 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 -58.58 -54.3 48.66 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 119.672 1.124 . . . . 0.0 112.809 168.66 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 1.136 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 32.3 tt0 -49.55 -32.81 13.28 Favored 'General case' 0 CA--C 1.575 1.906 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 166.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' MET . . . . . 1.097 ' O ' ' HB2' ' A' ' 103' ' ' ARG . 1.8 tpt -83.98 -40.54 18.33 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 117.619 2.452 . . . . 0.0 117.619 178.111 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.23 -45.21 61.2 Favored 'General case' 0 N--CA 1.505 2.317 0 CA-C-N 120.559 1.527 . . . . 0.0 112.504 172.525 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -76.93 -49.14 16.25 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 174.2 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 1.136 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 72.7 ttt180 -69.61 -43.57 72.46 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 177.001 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 1.097 ' HB2' ' O ' ' A' ' 99' ' ' MET . 42.5 mtp180 -63.88 -56.32 16.18 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 119.009 0.822 . . . . 0.0 111.895 165.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.02 48.75 0.76 Allowed Glycine 0 N--CA 1.48 1.592 0 O-C-N 124.049 0.843 . . . . 0.0 113.554 169.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 82.3 p -82.47 160.09 22.76 Favored 'General case' 0 CA--C 1.562 1.436 0 CA-C-N 113.909 -1.145 . . . . 0.0 110.019 169.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -69.38 128.16 35.58 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.827 -1.17 . . . . 0.0 110.356 -172.671 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 4.6 tp -94.57 93.56 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -177.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -98.44 -70.95 0.71 Allowed 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 116.043 -1.932 . . . . 0.0 109.176 168.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -151.83 133.93 15.09 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 121.698 2.044 . . . . 0.0 116.102 -168.946 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -92.35 122.08 43.5 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.163 0 N-CA-C 100.306 -3.961 . . . . 0.0 100.306 160.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.475 ' HA ' ' O ' ' A' ' 160' ' ' LYS . 44.0 mt -96.91 109.93 22.55 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 115.526 -2.178 . . . . 0.0 110.429 -176.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.501 ' HB2' HD22 ' A' ' 159' ' ' LEU . 9.5 tm-20 -101.46 113.75 27.14 Favored 'General case' 0 N--CA 1.536 3.831 0 N-CA-C 120.573 3.546 . . . . 0.0 120.573 170.095 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -86.04 114.63 23.07 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 119.268 -2.145 . . . . 0.0 110.815 170.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.449 ' O ' HG23 ' A' ' 115' ' ' VAL . 79.4 ttt180 -106.18 110.26 22.45 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.39 169.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 114' ' ' ARG 0.333 1.0 OUTLIER . . . . . 0 N--CA 1.506 2.332 0 CA-C-O 124.075 1.893 . . . . 0.0 108.836 160.021 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 . . . . . 0 N--CA 1.496 1.873 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -53.01 -48.46 67.53 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 125.231 1.412 . . . . 0.0 114.606 164.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 67.1 mtt -63.6 -35.52 80.8 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 168.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -60.75 -49.21 78.4 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 116.523 2.045 . . . . 0.0 116.523 169.483 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.4 p -64.45 -38.72 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 173.648 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -54.65 -48.48 72.28 Favored 'General case' 0 CA--C 1.579 2.063 0 C-N-CA 123.958 0.903 . . . . 0.0 112.604 167.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -56.26 -34.79 66.73 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 119.333 3.086 . . . . 0.0 119.333 174.119 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.65 -45.91 88.3 Favored 'General case' 0 N--CA 1.504 2.274 0 CA-C-N 120.44 1.473 . . . . 0.0 113.958 178.384 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' GLU . . . . . 0.467 ' OE2' ' HB2' ' A' ' 91' ' ' GLU . 22.2 mt-10 -142.22 -4.76 1.01 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 120.952 3.686 . . . . 0.0 120.952 -166.308 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 38.0 m -69.12 -30.01 68.19 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 -171.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -63.76 -56.45 25.46 Favored Pre-proline 0 CA--C 1.579 2.086 0 CA-C-O 116.209 -1.853 . . . . 0.0 111.555 169.026 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -53.33 -32.88 63.45 Favored 'Trans proline' 0 CA--C 1.577 2.659 0 C-N-CA 123.454 2.769 . . . . 0.0 118.745 167.431 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -62.85 -53.96 46.16 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.877 1.271 . . . . 0.0 110.83 172.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 1.2 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 45.1 tp -60.99 -20.71 62.76 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 171.223 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -71.34 -51.58 23.47 Favored 'General case' 0 CA--C 1.562 1.42 0 CA-C-N 122.744 2.52 . . . . 0.0 113.251 164.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -63.04 -55.57 24.44 Favored 'General case' 0 CA--C 1.57 1.726 0 CA-C-N 120.559 1.527 . . . . 0.0 112.855 178.275 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -72.2 -31.88 66.28 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-O 114.591 -2.623 . . . . 0.0 112.106 177.821 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 1.2 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 36.7 ttt180 -59.32 -34.92 72.92 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 124.949 3.522 . . . . 0.0 116.864 169.544 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -66.32 -37.53 85.59 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 166.765 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -83.41 -39.99 19.9 Favored 'General case' 0 CA--C 1.581 2.16 0 N-CA-C 118.991 2.959 . . . . 0.0 118.991 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' LEU . . . . . 0.501 HD22 ' HB2' ' A' ' 112' ' ' GLU . 2.0 pp -81.48 179.26 7.92 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 120.47 3.508 . . . . 0.0 120.47 -161.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 111' ' ' LEU 0.272 83.6 tttt -154.09 103.9 2.59 Favored 'General case' 0 C--N 1.361 1.08 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 166.018 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.465 ' HB ' ' N ' ' A' ' 112' ' ' GLU 1.149 24.3 m -124.44 -151.06 0.46 Allowed 'General case' 0 CA--C 1.568 1.673 1 O-C-N 114.839 -4.913 . . . . 0.0 108.339 149.507 . . . . . . . . 4 3 . 1 . 014 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . 0.388 2.5 t -121.39 176.49 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 CA-C-O 125.008 2.337 . . . . 0.0 113.731 -150.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -101.33 116.07 31.96 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 101.504 -3.517 . . . . 0.0 101.504 164.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.408 ' HB3' ' HB ' ' A' ' 115' ' ' VAL 0.346 . . -103.9 -120.39 0.2 Allowed 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 120.865 3.654 . . . . 0.0 120.865 -147.659 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 CA--C 1.568 1.666 0 N-CA-C 118.99 2.959 . . . . 0.0 118.99 -156.07 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 . . . . . 0 N--CA 1.501 2.081 0 N-CA-C 115.833 1.79 . . . . 0.0 115.833 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -62.73 -52.55 62.81 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 173.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -54.11 -38.57 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 173.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.679 ' CE1' ' HB3' ' A' ' 19' ' ' LYS . 5.8 t80 -60.74 -38.67 85.95 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 168.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -61.13 -54.14 48.25 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 174.892 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 55.9 mtt180 -62.31 -37.67 86.48 Favored 'General case' 0 CA--C 1.555 1.136 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 173.724 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.66 -45.31 85.72 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 115.761 1.763 . . . . 0.0 115.761 168.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.35 -40.83 87.64 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 168.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 40.6 mmt180 -71.8 -32.73 67.9 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 174.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.53 -48.39 75.25 Favored 'General case' 0 CA--C 1.561 1.378 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 170.21 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 65.9 tp -71.31 -42.57 68.45 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 119.859 1.209 . . . . 0.0 113.836 168.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.736 ' O ' ' CB ' ' A' ' 181' ' ' LYS . . . 97.47 52.61 1.42 Allowed Glycine 0 CA--C 1.554 2.491 0 CA-C-O 118.634 -1.092 . . . . 0.0 113.12 -169.152 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.736 ' CB ' ' O ' ' A' ' 180' ' ' GLY . 56.3 tttp . . . . . 0 C--O 1.251 1.135 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -170.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.2 mtt . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -158.96 166.45 31.76 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 117.416 2.376 . . . . 0.0 117.416 -167.909 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 51.6 t -132.06 150.59 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-O 123.924 1.821 . . . . 0.0 112.939 -164.479 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -130.4 115.9 17.52 Favored 'General case' 0 CA--C 1.559 1.317 0 CA-C-N 112.387 -2.188 . . . . 0.0 108.221 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.758 HD21 ' HB3' ' A' ' 13' ' ' LYS . 22.9 tp -96.91 127.5 42.95 Favored 'General case' 0 CA--C 1.567 1.629 0 CA-C-O 122.873 1.321 . . . . 0.0 110.314 -173.216 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.4 mt -122.28 148.9 44.45 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 112.048 -2.342 . . . . 0.0 111.658 -169.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 163.33 151.36 6.4 Favored Glycine 0 CA--C 1.558 2.754 0 CA-C-O 118.128 -1.373 . . . . 0.0 115.684 169.545 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo . . . . . 0 CA--C 1.575 2.544 0 C-N-CA 123.792 2.995 . . . . 0.0 117.542 174.911 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.758 ' HB3' HD21 ' A' ' 5' ' ' LEU . 13.6 mptt . . . . . 0 N--CA 1.496 1.829 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -51.66 -23.5 10.26 Favored Glycine 0 CA--C 1.553 2.457 0 N-CA-C 121.045 3.178 . . . . 0.0 121.045 177.604 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 65.1 m -66.83 -54.06 26.3 Favored 'General case' 0 CA--C 1.57 1.741 0 CA-C-N 120.119 1.96 . . . . 0.0 112.276 173.136 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.28 4.0 mm-40 -79.43 -14.39 58.95 Favored 'General case' 0 CA--C 1.579 2.083 0 CA-C-O 116.018 -1.944 . . . . 0.0 111.593 174.778 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.52 -43.18 63.92 Favored 'General case' 0 C--N 1.377 1.772 0 CA-C-N 123.75 2.977 . . . . 0.0 114.585 167.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.1 t -64.37 -41.92 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 CA-C-O 117.525 -1.226 . . . . 0.0 112.322 170.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.729 ' HB3' ' CE1' ' A' ' 172' ' ' PHE . 64.1 mmtt -65.45 -40.62 93.45 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 116.326 1.973 . . . . 0.0 116.326 171.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.6 tp -67.34 -34.67 77.81 Favored 'General case' 0 CA--C 1.572 1.824 0 CA-C-N 120.031 1.287 . . . . 0.0 113.522 173.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.02 94.14 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 166.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -56.58 -38.68 72.31 Favored 'General case' 0 CA--C 1.567 1.624 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 166.412 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -69.23 -53.78 18.1 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 120.306 1.412 . . . . 0.0 114.663 173.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.4 mt -84.4 -23.52 30.02 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 117.187 2.292 . . . . 0.0 117.187 -174.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.83 36.49 7.78 Favored Glycine 0 CA--C 1.555 2.555 0 N-CA-C 117.744 1.858 . . . . 0.0 117.744 -174.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.5 mm -104.46 153.67 38.94 Favored Pre-proline 0 CA--C 1.57 1.719 0 CA-C-N 118.899 1.349 . . . . 0.0 112.487 -169.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -82.65 98.13 0.88 Allowed 'Trans proline' 0 CA--C 1.566 2.118 0 CA-C-N 122.222 1.829 . . . . 0.0 109.586 163.383 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.01 114.82 12.76 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.811 0.815 . . . . 0.0 110.266 176.179 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 25.1 mm -101.99 112.32 34.75 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.6 t -95.08 134.59 37.61 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 170.447 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.0 p -68.97 -18.32 64.05 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 117.019 2.229 . . . . 0.0 117.019 -174.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -81.5 -21.23 62.52 Favored Glycine 0 CA--C 1.545 1.919 0 N-CA-C 118.619 2.207 . . . . 0.0 118.619 167.393 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -80.47 -51.75 8.44 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -169.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -63.61 -39.57 94.7 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 174.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.417 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 12.5 m-85 -70.28 -39.51 74.87 Favored 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 172.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 47.0 ttp180 -58.97 -40.64 85.39 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 120.182 1.355 . . . . 0.0 114.301 167.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -62.51 -39.46 93.59 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 169.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -68.53 -26.56 65.5 Favored 'General case' 0 CA--C 1.578 2.026 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 168.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 88.1 mt -63.89 -45.38 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 CA-C-N 120.267 1.394 . . . . 0.0 111.063 166.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -62.59 -40.86 98.24 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 173.944 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -64.64 -45.31 87.35 Favored 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 173.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.64 68.46 0.94 Allowed Glycine 0 CA--C 1.541 1.668 0 CA-C-O 118.452 -1.193 . . . . 0.0 113.555 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.807 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 63.9 p -97.48 -41.87 7.98 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -177.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.807 ' HB2' ' O ' ' A' ' 43' ' ' THR . 76.6 mttt 97.67 -38.75 0.01 OUTLIER 'General case' 0 CA--C 1.573 1.863 0 CA-C-O 116.904 -1.522 . . . . 0.0 111.869 -170.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.02 -18.66 55.62 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 122.246 2.293 . . . . 0.0 113.42 163.497 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.72 -53.4 46.25 Favored Glycine 0 C--N 1.356 1.657 0 CA-C-N 120.366 1.439 . . . . 0.0 115.332 172.628 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.627 ' O ' ' HB2' ' A' ' 51' ' ' ARG 0.27 11.8 p -77.91 -44.1 28.44 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.649 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 -169.673 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -59.35 -52.95 63.44 Favored 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 121.072 1.76 . . . . 0.0 113.315 169.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.69 -33.25 73.64 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -176.183 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.417 ' HB2' ' HB3' ' A' ' 35' ' ' PHE . 13.2 tmtt? -75.28 -19.93 59.41 Favored 'General case' 0 CA--C 1.562 1.442 0 CA-C-O 116.915 -1.517 . . . . 0.0 113.329 166.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ARG . . . . . 0.627 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 34.5 ttt180 -76.81 -53.04 8.45 Favored 'General case' 0 CA--C 1.589 2.47 1 CA-C-O 86.371 -16.061 . . . . 0.0 118.169 -179.479 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . 0.34 0.0 OUTLIER -40.92 -61.7 0.93 Allowed 'General case' 0 N--CA 1.511 2.605 1 O-C-N 109.99 -7.944 . . . . 0.0 119.559 147.869 . . . . . . . . 4 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 61.0 mt -52.0 -31.67 30.58 Favored 'General case' 0 N--CA 1.52 3.067 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 178.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -93.46 -44.22 8.35 Favored 'General case' 0 CA--C 1.567 1.61 0 N-CA-C 116.912 2.19 . . . . 0.0 116.912 170.154 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.12 -10.56 14.66 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 119.041 2.978 . . . . 0.0 119.041 -168.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.51 42.62 9.04 Favored Glycine 0 CA--C 1.541 1.679 0 CA-C-N 122.094 2.225 . . . . 0.0 116.269 -177.345 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -91.31 -175.52 4.28 Favored 'General case' 0 CA--C 1.568 1.636 0 CA-C-O 122.24 1.019 . . . . 0.0 110.739 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 65.4 mt -103.82 104.25 14.23 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 177.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.9 t -142.55 122.04 7.83 Favored Pre-proline 0 CA--C 1.584 2.259 0 CA-C-O 117.867 -1.063 . . . . 0.0 108.141 -170.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -57.63 170.1 2.08 Favored 'Trans proline' 0 CA--C 1.567 2.153 0 C-N-CA 124.278 3.319 . . . . 0.0 119.791 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.3 m -96.13 -169.4 1.92 Allowed 'General case' 0 CA--C 1.576 1.976 0 C-N-CA 124.444 1.098 . . . . 0.0 112.995 -178.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.278 19.1 m-20 80.55 -51.01 0.33 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 126.765 2.026 . . . . 0.0 115.144 172.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.44 -39.58 76.57 Favored 'General case' 0 N--CA 1.505 2.298 0 CA-C-N 120.359 1.436 . . . . 0.0 114.667 167.813 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.3 m -60.29 -47.51 85.71 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 114.669 -1.15 . . . . 0.0 112.688 172.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.92 -27.69 69.55 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 115.774 1.768 . . . . 0.0 115.774 168.051 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -68.36 -44.48 75.13 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 120.886 1.675 . . . . 0.0 114.523 171.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.9 mt -64.41 -38.57 91.5 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 168.637 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.0 t -57.58 -53.0 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-O 117.885 -1.055 . . . . 0.0 111.998 169.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -59.63 -37.32 78.33 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 116.436 2.013 . . . . 0.0 116.436 172.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -55.8 -49.02 74.36 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 116.715 -1.612 . . . . 0.0 113.084 170.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 61.3 mtp180 -88.94 7.85 32.45 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 120.515 3.524 . . . . 0.0 120.515 167.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 63.9 mt -66.19 -49.73 66.3 Favored 'General case' 0 CA--C 1.554 1.126 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 151.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 72.3 m-80 . . . . . 0 N--CA 1.503 2.2 0 CA-C-N 121.533 1.969 . . . . 0.0 110.981 -165.595 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.402 ' HA2' ' HB3' ' A' ' 2' ' ' ARG . . . . . . . . 0 N--CA 1.477 1.401 0 CA-C-O 122.732 1.184 . . . . 0.0 115.376 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.403 ' O ' ' HB2' ' A' ' 2' ' ' ARG . 23.2 p90 -173.98 135.74 0.5 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 112.585 -1.807 . . . . 0.0 109.827 168.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 33.6 mt -113.83 108.03 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 173.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.8 mt -110.96 122.4 47.79 Favored 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 123.33 0.652 . . . . 0.0 110.2 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -116.01 116.15 27.4 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 118.394 0.543 . . . . 0.0 110.746 -169.244 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.16 28.07 35.04 Favored Glycine 0 CA--C 1.548 2.138 0 N-CA-C 117.988 1.955 . . . . 0.0 117.988 176.146 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -86.68 -57.3 0.33 Allowed Pre-proline 0 CA--C 1.572 1.81 0 CA-C-O 114.297 -2.763 . . . . 0.0 110.791 175.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -61.88 50.25 0.1 OUTLIER 'Trans proline' 0 CA--C 1.578 2.719 0 N-CA-C 120.664 3.294 . . . . 0.0 120.664 167.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 1.264 ' NH2' HH12 ' A' ' 140' ' ' ARG . 0.0 OUTLIER -80.23 7.43 9.42 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 167.721 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.5 t -155.63 135.14 12.47 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 103.221 -2.881 . . . . 0.0 103.221 170.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.0 t -61.77 -34.21 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 CA-C-O 117.287 -1.34 . . . . 0.0 111.541 176.3 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.98 -35.39 64.27 Favored 'General case' 0 CA--C 1.564 1.505 0 N-CA-C 119.624 3.194 . . . . 0.0 119.624 165.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -72.26 -48.12 45.06 Favored 'General case' 0 CA--C 1.591 2.52 0 CA-C-N 121.679 2.036 . . . . 0.0 112.087 165.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.45 -33.18 75.29 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 116.677 2.103 . . . . 0.0 116.677 -169.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.2 tttp -61.25 -27.72 68.65 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 167.043 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.82 -42.45 63.8 Favored 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 168.295 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 36.8 tp -61.62 -40.83 96.23 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 169.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 43.7 t60 -64.09 -41.24 97.37 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 120.045 1.293 . . . . 0.0 113.986 169.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.705 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 29.7 tt0 -54.55 -40.84 69.09 Favored 'General case' 0 CA--C 1.567 1.61 0 CA-C-O 117.948 -1.025 . . . . 0.0 113.608 167.573 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' MET . . . . . 1.253 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 26.3 mmt -83.36 -21.26 33.16 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 117.553 2.427 . . . . 0.0 117.553 175.637 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.6 tt -73.06 -52.39 14.51 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-N 121.437 1.926 . . . . 0.0 110.39 172.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -75.37 -55.85 5.29 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 172.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.705 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 31.8 ttm180 -69.28 -39.81 78.14 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 178.063 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 1.253 ' HB3' ' O ' ' A' ' 99' ' ' MET . 76.5 ttt180 -63.45 -56.81 13.15 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 119.464 1.029 . . . . 0.0 111.036 165.159 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.27 50.0 0.74 Allowed Glycine 0 N--CA 1.483 1.794 0 O-C-N 124.184 0.927 . . . . 0.0 113.886 168.267 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 51.3 p -91.15 150.58 21.32 Favored 'General case' 0 CA--C 1.559 1.29 0 CA-C-N 113.481 -1.36 . . . . 0.0 109.797 176.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -67.94 132.55 47.53 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.899 -0.501 . . . . 0.0 112.053 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 6.3 tp -95.07 101.74 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -95.78 -69.45 0.75 Allowed 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 116.399 -1.763 . . . . 0.0 108.796 169.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -155.33 128.64 8.33 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 121.629 2.013 . . . . 0.0 113.929 177.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 33.3 t -93.72 108.37 20.46 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.726 0 N-CA-C 102.838 -3.023 . . . . 0.0 102.838 163.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.648 HD23 ' HB2' ' A' ' 160' ' ' LYS . 86.9 mt -101.43 110.8 22.87 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.776 0.83 . . . . 0.0 110.716 -169.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -89.57 121.23 31.58 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 121.638 0.732 . . . . 0.0 109.055 172.199 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -92.61 117.05 29.57 Favored 'General case' 0 CA--C 1.557 1.227 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 175.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.494 ' HB3' ' HA ' ' A' ' 163' ' ' ASP . 19.7 tpt180 -87.55 91.48 8.75 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 112.821 -1.99 . . . . 0.0 107.31 173.668 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.4 m . . . . . 0 CA--C 1.55 0.969 0 CA-C-N 112.839 -1.982 . . . . 0.0 106.038 -165.405 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.1 t30 . . . . . 0 N--CA 1.5 2.05 0 N-CA-C 114.849 1.425 . . . . 0.0 114.849 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 1.264 HH12 ' NH2' ' A' ' 88' ' ' ARG . 12.2 mmm180 -59.77 -42.13 92.64 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 169.484 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 58.9 mtt -66.49 -31.01 71.47 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 115.543 1.682 . . . . 0.0 115.543 169.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -63.64 -49.14 74.41 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 169.411 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' VAL . . . . . 0.6 HG11 HH22 ' A' ' 88' ' ' ARG . 7.8 p -64.57 -33.41 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 169.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -56.19 -52.36 64.68 Favored 'General case' 0 CA--C 1.581 2.168 0 CA-C-N 119.559 1.072 . . . . 0.0 111.779 167.773 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 31.1 ttp180 -52.19 -31.55 32.16 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 119.427 3.121 . . . . 0.0 119.427 170.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -48.47 -51.04 28.95 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 170.75 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -140.34 7.61 2.18 Favored 'General case' 0 CA--C 1.56 1.362 0 N-CA-C 119.944 3.312 . . . . 0.0 119.944 -167.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 23.9 m -55.27 -34.41 64.03 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 116.194 1.924 . . . . 0.0 116.194 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.14 -59.92 5.71 Favored Pre-proline 0 CA--C 1.578 2.054 0 CA-C-O 116.662 -1.637 . . . . 0.0 111.881 172.678 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -50.15 -31.3 28.12 Favored 'Trans proline' 0 CA--C 1.576 2.616 0 C-N-CA 123.365 2.71 . . . . 0.0 118.374 167.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.01 -55.58 18.13 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 125.391 1.476 . . . . 0.0 112.217 175.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 1.047 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 46.1 tp -65.32 -23.51 67.03 Favored 'General case' 0 CA--C 1.564 1.511 0 CA-C-O 116.504 -1.712 . . . . 0.0 114.704 176.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -71.55 -48.95 45.25 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 122.393 2.361 . . . . 0.0 113.444 165.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -67.16 -51.6 51.71 Favored 'General case' 0 CA--C 1.566 1.57 0 CA-C-N 120.042 1.292 . . . . 0.0 112.014 -177.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -80.81 -25.3 37.9 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-O 114.715 -2.564 . . . . 0.0 112.53 178.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 1.047 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 38.1 ttt180 -64.31 -35.63 81.48 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 124.893 3.497 . . . . 0.0 115.938 168.324 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -67.94 -37.74 81.97 Favored 'General case' 0 CA--C 1.574 1.89 0 CA-C-N 119.697 1.135 . . . . 0.0 113.949 167.303 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -80.71 -38.2 29.3 Favored 'General case' 0 CA--C 1.574 1.89 0 N-CA-C 119.351 3.093 . . . . 0.0 119.351 178.385 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.3 pp -78.08 173.69 11.94 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 119.675 3.213 . . . . 0.0 119.675 -160.271 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.648 ' HB2' HD23 ' A' ' 111' ' ' LEU . 91.0 mttt -124.83 134.35 52.77 Favored 'General case' 0 CA--C 1.561 1.399 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 166.027 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 60.4 m -98.1 148.95 23.03 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 122.79 1.281 . . . . 0.0 111.222 -170.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.471 HG13 ' HG3' ' A' ' 174' ' ' ARG . 44.8 t -127.84 138.67 54.05 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.871 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 167.024 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.494 ' HA ' ' HB3' ' A' ' 114' ' ' ARG . 14.7 t70 -114.95 127.32 55.62 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 170.308 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -151.53 -159.8 1.07 Allowed 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 -160.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . 0.511 5.7 p . . . . . 0 N--CA 1.497 1.905 0 C-N-CA 129.153 2.981 . . . . 0.0 114.498 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 . . . . . 0 N--CA 1.505 2.313 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 170' ' ' GLU . . . . . 0.97 ' HB3' HH21 ' A' ' 174' ' ' ARG . 47.6 mt-10 -59.42 -42.04 90.92 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 117.294 -1.336 . . . . 0.0 114.522 175.305 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 44.4 t -56.54 -38.65 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 CA-C-N 120.991 1.723 . . . . 0.0 113.419 172.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.729 ' CE1' ' HB3' ' A' ' 19' ' ' LYS . 22.8 t80 -57.95 -40.51 80.7 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 120.796 1.635 . . . . 0.0 115.103 166.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.558 ' O ' ' HB2' ' A' ' 177' ' ' ARG . . . -61.03 -50.85 71.64 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.97 HH21 ' HB3' ' A' ' 170' ' ' GLU . 11.7 ptp180 -73.32 -25.19 60.53 Favored 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 117.582 2.438 . . . . 0.0 117.582 171.056 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.11 -49.73 73.27 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 120.346 1.43 . . . . 0.0 114.715 169.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . 0.254 0.2 OUTLIER -66.77 -37.86 85.44 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 119.531 1.06 . . . . 0.0 113.429 167.471 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 177' ' ' ARG . . . . . 0.619 ' HB2' ' HA ' ' A' ' 174' ' ' ARG . 17.3 ttt180 -43.55 -44.05 5.89 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 117.126 2.269 . . . . 0.0 117.126 167.594 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -71.13 -53.98 12.65 Favored 'General case' 0 CA--C 1.564 1.497 0 CA-C-O 118.204 -0.903 . . . . 0.0 113.208 166.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -99.05 -59.6 1.7 Allowed 'General case' 0 CA--C 1.565 1.528 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -169.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.885 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -79.39 -39.14 19.55 Favored Glycine 0 CA--C 1.55 2.276 0 CA-C-N 121.388 1.904 . . . . 0.0 117.737 -171.46 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.885 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 85.9 tttt . . . . . 0 C--O 1.251 1.142 0 CA-C-N 118.482 1.141 . . . . 0.0 108.623 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.6 mtt . . . . . 0 CA--C 1.555 1.171 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.783 HH21 HD21 ' A' ' 4' ' ' LEU . 2.4 ptm180 -160.96 162.79 32.03 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 -167.043 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.551 HG13 HG23 ' A' ' 82' ' ' ILE . 8.5 p -131.4 145.69 34.84 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.4 0 CA-C-O 123.299 1.523 . . . . 0.0 110.956 -170.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.783 HD21 HH21 ' A' ' 2' ' ' ARG . 1.2 mm? -118.12 157.07 27.57 Favored 'General case' 0 CA--C 1.562 1.442 0 CA-C-N 112.853 -1.976 . . . . 0.0 108.52 168.976 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.439 HD22 ' HG2' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -128.23 117.07 20.87 Favored 'General case' 0 CA--C 1.569 1.69 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.201 -174.042 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.0 mt -116.17 158.48 23.2 Favored 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 127.669 2.387 . . . . 0.0 111.749 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.69 118.78 0.63 Allowed Glycine 0 CA--C 1.556 2.61 0 CA-C-O 116.996 -2.002 . . . . 0.0 114.029 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo . . . . . 0 CA--C 1.584 3.002 0 CA-C-N 122.572 3.186 . . . . 0.0 114.009 169.452 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.439 ' HG2' HD22 ' A' ' 5' ' ' LEU . 37.3 mtmm . . . . . 0 N--CA 1.485 1.325 0 N-CA-C 111.434 0.161 . . . . 0.0 111.434 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -54.04 -36.87 57.21 Favored Glycine 0 CA--C 1.552 2.346 0 N-CA-C 120.87 3.108 . . . . 0.0 120.87 -173.096 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 90.0 m -68.74 -49.09 61.61 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 119.397 1.598 . . . . 0.0 113.145 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.282 25.4 mp0 -77.57 -12.06 59.93 Favored 'General case' 0 CA--C 1.574 1.886 0 CA-C-O 115.325 -2.274 . . . . 0.0 112.071 169.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.07 -45.9 58.93 Favored 'General case' 0 C--N 1.373 1.61 0 CA-C-N 124.809 3.459 . . . . 0.0 114.389 167.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.2 t -67.01 -40.95 86.65 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.766 0 CA-C-O 117.523 -1.227 . . . . 0.0 111.793 171.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -62.62 -45.23 93.83 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 116.605 2.076 . . . . 0.0 116.605 171.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.26 -32.92 73.43 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-N 120.227 1.376 . . . . 0.0 113.85 173.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.03 -40.97 97.52 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 166.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -58.17 -40.25 80.97 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 166.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.9 tptt -68.62 -54.01 19.09 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 177.139 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.9 mt -83.31 -19.86 35.46 Favored 'General case' 0 CA--C 1.57 1.739 0 N-CA-C 116.972 2.212 . . . . 0.0 116.972 178.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.48 39.89 7.55 Favored Glycine 0 CA--C 1.554 2.482 0 N-CA-C 117.543 1.777 . . . . 0.0 117.543 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.515 ' CG2' ' HA ' ' A' ' 81' ' ' PHE . 18.8 mm -110.1 157.87 36.71 Favored Pre-proline 0 CA--C 1.572 1.827 0 CA-C-N 118.531 1.166 . . . . 0.0 113.457 -168.261 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -84.49 99.79 0.76 Allowed 'Trans proline' 0 CA--C 1.568 2.182 0 CA-C-N 122.146 1.802 . . . . 0.0 110.062 163.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.26 113.66 4.75 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.448 -0.783 . . . . 0.0 111.276 172.027 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 32.3 mm -98.12 108.14 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 N-CA-C 104.501 -2.407 . . . . 0.0 104.501 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 73.9 m -95.45 128.45 42.32 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 168.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.3 p -71.27 -8.28 52.6 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 116.94 2.2 . . . . 0.0 116.94 -172.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -87.12 -21.86 47.65 Favored Glycine 0 CA--C 1.551 2.288 0 N-CA-C 118.106 2.003 . . . . 0.0 118.106 165.361 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -79.79 -51.55 9.03 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -168.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -62.09 -41.85 98.61 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 172.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.431 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 26.0 m-85 -60.73 -37.08 80.54 Favored 'General case' 0 CA--C 1.564 1.513 0 N-CA-C 116.259 1.948 . . . . 0.0 116.259 168.35 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -60.09 -42.96 95.76 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 120.017 1.28 . . . . 0.0 114.035 167.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -60.33 -38.87 85.11 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 168.105 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -66.25 -28.14 68.49 Favored 'General case' 0 CA--C 1.575 1.923 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 168.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 73.9 mt -63.73 -46.74 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 CA-C-N 120.131 1.332 . . . . 0.0 111.434 168.28 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -65.35 -36.39 83.87 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 172.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -78.38 -32.08 48.71 Favored 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.14 73.69 1.28 Allowed Glycine 0 CA--C 1.544 1.855 0 CA-C-O 118.348 -1.251 . . . . 0.0 114.884 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.843 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 68.6 p -97.62 -44.53 6.75 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 178.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.843 ' HB2' ' O ' ' A' ' 43' ' ' THR . 76.9 mttt 102.35 -39.16 0.01 OUTLIER 'General case' 0 CA--C 1.579 2.072 0 CA-C-O 117.372 -1.299 . . . . 0.0 112.202 -171.396 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -89.01 1.8 54.98 Favored 'General case' 0 CA--C 1.58 2.103 0 CA-C-N 121.805 2.093 . . . . 0.0 113.251 163.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -81.9 -54.48 3.41 Favored Glycine 0 C--N 1.349 1.299 0 O-C-N 120.761 -1.212 . . . . 0.0 114.657 169.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.303 4.0 p -75.95 -52.38 18.02 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.441 0 N-CA-C 115.073 1.509 . . . . 0.0 115.073 -168.387 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -67.19 -48.93 66.42 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 120.586 1.539 . . . . 0.0 112.307 175.235 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.81 -19.32 62.01 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.431 ' HB2' ' HB3' ' A' ' 35' ' ' PHE . 14.2 tmtt? -74.64 -47.02 34.37 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 117.111 -1.423 . . . . 0.0 111.825 165.449 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -67.71 -53.55 26.66 Favored 'General case' 0 CA--C 1.591 2.539 1 CA-C-O 86.12 -16.181 . . . . 0.0 118.001 -173.047 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 15.9 m-30 -31.62 -64.41 0.16 Allowed 'General case' 0 N--CA 1.496 1.848 1 O-C-N 110.232 -7.793 . . . . 0.0 120.803 146.216 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.5 tp -60.8 -23.97 65.46 Favored 'General case' 0 CA--C 1.579 2.095 0 CA-C-N 122.201 2.273 . . . . 0.0 116.779 172.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -92.58 -43.27 9.22 Favored 'General case' 0 CA--C 1.569 1.68 0 C-N-CA 126.332 1.853 . . . . 0.0 114.737 168.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.41 -48.01 12.47 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 120.741 1.609 . . . . 0.0 115.318 -176.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.99 41.42 0.71 Allowed Glycine 0 CA--C 1.539 1.542 0 N-CA-C 116.389 1.316 . . . . 0.0 116.389 169.383 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -105.73 -132.47 0.31 Allowed 'General case' 0 CA--C 1.572 1.802 0 CA-C-O 118.584 -0.722 . . . . 0.0 109.479 168.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.9 mt -108.23 109.95 21.44 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 120.163 1.347 . . . . 0.0 111.334 -168.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.9 p -117.11 129.49 25.29 Favored Pre-proline 0 CA--C 1.573 1.829 0 CA-C-O 117.796 -1.097 . . . . 0.0 110.225 178.593 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -60.73 145.2 99.31 Favored 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 123.475 2.783 . . . . 0.0 116.288 173.722 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 98.8 p -78.12 -45.07 24.32 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 178.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -66.82 -40.65 88.08 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 115.726 1.751 . . . . 0.0 115.726 -175.713 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.67 -43.88 97.13 Favored 'General case' 0 N--CA 1.506 2.341 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 172.219 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.3 m -61.46 -41.19 96.86 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.201 -1.363 . . . . 0.0 112.986 173.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -65.08 -26.58 68.29 Favored 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 166.74 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.41 -46.49 73.06 Favored 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 170.392 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.8 mt -60.64 -48.28 82.49 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 169.129 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 55.5 t -58.99 -52.17 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 124.024 0.93 . . . . 0.0 112.435 174.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -62.68 -31.16 72.0 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 116.344 1.979 . . . . 0.0 116.344 173.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -58.74 -42.99 90.08 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 117.558 -1.211 . . . . 0.0 113.462 169.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -81.35 -16.78 51.31 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 119.217 3.043 . . . . 0.0 119.217 168.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 88.7 mt -92.82 -17.88 23.57 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 117.067 2.247 . . . . 0.0 117.067 177.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 . . . . . 0 N--CA 1.498 1.95 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 169.17 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.445 0 CA-C-O 122.942 1.301 . . . . 0.0 114.298 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.515 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . 28.8 p90 -165.85 139.56 4.41 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 113.236 -1.482 . . . . 0.0 111.967 175.862 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.551 HG23 HG13 ' A' ' 3' ' ' VAL . 1.3 mm -101.39 110.39 28.12 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.764 0 N-CA-C 104.624 -2.361 . . . . 0.0 104.624 170.383 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.9 mt -106.09 130.22 54.03 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 174.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -128.99 117.85 21.62 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 119.206 0.912 . . . . 0.0 110.916 -166.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 76.06 36.72 40.02 Favored Glycine 0 CA--C 1.55 2.231 0 N-CA-C 118.051 1.981 . . . . 0.0 118.051 -176.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . 0.256 2.3 t80 -107.24 -66.14 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.921 0 CA-C-O 113.834 -2.984 . . . . 0.0 112.105 -176.559 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -61.79 47.97 0.09 OUTLIER 'Trans proline' 0 CA--C 1.576 2.602 0 N-CA-C 122.229 3.896 . . . . 0.0 122.229 171.155 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.42 -21.76 66.74 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 116.821 2.156 . . . . 0.0 116.821 166.547 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 36.6 t -131.14 146.84 52.5 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 -172.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -61.89 -35.78 70.02 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.724 0 CA-C-O 117.26 -1.352 . . . . 0.0 110.827 169.543 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.56 -45.66 81.14 Favored 'General case' 0 CA--C 1.559 1.323 0 N-CA-C 120.524 3.528 . . . . 0.0 120.524 168.118 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -67.32 -47.47 70.44 Favored 'General case' 0 CA--C 1.588 2.437 0 CA-C-N 122.264 2.302 . . . . 0.0 112.927 169.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.14 -33.1 73.86 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 116.405 2.002 . . . . 0.0 116.405 -169.179 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -63.46 -28.1 69.73 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 166.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.93 -46.31 62.7 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 169.013 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 22.6 tp -64.41 -37.96 89.34 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 173.718 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -68.43 -39.35 81.59 Favored 'General case' 0 CA--C 1.567 1.63 0 CA-C-N 119.695 1.134 . . . . 0.0 113.825 169.001 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.936 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 22.8 mt-10 -52.2 -41.44 62.69 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 166.654 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' MET . . . . . 1.056 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 3.3 tpt -84.09 -26.93 28.58 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 117.724 2.49 . . . . 0.0 117.724 175.478 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LEU . . . . . 0.637 HD11 ' HB ' ' A' ' 107' ' ' ILE . 30.9 tp -64.28 -55.33 22.11 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 120.214 1.37 . . . . 0.0 112.393 168.474 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -80.26 -51.68 8.62 Favored 'General case' 0 CA--C 1.562 1.42 0 CA-C-O 118.671 -0.68 . . . . 0.0 112.715 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.936 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 75.0 mtp180 -71.66 -41.06 69.19 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 176.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 1.056 ' HB3' ' O ' ' A' ' 99' ' ' MET . 0.8 OUTLIER -63.2 -55.14 27.5 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 119.759 1.163 . . . . 0.0 110.59 164.638 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.67 48.4 1.04 Allowed Glycine 0 N--CA 1.482 1.713 0 O-C-N 123.83 0.706 . . . . 0.0 113.274 169.246 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 29.7 p -99.91 163.61 12.38 Favored 'General case' 0 CA--C 1.56 1.343 0 O-C-N 124.594 0.82 . . . . 0.0 111.074 -178.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -75.56 134.78 40.64 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.64 -0.663 . . . . 0.0 111.748 -169.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.637 ' HB ' HD11 ' A' ' 100' ' ' LEU . 8.0 tp -109.64 106.05 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.42 -68.21 0.81 Allowed 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 117.446 -1.264 . . . . 0.0 107.701 167.239 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -159.87 136.83 9.34 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 120.601 1.546 . . . . 0.0 115.119 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.537 HG22 HD23 ' A' ' 4' ' ' LEU . 48.7 t -91.35 114.38 28.51 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.734 0 N-CA-C 103.733 -2.691 . . . . 0.0 103.733 162.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 84.3 mt -103.04 110.74 22.77 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.338 0.655 . . . . 0.0 111.959 -169.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -96.06 124.47 40.08 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.313 0.578 . . . . 0.0 110.849 175.581 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -92.68 123.87 36.28 Favored 'General case' 0 CA--C 1.561 1.388 0 CA-C-O 123.341 1.543 . . . . 0.0 110.147 -173.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -82.09 95.05 7.34 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 112.559 -2.109 . . . . 0.0 109.229 168.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.6 p . . . . . 0 CA--C 1.559 1.299 0 C-N-CA 125.864 1.666 . . . . 0.0 107.348 -168.579 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 139' ' ' ASN . . . . . 0.416 ' HA ' ' HD3' ' A' ' 142' ' ' LYS . 11.6 t-20 . . . . . 0 N--CA 1.499 2.018 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.01 -38.93 77.09 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 165.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 24.7 ttt -65.03 -33.12 75.28 Favored 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 168.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' LYS . . . . . 0.416 ' HD3' ' HA ' ' A' ' 139' ' ' ASN . 60.5 mtpt -59.71 -52.23 66.4 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 168.471 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 14.8 p -62.67 -36.44 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.267 0 N-CA-C 114.109 1.152 . . . . 0.0 114.109 170.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -55.31 -50.29 69.95 Favored 'General case' 0 CA--C 1.581 2.161 0 CA-C-N 120.059 1.299 . . . . 0.0 112.974 169.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -61.55 -45.29 94.8 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 117.72 2.489 . . . . 0.0 117.72 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.01 -38.36 65.04 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 117.345 2.35 . . . . 0.0 117.345 175.663 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -123.47 -35.91 2.87 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 119.534 3.161 . . . . 0.0 119.534 -165.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 86.0 m -49.31 -31.3 8.85 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 118.441 2.756 . . . . 0.0 118.441 -166.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.17 -63.04 2.66 Favored Pre-proline 0 CA--C 1.582 2.192 0 CA-C-N 121.157 1.799 . . . . 0.0 111.212 170.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -54.21 -32.1 69.21 Favored 'Trans proline' 0 CA--C 1.571 2.363 0 C-N-CA 123.4 2.734 . . . . 0.0 118.899 167.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.3 tp -71.74 -42.87 66.74 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 117.812 -1.09 . . . . 0.0 112.511 174.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 1.048 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 49.5 tp -63.56 -24.43 67.8 Favored 'General case' 0 CA--C 1.569 1.704 0 CA-C-N 120.656 1.571 . . . . 0.0 113.875 170.331 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -69.84 -49.69 50.0 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 121.829 2.104 . . . . 0.0 113.038 163.3 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -65.19 -52.31 55.68 Favored 'General case' 0 CA--C 1.564 1.49 0 CA-C-N 121.15 1.795 . . . . 0.0 112.69 -177.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -82.0 -22.52 36.48 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-O 115.128 -2.368 . . . . 0.0 112.804 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 1.048 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 40.3 ttt180 -66.07 -35.87 81.7 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 125.016 3.553 . . . . 0.0 115.653 168.061 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -68.41 -36.9 79.78 Favored 'General case' 0 CA--C 1.575 1.928 0 CA-C-N 119.673 1.124 . . . . 0.0 114.006 167.043 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -88.08 -31.98 18.97 Favored 'General case' 0 CA--C 1.575 1.914 0 N-CA-C 119.203 3.038 . . . . 0.0 119.203 -178.613 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.8 pp -79.87 174.33 11.69 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 118.412 2.745 . . . . 0.0 118.412 -162.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -133.24 137.27 46.02 Favored 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 166.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.0 t -96.34 154.28 17.35 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.341 1.067 . . . . 0.0 112.085 -175.429 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 59.5 t -127.75 142.82 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 171.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -95.3 132.28 40.48 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 168.68 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -159.49 99.26 1.44 Allowed 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 122.26 1.029 . . . . 0.0 113.317 -163.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.9 t . . . . . 0 N--CA 1.487 1.396 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 174.431 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 . . . . . 0 N--CA 1.5 2.05 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -61.55 -53.24 58.88 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 119.371 0.987 . . . . 0.0 113.28 169.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 61.6 t -57.73 -37.94 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 176.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -62.07 -33.53 74.57 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 116.45 2.019 . . . . 0.0 116.45 168.609 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -63.01 -47.28 83.77 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 171.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -61.8 -41.63 97.98 Favored 'General case' 0 CA--C 1.556 1.208 0 N-CA-C 116.676 2.102 . . . . 0.0 116.676 169.881 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.37 -42.39 91.5 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 116.212 1.931 . . . . 0.0 116.212 171.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.6 mp -65.99 -40.38 91.15 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 117.403 -1.284 . . . . 0.0 114.294 169.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 37.6 mtt180 -53.38 -43.27 67.7 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 116.442 2.015 . . . . 0.0 116.442 168.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -69.7 -41.82 74.89 Favored 'General case' 0 CA--C 1.562 1.438 0 N-CA-C 116.335 1.976 . . . . 0.0 116.335 172.858 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 6.8 tt -74.87 -57.14 4.09 Favored 'General case' 0 CA--C 1.566 1.566 0 CA-C-N 121.003 1.729 . . . . 0.0 111.729 177.044 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.643 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -117.36 -59.86 0.3 Allowed Glycine 0 CA--C 1.551 2.333 0 CA-C-O 117.621 -1.655 . . . . 0.0 114.898 -177.099 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.643 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 36.5 ttmt . . . . . 0 C--O 1.252 1.195 0 CA-C-N 120.608 2.204 . . . . 0.0 107.369 -174.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.1 mtt . . . . . 0 N--CA 1.483 1.213 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.38 165.94 31.58 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 117.744 2.498 . . . . 0.0 117.744 -165.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.65 155.56 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-O 124.044 1.878 . . . . 0.0 112.978 -165.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.7 pp -138.86 127.31 23.03 Favored 'General case' 0 CA--C 1.559 1.313 0 CA-C-N 112.618 -2.083 . . . . 0.0 108.718 168.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 tt -96.53 134.72 39.39 Favored 'General case' 0 CA--C 1.559 1.304 0 CA-C-O 122.879 1.324 . . . . 0.0 113.765 -165.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -135.26 157.41 46.97 Favored 'General case' 0 CA--C 1.56 1.335 0 CA-C-N 112.062 -2.335 . . . . 0.0 111.356 -169.729 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 156.67 135.98 2.05 Favored Glycine 0 CA--C 1.554 2.495 0 CA-C-O 117.412 -1.771 . . . . 0.0 111.905 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo . . . . . 0 CA--C 1.577 2.625 0 CA-C-N 122.789 3.294 . . . . 0.0 113.241 171.43 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.8 mptt . . . . . 0 N--CA 1.496 1.842 0 CA-C-O 120.746 0.308 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -40.94 -30.67 0.39 Allowed Glycine 0 CA--C 1.557 2.667 0 N-CA-C 121.254 3.262 . . . . 0.0 121.254 169.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.2 p -58.62 -63.04 1.43 Allowed 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 119.543 1.671 . . . . 0.0 114.507 171.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.264 5.7 mm-40 -75.28 -13.67 60.45 Favored 'General case' 0 CA--C 1.571 1.754 0 CA-C-O 116.536 -1.697 . . . . 0.0 111.432 175.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.83 -48.38 63.68 Favored 'General case' 0 C--N 1.373 1.609 0 CA-C-N 122.532 2.424 . . . . 0.0 113.946 166.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.6 t -66.43 -38.23 81.32 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.834 0 CA-C-O 117.89 -1.053 . . . . 0.0 111.931 176.32 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -63.09 -51.3 67.15 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 116.809 2.151 . . . . 0.0 116.809 169.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.04 -35.24 78.0 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-N 119.969 1.259 . . . . 0.0 114.255 174.771 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.63 -45.21 94.92 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 116.405 2.002 . . . . 0.0 116.405 169.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.43 -28.64 63.48 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 164.3 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.0 tptm -63.82 -62.8 1.41 Allowed 'General case' 0 CA--C 1.552 1.026 0 CA-C-O 116.653 -1.641 . . . . 0.0 114.745 170.211 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . 0.297 0.6 OUTLIER -83.28 -15.44 50.21 Favored 'General case' 0 N--CA 1.506 2.365 0 N-CA-C 117.006 2.225 . . . . 0.0 117.006 -178.445 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.08 42.32 4.09 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 117.024 1.57 . . . . 0.0 117.024 176.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.553 ' CD1' ' HA ' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -116.69 149.16 43.43 Favored Pre-proline 0 CA--C 1.573 1.865 0 C-N-CA 127.337 2.255 . . . . 0.0 110.776 -168.911 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.515 ' HD2' HD12 ' A' ' 26' ' ' ILE . 22.2 Cg_endo -73.97 101.71 1.43 Allowed 'Trans proline' 0 CA--C 1.583 2.958 0 C-N-CA 121.794 1.663 . . . . 0.0 113.568 159.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -57.4 119.99 7.44 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.919 -1.113 . . . . 0.0 113.817 169.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.423 HD12 HD13 ' A' ' 34' ' ' LEU . 26.2 mm -101.8 109.34 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 169.292 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.7 p -95.17 125.05 39.55 Favored 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 103.928 -2.619 . . . . 0.0 103.928 163.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 47.4 p -67.48 -12.23 59.8 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 117.14 2.274 . . . . 0.0 117.14 -168.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -85.86 -19.57 57.55 Favored Glycine 0 CA--C 1.55 2.28 0 N-CA-C 118.347 2.099 . . . . 0.0 118.347 166.376 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -79.61 -53.44 6.85 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 118.756 1.278 . . . . 0.0 114.062 -168.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.423 HD13 HD12 ' A' ' 29' ' ' ILE . 2.5 pt? -59.18 -39.22 81.87 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 172.695 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -70.14 -43.16 71.5 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 116.262 -1.828 . . . . 0.0 113.204 171.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 47.5 ttt180 -51.8 -39.84 59.4 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 116.541 2.052 . . . . 0.0 116.541 169.216 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.9 -43.49 98.74 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 113.736 1.014 . . . . 0.0 113.736 169.382 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -65.7 -24.63 67.04 Favored 'General case' 0 CA--C 1.585 2.304 0 N-CA-C 116.441 2.015 . . . . 0.0 116.441 167.397 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.9 mt -62.99 -48.96 85.51 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.381 0 CA-C-N 121.288 1.858 . . . . 0.0 109.468 166.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -61.52 -41.41 97.27 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 114.355 1.242 . . . . 0.0 114.355 175.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -65.95 -40.15 91.07 Favored 'General case' 0 CA--C 1.564 1.489 0 N-CA-C 116.571 2.063 . . . . 0.0 116.571 171.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.85 70.61 1.03 Allowed Glycine 0 CA--C 1.545 1.942 0 CA-C-O 117.901 -1.5 . . . . 0.0 114.789 -179.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.871 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 64.1 p -95.67 -50.79 4.79 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-N 119.414 1.607 . . . . 0.0 114.502 177.42 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.871 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.251 73.5 mttt 103.99 -40.98 0.01 OUTLIER 'General case' 0 CA--C 1.573 1.846 0 CA-C-O 116.303 -1.808 . . . . 0.0 111.229 -171.257 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.91 -13.99 59.48 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 123.183 2.72 . . . . 0.0 112.901 163.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.494 ' O ' ' HB3' ' A' ' 50' ' ' LYS . . . -58.56 -60.45 8.92 Favored Glycine 0 C--N 1.355 1.587 0 CA-C-N 120.725 1.602 . . . . 0.0 115.032 170.063 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.281 7.6 p -73.68 -50.63 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.323 0 N-CA-C 116.21 1.93 . . . . 0.0 116.21 -168.587 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -66.3 -46.4 77.07 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 120.352 1.433 . . . . 0.0 112.384 175.621 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.58 -30.98 68.88 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -178.092 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.494 ' HB3' ' O ' ' A' ' 46' ' ' GLY 0.27 0.6 OUTLIER -78.03 -28.21 49.01 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-O 116.827 -1.559 . . . . 0.0 114.873 170.453 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -74.06 -56.52 4.83 Favored 'General case' 0 CA--C 1.595 2.682 1 CA-C-O 87.477 -15.535 . . . . 0.0 117.314 175.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . 0.259 11.4 m-30 -24.28 -66.53 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.836 1 O-C-N 109.279 -8.388 . . . . 0.0 119.929 145.522 . . . . . . . . 3 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 41.2 mt -53.66 -38.34 64.04 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-N 121.296 1.862 . . . . 0.0 115.735 171.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -80.37 -52.98 7.04 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-O 116.799 -1.572 . . . . 0.0 113.634 170.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -158.42 43.86 0.29 Allowed 'General case' 0 CA--C 1.574 1.87 0 CA-C-N 120.909 1.686 . . . . 0.0 115.463 -168.714 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -151.17 27.26 1.0 Allowed Glycine 0 CA--C 1.549 2.174 0 CA-C-N 121.942 2.155 . . . . 0.0 118.443 173.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . 0.318 9.1 t70 76.37 -118.46 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 120.034 1.917 . . . . 0.0 111.127 166.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 86.3 mt -75.6 114.48 14.22 Favored 'General case' 0 CA--C 1.559 1.317 0 N-CA-C 115.308 1.596 . . . . 0.0 115.308 -164.736 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.5 p -118.06 138.29 25.34 Favored Pre-proline 0 CA--C 1.573 1.845 0 C-N-CA 126.089 1.755 . . . . 0.0 108.529 174.61 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -56.46 135.46 70.39 Favored 'Trans proline' 0 CA--C 1.56 1.807 0 C-N-CA 123.373 2.715 . . . . 0.0 116.191 173.354 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.6 m -70.38 -48.11 57.77 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -60.5 -43.55 96.91 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 26.4 mt -56.59 -46.82 80.61 Favored 'General case' 0 N--CA 1.509 2.483 0 N-CA-C 116.393 1.998 . . . . 0.0 116.393 175.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.1 m -58.33 -44.54 88.72 Favored 'General case' 0 CA--C 1.565 1.529 0 CA-C-N 113.022 -1.899 . . . . 0.0 113.211 173.254 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -61.01 -33.25 72.97 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 166.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.35 -43.97 84.54 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 175.586 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.2 mt -64.24 -44.8 90.7 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 168.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 54.9 t -59.09 -50.24 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 CA-C-O 118.125 -0.94 . . . . 0.0 113.073 172.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -63.0 -35.46 80.29 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 174.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -56.4 -40.23 74.31 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 118.113 -0.946 . . . . 0.0 113.31 169.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.632 HH22 ' HG ' ' A' ' 83' ' ' LEU . 0.2 OUTLIER -67.62 -45.38 75.59 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 165.616 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 83.7 mt -68.83 -7.03 30.55 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 118.12 2.637 . . . . 0.0 118.12 -178.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 . . . . . 0 CA--C 1.582 2.193 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 165.455 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.567 0 N-CA-C 116.614 1.405 . . . . 0.0 116.614 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.553 ' HA ' ' CD1' ' A' ' 26' ' ' ILE 0.311 18.9 p90 -170.09 134.42 1.25 Allowed 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 114.747 -0.726 . . . . 0.0 112.064 168.53 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.1 mp -109.98 109.16 27.4 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.537 0 N-CA-C 104.134 -2.543 . . . . 0.0 104.134 168.197 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.632 ' HG ' HH22 ' A' ' 71' ' ' ARG . 10.2 mt -105.76 110.49 22.81 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.487 0.715 . . . . 0.0 109.752 169.331 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -103.73 130.65 51.26 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 118.511 0.596 . . . . 0.0 112.59 -173.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.58 40.32 98.55 Favored Glycine 0 CA--C 1.548 2.146 0 CA-C-O 116.867 -2.074 . . . . 0.0 116.274 -176.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -89.06 -54.27 0.33 Allowed Pre-proline 0 N--CA 1.502 2.172 0 CA-C-N 120.794 2.297 . . . . 0.0 108.205 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -61.18 60.03 0.1 Allowed 'Trans proline' 0 CA--C 1.576 2.588 0 N-CA-C 121.909 3.773 . . . . 0.0 121.909 167.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -56.36 -33.97 66.19 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 163.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.6 t -155.23 158.39 38.78 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -174.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 23.9 t -68.9 -31.57 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 CA-C-O 116.689 -1.624 . . . . 0.0 111.118 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.83 -39.16 76.99 Favored 'General case' 0 CA--C 1.56 1.363 0 N-CA-C 120.133 3.383 . . . . 0.0 120.133 167.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -72.25 -46.35 56.34 Favored 'General case' 0 CA--C 1.592 2.591 0 CA-C-N 122.505 2.411 . . . . 0.0 112.777 167.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.69 -34.79 78.64 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 127.2 2.2 . . . . 0.0 116.178 -168.933 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 57.9 tttt -61.41 -29.66 70.07 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 166.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.12 -36.77 72.25 Favored 'General case' 0 CA--C 1.568 1.651 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 168.288 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.7 tp -63.14 -38.29 90.59 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 168.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 31.5 t60 -63.67 -47.26 81.99 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 119.818 1.19 . . . . 0.0 112.973 168.529 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.919 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 34.4 mt-10 -52.02 -31.01 27.83 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 165.724 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' MET . . . . . 1.213 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 23.1 ttt -84.74 -31.58 23.93 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 117.578 2.436 . . . . 0.0 117.578 175.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.6 mt -64.34 -55.88 18.19 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 121.948 2.158 . . . . 0.0 110.927 167.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -76.83 -51.62 10.98 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.919 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 36.5 ttm180 -74.06 -38.51 63.93 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 115.154 1.539 . . . . 0.0 115.154 176.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 1.213 ' HB3' ' O ' ' A' ' 99' ' ' MET . 25.4 tpt180 -62.74 -54.51 38.09 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 119.986 1.266 . . . . 0.0 112.081 166.359 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 114.07 44.64 0.73 Allowed Glycine 0 N--CA 1.479 1.51 0 O-C-N 123.971 0.794 . . . . 0.0 113.76 168.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 31.3 p -116.23 135.33 53.99 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 177.432 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -65.88 135.45 54.82 Favored 'General case' 0 N--CA 1.508 2.465 0 CA-C-O 122.601 1.191 . . . . 0.0 112.435 -170.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.5 tp -84.28 99.49 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 CA-C-N 113.262 -1.79 . . . . 0.0 107.04 178.03 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -97.75 -68.37 0.8 Allowed 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 116.947 -1.501 . . . . 0.0 110.175 169.053 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -138.02 116.06 11.68 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 120.44 1.473 . . . . 0.0 114.544 -167.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 72.8 t -91.53 117.64 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 101.176 -3.638 . . . . 0.0 101.176 163.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.474 ' HA ' ' O ' ' A' ' 160' ' ' LYS 0.259 6.8 tp -116.16 109.59 17.67 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 114.804 -2.522 . . . . 0.0 115.2 -159.545 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.44 ' N ' ' HB ' ' A' ' 161' ' ' THR . 3.0 tm-20 -110.23 109.5 20.0 Favored 'General case' 0 N--CA 1.517 2.908 0 CA-C-N 123.856 3.025 . . . . 0.0 117.998 -177.14 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -87.85 123.51 32.69 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 125.667 1.587 . . . . 0.0 110.647 170.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -92.76 101.03 13.41 Favored 'General case' 0 CA--C 1.558 1.271 0 CA-C-N 112.543 -2.117 . . . . 0.0 109.312 169.47 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.5 p . . . . . 0 CA--C 1.563 1.446 0 C-N-CA 127.279 2.232 . . . . 0.0 107.894 -167.985 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 . . . . . 0 N--CA 1.497 1.891 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 69.2 mtp180 -60.43 -41.86 94.89 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 169.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 62.5 mtt -65.53 -34.18 77.65 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 169.06 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -64.48 -46.35 83.41 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 170.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.6 p -65.74 -32.95 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 170.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -56.73 -53.13 61.25 Favored 'General case' 0 CA--C 1.581 2.158 0 CA-C-N 119.782 1.173 . . . . 0.0 111.71 167.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 41.3 ttt180 -53.34 -22.75 7.81 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 120.37 3.47 . . . . 0.0 120.37 169.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.37 -56.81 13.67 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-N 119.858 1.208 . . . . 0.0 113.308 169.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -141.99 23.08 2.07 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 118.639 2.829 . . . . 0.0 118.639 -171.679 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 20.9 m -56.25 -30.26 62.16 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 116.124 1.898 . . . . 0.0 116.124 170.719 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.464 ' HB3' ' HD3' ' A' ' 150' ' ' PRO . . . -68.0 -60.41 5.26 Favored Pre-proline 0 CA--C 1.583 2.234 0 CA-C-N 120.68 1.582 . . . . 0.0 111.227 169.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.464 ' HD3' ' HB3' ' A' ' 149' ' ' ALA . 75.9 Cg_exo -53.03 -27.93 38.26 Favored 'Trans proline' 0 CA--C 1.568 2.194 0 N-CA-C 119.614 2.89 . . . . 0.0 119.614 168.443 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 8.2 tt -70.85 -55.58 8.19 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 116.876 -1.535 . . . . 0.0 109.751 172.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 0.942 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 39.5 tp -58.43 -26.47 63.34 Favored 'General case' 0 CA--C 1.564 1.515 0 CA-C-N 121.211 1.823 . . . . 0.0 113.962 -179.044 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -71.53 -48.02 51.41 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 121.635 2.016 . . . . 0.0 113.409 163.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -69.92 -49.37 52.7 Favored 'General case' 0 CA--C 1.571 1.764 0 CA-C-N 121.591 1.996 . . . . 0.0 112.548 -175.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -82.16 -27.06 32.9 Favored 'General case' 0 CA--C 1.557 1.234 0 CA-C-O 115.215 -2.326 . . . . 0.0 111.437 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 0.942 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 40.8 ttt180 -67.0 -32.66 74.04 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 124.926 3.512 . . . . 0.0 115.723 167.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -67.89 -41.57 82.53 Favored 'General case' 0 CA--C 1.573 1.833 0 CA-C-N 119.713 1.142 . . . . 0.0 113.458 167.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -90.96 -28.47 18.02 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 119.675 3.213 . . . . 0.0 119.675 -176.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.8 pp -80.54 159.36 25.51 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 118.297 2.703 . . . . 0.0 118.297 -162.319 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 111' ' ' LEU 0.296 97.6 mttt -145.48 101.1 3.54 Favored 'General case' 0 C--N 1.361 1.072 0 CA-C-O 117.748 -1.12 . . . . 0.0 110.791 162.915 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.44 ' HB ' ' N ' ' A' ' 112' ' ' GLU 1.254 24.4 m -131.44 -153.31 0.55 Allowed 'General case' 0 CA--C 1.573 1.856 1 O-C-N 115.74 -4.35 . . . . 0.0 110.059 149.926 . . . . . . . . 4 3 . 1 . 017 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . 0.361 4.6 t -124.53 -177.81 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.413 0 CA-C-N 111.973 -2.376 . . . . 0.0 112.976 -151.047 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -112.18 123.36 50.11 Favored 'General case' 0 CA--C 1.564 1.491 0 CA-C-N 111.324 -2.671 . . . . 0.0 104.47 166.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -160.5 122.59 3.19 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.295 0.638 . . . . 0.0 110.546 -161.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.1 t . . . . . 0 N--CA 1.487 1.378 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.754 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 . . . . . 0 N--CA 1.5 2.04 0 N-CA-C 116.126 1.898 . . . . 0.0 116.126 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -60.82 -51.82 67.71 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 170.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 87.5 t -58.81 -35.25 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 CA-C-O 117.311 -1.328 . . . . 0.0 113.949 176.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -60.07 -37.96 81.46 Favored 'General case' 0 N--CA 1.504 2.257 0 CA-C-N 121.262 1.846 . . . . 0.0 115.953 166.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -61.12 -53.55 55.69 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 175.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -56.42 -41.32 76.17 Favored 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 117.478 2.399 . . . . 0.0 117.478 169.138 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -53.28 -46.29 69.22 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 116.172 1.915 . . . . 0.0 116.172 169.24 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.7 mp -60.97 -44.99 96.54 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 117.388 -1.291 . . . . 0.0 113.962 168.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -50.66 -42.23 56.33 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 169.909 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -67.08 -45.17 78.11 Favored 'General case' 0 CA--C 1.561 1.369 0 N-CA-C 116.153 1.908 . . . . 0.0 116.153 171.257 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 6.6 tt -77.52 -55.15 5.62 Favored 'General case' 0 CA--C 1.568 1.665 0 CA-C-N 121.051 1.75 . . . . 0.0 112.38 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.817 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -130.7 -55.5 0.09 OUTLIER Glycine 0 CA--C 1.553 2.427 0 CA-C-O 117.628 -1.651 . . . . 0.0 115.807 -175.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.817 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 86.3 tttt . . . . . 0 C--O 1.251 1.153 0 CA-C-N 120.533 2.167 . . . . 0.0 108.874 -175.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.5 mtt . . . . . 0 CA--C 1.557 1.219 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.78 169.54 21.41 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 117.612 2.449 . . . . 0.0 117.612 -167.224 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.427 HG13 ' HA ' ' A' ' 82' ' ' ILE . 7.9 p -127.94 138.43 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 CA-C-N 115.116 -0.947 . . . . 0.0 113.532 -165.405 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -118.02 120.46 37.85 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 171.008 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.475 HD13 ' HB2' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -99.02 121.78 41.41 Favored 'General case' 0 CA--C 1.563 1.453 0 CA-C-O 122.376 1.084 . . . . 0.0 112.538 -167.484 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.4 mt -114.23 154.11 28.47 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 111.042 -2.799 . . . . 0.0 109.333 -172.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 175.24 107.9 0.21 Allowed Glycine 0 CA--C 1.549 2.178 0 CA-C-O 116.694 -2.17 . . . . 0.0 109.48 175.203 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo . . . . . 0 CA--C 1.574 2.525 0 CA-C-N 122.247 3.024 . . . . 0.0 117.863 -179.342 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt . . . . . 0 N--CA 1.488 1.454 0 N-CA-C 116.367 1.988 . . . . 0.0 116.367 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -32.59 -36.65 0.04 OUTLIER Glycine 0 CA--C 1.556 2.62 0 N-CA-C 122.877 3.911 . . . . 0.0 122.877 172.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.0 m -62.63 -56.26 19.48 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 120.069 1.934 . . . . 0.0 112.664 174.059 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.277 17.1 mp0 -74.55 -12.25 60.42 Favored 'General case' 0 CA--C 1.574 1.889 0 CA-C-O 115.427 -2.225 . . . . 0.0 112.655 170.194 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.475 ' HB2' HD13 ' A' ' 5' ' ' LEU . . . -69.67 -45.27 68.76 Favored 'General case' 0 C--N 1.374 1.664 0 CA-C-N 124.506 3.321 . . . . 0.0 114.513 167.249 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.7 t -69.95 -38.71 76.19 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.849 0 CA-C-O 117.672 -1.156 . . . . 0.0 111.569 174.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -61.33 -47.21 86.94 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 116.6 2.074 . . . . 0.0 116.6 169.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 mt -65.62 -31.08 71.92 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 172.408 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.97 -44.25 97.62 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 166.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -58.69 -37.69 76.63 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 168.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -67.1 -50.94 59.86 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 172.223 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.6 mt -83.69 -19.83 34.59 Favored 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 -177.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.97 36.11 10.52 Favored Glycine 0 CA--C 1.555 2.548 0 N-CA-C 117.889 1.915 . . . . 0.0 117.889 -177.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.4 mm -111.53 158.11 37.31 Favored Pre-proline 0 CA--C 1.572 1.796 0 CA-C-N 119.088 1.444 . . . . 0.0 113.811 -167.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -81.81 100.58 1.1 Allowed 'Trans proline' 0 CA--C 1.573 2.436 0 C-N-CA 122.115 1.876 . . . . 0.0 111.081 162.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -64.47 110.59 2.34 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 124.074 0.949 . . . . 0.0 111.887 171.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.7 mm -99.71 113.6 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 177.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 78.9 p -96.43 136.04 37.47 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 114.942 -1.026 . . . . 0.0 108.691 169.247 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.0 p -69.73 -7.88 43.23 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 117.585 2.439 . . . . 0.0 117.585 -175.221 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -90.43 -22.61 33.93 Favored Glycine 0 CA--C 1.545 1.937 0 N-CA-C 118.563 2.185 . . . . 0.0 118.563 165.828 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -80.74 -51.86 8.18 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -168.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -63.53 -41.44 98.48 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 173.57 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.488 ' HB3' ' CG ' ' A' ' 50' ' ' LYS . 29.6 m-85 -61.13 -43.4 98.94 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-O 116.431 -1.747 . . . . 0.0 115.136 168.516 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 72.8 ttt180 -54.97 -44.02 74.04 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 170.331 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 33.7 ttt180 -59.47 -40.98 88.67 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 114.668 1.358 . . . . 0.0 114.668 168.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -68.33 -24.19 64.8 Favored 'General case' 0 CA--C 1.582 2.188 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 169.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 82.5 mt -63.03 -49.49 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 CA-C-N 120.835 1.652 . . . . 0.0 110.299 167.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -65.26 -35.29 80.58 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 175.035 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -68.72 -42.8 77.17 Favored 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 174.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.45 69.4 1.27 Allowed Glycine 0 CA--C 1.545 1.947 0 CA-C-O 118.905 -0.942 . . . . 0.0 114.518 -174.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.866 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 64.8 p -91.52 -49.09 6.5 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 178.437 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.866 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.26 38.8 mttp 110.61 -42.37 0.0 OUTLIER 'General case' 0 CA--C 1.57 1.716 0 CA-C-O 116.135 -1.888 . . . . 0.0 110.876 -172.718 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -83.08 -10.86 58.48 Favored 'General case' 0 CA--C 1.574 1.872 0 CA-C-N 123.425 2.83 . . . . 0.0 113.106 162.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.37 -55.32 24.08 Favored Glycine 0 CA--C 1.544 1.853 0 CA-C-N 120.535 1.516 . . . . 0.0 114.276 169.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.267 1.0 OUTLIER -75.62 -50.21 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 116.729 2.122 . . . . 0.0 116.729 -168.556 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -67.16 -41.4 86.08 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 120.476 1.489 . . . . 0.0 112.565 174.495 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.88 -25.47 48.59 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -174.505 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.488 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -75.0 -41.01 60.34 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 117.064 -1.446 . . . . 0.0 111.871 166.699 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -71.63 -51.32 23.78 Favored 'General case' 0 CA--C 1.591 2.536 1 CA-C-O 85.298 -16.572 . . . . 0.0 118.444 -176.282 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 14.9 m-30 -35.25 -55.4 0.63 Allowed 'General case' 0 N--CA 1.496 1.844 2 O-C-N 108.913 -8.617 . . . . 0.0 121.85 147.209 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 71.6 mt -60.83 -32.77 72.14 Favored 'General case' 0 N--CA 1.51 2.571 0 CA-C-N 124.283 3.22 . . . . 0.0 114.799 167.917 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -83.09 -45.25 14.21 Favored 'General case' 0 CA--C 1.568 1.663 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 172.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.15 -28.23 25.67 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 116.81 2.152 . . . . 0.0 116.81 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.64 42.59 4.76 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-N 120.243 1.383 . . . . 0.0 115.952 170.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.423 ' O ' ' NH1' ' A' ' 88' ' ' ARG . 20.2 t70 -105.17 -132.53 0.31 Allowed 'General case' 0 CA--C 1.571 1.75 0 CA-C-O 118.532 -0.747 . . . . 0.0 109.548 169.328 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 88.8 mt -115.15 111.91 21.73 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 120.054 1.297 . . . . 0.0 110.192 -169.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.1 p -112.74 116.91 47.37 Favored Pre-proline 0 CA--C 1.568 1.651 0 CA-C-O 117.848 -1.072 . . . . 0.0 109.26 -178.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -59.64 144.24 99.48 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 123.477 2.785 . . . . 0.0 116.354 176.15 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 85.5 p -77.97 178.28 7.61 Favored 'General case' 0 CA--C 1.567 1.604 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 176.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.27 16.8 m-20 80.33 -51.53 0.35 Allowed 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 126.324 1.85 . . . . 0.0 113.998 175.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.9 pp -61.91 -42.46 99.1 Favored 'General case' 0 CA--C 1.563 1.459 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 167.249 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.2 m -61.43 -50.51 72.5 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.331 1.052 . . . . 0.0 112.805 174.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -64.41 -21.06 66.52 Favored 'General case' 0 CA--C 1.571 1.783 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 167.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -68.52 -47.11 67.8 Favored 'General case' 0 CA--C 1.557 1.234 0 CA-C-N 120.507 1.503 . . . . 0.0 114.0 168.707 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.9 mt -63.1 -37.74 88.42 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 168.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 56.7 t -58.39 -53.21 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-O 118.08 -0.962 . . . . 0.0 112.059 169.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -60.37 -36.17 77.42 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 172.82 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -56.61 -48.4 77.53 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 116.642 -1.646 . . . . 0.0 113.097 169.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -87.61 7.53 29.34 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 120.666 3.58 . . . . 0.0 120.666 167.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 69.9 mt -66.44 -49.38 66.92 Favored 'General case' 0 CA--C 1.559 1.296 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 150.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 . . . . . 0 N--CA 1.504 2.258 0 CA-C-N 121.267 1.848 . . . . 0.0 111.535 -167.409 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.551 0 CA-C-O 122.409 1.005 . . . . 0.0 114.061 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -175.83 136.95 0.33 Allowed 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 114.205 -0.998 . . . . 0.0 110.849 -176.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.427 ' HA ' HG13 ' A' ' 3' ' ' VAL . 4.9 mm -108.97 107.89 23.97 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.489 0 N-CA-C 103.224 -2.88 . . . . 0.0 103.224 167.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 79.5 mt -114.62 118.02 32.52 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -178.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -114.54 132.34 56.35 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 118.927 0.785 . . . . 0.0 112.398 -169.604 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 75.56 36.06 44.78 Favored Glycine 0 CA--C 1.55 2.265 0 N-CA-C 118.803 2.281 . . . . 0.0 118.803 172.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -99.65 -58.52 0.13 Allowed Pre-proline 0 N--CA 1.495 1.787 0 CA-C-O 113.536 -3.126 . . . . 0.0 111.479 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -59.66 61.5 0.07 OUTLIER 'Trans proline' 0 CA--C 1.574 2.492 1 N-CA-C 123.141 4.247 . . . . 0.0 123.141 170.487 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 1.427 ' CG ' HH12 ' A' ' 140' ' ' ARG . 13.9 ttp180 -52.01 -39.68 59.83 Favored 'General case' 0 CA--C 1.573 1.859 0 N-CA-C 116.124 1.898 . . . . 0.0 116.124 163.418 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.3 t -154.97 153.7 31.45 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.156 1.383 . . . . 0.0 107.636 -168.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.2 t -60.16 -37.5 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 CA-C-O 117.167 -1.397 . . . . 0.0 112.188 177.609 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.96 -37.02 80.93 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 120.596 3.554 . . . . 0.0 120.596 172.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -77.81 -46.77 20.58 Favored 'General case' 0 CA--C 1.588 2.418 0 CA-C-N 123.468 2.849 . . . . 0.0 111.635 166.397 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.16 -32.87 72.6 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 117.999 2.592 . . . . 0.0 117.999 -172.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -57.54 -33.54 68.21 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 168.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.77 -39.88 88.01 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 170.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 39.2 tp -64.62 -40.11 94.9 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 169.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -60.24 -53.06 62.22 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-N 119.715 1.143 . . . . 0.0 113.37 170.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 0.923 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 35.6 mt-10 -48.01 -38.47 17.15 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 167.373 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' MET . . . . . 1.216 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 25.0 ttt -84.38 -25.21 29.28 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 117.825 2.528 . . . . 0.0 117.825 176.737 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 41.9 tp -68.38 -53.7 22.12 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-N 120.59 1.541 . . . . 0.0 110.912 169.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -76.33 -54.4 6.81 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 119.37 0.987 . . . . 0.0 113.416 175.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.923 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 75.9 mtp180 -71.6 -39.39 70.53 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 177.473 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 1.216 ' HB3' ' O ' ' A' ' 99' ' ' MET . 3.6 tmt_? -61.78 -56.02 23.95 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 119.699 1.136 . . . . 0.0 110.375 164.787 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 113.26 41.63 0.96 Allowed Glycine 0 N--CA 1.481 1.692 0 O-C-N 124.076 0.86 . . . . 0.0 114.96 167.546 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 36.5 p -102.13 137.6 40.19 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 169.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -71.14 135.28 47.54 Favored 'General case' 0 N--CA 1.51 2.55 0 CA-C-O 122.699 1.238 . . . . 0.0 112.293 -171.252 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.2 tp -79.68 102.25 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 CA-C-N 113.356 -1.747 . . . . 0.0 108.089 172.773 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -96.08 -61.8 1.38 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 117.301 -1.333 . . . . 0.0 110.428 167.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -150.55 112.3 4.5 Favored 'General case' 0 C--N 1.36 1.024 0 CA-C-N 120.309 1.413 . . . . 0.0 113.707 -166.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -97.17 104.67 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.678 0 CA-C-N 115.085 -0.962 . . . . 0.0 111.0 167.805 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.946 HD12 ' HB3' ' A' ' 160' ' ' LYS 0.311 6.9 tp -103.49 111.23 23.58 Favored 'General case' 0 CA--C 1.556 1.201 0 N-CA-C 118.446 2.758 . . . . 0.0 118.446 -157.073 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.465 ' H ' ' N ' ' A' ' 161' ' ' THR . 68.0 mt-10 -96.72 107.47 19.94 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 122.062 2.21 . . . . 0.0 115.528 -172.161 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -88.0 108.93 19.45 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 118.706 -2.496 . . . . 0.0 108.324 170.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.681 ' HB3' ' HA ' ' A' ' 163' ' ' ASP . 10.1 tpt180 -95.18 95.14 8.34 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 112.575 -2.102 . . . . 0.0 110.359 -172.676 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.564 1.483 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 -168.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 . . . . . 0 N--CA 1.496 1.86 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 140' ' ' ARG . . . . . 1.427 HH12 ' CG ' ' A' ' 88' ' ' ARG . 14.6 tpt180 -63.39 -43.7 96.81 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 169.686 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 67.4 mtt -66.04 -27.77 68.35 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 169.021 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -68.05 -44.56 76.11 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 169.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.5 p -66.06 -35.77 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 CA-C-N 120.514 1.507 . . . . 0.0 114.251 170.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -53.35 -56.33 17.61 Favored 'General case' 0 CA--C 1.581 2.151 0 CA-C-N 120.129 1.331 . . . . 0.0 111.522 167.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 49.9 ttt180 -53.88 -27.59 31.16 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 120.326 3.454 . . . . 0.0 120.326 173.091 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -54.61 -38.25 66.56 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 171.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -141.33 10.03 2.08 Favored 'General case' 0 CA--C 1.561 1.38 0 N-CA-C 119.389 3.107 . . . . 0.0 119.389 -168.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 80.3 m -47.49 -36.49 10.29 Favored 'General case' 0 N--CA 1.505 2.321 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 177.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.62 -60.95 4.13 Favored Pre-proline 0 CA--C 1.578 2.054 0 CA-C-O 116.254 -1.831 . . . . 0.0 112.021 173.39 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -51.07 -32.9 41.02 Favored 'Trans proline' 0 CA--C 1.578 2.689 0 C-N-CA 123.407 2.738 . . . . 0.0 118.351 167.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -67.08 -50.45 61.66 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 125.02 1.328 . . . . 0.0 111.797 176.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 1.188 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 58.3 tp -63.26 -23.53 67.46 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 170.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -70.41 -50.92 33.55 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 122.696 2.498 . . . . 0.0 113.108 165.824 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -61.27 -53.75 52.78 Favored 'General case' 0 CA--C 1.571 1.788 0 C-N-CA 124.141 0.976 . . . . 0.0 112.864 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -80.87 -17.62 50.05 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-O 116.006 -1.949 . . . . 0.0 113.82 177.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 1.188 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 31.7 ttt180 -69.66 -33.86 73.19 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 123.591 2.905 . . . . 0.0 115.733 167.212 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -73.11 -40.47 64.93 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 119.979 1.263 . . . . 0.0 113.659 167.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -82.14 -18.05 44.23 Favored 'General case' 0 CA--C 1.577 1.985 0 N-CA-C 119.142 3.016 . . . . 0.0 119.142 177.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.29 127.19 18.89 Favored 'General case' 0 CA--C 1.585 2.309 1 N-CA-C 123.692 4.701 . . . . 0.0 123.692 -159.754 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.946 ' HB3' HD12 ' A' ' 111' ' ' LEU 0.257 46.7 mmtm -92.88 -154.15 0.38 Allowed 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 123.716 1.722 . . . . 0.0 107.708 155.385 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.627 HG23 ' HB ' ' A' ' 162' ' ' VAL 0.763 0.4 OUTLIER -30.93 -164.83 0.0 OUTLIER 'General case' 0 CA--C 1.62 3.663 1 N-CA-C 128.041 6.312 . . . . 0.0 128.041 -146.103 . . . . . . . . 5 4 . 1 . 018 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.747 HG21 ' HB3' ' A' ' 174' ' ' ARG 0.475 2.1 t -88.4 -174.42 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.673 3 C-N-CA 139.219 7.008 . . . . 0.0 122.586 -146.687 . . . . . . . . 4 3 . 1 . 018 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.681 ' HA ' ' HB3' ' A' ' 114' ' ' ARG . 12.6 t70 -102.49 134.77 45.28 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 111.38 -2.645 . . . . 0.0 106.59 168.455 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -143.37 -146.03 0.18 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 117.057 2.243 . . . . 0.0 117.057 -155.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . 0.532 3.5 p . . . . . 0 N--CA 1.492 1.66 0 C-N-CA 128.503 2.721 . . . . 0.0 114.078 -174.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 . . . . . 0 N--CA 1.5 2.05 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -60.16 -53.4 58.22 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 173.197 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 18.2 t -66.71 -31.67 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 CA-C-N 119.778 1.172 . . . . 0.0 111.533 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -58.78 -38.17 77.92 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 164.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.46 -50.69 64.43 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' ARG . . . . . 0.747 ' HB3' HG21 ' A' ' 162' ' ' VAL . 72.9 mtt180 -61.15 -42.18 98.09 Favored 'General case' 0 CA--C 1.557 1.216 0 N-CA-C 117.305 2.335 . . . . 0.0 117.305 169.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.04 -46.87 82.09 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 116.512 2.042 . . . . 0.0 116.512 172.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 6.0 mp -63.5 -39.49 94.57 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 117.832 -1.08 . . . . 0.0 113.756 168.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -50.42 -45.81 56.02 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 169.267 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -74.57 -42.83 58.05 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 116.14 1.904 . . . . 0.0 116.14 172.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 8.7 tt -73.57 -51.47 16.81 Favored 'General case' 0 CA--C 1.568 1.645 0 CA-C-N 121.005 1.73 . . . . 0.0 113.213 -179.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.923 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -114.74 -59.52 0.37 Allowed Glycine 0 CA--C 1.552 2.385 0 CA-C-O 117.709 -1.606 . . . . 0.0 114.507 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.923 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 63.7 tttm . . . . . 0 C--O 1.25 1.112 0 CA-C-N 120.391 2.096 . . . . 0.0 109.144 -177.007 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 CA--C 1.554 1.119 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.427 ' HB2' ' O ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -154.35 171.06 19.9 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -167.548 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . 0.413 HG22 ' HB3' ' A' ' 109' ' ' ALA . 77.8 t -133.9 147.86 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.66 0 CA-C-O 124.316 2.008 . . . . 0.0 111.883 -164.297 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -119.21 140.47 50.16 Favored 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 111.783 -2.462 . . . . 0.0 105.522 167.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -115.84 123.51 48.35 Favored 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 124.906 1.283 . . . . 0.0 109.81 -178.05 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.8 mp -126.17 157.07 39.11 Favored 'General case' 0 CA--C 1.559 1.304 0 CA-C-N 112.627 -2.079 . . . . 0.0 109.748 -166.182 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 167.96 154.31 8.64 Favored Glycine 0 CA--C 1.554 2.504 0 N-CA-C 115.494 0.957 . . . . 0.0 115.494 169.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo . . . . . 0 CA--C 1.576 2.576 0 C-N-CA 123.173 2.582 . . . . 0.0 114.195 173.484 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.813 ' HB3' ' OD1' ' A' ' 84' ' ' ASP . 7.7 mptt . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 121.28 0.562 . . . . 0.0 111.1 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -53.01 -27.34 29.86 Favored Glycine 0 CA--C 1.556 2.612 0 N-CA-C 120.952 3.141 . . . . 0.0 120.952 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 51.7 m -63.64 -51.44 65.18 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 119.892 1.846 . . . . 0.0 112.964 171.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.34 2.7 mp0 -77.91 -12.92 60.02 Favored 'General case' 0 CA--C 1.57 1.713 0 CA-C-O 115.088 -2.387 . . . . 0.0 112.537 172.499 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.43 -43.76 63.37 Favored 'General case' 0 C--N 1.376 1.733 0 CA-C-N 124.598 3.363 . . . . 0.0 114.142 165.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 93.4 t -65.74 -42.7 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-O 117.677 -1.154 . . . . 0.0 112.655 173.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LYS . . . . . 0.445 ' HB3' ' HE1' ' A' ' 172' ' ' PHE . 95.1 mttt -68.01 -44.35 76.75 Favored 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 115.797 1.777 . . . . 0.0 115.797 174.906 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.88 -29.08 68.89 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 120.58 1.536 . . . . 0.0 114.317 171.756 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.56 -41.3 98.42 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 167.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.97 -40.58 80.96 Favored 'General case' 0 CA--C 1.566 1.559 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 167.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -66.18 -50.86 62.44 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 172.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.2 mt -83.16 -22.72 33.2 Favored 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 116.807 2.151 . . . . 0.0 116.807 -177.268 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.23 34.6 8.61 Favored Glycine 0 CA--C 1.555 2.547 0 N-CA-C 117.742 1.857 . . . . 0.0 117.742 -174.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.1 mm -105.43 152.46 39.94 Favored Pre-proline 0 CA--C 1.568 1.651 0 CA-C-N 119.149 1.474 . . . . 0.0 112.205 -169.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -82.6 99.74 0.95 Allowed 'Trans proline' 0 CA--C 1.564 1.988 0 CA-C-N 122.06 1.771 . . . . 0.0 108.668 162.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.22 116.92 11.14 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.991 0.9 . . . . 0.0 110.226 176.262 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 38.6 mm -97.91 108.25 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 -176.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 70.0 p -96.2 129.56 43.48 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 172.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.6 p -71.36 -8.66 55.18 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 -170.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.535 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -92.12 -17.64 46.28 Favored Glycine 0 CA--C 1.55 2.23 0 N-CA-C 118.29 2.076 . . . . 0.0 118.29 165.486 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -79.37 -55.83 4.77 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 119.097 1.449 . . . . 0.0 113.683 -168.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -60.06 -38.02 81.59 Favored 'General case' 0 CA--C 1.565 1.522 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 173.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.421 ' HB2' ' HB2' ' A' ' 50' ' ' LYS . 41.8 m-85 -67.88 -41.81 82.21 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 116.676 -1.63 . . . . 0.0 113.719 169.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.535 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 35.2 ttt180 -54.05 -40.13 66.84 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 116.587 2.069 . . . . 0.0 116.587 169.365 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -63.29 -39.72 95.37 Favored 'General case' 0 CA--C 1.566 1.578 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 169.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -67.64 -23.63 65.36 Favored 'General case' 0 CA--C 1.587 2.398 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 167.171 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.5 mt -62.35 -50.46 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.485 0 CA-C-N 121.609 2.004 . . . . 0.0 109.239 166.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -60.3 -40.99 92.46 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 175.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -70.01 -37.2 75.58 Favored 'General case' 0 CA--C 1.563 1.462 0 N-CA-C 116.84 2.163 . . . . 0.0 116.84 173.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.65 75.07 1.29 Allowed Glycine 0 CA--C 1.544 1.895 0 CA-C-O 117.754 -1.581 . . . . 0.0 114.733 -175.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.939 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 82.2 p -96.45 -62.81 1.21 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 119.683 1.742 . . . . 0.0 111.29 170.182 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.939 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.302 13.0 mttt 115.83 -42.75 0.01 OUTLIER 'General case' 0 CA--C 1.573 1.861 0 CA-C-O 116.064 -1.922 . . . . 0.0 108.871 -173.423 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.41 -14.96 60.49 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 123.395 2.816 . . . . 0.0 112.891 161.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.456 ' O ' ' HB3' ' A' ' 50' ' ' LYS . . . -58.99 -62.9 5.7 Favored Glycine 0 C--N 1.355 1.598 0 CA-C-N 120.11 1.323 . . . . 0.0 114.148 169.455 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.295 7.7 p -69.23 -51.4 43.51 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.302 0 N-CA-C 116.862 2.171 . . . . 0.0 116.862 -168.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -67.09 -45.93 75.78 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 119.923 1.238 . . . . 0.0 112.397 176.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.27 -28.97 67.66 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.456 ' HB3' ' O ' ' A' ' 46' ' ' GLY 0.278 4.2 tptt -76.02 -37.43 58.42 Favored 'General case' 0 CA--C 1.559 1.319 0 CA-C-O 116.21 -1.852 . . . . 0.0 113.11 170.986 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -78.31 -45.57 22.36 Favored 'General case' 0 CA--C 1.602 2.968 1 CA-C-O 86.548 -15.977 . . . . 0.0 118.565 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 17.2 m-30 -31.07 -54.18 0.21 Allowed 'General case' 0 N--CA 1.498 1.937 1 O-C-N 108.236 -9.04 . . . . 0.0 120.467 145.215 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.49 -49.96 63.68 Favored 'General case' 0 CA--C 1.576 1.949 0 CA-C-N 121.796 2.089 . . . . 0.0 114.462 166.066 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -77.0 -44.81 29.55 Favored 'General case' 0 CA--C 1.565 1.542 0 N-CA-C 115.948 1.832 . . . . 0.0 115.948 177.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -87.22 -24.84 24.28 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 116.148 1.906 . . . . 0.0 116.148 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.32 22.64 11.31 Favored Glycine 0 CA--C 1.544 1.856 0 N-CA-C 117.883 1.913 . . . . 0.0 117.883 168.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -95.62 177.96 5.63 Favored 'General case' 0 CA--C 1.573 1.865 0 CA-C-N 118.617 1.208 . . . . 0.0 110.504 168.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.3 pp -76.64 124.17 27.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.494 -1.378 . . . . 0.0 112.836 -168.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 p -113.4 122.47 35.31 Favored Pre-proline 0 CA--C 1.567 1.627 0 C-N-CA 124.656 1.182 . . . . 0.0 108.601 -177.325 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -55.51 141.62 82.43 Favored 'Trans proline' 0 C--N 1.37 1.666 0 C-N-CA 123.449 2.766 . . . . 0.0 116.135 174.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.6 m -85.46 177.55 7.73 Favored 'General case' 0 CA--C 1.569 1.707 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.712 177.044 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.9 t70 82.09 -52.03 0.23 Allowed 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 125.77 1.628 . . . . 0.0 113.64 178.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.2 pp -58.17 -41.75 84.52 Favored 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 116.335 1.976 . . . . 0.0 116.335 168.387 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.5 m -58.63 -51.96 67.72 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 124.914 1.286 . . . . 0.0 113.313 170.864 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -62.08 -21.97 65.39 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 167.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -76.95 -45.86 26.15 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 125.366 1.466 . . . . 0.0 114.841 172.499 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.4 mt -61.97 -45.77 92.21 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 169.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 52.7 t -56.42 -55.55 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-O 117.944 -1.027 . . . . 0.0 111.497 171.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -61.22 -31.08 70.86 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 116.836 2.162 . . . . 0.0 116.836 175.485 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -60.61 -40.46 91.93 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-O 117.937 -1.03 . . . . 0.0 113.288 167.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -80.92 -23.37 38.95 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 118.521 2.786 . . . . 0.0 118.521 169.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 66.4 mt -85.59 -22.14 28.17 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 116.832 2.16 . . . . 0.0 116.832 178.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 . . . . . 0 N--CA 1.498 1.969 0 N-CA-C 116.994 2.22 . . . . 0.0 116.994 169.434 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.434 0 CA-C-O 122.302 0.946 . . . . 0.0 113.472 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 81' ' ' PHE . . . . . 0.427 ' O ' ' HB2' ' A' ' 2' ' ' ARG . 30.3 p90 -179.08 135.04 0.13 Allowed 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 113.862 -1.169 . . . . 0.0 111.121 176.073 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 22.1 mt -114.33 109.41 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 105.037 -2.208 . . . . 0.0 105.037 172.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.4 mt -101.21 120.95 40.99 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 118.643 -0.694 . . . . 0.0 109.638 174.184 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.813 ' OD1' ' HB3' ' A' ' 13' ' ' LYS . 25.1 t70 -110.13 129.21 55.74 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 119.006 0.821 . . . . 0.0 110.983 -177.138 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 74.27 39.62 43.35 Favored Glycine 0 CA--C 1.552 2.361 0 CA-C-O 117.361 -1.799 . . . . 0.0 117.258 -178.5 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . 0.256 1.0 OUTLIER -103.8 -58.05 0.08 OUTLIER Pre-proline 0 N--CA 1.496 1.834 0 CA-C-O 113.35 -3.214 . . . . 0.0 111.01 -174.439 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -63.22 70.89 0.14 Allowed 'Trans proline' 0 CA--C 1.571 2.35 0 CA-C-N 126.724 3.437 . . . . 0.0 119.29 167.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -67.53 -29.53 68.96 Favored 'General case' 0 CA--C 1.567 1.623 0 C-N-CA 125.907 1.683 . . . . 0.0 114.503 166.359 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 77.1 p -151.02 159.52 44.5 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.05 1.34 . . . . 0.0 108.78 -172.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.0 t -64.73 -41.69 92.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 CA-C-O 117.425 -1.274 . . . . 0.0 110.752 167.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.16 -37.79 86.58 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 120.672 3.582 . . . . 0.0 120.672 178.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -75.92 -48.29 21.88 Favored 'General case' 0 CA--C 1.583 2.225 0 CA-C-N 122.586 2.448 . . . . 0.0 111.94 167.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.14 -31.5 72.65 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 117.485 2.402 . . . . 0.0 117.485 -171.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 64.3 tttt -60.34 -30.48 69.55 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 168.557 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.53 -47.6 75.35 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 168.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.9 tp -58.48 -41.96 86.43 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 170.191 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 23.4 t-80 -72.81 -41.52 64.83 Favored 'General case' 0 CA--C 1.567 1.596 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 176.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 1.334 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 37.7 mt-10 -56.18 -32.62 64.51 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 165.706 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' MET . . . . . 1.304 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 26.8 ttt -84.72 -28.5 26.26 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 118.152 2.649 . . . . 0.0 118.152 173.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 64.0 tp -66.88 -54.22 24.48 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-N 120.319 1.418 . . . . 0.0 112.855 169.102 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -79.7 -49.55 11.93 Favored 'General case' 0 CA--C 1.563 1.472 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 176.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 1.334 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 38.0 mmt180 -68.64 -45.39 71.96 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 175.699 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 1.304 ' HB3' ' O ' ' A' ' 99' ' ' MET . 74.8 ttt180 -61.4 -57.25 13.01 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 118.843 0.747 . . . . 0.0 111.398 165.567 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.82 43.16 1.05 Allowed Glycine 0 N--CA 1.479 1.536 0 O-C-N 124.41 1.069 . . . . 0.0 113.941 169.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 40.2 p -90.97 147.18 23.27 Favored 'General case' 0 CA--C 1.559 1.318 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 168.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -65.12 130.62 44.01 Favored 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -169.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.5 tp -90.43 99.17 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 125.344 1.458 . . . . 0.0 107.512 177.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -98.55 -75.15 0.56 Allowed 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 115.898 -2.001 . . . . 0.0 108.419 168.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ALA . . . . . 0.413 ' HB3' HG22 ' A' ' 3' ' ' VAL . . . -136.3 117.37 14.36 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 121.644 2.02 . . . . 0.0 113.459 -174.11 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.4 t -94.99 108.07 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 101.628 -3.471 . . . . 0.0 101.628 167.796 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.464 HD23 ' HB3' ' A' ' 160' ' ' LYS . 78.8 mt -109.19 105.33 14.73 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -164.114 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -90.55 130.9 36.54 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.93 0.871 . . . . 0.0 111.478 172.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -100.38 110.1 22.29 Favored 'General case' 0 CA--C 1.559 1.316 0 CA-C-N 114.227 -1.351 . . . . 0.0 109.426 -176.603 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . 0.25 71.8 ttt180 -73.11 101.12 3.21 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 126.835 2.054 . . . . 0.0 109.497 169.039 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.9 p . . . . . 0 CA--C 1.566 1.584 0 CA-C-N 112.416 -2.175 . . . . 0.0 110.491 -165.512 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 . . . . . 0 N--CA 1.494 1.767 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -57.28 -37.98 73.23 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 115.262 1.579 . . . . 0.0 115.262 165.297 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 24.9 ttt -67.2 -33.97 76.52 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 168.678 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 60.9 mttm -60.73 -50.73 72.32 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 169.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.4 p -64.08 -31.53 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 170.239 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -54.45 -49.5 69.92 Favored 'General case' 0 CA--C 1.583 2.226 0 CA-C-N 119.755 1.161 . . . . 0.0 112.104 167.028 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 66.9 ttt180 -60.04 -41.4 92.21 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 118.461 2.763 . . . . 0.0 118.461 174.106 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -51.38 -29.06 14.34 Favored 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 118.998 2.962 . . . . 0.0 118.998 172.702 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -132.9 -37.31 1.01 Allowed 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 119.635 3.198 . . . . 0.0 119.635 -163.243 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 86.0 m -46.51 -39.69 11.26 Favored 'General case' 0 N--CA 1.504 2.248 0 N-CA-C 118.654 2.835 . . . . 0.0 118.654 -167.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.403 ' HB3' ' HD3' ' A' ' 150' ' ' PRO . . . -68.72 -61.4 3.69 Favored Pre-proline 0 CA--C 1.579 2.087 0 CA-C-O 116.466 -1.731 . . . . 0.0 112.118 175.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.403 ' HD3' ' HB3' ' A' ' 149' ' ' ALA . 86.9 Cg_exo -51.85 -31.16 41.45 Favored 'Trans proline' 0 CA--C 1.579 2.748 0 C-N-CA 123.387 2.725 . . . . 0.0 118.392 167.134 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.43 -54.38 33.62 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 125.515 1.526 . . . . 0.0 111.955 174.153 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 1.157 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 52.1 tp -65.47 -21.7 66.66 Favored 'General case' 0 CA--C 1.566 1.566 0 CA-C-O 116.803 -1.57 . . . . 0.0 114.801 175.671 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -71.44 -50.66 29.59 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 122.227 2.285 . . . . 0.0 113.307 164.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -65.86 -52.48 49.94 Favored 'General case' 0 CA--C 1.566 1.576 0 CA-C-N 120.466 1.484 . . . . 0.0 112.401 -178.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -76.59 -30.48 57.01 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-O 114.994 -2.431 . . . . 0.0 111.393 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 1.157 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 32.1 ttt180 -59.68 -34.05 72.36 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 124.955 3.525 . . . . 0.0 116.91 168.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -68.58 -41.88 79.04 Favored 'General case' 0 CA--C 1.573 1.83 0 CA-C-N 119.659 1.118 . . . . 0.0 113.519 167.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 38.9 mm-40 -90.63 -19.37 23.74 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 119.99 3.33 . . . . 0.0 119.99 -178.009 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.7 pp -77.97 179.72 6.59 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 119.506 3.15 . . . . 0.0 119.506 -161.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' LYS . . . . . 0.464 ' HB3' HD23 ' A' ' 111' ' ' LEU . 50.9 mttt -135.59 135.88 40.62 Favored 'General case' 0 CA--C 1.564 1.493 0 N-CA-C 105.113 -2.18 . . . . 0.0 105.113 167.934 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 42.0 m -100.34 146.15 27.3 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 122.217 1.008 . . . . 0.0 110.269 -172.127 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 43.1 t -131.36 136.11 58.17 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.392 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 167.536 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -94.95 126.97 40.65 Favored 'General case' 0 CA--C 1.565 1.555 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 169.379 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -109.34 7.85 25.29 Favored 'General case' 0 N--CA 1.493 1.678 1 N-CA-C 126.339 5.681 . . . . 0.0 126.339 -159.596 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . 0.486 29.2 m . . . . . 0 CA--C 1.594 2.641 1 CA-C-O 109.954 -4.831 . . . . 0.0 107.597 -178.009 . . . . . . . . 2 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 . . . . . 0 N--CA 1.502 2.169 0 N-CA-C 115.925 1.824 . . . . 0.0 115.925 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -60.18 -52.79 63.8 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 169.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 2.7 t -59.27 -35.25 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' PHE . . . . . 0.445 ' HE1' ' HB3' ' A' ' 19' ' ' LYS . 8.4 t80 -61.16 -40.81 95.27 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 167.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.12 -43.49 95.12 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 115.089 1.515 . . . . 0.0 115.089 175.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 82.2 mtt-85 -71.73 -36.74 70.58 Favored 'General case' 0 CA--C 1.56 1.36 0 N-CA-C 116.265 1.95 . . . . 0.0 116.265 173.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.38 -44.16 92.21 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 171.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.7 mp -64.88 -42.08 95.11 Favored 'General case' 0 CA--C 1.567 1.612 0 CA-C-O 117.148 -1.406 . . . . 0.0 110.656 167.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -46.64 -41.61 14.99 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 117.567 2.432 . . . . 0.0 117.567 168.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -67.1 -48.51 67.95 Favored 'General case' 0 CA--C 1.562 1.431 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 168.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 5.8 tt -86.25 -58.13 2.75 Favored 'General case' 0 CA--C 1.57 1.72 0 CA-C-N 120.275 1.398 . . . . 0.0 113.575 -176.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 0.539 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -118.49 -56.88 0.27 Allowed Glycine 0 CA--C 1.553 2.438 0 CA-C-O 117.339 -1.811 . . . . 0.0 116.353 -174.811 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 0.539 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 38.9 ttmt . . . . . 0 C--O 1.251 1.166 0 CA-C-N 120.957 2.378 . . . . 0.0 108.207 -173.771 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.5 ttm . . . . . 0 CA--C 1.56 1.328 0 CA-C-O 122.517 1.151 . . . . 0.0 109.631 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . 0.263 11.4 mpt_? -123.64 162.25 23.43 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 120.582 3.549 . . . . 0.0 120.582 -161.398 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.8 p -151.08 147.36 15.67 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.744 0 CA-C-O 123.931 1.825 . . . . 0.0 114.424 167.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.3 mt -131.83 133.44 44.68 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-N 111.42 -2.627 . . . . 0.0 108.375 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.48 120.26 41.03 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -169.062 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.8 mt -110.37 135.74 50.62 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 112.231 -2.258 . . . . 0.0 109.568 175.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 173.84 168.43 34.81 Favored Glycine 0 CA--C 1.56 2.869 0 N-CA-C 115.848 1.099 . . . . 0.0 115.848 171.591 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo . . . . . 0 CA--C 1.572 2.378 0 C-N-CA 123.44 2.76 . . . . 0.0 116.725 179.594 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt . . . . . 0 N--CA 1.484 1.249 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -57.84 -30.66 63.31 Favored Glycine 0 CA--C 1.552 2.386 0 N-CA-C 120.053 2.781 . . . . 0.0 120.053 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 54.6 m -66.78 -53.82 29.09 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 119.852 1.826 . . . . 0.0 112.539 176.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -74.31 -16.79 60.92 Favored 'General case' 0 CA--C 1.573 1.84 0 CA-C-O 116.057 -1.925 . . . . 0.0 112.403 172.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.57 -41.31 63.09 Favored 'General case' 0 C--N 1.372 1.582 0 CA-C-N 123.288 2.767 . . . . 0.0 114.912 169.035 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.7 t -69.03 -39.26 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 CA-C-O 117.644 -1.169 . . . . 0.0 111.789 171.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -61.62 -46.39 90.01 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 116.353 1.983 . . . . 0.0 116.353 170.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.93 -33.49 75.94 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 172.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.06 -41.6 96.92 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 167.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -59.49 -38.12 80.03 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 166.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -66.09 -50.78 62.9 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 116.142 1.905 . . . . 0.0 116.142 171.169 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.5 mt -81.39 -24.49 36.95 Favored 'General case' 0 CA--C 1.571 1.78 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 -178.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.15 37.07 7.89 Favored Glycine 0 CA--C 1.555 2.542 0 N-CA-C 117.771 1.868 . . . . 0.0 117.771 -176.3 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.1 mm -109.24 159.2 32.17 Favored Pre-proline 0 CA--C 1.567 1.624 0 CA-C-N 118.833 1.317 . . . . 0.0 113.53 -168.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' PRO . . . . . 0.412 ' HB2' HH11 ' A' ' 71' ' ' ARG . 73.1 Cg_exo -71.67 100.6 1.07 Allowed 'Trans proline' 0 CA--C 1.563 1.969 0 C-N-CA 122.0 1.8 . . . . 0.0 114.224 160.637 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -73.41 109.85 7.25 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.383 -0.823 . . . . 0.0 111.044 167.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.3 mm -98.23 119.84 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 167.419 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 62.9 p -99.89 124.66 45.43 Favored 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 161.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.5 p -66.05 -18.61 65.45 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 117.306 2.335 . . . . 0.0 117.306 -169.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLY . . . . . 0.429 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -80.29 -18.93 70.37 Favored Glycine 0 CA--C 1.548 2.098 0 N-CA-C 118.805 2.282 . . . . 0.0 118.805 168.187 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -80.24 -49.86 11.02 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -169.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -69.15 -36.35 77.33 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 174.439 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PHE . . . . . 0.442 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 42.5 m-85 -66.95 -38.48 86.21 Favored 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 125.379 1.472 . . . . 0.0 114.575 169.539 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 29.5 ttp180 -61.21 -40.67 94.85 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-N 120.109 1.322 . . . . 0.0 113.578 166.779 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -59.14 -37.15 76.58 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 168.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -66.36 -31.91 72.97 Favored 'General case' 0 CA--C 1.573 1.828 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 166.836 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.36 -45.68 97.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 CA-C-N 120.092 1.314 . . . . 0.0 112.65 170.17 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -68.17 -39.89 82.43 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 120.074 1.307 . . . . 0.0 113.814 174.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -77.05 -28.99 54.96 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 116.849 2.166 . . . . 0.0 116.849 178.143 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.08 74.17 1.28 Allowed Glycine 0 CA--C 1.542 1.757 0 CA-C-O 118.088 -1.395 . . . . 0.0 115.168 178.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.921 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 62.6 p -91.62 -60.24 1.93 Allowed 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 119.127 1.464 . . . . 0.0 111.285 169.283 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.921 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.287 13.4 mttt 114.44 -40.88 0.01 OUTLIER 'General case' 0 CA--C 1.567 1.604 0 CA-C-O 115.874 -2.012 . . . . 0.0 109.534 -173.103 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.513 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -73.14 -23.18 60.44 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 123.609 2.913 . . . . 0.0 111.729 161.146 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.55 -54.85 33.21 Favored Glycine 0 C--N 1.352 1.436 0 C-N-CA 125.673 1.606 . . . . 0.0 115.912 174.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.293 0.8 OUTLIER -65.62 -57.0 12.54 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.714 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -179.717 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -67.81 -51.01 53.69 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 120.033 1.288 . . . . 0.0 112.344 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' A' ' 45' ' ' LEU . . . -67.25 -19.51 65.52 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 176.618 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . 0.442 ' HB2' ' HB3' ' A' ' 35' ' ' PHE . 14.1 tmtt? -74.53 -45.52 45.15 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 120.577 1.535 . . . . 0.0 112.929 167.911 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -75.08 -48.37 24.24 Favored 'General case' 0 CA--C 1.583 2.227 1 CA-C-O 85.341 -16.552 . . . . 0.0 119.564 -176.066 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 12.9 m-30 -34.5 -54.33 0.53 Allowed 'General case' 0 N--CA 1.496 1.871 1 O-C-N 109.293 -8.38 . . . . 0.0 120.481 146.104 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.6 tp -59.41 -30.95 68.83 Favored 'General case' 0 CA--C 1.579 2.093 0 CA-C-N 122.366 2.348 . . . . 0.0 115.569 167.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -91.27 -41.79 10.75 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 115.964 1.838 . . . . 0.0 115.964 170.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.97 -35.29 26.05 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.42 34.04 5.18 Favored Glycine 0 N--CA 1.476 1.344 0 N-CA-C 118.146 2.018 . . . . 0.0 118.146 167.358 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -93.55 -129.69 0.13 Allowed 'General case' 0 CA--C 1.567 1.612 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 169.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 88.2 mt -103.12 97.58 7.65 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 119.971 1.259 . . . . 0.0 110.322 -169.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 p -104.03 118.2 57.66 Favored Pre-proline 0 CA--C 1.568 1.661 0 CA-C-O 117.603 -1.189 . . . . 0.0 108.786 176.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -57.26 141.4 94.57 Favored 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 123.491 2.794 . . . . 0.0 116.383 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 74.1 m -71.29 -49.91 38.01 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -65.79 -39.02 90.54 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 -177.083 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 28.4 mt -56.58 -50.57 71.54 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 117.54 2.422 . . . . 0.0 117.54 175.029 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 35.7 m -64.57 -46.46 82.64 Favored 'General case' 0 CA--C 1.566 1.593 0 CA-C-N 112.553 -2.112 . . . . 0.0 112.982 174.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -61.6 -21.5 64.4 Favored 'General case' 0 CA--C 1.577 2.003 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 165.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -75.11 -40.53 59.81 Favored 'General case' 0 CA--C 1.556 1.19 0 CA-C-N 121.026 1.739 . . . . 0.0 115.228 169.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 mt -59.89 -48.98 79.5 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-N 120.21 1.368 . . . . 0.0 114.129 167.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.491 HG22 HH21 ' A' ' 71' ' ' ARG . 0.4 OUTLIER -57.62 -44.64 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 172.667 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -67.17 -33.27 75.05 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.689 1.737 . . . . 0.0 115.689 169.652 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -58.62 -42.1 87.45 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 117.524 -1.227 . . . . 0.0 113.125 170.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ARG . . . . . 0.491 HH21 HG22 ' A' ' 68' ' ' VAL . 3.2 ppt_? -80.24 -16.99 53.5 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 118.582 2.808 . . . . 0.0 118.582 167.535 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.3 mt -103.96 3.41 33.49 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 119.192 3.034 . . . . 0.0 119.192 174.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 . . . . . 0 N--CA 1.505 2.285 0 CA-C-O 123.635 1.683 . . . . 0.0 112.558 162.543 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.551 0 CA-C-O 124.199 1.999 . . . . 0.0 115.933 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -167.48 138.59 3.03 Favored 'General case' 0 CA--C 1.551 1.019 0 CA-C-N 111.386 -2.407 . . . . 0.0 106.099 169.432 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -115.38 109.34 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 102.847 -3.02 . . . . 0.0 102.847 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.5 mt -109.82 141.96 41.75 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.518 0.727 . . . . 0.0 109.707 175.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -130.88 127.84 39.36 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 118.364 0.529 . . . . 0.0 111.928 169.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.56 39.04 86.98 Favored Glycine 0 CA--C 1.556 2.604 0 N-CA-C 117.378 1.711 . . . . 0.0 117.378 -178.261 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -99.63 -52.93 0.19 Allowed Pre-proline 0 N--CA 1.498 1.936 0 CA-C-O 115.139 -2.362 . . . . 0.0 108.807 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -66.41 72.06 0.41 Allowed 'Trans proline' 0 CA--C 1.568 2.199 0 CA-C-N 124.211 2.54 . . . . 0.0 117.932 165.26 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -65.32 -39.28 92.24 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 167.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.0 t -148.96 153.28 37.73 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -169.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.4 t -59.92 -38.49 76.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-O 117.298 -1.334 . . . . 0.0 112.355 178.414 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.66 -34.2 73.94 Favored 'General case' 0 C--N 1.361 1.074 0 N-CA-C 120.091 3.367 . . . . 0.0 120.091 173.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.04 -49.51 13.86 Favored 'General case' 0 CA--C 1.586 2.349 0 CA-C-N 122.326 2.33 . . . . 0.0 111.46 166.295 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.0 -31.43 71.81 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 117.102 2.26 . . . . 0.0 117.102 -170.113 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 58.5 tttt -61.97 -29.26 70.12 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 167.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.37 -39.55 74.55 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 167.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.3 tp -63.11 -36.5 83.79 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 168.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 57.0 t60 -63.84 -43.77 95.15 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 120.261 1.391 . . . . 0.0 113.243 167.579 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' GLU . . . . . 1.253 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 32.2 mt-10 -54.38 -33.51 59.33 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 167.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' MET . . . . . 0.997 ' O ' ' CB ' ' A' ' 103' ' ' ARG . 1.7 tmt? -85.99 -31.41 22.06 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 118.451 2.759 . . . . 0.0 118.451 171.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 tt -70.89 -53.59 14.53 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-N 121.257 1.844 . . . . 0.0 111.067 172.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -76.56 -50.95 12.61 Favored 'General case' 0 CA--C 1.564 1.507 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 174.212 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 1.253 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 25.2 mmt85 -71.0 -43.04 68.8 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 177.494 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.997 ' CB ' ' O ' ' A' ' 99' ' ' MET . 0.2 OUTLIER -61.93 -57.15 12.82 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 118.842 0.747 . . . . 0.0 111.083 165.995 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 111.54 47.48 0.74 Allowed Glycine 0 N--CA 1.481 1.648 0 O-C-N 124.227 0.954 . . . . 0.0 114.46 167.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 61.9 p -85.48 155.84 21.06 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-N 113.85 -1.175 . . . . 0.0 109.538 168.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -71.34 132.04 44.3 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.343 -0.848 . . . . 0.0 110.982 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 6.5 tp -93.84 96.71 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 -175.761 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -98.97 -73.29 0.63 Allowed 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 115.796 -2.049 . . . . 0.0 109.062 170.734 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -149.54 124.89 10.21 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 117.564 2.431 . . . . 0.0 117.564 -167.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 62.0 t -92.84 113.55 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 102.66 -3.089 . . . . 0.0 102.66 160.07 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 71.5 mt -98.15 101.31 12.74 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.838 -178.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -89.01 115.65 26.73 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.849 169.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -92.91 112.23 24.12 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 124.446 1.098 . . . . 0.0 111.478 -175.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ARG . . . . . 0.449 ' HB3' ' HA ' ' A' ' 163' ' ' ASP . 13.5 tpt180 -81.21 97.38 7.59 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.582 1.553 . . . . 0.0 109.053 168.616 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' VAL . . . . . 0.502 HG13 HG11 ' A' ' 165' ' ' VAL . 43.5 t . . . . . 0 CA--C 1.566 1.591 0 C-N-CA 126.142 1.777 . . . . 0.0 106.965 -170.724 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 . . . . . 0 N--CA 1.495 1.78 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 43.5 mmt-85 -64.3 -40.57 96.2 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 168.034 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 93.5 mmm -60.47 -26.97 67.18 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 165.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -65.73 -40.08 91.82 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 120.249 1.386 . . . . 0.0 113.43 164.137 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.8 t -63.47 -27.22 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 CA-C-N 119.794 1.179 . . . . 0.0 112.958 168.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -66.14 -51.56 56.73 Favored 'General case' 0 CA--C 1.575 1.939 0 CA-C-N 120.748 1.613 . . . . 0.0 112.538 165.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 47.9 ttt180 -52.4 -26.59 12.94 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 120.238 3.421 . . . . 0.0 120.238 177.309 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.81 -67.58 0.3 Allowed 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 119.911 1.232 . . . . 0.0 112.432 169.441 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -148.84 22.82 0.99 Allowed 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 119.534 3.161 . . . . 0.0 119.534 -168.084 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 69.4 m -56.48 -29.06 61.3 Favored 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' ALA . . . . . 0.423 ' HB3' ' HD3' ' A' ' 150' ' ' PRO . . . -71.49 -60.89 2.36 Favored Pre-proline 0 CA--C 1.58 2.099 0 CA-C-O 116.093 -1.908 . . . . 0.0 112.118 171.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' PRO . . . . . 0.423 ' HD3' ' HB3' ' A' ' 149' ' ' ALA . 78.5 Cg_exo -52.65 -33.19 57.97 Favored 'Trans proline' 0 CA--C 1.576 2.608 0 C-N-CA 123.458 2.772 . . . . 0.0 118.806 168.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.76 -52.14 53.44 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 125.259 1.423 . . . . 0.0 111.161 174.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' LEU . . . . . 1.154 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 49.1 tp -62.49 -21.78 65.75 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 171.352 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -72.01 -49.86 33.46 Favored 'General case' 0 CA--C 1.564 1.49 0 CA-C-N 122.759 2.527 . . . . 0.0 113.694 165.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -63.23 -54.06 43.37 Favored 'General case' 0 CA--C 1.567 1.629 0 CA-C-N 120.494 1.497 . . . . 0.0 112.676 178.447 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -74.06 -32.88 63.48 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-O 115.275 -2.298 . . . . 0.0 112.177 178.067 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ARG . . . . . 1.154 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 32.6 ttt180 -58.85 -34.91 72.11 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 124.187 3.176 . . . . 0.0 116.939 169.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -68.13 -38.84 82.64 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 167.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -89.3 -26.04 21.35 Favored 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 119.449 3.129 . . . . 0.0 119.449 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.4 pp -81.2 175.45 10.61 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 118.119 2.637 . . . . 0.0 118.119 -163.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 35.9 tttp -123.49 128.99 50.57 Favored 'General case' 0 CA--C 1.561 1.376 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 164.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 11.0 t -101.96 144.63 30.34 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 122.536 1.16 . . . . 0.0 110.065 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 27.7 t -110.52 130.51 63.7 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.325 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 169.794 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' ASP . . . . . 0.449 ' HA ' ' HB3' ' A' ' 114' ' ' ARG . 16.5 t70 -103.7 117.46 34.42 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 102.593 -3.114 . . . . 0.0 102.593 168.129 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -121.77 -174.44 2.87 Favored 'General case' 0 CA--C 1.555 1.136 0 N-CA-C 117.831 2.53 . . . . 0.0 117.831 -157.042 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' VAL . . . . . 0.502 HG11 HG13 ' A' ' 115' ' ' VAL 0.543 0.9 OUTLIER . . . . . 0 CA--C 1.559 1.296 0 CA-C-N 109.667 -3.424 . . . . 0.0 115.008 167.813 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 . . . . . 0 N--CA 1.512 2.644 0 N-CA-C 117.948 2.573 . . . . 0.0 117.948 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -46.51 -50.4 17.14 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 169.41 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 3.8 t -52.08 -38.77 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 175.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -63.14 -41.81 99.35 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 120.649 1.568 . . . . 0.0 114.829 168.455 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -57.38 -52.0 67.11 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 174.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 10.4 mtt-85 -66.02 -37.66 86.47 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 117.815 2.524 . . . . 0.0 117.815 174.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.67 -45.56 93.67 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 115.72 1.748 . . . . 0.0 115.72 172.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . 0.281 0.4 OUTLIER -72.27 -35.16 68.66 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 169.935 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -53.3 -41.83 66.02 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 167.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.86 -54.76 29.88 Favored 'General case' 0 CA--C 1.561 1.403 0 N-CA-C 114.73 1.382 . . . . 0.0 114.73 168.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 5.4 tt -81.68 -63.29 1.42 Allowed 'General case' 0 CA--C 1.565 1.558 0 CA-C-O 117.597 -1.192 . . . . 0.0 113.142 -176.112 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' GLY . . . . . 1.127 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -89.21 -48.72 3.7 Favored Glycine 0 CA--C 1.551 2.337 0 CA-C-N 120.915 1.689 . . . . 0.0 116.106 -174.308 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 181' ' ' LYS . . . . . 1.127 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.303 0 CA-C-N 119.259 1.529 . . . . 0.0 108.988 -175.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.5 mtt . . . . . 0 CA--C 1.558 1.276 0 CA-C-O 122.772 1.273 . . . . 0.0 111.881 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.439 HH11 ' HG3' ' A' ' 2' ' ' ARG 0.3 5.8 ttm-85 -150.27 152.99 35.37 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 116.612 2.079 . . . . 0.0 116.612 -162.777 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.5 t -141.59 145.04 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 CA-C-O 124.176 1.941 . . . . 0.0 111.098 -174.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -125.26 135.41 52.49 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 112.509 -2.132 . . . . 0.0 106.944 175.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.98 114.35 23.68 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-O 122.452 1.12 . . . . 0.0 110.533 -169.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.29 160.9 17.85 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 113.053 -1.885 . . . . 0.0 110.562 -168.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 151.8 149.36 5.06 Favored Glycine 0 CA--C 1.555 2.548 0 CA-C-O 118.2 -1.333 . . . . 0.0 114.129 169.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.28 168.27 2.13 Favored 'Trans proline' 0 CA--C 1.574 2.511 0 C-N-CA 123.375 2.717 . . . . 0.0 116.532 169.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -50.81 132.53 37.21 Favored 'Trans proline' 0 CA--C 1.561 1.869 0 C-N-CA 123.573 2.848 . . . . 0.0 114.615 170.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.3 110.36 0.48 Allowed Glycine 0 C--N 1.345 1.078 0 N-CA-C 107.58 -2.208 . . . . 0.0 107.58 -167.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -27.29 -46.27 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 121.751 3.982 . . . . 0.0 121.751 -177.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.437 ' O ' ' CG ' ' A' ' 13' ' ' LYS . . . -71.5 107.35 2.15 Favored Glycine 0 CA--C 1.549 2.204 0 CA-C-N 119.747 1.158 . . . . 0.0 115.362 -176.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.437 ' CG ' ' O ' ' A' ' 12' ' ' GLY . 23.1 mtmm -172.47 -78.09 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.741 0.817 . . . . 0.0 109.088 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -51.27 -27.45 16.11 Favored Glycine 0 CA--C 1.554 2.509 0 N-CA-C 120.416 2.926 . . . . 0.0 120.416 174.8 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.9 m -66.87 -52.29 45.24 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 119.663 1.731 . . . . 0.0 112.682 174.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.25 10.6 mm-40 -75.39 -15.63 60.44 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 115.904 -1.998 . . . . 0.0 112.455 171.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.85 -44.32 66.66 Favored 'General case' 0 C--N 1.374 1.637 0 CA-C-N 123.684 2.947 . . . . 0.0 114.319 168.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.78 -46.41 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 CA-C-N 119.282 0.946 . . . . 0.0 112.737 174.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -54.94 -44.25 74.14 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 116.623 2.083 . . . . 0.0 116.623 169.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.1 tp -67.24 -32.54 73.63 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 172.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.78 -38.89 92.42 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 167.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -59.33 -40.72 87.21 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 117.491 -1.243 . . . . 0.0 114.106 166.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -65.62 -49.09 70.0 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 172.465 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 65.8 mt -82.72 -25.0 33.33 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 117.383 2.364 . . . . 0.0 117.383 -177.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.56 41.31 7.37 Favored Glycine 0 CA--C 1.556 2.616 0 N-CA-C 117.521 1.768 . . . . 0.0 117.521 -172.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 22.8 mm -115.68 157.91 43.26 Favored Pre-proline 0 CA--C 1.57 1.738 0 CA-C-N 118.678 1.239 . . . . 0.0 113.748 -168.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -74.65 101.19 1.42 Allowed 'Trans proline' 0 CA--C 1.566 2.111 0 C-N-CA 121.885 1.723 . . . . 0.0 113.294 160.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -72.34 107.74 5.09 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.158 -0.964 . . . . 0.0 108.424 165.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.457 ' CD1' ' HB3' ' A' ' 71' ' ' ARG . 31.3 mm -104.25 109.38 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 176.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 74.1 p -96.45 128.96 43.86 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 168.585 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 18.4 p -68.36 -16.59 63.99 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 117.051 2.241 . . . . 0.0 117.051 -171.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -80.37 -23.25 61.1 Favored Glycine 0 CA--C 1.543 1.809 0 N-CA-C 118.932 2.333 . . . . 0.0 118.932 167.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -80.38 -52.63 7.45 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 -168.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -62.88 -39.09 93.39 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 173.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.479 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 7.9 m-85 -65.2 -47.09 78.11 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 172.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -54.25 -42.06 69.47 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 168.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.8 ttt180 -59.11 -40.36 85.11 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 168.251 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -68.35 -23.83 64.74 Favored 'General case' 0 CA--C 1.579 2.07 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 168.332 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 63.6 mt -64.1 -48.69 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 CA-C-N 120.75 1.614 . . . . 0.0 110.448 167.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -64.42 -37.67 88.32 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -67.02 -40.93 87.37 Favored 'General case' 0 CA--C 1.561 1.391 0 N-CA-C 116.236 1.939 . . . . 0.0 116.236 173.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.28 69.26 1.04 Allowed Glycine 0 CA--C 1.543 1.844 0 CA-C-O 118.473 -1.182 . . . . 0.0 114.66 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.835 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 67.5 p -92.02 -49.86 6.0 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-N 118.737 1.268 . . . . 0.0 114.291 175.743 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.835 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.251 73.8 mttt 105.84 -41.49 0.0 OUTLIER 'General case' 0 CA--C 1.57 1.729 0 CA-C-O 116.376 -1.774 . . . . 0.0 111.307 -172.477 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.07 -14.13 58.1 Favored 'General case' 0 CA--C 1.569 1.711 0 CA-C-N 123.059 2.663 . . . . 0.0 112.988 163.788 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.673 ' O ' ' HB3' ' A' ' 50' ' ' LYS . . . -58.22 -56.48 24.97 Favored Glycine 0 C--N 1.355 1.605 0 CA-C-N 120.574 1.534 . . . . 0.0 114.825 169.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.289 6.2 p -76.44 -50.01 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.478 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 -169.859 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -64.91 -48.48 74.04 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 121.09 1.768 . . . . 0.0 112.582 174.191 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.12 -29.15 66.03 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 114.819 1.415 . . . . 0.0 114.819 -177.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.673 ' HB3' ' O ' ' A' ' 46' ' ' GLY . 35.8 tptt -72.78 -34.73 67.14 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 168.021 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.601 ' O ' ' CG ' ' A' ' 51' ' ' ARG . 42.9 ttt180 -74.64 -55.89 5.4 Favored 'General case' 0 CA--C 1.591 2.522 1 CA-C-O 85.878 -16.296 . . . . 0.0 117.639 -179.715 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -27.64 -66.22 0.07 Allowed 'General case' 0 N--CA 1.495 1.814 1 O-C-N 108.766 -8.709 . . . . 0.0 120.43 146.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.6 tp -59.32 -29.32 67.54 Favored 'General case' 0 CA--C 1.573 1.861 0 N-CA-C 116.388 1.996 . . . . 0.0 116.388 174.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -92.39 -41.6 10.24 Favored 'General case' 0 CA--C 1.566 1.588 0 CA-C-O 116.554 -1.689 . . . . 0.0 115.155 169.208 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -87.94 -41.15 13.36 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 121.976 2.171 . . . . 0.0 114.906 -174.561 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.449 ' HA2' HH12 ' A' ' 88' ' ' ARG . . . 128.83 5.35 4.91 Favored Glycine 0 CA--C 1.541 1.669 0 N-CA-C 119.095 2.398 . . . . 0.0 119.095 168.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -83.41 173.71 11.28 Favored 'General case' 0 CA--C 1.575 1.91 0 CA-C-N 119.86 1.83 . . . . 0.0 110.067 167.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.5 pp -76.18 128.77 35.62 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.205 -1.559 . . . . 0.0 114.398 -166.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.6 p -115.88 128.72 25.75 Favored Pre-proline 0 CA--C 1.571 1.779 0 CA-C-O 117.656 -1.164 . . . . 0.0 109.447 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -60.11 149.33 85.41 Favored 'Trans proline' 0 CA--C 1.559 1.77 0 C-N-CA 123.396 2.731 . . . . 0.0 116.275 173.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 64.0 m -76.87 -45.88 26.63 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -64.27 -46.56 83.17 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 -169.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.407 ' HA ' ' HB2' ' A' ' 66' ' ' GLU . 1.7 pp -57.86 -42.13 83.87 Favored 'General case' 0 CA--C 1.56 1.347 0 N-CA-C 116.709 2.114 . . . . 0.0 116.709 169.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.4 m -61.46 -48.79 79.53 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 174.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -66.94 -20.05 65.83 Favored 'General case' 0 CA--C 1.575 1.919 0 N-CA-C 115.443 1.645 . . . . 0.0 115.443 167.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.407 ' HB2' ' HA ' ' A' ' 63' ' ' LEU . 9.4 mm-40 -72.26 -47.56 49.31 Favored 'General case' 0 CA--C 1.556 1.203 0 CA-C-N 120.529 1.513 . . . . 0.0 114.197 169.771 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.9 mt -63.72 -38.46 91.2 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 169.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 51.9 t -56.55 -50.93 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 CA-C-O 117.582 -1.199 . . . . 0.0 111.55 167.676 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -60.05 -36.8 78.11 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 116.563 2.06 . . . . 0.0 116.563 172.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -58.16 -45.79 86.82 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 117.282 -1.342 . . . . 0.0 112.971 169.057 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.457 ' HB3' ' CD1' ' A' ' 29' ' ' ILE . 40.9 mmt180 -87.03 6.12 34.06 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 120.407 3.484 . . . . 0.0 120.407 167.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 50.7 mt -68.2 -49.94 57.5 Favored 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 105.473 -2.047 . . . . 0.0 105.473 153.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 49.51 39.15 16.2 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-N 121.375 1.898 . . . . 0.0 110.879 -163.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -32.26 -28.11 0.01 OUTLIER Pre-proline 0 CA--C 1.57 1.719 1 N-CA-C 127.822 6.23 . . . . 0.0 127.822 -161.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_exo -59.07 -13.98 21.48 Favored 'Trans proline' 0 N--CA 1.511 2.536 1 CA-C-N 130.521 4.793 . . . . 0.0 119.809 169.627 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -96.26 -28.49 14.5 Favored 'General case' 0 CA--C 1.573 1.848 0 CA-C-N 110.756 -2.929 . . . . 0.0 114.196 162.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -114.28 23.59 12.7 Favored 'General case' 0 CA--C 1.577 2.012 0 CA-C-N 123.537 2.881 . . . . 0.0 115.533 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.87 -38.3 73.11 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 120.863 1.665 . . . . 0.0 114.34 174.386 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -101.25 19.75 17.08 Favored 'General case' 0 CA--C 1.578 2.043 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 169.514 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -175.73 150.16 10.6 Favored Glycine 0 C--N 1.359 1.848 0 CA-C-N 122.262 2.301 . . . . 0.0 113.945 168.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -176.18 138.93 0.34 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 112.018 -2.091 . . . . 0.0 109.58 173.261 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 44.6 mt -111.35 112.99 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 104.059 -2.571 . . . . 0.0 104.059 174.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.5 mt -96.7 147.42 23.93 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 168.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -134.11 131.72 39.05 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.8 0.81 . . . . 0.0 111.043 169.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 71.03 37.59 64.16 Favored Glycine 0 CA--C 1.551 2.297 0 CA-C-O 117.249 -1.862 . . . . 0.0 117.62 176.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -104.79 -56.02 0.09 OUTLIER Pre-proline 0 N--CA 1.496 1.834 0 CA-C-O 114.873 -2.489 . . . . 0.0 109.657 177.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.79 70.97 1.09 Allowed 'Trans proline' 0 CA--C 1.566 2.088 0 CA-C-N 124.921 2.793 . . . . 0.0 118.873 168.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.449 HH12 ' HA2' ' A' ' 56' ' ' GLY . 4.1 ptm180 -76.46 -31.57 57.88 Favored 'General case' 0 CA--C 1.567 1.602 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 167.205 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.492 ' HA ' ' HG3' ' A' ' 147' ' ' GLU . 77.6 p -141.59 134.62 29.06 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 -166.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -51.51 -38.29 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-N 120.298 1.408 . . . . 0.0 113.843 177.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.8 -38.62 91.61 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 120.753 3.612 . . . . 0.0 120.753 174.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -74.32 -47.81 32.26 Favored 'General case' 0 CA--C 1.587 2.401 0 CA-C-N 122.99 2.632 . . . . 0.0 111.802 166.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.33 -35.16 69.53 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 118.493 2.775 . . . . 0.0 118.493 -176.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.4 tttt -59.93 -26.6 66.09 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 116.571 2.063 . . . . 0.0 116.571 170.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.35 -43.86 84.87 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 168.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 23.6 tp -61.72 -37.93 86.01 Favored 'General case' 0 CA--C 1.569 1.695 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 169.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 28.9 t60 -67.85 -41.65 82.59 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 120.405 1.457 . . . . 0.0 113.749 169.081 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 1.35 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 0.5 OUTLIER -53.24 -35.05 59.56 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 167.414 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 99' ' ' MET . . . . . 1.183 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 63.3 mtt -85.39 -29.57 24.31 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 118.317 2.71 . . . . 0.0 118.317 171.014 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 tt -69.35 -54.65 13.44 Favored 'General case' 0 N--CA 1.502 2.16 0 CA-C-N 122.076 2.216 . . . . 0.0 111.126 173.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -77.23 -50.37 13.06 Favored 'General case' 0 CA--C 1.563 1.48 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 174.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 1.35 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 23.3 tpp180 -71.93 -46.06 58.93 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 178.63 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 1.183 ' HB3' ' O ' ' A' ' 99' ' ' MET . 21.5 tpp180 -63.94 -49.66 71.71 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 119.036 0.835 . . . . 0.0 111.793 167.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 106.31 50.07 0.89 Allowed Glycine 0 N--CA 1.485 1.941 0 CA-C-O 121.767 0.648 . . . . 0.0 114.162 167.333 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.8 p -92.67 168.96 10.87 Favored 'General case' 0 CA--C 1.567 1.612 0 CA-C-N 113.207 -1.496 . . . . 0.0 110.712 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.47 132.14 45.11 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.034 -1.041 . . . . 0.0 110.919 -175.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 6.4 tp -105.79 96.99 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 174.512 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -100.25 -77.04 0.54 Allowed 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 115.391 -2.242 . . . . 0.0 107.69 166.62 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -140.71 126.14 18.82 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 122.25 2.295 . . . . 0.0 115.5 -171.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 72.8 t -88.92 116.58 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 101.406 -3.553 . . . . 0.0 101.406 160.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.294 20.7 tp -112.93 90.22 3.29 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 113.14 -1.846 . . . . 0.0 109.17 -165.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -89.71 132.22 35.29 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -177.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -97.73 123.87 41.84 Favored 'General case' 0 CA--C 1.566 1.584 0 CA-C-O 123.202 1.477 . . . . 0.0 110.594 -172.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -93.4 104.01 16.19 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 127.299 2.24 . . . . 0.0 108.868 173.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.2 m -133.3 143.0 40.43 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.594 0 CA-C-N 113.12 -1.855 . . . . 0.0 109.837 -165.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' SER . . . . . 0.656 ' O ' HG22 ' A' ' 119' ' ' VAL . 19.6 m -91.72 155.42 18.29 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 123.417 0.687 . . . . 0.0 112.727 -176.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -45.31 -32.18 1.9 Allowed 'General case' 0 N--CA 1.506 2.366 0 N-CA-C 117.618 2.451 . . . . 0.0 117.618 171.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -48.98 -38.99 24.85 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 117.282 2.326 . . . . 0.0 117.282 171.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.656 HG22 ' O ' ' A' ' 116' ' ' SER . 2.6 m -60.11 -43.26 92.51 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.442 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 173.184 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 1.113 ' HA ' ' HB2' ' A' ' 123' ' ' ARG . 53.1 mt -58.25 -34.26 70.28 Favored 'General case' 0 N--CA 1.515 2.82 0 CA-C-O 123.315 1.531 . . . . 0.0 113.936 164.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.477 ' O ' ' HB3' ' A' ' 125' ' ' LYS . 15.9 mt -68.9 -21.36 64.24 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 175.072 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.451 ' O ' ' HA ' ' A' ' 124' ' ' LEU . 9.5 mm-40 -68.59 -60.69 2.24 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 113.49 -3.148 . . . . 0.0 106.626 155.572 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 1.113 ' HB2' ' HA ' ' A' ' 120' ' ' LEU . 14.8 mmt180 -25.15 47.74 0.0 OUTLIER 'General case' 0 N--CA 1.531 3.608 3 O-C-N 131.316 5.385 . . . . 0.0 122.118 156.436 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LEU . . . . . 0.451 ' HA ' ' O ' ' A' ' 122' ' ' GLU 0.368 0.0 OUTLIER 36.04 27.13 0.01 OUTLIER 'General case' 0 C--N 1.277 -2.574 3 C-N-CA 140.19 7.396 . . . . 0.0 129.594 -150.735 . . . . . . . . 5 4 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.477 ' HB3' ' O ' ' A' ' 121' ' ' LEU . 77.2 tttt -62.86 -18.08 62.38 Favored 'General case' 0 CA--C 1.599 2.856 0 C-N-CA 114.896 -2.721 . . . . 0.0 112.648 150.281 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.873 ' O ' ' HB2' ' A' ' 127' ' ' ARG . . . -83.32 -44.3 7.05 Favored Glycine 0 C--N 1.386 3.33 0 CA-C-N 124.717 3.417 . . . . 0.0 115.615 173.68 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.873 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 76.0 ttt180 153.3 110.51 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.351 1.575 . . . . 0.0 109.056 -177.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -166.11 -32.53 0.02 OUTLIER Glycine 0 CA--C 1.547 2.076 0 N-CA-C 117.641 1.817 . . . . 0.0 117.641 -173.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.412 ' HB3' ' H ' ' A' ' 130' ' ' ALA . 94.7 mtt180 -146.24 -157.25 0.78 Allowed 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 120.12 1.96 . . . . 0.0 113.3 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.412 ' H ' ' HB3' ' A' ' 129' ' ' ARG . . . -149.88 56.92 0.97 Allowed 'General case' 0 CA--C 1.575 1.912 0 CA-C-N 113.521 -1.672 . . . . 0.0 111.353 -172.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.1 p30 45.66 49.23 11.26 Favored 'General case' 0 N--CA 1.507 2.388 0 N-CA-C 119.177 3.029 . . . . 0.0 119.177 -177.131 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -70.52 -40.24 73.61 Favored 'General case' 0 N--CA 1.508 2.454 0 CA-C-N 113.454 -1.703 . . . . 0.0 109.381 155.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 75.2 p -57.14 -165.72 0.0 OUTLIER 'General case' 0 CA--C 1.584 2.275 0 C-N-CA 128.431 2.692 . . . . 0.0 111.043 157.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.5 t70 70.64 -62.45 0.44 Allowed 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 128.819 2.848 . . . . 0.0 111.792 -167.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -69.27 -42.9 74.91 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 167.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.3 t -63.57 -40.32 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 CA-C-N 119.379 0.991 . . . . 0.0 113.248 169.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 47.2 mm -63.08 -35.62 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 CA-C-O 117.821 -1.085 . . . . 0.0 113.748 169.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 26.4 mt -65.45 -46.97 77.78 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 120.654 1.57 . . . . 0.0 114.464 171.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -65.4 -37.39 86.84 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 172.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -60.58 -42.65 97.14 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 167.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 13.6 tpt -61.5 -32.15 72.17 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 168.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -60.96 -49.1 78.81 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 166.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 29.1 t -65.13 -25.46 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 169.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -65.45 -49.43 69.17 Favored 'General case' 0 CA--C 1.577 1.982 0 CA-C-N 119.74 1.154 . . . . 0.0 111.864 169.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -61.34 -44.51 97.07 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 117.71 2.485 . . . . 0.0 117.71 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -56.18 -32.22 64.14 Favored 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 117.785 2.513 . . . . 0.0 117.785 177.048 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.492 ' HG3' ' HA ' ' A' ' 89' ' ' SER . 4.4 mm-40 -121.38 -40.5 2.57 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 118.684 2.846 . . . . 0.0 118.684 -163.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 95.7 m -46.64 -39.96 12.24 Favored 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 118.226 2.676 . . . . 0.0 118.226 -167.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.38 -61.16 4.12 Favored Pre-proline 0 CA--C 1.579 2.07 0 CA-C-O 116.17 -1.871 . . . . 0.0 112.05 173.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -52.01 -32.58 49.0 Favored 'Trans proline' 0 CA--C 1.578 2.692 0 C-N-CA 123.374 2.716 . . . . 0.0 118.568 167.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -66.57 -51.51 55.69 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 125.193 1.397 . . . . 0.0 111.462 176.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 1.187 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 47.7 tp -64.49 -21.23 66.61 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 171.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -71.92 -48.73 43.37 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 122.657 2.48 . . . . 0.0 112.944 164.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -61.03 -56.74 17.42 Favored 'General case' 0 CA--C 1.57 1.718 0 CA-C-N 120.191 1.359 . . . . 0.0 112.711 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -77.13 -28.04 54.17 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-O 115.348 -2.263 . . . . 0.0 112.774 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 1.187 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 38.3 ttt180 -60.35 -37.23 80.04 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 124.017 3.099 . . . . 0.0 116.259 169.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -67.76 -37.91 82.74 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 167.358 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -79.96 -33.22 39.7 Favored 'General case' 0 CA--C 1.579 2.09 0 N-CA-C 119.623 3.194 . . . . 0.0 119.623 177.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.1 pp -82.01 174.72 10.98 Favored 'General case' 0 CA--C 1.575 1.907 0 N-CA-C 121.324 3.824 . . . . 0.0 121.324 -159.673 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -128.64 139.66 52.15 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 164.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.1 t -102.77 152.56 21.1 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 122.515 1.15 . . . . 0.0 112.362 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 53.2 t -120.26 139.29 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 168.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -94.52 134.53 36.96 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 167.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -157.88 95.56 1.42 Allowed 'General case' 0 N--CA 1.484 1.243 0 CA-C-O 122.791 1.281 . . . . 0.0 110.886 -164.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.5 t -151.92 124.95 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-N 113.143 -1.844 . . . . 0.0 106.878 -171.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 78.62 -74.34 2.13 Favored Glycine 0 N--CA 1.483 1.798 0 N-CA-C 117.749 1.86 . . . . 0.0 117.749 168.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 42.9 p -79.59 147.52 32.06 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 112.008 -2.096 . . . . 0.0 112.527 -169.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 65.8 mtt -91.39 -65.31 1.02 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.259 0.623 . . . . 0.0 111.154 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -68.28 -37.88 81.13 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 -176.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -61.26 -48.71 80.16 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 169.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 69.9 t -55.74 -39.44 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 173.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -60.43 -35.62 76.26 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 168.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -58.81 -48.33 81.67 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 171.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 81.5 mtt-85 -60.8 -36.85 80.08 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 117.874 2.546 . . . . 0.0 117.874 168.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.85 -44.09 97.47 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 172.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . 0.272 0.2 OUTLIER -71.26 -38.7 71.87 Favored 'General case' 0 N--CA 1.507 2.383 0 CA-C-N 120.014 1.279 . . . . 0.0 114.332 169.031 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -49.57 -39.3 34.53 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 168.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -70.3 -52.53 22.16 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 166.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -102.29 -60.03 1.61 Allowed 'General case' 0 CA--C 1.564 1.515 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -169.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.633 ' O ' ' CB ' ' A' ' 181' ' ' LYS . . . -79.22 -37.0 25.88 Favored Glycine 0 CA--C 1.551 2.34 0 CA-C-N 121.554 1.979 . . . . 0.0 118.036 -170.141 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.633 ' CB ' ' O ' ' A' ' 180' ' ' GLY . 37.2 ttmt . . . . . 0 C--O 1.252 1.212 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -177.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.7 mtt . . . . . 0 N--CA 1.483 1.217 0 CA-C-O 121.76 0.791 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.559 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -160.42 155.36 24.37 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -166.8 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.6 t -135.07 150.67 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 114.34 -1.3 . . . . 0.0 111.607 -168.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.405 HD22 HH12 ' A' ' 2' ' ' ARG . 2.2 mm? -125.7 122.13 35.42 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 114.003 -1.453 . . . . 0.0 108.607 169.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.8 tt -95.91 119.54 34.59 Favored 'General case' 0 CA--C 1.572 1.8 0 CA-C-O 122.504 1.145 . . . . 0.0 111.94 -173.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 33.0 mt -104.8 160.03 15.32 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 111.074 -2.785 . . . . 0.0 110.97 175.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 165.68 129.46 1.05 Allowed Glycine 0 CA--C 1.549 2.19 0 CA-C-O 117.355 -1.803 . . . . 0.0 113.77 171.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -58.01 169.72 2.57 Favored 'Trans proline' 0 CA--C 1.581 2.855 0 CA-C-N 122.035 2.917 . . . . 0.0 114.881 168.061 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -50.76 121.51 8.16 Favored 'Trans proline' 0 CA--C 1.561 1.845 0 C-N-CA 123.749 2.966 . . . . 0.0 115.103 176.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.91 103.68 0.19 Allowed Glycine 0 CA--C 1.536 1.351 0 N-CA-C 108.133 -1.987 . . . . 0.0 108.133 -167.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.414 ' H ' ' HB2' ' A' ' 120' ' ' LEU . . . -57.46 112.94 1.57 Allowed 'General case' 0 CA--C 1.566 1.561 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 -178.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -173.13 -117.13 0.44 Allowed Glycine 0 N--CA 1.482 1.754 0 N-CA-C 107.058 -2.417 . . . . 0.0 107.058 173.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.6 mttt 64.8 -92.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 164.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -50.53 -22.03 5.12 Favored Glycine 0 CA--C 1.554 2.496 0 N-CA-C 120.955 3.142 . . . . 0.0 120.955 174.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 98.1 m -68.27 -53.0 27.54 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 120.036 1.918 . . . . 0.0 112.265 173.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.261 14.4 mm-40 -76.48 -15.43 59.9 Favored 'General case' 0 CA--C 1.574 1.87 0 CA-C-O 115.508 -2.187 . . . . 0.0 112.295 171.418 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.96 -41.49 67.66 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 124.211 3.187 . . . . 0.0 115.265 167.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.5 t -70.89 -40.66 76.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 CA-C-O 117.84 -1.076 . . . . 0.0 111.766 173.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -61.44 -42.11 98.24 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 169.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 23.6 mt -67.93 -32.4 72.82 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 170.841 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.02 -40.12 96.78 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 120.267 1.394 . . . . 0.0 114.446 167.473 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -59.77 -37.6 79.5 Favored 'General case' 0 CA--C 1.565 1.554 0 N-CA-C 114.889 1.441 . . . . 0.0 114.889 166.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -68.61 -53.99 19.22 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 120.561 1.528 . . . . 0.0 114.787 174.327 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.4 mp -81.73 -22.83 37.07 Favored 'General case' 0 CA--C 1.573 1.861 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 -177.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.68 38.64 7.46 Favored Glycine 0 CA--C 1.555 2.546 0 N-CA-C 117.507 1.763 . . . . 0.0 117.507 -174.29 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.454 ' CG2' ' HA ' ' A' ' 81' ' ' PHE . 23.6 mm -106.46 157.02 35.99 Favored Pre-proline 0 CA--C 1.565 1.551 0 CA-C-N 118.647 1.224 . . . . 0.0 112.876 -169.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -73.79 102.86 1.56 Allowed 'Trans proline' 0 CA--C 1.558 1.724 0 C-N-CA 121.49 1.46 . . . . 0.0 111.968 159.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.7 tm0? -69.48 106.54 3.02 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 166.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 34.2 mm -97.95 109.33 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 63.4 p -95.59 129.22 42.86 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 169.523 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.3 p -74.07 2.17 9.45 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 117.241 2.311 . . . . 0.0 117.241 -174.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.477 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -97.14 -22.17 18.16 Favored Glycine 0 CA--C 1.54 1.628 0 N-CA-C 118.703 2.241 . . . . 0.0 118.703 163.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -81.21 -54.27 5.65 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 119.37 1.585 . . . . 0.0 114.618 -168.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -65.44 -38.66 90.52 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 113.037 0.755 . . . . 0.0 113.037 175.117 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.467 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 56.8 m-85 -68.79 -42.48 77.3 Favored 'General case' 0 CA--C 1.56 1.332 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 173.166 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 73.9 ttt180 -58.76 -42.24 88.44 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 115.046 1.498 . . . . 0.0 115.046 169.034 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -61.51 -39.02 89.48 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 115.227 1.566 . . . . 0.0 115.227 169.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -68.82 -27.57 65.96 Favored 'General case' 0 CA--C 1.575 1.932 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 168.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.644 HD11 ' HB3' ' A' ' 50' ' ' LYS . 86.1 mt -63.86 -43.94 97.96 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 CA-C-N 120.104 1.32 . . . . 0.0 111.251 167.251 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -64.02 -42.31 97.17 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 173.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -65.51 -41.74 92.82 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 173.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.4 70.83 1.17 Allowed Glycine 0 CA--C 1.539 1.593 0 CA-C-O 118.091 -1.394 . . . . 0.0 113.368 -177.036 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.545 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 67.0 p -92.16 -65.62 0.99 Allowed 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 119.187 1.494 . . . . 0.0 111.644 177.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.545 ' CB ' ' O ' ' A' ' 43' ' ' THR . 21.2 ptmt 128.81 -55.68 0.0 OUTLIER 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 123.934 0.894 . . . . 0.0 109.899 -166.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -75.76 -6.57 51.25 Favored 'General case' 0 CA--C 1.568 1.638 0 CA-C-O 118.136 -0.935 . . . . 0.0 113.021 167.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.22 -54.21 11.8 Favored Glycine 0 CA--C 1.544 1.905 0 CA-C-N 120.652 1.569 . . . . 0.0 113.254 166.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.292 11.9 p -76.22 -46.62 33.03 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.706 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 -169.122 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -56.38 -49.28 74.91 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 121.744 2.065 . . . . 0.0 113.339 169.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.03 -38.5 91.28 Favored 'General case' 0 C--N 1.348 0.527 0 CA-C-N 113.517 -1.674 . . . . 0.0 114.293 -176.063 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.644 ' HB3' HD11 ' A' ' 39' ' ' ILE . 5.1 tptt -80.14 -17.16 53.27 Favored 'General case' 0 CA--C 1.565 1.545 0 CA-C-O 116.809 -1.567 . . . . 0.0 113.855 173.026 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 62.6 mtp180 -76.59 -55.61 5.37 Favored 'General case' 0 CA--C 1.598 2.815 1 CA-C-O 86.227 -16.13 . . . . 0.0 118.297 172.572 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . 0.346 0.1 OUTLIER -38.02 -61.57 0.64 Allowed 'General case' 0 N--CA 1.516 2.847 1 O-C-N 109.303 -8.373 . . . . 0.0 120.564 149.349 . . . . . . . . 4 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 60.3 mt -58.05 -23.66 55.31 Favored 'General case' 0 N--CA 1.518 2.948 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 177.769 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -93.32 -49.41 5.96 Favored 'General case' 0 CA--C 1.571 1.763 0 CA-C-O 116.486 -1.721 . . . . 0.0 114.56 166.685 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -104.28 -5.57 21.72 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 118.112 2.634 . . . . 0.0 118.112 -170.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.673 ' HA2' HH11 ' A' ' 88' ' ' ARG . . . 73.64 47.09 22.22 Favored Glycine 0 CA--C 1.544 1.847 0 CA-C-N 122.203 2.274 . . . . 0.0 115.241 -178.257 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -101.51 -175.3 2.82 Favored 'General case' 0 CA--C 1.568 1.642 0 C-N-CA 123.763 0.825 . . . . 0.0 110.807 -170.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 74.7 mt -100.56 99.6 10.2 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.4 t -148.26 130.93 7.86 Favored Pre-proline 0 CA--C 1.586 2.353 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -169.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -50.15 161.01 1.18 Allowed 'Trans proline' 0 CA--C 1.567 2.152 0 C-N-CA 124.446 3.43 . . . . 0.0 120.955 -177.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 58.4 m -91.25 -53.88 4.16 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -174.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -57.86 -36.35 72.2 Favored 'General case' 0 N--CA 1.506 2.366 0 N-CA-C 117.412 2.375 . . . . 0.0 117.412 -171.235 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 79.5 mt -46.54 -45.56 18.73 Favored 'General case' 0 N--CA 1.506 2.358 0 N-CA-C 118.137 2.643 . . . . 0.0 118.137 170.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.2 m -70.04 -48.88 56.1 Favored 'General case' 0 CA--C 1.562 1.422 0 CA-C-N 112.223 -2.262 . . . . 0.0 112.756 177.897 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.64 -22.86 62.47 Favored 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 167.031 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -75.85 -42.36 49.72 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 125.395 1.478 . . . . 0.0 114.908 171.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.8 mt -59.53 -50.39 74.1 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 168.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 87.7 t -63.07 -47.8 90.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 CA-C-O 118.023 -0.989 . . . . 0.0 111.72 177.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -64.4 -30.4 71.44 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 116.443 2.016 . . . . 0.0 116.443 172.172 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -60.85 -41.21 95.4 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 119.714 1.143 . . . . 0.0 113.255 168.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 20.5 ttm-85 -81.52 -13.94 57.5 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 119.021 2.971 . . . . 0.0 119.021 169.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.8 mt -95.08 -16.86 22.34 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 117.656 2.465 . . . . 0.0 117.656 175.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -66.81 8.64 0.24 Allowed 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 118.014 2.598 . . . . 0.0 118.014 176.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -68.32 136.82 91.23 Favored Pre-proline 0 CA--C 1.574 1.873 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 163.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -52.87 -35.94 72.32 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 N-CA-C 119.292 2.766 . . . . 0.0 119.292 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -70.08 -19.02 63.28 Favored 'General case' 0 CA--C 1.569 1.686 0 N-CA-C 116.485 2.032 . . . . 0.0 116.485 171.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -109.56 16.16 22.4 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 116.265 1.95 . . . . 0.0 116.265 176.335 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.2 -53.56 10.64 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 121.138 1.79 . . . . 0.0 114.535 169.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.559 ' O ' ' HG2' ' A' ' 2' ' ' ARG . 24.7 p30 -74.1 -34.97 64.14 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 172.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.508 ' HA2' ' HB3' ' A' ' 2' ' ' ARG . . . -112.4 148.83 18.34 Favored Glycine 0 N--CA 1.482 1.723 0 CA-C-N 120.095 1.316 . . . . 0.0 114.256 177.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.549 ' H ' ' HB3' ' A' ' 2' ' ' ARG . 37.6 p90 178.58 135.76 0.08 Allowed 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 112.208 -1.996 . . . . 0.0 111.88 -178.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 21.7 mt -115.23 109.55 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 174.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.7 mt -106.15 126.0 51.68 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 174.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -108.09 127.71 54.04 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 119.272 0.942 . . . . 0.0 110.36 176.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.39 37.93 80.05 Favored Glycine 0 CA--C 1.556 2.653 0 N-CA-C 117.202 1.641 . . . . 0.0 117.202 -176.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -92.87 -54.06 0.25 Allowed Pre-proline 0 N--CA 1.494 1.765 0 CA-C-O 114.935 -2.46 . . . . 0.0 108.223 175.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -65.3 70.87 0.29 Allowed 'Trans proline' 0 CA--C 1.571 2.344 0 CA-C-N 124.343 2.587 . . . . 0.0 117.289 165.252 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.673 HH11 ' HA2' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -71.67 -24.28 61.81 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 166.714 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.8 t -150.93 151.39 32.09 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 -176.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 36.7 t -62.07 -40.25 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 CA-C-O 117.924 -1.036 . . . . 0.0 112.173 174.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -68.66 -25.37 64.77 Favored 'General case' 0 CA--C 1.55 0.981 0 N-CA-C 119.656 3.206 . . . . 0.0 119.656 174.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.04 -51.34 12.52 Favored 'General case' 0 CA--C 1.589 2.462 0 CA-C-N 123.405 2.82 . . . . 0.0 110.078 163.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -54.58 -28.11 43.78 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 117.834 2.531 . . . . 0.0 117.834 -176.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -58.79 -32.71 69.58 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 166.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.67 -44.31 86.66 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 169.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.6 tp -60.63 -39.03 86.75 Favored 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 170.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 51.0 t-80 -70.08 -42.86 72.22 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 120.021 1.282 . . . . 0.0 113.973 171.095 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 1.114 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 32.1 mt-10 -52.1 -36.46 51.0 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 166.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' MET . . . . . 1.061 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 25.2 ttt -84.37 -24.49 29.67 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 117.927 2.566 . . . . 0.0 117.927 171.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.607 HD21 HD13 ' A' ' 107' ' ' ILE . 66.3 tp -65.77 -55.65 16.12 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 120.771 1.623 . . . . 0.0 112.572 169.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -79.79 -50.8 10.02 Favored 'General case' 0 CA--C 1.562 1.427 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 175.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 1.114 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 73.4 ttt180 -66.87 -45.69 77.29 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 176.612 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 1.061 ' HB3' ' O ' ' A' ' 99' ' ' MET . 1.2 tmt_? -63.24 -55.85 21.44 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.01 0.524 . . . . 0.0 111.168 165.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.34 46.83 1.04 Allowed Glycine 0 N--CA 1.48 1.603 0 O-C-N 124.013 0.82 . . . . 0.0 113.347 169.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 67.4 p -93.53 152.28 19.15 Favored 'General case' 0 CA--C 1.561 1.39 0 O-C-N 124.402 0.707 . . . . 0.0 109.666 175.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -82.73 129.1 34.92 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.444 -0.785 . . . . 0.0 111.557 -169.091 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.607 HD13 HD21 ' A' ' 100' ' ' LEU . 7.6 tp -89.99 107.68 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 -173.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -90.33 -68.04 0.81 Allowed 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 117.006 -1.473 . . . . 0.0 107.082 168.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -159.0 137.92 11.16 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 120.887 1.676 . . . . 0.0 114.513 177.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.6 t -91.91 109.71 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.676 0 N-CA-C 100.863 -3.755 . . . . 0.0 100.863 161.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.309 25.8 tp -111.68 103.61 11.92 Favored 'General case' 0 CA--C 1.558 1.288 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.858 -161.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -94.12 129.65 40.61 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.449 0.643 . . . . 0.0 112.248 -177.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -92.55 119.04 31.62 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-O 123.157 1.456 . . . . 0.0 110.164 -178.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -84.08 96.8 9.02 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 112.527 -2.124 . . . . 0.0 109.347 168.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.0 p -137.36 131.64 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 125.245 1.418 . . . . 0.0 107.922 -168.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 58.5 m -86.28 142.12 28.77 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 114.111 -1.404 . . . . 0.0 112.329 -169.653 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -63.1 -26.83 69.01 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 116.76 2.133 . . . . 0.0 116.76 -176.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -58.62 -44.48 90.0 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 170.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -49.79 -45.56 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 175.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.414 ' HB2' ' H ' ' A' ' 11' ' ' ALA . 2.9 tm? -64.05 -52.51 59.06 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 124.683 1.193 . . . . 0.0 112.308 171.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.1 mp -50.91 -41.45 58.66 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 170.392 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -60.23 -47.78 84.53 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 125.11 1.364 . . . . 0.0 114.367 169.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -52.22 -52.23 53.59 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 168.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 81.3 mt -56.54 -43.14 79.57 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 171.667 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -58.17 -53.45 58.09 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 173.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -88.49 38.44 3.19 Favored Glycine 0 CA--C 1.551 2.335 0 N-CA-C 117.135 1.614 . . . . 0.0 117.135 171.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -150.13 -115.61 0.05 Allowed 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 118.491 1.146 . . . . 0.0 109.909 169.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.901 ' O ' ' HB2' ' A' ' 129' ' ' ARG . . . 178.4 -175.83 47.65 Favored Glycine 0 CA--C 1.571 3.532 0 CA-C-N 115.04 -0.982 . . . . 0.0 113.784 -172.155 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.901 ' HB2' ' O ' ' A' ' 128' ' ' GLY . 18.2 tpt180 158.01 128.16 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 121.137 2.469 . . . . 0.0 110.387 176.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -91.01 65.82 5.69 Favored 'General case' 0 CA--C 1.575 1.929 0 C-N-CA 123.443 0.697 . . . . 0.0 112.082 -178.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 65.04 5.75 3.12 Favored 'General case' 0 N--CA 1.507 2.406 0 N-CA-C 119.271 3.063 . . . . 0.0 119.271 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -91.54 57.9 3.41 Favored 'General case' 0 N--CA 1.506 2.374 0 CA-C-O 123.662 1.696 . . . . 0.0 107.118 160.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . 0.306 3.0 m -129.32 -118.33 0.24 Allowed 'General case' 0 CA--C 1.558 1.27 0 CA-C-N 112.582 -2.099 . . . . 0.0 109.742 -160.342 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -80.9 -33.38 34.29 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -64.46 -48.65 74.45 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 176.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.0 p -58.46 -36.78 60.61 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.948 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 168.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 1.3 mp -66.27 -34.9 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 C-N-CA 124.456 1.102 . . . . 0.0 113.684 169.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 40.6 mt -66.69 -39.38 88.06 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 120.258 1.39 . . . . 0.0 114.131 170.554 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -64.73 -36.71 85.16 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-N 120.347 1.431 . . . . 0.0 114.043 168.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 70.0 mtp180 -57.96 -39.69 78.76 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 165.272 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 25.3 ttt -64.58 -30.96 71.99 Favored 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 168.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -62.85 -48.03 80.79 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 168.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.5 p -66.47 -35.61 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 171.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -53.94 -54.07 43.92 Favored 'General case' 0 CA--C 1.585 2.3 0 CA-C-N 120.073 1.306 . . . . 0.0 111.436 167.528 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 32.4 ttp180 -51.99 -32.97 35.98 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 119.296 3.073 . . . . 0.0 119.296 172.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -52.86 -38.56 61.69 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 173.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -140.34 26.73 2.15 Favored 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 117.534 2.42 . . . . 0.0 117.534 -177.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 39.5 m -47.69 -37.39 12.89 Favored 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 116.053 1.872 . . . . 0.0 116.053 173.296 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -69.73 -60.2 3.98 Favored Pre-proline 0 CA--C 1.578 2.026 0 CA-C-O 116.75 -1.595 . . . . 0.0 112.102 172.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -49.87 -30.79 24.62 Favored 'Trans proline' 0 CA--C 1.576 2.605 0 C-N-CA 123.375 2.716 . . . . 0.0 118.562 167.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -63.86 -55.39 23.15 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 125.515 1.526 . . . . 0.0 111.722 173.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.917 ' O ' ' HB2' ' A' ' 156' ' ' ARG 0.317 0.0 OUTLIER -63.41 -26.11 68.59 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 177.021 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -70.52 -50.92 32.7 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 120.68 1.582 . . . . 0.0 114.182 167.234 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -67.93 -53.91 22.75 Favored 'General case' 0 CA--C 1.557 1.225 0 CA-C-N 120.007 1.276 . . . . 0.0 111.398 -176.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . 0.256 67.5 m-85 -84.98 -19.69 31.69 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-O 114.959 -2.448 . . . . 0.0 113.387 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.917 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 40.6 ttt180 -70.73 -35.62 72.77 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 125.077 3.58 . . . . 0.0 115.073 168.386 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -69.01 -37.59 78.76 Favored 'General case' 0 CA--C 1.573 1.854 0 CA-C-N 120.08 1.309 . . . . 0.0 113.906 167.071 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -84.2 -33.03 24.24 Favored 'General case' 0 CA--C 1.572 1.791 0 N-CA-C 118.727 2.862 . . . . 0.0 118.727 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.8 pp -75.46 172.05 13.2 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 118.437 2.754 . . . . 0.0 118.437 -162.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -131.83 141.31 49.39 Favored 'General case' 0 CA--C 1.558 1.258 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 166.302 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 54.5 m -99.9 146.67 26.39 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 122.351 1.072 . . . . 0.0 110.731 -173.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 30.0 t -123.39 134.34 66.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 167.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -93.83 130.11 39.98 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 167.776 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -154.7 93.63 1.59 Allowed 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 122.623 1.201 . . . . 0.0 111.9 -163.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.1 t -150.85 126.92 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 CA-C-N 114.16 -1.382 . . . . 0.0 107.391 -176.207 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 78.9 -71.82 2.53 Favored Glycine 0 N--CA 1.483 1.786 0 N-CA-C 118.205 2.042 . . . . 0.0 118.205 167.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 42.7 p -78.09 142.8 37.89 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 112.163 -2.018 . . . . 0.0 112.453 -168.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 27.8 ttt -86.93 -68.35 0.75 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.456 0.702 . . . . 0.0 111.259 -177.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -70.16 -36.0 74.41 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 116.153 1.909 . . . . 0.0 116.153 -177.312 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -59.94 -49.61 77.0 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 170.023 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 94.5 t -56.69 -37.92 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 173.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -61.42 -34.55 75.57 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 167.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -61.0 -43.24 99.18 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 170.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 81.1 mtt-85 -66.65 -33.87 76.61 Favored 'General case' 0 CA--C 1.554 1.131 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 169.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.23 -47.1 85.91 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 171.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . 0.294 0.5 OUTLIER -69.3 -34.0 74.02 Favored 'General case' 0 N--CA 1.504 2.228 0 CA-C-N 120.196 1.362 . . . . 0.0 114.506 169.214 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 29.3 mtp180 -49.23 -45.26 44.33 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 166.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -67.39 -51.33 53.23 Favored 'General case' 0 CA--C 1.565 1.546 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 168.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.81 -62.88 1.39 Allowed 'General case' 0 CA--C 1.566 1.571 0 CA-C-O 117.981 -1.009 . . . . 0.0 112.84 -175.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.89 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -91.39 -54.92 1.89 Allowed Glycine 0 CA--C 1.552 2.402 0 CA-C-O 117.983 -1.454 . . . . 0.0 114.802 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.89 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 55.0 tttp . . . . . 0 C--O 1.251 1.169 0 CA-C-N 119.861 1.83 . . . . 0.0 109.612 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.0 mtt . . . . . 0 CA--C 1.561 1.371 0 CA-C-O 122.933 1.349 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . 0.309 11.7 mpt_? -122.67 167.48 13.38 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 120.747 3.61 . . . . 0.0 120.747 -164.787 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.1 p -148.25 141.24 18.74 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.656 0 CA-C-O 123.87 1.795 . . . . 0.0 112.568 166.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -116.55 136.99 52.52 Favored 'General case' 0 CA--C 1.56 1.341 0 CA-C-N 111.971 -2.377 . . . . 0.0 104.853 166.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.5 mt -111.85 128.81 56.24 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 122.693 1.235 . . . . 0.0 111.433 -176.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.545 HD11 HG12 ' A' ' 110' ' ' VAL . 5.8 mp -130.75 155.42 46.67 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 111.564 -2.562 . . . . 0.0 111.455 -164.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 144.5 168.87 12.84 Favored Glycine 0 CA--C 1.554 2.522 0 CA-C-O 119.134 -0.814 . . . . 0.0 114.701 169.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.53 122.52 11.91 Favored 'Trans proline' 0 CA--C 1.573 2.474 0 C-N-CA 123.462 2.774 . . . . 0.0 113.448 172.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -80.46 108.11 2.1 Favored 'Trans proline' 0 CA--C 1.558 1.7 0 C-N-CA 122.516 2.144 . . . . 0.0 116.007 -166.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -158.35 -93.33 0.1 OUTLIER Glycine 0 CA--C 1.537 1.439 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 168.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -72.13 -80.49 0.06 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 -169.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.697 ' O ' ' CG ' ' A' ' 13' ' ' LYS . . . -92.85 150.23 19.9 Favored Glycine 0 N--CA 1.486 1.997 0 CA-C-N 119.683 1.129 . . . . 0.0 114.717 -169.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.697 ' CG ' ' O ' ' A' ' 12' ' ' GLY . 0.2 OUTLIER 153.56 -84.71 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -172.585 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.12 -32.81 57.11 Favored Glycine 0 CA--C 1.553 2.469 0 N-CA-C 120.057 2.783 . . . . 0.0 120.057 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 78.5 m -63.21 -48.79 76.84 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 119.116 1.458 . . . . 0.0 113.294 172.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.252 6.7 mm-40 -75.57 -15.85 60.32 Favored 'General case' 0 CA--C 1.57 1.713 0 CA-C-O 115.749 -2.072 . . . . 0.0 111.972 172.23 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.31 -47.44 61.12 Favored 'General case' 0 C--N 1.374 1.642 0 CA-C-N 123.605 2.911 . . . . 0.0 114.249 168.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.7 p -66.36 -42.11 90.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 174.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -63.96 -41.7 97.48 Favored 'General case' 0 CA--C 1.565 1.54 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 171.022 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mt -66.35 -30.91 71.4 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-N 120.819 1.645 . . . . 0.0 114.724 170.756 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.9 -42.88 98.89 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 167.555 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -58.46 -39.95 81.28 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 167.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.4 tptt -63.47 -55.54 23.32 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 172.301 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.0 mt -82.53 -21.51 35.36 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 117.068 2.247 . . . . 0.0 117.068 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.65 34.87 8.16 Favored Glycine 0 CA--C 1.556 2.614 0 N-CA-C 118.06 1.984 . . . . 0.0 118.06 -177.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.9 mm -109.06 159.42 31.21 Favored Pre-proline 0 CA--C 1.572 1.824 0 CA-C-N 119.059 1.429 . . . . 0.0 113.275 -168.438 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -83.88 101.53 0.9 Allowed 'Trans proline' 0 CA--C 1.568 2.184 0 C-N-CA 121.996 1.797 . . . . 0.0 110.592 163.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -59.54 113.94 2.47 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.647 0.779 . . . . 0.0 111.67 168.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 22.0 mm -98.35 106.21 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.212 0 N-CA-C 103.891 -2.633 . . . . 0.0 103.891 173.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 66.0 p -95.81 131.93 41.59 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 169.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.6 p -68.59 -11.21 59.7 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 117.312 2.338 . . . . 0.0 117.312 -174.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.512 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -87.65 -20.68 50.35 Favored Glycine 0 CA--C 1.544 1.846 0 N-CA-C 118.769 2.268 . . . . 0.0 118.769 166.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -81.63 -50.99 8.67 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 118.92 1.36 . . . . 0.0 114.652 -169.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -65.36 -37.75 87.98 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 174.254 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.598 ' HB3' ' CB ' ' A' ' 50' ' ' LYS . 27.2 m-85 -67.49 -41.88 83.81 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 169.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.512 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 73.2 ttt180 -57.08 -36.65 70.84 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 165.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.5 ttm180 -62.15 -43.05 99.69 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.568 1.147 . . . . 0.0 113.956 168.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -60.41 -43.81 96.33 Favored 'General case' 0 CA--C 1.573 1.852 0 CA-C-N 119.149 0.886 . . . . 0.0 113.255 167.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.473 ' HA ' HG23 ' A' ' 43' ' ' THR . 81.2 mt -51.27 -39.06 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.599 0 C-N-CA 125.93 1.692 . . . . 0.0 113.76 167.762 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -73.22 -32.62 64.88 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 115.786 1.772 . . . . 0.0 115.786 169.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -70.18 -50.43 40.28 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 175.855 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 166.33 -32.12 0.21 Allowed Glycine 0 CA--C 1.546 2.012 0 N-CA-C 117.818 1.887 . . . . 0.0 117.818 -169.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.618 ' O ' ' HG3' ' A' ' 44' ' ' LYS 0.322 44.7 p 49.45 125.29 0.0 OUTLIER 'General case' 0 N--CA 1.424 -1.749 1 N-CA-C 124.336 4.939 . . . . 0.0 124.336 -176.473 . . . . . . . . 4 3 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.618 ' HG3' ' O ' ' A' ' 43' ' ' THR 0.352 56.5 mtpt -142.46 -24.12 0.66 Allowed 'General case' 0 N--CA 1.507 2.406 0 CA-C-N 110.073 -3.239 . . . . 0.0 118.538 146.13 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -97.86 -24.93 15.21 Favored 'General case' 0 N--CA 1.514 2.726 0 CA-C-N 123.567 2.894 . . . . 0.0 112.332 161.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -40.52 -64.49 1.17 Allowed Glycine 0 CA--C 1.531 1.053 0 C-N-CA 130.583 3.944 . . . . 0.0 115.756 167.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.3 p -72.33 -48.65 47.19 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 N-CA-C 116.223 1.935 . . . . 0.0 116.223 -171.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -66.36 -44.85 82.05 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 120.359 1.436 . . . . 0.0 112.707 176.804 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.12 -38.43 85.57 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.598 ' CB ' ' HB3' ' A' ' 35' ' ' PHE 0.348 15.3 tptt -81.28 -19.79 42.27 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-O 116.943 -1.503 . . . . 0.0 113.238 174.613 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.596 ' O ' ' CG ' ' A' ' 51' ' ' ARG . 33.9 ttt180 -81.23 -57.76 3.36 Favored 'General case' 0 CA--C 1.59 2.501 1 CA-C-O 85.358 -16.544 . . . . 0.0 118.654 174.711 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 16.8 m-30 -28.28 -62.23 0.11 Allowed 'General case' 0 N--CA 1.497 1.91 1 O-C-N 107.744 -9.347 . . . . 0.0 120.853 147.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.5 tp -59.05 -33.8 71.19 Favored 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 116.415 2.006 . . . . 0.0 116.415 171.65 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -90.04 -39.99 12.58 Favored 'General case' 0 CA--C 1.567 1.603 0 N-CA-C 115.543 1.682 . . . . 0.0 115.543 174.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.53 -40.22 16.56 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 117.004 -1.474 . . . . 0.0 114.776 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 151.15 -38.91 0.83 Allowed Glycine 0 N--CA 1.476 1.333 0 CA-C-N 120.924 1.693 . . . . 0.0 116.729 170.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -67.31 171.72 5.59 Favored 'General case' 0 CA--C 1.57 1.741 0 CA-C-N 118.269 1.035 . . . . 0.0 111.626 -177.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 89.4 mt -92.76 135.93 33.69 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 121.383 -0.823 . . . . 0.0 112.12 -167.679 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 p -103.99 136.82 19.14 Favored Pre-proline 0 CA--C 1.58 2.12 0 CA-C-O 118.137 -0.935 . . . . 0.0 109.239 173.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -55.31 146.53 60.87 Favored 'Trans proline' 0 CA--C 1.562 1.911 0 C-N-CA 123.836 3.024 . . . . 0.0 116.671 169.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.8 m -73.97 -48.68 28.78 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 -168.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -61.52 -39.35 90.71 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 116.675 2.102 . . . . 0.0 116.675 -170.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 26.2 mt -57.3 -48.52 78.7 Favored 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 116.506 2.039 . . . . 0.0 116.506 172.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.4 m -61.31 -50.9 71.09 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 112.946 -1.934 . . . . 0.0 113.088 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 -64.08 -19.14 65.04 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 168.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -72.22 -44.12 63.41 Favored 'General case' 0 CA--C 1.558 1.273 0 CA-C-N 121.146 1.793 . . . . 0.0 114.18 168.573 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 mt -59.19 -49.96 75.86 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 120.207 1.367 . . . . 0.0 114.228 167.146 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 67.4 t -60.87 -46.79 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 123.811 0.844 . . . . 0.0 113.035 176.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -70.72 -27.16 63.76 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 175.136 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -64.47 -37.98 89.41 Favored 'General case' 0 CA--C 1.563 1.475 0 CA-C-N 119.808 1.186 . . . . 0.0 112.714 167.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -79.08 -24.0 43.79 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 118.414 2.746 . . . . 0.0 118.414 169.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.0 mp -81.7 -34.46 30.62 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 117.237 2.31 . . . . 0.0 117.237 176.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -71.53 15.96 0.12 Allowed 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 116.832 2.16 . . . . 0.0 116.832 169.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -75.77 144.35 76.46 Favored Pre-proline 0 CA--C 1.574 1.867 0 CA-C-O 118.024 -0.989 . . . . 0.0 108.947 165.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -47.72 -38.9 30.25 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 N-CA-C 119.156 2.714 . . . . 0.0 119.156 171.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.8 p30 -68.84 -16.03 63.66 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 117.043 2.238 . . . . 0.0 117.043 172.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -117.17 22.44 12.51 Favored 'General case' 0 CA--C 1.572 1.824 0 CA-C-N 121.567 1.985 . . . . 0.0 114.622 170.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.15 -46.29 67.95 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 121.65 2.023 . . . . 0.0 114.538 172.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -88.11 0.85 55.52 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 117.033 2.235 . . . . 0.0 117.033 172.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.61 167.51 38.53 Favored Glycine 0 N--CA 1.477 1.425 0 CA-C-N 121.998 2.181 . . . . 0.0 113.69 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -172.63 132.53 0.58 Allowed 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 112.875 -1.662 . . . . 0.0 107.729 -174.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 4.3 mm -101.2 107.67 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.563 0 N-CA-C 102.729 -3.063 . . . . 0.0 102.729 168.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.4 mt -100.97 133.95 44.69 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 169.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -125.32 129.98 51.06 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 119.33 0.968 . . . . 0.0 111.778 177.149 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.02 41.73 80.4 Favored Glycine 0 CA--C 1.546 1.984 0 CA-C-O 116.198 -2.445 . . . . 0.0 116.717 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . 0.257 1.6 t80 -106.28 -55.22 0.08 OUTLIER Pre-proline 0 N--CA 1.502 2.151 0 CA-C-N 121.281 2.54 . . . . 0.0 108.771 174.236 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -67.53 72.64 0.63 Allowed 'Trans proline' 0 CA--C 1.572 2.382 0 CA-C-N 124.02 2.471 . . . . 0.0 117.688 165.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.99 17.34 17.93 Favored 'General case' 0 CA--C 1.572 1.827 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 168.069 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.7 t -167.55 120.15 0.91 Allowed 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 101.656 -3.461 . . . . 0.0 101.656 -177.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . 0.342 4.6 p -69.01 -21.13 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 CA-C-O 116.337 -1.792 . . . . 0.0 111.991 -176.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -64.38 -31.39 72.58 Favored 'General case' 0 CA--C 1.557 1.247 0 N-CA-C 117.896 2.554 . . . . 0.0 117.896 162.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.28 -51.57 10.67 Favored 'General case' 0 CA--C 1.585 2.32 0 CA-C-N 124.034 3.106 . . . . 0.0 111.412 164.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.27 -29.13 68.61 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 117.274 2.324 . . . . 0.0 117.274 -172.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 64.7 tttt -56.34 -35.32 67.49 Favored 'General case' 0 CA--C 1.557 1.213 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 167.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.32 -37.33 74.69 Favored 'General case' 0 CA--C 1.566 1.559 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 169.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 22.9 tp -65.55 -34.03 77.29 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 168.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.03 -42.28 89.78 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 121.549 1.977 . . . . 0.0 112.623 169.182 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.971 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 34.9 mt-10 -56.02 -34.92 66.3 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 115.154 1.539 . . . . 0.0 115.154 167.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' MET . . . . . 1.226 ' O ' ' HB2' ' A' ' 103' ' ' ARG . 20.7 ttt -85.78 -32.99 21.51 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 118.567 2.803 . . . . 0.0 118.567 178.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.8 -44.71 47.97 Favored 'General case' 0 N--CA 1.507 2.387 0 CA-C-N 121.375 1.898 . . . . 0.0 111.705 170.266 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -73.52 -53.5 10.42 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 119.221 0.919 . . . . 0.0 113.269 173.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.971 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 72.3 ttt180 -67.71 -40.75 84.24 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 116.013 1.857 . . . . 0.0 116.013 176.038 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 1.226 ' HB2' ' O ' ' A' ' 99' ' ' MET . 15.0 mmm180 -61.42 -60.18 4.11 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 118.622 0.646 . . . . 0.0 111.447 166.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 113.63 49.27 0.56 Allowed Glycine 0 N--CA 1.478 1.478 0 O-C-N 124.629 1.205 . . . . 0.0 113.632 169.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 73.2 p -86.92 146.16 26.27 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-N 114.388 -0.906 . . . . 0.0 109.399 171.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -69.13 132.15 46.11 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.526 -0.734 . . . . 0.0 111.394 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.9 tp -89.25 97.21 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -173.607 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -97.76 -65.58 0.95 Allowed 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 115.802 -2.046 . . . . 0.0 109.163 169.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -149.32 118.08 6.63 Favored 'General case' 0 C--N 1.366 1.295 0 CA-C-N 121.988 2.176 . . . . 0.0 114.88 -170.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.545 HG12 HD11 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -94.99 110.74 24.42 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.162 1 N-CA-C 98.888 -4.486 . . . . 0.0 98.888 161.042 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 40.9 tp -114.02 103.81 11.52 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.246 -162.746 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -100.2 123.39 44.38 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -176.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 6.8 m-30 -93.98 126.58 39.27 Favored 'General case' 0 CA--C 1.561 1.369 0 CA-C-O 122.471 1.129 . . . . 0.0 109.562 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.405 ' HB3' ' HA ' ' A' ' 163' ' ' ASP . 1.6 tmm_? -82.72 88.31 6.73 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 113.602 -1.635 . . . . 0.0 109.134 168.356 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.49 HG21 ' H ' ' A' ' 12' ' ' GLY . 3.4 p -137.75 139.52 42.79 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.118 0 C-N-CA 125.758 1.623 . . . . 0.0 107.813 -169.496 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.5 m -86.41 127.09 34.79 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 113.526 -1.67 . . . . 0.0 111.023 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -64.09 -43.53 95.1 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 114.383 -1.281 . . . . 0.0 114.044 168.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -46.92 -40.64 14.6 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 117.384 2.365 . . . . 0.0 117.384 -176.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.2 t -59.1 -50.42 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.591 0 CA-C-N 120.337 1.426 . . . . 0.0 113.856 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.97 -35.13 79.67 Favored 'General case' 0 CA--C 1.565 1.536 0 CA-C-O 117.512 -1.232 . . . . 0.0 113.304 168.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.612 ' O ' ' HB2' ' A' ' 125' ' ' LYS . 35.2 mt -61.75 -29.4 70.1 Favored 'General case' 0 N--CA 1.505 2.297 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 169.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -66.42 -51.98 51.28 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.868 0.867 . . . . 0.0 112.634 167.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -47.42 -60.65 2.37 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 171.077 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.5 pp -68.57 -28.04 66.6 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 117.07 2.248 . . . . 0.0 117.07 174.75 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.612 ' HB2' ' O ' ' A' ' 121' ' ' LEU . 46.8 tttm -75.81 -57.27 3.98 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 115.864 1.801 . . . . 0.0 115.864 -177.391 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -92.12 42.07 2.76 Favored Glycine 0 CA--C 1.549 2.173 0 N-CA-C 116.646 1.418 . . . . 0.0 116.646 177.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -149.12 -94.92 0.07 Allowed 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 118.087 0.943 . . . . 0.0 109.739 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.658 ' O ' ' HG3' ' A' ' 129' ' ' ARG . . . -96.85 60.61 1.17 Allowed Glycine 0 CA--C 1.554 2.525 0 CA-C-O 117.047 -1.974 . . . . 0.0 115.736 -171.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.658 ' HG3' ' O ' ' A' ' 128' ' ' GLY . 79.3 mtp85 -163.49 151.94 13.74 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 121.507 2.654 . . . . 0.0 112.729 174.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -95.1 45.87 1.11 Allowed 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 174.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . 0.267 4.8 p-10 40.94 58.88 2.38 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 119.267 3.062 . . . . 0.0 119.267 -175.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASP . . . . . 0.532 ' HB3' ' NH2' ' A' ' 129' ' ' ARG . 23.7 t0 -79.93 -37.88 33.63 Favored 'General case' 0 N--CA 1.505 2.294 0 CA-C-N 112.592 -2.095 . . . . 0.0 111.633 160.03 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 65.1 p -5.35 -79.5 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 129.651 3.18 . . . . 0.0 119.467 165.365 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -59.73 -44.56 93.71 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 115.746 1.758 . . . . 0.0 115.746 -170.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -66.76 -39.45 87.89 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 169.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.8 t -57.38 -45.04 85.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 114.052 1.131 . . . . 0.0 114.052 169.389 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 48.9 mm -69.84 -28.7 37.85 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.787 0 CA-C-O 117.402 -1.285 . . . . 0.0 113.431 172.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 32.3 mt -65.43 -44.34 87.67 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 121.538 1.972 . . . . 0.0 114.262 169.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -67.61 -41.04 84.63 Favored 'General case' 0 N--CA 1.502 2.135 0 CA-C-N 120.654 1.57 . . . . 0.0 114.71 172.024 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 69.2 mtp180 -60.56 -38.68 85.34 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 169.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 56.1 mtt -71.62 -29.14 64.33 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 169.219 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -61.91 -50.35 72.53 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 120.459 1.482 . . . . 0.0 114.834 168.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.5 p -63.52 -33.83 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 169.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -54.21 -48.27 71.22 Favored 'General case' 0 CA--C 1.58 2.112 0 CA-C-N 119.983 1.265 . . . . 0.0 112.403 167.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -61.26 -45.57 93.98 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 117.859 2.54 . . . . 0.0 117.859 175.131 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -56.63 -32.1 64.99 Favored 'General case' 0 N--CA 1.507 2.385 0 N-CA-C 117.779 2.511 . . . . 0.0 117.779 177.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -114.61 -39.59 3.75 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 117.497 2.406 . . . . 0.0 117.497 -167.008 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 99.1 m -49.88 -34.2 19.44 Favored 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 117.525 2.417 . . . . 0.0 117.525 -168.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.442 ' HB3' ' HD3' ' A' ' 150' ' ' PRO . . . -67.8 -61.12 4.59 Favored Pre-proline 0 CA--C 1.581 2.168 0 CA-C-O 116.013 -1.946 . . . . 0.0 112.045 170.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.442 ' HD3' ' HB3' ' A' ' 149' ' ' ALA . 84.8 Cg_exo -55.74 -30.06 74.2 Favored 'Trans proline' 0 CA--C 1.582 2.919 0 N-CA-C 119.947 3.018 . . . . 0.0 119.947 169.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.3 -55.18 30.71 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 126.442 1.897 . . . . 0.0 111.524 169.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 1.3 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 28.9 tp -67.1 -22.52 65.81 Favored 'General case' 0 CA--C 1.562 1.409 0 CA-C-O 116.699 -1.619 . . . . 0.0 114.437 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -71.99 -49.35 37.91 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 122.008 2.185 . . . . 0.0 112.354 164.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -67.81 -54.4 19.42 Favored 'General case' 0 CA--C 1.562 1.438 0 CA-C-N 121.214 1.825 . . . . 0.0 112.158 -177.759 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -77.39 -23.27 50.73 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 114.49 -2.671 . . . . 0.0 112.337 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 1.3 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 0.1 OUTLIER -64.45 -40.25 95.38 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 125.878 3.945 . . . . 0.0 115.739 167.735 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -62.09 -37.0 83.4 Favored 'General case' 0 CA--C 1.576 1.947 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 167.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -90.48 -35.63 14.99 Favored 'General case' 0 CA--C 1.576 1.98 0 N-CA-C 118.653 2.834 . . . . 0.0 118.653 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.418 ' HA ' HG23 ' A' ' 110' ' ' VAL . 3.3 pp -71.87 171.81 11.04 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 119.843 3.275 . . . . 0.0 119.843 -163.449 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -129.72 126.3 37.92 Favored 'General case' 0 CA--C 1.566 1.585 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 166.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.3 t -101.64 160.45 14.44 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 122.798 1.285 . . . . 0.0 113.265 -169.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.525 HG13 ' HG3' ' A' ' 174' ' ' ARG . 91.9 t -131.74 150.41 33.94 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.887 0 CA-C-N 113.456 -1.702 . . . . 0.0 107.335 169.578 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.405 ' HA ' ' HB3' ' A' ' 114' ' ' ARG . 13.4 t70 -107.06 127.03 53.11 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 167.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -164.83 126.95 2.2 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -162.506 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.0 t -150.45 129.77 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.34 -0.85 . . . . 0.0 108.845 167.627 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 77.58 -60.3 3.68 Favored Glycine 0 N--CA 1.485 1.902 0 N-CA-C 120.705 3.042 . . . . 0.0 120.705 166.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 42.9 p -70.64 120.29 16.04 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 113.05 -1.575 . . . . 0.0 111.873 -168.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 27.9 ttt -73.4 -51.54 16.95 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -173.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -71.99 -44.25 63.78 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.844 ' HB3' ' NH2' ' A' ' 174' ' ' ARG . 45.1 mt-10 -58.99 -54.9 41.87 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 172.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 93.6 t -58.13 -37.8 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 176.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -60.48 -36.13 77.55 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 168.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -63.59 -56.05 18.91 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 175.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.844 ' NH2' ' HB3' ' A' ' 170' ' ' GLU . 9.8 ptp180 -66.07 -25.93 67.26 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 118.001 2.593 . . . . 0.0 118.001 171.736 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.5 -41.62 88.6 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 167.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.3 mp -62.82 -41.69 99.42 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 117.676 -1.154 . . . . 0.0 113.831 167.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -54.96 -45.18 74.89 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 168.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.64 -46.59 88.55 Favored 'General case' 0 CA--C 1.559 1.313 0 N-CA-C 116.655 2.095 . . . . 0.0 116.655 171.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 6.2 tt -83.74 -57.01 3.39 Favored 'General case' 0 CA--C 1.567 1.604 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.428 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.646 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -110.39 -58.89 0.49 Allowed Glycine 0 CA--C 1.552 2.366 0 CA-C-O 117.727 -1.596 . . . . 0.0 114.924 -176.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.646 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 37.0 ttmt . . . . . 0 C--O 1.251 1.151 0 CA-C-N 120.357 2.079 . . . . 0.0 107.328 -175.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 ptp . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 121.681 0.753 . . . . 0.0 111.551 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.729 ' HB3' ' HA2' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -160.42 159.0 30.47 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -168.782 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 99.4 t -136.7 150.2 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.543 0 CA-C-O 124.107 1.908 . . . . 0.0 110.262 -166.742 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.638 HD12 HH22 ' A' ' 2' ' ' ARG . 3.7 mt -117.46 134.04 55.29 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 127.234 2.214 . . . . 0.0 107.039 169.565 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 18.5 tp -116.65 119.35 35.23 Favored 'General case' 0 CA--C 1.571 1.769 0 CA-C-O 123.722 1.725 . . . . 0.0 108.716 -176.239 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -118.41 141.5 48.49 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 110.504 -3.044 . . . . 0.0 109.794 -166.815 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 171.2 167.85 32.05 Favored Glycine 0 CA--C 1.559 2.796 0 N-CA-C 116.04 1.176 . . . . 0.0 116.04 170.856 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -61.26 153.28 66.36 Favored 'Trans proline' 0 CA--C 1.574 2.5 0 C-N-CA 123.513 2.809 . . . . 0.0 116.002 174.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -84.99 90.35 0.79 Allowed 'Trans proline' 0 CA--C 1.562 1.902 0 C-N-CA 122.562 2.175 . . . . 0.0 114.684 -169.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -171.43 -87.64 0.07 OUTLIER Glycine 0 CA--C 1.536 1.377 0 N-CA-C 110.226 -1.149 . . . . 0.0 110.226 173.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -101.37 149.04 24.46 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -175.621 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.52 110.97 0.11 Allowed Glycine 0 N--CA 1.486 1.969 0 N-CA-C 116.956 1.542 . . . . 0.0 116.956 167.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm 170.56 -74.87 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.219 0.608 . . . . 0.0 110.158 173.756 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -51.06 -36.3 34.75 Favored Glycine 0 CA--C 1.554 2.509 0 N-CA-C 120.466 2.947 . . . . 0.0 120.466 -177.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 58.6 m -65.01 -52.45 56.07 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 119.151 1.475 . . . . 0.0 113.458 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.284 21.3 mp0 -76.51 -13.39 60.1 Favored 'General case' 0 CA--C 1.571 1.783 0 CA-C-O 115.545 -2.169 . . . . 0.0 112.329 171.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.39 -45.83 68.36 Favored 'General case' 0 C--N 1.373 1.619 0 CA-C-N 124.131 3.151 . . . . 0.0 114.389 166.901 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.9 p -66.22 -43.22 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-O 118.449 -0.786 . . . . 0.0 113.092 173.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.4 ' HB3' ' CE1' ' A' ' 172' ' ' PHE . 97.3 mttt -55.14 -48.61 73.46 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 116.6 2.074 . . . . 0.0 116.6 169.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 mt -66.16 -29.26 69.51 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 172.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.83 -39.83 94.21 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 167.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -59.32 -39.49 83.26 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 117.342 -1.313 . . . . 0.0 114.516 166.361 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -62.25 -58.89 6.08 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 120.901 1.682 . . . . 0.0 114.905 169.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.3 mt -82.31 -20.2 37.88 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 117.551 2.426 . . . . 0.0 117.551 -172.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.67 44.94 8.88 Favored Glycine 0 CA--C 1.553 2.432 0 CA-C-N 120.734 1.607 . . . . 0.0 117.071 -174.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.402 ' CG2' ' HA ' ' A' ' 81' ' ' PHE . 29.1 mm -112.32 156.02 42.74 Favored Pre-proline 0 CA--C 1.569 1.698 0 CA-C-N 118.219 1.01 . . . . 0.0 113.578 -168.227 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -73.04 100.65 1.24 Allowed 'Trans proline' 0 CA--C 1.562 1.894 0 C-N-CA 121.807 1.671 . . . . 0.0 112.685 160.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.23 105.34 4.61 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.302 -0.874 . . . . 0.0 108.809 167.446 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 44.6 mm -99.97 111.9 30.93 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 178.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.2 t -96.64 127.84 43.01 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 168.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 19.7 p -73.91 1.31 11.01 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 116.95 2.204 . . . . 0.0 116.95 -172.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.57 -18.67 29.71 Favored Glycine 0 CA--C 1.55 2.28 0 N-CA-C 118.014 1.966 . . . . 0.0 118.014 163.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -78.89 -55.87 4.82 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 119.494 1.647 . . . . 0.0 113.594 -168.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -57.0 -39.28 74.4 Favored 'General case' 0 CA--C 1.568 1.648 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 172.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -69.84 -37.46 76.19 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 117.415 -1.279 . . . . 0.0 114.05 169.329 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -52.9 -39.95 63.16 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 115.478 1.658 . . . . 0.0 115.478 167.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.43 ' HD2' ' HA ' ' A' ' 37' ' ' ARG . 9.8 tpt180 -67.64 -39.99 84.59 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 172.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -64.99 -31.76 73.16 Favored 'General case' 0 CA--C 1.579 2.074 0 N-CA-C 115.634 1.716 . . . . 0.0 115.634 166.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 57.6 mt -59.89 -45.68 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 C-N-CA 126.023 1.729 . . . . 0.0 111.362 167.439 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -63.06 -41.48 99.47 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 172.017 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -71.74 -37.77 70.52 Favored 'General case' 0 CA--C 1.563 1.444 0 N-CA-C 116.823 2.157 . . . . 0.0 116.823 176.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.05 71.06 1.18 Allowed Glycine 0 CA--C 1.545 1.967 0 CA-C-O 117.782 -1.566 . . . . 0.0 115.179 -176.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.874 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 59.2 p -92.33 -51.26 5.24 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-N 119.684 1.742 . . . . 0.0 114.286 174.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.874 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.25 73.4 mttt 105.87 -40.52 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.777 0 CA-C-O 116.325 -1.798 . . . . 0.0 111.651 -171.549 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.06 -14.84 57.43 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 123.066 2.666 . . . . 0.0 112.968 164.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.3 -57.53 19.31 Favored Glycine 0 C--N 1.358 1.755 0 CA-C-N 120.299 1.409 . . . . 0.0 115.082 168.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.268 10.9 p -75.13 -47.5 35.8 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.394 0 N-CA-C 116.45 2.018 . . . . 0.0 116.45 -168.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -65.42 -46.86 78.3 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 120.783 1.629 . . . . 0.0 112.8 173.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.02 -33.81 75.29 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -178.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -66.68 -42.46 86.51 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 168.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.591 ' CG ' ' O ' ' A' ' 51' ' ' ARG . 31.6 ttt180 -73.0 -51.53 17.9 Favored 'General case' 0 CA--C 1.59 2.518 1 CA-C-O 85.079 -16.677 . . . . 0.0 118.318 -173.725 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 16.9 m-30 -31.57 -56.91 0.27 Allowed 'General case' 0 N--CA 1.495 1.793 1 O-C-N 109.216 -8.428 . . . . 0.0 121.693 146.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 35.8 mt -59.17 -44.68 92.16 Favored 'General case' 0 CA--C 1.578 2.039 0 CA-C-N 122.941 2.609 . . . . 0.0 114.411 166.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -80.79 -34.12 34.33 Favored 'General case' 0 CA--C 1.564 1.488 0 N-CA-C 116.941 2.2 . . . . 0.0 116.941 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -97.05 -33.77 11.41 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 175.159 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.47 20.19 6.69 Favored Glycine 0 CA--C 1.546 1.987 0 CA-C-N 122.452 2.387 . . . . 0.0 118.068 169.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -97.98 173.06 7.25 Favored 'General case' 0 CA--C 1.574 1.904 0 CA-C-N 118.998 1.399 . . . . 0.0 110.083 167.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.7 mt -72.71 130.31 40.22 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 119.828 -1.795 . . . . 0.0 114.923 -166.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.4 p -116.35 113.55 40.98 Favored Pre-proline 0 CA--C 1.57 1.745 0 C-N-CA 124.817 1.247 . . . . 0.0 108.936 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -60.6 153.06 64.22 Favored 'Trans proline' 0 CA--C 1.559 1.746 0 C-N-CA 123.425 2.75 . . . . 0.0 116.996 177.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 90.5 p -79.35 172.91 13.14 Favored 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 177.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASP . . . . . 0.427 ' O ' ' HB2' ' A' ' 66' ' ' GLU . 6.0 t70 81.89 -46.12 0.19 Allowed 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 125.839 1.656 . . . . 0.0 114.713 175.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 22.6 mt -60.83 -50.96 71.33 Favored 'General case' 0 N--CA 1.506 2.354 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 168.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.4 m -58.84 -50.83 72.53 Favored 'General case' 0 CA--C 1.566 1.591 0 CA-C-N 112.989 -1.914 . . . . 0.0 112.904 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -62.17 -28.44 69.66 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 115.216 1.561 . . . . 0.0 115.216 168.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -64.69 -44.37 90.52 Favored 'General case' 0 CA--C 1.555 1.171 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 171.997 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.3 mt -60.9 -48.99 79.29 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.214 1.191 . . . . 0.0 114.214 167.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 78.5 t -61.39 -51.82 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 CA-C-O 117.989 -1.005 . . . . 0.0 111.497 175.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -64.4 -28.38 69.65 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 174.082 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -64.05 -41.43 97.38 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 119.706 1.139 . . . . 0.0 112.806 168.423 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 27.8 ttm-85 -82.4 -9.2 59.54 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 119.001 2.963 . . . . 0.0 119.001 170.43 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 89.9 mt -99.49 -23.42 15.11 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 175.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 -75.8 23.43 0.13 Allowed 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 116.318 1.97 . . . . 0.0 116.318 172.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -81.04 145.67 57.28 Favored Pre-proline 0 CA--C 1.578 2.024 0 C-N-CA 124.276 1.03 . . . . 0.0 108.661 166.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -49.83 -32.7 30.53 Favored 'Trans proline' 0 N--CA 1.507 2.269 0 N-CA-C 119.447 2.826 . . . . 0.0 119.447 169.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -66.34 -12.71 58.25 Favored 'General case' 0 CA--C 1.564 1.492 0 CA-C-O 116.011 -1.947 . . . . 0.0 115.616 175.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.81 -38.75 76.71 Favored 'General case' 0 CA--C 1.565 1.541 0 CA-C-N 123.254 2.752 . . . . 0.0 111.389 165.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 52.34 37.1 21.49 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 122.355 2.343 . . . . 0.0 114.973 -173.055 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 64.33 26.23 13.6 Favored 'General case' 0 CA--C 1.59 2.509 0 C-N-CA 124.453 1.101 . . . . 0.0 113.855 -168.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.729 ' HA2' ' HB3' ' A' ' 2' ' ' ARG . . . -133.89 159.98 23.91 Favored Glycine 0 C--N 1.365 2.146 0 CA-C-N 121.077 1.762 . . . . 0.0 112.612 177.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.402 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . 31.5 p90 -178.39 135.32 0.15 Allowed 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 113.355 -1.422 . . . . 0.0 112.111 -168.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 31.3 mt -109.5 106.03 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.545 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 174.235 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.9 mt -99.98 129.84 46.09 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.35 1.06 . . . . 0.0 110.261 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -124.22 115.96 21.91 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 118.501 0.591 . . . . 0.0 110.235 -172.528 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 75.18 32.64 55.72 Favored Glycine 0 CA--C 1.551 2.343 0 CA-C-O 117.549 -1.695 . . . . 0.0 117.046 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -95.9 -52.77 0.23 Allowed Pre-proline 0 N--CA 1.496 1.863 0 CA-C-O 115.068 -2.396 . . . . 0.0 108.664 174.425 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -66.13 70.7 0.4 Allowed 'Trans proline' 0 CA--C 1.573 2.437 0 CA-C-N 124.57 2.668 . . . . 0.0 117.835 165.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . 0.33 39.2 ttt-85 -72.61 -35.41 67.85 Favored 'General case' 0 CA--C 1.56 1.333 0 N-CA-C 116.789 2.144 . . . . 0.0 116.789 167.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.6 t -147.29 135.4 21.45 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 -169.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . 0.329 4.9 p -69.02 -19.0 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 CA-C-O 116.364 -1.779 . . . . 0.0 112.597 -178.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -68.08 -32.7 73.22 Favored 'General case' 0 CA--C 1.558 1.254 0 N-CA-C 118.781 2.882 . . . . 0.0 118.781 165.168 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -75.83 -50.35 15.39 Favored 'General case' 0 CA--C 1.587 2.387 0 CA-C-N 124.372 3.26 . . . . 0.0 111.204 164.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.73 -27.43 66.47 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 117.984 2.587 . . . . 0.0 117.984 -175.673 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 41.9 tttt -57.32 -33.91 68.2 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 167.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.35 -38.23 88.69 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 167.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 47.3 mt -66.9 -33.19 75.05 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 170.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -63.19 -55.02 28.55 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 120.064 1.302 . . . . 0.0 112.755 169.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 1.157 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 0.7 OUTLIER -49.73 -36.58 26.09 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 115.761 1.763 . . . . 0.0 115.761 168.13 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 99' ' ' MET . . . . . 1.125 ' O ' ' HB2' ' A' ' 103' ' ' ARG . 65.6 mtt -84.37 -28.84 26.71 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 117.802 2.519 . . . . 0.0 117.802 175.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 35.9 tp -65.23 -55.05 20.67 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 120.747 1.612 . . . . 0.0 111.862 170.624 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -80.1 -50.74 9.9 Favored 'General case' 0 CA--C 1.562 1.42 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 176.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 1.157 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 94.4 mtt180 -71.86 -42.15 67.21 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 177.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 1.125 ' HB2' ' O ' ' A' ' 99' ' ' MET . 43.6 mtt180 -65.18 -51.52 60.59 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 119.928 1.24 . . . . 0.0 111.621 164.526 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.4 44.33 1.26 Allowed Glycine 0 N--CA 1.48 1.612 0 C-N-CA 121.052 -0.594 . . . . 0.0 114.153 167.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 31.1 p -95.18 145.02 25.33 Favored 'General case' 0 CA--C 1.557 1.217 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 169.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -69.44 128.19 35.65 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.438 -0.789 . . . . 0.0 112.604 -169.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 4.5 tp -81.0 102.78 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 173.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . 0.268 24.2 t70 -96.5 -76.23 0.51 Allowed 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 116.111 -1.899 . . . . 0.0 106.8 167.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -138.87 127.14 22.78 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 121.141 1.791 . . . . 0.0 114.794 -173.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.4 t -93.66 109.92 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 103.144 -2.91 . . . . 0.0 103.144 162.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 91.3 mt -107.09 120.48 42.2 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 122.918 0.487 . . . . 0.0 109.873 -172.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -103.95 128.18 51.48 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 118.033 0.379 . . . . 0.0 110.358 177.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -91.46 119.42 31.41 Favored 'General case' 0 CA--C 1.556 1.192 0 CA-C-O 122.946 1.355 . . . . 0.0 109.584 177.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -82.0 93.59 6.99 Favored 'General case' 0 CA--C 1.557 1.224 0 CA-C-N 112.843 -1.98 . . . . 0.0 108.314 166.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.7 p -137.82 141.44 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-N 113.605 -1.634 . . . . 0.0 108.286 -168.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.9 m -84.73 122.03 28.52 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.236 169.793 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -59.61 -32.8 70.75 Favored 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 170.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -50.03 -30.26 10.38 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 117.851 2.537 . . . . 0.0 117.851 174.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.8 t -61.9 -53.88 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 CA-C-N 121.896 2.134 . . . . 0.0 113.664 176.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 9.5 mp -73.25 -26.07 60.96 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 172.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 9.4 mp -69.26 -35.56 76.22 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 120.942 1.701 . . . . 0.0 114.576 169.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -72.88 -33.79 66.28 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 120.45 1.477 . . . . 0.0 114.764 170.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -58.48 -50.17 74.7 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 168.494 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 10.9 mp -64.52 -55.76 18.49 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 173.23 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -73.24 -19.19 61.13 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 118.882 2.919 . . . . 0.0 118.882 -177.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.13 -34.63 88.74 Favored Glycine 0 CA--C 1.552 2.363 0 N-CA-C 119.322 2.489 . . . . 0.0 119.322 -176.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -137.23 94.74 2.98 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 118.892 1.346 . . . . 0.0 109.126 176.136 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.492 ' O ' ' HG3' ' A' ' 129' ' ' ARG . . . 84.18 175.13 50.71 Favored Glycine 0 CA--C 1.573 3.702 0 CA-C-O 118.706 -1.052 . . . . 0.0 114.325 179.129 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.492 ' HG3' ' O ' ' A' ' 128' ' ' GLY . 79.0 mtp180 -164.4 112.03 1.09 Allowed 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 121.378 2.589 . . . . 0.0 110.292 176.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -83.7 99.49 10.27 Favored 'General case' 0 CA--C 1.578 2.055 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 166.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -84.7 74.83 10.39 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 123.376 2.807 . . . . 0.0 115.25 -166.473 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -116.62 62.0 0.72 Allowed 'General case' 0 CA--C 1.577 1.983 0 N-CA-C 102.813 -3.032 . . . . 0.0 102.813 157.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 73.2 p -140.45 -109.79 0.15 Allowed 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 113.917 -1.492 . . . . 0.0 109.886 -161.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -56.96 -31.27 64.83 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 117.105 2.261 . . . . 0.0 117.105 -169.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -70.65 -46.62 62.91 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.678 ' O ' ' HG3' ' A' ' 140' ' ' ARG . 18.9 m -62.79 -31.29 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.622 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 168.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 49.2 mm -64.92 -40.75 90.12 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.893 0 CA-C-O 117.175 -1.393 . . . . 0.0 112.102 167.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -60.61 -41.71 95.35 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 121.623 2.011 . . . . 0.0 115.68 169.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -60.99 -39.15 88.55 Favored 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 167.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.678 ' HG3' ' O ' ' A' ' 136' ' ' VAL . 27.7 mtp180 -59.78 -38.4 81.75 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 167.008 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 63.3 mtt -65.64 -31.87 73.13 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 169.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -64.12 -49.63 71.43 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 168.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.6 p -65.97 -33.33 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 169.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -54.19 -51.41 64.48 Favored 'General case' 0 CA--C 1.579 2.077 0 CA-C-N 120.175 1.352 . . . . 0.0 111.191 167.506 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -55.61 -37.09 67.67 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 119.529 3.159 . . . . 0.0 119.529 173.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -51.46 -29.37 15.99 Favored 'General case' 0 N--CA 1.513 2.685 0 N-CA-C 117.844 2.535 . . . . 0.0 117.844 170.625 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -121.88 -28.94 4.38 Favored 'General case' 0 CA--C 1.559 1.309 0 N-CA-C 118.852 2.908 . . . . 0.0 118.852 -166.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 33.5 m -42.78 -37.08 1.66 Allowed 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 118.053 2.612 . . . . 0.0 118.053 -168.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.5 -62.46 2.99 Favored Pre-proline 0 CA--C 1.581 2.172 0 CA-C-O 116.175 -1.869 . . . . 0.0 111.822 172.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -52.08 -36.56 66.14 Favored 'Trans proline' 0 CA--C 1.58 2.819 0 C-N-CA 123.554 2.836 . . . . 0.0 118.546 167.993 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.68 -54.54 44.09 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 125.427 1.491 . . . . 0.0 111.973 171.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 1.004 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 44.2 tp -67.39 -23.55 65.58 Favored 'General case' 0 CA--C 1.561 1.396 0 CA-C-O 116.669 -1.634 . . . . 0.0 114.456 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -72.43 -46.01 57.02 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 122.022 2.192 . . . . 0.0 112.743 165.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -67.81 -52.07 41.37 Favored 'General case' 0 CA--C 1.565 1.534 0 CA-C-N 120.499 1.499 . . . . 0.0 112.245 -177.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -81.03 -24.3 38.01 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-O 115.119 -2.372 . . . . 0.0 113.405 178.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 1.004 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 39.8 ttt180 -65.04 -36.41 84.26 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 124.565 3.348 . . . . 0.0 115.581 168.29 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -68.17 -37.33 80.86 Favored 'General case' 0 CA--C 1.574 1.896 0 CA-C-N 119.806 1.185 . . . . 0.0 114.026 167.299 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -80.14 -35.93 35.94 Favored 'General case' 0 CA--C 1.575 1.91 0 N-CA-C 119.009 2.966 . . . . 0.0 119.009 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.2 pp -79.96 174.77 11.25 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 118.917 2.932 . . . . 0.0 118.917 -161.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 61.3 tttt -135.18 140.64 45.52 Favored 'General case' 0 CA--C 1.564 1.495 0 C-N-CA 125.249 1.42 . . . . 0.0 108.075 167.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 58.0 m -88.76 146.89 24.75 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.358 1.075 . . . . 0.0 112.14 -169.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 58.4 t -134.8 137.49 50.83 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.559 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 167.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -95.39 138.78 32.6 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 168.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -162.24 101.31 1.09 Allowed 'General case' 0 N--CA 1.482 1.13 0 O-C-N 121.466 -0.771 . . . . 0.0 112.323 -165.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.9 t -151.14 130.33 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 173.775 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 78.11 -68.45 2.86 Favored Glycine 0 N--CA 1.483 1.809 0 N-CA-C 119.092 2.397 . . . . 0.0 119.092 166.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 41.6 p -73.06 143.73 47.34 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 112.218 -1.991 . . . . 0.0 112.728 -168.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 27.8 ttt -85.37 -69.44 0.66 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.246 0.618 . . . . 0.0 111.044 -176.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -70.69 -36.02 73.08 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 -176.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.63 -51.95 67.62 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 171.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 79.5 t -55.47 -40.33 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 175.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.4 ' CE1' ' HB3' ' A' ' 19' ' ' LYS . 22.9 t80 -62.97 -33.2 74.89 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 169.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -62.02 -48.98 77.87 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 114.241 1.201 . . . . 0.0 114.241 171.452 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 80.0 mtt180 -58.93 -42.6 90.14 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 117.199 2.296 . . . . 0.0 117.199 169.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -58.93 -43.35 91.13 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 170.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.9 mp -64.84 -42.05 95.24 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 169.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -54.4 -41.25 69.06 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 116.412 2.004 . . . . 0.0 116.412 169.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -65.24 -51.67 59.36 Favored 'General case' 0 CA--C 1.561 1.37 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 169.815 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 7.4 tt -74.03 -57.65 3.83 Favored 'General case' 0 CA--C 1.566 1.574 0 CA-C-N 120.026 1.285 . . . . 0.0 112.636 -176.042 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.945 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -110.46 -57.66 0.5 Allowed Glycine 0 CA--C 1.552 2.362 0 CA-C-O 117.744 -1.587 . . . . 0.0 114.762 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.945 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 63.6 tttm . . . . . 0 C--O 1.251 1.173 0 CA-C-N 120.306 2.053 . . . . 0.0 109.212 -175.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.4 mmt . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 122.667 1.222 . . . . 0.0 111.444 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . 0.304 8.7 ttm-85 -148.59 147.07 28.57 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 118.162 2.652 . . . . 0.0 118.162 -158.429 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 37.7 t -142.76 148.83 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 124.624 2.154 . . . . 0.0 110.846 -172.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.4 HD11 HG22 ' A' ' 110' ' ' VAL 0.294 0.0 OUTLIER -135.56 122.03 20.63 Favored 'General case' 0 CA--C 1.564 1.513 0 CA-C-N 112.716 -2.038 . . . . 0.0 106.416 166.095 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.9 tt -97.98 133.31 42.63 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.823 1.649 . . . . 0.0 110.832 -166.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.6 mt -138.4 156.43 47.59 Favored 'General case' 0 CA--C 1.554 1.118 0 CA-C-N 113.98 -1.463 . . . . 0.0 111.174 -166.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 160.6 144.33 3.94 Favored Glycine 0 CA--C 1.555 2.544 0 CA-C-O 118.202 -1.332 . . . . 0.0 114.967 172.345 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -69.86 177.3 5.79 Favored 'Trans proline' 0 CA--C 1.579 2.733 0 CA-C-N 121.367 2.584 . . . . 0.0 114.847 169.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -47.78 132.07 21.06 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 124.057 3.171 . . . . 0.0 117.206 -177.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.22 98.76 0.25 Allowed Glycine 0 CA--C 1.533 1.211 0 N-CA-C 105.822 -2.911 . . . . 0.0 105.822 -167.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -72.78 100.64 2.91 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -168.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 179.1 85.49 0.06 OUTLIER Glycine 0 CA--C 1.539 1.563 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -159.61 -74.53 0.07 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.187 0.595 . . . . 0.0 109.519 -170.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -48.22 -33.07 10.33 Favored Glycine 0 CA--C 1.557 2.693 0 N-CA-C 120.175 2.83 . . . . 0.0 120.175 171.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 20.1 m -61.7 -52.18 65.34 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 118.872 1.336 . . . . 0.0 113.967 170.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.284 2.8 mp0 -75.09 -11.69 60.15 Favored 'General case' 0 CA--C 1.57 1.716 0 CA-C-O 115.719 -2.086 . . . . 0.0 112.683 171.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.91 -45.85 55.91 Favored 'General case' 0 C--N 1.372 1.581 0 CA-C-N 123.778 2.99 . . . . 0.0 113.929 166.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.3 p -65.22 -44.89 95.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 173.093 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.481 ' HB3' ' HE2' ' A' ' 172' ' ' PHE . 99.5 mttt -64.12 -46.06 85.84 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 116.325 1.972 . . . . 0.0 116.325 172.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.5 tp -65.26 -29.32 70.09 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 171.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.81 -45.15 93.97 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 168.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -52.71 -39.73 62.3 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 164.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -64.32 -48.2 76.52 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 170.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.7 mt -79.6 -19.01 50.33 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 116.505 2.039 . . . . 0.0 116.505 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.99 46.78 6.49 Favored Glycine 0 CA--C 1.554 2.513 0 CA-C-N 120.054 1.297 . . . . 0.0 116.14 -174.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.555 ' CD1' ' HA ' ' A' ' 81' ' ' PHE . 0.2 OUTLIER -130.86 147.93 68.17 Favored Pre-proline 0 CA--C 1.572 1.809 0 C-N-CA 125.855 1.662 . . . . 0.0 110.949 -165.773 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.476 ' HD2' HD12 ' A' ' 26' ' ' ILE . 19.2 Cg_endo -75.55 106.73 2.32 Favored 'Trans proline' 0 CA--C 1.574 2.489 0 C-N-CA 121.85 1.7 . . . . 0.0 111.049 158.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.35 132.62 48.05 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 120.643 -1.286 . . . . 0.0 112.028 169.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -94.98 107.25 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 N-CA-C 103.478 -2.786 . . . . 0.0 103.478 174.077 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 76.3 p -98.24 125.06 43.16 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 168.669 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.9 p -68.76 -4.6 16.57 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 117.68 2.474 . . . . 0.0 117.68 -175.032 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.77 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -89.34 -26.06 26.71 Favored Glycine 0 CA--C 1.539 1.573 0 N-CA-C 118.898 2.319 . . . . 0.0 118.898 165.722 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -82.11 -55.61 4.45 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 -168.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -63.9 -40.1 95.72 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 175.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.481 ' HB3' ' CB ' ' A' ' 50' ' ' LYS . 20.1 m-85 -71.09 -44.97 64.6 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 116.35 -1.786 . . . . 0.0 114.612 173.006 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.77 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 72.5 ttt180 -52.46 -41.86 63.68 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 168.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -61.84 -41.25 97.58 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 168.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -67.61 -25.65 65.86 Favored 'General case' 0 CA--C 1.583 2.218 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 168.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 66.8 mt -61.64 -48.38 88.98 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.458 0 CA-C-N 121.054 1.752 . . . . 0.0 110.264 166.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -61.72 -40.91 96.71 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 175.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -65.94 -44.19 85.79 Favored 'General case' 0 CA--C 1.558 1.257 0 N-CA-C 116.069 1.878 . . . . 0.0 116.069 174.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.06 66.96 1.26 Allowed Glycine 0 CA--C 1.544 1.859 0 CA-C-O 118.784 -1.009 . . . . 0.0 114.301 -176.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.837 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 70.4 p -91.43 -48.45 6.88 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.837 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.274 38.9 mttp 107.77 -41.54 0.0 OUTLIER 'General case' 0 CA--C 1.571 1.752 0 CA-C-O 116.31 -1.805 . . . . 0.0 111.007 -172.431 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.4 pp -79.5 -18.66 51.47 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 123.108 2.686 . . . . 0.0 114.147 163.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.26 -55.77 28.64 Favored Glycine 0 CA--C 1.548 2.141 0 CA-C-O 122.419 1.011 . . . . 0.0 114.951 169.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 1.082 ' O ' ' HB2' ' A' ' 51' ' ' ARG . 1.0 OUTLIER -75.89 -43.73 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 N-CA-C 117.158 2.281 . . . . 0.0 117.158 -167.988 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.48 ' HG2' HG23 ' A' ' 59' ' ' VAL . 29.7 tt0 -78.45 -24.79 45.86 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 122.369 2.349 . . . . 0.0 111.806 170.318 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.85 -47.76 70.96 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 123.163 2.71 . . . . 0.0 112.68 177.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.481 ' CB ' ' HB3' ' A' ' 35' ' ' PHE 0.356 38.5 tptt -81.56 -17.22 49.15 Favored 'General case' 0 CA--C 1.573 1.85 0 O-C-N 124.694 1.247 . . . . 0.0 114.339 173.111 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 1.082 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 21.5 ttt180 -83.61 -54.34 5.0 Favored 'General case' 0 CA--C 1.581 2.173 1 CA-C-O 85.034 -16.698 . . . . 0.0 118.562 175.691 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -37.99 -62.8 0.53 Allowed 'General case' 0 C--N 1.368 1.398 1 O-C-N 105.791 -10.568 . . . . 0.0 119.442 148.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . 0.271 1.2 tm? -41.18 -40.65 1.62 Allowed 'General case' 0 CA--C 1.58 2.123 0 CA-C-N 121.968 2.167 . . . . 0.0 116.845 170.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -90.72 -42.91 10.44 Favored 'General case' 0 CA--C 1.572 1.821 0 N-CA-C 117.045 2.239 . . . . 0.0 117.045 169.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -102.69 -23.45 13.83 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 118.31 2.707 . . . . 0.0 118.31 -169.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.48 32.45 7.32 Favored Glycine 0 CA--C 1.543 1.807 0 N-CA-C 118.58 2.192 . . . . 0.0 118.58 169.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -83.78 -127.09 0.03 OUTLIER 'General case' 0 CA--C 1.583 2.234 0 C-N-CA 123.833 0.853 . . . . 0.0 111.106 168.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 pp -128.81 179.08 5.91 Favored 'General case' 0 CA--C 1.573 1.835 0 C-N-CA 126.268 1.827 . . . . 0.0 110.462 169.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.48 HG23 ' HG2' ' A' ' 48' ' ' GLU . 0.3 OUTLIER -163.9 138.84 4.76 Favored Pre-proline 0 CA--C 1.574 1.899 0 O-C-N 119.484 -2.01 . . . . 0.0 110.593 170.927 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -60.01 145.42 98.43 Favored 'Trans proline' 0 CA--C 1.562 1.919 0 C-N-CA 123.432 2.755 . . . . 0.0 115.999 169.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 95.3 p -78.61 173.15 12.72 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 77.27 -38.39 0.29 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 117.15 2.278 . . . . 0.0 117.15 173.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' LEU . . . . . 0.452 ' O ' ' HB2' ' A' ' 66' ' ' GLU . 4.4 pp -54.55 -43.07 71.69 Favored 'General case' 0 N--CA 1.507 2.416 0 N-CA-C 118.03 2.604 . . . . 0.0 118.03 170.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.4 m -60.91 -58.39 8.65 Favored 'General case' 0 CA--C 1.562 1.424 0 CA-C-N 111.5 -2.591 . . . . 0.0 112.082 176.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -62.38 -19.14 63.1 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 166.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 63' ' ' LEU . 6.1 mm-40 -65.52 -44.84 85.67 Favored 'General case' 0 CA--C 1.558 1.276 0 CA-C-N 120.729 1.604 . . . . 0.0 114.036 168.129 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.5 mt -63.66 -43.79 95.69 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 114.571 1.322 . . . . 0.0 114.571 167.744 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 81.8 t -59.82 -48.9 85.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 CA-C-O 117.967 -1.016 . . . . 0.0 112.45 170.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -57.6 -37.6 73.49 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 116.976 2.213 . . . . 0.0 116.976 169.739 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -60.19 -39.45 86.57 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 169.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 76.8 mtp85 -79.44 -12.41 59.89 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 117.805 2.52 . . . . 0.0 117.805 167.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.1 mp -91.65 -23.67 19.76 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 117.527 2.417 . . . . 0.0 117.527 176.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 30.3 p30 -58.9 0.4 0.09 Allowed 'General case' 0 CA--C 1.578 2.054 0 N-CA-C 118.187 2.662 . . . . 0.0 118.187 168.418 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -59.26 -144.9 0.0 OUTLIER Pre-proline 0 CA--C 1.607 3.156 0 N-CA-C 117.513 2.412 . . . . 0.0 117.513 168.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_exo -59.11 38.79 0.05 OUTLIER 'Trans proline' 0 N--CA 1.514 2.699 2 C-N-CA 125.505 4.136 . . . . 0.0 122.552 171.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 60.46 32.57 20.57 Favored 'General case' 0 CA--C 1.588 2.404 0 C-N-CA 125.877 1.671 . . . . 0.0 109.77 -160.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 69.42 16.54 8.24 Favored 'General case' 0 C--N 1.381 1.946 0 CA-C-O 117.081 -1.437 . . . . 0.0 114.346 -166.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 51.95 34.14 13.11 Favored 'General case' 0 CA--C 1.577 1.996 0 CA-C-N 122.39 2.359 . . . . 0.0 113.368 -164.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 19.1 m120 59.55 31.46 20.99 Favored 'General case' 0 CA--C 1.577 1.999 0 CA-C-O 116.834 -1.555 . . . . 0.0 113.66 -166.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -143.49 -168.44 12.14 Favored Glycine 0 C--N 1.375 2.698 0 CA-C-N 122.958 2.617 . . . . 0.0 113.337 -176.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.555 ' HA ' ' CD1' ' A' ' 26' ' ' ILE 0.38 1.6 p90 171.75 139.21 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 113.605 -1.297 . . . . 0.0 111.357 163.11 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.9 mp -115.45 109.26 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 165.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.9 mt -100.36 108.99 21.15 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 168.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -103.61 129.29 50.85 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-N 120.111 1.323 . . . . 0.0 109.961 -173.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 67.49 47.17 64.21 Favored Glycine 0 CA--C 1.548 2.098 0 CA-C-O 116.609 -2.217 . . . . 0.0 116.191 -173.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -132.77 73.17 76.45 Favored Pre-proline 0 CA--C 1.568 1.67 0 CA-C-N 121.104 2.452 . . . . 0.0 115.297 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -97.94 -28.27 0.05 OUTLIER 'Trans proline' 0 CA--C 1.561 1.87 0 C-N-CA 122.817 2.344 . . . . 0.0 112.857 156.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 50.1 mtt85 41.64 24.28 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 118.324 2.713 . . . . 0.0 118.324 -163.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.521 ' HA ' ' HG3' ' A' ' 147' ' ' GLU . 27.6 t 103.99 153.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 127.164 2.185 . . . . 0.0 106.519 -170.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' VAL . . . . . 0.531 HG12 ' HB2' ' A' ' 147' ' ' GLU 0.307 7.7 p -57.77 -27.34 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 119.647 -1.908 . . . . 0.0 112.366 169.23 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -70.0 -25.76 63.76 Favored 'General case' 0 CA--C 1.557 1.218 0 N-CA-C 119.471 3.138 . . . . 0.0 119.471 166.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.3 tm0? -74.28 -49.96 20.91 Favored 'General case' 0 CA--C 1.59 2.505 0 CA-C-N 124.592 3.36 . . . . 0.0 108.961 162.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -53.09 -25.44 12.9 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 117.845 2.535 . . . . 0.0 117.845 -176.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -59.14 -33.05 70.43 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 166.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.12 -41.29 74.14 Favored 'General case' 0 CA--C 1.571 1.784 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 169.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 28.9 tp -63.16 -36.48 83.77 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 168.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 21.7 t60 -56.3 -53.6 55.36 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 125.219 1.408 . . . . 0.0 112.719 167.821 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.806 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 11.0 mm-40 -49.92 -36.55 28.08 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 115.694 1.738 . . . . 0.0 115.694 166.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' MET . . . . . 1.13 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 24.9 ttt -83.45 -31.75 26.41 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 118.117 2.636 . . . . 0.0 118.117 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.52 -44.28 51.96 Favored 'General case' 0 N--CA 1.508 2.449 0 CA-C-N 121.741 2.064 . . . . 0.0 111.486 169.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -71.91 -57.6 4.17 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 119.496 1.044 . . . . 0.0 113.694 173.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.806 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 76.8 mtp180 -71.76 -36.55 70.43 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 178.084 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 1.13 ' HB3' ' O ' ' A' ' 99' ' ' MET . 57.4 ttt85 -61.16 -56.59 19.0 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 119.462 1.028 . . . . 0.0 111.736 165.188 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 111.7 49.87 0.62 Allowed Glycine 0 N--CA 1.481 1.672 0 O-C-N 124.231 0.957 . . . . 0.0 114.09 167.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 62.0 p -97.88 163.74 12.66 Favored 'General case' 0 CA--C 1.561 1.387 0 CA-C-N 114.015 -1.093 . . . . 0.0 111.075 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -84.63 134.57 34.38 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.158 -0.964 . . . . 0.0 109.128 177.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.502 HD11 HG23 ' A' ' 110' ' ' VAL . 8.9 tt -95.88 107.2 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 172.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -89.36 -60.44 1.95 Allowed 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 115.399 -2.239 . . . . 0.0 106.478 166.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -156.13 131.35 9.35 Favored 'General case' 0 C--N 1.369 1.419 0 CA-C-N 122.611 2.46 . . . . 0.0 116.463 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.502 HG23 HD11 ' A' ' 107' ' ' ILE . 39.2 t -88.66 107.86 18.21 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.629 0 N-CA-C 100.638 -3.838 . . . . 0.0 100.638 160.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.5 HD23 ' HB2' ' A' ' 160' ' ' LYS . 68.6 mt -104.27 108.83 20.42 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 118.318 -0.849 . . . . 0.0 109.616 -168.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -106.84 125.78 51.45 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.966 0.888 . . . . 0.0 109.857 -176.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -100.69 116.64 33.08 Favored 'General case' 0 CA--C 1.557 1.235 0 CA-C-O 122.568 1.175 . . . . 0.0 110.469 -169.37 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -79.64 97.81 6.68 Favored 'General case' 0 CA--C 1.556 1.191 0 CA-C-N 113.546 -1.661 . . . . 0.0 108.835 165.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.0 p -149.98 124.42 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 -169.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 95.1 p -87.59 136.4 32.96 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 113.298 -1.774 . . . . 0.0 111.506 -177.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.25 -44.28 92.4 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 113.691 -1.595 . . . . 0.0 114.409 170.915 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -63.49 -26.85 68.91 Favored 'General case' 0 CA--C 1.555 1.159 0 N-CA-C 117.879 2.548 . . . . 0.0 117.879 -174.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -74.97 -45.74 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 CA-C-N 120.673 1.579 . . . . 0.0 114.904 178.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -71.42 -35.55 71.01 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 116.865 -1.54 . . . . 0.0 113.436 169.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 25.9 mt -66.07 -39.4 90.05 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 121.781 2.082 . . . . 0.0 116.464 170.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.34 -35.62 78.04 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 170.222 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -56.34 -56.8 16.6 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 169.102 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.6 pp -68.46 -36.16 78.6 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 177.725 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -81.17 -60.15 2.39 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 121.211 1.823 . . . . 0.0 113.516 177.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 101.79 -40.62 2.36 Favored Glycine 0 CA--C 1.549 2.208 0 CA-C-N 120.501 1.501 . . . . 0.0 116.49 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 178.59 111.13 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 118.242 1.021 . . . . 0.0 108.647 -174.611 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.17 172.74 48.89 Favored Glycine 0 CA--C 1.57 3.472 0 CA-C-O 118.625 -1.097 . . . . 0.0 113.106 -172.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 1.309 ' HB2' ' OD2' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -160.92 100.32 1.25 Allowed 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 121.638 2.719 . . . . 0.0 114.219 -174.676 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -81.69 -37.7 26.98 Favored 'General case' 0 CA--C 1.576 1.96 0 CA-C-O 118.382 -0.818 . . . . 0.0 110.33 161.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 1.309 ' OD2' ' HB2' ' A' ' 129' ' ' ARG 0.29 20.9 m-20 66.89 -92.32 0.03 OUTLIER 'General case' 0 C--N 1.365 1.267 0 C-N-CA 126.846 2.059 . . . . 0.0 115.545 166.05 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . 0.302 17.9 t70 82.88 -58.16 0.17 Allowed 'General case' 0 N--CA 1.506 2.333 0 CA-C-N 113.704 -1.589 . . . . 0.0 109.165 -161.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 73.0 p -27.78 -68.66 0.06 Allowed 'General case' 0 N--CA 1.504 2.247 0 C-N-CA 127.714 2.406 . . . . 0.0 117.483 164.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -52.03 -38.77 58.11 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 116.956 2.206 . . . . 0.0 116.956 171.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -67.5 -46.72 72.08 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 175.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.0 m -63.0 -32.81 57.45 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.805 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 169.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.5 -32.0 55.15 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.006 0 C-N-CA 125.037 1.335 . . . . 0.0 113.444 167.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 27.2 mt -67.75 -45.71 74.18 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 120.722 1.601 . . . . 0.0 113.551 170.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -61.4 -37.95 85.33 Favored 'General case' 0 N--CA 1.506 2.343 0 CA-C-N 120.228 1.376 . . . . 0.0 113.928 167.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -55.46 -39.11 69.95 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 166.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -67.6 -32.32 72.96 Favored 'General case' 0 CA--C 1.566 1.588 0 N-CA-C 114.97 1.471 . . . . 0.0 114.97 169.842 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -59.58 -54.18 49.44 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 120.561 1.528 . . . . 0.0 114.604 168.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . 0.253 7.3 p -63.67 -29.94 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 CA-C-O 117.085 -1.436 . . . . 0.0 114.054 170.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -56.65 -48.5 77.43 Favored 'General case' 0 CA--C 1.586 2.339 0 CA-C-N 121.441 1.928 . . . . 0.0 111.654 166.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.07 -21.2 11.74 Favored 'General case' 0 CA--C 1.564 1.493 0 N-CA-C 119.346 3.091 . . . . 0.0 119.346 170.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.31 -45.71 69.1 Favored 'General case' 0 N--CA 1.51 2.541 0 CA-C-N 121.339 1.882 . . . . 0.0 115.725 167.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.531 ' HB2' HG12 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -123.91 -18.57 5.95 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 120.742 3.608 . . . . 0.0 120.742 -167.31 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 53.7 m -43.72 -31.67 0.85 Allowed 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 117.899 2.555 . . . . 0.0 117.899 -169.081 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -71.48 -64.32 1.16 Allowed Pre-proline 0 CA--C 1.582 2.182 0 CA-C-O 116.123 -1.894 . . . . 0.0 112.21 172.259 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -56.53 -32.79 90.93 Favored 'Trans proline' 0 CA--C 1.579 2.772 0 CA-C-N 124.555 2.662 . . . . 0.0 118.905 168.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -63.2 -46.63 86.14 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 125.451 1.5 . . . . 0.0 112.711 171.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 1.075 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 54.2 tp -65.96 -21.91 66.45 Favored 'General case' 0 CA--C 1.57 1.719 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 169.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -70.62 -48.04 57.05 Favored 'General case' 0 CA--C 1.559 1.31 0 CA-C-N 122.362 2.346 . . . . 0.0 112.914 165.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -61.91 -54.31 43.72 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-N 120.271 1.396 . . . . 0.0 113.021 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' TYR . . . . . 0.422 ' CD1' HG11 ' A' ' 110' ' ' VAL . 22.0 m-85 -76.43 -27.52 56.28 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-O 115.739 -2.076 . . . . 0.0 113.438 178.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 1.075 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 26.0 ttt180 -62.34 -33.81 75.43 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 124.166 3.166 . . . . 0.0 116.754 169.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -70.57 -40.9 73.06 Favored 'General case' 0 CA--C 1.575 1.922 0 CA-C-N 119.708 1.14 . . . . 0.0 113.64 166.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -90.66 -19.69 23.34 Favored 'General case' 0 CA--C 1.575 1.932 0 N-CA-C 119.877 3.288 . . . . 0.0 119.877 -176.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.5 pp -78.06 172.16 13.93 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 119.887 3.291 . . . . 0.0 119.887 -160.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.5 ' HB2' HD23 ' A' ' 111' ' ' LEU . 90.5 mttt -132.65 123.98 27.41 Favored 'General case' 0 CA--C 1.563 1.45 0 N-CA-C 104.349 -2.463 . . . . 0.0 104.349 163.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.9 t -95.94 151.01 19.82 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 122.034 0.921 . . . . 0.0 111.99 -171.151 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.511 HG13 ' HG3' ' A' ' 174' ' ' ARG . 15.2 t -129.76 129.49 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 178.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -97.22 111.61 23.77 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 104.121 -2.548 . . . . 0.0 104.121 169.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -128.14 42.28 3.35 Favored 'General case' 0 N--CA 1.484 1.272 1 N-CA-C 123.571 4.656 . . . . 0.0 123.571 -156.596 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . 0.501 32.5 m -101.9 -127.39 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.602 2.958 1 CA-C-O 109.702 -4.951 . . . . 0.0 106.98 169.031 . . . . . . . . 3 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 59.62 -17.31 0.03 OUTLIER Glycine 0 C--N 1.392 3.64 3 CA-C-N 134.441 7.837 . . . . 0.0 125.326 -168.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 67.2 p 60.5 94.71 0.04 OUTLIER 'General case' 0 CA--C 1.571 1.784 0 C-N-CA 127.254 2.221 . . . . 0.0 116.232 172.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . 0.271 43.4 tpp 86.94 -91.7 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 126.865 2.066 . . . . 0.0 112.244 166.12 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -63.83 -37.31 86.9 Favored 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -171.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.557 ' HB3' ' NH2' ' A' ' 174' ' ' ARG . 50.3 mt-10 -59.14 -51.95 67.82 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 174.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 4.0 t -59.14 -36.25 61.78 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.925 0 CA-C-O 117.426 -1.273 . . . . 0.0 113.462 177.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.481 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 21.4 t80 -58.75 -40.64 84.46 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 121.082 1.764 . . . . 0.0 114.84 166.806 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -61.83 -54.44 42.17 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 178.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.557 ' NH2' ' HB3' ' A' ' 170' ' ' GLU . 11.4 ptp180 -69.08 -25.28 64.36 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 117.841 2.534 . . . . 0.0 117.841 172.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.56 -46.61 85.15 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 120.637 1.562 . . . . 0.0 113.862 168.013 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.3 mp -58.79 -43.91 90.58 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 167.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -53.47 -43.07 67.85 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 168.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.09 -44.96 90.73 Favored 'General case' 0 CA--C 1.56 1.364 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 172.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.81 -61.56 1.72 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 120.538 1.517 . . . . 0.0 110.897 172.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.885 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . 164.6 52.57 0.02 OUTLIER Glycine 0 CA--C 1.545 1.942 0 N-CA-C 118.795 2.278 . . . . 0.0 118.795 168.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.885 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 85.2 tttt . . . . . 0 C--O 1.252 1.187 0 CA-C-N 120.794 2.297 . . . . 0.0 110.565 168.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.2 mtt . . . . . 0 CA--C 1.556 1.206 0 CA-C-O 122.812 1.292 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . 0.309 11.6 mpt_? -120.57 171.44 8.56 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 121.231 3.789 . . . . 0.0 121.231 -163.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.6 p -150.16 144.58 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.297 0 CA-C-O 123.044 1.402 . . . . 0.0 111.633 166.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.2 pp -138.62 134.16 33.37 Favored 'General case' 0 CA--C 1.563 1.448 0 CA-C-N 113.676 -1.602 . . . . 0.0 109.714 169.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.5 121.36 44.81 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 115.675 1.731 . . . . 0.0 115.675 -161.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 85.7 mt -99.58 144.96 28.07 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 111.443 -2.617 . . . . 0.0 110.358 175.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 163.93 162.26 14.53 Favored Glycine 0 CA--C 1.557 2.681 0 CA-C-O 118.801 -0.999 . . . . 0.0 115.553 169.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.3 118.61 5.77 Favored 'Trans proline' 0 CA--C 1.578 2.711 0 C-N-CA 123.475 2.783 . . . . 0.0 111.838 175.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -65.19 113.16 2.3 Favored 'Trans proline' 0 CA--C 1.559 1.761 0 C-N-CA 122.936 2.424 . . . . 0.0 118.2 -169.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.87 -87.41 0.07 OUTLIER Glycine 0 CA--C 1.538 1.472 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 168.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.76 -71.17 0.53 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -172.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.435 ' O ' ' CG ' ' A' ' 13' ' ' LYS . . . -93.06 106.16 3.39 Favored Glycine 0 N--CA 1.484 1.886 0 CA-C-N 119.641 1.109 . . . . 0.0 114.991 -168.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.435 ' CG ' ' O ' ' A' ' 12' ' ' GLY . 3.6 mtmp? -175.48 -85.47 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 121.807 0.813 . . . . 0.0 110.347 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -53.8 -28.35 38.81 Favored Glycine 0 CA--C 1.554 2.48 0 N-CA-C 120.421 2.928 . . . . 0.0 120.421 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.1 m -65.76 -53.0 46.4 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 119.328 1.564 . . . . 0.0 113.265 176.011 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.28 20.0 mp0 -76.64 -13.32 60.07 Favored 'General case' 0 CA--C 1.569 1.698 0 CA-C-O 114.895 -2.479 . . . . 0.0 112.43 169.766 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.38 -47.08 68.3 Favored 'General case' 0 C--N 1.376 1.729 0 CA-C-N 125.145 3.611 . . . . 0.0 113.703 166.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.1 p -66.8 -39.94 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 174.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -62.13 -43.99 97.61 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 116.305 1.965 . . . . 0.0 116.305 169.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.84 -32.36 73.84 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 119.996 1.271 . . . . 0.0 114.152 171.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.38 -42.3 95.56 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 115.292 1.589 . . . . 0.0 115.292 167.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -58.2 -39.53 79.22 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 167.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.3 mmmt -65.9 -54.88 20.81 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 174.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.3 mt -83.51 -19.8 35.07 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 116.775 2.139 . . . . 0.0 116.775 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.02 38.6 7.83 Favored Glycine 0 CA--C 1.554 2.512 0 N-CA-C 117.62 1.808 . . . . 0.0 117.62 -176.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.9 mm -107.51 158.52 33.04 Favored Pre-proline 0 CA--C 1.57 1.724 0 CA-C-N 118.565 1.182 . . . . 0.0 113.419 -168.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -82.82 99.77 0.93 Allowed 'Trans proline' 0 CA--C 1.571 2.338 0 C-N-CA 121.867 1.712 . . . . 0.0 111.372 163.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -64.04 112.24 2.88 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 123.831 0.852 . . . . 0.0 112.117 170.635 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 21.5 mm -99.83 108.48 22.79 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.1 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 59.8 p -97.79 128.64 44.56 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 168.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.9 p -69.02 -19.34 64.11 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 117.066 2.247 . . . . 0.0 117.066 -169.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -81.67 -19.88 64.96 Favored Glycine 0 CA--C 1.543 1.839 0 N-CA-C 119.102 2.401 . . . . 0.0 119.102 167.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -80.84 -51.4 8.65 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -169.125 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -65.13 -41.07 95.15 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 174.346 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.452 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 25.2 m-85 -66.4 -41.1 89.82 Favored 'General case' 0 CA--C 1.559 1.298 0 N-CA-C 115.702 1.741 . . . . 0.0 115.702 172.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -59.3 -42.72 91.99 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 120.544 1.52 . . . . 0.0 114.203 168.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -59.21 -39.21 81.98 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 168.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -69.62 -24.47 63.65 Favored 'General case' 0 CA--C 1.581 2.14 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 168.315 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.0 mt -63.17 -49.46 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 CA-C-N 120.675 1.579 . . . . 0.0 110.96 167.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -67.95 -33.52 74.83 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 114.301 1.222 . . . . 0.0 114.301 175.254 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -73.7 -35.86 65.2 Favored 'General case' 0 CA--C 1.564 1.498 0 N-CA-C 116.299 1.962 . . . . 0.0 116.299 173.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.77 73.76 1.28 Allowed Glycine 0 CA--C 1.542 1.76 0 CA-C-O 118.065 -1.409 . . . . 0.0 114.482 -176.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.554 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 64.7 p -90.8 -65.59 1.0 Allowed 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 119.262 1.531 . . . . 0.0 111.911 173.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.554 ' CB ' ' O ' ' A' ' 43' ' ' THR . 21.3 ptmt 130.27 -57.13 0.0 OUTLIER 'General case' 0 CA--C 1.569 1.702 0 C-N-CA 123.661 0.784 . . . . 0.0 109.581 -166.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -80.03 6.83 10.39 Favored 'General case' 0 CA--C 1.575 1.913 0 C-N-CA 124.249 1.019 . . . . 0.0 113.454 166.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 50' ' ' LYS . . . -86.79 -52.77 3.05 Favored Glycine 0 CA--C 1.535 1.333 0 O-C-N 121.21 -0.931 . . . . 0.0 112.892 165.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.312 7.4 p -80.14 -52.03 15.22 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.581 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -167.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -66.94 -44.37 80.8 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 121.013 1.733 . . . . 0.0 112.686 172.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.79 -30.8 69.46 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.452 ' HB2' ' HB3' ' A' ' 35' ' ' PHE . 2.4 tptm -71.97 -36.87 69.95 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 167.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.571 ' HG2' ' O ' ' A' ' 51' ' ' ARG . 46.5 ttt180 -70.78 -58.71 3.35 Favored 'General case' 0 CA--C 1.591 2.534 1 CA-C-O 87.3 -15.619 . . . . 0.0 117.829 -178.531 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . 0.253 10.9 m-30 -26.47 -68.81 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.587 1 O-C-N 110.452 -7.655 . . . . 0.0 119.644 146.512 . . . . . . . . 3 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 26.6 tp -57.3 -32.07 66.29 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 116.517 2.043 . . . . 0.0 116.517 175.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -88.78 -47.25 8.35 Favored 'General case' 0 CA--C 1.559 1.311 0 CA-C-O 116.831 -1.557 . . . . 0.0 114.395 170.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -158.24 46.33 0.34 Allowed 'General case' 0 CA--C 1.573 1.837 0 CA-C-N 121.401 1.909 . . . . 0.0 113.32 -168.359 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -161.21 60.89 0.29 Allowed Glycine 0 C--N 1.358 1.785 0 CA-C-N 121.906 2.139 . . . . 0.0 111.727 169.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . 0.279 4.8 t70 75.56 -115.05 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 124.301 1.041 . . . . 0.0 110.423 168.619 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.568 ' HA ' HH22 ' A' ' 88' ' ' ARG . 74.7 mt -133.47 128.79 36.17 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 119.507 1.049 . . . . 0.0 110.628 -174.121 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.0 p -89.27 141.03 28.79 Favored Pre-proline 0 CA--C 1.578 2.031 0 CA-C-O 117.429 -1.272 . . . . 0.0 108.095 167.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -50.66 143.81 27.7 Favored 'Trans proline' 0 CA--C 1.565 2.03 0 C-N-CA 123.451 2.767 . . . . 0.0 116.696 169.765 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 59.6 m -65.71 -42.75 90.74 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 117.064 2.246 . . . . 0.0 117.064 -169.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -59.5 -37.71 79.01 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 116.832 2.16 . . . . 0.0 116.832 -175.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 35.5 mt -54.87 -51.82 64.75 Favored 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 169.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.7 m -64.99 -50.77 65.01 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 112.889 -1.96 . . . . 0.0 113.064 -178.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.83 -20.01 64.64 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 167.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -72.48 -46.87 52.79 Favored 'General case' 0 CA--C 1.556 1.185 0 CA-C-N 120.441 1.473 . . . . 0.0 114.588 170.02 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.1 mt -61.22 -46.0 92.26 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 169.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 97.3 t -61.77 -48.78 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 118.025 -0.988 . . . . 0.0 112.017 175.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -63.03 -35.78 81.36 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 115.993 1.849 . . . . 0.0 115.993 172.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -57.55 -42.83 83.73 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 117.695 -1.145 . . . . 0.0 113.779 170.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 83.2 mtt180 -80.26 -15.55 56.72 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 118.497 2.777 . . . . 0.0 118.497 168.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.419 HD13 HH12 ' A' ' 103' ' ' ARG . 96.6 mt -83.69 -14.69 51.14 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 116.527 2.047 . . . . 0.0 116.527 169.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -68.84 8.1 0.57 Allowed 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 117.17 2.285 . . . . 0.0 117.17 169.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -76.36 136.45 68.45 Favored Pre-proline 0 CA--C 1.574 1.885 0 CA-C-O 117.79 -1.1 . . . . 0.0 108.568 165.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -49.92 -24.42 10.46 Favored 'Trans proline' 0 N--CA 1.505 2.156 0 N-CA-C 122.25 3.904 . . . . 0.0 122.25 175.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -64.1 -10.73 24.18 Favored 'General case' 0 CA--C 1.573 1.845 0 CA-C-O 116.62 -1.657 . . . . 0.0 114.284 166.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.97 -19.14 57.68 Favored 'General case' 0 CA--C 1.564 1.516 0 CA-C-N 122.42 2.373 . . . . 0.0 115.68 168.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.82 -35.13 74.07 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 116.782 2.142 . . . . 0.0 116.782 174.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -106.14 16.72 24.55 Favored 'General case' 0 CA--C 1.574 1.884 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 172.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.26 178.6 38.56 Favored Glycine 0 C--N 1.358 1.782 0 CA-C-N 122.159 2.254 . . . . 0.0 115.266 173.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -173.44 131.87 0.46 Allowed 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 169.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 4.7 mm -104.65 108.21 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.504 0 N-CA-C 103.412 -2.81 . . . . 0.0 103.412 170.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 79.8 mt -100.09 138.82 36.63 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 171.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -127.9 127.96 44.31 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 119.575 1.08 . . . . 0.0 111.859 172.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 67.63 34.02 82.57 Favored Glycine 0 CA--C 1.552 2.373 0 N-CA-C 118.008 1.963 . . . . 0.0 118.008 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -94.34 -54.27 0.23 Allowed Pre-proline 0 N--CA 1.496 1.826 0 CA-C-O 114.956 -2.45 . . . . 0.0 108.968 173.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.3 68.63 1.42 Allowed 'Trans proline' 0 CA--C 1.565 2.071 0 CA-C-N 124.75 2.732 . . . . 0.0 118.82 167.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.568 HH22 ' HA ' ' A' ' 58' ' ' LEU . 26.8 ptt180 -66.61 -35.57 80.5 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 116.056 1.873 . . . . 0.0 116.056 166.186 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 37.7 t -149.18 141.17 23.81 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -168.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . 0.274 8.4 p -61.7 -27.24 41.77 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.653 0 CA-C-O 115.941 -1.981 . . . . 0.0 113.322 178.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -38.22 88.26 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 120.155 3.391 . . . . 0.0 120.155 166.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -75.68 -47.91 24.26 Favored 'General case' 0 CA--C 1.586 2.34 0 CA-C-N 123.356 2.798 . . . . 0.0 112.299 166.746 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.5 -31.0 70.07 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 -175.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -57.31 -29.72 64.15 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 168.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.18 -40.54 86.58 Favored 'General case' 0 CA--C 1.571 1.758 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 167.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LEU . . . . . 0.484 ' HA ' ' HG3' ' A' ' 99' ' ' MET . 40.1 tp -62.61 -38.3 89.66 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 169.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 55.8 t60 -64.89 -44.51 89.37 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 120.413 1.46 . . . . 0.0 113.313 168.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.839 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 32.0 mt-10 -51.58 -40.52 59.96 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 167.767 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' MET . . . . . 1.287 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -84.63 -19.95 32.14 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 117.934 2.568 . . . . 0.0 117.934 175.184 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 60.2 tp -72.45 -52.71 14.7 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 121.175 1.807 . . . . 0.0 111.47 170.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -74.85 -55.9 5.32 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 171.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.839 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 36.9 ttm180 -68.99 -39.22 79.51 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 178.076 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 1.287 ' HB3' ' O ' ' A' ' 99' ' ' MET . 66.1 ttt180 -62.37 -58.38 7.87 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 119.639 1.108 . . . . 0.0 110.365 164.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 111.47 46.66 0.78 Allowed Glycine 0 N--CA 1.479 1.529 0 O-C-N 124.366 1.041 . . . . 0.0 113.651 168.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 37.2 p -101.26 147.21 26.55 Favored 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 173.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -68.22 130.06 41.79 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.346 -0.846 . . . . 0.0 112.572 -170.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 4.4 tp -85.48 98.53 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 175.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -97.51 -67.77 0.83 Allowed 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 115.765 -2.064 . . . . 0.0 108.388 168.858 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -149.34 120.84 7.95 Favored 'General case' 0 C--N 1.367 1.367 0 CA-C-N 121.999 2.181 . . . . 0.0 115.114 -170.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 19.4 t -94.09 109.77 22.54 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.691 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 163.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.673 HD23 ' HB2' ' A' ' 160' ' ' LYS . 80.1 mt -105.07 117.97 35.35 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 123.423 0.689 . . . . 0.0 112.082 -172.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -88.68 136.19 33.12 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.398 0.618 . . . . 0.0 112.086 169.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -101.53 112.33 24.85 Favored 'General case' 0 CA--C 1.558 1.28 0 CA-C-O 122.998 1.38 . . . . 0.0 108.118 176.004 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.431 ' HB3' ' HA ' ' A' ' 163' ' ' ASP . 17.0 tpt180 -83.79 101.87 11.92 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 112.889 -1.959 . . . . 0.0 109.157 171.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.5 p -146.17 124.09 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 CA-C-N 113.128 -1.851 . . . . 0.0 106.717 -169.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 11.2 m -61.85 142.09 57.56 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 113.639 -1.619 . . . . 0.0 113.877 -169.444 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -54.32 -38.27 65.79 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 116.521 2.045 . . . . 0.0 116.521 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -70.66 -39.39 73.6 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 176.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.64 -47.58 92.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 CA-C-N 120.488 1.495 . . . . 0.0 114.318 175.685 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.3 pp -67.12 -43.48 82.35 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 114.423 -1.262 . . . . 0.0 114.233 177.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.2 mp -60.37 -35.68 76.25 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 167.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -60.82 -43.09 98.7 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 168.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -57.6 -48.83 78.31 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 168.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -49.46 -48.12 47.89 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 169.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -62.57 -55.28 28.73 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 176.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.744 ' O ' ' HB2' ' A' ' 127' ' ' ARG . . . -112.16 60.81 0.33 Allowed Glycine 0 CA--C 1.543 1.81 0 C-N-CA 123.141 0.4 . . . . 0.0 114.002 178.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.744 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 66.3 ttt180 161.99 89.6 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 177.288 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.525 ' O ' ' HB2' ' A' ' 129' ' ' ARG . . . 174.49 -51.7 0.14 Allowed Glycine 0 CA--C 1.551 2.326 0 CA-C-O 118.244 -1.309 . . . . 0.0 114.301 -178.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.525 ' HB2' ' O ' ' A' ' 128' ' ' GLY . 37.8 ttm180 167.65 -97.0 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 119.483 1.641 . . . . 0.0 107.065 177.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -151.29 -44.92 0.11 Allowed 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 116.964 -1.493 . . . . 0.0 112.636 169.977 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -136.24 61.6 1.64 Allowed 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 121.772 2.078 . . . . 0.0 112.081 175.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -117.97 61.48 0.77 Allowed 'General case' 0 CA--C 1.572 1.824 0 N-CA-C 102.974 -2.972 . . . . 0.0 102.974 159.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 81.6 p -140.09 -112.5 0.15 Allowed 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 114.047 -1.433 . . . . 0.0 110.63 -160.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -55.88 -45.27 78.6 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 117.079 2.251 . . . . 0.0 117.079 -168.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -67.65 -38.16 83.41 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 172.349 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 44.4 t -66.2 -38.2 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-O 117.871 -1.061 . . . . 0.0 112.795 174.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.5 tp -75.17 -25.24 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 CA-C-O 117.26 -1.352 . . . . 0.0 114.276 170.355 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 28.8 mt -66.11 -51.07 61.39 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 121.824 2.102 . . . . 0.0 113.246 168.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -66.53 -38.69 87.7 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 114.692 1.368 . . . . 0.0 114.692 173.351 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 63.4 mtp180 -63.36 -32.61 74.08 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 116.363 1.986 . . . . 0.0 116.363 170.192 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 48.3 mtt -72.42 -33.0 66.8 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 168.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -61.84 -51.48 68.04 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 169.185 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.3 p -64.26 -34.22 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 CA-C-O 117.466 -1.254 . . . . 0.0 114.128 171.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -53.2 -48.08 68.38 Favored 'General case' 0 CA--C 1.591 2.55 0 CA-C-N 120.404 1.456 . . . . 0.0 112.349 167.391 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 63.1 ttt180 -57.42 -37.83 73.39 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 119.115 3.005 . . . . 0.0 119.115 174.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -52.91 -34.16 53.75 Favored 'General case' 0 N--CA 1.512 2.673 0 N-CA-C 117.205 2.298 . . . . 0.0 117.205 170.675 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -110.83 -28.43 8.4 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 120.298 3.444 . . . . 0.0 120.298 -165.336 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 56.8 m -63.5 -30.67 71.75 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 117.093 2.257 . . . . 0.0 117.093 -166.198 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.58 -61.55 4.33 Favored Pre-proline 0 CA--C 1.58 2.118 0 CA-C-O 116.583 -1.675 . . . . 0.0 112.616 168.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -65.29 -33.11 49.64 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 123.161 2.574 . . . . 0.0 117.471 176.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.2 tt -63.07 -55.06 28.7 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 117.344 -1.312 . . . . 0.0 110.542 168.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.997 ' O ' ' HB2' ' A' ' 156' ' ' ARG 0.335 0.1 OUTLIER -57.21 -27.12 61.71 Favored 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 177.931 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -73.5 -41.97 62.41 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 116.126 -1.892 . . . . 0.0 113.115 165.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -66.88 -55.82 13.01 Favored 'General case' 0 CA--C 1.564 1.494 0 CA-C-N 122.719 2.509 . . . . 0.0 112.583 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -80.46 -30.74 37.47 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-O 115.174 -2.346 . . . . 0.0 112.017 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.997 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 37.6 ttt180 -63.02 -32.63 74.03 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 124.418 3.281 . . . . 0.0 116.177 171.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -68.42 -41.12 80.86 Favored 'General case' 0 CA--C 1.574 1.888 0 CA-C-N 119.236 0.926 . . . . 0.0 113.182 165.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -90.81 -21.03 21.69 Favored 'General case' 0 CA--C 1.578 2.047 0 N-CA-C 120.331 3.456 . . . . 0.0 120.331 -176.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.7 pp -80.82 -178.37 6.79 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 119.053 2.983 . . . . 0.0 119.053 -163.119 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.673 ' HB2' HD23 ' A' ' 111' ' ' LEU . 90.5 mttt -130.89 141.52 50.31 Favored 'General case' 0 CA--C 1.564 1.491 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 166.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 34.0 m -100.01 145.49 27.82 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 122.408 1.099 . . . . 0.0 110.672 -171.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 38.4 t -133.04 132.39 58.87 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.487 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 169.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.431 ' HA ' ' HB3' ' A' ' 114' ' ' ARG . 20.4 t70 -96.14 138.47 33.7 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 167.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . 0.253 . . -125.61 -132.35 0.25 Allowed 'General case' 0 N--CA 1.483 1.212 0 O-C-N 121.64 -0.663 . . . . 0.0 111.433 -165.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 31.3 t 72.24 133.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 C-N-CA 127.173 2.189 . . . . 0.0 112.674 167.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 78.52 -73.43 2.23 Favored Glycine 0 N--CA 1.479 1.557 0 N-CA-C 117.566 1.787 . . . . 0.0 117.566 167.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 55.3 p -85.08 134.06 34.21 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 111.87 -2.165 . . . . 0.0 111.329 -169.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 65.3 mtt -85.8 -62.88 1.42 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.08 0.552 . . . . 0.0 111.468 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -69.89 -36.23 75.26 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 116.142 1.904 . . . . 0.0 116.142 -178.208 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.734 ' HB3' ' NH2' ' A' ' 174' ' ' ARG . 48.1 mt-10 -61.32 -52.45 64.65 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 118.023 -0.989 . . . . 0.0 113.507 169.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 99.5 t -57.51 -37.9 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 175.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -62.04 -33.9 75.24 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 116.424 2.009 . . . . 0.0 116.424 168.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.78 -53.23 43.11 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 174.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.734 ' NH2' ' HB3' ' A' ' 170' ' ' GLU . 10.5 ptp180 -65.66 -29.64 70.23 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 117.586 2.439 . . . . 0.0 117.586 170.85 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.71 -45.83 92.28 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 119.856 1.207 . . . . 0.0 114.172 167.729 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.92 -44.7 91.35 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-O 117.013 -1.47 . . . . 0.0 114.698 168.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 26.5 mmm180 -55.79 -43.1 76.49 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 170.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.74 -39.5 94.29 Favored 'General case' 0 CA--C 1.563 1.444 0 N-CA-C 116.477 2.028 . . . . 0.0 116.477 172.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 5.8 tt -75.0 -51.68 13.0 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 120.968 1.713 . . . . 0.0 112.077 170.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -149.5 -57.48 0.01 OUTLIER Glycine 0 CA--C 1.552 2.377 0 CA-C-O 117.486 -1.73 . . . . 0.0 115.801 -176.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt . . . . . 0 C--O 1.252 1.205 0 CA-C-N 120.774 2.287 . . . . 0.0 108.655 -172.777 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.9 ttm . . . . . 0 CA--C 1.56 1.334 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.47 166.77 32.1 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 118.414 2.746 . . . . 0.0 118.414 -166.249 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.4 p -126.71 146.07 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-O 122.923 1.344 . . . . 0.0 114.193 -166.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -119.89 113.34 20.43 Favored 'General case' 0 CA--C 1.559 1.307 0 N-CA-C 104.867 -2.271 . . . . 0.0 104.867 168.406 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.2 tt -101.73 131.24 48.12 Favored 'General case' 0 CA--C 1.562 1.408 0 C-N-CA 125.788 1.635 . . . . 0.0 111.348 -165.155 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.8 mt -135.48 165.8 24.66 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 125.378 1.471 . . . . 0.0 113.825 -167.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.43 124.7 0.94 Allowed Glycine 0 CA--C 1.557 2.665 0 CA-C-O 117.362 -1.799 . . . . 0.0 111.274 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -72.46 -176.68 2.34 Favored 'Trans proline' 0 CA--C 1.579 2.745 0 CA-C-N 122.522 3.161 . . . . 0.0 114.101 176.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -52.18 109.83 0.38 Allowed 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 123.748 2.965 . . . . 0.0 114.513 176.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.32 91.68 2.22 Favored Glycine 0 CA--C 1.542 1.731 0 N-CA-C 106.522 -2.631 . . . . 0.0 106.522 -165.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.58 164.32 13.81 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 115.637 1.717 . . . . 0.0 115.637 -165.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -159.87 99.32 0.18 Allowed Glycine 0 CA--C 1.539 1.538 0 N-CA-C 107.924 -2.07 . . . . 0.0 107.924 169.707 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -137.19 -73.13 0.43 Allowed 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -167.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -42.61 -42.15 4.55 Favored Glycine 0 CA--C 1.551 2.332 0 N-CA-C 121.207 3.243 . . . . 0.0 121.207 -175.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.1 m -61.97 -57.32 12.14 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 118.992 1.396 . . . . 0.0 113.835 178.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.259 3.7 mm-40 -76.49 -14.22 60.05 Favored 'General case' 0 CA--C 1.573 1.859 0 CA-C-O 116.175 -1.869 . . . . 0.0 111.528 175.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.63 -47.38 60.38 Favored 'General case' 0 C--N 1.373 1.608 0 CA-C-N 123.219 2.736 . . . . 0.0 114.476 168.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.2 p -66.12 -40.76 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 172.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -58.94 -44.22 91.36 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 116.321 1.971 . . . . 0.0 116.321 169.348 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.91 -35.46 80.69 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 172.332 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.21 -42.1 90.16 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 167.677 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -59.82 -36.23 76.35 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 167.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -64.87 -59.44 4.2 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 170.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.1 mt -80.28 -20.92 43.3 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 116.422 2.008 . . . . 0.0 116.422 -176.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.95 34.19 8.46 Favored Glycine 0 CA--C 1.554 2.501 0 N-CA-C 117.681 1.833 . . . . 0.0 117.681 -177.287 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.3 mm -104.64 156.07 36.47 Favored Pre-proline 0 CA--C 1.568 1.649 0 CA-C-N 118.987 1.394 . . . . 0.0 112.561 -169.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -80.72 100.69 1.24 Allowed 'Trans proline' 0 CA--C 1.569 2.257 0 C-N-CA 121.816 1.677 . . . . 0.0 110.099 162.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -58.81 109.11 0.75 Allowed 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 124.347 1.059 . . . . 0.0 112.002 170.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 35.7 mm -98.0 107.64 20.55 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 68.9 p -95.46 126.99 41.14 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 167.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.4 p -65.73 -22.1 66.58 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 -169.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.638 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -83.56 -13.02 76.92 Favored Glycine 0 CA--C 1.544 1.871 0 N-CA-C 119.168 2.427 . . . . 0.0 119.168 168.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -81.8 -51.21 8.37 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 119.197 1.498 . . . . 0.0 114.648 -171.144 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -66.2 -42.17 89.18 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 173.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.54 ' HB3' ' CB ' ' A' ' 50' ' ' LYS . 32.9 m-85 -59.56 -43.93 93.41 Favored 'General case' 0 CA--C 1.569 1.674 0 C-N-CA 125.403 1.481 . . . . 0.0 114.477 168.126 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.638 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 72.2 ttt180 -54.94 -42.56 72.45 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 168.25 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.3 ttt180 -60.36 -36.58 78.37 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 168.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -69.29 -26.54 64.79 Favored 'General case' 0 CA--C 1.581 2.168 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 167.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.408 HG12 HG23 ' A' ' 47' ' ' VAL . 58.7 mt -60.67 -52.18 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.376 0 CA-C-N 120.933 1.697 . . . . 0.0 110.235 167.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -65.4 -35.48 81.06 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -70.3 -38.44 75.0 Favored 'General case' 0 CA--C 1.562 1.426 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 174.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.35 68.84 1.24 Allowed Glycine 0 CA--C 1.543 1.842 0 CA-C-O 118.905 -0.941 . . . . 0.0 114.623 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.822 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 74.5 p -92.63 -47.25 7.2 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 177.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.822 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.254 75.5 mttt 104.84 -40.04 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.725 0 CA-C-O 116.227 -1.844 . . . . 0.0 111.694 -172.737 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -83.8 -12.41 55.69 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 123.09 2.677 . . . . 0.0 112.586 163.224 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.33 -56.23 26.29 Favored Glycine 0 CA--C 1.547 2.047 0 CA-C-N 120.905 1.684 . . . . 0.0 114.167 168.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.408 HG23 HG12 ' A' ' 39' ' ' ILE 0.25 1.0 OUTLIER -74.33 -49.85 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 116.898 2.184 . . . . 0.0 116.898 -169.467 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -67.9 -38.59 83.19 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 119.907 1.23 . . . . 0.0 112.74 174.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.26 -35.85 66.29 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 117.969 -1.015 . . . . 0.0 113.594 -175.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.54 ' CB ' ' HB3' ' A' ' 35' ' ' PHE 0.33 1.7 tptt -81.14 -24.14 37.81 Favored 'General case' 0 CA--C 1.564 1.487 0 CA-C-O 116.961 -1.495 . . . . 0.0 113.36 173.022 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.585 ' HG2' ' O ' ' A' ' 51' ' ' ARG . 40.6 ttt180 -75.56 -56.99 4.16 Favored 'General case' 0 CA--C 1.591 2.553 1 CA-C-O 86.613 -15.946 . . . . 0.0 117.686 176.815 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . 0.254 15.7 m-30 -27.38 -64.46 0.08 Allowed 'General case' 0 N--CA 1.499 1.979 1 O-C-N 108.837 -8.664 . . . . 0.0 120.192 146.491 . . . . . . . . 3 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.2 tp -53.89 -39.56 65.84 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 116.998 2.222 . . . . 0.0 116.998 172.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -90.18 -41.1 11.8 Favored 'General case' 0 CA--C 1.566 1.559 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 173.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -153.03 41.63 0.58 Allowed 'General case' 0 CA--C 1.571 1.757 0 CA-C-N 120.86 1.664 . . . . 0.0 114.887 -169.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -165.78 59.26 0.24 Allowed Glycine 0 C--N 1.354 1.559 0 O-C-N 119.419 -2.051 . . . . 0.0 111.779 168.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . 0.273 5.0 t70 71.51 -117.7 0.08 Allowed 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 124.018 0.927 . . . . 0.0 109.555 169.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.1 pp -124.93 143.65 50.76 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 123.637 0.775 . . . . 0.0 112.06 -176.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.1 p -96.93 130.92 28.86 Favored Pre-proline 0 CA--C 1.573 1.832 0 CA-C-O 117.676 -1.154 . . . . 0.0 107.924 167.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -49.34 134.89 31.91 Favored 'Trans proline' 0 CA--C 1.56 1.821 0 C-N-CA 123.537 2.825 . . . . 0.0 116.042 172.641 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.8 m -68.82 175.65 3.5 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -169.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.3 t70 86.09 -44.43 0.05 Allowed 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 126.339 1.856 . . . . 0.0 113.999 -176.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.8 mt -60.44 -47.37 86.39 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 168.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.8 m -57.6 -50.26 73.72 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 113.544 -1.662 . . . . 0.0 113.449 177.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -69.76 -21.25 63.45 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 168.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -65.59 -43.61 89.16 Favored 'General case' 0 CA--C 1.559 1.316 0 CA-C-N 120.557 1.526 . . . . 0.0 114.957 168.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 44.2 mt -65.56 -46.31 79.95 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 167.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -56.71 -50.99 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 172.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -65.09 -34.22 77.9 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 175.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -58.1 -43.34 87.06 Favored 'General case' 0 CA--C 1.559 1.31 0 CA-C-O 117.793 -1.098 . . . . 0.0 113.497 168.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -81.76 -9.82 59.52 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 119.256 3.058 . . . . 0.0 119.256 169.08 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 13.1 tp -87.66 -14.68 39.28 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 169.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -57.45 1.77 0.03 OUTLIER 'General case' 0 CA--C 1.583 2.218 0 N-CA-C 118.441 2.756 . . . . 0.0 118.441 168.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . 0.259 0.8 OUTLIER -48.1 -132.52 0.0 OUTLIER Pre-proline 0 CA--C 1.609 3.244 0 N-CA-C 118.93 2.937 . . . . 0.0 118.93 169.836 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -62.74 40.34 0.09 OUTLIER 'Trans proline' 0 C--N 1.387 2.563 0 C-N-CA 124.889 3.726 . . . . 0.0 121.221 169.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.7 t70 61.65 31.66 18.62 Favored 'General case' 0 CA--C 1.591 2.549 0 C-N-CA 124.434 1.093 . . . . 0.0 109.608 -161.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 82.32 -1.05 1.41 Allowed 'General case' 0 C--N 1.381 1.965 0 CA-C-O 116.347 -1.787 . . . . 0.0 114.638 -168.271 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 52.14 31.59 9.25 Favored 'General case' 0 CA--C 1.576 1.975 0 CA-C-N 123.873 3.033 . . . . 0.0 114.209 -165.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 60.02 32.99 21.31 Favored 'General case' 0 CA--C 1.586 2.328 0 CA-C-O 117.058 -1.449 . . . . 0.0 112.273 -166.686 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -179.72 173.64 45.34 Favored Glycine 0 C--N 1.374 2.673 0 CA-C-N 123.185 2.721 . . . . 0.0 117.883 -172.344 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -170.46 132.63 0.99 Allowed 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 114.189 -1.005 . . . . 0.0 108.88 -175.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.1 mm -102.43 105.48 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.577 0 N-CA-C 102.745 -3.057 . . . . 0.0 102.745 166.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -110.5 122.76 48.51 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -176.65 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.25 119.67 32.94 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 119.048 0.84 . . . . 0.0 110.467 -165.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.39 43.68 68.67 Favored Glycine 0 CA--C 1.548 2.094 0 CA-C-O 116.098 -2.501 . . . . 0.0 116.345 -174.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . 0.257 2.9 t80 -95.97 -57.32 0.2 Allowed Pre-proline 0 N--CA 1.504 2.234 0 CA-C-N 121.737 2.768 . . . . 0.0 108.276 176.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -60.59 59.67 0.09 OUTLIER 'Trans proline' 0 CA--C 1.577 2.654 0 N-CA-C 121.547 3.633 . . . . 0.0 121.547 168.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.533 HH11 ' HB2' ' A' ' 89' ' ' SER . 7.0 tmm_? -69.55 -28.43 66.0 Favored 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 166.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.533 ' HB2' HH11 ' A' ' 88' ' ' ARG . 30.3 t -151.68 155.51 38.48 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 120.279 1.399 . . . . 0.0 107.913 -176.184 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.5 t -61.87 -37.0 77.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-O 116.981 -1.485 . . . . 0.0 111.793 173.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.34 -40.41 77.94 Favored 'General case' 0 CA--C 1.558 1.268 0 N-CA-C 119.882 3.29 . . . . 0.0 119.882 169.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 22.3 mm100 -71.41 -48.21 51.17 Favored 'General case' 0 CA--C 1.589 2.471 0 CA-C-N 122.279 2.308 . . . . 0.0 113.322 168.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.78 -29.49 66.82 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 126.894 2.078 . . . . 0.0 116.05 -168.184 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 57.6 tttt -63.68 -31.57 72.78 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 166.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.97 -39.08 69.58 Favored 'General case' 0 CA--C 1.569 1.688 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 169.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 16.8 tp -63.01 -40.88 99.09 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 168.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -58.5 -52.49 65.43 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 119.431 1.014 . . . . 0.0 113.463 169.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.904 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 21.5 mm-40 -48.63 -41.79 32.19 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 115.956 1.836 . . . . 0.0 115.956 168.067 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' MET . . . . . 1.184 ' O ' ' HB2' ' A' ' 103' ' ' ARG . 55.1 mtt -84.12 -20.73 32.03 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 117.956 2.576 . . . . 0.0 117.956 175.569 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.1 tt -75.73 -48.93 19.8 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-N 121.301 1.864 . . . . 0.0 110.866 172.556 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -72.45 -56.28 5.67 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 119.57 1.077 . . . . 0.0 113.199 169.714 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.904 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 70.6 ttt180 -64.15 -44.63 91.54 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 116.353 1.983 . . . . 0.0 116.353 177.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 1.184 ' HB2' ' O ' ' A' ' 99' ' ' MET . 15.3 mtp-105 -65.13 -53.92 37.84 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 118.992 0.814 . . . . 0.0 111.196 165.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 111.02 48.62 0.71 Allowed Glycine 0 N--CA 1.483 1.831 0 C-N-CA 120.808 -0.71 . . . . 0.0 114.752 166.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 71.7 p -89.91 158.14 17.55 Favored 'General case' 0 CA--C 1.563 1.479 0 CA-C-N 113.22 -1.49 . . . . 0.0 110.307 169.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -72.55 138.69 47.07 Favored 'General case' 0 N--CA 1.507 2.381 0 CA-C-O 122.37 1.081 . . . . 0.0 111.38 172.835 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.6 tp -98.99 102.72 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -95.12 -70.32 0.72 Allowed 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 116.738 -1.601 . . . . 0.0 108.032 166.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.91 124.23 7.61 Favored 'General case' 0 C--N 1.36 1.05 0 CA-C-N 120.938 1.699 . . . . 0.0 113.818 -169.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 24.0 t -92.29 108.92 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.638 1 N-CA-C 99.97 -4.085 . . . . 0.0 99.97 162.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.255 52.2 tp -118.94 114.48 22.63 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.937 0.895 . . . . 0.0 112.607 -159.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -103.17 127.81 50.34 Favored 'General case' 0 CA--C 1.563 1.454 0 CA-C-O 121.448 0.642 . . . . 0.0 112.34 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -95.79 113.9 25.58 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.902 1.281 . . . . 0.0 109.796 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -86.33 96.06 9.85 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.214 170.614 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 56.1 t -132.63 146.66 32.45 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.565 0 C-N-CA 127.891 2.476 . . . . 0.0 106.016 -171.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.8 m -75.94 137.3 40.25 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 113.476 -1.693 . . . . 0.0 112.647 -175.043 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -65.17 -28.09 69.16 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 174.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -60.35 -35.86 76.66 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 122.102 2.228 . . . . 0.0 115.588 172.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -62.19 -46.55 96.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 169.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.18 -52.47 47.84 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 124.134 0.974 . . . . 0.0 113.505 175.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.0 mp -59.68 -34.98 73.56 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 116.137 1.902 . . . . 0.0 116.137 172.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.45 -33.87 69.75 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 120.813 1.642 . . . . 0.0 114.522 169.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -57.32 -52.6 64.69 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 168.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 72.4 mt -61.19 -48.41 81.65 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 171.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.475 ' HG3' ' NH1' ' A' ' 129' ' ' ARG . 24.0 ttmm -72.78 -54.91 7.62 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 116.769 2.137 . . . . 0.0 116.769 -173.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -67.2 -44.91 85.26 Favored Glycine 0 CA--C 1.552 2.404 0 N-CA-C 118.072 1.989 . . . . 0.0 118.072 -170.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -92.69 76.84 4.94 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 119.871 1.836 . . . . 0.0 111.428 178.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 129' ' ' ARG . . . 72.34 171.9 18.28 Favored Glycine 0 CA--C 1.573 3.661 0 CA-C-O 118.537 -1.146 . . . . 0.0 114.354 -172.587 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.595 ' HB3' ' O ' ' A' ' 128' ' ' GLY . 34.0 ptt180 170.72 163.4 0.08 Allowed 'General case' 0 C--N 1.363 1.171 0 CA-C-N 121.732 2.766 . . . . 0.0 115.848 174.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -157.69 -38.96 0.07 Allowed 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 111.582 -2.554 . . . . 0.0 110.739 166.634 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -59.94 -74.24 0.08 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 120.043 1.292 . . . . 0.0 112.402 166.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 38.47 40.7 0.39 Allowed 'General case' 0 N--CA 1.505 2.311 0 C-N-CA 124.603 1.161 . . . . 0.0 113.755 -162.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . 0.29 5.9 t 14.86 101.54 0.0 OUTLIER 'General case' 0 CA--C 1.566 1.57 0 C-N-CA 129.727 3.211 . . . . 0.0 118.18 -166.89 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -136.16 -67.69 0.52 Allowed 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 110.571 -3.013 . . . . 0.0 106.78 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -68.37 -35.22 77.4 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 117.897 -1.049 . . . . 0.0 113.306 165.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.806 ' O ' ' HG2' ' A' ' 140' ' ' ARG . 48.9 t -66.99 -34.39 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 CA-C-N 120.256 1.389 . . . . 0.0 112.807 169.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -71.94 -34.95 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 CA-C-N 119.729 1.149 . . . . 0.0 113.074 174.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 40.7 mt -69.38 -48.57 60.79 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 119.701 1.137 . . . . 0.0 113.834 173.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -66.43 -38.17 86.82 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 173.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.806 ' HG2' ' O ' ' A' ' 136' ' ' VAL . 47.8 mmm-85 -60.65 -43.94 97.01 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 169.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 37.0 mtt -64.26 -32.99 74.8 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 115.833 1.79 . . . . 0.0 115.833 169.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -64.44 -48.65 74.51 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 170.167 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.8 -31.26 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 172.195 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -57.8 -52.38 65.72 Favored 'General case' 0 CA--C 1.581 2.164 0 CA-C-N 119.492 1.042 . . . . 0.0 111.452 166.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -52.83 -25.38 11.3 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 120.2 3.408 . . . . 0.0 120.2 169.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.89 -55.48 19.89 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 170.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -145.43 13.84 1.4 Allowed 'General case' 0 CA--C 1.563 1.467 0 N-CA-C 119.497 3.147 . . . . 0.0 119.497 -169.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 17.7 m -51.9 -29.19 18.96 Favored 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.432 ' HB3' ' HD3' ' A' ' 150' ' ' PRO . . . -70.81 -61.33 2.49 Favored Pre-proline 0 CA--C 1.58 2.102 0 CA-C-O 116.148 -1.882 . . . . 0.0 112.142 171.692 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.432 ' HD3' ' HB3' ' A' ' 149' ' ' ALA . 46.8 Cg_exo -55.34 -27.8 59.64 Favored 'Trans proline' 0 CA--C 1.574 2.485 0 N-CA-C 119.492 2.843 . . . . 0.0 119.492 169.207 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -66.88 -53.01 36.54 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 125.156 1.383 . . . . 0.0 110.988 172.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.989 ' O ' ' HB2' ' A' ' 156' ' ' ARG 0.316 0.0 OUTLIER -61.32 -25.01 66.84 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 174.384 . . . . . . . . 4 4 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -71.3 -51.65 23.19 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 120.601 1.546 . . . . 0.0 113.667 166.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -62.66 -55.23 28.84 Favored 'General case' 0 CA--C 1.565 1.527 0 CA-C-N 120.045 1.293 . . . . 0.0 112.221 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -81.52 -25.94 35.53 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 115.153 -2.356 . . . . 0.0 113.399 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.989 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 43.9 ttt180 -67.3 -34.27 77.03 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 124.438 3.29 . . . . 0.0 115.919 170.785 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -69.5 -37.99 77.43 Favored 'General case' 0 CA--C 1.572 1.827 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 166.642 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -90.15 -24.37 21.08 Favored 'General case' 0 CA--C 1.575 1.926 0 N-CA-C 118.876 2.917 . . . . 0.0 118.876 -177.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.1 pp -76.06 178.75 6.09 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 117.478 2.399 . . . . 0.0 117.478 -165.446 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -128.91 129.31 45.33 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 169.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 27.1 m -100.38 149.95 23.11 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 122.079 0.943 . . . . 0.0 111.006 -171.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 4.1 t -128.14 134.74 64.42 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.663 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 167.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -110.86 121.43 45.32 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 104.435 -2.432 . . . . 0.0 104.435 166.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . 0.289 . . -165.58 162.03 18.8 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.095 0.958 . . . . 0.0 111.106 -161.034 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 4.5 t -139.36 119.47 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 160.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -79.45 72.93 2.45 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 119.866 2.706 . . . . 0.0 119.866 -165.523 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 6.6 t -158.52 60.66 0.44 Allowed 'General case' 0 CA--C 1.566 1.56 0 CA-C-N 111.293 -2.454 . . . . 0.0 108.437 -178.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 2.8 ttt -159.31 -35.39 0.06 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 -168.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 7.4 t70 80.79 -37.62 0.14 Allowed 'General case' 0 N--CA 1.508 2.451 0 CA-C-N 120.849 1.659 . . . . 0.0 111.869 -164.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -55.15 -39.04 69.03 Favored 'General case' 0 CA--C 1.559 1.295 0 CA-C-O 116.651 -1.642 . . . . 0.0 113.429 165.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 89.5 t -56.34 -39.26 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 CA-C-N 121.363 1.892 . . . . 0.0 114.309 171.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -57.77 -39.03 76.5 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-N 120.472 1.487 . . . . 0.0 114.86 166.381 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -60.53 -46.85 88.66 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 115.481 1.659 . . . . 0.0 115.481 173.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 12.2 mtt-85 -61.48 -43.14 99.4 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 169.403 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.11 -40.37 70.39 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 169.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 8.4 mp -64.18 -49.12 73.28 Favored 'General case' 0 CA--C 1.565 1.533 0 CA-C-O 118.413 -0.804 . . . . 0.0 112.608 168.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 36.4 mtt180 -51.24 -40.81 59.65 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 117.581 2.437 . . . . 0.0 117.581 171.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.11 -51.53 66.19 Favored 'General case' 0 CA--C 1.561 1.4 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 169.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -99.65 -60.46 1.53 Allowed 'General case' 0 CA--C 1.565 1.538 0 CA-C-O 117.993 -1.003 . . . . 0.0 113.469 -169.418 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.803 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -102.82 -50.52 1.08 Allowed Glycine 0 CA--C 1.551 2.34 0 CA-C-N 120.537 1.517 . . . . 0.0 116.885 -169.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.803 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 87.0 tttt . . . . . 0 C--O 1.252 1.201 0 CA-C-N 119.489 1.645 . . . . 0.0 108.356 -174.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.0 mtt . . . . . 0 N--CA 1.482 1.125 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.578 ' HE ' ' HA2' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -149.01 174.9 11.79 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 116.685 2.105 . . . . 0.0 116.685 -168.967 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 93.5 t -133.75 147.22 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-O 122.992 1.377 . . . . 0.0 113.319 -164.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -121.63 117.57 27.03 Favored 'General case' 0 CA--C 1.56 1.347 0 CA-C-N 113.491 -1.686 . . . . 0.0 107.284 169.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 17.5 tp -99.87 125.13 45.79 Favored 'General case' 0 CA--C 1.575 1.908 0 CA-C-O 123.706 1.717 . . . . 0.0 109.389 -170.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.1 mt -122.23 161.01 24.03 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 110.021 -3.263 . . . . 0.0 112.481 -165.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 148.39 -179.68 25.05 Favored Glycine 0 CA--C 1.559 2.809 0 CA-C-N 115.258 -0.883 . . . . 0.0 114.821 170.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -63.53 130.19 27.47 Favored 'Trans proline' 0 CA--C 1.574 2.508 0 C-N-CA 123.355 2.703 . . . . 0.0 113.765 176.22 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -82.01 131.98 7.16 Favored 'Trans proline' 0 CA--C 1.561 1.844 0 C-N-CA 122.648 2.232 . . . . 0.0 114.808 -169.82 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.2 -88.06 0.07 OUTLIER Glycine 0 CA--C 1.537 1.413 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 169.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.449 ' H ' ' HB2' ' A' ' 120' ' ' LEU . . . -151.65 106.63 3.27 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 175.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 175.11 -167.64 39.83 Favored Glycine 0 CA--C 1.546 2.018 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.9 -178.086 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.41 ' CB ' ' OD2' ' A' ' 84' ' ' ASP . 0.3 OUTLIER 78.26 -54.77 0.49 Allowed 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 175.577 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -49.48 -27.22 8.09 Favored Glycine 0 CA--C 1.553 2.465 0 N-CA-C 121.201 3.241 . . . . 0.0 121.201 177.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 52.0 m -66.99 -52.75 38.81 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 120.237 2.018 . . . . 0.0 112.598 173.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.291 0.6 OUTLIER -76.19 -13.88 60.17 Favored 'General case' 0 CA--C 1.568 1.667 0 CA-C-O 115.893 -2.003 . . . . 0.0 113.855 170.509 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.31 -47.17 36.37 Favored 'General case' 0 C--N 1.371 1.513 0 CA-C-N 123.421 2.828 . . . . 0.0 113.433 167.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.2 t -65.37 -36.74 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-N 120.06 1.3 . . . . 0.0 113.848 172.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -66.44 -45.78 78.67 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 171.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.0 tp -65.49 -30.65 71.45 Favored 'General case' 0 CA--C 1.574 1.902 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 170.522 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.22 -39.75 94.63 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 168.062 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -59.93 -37.7 80.25 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 166.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.3 tptt -64.3 -56.89 11.43 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 170.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 77.3 mt -83.23 -25.02 32.08 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 117.341 2.348 . . . . 0.0 117.341 -174.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.74 39.73 7.0 Favored Glycine 0 CA--C 1.556 2.612 0 N-CA-C 117.578 1.791 . . . . 0.0 117.578 -173.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 15.2 mm -104.56 154.69 38.27 Favored Pre-proline 0 CA--C 1.567 1.606 0 CA-C-O 117.567 -1.206 . . . . 0.0 113.11 -169.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -81.83 98.6 0.98 Allowed 'Trans proline' 0 CA--C 1.569 2.232 0 CA-C-N 122.219 1.828 . . . . 0.0 109.801 162.645 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -73.91 110.42 8.19 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.305 0.574 . . . . 0.0 110.189 176.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.0 mm -100.35 108.97 24.0 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 N-CA-C 105.515 -2.032 . . . . 0.0 105.515 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 72.7 p -96.98 127.74 43.25 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 171.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.0 p -67.29 -18.36 65.16 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 117.356 2.354 . . . . 0.0 117.356 -172.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.429 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -81.06 -20.24 65.49 Favored Glycine 0 CA--C 1.539 1.56 0 N-CA-C 119.242 2.457 . . . . 0.0 119.242 168.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -81.0 -51.47 8.48 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -169.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -64.3 -41.7 96.73 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 174.846 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.439 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 21.5 m-85 -68.92 -39.69 79.51 Favored 'General case' 0 CA--C 1.561 1.375 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 174.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 46.4 ttp180 -58.68 -41.71 86.81 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 120.473 1.488 . . . . 0.0 114.322 167.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -60.54 -38.71 85.36 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 168.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -67.55 -29.32 68.68 Favored 'General case' 0 CA--C 1.572 1.824 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 168.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 79.0 mt -62.7 -45.54 98.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 CA-C-N 120.111 1.323 . . . . 0.0 111.921 168.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -66.71 -38.96 87.77 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 120.25 1.387 . . . . 0.0 114.438 172.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -78.47 -27.85 46.38 Favored 'General case' 0 CA--C 1.562 1.413 0 N-CA-C 117.065 2.246 . . . . 0.0 117.065 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.11 72.99 1.23 Allowed Glycine 0 CA--C 1.545 1.935 0 CA-C-O 118.223 -1.321 . . . . 0.0 115.878 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.855 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 81.4 p -91.29 -45.92 8.34 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 172.106 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.855 ' HB2' ' O ' ' A' ' 43' ' ' THR . 75.6 mttt 104.56 -40.36 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.753 0 CA-C-O 116.493 -1.718 . . . . 0.0 111.633 -171.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -83.91 -10.32 58.06 Favored 'General case' 0 CA--C 1.574 1.894 0 CA-C-N 122.762 2.528 . . . . 0.0 113.222 163.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.21 -54.48 23.69 Favored Glycine 0 C--N 1.355 1.588 0 CA-C-N 120.385 1.448 . . . . 0.0 115.531 169.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.286 7.7 p -76.94 -47.5 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.514 0 N-CA-C 116.077 1.88 . . . . 0.0 116.077 -168.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -64.24 -48.31 76.29 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 121.111 1.778 . . . . 0.0 112.692 172.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.59 -28.04 64.57 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -178.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.447 ' HA ' ' HD2' ' A' ' 50' ' ' LYS . 10.8 tptt -74.91 -30.59 61.31 Favored 'General case' 0 CA--C 1.566 1.584 0 CA-C-O 115.909 -1.996 . . . . 0.0 113.762 168.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -57.02 -36.97 71.06 Favored 'General case' 0 CA--C 1.607 3.164 1 CA-C-O 90.989 -13.863 . . . . 0.0 119.424 164.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 9.5 m-30 -92.58 -49.65 6.0 Favored 'General case' 0 CA--C 1.591 2.538 2 O-C-N 110.588 -7.57 . . . . 0.0 100.415 -152.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.9 tp -51.38 -46.99 62.97 Favored 'General case' 0 CA--C 1.569 1.683 0 C-N-CA 126.209 1.803 . . . . 0.0 115.516 161.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -78.96 -41.9 28.14 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 176.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -95.38 -38.69 10.38 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -170.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 0.901 ' HA2' HH22 ' A' ' 88' ' ' ARG . . . 119.79 22.48 3.29 Favored Glycine 0 CA--C 1.541 1.685 0 N-CA-C 118.235 2.054 . . . . 0.0 118.235 168.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -97.3 -179.32 4.47 Favored 'General case' 0 CA--C 1.575 1.941 0 CA-C-N 118.805 1.303 . . . . 0.0 110.243 167.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.9 mt -82.34 127.97 33.76 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.184 -1.573 . . . . 0.0 114.382 -166.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.4 p -118.3 124.08 28.87 Favored Pre-proline 0 CA--C 1.572 1.806 0 C-N-CA 124.935 1.294 . . . . 0.0 110.485 -174.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -60.72 153.1 64.69 Favored 'Trans proline' 0 CA--C 1.56 1.81 0 C-N-CA 123.425 2.75 . . . . 0.0 116.337 172.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 97.2 p -80.24 -49.62 11.36 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 -177.275 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -63.61 -45.69 89.15 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 -169.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 pp -57.76 -43.1 85.23 Favored 'General case' 0 CA--C 1.562 1.421 0 N-CA-C 117.266 2.321 . . . . 0.0 117.266 169.694 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.0 m -62.24 -42.32 99.21 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 123.93 0.892 . . . . 0.0 112.578 174.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -62.77 -30.57 71.55 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 166.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.48 -42.35 83.1 Favored 'General case' 0 CA--C 1.555 1.138 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 174.497 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mt -64.75 -46.15 83.42 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 168.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -56.08 -51.13 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 169.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -60.83 -38.38 85.27 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 115.794 1.775 . . . . 0.0 115.794 174.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -57.23 -44.18 83.53 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 117.592 -1.194 . . . . 0.0 113.421 170.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -84.3 1.84 43.03 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 119.51 3.152 . . . . 0.0 119.51 168.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 21.7 tp -115.64 -5.91 12.18 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 117.813 2.524 . . . . 0.0 117.813 172.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -54.61 -32.39 58.72 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 169.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.467 ' HB3' ' CD ' ' A' ' 75' ' ' PRO 0.38 2.4 m-20 -8.87 -120.54 0.0 OUTLIER Pre-proline 0 CA--C 1.604 3.022 0 N-CA-C 120.752 3.612 . . . . 0.0 120.752 168.521 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.467 ' CD ' ' HB3' ' A' ' 74' ' ' ASN . 71.5 Cg_exo -64.94 27.29 0.08 OUTLIER 'Trans proline' 0 N--CA 1.52 3.031 1 CA-C-N 128.376 4.027 . . . . 0.0 120.589 167.617 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.0 t70 62.15 28.92 17.38 Favored 'General case' 0 CA--C 1.577 2.014 0 C-N-CA 126.311 1.844 . . . . 0.0 109.142 -158.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 56.67 27.87 13.25 Favored 'General case' 0 CA--C 1.583 2.214 0 CA-C-N 120.694 1.588 . . . . 0.0 113.036 -163.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.08 -40.33 60.19 Favored 'General case' 0 C--N 1.378 1.847 0 CA-C-N 121.746 2.066 . . . . 0.0 114.779 -177.249 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -73.45 -18.85 61.08 Favored 'General case' 0 CA--C 1.566 1.561 0 CA-C-O 115.621 -2.133 . . . . 0.0 115.325 172.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.578 ' HA2' ' HE ' ' A' ' 2' ' ' ARG . . . 137.17 -176.7 20.33 Favored Glycine 0 C--N 1.363 2.072 0 CA-C-N 123.332 2.787 . . . . 0.0 113.639 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.463 ' O ' ' HB2' ' A' ' 2' ' ' ARG . 21.9 p90 -167.41 131.52 1.84 Allowed 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 111.719 -2.241 . . . . 0.0 109.092 172.593 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 17.5 mt -110.47 106.56 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 104.099 -2.556 . . . . 0.0 104.099 170.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.7 mt -110.35 112.75 24.9 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.718 0.807 . . . . 0.0 108.832 -176.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.41 ' OD2' ' CB ' ' A' ' 13' ' ' LYS . 35.4 t0 -109.46 128.65 55.31 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 118.732 0.696 . . . . 0.0 111.688 -175.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 73.54 35.39 55.77 Favored Glycine 0 CA--C 1.552 2.373 0 CA-C-O 117.563 -1.687 . . . . 0.0 117.279 176.258 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -103.56 -51.89 0.13 Allowed Pre-proline 0 N--CA 1.497 1.906 0 CA-C-O 114.761 -2.542 . . . . 0.0 109.333 173.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -62.08 71.61 0.1 Allowed 'Trans proline' 0 CA--C 1.568 2.22 0 CA-C-N 124.874 2.776 . . . . 0.0 118.838 165.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.901 HH22 ' HA2' ' A' ' 56' ' ' GLY . 1.4 ptm180 -78.05 -36.95 47.83 Favored 'General case' 0 CA--C 1.56 1.342 0 N-CA-C 115.54 1.681 . . . . 0.0 115.54 167.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 69.1 p -137.18 151.42 48.77 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 -168.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.2 t -71.01 -31.03 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-O 116.884 -1.532 . . . . 0.0 111.153 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.71 -40.21 94.23 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 120.149 3.388 . . . . 0.0 120.149 168.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -71.25 -49.29 44.7 Favored 'General case' 0 CA--C 1.589 2.456 0 CA-C-N 122.413 2.37 . . . . 0.0 112.462 168.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.6 -28.87 66.32 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 126.756 2.023 . . . . 0.0 115.646 -170.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.6 ttpm? -58.54 -31.95 68.42 Favored 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 166.321 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.05 -43.81 94.35 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 114.668 1.358 . . . . 0.0 114.668 168.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.0 mt -66.69 -33.82 76.49 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 172.633 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -66.22 -58.38 5.51 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 125.349 1.46 . . . . 0.0 112.646 173.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.933 ' O ' ' CB ' ' A' ' 102' ' ' ARG . 47.8 mt-10 -54.66 -36.48 64.64 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 171.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 24.7 ttt -82.72 -40.62 20.33 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 176.467 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 24.6 tp -57.12 -61.79 2.21 Favored 'General case' 0 N--CA 1.508 2.431 0 CA-C-N 121.503 1.956 . . . . 0.0 110.499 174.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -81.74 -37.27 27.51 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 -177.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.933 ' CB ' ' O ' ' A' ' 98' ' ' GLU . 52.8 ttt85 -60.29 -41.34 93.15 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 176.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.544 ' HB2' ' O ' ' A' ' 102' ' ' ARG . 54.9 ttt180 -174.92 41.72 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 114.464 -2.684 . . . . 0.0 115.851 168.057 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -114.77 -61.25 0.38 Allowed Glycine 0 C--N 1.362 2.021 0 CA-C-N 123.565 2.893 . . . . 0.0 113.441 174.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 23.5 p -148.28 159.4 44.02 Favored 'General case' 0 CA--C 1.554 1.13 0 CA-C-O 122.957 1.361 . . . . 0.0 112.894 -159.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -74.68 134.74 41.93 Favored 'General case' 0 N--CA 1.503 2.198 0 CA-C-N 114.379 -1.282 . . . . 0.0 113.439 176.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 4.7 tp -86.65 105.82 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.516 0 C-N-CA 125.06 1.344 . . . . 0.0 107.714 175.488 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -96.92 -70.4 0.72 Allowed 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 115.136 -2.364 . . . . 0.0 108.115 168.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -140.28 122.65 16.0 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 122.503 2.41 . . . . 0.0 115.015 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -92.83 107.81 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.417 0 N-CA-C 100.974 -3.713 . . . . 0.0 100.974 161.768 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.288 59.5 tp -114.5 105.24 12.87 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.753 -161.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -96.04 126.12 41.06 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.16 0.584 . . . . 0.0 111.541 -176.297 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -95.06 114.17 25.95 Favored 'General case' 0 CA--C 1.56 1.355 0 CA-C-O 122.537 1.16 . . . . 0.0 110.185 177.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -89.03 100.38 13.16 Favored 'General case' 0 CA--C 1.556 1.187 0 CA-C-N 113.597 -1.638 . . . . 0.0 109.459 168.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.4 p -137.97 143.09 34.21 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.387 0 C-N-CA 125.921 1.688 . . . . 0.0 108.376 -168.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.8 m -62.29 141.85 58.05 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.568 175.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -55.61 -46.05 77.39 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 172.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -46.82 -35.44 6.3 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 117.962 2.579 . . . . 0.0 117.962 177.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.6 t -69.42 -49.66 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 CA-C-N 120.032 1.287 . . . . 0.0 113.141 176.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.449 ' HB2' ' H ' ' A' ' 11' ' ' ALA . 3.8 pp -65.09 -34.95 79.63 Favored 'General case' 0 CA--C 1.561 1.391 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 169.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' LEU . . . . . 0.571 ' O ' ' HB2' ' A' ' 125' ' ' LYS . 49.8 mt -71.72 -34.82 69.9 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 117.121 2.267 . . . . 0.0 117.121 172.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLU . . . . . 0.575 ' OE2' ' HG3' ' A' ' 123' ' ' ARG . 1.1 pp20? -71.39 -38.66 71.47 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 170.924 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.575 ' HG3' ' OE2' ' A' ' 122' ' ' GLU . 51.4 mtp180 -60.98 -52.13 66.31 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 171.123 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.5 pp -68.87 -34.65 75.8 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 115.872 1.805 . . . . 0.0 115.872 171.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . 0.571 ' HB2' ' O ' ' A' ' 121' ' ' LEU . 82.6 tttt -61.06 -46.82 89.12 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 116.847 2.165 . . . . 0.0 116.847 176.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -53.34 -33.43 46.43 Favored Glycine 0 CA--C 1.558 2.722 0 N-CA-C 118.876 2.31 . . . . 0.0 118.876 173.1 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -154.46 102.17 2.4 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 118.837 1.319 . . . . 0.0 108.79 171.006 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -171.86 39.88 0.17 Allowed Glycine 0 CA--C 1.549 2.207 0 N-CA-C 117.271 1.668 . . . . 0.0 117.271 174.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 73.43 -162.11 0.09 Allowed 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 119.616 1.708 . . . . 0.0 114.878 169.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -72.53 -30.22 64.26 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 169.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -89.74 86.44 6.68 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 122.778 1.275 . . . . 0.0 108.763 168.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -99.18 67.55 1.6 Allowed 'General case' 0 CA--C 1.564 1.486 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 163.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 23.9 p 36.69 108.57 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 118.839 2.903 . . . . 0.0 118.839 -168.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -151.51 -72.85 0.15 Allowed 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 112.432 -2.167 . . . . 0.0 107.38 167.02 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -66.18 -33.04 74.86 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 167.233 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.651 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 95.0 t -66.85 -40.15 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 CA-C-O 117.468 -1.253 . . . . 0.0 112.701 171.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.9 tp -74.61 -27.26 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 CA-C-N 120.261 1.391 . . . . 0.0 114.326 172.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 43.7 mt -72.59 -48.01 43.3 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 121.503 1.956 . . . . 0.0 113.874 171.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -70.32 -36.45 74.28 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 175.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.651 ' HB2' ' O ' ' A' ' 136' ' ' VAL . 14.8 tpt85 -63.42 -45.98 88.5 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 169.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 46.3 mtt -61.31 -29.51 69.92 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 167.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -63.31 -43.76 96.9 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 167.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 20.5 t -70.49 -26.69 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.533 0 CA-C-N 120.088 1.313 . . . . 0.0 113.521 171.202 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -65.34 -56.75 10.89 Favored 'General case' 0 CA--C 1.583 2.242 0 CA-C-N 120.68 1.582 . . . . 0.0 110.766 167.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 54.3 ttt180 -52.78 -26.8 15.42 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 119.711 3.226 . . . . 0.0 119.711 172.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -47.46 -51.42 20.32 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 169.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -142.55 42.33 1.61 Allowed 'General case' 0 CA--C 1.563 1.461 0 N-CA-C 117.084 2.253 . . . . 0.0 117.084 176.228 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 36.7 m -49.25 -36.65 20.97 Favored 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 166.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.414 ' HB3' ' HD3' ' A' ' 150' ' ' PRO . . . -68.09 -59.28 6.53 Favored Pre-proline 0 CA--C 1.577 2.014 0 CA-C-O 116.556 -1.688 . . . . 0.0 111.891 172.111 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.414 ' HD3' ' HB3' ' A' ' 149' ' ' ALA . 71.8 Cg_exo -53.03 -26.95 34.09 Favored 'Trans proline' 0 CA--C 1.577 2.666 0 N-CA-C 119.608 2.888 . . . . 0.0 119.608 168.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -65.25 -56.31 13.51 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 125.764 1.625 . . . . 0.0 111.371 172.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.868 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 44.4 tp -62.48 -24.19 67.33 Favored 'General case' 0 CA--C 1.571 1.776 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 175.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -71.23 -47.81 55.06 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 122.247 2.294 . . . . 0.0 113.745 166.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -60.77 -57.02 14.45 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 119.846 1.203 . . . . 0.0 111.966 177.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -80.2 -19.45 46.99 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 115.409 -2.234 . . . . 0.0 113.803 -178.242 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.868 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 33.2 ttt180 -74.21 -31.09 62.48 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 124.436 3.289 . . . . 0.0 116.202 168.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -68.77 -44.28 74.02 Favored 'General case' 0 CA--C 1.57 1.738 0 CA-C-N 119.688 1.131 . . . . 0.0 113.126 167.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -91.43 -30.21 16.62 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 119.164 3.024 . . . . 0.0 119.164 -176.542 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.5 pp -39.73 156.81 0.02 OUTLIER 'General case' 0 CA--C 1.582 2.183 1 N-CA-C 122.37 4.211 . . . . 0.0 122.37 -164.304 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -133.43 113.1 12.15 Favored 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 101.71 -3.441 . . . . 0.0 101.71 164.778 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 60.4 m -94.7 146.58 24.06 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 122.499 1.142 . . . . 0.0 110.349 -168.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 47.3 t -130.8 130.67 64.52 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.259 0 CA-C-N 113.654 -1.612 . . . . 0.0 106.721 169.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -98.48 117.9 33.96 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 100.892 -3.744 . . . . 0.0 100.892 163.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . 0.293 . . -105.41 -138.01 0.36 Allowed 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 -154.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . 0.252 14.6 m 9.76 92.26 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.573 1.849 1 N-CA-C 123.812 4.745 . . . . 0.0 123.812 -171.559 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -136.31 75.21 0.4 Allowed Glycine 0 N--CA 1.48 1.621 0 CA-C-O 122.966 1.315 . . . . 0.0 112.741 163.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 69.7 p 46.19 53.76 9.04 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 175.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 61.7 mtt 74.62 -68.08 0.23 Allowed 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 125.627 1.571 . . . . 0.0 113.87 175.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -63.06 -39.43 94.71 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 -174.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -61.69 -49.11 77.81 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 117.737 -1.125 . . . . 0.0 112.535 169.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 3.0 t -54.43 -37.87 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 174.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -62.61 -38.16 89.07 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 116.119 1.896 . . . . 0.0 116.119 169.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -61.83 -48.02 82.46 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 175.552 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.577 ' HA ' ' HB2' ' A' ' 177' ' ' ARG . 1.2 ptt-85 -70.36 -29.14 65.74 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 117.036 2.235 . . . . 0.0 117.036 170.331 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.77 -46.63 88.75 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 169.082 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 10.9 mp -64.4 -43.33 94.75 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 117.411 -1.281 . . . . 0.0 111.402 167.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.577 ' HB2' ' HA ' ' A' ' 174' ' ' ARG . 41.1 mtt180 -46.64 -40.87 13.84 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 117.883 2.549 . . . . 0.0 117.883 169.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -69.0 -48.72 62.39 Favored 'General case' 0 CA--C 1.562 1.423 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 169.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.7 tt -83.13 -52.3 6.75 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 120.583 1.538 . . . . 0.0 114.336 -176.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -135.18 -60.18 0.06 OUTLIER Glycine 0 CA--C 1.551 2.284 0 CA-C-O 116.952 -2.027 . . . . 0.0 115.594 -170.092 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 39.7 ttmt . . . . . 0 C--O 1.251 1.17 0 CA-C-N 121.548 2.674 . . . . 0.0 109.595 -175.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.8 ttp . . . . . 0 CA--C 1.56 1.333 0 CA-C-O 122.382 1.086 . . . . 0.0 109.25 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . 0.275 11.4 mpt_? -124.5 167.73 14.05 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 120.878 3.659 . . . . 0.0 120.878 -162.621 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.3 p -148.11 151.18 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.695 0 CA-C-O 123.611 1.672 . . . . 0.0 113.067 167.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . 0.285 0.0 OUTLIER -143.56 133.87 24.58 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 113.922 -1.49 . . . . 0.0 110.99 166.965 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.729 HD11 ' CB ' ' A' ' 13' ' ' LYS . 3.7 tt -95.64 125.51 40.28 Favored 'General case' 0 CA--C 1.572 1.795 0 C-N-CA 125.188 1.395 . . . . 0.0 114.649 -165.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.6 mt -109.78 155.49 21.54 Favored 'General case' 0 CA--C 1.567 1.607 0 CA-C-N 110.559 -3.019 . . . . 0.0 109.847 169.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -174.36 99.49 0.14 Allowed Glycine 0 CA--C 1.55 2.24 0 CA-C-O 116.729 -2.15 . . . . 0.0 113.468 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.281 33.3 Cg_endo -66.13 -69.97 0.03 OUTLIER 'Trans proline' 0 CA--C 1.58 2.778 0 CA-C-N 122.277 3.039 . . . . 0.0 111.853 175.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -74.94 102.14 1.55 Allowed 'Trans proline' 0 C--N 1.378 2.12 0 CA-C-N 127.247 3.624 . . . . 0.0 111.032 167.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.89 99.94 0.78 Allowed Glycine 0 N--CA 1.476 1.302 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -172.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.35 -27.75 67.62 Favored 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 118.185 2.661 . . . . 0.0 118.185 176.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -167.65 134.29 3.2 Favored Glycine 0 CA--C 1.545 1.933 0 CA-C-N 120.327 1.421 . . . . 0.0 112.515 173.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.729 ' CB ' HD11 ' A' ' 5' ' ' LEU . 32.1 mmtt -94.73 59.26 2.39 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 176.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.91 -35.74 92.4 Favored Glycine 0 CA--C 1.552 2.362 0 N-CA-C 118.609 2.204 . . . . 0.0 118.609 173.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 40.3 m -61.65 -53.48 55.6 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 119.324 1.562 . . . . 0.0 113.416 174.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.259 0.1 OUTLIER -79.59 -17.45 53.85 Favored 'General case' 0 CA--C 1.58 2.106 0 CA-C-O 116.639 -1.648 . . . . 0.0 111.491 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.28 -43.7 55.79 Favored 'General case' 0 C--N 1.374 1.633 0 CA-C-N 122.712 2.506 . . . . 0.0 115.337 168.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.5 t -65.77 -37.99 81.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 CA-C-O 117.691 -1.147 . . . . 0.0 112.335 170.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -59.68 -51.61 69.05 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 169.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.5 tp -64.37 -31.5 72.73 Favored 'General case' 0 CA--C 1.575 1.937 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 174.253 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.29 -39.46 93.97 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 168.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -63.73 -35.13 79.55 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 166.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 43.7 tptt -68.28 -55.49 11.98 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 174.584 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 65.0 mt -83.83 -26.51 29.46 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 116.648 2.092 . . . . 0.0 116.648 -178.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.27 39.28 6.44 Favored Glycine 0 CA--C 1.555 2.534 0 N-CA-C 117.313 1.685 . . . . 0.0 117.313 -172.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.404 ' CG2' ' HA ' ' A' ' 81' ' ' PHE . 20.4 mm -104.22 153.91 38.63 Favored Pre-proline 0 CA--C 1.567 1.605 0 CA-C-N 119.029 1.414 . . . . 0.0 112.271 -170.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -81.3 101.52 1.25 Allowed 'Trans proline' 0 CA--C 1.568 2.22 0 CA-C-N 121.65 1.625 . . . . 0.0 108.667 161.028 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.96 119.24 17.9 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 122.088 0.947 . . . . 0.0 110.197 173.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.477 HD11 ' HB3' ' A' ' 71' ' ' ARG . 1.8 mp -95.28 109.06 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 N-CA-C 104.089 -2.56 . . . . 0.0 104.089 176.142 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 78.0 p -97.41 128.15 43.96 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 166.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.8 p -67.33 -10.89 55.39 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 117.822 2.526 . . . . 0.0 117.822 -169.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -82.41 -27.85 42.08 Favored Glycine 0 CA--C 1.553 2.409 0 N-CA-C 117.951 1.94 . . . . 0.0 117.951 165.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -81.3 -46.14 15.17 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -168.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -69.68 -37.32 76.61 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 173.181 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.485 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 42.4 m-85 -65.67 -46.85 77.55 Favored 'General case' 0 CA--C 1.557 1.234 0 CA-C-O 116.538 -1.696 . . . . 0.0 112.855 170.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -54.84 -40.65 69.84 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 168.716 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -59.44 -40.47 86.9 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 169.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -68.39 -25.47 65.07 Favored 'General case' 0 CA--C 1.583 2.238 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 167.703 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ILE . . . . . 0.42 HG12 HG23 ' A' ' 47' ' ' VAL . 50.5 mt -62.91 -50.16 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 CA-C-N 120.383 1.447 . . . . 0.0 110.768 167.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.53 -31.55 69.83 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -67.76 -39.92 84.11 Favored 'General case' 0 CA--C 1.565 1.524 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 169.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.98 70.73 1.0 Allowed Glycine 0 CA--C 1.536 1.394 0 CA-C-O 118.577 -1.124 . . . . 0.0 112.886 175.172 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.566 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 56.9 p -96.18 -66.4 0.91 Allowed 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 118.291 1.046 . . . . 0.0 110.609 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.566 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.0 OUTLIER 124.88 -54.97 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 119.436 1.016 . . . . 0.0 110.117 -167.061 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.462 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.8 OUTLIER -71.8 -15.04 62.14 Favored 'General case' 0 CA--C 1.57 1.747 0 CA-C-O 118.48 -0.771 . . . . 0.0 112.54 167.058 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.89 -53.66 44.03 Favored Glycine 0 CA--C 1.555 2.586 0 CA-C-N 120.102 1.319 . . . . 0.0 114.009 166.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.42 HG23 HG12 ' A' ' 39' ' ' ILE . 1.0 OUTLIER -75.05 -50.88 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 -170.984 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -65.4 -41.8 93.25 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 120.908 1.685 . . . . 0.0 113.196 172.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 45' ' ' LEU . . . -75.57 -24.26 56.61 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -176.105 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.485 ' HB2' ' HB3' ' A' ' 35' ' ' PHE . 9.6 tmtm? -76.18 -38.82 56.09 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 117.127 -1.416 . . . . 0.0 112.978 166.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.603 ' O ' ' CG ' ' A' ' 51' ' ' ARG . 51.1 ttt180 -70.58 -55.45 8.82 Favored 'General case' 0 CA--C 1.591 2.543 1 CA-C-O 86.101 -16.19 . . . . 0.0 118.413 -178.013 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 12.6 m-30 -33.15 -60.32 0.34 Allowed 'General case' 0 N--CA 1.496 1.858 1 O-C-N 109.089 -8.507 . . . . 0.0 121.273 146.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.7 tp -60.75 -23.67 65.14 Favored 'General case' 0 CA--C 1.576 1.966 0 CA-C-N 122.58 2.446 . . . . 0.0 117.226 169.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -93.09 -44.52 8.34 Favored 'General case' 0 CA--C 1.569 1.688 0 C-N-CA 126.112 1.765 . . . . 0.0 114.376 168.344 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.23 -36.27 24.74 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 116.669 2.1 . . . . 0.0 116.669 -177.155 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.97 40.04 2.55 Favored Glycine 0 CA--C 1.537 1.412 0 N-CA-C 116.157 1.223 . . . . 0.0 116.157 169.555 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -103.29 -135.94 0.34 Allowed 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 169.169 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.6 mt -105.56 108.57 20.16 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 120.857 1.662 . . . . 0.0 110.304 -170.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.3 p -112.05 109.58 54.6 Favored Pre-proline 0 CA--C 1.565 1.551 0 CA-C-O 117.483 -1.246 . . . . 0.0 108.23 175.46 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -64.28 154.82 69.01 Favored 'Trans proline' 0 CA--C 1.558 1.705 0 C-N-CA 123.094 2.529 . . . . 0.0 116.567 178.627 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 71.9 m -78.03 174.98 10.53 Favored 'General case' 0 CA--C 1.571 1.762 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.969 169.75 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.7 t70 83.17 -47.11 0.13 Allowed 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 125.884 1.674 . . . . 0.0 114.075 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 24.9 mt -65.47 -53.98 34.87 Favored 'General case' 0 N--CA 1.505 2.276 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 168.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 53.7 m -53.68 -49.85 67.1 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 113.112 -1.858 . . . . 0.0 113.678 169.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -59.63 -27.24 66.16 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 116.534 2.05 . . . . 0.0 116.534 167.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.57 -47.56 54.16 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 173.082 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.381 4.5 pp -74.59 -25.73 59.46 Favored 'General case' 0 CA--C 1.588 2.439 0 CA-C-N 119.743 1.156 . . . . 0.0 112.952 174.51 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.0 -48.01 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 CA-C-N 121.78 2.082 . . . . 0.0 112.816 165.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -58.57 -32.82 69.28 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 171.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -59.58 -45.84 90.68 Favored 'General case' 0 CA--C 1.566 1.585 0 CA-C-O 117.555 -1.212 . . . . 0.0 112.697 166.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.477 ' HB3' HD11 ' A' ' 29' ' ' ILE . 83.0 mtt180 -82.93 7.9 14.11 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 118.59 2.811 . . . . 0.0 118.59 167.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.8 mt -123.69 -5.87 8.06 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 118.294 2.701 . . . . 0.0 118.294 170.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 55.9 p30 -73.06 13.32 0.42 Allowed 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 171.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.485 ' HB3' ' CD ' ' A' ' 75' ' ' PRO 0.352 6.1 m120 -73.17 -129.05 0.0 OUTLIER Pre-proline 0 CA--C 1.592 2.58 0 CA-C-O 115.362 -2.256 . . . . 0.0 116.724 -169.367 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.485 ' CD ' ' HB3' ' A' ' 74' ' ' ASN . 68.2 Cg_exo -60.71 40.06 0.06 OUTLIER 'Trans proline' 0 C--N 1.386 2.552 0 N-CA-C 121.973 3.797 . . . . 0.0 121.973 168.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 59.78 33.61 21.77 Favored 'General case' 0 CA--C 1.583 2.246 0 C-N-CA 125.97 1.708 . . . . 0.0 109.848 -161.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 84.24 -3.35 1.05 Allowed 'General case' 0 C--N 1.385 2.133 0 CA-C-O 116.584 -1.674 . . . . 0.0 114.246 -168.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 51.18 34.6 11.54 Favored 'General case' 0 CA--C 1.573 1.861 0 CA-C-N 124.11 3.141 . . . . 0.0 114.701 -166.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 62.42 37.97 13.19 Favored 'General case' 0 CA--C 1.584 2.264 0 CA-C-O 117.057 -1.449 . . . . 0.0 111.928 -167.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.42 171.49 31.7 Favored Glycine 0 C--N 1.375 2.697 0 CA-C-N 123.21 2.732 . . . . 0.0 117.325 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.404 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . 13.9 p90 -171.39 135.84 0.97 Allowed 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 113.344 -1.428 . . . . 0.0 107.675 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 9.1 mt -111.56 108.92 26.69 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.542 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 172.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 26.2 mt -107.24 121.06 43.78 Favored 'General case' 0 N--CA 1.504 2.235 0 CA-C-O 117.402 -1.285 . . . . 0.0 110.009 177.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -117.74 118.17 31.34 Favored 'General case' 0 N--CA 1.506 2.369 0 CA-C-N 121.566 1.985 . . . . 0.0 111.588 -169.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 74.63 35.8 50.37 Favored Glycine 0 CA--C 1.555 2.537 0 CA-C-O 117.986 -1.452 . . . . 0.0 116.653 -174.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -94.64 -52.67 0.24 Allowed Pre-proline 0 N--CA 1.493 1.709 0 CA-C-O 115.361 -2.257 . . . . 0.0 108.672 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -68.41 68.71 1.04 Allowed 'Trans proline' 0 CA--C 1.57 2.321 0 CA-C-N 124.071 2.49 . . . . 0.0 117.623 164.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -20.99 61.47 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 165.711 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.2 m -147.19 143.38 28.16 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 -173.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . 0.313 9.8 p -69.54 -23.2 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 CA-C-O 116.158 -1.877 . . . . 0.0 112.337 175.223 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -63.43 -31.89 73.17 Favored 'General case' 0 CA--C 1.563 1.449 0 N-CA-C 118.943 2.942 . . . . 0.0 118.943 166.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -76.84 -48.16 19.26 Favored 'General case' 0 CA--C 1.588 2.409 0 CA-C-N 122.281 2.31 . . . . 0.0 112.159 165.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.36 -35.47 80.97 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 126.932 2.093 . . . . 0.0 116.003 -169.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.0 tttt -57.71 -29.48 64.74 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 115.683 1.735 . . . . 0.0 115.683 167.036 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.74 -41.0 72.39 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 168.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 23.6 tp -60.41 -40.36 90.69 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 168.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -56.12 -53.08 61.35 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 124.003 0.921 . . . . 0.0 113.147 168.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.902 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 14.3 mm-40 -46.88 -42.71 17.91 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 116.012 1.856 . . . . 0.0 116.012 167.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' MET . . . . . 1.284 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 58.7 mtt -83.87 -19.66 34.45 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 117.793 2.516 . . . . 0.0 117.793 177.381 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 60.6 tp -73.81 -50.36 20.83 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 120.835 1.652 . . . . 0.0 111.741 169.839 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -74.2 -56.78 4.5 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 171.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.902 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 96.4 mtt180 -68.58 -37.98 80.29 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 177.078 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 1.284 ' HB3' ' O ' ' A' ' 99' ' ' MET . 70.7 ttt180 -62.25 -59.31 5.21 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 119.857 1.208 . . . . 0.0 110.193 164.083 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 113.11 46.22 0.71 Allowed Glycine 0 N--CA 1.48 1.632 0 O-C-N 124.435 1.085 . . . . 0.0 114.011 167.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.2 p -103.61 146.63 28.28 Favored 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 172.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -68.81 128.96 38.55 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.183 -0.948 . . . . 0.0 112.894 -170.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.8 tp -82.23 101.15 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -103.32 -72.0 0.71 Allowed 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 115.737 -2.078 . . . . 0.0 109.21 167.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -142.6 119.76 11.45 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 116.543 2.053 . . . . 0.0 116.543 -166.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 93.8 t -92.87 114.28 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 100.532 -3.877 . . . . 0.0 100.532 161.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 32.9 tp -117.96 109.47 16.54 Favored 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 122.778 0.431 . . . . 0.0 111.454 -165.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -96.64 115.91 28.23 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 122.986 0.514 . . . . 0.0 112.062 -178.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -93.09 108.86 20.36 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 175.448 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.5 ' O ' HG23 ' A' ' 115' ' ' VAL . 80.0 ttt180 -103.13 110.89 23.0 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.949 0.899 . . . . 0.0 108.745 172.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 114' ' ' ARG 0.31 1.3 t 179.35 141.1 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 CA-C-O 123.925 1.821 . . . . 0.0 108.252 159.688 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 92.2 p 59.34 133.11 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.359 0 N-CA-C 119.022 2.971 . . . . 0.0 119.022 169.637 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -72.7 -31.86 65.32 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 116.366 1.988 . . . . 0.0 116.366 171.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -45.18 -44.89 11.2 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 115.664 1.727 . . . . 0.0 115.664 173.312 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.2 t -46.96 -48.97 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.455 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 174.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 5.9 tt -67.17 -40.46 86.61 Favored 'General case' 0 CA--C 1.559 1.289 0 CA-C-O 116.572 -1.68 . . . . 0.0 113.015 173.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . 0.389 0.0 OUTLIER -76.96 -12.89 60.01 Favored 'General case' 0 N--CA 1.51 2.572 0 CA-C-N 121.191 1.814 . . . . 0.0 114.974 173.52 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -73.32 -46.71 47.87 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 121.18 1.809 . . . . 0.0 111.895 166.241 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 1.015 ' O ' ' HB2' ' A' ' 127' ' ' ARG . 18.8 mmt180 -53.52 -48.64 68.85 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 167.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 75.9 mt -58.95 -58.95 6.39 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 169.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -81.02 -59.59 2.6 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 -171.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -91.08 44.83 2.83 Favored Glycine 0 CA--C 1.55 2.277 0 N-CA-C 115.92 1.128 . . . . 0.0 115.92 173.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 1.015 ' HB2' ' O ' ' A' ' 123' ' ' ARG . 18.3 mmm180 -150.5 -73.03 0.17 Allowed 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 173.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -90.16 38.05 3.27 Favored Glycine 0 CA--C 1.555 2.586 0 N-CA-C 118.024 1.97 . . . . 0.0 118.024 172.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.499 ' HB3' ' H ' ' A' ' 130' ' ' ALA . 98.3 mtt180 71.33 -143.51 0.06 Allowed 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 169.256 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.499 ' H ' ' HB3' ' A' ' 129' ' ' ARG . . . -90.29 64.57 6.04 Favored 'General case' 0 CA--C 1.564 1.517 0 CA-C-N 113.358 -1.746 . . . . 0.0 111.573 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . 0.3 8.0 m-20 75.94 -90.97 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 119.894 1.224 . . . . 0.0 108.469 -169.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . 0.274 16.0 t70 74.3 -56.19 0.65 Allowed 'General case' 0 N--CA 1.508 2.432 0 C-N-CA 125.234 1.413 . . . . 0.0 111.022 -162.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 70.9 p -55.26 -113.17 0.0 OUTLIER 'General case' 0 CA--C 1.57 1.735 0 C-N-CA 130.239 3.415 . . . . 0.0 111.263 164.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.3 t70 72.49 -64.05 0.41 Allowed 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 127.197 2.199 . . . . 0.0 110.708 -168.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -68.05 -36.09 79.31 Favored 'General case' 0 CA--C 1.559 1.291 0 CA-C-O 117.662 -1.161 . . . . 0.0 113.863 165.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.8 t -70.89 -37.04 66.63 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.717 0 CA-C-N 120.79 1.632 . . . . 0.0 112.683 174.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.459 ' O ' ' HB3' ' A' ' 140' ' ' ARG . 10.6 tp -69.46 -33.08 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 CA-C-N 119.869 1.213 . . . . 0.0 113.278 169.107 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 30.5 mt -62.94 -42.82 99.93 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 120.768 1.622 . . . . 0.0 114.075 167.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -62.76 -33.29 74.85 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 168.372 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.459 ' HB3' ' O ' ' A' ' 137' ' ' ILE . 9.5 tpt180 -57.69 -45.45 85.65 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 166.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 25.1 ttt -64.18 -33.02 74.84 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 169.049 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -60.89 -48.92 79.61 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 169.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 12.4 p -65.32 -33.09 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 169.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -55.02 -49.57 71.2 Favored 'General case' 0 CA--C 1.581 2.162 0 CA-C-N 119.922 1.237 . . . . 0.0 111.652 167.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -56.74 -41.63 77.85 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 118.878 2.918 . . . . 0.0 118.878 171.857 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -46.71 -42.45 16.65 Favored 'General case' 0 N--CA 1.506 2.342 0 N-CA-C 117.969 2.581 . . . . 0.0 117.969 174.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -125.69 -29.3 3.17 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 117.597 2.443 . . . . 0.0 117.597 -166.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 51.7 m -45.97 -34.29 3.88 Favored 'General case' 0 N--CA 1.505 2.29 0 N-CA-C 117.543 2.423 . . . . 0.0 117.543 -171.097 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -66.86 -62.49 3.77 Favored Pre-proline 0 CA--C 1.583 2.247 0 CA-C-O 116.144 -1.884 . . . . 0.0 112.09 170.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -53.15 -35.86 74.78 Favored 'Trans proline' 0 CA--C 1.584 3.004 0 C-N-CA 123.632 2.888 . . . . 0.0 118.945 168.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.97 -53.75 54.86 Favored 'General case' 0 N--CA 1.496 1.875 0 C-N-CA 126.165 1.786 . . . . 0.0 112.174 169.458 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 1.27 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 28.8 tp -68.09 -21.57 64.96 Favored 'General case' 0 CA--C 1.563 1.467 0 CA-C-O 116.749 -1.596 . . . . 0.0 114.214 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -71.98 -49.02 40.76 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 121.961 2.164 . . . . 0.0 112.618 164.607 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -68.63 -51.75 38.8 Favored 'General case' 0 CA--C 1.567 1.613 0 CA-C-N 120.569 1.531 . . . . 0.0 112.302 -176.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -78.56 -26.23 45.59 Favored 'General case' 0 CA--C 1.554 1.109 0 CA-C-O 114.854 -2.498 . . . . 0.0 113.072 176.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 1.27 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 0.1 OUTLIER -60.96 -41.97 97.37 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 125.24 3.655 . . . . 0.0 115.543 168.393 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -62.87 -36.0 81.86 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 167.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -88.3 -34.42 17.68 Favored 'General case' 0 CA--C 1.576 1.977 0 N-CA-C 119.336 3.088 . . . . 0.0 119.336 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.1 pp -80.35 173.71 12.32 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 117.803 2.52 . . . . 0.0 117.803 -162.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -122.78 123.53 41.25 Favored 'General case' 0 CA--C 1.557 1.221 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 166.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 1.4 t -100.2 156.9 16.96 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 123.195 1.474 . . . . 0.0 110.241 -178.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 40.0 t -132.61 143.99 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.367 0 CA-C-N 113.096 -1.865 . . . . 0.0 106.651 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -95.05 120.25 34.94 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 100.32 -3.955 . . . . 0.0 100.32 164.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . 0.307 . . -99.34 -101.74 0.22 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 119.489 3.144 . . . . 0.0 119.489 -150.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.3 t -57.54 95.22 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.564 1.492 0 N-CA-C 117.492 2.405 . . . . 0.0 117.492 -158.005 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -112.77 65.76 0.26 Allowed Glycine 0 N--CA 1.48 1.611 0 CA-C-O 122.211 0.895 . . . . 0.0 112.953 163.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 61.6 p 43.38 65.8 0.92 Allowed 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 116.257 1.947 . . . . 0.0 116.257 177.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 55.2 mtt 80.02 -57.77 0.35 Allowed 'General case' 0 N--CA 1.501 2.082 0 C-N-CA 125.59 1.556 . . . . 0.0 114.917 170.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -75.4 -42.38 53.9 Favored 'General case' 0 N--CA 1.506 2.346 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -175.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -63.99 -44.76 91.7 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 174.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -40.58 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-O 117.947 -1.025 . . . . 0.0 113.667 172.122 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -54.7 -38.81 67.49 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 116.656 2.095 . . . . 0.0 116.656 166.19 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -62.57 -53.46 54.28 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.449 ' HA ' ' HB2' ' A' ' 177' ' ' ARG . 74.7 mtt85 -70.94 -28.38 64.44 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 117.91 2.559 . . . . 0.0 117.91 174.187 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.14 -45.42 94.74 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 167.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.5 mp -62.76 -43.17 99.51 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 117.852 -1.07 . . . . 0.0 113.641 168.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.449 ' HB2' ' HA ' ' A' ' 174' ' ' ARG . 39.6 mtt180 -52.56 -42.65 64.64 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 117.034 2.235 . . . . 0.0 117.034 169.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -66.8 -50.86 61.28 Favored 'General case' 0 CA--C 1.558 1.264 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 172.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.86 -59.59 2.67 Favored 'General case' 0 CA--C 1.569 1.688 0 CA-C-N 119.833 1.197 . . . . 0.0 112.565 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.638 ' O ' ' CB ' ' A' ' 181' ' ' LYS . . . -106.59 -55.68 0.66 Allowed Glycine 0 CA--C 1.55 2.249 0 CA-C-O 117.902 -1.499 . . . . 0.0 115.095 -175.441 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.638 ' CB ' ' O ' ' A' ' 180' ' ' GLY . 36.5 ttmt . . . . . 0 C--O 1.251 1.139 0 CA-C-N 120.13 1.965 . . . . 0.0 107.507 -175.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.9 mmt . . . . . 0 CA--C 1.555 1.154 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.98 169.74 21.03 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 115.837 1.791 . . . . 0.0 115.837 -165.408 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.9 t -131.51 148.57 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 123.66 1.695 . . . . 0.0 113.135 -162.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -119.47 113.54 20.92 Favored 'General case' 0 CA--C 1.558 1.262 0 CA-C-N 112.576 -2.102 . . . . 0.0 105.331 169.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.8 tp -99.67 127.03 45.78 Favored 'General case' 0 CA--C 1.562 1.424 0 CA-C-O 123.44 1.59 . . . . 0.0 108.399 -168.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.3 mt -134.67 163.73 29.11 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 111.695 -2.502 . . . . 0.0 113.277 -164.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 172.96 115.6 0.38 Allowed Glycine 0 CA--C 1.546 2.007 0 CA-C-O 117.015 -1.991 . . . . 0.0 110.953 -171.07 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.91 -177.68 0.09 OUTLIER 'Trans proline' 0 CA--C 1.577 2.656 0 CA-C-N 122.147 2.973 . . . . 0.0 115.196 168.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.78 112.32 0.74 Allowed 'Trans proline' 0 CA--C 1.56 1.795 0 C-N-CA 123.469 2.779 . . . . 0.0 113.822 172.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.06 90.19 0.08 OUTLIER Glycine 0 CA--C 1.533 1.216 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 -168.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 53.48 -98.18 0.07 Allowed 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 171.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -167.22 -169.37 30.7 Favored Glycine 0 CA--C 1.548 2.126 0 CA-C-N 120.585 1.539 . . . . 0.0 115.934 -174.026 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -152.17 -33.28 0.14 Allowed 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -169.646 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -44.61 -33.49 3.31 Favored Glycine 0 CA--C 1.551 2.332 0 N-CA-C 120.887 3.115 . . . . 0.0 120.887 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.8 p -57.92 -61.12 2.76 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 119.322 1.561 . . . . 0.0 115.21 173.225 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.259 5.2 mm-40 -75.95 -12.53 60.16 Favored 'General case' 0 CA--C 1.567 1.598 0 CA-C-O 116.539 -1.696 . . . . 0.0 111.59 175.09 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.68 -50.56 42.73 Favored 'General case' 0 C--N 1.37 1.458 0 CA-C-N 122.57 2.441 . . . . 0.0 113.639 167.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.8 p -66.9 -39.83 84.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 173.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.539 ' HB3' ' CE1' ' A' ' 172' ' ' PHE . 58.5 mmtt -62.89 -42.48 99.79 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 116.21 1.929 . . . . 0.0 116.21 170.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 20.0 tp -66.67 -36.81 83.42 Favored 'General case' 0 CA--C 1.571 1.766 0 CA-C-N 120.04 1.291 . . . . 0.0 113.53 172.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.24 -39.29 86.21 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 166.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -56.59 -39.88 74.32 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 166.168 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -68.71 -53.44 22.16 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 174.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.1 mt -83.87 -23.81 31.12 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 117.274 2.324 . . . . 0.0 117.274 -176.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.91 35.42 7.72 Favored Glycine 0 CA--C 1.555 2.582 0 N-CA-C 117.8 1.88 . . . . 0.0 117.8 -174.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.0 mm -105.39 155.21 38.3 Favored Pre-proline 0 CA--C 1.57 1.722 0 CA-C-N 119.136 1.468 . . . . 0.0 112.434 -169.345 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -81.95 99.72 1.03 Allowed 'Trans proline' 0 CA--C 1.569 2.23 0 C-N-CA 121.695 1.596 . . . . 0.0 109.953 162.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.85 112.69 3.38 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 123.511 0.724 . . . . 0.0 110.539 170.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 27.3 mm -104.11 108.92 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 175.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.0 t -94.77 136.51 34.99 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 169.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.1 p -70.35 -6.53 35.98 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 117.531 2.419 . . . . 0.0 117.531 -177.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -89.72 -24.05 31.51 Favored Glycine 0 CA--C 1.544 1.886 0 N-CA-C 118.324 2.09 . . . . 0.0 118.324 165.194 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -81.18 -51.23 8.65 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -168.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -64.71 -39.08 93.04 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 174.06 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.544 ' HB3' ' CG ' ' A' ' 50' ' ' LYS . 41.6 m-85 -66.3 -37.6 85.78 Favored 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 116.183 1.92 . . . . 0.0 116.183 169.184 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 74.4 ttt180 -58.59 -41.05 84.91 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 166.084 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -63.81 -38.88 92.76 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 114.746 1.388 . . . . 0.0 114.746 169.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -64.28 -34.34 77.9 Favored 'General case' 0 CA--C 1.573 1.862 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 167.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 51.8 mt -59.35 -43.53 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 C-N-CA 124.994 1.318 . . . . 0.0 111.933 168.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -63.88 -40.62 96.95 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 170.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -72.68 -40.34 66.33 Favored 'General case' 0 CA--C 1.558 1.257 0 N-CA-C 116.266 1.95 . . . . 0.0 116.266 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.01 72.12 1.29 Allowed Glycine 0 CA--C 1.542 1.774 0 CA-C-O 118.383 -1.232 . . . . 0.0 113.965 -171.368 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.562 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 76.4 p -91.55 -65.47 1.01 Allowed 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 118.887 1.343 . . . . 0.0 111.267 177.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.562 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.0 OUTLIER 128.3 -55.76 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.942 0.897 . . . . 0.0 110.349 -167.422 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -74.67 -11.17 60.11 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 166.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.08 -54.31 25.06 Favored Glycine 0 CA--C 1.546 2.028 0 CA-C-N 119.324 0.965 . . . . 0.0 114.393 167.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.414 ' O ' ' HB2' ' A' ' 51' ' ' ARG 0.268 1.0 OUTLIER -76.44 -47.37 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 116.593 2.072 . . . . 0.0 116.593 -168.624 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -67.05 -36.81 82.89 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 120.985 1.72 . . . . 0.0 113.363 171.156 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -74.77 -34.24 62.43 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -177.32 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.544 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -73.92 -34.06 64.21 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 117.736 -1.126 . . . . 0.0 112.503 169.573 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 51' ' ' ARG . 22.0 ttt180 -74.12 -51.12 16.62 Favored 'General case' 0 CA--C 1.586 2.359 1 CA-C-O 84.252 -17.07 . . . . 0.0 118.583 -178.761 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . 0.251 21.4 m-85 -36.83 -57.42 0.81 Allowed 'General case' 0 N--CA 1.494 1.769 2 O-C-N 107.666 -9.396 . . . . 0.0 122.029 147.869 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 38.4 mt -57.43 -33.92 68.4 Favored 'General case' 0 N--CA 1.511 2.597 0 CA-C-N 123.241 2.746 . . . . 0.0 115.501 168.625 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -90.71 -38.38 13.09 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 175.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.96 -37.78 38.71 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 178.203 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.89 40.41 1.44 Allowed Glycine 0 CA--C 1.536 1.403 0 N-CA-C 116.475 1.35 . . . . 0.0 116.475 171.213 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -119.31 -142.94 0.36 Allowed 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 165.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 79.9 mt -129.92 133.77 47.06 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.307 -0.87 . . . . 0.0 109.77 -170.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.609 HG12 HH22 ' A' ' 88' ' ' ARG . 7.0 p -109.01 133.03 20.85 Favored Pre-proline 0 CA--C 1.573 1.863 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 172.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -54.95 146.72 55.85 Favored 'Trans proline' 0 CA--C 1.561 1.838 0 C-N-CA 123.33 2.687 . . . . 0.0 116.839 173.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 96.4 p -72.64 175.6 6.24 Favored 'General case' 0 CA--C 1.57 1.739 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 176.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.6 t70 81.04 -45.18 0.22 Allowed 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 125.822 1.649 . . . . 0.0 114.29 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 34.8 mt -62.3 -54.51 39.55 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 168.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.8 m -56.65 -48.72 76.95 Favored 'General case' 0 CA--C 1.571 1.765 0 CA-C-N 113.051 -1.886 . . . . 0.0 113.07 173.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 18.1 m120 -58.04 -35.28 71.09 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 168.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -64.95 -44.6 88.9 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 173.426 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.8 mt -62.93 -44.27 96.53 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 170.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 82.7 t -58.29 -46.77 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-O 117.799 -1.096 . . . . 0.0 112.463 170.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -60.0 -39.21 84.98 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 116.013 1.857 . . . . 0.0 116.013 172.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -58.67 -41.83 87.07 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 120.331 1.423 . . . . 0.0 113.44 169.009 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -82.11 2.01 33.37 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 119.198 3.036 . . . . 0.0 119.198 167.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 23.3 tp -121.68 -7.94 9.04 Favored 'General case' 0 CA--C 1.564 1.49 0 N-CA-C 118.407 2.743 . . . . 0.0 118.407 175.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -57.78 -34.13 69.28 Favored 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 174.494 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.494 ' HB3' ' CD ' ' A' ' 75' ' ' PRO 0.299 1.6 m-20 -5.35 -127.58 0.0 OUTLIER Pre-proline 0 CA--C 1.6 2.9 1 N-CA-C 121.97 4.063 . . . . 0.0 121.97 169.668 . . . . . . . . 4 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.494 ' CD ' ' HB3' ' A' ' 74' ' ' ASN . 85.9 Cg_exo -68.38 36.77 0.19 Allowed 'Trans proline' 0 N--CA 1.513 2.676 0 CA-C-N 126.727 3.438 . . . . 0.0 119.893 168.635 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.4 t70 62.5 31.88 16.84 Favored 'General case' 0 CA--C 1.587 2.388 0 C-N-CA 124.623 1.169 . . . . 0.0 109.235 -158.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 76.53 5.25 3.55 Favored 'General case' 0 C--N 1.383 2.022 0 CA-C-O 116.787 -1.578 . . . . 0.0 115.078 -168.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 50.83 31.7 6.37 Favored 'General case' 0 CA--C 1.575 1.933 0 CA-C-N 123.144 2.702 . . . . 0.0 114.281 -165.352 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 60.02 34.17 21.4 Favored 'General case' 0 CA--C 1.585 2.32 0 CA-C-O 116.907 -1.521 . . . . 0.0 112.193 -166.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 179.02 171.12 41.86 Favored Glycine 0 C--N 1.377 2.84 0 CA-C-N 123.398 2.817 . . . . 0.0 118.874 -175.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -175.89 136.75 0.32 Allowed 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 113.731 -1.234 . . . . 0.0 110.438 -169.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 22.6 mt -113.32 106.27 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 169.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 58.8 mt -105.72 120.52 41.89 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 123.151 0.58 . . . . 0.0 109.454 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -113.49 122.09 46.22 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 118.645 0.657 . . . . 0.0 110.621 -167.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 72.73 38.87 56.61 Favored Glycine 0 CA--C 1.548 2.114 0 CA-C-O 117.287 -1.841 . . . . 0.0 115.801 -178.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -99.66 -54.16 0.18 Allowed Pre-proline 0 N--CA 1.498 1.967 0 CA-C-O 115.359 -2.257 . . . . 0.0 107.536 176.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -60.87 70.04 0.08 OUTLIER 'Trans proline' 0 CA--C 1.575 2.555 0 N-CA-C 118.784 2.571 . . . . 0.0 118.784 164.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.609 HH22 HG12 ' A' ' 59' ' ' VAL . 4.5 ttm105 -69.94 -37.56 75.92 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 168.107 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.0 p -151.56 126.95 9.99 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 104.316 -2.475 . . . . 0.0 104.316 -164.855 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . 0.317 5.8 p -62.28 -21.3 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-O 116.089 -1.91 . . . . 0.0 113.6 -173.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.09 -36.92 85.61 Favored 'General case' 0 CA--C 1.557 1.221 0 N-CA-C 119.435 3.124 . . . . 0.0 119.435 165.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -73.04 -48.54 35.28 Favored 'General case' 0 CA--C 1.586 2.361 0 CA-C-N 124.422 3.283 . . . . 0.0 111.088 165.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.16 -32.03 67.8 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 118.078 2.621 . . . . 0.0 118.078 -174.212 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.519 ' O ' ' HB2' ' A' ' 98' ' ' GLU . 60.2 tttt -59.48 -25.15 64.18 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 116.604 2.076 . . . . 0.0 116.604 168.706 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.62 -45.69 64.76 Favored 'General case' 0 CA--C 1.568 1.648 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 166.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 11.2 tp -61.48 -43.73 98.34 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 171.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -59.51 -51.11 71.27 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 168.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.984 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 5.5 tp10 -43.96 -39.3 3.95 Favored 'General case' 0 CA--C 1.573 1.865 0 N-CA-C 115.548 1.684 . . . . 0.0 115.548 166.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' MET . . . . . 1.122 ' O ' ' HB2' ' A' ' 103' ' ' ARG . 66.5 mtt -83.05 -26.02 31.56 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 117.673 2.471 . . . . 0.0 117.673 174.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 41.1 tp -65.53 -54.94 20.95 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-N 120.681 1.582 . . . . 0.0 112.13 169.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -78.29 -51.04 10.73 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 119.269 0.941 . . . . 0.0 113.281 175.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.984 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 74.8 ttt180 -67.79 -46.43 71.98 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 177.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 1.122 ' HB2' ' O ' ' A' ' 99' ' ' MET . 58.1 mtt180 -65.09 -51.29 62.25 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 118.892 0.769 . . . . 0.0 111.97 165.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.38 42.66 1.14 Allowed Glycine 0 N--CA 1.482 1.758 0 N-CA-C 114.914 0.726 . . . . 0.0 114.914 167.102 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 41.4 p -97.5 142.65 29.08 Favored 'General case' 0 CA--C 1.559 1.315 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 169.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -66.73 131.92 46.98 Favored 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -170.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 4.8 tp -84.75 102.89 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 125.402 1.481 . . . . 0.0 108.144 175.563 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -99.33 -74.27 0.6 Allowed 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 115.369 -2.253 . . . . 0.0 108.412 167.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -137.93 124.94 21.37 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 122.34 2.336 . . . . 0.0 114.908 -176.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 44.2 t -92.42 109.82 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 1 N-CA-C 98.854 -4.498 . . . . 0.0 98.854 162.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.255 49.9 tp -118.17 111.6 19.05 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.446 -160.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -112.96 128.27 56.44 Favored 'General case' 0 CA--C 1.556 1.201 0 CA-C-O 122.39 1.09 . . . . 0.0 111.507 -171.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -96.45 122.43 39.34 Favored 'General case' 0 CA--C 1.558 1.288 0 CA-C-N 113.612 -1.631 . . . . 0.0 109.853 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -85.58 96.43 9.65 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 112.931 -1.941 . . . . 0.0 110.158 169.394 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.4 p -137.74 147.11 26.45 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.626 0 C-N-CA 125.849 1.659 . . . . 0.0 109.217 -167.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 50.8 m -95.93 139.51 32.02 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 122.957 1.361 . . . . 0.0 113.883 -168.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -61.21 -37.64 83.74 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 112.794 -2.003 . . . . 0.0 115.883 173.623 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -49.5 -33.59 14.9 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 117.507 2.41 . . . . 0.0 117.507 177.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.1 t -63.45 -48.46 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 CA-C-N 119.883 1.219 . . . . 0.0 113.725 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 5.2 tp -64.97 -38.22 90.23 Favored 'General case' 0 CA--C 1.555 1.142 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 168.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 9.7 mp -64.09 -42.29 96.98 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 175.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -68.3 -35.31 77.63 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 114.76 1.392 . . . . 0.0 114.76 169.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.928 ' O ' ' HB3' ' A' ' 127' ' ' ARG . 32.2 ttm180 -56.0 -54.92 39.03 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 168.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.9 pp -70.31 -37.34 74.72 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 178.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -63.9 -48.87 74.91 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 116.352 1.982 . . . . 0.0 116.352 170.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -107.71 63.99 0.27 Allowed Glycine 0 CA--C 1.542 1.754 0 CA-C-N 118.888 0.767 . . . . 0.0 112.405 172.254 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.928 ' HB3' ' O ' ' A' ' 123' ' ' ARG . 24.3 tpt180 -172.56 -85.19 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -178.592 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -166.99 175.47 42.2 Favored Glycine 0 CA--C 1.57 3.502 0 CA-C-O 118.619 -1.1 . . . . 0.0 113.075 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -154.09 -144.37 0.14 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 121.723 2.761 . . . . 0.0 112.6 -177.411 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -151.31 -25.74 0.2 Allowed 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 111.934 -2.394 . . . . 0.0 114.625 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.5 t70 81.1 -43.6 0.19 Allowed 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 117.225 2.306 . . . . 0.0 117.225 -176.069 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -61.7 -30.09 70.53 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 162.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . 0.293 10.0 t -33.68 -51.3 0.38 Allowed 'General case' 0 N--CA 1.493 1.7 1 N-CA-C 122.045 4.091 . . . . 0.0 122.045 176.561 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -65.98 -51.34 59.33 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -64.72 -34.29 77.97 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 169.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 17.5 t -61.37 -41.45 89.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 C-N-CA 124.875 1.27 . . . . 0.0 113.605 169.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 34.5 mm -69.91 -35.96 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-O 117.658 -1.163 . . . . 0.0 113.17 171.099 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 41.7 mt -62.34 -42.6 99.52 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 120.811 1.642 . . . . 0.0 114.313 169.307 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -63.15 -38.49 91.38 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 169.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -60.11 -35.5 75.37 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 166.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 64.1 mtt -68.63 -29.8 68.38 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 167.778 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -62.22 -51.42 67.82 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 120.424 1.466 . . . . 0.0 114.889 168.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.7 p -64.18 -32.58 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 170.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -54.7 -50.38 68.43 Favored 'General case' 0 CA--C 1.579 2.066 0 CA-C-N 119.678 1.127 . . . . 0.0 111.965 167.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.55 -38.05 76.99 Favored 'General case' 0 CA--C 1.563 1.454 0 N-CA-C 118.401 2.741 . . . . 0.0 118.401 174.203 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -50.67 -33.95 24.6 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 118.478 2.77 . . . . 0.0 118.478 172.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -130.3 -28.76 2.08 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 118.473 2.768 . . . . 0.0 118.473 -166.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 62.6 m -47.46 -33.61 6.37 Favored 'General case' 0 N--CA 1.504 2.225 0 N-CA-C 117.503 2.409 . . . . 0.0 117.503 -170.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -66.58 -61.93 4.56 Favored Pre-proline 0 CA--C 1.58 2.129 0 CA-C-O 115.97 -1.967 . . . . 0.0 112.207 171.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -55.17 -31.24 74.9 Favored 'Trans proline' 0 CA--C 1.578 2.718 0 N-CA-C 119.302 2.77 . . . . 0.0 119.302 169.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.99 -56.42 19.24 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 125.409 1.483 . . . . 0.0 111.842 169.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.981 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 42.3 tp -66.07 -23.12 66.46 Favored 'General case' 0 CA--C 1.562 1.435 0 CA-C-O 116.675 -1.631 . . . . 0.0 114.569 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -71.74 -47.36 54.28 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 121.976 2.171 . . . . 0.0 112.084 165.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -66.75 -54.99 17.03 Favored 'General case' 0 CA--C 1.564 1.495 0 CA-C-N 120.613 1.551 . . . . 0.0 112.047 -176.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . 0.262 21.4 m-30 -81.94 -19.74 40.07 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-O 114.69 -2.576 . . . . 0.0 112.456 178.566 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.981 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 43.5 ttt180 -66.24 -36.04 81.99 Favored 'General case' 0 N--CA 1.487 1.413 1 CA-C-N 126.28 4.127 . . . . 0.0 115.592 167.721 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -68.86 -38.2 79.58 Favored 'General case' 0 CA--C 1.576 1.962 0 CA-C-N 119.848 1.204 . . . . 0.0 113.917 166.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -90.45 -27.58 19.17 Favored 'General case' 0 CA--C 1.576 1.979 0 N-CA-C 119.14 3.015 . . . . 0.0 119.14 -176.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.0 pp -79.76 174.9 11.12 Favored 'General case' 0 N--CA 1.504 2.272 0 CA-C-N 122.773 2.533 . . . . 0.0 116.852 -164.727 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 37.8 tttp -127.38 131.56 50.32 Favored 'General case' 0 CA--C 1.559 1.298 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 168.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 31.5 m -94.93 148.86 21.87 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 122.224 1.012 . . . . 0.0 112.639 -167.899 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 36.2 t -132.09 134.34 59.73 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.523 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 166.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.412 ' HB3' ' NH1' ' A' ' 174' ' ' ARG . 13.6 t70 -96.88 131.45 43.63 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 167.778 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -163.61 118.93 1.64 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -163.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.6 t -150.05 127.53 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-O 118.257 -0.878 . . . . 0.0 109.345 173.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 77.84 -65.24 3.24 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 119.963 2.745 . . . . 0.0 119.963 166.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 5.8 t -72.79 118.83 16.2 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 112.419 -1.89 . . . . 0.0 111.59 -169.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 64.8 mtt -69.91 -59.61 2.82 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -170.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -66.93 -37.47 84.4 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 116.013 1.857 . . . . 0.0 116.013 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -65.46 -45.35 84.06 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 171.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 69.0 t -56.49 -41.86 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.345 0 CA-C-N 120.622 1.555 . . . . 0.0 113.847 172.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.539 ' CE1' ' HB3' ' A' ' 19' ' ' LYS . 29.3 t80 -57.99 -36.16 72.24 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 115.783 1.771 . . . . 0.0 115.783 167.204 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -61.03 -53.29 59.07 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-O 118.141 -0.933 . . . . 0.0 113.459 176.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.412 ' NH1' ' HB3' ' A' ' 163' ' ' ASP . 93.6 mtt180 -63.96 -32.09 73.5 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 118.206 2.669 . . . . 0.0 118.206 171.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.95 -47.31 87.02 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 116.577 2.066 . . . . 0.0 116.577 170.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . 0.265 0.2 OUTLIER -71.06 -39.47 72.2 Favored 'General case' 0 N--CA 1.505 2.32 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 169.81 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -48.92 -39.46 26.23 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 168.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -69.51 -56.7 6.61 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 166.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -103.84 -56.18 2.25 Favored 'General case' 0 CA--C 1.563 1.462 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 -168.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.824 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -78.23 -37.08 29.27 Favored Glycine 0 CA--C 1.55 2.258 0 CA-C-N 121.308 1.867 . . . . 0.0 117.764 -169.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.824 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 86.1 tttt . . . . . 0 C--O 1.252 1.186 0 CA-C-N 118.073 0.936 . . . . 0.0 108.523 178.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 mmt . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 122.278 1.037 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.457 ' NH1' ' HA2' ' A' ' 80' ' ' GLY 0.324 16.0 ttm-85 -147.25 144.64 29.01 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 118.423 2.749 . . . . 0.0 118.423 -158.985 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.8 t -141.42 147.85 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 CA-C-O 123.951 1.834 . . . . 0.0 111.964 -171.355 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.6 mt -133.29 120.74 21.45 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 126.949 2.099 . . . . 0.0 108.995 -175.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 13.0 tp -105.88 122.51 46.27 Favored 'General case' 0 CA--C 1.577 2.005 0 CA-C-O 123.202 1.477 . . . . 0.0 111.066 -168.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.7 mt -120.93 164.67 16.34 Favored 'General case' 0 CA--C 1.563 1.478 0 CA-C-N 110.607 -2.997 . . . . 0.0 112.742 -171.598 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 142.08 170.67 12.66 Favored Glycine 0 CA--C 1.562 2.984 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.563 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.81 119.45 6.45 Favored 'Trans proline' 0 CA--C 1.579 2.761 0 CA-C-N 121.45 2.625 . . . . 0.0 110.145 170.035 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -79.57 112.26 2.92 Favored 'Trans proline' 0 CA--C 1.56 1.809 0 C-N-CA 122.511 2.141 . . . . 0.0 116.902 -165.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -172.69 -84.21 0.06 OUTLIER Glycine 0 CA--C 1.534 1.229 0 N-CA-C 107.96 -2.056 . . . . 0.0 107.96 168.087 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.15 143.47 35.41 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 175.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 1.065 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . 81.69 -176.04 54.17 Favored Glycine 0 CA--C 1.547 2.045 0 N-CA-C 115.297 0.879 . . . . 0.0 115.297 177.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 1.065 ' HB2' ' O ' ' A' ' 12' ' ' GLY . 45.7 mttt 94.59 -90.2 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 170.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -46.39 -40.26 10.8 Favored Glycine 0 CA--C 1.555 2.571 0 N-CA-C 120.939 3.136 . . . . 0.0 120.939 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.7 m -52.82 -54.63 31.48 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-N 119.012 1.406 . . . . 0.0 114.359 169.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.25 0.0 OUTLIER -76.67 -17.12 59.32 Favored 'General case' 0 CA--C 1.575 1.927 0 CA-C-O 117.055 -1.45 . . . . 0.0 112.697 177.454 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.23 -44.18 65.83 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 122.068 2.213 . . . . 0.0 114.629 167.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.9 p -66.13 -46.81 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 172.289 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.675 ' HB3' ' CE1' ' A' ' 172' ' ' PHE . 45.0 mmtm -54.9 -46.74 74.87 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 169.574 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 12.5 tp -70.33 -27.76 64.62 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 175.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.15 -39.06 89.53 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 166.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -58.78 -43.35 90.41 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 117.31 -1.328 . . . . 0.0 114.131 166.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -68.12 -46.83 69.8 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 116.455 2.02 . . . . 0.0 116.455 173.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.0 mt -82.54 -26.63 32.27 Favored 'General case' 0 CA--C 1.574 1.893 0 N-CA-C 117.092 2.256 . . . . 0.0 117.092 -177.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.06 43.47 7.11 Favored Glycine 0 CA--C 1.555 2.557 0 N-CA-C 117.378 1.711 . . . . 0.0 117.378 -173.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 22.2 mm -114.62 157.98 41.43 Favored Pre-proline 0 CA--C 1.57 1.716 0 C-N-CA 124.551 1.14 . . . . 0.0 113.8 -168.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.468 ' HG2' HD22 ' A' ' 74' ' ' ASN . 34.9 Cg_exo -76.3 103.18 1.7 Allowed 'Trans proline' 0 C--N 1.376 2.008 0 CA-C-N 121.582 1.601 . . . . 0.0 111.453 159.138 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.47 107.02 10.81 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.237 -0.914 . . . . 0.0 109.052 168.156 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.7 mm -99.17 112.0 30.21 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 -178.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.3 t -96.44 127.35 42.35 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 169.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 42.5 p -69.96 -10.55 58.98 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 116.802 2.149 . . . . 0.0 116.802 -175.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -83.76 -23.2 53.85 Favored Glycine 0 CA--C 1.545 1.912 0 N-CA-C 118.642 2.217 . . . . 0.0 118.642 166.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -80.52 -51.9 8.24 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 114.714 1.375 . . . . 0.0 114.714 -168.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -64.09 -39.21 93.57 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 174.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.447 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 13.5 m-85 -68.16 -42.19 80.42 Favored 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 172.397 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 29.2 ttp180 -57.33 -41.62 80.33 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 120.467 1.485 . . . . 0.0 114.073 167.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.2 ttt180 -58.88 -39.21 80.74 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 168.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -67.18 -27.8 67.57 Favored 'General case' 0 CA--C 1.577 1.988 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 167.198 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 97.4 mt -63.03 -45.51 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 CA-C-N 120.476 1.489 . . . . 0.0 111.403 168.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -66.86 -38.04 85.6 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 120.086 1.312 . . . . 0.0 114.285 173.447 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -67.85 -40.26 83.71 Favored 'General case' 0 CA--C 1.56 1.356 0 N-CA-C 116.339 1.977 . . . . 0.0 116.339 174.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.82 69.36 1.19 Allowed Glycine 0 CA--C 1.545 1.909 0 CA-C-O 118.379 -1.234 . . . . 0.0 114.645 -177.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.855 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 70.8 p -91.58 -49.1 6.48 Favored 'General case' 0 N--CA 1.5 2.025 0 CA-C-N 118.781 1.29 . . . . 0.0 114.341 176.21 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.855 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.255 74.2 mttt 105.96 -41.64 0.0 OUTLIER 'General case' 0 CA--C 1.569 1.705 0 CA-C-O 116.331 -1.795 . . . . 0.0 111.212 -172.181 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.3 -13.63 58.22 Favored 'General case' 0 CA--C 1.57 1.717 0 CA-C-N 123.117 2.689 . . . . 0.0 113.231 163.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.53 -55.03 32.26 Favored Glycine 0 C--N 1.354 1.529 0 CA-C-N 120.534 1.515 . . . . 0.0 115.2 169.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.28 8.7 p -76.42 -47.83 28.95 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.474 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -169.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -64.94 -47.42 77.73 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 121.291 1.859 . . . . 0.0 112.957 172.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.19 -31.03 69.35 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -179.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.447 ' HB2' ' HB3' ' A' ' 35' ' ' PHE . 2.0 tptm -69.7 -36.82 76.28 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 168.045 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.572 ' HG2' ' O ' ' A' ' 51' ' ' ARG . 29.0 ttt180 -74.48 -52.5 11.78 Favored 'General case' 0 CA--C 1.59 2.487 1 CA-C-O 85.183 -16.627 . . . . 0.0 117.991 -178.378 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 18.5 m-30 -30.41 -55.55 0.19 Allowed 'General case' 0 N--CA 1.493 1.717 1 O-C-N 108.661 -8.774 . . . . 0.0 121.6 146.736 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 26.5 mt -61.43 -44.01 97.88 Favored 'General case' 0 CA--C 1.572 1.789 0 CA-C-N 123.455 2.843 . . . . 0.0 114.489 167.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -76.08 -41.68 49.71 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 116.297 1.962 . . . . 0.0 116.297 176.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.45 -33.49 20.38 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 175.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.66 38.12 3.77 Favored Glycine 0 CA--C 1.54 1.607 0 CA-C-N 121.112 1.778 . . . . 0.0 116.521 169.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -101.48 -132.44 0.27 Allowed 'General case' 0 CA--C 1.571 1.773 0 CA-C-O 118.589 -0.72 . . . . 0.0 109.374 169.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.8 pp -120.87 123.5 42.69 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 120.007 1.276 . . . . 0.0 111.491 -169.517 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.49 HG12 HH22 ' A' ' 88' ' ' ARG . 6.1 p -120.71 133.69 24.12 Favored Pre-proline 0 CA--C 1.574 1.893 0 CA-C-O 117.782 -1.104 . . . . 0.0 109.883 -176.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -59.47 148.56 86.45 Favored 'Trans proline' 0 CA--C 1.561 1.829 0 C-N-CA 123.447 2.764 . . . . 0.0 116.505 174.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 88.0 p -80.61 -35.81 33.57 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 117.314 2.338 . . . . 0.0 117.314 -175.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -71.76 -51.6 21.87 Favored 'General case' 0 N--CA 1.508 2.473 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -171.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.8 pp -54.51 -42.0 70.29 Favored 'General case' 0 CA--C 1.564 1.496 0 N-CA-C 117.521 2.415 . . . . 0.0 117.521 171.252 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.0 m -61.19 -48.31 82.12 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 123.905 0.882 . . . . 0.0 113.282 172.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -67.04 -19.76 65.73 Favored 'General case' 0 CA--C 1.572 1.817 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 169.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -75.17 -42.37 56.02 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 121.116 1.78 . . . . 0.0 115.128 170.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mt -61.53 -47.29 86.23 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 168.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -54.24 -48.42 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 169.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -61.94 -36.17 80.62 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 171.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -55.54 -42.03 74.04 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 117.95 -1.024 . . . . 0.0 113.611 169.28 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 88.2 mtt-85 -81.14 -21.82 39.49 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 118.112 2.634 . . . . 0.0 118.112 168.395 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.0 mp -89.3 7.69 34.32 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 118.331 2.715 . . . . 0.0 118.331 172.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -68.67 4.76 1.28 Allowed 'General case' 0 CA--C 1.585 2.317 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 163.166 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.468 HD22 ' HG2' ' A' ' 27' ' ' PRO 0.293 49.7 p30 -44.33 -156.67 0.0 OUTLIER Pre-proline 0 CA--C 1.594 2.639 0 N-CA-C 120.842 3.645 . . . . 0.0 120.842 164.192 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.413 ' HD2' ' HB2' ' A' ' 74' ' ' ASN . 15.2 Cg_exo -40.2 25.74 0.0 OUTLIER 'Trans proline' 0 N--CA 1.515 2.747 2 C-N-CA 127.699 5.599 . . . . 0.0 125.586 163.193 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.6 t70 61.85 27.69 16.89 Favored 'General case' 0 CA--C 1.582 2.197 0 C-N-CA 125.538 1.535 . . . . 0.0 109.154 -160.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 58.61 33.61 23.22 Favored 'General case' 0 CA--C 1.578 2.028 0 CA-C-N 120.952 1.705 . . . . 0.0 112.452 -165.75 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.83 -39.52 92.11 Favored 'General case' 0 C--N 1.38 1.899 0 CA-C-N 121.689 2.041 . . . . 0.0 115.73 176.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -74.24 -25.11 59.45 Favored 'General case' 0 CA--C 1.566 1.576 0 N-CA-C 116.488 2.033 . . . . 0.0 116.488 169.269 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.457 ' HA2' ' NH1' ' A' ' 2' ' ' ARG . . . 130.95 -167.71 22.21 Favored Glycine 0 C--N 1.36 1.884 0 CA-C-O 125.52 2.733 . . . . 0.0 113.776 -168.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.405 ' CZ ' ' HD3' ' A' ' 2' ' ' ARG . 21.7 p90 -169.72 135.5 1.49 Allowed 'General case' 0 CA--C 1.56 1.362 0 CA-C-N 109.039 -3.581 . . . . 0.0 105.975 169.382 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 13.9 mt -106.79 106.32 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 173.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.3 mt -108.03 114.59 28.61 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.069 -176.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -106.77 125.28 50.8 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 119.467 1.031 . . . . 0.0 110.632 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 75.19 28.38 62.24 Favored Glycine 0 CA--C 1.551 2.293 0 N-CA-C 118.377 2.111 . . . . 0.0 118.377 177.37 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -88.81 -55.0 0.32 Allowed Pre-proline 0 N--CA 1.496 1.865 0 CA-C-O 115.234 -2.317 . . . . 0.0 107.264 168.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -67.56 66.51 0.79 Allowed 'Trans proline' 0 CA--C 1.574 2.475 0 N-CA-C 118.381 2.416 . . . . 0.0 118.381 166.349 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.49 HH22 HG12 ' A' ' 59' ' ' VAL . 8.0 tmm_? -76.41 -20.39 57.17 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 167.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.491 ' HA ' ' HG3' ' A' ' 147' ' ' GLU . 28.3 t -153.54 127.56 8.98 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 104.197 -2.52 . . . . 0.0 104.197 -167.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . 0.302 5.8 p -61.3 -27.18 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 CA-C-O 116.387 -1.768 . . . . 0.0 113.017 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.61 -32.6 70.01 Favored 'General case' 0 C--N 1.362 1.132 0 N-CA-C 119.631 3.197 . . . . 0.0 119.631 165.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -74.04 -49.95 21.93 Favored 'General case' 0 CA--C 1.588 2.405 0 CA-C-N 124.391 3.269 . . . . 0.0 111.493 166.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -53.99 -28.02 35.3 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 118.319 2.711 . . . . 0.0 118.319 178.102 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.2 tttp -57.18 -30.35 64.43 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 168.74 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.56 -44.79 81.35 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 168.218 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.9 tp -62.2 -35.57 79.28 Favored 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 169.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 64.5 t-80 -64.45 -43.8 93.12 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 119.651 1.114 . . . . 0.0 113.175 167.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 1.156 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 0.5 OUTLIER -54.94 -30.61 59.18 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 166.696 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' MET . . . . . 1.346 ' O ' ' HB2' ' A' ' 103' ' ' ARG . 47.3 mtt -85.28 -33.71 22.08 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 118.946 2.943 . . . . 0.0 118.946 172.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.5 tt -69.51 -54.11 15.78 Favored 'General case' 0 N--CA 1.504 2.27 0 CA-C-N 121.372 1.897 . . . . 0.0 110.906 172.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -78.15 -49.41 13.9 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 117.662 -1.161 . . . . 0.0 114.065 175.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 1.156 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 93.0 mtt180 -75.08 -39.67 60.6 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 177.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 1.346 ' HB2' ' O ' ' A' ' 99' ' ' MET . 32.8 mmt180 -64.36 -54.36 34.07 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 120.123 1.329 . . . . 0.0 111.538 165.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.3 50.74 0.7 Allowed Glycine 0 N--CA 1.485 1.938 0 O-C-N 123.836 0.71 . . . . 0.0 113.957 168.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.0 p -92.65 169.05 10.81 Favored 'General case' 0 CA--C 1.566 1.562 0 CA-C-N 113.188 -1.506 . . . . 0.0 110.247 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -72.42 133.24 44.78 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.1 -1.0 . . . . 0.0 110.72 -174.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 7.8 tp -102.21 98.44 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 177.474 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -98.32 -77.45 0.51 Allowed 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 116.218 -1.849 . . . . 0.0 107.866 168.055 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.46 130.55 11.88 Favored 'General case' 0 C--N 1.362 1.149 0 CA-C-N 121.665 2.03 . . . . 0.0 113.94 -169.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 24.1 t -92.72 110.96 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 103.497 -2.779 . . . . 0.0 103.497 162.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.455 HD23 ' HB3' ' A' ' 160' ' ' LYS . 89.4 mt -96.6 95.65 8.11 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.478 -172.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -88.98 123.95 33.79 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.173 0.511 . . . . 0.0 111.608 177.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -90.93 124.07 34.91 Favored 'General case' 0 CA--C 1.559 1.289 0 CA-C-O 123.16 1.457 . . . . 0.0 110.915 -176.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -85.37 97.35 9.94 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 112.412 -2.177 . . . . 0.0 108.391 167.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.1 p -134.46 133.49 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 CA-C-N 113.477 -1.692 . . . . 0.0 107.455 -168.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.1 m -74.92 138.98 42.75 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.432 -175.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -64.97 -26.63 68.38 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 175.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -52.46 -45.69 66.2 Favored 'General case' 0 CA--C 1.563 1.469 0 CA-C-N 121.704 2.047 . . . . 0.0 114.998 167.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.5 t -65.22 -44.89 95.1 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 173.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -51.25 -45.14 61.91 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 124.792 1.237 . . . . 0.0 114.123 168.002 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.1 mp -61.58 -37.58 84.39 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 169.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -56.61 -43.66 80.38 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 167.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 86.5 mmt-85 -56.35 -50.75 70.6 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 168.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -52.56 -48.38 66.2 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 169.533 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -59.07 -43.64 91.77 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 117.249 2.315 . . . . 0.0 117.249 173.685 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -96.26 54.13 1.55 Allowed Glycine 0 CA--C 1.547 2.036 0 N-CA-C 114.979 0.752 . . . . 0.0 114.979 172.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 75.4 mtp85 -150.35 115.14 5.28 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 171.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.597 ' O ' ' CB ' ' A' ' 129' ' ' ARG . . . -78.23 -178.86 49.94 Favored Glycine 0 CA--C 1.572 3.62 0 N-CA-C 116.072 1.189 . . . . 0.0 116.072 -169.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.597 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 33.4 ttm180 101.9 126.48 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 120.93 2.365 . . . . 0.0 109.54 -173.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -68.08 -35.4 78.12 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 117.0 2.222 . . . . 0.0 117.0 -175.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -136.67 58.94 1.71 Allowed 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 120.833 1.652 . . . . 0.0 113.653 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -122.67 61.3 1.0 Allowed 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 103.241 -2.874 . . . . 0.0 103.241 158.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 82.7 p -143.0 -115.39 0.1 Allowed 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 113.707 -1.588 . . . . 0.0 110.103 -160.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -59.13 -41.38 88.1 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 117.125 2.268 . . . . 0.0 117.125 -169.165 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -75.07 -36.06 61.79 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 115.518 1.673 . . . . 0.0 115.518 177.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.4 t -64.38 -40.59 89.61 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.68 0 CA-C-O 117.582 -1.199 . . . . 0.0 111.571 169.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.7 tp -74.29 -30.06 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 CA-C-N 120.503 1.501 . . . . 0.0 113.879 174.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 31.3 mt -63.88 -46.46 84.83 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 121.139 1.79 . . . . 0.0 113.332 168.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -61.96 -40.32 95.16 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 172.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -62.48 -37.31 85.48 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 168.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 57.8 mtt -67.93 -29.51 68.6 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 168.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -63.56 -50.69 68.53 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 120.412 1.46 . . . . 0.0 114.377 168.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.1 p -65.79 -33.08 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.221 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 170.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -57.2 -47.0 82.38 Favored 'General case' 0 CA--C 1.583 2.214 0 CA-C-N 119.994 1.27 . . . . 0.0 112.032 168.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -61.77 -54.08 47.18 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 117.445 2.387 . . . . 0.0 117.445 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.49 -43.81 62.32 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 116.922 2.193 . . . . 0.0 116.922 174.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.491 ' HG3' ' HA ' ' A' ' 89' ' ' SER . 32.9 mm-40 -98.84 -42.3 7.24 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 116.487 2.032 . . . . 0.0 116.487 -167.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 97.8 m -50.76 -33.38 22.95 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 117.427 2.38 . . . . 0.0 117.427 -167.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.444 ' HB3' ' HD3' ' A' ' 150' ' ' PRO . . . -71.04 -61.38 2.34 Favored Pre-proline 0 CA--C 1.583 2.212 0 CA-C-O 115.83 -2.033 . . . . 0.0 111.844 169.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.444 ' HD3' ' HB3' ' A' ' 149' ' ' ALA . 75.7 Cg_exo -54.31 -37.02 88.56 Favored 'Trans proline' 0 CA--C 1.58 2.796 0 C-N-CA 123.625 2.883 . . . . 0.0 119.3 169.668 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -61.14 -53.27 59.11 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 126.193 1.797 . . . . 0.0 111.58 171.536 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 1.113 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 45.3 tp -64.32 -20.73 66.28 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 115.378 1.621 . . . . 0.0 115.378 174.247 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -71.6 -50.4 31.25 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 122.436 2.38 . . . . 0.0 112.667 164.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -65.05 -53.16 50.04 Favored 'General case' 0 CA--C 1.568 1.658 0 CA-C-N 120.106 1.321 . . . . 0.0 112.432 -179.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -74.87 -29.23 60.95 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-O 115.178 -2.344 . . . . 0.0 113.491 176.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 1.113 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 34.7 ttt180 -60.95 -36.42 79.33 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 124.535 3.334 . . . . 0.0 116.389 169.501 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -67.72 -36.49 80.7 Favored 'General case' 0 CA--C 1.575 1.935 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 166.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -86.87 -29.5 22.14 Favored 'General case' 0 CA--C 1.577 2.001 0 N-CA-C 119.43 3.122 . . . . 0.0 119.43 -178.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.1 pp -80.4 176.64 9.59 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 119.673 3.212 . . . . 0.0 119.673 -160.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.455 ' HB3' HD23 ' A' ' 111' ' ' LEU . 6.0 tmtt? -131.0 135.25 47.44 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 104.062 -2.57 . . . . 0.0 104.062 166.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 83.0 m -97.06 148.88 22.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.991 -1.068 . . . . 0.0 109.666 -174.745 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 34.3 t -130.38 138.18 54.44 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.442 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 168.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -91.14 136.8 32.84 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 169.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -160.26 99.89 1.34 Allowed 'General case' 0 N--CA 1.481 1.085 0 CA-C-O 121.711 0.767 . . . . 0.0 111.516 -163.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.3 t -149.92 126.77 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -176.989 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.14 -69.83 3.04 Favored Glycine 0 N--CA 1.482 1.731 0 N-CA-C 117.471 1.748 . . . . 0.0 117.471 168.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 44.5 p -81.23 138.28 35.79 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 112.139 -2.03 . . . . 0.0 111.628 -169.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 53.9 mtt -88.39 -58.05 2.7 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 118.742 -0.647 . . . . 0.0 111.807 175.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -69.57 -37.48 76.99 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 116.112 1.893 . . . . 0.0 116.112 -177.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.576 ' HB3' HH21 ' A' ' 174' ' ' ARG . 46.8 mt-10 -64.39 -47.7 78.25 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 119.491 1.041 . . . . 0.0 113.635 169.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 99.8 t -58.92 -36.65 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 CA-C-N 119.399 0.999 . . . . 0.0 113.543 173.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.675 ' CE1' ' HB3' ' A' ' 19' ' ' LYS . 43.0 t80 -57.34 -36.65 71.44 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 164.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.43 -54.43 32.72 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 175.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.576 HH21 ' HB3' ' A' ' 170' ' ' GLU . 9.7 ptp180 -66.36 -26.06 67.1 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 117.588 2.44 . . . . 0.0 117.588 170.504 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.93 -41.93 95.1 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 120.06 1.3 . . . . 0.0 114.211 167.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 4.5 mp -60.08 -46.14 90.56 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 118.265 -0.874 . . . . 0.0 113.035 166.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.433 ' HB2' ' HA ' ' A' ' 174' ' ' ARG . 26.3 mtp180 -51.52 -45.61 62.97 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 169.182 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.32 -49.05 79.3 Favored 'General case' 0 CA--C 1.558 1.27 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 171.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -84.19 -61.34 1.83 Allowed 'General case' 0 CA--C 1.564 1.515 0 CA-C-O 117.781 -1.104 . . . . 0.0 112.326 -177.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.958 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -101.45 -56.62 0.86 Allowed Glycine 0 CA--C 1.551 2.296 0 CA-C-N 120.523 1.51 . . . . 0.0 114.937 -177.092 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.958 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 57.5 tttp . . . . . 0 C--O 1.251 1.132 0 CA-C-N 120.003 1.902 . . . . 0.0 109.195 -176.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.3 mtt . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.456 ' HB2' ' O ' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -149.68 172.97 14.2 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 116.613 2.079 . . . . 0.0 116.613 -168.024 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 54.7 t -134.25 156.04 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 CA-C-O 123.474 1.607 . . . . 0.0 112.802 -162.558 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . 0.259 0.0 OUTLIER -140.77 132.19 26.84 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 113.936 -1.484 . . . . 0.0 110.091 167.038 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 1.099 HD21 ' HB3' ' A' ' 13' ' ' LYS . 23.8 tp -99.56 126.37 45.52 Favored 'General case' 0 CA--C 1.573 1.849 0 CA-C-O 123.132 1.444 . . . . 0.0 112.121 -167.666 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.3 mt -116.51 153.03 32.89 Favored 'General case' 0 CA--C 1.559 1.305 0 CA-C-N 109.921 -3.309 . . . . 0.0 109.898 -177.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -179.38 108.26 0.24 Allowed Glycine 0 CA--C 1.547 2.036 0 CA-C-O 117.029 -1.984 . . . . 0.0 113.289 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.45 175.41 0.39 Allowed 'Trans proline' 0 CA--C 1.579 2.725 0 CA-C-N 121.926 2.863 . . . . 0.0 115.689 168.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -47.97 114.76 1.21 Allowed 'Trans proline' 0 CA--C 1.561 1.862 0 C-N-CA 123.94 3.093 . . . . 0.0 116.905 -174.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.21 89.86 0.07 OUTLIER Glycine 0 CA--C 1.539 1.57 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -169.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 64.02 -111.6 0.31 Allowed 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 124.951 1.3 . . . . 0.0 114.068 173.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 165.55 118.98 0.46 Allowed Glycine 0 CA--C 1.543 1.803 0 CA-C-N 120.065 1.302 . . . . 0.0 110.438 -171.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 1.099 ' HB3' HD21 ' A' ' 5' ' ' LEU . 0.5 OUTLIER -86.43 10.34 15.43 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 118.826 2.898 . . . . 0.0 118.826 -169.02 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.76 -24.46 40.87 Favored Glycine 0 CA--C 1.561 2.928 0 N-CA-C 118.972 2.349 . . . . 0.0 118.972 168.029 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 16.6 m -63.07 -56.22 18.8 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 119.378 1.589 . . . . 0.0 113.331 170.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.48 ' HA ' ' HB2' ' A' ' 19' ' ' LYS 0.286 1.8 mp0 -77.82 -12.29 59.96 Favored 'General case' 0 CA--C 1.571 1.78 0 CA-C-O 115.695 -2.098 . . . . 0.0 112.804 173.54 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.53 -46.83 45.29 Favored 'General case' 0 C--N 1.375 1.697 0 CA-C-N 123.831 3.014 . . . . 0.0 113.744 167.477 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.7 t -67.2 -38.24 80.68 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.995 0 CA-C-N 119.772 1.169 . . . . 0.0 111.893 173.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.48 ' HB2' ' HA ' ' A' ' 16' ' ' GLN . 18.9 mmmt -57.42 -54.34 47.88 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 116.38 1.993 . . . . 0.0 116.38 169.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.7 tp -65.09 -29.55 70.43 Favored 'General case' 0 CA--C 1.575 1.924 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 174.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.48 -39.13 91.59 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 167.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -61.03 -36.05 78.51 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 166.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.2 mmmt -65.21 -51.63 59.81 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 169.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.4 mt -85.15 -25.55 27.39 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 116.931 2.197 . . . . 0.0 116.931 -174.445 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.04 37.86 7.61 Favored Glycine 0 CA--C 1.554 2.525 0 N-CA-C 117.694 1.838 . . . . 0.0 117.694 -174.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.2 mm -105.21 155.95 36.98 Favored Pre-proline 0 CA--C 1.569 1.681 0 CA-C-N 119.26 1.53 . . . . 0.0 113.281 -168.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -80.64 99.06 1.11 Allowed 'Trans proline' 0 CA--C 1.567 2.125 0 CA-C-N 122.426 1.902 . . . . 0.0 109.549 162.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -72.18 112.47 8.29 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.923 -0.486 . . . . 0.0 110.108 177.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 12.8 mm -98.67 104.26 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 41.7 t -98.77 127.88 44.83 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 167.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 37.9 p -67.64 -18.73 65.06 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 117.41 2.374 . . . . 0.0 117.41 -168.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -82.88 -18.66 64.91 Favored Glycine 0 CA--C 1.548 2.126 0 N-CA-C 118.667 2.227 . . . . 0.0 118.667 167.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -78.96 -53.6 6.88 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 119.009 1.404 . . . . 0.0 114.189 -169.497 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -65.16 -38.02 89.23 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 174.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.47 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 15.3 m-85 -64.54 -38.53 91.32 Favored 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 168.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 49.0 ttp180 -58.6 -41.68 86.39 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 119.929 1.241 . . . . 0.0 114.273 167.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -60.65 -41.28 94.67 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 168.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -69.08 -24.31 64.13 Favored 'General case' 0 CA--C 1.579 2.059 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 169.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 65.6 mt -63.69 -47.98 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 CA-C-N 120.245 1.384 . . . . 0.0 110.97 167.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -65.63 -36.7 84.45 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 114.341 1.238 . . . . 0.0 114.341 174.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -66.46 -42.74 87.1 Favored 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 115.98 1.844 . . . . 0.0 115.98 173.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.79 69.44 1.06 Allowed Glycine 0 CA--C 1.543 1.829 0 CA-C-O 118.607 -1.107 . . . . 0.0 114.101 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.86 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 73.3 p -93.33 -48.74 6.28 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.86 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.253 74.6 mttt 106.17 -41.37 0.0 OUTLIER 'General case' 0 CA--C 1.572 1.818 0 CA-C-O 116.455 -1.736 . . . . 0.0 111.29 -172.607 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.401 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -81.88 -14.14 56.61 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 122.955 2.616 . . . . 0.0 112.895 163.789 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.54 -55.64 27.69 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-N 120.287 1.403 . . . . 0.0 114.864 170.654 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.297 7.4 p -76.32 -50.41 22.31 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.444 0 N-CA-C 115.883 1.808 . . . . 0.0 115.883 -168.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -66.71 -45.94 77.14 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 121.127 1.785 . . . . 0.0 112.922 173.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 45' ' ' LEU . . . -71.47 -27.42 63.23 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -178.031 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.47 ' HB2' ' HB3' ' A' ' 35' ' ' PHE . 1.3 tmtp? -72.53 -41.97 65.26 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 117.302 -1.333 . . . . 0.0 112.946 166.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.594 ' O ' ' CG ' ' A' ' 51' ' ' ARG . 32.4 ttt180 -71.2 -51.77 22.86 Favored 'General case' 0 CA--C 1.586 2.342 1 CA-C-O 85.232 -16.604 . . . . 0.0 118.623 -174.139 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -34.58 -62.53 0.34 Allowed 'General case' 0 N--CA 1.494 1.732 1 O-C-N 108.992 -8.567 . . . . 0.0 121.129 146.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.5 tp -57.01 -29.47 63.36 Favored 'General case' 0 CA--C 1.582 2.206 0 CA-C-N 122.012 2.187 . . . . 0.0 116.223 171.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -92.58 -39.45 11.33 Favored 'General case' 0 CA--C 1.568 1.672 0 C-N-CA 126.738 2.015 . . . . 0.0 116.27 170.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -87.08 -27.88 22.88 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 116.874 2.176 . . . . 0.0 116.874 -176.425 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.75 22.01 6.87 Favored Glycine 0 CA--C 1.542 1.733 0 N-CA-C 118.588 2.195 . . . . 0.0 118.588 167.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -100.28 -132.23 0.25 Allowed 'General case' 0 CA--C 1.57 1.746 0 CA-C-N 118.935 1.367 . . . . 0.0 110.045 173.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 89.2 mt -116.17 119.31 35.39 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 119.916 1.235 . . . . 0.0 110.874 -168.748 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.491 HG12 HH12 ' A' ' 88' ' ' ARG . 13.2 p -121.37 136.48 25.88 Favored Pre-proline 0 CA--C 1.573 1.846 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.322 176.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -61.08 150.01 86.37 Favored 'Trans proline' 0 CA--C 1.561 1.857 0 C-N-CA 123.136 2.557 . . . . 0.0 115.275 169.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.1 t -83.85 -33.88 24.75 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -64.0 -44.91 91.22 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -174.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 pp -56.76 -43.63 80.98 Favored 'General case' 0 CA--C 1.562 1.425 0 N-CA-C 117.09 2.255 . . . . 0.0 117.09 169.573 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.5 m -61.77 -46.21 90.54 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 123.834 0.854 . . . . 0.0 113.013 174.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.45 -23.63 67.35 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 167.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -74.26 -45.74 45.9 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 175.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.4 mt -65.79 -45.81 81.01 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 169.371 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 69.0 t -57.65 -53.8 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 117.645 -1.169 . . . . 0.0 111.688 172.644 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -62.14 -30.7 71.21 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 116.002 1.853 . . . . 0.0 116.002 174.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -57.94 -43.7 86.49 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 117.162 -1.399 . . . . 0.0 113.404 169.733 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.5 ttm-85 -81.64 -15.34 54.91 Favored 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 118.499 2.778 . . . . 0.0 118.499 168.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 74.7 mt -85.13 -6.62 59.29 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 166.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -72.02 45.42 0.12 Allowed 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 126.237 2.922 . . . . 0.0 118.485 165.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.409 ' HA ' ' H ' ' A' ' 77' ' ' ALA 0.362 0.7 OUTLIER 74.33 90.71 0.06 OUTLIER Pre-proline 0 CA--C 1.556 1.183 2 N-CA-C 123.532 4.642 . . . . 0.0 123.532 146.568 . . . . . . . . 5 4 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -80.92 37.04 0.65 Allowed 'Trans proline' 0 CA--C 1.578 2.687 0 C-N-CA 121.985 1.79 . . . . 0.0 113.002 149.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 63.61 30.43 14.96 Favored 'General case' 0 CA--C 1.594 2.656 0 C-N-CA 125.97 1.708 . . . . 0.0 107.684 -151.578 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.409 ' H ' ' HA ' ' A' ' 74' ' ' ASN . . . 61.41 5.33 1.14 Allowed 'General case' 0 C--N 1.398 2.681 0 CA-C-N 123.027 2.649 . . . . 0.0 114.2 -162.063 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 47.87 34.18 3.79 Favored 'General case' 0 CA--C 1.583 2.217 0 CA-C-N 122.542 2.428 . . . . 0.0 113.829 -158.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 18.3 m120 59.67 28.96 18.5 Favored 'General case' 0 CA--C 1.582 2.183 0 C-N-CA 125.576 1.55 . . . . 0.0 113.828 -166.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.89 -169.64 42.27 Favored Glycine 0 C--N 1.373 2.593 0 CA-C-N 123.226 2.739 . . . . 0.0 116.324 -169.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.456 ' O ' ' HB2' ' A' ' 2' ' ' ARG . 17.2 p90 -177.6 132.14 0.16 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 112.958 -1.621 . . . . 0.0 109.278 169.675 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 16.7 mt -112.59 109.53 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 172.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 24.8 mt -104.01 114.33 28.51 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 117.52 -1.229 . . . . 0.0 109.87 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -104.5 125.71 50.92 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 121.32 1.873 . . . . 0.0 110.884 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 74.04 32.36 58.7 Favored Glycine 0 CA--C 1.548 2.147 0 N-CA-C 117.95 1.94 . . . . 0.0 117.95 174.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -91.15 -55.8 0.26 Allowed Pre-proline 0 N--CA 1.496 1.853 0 CA-C-O 115.163 -2.351 . . . . 0.0 108.418 169.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -66.74 63.79 0.57 Allowed 'Trans proline' 0 CA--C 1.575 2.555 0 N-CA-C 120.192 3.112 . . . . 0.0 120.192 168.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.491 HH12 HG12 ' A' ' 59' ' ' VAL 0.331 29.6 ttt180 -69.59 -31.42 69.55 Favored 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 116.892 2.182 . . . . 0.0 116.892 165.877 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.9 t -151.72 129.32 11.49 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 104.742 -2.318 . . . . 0.0 104.742 -166.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . 0.33 12.8 p -61.86 -25.3 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 CA-C-O 116.726 -1.607 . . . . 0.0 113.718 -172.397 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.07 -38.21 75.92 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 119.506 3.15 . . . . 0.0 119.506 165.185 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -70.09 -47.95 59.72 Favored 'General case' 0 CA--C 1.592 2.589 0 CA-C-N 122.526 2.421 . . . . 0.0 111.939 165.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.07 -31.63 72.94 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 127.198 2.199 . . . . 0.0 116.279 -169.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -57.28 -32.61 66.8 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 166.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.62 -43.05 90.74 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 169.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 32.0 tp -64.22 -36.82 85.32 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 169.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 28.3 t-80 -60.26 -53.08 61.92 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 119.867 1.212 . . . . 0.0 113.042 169.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 1.222 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 35.6 mt-10 -49.01 -34.54 13.4 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 167.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' MET . . . . . 1.248 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 26.3 mmt -85.96 -30.56 22.68 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 118.182 2.66 . . . . 0.0 118.182 173.917 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 46.4 tp -67.48 -52.26 41.44 Favored 'General case' 0 N--CA 1.504 2.26 0 CA-C-N 121.281 1.855 . . . . 0.0 112.02 169.81 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -79.01 -51.37 9.68 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 123.512 0.725 . . . . 0.0 112.675 176.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 1.222 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 72.9 ttt180 -69.65 -44.94 69.53 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 176.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 1.248 ' HB3' ' O ' ' A' ' 99' ' ' MET . 72.0 ttt180 -59.8 -56.18 25.01 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 118.867 0.758 . . . . 0.0 110.953 164.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.27 43.78 1.05 Allowed Glycine 0 N--CA 1.48 1.588 0 O-C-N 124.282 0.989 . . . . 0.0 114.211 168.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 34.5 p -100.49 143.81 30.23 Favored 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 170.459 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -67.4 131.43 45.69 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -171.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 4.7 tp -82.91 103.19 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 C-N-CA 125.21 1.404 . . . . 0.0 108.257 175.258 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -97.95 -71.66 0.68 Allowed 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 114.925 -2.464 . . . . 0.0 108.237 168.049 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -144.96 125.5 14.06 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 122.852 2.569 . . . . 0.0 116.366 -174.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 69.2 t -92.3 109.14 21.06 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.626 0 N-CA-C 102.269 -3.234 . . . . 0.0 102.269 162.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.585 HD23 ' HB2' ' A' ' 160' ' ' LYS . 83.2 mt -102.18 107.04 17.98 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.083 0.553 . . . . 0.0 110.559 -173.144 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -99.3 122.15 42.05 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-O 122.387 1.089 . . . . 0.0 110.409 175.195 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -93.69 123.3 36.92 Favored 'General case' 0 CA--C 1.559 1.304 0 CA-C-N 113.661 -1.609 . . . . 0.0 108.709 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -82.68 98.27 8.96 Favored 'General case' 0 CA--C 1.555 1.163 0 CA-C-N 112.444 -2.162 . . . . 0.0 108.484 169.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.0 p -137.97 136.26 45.2 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.223 0 CA-C-N 112.977 -1.92 . . . . 0.0 107.187 -168.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 65.1 m -88.18 134.03 33.88 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 113.338 -1.756 . . . . 0.0 113.039 -169.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -63.94 -27.1 68.91 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 175.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -62.02 -30.36 70.9 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 115.691 1.737 . . . . 0.0 115.691 175.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -59.01 -51.19 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 177.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.8 tt -72.55 -39.74 67.26 Favored 'General case' 0 CA--C 1.569 1.693 0 CA-C-N 114.543 -1.208 . . . . 0.0 113.185 174.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.7 mp -58.31 -35.15 71.42 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 167.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -67.77 -43.06 80.67 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 119.387 0.994 . . . . 0.0 113.607 168.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -51.61 -49.78 61.51 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 168.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 10.7 mt -59.16 -60.72 3.42 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 114.525 1.305 . . . . 0.0 114.525 170.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.7 tmtp? -75.87 -56.9 4.23 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 -170.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -59.0 -33.55 74.68 Favored Glycine 0 CA--C 1.552 2.39 0 N-CA-C 119.16 2.424 . . . . 0.0 119.16 -175.838 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.77 -73.42 0.29 Allowed 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 118.965 1.382 . . . . 0.0 111.388 174.056 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.74 ' O ' ' HB2' ' A' ' 129' ' ' ARG . . . -162.0 -48.53 0.02 OUTLIER Glycine 0 CA--C 1.549 2.179 0 CA-C-O 118.194 -1.337 . . . . 0.0 115.519 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.74 ' HB2' ' O ' ' A' ' 128' ' ' GLY . 6.4 mmm180 108.41 101.35 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 119.721 1.76 . . . . 0.0 108.74 -174.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -98.25 30.92 2.95 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 178.704 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 47.58 55.41 8.41 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 116.862 2.171 . . . . 0.0 116.862 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -91.68 84.91 5.52 Favored 'General case' 0 N--CA 1.489 1.505 1 N-CA-C 97.279 -5.082 . . . . 0.0 97.279 156.972 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 6.8 t -61.24 138.35 58.23 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 116.718 2.118 . . . . 0.0 116.718 -155.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -48.58 -34.82 12.2 Favored 'General case' 0 CA--C 1.575 1.911 0 CA-C-N 111.509 -2.587 . . . . 0.0 117.271 172.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -67.43 -37.12 82.51 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 172.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.2 t -65.28 -35.94 76.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 CA-C-N 119.073 0.851 . . . . 0.0 113.113 168.012 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 2.2 mp -64.31 -40.83 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 CA-C-O 118.522 -0.752 . . . . 0.0 112.4 169.638 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 32.5 mt -63.9 -36.37 83.72 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 115.043 1.498 . . . . 0.0 115.043 169.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -64.64 -39.95 94.59 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 169.621 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -63.05 -36.52 83.85 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 167.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 13.2 tpt -67.09 -29.77 69.62 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 114.671 1.359 . . . . 0.0 114.671 168.078 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -62.77 -50.71 69.96 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 168.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 10.1 p -64.56 -34.72 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 170.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -54.95 -49.36 71.57 Favored 'General case' 0 CA--C 1.578 2.046 0 CA-C-N 119.662 1.119 . . . . 0.0 112.335 167.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -57.19 -39.44 75.38 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 118.9 2.926 . . . . 0.0 118.9 173.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -57.21 -34.4 68.49 Favored 'General case' 0 N--CA 1.506 2.365 0 N-CA-C 117.011 2.226 . . . . 0.0 117.011 178.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -131.1 -26.59 2.12 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 119.225 3.046 . . . . 0.0 119.225 -166.241 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 73.2 m -45.4 -32.84 2.28 Favored 'General case' 0 N--CA 1.508 2.452 0 CA-C-N 122.667 2.485 . . . . 0.0 117.425 -171.552 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.403 ' HB3' ' HD3' ' A' ' 150' ' ' PRO . . . -68.53 -62.38 3.04 Favored Pre-proline 0 CA--C 1.584 2.261 0 CA-C-O 115.682 -2.104 . . . . 0.0 112.067 169.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.403 ' HD3' ' HB3' ' A' ' 149' ' ' ALA . 75.3 Cg_exo -56.46 -31.73 86.83 Favored 'Trans proline' 0 CA--C 1.578 2.685 0 N-CA-C 120.083 3.07 . . . . 0.0 120.083 169.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -62.78 -53.17 58.39 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 125.719 1.608 . . . . 0.0 111.03 169.516 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.987 ' O ' ' HB2' ' A' ' 156' ' ' ARG 0.306 0.1 OUTLIER -62.03 -24.94 67.36 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 175.872 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -71.29 -50.73 29.62 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 120.366 1.439 . . . . 0.0 113.137 166.604 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -64.5 -53.54 46.45 Favored 'General case' 0 CA--C 1.568 1.666 0 CA-C-N 120.416 1.462 . . . . 0.0 112.728 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -80.86 -24.66 38.21 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 115.209 -2.329 . . . . 0.0 113.724 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.987 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 14.9 tpt180 -64.37 -37.49 87.68 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 124.144 3.156 . . . . 0.0 115.175 169.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -67.16 -38.09 84.86 Favored 'General case' 0 CA--C 1.574 1.87 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 167.359 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -80.47 -29.7 37.45 Favored 'General case' 0 CA--C 1.578 2.028 0 N-CA-C 119.713 3.227 . . . . 0.0 119.713 177.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.5 pp -79.21 175.76 10.3 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 119.933 3.309 . . . . 0.0 119.933 -161.17 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.585 ' HB2' HD23 ' A' ' 111' ' ' LEU . 95.1 mttt -128.55 133.38 48.38 Favored 'General case' 0 CA--C 1.561 1.392 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 166.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 62.4 m -96.07 148.4 22.71 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 122.261 1.029 . . . . 0.0 110.818 -172.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 1.018 HG13 ' HB3' ' A' ' 174' ' ' ARG . 58.6 t -130.35 136.14 59.18 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.48 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 167.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.549 ' O ' ' HG3' ' A' ' 174' ' ' ARG . 10.0 t0 -95.07 129.05 42.31 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 168.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -163.43 120.9 1.86 Allowed 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.447 -162.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.9 t -149.32 130.23 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-O 118.419 -0.801 . . . . 0.0 109.075 175.382 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 78.52 -65.98 3.34 Favored Glycine 0 N--CA 1.484 1.845 0 N-CA-C 118.785 2.274 . . . . 0.0 118.785 167.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 40.9 p -70.34 149.95 46.83 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 112.068 -2.066 . . . . 0.0 113.072 -169.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 61.1 mtt -91.97 -60.17 1.92 Allowed 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 118.722 -0.656 . . . . 0.0 111.549 176.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -69.42 -38.67 77.97 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 -176.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -64.03 -47.98 78.11 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 119.505 1.048 . . . . 0.0 113.653 169.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 99.3 t -56.7 -38.04 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-N 119.746 1.157 . . . . 0.0 113.647 172.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -59.0 -35.96 74.12 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 116.619 2.081 . . . . 0.0 116.619 167.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -60.37 -48.31 82.32 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 170.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 1.018 ' HB3' HG13 ' A' ' 162' ' ' VAL . 1.4 mmp_? -50.3 -57.2 8.41 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 117.337 2.347 . . . . 0.0 117.337 168.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -49.92 -44.5 50.33 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 116.752 2.13 . . . . 0.0 116.752 172.673 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.5 mp -62.69 -43.11 99.63 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 117.515 -1.231 . . . . 0.0 114.013 168.181 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -53.35 -47.81 69.07 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 171.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -67.87 -45.03 75.71 Favored 'General case' 0 CA--C 1.559 1.303 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 175.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -81.11 -56.6 3.98 Favored 'General case' 0 CA--C 1.564 1.513 0 CA-C-N 120.063 1.301 . . . . 0.0 112.878 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.65 ' O ' ' CB ' ' A' ' 181' ' ' LYS . . . -101.36 -57.87 0.83 Allowed Glycine 0 CA--C 1.552 2.389 0 CA-C-O 117.803 -1.554 . . . . 0.0 114.836 -177.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.65 ' CB ' ' O ' ' A' ' 180' ' ' GLY . 36.5 ttmt . . . . . 0 C--O 1.251 1.157 0 CA-C-N 120.296 2.048 . . . . 0.0 107.579 -177.314 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.0 tpp . . . . . 0 CA--C 1.56 1.344 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.492 ' NH1' ' HA ' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -160.75 166.95 27.82 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 119.65 3.204 . . . . 0.0 119.65 -166.434 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.8 p -123.49 145.0 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 123.237 1.494 . . . . 0.0 113.462 -167.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.2 mt -120.85 114.12 21.13 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 112.123 -2.308 . . . . 0.0 106.27 172.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.3 tt -102.67 126.77 49.88 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.806 1.243 . . . . 0.0 111.014 -165.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.1 mt -139.29 164.23 30.39 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 114.527 -1.215 . . . . 0.0 112.431 -166.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 151.68 171.22 19.31 Favored Glycine 0 CA--C 1.558 2.752 0 CA-C-O 119.088 -0.84 . . . . 0.0 114.728 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.75 123.24 12.86 Favored 'Trans proline' 0 CA--C 1.573 2.47 0 C-N-CA 123.576 2.851 . . . . 0.0 113.013 170.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -81.45 104.44 1.49 Allowed 'Trans proline' 0 CA--C 1.56 1.775 0 C-N-CA 122.413 2.076 . . . . 0.0 114.911 -168.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -162.38 -93.43 0.09 OUTLIER Glycine 0 CA--C 1.534 1.233 0 N-CA-C 107.769 -2.132 . . . . 0.0 107.769 169.027 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.65 151.41 21.29 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 175.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.01 -168.86 35.91 Favored Glycine 0 CA--C 1.546 2.001 0 CA-C-N 115.729 -0.669 . . . . 0.0 114.556 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? 80.36 -82.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 174.622 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -48.01 -31.09 7.84 Favored Glycine 0 CA--C 1.556 2.618 0 N-CA-C 120.96 3.144 . . . . 0.0 120.96 175.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.3 m -66.45 -55.64 14.74 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 119.558 1.679 . . . . 0.0 113.136 176.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.273 10.9 mm-40 -76.86 -12.16 59.93 Favored 'General case' 0 CA--C 1.573 1.848 0 CA-C-O 116.235 -1.841 . . . . 0.0 111.858 172.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.33 -47.65 60.09 Favored 'General case' 0 C--N 1.372 1.554 0 CA-C-N 123.346 2.794 . . . . 0.0 114.387 167.695 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.5 t -66.95 -44.72 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 CA-C-O 117.742 -1.123 . . . . 0.0 111.201 173.346 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -59.33 -41.41 89.07 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 116.596 2.073 . . . . 0.0 116.596 171.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.7 tp -66.35 -33.71 76.33 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 119.721 1.146 . . . . 0.0 113.82 171.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.68 -39.03 89.96 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 167.702 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -63.03 -38.54 91.6 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 166.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 42.1 tptt -64.84 -53.87 39.94 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 175.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.6 mt -83.34 -27.19 29.89 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 116.956 2.206 . . . . 0.0 116.956 178.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.06 40.02 5.95 Favored Glycine 0 CA--C 1.555 2.569 0 N-CA-C 117.516 1.766 . . . . 0.0 117.516 -174.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.429 ' CG2' ' HA ' ' A' ' 81' ' ' PHE . 19.2 mm -110.06 160.34 28.56 Favored Pre-proline 0 CA--C 1.567 1.634 0 CA-C-N 118.853 1.326 . . . . 0.0 114.103 -168.28 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -74.37 103.53 1.71 Allowed 'Trans proline' 0 CA--C 1.565 2.027 0 C-N-CA 121.766 1.644 . . . . 0.0 112.776 159.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.3 tm0? -69.5 104.96 2.46 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 165.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 35.2 mm -100.83 107.68 21.7 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 177.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.0 t -95.59 129.92 42.62 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 168.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.4 p -67.17 -19.48 65.58 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 117.037 2.236 . . . . 0.0 117.037 -170.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -84.92 -16.49 65.21 Favored Glycine 0 CA--C 1.544 1.895 0 N-CA-C 119.079 2.392 . . . . 0.0 119.079 168.031 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -80.34 -55.62 4.77 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 119.529 1.664 . . . . 0.0 114.519 -168.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -59.36 -40.15 85.55 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 172.267 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.586 ' HB3' ' CB ' ' A' ' 50' ' ' LYS . 6.4 m-85 -60.44 -46.79 88.75 Favored 'General case' 0 CA--C 1.558 1.26 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 170.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -55.22 -42.28 73.17 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 168.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -59.94 -38.14 81.57 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 167.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -68.97 -23.62 64.14 Favored 'General case' 0 CA--C 1.581 2.168 0 N-CA-C 115.024 1.491 . . . . 0.0 115.024 167.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 53.9 mt -62.91 -49.6 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.522 0 CA-C-N 120.927 1.694 . . . . 0.0 109.871 166.303 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -60.85 -40.34 92.51 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 176.072 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -67.19 -41.76 85.32 Favored 'General case' 0 CA--C 1.562 1.427 0 N-CA-C 116.268 1.951 . . . . 0.0 116.268 173.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.77 70.0 0.99 Allowed Glycine 0 CA--C 1.544 1.872 0 CA-C-O 118.349 -1.25 . . . . 0.0 114.425 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.855 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 68.5 p -94.0 -50.79 5.15 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 118.837 1.319 . . . . 0.0 114.407 178.032 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.855 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.251 37.6 mttp 106.24 -41.42 0.0 OUTLIER 'General case' 0 CA--C 1.571 1.755 0 CA-C-O 116.428 -1.749 . . . . 0.0 111.514 -172.234 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.403 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.6 OUTLIER -81.98 -14.02 56.62 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 122.972 2.623 . . . . 0.0 113.013 163.682 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.23 -57.56 19.08 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 120.318 1.417 . . . . 0.0 114.494 170.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.304 4.2 p -75.52 -51.96 19.55 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.353 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -169.304 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -68.73 -44.07 74.58 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 120.703 1.592 . . . . 0.0 112.84 176.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 45' ' ' LEU . . . -73.74 -29.16 62.07 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 117.267 -1.349 . . . . 0.0 114.282 -178.01 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.586 ' CB ' ' HB3' ' A' ' 35' ' ' PHE 0.273 0.0 OUTLIER -77.77 -33.94 52.55 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 117.084 -1.436 . . . . 0.0 113.689 169.832 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.543 ' HG2' ' O ' ' A' ' 51' ' ' ARG . 29.1 ttt180 -76.06 -47.1 25.97 Favored 'General case' 0 CA--C 1.584 2.27 1 CA-C-O 84.928 -16.749 . . . . 0.0 118.477 -179.075 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -35.35 -56.71 0.62 Allowed 'General case' 0 N--CA 1.494 1.748 1 O-C-N 107.542 -9.474 . . . . 0.0 120.383 145.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 49.2 mt -54.33 -35.85 63.13 Favored 'General case' 0 N--CA 1.511 2.587 0 CA-C-N 123.869 3.031 . . . . 0.0 115.023 167.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -86.96 -42.17 13.35 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 116.139 1.904 . . . . 0.0 116.139 172.805 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.26 -42.79 54.24 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . 1.04 ' HA2' HH12 ' A' ' 88' ' ' ARG . . . 107.61 40.99 1.66 Allowed Glycine 0 CA--C 1.537 1.463 0 N-CA-C 116.466 1.346 . . . . 0.0 116.466 168.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -118.75 -164.53 1.04 Allowed 'General case' 0 CA--C 1.569 1.692 0 C-N-CA 124.052 0.941 . . . . 0.0 111.076 168.049 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.5 mt -80.22 108.16 13.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.342 -0.849 . . . . 0.0 112.257 -169.273 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 p -103.57 132.3 21.2 Favored Pre-proline 0 CA--C 1.571 1.761 0 C-N-CA 124.708 1.203 . . . . 0.0 110.002 175.108 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -60.18 145.87 97.56 Favored 'Trans proline' 0 CA--C 1.558 1.724 0 C-N-CA 123.367 2.711 . . . . 0.0 116.238 171.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 73.7 m -82.8 178.64 8.08 Favored 'General case' 0 CA--C 1.571 1.767 0 CA-C-O 121.623 0.725 . . . . 0.0 111.591 170.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.0 t70 83.05 -52.81 0.17 Allowed 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 125.926 1.691 . . . . 0.0 113.583 176.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.9 pp -57.85 -42.35 84.26 Favored 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 116.547 2.055 . . . . 0.0 116.547 168.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.0 m -59.34 -49.5 77.57 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 124.354 1.062 . . . . 0.0 113.651 171.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -64.73 -21.04 66.66 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 167.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -77.67 -44.35 28.33 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 173.538 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.6 mt -66.37 -44.66 82.54 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 169.564 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 56.1 t -56.5 -52.53 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.954 170.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -63.57 -28.35 69.87 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 116.615 2.08 . . . . 0.0 116.615 173.177 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -60.44 -42.0 95.18 Favored 'General case' 0 CA--C 1.563 1.46 0 CA-C-O 117.743 -1.123 . . . . 0.0 113.081 168.461 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -81.31 -21.41 39.27 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 119.044 2.979 . . . . 0.0 119.044 168.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 88.4 mt -84.71 -20.08 31.74 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 117.156 2.28 . . . . 0.0 117.156 176.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -70.0 9.02 0.61 Allowed 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 169.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -68.94 139.55 90.71 Favored Pre-proline 0 CA--C 1.575 1.906 0 CA-C-O 118.016 -0.992 . . . . 0.0 108.776 164.497 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -55.03 -33.04 81.87 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 N-CA-C 119.395 2.806 . . . . 0.0 119.395 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -66.92 -12.73 60.42 Favored 'General case' 0 CA--C 1.569 1.677 0 CA-C-O 116.517 -1.706 . . . . 0.0 115.47 170.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -107.11 18.87 21.18 Favored 'General case' 0 CA--C 1.574 1.896 0 CA-C-N 122.197 2.271 . . . . 0.0 114.437 168.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.57 -42.48 82.49 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 121.248 1.84 . . . . 0.0 115.16 174.416 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ASN . . . . . 0.492 ' HA ' ' NH1' ' A' ' 2' ' ' ARG . 25.3 m120 -111.02 38.01 2.65 Favored 'General case' 0 CA--C 1.58 2.101 0 C-N-CA 123.696 0.798 . . . . 0.0 111.504 168.878 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -172.32 160.23 31.51 Favored Glycine 0 C--N 1.364 2.127 0 CA-C-N 121.897 2.135 . . . . 0.0 114.493 169.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.429 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . 14.5 p90 -175.52 133.83 0.3 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 113.674 -1.263 . . . . 0.0 109.946 169.709 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.9 mm -102.45 106.21 19.49 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.736 0 N-CA-C 102.84 -3.022 . . . . 0.0 102.84 167.383 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.2 mt -103.22 134.5 46.53 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 123.728 0.811 . . . . 0.0 108.812 174.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -133.52 119.64 19.78 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 118.987 0.812 . . . . 0.0 111.099 -167.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 77.56 41.17 20.88 Favored Glycine 0 CA--C 1.55 2.223 0 CA-C-O 117.418 -1.768 . . . . 0.0 116.96 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . 0.275 0.9 OUTLIER -104.68 -66.84 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.833 0 CA-C-O 113.202 -3.285 . . . . 0.0 110.433 -175.375 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -63.13 60.38 0.17 Allowed 'Trans proline' 0 CA--C 1.57 2.311 0 CA-C-N 127.169 3.596 . . . . 0.0 121.212 170.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 1.04 HH12 ' HA2' ' A' ' 56' ' ' GLY . 16.4 ptt85 -62.79 -25.75 68.39 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 117.48 2.4 . . . . 0.0 117.48 167.129 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.467 ' HB2' ' HG3' ' A' ' 147' ' ' GLU . 77.9 p -151.18 138.99 19.83 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 125.824 1.65 . . . . 0.0 107.045 -167.369 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -55.95 -33.37 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-N 121.283 1.856 . . . . 0.0 113.462 172.82 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -61.92 -39.13 90.98 Favored 'General case' 0 C--N 1.362 1.115 0 N-CA-C 120.669 3.581 . . . . 0.0 120.669 172.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -74.87 -46.98 32.64 Favored 'General case' 0 CA--C 1.586 2.351 0 CA-C-N 123.51 2.868 . . . . 0.0 111.847 165.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.11 -29.96 68.95 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 118.412 2.745 . . . . 0.0 118.412 -175.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -58.65 -34.86 71.68 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 168.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.75 -42.71 90.6 Favored 'General case' 0 CA--C 1.566 1.592 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 170.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 26.6 tp -68.0 -33.93 75.56 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 171.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -63.12 -52.85 60.93 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 119.957 1.253 . . . . 0.0 112.816 169.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.982 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 35.6 mt-10 -47.05 -39.39 12.77 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 166.484 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.83 ' O ' ' HB2' ' A' ' 103' ' ' ARG . 1.7 tpt -83.12 -24.85 32.44 Favored 'General case' 0 CA--C 1.569 1.686 0 N-CA-C 117.756 2.502 . . . . 0.0 117.756 176.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.0 tt -73.8 -49.58 24.58 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-N 120.183 1.356 . . . . 0.0 111.68 171.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -74.78 -54.29 7.61 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 172.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.982 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 92.6 mtt180 -69.82 -40.23 76.04 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 177.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.83 ' HB2' ' O ' ' A' ' 99' ' ' MET . 6.9 ttt-85 -65.31 -53.6 41.54 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 119.831 1.196 . . . . 0.0 111.722 164.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 108.26 50.36 0.77 Allowed Glycine 0 N--CA 1.483 1.798 0 O-C-N 123.81 0.694 . . . . 0.0 114.096 167.475 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 68.5 p -88.96 146.2 25.04 Favored 'General case' 0 CA--C 1.558 1.285 0 CA-C-N 113.205 -1.498 . . . . 0.0 109.9 175.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -66.32 132.69 48.94 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.77 -0.581 . . . . 0.0 112.053 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 7.1 tp -95.26 100.74 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -175.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -94.27 -66.92 0.88 Allowed 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 117.074 -1.441 . . . . 0.0 108.847 168.109 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -153.91 123.11 6.49 Favored 'General case' 0 C--N 1.358 0.965 0 CA-C-N 120.605 1.548 . . . . 0.0 113.246 -169.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.3 t -91.8 109.07 20.8 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.583 0 N-CA-C 100.312 -3.958 . . . . 0.0 100.312 162.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.475 ' HA ' ' O ' ' A' ' 160' ' ' LYS 0.252 37.7 tp -112.97 104.07 12.03 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 114.957 -1.019 . . . . 0.0 112.369 -159.483 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -99.56 134.31 42.62 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-O 122.071 0.939 . . . . 0.0 110.987 -176.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -94.76 122.17 37.09 Favored 'General case' 0 CA--C 1.561 1.386 0 CA-C-O 122.903 1.335 . . . . 0.0 110.722 -173.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -85.62 95.05 9.22 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 113.018 -1.901 . . . . 0.0 109.637 169.319 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.1 p -133.92 132.34 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 125.725 1.61 . . . . 0.0 107.226 -169.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 44.3 t -80.23 147.12 31.37 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 114.465 -1.243 . . . . 0.0 112.432 -169.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -59.59 -27.6 66.43 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 116.895 2.183 . . . . 0.0 116.895 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -63.02 -42.37 99.79 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 171.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.6 t -63.57 -48.1 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 CA-C-N 120.311 1.414 . . . . 0.0 113.515 -177.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.0 pp -60.32 -37.61 81.13 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 169.746 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.0 mp -58.46 -41.62 85.58 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 167.168 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -56.35 -49.29 74.79 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 170.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 55.6 ttm-85 -55.13 -47.89 74.42 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 116.335 1.976 . . . . 0.0 116.335 171.426 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -59.49 -45.11 92.62 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 169.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -59.74 -38.92 83.06 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 117.423 2.379 . . . . 0.0 117.423 175.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.521 ' O ' ' HB2' ' A' ' 127' ' ' ARG . . . -80.65 24.3 3.82 Favored Glycine 0 CA--C 1.556 2.633 0 N-CA-C 118.639 2.215 . . . . 0.0 118.639 171.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.521 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 98.7 mtt180 80.59 -148.24 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 169.679 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.488 ' H ' ' HB3' ' A' ' 127' ' ' ARG . . . 154.85 -51.67 0.46 Allowed Glycine 0 CA--C 1.552 2.355 0 CA-C-N 112.972 -1.922 . . . . 0.0 113.807 -173.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -155.99 -101.57 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 119.562 1.681 . . . . 0.0 107.679 175.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -148.24 -45.07 0.16 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 116.99 -1.481 . . . . 0.0 112.529 170.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -136.28 61.49 1.64 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-N 121.868 2.122 . . . . 0.0 112.078 174.036 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -116.72 62.53 0.72 Allowed 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 102.5 -3.148 . . . . 0.0 102.5 158.681 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 82.6 p -138.29 -114.97 0.16 Allowed 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 113.916 -1.493 . . . . 0.0 110.183 -160.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -59.24 -43.14 92.4 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 116.695 2.109 . . . . 0.0 116.695 -169.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -73.63 -38.27 65.09 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 177.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 20.4 t -64.25 -39.87 87.06 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.508 0 CA-C-O 117.317 -1.325 . . . . 0.0 112.124 170.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 8.3 tp -75.32 -25.6 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 CA-C-N 120.463 1.483 . . . . 0.0 114.333 173.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 30.0 mt -67.63 -46.67 71.8 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 120.92 1.691 . . . . 0.0 113.676 169.115 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -68.99 -34.55 75.47 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 172.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 69.2 mtp180 -60.43 -40.66 91.88 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 167.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 25.8 ttt -65.7 -32.68 74.37 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 168.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -60.25 -50.04 75.22 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 169.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.0 p -65.57 -32.97 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 169.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -55.52 -53.44 56.37 Favored 'General case' 0 CA--C 1.58 2.112 0 CA-C-N 119.495 1.043 . . . . 0.0 111.716 169.567 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -62.96 -42.09 99.72 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 118.063 2.616 . . . . 0.0 118.063 175.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.26 -44.53 61.8 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 116.975 2.213 . . . . 0.0 116.975 174.961 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.467 ' HG3' ' HB2' ' A' ' 89' ' ' SER . 8.9 mm-40 -124.08 -30.43 3.48 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 118.54 2.792 . . . . 0.0 118.54 -166.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 63.7 m -55.07 -34.86 63.95 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 117.387 2.365 . . . . 0.0 117.387 -167.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -65.15 -60.4 7.98 Favored Pre-proline 0 CA--C 1.579 2.085 0 CA-C-O 116.305 -1.807 . . . . 0.0 111.751 171.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -51.59 -32.24 43.48 Favored 'Trans proline' 0 CA--C 1.579 2.754 0 C-N-CA 123.394 2.729 . . . . 0.0 118.549 166.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -66.77 -51.94 50.02 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 125.083 1.353 . . . . 0.0 111.305 175.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 1.215 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 38.2 tp -62.43 -22.04 65.87 Favored 'General case' 0 CA--C 1.571 1.752 0 N-CA-C 115.718 1.747 . . . . 0.0 115.718 170.65 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -70.82 -50.2 38.08 Favored 'General case' 0 CA--C 1.56 1.332 0 CA-C-N 122.681 2.491 . . . . 0.0 112.463 165.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -61.13 -56.48 20.37 Favored 'General case' 0 CA--C 1.574 1.895 0 CA-C-N 119.931 1.241 . . . . 0.0 113.488 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -77.75 -15.16 59.32 Favored 'General case' 0 CA--C 1.562 1.429 0 CA-C-O 116.647 -1.644 . . . . 0.0 114.268 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 1.215 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 0.1 OUTLIER -68.85 -40.3 79.46 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 121.723 2.056 . . . . 0.0 114.871 166.023 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -65.76 -38.97 90.54 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 167.424 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -75.47 -18.94 59.72 Favored 'General case' 0 CA--C 1.585 2.305 0 N-CA-C 118.386 2.735 . . . . 0.0 118.386 169.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.7 mt -39.26 143.04 0.21 Allowed 'General case' 0 CA--C 1.58 2.101 1 N-CA-C 123.741 4.719 . . . . 0.0 123.741 -164.191 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 111' ' ' LEU . 28.4 mttm -136.08 121.74 19.65 Favored 'General case' 0 CA--C 1.56 1.332 0 N-CA-C 103.435 -2.802 . . . . 0.0 103.435 160.187 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.0 t -103.76 156.42 17.83 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.531 -1.356 . . . . 0.0 113.126 -172.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 34.7 t -124.35 142.47 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 169.517 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -98.76 127.71 44.77 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 165.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.74 92.67 1.68 Allowed 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 122.68 1.229 . . . . 0.0 112.155 -163.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.2 t -150.7 125.73 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 CA-C-N 113.927 -1.488 . . . . 0.0 107.178 -175.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 79.01 -72.46 2.46 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 118.349 2.1 . . . . 0.0 118.349 168.337 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 40.8 p -79.09 144.14 34.86 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 112.124 -2.038 . . . . 0.0 112.371 -169.092 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.98 -46.22 6.29 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 178.181 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -72.73 -42.02 64.54 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 177.906 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -62.56 -49.98 73.14 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 117.855 -1.069 . . . . 0.0 113.602 170.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 97.7 t -60.41 -36.05 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 CA-C-N 120.029 1.286 . . . . 0.0 114.014 177.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -59.31 -38.21 79.68 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 166.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.07 -44.62 91.85 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 174.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -62.7 -40.6 97.66 Favored 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 116.512 2.042 . . . . 0.0 116.512 170.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.68 -42.98 94.12 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 169.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 4.9 mp -59.61 -42.61 93.0 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 167.718 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.57 ' HA ' ' HB3' ' A' ' 181' ' ' LYS . 45.1 mtt180 -55.41 -42.18 73.76 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 116.827 2.158 . . . . 0.0 116.827 169.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.91 -48.18 80.05 Favored 'General case' 0 CA--C 1.561 1.386 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 170.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.7 tt -83.08 -57.49 3.26 Favored 'General case' 0 CA--C 1.567 1.596 0 CA-C-N 120.778 1.627 . . . . 0.0 113.117 -178.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -104.6 -52.4 0.86 Allowed Glycine 0 CA--C 1.547 2.073 0 CA-C-O 117.456 -1.747 . . . . 0.0 114.64 -173.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.57 ' HB3' ' HA ' ' A' ' 177' ' ' ARG . 86.4 tttt . . . . . 0 C--O 1.251 1.184 0 CA-C-N 120.564 2.182 . . . . 0.0 112.735 -176.149 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.0 mtt . . . . . 0 CA--C 1.558 1.283 0 CA-C-O 123.095 1.426 . . . . 0.0 111.652 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.5 ttm-85 -141.39 149.46 41.12 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 116.736 2.125 . . . . 0.0 116.736 -161.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.7 p -143.84 146.16 21.25 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.861 0 CA-C-O 123.793 1.759 . . . . 0.0 114.797 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -131.86 111.57 11.7 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 112.417 -2.174 . . . . 0.0 108.009 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 14.5 tp -98.32 131.46 44.61 Favored 'General case' 0 CA--C 1.571 1.75 0 CA-C-O 122.706 1.241 . . . . 0.0 112.314 -167.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.7 mt -138.99 163.19 33.02 Favored 'General case' 0 CA--C 1.563 1.454 0 C-N-CA 127.607 2.363 . . . . 0.0 110.782 -166.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 141.89 129.22 2.41 Favored Glycine 0 CA--C 1.553 2.439 0 CA-C-O 116.975 -2.014 . . . . 0.0 111.657 -174.348 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -51.42 143.59 34.53 Favored 'Trans proline' 0 CA--C 1.573 2.429 0 CA-C-N 122.838 3.319 . . . . 0.0 116.024 172.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -54.45 106.81 0.18 Allowed 'Trans proline' 0 CA--C 1.56 1.796 0 C-N-CA 123.471 2.781 . . . . 0.0 116.75 -169.802 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.72 73.76 0.08 OUTLIER Glycine 0 N--CA 1.479 1.545 0 CA-C-O 119.65 -0.528 . . . . 0.0 114.393 -169.455 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 39.88 76.59 0.06 Allowed 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 117.468 2.396 . . . . 0.0 117.468 170.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.461 ' O ' ' HG3' ' A' ' 13' ' ' LYS . . . 156.28 107.54 0.27 Allowed Glycine 0 N--CA 1.479 1.536 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -176.214 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 12' ' ' GLY . 19.7 mttt 164.44 -92.29 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.851 0.325 . . . . 0.0 110.351 -172.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -50.81 -41.21 43.47 Favored Glycine 0 CA--C 1.558 2.72 0 N-CA-C 119.01 2.364 . . . . 0.0 119.01 175.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.5 m -58.82 -44.29 90.83 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 169.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLN . . . . . 0.569 ' HA ' ' HB2' ' A' ' 19' ' ' LYS 0.264 5.1 mm-40 -78.98 -14.05 59.43 Favored 'General case' 0 CA--C 1.576 1.958 0 CA-C-O 116.571 -1.68 . . . . 0.0 112.32 173.536 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.68 -45.22 62.58 Favored 'General case' 0 C--N 1.371 1.531 0 CA-C-N 123.062 2.665 . . . . 0.0 113.597 167.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 p -65.15 -41.53 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 169.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.679 ' HB3' ' CE1' ' A' ' 172' ' ' PHE . 31.1 mmtp -54.72 -42.13 71.16 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 116.11 1.892 . . . . 0.0 116.11 168.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 1.09 ' HA ' ' HB3' ' A' ' 23' ' ' LYS . 22.0 mt -68.67 -30.87 69.65 Favored 'General case' 0 CA--C 1.595 2.676 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 168.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.12 -29.58 70.7 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 118.394 -2.692 . . . . 0.0 115.707 167.723 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -64.06 -51.44 64.09 Favored 'General case' 0 CA--C 1.596 2.726 0 CA-C-N 120.324 1.42 . . . . 0.0 110.899 156.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 1.09 ' HB3' ' HA ' ' A' ' 20' ' ' LEU 0.29 4.5 tppt? -53.26 51.93 0.0 OUTLIER 'General case' 0 CA--C 1.576 1.944 2 C-N-CA 133.45 4.7 . . . . 0.0 122.424 166.647 . . . . . . . . 4 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.709 HD13 HD11 ' A' ' 26' ' ' ILE . 0.2 OUTLIER 67.84 25.19 7.94 Favored 'General case' 0 N--CA 1.522 3.13 2 C-N-CA 144.854 9.262 . . . . 0.0 134.891 -152.331 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.44 29.98 28.73 Favored Glycine 0 N--CA 1.506 3.323 0 O-C-N 117.458 -3.276 . . . . 0.0 120.468 157.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.709 HD11 HD13 ' A' ' 24' ' ' LEU . 25.6 mm -90.25 149.23 40.88 Favored Pre-proline 0 CA--C 1.556 1.178 0 CA-C-N 112.381 -1.91 . . . . 0.0 110.969 -168.172 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -77.7 91.66 1.17 Allowed 'Trans proline' 0 CA--C 1.561 1.86 0 CA-C-N 122.082 1.779 . . . . 0.0 111.497 168.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.13 108.85 3.28 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.576 175.154 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 22.5 mm -105.65 114.94 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 82.8 p -96.25 132.36 41.78 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 169.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.7 p -68.37 -16.55 63.97 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 117.136 2.272 . . . . 0.0 117.136 -173.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -84.67 -19.83 59.24 Favored Glycine 0 CA--C 1.547 2.053 0 N-CA-C 118.736 2.254 . . . . 0.0 118.736 167.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -81.13 -49.67 10.56 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -169.174 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -65.4 -39.49 92.27 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 173.886 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.712 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 32.8 m-85 -64.59 -40.98 96.49 Favored 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 115.027 1.492 . . . . 0.0 115.027 169.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -57.28 -41.81 80.44 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 167.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.3 ttt180 -61.62 -37.98 85.97 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 168.89 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -68.09 -30.2 69.33 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 168.307 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 64.9 mt -62.75 -44.74 99.73 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 C-N-CA 124.893 1.277 . . . . 0.0 112.085 168.38 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -65.05 -42.09 94.58 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 173.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -76.31 -30.93 57.92 Favored 'General case' 0 CA--C 1.563 1.448 0 N-CA-C 116.784 2.142 . . . . 0.0 116.784 178.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.38 71.99 1.28 Allowed Glycine 0 CA--C 1.543 1.833 0 CA-C-O 118.083 -1.399 . . . . 0.0 115.282 178.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.847 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 70.8 p -93.69 -47.77 6.64 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 119.036 1.418 . . . . 0.0 114.571 174.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.847 ' HB2' ' O ' ' A' ' 43' ' ' THR . 74.8 mttt 103.62 -40.53 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.754 0 CA-C-O 116.247 -1.835 . . . . 0.0 111.527 -171.316 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.05 -12.33 58.33 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 123.053 2.66 . . . . 0.0 112.752 163.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.95 -56.07 23.0 Favored Glycine 0 C--N 1.353 1.525 0 CA-C-N 120.852 1.66 . . . . 0.0 114.743 170.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.286 7.1 p -74.57 -50.09 27.94 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.416 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 -169.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -66.49 -44.54 82.35 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 120.303 1.41 . . . . 0.0 112.691 174.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.34 -29.41 63.78 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 114.976 1.472 . . . . 0.0 114.976 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.712 ' HB2' ' HB3' ' A' ' 35' ' ' PHE 0.294 0.6 OUTLIER -75.34 -35.15 61.23 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 116.717 -1.611 . . . . 0.0 112.08 168.011 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.487 ' O ' ' CG ' ' A' ' 51' ' ' ARG . 18.8 ttt180 -74.2 -52.82 11.28 Favored 'General case' 0 CA--C 1.591 2.557 1 CA-C-O 87.026 -15.749 . . . . 0.0 118.197 -176.447 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 12.6 m-30 -26.28 -69.12 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.975 1 O-C-N 109.59 -8.193 . . . . 0.0 119.146 144.03 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 29.5 tp -54.12 -33.44 57.81 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 116.429 2.011 . . . . 0.0 116.429 175.253 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -91.56 -44.13 9.25 Favored 'General case' 0 CA--C 1.564 1.499 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 169.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -155.21 44.41 0.48 Allowed 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -166.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.54 50.44 0.32 Allowed Glycine 0 C--N 1.355 1.599 0 CA-C-N 121.628 2.013 . . . . 0.0 114.636 169.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . 0.294 5.6 t70 72.49 -112.94 0.05 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.608 1.163 . . . . 0.0 110.4 167.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.6 pp -105.8 144.35 32.66 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 122.691 1.234 . . . . 0.0 113.232 -169.512 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 p -129.76 140.27 38.13 Favored Pre-proline 0 CA--C 1.575 1.93 0 CA-C-N 113.307 -1.769 . . . . 0.0 109.139 -177.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -55.87 136.96 77.21 Favored 'Trans proline' 0 CA--C 1.56 1.805 0 C-N-CA 123.629 2.886 . . . . 0.0 116.679 173.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 98.6 p -72.42 -48.6 39.94 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 -178.32 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -62.38 -38.74 90.76 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 -178.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 17.3 mt -58.79 -48.2 82.09 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 172.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.0 m -61.36 -48.14 82.65 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 113.647 -1.615 . . . . 0.0 113.312 176.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -65.22 -22.04 66.83 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 168.518 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -73.03 -42.95 62.61 Favored 'General case' 0 CA--C 1.557 1.242 0 CA-C-N 120.975 1.716 . . . . 0.0 115.443 169.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.7 mt -61.31 -47.24 86.85 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 168.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -57.35 -49.87 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 172.393 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -60.71 -37.67 82.49 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 171.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -56.87 -43.78 81.56 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 117.818 -1.087 . . . . 0.0 113.643 170.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -81.4 -10.4 59.53 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 118.891 2.923 . . . . 0.0 118.891 168.038 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 87.7 mt -94.27 -8.71 38.32 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 116.669 2.1 . . . . 0.0 116.669 171.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -66.06 8.07 0.24 Allowed 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 117.863 2.542 . . . . 0.0 117.863 172.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -71.56 143.74 87.91 Favored Pre-proline 0 CA--C 1.579 2.078 0 C-N-CA 124.511 1.124 . . . . 0.0 109.357 164.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -56.6 -27.56 70.34 Favored 'Trans proline' 0 N--CA 1.504 2.113 0 N-CA-C 120.537 3.245 . . . . 0.0 120.537 176.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -63.71 -14.2 50.15 Favored 'General case' 0 CA--C 1.579 2.071 0 CA-C-O 116.689 -1.624 . . . . 0.0 114.739 169.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.45 -20.38 61.41 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 122.804 2.547 . . . . 0.0 115.954 168.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.66 -38.38 87.52 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 169.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -86.12 -7.05 58.86 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 117.281 2.326 . . . . 0.0 117.281 172.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.35 -178.38 43.74 Favored Glycine 0 CA--C 1.539 1.593 0 CA-C-N 121.406 1.912 . . . . 0.0 113.944 -175.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.4 p90 179.58 142.0 0.13 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 112.948 -1.626 . . . . 0.0 108.145 169.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 9.8 mt -110.11 108.79 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 103.301 -2.852 . . . . 0.0 103.301 169.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 44.6 mt -110.7 120.59 42.89 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 173.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -111.45 128.16 55.91 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 118.917 0.78 . . . . 0.0 110.779 -175.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 75.12 34.47 51.9 Favored Glycine 0 CA--C 1.553 2.413 0 N-CA-C 118.901 2.32 . . . . 0.0 118.901 176.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . 0.254 0.8 OUTLIER -93.37 -62.62 0.17 Allowed Pre-proline 0 CA--C 1.571 1.775 0 CA-C-O 114.126 -2.845 . . . . 0.0 109.538 175.519 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -63.6 56.99 0.19 Allowed 'Trans proline' 0 CA--C 1.57 2.309 0 N-CA-C 121.129 3.473 . . . . 0.0 121.129 169.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.25 -5.04 50.75 Favored 'General case' 0 CA--C 1.57 1.75 0 N-CA-C 117.057 2.243 . . . . 0.0 117.057 168.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.6 t -161.22 139.9 9.87 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 -171.513 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -58.33 -37.84 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-N 120.157 1.344 . . . . 0.0 112.778 -178.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.467 ' HB2' ' OE2' ' A' ' 147' ' ' GLU . 0.1 OUTLIER -65.6 -30.83 71.61 Favored 'General case' 0 C--N 1.36 1.035 0 N-CA-C 119.68 3.215 . . . . 0.0 119.68 175.825 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -80.43 -44.79 18.7 Favored 'General case' 0 CA--C 1.585 2.316 0 CA-C-N 122.008 2.185 . . . . 0.0 112.497 166.257 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.16 -35.0 72.75 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 118.428 2.751 . . . . 0.0 118.428 -176.876 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -58.66 -30.63 67.49 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 116.523 2.045 . . . . 0.0 116.523 169.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.51 -43.41 69.71 Favored 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 169.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.4 tp -67.89 -35.75 79.05 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 171.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 -58.58 -54.3 48.66 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 119.672 1.124 . . . . 0.0 112.809 168.66 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 1.136 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 32.3 tt0 -49.55 -32.81 13.28 Favored 'General case' 0 CA--C 1.575 1.906 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 166.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' MET . . . . . 1.097 ' O ' ' HB2' ' A' ' 103' ' ' ARG . 1.8 tpt -83.98 -40.54 18.33 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 117.619 2.452 . . . . 0.0 117.619 178.111 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.23 -45.21 61.2 Favored 'General case' 0 N--CA 1.505 2.317 0 CA-C-N 120.559 1.527 . . . . 0.0 112.504 172.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -76.93 -49.14 16.25 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 174.2 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 1.136 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 72.7 ttt180 -69.61 -43.57 72.46 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 177.001 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 1.097 ' HB2' ' O ' ' A' ' 99' ' ' MET . 42.5 mtp180 -63.88 -56.32 16.18 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 119.009 0.822 . . . . 0.0 111.895 165.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.02 48.75 0.76 Allowed Glycine 0 N--CA 1.48 1.592 0 O-C-N 124.049 0.843 . . . . 0.0 113.554 169.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 82.3 p -82.47 160.09 22.76 Favored 'General case' 0 CA--C 1.562 1.436 0 CA-C-N 113.909 -1.145 . . . . 0.0 110.019 169.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -69.38 128.16 35.58 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.827 -1.17 . . . . 0.0 110.356 -172.671 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 4.6 tp -94.57 93.56 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -177.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -98.44 -70.95 0.71 Allowed 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 116.043 -1.932 . . . . 0.0 109.176 168.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -151.83 133.93 15.09 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 121.698 2.044 . . . . 0.0 116.102 -168.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -92.35 122.08 43.5 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.163 0 N-CA-C 100.306 -3.961 . . . . 0.0 100.306 160.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.475 ' HA ' ' O ' ' A' ' 160' ' ' LYS . 44.0 mt -96.91 109.93 22.55 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 115.526 -2.178 . . . . 0.0 110.429 -176.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.501 ' HB2' HD22 ' A' ' 159' ' ' LEU . 9.5 tm-20 -101.46 113.75 27.14 Favored 'General case' 0 N--CA 1.536 3.831 0 N-CA-C 120.573 3.546 . . . . 0.0 120.573 170.095 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -86.04 114.63 23.07 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 119.268 -2.145 . . . . 0.0 110.815 170.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.449 ' O ' HG23 ' A' ' 115' ' ' VAL . 79.4 ttt180 -106.18 110.26 22.45 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.39 169.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 114' ' ' ARG 0.333 1.0 OUTLIER -179.0 146.41 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.332 0 CA-C-O 124.075 1.893 . . . . 0.0 108.836 160.021 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . 0.374 75.1 m 56.5 -79.98 0.01 OUTLIER 'General case' 0 CA--C 1.568 1.673 1 N-CA-C 123.223 4.527 . . . . 0.0 123.223 174.391 . . . . . . . . 3 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 78.02 -34.55 0.19 Allowed 'General case' 0 CA--C 1.566 1.563 0 C-N-CA 126.684 1.994 . . . . 0.0 116.019 -166.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -63.37 -31.43 72.58 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 115.359 1.614 . . . . 0.0 115.359 176.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.5 t -52.61 -50.68 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 C-N-CA 125.231 1.413 . . . . 0.0 114.398 173.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 39.8 tp -64.9 -38.75 92.0 Favored 'General case' 0 CA--C 1.561 1.384 0 C-N-CA 124.179 0.991 . . . . 0.0 113.658 168.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 46.8 mt -57.86 -34.23 69.52 Favored 'General case' 0 N--CA 1.508 2.444 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 168.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -63.81 -49.79 71.52 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 124.526 1.131 . . . . 0.0 113.825 168.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 -51.64 -53.44 38.67 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 170.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.0 mt -56.42 -45.67 80.58 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 115.927 1.825 . . . . 0.0 115.927 170.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -60.96 -44.24 97.6 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 117.318 2.34 . . . . 0.0 117.318 175.302 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.737 ' O ' ' HB2' ' A' ' 127' ' ' ARG . . . -95.9 57.74 1.53 Allowed Glycine 0 CA--C 1.544 1.899 0 CA-C-N 118.473 0.579 . . . . 0.0 113.874 170.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.737 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 89.6 mtt180 92.71 91.58 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.582 0.753 . . . . 0.0 111.768 175.274 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -97.05 -57.24 1.09 Allowed Glycine 0 CA--C 1.55 2.27 0 CA-C-O 117.452 -1.749 . . . . 0.0 114.489 176.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 48.9 mtm180 -156.23 -118.11 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 120.36 2.08 . . . . 0.0 109.568 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -145.79 62.37 1.26 Allowed 'General case' 0 CA--C 1.574 1.896 0 C-N-CA 123.715 0.806 . . . . 0.0 109.935 -174.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 65.49 2.43 2.01 Favored 'General case' 0 N--CA 1.511 2.59 0 N-CA-C 119.27 3.063 . . . . 0.0 119.27 -176.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -92.05 62.73 4.27 Favored 'General case' 0 CA--C 1.581 2.139 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 159.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 80.8 p -135.26 -110.08 0.21 Allowed 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 114.33 -1.305 . . . . 0.0 110.722 -162.381 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -53.2 -41.35 65.2 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 117.028 2.233 . . . . 0.0 117.028 -170.571 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -67.6 -40.06 84.75 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 172.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.715 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 17.0 t -63.85 -31.14 51.99 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.816 0 C-N-CA 125.317 1.447 . . . . 0.0 114.395 168.779 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.635 ' O ' ' HB3' ' A' ' 140' ' ' ARG . 1.7 mp -71.6 -38.39 67.03 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.998 0 C-N-CA 124.536 1.134 . . . . 0.0 112.337 169.034 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 37.1 mt -64.55 -50.91 65.45 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 120.535 1.516 . . . . 0.0 113.434 173.297 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -65.54 -27.61 68.57 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 168.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.715 ' HB2' ' O ' ' A' ' 136' ' ' VAL . 14.6 tpt180 -53.01 -48.46 67.53 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 125.231 1.412 . . . . 0.0 114.606 164.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 67.1 mtt -63.6 -35.52 80.8 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 168.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -60.75 -49.21 78.4 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 116.523 2.045 . . . . 0.0 116.523 169.483 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.4 p -64.45 -38.72 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 173.648 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -54.65 -48.48 72.28 Favored 'General case' 0 CA--C 1.579 2.063 0 C-N-CA 123.958 0.903 . . . . 0.0 112.604 167.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -56.26 -34.79 66.73 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 119.333 3.086 . . . . 0.0 119.333 174.119 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.65 -45.91 88.3 Favored 'General case' 0 N--CA 1.504 2.274 0 CA-C-N 120.44 1.473 . . . . 0.0 113.958 178.384 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' GLU . . . . . 0.467 ' OE2' ' HB2' ' A' ' 91' ' ' GLU . 22.2 mt-10 -142.22 -4.76 1.01 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 120.952 3.686 . . . . 0.0 120.952 -166.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 38.0 m -69.12 -30.01 68.19 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 -171.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -63.76 -56.45 25.46 Favored Pre-proline 0 CA--C 1.579 2.086 0 CA-C-O 116.209 -1.853 . . . . 0.0 111.555 169.026 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -53.33 -32.88 63.45 Favored 'Trans proline' 0 CA--C 1.577 2.659 0 C-N-CA 123.454 2.769 . . . . 0.0 118.745 167.431 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -62.85 -53.96 46.16 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.877 1.271 . . . . 0.0 110.83 172.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 1.2 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 45.1 tp -60.99 -20.71 62.76 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 171.223 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -71.34 -51.58 23.47 Favored 'General case' 0 CA--C 1.562 1.42 0 CA-C-N 122.744 2.52 . . . . 0.0 113.251 164.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -63.04 -55.57 24.44 Favored 'General case' 0 CA--C 1.57 1.726 0 CA-C-N 120.559 1.527 . . . . 0.0 112.855 178.275 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -72.2 -31.88 66.28 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-O 114.591 -2.623 . . . . 0.0 112.106 177.821 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 1.2 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 36.7 ttt180 -59.32 -34.92 72.92 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 124.949 3.522 . . . . 0.0 116.864 169.544 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -66.32 -37.53 85.59 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 166.765 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -83.41 -39.99 19.9 Favored 'General case' 0 CA--C 1.581 2.16 0 N-CA-C 118.991 2.959 . . . . 0.0 118.991 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' LEU . . . . . 0.501 HD22 ' HB2' ' A' ' 112' ' ' GLU . 2.0 pp -81.48 179.26 7.92 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 120.47 3.508 . . . . 0.0 120.47 -161.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 111' ' ' LEU 0.272 83.6 tttt -154.09 103.9 2.59 Favored 'General case' 0 C--N 1.361 1.08 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 166.018 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.465 ' HB ' ' N ' ' A' ' 112' ' ' GLU 1.149 24.3 m -124.44 -151.06 0.46 Allowed 'General case' 0 CA--C 1.568 1.673 1 O-C-N 114.839 -4.913 . . . . 0.0 108.339 149.507 . . . . . . . . 4 3 . 1 . 014 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . 0.388 2.5 t -121.39 176.49 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 CA-C-O 125.008 2.337 . . . . 0.0 113.731 -150.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -101.33 116.07 31.96 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 101.504 -3.517 . . . . 0.0 101.504 164.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ALA . . . . . 0.408 ' HB3' ' HB ' ' A' ' 115' ' ' VAL 0.346 . . -103.9 -120.39 0.2 Allowed 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 120.865 3.654 . . . . 0.0 120.865 -147.659 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.7 t -29.01 91.07 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.666 0 N-CA-C 118.99 2.959 . . . . 0.0 118.99 -156.07 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -110.1 63.79 0.27 Allowed Glycine 0 C--N 1.355 1.634 0 CA-C-O 121.879 0.711 . . . . 0.0 113.551 164.554 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 62.0 p 41.11 64.57 0.97 Allowed 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 178.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . 0.253 58.2 mtt 80.57 -64.48 0.18 Allowed 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 125.774 1.63 . . . . 0.0 114.081 171.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -71.8 -41.61 68.07 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 115.833 1.79 . . . . 0.0 115.833 -172.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -62.73 -52.55 62.81 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 173.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -54.11 -38.57 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 173.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.679 ' CE1' ' HB3' ' A' ' 19' ' ' LYS . 5.8 t80 -60.74 -38.67 85.95 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 168.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -61.13 -54.14 48.25 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 174.892 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 55.9 mtt180 -62.31 -37.67 86.48 Favored 'General case' 0 CA--C 1.555 1.136 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 173.724 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.66 -45.31 85.72 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 115.761 1.763 . . . . 0.0 115.761 168.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.35 -40.83 87.64 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 168.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 40.6 mmt180 -71.8 -32.73 67.9 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 174.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.53 -48.39 75.25 Favored 'General case' 0 CA--C 1.561 1.378 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 170.21 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 65.9 tp -71.31 -42.57 68.45 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 119.859 1.209 . . . . 0.0 113.836 168.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.736 ' O ' ' CB ' ' A' ' 181' ' ' LYS . . . 97.47 52.61 1.42 Allowed Glycine 0 CA--C 1.554 2.491 0 CA-C-O 118.634 -1.092 . . . . 0.0 113.12 -169.152 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.736 ' CB ' ' O ' ' A' ' 180' ' ' GLY . 56.3 tttp . . . . . 0 C--O 1.251 1.135 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -170.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.2 mtt . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -158.96 166.45 31.76 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 117.416 2.376 . . . . 0.0 117.416 -167.909 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 51.6 t -132.06 150.59 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-O 123.924 1.821 . . . . 0.0 112.939 -164.479 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -130.4 115.9 17.52 Favored 'General case' 0 CA--C 1.559 1.317 0 CA-C-N 112.387 -2.188 . . . . 0.0 108.221 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.758 HD21 ' HB3' ' A' ' 13' ' ' LYS . 22.9 tp -96.91 127.5 42.95 Favored 'General case' 0 CA--C 1.567 1.629 0 CA-C-O 122.873 1.321 . . . . 0.0 110.314 -173.216 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.4 mt -122.28 148.9 44.45 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 112.048 -2.342 . . . . 0.0 111.658 -169.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 163.33 151.36 6.4 Favored Glycine 0 CA--C 1.558 2.754 0 CA-C-O 118.128 -1.373 . . . . 0.0 115.684 169.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -55.75 155.04 23.57 Favored 'Trans proline' 0 CA--C 1.575 2.544 0 C-N-CA 123.792 2.995 . . . . 0.0 117.542 174.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -81.79 97.11 0.92 Allowed 'Trans proline' 0 CA--C 1.562 1.922 0 C-N-CA 122.828 2.352 . . . . 0.0 115.024 -169.469 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -168.17 -86.1 0.06 OUTLIER Glycine 0 N--CA 1.476 1.328 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 172.45 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.76 149.81 45.98 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 115.042 1.497 . . . . 0.0 115.042 179.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.29 148.02 29.22 Favored Glycine 0 CA--C 1.548 2.096 0 N-CA-C 117.254 1.662 . . . . 0.0 117.254 -168.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.758 ' HB3' HD21 ' A' ' 5' ' ' LEU . 13.6 mptt -119.8 -33.68 3.94 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 124.626 1.171 . . . . 0.0 114.063 176.451 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -51.66 -23.5 10.26 Favored Glycine 0 CA--C 1.553 2.457 0 N-CA-C 121.045 3.178 . . . . 0.0 121.045 177.604 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 65.1 m -66.83 -54.06 26.3 Favored 'General case' 0 CA--C 1.57 1.741 0 CA-C-N 120.119 1.96 . . . . 0.0 112.276 173.136 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.28 4.0 mm-40 -79.43 -14.39 58.95 Favored 'General case' 0 CA--C 1.579 2.083 0 CA-C-O 116.018 -1.944 . . . . 0.0 111.593 174.778 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.52 -43.18 63.92 Favored 'General case' 0 C--N 1.377 1.772 0 CA-C-N 123.75 2.977 . . . . 0.0 114.585 167.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.1 t -64.37 -41.92 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 CA-C-O 117.525 -1.226 . . . . 0.0 112.322 170.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.729 ' HB3' ' CE1' ' A' ' 172' ' ' PHE . 64.1 mmtt -65.45 -40.62 93.45 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 116.326 1.973 . . . . 0.0 116.326 171.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.6 tp -67.34 -34.67 77.81 Favored 'General case' 0 CA--C 1.572 1.824 0 CA-C-N 120.031 1.287 . . . . 0.0 113.522 173.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.02 94.14 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 166.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -56.58 -38.68 72.31 Favored 'General case' 0 CA--C 1.567 1.624 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 166.412 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -69.23 -53.78 18.1 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 120.306 1.412 . . . . 0.0 114.663 173.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.4 mt -84.4 -23.52 30.02 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 117.187 2.292 . . . . 0.0 117.187 -174.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.83 36.49 7.78 Favored Glycine 0 CA--C 1.555 2.555 0 N-CA-C 117.744 1.858 . . . . 0.0 117.744 -174.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.5 mm -104.46 153.67 38.94 Favored Pre-proline 0 CA--C 1.57 1.719 0 CA-C-N 118.899 1.349 . . . . 0.0 112.487 -169.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -82.65 98.13 0.88 Allowed 'Trans proline' 0 CA--C 1.566 2.118 0 CA-C-N 122.222 1.829 . . . . 0.0 109.586 163.383 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.01 114.82 12.76 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.811 0.815 . . . . 0.0 110.266 176.179 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 25.1 mm -101.99 112.32 34.75 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.6 t -95.08 134.59 37.61 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 170.447 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.0 p -68.97 -18.32 64.05 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 117.019 2.229 . . . . 0.0 117.019 -174.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -81.5 -21.23 62.52 Favored Glycine 0 CA--C 1.545 1.919 0 N-CA-C 118.619 2.207 . . . . 0.0 118.619 167.393 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -80.47 -51.75 8.44 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -169.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -63.61 -39.57 94.7 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 174.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.417 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 12.5 m-85 -70.28 -39.51 74.87 Favored 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 172.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 47.0 ttp180 -58.97 -40.64 85.39 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 120.182 1.355 . . . . 0.0 114.301 167.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -62.51 -39.46 93.59 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 169.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -68.53 -26.56 65.5 Favored 'General case' 0 CA--C 1.578 2.026 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 168.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 88.1 mt -63.89 -45.38 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 CA-C-N 120.267 1.394 . . . . 0.0 111.063 166.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -62.59 -40.86 98.24 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 173.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -64.64 -45.31 87.35 Favored 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 173.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.64 68.46 0.94 Allowed Glycine 0 CA--C 1.541 1.668 0 CA-C-O 118.452 -1.193 . . . . 0.0 113.555 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.807 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 63.9 p -97.48 -41.87 7.98 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -177.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.807 ' HB2' ' O ' ' A' ' 43' ' ' THR . 76.6 mttt 97.67 -38.75 0.01 OUTLIER 'General case' 0 CA--C 1.573 1.863 0 CA-C-O 116.904 -1.522 . . . . 0.0 111.869 -170.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.02 -18.66 55.62 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 122.246 2.293 . . . . 0.0 113.42 163.497 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.72 -53.4 46.25 Favored Glycine 0 C--N 1.356 1.657 0 CA-C-N 120.366 1.439 . . . . 0.0 115.332 172.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.627 ' O ' ' HB2' ' A' ' 51' ' ' ARG 0.27 11.8 p -77.91 -44.1 28.44 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.649 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 -169.673 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -59.35 -52.95 63.44 Favored 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 121.072 1.76 . . . . 0.0 113.315 169.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.69 -33.25 73.64 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -176.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.417 ' HB2' ' HB3' ' A' ' 35' ' ' PHE . 13.2 tmtt? -75.28 -19.93 59.41 Favored 'General case' 0 CA--C 1.562 1.442 0 CA-C-O 116.915 -1.517 . . . . 0.0 113.329 166.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ARG . . . . . 0.627 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 34.5 ttt180 -76.81 -53.04 8.45 Favored 'General case' 0 CA--C 1.589 2.47 1 CA-C-O 86.371 -16.061 . . . . 0.0 118.169 -179.479 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . 0.34 0.0 OUTLIER -40.92 -61.7 0.93 Allowed 'General case' 0 N--CA 1.511 2.605 1 O-C-N 109.99 -7.944 . . . . 0.0 119.559 147.869 . . . . . . . . 4 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 61.0 mt -52.0 -31.67 30.58 Favored 'General case' 0 N--CA 1.52 3.067 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 178.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -93.46 -44.22 8.35 Favored 'General case' 0 CA--C 1.567 1.61 0 N-CA-C 116.912 2.19 . . . . 0.0 116.912 170.154 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.12 -10.56 14.66 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 119.041 2.978 . . . . 0.0 119.041 -168.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.51 42.62 9.04 Favored Glycine 0 CA--C 1.541 1.679 0 CA-C-N 122.094 2.225 . . . . 0.0 116.269 -177.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -91.31 -175.52 4.28 Favored 'General case' 0 CA--C 1.568 1.636 0 CA-C-O 122.24 1.019 . . . . 0.0 110.739 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 65.4 mt -103.82 104.25 14.23 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 177.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.9 t -142.55 122.04 7.83 Favored Pre-proline 0 CA--C 1.584 2.259 0 CA-C-O 117.867 -1.063 . . . . 0.0 108.141 -170.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -57.63 170.1 2.08 Favored 'Trans proline' 0 CA--C 1.567 2.153 0 C-N-CA 124.278 3.319 . . . . 0.0 119.791 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.3 m -96.13 -169.4 1.92 Allowed 'General case' 0 CA--C 1.576 1.976 0 C-N-CA 124.444 1.098 . . . . 0.0 112.995 -178.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.278 19.1 m-20 80.55 -51.01 0.33 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 126.765 2.026 . . . . 0.0 115.144 172.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.44 -39.58 76.57 Favored 'General case' 0 N--CA 1.505 2.298 0 CA-C-N 120.359 1.436 . . . . 0.0 114.667 167.813 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.3 m -60.29 -47.51 85.71 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 114.669 -1.15 . . . . 0.0 112.688 172.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -62.92 -27.69 69.55 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 115.774 1.768 . . . . 0.0 115.774 168.051 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -68.36 -44.48 75.13 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 120.886 1.675 . . . . 0.0 114.523 171.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.9 mt -64.41 -38.57 91.5 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 168.637 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.0 t -57.58 -53.0 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-O 117.885 -1.055 . . . . 0.0 111.998 169.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -59.63 -37.32 78.33 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 116.436 2.013 . . . . 0.0 116.436 172.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -55.8 -49.02 74.36 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 116.715 -1.612 . . . . 0.0 113.084 170.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 61.3 mtp180 -88.94 7.85 32.45 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 120.515 3.524 . . . . 0.0 120.515 167.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 63.9 mt -66.19 -49.73 66.3 Favored 'General case' 0 CA--C 1.554 1.126 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 151.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 72.3 m-80 48.81 40.07 15.46 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-N 121.533 1.969 . . . . 0.0 110.981 -165.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -30.53 -32.91 0.03 OUTLIER Pre-proline 0 CA--C 1.573 1.84 1 N-CA-C 127.349 6.055 . . . . 0.0 127.349 -161.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_exo -58.61 -16.24 29.31 Favored 'Trans proline' 0 N--CA 1.511 2.504 1 CA-C-N 129.85 4.553 . . . . 0.0 118.963 168.012 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -96.88 -18.83 19.26 Favored 'General case' 0 CA--C 1.577 2.01 0 CA-C-N 110.82 -2.9 . . . . 0.0 113.587 164.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -109.17 25.04 12.27 Favored 'General case' 0 CA--C 1.58 2.112 0 CA-C-N 125.146 3.612 . . . . 0.0 114.221 168.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.6 -36.78 73.71 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 120.989 1.722 . . . . 0.0 115.148 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -105.89 18.99 21.27 Favored 'General case' 0 CA--C 1.576 1.957 0 CA-C-O 117.555 -1.212 . . . . 0.0 113.747 168.779 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.402 ' HA2' ' HB3' ' A' ' 2' ' ' ARG . . . -177.56 153.42 13.38 Favored Glycine 0 C--N 1.361 1.957 0 CA-C-N 122.344 2.338 . . . . 0.0 115.376 169.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.403 ' O ' ' HB2' ' A' ' 2' ' ' ARG . 23.2 p90 -173.98 135.74 0.5 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 112.585 -1.807 . . . . 0.0 109.827 168.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 33.6 mt -113.83 108.03 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 173.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.8 mt -110.96 122.4 47.79 Favored 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 123.33 0.652 . . . . 0.0 110.2 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -116.01 116.15 27.4 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 118.394 0.543 . . . . 0.0 110.746 -169.244 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.16 28.07 35.04 Favored Glycine 0 CA--C 1.548 2.138 0 N-CA-C 117.988 1.955 . . . . 0.0 117.988 176.146 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -86.68 -57.3 0.33 Allowed Pre-proline 0 CA--C 1.572 1.81 0 CA-C-O 114.297 -2.763 . . . . 0.0 110.791 175.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -61.88 50.25 0.1 OUTLIER 'Trans proline' 0 CA--C 1.578 2.719 0 N-CA-C 120.664 3.294 . . . . 0.0 120.664 167.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 1.264 ' NH2' HH12 ' A' ' 140' ' ' ARG . 0.0 OUTLIER -80.23 7.43 9.42 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 167.721 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.5 t -155.63 135.14 12.47 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 103.221 -2.881 . . . . 0.0 103.221 170.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.0 t -61.77 -34.21 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 CA-C-O 117.287 -1.34 . . . . 0.0 111.541 176.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.98 -35.39 64.27 Favored 'General case' 0 CA--C 1.564 1.505 0 N-CA-C 119.624 3.194 . . . . 0.0 119.624 165.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -72.26 -48.12 45.06 Favored 'General case' 0 CA--C 1.591 2.52 0 CA-C-N 121.679 2.036 . . . . 0.0 112.087 165.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.45 -33.18 75.29 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 116.677 2.103 . . . . 0.0 116.677 -169.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.2 tttp -61.25 -27.72 68.65 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 167.043 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.82 -42.45 63.8 Favored 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 168.295 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 36.8 tp -61.62 -40.83 96.23 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 169.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 43.7 t60 -64.09 -41.24 97.37 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 120.045 1.293 . . . . 0.0 113.986 169.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.705 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 29.7 tt0 -54.55 -40.84 69.09 Favored 'General case' 0 CA--C 1.567 1.61 0 CA-C-O 117.948 -1.025 . . . . 0.0 113.608 167.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' MET . . . . . 1.253 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 26.3 mmt -83.36 -21.26 33.16 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 117.553 2.427 . . . . 0.0 117.553 175.637 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.6 tt -73.06 -52.39 14.51 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-N 121.437 1.926 . . . . 0.0 110.39 172.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -75.37 -55.85 5.29 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 172.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.705 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 31.8 ttm180 -69.28 -39.81 78.14 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 178.063 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 1.253 ' HB3' ' O ' ' A' ' 99' ' ' MET . 76.5 ttt180 -63.45 -56.81 13.15 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 119.464 1.029 . . . . 0.0 111.036 165.159 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.27 50.0 0.74 Allowed Glycine 0 N--CA 1.483 1.794 0 O-C-N 124.184 0.927 . . . . 0.0 113.886 168.267 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 51.3 p -91.15 150.58 21.32 Favored 'General case' 0 CA--C 1.559 1.29 0 CA-C-N 113.481 -1.36 . . . . 0.0 109.797 176.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -67.94 132.55 47.53 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.899 -0.501 . . . . 0.0 112.053 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 6.3 tp -95.07 101.74 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -95.78 -69.45 0.75 Allowed 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 116.399 -1.763 . . . . 0.0 108.796 169.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -155.33 128.64 8.33 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 121.629 2.013 . . . . 0.0 113.929 177.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 33.3 t -93.72 108.37 20.46 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.726 0 N-CA-C 102.838 -3.023 . . . . 0.0 102.838 163.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.648 HD23 ' HB2' ' A' ' 160' ' ' LYS . 86.9 mt -101.43 110.8 22.87 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.776 0.83 . . . . 0.0 110.716 -169.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -89.57 121.23 31.58 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 121.638 0.732 . . . . 0.0 109.055 172.199 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -92.61 117.05 29.57 Favored 'General case' 0 CA--C 1.557 1.227 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 175.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.494 ' HB3' ' HA ' ' A' ' 163' ' ' ASP . 19.7 tpt180 -87.55 91.48 8.75 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 112.821 -1.99 . . . . 0.0 107.31 173.668 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.4 m -142.16 116.21 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 CA-C-N 112.839 -1.982 . . . . 0.0 106.038 -165.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 18.9 p -66.86 120.7 14.0 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.997 0.903 . . . . 0.0 113.01 -172.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -54.89 -45.93 74.73 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -49.2 -29.5 5.69 Favored 'General case' 0 CA--C 1.558 1.255 0 N-CA-C 118.217 2.673 . . . . 0.0 118.217 176.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.5 t -63.5 -48.26 87.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 CA-C-N 120.625 1.557 . . . . 0.0 113.865 178.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 9.0 mp -73.24 -23.32 60.33 Favored 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 116.74 -1.6 . . . . 0.0 113.992 168.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 48.0 mt -66.07 -45.88 79.72 Favored 'General case' 0 N--CA 1.502 2.125 0 CA-C-N 121.996 2.18 . . . . 0.0 115.143 169.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -65.09 -36.8 85.45 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 170.037 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -55.35 -55.92 26.0 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 168.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.7 pp -66.76 -34.21 77.34 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 177.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -77.33 -64.83 1.05 Allowed 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 120.91 1.686 . . . . 0.0 113.335 173.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.563 ' O ' ' HB2' ' A' ' 127' ' ' ARG . . . 60.01 43.94 97.71 Favored Glycine 0 CA--C 1.548 2.148 0 N-CA-C 118.616 2.206 . . . . 0.0 118.616 170.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.563 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 76.6 mtp85 76.14 93.38 0.07 Allowed 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 118.028 0.914 . . . . 0.0 111.104 -174.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 96.02 -176.43 33.18 Favored Glycine 0 CA--C 1.572 3.606 0 CA-C-O 118.854 -0.97 . . . . 0.0 113.278 -172.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -171.37 177.39 3.55 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 121.316 2.558 . . . . 0.0 114.428 -176.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -127.91 30.18 5.31 Favored 'General case' 0 CA--C 1.571 1.758 0 CA-C-N 113.233 -1.803 . . . . 0.0 113.806 168.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 57.72 12.09 1.53 Allowed 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 119.138 3.014 . . . . 0.0 119.138 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -87.19 52.08 2.42 Favored 'General case' 0 CA--C 1.58 2.106 0 CA-C-O 122.988 1.375 . . . . 0.0 109.176 162.24 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 73.3 p -140.55 -118.83 0.12 Allowed 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 113.998 -1.455 . . . . 0.0 109.494 -162.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -56.85 -41.28 77.66 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 116.728 2.121 . . . . 0.0 116.728 -169.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -71.64 -38.91 70.68 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 177.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.997 ' O ' ' HG2' ' A' ' 140' ' ' ARG . 50.8 t -62.72 -38.58 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 C-N-CA 124.122 0.969 . . . . 0.0 112.539 168.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 1.7 mp -72.35 -29.81 32.89 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.962 0 CA-C-O 117.546 -1.216 . . . . 0.0 113.205 173.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 31.2 mt -66.66 -46.38 75.9 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 121.382 1.901 . . . . 0.0 113.881 170.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -65.94 -37.52 86.26 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 114.849 1.425 . . . . 0.0 114.849 171.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 1.264 HH12 ' NH2' ' A' ' 88' ' ' ARG . 12.2 mmm180 -59.77 -42.13 92.64 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 169.484 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 58.9 mtt -66.49 -31.01 71.47 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 115.543 1.682 . . . . 0.0 115.543 169.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -63.64 -49.14 74.41 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 169.411 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' VAL . . . . . 0.6 HG11 HH22 ' A' ' 88' ' ' ARG . 7.8 p -64.57 -33.41 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 169.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -56.19 -52.36 64.68 Favored 'General case' 0 CA--C 1.581 2.168 0 CA-C-N 119.559 1.072 . . . . 0.0 111.779 167.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 31.1 ttp180 -52.19 -31.55 32.16 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 119.427 3.121 . . . . 0.0 119.427 170.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -48.47 -51.04 28.95 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 170.75 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -140.34 7.61 2.18 Favored 'General case' 0 CA--C 1.56 1.362 0 N-CA-C 119.944 3.312 . . . . 0.0 119.944 -167.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 23.9 m -55.27 -34.41 64.03 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 116.194 1.924 . . . . 0.0 116.194 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.14 -59.92 5.71 Favored Pre-proline 0 CA--C 1.578 2.054 0 CA-C-O 116.662 -1.637 . . . . 0.0 111.881 172.678 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -50.15 -31.3 28.12 Favored 'Trans proline' 0 CA--C 1.576 2.616 0 C-N-CA 123.365 2.71 . . . . 0.0 118.374 167.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.01 -55.58 18.13 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 125.391 1.476 . . . . 0.0 112.217 175.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 1.047 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 46.1 tp -65.32 -23.51 67.03 Favored 'General case' 0 CA--C 1.564 1.511 0 CA-C-O 116.504 -1.712 . . . . 0.0 114.704 176.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -71.55 -48.95 45.25 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 122.393 2.361 . . . . 0.0 113.444 165.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -67.16 -51.6 51.71 Favored 'General case' 0 CA--C 1.566 1.57 0 CA-C-N 120.042 1.292 . . . . 0.0 112.014 -177.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -80.81 -25.3 37.9 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-O 114.715 -2.564 . . . . 0.0 112.53 178.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 1.047 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 38.1 ttt180 -64.31 -35.63 81.48 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 124.893 3.497 . . . . 0.0 115.938 168.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -67.94 -37.74 81.97 Favored 'General case' 0 CA--C 1.574 1.89 0 CA-C-N 119.697 1.135 . . . . 0.0 113.949 167.303 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -80.71 -38.2 29.3 Favored 'General case' 0 CA--C 1.574 1.89 0 N-CA-C 119.351 3.093 . . . . 0.0 119.351 178.385 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.3 pp -78.08 173.69 11.94 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 119.675 3.213 . . . . 0.0 119.675 -160.271 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.648 ' HB2' HD23 ' A' ' 111' ' ' LEU . 91.0 mttt -124.83 134.35 52.77 Favored 'General case' 0 CA--C 1.561 1.399 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 166.027 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 60.4 m -98.1 148.95 23.03 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 122.79 1.281 . . . . 0.0 111.222 -170.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.471 HG13 ' HG3' ' A' ' 174' ' ' ARG . 44.8 t -127.84 138.67 54.05 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.871 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 167.024 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.494 ' HA ' ' HB3' ' A' ' 114' ' ' ARG . 14.7 t70 -114.95 127.32 55.62 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 170.308 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -151.53 -159.8 1.07 Allowed 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 -160.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.509 HG22 ' H ' ' A' ' 166' ' ' GLY 0.511 5.7 p 58.28 178.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 C-N-CA 129.153 2.981 . . . . 0.0 114.498 -179.376 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.509 ' H ' HG22 ' A' ' 165' ' ' VAL . . . 72.52 -17.41 1.52 Allowed Glycine 0 CA--C 1.559 2.843 0 N-CA-C 117.821 1.888 . . . . 0.0 117.821 -151.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 82.7 p -141.28 145.38 35.44 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 118.735 1.267 . . . . 0.0 110.91 -168.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -88.88 -67.62 0.82 Allowed 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 118.751 -0.642 . . . . 0.0 112.143 174.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -70.03 -37.04 75.49 Favored 'General case' 0 N--CA 1.505 2.313 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 -176.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' GLU . . . . . 0.97 ' HB3' HH21 ' A' ' 174' ' ' ARG . 47.6 mt-10 -59.42 -42.04 90.92 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 117.294 -1.336 . . . . 0.0 114.522 175.305 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 44.4 t -56.54 -38.65 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 CA-C-N 120.991 1.723 . . . . 0.0 113.419 172.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.729 ' CE1' ' HB3' ' A' ' 19' ' ' LYS . 22.8 t80 -57.95 -40.51 80.7 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 120.796 1.635 . . . . 0.0 115.103 166.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.558 ' O ' ' HB2' ' A' ' 177' ' ' ARG . . . -61.03 -50.85 71.64 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.97 HH21 ' HB3' ' A' ' 170' ' ' GLU . 11.7 ptp180 -73.32 -25.19 60.53 Favored 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 117.582 2.438 . . . . 0.0 117.582 171.056 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.11 -49.73 73.27 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 120.346 1.43 . . . . 0.0 114.715 169.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . 0.254 0.2 OUTLIER -66.77 -37.86 85.44 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 119.531 1.06 . . . . 0.0 113.429 167.471 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 177' ' ' ARG . . . . . 0.619 ' HB2' ' HA ' ' A' ' 174' ' ' ARG . 17.3 ttt180 -43.55 -44.05 5.89 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 117.126 2.269 . . . . 0.0 117.126 167.594 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -71.13 -53.98 12.65 Favored 'General case' 0 CA--C 1.564 1.497 0 CA-C-O 118.204 -0.903 . . . . 0.0 113.208 166.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -99.05 -59.6 1.7 Allowed 'General case' 0 CA--C 1.565 1.528 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -169.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.885 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -79.39 -39.14 19.55 Favored Glycine 0 CA--C 1.55 2.276 0 CA-C-N 121.388 1.904 . . . . 0.0 117.737 -171.46 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.885 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 85.9 tttt . . . . . 0 C--O 1.251 1.142 0 CA-C-N 118.482 1.141 . . . . 0.0 108.623 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.6 mtt . . . . . 0 CA--C 1.555 1.171 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.783 HH21 HD21 ' A' ' 4' ' ' LEU . 2.4 ptm180 -160.96 162.79 32.03 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 -167.043 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.551 HG13 HG23 ' A' ' 82' ' ' ILE . 8.5 p -131.4 145.69 34.84 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.4 0 CA-C-O 123.299 1.523 . . . . 0.0 110.956 -170.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.783 HD21 HH21 ' A' ' 2' ' ' ARG . 1.2 mm? -118.12 157.07 27.57 Favored 'General case' 0 CA--C 1.562 1.442 0 CA-C-N 112.853 -1.976 . . . . 0.0 108.52 168.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.439 HD22 ' HG2' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -128.23 117.07 20.87 Favored 'General case' 0 CA--C 1.569 1.69 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.201 -174.042 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.0 mt -116.17 158.48 23.2 Favored 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 127.669 2.387 . . . . 0.0 111.749 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.69 118.78 0.63 Allowed Glycine 0 CA--C 1.556 2.61 0 CA-C-O 116.996 -2.002 . . . . 0.0 114.029 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -70.83 -178.07 2.56 Favored 'Trans proline' 0 CA--C 1.584 3.002 0 CA-C-N 122.572 3.186 . . . . 0.0 114.009 169.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -48.03 125.98 12.52 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 124.132 3.221 . . . . 0.0 116.111 -178.652 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.57 101.74 2.41 Favored Glycine 0 CA--C 1.538 1.476 0 N-CA-C 106.093 -2.803 . . . . 0.0 106.093 -165.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.02 129.58 34.61 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -169.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -166.57 98.94 0.15 Allowed Glycine 0 N--CA 1.48 1.598 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.439 ' HG2' HD22 ' A' ' 5' ' ' LEU . 37.3 mtmm -158.34 -65.63 0.09 Allowed 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 122.896 0.478 . . . . 0.0 111.434 -172.319 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -54.04 -36.87 57.21 Favored Glycine 0 CA--C 1.552 2.346 0 N-CA-C 120.87 3.108 . . . . 0.0 120.87 -173.096 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 90.0 m -68.74 -49.09 61.61 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 119.397 1.598 . . . . 0.0 113.145 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.282 25.4 mp0 -77.57 -12.06 59.93 Favored 'General case' 0 CA--C 1.574 1.886 0 CA-C-O 115.325 -2.274 . . . . 0.0 112.071 169.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.07 -45.9 58.93 Favored 'General case' 0 C--N 1.373 1.61 0 CA-C-N 124.809 3.459 . . . . 0.0 114.389 167.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.2 t -67.01 -40.95 86.65 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.766 0 CA-C-O 117.523 -1.227 . . . . 0.0 111.793 171.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -62.62 -45.23 93.83 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 116.605 2.076 . . . . 0.0 116.605 171.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.26 -32.92 73.43 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-N 120.227 1.376 . . . . 0.0 113.85 173.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.03 -40.97 97.52 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 166.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -58.17 -40.25 80.97 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 166.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.9 tptt -68.62 -54.01 19.09 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 177.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.9 mt -83.31 -19.86 35.46 Favored 'General case' 0 CA--C 1.57 1.739 0 N-CA-C 116.972 2.212 . . . . 0.0 116.972 178.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.48 39.89 7.55 Favored Glycine 0 CA--C 1.554 2.482 0 N-CA-C 117.543 1.777 . . . . 0.0 117.543 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.515 ' CG2' ' HA ' ' A' ' 81' ' ' PHE . 18.8 mm -110.1 157.87 36.71 Favored Pre-proline 0 CA--C 1.572 1.827 0 CA-C-N 118.531 1.166 . . . . 0.0 113.457 -168.261 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -84.49 99.79 0.76 Allowed 'Trans proline' 0 CA--C 1.568 2.182 0 CA-C-N 122.146 1.802 . . . . 0.0 110.062 163.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.26 113.66 4.75 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.448 -0.783 . . . . 0.0 111.276 172.027 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 32.3 mm -98.12 108.14 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 N-CA-C 104.501 -2.407 . . . . 0.0 104.501 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 73.9 m -95.45 128.45 42.32 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 168.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.3 p -71.27 -8.28 52.6 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 116.94 2.2 . . . . 0.0 116.94 -172.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -87.12 -21.86 47.65 Favored Glycine 0 CA--C 1.551 2.288 0 N-CA-C 118.106 2.003 . . . . 0.0 118.106 165.361 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -79.79 -51.55 9.03 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -168.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -62.09 -41.85 98.61 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 172.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.431 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 26.0 m-85 -60.73 -37.08 80.54 Favored 'General case' 0 CA--C 1.564 1.513 0 N-CA-C 116.259 1.948 . . . . 0.0 116.259 168.35 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -60.09 -42.96 95.76 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 120.017 1.28 . . . . 0.0 114.035 167.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -60.33 -38.87 85.11 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 168.105 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -66.25 -28.14 68.49 Favored 'General case' 0 CA--C 1.575 1.923 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 168.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 73.9 mt -63.73 -46.74 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 CA-C-N 120.131 1.332 . . . . 0.0 111.434 168.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -65.35 -36.39 83.87 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 172.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -78.38 -32.08 48.71 Favored 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.14 73.69 1.28 Allowed Glycine 0 CA--C 1.544 1.855 0 CA-C-O 118.348 -1.251 . . . . 0.0 114.884 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.843 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 68.6 p -97.62 -44.53 6.75 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 178.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.843 ' HB2' ' O ' ' A' ' 43' ' ' THR . 76.9 mttt 102.35 -39.16 0.01 OUTLIER 'General case' 0 CA--C 1.579 2.072 0 CA-C-O 117.372 -1.299 . . . . 0.0 112.202 -171.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -89.01 1.8 54.98 Favored 'General case' 0 CA--C 1.58 2.103 0 CA-C-N 121.805 2.093 . . . . 0.0 113.251 163.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -81.9 -54.48 3.41 Favored Glycine 0 C--N 1.349 1.299 0 O-C-N 120.761 -1.212 . . . . 0.0 114.657 169.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.303 4.0 p -75.95 -52.38 18.02 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.441 0 N-CA-C 115.073 1.509 . . . . 0.0 115.073 -168.387 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -67.19 -48.93 66.42 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 120.586 1.539 . . . . 0.0 112.307 175.235 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.81 -19.32 62.01 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.431 ' HB2' ' HB3' ' A' ' 35' ' ' PHE . 14.2 tmtt? -74.64 -47.02 34.37 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 117.111 -1.423 . . . . 0.0 111.825 165.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -67.71 -53.55 26.66 Favored 'General case' 0 CA--C 1.591 2.539 1 CA-C-O 86.12 -16.181 . . . . 0.0 118.001 -173.047 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 15.9 m-30 -31.62 -64.41 0.16 Allowed 'General case' 0 N--CA 1.496 1.848 1 O-C-N 110.232 -7.793 . . . . 0.0 120.803 146.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.5 tp -60.8 -23.97 65.46 Favored 'General case' 0 CA--C 1.579 2.095 0 CA-C-N 122.201 2.273 . . . . 0.0 116.779 172.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -92.58 -43.27 9.22 Favored 'General case' 0 CA--C 1.569 1.68 0 C-N-CA 126.332 1.853 . . . . 0.0 114.737 168.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.41 -48.01 12.47 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 120.741 1.609 . . . . 0.0 115.318 -176.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.99 41.42 0.71 Allowed Glycine 0 CA--C 1.539 1.542 0 N-CA-C 116.389 1.316 . . . . 0.0 116.389 169.383 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -105.73 -132.47 0.31 Allowed 'General case' 0 CA--C 1.572 1.802 0 CA-C-O 118.584 -0.722 . . . . 0.0 109.479 168.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.9 mt -108.23 109.95 21.44 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 120.163 1.347 . . . . 0.0 111.334 -168.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.9 p -117.11 129.49 25.29 Favored Pre-proline 0 CA--C 1.573 1.829 0 CA-C-O 117.796 -1.097 . . . . 0.0 110.225 178.593 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -60.73 145.2 99.31 Favored 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 123.475 2.783 . . . . 0.0 116.288 173.722 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 98.8 p -78.12 -45.07 24.32 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 178.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -66.82 -40.65 88.08 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 115.726 1.751 . . . . 0.0 115.726 -175.713 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.67 -43.88 97.13 Favored 'General case' 0 N--CA 1.506 2.341 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 172.219 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.3 m -61.46 -41.19 96.86 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.201 -1.363 . . . . 0.0 112.986 173.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -65.08 -26.58 68.29 Favored 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 166.74 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.41 -46.49 73.06 Favored 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 170.392 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.8 mt -60.64 -48.28 82.49 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 169.129 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 55.5 t -58.99 -52.17 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 124.024 0.93 . . . . 0.0 112.435 174.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -62.68 -31.16 72.0 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 116.344 1.979 . . . . 0.0 116.344 173.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -58.74 -42.99 90.08 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 117.558 -1.211 . . . . 0.0 113.462 169.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -81.35 -16.78 51.31 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 119.217 3.043 . . . . 0.0 119.217 168.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 88.7 mt -92.82 -17.88 23.57 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 117.067 2.247 . . . . 0.0 117.067 177.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -71.95 9.03 1.02 Allowed 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 169.17 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -67.95 141.77 94.78 Favored Pre-proline 0 CA--C 1.574 1.896 0 CA-C-O 117.816 -1.088 . . . . 0.0 109.837 166.116 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -48.59 -36.69 32.56 Favored 'Trans proline' 0 N--CA 1.5 1.898 0 N-CA-C 119.419 2.815 . . . . 0.0 119.419 174.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.8 p30 -65.65 -19.54 65.95 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 116.824 2.157 . . . . 0.0 116.824 172.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -100.7 9.19 42.75 Favored 'General case' 0 CA--C 1.572 1.811 0 CA-C-N 121.696 2.044 . . . . 0.0 115.897 171.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.62 -45.23 83.87 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 121.148 1.794 . . . . 0.0 114.51 169.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -93.17 16.18 13.62 Favored 'General case' 0 CA--C 1.577 1.998 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 173.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.82 163.95 21.55 Favored Glycine 0 C--N 1.354 1.552 0 CA-C-N 121.336 1.88 . . . . 0.0 114.298 169.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.515 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . 28.8 p90 -165.85 139.56 4.41 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 113.236 -1.482 . . . . 0.0 111.967 175.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.551 HG23 HG13 ' A' ' 3' ' ' VAL . 1.3 mm -101.39 110.39 28.12 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.764 0 N-CA-C 104.624 -2.361 . . . . 0.0 104.624 170.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.9 mt -106.09 130.22 54.03 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 174.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -128.99 117.85 21.62 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 119.206 0.912 . . . . 0.0 110.916 -166.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 76.06 36.72 40.02 Favored Glycine 0 CA--C 1.55 2.231 0 N-CA-C 118.051 1.981 . . . . 0.0 118.051 -176.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . 0.256 2.3 t80 -107.24 -66.14 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.921 0 CA-C-O 113.834 -2.984 . . . . 0.0 112.105 -176.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -61.79 47.97 0.09 OUTLIER 'Trans proline' 0 CA--C 1.576 2.602 0 N-CA-C 122.229 3.896 . . . . 0.0 122.229 171.155 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.42 -21.76 66.74 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 116.821 2.156 . . . . 0.0 116.821 166.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 36.6 t -131.14 146.84 52.5 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 -172.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -61.89 -35.78 70.02 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.724 0 CA-C-O 117.26 -1.352 . . . . 0.0 110.827 169.543 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.56 -45.66 81.14 Favored 'General case' 0 CA--C 1.559 1.323 0 N-CA-C 120.524 3.528 . . . . 0.0 120.524 168.118 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -67.32 -47.47 70.44 Favored 'General case' 0 CA--C 1.588 2.437 0 CA-C-N 122.264 2.302 . . . . 0.0 112.927 169.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.14 -33.1 73.86 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 116.405 2.002 . . . . 0.0 116.405 -169.179 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -63.46 -28.1 69.73 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 166.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.93 -46.31 62.7 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 169.013 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 22.6 tp -64.41 -37.96 89.34 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 173.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 46.6 t-80 -68.43 -39.35 81.59 Favored 'General case' 0 CA--C 1.567 1.63 0 CA-C-N 119.695 1.134 . . . . 0.0 113.825 169.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.936 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 22.8 mt-10 -52.2 -41.44 62.69 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 166.654 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' MET . . . . . 1.056 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 3.3 tpt -84.09 -26.93 28.58 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 117.724 2.49 . . . . 0.0 117.724 175.478 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LEU . . . . . 0.637 HD11 ' HB ' ' A' ' 107' ' ' ILE . 30.9 tp -64.28 -55.33 22.11 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 120.214 1.37 . . . . 0.0 112.393 168.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -80.26 -51.68 8.62 Favored 'General case' 0 CA--C 1.562 1.42 0 CA-C-O 118.671 -0.68 . . . . 0.0 112.715 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.936 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 75.0 mtp180 -71.66 -41.06 69.19 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 176.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 1.056 ' HB3' ' O ' ' A' ' 99' ' ' MET . 0.8 OUTLIER -63.2 -55.14 27.5 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 119.759 1.163 . . . . 0.0 110.59 164.638 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.67 48.4 1.04 Allowed Glycine 0 N--CA 1.482 1.713 0 O-C-N 123.83 0.706 . . . . 0.0 113.274 169.246 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 29.7 p -99.91 163.61 12.38 Favored 'General case' 0 CA--C 1.56 1.343 0 O-C-N 124.594 0.82 . . . . 0.0 111.074 -178.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -75.56 134.78 40.64 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.64 -0.663 . . . . 0.0 111.748 -169.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.637 ' HB ' HD11 ' A' ' 100' ' ' LEU . 8.0 tp -109.64 106.05 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.42 -68.21 0.81 Allowed 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 117.446 -1.264 . . . . 0.0 107.701 167.239 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -159.87 136.83 9.34 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 120.601 1.546 . . . . 0.0 115.119 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.537 HG22 HD23 ' A' ' 4' ' ' LEU . 48.7 t -91.35 114.38 28.51 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.734 0 N-CA-C 103.733 -2.691 . . . . 0.0 103.733 162.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 84.3 mt -103.04 110.74 22.77 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.338 0.655 . . . . 0.0 111.959 -169.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -96.06 124.47 40.08 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.313 0.578 . . . . 0.0 110.849 175.581 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -92.68 123.87 36.28 Favored 'General case' 0 CA--C 1.561 1.388 0 CA-C-O 123.341 1.543 . . . . 0.0 110.147 -173.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -82.09 95.05 7.34 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 112.559 -2.109 . . . . 0.0 109.229 168.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.6 p -138.55 139.3 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.299 0 C-N-CA 125.864 1.666 . . . . 0.0 107.348 -168.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.4 m -76.94 140.35 40.45 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 114.341 -1.299 . . . . 0.0 112.699 -169.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -57.16 -41.78 79.83 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 169.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -47.41 -36.91 10.48 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 117.992 2.59 . . . . 0.0 117.992 174.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.3 t -61.14 -51.24 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.329 0 CA-C-N 119.856 1.207 . . . . 0.0 113.714 176.423 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 14.0 tp -61.08 -39.93 91.78 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 168.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 9.0 mp -62.45 -43.88 97.75 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 174.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -66.61 -35.92 81.35 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 171.668 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.442 ' O ' ' HB3' ' A' ' 127' ' ' ARG . 98.9 mtt180 -57.28 -52.85 63.69 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 168.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 10.5 mp -60.81 -48.96 79.43 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 174.009 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -60.15 -46.98 87.84 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 116.406 2.002 . . . . 0.0 116.406 176.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.591 ' O ' ' HB2' ' A' ' 127' ' ' ARG . . . -102.3 56.35 0.66 Allowed Glycine 0 CA--C 1.546 1.979 0 CA-C-N 118.746 0.703 . . . . 0.0 113.978 169.794 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.591 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 35.9 ttm180 154.25 91.76 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.224 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.745 ' O ' ' HB2' ' A' ' 129' ' ' ARG . . . -174.42 -44.71 0.05 OUTLIER Glycine 0 CA--C 1.548 2.151 0 N-CA-C 116.639 1.416 . . . . 0.0 116.639 -175.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.745 ' HB2' ' O ' ' A' ' 128' ' ' GLY . 94.2 mtt180 89.6 -128.99 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 119.626 1.713 . . . . 0.0 112.319 -175.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.485 ' H ' ' HB3' ' A' ' 129' ' ' ARG . . . -93.68 -41.08 9.9 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 115.127 1.529 . . . . 0.0 115.127 -175.343 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -138.05 62.64 1.56 Allowed 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 121.426 1.921 . . . . 0.0 113.131 177.343 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -121.83 62.96 0.92 Allowed 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 102.445 -3.168 . . . . 0.0 102.445 159.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 76.2 p -143.7 -117.55 0.09 Allowed 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 113.98 -1.464 . . . . 0.0 110.374 -160.385 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -84.87 -33.5 22.79 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 115.513 1.671 . . . . 0.0 115.513 -171.061 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -68.22 -40.03 82.2 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 177.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 5.0 p -59.97 -46.45 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 172.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.8 tp -70.88 -26.81 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 174.452 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 33.7 mt -66.66 -40.7 88.76 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 120.51 1.505 . . . . 0.0 114.175 168.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' ASN . . . . . 0.416 ' HA ' ' HD3' ' A' ' 142' ' ' LYS . 11.6 t-20 -68.62 -37.12 79.49 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 120.495 1.498 . . . . 0.0 114.316 170.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.01 -38.93 77.09 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 165.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 24.7 ttt -65.03 -33.12 75.28 Favored 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 168.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' LYS . . . . . 0.416 ' HD3' ' HA ' ' A' ' 139' ' ' ASN . 60.5 mtpt -59.71 -52.23 66.4 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 168.471 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 14.8 p -62.67 -36.44 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.267 0 N-CA-C 114.109 1.152 . . . . 0.0 114.109 170.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -55.31 -50.29 69.95 Favored 'General case' 0 CA--C 1.581 2.161 0 CA-C-N 120.059 1.299 . . . . 0.0 112.974 169.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -61.55 -45.29 94.8 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 117.72 2.489 . . . . 0.0 117.72 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.01 -38.36 65.04 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 117.345 2.35 . . . . 0.0 117.345 175.663 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -123.47 -35.91 2.87 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 119.534 3.161 . . . . 0.0 119.534 -165.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 86.0 m -49.31 -31.3 8.85 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 118.441 2.756 . . . . 0.0 118.441 -166.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.17 -63.04 2.66 Favored Pre-proline 0 CA--C 1.582 2.192 0 CA-C-N 121.157 1.799 . . . . 0.0 111.212 170.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -54.21 -32.1 69.21 Favored 'Trans proline' 0 CA--C 1.571 2.363 0 C-N-CA 123.4 2.734 . . . . 0.0 118.899 167.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.3 tp -71.74 -42.87 66.74 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 117.812 -1.09 . . . . 0.0 112.511 174.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 1.048 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 49.5 tp -63.56 -24.43 67.8 Favored 'General case' 0 CA--C 1.569 1.704 0 CA-C-N 120.656 1.571 . . . . 0.0 113.875 170.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -69.84 -49.69 50.0 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 121.829 2.104 . . . . 0.0 113.038 163.3 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -65.19 -52.31 55.68 Favored 'General case' 0 CA--C 1.564 1.49 0 CA-C-N 121.15 1.795 . . . . 0.0 112.69 -177.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -82.0 -22.52 36.48 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-O 115.128 -2.368 . . . . 0.0 112.804 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 1.048 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 40.3 ttt180 -66.07 -35.87 81.7 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 125.016 3.553 . . . . 0.0 115.653 168.061 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -68.41 -36.9 79.78 Favored 'General case' 0 CA--C 1.575 1.928 0 CA-C-N 119.673 1.124 . . . . 0.0 114.006 167.043 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -88.08 -31.98 18.97 Favored 'General case' 0 CA--C 1.575 1.914 0 N-CA-C 119.203 3.038 . . . . 0.0 119.203 -178.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.8 pp -79.87 174.33 11.69 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 118.412 2.745 . . . . 0.0 118.412 -162.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -133.24 137.27 46.02 Favored 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 166.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.0 t -96.34 154.28 17.35 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.341 1.067 . . . . 0.0 112.085 -175.429 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 59.5 t -127.75 142.82 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 171.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -95.3 132.28 40.48 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 168.68 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -159.49 99.26 1.44 Allowed 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 122.26 1.029 . . . . 0.0 113.317 -163.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.9 t -150.92 130.81 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 174.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 79.58 -70.99 2.76 Favored Glycine 0 N--CA 1.482 1.735 0 N-CA-C 118.314 2.086 . . . . 0.0 118.314 167.375 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 40.6 p -76.98 142.36 40.01 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 112.215 -1.992 . . . . 0.0 112.26 -169.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 61.3 mtt -88.35 -61.65 1.66 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 118.699 -0.667 . . . . 0.0 111.579 178.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -69.64 -37.63 76.84 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 -176.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -61.55 -53.24 58.88 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 119.371 0.987 . . . . 0.0 113.28 169.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 61.6 t -57.73 -37.94 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 176.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -62.07 -33.53 74.57 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 116.45 2.019 . . . . 0.0 116.45 168.609 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -63.01 -47.28 83.77 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 171.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -61.8 -41.63 97.98 Favored 'General case' 0 CA--C 1.556 1.208 0 N-CA-C 116.676 2.102 . . . . 0.0 116.676 169.881 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.37 -42.39 91.5 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 116.212 1.931 . . . . 0.0 116.212 171.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.6 mp -65.99 -40.38 91.15 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 117.403 -1.284 . . . . 0.0 114.294 169.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 37.6 mtt180 -53.38 -43.27 67.7 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 116.442 2.015 . . . . 0.0 116.442 168.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -69.7 -41.82 74.89 Favored 'General case' 0 CA--C 1.562 1.438 0 N-CA-C 116.335 1.976 . . . . 0.0 116.335 172.858 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 6.8 tt -74.87 -57.14 4.09 Favored 'General case' 0 CA--C 1.566 1.566 0 CA-C-N 121.003 1.729 . . . . 0.0 111.729 177.044 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.643 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -117.36 -59.86 0.3 Allowed Glycine 0 CA--C 1.551 2.333 0 CA-C-O 117.621 -1.655 . . . . 0.0 114.898 -177.099 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.643 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 36.5 ttmt . . . . . 0 C--O 1.252 1.195 0 CA-C-N 120.608 2.204 . . . . 0.0 107.369 -174.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.1 mtt . . . . . 0 N--CA 1.483 1.213 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.38 165.94 31.58 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 117.744 2.498 . . . . 0.0 117.744 -165.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.65 155.56 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-O 124.044 1.878 . . . . 0.0 112.978 -165.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.7 pp -138.86 127.31 23.03 Favored 'General case' 0 CA--C 1.559 1.313 0 CA-C-N 112.618 -2.083 . . . . 0.0 108.718 168.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 tt -96.53 134.72 39.39 Favored 'General case' 0 CA--C 1.559 1.304 0 CA-C-O 122.879 1.324 . . . . 0.0 113.765 -165.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -135.26 157.41 46.97 Favored 'General case' 0 CA--C 1.56 1.335 0 CA-C-N 112.062 -2.335 . . . . 0.0 111.356 -169.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 156.67 135.98 2.05 Favored Glycine 0 CA--C 1.554 2.495 0 CA-C-O 117.412 -1.771 . . . . 0.0 111.905 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.21 154.1 75.3 Favored 'Trans proline' 0 CA--C 1.577 2.625 0 CA-C-N 122.789 3.294 . . . . 0.0 113.241 171.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -43.28 132.02 6.62 Favored 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 124.359 3.373 . . . . 0.0 118.519 -169.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 164.24 89.98 0.08 OUTLIER Glycine 0 CA--C 1.536 1.384 0 CA-C-N 116.343 -0.389 . . . . 0.0 112.658 -170.161 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 48.45 -83.47 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 120.602 3.556 . . . . 0.0 120.602 167.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.92 -115.22 0.09 OUTLIER Glycine 0 CA--C 1.544 1.901 0 N-CA-C 117.247 1.659 . . . . 0.0 117.247 -167.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.8 mptt 78.28 -83.8 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 124.503 1.121 . . . . 0.0 111.191 -169.366 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -40.94 -30.67 0.39 Allowed Glycine 0 CA--C 1.557 2.667 0 N-CA-C 121.254 3.262 . . . . 0.0 121.254 169.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.2 p -58.62 -63.04 1.43 Allowed 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 119.543 1.671 . . . . 0.0 114.507 171.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.264 5.7 mm-40 -75.28 -13.67 60.45 Favored 'General case' 0 CA--C 1.571 1.754 0 CA-C-O 116.536 -1.697 . . . . 0.0 111.432 175.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.83 -48.38 63.68 Favored 'General case' 0 C--N 1.373 1.609 0 CA-C-N 122.532 2.424 . . . . 0.0 113.946 166.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.6 t -66.43 -38.23 81.32 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.834 0 CA-C-O 117.89 -1.053 . . . . 0.0 111.931 176.32 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -63.09 -51.3 67.15 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 116.809 2.151 . . . . 0.0 116.809 169.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.04 -35.24 78.0 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-N 119.969 1.259 . . . . 0.0 114.255 174.771 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.63 -45.21 94.92 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 116.405 2.002 . . . . 0.0 116.405 169.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.43 -28.64 63.48 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 164.3 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.0 tptm -63.82 -62.8 1.41 Allowed 'General case' 0 CA--C 1.552 1.026 0 CA-C-O 116.653 -1.641 . . . . 0.0 114.745 170.211 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . 0.297 0.6 OUTLIER -83.28 -15.44 50.21 Favored 'General case' 0 N--CA 1.506 2.365 0 N-CA-C 117.006 2.225 . . . . 0.0 117.006 -178.445 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.08 42.32 4.09 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 117.024 1.57 . . . . 0.0 117.024 176.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.553 ' CD1' ' HA ' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -116.69 149.16 43.43 Favored Pre-proline 0 CA--C 1.573 1.865 0 C-N-CA 127.337 2.255 . . . . 0.0 110.776 -168.911 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.515 ' HD2' HD12 ' A' ' 26' ' ' ILE . 22.2 Cg_endo -73.97 101.71 1.43 Allowed 'Trans proline' 0 CA--C 1.583 2.958 0 C-N-CA 121.794 1.663 . . . . 0.0 113.568 159.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -57.4 119.99 7.44 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.919 -1.113 . . . . 0.0 113.817 169.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.423 HD12 HD13 ' A' ' 34' ' ' LEU . 26.2 mm -101.8 109.34 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 169.292 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.7 p -95.17 125.05 39.55 Favored 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 103.928 -2.619 . . . . 0.0 103.928 163.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 47.4 p -67.48 -12.23 59.8 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 117.14 2.274 . . . . 0.0 117.14 -168.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -85.86 -19.57 57.55 Favored Glycine 0 CA--C 1.55 2.28 0 N-CA-C 118.347 2.099 . . . . 0.0 118.347 166.376 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -79.61 -53.44 6.85 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 118.756 1.278 . . . . 0.0 114.062 -168.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.423 HD13 HD12 ' A' ' 29' ' ' ILE . 2.5 pt? -59.18 -39.22 81.87 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 172.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -70.14 -43.16 71.5 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 116.262 -1.828 . . . . 0.0 113.204 171.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 47.5 ttt180 -51.8 -39.84 59.4 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 116.541 2.052 . . . . 0.0 116.541 169.216 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.9 -43.49 98.74 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 113.736 1.014 . . . . 0.0 113.736 169.382 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -65.7 -24.63 67.04 Favored 'General case' 0 CA--C 1.585 2.304 0 N-CA-C 116.441 2.015 . . . . 0.0 116.441 167.397 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.9 mt -62.99 -48.96 85.51 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.381 0 CA-C-N 121.288 1.858 . . . . 0.0 109.468 166.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -61.52 -41.41 97.27 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 114.355 1.242 . . . . 0.0 114.355 175.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -65.95 -40.15 91.07 Favored 'General case' 0 CA--C 1.564 1.489 0 N-CA-C 116.571 2.063 . . . . 0.0 116.571 171.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.85 70.61 1.03 Allowed Glycine 0 CA--C 1.545 1.942 0 CA-C-O 117.901 -1.5 . . . . 0.0 114.789 -179.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.871 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 64.1 p -95.67 -50.79 4.79 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-N 119.414 1.607 . . . . 0.0 114.502 177.42 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.871 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.251 73.5 mttt 103.99 -40.98 0.01 OUTLIER 'General case' 0 CA--C 1.573 1.846 0 CA-C-O 116.303 -1.808 . . . . 0.0 111.229 -171.257 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.91 -13.99 59.48 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 123.183 2.72 . . . . 0.0 112.901 163.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.494 ' O ' ' HB3' ' A' ' 50' ' ' LYS . . . -58.56 -60.45 8.92 Favored Glycine 0 C--N 1.355 1.587 0 CA-C-N 120.725 1.602 . . . . 0.0 115.032 170.063 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.281 7.6 p -73.68 -50.63 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.323 0 N-CA-C 116.21 1.93 . . . . 0.0 116.21 -168.587 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -66.3 -46.4 77.07 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 120.352 1.433 . . . . 0.0 112.384 175.621 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.58 -30.98 68.88 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -178.092 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.494 ' HB3' ' O ' ' A' ' 46' ' ' GLY 0.27 0.6 OUTLIER -78.03 -28.21 49.01 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-O 116.827 -1.559 . . . . 0.0 114.873 170.453 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -74.06 -56.52 4.83 Favored 'General case' 0 CA--C 1.595 2.682 1 CA-C-O 87.477 -15.535 . . . . 0.0 117.314 175.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . 0.259 11.4 m-30 -24.28 -66.53 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.836 1 O-C-N 109.279 -8.388 . . . . 0.0 119.929 145.522 . . . . . . . . 3 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 41.2 mt -53.66 -38.34 64.04 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-N 121.296 1.862 . . . . 0.0 115.735 171.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -80.37 -52.98 7.04 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-O 116.799 -1.572 . . . . 0.0 113.634 170.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -158.42 43.86 0.29 Allowed 'General case' 0 CA--C 1.574 1.87 0 CA-C-N 120.909 1.686 . . . . 0.0 115.463 -168.714 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -151.17 27.26 1.0 Allowed Glycine 0 CA--C 1.549 2.174 0 CA-C-N 121.942 2.155 . . . . 0.0 118.443 173.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . 0.318 9.1 t70 76.37 -118.46 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 120.034 1.917 . . . . 0.0 111.127 166.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 86.3 mt -75.6 114.48 14.22 Favored 'General case' 0 CA--C 1.559 1.317 0 N-CA-C 115.308 1.596 . . . . 0.0 115.308 -164.736 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.5 p -118.06 138.29 25.34 Favored Pre-proline 0 CA--C 1.573 1.845 0 C-N-CA 126.089 1.755 . . . . 0.0 108.529 174.61 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -56.46 135.46 70.39 Favored 'Trans proline' 0 CA--C 1.56 1.807 0 C-N-CA 123.373 2.715 . . . . 0.0 116.191 173.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.6 m -70.38 -48.11 57.77 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -60.5 -43.55 96.91 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 26.4 mt -56.59 -46.82 80.61 Favored 'General case' 0 N--CA 1.509 2.483 0 N-CA-C 116.393 1.998 . . . . 0.0 116.393 175.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.1 m -58.33 -44.54 88.72 Favored 'General case' 0 CA--C 1.565 1.529 0 CA-C-N 113.022 -1.899 . . . . 0.0 113.211 173.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -61.01 -33.25 72.97 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 166.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.35 -43.97 84.54 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 175.586 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.2 mt -64.24 -44.8 90.7 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 168.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 54.9 t -59.09 -50.24 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 CA-C-O 118.125 -0.94 . . . . 0.0 113.073 172.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -63.0 -35.46 80.29 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 174.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -56.4 -40.23 74.31 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 118.113 -0.946 . . . . 0.0 113.31 169.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.632 HH22 ' HG ' ' A' ' 83' ' ' LEU . 0.2 OUTLIER -67.62 -45.38 75.59 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 165.616 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 83.7 mt -68.83 -7.03 30.55 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 118.12 2.637 . . . . 0.0 118.12 -178.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -73.06 6.63 2.57 Favored 'General case' 0 CA--C 1.582 2.193 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 165.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.401 ' HB2' ' HD2' ' A' ' 75' ' ' PRO . 15.6 p30 -52.58 -170.44 0.0 OUTLIER Pre-proline 0 CA--C 1.574 1.871 0 N-CA-C 120.688 3.588 . . . . 0.0 120.688 167.094 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PRO . . . . . 0.401 ' HD2' ' HB2' ' A' ' 74' ' ' ASN . 19.0 Cg_exo -35.6 39.86 0.0 OUTLIER 'Trans proline' 0 C--N 1.385 2.495 2 C-N-CA 127.666 5.578 . . . . 0.0 125.331 163.086 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.8 t70 59.66 34.1 22.09 Favored 'General case' 0 CA--C 1.582 2.183 0 C-N-CA 124.307 1.043 . . . . 0.0 110.366 -164.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.405 ' HB1' ' O ' ' A' ' 80' ' ' GLY 0.258 . . 78.92 4.4 2.4 Favored 'General case' 0 C--N 1.376 1.73 0 CA-C-O 116.269 -1.824 . . . . 0.0 114.996 -169.47 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 51.06 30.6 5.59 Favored 'General case' 0 CA--C 1.58 2.129 0 CA-C-N 123.441 2.837 . . . . 0.0 113.719 -164.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 59.58 32.98 21.93 Favored 'General case' 0 CA--C 1.581 2.163 0 CA-C-O 116.765 -1.588 . . . . 0.0 113.101 -165.882 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.405 ' O ' ' HB1' ' A' ' 77' ' ' ALA . . . -170.68 174.28 44.55 Favored Glycine 0 C--N 1.376 2.759 0 CA-C-N 123.508 2.867 . . . . 0.0 116.614 -178.048 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.553 ' HA ' ' CD1' ' A' ' 26' ' ' ILE 0.311 18.9 p90 -170.09 134.42 1.25 Allowed 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 114.747 -0.726 . . . . 0.0 112.064 168.53 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.1 mp -109.98 109.16 27.4 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.537 0 N-CA-C 104.134 -2.543 . . . . 0.0 104.134 168.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.632 ' HG ' HH22 ' A' ' 71' ' ' ARG . 10.2 mt -105.76 110.49 22.81 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.487 0.715 . . . . 0.0 109.752 169.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -103.73 130.65 51.26 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 118.511 0.596 . . . . 0.0 112.59 -173.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.58 40.32 98.55 Favored Glycine 0 CA--C 1.548 2.146 0 CA-C-O 116.867 -2.074 . . . . 0.0 116.274 -176.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -89.06 -54.27 0.33 Allowed Pre-proline 0 N--CA 1.502 2.172 0 CA-C-N 120.794 2.297 . . . . 0.0 108.205 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -61.18 60.03 0.1 Allowed 'Trans proline' 0 CA--C 1.576 2.588 0 N-CA-C 121.909 3.773 . . . . 0.0 121.909 167.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -56.36 -33.97 66.19 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 163.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.6 t -155.23 158.39 38.78 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -174.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 23.9 t -68.9 -31.57 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 CA-C-O 116.689 -1.624 . . . . 0.0 111.118 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.83 -39.16 76.99 Favored 'General case' 0 CA--C 1.56 1.363 0 N-CA-C 120.133 3.383 . . . . 0.0 120.133 167.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -72.25 -46.35 56.34 Favored 'General case' 0 CA--C 1.592 2.591 0 CA-C-N 122.505 2.411 . . . . 0.0 112.777 167.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.69 -34.79 78.64 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 127.2 2.2 . . . . 0.0 116.178 -168.933 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 57.9 tttt -61.41 -29.66 70.07 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 166.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.12 -36.77 72.25 Favored 'General case' 0 CA--C 1.568 1.651 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 168.288 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.7 tp -63.14 -38.29 90.59 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 168.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 31.5 t60 -63.67 -47.26 81.99 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 119.818 1.19 . . . . 0.0 112.973 168.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.919 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 34.4 mt-10 -52.02 -31.01 27.83 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 165.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' MET . . . . . 1.213 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 23.1 ttt -84.74 -31.58 23.93 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 117.578 2.436 . . . . 0.0 117.578 175.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.6 mt -64.34 -55.88 18.19 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 121.948 2.158 . . . . 0.0 110.927 167.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -76.83 -51.62 10.98 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.919 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 36.5 ttm180 -74.06 -38.51 63.93 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 115.154 1.539 . . . . 0.0 115.154 176.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 1.213 ' HB3' ' O ' ' A' ' 99' ' ' MET . 25.4 tpt180 -62.74 -54.51 38.09 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 119.986 1.266 . . . . 0.0 112.081 166.359 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 114.07 44.64 0.73 Allowed Glycine 0 N--CA 1.479 1.51 0 O-C-N 123.971 0.794 . . . . 0.0 113.76 168.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 31.3 p -116.23 135.33 53.99 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 177.432 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -65.88 135.45 54.82 Favored 'General case' 0 N--CA 1.508 2.465 0 CA-C-O 122.601 1.191 . . . . 0.0 112.435 -170.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.5 tp -84.28 99.49 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 CA-C-N 113.262 -1.79 . . . . 0.0 107.04 178.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -97.75 -68.37 0.8 Allowed 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 116.947 -1.501 . . . . 0.0 110.175 169.053 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -138.02 116.06 11.68 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 120.44 1.473 . . . . 0.0 114.544 -167.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 72.8 t -91.53 117.64 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 101.176 -3.638 . . . . 0.0 101.176 163.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.474 ' HA ' ' O ' ' A' ' 160' ' ' LYS 0.259 6.8 tp -116.16 109.59 17.67 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 114.804 -2.522 . . . . 0.0 115.2 -159.545 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.44 ' N ' ' HB ' ' A' ' 161' ' ' THR . 3.0 tm-20 -110.23 109.5 20.0 Favored 'General case' 0 N--CA 1.517 2.908 0 CA-C-N 123.856 3.025 . . . . 0.0 117.998 -177.14 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -87.85 123.51 32.69 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 125.667 1.587 . . . . 0.0 110.647 170.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -92.76 101.03 13.41 Favored 'General case' 0 CA--C 1.558 1.271 0 CA-C-N 112.543 -2.117 . . . . 0.0 109.312 169.47 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.5 p -135.89 141.94 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.446 0 C-N-CA 127.279 2.232 . . . . 0.0 107.894 -167.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.6 m -83.9 137.49 33.63 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 114.071 -1.422 . . . . 0.0 114.423 -167.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -58.32 -46.57 85.92 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 168.984 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -45.56 -36.47 4.67 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 117.995 2.591 . . . . 0.0 117.995 177.824 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.2 t -59.84 -52.78 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 177.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 5.3 tt -67.41 -36.65 81.7 Favored 'General case' 0 CA--C 1.56 1.357 0 CA-C-O 117.255 -1.355 . . . . 0.0 113.0 171.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.3 mp -59.46 -32.3 70.11 Favored 'General case' 0 N--CA 1.503 2.202 0 CA-C-N 120.852 1.66 . . . . 0.0 115.18 168.851 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -66.6 -47.3 73.12 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 119.231 0.923 . . . . 0.0 113.436 168.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -51.63 -54.99 21.9 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 116.316 1.969 . . . . 0.0 116.316 169.134 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 79.8 mt -52.95 -48.37 67.4 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 169.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 38.1 tptt -61.72 -42.64 99.22 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 116.949 2.203 . . . . 0.0 116.949 177.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.6 ' O ' ' HB2' ' A' ' 127' ' ' ARG . . . -96.74 57.79 1.3 Allowed Glycine 0 CA--C 1.545 1.908 0 CA-C-N 118.642 0.656 . . . . 0.0 113.983 170.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.6 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 74.3 mtp180 107.13 96.07 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.873 0.869 . . . . 0.0 110.481 174.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 139.37 64.19 0.04 OUTLIER Glycine 0 CA--C 1.549 2.186 0 CA-C-O 117.069 -1.962 . . . . 0.0 112.906 177.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 41.7 ptt85 -165.3 95.88 0.67 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 121.751 2.776 . . . . 0.0 112.01 -179.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -122.21 58.77 1.03 Allowed 'General case' 0 CA--C 1.573 1.863 0 C-N-CA 123.729 0.812 . . . . 0.0 109.809 171.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 63.89 8.09 3.66 Favored 'General case' 0 N--CA 1.506 2.341 0 N-CA-C 119.289 3.07 . . . . 0.0 119.289 -176.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -91.75 60.22 3.9 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 160.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 82.6 p -139.05 -113.24 0.15 Allowed 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 114.146 -1.388 . . . . 0.0 110.284 -162.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -58.63 -42.09 87.46 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -170.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -66.93 -35.77 80.74 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 172.051 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.631 ' O ' ' HG3' ' A' ' 140' ' ' ARG . 60.7 t -64.58 -42.54 95.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 C-N-CA 124.293 1.037 . . . . 0.0 112.3 173.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.1 tp -72.64 -28.58 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 171.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 32.3 mt -64.67 -44.33 90.7 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-N 121.152 1.796 . . . . 0.0 113.887 168.672 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -65.27 -36.95 85.7 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 170.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.631 ' HG3' ' O ' ' A' ' 136' ' ' VAL . 69.2 mtp180 -60.43 -41.86 94.89 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 169.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 62.5 mtt -65.53 -34.18 77.65 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 169.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -64.48 -46.35 83.41 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 170.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.6 p -65.74 -32.95 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 170.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -56.73 -53.13 61.25 Favored 'General case' 0 CA--C 1.581 2.158 0 CA-C-N 119.782 1.173 . . . . 0.0 111.71 167.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 41.3 ttt180 -53.34 -22.75 7.81 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 120.37 3.47 . . . . 0.0 120.37 169.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.37 -56.81 13.67 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-N 119.858 1.208 . . . . 0.0 113.308 169.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -141.99 23.08 2.07 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 118.639 2.829 . . . . 0.0 118.639 -171.679 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 20.9 m -56.25 -30.26 62.16 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 116.124 1.898 . . . . 0.0 116.124 170.719 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.464 ' HB3' ' HD3' ' A' ' 150' ' ' PRO . . . -68.0 -60.41 5.26 Favored Pre-proline 0 CA--C 1.583 2.234 0 CA-C-N 120.68 1.582 . . . . 0.0 111.227 169.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.464 ' HD3' ' HB3' ' A' ' 149' ' ' ALA . 75.9 Cg_exo -53.03 -27.93 38.26 Favored 'Trans proline' 0 CA--C 1.568 2.194 0 N-CA-C 119.614 2.89 . . . . 0.0 119.614 168.443 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 8.2 tt -70.85 -55.58 8.19 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 116.876 -1.535 . . . . 0.0 109.751 172.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 0.942 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 39.5 tp -58.43 -26.47 63.34 Favored 'General case' 0 CA--C 1.564 1.515 0 CA-C-N 121.211 1.823 . . . . 0.0 113.962 -179.044 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -71.53 -48.02 51.41 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 121.635 2.016 . . . . 0.0 113.409 163.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -69.92 -49.37 52.7 Favored 'General case' 0 CA--C 1.571 1.764 0 CA-C-N 121.591 1.996 . . . . 0.0 112.548 -175.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -82.16 -27.06 32.9 Favored 'General case' 0 CA--C 1.557 1.234 0 CA-C-O 115.215 -2.326 . . . . 0.0 111.437 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 0.942 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 40.8 ttt180 -67.0 -32.66 74.04 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 124.926 3.512 . . . . 0.0 115.723 167.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -67.89 -41.57 82.53 Favored 'General case' 0 CA--C 1.573 1.833 0 CA-C-N 119.713 1.142 . . . . 0.0 113.458 167.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -90.96 -28.47 18.02 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 119.675 3.213 . . . . 0.0 119.675 -176.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.8 pp -80.54 159.36 25.51 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 118.297 2.703 . . . . 0.0 118.297 -162.319 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 111' ' ' LEU 0.296 97.6 mttt -145.48 101.1 3.54 Favored 'General case' 0 C--N 1.361 1.072 0 CA-C-O 117.748 -1.12 . . . . 0.0 110.791 162.915 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.44 ' HB ' ' N ' ' A' ' 112' ' ' GLU 1.254 24.4 m -131.44 -153.31 0.55 Allowed 'General case' 0 CA--C 1.573 1.856 1 O-C-N 115.74 -4.35 . . . . 0.0 110.059 149.926 . . . . . . . . 4 3 . 1 . 017 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . 0.361 4.6 t -124.53 -177.81 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.413 0 CA-C-N 111.973 -2.376 . . . . 0.0 112.976 -151.047 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -112.18 123.36 50.11 Favored 'General case' 0 CA--C 1.564 1.491 0 CA-C-N 111.324 -2.671 . . . . 0.0 104.47 166.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -160.5 122.59 3.19 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.295 0.638 . . . . 0.0 110.546 -161.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.1 t -149.76 128.63 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 78.02 -55.12 3.9 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 120.258 2.863 . . . . 0.0 120.258 168.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 52.9 p -74.41 119.41 18.58 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 114.051 -1.074 . . . . 0.0 111.062 -169.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 64.7 mtt -73.76 -63.66 1.16 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -172.256 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -67.58 -36.03 80.13 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 116.126 1.898 . . . . 0.0 116.126 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -60.82 -51.82 67.71 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 170.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 87.5 t -58.81 -35.25 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 CA-C-O 117.311 -1.328 . . . . 0.0 113.949 176.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -60.07 -37.96 81.46 Favored 'General case' 0 N--CA 1.504 2.257 0 CA-C-N 121.262 1.846 . . . . 0.0 115.953 166.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -61.12 -53.55 55.69 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 175.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -56.42 -41.32 76.17 Favored 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 117.478 2.399 . . . . 0.0 117.478 169.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -53.28 -46.29 69.22 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 116.172 1.915 . . . . 0.0 116.172 169.24 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.7 mp -60.97 -44.99 96.54 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 117.388 -1.291 . . . . 0.0 113.962 168.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -50.66 -42.23 56.33 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 169.909 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -67.08 -45.17 78.11 Favored 'General case' 0 CA--C 1.561 1.369 0 N-CA-C 116.153 1.908 . . . . 0.0 116.153 171.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 6.6 tt -77.52 -55.15 5.62 Favored 'General case' 0 CA--C 1.568 1.665 0 CA-C-N 121.051 1.75 . . . . 0.0 112.38 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.817 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -130.7 -55.5 0.09 OUTLIER Glycine 0 CA--C 1.553 2.427 0 CA-C-O 117.628 -1.651 . . . . 0.0 115.807 -175.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.817 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 86.3 tttt . . . . . 0 C--O 1.251 1.153 0 CA-C-N 120.533 2.167 . . . . 0.0 108.874 -175.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.5 mtt . . . . . 0 CA--C 1.557 1.219 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.78 169.54 21.41 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 117.612 2.449 . . . . 0.0 117.612 -167.224 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.427 HG13 ' HA ' ' A' ' 82' ' ' ILE . 7.9 p -127.94 138.43 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 CA-C-N 115.116 -0.947 . . . . 0.0 113.532 -165.405 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -118.02 120.46 37.85 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 171.008 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.475 HD13 ' HB2' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -99.02 121.78 41.41 Favored 'General case' 0 CA--C 1.563 1.453 0 CA-C-O 122.376 1.084 . . . . 0.0 112.538 -167.484 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.4 mt -114.23 154.11 28.47 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 111.042 -2.799 . . . . 0.0 109.333 -172.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 175.24 107.9 0.21 Allowed Glycine 0 CA--C 1.549 2.178 0 CA-C-O 116.694 -2.17 . . . . 0.0 109.48 175.203 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -55.39 173.95 0.29 Allowed 'Trans proline' 0 CA--C 1.574 2.525 0 CA-C-N 122.247 3.024 . . . . 0.0 117.863 -179.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -46.7 116.17 1.52 Allowed 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 124.248 3.299 . . . . 0.0 115.642 -177.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.79 101.94 0.92 Allowed Glycine 0 CA--C 1.534 1.273 0 N-CA-C 106.523 -2.631 . . . . 0.0 106.523 -166.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.17 132.96 36.72 Favored 'General case' 0 CA--C 1.557 1.25 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 -167.854 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -153.37 -115.96 0.61 Allowed Glycine 0 CA--C 1.542 1.72 0 N-CA-C 105.882 -2.887 . . . . 0.0 105.882 167.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 12' ' ' GLY . 48.3 mtpt 79.35 -88.03 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 116.367 1.988 . . . . 0.0 116.367 164.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -32.59 -36.65 0.04 OUTLIER Glycine 0 CA--C 1.556 2.62 0 N-CA-C 122.877 3.911 . . . . 0.0 122.877 172.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.0 m -62.63 -56.26 19.48 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 120.069 1.934 . . . . 0.0 112.664 174.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.277 17.1 mp0 -74.55 -12.25 60.42 Favored 'General case' 0 CA--C 1.574 1.889 0 CA-C-O 115.427 -2.225 . . . . 0.0 112.655 170.194 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.475 ' HB2' HD13 ' A' ' 5' ' ' LEU . . . -69.67 -45.27 68.76 Favored 'General case' 0 C--N 1.374 1.664 0 CA-C-N 124.506 3.321 . . . . 0.0 114.513 167.249 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.7 t -69.95 -38.71 76.19 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.849 0 CA-C-O 117.672 -1.156 . . . . 0.0 111.569 174.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -61.33 -47.21 86.94 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 116.6 2.074 . . . . 0.0 116.6 169.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 mt -65.62 -31.08 71.92 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 172.408 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.97 -44.25 97.62 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 166.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -58.69 -37.69 76.63 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 168.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -67.1 -50.94 59.86 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 172.223 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.6 mt -83.69 -19.83 34.59 Favored 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 -177.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.97 36.11 10.52 Favored Glycine 0 CA--C 1.555 2.548 0 N-CA-C 117.889 1.915 . . . . 0.0 117.889 -177.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.4 mm -111.53 158.11 37.31 Favored Pre-proline 0 CA--C 1.572 1.796 0 CA-C-N 119.088 1.444 . . . . 0.0 113.811 -167.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -81.81 100.58 1.1 Allowed 'Trans proline' 0 CA--C 1.573 2.436 0 C-N-CA 122.115 1.876 . . . . 0.0 111.081 162.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -64.47 110.59 2.34 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 124.074 0.949 . . . . 0.0 111.887 171.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.7 mm -99.71 113.6 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 177.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 78.9 p -96.43 136.04 37.47 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 114.942 -1.026 . . . . 0.0 108.691 169.247 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.0 p -69.73 -7.88 43.23 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 117.585 2.439 . . . . 0.0 117.585 -175.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -90.43 -22.61 33.93 Favored Glycine 0 CA--C 1.545 1.937 0 N-CA-C 118.563 2.185 . . . . 0.0 118.563 165.828 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -80.74 -51.86 8.18 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -168.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -63.53 -41.44 98.48 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 173.57 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.488 ' HB3' ' CG ' ' A' ' 50' ' ' LYS . 29.6 m-85 -61.13 -43.4 98.94 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-O 116.431 -1.747 . . . . 0.0 115.136 168.516 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 72.8 ttt180 -54.97 -44.02 74.04 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 170.331 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 33.7 ttt180 -59.47 -40.98 88.67 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 114.668 1.358 . . . . 0.0 114.668 168.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -68.33 -24.19 64.8 Favored 'General case' 0 CA--C 1.582 2.188 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 169.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 82.5 mt -63.03 -49.49 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 CA-C-N 120.835 1.652 . . . . 0.0 110.299 167.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -65.26 -35.29 80.58 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 175.035 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -68.72 -42.8 77.17 Favored 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 174.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.45 69.4 1.27 Allowed Glycine 0 CA--C 1.545 1.947 0 CA-C-O 118.905 -0.942 . . . . 0.0 114.518 -174.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.866 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 64.8 p -91.52 -49.09 6.5 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 178.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.866 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.26 38.8 mttp 110.61 -42.37 0.0 OUTLIER 'General case' 0 CA--C 1.57 1.716 0 CA-C-O 116.135 -1.888 . . . . 0.0 110.876 -172.718 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -83.08 -10.86 58.48 Favored 'General case' 0 CA--C 1.574 1.872 0 CA-C-N 123.425 2.83 . . . . 0.0 113.106 162.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.37 -55.32 24.08 Favored Glycine 0 CA--C 1.544 1.853 0 CA-C-N 120.535 1.516 . . . . 0.0 114.276 169.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.267 1.0 OUTLIER -75.62 -50.21 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 116.729 2.122 . . . . 0.0 116.729 -168.556 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -67.16 -41.4 86.08 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 120.476 1.489 . . . . 0.0 112.565 174.495 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.88 -25.47 48.59 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -174.505 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.488 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -75.0 -41.01 60.34 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 117.064 -1.446 . . . . 0.0 111.871 166.699 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -71.63 -51.32 23.78 Favored 'General case' 0 CA--C 1.591 2.536 1 CA-C-O 85.298 -16.572 . . . . 0.0 118.444 -176.282 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 14.9 m-30 -35.25 -55.4 0.63 Allowed 'General case' 0 N--CA 1.496 1.844 2 O-C-N 108.913 -8.617 . . . . 0.0 121.85 147.209 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 71.6 mt -60.83 -32.77 72.14 Favored 'General case' 0 N--CA 1.51 2.571 0 CA-C-N 124.283 3.22 . . . . 0.0 114.799 167.917 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -83.09 -45.25 14.21 Favored 'General case' 0 CA--C 1.568 1.663 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 172.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.15 -28.23 25.67 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 116.81 2.152 . . . . 0.0 116.81 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.64 42.59 4.76 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-N 120.243 1.383 . . . . 0.0 115.952 170.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.423 ' O ' ' NH1' ' A' ' 88' ' ' ARG . 20.2 t70 -105.17 -132.53 0.31 Allowed 'General case' 0 CA--C 1.571 1.75 0 CA-C-O 118.532 -0.747 . . . . 0.0 109.548 169.328 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 88.8 mt -115.15 111.91 21.73 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 120.054 1.297 . . . . 0.0 110.192 -169.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.1 p -112.74 116.91 47.37 Favored Pre-proline 0 CA--C 1.568 1.651 0 CA-C-O 117.848 -1.072 . . . . 0.0 109.26 -178.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -59.64 144.24 99.48 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 123.477 2.785 . . . . 0.0 116.354 176.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 85.5 p -77.97 178.28 7.61 Favored 'General case' 0 CA--C 1.567 1.604 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 176.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.27 16.8 m-20 80.33 -51.53 0.35 Allowed 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 126.324 1.85 . . . . 0.0 113.998 175.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.9 pp -61.91 -42.46 99.1 Favored 'General case' 0 CA--C 1.563 1.459 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 167.249 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.2 m -61.43 -50.51 72.5 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.331 1.052 . . . . 0.0 112.805 174.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -64.41 -21.06 66.52 Favored 'General case' 0 CA--C 1.571 1.783 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 167.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -68.52 -47.11 67.8 Favored 'General case' 0 CA--C 1.557 1.234 0 CA-C-N 120.507 1.503 . . . . 0.0 114.0 168.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.9 mt -63.1 -37.74 88.42 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 168.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 56.7 t -58.39 -53.21 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-O 118.08 -0.962 . . . . 0.0 112.059 169.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -60.37 -36.17 77.42 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 172.82 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -56.61 -48.4 77.53 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 116.642 -1.646 . . . . 0.0 113.097 169.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -87.61 7.53 29.34 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 120.666 3.58 . . . . 0.0 120.666 167.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 69.9 mt -66.44 -49.38 66.92 Favored 'General case' 0 CA--C 1.559 1.296 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 150.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 50.39 33.96 8.41 Favored 'General case' 0 N--CA 1.504 2.258 0 CA-C-N 121.267 1.848 . . . . 0.0 111.535 -167.409 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . 0.277 16.4 p-10 -15.57 -48.47 0.03 OUTLIER Pre-proline 0 CA--C 1.587 2.387 1 N-CA-C 127.815 6.228 . . . . 0.0 127.815 -162.604 . . . . . . . . 3 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -57.51 -22.67 52.19 Favored 'Trans proline' 0 N--CA 1.512 2.6 1 CA-C-N 130.288 4.71 . . . . 0.0 117.419 166.763 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -81.81 -18.21 44.8 Favored 'General case' 0 CA--C 1.58 2.098 0 CA-C-N 110.426 -3.079 . . . . 0.0 113.231 163.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.01 -27.42 68.81 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 124.134 3.152 . . . . 0.0 114.48 165.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 57.21 37.8 28.52 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 121.595 1.998 . . . . 0.0 114.273 -174.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 66.1 m-80 57.53 38.87 28.13 Favored 'General case' 0 CA--C 1.582 2.191 0 CA-C-O 117.554 -1.213 . . . . 0.0 112.023 -167.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -157.29 163.86 32.65 Favored Glycine 0 C--N 1.372 2.53 0 CA-C-N 122.28 2.309 . . . . 0.0 114.061 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -175.83 136.95 0.33 Allowed 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 114.205 -0.998 . . . . 0.0 110.849 -176.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.427 ' HA ' HG13 ' A' ' 3' ' ' VAL . 4.9 mm -108.97 107.89 23.97 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.489 0 N-CA-C 103.224 -2.88 . . . . 0.0 103.224 167.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 79.5 mt -114.62 118.02 32.52 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -178.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -114.54 132.34 56.35 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 118.927 0.785 . . . . 0.0 112.398 -169.604 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 75.56 36.06 44.78 Favored Glycine 0 CA--C 1.55 2.265 0 N-CA-C 118.803 2.281 . . . . 0.0 118.803 172.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -99.65 -58.52 0.13 Allowed Pre-proline 0 N--CA 1.495 1.787 0 CA-C-O 113.536 -3.126 . . . . 0.0 111.479 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -59.66 61.5 0.07 OUTLIER 'Trans proline' 0 CA--C 1.574 2.492 1 N-CA-C 123.141 4.247 . . . . 0.0 123.141 170.487 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 1.427 ' CG ' HH12 ' A' ' 140' ' ' ARG . 13.9 ttp180 -52.01 -39.68 59.83 Favored 'General case' 0 CA--C 1.573 1.859 0 N-CA-C 116.124 1.898 . . . . 0.0 116.124 163.418 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.3 t -154.97 153.7 31.45 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.156 1.383 . . . . 0.0 107.636 -168.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.2 t -60.16 -37.5 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 CA-C-O 117.167 -1.397 . . . . 0.0 112.188 177.609 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.96 -37.02 80.93 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 120.596 3.554 . . . . 0.0 120.596 172.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -77.81 -46.77 20.58 Favored 'General case' 0 CA--C 1.588 2.418 0 CA-C-N 123.468 2.849 . . . . 0.0 111.635 166.397 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.16 -32.87 72.6 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 117.999 2.592 . . . . 0.0 117.999 -172.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -57.54 -33.54 68.21 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 168.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.77 -39.88 88.01 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 170.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 39.2 tp -64.62 -40.11 94.9 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 169.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -60.24 -53.06 62.22 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-N 119.715 1.143 . . . . 0.0 113.37 170.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 0.923 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 35.6 mt-10 -48.01 -38.47 17.15 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 167.373 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' MET . . . . . 1.216 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 25.0 ttt -84.38 -25.21 29.28 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 117.825 2.528 . . . . 0.0 117.825 176.737 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 41.9 tp -68.38 -53.7 22.12 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-N 120.59 1.541 . . . . 0.0 110.912 169.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -76.33 -54.4 6.81 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 119.37 0.987 . . . . 0.0 113.416 175.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.923 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 75.9 mtp180 -71.6 -39.39 70.53 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 177.473 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 1.216 ' HB3' ' O ' ' A' ' 99' ' ' MET . 3.6 tmt_? -61.78 -56.02 23.95 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 119.699 1.136 . . . . 0.0 110.375 164.787 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 113.26 41.63 0.96 Allowed Glycine 0 N--CA 1.481 1.692 0 O-C-N 124.076 0.86 . . . . 0.0 114.96 167.546 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 36.5 p -102.13 137.6 40.19 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 169.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -71.14 135.28 47.54 Favored 'General case' 0 N--CA 1.51 2.55 0 CA-C-O 122.699 1.238 . . . . 0.0 112.293 -171.252 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.2 tp -79.68 102.25 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 CA-C-N 113.356 -1.747 . . . . 0.0 108.089 172.773 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -96.08 -61.8 1.38 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 117.301 -1.333 . . . . 0.0 110.428 167.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -150.55 112.3 4.5 Favored 'General case' 0 C--N 1.36 1.024 0 CA-C-N 120.309 1.413 . . . . 0.0 113.707 -166.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -97.17 104.67 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.678 0 CA-C-N 115.085 -0.962 . . . . 0.0 111.0 167.805 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.946 HD12 ' HB3' ' A' ' 160' ' ' LYS 0.311 6.9 tp -103.49 111.23 23.58 Favored 'General case' 0 CA--C 1.556 1.201 0 N-CA-C 118.446 2.758 . . . . 0.0 118.446 -157.073 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.465 ' H ' ' N ' ' A' ' 161' ' ' THR . 68.0 mt-10 -96.72 107.47 19.94 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 122.062 2.21 . . . . 0.0 115.528 -172.161 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -88.0 108.93 19.45 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 118.706 -2.496 . . . . 0.0 108.324 170.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.681 ' HB3' ' HA ' ' A' ' 163' ' ' ASP . 10.1 tpt180 -95.18 95.14 8.34 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 112.575 -2.102 . . . . 0.0 110.359 -172.676 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.19 122.47 60.0 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.483 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 -168.453 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 52.0 p -59.24 140.12 56.29 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -172.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -52.94 -36.08 59.41 Favored 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 116.628 2.085 . . . . 0.0 116.628 177.815 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -52.53 -32.82 42.43 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 116.956 2.206 . . . . 0.0 116.956 174.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -59.48 -47.25 91.48 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 N-CA-C 115.848 1.796 . . . . 0.0 115.848 170.176 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 34.5 tp -65.02 -40.13 94.41 Favored 'General case' 0 CA--C 1.563 1.464 0 CA-C-N 114.506 -1.225 . . . . 0.0 114.059 170.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 69.1 mt -59.1 -47.53 84.92 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 115.732 1.752 . . . . 0.0 115.732 171.463 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -63.64 -40.53 97.12 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 173.436 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -58.69 -47.45 84.47 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 168.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.6 mp -52.85 -51.86 59.42 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 115.376 1.621 . . . . 0.0 115.376 171.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -74.84 -61.65 1.81 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 85.62 -41.01 3.04 Favored Glycine 0 CA--C 1.555 2.553 0 N-CA-C 116.128 1.211 . . . . 0.0 116.128 -175.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -151.98 -93.04 0.05 Allowed 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.579 ' O ' ' HB2' ' A' ' 129' ' ' ARG . . . -113.07 50.47 0.77 Allowed Glycine 0 CA--C 1.551 2.319 0 CA-C-O 118.095 -1.392 . . . . 0.0 114.873 171.434 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.579 ' HB2' ' O ' ' A' ' 128' ' ' GLY . 78.5 mtp180 82.45 101.34 0.05 Allowed 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 119.893 1.847 . . . . 0.0 112.323 175.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -101.53 32.1 3.49 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 176.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 46.66 50.76 12.82 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 118.194 2.664 . . . . 0.0 118.194 -177.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -100.15 86.74 3.29 Favored 'General case' 0 N--CA 1.487 1.404 1 N-CA-C 96.837 -5.246 . . . . 0.0 96.837 158.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 33.6 p -49.34 134.31 18.76 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 118.408 2.744 . . . . 0.0 118.408 -156.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -58.48 -36.83 74.36 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 111.116 -2.765 . . . . 0.0 115.259 169.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -64.15 -37.28 86.9 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 115.984 1.846 . . . . 0.0 115.984 169.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.4 t -64.67 -44.0 96.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 CA-C-N 120.718 1.599 . . . . 0.0 113.026 174.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.1 tp -69.5 -33.2 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 172.221 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 42.6 mt -64.95 -40.76 95.51 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 120.37 1.441 . . . . 0.0 114.107 168.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -65.47 -38.23 89.18 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 172.29 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 1.427 HH12 ' CG ' ' A' ' 88' ' ' ARG . 14.6 tpt180 -63.39 -43.7 96.81 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 169.686 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 67.4 mtt -66.04 -27.77 68.35 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 169.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -68.05 -44.56 76.11 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 169.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.5 p -66.06 -35.77 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 CA-C-N 120.514 1.507 . . . . 0.0 114.251 170.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -53.35 -56.33 17.61 Favored 'General case' 0 CA--C 1.581 2.151 0 CA-C-N 120.129 1.331 . . . . 0.0 111.522 167.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 49.9 ttt180 -53.88 -27.59 31.16 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 120.326 3.454 . . . . 0.0 120.326 173.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -54.61 -38.25 66.56 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 171.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -141.33 10.03 2.08 Favored 'General case' 0 CA--C 1.561 1.38 0 N-CA-C 119.389 3.107 . . . . 0.0 119.389 -168.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 80.3 m -47.49 -36.49 10.29 Favored 'General case' 0 N--CA 1.505 2.321 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 177.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.62 -60.95 4.13 Favored Pre-proline 0 CA--C 1.578 2.054 0 CA-C-O 116.254 -1.831 . . . . 0.0 112.021 173.39 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -51.07 -32.9 41.02 Favored 'Trans proline' 0 CA--C 1.578 2.689 0 C-N-CA 123.407 2.738 . . . . 0.0 118.351 167.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -67.08 -50.45 61.66 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 125.02 1.328 . . . . 0.0 111.797 176.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 1.188 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 58.3 tp -63.26 -23.53 67.46 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 170.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -70.41 -50.92 33.55 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 122.696 2.498 . . . . 0.0 113.108 165.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -61.27 -53.75 52.78 Favored 'General case' 0 CA--C 1.571 1.788 0 C-N-CA 124.141 0.976 . . . . 0.0 112.864 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -80.87 -17.62 50.05 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-O 116.006 -1.949 . . . . 0.0 113.82 177.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 1.188 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 31.7 ttt180 -69.66 -33.86 73.19 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 123.591 2.905 . . . . 0.0 115.733 167.212 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -73.11 -40.47 64.93 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 119.979 1.263 . . . . 0.0 113.659 167.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -82.14 -18.05 44.23 Favored 'General case' 0 CA--C 1.577 1.985 0 N-CA-C 119.142 3.016 . . . . 0.0 119.142 177.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.29 127.19 18.89 Favored 'General case' 0 CA--C 1.585 2.309 1 N-CA-C 123.692 4.701 . . . . 0.0 123.692 -159.754 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.946 ' HB3' HD12 ' A' ' 111' ' ' LEU 0.257 46.7 mmtm -92.88 -154.15 0.38 Allowed 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 123.716 1.722 . . . . 0.0 107.708 155.385 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.627 HG23 ' HB ' ' A' ' 162' ' ' VAL 0.763 0.4 OUTLIER -30.93 -164.83 0.0 OUTLIER 'General case' 0 CA--C 1.62 3.663 1 N-CA-C 128.041 6.312 . . . . 0.0 128.041 -146.103 . . . . . . . . 5 4 . 1 . 018 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.747 HG21 ' HB3' ' A' ' 174' ' ' ARG 0.475 2.1 t -88.4 -174.42 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.673 3 C-N-CA 139.219 7.008 . . . . 0.0 122.586 -146.687 . . . . . . . . 4 3 . 1 . 018 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.681 ' HA ' ' HB3' ' A' ' 114' ' ' ARG . 12.6 t70 -102.49 134.77 45.28 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 111.38 -2.645 . . . . 0.0 106.59 168.455 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -143.37 -146.03 0.18 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 117.057 2.243 . . . . 0.0 117.057 -155.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . 0.532 3.5 p 59.14 170.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 C-N-CA 128.503 2.721 . . . . 0.0 114.078 -174.548 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.81 -36.74 2.3 Favored Glycine 0 CA--C 1.568 3.362 0 C-N-CA 119.051 -1.547 . . . . 0.0 114.689 -149.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 72.0 p 36.31 86.82 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 117.69 2.478 . . . . 0.0 117.69 170.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 21.5 ptt? -159.24 -114.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 117.618 -1.182 . . . . 0.0 108.749 168.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -79.44 -36.82 38.32 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 121.236 1.835 . . . . 0.0 114.479 -179.344 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -60.16 -53.4 58.22 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 173.197 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 18.2 t -66.71 -31.67 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 CA-C-N 119.778 1.172 . . . . 0.0 111.533 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -58.78 -38.17 77.92 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 164.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.46 -50.69 64.43 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' ARG . . . . . 0.747 ' HB3' HG21 ' A' ' 162' ' ' VAL . 72.9 mtt180 -61.15 -42.18 98.09 Favored 'General case' 0 CA--C 1.557 1.216 0 N-CA-C 117.305 2.335 . . . . 0.0 117.305 169.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.04 -46.87 82.09 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 116.512 2.042 . . . . 0.0 116.512 172.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 6.0 mp -63.5 -39.49 94.57 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 117.832 -1.08 . . . . 0.0 113.756 168.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -50.42 -45.81 56.02 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 169.267 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -74.57 -42.83 58.05 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 116.14 1.904 . . . . 0.0 116.14 172.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 8.7 tt -73.57 -51.47 16.81 Favored 'General case' 0 CA--C 1.568 1.645 0 CA-C-N 121.005 1.73 . . . . 0.0 113.213 -179.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.923 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -114.74 -59.52 0.37 Allowed Glycine 0 CA--C 1.552 2.385 0 CA-C-O 117.709 -1.606 . . . . 0.0 114.507 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.923 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 63.7 tttm . . . . . 0 C--O 1.25 1.112 0 CA-C-N 120.391 2.096 . . . . 0.0 109.144 -177.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 CA--C 1.554 1.119 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.427 ' HB2' ' O ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -154.35 171.06 19.9 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -167.548 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . 0.413 HG22 ' HB3' ' A' ' 109' ' ' ALA . 77.8 t -133.9 147.86 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.66 0 CA-C-O 124.316 2.008 . . . . 0.0 111.883 -164.297 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -119.21 140.47 50.16 Favored 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 111.783 -2.462 . . . . 0.0 105.522 167.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -115.84 123.51 48.35 Favored 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 124.906 1.283 . . . . 0.0 109.81 -178.05 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.8 mp -126.17 157.07 39.11 Favored 'General case' 0 CA--C 1.559 1.304 0 CA-C-N 112.627 -2.079 . . . . 0.0 109.748 -166.182 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 167.96 154.31 8.64 Favored Glycine 0 CA--C 1.554 2.504 0 N-CA-C 115.494 0.957 . . . . 0.0 115.494 169.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -73.85 177.42 8.13 Favored 'Trans proline' 0 CA--C 1.576 2.576 0 C-N-CA 123.173 2.582 . . . . 0.0 114.195 173.484 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -55.02 111.16 0.66 Allowed 'Trans proline' 0 CA--C 1.561 1.854 0 C-N-CA 123.44 2.76 . . . . 0.0 113.831 173.117 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 161.43 95.02 0.1 Allowed Glycine 0 CA--C 1.535 1.301 0 N-CA-C 107.532 -2.227 . . . . 0.0 107.532 -167.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.38 120.36 10.3 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 115.489 1.662 . . . . 0.0 115.489 -170.404 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 165.56 84.99 0.06 OUTLIER Glycine 0 CA--C 1.543 1.821 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 177.09 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.813 ' HB3' ' OD1' ' A' ' 84' ' ' ASP . 7.7 mptt -153.1 -69.58 0.15 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.576 0.75 . . . . 0.0 111.1 -174.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -53.01 -27.34 29.86 Favored Glycine 0 CA--C 1.556 2.612 0 N-CA-C 120.952 3.141 . . . . 0.0 120.952 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 51.7 m -63.64 -51.44 65.18 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 119.892 1.846 . . . . 0.0 112.964 171.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.34 2.7 mp0 -77.91 -12.92 60.02 Favored 'General case' 0 CA--C 1.57 1.713 0 CA-C-O 115.088 -2.387 . . . . 0.0 112.537 172.499 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.43 -43.76 63.37 Favored 'General case' 0 C--N 1.376 1.733 0 CA-C-N 124.598 3.363 . . . . 0.0 114.142 165.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 93.4 t -65.74 -42.7 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-O 117.677 -1.154 . . . . 0.0 112.655 173.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . 0.445 ' HB3' ' HE1' ' A' ' 172' ' ' PHE . 95.1 mttt -68.01 -44.35 76.75 Favored 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 115.797 1.777 . . . . 0.0 115.797 174.906 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.88 -29.08 68.89 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 120.58 1.536 . . . . 0.0 114.317 171.756 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.56 -41.3 98.42 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 167.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.97 -40.58 80.96 Favored 'General case' 0 CA--C 1.566 1.559 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 167.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -66.18 -50.86 62.44 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 172.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.2 mt -83.16 -22.72 33.2 Favored 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 116.807 2.151 . . . . 0.0 116.807 -177.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.23 34.6 8.61 Favored Glycine 0 CA--C 1.555 2.547 0 N-CA-C 117.742 1.857 . . . . 0.0 117.742 -174.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.1 mm -105.43 152.46 39.94 Favored Pre-proline 0 CA--C 1.568 1.651 0 CA-C-N 119.149 1.474 . . . . 0.0 112.205 -169.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -82.6 99.74 0.95 Allowed 'Trans proline' 0 CA--C 1.564 1.988 0 CA-C-N 122.06 1.771 . . . . 0.0 108.668 162.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.22 116.92 11.14 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.991 0.9 . . . . 0.0 110.226 176.262 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 38.6 mm -97.91 108.25 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 -176.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 70.0 p -96.2 129.56 43.48 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 172.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.6 p -71.36 -8.66 55.18 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 -170.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.535 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -92.12 -17.64 46.28 Favored Glycine 0 CA--C 1.55 2.23 0 N-CA-C 118.29 2.076 . . . . 0.0 118.29 165.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -79.37 -55.83 4.77 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 119.097 1.449 . . . . 0.0 113.683 -168.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -60.06 -38.02 81.59 Favored 'General case' 0 CA--C 1.565 1.522 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 173.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.421 ' HB2' ' HB2' ' A' ' 50' ' ' LYS . 41.8 m-85 -67.88 -41.81 82.21 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 116.676 -1.63 . . . . 0.0 113.719 169.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.535 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 35.2 ttt180 -54.05 -40.13 66.84 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 116.587 2.069 . . . . 0.0 116.587 169.365 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -63.29 -39.72 95.37 Favored 'General case' 0 CA--C 1.566 1.578 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 169.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -67.64 -23.63 65.36 Favored 'General case' 0 CA--C 1.587 2.398 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 167.171 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.5 mt -62.35 -50.46 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.485 0 CA-C-N 121.609 2.004 . . . . 0.0 109.239 166.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -60.3 -40.99 92.46 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 175.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -70.01 -37.2 75.58 Favored 'General case' 0 CA--C 1.563 1.462 0 N-CA-C 116.84 2.163 . . . . 0.0 116.84 173.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.65 75.07 1.29 Allowed Glycine 0 CA--C 1.544 1.895 0 CA-C-O 117.754 -1.581 . . . . 0.0 114.733 -175.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.939 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 82.2 p -96.45 -62.81 1.21 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 119.683 1.742 . . . . 0.0 111.29 170.182 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.939 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.302 13.0 mttt 115.83 -42.75 0.01 OUTLIER 'General case' 0 CA--C 1.573 1.861 0 CA-C-O 116.064 -1.922 . . . . 0.0 108.871 -173.423 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.41 -14.96 60.49 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 123.395 2.816 . . . . 0.0 112.891 161.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.456 ' O ' ' HB3' ' A' ' 50' ' ' LYS . . . -58.99 -62.9 5.7 Favored Glycine 0 C--N 1.355 1.598 0 CA-C-N 120.11 1.323 . . . . 0.0 114.148 169.455 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.295 7.7 p -69.23 -51.4 43.51 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.302 0 N-CA-C 116.862 2.171 . . . . 0.0 116.862 -168.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -67.09 -45.93 75.78 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 119.923 1.238 . . . . 0.0 112.397 176.86 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.27 -28.97 67.66 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.456 ' HB3' ' O ' ' A' ' 46' ' ' GLY 0.278 4.2 tptt -76.02 -37.43 58.42 Favored 'General case' 0 CA--C 1.559 1.319 0 CA-C-O 116.21 -1.852 . . . . 0.0 113.11 170.986 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -78.31 -45.57 22.36 Favored 'General case' 0 CA--C 1.602 2.968 1 CA-C-O 86.548 -15.977 . . . . 0.0 118.565 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 17.2 m-30 -31.07 -54.18 0.21 Allowed 'General case' 0 N--CA 1.498 1.937 1 O-C-N 108.236 -9.04 . . . . 0.0 120.467 145.215 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.49 -49.96 63.68 Favored 'General case' 0 CA--C 1.576 1.949 0 CA-C-N 121.796 2.089 . . . . 0.0 114.462 166.066 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -77.0 -44.81 29.55 Favored 'General case' 0 CA--C 1.565 1.542 0 N-CA-C 115.948 1.832 . . . . 0.0 115.948 177.432 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -87.22 -24.84 24.28 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 116.148 1.906 . . . . 0.0 116.148 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.32 22.64 11.31 Favored Glycine 0 CA--C 1.544 1.856 0 N-CA-C 117.883 1.913 . . . . 0.0 117.883 168.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -95.62 177.96 5.63 Favored 'General case' 0 CA--C 1.573 1.865 0 CA-C-N 118.617 1.208 . . . . 0.0 110.504 168.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.3 pp -76.64 124.17 27.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.494 -1.378 . . . . 0.0 112.836 -168.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 p -113.4 122.47 35.31 Favored Pre-proline 0 CA--C 1.567 1.627 0 C-N-CA 124.656 1.182 . . . . 0.0 108.601 -177.325 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -55.51 141.62 82.43 Favored 'Trans proline' 0 C--N 1.37 1.666 0 C-N-CA 123.449 2.766 . . . . 0.0 116.135 174.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.6 m -85.46 177.55 7.73 Favored 'General case' 0 CA--C 1.569 1.707 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.712 177.044 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.9 t70 82.09 -52.03 0.23 Allowed 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 125.77 1.628 . . . . 0.0 113.64 178.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.2 pp -58.17 -41.75 84.52 Favored 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 116.335 1.976 . . . . 0.0 116.335 168.387 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.5 m -58.63 -51.96 67.72 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 124.914 1.286 . . . . 0.0 113.313 170.864 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -62.08 -21.97 65.39 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 167.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -76.95 -45.86 26.15 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 125.366 1.466 . . . . 0.0 114.841 172.499 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.4 mt -61.97 -45.77 92.21 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 169.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 52.7 t -56.42 -55.55 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-O 117.944 -1.027 . . . . 0.0 111.497 171.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -61.22 -31.08 70.86 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 116.836 2.162 . . . . 0.0 116.836 175.485 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -60.61 -40.46 91.93 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-O 117.937 -1.03 . . . . 0.0 113.288 167.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -80.92 -23.37 38.95 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 118.521 2.786 . . . . 0.0 118.521 169.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 66.4 mt -85.59 -22.14 28.17 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 116.832 2.16 . . . . 0.0 116.832 178.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -68.77 8.37 0.52 Allowed 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 116.994 2.22 . . . . 0.0 116.994 169.434 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -66.45 144.0 98.47 Favored Pre-proline 0 CA--C 1.576 1.957 0 C-N-CA 124.261 1.025 . . . . 0.0 109.957 165.294 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -50.44 -37.37 51.18 Favored 'Trans proline' 0 N--CA 1.5 1.875 0 N-CA-C 118.412 2.428 . . . . 0.0 118.412 171.386 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -68.85 -15.03 63.39 Favored 'General case' 0 CA--C 1.57 1.72 0 CA-C-O 116.367 -1.778 . . . . 0.0 115.674 174.264 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -111.67 20.71 16.84 Favored 'General case' 0 CA--C 1.574 1.887 0 CA-C-N 122.566 2.439 . . . . 0.0 114.401 168.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.54 -52.4 32.41 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 121.453 1.933 . . . . 0.0 113.664 171.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -93.99 20.88 7.27 Favored 'General case' 0 CA--C 1.577 1.985 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 171.262 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -173.29 159.49 29.63 Favored Glycine 0 C--N 1.358 1.77 0 CA-C-N 122.028 2.195 . . . . 0.0 113.472 176.305 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' PHE . . . . . 0.427 ' O ' ' HB2' ' A' ' 2' ' ' ARG . 30.3 p90 -179.08 135.04 0.13 Allowed 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 113.862 -1.169 . . . . 0.0 111.121 176.073 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 22.1 mt -114.33 109.41 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 105.037 -2.208 . . . . 0.0 105.037 172.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.4 mt -101.21 120.95 40.99 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 118.643 -0.694 . . . . 0.0 109.638 174.184 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.813 ' OD1' ' HB3' ' A' ' 13' ' ' LYS . 25.1 t70 -110.13 129.21 55.74 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 119.006 0.821 . . . . 0.0 110.983 -177.138 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 74.27 39.62 43.35 Favored Glycine 0 CA--C 1.552 2.361 0 CA-C-O 117.361 -1.799 . . . . 0.0 117.258 -178.5 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . 0.256 1.0 OUTLIER -103.8 -58.05 0.08 OUTLIER Pre-proline 0 N--CA 1.496 1.834 0 CA-C-O 113.35 -3.214 . . . . 0.0 111.01 -174.439 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -63.22 70.89 0.14 Allowed 'Trans proline' 0 CA--C 1.571 2.35 0 CA-C-N 126.724 3.437 . . . . 0.0 119.29 167.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -67.53 -29.53 68.96 Favored 'General case' 0 CA--C 1.567 1.623 0 C-N-CA 125.907 1.683 . . . . 0.0 114.503 166.359 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 77.1 p -151.02 159.52 44.5 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.05 1.34 . . . . 0.0 108.78 -172.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.0 t -64.73 -41.69 92.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 CA-C-O 117.425 -1.274 . . . . 0.0 110.752 167.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.16 -37.79 86.58 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 120.672 3.582 . . . . 0.0 120.672 178.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -75.92 -48.29 21.88 Favored 'General case' 0 CA--C 1.583 2.225 0 CA-C-N 122.586 2.448 . . . . 0.0 111.94 167.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.14 -31.5 72.65 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 117.485 2.402 . . . . 0.0 117.485 -171.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 64.3 tttt -60.34 -30.48 69.55 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 168.557 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.53 -47.6 75.35 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 168.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.9 tp -58.48 -41.96 86.43 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 170.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 23.4 t-80 -72.81 -41.52 64.83 Favored 'General case' 0 CA--C 1.567 1.596 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 176.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 1.334 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 37.7 mt-10 -56.18 -32.62 64.51 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 165.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' MET . . . . . 1.304 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 26.8 ttt -84.72 -28.5 26.26 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 118.152 2.649 . . . . 0.0 118.152 173.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 64.0 tp -66.88 -54.22 24.48 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-N 120.319 1.418 . . . . 0.0 112.855 169.102 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -79.7 -49.55 11.93 Favored 'General case' 0 CA--C 1.563 1.472 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 176.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 1.334 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 38.0 mmt180 -68.64 -45.39 71.96 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 175.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 1.304 ' HB3' ' O ' ' A' ' 99' ' ' MET . 74.8 ttt180 -61.4 -57.25 13.01 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 118.843 0.747 . . . . 0.0 111.398 165.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.82 43.16 1.05 Allowed Glycine 0 N--CA 1.479 1.536 0 O-C-N 124.41 1.069 . . . . 0.0 113.941 169.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 40.2 p -90.97 147.18 23.27 Favored 'General case' 0 CA--C 1.559 1.318 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 168.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -65.12 130.62 44.01 Favored 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -169.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.5 tp -90.43 99.17 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 125.344 1.458 . . . . 0.0 107.512 177.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -98.55 -75.15 0.56 Allowed 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 115.898 -2.001 . . . . 0.0 108.419 168.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ALA . . . . . 0.413 ' HB3' HG22 ' A' ' 3' ' ' VAL . . . -136.3 117.37 14.36 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 121.644 2.02 . . . . 0.0 113.459 -174.11 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.4 t -94.99 108.07 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 101.628 -3.471 . . . . 0.0 101.628 167.796 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.464 HD23 ' HB3' ' A' ' 160' ' ' LYS . 78.8 mt -109.19 105.33 14.73 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -164.114 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -90.55 130.9 36.54 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.93 0.871 . . . . 0.0 111.478 172.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -100.38 110.1 22.29 Favored 'General case' 0 CA--C 1.559 1.316 0 CA-C-N 114.227 -1.351 . . . . 0.0 109.426 -176.603 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . 0.25 71.8 ttt180 -73.11 101.12 3.21 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 126.835 2.054 . . . . 0.0 109.497 169.039 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.9 p -130.4 161.79 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.584 0 CA-C-N 112.416 -2.175 . . . . 0.0 110.491 -165.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.1 m -103.81 151.86 22.57 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.164 -168.842 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -59.77 -45.82 91.09 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 168.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -51.65 -39.24 57.79 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 117.343 2.349 . . . . 0.0 117.343 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.4 m -61.36 -46.3 96.88 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.405 0 N-CA-C 117.011 2.226 . . . . 0.0 117.011 172.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.484 ' O ' ' HB2' ' A' ' 123' ' ' ARG . 8.6 tt -55.47 -39.39 70.32 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 115.039 -0.982 . . . . 0.0 113.547 166.04 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 25.4 mt -60.26 -38.12 82.56 Favored 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 170.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -57.01 -47.32 81.14 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 167.176 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.484 ' HB2' ' O ' ' A' ' 120' ' ' LEU . 31.2 mmt180 -51.61 -45.37 63.21 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 116.702 2.112 . . . . 0.0 116.702 167.409 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 70.6 mt -60.82 -48.12 83.23 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.042 1.497 . . . . 0.0 115.042 171.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -56.72 -45.9 81.63 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 172.753 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -102.77 70.54 0.31 Allowed Glycine 0 CA--C 1.543 1.81 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 167.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -38.66 134.46 0.94 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 119.032 2.975 . . . . 0.0 119.032 -168.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 129' ' ' ARG . . . -162.16 -164.35 16.94 Favored Glycine 0 CA--C 1.569 3.416 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.421 -174.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' A' ' 128' ' ' GLY . 2.2 mpt_? 73.53 -138.31 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 120.988 2.394 . . . . 0.0 113.484 176.218 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.445 ' H ' ' HB3' ' A' ' 129' ' ' ARG . . . -121.47 36.37 4.63 Favored 'General case' 0 CA--C 1.572 1.803 0 CA-C-N 111.452 -2.613 . . . . 0.0 112.164 167.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -73.61 92.28 1.93 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 126.05 1.74 . . . . 0.0 110.34 -178.137 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -88.09 63.73 7.42 Favored 'General case' 0 CA--C 1.574 1.891 0 CA-C-N 111.664 -2.516 . . . . 0.0 106.98 163.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 32.0 p -0.35 117.92 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 120.937 3.68 . . . . 0.0 120.937 -165.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.293 1.2 p30 76.69 -42.45 0.43 Allowed 'General case' 0 N--CA 1.502 2.146 0 CA-C-N 111.013 -2.812 . . . . 0.0 116.011 168.126 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -69.43 -35.29 75.56 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 172.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.6 t -59.15 -46.31 92.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 169.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.4 tp -73.6 -31.25 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 175.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 38.5 tp -66.95 -37.5 84.39 Favored 'General case' 0 CA--C 1.571 1.781 0 CA-C-N 120.962 1.71 . . . . 0.0 113.381 168.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -68.79 -36.1 77.85 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 120.797 1.635 . . . . 0.0 113.96 169.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -57.28 -37.98 73.23 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 115.262 1.579 . . . . 0.0 115.262 165.297 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 24.9 ttt -67.2 -33.97 76.52 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 168.678 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 60.9 mttm -60.73 -50.73 72.32 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 169.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.4 p -64.08 -31.53 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 170.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -54.45 -49.5 69.92 Favored 'General case' 0 CA--C 1.583 2.226 0 CA-C-N 119.755 1.161 . . . . 0.0 112.104 167.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 66.9 ttt180 -60.04 -41.4 92.21 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 118.461 2.763 . . . . 0.0 118.461 174.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -51.38 -29.06 14.34 Favored 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 118.998 2.962 . . . . 0.0 118.998 172.702 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -132.9 -37.31 1.01 Allowed 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 119.635 3.198 . . . . 0.0 119.635 -163.243 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 86.0 m -46.51 -39.69 11.26 Favored 'General case' 0 N--CA 1.504 2.248 0 N-CA-C 118.654 2.835 . . . . 0.0 118.654 -167.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.403 ' HB3' ' HD3' ' A' ' 150' ' ' PRO . . . -68.72 -61.4 3.69 Favored Pre-proline 0 CA--C 1.579 2.087 0 CA-C-O 116.466 -1.731 . . . . 0.0 112.118 175.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.403 ' HD3' ' HB3' ' A' ' 149' ' ' ALA . 86.9 Cg_exo -51.85 -31.16 41.45 Favored 'Trans proline' 0 CA--C 1.579 2.748 0 C-N-CA 123.387 2.725 . . . . 0.0 118.392 167.134 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.43 -54.38 33.62 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 125.515 1.526 . . . . 0.0 111.955 174.153 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 1.157 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 52.1 tp -65.47 -21.7 66.66 Favored 'General case' 0 CA--C 1.566 1.566 0 CA-C-O 116.803 -1.57 . . . . 0.0 114.801 175.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -71.44 -50.66 29.59 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 122.227 2.285 . . . . 0.0 113.307 164.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -65.86 -52.48 49.94 Favored 'General case' 0 CA--C 1.566 1.576 0 CA-C-N 120.466 1.484 . . . . 0.0 112.401 -178.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -76.59 -30.48 57.01 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-O 114.994 -2.431 . . . . 0.0 111.393 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 1.157 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 32.1 ttt180 -59.68 -34.05 72.36 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 124.955 3.525 . . . . 0.0 116.91 168.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -68.58 -41.88 79.04 Favored 'General case' 0 CA--C 1.573 1.83 0 CA-C-N 119.659 1.118 . . . . 0.0 113.519 167.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 38.9 mm-40 -90.63 -19.37 23.74 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 119.99 3.33 . . . . 0.0 119.99 -178.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.7 pp -77.97 179.72 6.59 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 119.506 3.15 . . . . 0.0 119.506 -161.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' LYS . . . . . 0.464 ' HB3' HD23 ' A' ' 111' ' ' LEU . 50.9 mttt -135.59 135.88 40.62 Favored 'General case' 0 CA--C 1.564 1.493 0 N-CA-C 105.113 -2.18 . . . . 0.0 105.113 167.934 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 42.0 m -100.34 146.15 27.3 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 122.217 1.008 . . . . 0.0 110.269 -172.127 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 43.1 t -131.36 136.11 58.17 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.392 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 167.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -94.95 126.97 40.65 Favored 'General case' 0 CA--C 1.565 1.555 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 169.379 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -109.34 7.85 25.29 Favored 'General case' 0 N--CA 1.493 1.678 1 N-CA-C 126.339 5.681 . . . . 0.0 126.339 -159.596 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . 0.486 29.2 m -111.17 -127.79 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.594 2.641 1 CA-C-O 109.954 -4.831 . . . . 0.0 107.597 -178.009 . . . . . . . . 3 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 53.38 -3.11 0.01 OUTLIER Glycine 0 C--N 1.391 3.591 3 CA-C-N 133.611 7.459 . . . . 0.0 126.235 -168.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 69.0 p 59.51 80.12 0.21 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 127.377 2.271 . . . . 0.0 115.501 173.834 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . 0.25 59.2 mtt 78.01 -75.51 0.05 Allowed 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 126.202 1.801 . . . . 0.0 114.119 167.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -61.51 -39.48 91.13 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 115.925 1.824 . . . . 0.0 115.925 -174.373 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -60.18 -52.79 63.8 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 169.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 2.7 t -59.27 -35.25 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' PHE . . . . . 0.445 ' HE1' ' HB3' ' A' ' 19' ' ' LYS . 8.4 t80 -61.16 -40.81 95.27 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 167.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.12 -43.49 95.12 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 115.089 1.515 . . . . 0.0 115.089 175.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 82.2 mtt-85 -71.73 -36.74 70.58 Favored 'General case' 0 CA--C 1.56 1.36 0 N-CA-C 116.265 1.95 . . . . 0.0 116.265 173.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.38 -44.16 92.21 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 171.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.7 mp -64.88 -42.08 95.11 Favored 'General case' 0 CA--C 1.567 1.612 0 CA-C-O 117.148 -1.406 . . . . 0.0 110.656 167.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -46.64 -41.61 14.99 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 117.567 2.432 . . . . 0.0 117.567 168.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -67.1 -48.51 67.95 Favored 'General case' 0 CA--C 1.562 1.431 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 168.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 5.8 tt -86.25 -58.13 2.75 Favored 'General case' 0 CA--C 1.57 1.72 0 CA-C-N 120.275 1.398 . . . . 0.0 113.575 -176.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 0.539 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -118.49 -56.88 0.27 Allowed Glycine 0 CA--C 1.553 2.438 0 CA-C-O 117.339 -1.811 . . . . 0.0 116.353 -174.811 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 0.539 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 38.9 ttmt . . . . . 0 C--O 1.251 1.166 0 CA-C-N 120.957 2.378 . . . . 0.0 108.207 -173.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.5 ttm . . . . . 0 CA--C 1.56 1.328 0 CA-C-O 122.517 1.151 . . . . 0.0 109.631 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . 0.263 11.4 mpt_? -123.64 162.25 23.43 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 120.582 3.549 . . . . 0.0 120.582 -161.398 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.8 p -151.08 147.36 15.67 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.744 0 CA-C-O 123.931 1.825 . . . . 0.0 114.424 167.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.3 mt -131.83 133.44 44.68 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-N 111.42 -2.627 . . . . 0.0 108.375 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.48 120.26 41.03 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -169.062 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.8 mt -110.37 135.74 50.62 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 112.231 -2.258 . . . . 0.0 109.568 175.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 173.84 168.43 34.81 Favored Glycine 0 CA--C 1.56 2.869 0 N-CA-C 115.848 1.099 . . . . 0.0 115.848 171.591 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -62.44 152.59 76.27 Favored 'Trans proline' 0 CA--C 1.572 2.378 0 C-N-CA 123.44 2.76 . . . . 0.0 116.725 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.475 ' HG3' ' HB3' ' A' ' 140' ' ' ARG . 74.4 Cg_endo -77.47 98.93 1.25 Allowed 'Trans proline' 0 CA--C 1.56 1.815 0 C-N-CA 123.296 2.664 . . . . 0.0 113.589 -173.035 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.691 ' HA2' ' HG2' ' A' ' 123' ' ' ARG . . . 137.81 -64.43 0.56 Allowed Glycine 0 N--CA 1.485 1.925 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 -169.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -33.11 159.29 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.539 0 N-CA-C 119.839 3.274 . . . . 0.0 119.839 173.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.86 116.3 9.02 Favored Glycine 0 CA--C 1.546 2.003 0 N-CA-C 115.293 0.877 . . . . 0.0 115.293 -174.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -152.3 -75.09 0.14 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.261 0.624 . . . . 0.0 109.761 -169.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -57.84 -30.66 63.31 Favored Glycine 0 CA--C 1.552 2.386 0 N-CA-C 120.053 2.781 . . . . 0.0 120.053 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 54.6 m -66.78 -53.82 29.09 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 119.852 1.826 . . . . 0.0 112.539 176.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -74.31 -16.79 60.92 Favored 'General case' 0 CA--C 1.573 1.84 0 CA-C-O 116.057 -1.925 . . . . 0.0 112.403 172.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.57 -41.31 63.09 Favored 'General case' 0 C--N 1.372 1.582 0 CA-C-N 123.288 2.767 . . . . 0.0 114.912 169.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.7 t -69.03 -39.26 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 CA-C-O 117.644 -1.169 . . . . 0.0 111.789 171.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -61.62 -46.39 90.01 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 116.353 1.983 . . . . 0.0 116.353 170.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.93 -33.49 75.94 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 172.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.06 -41.6 96.92 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 167.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -59.49 -38.12 80.03 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 166.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -66.09 -50.78 62.9 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 116.142 1.905 . . . . 0.0 116.142 171.169 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.5 mt -81.39 -24.49 36.95 Favored 'General case' 0 CA--C 1.571 1.78 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 -178.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.15 37.07 7.89 Favored Glycine 0 CA--C 1.555 2.542 0 N-CA-C 117.771 1.868 . . . . 0.0 117.771 -176.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.1 mm -109.24 159.2 32.17 Favored Pre-proline 0 CA--C 1.567 1.624 0 CA-C-N 118.833 1.317 . . . . 0.0 113.53 -168.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.412 ' HB2' HH11 ' A' ' 71' ' ' ARG . 73.1 Cg_exo -71.67 100.6 1.07 Allowed 'Trans proline' 0 CA--C 1.563 1.969 0 C-N-CA 122.0 1.8 . . . . 0.0 114.224 160.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -73.41 109.85 7.25 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.383 -0.823 . . . . 0.0 111.044 167.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.3 mm -98.23 119.84 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 167.419 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 62.9 p -99.89 124.66 45.43 Favored 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 161.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.5 p -66.05 -18.61 65.45 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 117.306 2.335 . . . . 0.0 117.306 -169.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.429 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -80.29 -18.93 70.37 Favored Glycine 0 CA--C 1.548 2.098 0 N-CA-C 118.805 2.282 . . . . 0.0 118.805 168.187 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -80.24 -49.86 11.02 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -169.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -69.15 -36.35 77.33 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 174.439 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PHE . . . . . 0.442 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 42.5 m-85 -66.95 -38.48 86.21 Favored 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 125.379 1.472 . . . . 0.0 114.575 169.539 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 29.5 ttp180 -61.21 -40.67 94.85 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-N 120.109 1.322 . . . . 0.0 113.578 166.779 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -59.14 -37.15 76.58 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 168.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -66.36 -31.91 72.97 Favored 'General case' 0 CA--C 1.573 1.828 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 166.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.36 -45.68 97.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 CA-C-N 120.092 1.314 . . . . 0.0 112.65 170.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -68.17 -39.89 82.43 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 120.074 1.307 . . . . 0.0 113.814 174.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -77.05 -28.99 54.96 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 116.849 2.166 . . . . 0.0 116.849 178.143 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.08 74.17 1.28 Allowed Glycine 0 CA--C 1.542 1.757 0 CA-C-O 118.088 -1.395 . . . . 0.0 115.168 178.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.921 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 62.6 p -91.62 -60.24 1.93 Allowed 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 119.127 1.464 . . . . 0.0 111.285 169.283 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.921 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.287 13.4 mttt 114.44 -40.88 0.01 OUTLIER 'General case' 0 CA--C 1.567 1.604 0 CA-C-O 115.874 -2.012 . . . . 0.0 109.534 -173.103 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.513 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -73.14 -23.18 60.44 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 123.609 2.913 . . . . 0.0 111.729 161.146 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.55 -54.85 33.21 Favored Glycine 0 C--N 1.352 1.436 0 C-N-CA 125.673 1.606 . . . . 0.0 115.912 174.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.293 0.8 OUTLIER -65.62 -57.0 12.54 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.714 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -179.717 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -67.81 -51.01 53.69 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 120.033 1.288 . . . . 0.0 112.344 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' A' ' 45' ' ' LEU . . . -67.25 -19.51 65.52 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 176.618 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . 0.442 ' HB2' ' HB3' ' A' ' 35' ' ' PHE . 14.1 tmtt? -74.53 -45.52 45.15 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 120.577 1.535 . . . . 0.0 112.929 167.911 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -75.08 -48.37 24.24 Favored 'General case' 0 CA--C 1.583 2.227 1 CA-C-O 85.341 -16.552 . . . . 0.0 119.564 -176.066 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 12.9 m-30 -34.5 -54.33 0.53 Allowed 'General case' 0 N--CA 1.496 1.871 1 O-C-N 109.293 -8.38 . . . . 0.0 120.481 146.104 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.6 tp -59.41 -30.95 68.83 Favored 'General case' 0 CA--C 1.579 2.093 0 CA-C-N 122.366 2.348 . . . . 0.0 115.569 167.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -91.27 -41.79 10.75 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 115.964 1.838 . . . . 0.0 115.964 170.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.97 -35.29 26.05 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.42 34.04 5.18 Favored Glycine 0 N--CA 1.476 1.344 0 N-CA-C 118.146 2.018 . . . . 0.0 118.146 167.358 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -93.55 -129.69 0.13 Allowed 'General case' 0 CA--C 1.567 1.612 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 169.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 88.2 mt -103.12 97.58 7.65 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 119.971 1.259 . . . . 0.0 110.322 -169.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 p -104.03 118.2 57.66 Favored Pre-proline 0 CA--C 1.568 1.661 0 CA-C-O 117.603 -1.189 . . . . 0.0 108.786 176.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -57.26 141.4 94.57 Favored 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 123.491 2.794 . . . . 0.0 116.383 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 74.1 m -71.29 -49.91 38.01 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -65.79 -39.02 90.54 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 -177.083 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 28.4 mt -56.58 -50.57 71.54 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 117.54 2.422 . . . . 0.0 117.54 175.029 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 35.7 m -64.57 -46.46 82.64 Favored 'General case' 0 CA--C 1.566 1.593 0 CA-C-N 112.553 -2.112 . . . . 0.0 112.982 174.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -61.6 -21.5 64.4 Favored 'General case' 0 CA--C 1.577 2.003 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 165.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -75.11 -40.53 59.81 Favored 'General case' 0 CA--C 1.556 1.19 0 CA-C-N 121.026 1.739 . . . . 0.0 115.228 169.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 mt -59.89 -48.98 79.5 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-N 120.21 1.368 . . . . 0.0 114.129 167.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.491 HG22 HH21 ' A' ' 71' ' ' ARG . 0.4 OUTLIER -57.62 -44.64 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 172.667 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -67.17 -33.27 75.05 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.689 1.737 . . . . 0.0 115.689 169.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -58.62 -42.1 87.45 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 117.524 -1.227 . . . . 0.0 113.125 170.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ARG . . . . . 0.491 HH21 HG22 ' A' ' 68' ' ' VAL . 3.2 ppt_? -80.24 -16.99 53.5 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 118.582 2.808 . . . . 0.0 118.582 167.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 74' ' ' ASN . 12.3 mt -103.96 3.41 33.49 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 119.192 3.034 . . . . 0.0 119.192 174.402 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -77.95 37.06 0.24 Allowed 'General case' 0 N--CA 1.505 2.285 0 CA-C-O 123.635 1.683 . . . . 0.0 112.558 162.543 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.401 ' H ' ' C ' ' A' ' 72' ' ' LEU 0.336 7.3 m120 -122.64 146.02 46.66 Favored Pre-proline 0 CA--C 1.569 1.677 0 C-N-CA 128.272 2.629 . . . . 0.0 106.835 -172.564 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -49.45 -23.25 7.19 Favored 'Trans proline' 0 N--CA 1.507 2.293 0 N-CA-C 122.091 3.843 . . . . 0.0 122.091 175.273 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -63.53 -12.28 31.01 Favored 'General case' 0 CA--C 1.571 1.788 0 CA-C-O 115.558 -2.163 . . . . 0.0 114.344 166.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.89 -21.78 62.36 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 123.795 2.998 . . . . 0.0 114.867 167.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.47 -38.37 89.59 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 120.711 1.596 . . . . 0.0 115.079 167.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -92.18 -9.39 42.51 Favored 'General case' 0 CA--C 1.568 1.644 0 N-CA-C 117.533 2.42 . . . . 0.0 117.533 178.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.76 -178.2 30.03 Favored Glycine 0 C--N 1.357 1.726 0 CA-C-N 122.794 2.543 . . . . 0.0 115.933 -176.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -167.48 138.59 3.03 Favored 'General case' 0 CA--C 1.551 1.019 0 CA-C-N 111.386 -2.407 . . . . 0.0 106.099 169.432 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -115.38 109.34 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 102.847 -3.02 . . . . 0.0 102.847 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.5 mt -109.82 141.96 41.75 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.518 0.727 . . . . 0.0 109.707 175.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -130.88 127.84 39.36 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 118.364 0.529 . . . . 0.0 111.928 169.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.56 39.04 86.98 Favored Glycine 0 CA--C 1.556 2.604 0 N-CA-C 117.378 1.711 . . . . 0.0 117.378 -178.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -99.63 -52.93 0.19 Allowed Pre-proline 0 N--CA 1.498 1.936 0 CA-C-O 115.139 -2.362 . . . . 0.0 108.807 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -66.41 72.06 0.41 Allowed 'Trans proline' 0 CA--C 1.568 2.199 0 CA-C-N 124.211 2.54 . . . . 0.0 117.932 165.26 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -65.32 -39.28 92.24 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 167.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.0 t -148.96 153.28 37.73 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -169.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.4 t -59.92 -38.49 76.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-O 117.298 -1.334 . . . . 0.0 112.355 178.414 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.66 -34.2 73.94 Favored 'General case' 0 C--N 1.361 1.074 0 N-CA-C 120.091 3.367 . . . . 0.0 120.091 173.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.04 -49.51 13.86 Favored 'General case' 0 CA--C 1.586 2.349 0 CA-C-N 122.326 2.33 . . . . 0.0 111.46 166.295 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.0 -31.43 71.81 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 117.102 2.26 . . . . 0.0 117.102 -170.113 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 58.5 tttt -61.97 -29.26 70.12 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 167.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.37 -39.55 74.55 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 167.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.3 tp -63.11 -36.5 83.79 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 168.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 57.0 t60 -63.84 -43.77 95.15 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 120.261 1.391 . . . . 0.0 113.243 167.579 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' GLU . . . . . 1.253 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 32.2 mt-10 -54.38 -33.51 59.33 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 167.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' MET . . . . . 0.997 ' O ' ' CB ' ' A' ' 103' ' ' ARG . 1.7 tmt? -85.99 -31.41 22.06 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 118.451 2.759 . . . . 0.0 118.451 171.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 tt -70.89 -53.59 14.53 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-N 121.257 1.844 . . . . 0.0 111.067 172.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -76.56 -50.95 12.61 Favored 'General case' 0 CA--C 1.564 1.507 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 174.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 1.253 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 25.2 mmt85 -71.0 -43.04 68.8 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 177.494 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.997 ' CB ' ' O ' ' A' ' 99' ' ' MET . 0.2 OUTLIER -61.93 -57.15 12.82 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 118.842 0.747 . . . . 0.0 111.083 165.995 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 111.54 47.48 0.74 Allowed Glycine 0 N--CA 1.481 1.648 0 O-C-N 124.227 0.954 . . . . 0.0 114.46 167.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 61.9 p -85.48 155.84 21.06 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-N 113.85 -1.175 . . . . 0.0 109.538 168.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -71.34 132.04 44.3 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.343 -0.848 . . . . 0.0 110.982 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 6.5 tp -93.84 96.71 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 -175.761 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -98.97 -73.29 0.63 Allowed 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 115.796 -2.049 . . . . 0.0 109.062 170.734 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -149.54 124.89 10.21 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 117.564 2.431 . . . . 0.0 117.564 -167.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 62.0 t -92.84 113.55 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 102.66 -3.089 . . . . 0.0 102.66 160.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 71.5 mt -98.15 101.31 12.74 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.838 -178.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -89.01 115.65 26.73 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.849 169.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -92.91 112.23 24.12 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 124.446 1.098 . . . . 0.0 111.478 -175.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ARG . . . . . 0.449 ' HB3' ' HA ' ' A' ' 163' ' ' ASP . 13.5 tpt180 -81.21 97.38 7.59 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.582 1.553 . . . . 0.0 109.053 168.616 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' VAL . . . . . 0.502 HG13 HG11 ' A' ' 165' ' ' VAL . 43.5 t -125.58 150.11 30.69 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.591 0 C-N-CA 126.142 1.777 . . . . 0.0 106.965 -170.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 63.5 p -70.63 143.0 51.59 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 114.58 -1.191 . . . . 0.0 113.014 178.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.95 -30.05 65.66 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 116.023 1.86 . . . . 0.0 116.023 176.808 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -54.5 -35.77 63.47 Favored 'General case' 0 CA--C 1.565 1.543 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 169.108 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.3 t -64.16 -42.64 96.19 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 CA-C-N 119.542 1.065 . . . . 0.0 113.016 170.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.32 -32.44 71.24 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 167.364 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.7 mp -65.39 -40.2 93.15 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 169.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -62.58 -46.45 88.26 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 171.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.691 ' HG2' ' HA2' ' A' ' 10' ' ' GLY . 21.9 tpt180 -56.62 -43.96 80.71 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 169.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 8.7 mt -53.95 -59.51 4.54 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 167.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -77.28 -65.83 0.9 Allowed 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 -174.336 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.745 ' O ' ' CB ' ' A' ' 127' ' ' ARG . . . 68.34 63.9 3.36 Favored Glycine 0 CA--C 1.548 2.107 0 N-CA-C 115.438 0.935 . . . . 0.0 115.438 -173.379 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ARG . . . . . 0.745 ' CB ' ' O ' ' A' ' 126' ' ' GLY . 11.3 tpt180 108.76 -86.71 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 175.429 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -148.45 70.13 0.33 Allowed Glycine 0 CA--C 1.554 2.487 0 CA-C-O 116.858 -2.079 . . . . 0.0 111.546 -169.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 26.3 mtt180 -149.06 94.72 2.28 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 121.58 2.69 . . . . 0.0 108.17 -173.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -72.04 -29.54 64.27 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 118.106 2.632 . . . . 0.0 118.106 -170.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -56.42 -76.92 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 120.567 1.531 . . . . 0.0 111.965 168.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.7 p30 35.51 42.57 0.13 Allowed 'General case' 0 N--CA 1.51 2.551 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -166.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' THR . . . . . 0.412 ' HB ' ' H ' ' A' ' 136' ' ' VAL 0.285 0.6 OUTLIER 8.7 116.67 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 119.695 3.22 . . . . 0.0 119.695 -159.347 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -55.54 -38.69 69.61 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 112.641 -2.072 . . . . 0.0 113.695 165.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -63.95 -33.54 75.95 Favored 'General case' 0 CA--C 1.561 1.378 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 166.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.412 ' H ' ' HB ' ' A' ' 133' ' ' THR . 0.9 OUTLIER -58.18 -50.23 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-N 121.902 2.137 . . . . 0.0 113.338 169.988 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.0 tp -69.6 -32.01 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 176.205 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 47.9 mt -65.86 -36.49 83.58 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 119.834 1.197 . . . . 0.0 113.977 167.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -64.61 -37.18 86.67 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 170.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' ARG . . . . . 0.475 ' HB3' ' HG3' ' A' ' 9' ' ' PRO . 43.5 mmt-85 -64.3 -40.57 96.2 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 168.034 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 93.5 mmm -60.47 -26.97 67.18 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 165.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -65.73 -40.08 91.82 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 120.249 1.386 . . . . 0.0 113.43 164.137 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.8 t -63.47 -27.22 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 CA-C-N 119.794 1.179 . . . . 0.0 112.958 168.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -66.14 -51.56 56.73 Favored 'General case' 0 CA--C 1.575 1.939 0 CA-C-N 120.748 1.613 . . . . 0.0 112.538 165.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 47.9 ttt180 -52.4 -26.59 12.94 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 120.238 3.421 . . . . 0.0 120.238 177.309 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.81 -67.58 0.3 Allowed 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 119.911 1.232 . . . . 0.0 112.432 169.441 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -148.84 22.82 0.99 Allowed 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 119.534 3.161 . . . . 0.0 119.534 -168.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 69.4 m -56.48 -29.06 61.3 Favored 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ALA . . . . . 0.423 ' HB3' ' HD3' ' A' ' 150' ' ' PRO . . . -71.49 -60.89 2.36 Favored Pre-proline 0 CA--C 1.58 2.099 0 CA-C-O 116.093 -1.908 . . . . 0.0 112.118 171.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' PRO . . . . . 0.423 ' HD3' ' HB3' ' A' ' 149' ' ' ALA . 78.5 Cg_exo -52.65 -33.19 57.97 Favored 'Trans proline' 0 CA--C 1.576 2.608 0 C-N-CA 123.458 2.772 . . . . 0.0 118.806 168.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.76 -52.14 53.44 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 125.259 1.423 . . . . 0.0 111.161 174.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' LEU . . . . . 1.154 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 49.1 tp -62.49 -21.78 65.75 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 171.352 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -72.01 -49.86 33.46 Favored 'General case' 0 CA--C 1.564 1.49 0 CA-C-N 122.759 2.527 . . . . 0.0 113.694 165.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -63.23 -54.06 43.37 Favored 'General case' 0 CA--C 1.567 1.629 0 CA-C-N 120.494 1.497 . . . . 0.0 112.676 178.447 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -74.06 -32.88 63.48 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-O 115.275 -2.298 . . . . 0.0 112.177 178.067 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ARG . . . . . 1.154 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 32.6 ttt180 -58.85 -34.91 72.11 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 124.187 3.176 . . . . 0.0 116.939 169.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -68.13 -38.84 82.64 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 167.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -89.3 -26.04 21.35 Favored 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 119.449 3.129 . . . . 0.0 119.449 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.4 pp -81.2 175.45 10.61 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 118.119 2.637 . . . . 0.0 118.119 -163.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 35.9 tttp -123.49 128.99 50.57 Favored 'General case' 0 CA--C 1.561 1.376 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 164.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 11.0 t -101.96 144.63 30.34 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 122.536 1.16 . . . . 0.0 110.065 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 27.7 t -110.52 130.51 63.7 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.325 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 169.794 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' ASP . . . . . 0.449 ' HA ' ' HB3' ' A' ' 114' ' ' ARG . 16.5 t70 -103.7 117.46 34.42 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 102.593 -3.114 . . . . 0.0 102.593 168.129 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -121.77 -174.44 2.87 Favored 'General case' 0 CA--C 1.555 1.136 0 N-CA-C 117.831 2.53 . . . . 0.0 117.831 -157.042 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' VAL . . . . . 0.502 HG11 HG13 ' A' ' 115' ' ' VAL 0.543 0.9 OUTLIER 69.5 -115.31 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.296 0 CA-C-N 109.667 -3.424 . . . . 0.0 115.008 167.813 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 78.61 -68.9 2.91 Favored Glycine 0 CA--C 1.556 2.639 1 CA-C-N 126.201 4.092 . . . . 0.0 112.709 -159.189 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 35.5 p -129.4 -153.05 0.54 Allowed 'General case' 0 CA--C 1.582 2.19 0 C-N-CA 127.601 2.36 . . . . 0.0 108.915 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 14.8 tpt -98.97 -59.43 1.73 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.83 -1.169 . . . . 0.0 112.835 174.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -57.41 -31.75 66.16 Favored 'General case' 0 N--CA 1.512 2.644 0 N-CA-C 117.948 2.573 . . . . 0.0 117.948 -177.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -46.51 -50.4 17.14 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 169.41 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 3.8 t -52.08 -38.77 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 175.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -63.14 -41.81 99.35 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 120.649 1.568 . . . . 0.0 114.829 168.455 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -57.38 -52.0 67.11 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 174.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 10.4 mtt-85 -66.02 -37.66 86.47 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 117.815 2.524 . . . . 0.0 117.815 174.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.67 -45.56 93.67 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 115.72 1.748 . . . . 0.0 115.72 172.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . 0.281 0.4 OUTLIER -72.27 -35.16 68.66 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 169.935 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -53.3 -41.83 66.02 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 167.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.86 -54.76 29.88 Favored 'General case' 0 CA--C 1.561 1.403 0 N-CA-C 114.73 1.382 . . . . 0.0 114.73 168.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 5.4 tt -81.68 -63.29 1.42 Allowed 'General case' 0 CA--C 1.565 1.558 0 CA-C-O 117.597 -1.192 . . . . 0.0 113.142 -176.112 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' GLY . . . . . 1.127 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -89.21 -48.72 3.7 Favored Glycine 0 CA--C 1.551 2.337 0 CA-C-N 120.915 1.689 . . . . 0.0 116.106 -174.308 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 181' ' ' LYS . . . . . 1.127 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.303 0 CA-C-N 119.259 1.529 . . . . 0.0 108.988 -175.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.5 mtt . . . . . 0 CA--C 1.558 1.276 0 CA-C-O 122.772 1.273 . . . . 0.0 111.881 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.439 ' HG3' HH11 ' A' ' 2' ' ' ARG 0.3 5.8 ttm-85 -150.27 152.99 35.37 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 116.612 2.079 . . . . 0.0 116.612 -162.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.5 t -141.59 145.04 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 CA-C-O 124.176 1.941 . . . . 0.0 111.098 -174.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -125.26 135.41 52.49 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 112.509 -2.132 . . . . 0.0 106.944 175.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.98 114.35 23.68 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-O 122.452 1.12 . . . . 0.0 110.533 -169.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.29 160.9 17.85 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 113.053 -1.885 . . . . 0.0 110.562 -168.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 151.8 149.36 5.06 Favored Glycine 0 CA--C 1.555 2.548 0 CA-C-O 118.2 -1.333 . . . . 0.0 114.129 169.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo . . . . . 0 CA--C 1.574 2.511 0 C-N-CA 123.375 2.717 . . . . 0.0 116.532 169.576 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 23.1 mtmm . . . . . 0 N--CA 1.485 1.294 0 N-CA-C 109.088 -0.708 . . . . 0.0 109.088 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -51.27 -27.45 16.11 Favored Glycine 0 CA--C 1.554 2.509 0 N-CA-C 120.416 2.926 . . . . 0.0 120.416 174.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.9 m -66.87 -52.29 45.24 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 119.663 1.731 . . . . 0.0 112.682 174.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.25 10.6 mm-40 -75.39 -15.63 60.44 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 115.904 -1.998 . . . . 0.0 112.455 171.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.85 -44.32 66.66 Favored 'General case' 0 C--N 1.374 1.637 0 CA-C-N 123.684 2.947 . . . . 0.0 114.319 168.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.78 -46.41 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 CA-C-N 119.282 0.946 . . . . 0.0 112.737 174.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -54.94 -44.25 74.14 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 116.623 2.083 . . . . 0.0 116.623 169.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.1 tp -67.24 -32.54 73.63 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 172.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.78 -38.89 92.42 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 167.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -59.33 -40.72 87.21 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 117.491 -1.243 . . . . 0.0 114.106 166.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -65.62 -49.09 70.0 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 172.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 65.8 mt -82.72 -25.0 33.33 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 117.383 2.364 . . . . 0.0 117.383 -177.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.56 41.31 7.37 Favored Glycine 0 CA--C 1.556 2.616 0 N-CA-C 117.521 1.768 . . . . 0.0 117.521 -172.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 22.8 mm -115.68 157.91 43.26 Favored Pre-proline 0 CA--C 1.57 1.738 0 CA-C-N 118.678 1.239 . . . . 0.0 113.748 -168.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -74.65 101.19 1.42 Allowed 'Trans proline' 0 CA--C 1.566 2.111 0 C-N-CA 121.885 1.723 . . . . 0.0 113.294 160.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -72.34 107.74 5.09 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.158 -0.964 . . . . 0.0 108.424 165.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.457 ' CD1' ' HB3' ' A' ' 71' ' ' ARG . 31.3 mm -104.25 109.38 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 176.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 74.1 p -96.45 128.96 43.86 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 168.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 18.4 p -68.36 -16.59 63.99 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 117.051 2.241 . . . . 0.0 117.051 -171.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -80.37 -23.25 61.1 Favored Glycine 0 CA--C 1.543 1.809 0 N-CA-C 118.932 2.333 . . . . 0.0 118.932 167.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -80.38 -52.63 7.45 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 -168.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -62.88 -39.09 93.39 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 173.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.479 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 7.9 m-85 -65.2 -47.09 78.11 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 172.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -54.25 -42.06 69.47 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 168.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.8 ttt180 -59.11 -40.36 85.11 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 168.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -68.35 -23.83 64.74 Favored 'General case' 0 CA--C 1.579 2.07 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 168.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 63.6 mt -64.1 -48.69 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 CA-C-N 120.75 1.614 . . . . 0.0 110.448 167.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -64.42 -37.67 88.32 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -67.02 -40.93 87.37 Favored 'General case' 0 CA--C 1.561 1.391 0 N-CA-C 116.236 1.939 . . . . 0.0 116.236 173.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.28 69.26 1.04 Allowed Glycine 0 CA--C 1.543 1.844 0 CA-C-O 118.473 -1.182 . . . . 0.0 114.66 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.835 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 67.5 p -92.02 -49.86 6.0 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-N 118.737 1.268 . . . . 0.0 114.291 175.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.835 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.251 73.8 mttt 105.84 -41.49 0.0 OUTLIER 'General case' 0 CA--C 1.57 1.729 0 CA-C-O 116.376 -1.774 . . . . 0.0 111.307 -172.477 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.07 -14.13 58.1 Favored 'General case' 0 CA--C 1.569 1.711 0 CA-C-N 123.059 2.663 . . . . 0.0 112.988 163.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.673 ' O ' ' HB3' ' A' ' 50' ' ' LYS . . . -58.22 -56.48 24.97 Favored Glycine 0 C--N 1.355 1.605 0 CA-C-N 120.574 1.534 . . . . 0.0 114.825 169.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.289 6.2 p -76.44 -50.01 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.478 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 -169.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -64.91 -48.48 74.04 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 121.09 1.768 . . . . 0.0 112.582 174.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.12 -29.15 66.03 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 114.819 1.415 . . . . 0.0 114.819 -177.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.673 ' HB3' ' O ' ' A' ' 46' ' ' GLY . 35.8 tptt -72.78 -34.73 67.14 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 168.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.601 ' CG ' ' O ' ' A' ' 51' ' ' ARG . 42.9 ttt180 -74.64 -55.89 5.4 Favored 'General case' 0 CA--C 1.591 2.522 1 CA-C-O 85.878 -16.296 . . . . 0.0 117.639 -179.715 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -27.64 -66.22 0.07 Allowed 'General case' 0 N--CA 1.495 1.814 1 O-C-N 108.766 -8.709 . . . . 0.0 120.43 146.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.6 tp -59.32 -29.32 67.54 Favored 'General case' 0 CA--C 1.573 1.861 0 N-CA-C 116.388 1.996 . . . . 0.0 116.388 174.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -92.39 -41.6 10.24 Favored 'General case' 0 CA--C 1.566 1.588 0 CA-C-O 116.554 -1.689 . . . . 0.0 115.155 169.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -87.94 -41.15 13.36 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 121.976 2.171 . . . . 0.0 114.906 -174.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.449 ' HA2' HH12 ' A' ' 88' ' ' ARG . . . 128.83 5.35 4.91 Favored Glycine 0 CA--C 1.541 1.669 0 N-CA-C 119.095 2.398 . . . . 0.0 119.095 168.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -83.41 173.71 11.28 Favored 'General case' 0 CA--C 1.575 1.91 0 CA-C-N 119.86 1.83 . . . . 0.0 110.067 167.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.5 pp -76.18 128.77 35.62 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.205 -1.559 . . . . 0.0 114.398 -166.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.6 p -115.88 128.72 25.75 Favored Pre-proline 0 CA--C 1.571 1.779 0 CA-C-O 117.656 -1.164 . . . . 0.0 109.447 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -60.11 149.33 85.41 Favored 'Trans proline' 0 CA--C 1.559 1.77 0 C-N-CA 123.396 2.731 . . . . 0.0 116.275 173.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 64.0 m -76.87 -45.88 26.63 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -64.27 -46.56 83.17 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 -169.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.407 ' HA ' ' HB2' ' A' ' 66' ' ' GLU . 1.7 pp -57.86 -42.13 83.87 Favored 'General case' 0 CA--C 1.56 1.347 0 N-CA-C 116.709 2.114 . . . . 0.0 116.709 169.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.4 m -61.46 -48.79 79.53 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 174.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -66.94 -20.05 65.83 Favored 'General case' 0 CA--C 1.575 1.919 0 N-CA-C 115.443 1.645 . . . . 0.0 115.443 167.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.407 ' HB2' ' HA ' ' A' ' 63' ' ' LEU . 9.4 mm-40 -72.26 -47.56 49.31 Favored 'General case' 0 CA--C 1.556 1.203 0 CA-C-N 120.529 1.513 . . . . 0.0 114.197 169.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.9 mt -63.72 -38.46 91.2 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 169.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 51.9 t -56.55 -50.93 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 CA-C-O 117.582 -1.199 . . . . 0.0 111.55 167.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -60.05 -36.8 78.11 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 116.563 2.06 . . . . 0.0 116.563 172.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -58.16 -45.79 86.82 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 117.282 -1.342 . . . . 0.0 112.971 169.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.457 ' HB3' ' CD1' ' A' ' 29' ' ' ILE . 40.9 mmt180 -87.03 6.12 34.06 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 120.407 3.484 . . . . 0.0 120.407 167.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 50.7 mt -68.2 -49.94 57.5 Favored 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 105.473 -2.047 . . . . 0.0 105.473 153.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 . . . . . 0 N--CA 1.503 2.176 0 CA-C-N 121.375 1.898 . . . . 0.0 110.879 -163.81 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.56 0 CA-C-O 123.156 1.42 . . . . 0.0 113.945 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -176.18 138.93 0.34 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 112.018 -2.091 . . . . 0.0 109.58 173.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 44.6 mt -111.35 112.99 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 104.059 -2.571 . . . . 0.0 104.059 174.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.5 mt -96.7 147.42 23.93 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 168.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -134.11 131.72 39.05 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.8 0.81 . . . . 0.0 111.043 169.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 71.03 37.59 64.16 Favored Glycine 0 CA--C 1.551 2.297 0 CA-C-O 117.249 -1.862 . . . . 0.0 117.62 176.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -104.79 -56.02 0.09 OUTLIER Pre-proline 0 N--CA 1.496 1.834 0 CA-C-O 114.873 -2.489 . . . . 0.0 109.657 177.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.79 70.97 1.09 Allowed 'Trans proline' 0 CA--C 1.566 2.088 0 CA-C-N 124.921 2.793 . . . . 0.0 118.873 168.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.449 HH12 ' HA2' ' A' ' 56' ' ' GLY . 4.1 ptm180 -76.46 -31.57 57.88 Favored 'General case' 0 CA--C 1.567 1.602 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 167.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.492 ' HA ' ' HG3' ' A' ' 147' ' ' GLU . 77.6 p -141.59 134.62 29.06 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 -166.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -51.51 -38.29 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-N 120.298 1.408 . . . . 0.0 113.843 177.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.8 -38.62 91.61 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 120.753 3.612 . . . . 0.0 120.753 174.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -74.32 -47.81 32.26 Favored 'General case' 0 CA--C 1.587 2.401 0 CA-C-N 122.99 2.632 . . . . 0.0 111.802 166.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.33 -35.16 69.53 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 118.493 2.775 . . . . 0.0 118.493 -176.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.4 tttt -59.93 -26.6 66.09 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 116.571 2.063 . . . . 0.0 116.571 170.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.35 -43.86 84.87 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 168.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 23.6 tp -61.72 -37.93 86.01 Favored 'General case' 0 CA--C 1.569 1.695 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 169.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 28.9 t60 -67.85 -41.65 82.59 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 120.405 1.457 . . . . 0.0 113.749 169.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 1.35 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 0.5 OUTLIER -53.24 -35.05 59.56 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 167.414 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 1.183 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 63.3 mtt -85.39 -29.57 24.31 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 118.317 2.71 . . . . 0.0 118.317 171.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 tt -69.35 -54.65 13.44 Favored 'General case' 0 N--CA 1.502 2.16 0 CA-C-N 122.076 2.216 . . . . 0.0 111.126 173.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -77.23 -50.37 13.06 Favored 'General case' 0 CA--C 1.563 1.48 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 174.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 1.35 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 23.3 tpp180 -71.93 -46.06 58.93 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 178.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 1.183 ' HB3' ' O ' ' A' ' 99' ' ' MET . 21.5 tpp180 -63.94 -49.66 71.71 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 119.036 0.835 . . . . 0.0 111.793 167.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 106.31 50.07 0.89 Allowed Glycine 0 N--CA 1.485 1.941 0 CA-C-O 121.767 0.648 . . . . 0.0 114.162 167.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.8 p -92.67 168.96 10.87 Favored 'General case' 0 CA--C 1.567 1.612 0 CA-C-N 113.207 -1.496 . . . . 0.0 110.712 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.47 132.14 45.11 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.034 -1.041 . . . . 0.0 110.919 -175.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 6.4 tp -105.79 96.99 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 174.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -100.25 -77.04 0.54 Allowed 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 115.391 -2.242 . . . . 0.0 107.69 166.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -140.71 126.14 18.82 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 122.25 2.295 . . . . 0.0 115.5 -171.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 72.8 t -88.92 116.58 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 101.406 -3.553 . . . . 0.0 101.406 160.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.294 20.7 tp -112.93 90.22 3.29 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 113.14 -1.846 . . . . 0.0 109.17 -165.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -89.71 132.22 35.29 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -177.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -97.73 123.87 41.84 Favored 'General case' 0 CA--C 1.566 1.584 0 CA-C-O 123.202 1.477 . . . . 0.0 110.594 -172.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -93.4 104.01 16.19 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 127.299 2.24 . . . . 0.0 108.868 173.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.2 m . . . . . 0 CA--C 1.566 1.594 0 CA-C-N 113.12 -1.855 . . . . 0.0 109.837 -165.6 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 . . . . . 0 N--CA 1.501 2.11 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -60.58 -42.65 97.14 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 167.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 13.6 tpt -61.5 -32.15 72.17 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 168.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -60.96 -49.1 78.81 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 166.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 29.1 t -65.13 -25.46 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 169.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -65.45 -49.43 69.17 Favored 'General case' 0 CA--C 1.577 1.982 0 CA-C-N 119.74 1.154 . . . . 0.0 111.864 169.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -61.34 -44.51 97.07 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 117.71 2.485 . . . . 0.0 117.71 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -56.18 -32.22 64.14 Favored 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 117.785 2.513 . . . . 0.0 117.785 177.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.492 ' HG3' ' HA ' ' A' ' 89' ' ' SER . 4.4 mm-40 -121.38 -40.5 2.57 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 118.684 2.846 . . . . 0.0 118.684 -163.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 95.7 m -46.64 -39.96 12.24 Favored 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 118.226 2.676 . . . . 0.0 118.226 -167.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.38 -61.16 4.12 Favored Pre-proline 0 CA--C 1.579 2.07 0 CA-C-O 116.17 -1.871 . . . . 0.0 112.05 173.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -52.01 -32.58 49.0 Favored 'Trans proline' 0 CA--C 1.578 2.692 0 C-N-CA 123.374 2.716 . . . . 0.0 118.568 167.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -66.57 -51.51 55.69 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 125.193 1.397 . . . . 0.0 111.462 176.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 1.187 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 47.7 tp -64.49 -21.23 66.61 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 171.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -71.92 -48.73 43.37 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 122.657 2.48 . . . . 0.0 112.944 164.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -61.03 -56.74 17.42 Favored 'General case' 0 CA--C 1.57 1.718 0 CA-C-N 120.191 1.359 . . . . 0.0 112.711 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -77.13 -28.04 54.17 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-O 115.348 -2.263 . . . . 0.0 112.774 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 1.187 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 38.3 ttt180 -60.35 -37.23 80.04 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 124.017 3.099 . . . . 0.0 116.259 169.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -67.76 -37.91 82.74 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 167.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -79.96 -33.22 39.7 Favored 'General case' 0 CA--C 1.579 2.09 0 N-CA-C 119.623 3.194 . . . . 0.0 119.623 177.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.1 pp -82.01 174.72 10.98 Favored 'General case' 0 CA--C 1.575 1.907 0 N-CA-C 121.324 3.824 . . . . 0.0 121.324 -159.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -128.64 139.66 52.15 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 164.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.1 t -102.77 152.56 21.1 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 122.515 1.15 . . . . 0.0 112.362 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 53.2 t -120.26 139.29 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 168.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -94.52 134.53 36.96 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 167.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -157.88 95.56 1.42 Allowed 'General case' 0 N--CA 1.484 1.243 0 CA-C-O 122.791 1.281 . . . . 0.0 110.886 -164.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.5 t . . . . . 0 N--CA 1.482 1.126 0 CA-C-N 113.143 -1.844 . . . . 0.0 106.878 -171.483 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 . . . . . 0 N--CA 1.501 2.078 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -61.26 -48.71 80.16 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 169.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 69.9 t -55.74 -39.44 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 173.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -60.43 -35.62 76.26 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 168.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -58.81 -48.33 81.67 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 171.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 81.5 mtt-85 -60.8 -36.85 80.08 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 117.874 2.546 . . . . 0.0 117.874 168.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.85 -44.09 97.47 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 172.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . 0.272 0.2 OUTLIER -71.26 -38.7 71.87 Favored 'General case' 0 N--CA 1.507 2.383 0 CA-C-N 120.014 1.279 . . . . 0.0 114.332 169.031 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -49.57 -39.3 34.53 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 168.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -70.3 -52.53 22.16 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 166.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -102.29 -60.03 1.61 Allowed 'General case' 0 CA--C 1.564 1.515 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -169.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.633 ' O ' ' CB ' ' A' ' 181' ' ' LYS . . . -79.22 -37.0 25.88 Favored Glycine 0 CA--C 1.551 2.34 0 CA-C-N 121.554 1.979 . . . . 0.0 118.036 -170.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.633 ' CB ' ' O ' ' A' ' 180' ' ' GLY . 37.2 ttmt . . . . . 0 C--O 1.252 1.212 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -177.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.7 mtt . . . . . 0 N--CA 1.483 1.217 0 CA-C-O 121.76 0.791 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.549 ' HB3' ' H ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -160.42 155.36 24.37 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -166.8 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.6 t -135.07 150.67 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 114.34 -1.3 . . . . 0.0 111.607 -168.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.405 HD22 HH12 ' A' ' 2' ' ' ARG . 2.2 mm? -125.7 122.13 35.42 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 114.003 -1.453 . . . . 0.0 108.607 169.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.8 tt -95.91 119.54 34.59 Favored 'General case' 0 CA--C 1.572 1.8 0 CA-C-O 122.504 1.145 . . . . 0.0 111.94 -173.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 33.0 mt -104.8 160.03 15.32 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 111.074 -2.785 . . . . 0.0 110.97 175.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 165.68 129.46 1.05 Allowed Glycine 0 CA--C 1.549 2.19 0 CA-C-O 117.355 -1.803 . . . . 0.0 113.77 171.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo . . . . . 0 CA--C 1.581 2.855 0 CA-C-N 122.035 2.917 . . . . 0.0 114.881 168.061 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.6 mttt . . . . . 0 N--CA 1.492 1.639 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -50.53 -22.03 5.12 Favored Glycine 0 CA--C 1.554 2.496 0 N-CA-C 120.955 3.142 . . . . 0.0 120.955 174.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 98.1 m -68.27 -53.0 27.54 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 120.036 1.918 . . . . 0.0 112.265 173.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.261 14.4 mm-40 -76.48 -15.43 59.9 Favored 'General case' 0 CA--C 1.574 1.87 0 CA-C-O 115.508 -2.187 . . . . 0.0 112.295 171.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.96 -41.49 67.66 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 124.211 3.187 . . . . 0.0 115.265 167.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.5 t -70.89 -40.66 76.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 CA-C-O 117.84 -1.076 . . . . 0.0 111.766 173.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -61.44 -42.11 98.24 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 169.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 23.6 mt -67.93 -32.4 72.82 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 170.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.02 -40.12 96.78 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 120.267 1.394 . . . . 0.0 114.446 167.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -59.77 -37.6 79.5 Favored 'General case' 0 CA--C 1.565 1.554 0 N-CA-C 114.889 1.441 . . . . 0.0 114.889 166.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -68.61 -53.99 19.22 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 120.561 1.528 . . . . 0.0 114.787 174.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.4 mp -81.73 -22.83 37.07 Favored 'General case' 0 CA--C 1.573 1.861 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 -177.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.68 38.64 7.46 Favored Glycine 0 CA--C 1.555 2.546 0 N-CA-C 117.507 1.763 . . . . 0.0 117.507 -174.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.454 ' CG2' ' HA ' ' A' ' 81' ' ' PHE . 23.6 mm -106.46 157.02 35.99 Favored Pre-proline 0 CA--C 1.565 1.551 0 CA-C-N 118.647 1.224 . . . . 0.0 112.876 -169.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -73.79 102.86 1.56 Allowed 'Trans proline' 0 CA--C 1.558 1.724 0 C-N-CA 121.49 1.46 . . . . 0.0 111.968 159.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.7 tm0? -69.48 106.54 3.02 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 166.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 34.2 mm -97.95 109.33 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 63.4 p -95.59 129.22 42.86 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 169.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.3 p -74.07 2.17 9.45 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 117.241 2.311 . . . . 0.0 117.241 -174.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.477 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -97.14 -22.17 18.16 Favored Glycine 0 CA--C 1.54 1.628 0 N-CA-C 118.703 2.241 . . . . 0.0 118.703 163.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -81.21 -54.27 5.65 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 119.37 1.585 . . . . 0.0 114.618 -168.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -65.44 -38.66 90.52 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 113.037 0.755 . . . . 0.0 113.037 175.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.467 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 56.8 m-85 -68.79 -42.48 77.3 Favored 'General case' 0 CA--C 1.56 1.332 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 173.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 73.9 ttt180 -58.76 -42.24 88.44 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 115.046 1.498 . . . . 0.0 115.046 169.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -61.51 -39.02 89.48 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 115.227 1.566 . . . . 0.0 115.227 169.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -68.82 -27.57 65.96 Favored 'General case' 0 CA--C 1.575 1.932 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 168.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.644 HD11 ' HB3' ' A' ' 50' ' ' LYS . 86.1 mt -63.86 -43.94 97.96 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 CA-C-N 120.104 1.32 . . . . 0.0 111.251 167.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -64.02 -42.31 97.17 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 173.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -65.51 -41.74 92.82 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 173.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.4 70.83 1.17 Allowed Glycine 0 CA--C 1.539 1.593 0 CA-C-O 118.091 -1.394 . . . . 0.0 113.368 -177.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.545 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 67.0 p -92.16 -65.62 0.99 Allowed 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 119.187 1.494 . . . . 0.0 111.644 177.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.545 ' CB ' ' O ' ' A' ' 43' ' ' THR . 21.2 ptmt 128.81 -55.68 0.0 OUTLIER 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 123.934 0.894 . . . . 0.0 109.899 -166.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -75.76 -6.57 51.25 Favored 'General case' 0 CA--C 1.568 1.638 0 CA-C-O 118.136 -0.935 . . . . 0.0 113.021 167.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.22 -54.21 11.8 Favored Glycine 0 CA--C 1.544 1.905 0 CA-C-N 120.652 1.569 . . . . 0.0 113.254 166.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.292 11.9 p -76.22 -46.62 33.03 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.706 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 -169.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -56.38 -49.28 74.91 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 121.744 2.065 . . . . 0.0 113.339 169.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.03 -38.5 91.28 Favored 'General case' 0 C--N 1.348 0.527 0 CA-C-N 113.517 -1.674 . . . . 0.0 114.293 -176.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.644 ' HB3' HD11 ' A' ' 39' ' ' ILE . 5.1 tptt -80.14 -17.16 53.27 Favored 'General case' 0 CA--C 1.565 1.545 0 CA-C-O 116.809 -1.567 . . . . 0.0 113.855 173.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 62.6 mtp180 -76.59 -55.61 5.37 Favored 'General case' 0 CA--C 1.598 2.815 1 CA-C-O 86.227 -16.13 . . . . 0.0 118.297 172.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . 0.346 0.1 OUTLIER -38.02 -61.57 0.64 Allowed 'General case' 0 N--CA 1.516 2.847 1 O-C-N 109.303 -8.373 . . . . 0.0 120.564 149.349 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 60.3 mt -58.05 -23.66 55.31 Favored 'General case' 0 N--CA 1.518 2.948 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 177.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -93.32 -49.41 5.96 Favored 'General case' 0 CA--C 1.571 1.763 0 CA-C-O 116.486 -1.721 . . . . 0.0 114.56 166.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -104.28 -5.57 21.72 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 118.112 2.634 . . . . 0.0 118.112 -170.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.673 ' HA2' HH11 ' A' ' 88' ' ' ARG . . . 73.64 47.09 22.22 Favored Glycine 0 CA--C 1.544 1.847 0 CA-C-N 122.203 2.274 . . . . 0.0 115.241 -178.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -101.51 -175.3 2.82 Favored 'General case' 0 CA--C 1.568 1.642 0 C-N-CA 123.763 0.825 . . . . 0.0 110.807 -170.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 74.7 mt -100.56 99.6 10.2 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.4 t -148.26 130.93 7.86 Favored Pre-proline 0 CA--C 1.586 2.353 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -169.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -50.15 161.01 1.18 Allowed 'Trans proline' 0 CA--C 1.567 2.152 0 C-N-CA 124.446 3.43 . . . . 0.0 120.955 -177.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 58.4 m -91.25 -53.88 4.16 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -174.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -57.86 -36.35 72.2 Favored 'General case' 0 N--CA 1.506 2.366 0 N-CA-C 117.412 2.375 . . . . 0.0 117.412 -171.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 79.5 mt -46.54 -45.56 18.73 Favored 'General case' 0 N--CA 1.506 2.358 0 N-CA-C 118.137 2.643 . . . . 0.0 118.137 170.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.2 m -70.04 -48.88 56.1 Favored 'General case' 0 CA--C 1.562 1.422 0 CA-C-N 112.223 -2.262 . . . . 0.0 112.756 177.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.64 -22.86 62.47 Favored 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 167.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -75.85 -42.36 49.72 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 125.395 1.478 . . . . 0.0 114.908 171.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.8 mt -59.53 -50.39 74.1 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 168.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 87.7 t -63.07 -47.8 90.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 CA-C-O 118.023 -0.989 . . . . 0.0 111.72 177.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -64.4 -30.4 71.44 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 116.443 2.016 . . . . 0.0 116.443 172.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -60.85 -41.21 95.4 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 119.714 1.143 . . . . 0.0 113.255 168.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 20.5 ttm-85 -81.52 -13.94 57.5 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 119.021 2.971 . . . . 0.0 119.021 169.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.8 mt -95.08 -16.86 22.34 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 117.656 2.465 . . . . 0.0 117.656 175.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 . . . . . 0 N--CA 1.5 2.048 0 N-CA-C 118.014 2.598 . . . . 0.0 118.014 176.197 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.508 ' HA2' ' HB3' ' A' ' 2' ' ' ARG . . . . . . . . 0 N--CA 1.482 1.723 0 CA-C-O 122.9 1.278 . . . . 0.0 114.256 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.549 ' H ' ' HB3' ' A' ' 2' ' ' ARG . 37.6 p90 178.58 135.76 0.08 Allowed 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 112.208 -1.996 . . . . 0.0 111.88 -178.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 21.7 mt -115.23 109.55 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 174.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.7 mt -106.15 126.0 51.68 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 174.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -108.09 127.71 54.04 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 119.272 0.942 . . . . 0.0 110.36 176.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.39 37.93 80.05 Favored Glycine 0 CA--C 1.556 2.653 0 N-CA-C 117.202 1.641 . . . . 0.0 117.202 -176.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -92.87 -54.06 0.25 Allowed Pre-proline 0 N--CA 1.494 1.765 0 CA-C-O 114.935 -2.46 . . . . 0.0 108.223 175.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -65.3 70.87 0.29 Allowed 'Trans proline' 0 CA--C 1.571 2.344 0 CA-C-N 124.343 2.587 . . . . 0.0 117.289 165.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.673 HH11 ' HA2' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -71.67 -24.28 61.81 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 166.714 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.8 t -150.93 151.39 32.09 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 -176.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 36.7 t -62.07 -40.25 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 CA-C-O 117.924 -1.036 . . . . 0.0 112.173 174.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -68.66 -25.37 64.77 Favored 'General case' 0 CA--C 1.55 0.981 0 N-CA-C 119.656 3.206 . . . . 0.0 119.656 174.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.04 -51.34 12.52 Favored 'General case' 0 CA--C 1.589 2.462 0 CA-C-N 123.405 2.82 . . . . 0.0 110.078 163.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -54.58 -28.11 43.78 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 117.834 2.531 . . . . 0.0 117.834 -176.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -58.79 -32.71 69.58 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 166.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.67 -44.31 86.66 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 169.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.6 tp -60.63 -39.03 86.75 Favored 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 170.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 47.8 t60 -70.08 -42.86 72.22 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 120.021 1.282 . . . . 0.0 113.973 171.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 1.114 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 32.1 mt-10 -52.1 -36.46 51.0 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 166.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 1.061 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 25.2 ttt -84.37 -24.49 29.67 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 117.927 2.566 . . . . 0.0 117.927 171.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.607 HD21 HD13 ' A' ' 107' ' ' ILE . 66.3 tp -65.77 -55.65 16.12 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 120.771 1.623 . . . . 0.0 112.572 169.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -79.79 -50.8 10.02 Favored 'General case' 0 CA--C 1.562 1.427 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 175.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 1.114 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 73.4 ttt180 -66.87 -45.69 77.29 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 176.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 1.061 ' HB3' ' O ' ' A' ' 99' ' ' MET . 1.2 tmt_? -63.24 -55.85 21.44 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.01 0.524 . . . . 0.0 111.168 165.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.34 46.83 1.04 Allowed Glycine 0 N--CA 1.48 1.603 0 O-C-N 124.013 0.82 . . . . 0.0 113.347 169.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 67.4 p -93.53 152.28 19.15 Favored 'General case' 0 CA--C 1.561 1.39 0 O-C-N 124.402 0.707 . . . . 0.0 109.666 175.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -82.73 129.1 34.92 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.444 -0.785 . . . . 0.0 111.557 -169.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.607 HD13 HD21 ' A' ' 100' ' ' LEU . 7.6 tp -89.99 107.68 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 -173.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -90.33 -68.04 0.81 Allowed 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 117.006 -1.473 . . . . 0.0 107.082 168.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -159.0 137.92 11.16 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 120.887 1.676 . . . . 0.0 114.513 177.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.6 t -91.91 109.71 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.676 0 N-CA-C 100.863 -3.755 . . . . 0.0 100.863 161.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.309 25.8 tp -111.68 103.61 11.92 Favored 'General case' 0 CA--C 1.558 1.288 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.858 -161.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -94.12 129.65 40.61 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.449 0.643 . . . . 0.0 112.248 -177.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -92.55 119.04 31.62 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-O 123.157 1.456 . . . . 0.0 110.164 -178.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -84.08 96.8 9.02 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 112.527 -2.124 . . . . 0.0 109.347 168.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.0 p . . . . . 0 N--CA 1.485 1.276 0 C-N-CA 125.245 1.418 . . . . 0.0 107.922 -168.453 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 . . . . . 0 N--CA 1.501 2.104 0 N-CA-C 114.043 1.127 . . . . 0.0 114.043 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 70.0 mtp180 -57.96 -39.69 78.76 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 165.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 25.3 ttt -64.58 -30.96 71.99 Favored 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 168.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -62.85 -48.03 80.79 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 168.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.5 p -66.47 -35.61 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 171.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -53.94 -54.07 43.92 Favored 'General case' 0 CA--C 1.585 2.3 0 CA-C-N 120.073 1.306 . . . . 0.0 111.436 167.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 32.4 ttp180 -51.99 -32.97 35.98 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 119.296 3.073 . . . . 0.0 119.296 172.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -52.86 -38.56 61.69 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 173.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -140.34 26.73 2.15 Favored 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 117.534 2.42 . . . . 0.0 117.534 -177.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 39.5 m -47.69 -37.39 12.89 Favored 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 116.053 1.872 . . . . 0.0 116.053 173.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -69.73 -60.2 3.98 Favored Pre-proline 0 CA--C 1.578 2.026 0 CA-C-O 116.75 -1.595 . . . . 0.0 112.102 172.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -49.87 -30.79 24.62 Favored 'Trans proline' 0 CA--C 1.576 2.605 0 C-N-CA 123.375 2.716 . . . . 0.0 118.562 167.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -63.86 -55.39 23.15 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 125.515 1.526 . . . . 0.0 111.722 173.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.917 ' O ' ' HB2' ' A' ' 156' ' ' ARG 0.317 0.0 OUTLIER -63.41 -26.11 68.59 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 177.021 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -70.52 -50.92 32.7 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 120.68 1.582 . . . . 0.0 114.182 167.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -67.93 -53.91 22.75 Favored 'General case' 0 CA--C 1.557 1.225 0 CA-C-N 120.007 1.276 . . . . 0.0 111.398 -176.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . 0.256 67.5 m-85 -84.98 -19.69 31.69 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-O 114.959 -2.448 . . . . 0.0 113.387 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.917 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 40.6 ttt180 -70.73 -35.62 72.77 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 125.077 3.58 . . . . 0.0 115.073 168.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -69.01 -37.59 78.76 Favored 'General case' 0 CA--C 1.573 1.854 0 CA-C-N 120.08 1.309 . . . . 0.0 113.906 167.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -84.2 -33.03 24.24 Favored 'General case' 0 CA--C 1.572 1.791 0 N-CA-C 118.727 2.862 . . . . 0.0 118.727 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.8 pp -75.46 172.05 13.2 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 118.437 2.754 . . . . 0.0 118.437 -162.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -131.83 141.31 49.39 Favored 'General case' 0 CA--C 1.558 1.258 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 166.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 54.5 m -99.9 146.67 26.39 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 122.351 1.072 . . . . 0.0 110.731 -173.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 30.0 t -123.39 134.34 66.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 167.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -93.83 130.11 39.98 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 167.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -154.7 93.63 1.59 Allowed 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 122.623 1.201 . . . . 0.0 111.9 -163.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.1 t . . . . . 0 N--CA 1.484 1.251 0 CA-C-N 114.16 -1.382 . . . . 0.0 107.391 -176.207 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 . . . . . 0 N--CA 1.5 2.056 0 N-CA-C 116.153 1.909 . . . . 0.0 116.153 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -59.94 -49.61 77.0 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 170.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 94.5 t -56.69 -37.92 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 173.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -61.42 -34.55 75.57 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 167.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -61.0 -43.24 99.18 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 170.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 81.1 mtt-85 -66.65 -33.87 76.61 Favored 'General case' 0 CA--C 1.554 1.131 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 169.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.23 -47.1 85.91 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 171.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . 0.294 0.5 OUTLIER -69.3 -34.0 74.02 Favored 'General case' 0 N--CA 1.504 2.228 0 CA-C-N 120.196 1.362 . . . . 0.0 114.506 169.214 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 29.3 mtp180 -49.23 -45.26 44.33 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 166.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -67.39 -51.33 53.23 Favored 'General case' 0 CA--C 1.565 1.546 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 168.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.81 -62.88 1.39 Allowed 'General case' 0 CA--C 1.566 1.571 0 CA-C-O 117.981 -1.009 . . . . 0.0 112.84 -175.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.89 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -91.39 -54.92 1.89 Allowed Glycine 0 CA--C 1.552 2.402 0 CA-C-O 117.983 -1.454 . . . . 0.0 114.802 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.89 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 55.0 tttp . . . . . 0 C--O 1.251 1.169 0 CA-C-N 119.861 1.83 . . . . 0.0 109.612 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.0 mtt . . . . . 0 CA--C 1.561 1.371 0 CA-C-O 122.933 1.349 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . 0.309 11.7 mpt_? -122.67 167.48 13.38 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 120.747 3.61 . . . . 0.0 120.747 -164.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.1 p -148.25 141.24 18.74 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.656 0 CA-C-O 123.87 1.795 . . . . 0.0 112.568 166.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -116.55 136.99 52.52 Favored 'General case' 0 CA--C 1.56 1.341 0 CA-C-N 111.971 -2.377 . . . . 0.0 104.853 166.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.5 mt -111.85 128.81 56.24 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 122.693 1.235 . . . . 0.0 111.433 -176.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.545 HD11 HG12 ' A' ' 110' ' ' VAL . 5.8 mp -130.75 155.42 46.67 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 111.564 -2.562 . . . . 0.0 111.455 -164.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 144.5 168.87 12.84 Favored Glycine 0 CA--C 1.554 2.522 0 CA-C-O 119.134 -0.814 . . . . 0.0 114.701 169.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo . . . . . 0 CA--C 1.573 2.474 0 C-N-CA 123.462 2.774 . . . . 0.0 113.448 172.195 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.484 1.232 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.12 -32.81 57.11 Favored Glycine 0 CA--C 1.553 2.469 0 N-CA-C 120.057 2.783 . . . . 0.0 120.057 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 78.5 m -63.21 -48.79 76.84 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 119.116 1.458 . . . . 0.0 113.294 172.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.252 6.7 mm-40 -75.57 -15.85 60.32 Favored 'General case' 0 CA--C 1.57 1.713 0 CA-C-O 115.749 -2.072 . . . . 0.0 111.972 172.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.31 -47.44 61.12 Favored 'General case' 0 C--N 1.374 1.642 0 CA-C-N 123.605 2.911 . . . . 0.0 114.249 168.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.7 p -66.36 -42.11 90.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 174.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -63.96 -41.7 97.48 Favored 'General case' 0 CA--C 1.565 1.54 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 171.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mt -66.35 -30.91 71.4 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-N 120.819 1.645 . . . . 0.0 114.724 170.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.9 -42.88 98.89 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 167.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -58.46 -39.95 81.28 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 167.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.4 tptt -63.47 -55.54 23.32 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 172.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.0 mt -82.53 -21.51 35.36 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 117.068 2.247 . . . . 0.0 117.068 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.65 34.87 8.16 Favored Glycine 0 CA--C 1.556 2.614 0 N-CA-C 118.06 1.984 . . . . 0.0 118.06 -177.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.9 mm -109.06 159.42 31.21 Favored Pre-proline 0 CA--C 1.572 1.824 0 CA-C-N 119.059 1.429 . . . . 0.0 113.275 -168.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -83.88 101.53 0.9 Allowed 'Trans proline' 0 CA--C 1.568 2.184 0 C-N-CA 121.996 1.797 . . . . 0.0 110.592 163.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -59.54 113.94 2.47 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.647 0.779 . . . . 0.0 111.67 168.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 22.0 mm -98.35 106.21 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.212 0 N-CA-C 103.891 -2.633 . . . . 0.0 103.891 173.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 66.0 p -95.81 131.93 41.59 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 169.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.6 p -68.59 -11.21 59.7 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 117.312 2.338 . . . . 0.0 117.312 -174.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.512 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -87.65 -20.68 50.35 Favored Glycine 0 CA--C 1.544 1.846 0 N-CA-C 118.769 2.268 . . . . 0.0 118.769 166.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -81.63 -50.99 8.67 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 118.92 1.36 . . . . 0.0 114.652 -169.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -65.36 -37.75 87.98 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 174.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.598 ' HB3' ' CB ' ' A' ' 50' ' ' LYS . 27.2 m-85 -67.49 -41.88 83.81 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 169.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.512 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 73.2 ttt180 -57.08 -36.65 70.84 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 165.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.5 ttm180 -62.15 -43.05 99.69 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.568 1.147 . . . . 0.0 113.956 168.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -60.41 -43.81 96.33 Favored 'General case' 0 CA--C 1.573 1.852 0 CA-C-N 119.149 0.886 . . . . 0.0 113.255 167.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.473 ' HA ' HG23 ' A' ' 43' ' ' THR . 81.2 mt -51.27 -39.06 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.599 0 C-N-CA 125.93 1.692 . . . . 0.0 113.76 167.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -73.22 -32.62 64.88 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 115.786 1.772 . . . . 0.0 115.786 169.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -70.18 -50.43 40.28 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 175.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 166.33 -32.12 0.21 Allowed Glycine 0 CA--C 1.546 2.012 0 N-CA-C 117.818 1.887 . . . . 0.0 117.818 -169.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.618 ' O ' ' HG3' ' A' ' 44' ' ' LYS 0.322 44.7 p 49.45 125.29 0.0 OUTLIER 'General case' 0 N--CA 1.424 -1.749 1 N-CA-C 124.336 4.939 . . . . 0.0 124.336 -176.473 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.618 ' HG3' ' O ' ' A' ' 43' ' ' THR 0.352 56.5 mtpt -142.46 -24.12 0.66 Allowed 'General case' 0 N--CA 1.507 2.406 0 CA-C-N 110.073 -3.239 . . . . 0.0 118.538 146.13 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -97.86 -24.93 15.21 Favored 'General case' 0 N--CA 1.514 2.726 0 CA-C-N 123.567 2.894 . . . . 0.0 112.332 161.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -40.52 -64.49 1.17 Allowed Glycine 0 CA--C 1.531 1.053 0 C-N-CA 130.583 3.944 . . . . 0.0 115.756 167.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.3 p -72.33 -48.65 47.19 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 N-CA-C 116.223 1.935 . . . . 0.0 116.223 -171.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -66.36 -44.85 82.05 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 120.359 1.436 . . . . 0.0 112.707 176.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.12 -38.43 85.57 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.598 ' CB ' ' HB3' ' A' ' 35' ' ' PHE 0.348 15.3 tptt -81.28 -19.79 42.27 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-O 116.943 -1.503 . . . . 0.0 113.238 174.613 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.596 ' O ' ' CG ' ' A' ' 51' ' ' ARG . 33.9 ttt180 -81.23 -57.76 3.36 Favored 'General case' 0 CA--C 1.59 2.501 1 CA-C-O 85.358 -16.544 . . . . 0.0 118.654 174.711 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 16.8 m-30 -28.28 -62.23 0.11 Allowed 'General case' 0 N--CA 1.497 1.91 1 O-C-N 107.744 -9.347 . . . . 0.0 120.853 147.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.5 tp -59.05 -33.8 71.19 Favored 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 116.415 2.006 . . . . 0.0 116.415 171.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -90.04 -39.99 12.58 Favored 'General case' 0 CA--C 1.567 1.603 0 N-CA-C 115.543 1.682 . . . . 0.0 115.543 174.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.53 -40.22 16.56 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 117.004 -1.474 . . . . 0.0 114.776 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 151.15 -38.91 0.83 Allowed Glycine 0 N--CA 1.476 1.333 0 CA-C-N 120.924 1.693 . . . . 0.0 116.729 170.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -67.31 171.72 5.59 Favored 'General case' 0 CA--C 1.57 1.741 0 CA-C-N 118.269 1.035 . . . . 0.0 111.626 -177.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 89.4 mt -92.76 135.93 33.69 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 121.383 -0.823 . . . . 0.0 112.12 -167.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.543 HG13 HE21 ' A' ' 92' ' ' GLN . 2.4 p -103.99 136.82 19.14 Favored Pre-proline 0 CA--C 1.58 2.12 0 CA-C-O 118.137 -0.935 . . . . 0.0 109.239 173.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -55.31 146.53 60.87 Favored 'Trans proline' 0 CA--C 1.562 1.911 0 C-N-CA 123.836 3.024 . . . . 0.0 116.671 169.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.8 m -73.97 -48.68 28.78 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 -168.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -61.52 -39.35 90.71 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 116.675 2.102 . . . . 0.0 116.675 -170.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 26.2 mt -57.3 -48.52 78.7 Favored 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 116.506 2.039 . . . . 0.0 116.506 172.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.4 m -61.31 -50.9 71.09 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 112.946 -1.934 . . . . 0.0 113.088 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 -64.08 -19.14 65.04 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 168.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -72.22 -44.12 63.41 Favored 'General case' 0 CA--C 1.558 1.273 0 CA-C-N 121.146 1.793 . . . . 0.0 114.18 168.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 mt -59.19 -49.96 75.86 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 120.207 1.367 . . . . 0.0 114.228 167.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 67.4 t -60.87 -46.79 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 123.811 0.844 . . . . 0.0 113.035 176.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -70.72 -27.16 63.76 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 175.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -64.47 -37.98 89.41 Favored 'General case' 0 CA--C 1.563 1.475 0 CA-C-N 119.808 1.186 . . . . 0.0 112.714 167.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -79.08 -24.0 43.79 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 118.414 2.746 . . . . 0.0 118.414 169.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.0 mp -81.7 -34.46 30.62 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 117.237 2.31 . . . . 0.0 117.237 176.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 28.2 m120 . . . . . 0 N--CA 1.5 2.036 0 N-CA-C 116.832 2.16 . . . . 0.0 116.832 169.462 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.477 1.425 0 CA-C-O 123.413 1.563 . . . . 0.0 113.69 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -172.63 132.53 0.58 Allowed 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 112.875 -1.662 . . . . 0.0 107.729 -174.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 4.3 mm -101.2 107.67 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.563 0 N-CA-C 102.729 -3.063 . . . . 0.0 102.729 168.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.4 mt -100.97 133.95 44.69 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 169.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -125.32 129.98 51.06 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 119.33 0.968 . . . . 0.0 111.778 177.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.02 41.73 80.4 Favored Glycine 0 CA--C 1.546 1.984 0 CA-C-O 116.198 -2.445 . . . . 0.0 116.717 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . 0.257 1.6 t80 -106.28 -55.22 0.08 OUTLIER Pre-proline 0 N--CA 1.502 2.151 0 CA-C-N 121.281 2.54 . . . . 0.0 108.771 174.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -67.53 72.64 0.63 Allowed 'Trans proline' 0 CA--C 1.572 2.382 0 CA-C-N 124.02 2.471 . . . . 0.0 117.688 165.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.99 17.34 17.93 Favored 'General case' 0 CA--C 1.572 1.827 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 168.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.7 t -167.55 120.15 0.91 Allowed 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 101.656 -3.461 . . . . 0.0 101.656 -177.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . 0.342 4.6 p -69.01 -21.13 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 CA-C-O 116.337 -1.792 . . . . 0.0 111.991 -176.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -64.38 -31.39 72.58 Favored 'General case' 0 CA--C 1.557 1.247 0 N-CA-C 117.896 2.554 . . . . 0.0 117.896 162.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.543 HE21 HG13 ' A' ' 59' ' ' VAL . 2.6 mm-40 -77.28 -51.57 10.67 Favored 'General case' 0 CA--C 1.585 2.32 0 CA-C-N 124.034 3.106 . . . . 0.0 111.412 164.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.27 -29.13 68.61 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 117.274 2.324 . . . . 0.0 117.274 -172.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 64.7 tttt -56.34 -35.32 67.49 Favored 'General case' 0 CA--C 1.557 1.213 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 167.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.32 -37.33 74.69 Favored 'General case' 0 CA--C 1.566 1.559 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 169.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 22.9 tp -65.55 -34.03 77.29 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 168.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.03 -42.28 89.78 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 121.549 1.977 . . . . 0.0 112.623 169.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.971 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 34.9 mt-10 -56.02 -34.92 66.3 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 115.154 1.539 . . . . 0.0 115.154 167.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 1.226 ' O ' ' HB2' ' A' ' 103' ' ' ARG . 20.7 ttt -85.78 -32.99 21.51 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 118.567 2.803 . . . . 0.0 118.567 178.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.8 -44.71 47.97 Favored 'General case' 0 N--CA 1.507 2.387 0 CA-C-N 121.375 1.898 . . . . 0.0 111.705 170.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -73.52 -53.5 10.42 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 119.221 0.919 . . . . 0.0 113.269 173.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.971 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 72.3 ttt180 -67.71 -40.75 84.24 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 116.013 1.857 . . . . 0.0 116.013 176.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 1.226 ' HB2' ' O ' ' A' ' 99' ' ' MET . 15.0 mmm180 -61.42 -60.18 4.11 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 118.622 0.646 . . . . 0.0 111.447 166.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 113.63 49.27 0.56 Allowed Glycine 0 N--CA 1.478 1.478 0 O-C-N 124.629 1.205 . . . . 0.0 113.632 169.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 73.2 p -86.92 146.16 26.27 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-N 114.388 -0.906 . . . . 0.0 109.399 171.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -69.13 132.15 46.11 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.526 -0.734 . . . . 0.0 111.394 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.9 tp -89.25 97.21 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -173.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -97.76 -65.58 0.95 Allowed 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 115.802 -2.046 . . . . 0.0 109.163 169.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -149.32 118.08 6.63 Favored 'General case' 0 C--N 1.366 1.295 0 CA-C-N 121.988 2.176 . . . . 0.0 114.88 -170.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.545 HG12 HD11 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -94.99 110.74 24.42 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.162 1 N-CA-C 98.888 -4.486 . . . . 0.0 98.888 161.042 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 40.9 tp -114.02 103.81 11.52 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.246 -162.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -100.2 123.39 44.38 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -176.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 6.8 m-30 -93.98 126.58 39.27 Favored 'General case' 0 CA--C 1.561 1.369 0 CA-C-O 122.471 1.129 . . . . 0.0 109.562 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.405 ' HB3' ' HA ' ' A' ' 163' ' ' ASP . 1.6 tmm_? -82.72 88.31 6.73 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 113.602 -1.635 . . . . 0.0 109.134 168.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.4 p . . . . . 0 CA--C 1.554 1.118 0 C-N-CA 125.758 1.623 . . . . 0.0 107.813 -169.496 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 . . . . . 0 N--CA 1.502 2.135 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 69.2 mtp180 -60.56 -38.68 85.34 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 169.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 56.1 mtt -71.62 -29.14 64.33 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 169.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -61.91 -50.35 72.53 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 120.459 1.482 . . . . 0.0 114.834 168.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.5 p -63.52 -33.83 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 169.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -54.21 -48.27 71.22 Favored 'General case' 0 CA--C 1.58 2.112 0 CA-C-N 119.983 1.265 . . . . 0.0 112.403 167.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -61.26 -45.57 93.98 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 117.859 2.54 . . . . 0.0 117.859 175.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -56.63 -32.1 64.99 Favored 'General case' 0 N--CA 1.507 2.385 0 N-CA-C 117.779 2.511 . . . . 0.0 117.779 177.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -114.61 -39.59 3.75 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 117.497 2.406 . . . . 0.0 117.497 -167.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 99.1 m -49.88 -34.2 19.44 Favored 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 117.525 2.417 . . . . 0.0 117.525 -168.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.442 ' HB3' ' HD3' ' A' ' 150' ' ' PRO . . . -67.8 -61.12 4.59 Favored Pre-proline 0 CA--C 1.581 2.168 0 CA-C-O 116.013 -1.946 . . . . 0.0 112.045 170.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.442 ' HD3' ' HB3' ' A' ' 149' ' ' ALA . 84.8 Cg_exo -55.74 -30.06 74.2 Favored 'Trans proline' 0 CA--C 1.582 2.919 0 N-CA-C 119.947 3.018 . . . . 0.0 119.947 169.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.3 -55.18 30.71 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 126.442 1.897 . . . . 0.0 111.524 169.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 1.3 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 28.9 tp -67.1 -22.52 65.81 Favored 'General case' 0 CA--C 1.562 1.409 0 CA-C-O 116.699 -1.619 . . . . 0.0 114.437 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -71.99 -49.35 37.91 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 122.008 2.185 . . . . 0.0 112.354 164.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -67.81 -54.4 19.42 Favored 'General case' 0 CA--C 1.562 1.438 0 CA-C-N 121.214 1.825 . . . . 0.0 112.158 -177.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -77.39 -23.27 50.73 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 114.49 -2.671 . . . . 0.0 112.337 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 1.3 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 0.1 OUTLIER -64.45 -40.25 95.38 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 125.878 3.945 . . . . 0.0 115.739 167.735 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -62.09 -37.0 83.4 Favored 'General case' 0 CA--C 1.576 1.947 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 167.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -90.48 -35.63 14.99 Favored 'General case' 0 CA--C 1.576 1.98 0 N-CA-C 118.653 2.834 . . . . 0.0 118.653 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.418 ' HA ' HG23 ' A' ' 110' ' ' VAL . 3.3 pp -71.87 171.81 11.04 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 119.843 3.275 . . . . 0.0 119.843 -163.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -129.72 126.3 37.92 Favored 'General case' 0 CA--C 1.566 1.585 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 166.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.3 t -101.64 160.45 14.44 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 122.798 1.285 . . . . 0.0 113.265 -169.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.525 HG13 ' HG3' ' A' ' 174' ' ' ARG . 91.9 t -131.74 150.41 33.94 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.887 0 CA-C-N 113.456 -1.702 . . . . 0.0 107.335 169.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.405 ' HA ' ' HB3' ' A' ' 114' ' ' ARG . 13.4 t70 -107.06 127.03 53.11 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 167.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -164.83 126.95 2.2 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -162.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.0 t . . . . . 0 N--CA 1.49 1.549 0 O-C-N 121.34 -0.85 . . . . 0.0 108.845 167.627 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 . . . . . 0 N--CA 1.496 1.87 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.844 ' HB3' ' NH2' ' A' ' 174' ' ' ARG . 45.1 mt-10 -58.99 -54.9 41.87 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 172.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 93.6 t -58.13 -37.8 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 176.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -60.48 -36.13 77.55 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 168.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -63.59 -56.05 18.91 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 175.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.844 ' NH2' ' HB3' ' A' ' 170' ' ' GLU . 9.8 ptp180 -66.07 -25.93 67.26 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 118.001 2.593 . . . . 0.0 118.001 171.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.5 -41.62 88.6 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 167.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.3 mp -62.82 -41.69 99.42 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 117.676 -1.154 . . . . 0.0 113.831 167.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -54.96 -45.18 74.89 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 168.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.64 -46.59 88.55 Favored 'General case' 0 CA--C 1.559 1.313 0 N-CA-C 116.655 2.095 . . . . 0.0 116.655 171.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 6.2 tt -83.74 -57.01 3.39 Favored 'General case' 0 CA--C 1.567 1.604 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.428 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.646 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -110.39 -58.89 0.49 Allowed Glycine 0 CA--C 1.552 2.366 0 CA-C-O 117.727 -1.596 . . . . 0.0 114.924 -176.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.646 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 37.0 ttmt . . . . . 0 C--O 1.251 1.151 0 CA-C-N 120.357 2.079 . . . . 0.0 107.328 -175.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 ptp . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 121.681 0.753 . . . . 0.0 111.551 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.729 ' HB3' ' HA2' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -160.42 159.0 30.47 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -168.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 99.4 t -136.7 150.2 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.543 0 CA-C-O 124.107 1.908 . . . . 0.0 110.262 -166.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.638 HD12 HH22 ' A' ' 2' ' ' ARG . 3.7 mt -117.46 134.04 55.29 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 127.234 2.214 . . . . 0.0 107.039 169.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 18.5 tp -116.65 119.35 35.23 Favored 'General case' 0 CA--C 1.571 1.769 0 CA-C-O 123.722 1.725 . . . . 0.0 108.716 -176.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -118.41 141.5 48.49 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 110.504 -3.044 . . . . 0.0 109.794 -166.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 171.2 167.85 32.05 Favored Glycine 0 CA--C 1.559 2.796 0 N-CA-C 116.04 1.176 . . . . 0.0 116.04 170.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo . . . . . 0 CA--C 1.574 2.5 0 C-N-CA 123.513 2.809 . . . . 0.0 116.002 174.906 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm . . . . . 0 N--CA 1.486 1.35 0 CA-C-O 120.853 0.359 . . . . 0.0 110.158 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -51.06 -36.3 34.75 Favored Glycine 0 CA--C 1.554 2.509 0 N-CA-C 120.466 2.947 . . . . 0.0 120.466 -177.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 58.6 m -65.01 -52.45 56.07 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 119.151 1.475 . . . . 0.0 113.458 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.284 21.3 mp0 -76.51 -13.39 60.1 Favored 'General case' 0 CA--C 1.571 1.783 0 CA-C-O 115.545 -2.169 . . . . 0.0 112.329 171.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.39 -45.83 68.36 Favored 'General case' 0 C--N 1.373 1.619 0 CA-C-N 124.131 3.151 . . . . 0.0 114.389 166.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.9 p -66.22 -43.22 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-O 118.449 -0.786 . . . . 0.0 113.092 173.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.4 ' HB3' ' CE1' ' A' ' 172' ' ' PHE . 97.3 mttt -55.14 -48.61 73.46 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 116.6 2.074 . . . . 0.0 116.6 169.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 mt -66.16 -29.26 69.51 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 172.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.83 -39.83 94.21 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 167.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -59.32 -39.49 83.26 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 117.342 -1.313 . . . . 0.0 114.516 166.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -62.25 -58.89 6.08 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 120.901 1.682 . . . . 0.0 114.905 169.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.3 mt -82.31 -20.2 37.88 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 117.551 2.426 . . . . 0.0 117.551 -172.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.67 44.94 8.88 Favored Glycine 0 CA--C 1.553 2.432 0 CA-C-N 120.734 1.607 . . . . 0.0 117.071 -174.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.402 ' CG2' ' HA ' ' A' ' 81' ' ' PHE . 29.1 mm -112.32 156.02 42.74 Favored Pre-proline 0 CA--C 1.569 1.698 0 CA-C-N 118.219 1.01 . . . . 0.0 113.578 -168.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -73.04 100.65 1.24 Allowed 'Trans proline' 0 CA--C 1.562 1.894 0 C-N-CA 121.807 1.671 . . . . 0.0 112.685 160.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.23 105.34 4.61 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.302 -0.874 . . . . 0.0 108.809 167.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 44.6 mm -99.97 111.9 30.93 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 178.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.2 t -96.64 127.84 43.01 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 168.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 19.7 p -73.91 1.31 11.01 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 116.95 2.204 . . . . 0.0 116.95 -172.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.57 -18.67 29.71 Favored Glycine 0 CA--C 1.55 2.28 0 N-CA-C 118.014 1.966 . . . . 0.0 118.014 163.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -78.89 -55.87 4.82 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 119.494 1.647 . . . . 0.0 113.594 -168.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -57.0 -39.28 74.4 Favored 'General case' 0 CA--C 1.568 1.648 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 172.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -69.84 -37.46 76.19 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 117.415 -1.279 . . . . 0.0 114.05 169.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -52.9 -39.95 63.16 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 115.478 1.658 . . . . 0.0 115.478 167.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.43 ' HD2' ' HA ' ' A' ' 37' ' ' ARG . 9.8 tpt180 -67.64 -39.99 84.59 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 172.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -64.99 -31.76 73.16 Favored 'General case' 0 CA--C 1.579 2.074 0 N-CA-C 115.634 1.716 . . . . 0.0 115.634 166.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 57.6 mt -59.89 -45.68 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 C-N-CA 126.023 1.729 . . . . 0.0 111.362 167.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -63.06 -41.48 99.47 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 172.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -71.74 -37.77 70.52 Favored 'General case' 0 CA--C 1.563 1.444 0 N-CA-C 116.823 2.157 . . . . 0.0 116.823 176.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.05 71.06 1.18 Allowed Glycine 0 CA--C 1.545 1.967 0 CA-C-O 117.782 -1.566 . . . . 0.0 115.179 -176.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.874 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 59.2 p -92.33 -51.26 5.24 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-N 119.684 1.742 . . . . 0.0 114.286 174.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.874 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.25 73.4 mttt 105.87 -40.52 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.777 0 CA-C-O 116.325 -1.798 . . . . 0.0 111.651 -171.549 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.06 -14.84 57.43 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 123.066 2.666 . . . . 0.0 112.968 164.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.3 -57.53 19.31 Favored Glycine 0 C--N 1.358 1.755 0 CA-C-N 120.299 1.409 . . . . 0.0 115.082 168.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.268 10.9 p -75.13 -47.5 35.8 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.394 0 N-CA-C 116.45 2.018 . . . . 0.0 116.45 -168.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -65.42 -46.86 78.3 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 120.783 1.629 . . . . 0.0 112.8 173.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.02 -33.81 75.29 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -178.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -66.68 -42.46 86.51 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 168.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.591 ' CG ' ' O ' ' A' ' 51' ' ' ARG . 31.6 ttt180 -73.0 -51.53 17.9 Favored 'General case' 0 CA--C 1.59 2.518 1 CA-C-O 85.079 -16.677 . . . . 0.0 118.318 -173.725 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 16.9 m-30 -31.57 -56.91 0.27 Allowed 'General case' 0 N--CA 1.495 1.793 1 O-C-N 109.216 -8.428 . . . . 0.0 121.693 146.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 35.8 mt -59.17 -44.68 92.16 Favored 'General case' 0 CA--C 1.578 2.039 0 CA-C-N 122.941 2.609 . . . . 0.0 114.411 166.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -80.79 -34.12 34.33 Favored 'General case' 0 CA--C 1.564 1.488 0 N-CA-C 116.941 2.2 . . . . 0.0 116.941 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -97.05 -33.77 11.41 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 175.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.47 20.19 6.69 Favored Glycine 0 CA--C 1.546 1.987 0 CA-C-N 122.452 2.387 . . . . 0.0 118.068 169.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -97.98 173.06 7.25 Favored 'General case' 0 CA--C 1.574 1.904 0 CA-C-N 118.998 1.399 . . . . 0.0 110.083 167.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.7 mt -72.71 130.31 40.22 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 119.828 -1.795 . . . . 0.0 114.923 -166.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.4 p -116.35 113.55 40.98 Favored Pre-proline 0 CA--C 1.57 1.745 0 C-N-CA 124.817 1.247 . . . . 0.0 108.936 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -60.6 153.06 64.22 Favored 'Trans proline' 0 CA--C 1.559 1.746 0 C-N-CA 123.425 2.75 . . . . 0.0 116.996 177.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 90.5 p -79.35 172.91 13.14 Favored 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 177.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . 0.427 ' O ' ' HB2' ' A' ' 66' ' ' GLU . 6.0 t70 81.89 -46.12 0.19 Allowed 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 125.839 1.656 . . . . 0.0 114.713 175.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 22.6 mt -60.83 -50.96 71.33 Favored 'General case' 0 N--CA 1.506 2.354 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 168.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.4 m -58.84 -50.83 72.53 Favored 'General case' 0 CA--C 1.566 1.591 0 CA-C-N 112.989 -1.914 . . . . 0.0 112.904 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -62.17 -28.44 69.66 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 115.216 1.561 . . . . 0.0 115.216 168.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -64.69 -44.37 90.52 Favored 'General case' 0 CA--C 1.555 1.171 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 171.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.3 mt -60.9 -48.99 79.29 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.214 1.191 . . . . 0.0 114.214 167.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 78.5 t -61.39 -51.82 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 CA-C-O 117.989 -1.005 . . . . 0.0 111.497 175.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -64.4 -28.38 69.65 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 174.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -64.05 -41.43 97.38 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 119.706 1.139 . . . . 0.0 112.806 168.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 27.8 ttm-85 -82.4 -9.2 59.54 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 119.001 2.963 . . . . 0.0 119.001 170.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 89.9 mt -99.49 -23.42 15.11 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 175.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 . . . . . 0 N--CA 1.5 2.028 0 N-CA-C 116.318 1.97 . . . . 0.0 116.318 172.168 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.729 ' HA2' ' HB3' ' A' ' 2' ' ' ARG . . . . . . . . 0 N--CA 1.483 1.786 0 CA-C-O 122.969 1.316 . . . . 0.0 112.612 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.402 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . 31.5 p90 -178.39 135.32 0.15 Allowed 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 113.355 -1.422 . . . . 0.0 112.111 -168.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 31.3 mt -109.5 106.03 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.545 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 174.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.9 mt -99.98 129.84 46.09 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.35 1.06 . . . . 0.0 110.261 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -124.22 115.96 21.91 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 118.501 0.591 . . . . 0.0 110.235 -172.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 75.18 32.64 55.72 Favored Glycine 0 CA--C 1.551 2.343 0 CA-C-O 117.549 -1.695 . . . . 0.0 117.046 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -95.9 -52.77 0.23 Allowed Pre-proline 0 N--CA 1.496 1.863 0 CA-C-O 115.068 -2.396 . . . . 0.0 108.664 174.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -66.13 70.7 0.4 Allowed 'Trans proline' 0 CA--C 1.573 2.437 0 CA-C-N 124.57 2.668 . . . . 0.0 117.835 165.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . 0.33 39.2 ttt-85 -72.61 -35.41 67.85 Favored 'General case' 0 CA--C 1.56 1.333 0 N-CA-C 116.789 2.144 . . . . 0.0 116.789 167.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.6 t -147.29 135.4 21.45 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 -169.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . 0.329 4.9 p -69.02 -19.0 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 CA-C-O 116.364 -1.779 . . . . 0.0 112.597 -178.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -68.08 -32.7 73.22 Favored 'General case' 0 CA--C 1.558 1.254 0 N-CA-C 118.781 2.882 . . . . 0.0 118.781 165.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -75.83 -50.35 15.39 Favored 'General case' 0 CA--C 1.587 2.387 0 CA-C-N 124.372 3.26 . . . . 0.0 111.204 164.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.73 -27.43 66.47 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 117.984 2.587 . . . . 0.0 117.984 -175.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 41.9 tttt -57.32 -33.91 68.2 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 167.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.35 -38.23 88.69 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 167.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 47.3 mt -66.9 -33.19 75.05 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 170.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -63.19 -55.02 28.55 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 120.064 1.302 . . . . 0.0 112.755 169.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 1.157 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 0.7 OUTLIER -49.73 -36.58 26.09 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 115.761 1.763 . . . . 0.0 115.761 168.13 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 1.125 ' O ' ' HB2' ' A' ' 103' ' ' ARG . 65.6 mtt -84.37 -28.84 26.71 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 117.802 2.519 . . . . 0.0 117.802 175.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 35.9 tp -65.23 -55.05 20.67 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 120.747 1.612 . . . . 0.0 111.862 170.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -80.1 -50.74 9.9 Favored 'General case' 0 CA--C 1.562 1.42 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 176.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 1.157 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 94.4 mtt180 -71.86 -42.15 67.21 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 177.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 1.125 ' HB2' ' O ' ' A' ' 99' ' ' MET . 43.6 mtt180 -65.18 -51.52 60.59 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 119.928 1.24 . . . . 0.0 111.621 164.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.4 44.33 1.26 Allowed Glycine 0 N--CA 1.48 1.612 0 C-N-CA 121.052 -0.594 . . . . 0.0 114.153 167.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 31.1 p -95.18 145.02 25.33 Favored 'General case' 0 CA--C 1.557 1.217 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 169.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -69.44 128.19 35.65 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.438 -0.789 . . . . 0.0 112.604 -169.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 4.5 tp -81.0 102.78 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 173.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . 0.268 24.2 t70 -96.5 -76.23 0.51 Allowed 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 116.111 -1.899 . . . . 0.0 106.8 167.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -138.87 127.14 22.78 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 121.141 1.791 . . . . 0.0 114.794 -173.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.4 t -93.66 109.92 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 103.144 -2.91 . . . . 0.0 103.144 162.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 91.3 mt -107.09 120.48 42.2 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 122.918 0.487 . . . . 0.0 109.873 -172.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -103.95 128.18 51.48 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 118.033 0.379 . . . . 0.0 110.358 177.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -91.46 119.42 31.41 Favored 'General case' 0 CA--C 1.556 1.192 0 CA-C-O 122.946 1.355 . . . . 0.0 109.584 177.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -82.0 93.59 6.99 Favored 'General case' 0 CA--C 1.557 1.224 0 CA-C-N 112.843 -1.98 . . . . 0.0 108.314 166.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.481 1.076 0 CA-C-N 113.605 -1.634 . . . . 0.0 108.286 -168.499 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 48.3 t30 . . . . . 0 N--CA 1.503 2.211 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 27.7 mtp180 -59.78 -38.4 81.75 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 167.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 63.3 mtt -65.64 -31.87 73.13 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 169.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -64.12 -49.63 71.43 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 168.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.6 p -65.97 -33.33 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 169.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -54.19 -51.41 64.48 Favored 'General case' 0 CA--C 1.579 2.077 0 CA-C-N 120.175 1.352 . . . . 0.0 111.191 167.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -55.61 -37.09 67.67 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 119.529 3.159 . . . . 0.0 119.529 173.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -51.46 -29.37 15.99 Favored 'General case' 0 N--CA 1.513 2.685 0 N-CA-C 117.844 2.535 . . . . 0.0 117.844 170.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -121.88 -28.94 4.38 Favored 'General case' 0 CA--C 1.559 1.309 0 N-CA-C 118.852 2.908 . . . . 0.0 118.852 -166.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 33.5 m -42.78 -37.08 1.66 Allowed 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 118.053 2.612 . . . . 0.0 118.053 -168.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.5 -62.46 2.99 Favored Pre-proline 0 CA--C 1.581 2.172 0 CA-C-O 116.175 -1.869 . . . . 0.0 111.822 172.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -52.08 -36.56 66.14 Favored 'Trans proline' 0 CA--C 1.58 2.819 0 C-N-CA 123.554 2.836 . . . . 0.0 118.546 167.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.68 -54.54 44.09 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 125.427 1.491 . . . . 0.0 111.973 171.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 1.004 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 44.2 tp -67.39 -23.55 65.58 Favored 'General case' 0 CA--C 1.561 1.396 0 CA-C-O 116.669 -1.634 . . . . 0.0 114.456 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -72.43 -46.01 57.02 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 122.022 2.192 . . . . 0.0 112.743 165.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -67.81 -52.07 41.37 Favored 'General case' 0 CA--C 1.565 1.534 0 CA-C-N 120.499 1.499 . . . . 0.0 112.245 -177.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -81.03 -24.3 38.01 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-O 115.119 -2.372 . . . . 0.0 113.405 178.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 1.004 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 39.8 ttt180 -65.04 -36.41 84.26 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 124.565 3.348 . . . . 0.0 115.581 168.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -68.17 -37.33 80.86 Favored 'General case' 0 CA--C 1.574 1.896 0 CA-C-N 119.806 1.185 . . . . 0.0 114.026 167.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -80.14 -35.93 35.94 Favored 'General case' 0 CA--C 1.575 1.91 0 N-CA-C 119.009 2.966 . . . . 0.0 119.009 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.2 pp -79.96 174.77 11.25 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 118.917 2.932 . . . . 0.0 118.917 -161.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 61.3 tttt -135.18 140.64 45.52 Favored 'General case' 0 CA--C 1.564 1.495 0 C-N-CA 125.249 1.42 . . . . 0.0 108.075 167.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 58.0 m -88.76 146.89 24.75 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.358 1.075 . . . . 0.0 112.14 -169.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 58.4 t -134.8 137.49 50.83 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.559 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 167.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -95.39 138.78 32.6 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 168.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -162.24 101.31 1.09 Allowed 'General case' 0 N--CA 1.482 1.13 0 O-C-N 121.466 -0.771 . . . . 0.0 112.323 -165.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.9 t . . . . . 0 N--CA 1.489 1.504 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 173.775 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 . . . . . 0 N--CA 1.499 2.003 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.63 -51.95 67.62 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 171.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 79.5 t -55.47 -40.33 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 175.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.4 ' CE1' ' HB3' ' A' ' 19' ' ' LYS . 22.9 t80 -62.97 -33.2 74.89 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 169.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -62.02 -48.98 77.87 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 114.241 1.201 . . . . 0.0 114.241 171.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 80.0 mtt180 -58.93 -42.6 90.14 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 117.199 2.296 . . . . 0.0 117.199 169.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -58.93 -43.35 91.13 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 170.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.9 mp -64.84 -42.05 95.24 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 169.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -54.4 -41.25 69.06 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 116.412 2.004 . . . . 0.0 116.412 169.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -65.24 -51.67 59.36 Favored 'General case' 0 CA--C 1.561 1.37 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 169.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 7.4 tt -74.03 -57.65 3.83 Favored 'General case' 0 CA--C 1.566 1.574 0 CA-C-N 120.026 1.285 . . . . 0.0 112.636 -176.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.945 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -110.46 -57.66 0.5 Allowed Glycine 0 CA--C 1.552 2.362 0 CA-C-O 117.744 -1.587 . . . . 0.0 114.762 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.945 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 63.6 tttm . . . . . 0 C--O 1.251 1.173 0 CA-C-N 120.306 2.053 . . . . 0.0 109.212 -175.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.4 mmt . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 122.667 1.222 . . . . 0.0 111.444 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . 0.304 8.7 ttm-85 -148.59 147.07 28.57 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 118.162 2.652 . . . . 0.0 118.162 -158.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 37.7 t -142.76 148.83 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 124.624 2.154 . . . . 0.0 110.846 -172.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.4 HD11 HG22 ' A' ' 110' ' ' VAL 0.294 0.0 OUTLIER -135.56 122.03 20.63 Favored 'General case' 0 CA--C 1.564 1.513 0 CA-C-N 112.716 -2.038 . . . . 0.0 106.416 166.095 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.9 tt -97.98 133.31 42.63 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.823 1.649 . . . . 0.0 110.832 -166.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.6 mt -138.4 156.43 47.59 Favored 'General case' 0 CA--C 1.554 1.118 0 CA-C-N 113.98 -1.463 . . . . 0.0 111.174 -166.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 160.6 144.33 3.94 Favored Glycine 0 CA--C 1.555 2.544 0 CA-C-O 118.202 -1.332 . . . . 0.0 114.967 172.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo . . . . . 0 CA--C 1.579 2.733 0 CA-C-N 121.367 2.584 . . . . 0.0 114.847 169.966 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm . . . . . 0 N--CA 1.484 1.274 0 N-CA-C 109.519 -0.548 . . . . 0.0 109.519 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -48.22 -33.07 10.33 Favored Glycine 0 CA--C 1.557 2.693 0 N-CA-C 120.175 2.83 . . . . 0.0 120.175 171.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 20.1 m -61.7 -52.18 65.34 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 118.872 1.336 . . . . 0.0 113.967 170.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.284 2.8 mp0 -75.09 -11.69 60.15 Favored 'General case' 0 CA--C 1.57 1.716 0 CA-C-O 115.719 -2.086 . . . . 0.0 112.683 171.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.91 -45.85 55.91 Favored 'General case' 0 C--N 1.372 1.581 0 CA-C-N 123.778 2.99 . . . . 0.0 113.929 166.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.3 p -65.22 -44.89 95.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 173.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.481 ' HB3' ' HE2' ' A' ' 172' ' ' PHE . 99.5 mttt -64.12 -46.06 85.84 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 116.325 1.972 . . . . 0.0 116.325 172.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.5 tp -65.26 -29.32 70.09 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 171.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.81 -45.15 93.97 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 168.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -52.71 -39.73 62.3 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 164.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -64.32 -48.2 76.52 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 170.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.7 mt -79.6 -19.01 50.33 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 116.505 2.039 . . . . 0.0 116.505 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.99 46.78 6.49 Favored Glycine 0 CA--C 1.554 2.513 0 CA-C-N 120.054 1.297 . . . . 0.0 116.14 -174.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.555 ' CD1' ' HA ' ' A' ' 81' ' ' PHE . 0.2 OUTLIER -130.86 147.93 68.17 Favored Pre-proline 0 CA--C 1.572 1.809 0 C-N-CA 125.855 1.662 . . . . 0.0 110.949 -165.773 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.476 ' HD2' HD12 ' A' ' 26' ' ' ILE . 19.2 Cg_endo -75.55 106.73 2.32 Favored 'Trans proline' 0 CA--C 1.574 2.489 0 C-N-CA 121.85 1.7 . . . . 0.0 111.049 158.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.35 132.62 48.05 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 120.643 -1.286 . . . . 0.0 112.028 169.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -94.98 107.25 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 N-CA-C 103.478 -2.786 . . . . 0.0 103.478 174.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 76.3 p -98.24 125.06 43.16 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 168.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.9 p -68.76 -4.6 16.57 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 117.68 2.474 . . . . 0.0 117.68 -175.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.77 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -89.34 -26.06 26.71 Favored Glycine 0 CA--C 1.539 1.573 0 N-CA-C 118.898 2.319 . . . . 0.0 118.898 165.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -82.11 -55.61 4.45 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 -168.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -63.9 -40.1 95.72 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 175.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.481 ' HB3' ' CB ' ' A' ' 50' ' ' LYS . 20.1 m-85 -71.09 -44.97 64.6 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 116.35 -1.786 . . . . 0.0 114.612 173.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.77 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 72.5 ttt180 -52.46 -41.86 63.68 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 168.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -61.84 -41.25 97.58 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 168.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -67.61 -25.65 65.86 Favored 'General case' 0 CA--C 1.583 2.218 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 168.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 66.8 mt -61.64 -48.38 88.98 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.458 0 CA-C-N 121.054 1.752 . . . . 0.0 110.264 166.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -61.72 -40.91 96.71 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 175.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -65.94 -44.19 85.79 Favored 'General case' 0 CA--C 1.558 1.257 0 N-CA-C 116.069 1.878 . . . . 0.0 116.069 174.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.06 66.96 1.26 Allowed Glycine 0 CA--C 1.544 1.859 0 CA-C-O 118.784 -1.009 . . . . 0.0 114.301 -176.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.837 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 70.4 p -91.43 -48.45 6.88 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.837 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.274 38.9 mttp 107.77 -41.54 0.0 OUTLIER 'General case' 0 CA--C 1.571 1.752 0 CA-C-O 116.31 -1.805 . . . . 0.0 111.007 -172.431 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.4 pp -79.5 -18.66 51.47 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 123.108 2.686 . . . . 0.0 114.147 163.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.26 -55.77 28.64 Favored Glycine 0 CA--C 1.548 2.141 0 CA-C-O 122.419 1.011 . . . . 0.0 114.951 169.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 1.082 ' O ' ' HB2' ' A' ' 51' ' ' ARG . 1.0 OUTLIER -75.89 -43.73 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 N-CA-C 117.158 2.281 . . . . 0.0 117.158 -167.988 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.48 ' HG2' HG23 ' A' ' 59' ' ' VAL . 29.7 tt0 -78.45 -24.79 45.86 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 122.369 2.349 . . . . 0.0 111.806 170.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.85 -47.76 70.96 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 123.163 2.71 . . . . 0.0 112.68 177.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.481 ' CB ' ' HB3' ' A' ' 35' ' ' PHE 0.356 38.5 tptt -81.56 -17.22 49.15 Favored 'General case' 0 CA--C 1.573 1.85 0 O-C-N 124.694 1.247 . . . . 0.0 114.339 173.111 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 1.082 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 21.5 ttt180 -83.61 -54.34 5.0 Favored 'General case' 0 CA--C 1.581 2.173 1 CA-C-O 85.034 -16.698 . . . . 0.0 118.562 175.691 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -37.99 -62.8 0.53 Allowed 'General case' 0 C--N 1.368 1.398 1 O-C-N 105.791 -10.568 . . . . 0.0 119.442 148.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . 0.271 1.2 tm? -41.18 -40.65 1.62 Allowed 'General case' 0 CA--C 1.58 2.123 0 CA-C-N 121.968 2.167 . . . . 0.0 116.845 170.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -90.72 -42.91 10.44 Favored 'General case' 0 CA--C 1.572 1.821 0 N-CA-C 117.045 2.239 . . . . 0.0 117.045 169.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -102.69 -23.45 13.83 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 118.31 2.707 . . . . 0.0 118.31 -169.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.48 32.45 7.32 Favored Glycine 0 CA--C 1.543 1.807 0 N-CA-C 118.58 2.192 . . . . 0.0 118.58 169.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -83.78 -127.09 0.03 OUTLIER 'General case' 0 CA--C 1.583 2.234 0 C-N-CA 123.833 0.853 . . . . 0.0 111.106 168.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 pp -128.81 179.08 5.91 Favored 'General case' 0 CA--C 1.573 1.835 0 C-N-CA 126.268 1.827 . . . . 0.0 110.462 169.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.48 HG23 ' HG2' ' A' ' 48' ' ' GLU . 0.3 OUTLIER -163.9 138.84 4.76 Favored Pre-proline 0 CA--C 1.574 1.899 0 O-C-N 119.484 -2.01 . . . . 0.0 110.593 170.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -60.01 145.42 98.43 Favored 'Trans proline' 0 CA--C 1.562 1.919 0 C-N-CA 123.432 2.755 . . . . 0.0 115.999 169.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 95.3 p -78.61 173.15 12.72 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 77.27 -38.39 0.29 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 117.15 2.278 . . . . 0.0 117.15 173.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . 0.452 ' O ' ' HB2' ' A' ' 66' ' ' GLU . 4.4 pp -54.55 -43.07 71.69 Favored 'General case' 0 N--CA 1.507 2.416 0 N-CA-C 118.03 2.604 . . . . 0.0 118.03 170.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.4 m -60.91 -58.39 8.65 Favored 'General case' 0 CA--C 1.562 1.424 0 CA-C-N 111.5 -2.591 . . . . 0.0 112.082 176.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -62.38 -19.14 63.1 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 166.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 63' ' ' LEU . 6.1 mm-40 -65.52 -44.84 85.67 Favored 'General case' 0 CA--C 1.558 1.276 0 CA-C-N 120.729 1.604 . . . . 0.0 114.036 168.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.5 mt -63.66 -43.79 95.69 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 114.571 1.322 . . . . 0.0 114.571 167.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 81.8 t -59.82 -48.9 85.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 CA-C-O 117.967 -1.016 . . . . 0.0 112.45 170.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -57.6 -37.6 73.49 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 116.976 2.213 . . . . 0.0 116.976 169.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -60.19 -39.45 86.57 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 169.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 76.8 mtp85 -79.44 -12.41 59.89 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 117.805 2.52 . . . . 0.0 117.805 167.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.1 mp -91.65 -23.67 19.76 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 117.527 2.417 . . . . 0.0 117.527 176.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 30.3 p30 . . . . . 0 CA--C 1.578 2.054 0 N-CA-C 118.187 2.662 . . . . 0.0 118.187 168.418 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.502 0 CA-C-O 122.5 1.056 . . . . 0.0 113.337 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.555 ' HA ' ' CD1' ' A' ' 26' ' ' ILE 0.38 1.6 p90 171.75 139.21 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 113.605 -1.297 . . . . 0.0 111.357 163.11 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.9 mp -115.45 109.26 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 165.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.9 mt -100.36 108.99 21.15 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 168.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -103.61 129.29 50.85 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-N 120.111 1.323 . . . . 0.0 109.961 -173.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 67.49 47.17 64.21 Favored Glycine 0 CA--C 1.548 2.098 0 CA-C-O 116.609 -2.217 . . . . 0.0 116.191 -173.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -132.77 73.17 76.45 Favored Pre-proline 0 CA--C 1.568 1.67 0 CA-C-N 121.104 2.452 . . . . 0.0 115.297 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -97.94 -28.27 0.05 OUTLIER 'Trans proline' 0 CA--C 1.561 1.87 0 C-N-CA 122.817 2.344 . . . . 0.0 112.857 156.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 50.1 mtt85 41.64 24.28 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 118.324 2.713 . . . . 0.0 118.324 -163.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.521 ' HA ' ' HG3' ' A' ' 147' ' ' GLU . 27.6 t 103.99 153.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 127.164 2.185 . . . . 0.0 106.519 -170.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . 0.531 HG12 ' HB2' ' A' ' 147' ' ' GLU 0.307 7.7 p -57.77 -27.34 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 119.647 -1.908 . . . . 0.0 112.366 169.23 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -70.0 -25.76 63.76 Favored 'General case' 0 CA--C 1.557 1.218 0 N-CA-C 119.471 3.138 . . . . 0.0 119.471 166.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.3 tm0? -74.28 -49.96 20.91 Favored 'General case' 0 CA--C 1.59 2.505 0 CA-C-N 124.592 3.36 . . . . 0.0 108.961 162.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -53.09 -25.44 12.9 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 117.845 2.535 . . . . 0.0 117.845 -176.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -59.14 -33.05 70.43 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 166.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.12 -41.29 74.14 Favored 'General case' 0 CA--C 1.571 1.784 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 169.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 28.9 tp -63.16 -36.48 83.77 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 168.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -56.3 -53.6 55.36 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 125.219 1.408 . . . . 0.0 112.719 167.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.806 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 11.0 mm-40 -49.92 -36.55 28.08 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 115.694 1.738 . . . . 0.0 115.694 166.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 1.13 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 24.9 ttt -83.45 -31.75 26.41 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 118.117 2.636 . . . . 0.0 118.117 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.52 -44.28 51.96 Favored 'General case' 0 N--CA 1.508 2.449 0 CA-C-N 121.741 2.064 . . . . 0.0 111.486 169.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -71.91 -57.6 4.17 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 119.496 1.044 . . . . 0.0 113.694 173.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.806 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 76.8 mtp180 -71.76 -36.55 70.43 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 178.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 1.13 ' HB3' ' O ' ' A' ' 99' ' ' MET . 57.4 ttt85 -61.16 -56.59 19.0 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 119.462 1.028 . . . . 0.0 111.736 165.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 111.7 49.87 0.62 Allowed Glycine 0 N--CA 1.481 1.672 0 O-C-N 124.231 0.957 . . . . 0.0 114.09 167.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 62.0 p -97.88 163.74 12.66 Favored 'General case' 0 CA--C 1.561 1.387 0 CA-C-N 114.015 -1.093 . . . . 0.0 111.075 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -84.63 134.57 34.38 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.158 -0.964 . . . . 0.0 109.128 177.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.502 HD11 HG23 ' A' ' 110' ' ' VAL . 8.9 tt -95.88 107.2 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 172.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -89.36 -60.44 1.95 Allowed 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 115.399 -2.239 . . . . 0.0 106.478 166.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -156.13 131.35 9.35 Favored 'General case' 0 C--N 1.369 1.419 0 CA-C-N 122.611 2.46 . . . . 0.0 116.463 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.502 HG23 HD11 ' A' ' 107' ' ' ILE . 39.2 t -88.66 107.86 18.21 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.629 0 N-CA-C 100.638 -3.838 . . . . 0.0 100.638 160.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.5 HD23 ' HB2' ' A' ' 160' ' ' LYS . 68.6 mt -104.27 108.83 20.42 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 118.318 -0.849 . . . . 0.0 109.616 -168.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -106.84 125.78 51.45 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.966 0.888 . . . . 0.0 109.857 -176.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -100.69 116.64 33.08 Favored 'General case' 0 CA--C 1.557 1.235 0 CA-C-O 122.568 1.175 . . . . 0.0 110.469 -169.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -79.64 97.81 6.68 Favored 'General case' 0 CA--C 1.556 1.191 0 CA-C-N 113.546 -1.661 . . . . 0.0 108.835 165.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.0 p . . . . . 0 CA--C 1.553 1.063 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 -169.265 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 . . . . . 0 N--CA 1.506 2.343 0 N-CA-C 113.928 1.085 . . . . 0.0 113.928 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -55.46 -39.11 69.95 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 166.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -67.6 -32.32 72.96 Favored 'General case' 0 CA--C 1.566 1.588 0 N-CA-C 114.97 1.471 . . . . 0.0 114.97 169.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -59.58 -54.18 49.44 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 120.561 1.528 . . . . 0.0 114.604 168.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . 0.253 7.3 p -63.67 -29.94 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 CA-C-O 117.085 -1.436 . . . . 0.0 114.054 170.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -56.65 -48.5 77.43 Favored 'General case' 0 CA--C 1.586 2.339 0 CA-C-N 121.441 1.928 . . . . 0.0 111.654 166.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.07 -21.2 11.74 Favored 'General case' 0 CA--C 1.564 1.493 0 N-CA-C 119.346 3.091 . . . . 0.0 119.346 170.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.31 -45.71 69.1 Favored 'General case' 0 N--CA 1.51 2.541 0 CA-C-N 121.339 1.882 . . . . 0.0 115.725 167.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.531 ' HB2' HG12 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -123.91 -18.57 5.95 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 120.742 3.608 . . . . 0.0 120.742 -167.31 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 53.7 m -43.72 -31.67 0.85 Allowed 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 117.899 2.555 . . . . 0.0 117.899 -169.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -71.48 -64.32 1.16 Allowed Pre-proline 0 CA--C 1.582 2.182 0 CA-C-O 116.123 -1.894 . . . . 0.0 112.21 172.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -56.53 -32.79 90.93 Favored 'Trans proline' 0 CA--C 1.579 2.772 0 CA-C-N 124.555 2.662 . . . . 0.0 118.905 168.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -63.2 -46.63 86.14 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 125.451 1.5 . . . . 0.0 112.711 171.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 1.075 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 54.2 tp -65.96 -21.91 66.45 Favored 'General case' 0 CA--C 1.57 1.719 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 169.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -70.62 -48.04 57.05 Favored 'General case' 0 CA--C 1.559 1.31 0 CA-C-N 122.362 2.346 . . . . 0.0 112.914 165.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -61.91 -54.31 43.72 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-N 120.271 1.396 . . . . 0.0 113.021 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . 0.422 ' CD1' HG11 ' A' ' 110' ' ' VAL . 22.0 m-85 -76.43 -27.52 56.28 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-O 115.739 -2.076 . . . . 0.0 113.438 178.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 1.075 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 26.0 ttt180 -62.34 -33.81 75.43 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 124.166 3.166 . . . . 0.0 116.754 169.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -70.57 -40.9 73.06 Favored 'General case' 0 CA--C 1.575 1.922 0 CA-C-N 119.708 1.14 . . . . 0.0 113.64 166.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -90.66 -19.69 23.34 Favored 'General case' 0 CA--C 1.575 1.932 0 N-CA-C 119.877 3.288 . . . . 0.0 119.877 -176.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.5 pp -78.06 172.16 13.93 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 119.887 3.291 . . . . 0.0 119.887 -160.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.5 ' HB2' HD23 ' A' ' 111' ' ' LEU . 90.5 mttt -132.65 123.98 27.41 Favored 'General case' 0 CA--C 1.563 1.45 0 N-CA-C 104.349 -2.463 . . . . 0.0 104.349 163.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.9 t -95.94 151.01 19.82 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 122.034 0.921 . . . . 0.0 111.99 -171.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.511 HG13 ' HG3' ' A' ' 174' ' ' ARG . 15.2 t -129.76 129.49 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 178.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -97.22 111.61 23.77 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 104.121 -2.548 . . . . 0.0 104.121 169.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -128.14 42.28 3.35 Favored 'General case' 0 N--CA 1.484 1.272 1 N-CA-C 123.571 4.656 . . . . 0.0 123.571 -156.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . 0.501 32.5 m . . . . . 0 CA--C 1.602 2.958 1 CA-C-O 109.702 -4.951 . . . . 0.0 106.98 169.031 . . . . . . . . 2 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 . . . . . 0 N--CA 1.504 2.261 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.557 ' HB3' ' NH2' ' A' ' 174' ' ' ARG . 50.3 mt-10 -59.14 -51.95 67.82 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 174.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 4.0 t -59.14 -36.25 61.78 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.925 0 CA-C-O 117.426 -1.273 . . . . 0.0 113.462 177.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.481 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 21.4 t80 -58.75 -40.64 84.46 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 121.082 1.764 . . . . 0.0 114.84 166.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -61.83 -54.44 42.17 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 178.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.557 ' NH2' ' HB3' ' A' ' 170' ' ' GLU . 11.4 ptp180 -69.08 -25.28 64.36 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 117.841 2.534 . . . . 0.0 117.841 172.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.56 -46.61 85.15 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 120.637 1.562 . . . . 0.0 113.862 168.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.3 mp -58.79 -43.91 90.58 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 167.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -53.47 -43.07 67.85 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 168.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.09 -44.96 90.73 Favored 'General case' 0 CA--C 1.56 1.364 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 172.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.81 -61.56 1.72 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 120.538 1.517 . . . . 0.0 110.897 172.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.885 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . 164.6 52.57 0.02 OUTLIER Glycine 0 CA--C 1.545 1.942 0 N-CA-C 118.795 2.278 . . . . 0.0 118.795 168.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.885 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 85.2 tttt . . . . . 0 C--O 1.252 1.187 0 CA-C-N 120.794 2.297 . . . . 0.0 110.565 168.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.2 mtt . . . . . 0 CA--C 1.556 1.206 0 CA-C-O 122.812 1.292 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . 0.309 11.6 mpt_? -120.57 171.44 8.56 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 121.231 3.789 . . . . 0.0 121.231 -163.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.6 p -150.16 144.58 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.297 0 CA-C-O 123.044 1.402 . . . . 0.0 111.633 166.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.2 pp -138.62 134.16 33.37 Favored 'General case' 0 CA--C 1.563 1.448 0 CA-C-N 113.676 -1.602 . . . . 0.0 109.714 169.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.5 121.36 44.81 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 115.675 1.731 . . . . 0.0 115.675 -161.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 85.7 mt -99.58 144.96 28.07 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 111.443 -2.617 . . . . 0.0 110.358 175.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 163.93 162.26 14.53 Favored Glycine 0 CA--C 1.557 2.681 0 CA-C-O 118.801 -0.999 . . . . 0.0 115.553 169.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo . . . . . 0 CA--C 1.578 2.711 0 C-N-CA 123.475 2.783 . . . . 0.0 111.838 175.597 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 3.6 mtmp? . . . . . 0 N--CA 1.484 1.248 0 CA-C-O 121.807 0.813 . . . . 0.0 110.347 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -53.8 -28.35 38.81 Favored Glycine 0 CA--C 1.554 2.48 0 N-CA-C 120.421 2.928 . . . . 0.0 120.421 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.1 m -65.76 -53.0 46.4 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 119.328 1.564 . . . . 0.0 113.265 176.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.28 20.0 mp0 -76.64 -13.32 60.07 Favored 'General case' 0 CA--C 1.569 1.698 0 CA-C-O 114.895 -2.479 . . . . 0.0 112.43 169.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.38 -47.08 68.3 Favored 'General case' 0 C--N 1.376 1.729 0 CA-C-N 125.145 3.611 . . . . 0.0 113.703 166.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.1 p -66.8 -39.94 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 174.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -62.13 -43.99 97.61 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 116.305 1.965 . . . . 0.0 116.305 169.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.84 -32.36 73.84 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 119.996 1.271 . . . . 0.0 114.152 171.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.38 -42.3 95.56 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 115.292 1.589 . . . . 0.0 115.292 167.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -58.2 -39.53 79.22 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 167.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.3 mmmt -65.9 -54.88 20.81 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 174.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.3 mt -83.51 -19.8 35.07 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 116.775 2.139 . . . . 0.0 116.775 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.02 38.6 7.83 Favored Glycine 0 CA--C 1.554 2.512 0 N-CA-C 117.62 1.808 . . . . 0.0 117.62 -176.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.9 mm -107.51 158.52 33.04 Favored Pre-proline 0 CA--C 1.57 1.724 0 CA-C-N 118.565 1.182 . . . . 0.0 113.419 -168.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -82.82 99.77 0.93 Allowed 'Trans proline' 0 CA--C 1.571 2.338 0 C-N-CA 121.867 1.712 . . . . 0.0 111.372 163.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -64.04 112.24 2.88 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 123.831 0.852 . . . . 0.0 112.117 170.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 21.5 mm -99.83 108.48 22.79 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.1 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 59.8 p -97.79 128.64 44.56 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 168.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.9 p -69.02 -19.34 64.11 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 117.066 2.247 . . . . 0.0 117.066 -169.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -81.67 -19.88 64.96 Favored Glycine 0 CA--C 1.543 1.839 0 N-CA-C 119.102 2.401 . . . . 0.0 119.102 167.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -80.84 -51.4 8.65 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -169.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -65.13 -41.07 95.15 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 174.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.452 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 25.2 m-85 -66.4 -41.1 89.82 Favored 'General case' 0 CA--C 1.559 1.298 0 N-CA-C 115.702 1.741 . . . . 0.0 115.702 172.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -59.3 -42.72 91.99 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 120.544 1.52 . . . . 0.0 114.203 168.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -59.21 -39.21 81.98 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 168.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -69.62 -24.47 63.65 Favored 'General case' 0 CA--C 1.581 2.14 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 168.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.0 mt -63.17 -49.46 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 CA-C-N 120.675 1.579 . . . . 0.0 110.96 167.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -67.95 -33.52 74.83 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 114.301 1.222 . . . . 0.0 114.301 175.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -73.7 -35.86 65.2 Favored 'General case' 0 CA--C 1.564 1.498 0 N-CA-C 116.299 1.962 . . . . 0.0 116.299 173.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.77 73.76 1.28 Allowed Glycine 0 CA--C 1.542 1.76 0 CA-C-O 118.065 -1.409 . . . . 0.0 114.482 -176.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.554 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 64.7 p -90.8 -65.59 1.0 Allowed 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 119.262 1.531 . . . . 0.0 111.911 173.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.554 ' CB ' ' O ' ' A' ' 43' ' ' THR . 21.3 ptmt 130.27 -57.13 0.0 OUTLIER 'General case' 0 CA--C 1.569 1.702 0 C-N-CA 123.661 0.784 . . . . 0.0 109.581 -166.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -80.03 6.83 10.39 Favored 'General case' 0 CA--C 1.575 1.913 0 C-N-CA 124.249 1.019 . . . . 0.0 113.454 166.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 50' ' ' LYS . . . -86.79 -52.77 3.05 Favored Glycine 0 CA--C 1.535 1.333 0 O-C-N 121.21 -0.931 . . . . 0.0 112.892 165.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.312 7.4 p -80.14 -52.03 15.22 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.581 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -167.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -66.94 -44.37 80.8 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 121.013 1.733 . . . . 0.0 112.686 172.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.79 -30.8 69.46 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.452 ' HB2' ' HB3' ' A' ' 35' ' ' PHE . 2.4 tptm -71.97 -36.87 69.95 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 167.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.571 ' HG2' ' O ' ' A' ' 51' ' ' ARG . 46.5 ttt180 -70.78 -58.71 3.35 Favored 'General case' 0 CA--C 1.591 2.534 1 CA-C-O 87.3 -15.619 . . . . 0.0 117.829 -178.531 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . 0.253 10.9 m-30 -26.47 -68.81 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.587 1 O-C-N 110.452 -7.655 . . . . 0.0 119.644 146.512 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 26.6 tp -57.3 -32.07 66.29 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 116.517 2.043 . . . . 0.0 116.517 175.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -88.78 -47.25 8.35 Favored 'General case' 0 CA--C 1.559 1.311 0 CA-C-O 116.831 -1.557 . . . . 0.0 114.395 170.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -158.24 46.33 0.34 Allowed 'General case' 0 CA--C 1.573 1.837 0 CA-C-N 121.401 1.909 . . . . 0.0 113.32 -168.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -161.21 60.89 0.29 Allowed Glycine 0 C--N 1.358 1.785 0 CA-C-N 121.906 2.139 . . . . 0.0 111.727 169.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . 0.279 4.8 t70 75.56 -115.05 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 124.301 1.041 . . . . 0.0 110.423 168.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.568 ' HA ' HH22 ' A' ' 88' ' ' ARG . 74.7 mt -133.47 128.79 36.17 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 119.507 1.049 . . . . 0.0 110.628 -174.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.0 p -89.27 141.03 28.79 Favored Pre-proline 0 CA--C 1.578 2.031 0 CA-C-O 117.429 -1.272 . . . . 0.0 108.095 167.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -50.66 143.81 27.7 Favored 'Trans proline' 0 CA--C 1.565 2.03 0 C-N-CA 123.451 2.767 . . . . 0.0 116.696 169.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 59.6 m -65.71 -42.75 90.74 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 117.064 2.246 . . . . 0.0 117.064 -169.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -59.5 -37.71 79.01 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 116.832 2.16 . . . . 0.0 116.832 -175.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 35.5 mt -54.87 -51.82 64.75 Favored 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 169.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.7 m -64.99 -50.77 65.01 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 112.889 -1.96 . . . . 0.0 113.064 -178.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.83 -20.01 64.64 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 167.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -72.48 -46.87 52.79 Favored 'General case' 0 CA--C 1.556 1.185 0 CA-C-N 120.441 1.473 . . . . 0.0 114.588 170.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.1 mt -61.22 -46.0 92.26 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 169.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 97.3 t -61.77 -48.78 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 118.025 -0.988 . . . . 0.0 112.017 175.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -63.03 -35.78 81.36 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 115.993 1.849 . . . . 0.0 115.993 172.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -57.55 -42.83 83.73 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 117.695 -1.145 . . . . 0.0 113.779 170.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 83.2 mtt180 -80.26 -15.55 56.72 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 118.497 2.777 . . . . 0.0 118.497 168.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.419 HD13 HH12 ' A' ' 103' ' ' ARG . 96.6 mt -83.69 -14.69 51.14 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 116.527 2.047 . . . . 0.0 116.527 169.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 . . . . . 0 N--CA 1.5 2.03 0 N-CA-C 117.17 2.285 . . . . 0.0 117.17 169.917 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.451 0 CA-C-O 123.495 1.608 . . . . 0.0 115.266 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -173.44 131.87 0.46 Allowed 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 169.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 4.7 mm -104.65 108.21 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.504 0 N-CA-C 103.412 -2.81 . . . . 0.0 103.412 170.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 79.8 mt -100.09 138.82 36.63 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 171.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -127.9 127.96 44.31 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 119.575 1.08 . . . . 0.0 111.859 172.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 67.63 34.02 82.57 Favored Glycine 0 CA--C 1.552 2.373 0 N-CA-C 118.008 1.963 . . . . 0.0 118.008 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -94.34 -54.27 0.23 Allowed Pre-proline 0 N--CA 1.496 1.826 0 CA-C-O 114.956 -2.45 . . . . 0.0 108.968 173.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.3 68.63 1.42 Allowed 'Trans proline' 0 CA--C 1.565 2.071 0 CA-C-N 124.75 2.732 . . . . 0.0 118.82 167.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.568 HH22 ' HA ' ' A' ' 58' ' ' LEU . 26.8 ptt180 -66.61 -35.57 80.5 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 116.056 1.873 . . . . 0.0 116.056 166.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 37.7 t -149.18 141.17 23.81 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -168.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . 0.274 8.4 p -61.7 -27.24 41.77 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.653 0 CA-C-O 115.941 -1.981 . . . . 0.0 113.322 178.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -38.22 88.26 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 120.155 3.391 . . . . 0.0 120.155 166.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -75.68 -47.91 24.26 Favored 'General case' 0 CA--C 1.586 2.34 0 CA-C-N 123.356 2.798 . . . . 0.0 112.299 166.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.5 -31.0 70.07 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 -175.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -57.31 -29.72 64.15 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 168.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.18 -40.54 86.58 Favored 'General case' 0 CA--C 1.571 1.758 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 167.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . 0.484 ' HA ' ' HG3' ' A' ' 99' ' ' MET . 40.1 tp -62.61 -38.3 89.66 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 169.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 55.8 t60 -64.89 -44.51 89.37 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 120.413 1.46 . . . . 0.0 113.313 168.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.839 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 32.0 mt-10 -51.58 -40.52 59.96 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 167.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 1.287 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -84.63 -19.95 32.14 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 117.934 2.568 . . . . 0.0 117.934 175.184 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 60.2 tp -72.45 -52.71 14.7 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 121.175 1.807 . . . . 0.0 111.47 170.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -74.85 -55.9 5.32 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 171.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.839 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 36.9 ttm180 -68.99 -39.22 79.51 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 178.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 1.287 ' HB3' ' O ' ' A' ' 99' ' ' MET . 66.1 ttt180 -62.37 -58.38 7.87 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 119.639 1.108 . . . . 0.0 110.365 164.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 111.47 46.66 0.78 Allowed Glycine 0 N--CA 1.479 1.529 0 O-C-N 124.366 1.041 . . . . 0.0 113.651 168.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 37.2 p -101.26 147.21 26.55 Favored 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 173.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -68.22 130.06 41.79 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.346 -0.846 . . . . 0.0 112.572 -170.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 4.4 tp -85.48 98.53 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 175.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -97.51 -67.77 0.83 Allowed 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 115.765 -2.064 . . . . 0.0 108.388 168.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -149.34 120.84 7.95 Favored 'General case' 0 C--N 1.367 1.367 0 CA-C-N 121.999 2.181 . . . . 0.0 115.114 -170.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 19.4 t -94.09 109.77 22.54 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.691 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 163.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.673 HD23 ' HB2' ' A' ' 160' ' ' LYS . 80.1 mt -105.07 117.97 35.35 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 123.423 0.689 . . . . 0.0 112.082 -172.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -88.68 136.19 33.12 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.398 0.618 . . . . 0.0 112.086 169.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -101.53 112.33 24.85 Favored 'General case' 0 CA--C 1.558 1.28 0 CA-C-O 122.998 1.38 . . . . 0.0 108.118 176.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.431 ' HB3' ' HA ' ' A' ' 163' ' ' ASP . 17.0 tpt180 -83.79 101.87 11.92 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 112.889 -1.959 . . . . 0.0 109.157 171.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.5 p . . . . . 0 CA--C 1.556 1.185 0 CA-C-N 113.128 -1.851 . . . . 0.0 106.717 -169.349 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.9 t30 . . . . . 0 N--CA 1.497 1.904 0 N-CA-C 114.692 1.368 . . . . 0.0 114.692 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 63.4 mtp180 -63.36 -32.61 74.08 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 116.363 1.986 . . . . 0.0 116.363 170.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 48.3 mtt -72.42 -33.0 66.8 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 168.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -61.84 -51.48 68.04 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 169.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.3 p -64.26 -34.22 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 CA-C-O 117.466 -1.254 . . . . 0.0 114.128 171.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -53.2 -48.08 68.38 Favored 'General case' 0 CA--C 1.591 2.55 0 CA-C-N 120.404 1.456 . . . . 0.0 112.349 167.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 63.1 ttt180 -57.42 -37.83 73.39 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 119.115 3.005 . . . . 0.0 119.115 174.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -52.91 -34.16 53.75 Favored 'General case' 0 N--CA 1.512 2.673 0 N-CA-C 117.205 2.298 . . . . 0.0 117.205 170.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -110.83 -28.43 8.4 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 120.298 3.444 . . . . 0.0 120.298 -165.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 56.8 m -63.5 -30.67 71.75 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 117.093 2.257 . . . . 0.0 117.093 -166.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.58 -61.55 4.33 Favored Pre-proline 0 CA--C 1.58 2.118 0 CA-C-O 116.583 -1.675 . . . . 0.0 112.616 168.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -65.29 -33.11 49.64 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 123.161 2.574 . . . . 0.0 117.471 176.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.2 tt -63.07 -55.06 28.7 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 117.344 -1.312 . . . . 0.0 110.542 168.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.997 ' O ' ' HB2' ' A' ' 156' ' ' ARG 0.335 0.1 OUTLIER -57.21 -27.12 61.71 Favored 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 177.931 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -73.5 -41.97 62.41 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 116.126 -1.892 . . . . 0.0 113.115 165.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -66.88 -55.82 13.01 Favored 'General case' 0 CA--C 1.564 1.494 0 CA-C-N 122.719 2.509 . . . . 0.0 112.583 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -80.46 -30.74 37.47 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-O 115.174 -2.346 . . . . 0.0 112.017 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.997 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 37.6 ttt180 -63.02 -32.63 74.03 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 124.418 3.281 . . . . 0.0 116.177 171.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -68.42 -41.12 80.86 Favored 'General case' 0 CA--C 1.574 1.888 0 CA-C-N 119.236 0.926 . . . . 0.0 113.182 165.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -90.81 -21.03 21.69 Favored 'General case' 0 CA--C 1.578 2.047 0 N-CA-C 120.331 3.456 . . . . 0.0 120.331 -176.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.7 pp -80.82 -178.37 6.79 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 119.053 2.983 . . . . 0.0 119.053 -163.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.673 ' HB2' HD23 ' A' ' 111' ' ' LEU . 90.5 mttt -130.89 141.52 50.31 Favored 'General case' 0 CA--C 1.564 1.491 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 166.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 34.0 m -100.01 145.49 27.82 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 122.408 1.099 . . . . 0.0 110.672 -171.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 38.4 t -133.04 132.39 58.87 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.487 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 169.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.431 ' HA ' ' HB3' ' A' ' 114' ' ' ARG . 20.4 t70 -96.14 138.47 33.7 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 167.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . 0.253 . . -125.61 -132.35 0.25 Allowed 'General case' 0 N--CA 1.483 1.212 0 O-C-N 121.64 -0.663 . . . . 0.0 111.433 -165.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 31.3 t . . . . . 0 N--CA 1.497 1.886 0 C-N-CA 127.173 2.189 . . . . 0.0 112.674 167.275 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 . . . . . 0 N--CA 1.498 1.971 0 N-CA-C 116.142 1.904 . . . . 0.0 116.142 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.734 ' HB3' ' NH2' ' A' ' 174' ' ' ARG . 48.1 mt-10 -61.32 -52.45 64.65 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 118.023 -0.989 . . . . 0.0 113.507 169.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 99.5 t -57.51 -37.9 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 175.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -62.04 -33.9 75.24 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 116.424 2.009 . . . . 0.0 116.424 168.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.78 -53.23 43.11 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 174.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.734 ' NH2' ' HB3' ' A' ' 170' ' ' GLU . 10.5 ptp180 -65.66 -29.64 70.23 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 117.586 2.439 . . . . 0.0 117.586 170.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.71 -45.83 92.28 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 119.856 1.207 . . . . 0.0 114.172 167.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.92 -44.7 91.35 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-O 117.013 -1.47 . . . . 0.0 114.698 168.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 26.5 mmm180 -55.79 -43.1 76.49 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 170.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.74 -39.5 94.29 Favored 'General case' 0 CA--C 1.563 1.444 0 N-CA-C 116.477 2.028 . . . . 0.0 116.477 172.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 5.8 tt -75.0 -51.68 13.0 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 120.968 1.713 . . . . 0.0 112.077 170.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -149.5 -57.48 0.01 OUTLIER Glycine 0 CA--C 1.552 2.377 0 CA-C-O 117.486 -1.73 . . . . 0.0 115.801 -176.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt . . . . . 0 C--O 1.252 1.205 0 CA-C-N 120.774 2.287 . . . . 0.0 108.655 -172.777 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.9 ttm . . . . . 0 CA--C 1.56 1.334 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.47 166.77 32.1 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 118.414 2.746 . . . . 0.0 118.414 -166.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.4 p -126.71 146.07 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-O 122.923 1.344 . . . . 0.0 114.193 -166.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -119.89 113.34 20.43 Favored 'General case' 0 CA--C 1.559 1.307 0 N-CA-C 104.867 -2.271 . . . . 0.0 104.867 168.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.2 tt -101.73 131.24 48.12 Favored 'General case' 0 CA--C 1.562 1.408 0 C-N-CA 125.788 1.635 . . . . 0.0 111.348 -165.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.8 mt -135.48 165.8 24.66 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 125.378 1.471 . . . . 0.0 113.825 -167.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.43 124.7 0.94 Allowed Glycine 0 CA--C 1.557 2.665 0 CA-C-O 117.362 -1.799 . . . . 0.0 111.274 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo . . . . . 0 CA--C 1.579 2.745 0 CA-C-N 122.522 3.161 . . . . 0.0 114.101 176.939 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt . . . . . 0 N--CA 1.487 1.383 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -42.61 -42.15 4.55 Favored Glycine 0 CA--C 1.551 2.332 0 N-CA-C 121.207 3.243 . . . . 0.0 121.207 -175.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.1 m -61.97 -57.32 12.14 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 118.992 1.396 . . . . 0.0 113.835 178.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.259 3.7 mm-40 -76.49 -14.22 60.05 Favored 'General case' 0 CA--C 1.573 1.859 0 CA-C-O 116.175 -1.869 . . . . 0.0 111.528 175.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.63 -47.38 60.38 Favored 'General case' 0 C--N 1.373 1.608 0 CA-C-N 123.219 2.736 . . . . 0.0 114.476 168.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.2 p -66.12 -40.76 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 172.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -58.94 -44.22 91.36 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 116.321 1.971 . . . . 0.0 116.321 169.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.91 -35.46 80.69 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 172.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.21 -42.1 90.16 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 167.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -59.82 -36.23 76.35 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 167.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -64.87 -59.44 4.2 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 170.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.1 mt -80.28 -20.92 43.3 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 116.422 2.008 . . . . 0.0 116.422 -176.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.95 34.19 8.46 Favored Glycine 0 CA--C 1.554 2.501 0 N-CA-C 117.681 1.833 . . . . 0.0 117.681 -177.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.3 mm -104.64 156.07 36.47 Favored Pre-proline 0 CA--C 1.568 1.649 0 CA-C-N 118.987 1.394 . . . . 0.0 112.561 -169.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -80.72 100.69 1.24 Allowed 'Trans proline' 0 CA--C 1.569 2.257 0 C-N-CA 121.816 1.677 . . . . 0.0 110.099 162.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -58.81 109.11 0.75 Allowed 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 124.347 1.059 . . . . 0.0 112.002 170.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 35.7 mm -98.0 107.64 20.55 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 68.9 p -95.46 126.99 41.14 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 167.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.4 p -65.73 -22.1 66.58 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 -169.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.638 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -83.56 -13.02 76.92 Favored Glycine 0 CA--C 1.544 1.871 0 N-CA-C 119.168 2.427 . . . . 0.0 119.168 168.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -81.8 -51.21 8.37 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 119.197 1.498 . . . . 0.0 114.648 -171.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -66.2 -42.17 89.18 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 173.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.54 ' HB3' ' CB ' ' A' ' 50' ' ' LYS . 32.9 m-85 -59.56 -43.93 93.41 Favored 'General case' 0 CA--C 1.569 1.674 0 C-N-CA 125.403 1.481 . . . . 0.0 114.477 168.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.638 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 72.2 ttt180 -54.94 -42.56 72.45 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 168.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.3 ttt180 -60.36 -36.58 78.37 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 168.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -69.29 -26.54 64.79 Favored 'General case' 0 CA--C 1.581 2.168 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 167.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.408 HG12 HG23 ' A' ' 47' ' ' VAL . 58.7 mt -60.67 -52.18 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.376 0 CA-C-N 120.933 1.697 . . . . 0.0 110.235 167.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -65.4 -35.48 81.06 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -70.3 -38.44 75.0 Favored 'General case' 0 CA--C 1.562 1.426 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 174.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.35 68.84 1.24 Allowed Glycine 0 CA--C 1.543 1.842 0 CA-C-O 118.905 -0.941 . . . . 0.0 114.623 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.822 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 74.5 p -92.63 -47.25 7.2 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 177.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.822 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.254 75.5 mttt 104.84 -40.04 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.725 0 CA-C-O 116.227 -1.844 . . . . 0.0 111.694 -172.737 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -83.8 -12.41 55.69 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 123.09 2.677 . . . . 0.0 112.586 163.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.33 -56.23 26.29 Favored Glycine 0 CA--C 1.547 2.047 0 CA-C-N 120.905 1.684 . . . . 0.0 114.167 168.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.408 HG23 HG12 ' A' ' 39' ' ' ILE 0.25 1.0 OUTLIER -74.33 -49.85 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 116.898 2.184 . . . . 0.0 116.898 -169.467 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -67.9 -38.59 83.19 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 119.907 1.23 . . . . 0.0 112.74 174.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.26 -35.85 66.29 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 117.969 -1.015 . . . . 0.0 113.594 -175.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.54 ' CB ' ' HB3' ' A' ' 35' ' ' PHE 0.33 1.7 tptt -81.14 -24.14 37.81 Favored 'General case' 0 CA--C 1.564 1.487 0 CA-C-O 116.961 -1.495 . . . . 0.0 113.36 173.022 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.585 ' HG2' ' O ' ' A' ' 51' ' ' ARG . 40.6 ttt180 -75.56 -56.99 4.16 Favored 'General case' 0 CA--C 1.591 2.553 1 CA-C-O 86.613 -15.946 . . . . 0.0 117.686 176.815 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . 0.254 15.7 m-30 -27.38 -64.46 0.08 Allowed 'General case' 0 N--CA 1.499 1.979 1 O-C-N 108.837 -8.664 . . . . 0.0 120.192 146.491 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.2 tp -53.89 -39.56 65.84 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 116.998 2.222 . . . . 0.0 116.998 172.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -90.18 -41.1 11.8 Favored 'General case' 0 CA--C 1.566 1.559 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 173.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -153.03 41.63 0.58 Allowed 'General case' 0 CA--C 1.571 1.757 0 CA-C-N 120.86 1.664 . . . . 0.0 114.887 -169.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -165.78 59.26 0.24 Allowed Glycine 0 C--N 1.354 1.559 0 O-C-N 119.419 -2.051 . . . . 0.0 111.779 168.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . 0.273 5.0 t70 71.51 -117.7 0.08 Allowed 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 124.018 0.927 . . . . 0.0 109.555 169.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.1 pp -124.93 143.65 50.76 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 123.637 0.775 . . . . 0.0 112.06 -176.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.1 p -96.93 130.92 28.86 Favored Pre-proline 0 CA--C 1.573 1.832 0 CA-C-O 117.676 -1.154 . . . . 0.0 107.924 167.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -49.34 134.89 31.91 Favored 'Trans proline' 0 CA--C 1.56 1.821 0 C-N-CA 123.537 2.825 . . . . 0.0 116.042 172.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.8 m -68.82 175.65 3.5 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -169.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.3 t70 86.09 -44.43 0.05 Allowed 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 126.339 1.856 . . . . 0.0 113.999 -176.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.8 mt -60.44 -47.37 86.39 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 168.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.8 m -57.6 -50.26 73.72 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 113.544 -1.662 . . . . 0.0 113.449 177.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -69.76 -21.25 63.45 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 168.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -65.59 -43.61 89.16 Favored 'General case' 0 CA--C 1.559 1.316 0 CA-C-N 120.557 1.526 . . . . 0.0 114.957 168.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 44.2 mt -65.56 -46.31 79.95 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 167.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -56.71 -50.99 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 172.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -65.09 -34.22 77.9 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 175.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -58.1 -43.34 87.06 Favored 'General case' 0 CA--C 1.559 1.31 0 CA-C-O 117.793 -1.098 . . . . 0.0 113.497 168.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -81.76 -9.82 59.52 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 119.256 3.058 . . . . 0.0 119.256 169.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 13.1 tp -87.66 -14.68 39.28 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 169.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 . . . . . 0 CA--C 1.583 2.218 0 N-CA-C 118.441 2.756 . . . . 0.0 118.441 168.491 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.784 0 N-CA-C 117.883 1.913 . . . . 0.0 117.883 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -170.46 132.63 0.99 Allowed 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 114.189 -1.005 . . . . 0.0 108.88 -175.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.1 mm -102.43 105.48 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.577 0 N-CA-C 102.745 -3.057 . . . . 0.0 102.745 166.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -110.5 122.76 48.51 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -176.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.25 119.67 32.94 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 119.048 0.84 . . . . 0.0 110.467 -165.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.39 43.68 68.67 Favored Glycine 0 CA--C 1.548 2.094 0 CA-C-O 116.098 -2.501 . . . . 0.0 116.345 -174.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . 0.257 2.9 t80 -95.97 -57.32 0.2 Allowed Pre-proline 0 N--CA 1.504 2.234 0 CA-C-N 121.737 2.768 . . . . 0.0 108.276 176.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -60.59 59.67 0.09 OUTLIER 'Trans proline' 0 CA--C 1.577 2.654 0 N-CA-C 121.547 3.633 . . . . 0.0 121.547 168.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.533 HH11 ' HB2' ' A' ' 89' ' ' SER . 7.0 tmm_? -69.55 -28.43 66.0 Favored 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 166.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.533 ' HB2' HH11 ' A' ' 88' ' ' ARG . 30.3 t -151.68 155.51 38.48 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 120.279 1.399 . . . . 0.0 107.913 -176.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.5 t -61.87 -37.0 77.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-O 116.981 -1.485 . . . . 0.0 111.793 173.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.34 -40.41 77.94 Favored 'General case' 0 CA--C 1.558 1.268 0 N-CA-C 119.882 3.29 . . . . 0.0 119.882 169.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 22.3 mm100 -71.41 -48.21 51.17 Favored 'General case' 0 CA--C 1.589 2.471 0 CA-C-N 122.279 2.308 . . . . 0.0 113.322 168.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.78 -29.49 66.82 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 126.894 2.078 . . . . 0.0 116.05 -168.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 57.6 tttt -63.68 -31.57 72.78 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 166.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.97 -39.08 69.58 Favored 'General case' 0 CA--C 1.569 1.688 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 169.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 16.8 tp -63.01 -40.88 99.09 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 168.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -58.5 -52.49 65.43 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 119.431 1.014 . . . . 0.0 113.463 169.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.904 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 21.5 mm-40 -48.63 -41.79 32.19 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 115.956 1.836 . . . . 0.0 115.956 168.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 1.184 ' O ' ' HB2' ' A' ' 103' ' ' ARG . 55.1 mtt -84.12 -20.73 32.03 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 117.956 2.576 . . . . 0.0 117.956 175.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.1 tt -75.73 -48.93 19.8 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-N 121.301 1.864 . . . . 0.0 110.866 172.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -72.45 -56.28 5.67 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 119.57 1.077 . . . . 0.0 113.199 169.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.904 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 70.6 ttt180 -64.15 -44.63 91.54 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 116.353 1.983 . . . . 0.0 116.353 177.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 1.184 ' HB2' ' O ' ' A' ' 99' ' ' MET . 15.3 mtp-105 -65.13 -53.92 37.84 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 118.992 0.814 . . . . 0.0 111.196 165.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 111.02 48.62 0.71 Allowed Glycine 0 N--CA 1.483 1.831 0 C-N-CA 120.808 -0.71 . . . . 0.0 114.752 166.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 71.7 p -89.91 158.14 17.55 Favored 'General case' 0 CA--C 1.563 1.479 0 CA-C-N 113.22 -1.49 . . . . 0.0 110.307 169.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -72.55 138.69 47.07 Favored 'General case' 0 N--CA 1.507 2.381 0 CA-C-O 122.37 1.081 . . . . 0.0 111.38 172.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.6 tp -98.99 102.72 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -95.12 -70.32 0.72 Allowed 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 116.738 -1.601 . . . . 0.0 108.032 166.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.91 124.23 7.61 Favored 'General case' 0 C--N 1.36 1.05 0 CA-C-N 120.938 1.699 . . . . 0.0 113.818 -169.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 24.0 t -92.29 108.92 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.638 1 N-CA-C 99.97 -4.085 . . . . 0.0 99.97 162.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.255 52.2 tp -118.94 114.48 22.63 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.937 0.895 . . . . 0.0 112.607 -159.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -103.17 127.81 50.34 Favored 'General case' 0 CA--C 1.563 1.454 0 CA-C-O 121.448 0.642 . . . . 0.0 112.34 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -95.79 113.9 25.58 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.902 1.281 . . . . 0.0 109.796 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -86.33 96.06 9.85 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.214 170.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 56.1 t . . . . . 0 CA--C 1.566 1.565 0 C-N-CA 127.891 2.476 . . . . 0.0 106.016 -171.734 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 . . . . . 0 N--CA 1.496 1.829 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 47.8 mmm-85 -60.65 -43.94 97.01 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 169.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 37.0 mtt -64.26 -32.99 74.8 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 115.833 1.79 . . . . 0.0 115.833 169.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -64.44 -48.65 74.51 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 170.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.8 -31.26 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 172.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -57.8 -52.38 65.72 Favored 'General case' 0 CA--C 1.581 2.164 0 CA-C-N 119.492 1.042 . . . . 0.0 111.452 166.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -52.83 -25.38 11.3 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 120.2 3.408 . . . . 0.0 120.2 169.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.89 -55.48 19.89 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 170.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -145.43 13.84 1.4 Allowed 'General case' 0 CA--C 1.563 1.467 0 N-CA-C 119.497 3.147 . . . . 0.0 119.497 -169.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 17.7 m -51.9 -29.19 18.96 Favored 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.432 ' HB3' ' HD3' ' A' ' 150' ' ' PRO . . . -70.81 -61.33 2.49 Favored Pre-proline 0 CA--C 1.58 2.102 0 CA-C-O 116.148 -1.882 . . . . 0.0 112.142 171.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.432 ' HD3' ' HB3' ' A' ' 149' ' ' ALA . 46.8 Cg_exo -55.34 -27.8 59.64 Favored 'Trans proline' 0 CA--C 1.574 2.485 0 N-CA-C 119.492 2.843 . . . . 0.0 119.492 169.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -66.88 -53.01 36.54 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 125.156 1.383 . . . . 0.0 110.988 172.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.989 ' O ' ' HB2' ' A' ' 156' ' ' ARG 0.316 0.0 OUTLIER -61.32 -25.01 66.84 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 174.384 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -71.3 -51.65 23.19 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 120.601 1.546 . . . . 0.0 113.667 166.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -62.66 -55.23 28.84 Favored 'General case' 0 CA--C 1.565 1.527 0 CA-C-N 120.045 1.293 . . . . 0.0 112.221 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -81.52 -25.94 35.53 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 115.153 -2.356 . . . . 0.0 113.399 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.989 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 43.9 ttt180 -67.3 -34.27 77.03 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 124.438 3.29 . . . . 0.0 115.919 170.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -69.5 -37.99 77.43 Favored 'General case' 0 CA--C 1.572 1.827 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 166.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -90.15 -24.37 21.08 Favored 'General case' 0 CA--C 1.575 1.926 0 N-CA-C 118.876 2.917 . . . . 0.0 118.876 -177.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.1 pp -76.06 178.75 6.09 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 117.478 2.399 . . . . 0.0 117.478 -165.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -128.91 129.31 45.33 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 169.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 27.1 m -100.38 149.95 23.11 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 122.079 0.943 . . . . 0.0 111.006 -171.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 4.1 t -128.14 134.74 64.42 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.663 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 167.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -110.86 121.43 45.32 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 104.435 -2.432 . . . . 0.0 104.435 166.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . 0.289 . . -165.58 162.03 18.8 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.095 0.958 . . . . 0.0 111.106 -161.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 4.5 t . . . . . 0 N--CA 1.492 1.669 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 160.574 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 7.4 t70 . . . . . 0 N--CA 1.508 2.451 0 CA-C-O 121.127 0.489 . . . . 0.0 111.869 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -55.15 -39.04 69.03 Favored 'General case' 0 CA--C 1.559 1.295 0 CA-C-O 116.651 -1.642 . . . . 0.0 113.429 165.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 89.5 t -56.34 -39.26 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 CA-C-N 121.363 1.892 . . . . 0.0 114.309 171.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -57.77 -39.03 76.5 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-N 120.472 1.487 . . . . 0.0 114.86 166.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -60.53 -46.85 88.66 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 115.481 1.659 . . . . 0.0 115.481 173.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 12.2 mtt-85 -61.48 -43.14 99.4 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 169.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.11 -40.37 70.39 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 169.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 8.4 mp -64.18 -49.12 73.28 Favored 'General case' 0 CA--C 1.565 1.533 0 CA-C-O 118.413 -0.804 . . . . 0.0 112.608 168.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 36.4 mtt180 -51.24 -40.81 59.65 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 117.581 2.437 . . . . 0.0 117.581 171.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.11 -51.53 66.19 Favored 'General case' 0 CA--C 1.561 1.4 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 169.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -99.65 -60.46 1.53 Allowed 'General case' 0 CA--C 1.565 1.538 0 CA-C-O 117.993 -1.003 . . . . 0.0 113.469 -169.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.803 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -102.82 -50.52 1.08 Allowed Glycine 0 CA--C 1.551 2.34 0 CA-C-N 120.537 1.517 . . . . 0.0 116.885 -169.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.803 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 87.0 tttt . . . . . 0 C--O 1.252 1.201 0 CA-C-N 119.489 1.645 . . . . 0.0 108.356 -174.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.0 mtt . . . . . 0 N--CA 1.482 1.125 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.578 ' HE ' ' HA2' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -149.01 174.9 11.79 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 116.685 2.105 . . . . 0.0 116.685 -168.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 93.5 t -133.75 147.22 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-O 122.992 1.377 . . . . 0.0 113.319 -164.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -121.63 117.57 27.03 Favored 'General case' 0 CA--C 1.56 1.347 0 CA-C-N 113.491 -1.686 . . . . 0.0 107.284 169.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 17.5 tp -99.87 125.13 45.79 Favored 'General case' 0 CA--C 1.575 1.908 0 CA-C-O 123.706 1.717 . . . . 0.0 109.389 -170.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.1 mt -122.23 161.01 24.03 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 110.021 -3.263 . . . . 0.0 112.481 -165.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 148.39 -179.68 25.05 Favored Glycine 0 CA--C 1.559 2.809 0 CA-C-N 115.258 -0.883 . . . . 0.0 114.821 170.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo . . . . . 0 CA--C 1.574 2.508 0 C-N-CA 123.355 2.703 . . . . 0.0 113.765 176.22 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.41 ' CB ' ' OD2' ' A' ' 84' ' ' ASP . 0.3 OUTLIER . . . . . 0 N--CA 1.501 2.085 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -49.48 -27.22 8.09 Favored Glycine 0 CA--C 1.553 2.465 0 N-CA-C 121.201 3.241 . . . . 0.0 121.201 177.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 52.0 m -66.99 -52.75 38.81 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 120.237 2.018 . . . . 0.0 112.598 173.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.291 0.6 OUTLIER -76.19 -13.88 60.17 Favored 'General case' 0 CA--C 1.568 1.667 0 CA-C-O 115.893 -2.003 . . . . 0.0 113.855 170.509 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.31 -47.17 36.37 Favored 'General case' 0 C--N 1.371 1.513 0 CA-C-N 123.421 2.828 . . . . 0.0 113.433 167.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.2 t -65.37 -36.74 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-N 120.06 1.3 . . . . 0.0 113.848 172.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -66.44 -45.78 78.67 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 171.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.0 tp -65.49 -30.65 71.45 Favored 'General case' 0 CA--C 1.574 1.902 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 170.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.22 -39.75 94.63 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 168.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -59.93 -37.7 80.25 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 166.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.3 tptt -64.3 -56.89 11.43 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 170.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 77.3 mt -83.23 -25.02 32.08 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 117.341 2.348 . . . . 0.0 117.341 -174.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.74 39.73 7.0 Favored Glycine 0 CA--C 1.556 2.612 0 N-CA-C 117.578 1.791 . . . . 0.0 117.578 -173.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 15.2 mm -104.56 154.69 38.27 Favored Pre-proline 0 CA--C 1.567 1.606 0 CA-C-O 117.567 -1.206 . . . . 0.0 113.11 -169.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -81.83 98.6 0.98 Allowed 'Trans proline' 0 CA--C 1.569 2.232 0 CA-C-N 122.219 1.828 . . . . 0.0 109.801 162.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -73.91 110.42 8.19 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.305 0.574 . . . . 0.0 110.189 176.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.0 mm -100.35 108.97 24.0 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 N-CA-C 105.515 -2.032 . . . . 0.0 105.515 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 72.7 p -96.98 127.74 43.25 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 171.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.0 p -67.29 -18.36 65.16 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 117.356 2.354 . . . . 0.0 117.356 -172.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.429 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -81.06 -20.24 65.49 Favored Glycine 0 CA--C 1.539 1.56 0 N-CA-C 119.242 2.457 . . . . 0.0 119.242 168.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -81.0 -51.47 8.48 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -169.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -64.3 -41.7 96.73 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 174.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.439 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 21.5 m-85 -68.92 -39.69 79.51 Favored 'General case' 0 CA--C 1.561 1.375 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 174.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 46.4 ttp180 -58.68 -41.71 86.81 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 120.473 1.488 . . . . 0.0 114.322 167.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -60.54 -38.71 85.36 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 168.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -67.55 -29.32 68.68 Favored 'General case' 0 CA--C 1.572 1.824 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 168.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 79.0 mt -62.7 -45.54 98.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 CA-C-N 120.111 1.323 . . . . 0.0 111.921 168.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -66.71 -38.96 87.77 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 120.25 1.387 . . . . 0.0 114.438 172.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -78.47 -27.85 46.38 Favored 'General case' 0 CA--C 1.562 1.413 0 N-CA-C 117.065 2.246 . . . . 0.0 117.065 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.11 72.99 1.23 Allowed Glycine 0 CA--C 1.545 1.935 0 CA-C-O 118.223 -1.321 . . . . 0.0 115.878 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.855 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 81.4 p -91.29 -45.92 8.34 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 172.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.855 ' HB2' ' O ' ' A' ' 43' ' ' THR . 75.6 mttt 104.56 -40.36 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.753 0 CA-C-O 116.493 -1.718 . . . . 0.0 111.633 -171.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -83.91 -10.32 58.06 Favored 'General case' 0 CA--C 1.574 1.894 0 CA-C-N 122.762 2.528 . . . . 0.0 113.222 163.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.21 -54.48 23.69 Favored Glycine 0 C--N 1.355 1.588 0 CA-C-N 120.385 1.448 . . . . 0.0 115.531 169.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.286 7.7 p -76.94 -47.5 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.514 0 N-CA-C 116.077 1.88 . . . . 0.0 116.077 -168.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -64.24 -48.31 76.29 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 121.111 1.778 . . . . 0.0 112.692 172.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.59 -28.04 64.57 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -178.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.447 ' HA ' ' HD2' ' A' ' 50' ' ' LYS . 10.8 tptt -74.91 -30.59 61.31 Favored 'General case' 0 CA--C 1.566 1.584 0 CA-C-O 115.909 -1.996 . . . . 0.0 113.762 168.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -57.02 -36.97 71.06 Favored 'General case' 0 CA--C 1.607 3.164 1 CA-C-O 90.989 -13.863 . . . . 0.0 119.424 164.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 9.5 m-30 -92.58 -49.65 6.0 Favored 'General case' 0 CA--C 1.591 2.538 2 O-C-N 110.588 -7.57 . . . . 0.0 100.415 -152.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.9 tp -51.38 -46.99 62.97 Favored 'General case' 0 CA--C 1.569 1.683 0 C-N-CA 126.209 1.803 . . . . 0.0 115.516 161.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -78.96 -41.9 28.14 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 176.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -95.38 -38.69 10.38 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -170.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 0.901 ' HA2' HH22 ' A' ' 88' ' ' ARG . . . 119.79 22.48 3.29 Favored Glycine 0 CA--C 1.541 1.685 0 N-CA-C 118.235 2.054 . . . . 0.0 118.235 168.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -97.3 -179.32 4.47 Favored 'General case' 0 CA--C 1.575 1.941 0 CA-C-N 118.805 1.303 . . . . 0.0 110.243 167.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.9 mt -82.34 127.97 33.76 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.184 -1.573 . . . . 0.0 114.382 -166.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.4 p -118.3 124.08 28.87 Favored Pre-proline 0 CA--C 1.572 1.806 0 C-N-CA 124.935 1.294 . . . . 0.0 110.485 -174.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -60.72 153.1 64.69 Favored 'Trans proline' 0 CA--C 1.56 1.81 0 C-N-CA 123.425 2.75 . . . . 0.0 116.337 172.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 97.2 p -80.24 -49.62 11.36 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 -177.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -63.61 -45.69 89.15 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 -169.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 pp -57.76 -43.1 85.23 Favored 'General case' 0 CA--C 1.562 1.421 0 N-CA-C 117.266 2.321 . . . . 0.0 117.266 169.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.0 m -62.24 -42.32 99.21 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 123.93 0.892 . . . . 0.0 112.578 174.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -62.77 -30.57 71.55 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 166.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.48 -42.35 83.1 Favored 'General case' 0 CA--C 1.555 1.138 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 174.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mt -64.75 -46.15 83.42 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 168.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -56.08 -51.13 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 169.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -60.83 -38.38 85.27 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 115.794 1.775 . . . . 0.0 115.794 174.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -57.23 -44.18 83.53 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 117.592 -1.194 . . . . 0.0 113.421 170.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -84.3 1.84 43.03 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 119.51 3.152 . . . . 0.0 119.51 168.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 21.7 tp -115.64 -5.91 12.18 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 117.813 2.524 . . . . 0.0 117.813 172.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 . . . . . 0 N--CA 1.503 2.204 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 169.737 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.578 ' HA2' ' HE ' ' A' ' 2' ' ' ARG . . . . . . . . 0 CA--C 1.531 1.083 0 CA-C-O 124.011 1.895 . . . . 0.0 113.639 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.463 ' O ' ' HB2' ' A' ' 2' ' ' ARG . 21.9 p90 -167.41 131.52 1.84 Allowed 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 111.719 -2.241 . . . . 0.0 109.092 172.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 17.5 mt -110.47 106.56 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 104.099 -2.556 . . . . 0.0 104.099 170.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.7 mt -110.35 112.75 24.9 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.718 0.807 . . . . 0.0 108.832 -176.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.41 ' OD2' ' CB ' ' A' ' 13' ' ' LYS . 35.4 t0 -109.46 128.65 55.31 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 118.732 0.696 . . . . 0.0 111.688 -175.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 73.54 35.39 55.77 Favored Glycine 0 CA--C 1.552 2.373 0 CA-C-O 117.563 -1.687 . . . . 0.0 117.279 176.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -103.56 -51.89 0.13 Allowed Pre-proline 0 N--CA 1.497 1.906 0 CA-C-O 114.761 -2.542 . . . . 0.0 109.333 173.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -62.08 71.61 0.1 Allowed 'Trans proline' 0 CA--C 1.568 2.22 0 CA-C-N 124.874 2.776 . . . . 0.0 118.838 165.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.901 HH22 ' HA2' ' A' ' 56' ' ' GLY . 1.4 ptm180 -78.05 -36.95 47.83 Favored 'General case' 0 CA--C 1.56 1.342 0 N-CA-C 115.54 1.681 . . . . 0.0 115.54 167.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 69.1 p -137.18 151.42 48.77 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 -168.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.2 t -71.01 -31.03 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-O 116.884 -1.532 . . . . 0.0 111.153 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.71 -40.21 94.23 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 120.149 3.388 . . . . 0.0 120.149 168.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -71.25 -49.29 44.7 Favored 'General case' 0 CA--C 1.589 2.456 0 CA-C-N 122.413 2.37 . . . . 0.0 112.462 168.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.6 -28.87 66.32 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 126.756 2.023 . . . . 0.0 115.646 -170.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.6 ttpm? -58.54 -31.95 68.42 Favored 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 166.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.05 -43.81 94.35 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 114.668 1.358 . . . . 0.0 114.668 168.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.0 mt -66.69 -33.82 76.49 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 172.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -66.22 -58.38 5.51 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 125.349 1.46 . . . . 0.0 112.646 173.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.933 ' O ' ' CB ' ' A' ' 102' ' ' ARG . 47.8 mt-10 -54.66 -36.48 64.64 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 171.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 24.7 ttt -82.72 -40.62 20.33 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 176.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 24.6 tp -57.12 -61.79 2.21 Favored 'General case' 0 N--CA 1.508 2.431 0 CA-C-N 121.503 1.956 . . . . 0.0 110.499 174.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -81.74 -37.27 27.51 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 -177.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.933 ' CB ' ' O ' ' A' ' 98' ' ' GLU . 52.8 ttt85 -60.29 -41.34 93.15 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 176.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.544 ' HB2' ' O ' ' A' ' 102' ' ' ARG . 54.9 ttt180 -174.92 41.72 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 114.464 -2.684 . . . . 0.0 115.851 168.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -114.77 -61.25 0.38 Allowed Glycine 0 C--N 1.362 2.021 0 CA-C-N 123.565 2.893 . . . . 0.0 113.441 174.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 23.5 p -148.28 159.4 44.02 Favored 'General case' 0 CA--C 1.554 1.13 0 CA-C-O 122.957 1.361 . . . . 0.0 112.894 -159.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -74.68 134.74 41.93 Favored 'General case' 0 N--CA 1.503 2.198 0 CA-C-N 114.379 -1.282 . . . . 0.0 113.439 176.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 4.7 tp -86.65 105.82 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.516 0 C-N-CA 125.06 1.344 . . . . 0.0 107.714 175.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -96.92 -70.4 0.72 Allowed 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 115.136 -2.364 . . . . 0.0 108.115 168.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -140.28 122.65 16.0 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 122.503 2.41 . . . . 0.0 115.015 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -92.83 107.81 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.417 0 N-CA-C 100.974 -3.713 . . . . 0.0 100.974 161.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.288 59.5 tp -114.5 105.24 12.87 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.753 -161.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -96.04 126.12 41.06 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.16 0.584 . . . . 0.0 111.541 -176.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -95.06 114.17 25.95 Favored 'General case' 0 CA--C 1.56 1.355 0 CA-C-O 122.537 1.16 . . . . 0.0 110.185 177.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -89.03 100.38 13.16 Favored 'General case' 0 CA--C 1.556 1.187 0 CA-C-N 113.597 -1.638 . . . . 0.0 109.459 168.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.4 p . . . . . 0 CA--C 1.561 1.387 0 C-N-CA 125.921 1.688 . . . . 0.0 108.376 -168.874 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 36.1 t30 . . . . . 0 N--CA 1.496 1.84 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.8 tpt85 -63.42 -45.98 88.5 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 169.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 46.3 mtt -61.31 -29.51 69.92 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 167.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -63.31 -43.76 96.9 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 167.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 20.5 t -70.49 -26.69 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.533 0 CA-C-N 120.088 1.313 . . . . 0.0 113.521 171.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -65.34 -56.75 10.89 Favored 'General case' 0 CA--C 1.583 2.242 0 CA-C-N 120.68 1.582 . . . . 0.0 110.766 167.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 54.3 ttt180 -52.78 -26.8 15.42 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 119.711 3.226 . . . . 0.0 119.711 172.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -47.46 -51.42 20.32 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 169.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -142.55 42.33 1.61 Allowed 'General case' 0 CA--C 1.563 1.461 0 N-CA-C 117.084 2.253 . . . . 0.0 117.084 176.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 36.7 m -49.25 -36.65 20.97 Favored 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 166.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.414 ' HB3' ' HD3' ' A' ' 150' ' ' PRO . . . -68.09 -59.28 6.53 Favored Pre-proline 0 CA--C 1.577 2.014 0 CA-C-O 116.556 -1.688 . . . . 0.0 111.891 172.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.414 ' HD3' ' HB3' ' A' ' 149' ' ' ALA . 71.8 Cg_exo -53.03 -26.95 34.09 Favored 'Trans proline' 0 CA--C 1.577 2.666 0 N-CA-C 119.608 2.888 . . . . 0.0 119.608 168.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -65.25 -56.31 13.51 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 125.764 1.625 . . . . 0.0 111.371 172.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.868 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 44.4 tp -62.48 -24.19 67.33 Favored 'General case' 0 CA--C 1.571 1.776 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 175.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -71.23 -47.81 55.06 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 122.247 2.294 . . . . 0.0 113.745 166.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -60.77 -57.02 14.45 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 119.846 1.203 . . . . 0.0 111.966 177.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -80.2 -19.45 46.99 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 115.409 -2.234 . . . . 0.0 113.803 -178.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.868 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 33.2 ttt180 -74.21 -31.09 62.48 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 124.436 3.289 . . . . 0.0 116.202 168.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -68.77 -44.28 74.02 Favored 'General case' 0 CA--C 1.57 1.738 0 CA-C-N 119.688 1.131 . . . . 0.0 113.126 167.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -91.43 -30.21 16.62 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 119.164 3.024 . . . . 0.0 119.164 -176.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.5 pp -39.73 156.81 0.02 OUTLIER 'General case' 0 CA--C 1.582 2.183 1 N-CA-C 122.37 4.211 . . . . 0.0 122.37 -164.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -133.43 113.1 12.15 Favored 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 101.71 -3.441 . . . . 0.0 101.71 164.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 60.4 m -94.7 146.58 24.06 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 122.499 1.142 . . . . 0.0 110.349 -168.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 47.3 t -130.8 130.67 64.52 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.259 0 CA-C-N 113.654 -1.612 . . . . 0.0 106.721 169.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -98.48 117.9 33.96 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 100.892 -3.744 . . . . 0.0 100.892 163.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . 0.293 . . -105.41 -138.01 0.36 Allowed 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 -154.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . 0.252 14.6 m . . . . . 0 CA--C 1.573 1.849 1 N-CA-C 123.812 4.745 . . . . 0.0 123.812 -171.559 . . . . . . . . 2 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 . . . . . 0 N--CA 1.5 2.073 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -61.69 -49.11 77.81 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 117.737 -1.125 . . . . 0.0 112.535 169.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 3.0 t -54.43 -37.87 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 174.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -62.61 -38.16 89.07 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 116.119 1.896 . . . . 0.0 116.119 169.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -61.83 -48.02 82.46 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 175.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.577 ' HA ' ' HB2' ' A' ' 177' ' ' ARG . 1.2 ptt-85 -70.36 -29.14 65.74 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 117.036 2.235 . . . . 0.0 117.036 170.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.77 -46.63 88.75 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 169.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 10.9 mp -64.4 -43.33 94.75 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 117.411 -1.281 . . . . 0.0 111.402 167.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.577 ' HB2' ' HA ' ' A' ' 174' ' ' ARG . 41.1 mtt180 -46.64 -40.87 13.84 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 117.883 2.549 . . . . 0.0 117.883 169.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -69.0 -48.72 62.39 Favored 'General case' 0 CA--C 1.562 1.423 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 169.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.7 tt -83.13 -52.3 6.75 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 120.583 1.538 . . . . 0.0 114.336 -176.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -135.18 -60.18 0.06 OUTLIER Glycine 0 CA--C 1.551 2.284 0 CA-C-O 116.952 -2.027 . . . . 0.0 115.594 -170.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 39.7 ttmt . . . . . 0 C--O 1.251 1.17 0 CA-C-N 121.548 2.674 . . . . 0.0 109.595 -175.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.8 ttp . . . . . 0 CA--C 1.56 1.333 0 CA-C-O 122.382 1.086 . . . . 0.0 109.25 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . 0.275 11.4 mpt_? -124.5 167.73 14.05 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 120.878 3.659 . . . . 0.0 120.878 -162.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.3 p -148.11 151.18 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.695 0 CA-C-O 123.611 1.672 . . . . 0.0 113.067 167.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . 0.285 0.0 OUTLIER -143.56 133.87 24.58 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 113.922 -1.49 . . . . 0.0 110.99 166.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.729 HD11 ' CB ' ' A' ' 13' ' ' LYS . 3.7 tt -95.64 125.51 40.28 Favored 'General case' 0 CA--C 1.572 1.795 0 C-N-CA 125.188 1.395 . . . . 0.0 114.649 -165.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.6 mt -109.78 155.49 21.54 Favored 'General case' 0 CA--C 1.567 1.607 0 CA-C-N 110.559 -3.019 . . . . 0.0 109.847 169.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -174.36 99.49 0.14 Allowed Glycine 0 CA--C 1.55 2.24 0 CA-C-O 116.729 -2.15 . . . . 0.0 113.468 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.281 33.3 Cg_endo . . . . . 0 CA--C 1.58 2.778 0 CA-C-N 122.277 3.039 . . . . 0.0 111.853 175.25 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.729 ' CB ' HD11 ' A' ' 5' ' ' LEU . 32.1 mmtt . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.91 -35.74 92.4 Favored Glycine 0 CA--C 1.552 2.362 0 N-CA-C 118.609 2.204 . . . . 0.0 118.609 173.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 40.3 m -61.65 -53.48 55.6 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 119.324 1.562 . . . . 0.0 113.416 174.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.259 0.1 OUTLIER -79.59 -17.45 53.85 Favored 'General case' 0 CA--C 1.58 2.106 0 CA-C-O 116.639 -1.648 . . . . 0.0 111.491 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.28 -43.7 55.79 Favored 'General case' 0 C--N 1.374 1.633 0 CA-C-N 122.712 2.506 . . . . 0.0 115.337 168.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.5 t -65.77 -37.99 81.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 CA-C-O 117.691 -1.147 . . . . 0.0 112.335 170.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -59.68 -51.61 69.05 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 169.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.5 tp -64.37 -31.5 72.73 Favored 'General case' 0 CA--C 1.575 1.937 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 174.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.29 -39.46 93.97 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 168.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -63.73 -35.13 79.55 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 166.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 43.7 tptt -68.28 -55.49 11.98 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 174.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 65.0 mt -83.83 -26.51 29.46 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 116.648 2.092 . . . . 0.0 116.648 -178.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.27 39.28 6.44 Favored Glycine 0 CA--C 1.555 2.534 0 N-CA-C 117.313 1.685 . . . . 0.0 117.313 -172.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.404 ' CG2' ' HA ' ' A' ' 81' ' ' PHE . 20.4 mm -104.22 153.91 38.63 Favored Pre-proline 0 CA--C 1.567 1.605 0 CA-C-N 119.029 1.414 . . . . 0.0 112.271 -170.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -81.3 101.52 1.25 Allowed 'Trans proline' 0 CA--C 1.568 2.22 0 CA-C-N 121.65 1.625 . . . . 0.0 108.667 161.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.96 119.24 17.9 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 122.088 0.947 . . . . 0.0 110.197 173.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.477 HD11 ' HB3' ' A' ' 71' ' ' ARG . 1.8 mp -95.28 109.06 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 N-CA-C 104.089 -2.56 . . . . 0.0 104.089 176.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 78.0 p -97.41 128.15 43.96 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 166.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.8 p -67.33 -10.89 55.39 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 117.822 2.526 . . . . 0.0 117.822 -169.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -82.41 -27.85 42.08 Favored Glycine 0 CA--C 1.553 2.409 0 N-CA-C 117.951 1.94 . . . . 0.0 117.951 165.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -81.3 -46.14 15.17 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -168.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -69.68 -37.32 76.61 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 173.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.485 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 42.4 m-85 -65.67 -46.85 77.55 Favored 'General case' 0 CA--C 1.557 1.234 0 CA-C-O 116.538 -1.696 . . . . 0.0 112.855 170.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -54.84 -40.65 69.84 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 168.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -59.44 -40.47 86.9 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 169.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -68.39 -25.47 65.07 Favored 'General case' 0 CA--C 1.583 2.238 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 167.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . 0.42 HG12 HG23 ' A' ' 47' ' ' VAL . 50.5 mt -62.91 -50.16 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 CA-C-N 120.383 1.447 . . . . 0.0 110.768 167.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.53 -31.55 69.83 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -67.76 -39.92 84.11 Favored 'General case' 0 CA--C 1.565 1.524 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 169.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.98 70.73 1.0 Allowed Glycine 0 CA--C 1.536 1.394 0 CA-C-O 118.577 -1.124 . . . . 0.0 112.886 175.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.566 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 56.9 p -96.18 -66.4 0.91 Allowed 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 118.291 1.046 . . . . 0.0 110.609 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.566 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.0 OUTLIER 124.88 -54.97 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 119.436 1.016 . . . . 0.0 110.117 -167.061 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.462 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.8 OUTLIER -71.8 -15.04 62.14 Favored 'General case' 0 CA--C 1.57 1.747 0 CA-C-O 118.48 -0.771 . . . . 0.0 112.54 167.058 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.89 -53.66 44.03 Favored Glycine 0 CA--C 1.555 2.586 0 CA-C-N 120.102 1.319 . . . . 0.0 114.009 166.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.42 HG23 HG12 ' A' ' 39' ' ' ILE . 1.0 OUTLIER -75.05 -50.88 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 -170.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -65.4 -41.8 93.25 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 120.908 1.685 . . . . 0.0 113.196 172.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 45' ' ' LEU . . . -75.57 -24.26 56.61 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -176.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.485 ' HB2' ' HB3' ' A' ' 35' ' ' PHE . 9.6 tmtm? -76.18 -38.82 56.09 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 117.127 -1.416 . . . . 0.0 112.978 166.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.603 ' O ' ' CG ' ' A' ' 51' ' ' ARG . 51.1 ttt180 -70.58 -55.45 8.82 Favored 'General case' 0 CA--C 1.591 2.543 1 CA-C-O 86.101 -16.19 . . . . 0.0 118.413 -178.013 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 12.6 m-30 -33.15 -60.32 0.34 Allowed 'General case' 0 N--CA 1.496 1.858 1 O-C-N 109.089 -8.507 . . . . 0.0 121.273 146.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.7 tp -60.75 -23.67 65.14 Favored 'General case' 0 CA--C 1.576 1.966 0 CA-C-N 122.58 2.446 . . . . 0.0 117.226 169.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -93.09 -44.52 8.34 Favored 'General case' 0 CA--C 1.569 1.688 0 C-N-CA 126.112 1.765 . . . . 0.0 114.376 168.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.23 -36.27 24.74 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 116.669 2.1 . . . . 0.0 116.669 -177.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.97 40.04 2.55 Favored Glycine 0 CA--C 1.537 1.412 0 N-CA-C 116.157 1.223 . . . . 0.0 116.157 169.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -103.29 -135.94 0.34 Allowed 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 169.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.6 mt -105.56 108.57 20.16 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 120.857 1.662 . . . . 0.0 110.304 -170.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.3 p -112.05 109.58 54.6 Favored Pre-proline 0 CA--C 1.565 1.551 0 CA-C-O 117.483 -1.246 . . . . 0.0 108.23 175.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -64.28 154.82 69.01 Favored 'Trans proline' 0 CA--C 1.558 1.705 0 C-N-CA 123.094 2.529 . . . . 0.0 116.567 178.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 71.9 m -78.03 174.98 10.53 Favored 'General case' 0 CA--C 1.571 1.762 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.969 169.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.7 t70 83.17 -47.11 0.13 Allowed 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 125.884 1.674 . . . . 0.0 114.075 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 24.9 mt -65.47 -53.98 34.87 Favored 'General case' 0 N--CA 1.505 2.276 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 168.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 53.7 m -53.68 -49.85 67.1 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 113.112 -1.858 . . . . 0.0 113.678 169.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -59.63 -27.24 66.16 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 116.534 2.05 . . . . 0.0 116.534 167.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.57 -47.56 54.16 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 173.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.381 4.5 pp -74.59 -25.73 59.46 Favored 'General case' 0 CA--C 1.588 2.439 0 CA-C-N 119.743 1.156 . . . . 0.0 112.952 174.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.0 -48.01 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 CA-C-N 121.78 2.082 . . . . 0.0 112.816 165.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -58.57 -32.82 69.28 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 171.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -59.58 -45.84 90.68 Favored 'General case' 0 CA--C 1.566 1.585 0 CA-C-O 117.555 -1.212 . . . . 0.0 112.697 166.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.477 ' HB3' HD11 ' A' ' 29' ' ' ILE . 83.0 mtt180 -82.93 7.9 14.11 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 118.59 2.811 . . . . 0.0 118.59 167.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.8 mt -123.69 -5.87 8.06 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 118.294 2.701 . . . . 0.0 118.294 170.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 55.9 p30 . . . . . 0 N--CA 1.5 2.052 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 171.921 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.838 0 CA-C-O 123.993 1.885 . . . . 0.0 117.325 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.404 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . 13.9 p90 -171.39 135.84 0.97 Allowed 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 113.344 -1.428 . . . . 0.0 107.675 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 9.1 mt -111.56 108.92 26.69 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.542 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 172.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 26.2 mt -107.24 121.06 43.78 Favored 'General case' 0 N--CA 1.504 2.235 0 CA-C-O 117.402 -1.285 . . . . 0.0 110.009 177.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -117.74 118.17 31.34 Favored 'General case' 0 N--CA 1.506 2.369 0 CA-C-N 121.566 1.985 . . . . 0.0 111.588 -169.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 74.63 35.8 50.37 Favored Glycine 0 CA--C 1.555 2.537 0 CA-C-O 117.986 -1.452 . . . . 0.0 116.653 -174.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -94.64 -52.67 0.24 Allowed Pre-proline 0 N--CA 1.493 1.709 0 CA-C-O 115.361 -2.257 . . . . 0.0 108.672 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -68.41 68.71 1.04 Allowed 'Trans proline' 0 CA--C 1.57 2.321 0 CA-C-N 124.071 2.49 . . . . 0.0 117.623 164.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -20.99 61.47 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 165.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.2 m -147.19 143.38 28.16 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 -173.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . 0.313 9.8 p -69.54 -23.2 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 CA-C-O 116.158 -1.877 . . . . 0.0 112.337 175.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -63.43 -31.89 73.17 Favored 'General case' 0 CA--C 1.563 1.449 0 N-CA-C 118.943 2.942 . . . . 0.0 118.943 166.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -76.84 -48.16 19.26 Favored 'General case' 0 CA--C 1.588 2.409 0 CA-C-N 122.281 2.31 . . . . 0.0 112.159 165.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.36 -35.47 80.97 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 126.932 2.093 . . . . 0.0 116.003 -169.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.0 tttt -57.71 -29.48 64.74 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 115.683 1.735 . . . . 0.0 115.683 167.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.74 -41.0 72.39 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 168.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 23.6 tp -60.41 -40.36 90.69 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 168.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -56.12 -53.08 61.35 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 124.003 0.921 . . . . 0.0 113.147 168.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.902 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 14.3 mm-40 -46.88 -42.71 17.91 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 116.012 1.856 . . . . 0.0 116.012 167.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 1.284 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 58.7 mtt -83.87 -19.66 34.45 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 117.793 2.516 . . . . 0.0 117.793 177.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 60.6 tp -73.81 -50.36 20.83 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 120.835 1.652 . . . . 0.0 111.741 169.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -74.2 -56.78 4.5 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 171.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.902 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 96.4 mtt180 -68.58 -37.98 80.29 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 177.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 1.284 ' HB3' ' O ' ' A' ' 99' ' ' MET . 70.7 ttt180 -62.25 -59.31 5.21 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 119.857 1.208 . . . . 0.0 110.193 164.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 113.11 46.22 0.71 Allowed Glycine 0 N--CA 1.48 1.632 0 O-C-N 124.435 1.085 . . . . 0.0 114.011 167.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.2 p -103.61 146.63 28.28 Favored 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 172.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -68.81 128.96 38.55 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.183 -0.948 . . . . 0.0 112.894 -170.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.8 tp -82.23 101.15 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -103.32 -72.0 0.71 Allowed 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 115.737 -2.078 . . . . 0.0 109.21 167.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -142.6 119.76 11.45 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 116.543 2.053 . . . . 0.0 116.543 -166.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 93.8 t -92.87 114.28 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 100.532 -3.877 . . . . 0.0 100.532 161.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 32.9 tp -117.96 109.47 16.54 Favored 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 122.778 0.431 . . . . 0.0 111.454 -165.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -96.64 115.91 28.23 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 122.986 0.514 . . . . 0.0 112.062 -178.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -93.09 108.86 20.36 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 175.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.5 ' O ' HG23 ' A' ' 115' ' ' VAL . 80.0 ttt180 -103.13 110.89 23.0 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.949 0.899 . . . . 0.0 108.745 172.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 114' ' ' ARG 0.31 1.3 t . . . . . 0 N--CA 1.499 1.984 0 CA-C-O 123.925 1.821 . . . . 0.0 108.252 159.688 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 . . . . . 0 N--CA 1.5 2.075 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 9.5 tpt180 -57.69 -45.45 85.65 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 166.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 25.1 ttt -64.18 -33.02 74.84 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 169.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -60.89 -48.92 79.61 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 169.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 12.4 p -65.32 -33.09 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 169.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -55.02 -49.57 71.2 Favored 'General case' 0 CA--C 1.581 2.162 0 CA-C-N 119.922 1.237 . . . . 0.0 111.652 167.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -56.74 -41.63 77.85 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 118.878 2.918 . . . . 0.0 118.878 171.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -46.71 -42.45 16.65 Favored 'General case' 0 N--CA 1.506 2.342 0 N-CA-C 117.969 2.581 . . . . 0.0 117.969 174.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -125.69 -29.3 3.17 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 117.597 2.443 . . . . 0.0 117.597 -166.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 51.7 m -45.97 -34.29 3.88 Favored 'General case' 0 N--CA 1.505 2.29 0 N-CA-C 117.543 2.423 . . . . 0.0 117.543 -171.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -66.86 -62.49 3.77 Favored Pre-proline 0 CA--C 1.583 2.247 0 CA-C-O 116.144 -1.884 . . . . 0.0 112.09 170.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -53.15 -35.86 74.78 Favored 'Trans proline' 0 CA--C 1.584 3.004 0 C-N-CA 123.632 2.888 . . . . 0.0 118.945 168.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.97 -53.75 54.86 Favored 'General case' 0 N--CA 1.496 1.875 0 C-N-CA 126.165 1.786 . . . . 0.0 112.174 169.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 1.27 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 28.8 tp -68.09 -21.57 64.96 Favored 'General case' 0 CA--C 1.563 1.467 0 CA-C-O 116.749 -1.596 . . . . 0.0 114.214 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -71.98 -49.02 40.76 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 121.961 2.164 . . . . 0.0 112.618 164.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -68.63 -51.75 38.8 Favored 'General case' 0 CA--C 1.567 1.613 0 CA-C-N 120.569 1.531 . . . . 0.0 112.302 -176.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -78.56 -26.23 45.59 Favored 'General case' 0 CA--C 1.554 1.109 0 CA-C-O 114.854 -2.498 . . . . 0.0 113.072 176.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 1.27 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 0.1 OUTLIER -60.96 -41.97 97.37 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 125.24 3.655 . . . . 0.0 115.543 168.393 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -62.87 -36.0 81.86 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 167.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -88.3 -34.42 17.68 Favored 'General case' 0 CA--C 1.576 1.977 0 N-CA-C 119.336 3.088 . . . . 0.0 119.336 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.1 pp -80.35 173.71 12.32 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 117.803 2.52 . . . . 0.0 117.803 -162.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -122.78 123.53 41.25 Favored 'General case' 0 CA--C 1.557 1.221 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 166.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 1.4 t -100.2 156.9 16.96 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 123.195 1.474 . . . . 0.0 110.241 -178.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 40.0 t -132.61 143.99 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.367 0 CA-C-N 113.096 -1.865 . . . . 0.0 106.651 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -95.05 120.25 34.94 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 100.32 -3.955 . . . . 0.0 100.32 164.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . 0.307 . . -99.34 -101.74 0.22 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 119.489 3.144 . . . . 0.0 119.489 -150.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.3 t . . . . . 0 CA--C 1.564 1.492 0 N-CA-C 117.492 2.405 . . . . 0.0 117.492 -158.005 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 8.9 t70 . . . . . 0 N--CA 1.506 2.346 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -63.99 -44.76 91.7 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 174.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -40.58 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-O 117.947 -1.025 . . . . 0.0 113.667 172.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -54.7 -38.81 67.49 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 116.656 2.095 . . . . 0.0 116.656 166.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -62.57 -53.46 54.28 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.449 ' HA ' ' HB2' ' A' ' 177' ' ' ARG . 74.7 mtt85 -70.94 -28.38 64.44 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 117.91 2.559 . . . . 0.0 117.91 174.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.14 -45.42 94.74 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 167.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.5 mp -62.76 -43.17 99.51 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 117.852 -1.07 . . . . 0.0 113.641 168.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.449 ' HB2' ' HA ' ' A' ' 174' ' ' ARG . 39.6 mtt180 -52.56 -42.65 64.64 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 117.034 2.235 . . . . 0.0 117.034 169.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -66.8 -50.86 61.28 Favored 'General case' 0 CA--C 1.558 1.264 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 172.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.86 -59.59 2.67 Favored 'General case' 0 CA--C 1.569 1.688 0 CA-C-N 119.833 1.197 . . . . 0.0 112.565 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.638 ' O ' ' CB ' ' A' ' 181' ' ' LYS . . . -106.59 -55.68 0.66 Allowed Glycine 0 CA--C 1.55 2.249 0 CA-C-O 117.902 -1.499 . . . . 0.0 115.095 -175.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.638 ' CB ' ' O ' ' A' ' 180' ' ' GLY . 36.5 ttmt . . . . . 0 C--O 1.251 1.139 0 CA-C-N 120.13 1.965 . . . . 0.0 107.507 -175.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.9 mmt . . . . . 0 CA--C 1.555 1.154 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.98 169.74 21.03 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 115.837 1.791 . . . . 0.0 115.837 -165.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.9 t -131.51 148.57 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 123.66 1.695 . . . . 0.0 113.135 -162.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -119.47 113.54 20.92 Favored 'General case' 0 CA--C 1.558 1.262 0 CA-C-N 112.576 -2.102 . . . . 0.0 105.331 169.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.8 tp -99.67 127.03 45.78 Favored 'General case' 0 CA--C 1.562 1.424 0 CA-C-O 123.44 1.59 . . . . 0.0 108.399 -168.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.3 mt -134.67 163.73 29.11 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 111.695 -2.502 . . . . 0.0 113.277 -164.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 172.96 115.6 0.38 Allowed Glycine 0 CA--C 1.546 2.007 0 CA-C-O 117.015 -1.991 . . . . 0.0 110.953 -171.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo . . . . . 0 CA--C 1.577 2.656 0 CA-C-N 122.147 2.973 . . . . 0.0 115.196 168.751 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt . . . . . 0 N--CA 1.497 1.913 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -44.61 -33.49 3.31 Favored Glycine 0 CA--C 1.551 2.332 0 N-CA-C 120.887 3.115 . . . . 0.0 120.887 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.8 p -57.92 -61.12 2.76 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 119.322 1.561 . . . . 0.0 115.21 173.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.259 5.2 mm-40 -75.95 -12.53 60.16 Favored 'General case' 0 CA--C 1.567 1.598 0 CA-C-O 116.539 -1.696 . . . . 0.0 111.59 175.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.68 -50.56 42.73 Favored 'General case' 0 C--N 1.37 1.458 0 CA-C-N 122.57 2.441 . . . . 0.0 113.639 167.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.8 p -66.9 -39.83 84.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 173.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.539 ' HB3' ' CE1' ' A' ' 172' ' ' PHE . 58.5 mmtt -62.89 -42.48 99.79 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 116.21 1.929 . . . . 0.0 116.21 170.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 20.0 tp -66.67 -36.81 83.42 Favored 'General case' 0 CA--C 1.571 1.766 0 CA-C-N 120.04 1.291 . . . . 0.0 113.53 172.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.24 -39.29 86.21 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 166.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -56.59 -39.88 74.32 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 166.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -68.71 -53.44 22.16 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 174.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.1 mt -83.87 -23.81 31.12 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 117.274 2.324 . . . . 0.0 117.274 -176.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.91 35.42 7.72 Favored Glycine 0 CA--C 1.555 2.582 0 N-CA-C 117.8 1.88 . . . . 0.0 117.8 -174.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.0 mm -105.39 155.21 38.3 Favored Pre-proline 0 CA--C 1.57 1.722 0 CA-C-N 119.136 1.468 . . . . 0.0 112.434 -169.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -81.95 99.72 1.03 Allowed 'Trans proline' 0 CA--C 1.569 2.23 0 C-N-CA 121.695 1.596 . . . . 0.0 109.953 162.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.85 112.69 3.38 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 123.511 0.724 . . . . 0.0 110.539 170.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 27.3 mm -104.11 108.92 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 175.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.0 t -94.77 136.51 34.99 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 169.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.1 p -70.35 -6.53 35.98 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 117.531 2.419 . . . . 0.0 117.531 -177.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -89.72 -24.05 31.51 Favored Glycine 0 CA--C 1.544 1.886 0 N-CA-C 118.324 2.09 . . . . 0.0 118.324 165.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -81.18 -51.23 8.65 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -168.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -64.71 -39.08 93.04 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 174.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.544 ' HB3' ' CG ' ' A' ' 50' ' ' LYS . 41.6 m-85 -66.3 -37.6 85.78 Favored 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 116.183 1.92 . . . . 0.0 116.183 169.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 74.4 ttt180 -58.59 -41.05 84.91 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 166.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -63.81 -38.88 92.76 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 114.746 1.388 . . . . 0.0 114.746 169.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -64.28 -34.34 77.9 Favored 'General case' 0 CA--C 1.573 1.862 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 167.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 51.8 mt -59.35 -43.53 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 C-N-CA 124.994 1.318 . . . . 0.0 111.933 168.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -63.88 -40.62 96.95 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 170.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -72.68 -40.34 66.33 Favored 'General case' 0 CA--C 1.558 1.257 0 N-CA-C 116.266 1.95 . . . . 0.0 116.266 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.01 72.12 1.29 Allowed Glycine 0 CA--C 1.542 1.774 0 CA-C-O 118.383 -1.232 . . . . 0.0 113.965 -171.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.562 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 76.4 p -91.55 -65.47 1.01 Allowed 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 118.887 1.343 . . . . 0.0 111.267 177.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.562 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.0 OUTLIER 128.3 -55.76 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.942 0.897 . . . . 0.0 110.349 -167.422 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -74.67 -11.17 60.11 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 166.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.08 -54.31 25.06 Favored Glycine 0 CA--C 1.546 2.028 0 CA-C-N 119.324 0.965 . . . . 0.0 114.393 167.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.414 ' O ' ' HB2' ' A' ' 51' ' ' ARG 0.268 1.0 OUTLIER -76.44 -47.37 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 116.593 2.072 . . . . 0.0 116.593 -168.624 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -67.05 -36.81 82.89 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 120.985 1.72 . . . . 0.0 113.363 171.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -74.77 -34.24 62.43 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -177.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.544 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -73.92 -34.06 64.21 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 117.736 -1.126 . . . . 0.0 112.503 169.573 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 51' ' ' ARG . 22.0 ttt180 -74.12 -51.12 16.62 Favored 'General case' 0 CA--C 1.586 2.359 1 CA-C-O 84.252 -17.07 . . . . 0.0 118.583 -178.761 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . 0.251 21.4 m-85 -36.83 -57.42 0.81 Allowed 'General case' 0 N--CA 1.494 1.769 2 O-C-N 107.666 -9.396 . . . . 0.0 122.029 147.869 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 38.4 mt -57.43 -33.92 68.4 Favored 'General case' 0 N--CA 1.511 2.597 0 CA-C-N 123.241 2.746 . . . . 0.0 115.501 168.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -90.71 -38.38 13.09 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 175.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.96 -37.78 38.71 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 178.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.89 40.41 1.44 Allowed Glycine 0 CA--C 1.536 1.403 0 N-CA-C 116.475 1.35 . . . . 0.0 116.475 171.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -119.31 -142.94 0.36 Allowed 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 165.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 79.9 mt -129.92 133.77 47.06 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.307 -0.87 . . . . 0.0 109.77 -170.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.609 HG12 HH22 ' A' ' 88' ' ' ARG . 7.0 p -109.01 133.03 20.85 Favored Pre-proline 0 CA--C 1.573 1.863 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 172.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -54.95 146.72 55.85 Favored 'Trans proline' 0 CA--C 1.561 1.838 0 C-N-CA 123.33 2.687 . . . . 0.0 116.839 173.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 96.4 p -72.64 175.6 6.24 Favored 'General case' 0 CA--C 1.57 1.739 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 176.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.6 t70 81.04 -45.18 0.22 Allowed 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 125.822 1.649 . . . . 0.0 114.29 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 34.8 mt -62.3 -54.51 39.55 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 168.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.8 m -56.65 -48.72 76.95 Favored 'General case' 0 CA--C 1.571 1.765 0 CA-C-N 113.051 -1.886 . . . . 0.0 113.07 173.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -58.04 -35.28 71.09 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 168.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -64.95 -44.6 88.9 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 173.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.8 mt -62.93 -44.27 96.53 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 170.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 82.7 t -58.29 -46.77 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-O 117.799 -1.096 . . . . 0.0 112.463 170.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -60.0 -39.21 84.98 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 116.013 1.857 . . . . 0.0 116.013 172.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -58.67 -41.83 87.07 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 120.331 1.423 . . . . 0.0 113.44 169.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -82.11 2.01 33.37 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 119.198 3.036 . . . . 0.0 119.198 167.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 23.3 tp -121.68 -7.94 9.04 Favored 'General case' 0 CA--C 1.564 1.49 0 N-CA-C 118.407 2.743 . . . . 0.0 118.407 175.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 . . . . . 0 N--CA 1.504 2.251 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 174.494 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.687 0 N-CA-C 118.874 2.31 . . . . 0.0 118.874 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -175.89 136.75 0.32 Allowed 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 113.731 -1.234 . . . . 0.0 110.438 -169.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 22.6 mt -113.32 106.27 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 169.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 58.8 mt -105.72 120.52 41.89 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 123.151 0.58 . . . . 0.0 109.454 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -113.49 122.09 46.22 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 118.645 0.657 . . . . 0.0 110.621 -167.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 72.73 38.87 56.61 Favored Glycine 0 CA--C 1.548 2.114 0 CA-C-O 117.287 -1.841 . . . . 0.0 115.801 -178.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -99.66 -54.16 0.18 Allowed Pre-proline 0 N--CA 1.498 1.967 0 CA-C-O 115.359 -2.257 . . . . 0.0 107.536 176.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -60.87 70.04 0.08 OUTLIER 'Trans proline' 0 CA--C 1.575 2.555 0 N-CA-C 118.784 2.571 . . . . 0.0 118.784 164.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.609 HH22 HG12 ' A' ' 59' ' ' VAL . 4.5 ttm105 -69.94 -37.56 75.92 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 168.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.0 p -151.56 126.95 9.99 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 104.316 -2.475 . . . . 0.0 104.316 -164.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . 0.317 5.8 p -62.28 -21.3 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-O 116.089 -1.91 . . . . 0.0 113.6 -173.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.09 -36.92 85.61 Favored 'General case' 0 CA--C 1.557 1.221 0 N-CA-C 119.435 3.124 . . . . 0.0 119.435 165.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -73.04 -48.54 35.28 Favored 'General case' 0 CA--C 1.586 2.361 0 CA-C-N 124.422 3.283 . . . . 0.0 111.088 165.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.16 -32.03 67.8 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 118.078 2.621 . . . . 0.0 118.078 -174.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.519 ' O ' ' HB2' ' A' ' 98' ' ' GLU . 60.2 tttt -59.48 -25.15 64.18 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 116.604 2.076 . . . . 0.0 116.604 168.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.62 -45.69 64.76 Favored 'General case' 0 CA--C 1.568 1.648 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 166.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 11.2 tp -61.48 -43.73 98.34 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 171.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -59.51 -51.11 71.27 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 168.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.984 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 5.5 tp10 -43.96 -39.3 3.95 Favored 'General case' 0 CA--C 1.573 1.865 0 N-CA-C 115.548 1.684 . . . . 0.0 115.548 166.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 1.122 ' O ' ' HB2' ' A' ' 103' ' ' ARG . 66.5 mtt -83.05 -26.02 31.56 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 117.673 2.471 . . . . 0.0 117.673 174.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 41.1 tp -65.53 -54.94 20.95 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-N 120.681 1.582 . . . . 0.0 112.13 169.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -78.29 -51.04 10.73 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 119.269 0.941 . . . . 0.0 113.281 175.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.984 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 74.8 ttt180 -67.79 -46.43 71.98 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 177.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 1.122 ' HB2' ' O ' ' A' ' 99' ' ' MET . 58.1 mtt180 -65.09 -51.29 62.25 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 118.892 0.769 . . . . 0.0 111.97 165.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.38 42.66 1.14 Allowed Glycine 0 N--CA 1.482 1.758 0 N-CA-C 114.914 0.726 . . . . 0.0 114.914 167.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 41.4 p -97.5 142.65 29.08 Favored 'General case' 0 CA--C 1.559 1.315 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 169.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -66.73 131.92 46.98 Favored 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -170.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 4.8 tp -84.75 102.89 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 125.402 1.481 . . . . 0.0 108.144 175.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -99.33 -74.27 0.6 Allowed 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 115.369 -2.253 . . . . 0.0 108.412 167.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -137.93 124.94 21.37 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 122.34 2.336 . . . . 0.0 114.908 -176.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 44.2 t -92.42 109.82 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 1 N-CA-C 98.854 -4.498 . . . . 0.0 98.854 162.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.255 49.9 tp -118.17 111.6 19.05 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.446 -160.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -112.96 128.27 56.44 Favored 'General case' 0 CA--C 1.556 1.201 0 CA-C-O 122.39 1.09 . . . . 0.0 111.507 -171.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -96.45 122.43 39.34 Favored 'General case' 0 CA--C 1.558 1.288 0 CA-C-N 113.612 -1.631 . . . . 0.0 109.853 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -85.58 96.43 9.65 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 112.931 -1.941 . . . . 0.0 110.158 169.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.4 p . . . . . 0 CA--C 1.567 1.626 0 C-N-CA 125.849 1.659 . . . . 0.0 109.217 -167.923 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 . . . . . 0 N--CA 1.498 1.93 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -60.11 -35.5 75.37 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 166.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 64.1 mtt -68.63 -29.8 68.38 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 167.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -62.22 -51.42 67.82 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 120.424 1.466 . . . . 0.0 114.889 168.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.7 p -64.18 -32.58 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 170.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -54.7 -50.38 68.43 Favored 'General case' 0 CA--C 1.579 2.066 0 CA-C-N 119.678 1.127 . . . . 0.0 111.965 167.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.55 -38.05 76.99 Favored 'General case' 0 CA--C 1.563 1.454 0 N-CA-C 118.401 2.741 . . . . 0.0 118.401 174.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -50.67 -33.95 24.6 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 118.478 2.77 . . . . 0.0 118.478 172.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -130.3 -28.76 2.08 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 118.473 2.768 . . . . 0.0 118.473 -166.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 62.6 m -47.46 -33.61 6.37 Favored 'General case' 0 N--CA 1.504 2.225 0 N-CA-C 117.503 2.409 . . . . 0.0 117.503 -170.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -66.58 -61.93 4.56 Favored Pre-proline 0 CA--C 1.58 2.129 0 CA-C-O 115.97 -1.967 . . . . 0.0 112.207 171.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -55.17 -31.24 74.9 Favored 'Trans proline' 0 CA--C 1.578 2.718 0 N-CA-C 119.302 2.77 . . . . 0.0 119.302 169.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.99 -56.42 19.24 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 125.409 1.483 . . . . 0.0 111.842 169.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.981 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 42.3 tp -66.07 -23.12 66.46 Favored 'General case' 0 CA--C 1.562 1.435 0 CA-C-O 116.675 -1.631 . . . . 0.0 114.569 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -71.74 -47.36 54.28 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 121.976 2.171 . . . . 0.0 112.084 165.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -66.75 -54.99 17.03 Favored 'General case' 0 CA--C 1.564 1.495 0 CA-C-N 120.613 1.551 . . . . 0.0 112.047 -176.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . 0.262 21.4 m-30 -81.94 -19.74 40.07 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-O 114.69 -2.576 . . . . 0.0 112.456 178.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.981 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 43.5 ttt180 -66.24 -36.04 81.99 Favored 'General case' 0 N--CA 1.487 1.413 1 CA-C-N 126.28 4.127 . . . . 0.0 115.592 167.721 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -68.86 -38.2 79.58 Favored 'General case' 0 CA--C 1.576 1.962 0 CA-C-N 119.848 1.204 . . . . 0.0 113.917 166.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -90.45 -27.58 19.17 Favored 'General case' 0 CA--C 1.576 1.979 0 N-CA-C 119.14 3.015 . . . . 0.0 119.14 -176.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.0 pp -79.76 174.9 11.12 Favored 'General case' 0 N--CA 1.504 2.272 0 CA-C-N 122.773 2.533 . . . . 0.0 116.852 -164.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 37.8 tttp -127.38 131.56 50.32 Favored 'General case' 0 CA--C 1.559 1.298 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 168.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 31.5 m -94.93 148.86 21.87 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 122.224 1.012 . . . . 0.0 112.639 -167.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 36.2 t -132.09 134.34 59.73 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.523 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 166.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.412 ' HB3' ' NH1' ' A' ' 174' ' ' ARG . 13.6 t70 -96.88 131.45 43.63 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 167.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -163.61 118.93 1.64 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -163.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.6 t . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 118.257 -0.878 . . . . 0.0 109.345 173.969 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 . . . . . 0 N--CA 1.499 2.007 0 N-CA-C 116.013 1.857 . . . . 0.0 116.013 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -65.46 -45.35 84.06 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 171.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 69.0 t -56.49 -41.86 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.345 0 CA-C-N 120.622 1.555 . . . . 0.0 113.847 172.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.539 ' CE1' ' HB3' ' A' ' 19' ' ' LYS . 29.3 t80 -57.99 -36.16 72.24 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 115.783 1.771 . . . . 0.0 115.783 167.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -61.03 -53.29 59.07 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-O 118.141 -0.933 . . . . 0.0 113.459 176.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.412 ' NH1' ' HB3' ' A' ' 163' ' ' ASP . 93.6 mtt180 -63.96 -32.09 73.5 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 118.206 2.669 . . . . 0.0 118.206 171.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.95 -47.31 87.02 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 116.577 2.066 . . . . 0.0 116.577 170.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . 0.265 0.2 OUTLIER -71.06 -39.47 72.2 Favored 'General case' 0 N--CA 1.505 2.32 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 169.81 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -48.92 -39.46 26.23 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 168.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -69.51 -56.7 6.61 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 166.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -103.84 -56.18 2.25 Favored 'General case' 0 CA--C 1.563 1.462 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 -168.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.824 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -78.23 -37.08 29.27 Favored Glycine 0 CA--C 1.55 2.258 0 CA-C-N 121.308 1.867 . . . . 0.0 117.764 -169.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.824 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 86.1 tttt . . . . . 0 C--O 1.252 1.186 0 CA-C-N 118.073 0.936 . . . . 0.0 108.523 178.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 mmt . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 122.278 1.037 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.457 ' NH1' ' HA2' ' A' ' 80' ' ' GLY 0.324 16.0 ttm-85 -147.25 144.64 29.01 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 118.423 2.749 . . . . 0.0 118.423 -158.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.8 t -141.42 147.85 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 CA-C-O 123.951 1.834 . . . . 0.0 111.964 -171.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.6 mt -133.29 120.74 21.45 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 126.949 2.099 . . . . 0.0 108.995 -175.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 13.0 tp -105.88 122.51 46.27 Favored 'General case' 0 CA--C 1.577 2.005 0 CA-C-O 123.202 1.477 . . . . 0.0 111.066 -168.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.7 mt -120.93 164.67 16.34 Favored 'General case' 0 CA--C 1.563 1.478 0 CA-C-N 110.607 -2.997 . . . . 0.0 112.742 -171.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 142.08 170.67 12.66 Favored Glycine 0 CA--C 1.562 2.984 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.563 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo . . . . . 0 CA--C 1.579 2.761 0 CA-C-N 121.45 2.625 . . . . 0.0 110.145 170.035 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 45.7 mttt . . . . . 0 N--CA 1.479 1.013 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -46.39 -40.26 10.8 Favored Glycine 0 CA--C 1.555 2.571 0 N-CA-C 120.939 3.136 . . . . 0.0 120.939 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.7 m -52.82 -54.63 31.48 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-N 119.012 1.406 . . . . 0.0 114.359 169.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.25 0.0 OUTLIER -76.67 -17.12 59.32 Favored 'General case' 0 CA--C 1.575 1.927 0 CA-C-O 117.055 -1.45 . . . . 0.0 112.697 177.454 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.23 -44.18 65.83 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 122.068 2.213 . . . . 0.0 114.629 167.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.9 p -66.13 -46.81 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 172.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.675 ' HB3' ' CE1' ' A' ' 172' ' ' PHE . 45.0 mmtm -54.9 -46.74 74.87 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 169.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 12.5 tp -70.33 -27.76 64.62 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 175.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.15 -39.06 89.53 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 166.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -58.78 -43.35 90.41 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 117.31 -1.328 . . . . 0.0 114.131 166.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -68.12 -46.83 69.8 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 116.455 2.02 . . . . 0.0 116.455 173.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.0 mt -82.54 -26.63 32.27 Favored 'General case' 0 CA--C 1.574 1.893 0 N-CA-C 117.092 2.256 . . . . 0.0 117.092 -177.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.06 43.47 7.11 Favored Glycine 0 CA--C 1.555 2.557 0 N-CA-C 117.378 1.711 . . . . 0.0 117.378 -173.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 22.2 mm -114.62 157.98 41.43 Favored Pre-proline 0 CA--C 1.57 1.716 0 C-N-CA 124.551 1.14 . . . . 0.0 113.8 -168.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -76.3 103.18 1.7 Allowed 'Trans proline' 0 C--N 1.376 2.008 0 CA-C-N 121.582 1.601 . . . . 0.0 111.453 159.138 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.47 107.02 10.81 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.237 -0.914 . . . . 0.0 109.052 168.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.7 mm -99.17 112.0 30.21 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 -178.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.3 t -96.44 127.35 42.35 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 169.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 42.5 p -69.96 -10.55 58.98 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 116.802 2.149 . . . . 0.0 116.802 -175.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -83.76 -23.2 53.85 Favored Glycine 0 CA--C 1.545 1.912 0 N-CA-C 118.642 2.217 . . . . 0.0 118.642 166.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -80.52 -51.9 8.24 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 114.714 1.375 . . . . 0.0 114.714 -168.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -64.09 -39.21 93.57 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 174.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.447 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 13.5 m-85 -68.16 -42.19 80.42 Favored 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 172.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 29.2 ttp180 -57.33 -41.62 80.33 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 120.467 1.485 . . . . 0.0 114.073 167.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.2 ttt180 -58.88 -39.21 80.74 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 168.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -67.18 -27.8 67.57 Favored 'General case' 0 CA--C 1.577 1.988 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 167.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 97.4 mt -63.03 -45.51 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 CA-C-N 120.476 1.489 . . . . 0.0 111.403 168.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -66.86 -38.04 85.6 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 120.086 1.312 . . . . 0.0 114.285 173.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -67.85 -40.26 83.71 Favored 'General case' 0 CA--C 1.56 1.356 0 N-CA-C 116.339 1.977 . . . . 0.0 116.339 174.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.82 69.36 1.19 Allowed Glycine 0 CA--C 1.545 1.909 0 CA-C-O 118.379 -1.234 . . . . 0.0 114.645 -177.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.855 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 70.8 p -91.58 -49.1 6.48 Favored 'General case' 0 N--CA 1.5 2.025 0 CA-C-N 118.781 1.29 . . . . 0.0 114.341 176.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.855 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.255 74.2 mttt 105.96 -41.64 0.0 OUTLIER 'General case' 0 CA--C 1.569 1.705 0 CA-C-O 116.331 -1.795 . . . . 0.0 111.212 -172.181 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.3 -13.63 58.22 Favored 'General case' 0 CA--C 1.57 1.717 0 CA-C-N 123.117 2.689 . . . . 0.0 113.231 163.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.53 -55.03 32.26 Favored Glycine 0 C--N 1.354 1.529 0 CA-C-N 120.534 1.515 . . . . 0.0 115.2 169.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.28 8.7 p -76.42 -47.83 28.95 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.474 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -169.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -64.94 -47.42 77.73 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 121.291 1.859 . . . . 0.0 112.957 172.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.19 -31.03 69.35 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -179.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.447 ' HB2' ' HB3' ' A' ' 35' ' ' PHE . 2.0 tptm -69.7 -36.82 76.28 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 168.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.572 ' HG2' ' O ' ' A' ' 51' ' ' ARG . 29.0 ttt180 -74.48 -52.5 11.78 Favored 'General case' 0 CA--C 1.59 2.487 1 CA-C-O 85.183 -16.627 . . . . 0.0 117.991 -178.378 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 18.5 m-30 -30.41 -55.55 0.19 Allowed 'General case' 0 N--CA 1.493 1.717 1 O-C-N 108.661 -8.774 . . . . 0.0 121.6 146.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 26.5 mt -61.43 -44.01 97.88 Favored 'General case' 0 CA--C 1.572 1.789 0 CA-C-N 123.455 2.843 . . . . 0.0 114.489 167.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -76.08 -41.68 49.71 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 116.297 1.962 . . . . 0.0 116.297 176.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.45 -33.49 20.38 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 175.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.66 38.12 3.77 Favored Glycine 0 CA--C 1.54 1.607 0 CA-C-N 121.112 1.778 . . . . 0.0 116.521 169.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -101.48 -132.44 0.27 Allowed 'General case' 0 CA--C 1.571 1.773 0 CA-C-O 118.589 -0.72 . . . . 0.0 109.374 169.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.8 pp -120.87 123.5 42.69 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 120.007 1.276 . . . . 0.0 111.491 -169.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.49 HG12 HH22 ' A' ' 88' ' ' ARG . 6.1 p -120.71 133.69 24.12 Favored Pre-proline 0 CA--C 1.574 1.893 0 CA-C-O 117.782 -1.104 . . . . 0.0 109.883 -176.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -59.47 148.56 86.45 Favored 'Trans proline' 0 CA--C 1.561 1.829 0 C-N-CA 123.447 2.764 . . . . 0.0 116.505 174.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 88.0 p -80.61 -35.81 33.57 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 117.314 2.338 . . . . 0.0 117.314 -175.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -71.76 -51.6 21.87 Favored 'General case' 0 N--CA 1.508 2.473 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -171.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.8 pp -54.51 -42.0 70.29 Favored 'General case' 0 CA--C 1.564 1.496 0 N-CA-C 117.521 2.415 . . . . 0.0 117.521 171.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.0 m -61.19 -48.31 82.12 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 123.905 0.882 . . . . 0.0 113.282 172.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -67.04 -19.76 65.73 Favored 'General case' 0 CA--C 1.572 1.817 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 169.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -75.17 -42.37 56.02 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 121.116 1.78 . . . . 0.0 115.128 170.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mt -61.53 -47.29 86.23 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 168.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -54.24 -48.42 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 169.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -61.94 -36.17 80.62 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 171.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -55.54 -42.03 74.04 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 117.95 -1.024 . . . . 0.0 113.611 169.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 88.2 mtt-85 -81.14 -21.82 39.49 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 118.112 2.634 . . . . 0.0 118.112 168.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.0 mp -89.3 7.69 34.32 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 118.331 2.715 . . . . 0.0 118.331 172.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 . . . . . 0 CA--C 1.585 2.317 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 163.166 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.457 ' HA2' ' NH1' ' A' ' 2' ' ' ARG . . . . . . . . 0 CA--C 1.544 1.847 0 CA-C-O 125.52 2.733 . . . . 0.0 113.776 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.405 ' CZ ' ' HD3' ' A' ' 2' ' ' ARG . 21.7 p90 -169.72 135.5 1.49 Allowed 'General case' 0 CA--C 1.56 1.362 0 CA-C-N 109.039 -3.581 . . . . 0.0 105.975 169.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 13.9 mt -106.79 106.32 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 173.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.3 mt -108.03 114.59 28.61 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.069 -176.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -106.77 125.28 50.8 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 119.467 1.031 . . . . 0.0 110.632 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 75.19 28.38 62.24 Favored Glycine 0 CA--C 1.551 2.293 0 N-CA-C 118.377 2.111 . . . . 0.0 118.377 177.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -88.81 -55.0 0.32 Allowed Pre-proline 0 N--CA 1.496 1.865 0 CA-C-O 115.234 -2.317 . . . . 0.0 107.264 168.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -67.56 66.51 0.79 Allowed 'Trans proline' 0 CA--C 1.574 2.475 0 N-CA-C 118.381 2.416 . . . . 0.0 118.381 166.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.49 HH22 HG12 ' A' ' 59' ' ' VAL . 8.0 tmm_? -76.41 -20.39 57.17 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 167.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.491 ' HA ' ' HG3' ' A' ' 147' ' ' GLU . 28.3 t -153.54 127.56 8.98 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 104.197 -2.52 . . . . 0.0 104.197 -167.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . 0.302 5.8 p -61.3 -27.18 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 CA-C-O 116.387 -1.768 . . . . 0.0 113.017 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.61 -32.6 70.01 Favored 'General case' 0 C--N 1.362 1.132 0 N-CA-C 119.631 3.197 . . . . 0.0 119.631 165.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -74.04 -49.95 21.93 Favored 'General case' 0 CA--C 1.588 2.405 0 CA-C-N 124.391 3.269 . . . . 0.0 111.493 166.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -53.99 -28.02 35.3 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 118.319 2.711 . . . . 0.0 118.319 178.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.2 tttp -57.18 -30.35 64.43 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 168.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.56 -44.79 81.35 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 168.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.9 tp -62.2 -35.57 79.28 Favored 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 169.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 13.3 t60 -64.45 -43.8 93.12 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 119.651 1.114 . . . . 0.0 113.175 167.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 1.156 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 0.5 OUTLIER -54.94 -30.61 59.18 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 166.696 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 1.346 ' O ' ' HB2' ' A' ' 103' ' ' ARG . 47.3 mtt -85.28 -33.71 22.08 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 118.946 2.943 . . . . 0.0 118.946 172.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.5 tt -69.51 -54.11 15.78 Favored 'General case' 0 N--CA 1.504 2.27 0 CA-C-N 121.372 1.897 . . . . 0.0 110.906 172.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -78.15 -49.41 13.9 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 117.662 -1.161 . . . . 0.0 114.065 175.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 1.156 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 93.0 mtt180 -75.08 -39.67 60.6 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 177.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 1.346 ' HB2' ' O ' ' A' ' 99' ' ' MET . 32.8 mmt180 -64.36 -54.36 34.07 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 120.123 1.329 . . . . 0.0 111.538 165.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.3 50.74 0.7 Allowed Glycine 0 N--CA 1.485 1.938 0 O-C-N 123.836 0.71 . . . . 0.0 113.957 168.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.0 p -92.65 169.05 10.81 Favored 'General case' 0 CA--C 1.566 1.562 0 CA-C-N 113.188 -1.506 . . . . 0.0 110.247 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -72.42 133.24 44.78 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.1 -1.0 . . . . 0.0 110.72 -174.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 7.8 tp -102.21 98.44 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 177.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -98.32 -77.45 0.51 Allowed 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 116.218 -1.849 . . . . 0.0 107.866 168.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.46 130.55 11.88 Favored 'General case' 0 C--N 1.362 1.149 0 CA-C-N 121.665 2.03 . . . . 0.0 113.94 -169.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 24.1 t -92.72 110.96 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 103.497 -2.779 . . . . 0.0 103.497 162.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.455 HD23 ' HB3' ' A' ' 160' ' ' LYS . 89.4 mt -96.6 95.65 8.11 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.478 -172.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -88.98 123.95 33.79 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.173 0.511 . . . . 0.0 111.608 177.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -90.93 124.07 34.91 Favored 'General case' 0 CA--C 1.559 1.289 0 CA-C-O 123.16 1.457 . . . . 0.0 110.915 -176.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -85.37 97.35 9.94 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 112.412 -2.177 . . . . 0.0 108.391 167.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.482 1.139 0 CA-C-N 113.477 -1.692 . . . . 0.0 107.455 -168.567 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 44.5 t30 . . . . . 0 N--CA 1.498 1.942 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -62.48 -37.31 85.48 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 168.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 57.8 mtt -67.93 -29.51 68.6 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 168.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -63.56 -50.69 68.53 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 120.412 1.46 . . . . 0.0 114.377 168.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.1 p -65.79 -33.08 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.221 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 170.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -57.2 -47.0 82.38 Favored 'General case' 0 CA--C 1.583 2.214 0 CA-C-N 119.994 1.27 . . . . 0.0 112.032 168.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -61.77 -54.08 47.18 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 117.445 2.387 . . . . 0.0 117.445 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.49 -43.81 62.32 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 116.922 2.193 . . . . 0.0 116.922 174.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.491 ' HG3' ' HA ' ' A' ' 89' ' ' SER . 32.9 mm-40 -98.84 -42.3 7.24 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 116.487 2.032 . . . . 0.0 116.487 -167.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 97.8 m -50.76 -33.38 22.95 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 117.427 2.38 . . . . 0.0 117.427 -167.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.444 ' HB3' ' HD3' ' A' ' 150' ' ' PRO . . . -71.04 -61.38 2.34 Favored Pre-proline 0 CA--C 1.583 2.212 0 CA-C-O 115.83 -2.033 . . . . 0.0 111.844 169.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.444 ' HD3' ' HB3' ' A' ' 149' ' ' ALA . 75.7 Cg_exo -54.31 -37.02 88.56 Favored 'Trans proline' 0 CA--C 1.58 2.796 0 C-N-CA 123.625 2.883 . . . . 0.0 119.3 169.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -61.14 -53.27 59.11 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 126.193 1.797 . . . . 0.0 111.58 171.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 1.113 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 45.3 tp -64.32 -20.73 66.28 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 115.378 1.621 . . . . 0.0 115.378 174.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -71.6 -50.4 31.25 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 122.436 2.38 . . . . 0.0 112.667 164.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -65.05 -53.16 50.04 Favored 'General case' 0 CA--C 1.568 1.658 0 CA-C-N 120.106 1.321 . . . . 0.0 112.432 -179.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -74.87 -29.23 60.95 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-O 115.178 -2.344 . . . . 0.0 113.491 176.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 1.113 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 34.7 ttt180 -60.95 -36.42 79.33 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 124.535 3.334 . . . . 0.0 116.389 169.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -67.72 -36.49 80.7 Favored 'General case' 0 CA--C 1.575 1.935 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 166.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -86.87 -29.5 22.14 Favored 'General case' 0 CA--C 1.577 2.001 0 N-CA-C 119.43 3.122 . . . . 0.0 119.43 -178.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.1 pp -80.4 176.64 9.59 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 119.673 3.212 . . . . 0.0 119.673 -160.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.455 ' HB3' HD23 ' A' ' 111' ' ' LEU . 6.0 tmtt? -131.0 135.25 47.44 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 104.062 -2.57 . . . . 0.0 104.062 166.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 83.0 m -97.06 148.88 22.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.991 -1.068 . . . . 0.0 109.666 -174.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 34.3 t -130.38 138.18 54.44 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.442 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 168.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -91.14 136.8 32.84 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 169.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -160.26 99.89 1.34 Allowed 'General case' 0 N--CA 1.481 1.085 0 CA-C-O 121.711 0.767 . . . . 0.0 111.516 -163.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.3 t . . . . . 0 N--CA 1.488 1.441 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -176.989 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 . . . . . 0 N--CA 1.5 2.068 0 N-CA-C 116.112 1.893 . . . . 0.0 116.112 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.576 ' HB3' HH21 ' A' ' 174' ' ' ARG . 46.8 mt-10 -64.39 -47.7 78.25 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 119.491 1.041 . . . . 0.0 113.635 169.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 99.8 t -58.92 -36.65 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 CA-C-N 119.399 0.999 . . . . 0.0 113.543 173.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.675 ' CE1' ' HB3' ' A' ' 19' ' ' LYS . 43.0 t80 -57.34 -36.65 71.44 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 164.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.43 -54.43 32.72 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 175.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.576 HH21 ' HB3' ' A' ' 170' ' ' GLU . 9.7 ptp180 -66.36 -26.06 67.1 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 117.588 2.44 . . . . 0.0 117.588 170.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.93 -41.93 95.1 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 120.06 1.3 . . . . 0.0 114.211 167.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 4.5 mp -60.08 -46.14 90.56 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 118.265 -0.874 . . . . 0.0 113.035 166.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.433 ' HB2' ' HA ' ' A' ' 174' ' ' ARG . 26.3 mtp180 -51.52 -45.61 62.97 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 169.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.32 -49.05 79.3 Favored 'General case' 0 CA--C 1.558 1.27 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 171.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -84.19 -61.34 1.83 Allowed 'General case' 0 CA--C 1.564 1.515 0 CA-C-O 117.781 -1.104 . . . . 0.0 112.326 -177.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.958 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -101.45 -56.62 0.86 Allowed Glycine 0 CA--C 1.551 2.296 0 CA-C-N 120.523 1.51 . . . . 0.0 114.937 -177.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.958 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 57.5 tttp . . . . . 0 C--O 1.251 1.132 0 CA-C-N 120.003 1.902 . . . . 0.0 109.195 -176.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.3 mtt . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.456 ' HB2' ' O ' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -149.68 172.97 14.2 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 116.613 2.079 . . . . 0.0 116.613 -168.024 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 54.7 t -134.25 156.04 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 CA-C-O 123.474 1.607 . . . . 0.0 112.802 -162.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . 0.259 0.0 OUTLIER -140.77 132.19 26.84 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 113.936 -1.484 . . . . 0.0 110.091 167.038 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 1.099 HD21 ' HB3' ' A' ' 13' ' ' LYS . 23.8 tp -99.56 126.37 45.52 Favored 'General case' 0 CA--C 1.573 1.849 0 CA-C-O 123.132 1.444 . . . . 0.0 112.121 -167.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.3 mt -116.51 153.03 32.89 Favored 'General case' 0 CA--C 1.559 1.305 0 CA-C-N 109.921 -3.309 . . . . 0.0 109.898 -177.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -179.38 108.26 0.24 Allowed Glycine 0 CA--C 1.547 2.036 0 CA-C-O 117.029 -1.984 . . . . 0.0 113.289 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo . . . . . 0 CA--C 1.579 2.725 0 CA-C-N 121.926 2.863 . . . . 0.0 115.689 168.422 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 1.099 ' HB3' HD21 ' A' ' 5' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.497 1.92 0 N-CA-C 118.826 2.898 . . . . 0.0 118.826 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.76 -24.46 40.87 Favored Glycine 0 CA--C 1.561 2.928 0 N-CA-C 118.972 2.349 . . . . 0.0 118.972 168.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 16.6 m -63.07 -56.22 18.8 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 119.378 1.589 . . . . 0.0 113.331 170.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.48 ' HA ' ' HB2' ' A' ' 19' ' ' LYS 0.286 1.8 mp0 -77.82 -12.29 59.96 Favored 'General case' 0 CA--C 1.571 1.78 0 CA-C-O 115.695 -2.098 . . . . 0.0 112.804 173.54 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.53 -46.83 45.29 Favored 'General case' 0 C--N 1.375 1.697 0 CA-C-N 123.831 3.014 . . . . 0.0 113.744 167.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.7 t -67.2 -38.24 80.68 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.995 0 CA-C-N 119.772 1.169 . . . . 0.0 111.893 173.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.48 ' HB2' ' HA ' ' A' ' 16' ' ' GLN . 18.9 mmmt -57.42 -54.34 47.88 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 116.38 1.993 . . . . 0.0 116.38 169.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.7 tp -65.09 -29.55 70.43 Favored 'General case' 0 CA--C 1.575 1.924 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 174.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.48 -39.13 91.59 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 167.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -61.03 -36.05 78.51 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 166.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.2 mmmt -65.21 -51.63 59.81 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 169.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.4 mt -85.15 -25.55 27.39 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 116.931 2.197 . . . . 0.0 116.931 -174.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.04 37.86 7.61 Favored Glycine 0 CA--C 1.554 2.525 0 N-CA-C 117.694 1.838 . . . . 0.0 117.694 -174.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.2 mm -105.21 155.95 36.98 Favored Pre-proline 0 CA--C 1.569 1.681 0 CA-C-N 119.26 1.53 . . . . 0.0 113.281 -168.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -80.64 99.06 1.11 Allowed 'Trans proline' 0 CA--C 1.567 2.125 0 CA-C-N 122.426 1.902 . . . . 0.0 109.549 162.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -72.18 112.47 8.29 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.923 -0.486 . . . . 0.0 110.108 177.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 12.8 mm -98.67 104.26 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 41.7 t -98.77 127.88 44.83 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 167.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 37.9 p -67.64 -18.73 65.06 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 117.41 2.374 . . . . 0.0 117.41 -168.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -82.88 -18.66 64.91 Favored Glycine 0 CA--C 1.548 2.126 0 N-CA-C 118.667 2.227 . . . . 0.0 118.667 167.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -78.96 -53.6 6.88 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 119.009 1.404 . . . . 0.0 114.189 -169.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -65.16 -38.02 89.23 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 174.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.47 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 15.3 m-85 -64.54 -38.53 91.32 Favored 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 168.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 49.0 ttp180 -58.6 -41.68 86.39 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 119.929 1.241 . . . . 0.0 114.273 167.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -60.65 -41.28 94.67 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 168.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -69.08 -24.31 64.13 Favored 'General case' 0 CA--C 1.579 2.059 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 169.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 65.6 mt -63.69 -47.98 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 CA-C-N 120.245 1.384 . . . . 0.0 110.97 167.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -65.63 -36.7 84.45 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 114.341 1.238 . . . . 0.0 114.341 174.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -66.46 -42.74 87.1 Favored 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 115.98 1.844 . . . . 0.0 115.98 173.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.79 69.44 1.06 Allowed Glycine 0 CA--C 1.543 1.829 0 CA-C-O 118.607 -1.107 . . . . 0.0 114.101 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.86 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 73.3 p -93.33 -48.74 6.28 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.86 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.253 74.6 mttt 106.17 -41.37 0.0 OUTLIER 'General case' 0 CA--C 1.572 1.818 0 CA-C-O 116.455 -1.736 . . . . 0.0 111.29 -172.607 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.401 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -81.88 -14.14 56.61 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 122.955 2.616 . . . . 0.0 112.895 163.789 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.54 -55.64 27.69 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-N 120.287 1.403 . . . . 0.0 114.864 170.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.297 7.4 p -76.32 -50.41 22.31 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.444 0 N-CA-C 115.883 1.808 . . . . 0.0 115.883 -168.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -66.71 -45.94 77.14 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 121.127 1.785 . . . . 0.0 112.922 173.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 45' ' ' LEU . . . -71.47 -27.42 63.23 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -178.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.47 ' HB2' ' HB3' ' A' ' 35' ' ' PHE . 1.3 tmtp? -72.53 -41.97 65.26 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 117.302 -1.333 . . . . 0.0 112.946 166.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.594 ' O ' ' CG ' ' A' ' 51' ' ' ARG . 32.4 ttt180 -71.2 -51.77 22.86 Favored 'General case' 0 CA--C 1.586 2.342 1 CA-C-O 85.232 -16.604 . . . . 0.0 118.623 -174.139 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -34.58 -62.53 0.34 Allowed 'General case' 0 N--CA 1.494 1.732 1 O-C-N 108.992 -8.567 . . . . 0.0 121.129 146.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.5 tp -57.01 -29.47 63.36 Favored 'General case' 0 CA--C 1.582 2.206 0 CA-C-N 122.012 2.187 . . . . 0.0 116.223 171.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -92.58 -39.45 11.33 Favored 'General case' 0 CA--C 1.568 1.672 0 C-N-CA 126.738 2.015 . . . . 0.0 116.27 170.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -87.08 -27.88 22.88 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 116.874 2.176 . . . . 0.0 116.874 -176.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.75 22.01 6.87 Favored Glycine 0 CA--C 1.542 1.733 0 N-CA-C 118.588 2.195 . . . . 0.0 118.588 167.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -100.28 -132.23 0.25 Allowed 'General case' 0 CA--C 1.57 1.746 0 CA-C-N 118.935 1.367 . . . . 0.0 110.045 173.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 89.2 mt -116.17 119.31 35.39 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 119.916 1.235 . . . . 0.0 110.874 -168.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.491 HG12 HH12 ' A' ' 88' ' ' ARG . 13.2 p -121.37 136.48 25.88 Favored Pre-proline 0 CA--C 1.573 1.846 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.322 176.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -61.08 150.01 86.37 Favored 'Trans proline' 0 CA--C 1.561 1.857 0 C-N-CA 123.136 2.557 . . . . 0.0 115.275 169.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.1 t -83.85 -33.88 24.75 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -64.0 -44.91 91.22 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -174.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 pp -56.76 -43.63 80.98 Favored 'General case' 0 CA--C 1.562 1.425 0 N-CA-C 117.09 2.255 . . . . 0.0 117.09 169.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.5 m -61.77 -46.21 90.54 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 123.834 0.854 . . . . 0.0 113.013 174.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.45 -23.63 67.35 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 167.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -74.26 -45.74 45.9 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 175.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.4 mt -65.79 -45.81 81.01 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 169.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 69.0 t -57.65 -53.8 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 117.645 -1.169 . . . . 0.0 111.688 172.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -62.14 -30.7 71.21 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 116.002 1.853 . . . . 0.0 116.002 174.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -57.94 -43.7 86.49 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 117.162 -1.399 . . . . 0.0 113.404 169.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.5 ttm-85 -81.64 -15.34 54.91 Favored 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 118.499 2.778 . . . . 0.0 118.499 168.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 74.7 mt -85.13 -6.62 59.29 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 166.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 . . . . . 0 N--CA 1.495 1.806 0 CA-C-O 126.237 2.922 . . . . 0.0 118.485 165.726 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.409 0 CA-C-O 123.856 1.809 . . . . 0.0 116.324 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.456 ' O ' ' HB2' ' A' ' 2' ' ' ARG . 17.2 p90 -177.6 132.14 0.16 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 112.958 -1.621 . . . . 0.0 109.278 169.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 16.7 mt -112.59 109.53 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 172.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 24.8 mt -104.01 114.33 28.51 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 117.52 -1.229 . . . . 0.0 109.87 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -104.5 125.71 50.92 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 121.32 1.873 . . . . 0.0 110.884 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 74.04 32.36 58.7 Favored Glycine 0 CA--C 1.548 2.147 0 N-CA-C 117.95 1.94 . . . . 0.0 117.95 174.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -91.15 -55.8 0.26 Allowed Pre-proline 0 N--CA 1.496 1.853 0 CA-C-O 115.163 -2.351 . . . . 0.0 108.418 169.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -66.74 63.79 0.57 Allowed 'Trans proline' 0 CA--C 1.575 2.555 0 N-CA-C 120.192 3.112 . . . . 0.0 120.192 168.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.491 HH12 HG12 ' A' ' 59' ' ' VAL 0.331 29.6 ttt180 -69.59 -31.42 69.55 Favored 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 116.892 2.182 . . . . 0.0 116.892 165.877 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.9 t -151.72 129.32 11.49 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 104.742 -2.318 . . . . 0.0 104.742 -166.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . 0.33 12.8 p -61.86 -25.3 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 CA-C-O 116.726 -1.607 . . . . 0.0 113.718 -172.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.07 -38.21 75.92 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 119.506 3.15 . . . . 0.0 119.506 165.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -70.09 -47.95 59.72 Favored 'General case' 0 CA--C 1.592 2.589 0 CA-C-N 122.526 2.421 . . . . 0.0 111.939 165.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.07 -31.63 72.94 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 127.198 2.199 . . . . 0.0 116.279 -169.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -57.28 -32.61 66.8 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 166.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.62 -43.05 90.74 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 169.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 32.0 tp -64.22 -36.82 85.32 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 169.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 28.3 t-80 -60.26 -53.08 61.92 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 119.867 1.212 . . . . 0.0 113.042 169.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 1.222 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 35.6 mt-10 -49.01 -34.54 13.4 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 167.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 1.248 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 26.3 mmt -85.96 -30.56 22.68 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 118.182 2.66 . . . . 0.0 118.182 173.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 46.4 tp -67.48 -52.26 41.44 Favored 'General case' 0 N--CA 1.504 2.26 0 CA-C-N 121.281 1.855 . . . . 0.0 112.02 169.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -79.01 -51.37 9.68 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 123.512 0.725 . . . . 0.0 112.675 176.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 1.222 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 72.9 ttt180 -69.65 -44.94 69.53 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 176.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 1.248 ' HB3' ' O ' ' A' ' 99' ' ' MET . 72.0 ttt180 -59.8 -56.18 25.01 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 118.867 0.758 . . . . 0.0 110.953 164.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.27 43.78 1.05 Allowed Glycine 0 N--CA 1.48 1.588 0 O-C-N 124.282 0.989 . . . . 0.0 114.211 168.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 34.5 p -100.49 143.81 30.23 Favored 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 170.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -67.4 131.43 45.69 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -171.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 4.7 tp -82.91 103.19 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 C-N-CA 125.21 1.404 . . . . 0.0 108.257 175.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -97.95 -71.66 0.68 Allowed 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 114.925 -2.464 . . . . 0.0 108.237 168.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -144.96 125.5 14.06 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 122.852 2.569 . . . . 0.0 116.366 -174.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 69.2 t -92.3 109.14 21.06 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.626 0 N-CA-C 102.269 -3.234 . . . . 0.0 102.269 162.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.585 HD23 ' HB2' ' A' ' 160' ' ' LYS . 83.2 mt -102.18 107.04 17.98 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.083 0.553 . . . . 0.0 110.559 -173.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -99.3 122.15 42.05 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-O 122.387 1.089 . . . . 0.0 110.409 175.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -93.69 123.3 36.92 Favored 'General case' 0 CA--C 1.559 1.304 0 CA-C-N 113.661 -1.609 . . . . 0.0 108.709 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -82.68 98.27 8.96 Favored 'General case' 0 CA--C 1.555 1.163 0 CA-C-N 112.444 -2.162 . . . . 0.0 108.484 169.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.0 p . . . . . 0 CA--C 1.557 1.223 0 CA-C-N 112.977 -1.92 . . . . 0.0 107.187 -168.923 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 . . . . . 0 N--CA 1.497 1.892 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -63.05 -36.52 83.85 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 167.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 13.2 tpt -67.09 -29.77 69.62 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 114.671 1.359 . . . . 0.0 114.671 168.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -62.77 -50.71 69.96 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 168.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 10.1 p -64.56 -34.72 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 170.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -54.95 -49.36 71.57 Favored 'General case' 0 CA--C 1.578 2.046 0 CA-C-N 119.662 1.119 . . . . 0.0 112.335 167.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -57.19 -39.44 75.38 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 118.9 2.926 . . . . 0.0 118.9 173.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -57.21 -34.4 68.49 Favored 'General case' 0 N--CA 1.506 2.365 0 N-CA-C 117.011 2.226 . . . . 0.0 117.011 178.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -131.1 -26.59 2.12 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 119.225 3.046 . . . . 0.0 119.225 -166.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 73.2 m -45.4 -32.84 2.28 Favored 'General case' 0 N--CA 1.508 2.452 0 CA-C-N 122.667 2.485 . . . . 0.0 117.425 -171.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.403 ' HB3' ' HD3' ' A' ' 150' ' ' PRO . . . -68.53 -62.38 3.04 Favored Pre-proline 0 CA--C 1.584 2.261 0 CA-C-O 115.682 -2.104 . . . . 0.0 112.067 169.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.403 ' HD3' ' HB3' ' A' ' 149' ' ' ALA . 75.3 Cg_exo -56.46 -31.73 86.83 Favored 'Trans proline' 0 CA--C 1.578 2.685 0 N-CA-C 120.083 3.07 . . . . 0.0 120.083 169.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -62.78 -53.17 58.39 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 125.719 1.608 . . . . 0.0 111.03 169.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.987 ' O ' ' HB2' ' A' ' 156' ' ' ARG 0.306 0.1 OUTLIER -62.03 -24.94 67.36 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 175.872 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -71.29 -50.73 29.62 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 120.366 1.439 . . . . 0.0 113.137 166.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -64.5 -53.54 46.45 Favored 'General case' 0 CA--C 1.568 1.666 0 CA-C-N 120.416 1.462 . . . . 0.0 112.728 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -80.86 -24.66 38.21 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 115.209 -2.329 . . . . 0.0 113.724 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.987 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 14.9 tpt180 -64.37 -37.49 87.68 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 124.144 3.156 . . . . 0.0 115.175 169.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -67.16 -38.09 84.86 Favored 'General case' 0 CA--C 1.574 1.87 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 167.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -80.47 -29.7 37.45 Favored 'General case' 0 CA--C 1.578 2.028 0 N-CA-C 119.713 3.227 . . . . 0.0 119.713 177.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.5 pp -79.21 175.76 10.3 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 119.933 3.309 . . . . 0.0 119.933 -161.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.585 ' HB2' HD23 ' A' ' 111' ' ' LEU . 95.1 mttt -128.55 133.38 48.38 Favored 'General case' 0 CA--C 1.561 1.392 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 166.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 62.4 m -96.07 148.4 22.71 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 122.261 1.029 . . . . 0.0 110.818 -172.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 1.018 HG13 ' HB3' ' A' ' 174' ' ' ARG . 58.6 t -130.35 136.14 59.18 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.48 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 167.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.549 ' O ' ' HG3' ' A' ' 174' ' ' ARG . 10.0 t0 -95.07 129.05 42.31 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 168.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -163.43 120.9 1.86 Allowed 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.447 -162.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.9 t . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 118.419 -0.801 . . . . 0.0 109.075 175.382 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 . . . . . 0 N--CA 1.5 2.063 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -64.03 -47.98 78.11 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 119.505 1.048 . . . . 0.0 113.653 169.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 99.3 t -56.7 -38.04 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-N 119.746 1.157 . . . . 0.0 113.647 172.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -59.0 -35.96 74.12 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 116.619 2.081 . . . . 0.0 116.619 167.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -60.37 -48.31 82.32 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 170.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 1.018 ' HB3' HG13 ' A' ' 162' ' ' VAL . 1.4 mmp_? -50.3 -57.2 8.41 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 117.337 2.347 . . . . 0.0 117.337 168.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -49.92 -44.5 50.33 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 116.752 2.13 . . . . 0.0 116.752 172.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.5 mp -62.69 -43.11 99.63 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 117.515 -1.231 . . . . 0.0 114.013 168.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -53.35 -47.81 69.07 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 171.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -67.87 -45.03 75.71 Favored 'General case' 0 CA--C 1.559 1.303 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 175.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -81.11 -56.6 3.98 Favored 'General case' 0 CA--C 1.564 1.513 0 CA-C-N 120.063 1.301 . . . . 0.0 112.878 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.65 ' O ' ' CB ' ' A' ' 181' ' ' LYS . . . -101.36 -57.87 0.83 Allowed Glycine 0 CA--C 1.552 2.389 0 CA-C-O 117.803 -1.554 . . . . 0.0 114.836 -177.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.65 ' CB ' ' O ' ' A' ' 180' ' ' GLY . 36.5 ttmt . . . . . 0 C--O 1.251 1.157 0 CA-C-N 120.296 2.048 . . . . 0.0 107.579 -177.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.0 tpp . . . . . 0 CA--C 1.56 1.344 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -160.75 166.95 27.82 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 119.65 3.204 . . . . 0.0 119.65 -166.434 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.8 p -123.49 145.0 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 123.237 1.494 . . . . 0.0 113.462 -167.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.2 mt -120.85 114.12 21.13 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 112.123 -2.308 . . . . 0.0 106.27 172.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.3 tt -102.67 126.77 49.88 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.806 1.243 . . . . 0.0 111.014 -165.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.1 mt -139.29 164.23 30.39 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 114.527 -1.215 . . . . 0.0 112.431 -166.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 151.68 171.22 19.31 Favored Glycine 0 CA--C 1.558 2.752 0 CA-C-O 119.088 -0.84 . . . . 0.0 114.728 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo . . . . . 0 CA--C 1.573 2.47 0 C-N-CA 123.576 2.851 . . . . 0.0 113.013 170.383 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? . . . . . 0 N--CA 1.49 1.556 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -48.01 -31.09 7.84 Favored Glycine 0 CA--C 1.556 2.618 0 N-CA-C 120.96 3.144 . . . . 0.0 120.96 175.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.3 m -66.45 -55.64 14.74 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 119.558 1.679 . . . . 0.0 113.136 176.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.273 10.9 mm-40 -76.86 -12.16 59.93 Favored 'General case' 0 CA--C 1.573 1.848 0 CA-C-O 116.235 -1.841 . . . . 0.0 111.858 172.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.33 -47.65 60.09 Favored 'General case' 0 C--N 1.372 1.554 0 CA-C-N 123.346 2.794 . . . . 0.0 114.387 167.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.5 t -66.95 -44.72 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 CA-C-O 117.742 -1.123 . . . . 0.0 111.201 173.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -59.33 -41.41 89.07 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 116.596 2.073 . . . . 0.0 116.596 171.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.7 tp -66.35 -33.71 76.33 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 119.721 1.146 . . . . 0.0 113.82 171.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.68 -39.03 89.96 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 167.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -63.03 -38.54 91.6 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 166.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 42.1 tptt -64.84 -53.87 39.94 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 175.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.6 mt -83.34 -27.19 29.89 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 116.956 2.206 . . . . 0.0 116.956 178.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.06 40.02 5.95 Favored Glycine 0 CA--C 1.555 2.569 0 N-CA-C 117.516 1.766 . . . . 0.0 117.516 -174.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.429 ' CG2' ' HA ' ' A' ' 81' ' ' PHE . 19.2 mm -110.06 160.34 28.56 Favored Pre-proline 0 CA--C 1.567 1.634 0 CA-C-N 118.853 1.326 . . . . 0.0 114.103 -168.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -74.37 103.53 1.71 Allowed 'Trans proline' 0 CA--C 1.565 2.027 0 C-N-CA 121.766 1.644 . . . . 0.0 112.776 159.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.3 tm0? -69.5 104.96 2.46 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 165.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 35.2 mm -100.83 107.68 21.7 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 177.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.0 t -95.59 129.92 42.62 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 168.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.4 p -67.17 -19.48 65.58 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 117.037 2.236 . . . . 0.0 117.037 -170.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -84.92 -16.49 65.21 Favored Glycine 0 CA--C 1.544 1.895 0 N-CA-C 119.079 2.392 . . . . 0.0 119.079 168.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -80.34 -55.62 4.77 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 119.529 1.664 . . . . 0.0 114.519 -168.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -59.36 -40.15 85.55 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 172.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.586 ' HB3' ' CB ' ' A' ' 50' ' ' LYS . 6.4 m-85 -60.44 -46.79 88.75 Favored 'General case' 0 CA--C 1.558 1.26 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 170.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -55.22 -42.28 73.17 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 168.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -59.94 -38.14 81.57 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 167.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -68.97 -23.62 64.14 Favored 'General case' 0 CA--C 1.581 2.168 0 N-CA-C 115.024 1.491 . . . . 0.0 115.024 167.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 53.9 mt -62.91 -49.6 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.522 0 CA-C-N 120.927 1.694 . . . . 0.0 109.871 166.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -60.85 -40.34 92.51 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 176.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -67.19 -41.76 85.32 Favored 'General case' 0 CA--C 1.562 1.427 0 N-CA-C 116.268 1.951 . . . . 0.0 116.268 173.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.77 70.0 0.99 Allowed Glycine 0 CA--C 1.544 1.872 0 CA-C-O 118.349 -1.25 . . . . 0.0 114.425 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.855 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 68.5 p -94.0 -50.79 5.15 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 118.837 1.319 . . . . 0.0 114.407 178.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.855 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.251 37.6 mttp 106.24 -41.42 0.0 OUTLIER 'General case' 0 CA--C 1.571 1.755 0 CA-C-O 116.428 -1.749 . . . . 0.0 111.514 -172.234 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.403 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.6 OUTLIER -81.98 -14.02 56.62 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 122.972 2.623 . . . . 0.0 113.013 163.682 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.23 -57.56 19.08 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 120.318 1.417 . . . . 0.0 114.494 170.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.304 4.2 p -75.52 -51.96 19.55 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.353 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -169.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -68.73 -44.07 74.58 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 120.703 1.592 . . . . 0.0 112.84 176.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 45' ' ' LEU . . . -73.74 -29.16 62.07 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 117.267 -1.349 . . . . 0.0 114.282 -178.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.586 ' CB ' ' HB3' ' A' ' 35' ' ' PHE 0.273 0.0 OUTLIER -77.77 -33.94 52.55 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 117.084 -1.436 . . . . 0.0 113.689 169.832 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.543 ' HG2' ' O ' ' A' ' 51' ' ' ARG . 29.1 ttt180 -76.06 -47.1 25.97 Favored 'General case' 0 CA--C 1.584 2.27 1 CA-C-O 84.928 -16.749 . . . . 0.0 118.477 -179.075 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -35.35 -56.71 0.62 Allowed 'General case' 0 N--CA 1.494 1.748 1 O-C-N 107.542 -9.474 . . . . 0.0 120.383 145.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 49.2 mt -54.33 -35.85 63.13 Favored 'General case' 0 N--CA 1.511 2.587 0 CA-C-N 123.869 3.031 . . . . 0.0 115.023 167.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -86.96 -42.17 13.35 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 116.139 1.904 . . . . 0.0 116.139 172.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.26 -42.79 54.24 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . 1.04 ' HA2' HH12 ' A' ' 88' ' ' ARG . . . 107.61 40.99 1.66 Allowed Glycine 0 CA--C 1.537 1.463 0 N-CA-C 116.466 1.346 . . . . 0.0 116.466 168.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -118.75 -164.53 1.04 Allowed 'General case' 0 CA--C 1.569 1.692 0 C-N-CA 124.052 0.941 . . . . 0.0 111.076 168.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.5 mt -80.22 108.16 13.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.342 -0.849 . . . . 0.0 112.257 -169.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 p -103.57 132.3 21.2 Favored Pre-proline 0 CA--C 1.571 1.761 0 C-N-CA 124.708 1.203 . . . . 0.0 110.002 175.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -60.18 145.87 97.56 Favored 'Trans proline' 0 CA--C 1.558 1.724 0 C-N-CA 123.367 2.711 . . . . 0.0 116.238 171.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 73.7 m -82.8 178.64 8.08 Favored 'General case' 0 CA--C 1.571 1.767 0 CA-C-O 121.623 0.725 . . . . 0.0 111.591 170.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.0 t70 83.05 -52.81 0.17 Allowed 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 125.926 1.691 . . . . 0.0 113.583 176.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.9 pp -57.85 -42.35 84.26 Favored 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 116.547 2.055 . . . . 0.0 116.547 168.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.0 m -59.34 -49.5 77.57 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 124.354 1.062 . . . . 0.0 113.651 171.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -64.73 -21.04 66.66 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 167.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -77.67 -44.35 28.33 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 173.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.6 mt -66.37 -44.66 82.54 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 169.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 56.1 t -56.5 -52.53 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.954 170.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -63.57 -28.35 69.87 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 116.615 2.08 . . . . 0.0 116.615 173.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -60.44 -42.0 95.18 Favored 'General case' 0 CA--C 1.563 1.46 0 CA-C-O 117.743 -1.123 . . . . 0.0 113.081 168.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -81.31 -21.41 39.27 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 119.044 2.979 . . . . 0.0 119.044 168.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 88.4 mt -84.71 -20.08 31.74 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 117.156 2.28 . . . . 0.0 117.156 176.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 . . . . . 0 N--CA 1.498 1.972 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 169.418 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.55 0 CA-C-O 122.289 0.939 . . . . 0.0 114.493 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.429 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . 14.5 p90 -175.52 133.83 0.3 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 113.674 -1.263 . . . . 0.0 109.946 169.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.9 mm -102.45 106.21 19.49 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.736 0 N-CA-C 102.84 -3.022 . . . . 0.0 102.84 167.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.2 mt -103.22 134.5 46.53 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 123.728 0.811 . . . . 0.0 108.812 174.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -133.52 119.64 19.78 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 118.987 0.812 . . . . 0.0 111.099 -167.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 77.56 41.17 20.88 Favored Glycine 0 CA--C 1.55 2.223 0 CA-C-O 117.418 -1.768 . . . . 0.0 116.96 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . 0.275 0.9 OUTLIER -104.68 -66.84 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.833 0 CA-C-O 113.202 -3.285 . . . . 0.0 110.433 -175.375 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -63.13 60.38 0.17 Allowed 'Trans proline' 0 CA--C 1.57 2.311 0 CA-C-N 127.169 3.596 . . . . 0.0 121.212 170.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 1.04 HH12 ' HA2' ' A' ' 56' ' ' GLY . 16.4 ptt85 -62.79 -25.75 68.39 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 117.48 2.4 . . . . 0.0 117.48 167.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.467 ' HB2' ' HG3' ' A' ' 147' ' ' GLU . 77.9 p -151.18 138.99 19.83 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 125.824 1.65 . . . . 0.0 107.045 -167.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -55.95 -33.37 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-N 121.283 1.856 . . . . 0.0 113.462 172.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -61.92 -39.13 90.98 Favored 'General case' 0 C--N 1.362 1.115 0 N-CA-C 120.669 3.581 . . . . 0.0 120.669 172.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -74.87 -46.98 32.64 Favored 'General case' 0 CA--C 1.586 2.351 0 CA-C-N 123.51 2.868 . . . . 0.0 111.847 165.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.11 -29.96 68.95 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 118.412 2.745 . . . . 0.0 118.412 -175.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -58.65 -34.86 71.68 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 168.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.75 -42.71 90.6 Favored 'General case' 0 CA--C 1.566 1.592 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 170.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 26.6 tp -68.0 -33.93 75.56 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 171.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -63.12 -52.85 60.93 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 119.957 1.253 . . . . 0.0 112.816 169.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.982 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 35.6 mt-10 -47.05 -39.39 12.77 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 166.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.83 ' O ' ' HB2' ' A' ' 103' ' ' ARG . 1.7 tpt -83.12 -24.85 32.44 Favored 'General case' 0 CA--C 1.569 1.686 0 N-CA-C 117.756 2.502 . . . . 0.0 117.756 176.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.0 tt -73.8 -49.58 24.58 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-N 120.183 1.356 . . . . 0.0 111.68 171.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -74.78 -54.29 7.61 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 172.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.982 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 92.6 mtt180 -69.82 -40.23 76.04 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 177.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.83 ' HB2' ' O ' ' A' ' 99' ' ' MET . 6.9 ttt-85 -65.31 -53.6 41.54 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 119.831 1.196 . . . . 0.0 111.722 164.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 108.26 50.36 0.77 Allowed Glycine 0 N--CA 1.483 1.798 0 O-C-N 123.81 0.694 . . . . 0.0 114.096 167.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 68.5 p -88.96 146.2 25.04 Favored 'General case' 0 CA--C 1.558 1.285 0 CA-C-N 113.205 -1.498 . . . . 0.0 109.9 175.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -66.32 132.69 48.94 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.77 -0.581 . . . . 0.0 112.053 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 7.1 tp -95.26 100.74 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -175.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -94.27 -66.92 0.88 Allowed 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 117.074 -1.441 . . . . 0.0 108.847 168.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -153.91 123.11 6.49 Favored 'General case' 0 C--N 1.358 0.965 0 CA-C-N 120.605 1.548 . . . . 0.0 113.246 -169.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.3 t -91.8 109.07 20.8 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.583 0 N-CA-C 100.312 -3.958 . . . . 0.0 100.312 162.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.475 ' HA ' ' O ' ' A' ' 160' ' ' LYS 0.252 37.7 tp -112.97 104.07 12.03 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 114.957 -1.019 . . . . 0.0 112.369 -159.483 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -99.56 134.31 42.62 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-O 122.071 0.939 . . . . 0.0 110.987 -176.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -94.76 122.17 37.09 Favored 'General case' 0 CA--C 1.561 1.386 0 CA-C-O 122.903 1.335 . . . . 0.0 110.722 -173.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -85.62 95.05 9.22 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 113.018 -1.901 . . . . 0.0 109.637 169.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.1 p . . . . . 0 N--CA 1.483 1.204 0 C-N-CA 125.725 1.61 . . . . 0.0 107.226 -169.037 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 37.3 t30 . . . . . 0 N--CA 1.5 2.062 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 69.2 mtp180 -60.43 -40.66 91.88 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 167.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 25.8 ttt -65.7 -32.68 74.37 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 168.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -60.25 -50.04 75.22 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 169.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.0 p -65.57 -32.97 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 169.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -55.52 -53.44 56.37 Favored 'General case' 0 CA--C 1.58 2.112 0 CA-C-N 119.495 1.043 . . . . 0.0 111.716 169.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -62.96 -42.09 99.72 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 118.063 2.616 . . . . 0.0 118.063 175.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.26 -44.53 61.8 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 116.975 2.213 . . . . 0.0 116.975 174.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.467 ' HG3' ' HB2' ' A' ' 89' ' ' SER . 8.9 mm-40 -124.08 -30.43 3.48 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 118.54 2.792 . . . . 0.0 118.54 -166.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 63.7 m -55.07 -34.86 63.95 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 117.387 2.365 . . . . 0.0 117.387 -167.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -65.15 -60.4 7.98 Favored Pre-proline 0 CA--C 1.579 2.085 0 CA-C-O 116.305 -1.807 . . . . 0.0 111.751 171.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -51.59 -32.24 43.48 Favored 'Trans proline' 0 CA--C 1.579 2.754 0 C-N-CA 123.394 2.729 . . . . 0.0 118.549 166.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -66.77 -51.94 50.02 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 125.083 1.353 . . . . 0.0 111.305 175.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 1.215 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 38.2 tp -62.43 -22.04 65.87 Favored 'General case' 0 CA--C 1.571 1.752 0 N-CA-C 115.718 1.747 . . . . 0.0 115.718 170.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -70.82 -50.2 38.08 Favored 'General case' 0 CA--C 1.56 1.332 0 CA-C-N 122.681 2.491 . . . . 0.0 112.463 165.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -61.13 -56.48 20.37 Favored 'General case' 0 CA--C 1.574 1.895 0 CA-C-N 119.931 1.241 . . . . 0.0 113.488 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -77.75 -15.16 59.32 Favored 'General case' 0 CA--C 1.562 1.429 0 CA-C-O 116.647 -1.644 . . . . 0.0 114.268 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 1.215 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 0.1 OUTLIER -68.85 -40.3 79.46 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 121.723 2.056 . . . . 0.0 114.871 166.023 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -65.76 -38.97 90.54 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 167.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -75.47 -18.94 59.72 Favored 'General case' 0 CA--C 1.585 2.305 0 N-CA-C 118.386 2.735 . . . . 0.0 118.386 169.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.7 mt -39.26 143.04 0.21 Allowed 'General case' 0 CA--C 1.58 2.101 1 N-CA-C 123.741 4.719 . . . . 0.0 123.741 -164.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 111' ' ' LEU . 28.4 mttm -136.08 121.74 19.65 Favored 'General case' 0 CA--C 1.56 1.332 0 N-CA-C 103.435 -2.802 . . . . 0.0 103.435 160.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.0 t -103.76 156.42 17.83 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.531 -1.356 . . . . 0.0 113.126 -172.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 34.7 t -124.35 142.47 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 169.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -98.76 127.71 44.77 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 165.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.74 92.67 1.68 Allowed 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 122.68 1.229 . . . . 0.0 112.155 -163.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.2 t . . . . . 0 N--CA 1.486 1.346 0 CA-C-N 113.927 -1.488 . . . . 0.0 107.178 -175.905 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 . . . . . 0 N--CA 1.5 2.034 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -62.56 -49.98 73.14 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 117.855 -1.069 . . . . 0.0 113.602 170.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 97.7 t -60.41 -36.05 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 CA-C-N 120.029 1.286 . . . . 0.0 114.014 177.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -59.31 -38.21 79.68 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 166.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.07 -44.62 91.85 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 174.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -62.7 -40.6 97.66 Favored 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 116.512 2.042 . . . . 0.0 116.512 170.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.68 -42.98 94.12 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 169.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 4.9 mp -59.61 -42.61 93.0 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 167.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.57 ' HA ' ' HB3' ' A' ' 181' ' ' LYS . 45.1 mtt180 -55.41 -42.18 73.76 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 116.827 2.158 . . . . 0.0 116.827 169.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.91 -48.18 80.05 Favored 'General case' 0 CA--C 1.561 1.386 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 170.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.7 tt -83.08 -57.49 3.26 Favored 'General case' 0 CA--C 1.567 1.596 0 CA-C-N 120.778 1.627 . . . . 0.0 113.117 -178.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -104.6 -52.4 0.86 Allowed Glycine 0 CA--C 1.547 2.073 0 CA-C-O 117.456 -1.747 . . . . 0.0 114.64 -173.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.57 ' HB3' ' HA ' ' A' ' 177' ' ' ARG . 86.4 tttt . . . . . 0 C--O 1.251 1.184 0 CA-C-N 120.564 2.182 . . . . 0.0 112.735 -176.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.0 mtt . . . . . 0 CA--C 1.558 1.283 0 CA-C-O 123.095 1.426 . . . . 0.0 111.652 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.5 ttm-85 -141.39 149.46 41.12 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 116.736 2.125 . . . . 0.0 116.736 -161.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.7 p -143.84 146.16 21.25 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.861 0 CA-C-O 123.793 1.759 . . . . 0.0 114.797 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -131.86 111.57 11.7 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 112.417 -2.174 . . . . 0.0 108.009 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 14.5 tp -98.32 131.46 44.61 Favored 'General case' 0 CA--C 1.571 1.75 0 CA-C-O 122.706 1.241 . . . . 0.0 112.314 -167.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.7 mt -138.99 163.19 33.02 Favored 'General case' 0 CA--C 1.563 1.454 0 C-N-CA 127.607 2.363 . . . . 0.0 110.782 -166.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 141.89 129.22 2.41 Favored Glycine 0 CA--C 1.553 2.439 0 CA-C-O 116.975 -2.014 . . . . 0.0 111.657 -174.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo . . . . . 0 CA--C 1.573 2.429 0 CA-C-N 122.838 3.319 . . . . 0.0 116.024 172.969 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 19.7 mttt . . . . . 0 N--CA 1.474 0.743 0 N-CA-C 110.351 -0.24 . . . . 0.0 110.351 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -50.81 -41.21 43.47 Favored Glycine 0 CA--C 1.558 2.72 0 N-CA-C 119.01 2.364 . . . . 0.0 119.01 175.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.5 m -58.82 -44.29 90.83 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 169.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . 0.569 ' HA ' ' HB2' ' A' ' 19' ' ' LYS 0.264 5.1 mm-40 -78.98 -14.05 59.43 Favored 'General case' 0 CA--C 1.576 1.958 0 CA-C-O 116.571 -1.68 . . . . 0.0 112.32 173.536 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.68 -45.22 62.58 Favored 'General case' 0 C--N 1.371 1.531 0 CA-C-N 123.062 2.665 . . . . 0.0 113.597 167.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 p -65.15 -41.53 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 169.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.679 ' HB3' ' CE1' ' A' ' 172' ' ' PHE . 31.1 mmtp -54.72 -42.13 71.16 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 116.11 1.892 . . . . 0.0 116.11 168.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 1.09 ' HA ' ' HB3' ' A' ' 23' ' ' LYS . 22.0 mt -68.67 -30.87 69.65 Favored 'General case' 0 CA--C 1.595 2.676 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 168.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.12 -29.58 70.7 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 118.394 -2.692 . . . . 0.0 115.707 167.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -64.06 -51.44 64.09 Favored 'General case' 0 CA--C 1.596 2.726 0 CA-C-N 120.324 1.42 . . . . 0.0 110.899 156.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 1.09 ' HB3' ' HA ' ' A' ' 20' ' ' LEU 0.29 4.5 tppt? -53.26 51.93 0.0 OUTLIER 'General case' 0 CA--C 1.576 1.944 2 C-N-CA 133.45 4.7 . . . . 0.0 122.424 166.647 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.709 HD13 HD11 ' A' ' 26' ' ' ILE . 0.2 OUTLIER 67.84 25.19 7.94 Favored 'General case' 0 N--CA 1.522 3.13 2 C-N-CA 144.854 9.262 . . . . 0.0 134.891 -152.331 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.44 29.98 28.73 Favored Glycine 0 N--CA 1.506 3.323 0 O-C-N 117.458 -3.276 . . . . 0.0 120.468 157.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.709 HD11 HD13 ' A' ' 24' ' ' LEU . 25.6 mm -90.25 149.23 40.88 Favored Pre-proline 0 CA--C 1.556 1.178 0 CA-C-N 112.381 -1.91 . . . . 0.0 110.969 -168.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -77.7 91.66 1.17 Allowed 'Trans proline' 0 CA--C 1.561 1.86 0 CA-C-N 122.082 1.779 . . . . 0.0 111.497 168.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.13 108.85 3.28 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.576 175.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 22.5 mm -105.65 114.94 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 82.8 p -96.25 132.36 41.78 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 169.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.7 p -68.37 -16.55 63.97 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 117.136 2.272 . . . . 0.0 117.136 -173.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -84.67 -19.83 59.24 Favored Glycine 0 CA--C 1.547 2.053 0 N-CA-C 118.736 2.254 . . . . 0.0 118.736 167.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -81.13 -49.67 10.56 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -169.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -65.4 -39.49 92.27 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 173.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.712 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 32.8 m-85 -64.59 -40.98 96.49 Favored 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 115.027 1.492 . . . . 0.0 115.027 169.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -57.28 -41.81 80.44 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 167.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.3 ttt180 -61.62 -37.98 85.97 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 168.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -68.09 -30.2 69.33 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 168.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 64.9 mt -62.75 -44.74 99.73 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 C-N-CA 124.893 1.277 . . . . 0.0 112.085 168.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -65.05 -42.09 94.58 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 173.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -76.31 -30.93 57.92 Favored 'General case' 0 CA--C 1.563 1.448 0 N-CA-C 116.784 2.142 . . . . 0.0 116.784 178.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.38 71.99 1.28 Allowed Glycine 0 CA--C 1.543 1.833 0 CA-C-O 118.083 -1.399 . . . . 0.0 115.282 178.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.847 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 70.8 p -93.69 -47.77 6.64 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 119.036 1.418 . . . . 0.0 114.571 174.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.847 ' HB2' ' O ' ' A' ' 43' ' ' THR . 74.8 mttt 103.62 -40.53 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.754 0 CA-C-O 116.247 -1.835 . . . . 0.0 111.527 -171.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.05 -12.33 58.33 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 123.053 2.66 . . . . 0.0 112.752 163.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.95 -56.07 23.0 Favored Glycine 0 C--N 1.353 1.525 0 CA-C-N 120.852 1.66 . . . . 0.0 114.743 170.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.286 7.1 p -74.57 -50.09 27.94 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.416 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 -169.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -66.49 -44.54 82.35 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 120.303 1.41 . . . . 0.0 112.691 174.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.34 -29.41 63.78 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 114.976 1.472 . . . . 0.0 114.976 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.712 ' HB2' ' HB3' ' A' ' 35' ' ' PHE 0.294 0.6 OUTLIER -75.34 -35.15 61.23 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 116.717 -1.611 . . . . 0.0 112.08 168.011 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.487 ' O ' ' CG ' ' A' ' 51' ' ' ARG . 18.8 ttt180 -74.2 -52.82 11.28 Favored 'General case' 0 CA--C 1.591 2.557 1 CA-C-O 87.026 -15.749 . . . . 0.0 118.197 -176.447 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 12.6 m-30 -26.28 -69.12 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.975 1 O-C-N 109.59 -8.193 . . . . 0.0 119.146 144.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 29.5 tp -54.12 -33.44 57.81 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 116.429 2.011 . . . . 0.0 116.429 175.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -91.56 -44.13 9.25 Favored 'General case' 0 CA--C 1.564 1.499 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 169.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -155.21 44.41 0.48 Allowed 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -166.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.54 50.44 0.32 Allowed Glycine 0 C--N 1.355 1.599 0 CA-C-N 121.628 2.013 . . . . 0.0 114.636 169.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . 0.294 5.6 t70 72.49 -112.94 0.05 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.608 1.163 . . . . 0.0 110.4 167.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.6 pp -105.8 144.35 32.66 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 122.691 1.234 . . . . 0.0 113.232 -169.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 p -129.76 140.27 38.13 Favored Pre-proline 0 CA--C 1.575 1.93 0 CA-C-N 113.307 -1.769 . . . . 0.0 109.139 -177.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -55.87 136.96 77.21 Favored 'Trans proline' 0 CA--C 1.56 1.805 0 C-N-CA 123.629 2.886 . . . . 0.0 116.679 173.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 98.6 p -72.42 -48.6 39.94 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 -178.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -62.38 -38.74 90.76 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 -178.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 17.3 mt -58.79 -48.2 82.09 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 172.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.0 m -61.36 -48.14 82.65 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 113.647 -1.615 . . . . 0.0 113.312 176.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -65.22 -22.04 66.83 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 168.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -73.03 -42.95 62.61 Favored 'General case' 0 CA--C 1.557 1.242 0 CA-C-N 120.975 1.716 . . . . 0.0 115.443 169.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.7 mt -61.31 -47.24 86.85 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 168.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -57.35 -49.87 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 172.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -60.71 -37.67 82.49 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 171.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -56.87 -43.78 81.56 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 117.818 -1.087 . . . . 0.0 113.643 170.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -81.4 -10.4 59.53 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 118.891 2.923 . . . . 0.0 118.891 168.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 87.7 mt -94.27 -8.71 38.32 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 116.669 2.1 . . . . 0.0 116.669 171.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 . . . . . 0 N--CA 1.503 2.201 0 N-CA-C 117.863 2.542 . . . . 0.0 117.863 172.73 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.593 0 CA-C-O 123.304 1.502 . . . . 0.0 113.944 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.4 p90 179.58 142.0 0.13 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 112.948 -1.626 . . . . 0.0 108.145 169.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 9.8 mt -110.11 108.79 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 103.301 -2.852 . . . . 0.0 103.301 169.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 44.6 mt -110.7 120.59 42.89 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 173.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -111.45 128.16 55.91 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 118.917 0.78 . . . . 0.0 110.779 -175.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 75.12 34.47 51.9 Favored Glycine 0 CA--C 1.553 2.413 0 N-CA-C 118.901 2.32 . . . . 0.0 118.901 176.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . 0.254 0.8 OUTLIER -93.37 -62.62 0.17 Allowed Pre-proline 0 CA--C 1.571 1.775 0 CA-C-O 114.126 -2.845 . . . . 0.0 109.538 175.519 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -63.6 56.99 0.19 Allowed 'Trans proline' 0 CA--C 1.57 2.309 0 N-CA-C 121.129 3.473 . . . . 0.0 121.129 169.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.25 -5.04 50.75 Favored 'General case' 0 CA--C 1.57 1.75 0 N-CA-C 117.057 2.243 . . . . 0.0 117.057 168.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.6 t -161.22 139.9 9.87 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 -171.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -58.33 -37.84 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-N 120.157 1.344 . . . . 0.0 112.778 -178.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.467 ' HB2' ' OE2' ' A' ' 147' ' ' GLU . 0.1 OUTLIER -65.6 -30.83 71.61 Favored 'General case' 0 C--N 1.36 1.035 0 N-CA-C 119.68 3.215 . . . . 0.0 119.68 175.825 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -80.43 -44.79 18.7 Favored 'General case' 0 CA--C 1.585 2.316 0 CA-C-N 122.008 2.185 . . . . 0.0 112.497 166.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.16 -35.0 72.75 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 118.428 2.751 . . . . 0.0 118.428 -176.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -58.66 -30.63 67.49 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 116.523 2.045 . . . . 0.0 116.523 169.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.51 -43.41 69.71 Favored 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 169.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.4 tp -67.89 -35.75 79.05 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 171.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 -58.58 -54.3 48.66 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 119.672 1.124 . . . . 0.0 112.809 168.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 1.136 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 32.3 tt0 -49.55 -32.81 13.28 Favored 'General case' 0 CA--C 1.575 1.906 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 166.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 1.097 ' O ' ' HB2' ' A' ' 103' ' ' ARG . 1.8 tpt -83.98 -40.54 18.33 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 117.619 2.452 . . . . 0.0 117.619 178.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.23 -45.21 61.2 Favored 'General case' 0 N--CA 1.505 2.317 0 CA-C-N 120.559 1.527 . . . . 0.0 112.504 172.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -76.93 -49.14 16.25 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 174.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 1.136 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 72.7 ttt180 -69.61 -43.57 72.46 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 177.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 1.097 ' HB2' ' O ' ' A' ' 99' ' ' MET . 42.5 mtp180 -63.88 -56.32 16.18 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 119.009 0.822 . . . . 0.0 111.895 165.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.02 48.75 0.76 Allowed Glycine 0 N--CA 1.48 1.592 0 O-C-N 124.049 0.843 . . . . 0.0 113.554 169.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 82.3 p -82.47 160.09 22.76 Favored 'General case' 0 CA--C 1.562 1.436 0 CA-C-N 113.909 -1.145 . . . . 0.0 110.019 169.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -69.38 128.16 35.58 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.827 -1.17 . . . . 0.0 110.356 -172.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 4.6 tp -94.57 93.56 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -177.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -98.44 -70.95 0.71 Allowed 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 116.043 -1.932 . . . . 0.0 109.176 168.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -151.83 133.93 15.09 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 121.698 2.044 . . . . 0.0 116.102 -168.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -92.35 122.08 43.5 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.163 0 N-CA-C 100.306 -3.961 . . . . 0.0 100.306 160.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.475 ' HA ' ' O ' ' A' ' 160' ' ' LYS . 44.0 mt -96.91 109.93 22.55 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 115.526 -2.178 . . . . 0.0 110.429 -176.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.501 ' HB2' HD22 ' A' ' 159' ' ' LEU . 9.5 tm-20 -101.46 113.75 27.14 Favored 'General case' 0 N--CA 1.536 3.831 0 N-CA-C 120.573 3.546 . . . . 0.0 120.573 170.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -86.04 114.63 23.07 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 119.268 -2.145 . . . . 0.0 110.815 170.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.449 ' O ' HG23 ' A' ' 115' ' ' VAL . 79.4 ttt180 -106.18 110.26 22.45 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.39 169.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 114' ' ' ARG 0.333 1.0 OUTLIER . . . . . 0 N--CA 1.506 2.332 0 CA-C-O 124.075 1.893 . . . . 0.0 108.836 160.021 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 . . . . . 0 N--CA 1.496 1.873 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.6 tpt180 -53.01 -48.46 67.53 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 125.231 1.412 . . . . 0.0 114.606 164.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 67.1 mtt -63.6 -35.52 80.8 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 168.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -60.75 -49.21 78.4 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 116.523 2.045 . . . . 0.0 116.523 169.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.4 p -64.45 -38.72 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 173.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -54.65 -48.48 72.28 Favored 'General case' 0 CA--C 1.579 2.063 0 C-N-CA 123.958 0.903 . . . . 0.0 112.604 167.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -56.26 -34.79 66.73 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 119.333 3.086 . . . . 0.0 119.333 174.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.65 -45.91 88.3 Favored 'General case' 0 N--CA 1.504 2.274 0 CA-C-N 120.44 1.473 . . . . 0.0 113.958 178.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . 0.467 ' OE2' ' HB2' ' A' ' 91' ' ' GLU . 22.2 mt-10 -142.22 -4.76 1.01 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 120.952 3.686 . . . . 0.0 120.952 -166.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 38.0 m -69.12 -30.01 68.19 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 -171.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -63.76 -56.45 25.46 Favored Pre-proline 0 CA--C 1.579 2.086 0 CA-C-O 116.209 -1.853 . . . . 0.0 111.555 169.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -53.33 -32.88 63.45 Favored 'Trans proline' 0 CA--C 1.577 2.659 0 C-N-CA 123.454 2.769 . . . . 0.0 118.745 167.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -62.85 -53.96 46.16 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.877 1.271 . . . . 0.0 110.83 172.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 1.2 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 45.1 tp -60.99 -20.71 62.76 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 171.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -71.34 -51.58 23.47 Favored 'General case' 0 CA--C 1.562 1.42 0 CA-C-N 122.744 2.52 . . . . 0.0 113.251 164.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -63.04 -55.57 24.44 Favored 'General case' 0 CA--C 1.57 1.726 0 CA-C-N 120.559 1.527 . . . . 0.0 112.855 178.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -72.2 -31.88 66.28 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-O 114.591 -2.623 . . . . 0.0 112.106 177.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 1.2 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 36.7 ttt180 -59.32 -34.92 72.92 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 124.949 3.522 . . . . 0.0 116.864 169.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -66.32 -37.53 85.59 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 166.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -83.41 -39.99 19.9 Favored 'General case' 0 CA--C 1.581 2.16 0 N-CA-C 118.991 2.959 . . . . 0.0 118.991 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . 0.501 HD22 ' HB2' ' A' ' 112' ' ' GLU . 2.0 pp -81.48 179.26 7.92 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 120.47 3.508 . . . . 0.0 120.47 -161.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 111' ' ' LEU 0.272 83.6 tttt -154.09 103.9 2.59 Favored 'General case' 0 C--N 1.361 1.08 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 166.018 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.465 ' HB ' ' N ' ' A' ' 112' ' ' GLU 1.149 24.3 m -124.44 -151.06 0.46 Allowed 'General case' 0 CA--C 1.568 1.673 1 O-C-N 114.839 -4.913 . . . . 0.0 108.339 149.507 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . 0.388 2.5 t -121.39 176.49 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 CA-C-O 125.008 2.337 . . . . 0.0 113.731 -150.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -101.33 116.07 31.96 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 101.504 -3.517 . . . . 0.0 101.504 164.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . 0.408 ' HB3' ' HB ' ' A' ' 115' ' ' VAL 0.346 . . -103.9 -120.39 0.2 Allowed 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 120.865 3.654 . . . . 0.0 120.865 -147.659 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.7 t . . . . . 0 CA--C 1.568 1.666 0 N-CA-C 118.99 2.959 . . . . 0.0 118.99 -156.07 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 . . . . . 0 N--CA 1.501 2.081 0 N-CA-C 115.833 1.79 . . . . 0.0 115.833 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -62.73 -52.55 62.81 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 173.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -54.11 -38.57 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 173.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.679 ' CE1' ' HB3' ' A' ' 19' ' ' LYS . 5.8 t80 -60.74 -38.67 85.95 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 168.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -61.13 -54.14 48.25 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 174.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 55.9 mtt180 -62.31 -37.67 86.48 Favored 'General case' 0 CA--C 1.555 1.136 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 173.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.66 -45.31 85.72 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 115.761 1.763 . . . . 0.0 115.761 168.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.35 -40.83 87.64 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 168.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 40.6 mmt180 -71.8 -32.73 67.9 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 174.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.53 -48.39 75.25 Favored 'General case' 0 CA--C 1.561 1.378 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 170.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 65.9 tp -71.31 -42.57 68.45 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 119.859 1.209 . . . . 0.0 113.836 168.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.736 ' O ' ' CB ' ' A' ' 181' ' ' LYS . . . 97.47 52.61 1.42 Allowed Glycine 0 CA--C 1.554 2.491 0 CA-C-O 118.634 -1.092 . . . . 0.0 113.12 -169.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.736 ' CB ' ' O ' ' A' ' 180' ' ' GLY . 56.3 tttp . . . . . 0 C--O 1.251 1.135 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -170.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.2 mtt . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -158.96 166.45 31.76 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 117.416 2.376 . . . . 0.0 117.416 -167.909 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 51.6 t -132.06 150.59 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-O 123.924 1.821 . . . . 0.0 112.939 -164.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -130.4 115.9 17.52 Favored 'General case' 0 CA--C 1.559 1.317 0 CA-C-N 112.387 -2.188 . . . . 0.0 108.221 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.758 HD21 ' HB3' ' A' ' 13' ' ' LYS . 22.9 tp -96.91 127.5 42.95 Favored 'General case' 0 CA--C 1.567 1.629 0 CA-C-O 122.873 1.321 . . . . 0.0 110.314 -173.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.4 mt -122.28 148.9 44.45 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 112.048 -2.342 . . . . 0.0 111.658 -169.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 163.33 151.36 6.4 Favored Glycine 0 CA--C 1.558 2.754 0 CA-C-O 118.128 -1.373 . . . . 0.0 115.684 169.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo . . . . . 0 CA--C 1.575 2.544 0 C-N-CA 123.792 2.995 . . . . 0.0 117.542 174.911 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.758 ' HB3' HD21 ' A' ' 5' ' ' LEU . 13.6 mptt . . . . . 0 N--CA 1.496 1.829 0 N-CA-C 114.063 1.134 . . . . 0.0 114.063 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -51.66 -23.5 10.26 Favored Glycine 0 CA--C 1.553 2.457 0 N-CA-C 121.045 3.178 . . . . 0.0 121.045 177.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 65.1 m -66.83 -54.06 26.3 Favored 'General case' 0 CA--C 1.57 1.741 0 CA-C-N 120.119 1.96 . . . . 0.0 112.276 173.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.28 4.0 mm-40 -79.43 -14.39 58.95 Favored 'General case' 0 CA--C 1.579 2.083 0 CA-C-O 116.018 -1.944 . . . . 0.0 111.593 174.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.52 -43.18 63.92 Favored 'General case' 0 C--N 1.377 1.772 0 CA-C-N 123.75 2.977 . . . . 0.0 114.585 167.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.1 t -64.37 -41.92 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 CA-C-O 117.525 -1.226 . . . . 0.0 112.322 170.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.729 ' HB3' ' CE1' ' A' ' 172' ' ' PHE . 64.1 mmtt -65.45 -40.62 93.45 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 116.326 1.973 . . . . 0.0 116.326 171.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.6 tp -67.34 -34.67 77.81 Favored 'General case' 0 CA--C 1.572 1.824 0 CA-C-N 120.031 1.287 . . . . 0.0 113.522 173.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.02 94.14 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 166.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -56.58 -38.68 72.31 Favored 'General case' 0 CA--C 1.567 1.624 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 166.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -69.23 -53.78 18.1 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 120.306 1.412 . . . . 0.0 114.663 173.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.4 mt -84.4 -23.52 30.02 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 117.187 2.292 . . . . 0.0 117.187 -174.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.83 36.49 7.78 Favored Glycine 0 CA--C 1.555 2.555 0 N-CA-C 117.744 1.858 . . . . 0.0 117.744 -174.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.5 mm -104.46 153.67 38.94 Favored Pre-proline 0 CA--C 1.57 1.719 0 CA-C-N 118.899 1.349 . . . . 0.0 112.487 -169.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -82.65 98.13 0.88 Allowed 'Trans proline' 0 CA--C 1.566 2.118 0 CA-C-N 122.222 1.829 . . . . 0.0 109.586 163.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.01 114.82 12.76 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.811 0.815 . . . . 0.0 110.266 176.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 25.1 mm -101.99 112.32 34.75 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.6 t -95.08 134.59 37.61 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 170.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.0 p -68.97 -18.32 64.05 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 117.019 2.229 . . . . 0.0 117.019 -174.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -81.5 -21.23 62.52 Favored Glycine 0 CA--C 1.545 1.919 0 N-CA-C 118.619 2.207 . . . . 0.0 118.619 167.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -80.47 -51.75 8.44 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -169.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -63.61 -39.57 94.7 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 174.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.417 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 12.5 m-85 -70.28 -39.51 74.87 Favored 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 172.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 47.0 ttp180 -58.97 -40.64 85.39 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 120.182 1.355 . . . . 0.0 114.301 167.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -62.51 -39.46 93.59 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 169.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -68.53 -26.56 65.5 Favored 'General case' 0 CA--C 1.578 2.026 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 168.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 88.1 mt -63.89 -45.38 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 CA-C-N 120.267 1.394 . . . . 0.0 111.063 166.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -62.59 -40.86 98.24 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 173.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -64.64 -45.31 87.35 Favored 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 173.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.64 68.46 0.94 Allowed Glycine 0 CA--C 1.541 1.668 0 CA-C-O 118.452 -1.193 . . . . 0.0 113.555 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.807 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 63.9 p -97.48 -41.87 7.98 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -177.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.807 ' HB2' ' O ' ' A' ' 43' ' ' THR . 76.6 mttt 97.67 -38.75 0.01 OUTLIER 'General case' 0 CA--C 1.573 1.863 0 CA-C-O 116.904 -1.522 . . . . 0.0 111.869 -170.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.02 -18.66 55.62 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 122.246 2.293 . . . . 0.0 113.42 163.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.72 -53.4 46.25 Favored Glycine 0 C--N 1.356 1.657 0 CA-C-N 120.366 1.439 . . . . 0.0 115.332 172.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.627 ' O ' ' HB2' ' A' ' 51' ' ' ARG 0.27 11.8 p -77.91 -44.1 28.44 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.649 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 -169.673 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -59.35 -52.95 63.44 Favored 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 121.072 1.76 . . . . 0.0 113.315 169.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.69 -33.25 73.64 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -176.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.417 ' HB2' ' HB3' ' A' ' 35' ' ' PHE . 13.2 tmtt? -75.28 -19.93 59.41 Favored 'General case' 0 CA--C 1.562 1.442 0 CA-C-O 116.915 -1.517 . . . . 0.0 113.329 166.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . 0.627 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 34.5 ttt180 -76.81 -53.04 8.45 Favored 'General case' 0 CA--C 1.589 2.47 1 CA-C-O 86.371 -16.061 . . . . 0.0 118.169 -179.479 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . 0.34 0.0 OUTLIER -40.92 -61.7 0.93 Allowed 'General case' 0 N--CA 1.511 2.605 1 O-C-N 109.99 -7.944 . . . . 0.0 119.559 147.869 . . . . . . . . 4 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 61.0 mt -52.0 -31.67 30.58 Favored 'General case' 0 N--CA 1.52 3.067 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 178.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -93.46 -44.22 8.35 Favored 'General case' 0 CA--C 1.567 1.61 0 N-CA-C 116.912 2.19 . . . . 0.0 116.912 170.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.12 -10.56 14.66 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 119.041 2.978 . . . . 0.0 119.041 -168.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.51 42.62 9.04 Favored Glycine 0 CA--C 1.541 1.679 0 CA-C-N 122.094 2.225 . . . . 0.0 116.269 -177.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -91.31 -175.52 4.28 Favored 'General case' 0 CA--C 1.568 1.636 0 CA-C-O 122.24 1.019 . . . . 0.0 110.739 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 65.4 mt -103.82 104.25 14.23 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 177.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.9 t -142.55 122.04 7.83 Favored Pre-proline 0 CA--C 1.584 2.259 0 CA-C-O 117.867 -1.063 . . . . 0.0 108.141 -170.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -57.63 170.1 2.08 Favored 'Trans proline' 0 CA--C 1.567 2.153 0 C-N-CA 124.278 3.319 . . . . 0.0 119.791 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.3 m -96.13 -169.4 1.92 Allowed 'General case' 0 CA--C 1.576 1.976 0 C-N-CA 124.444 1.098 . . . . 0.0 112.995 -178.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.278 19.1 m-20 80.55 -51.01 0.33 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 126.765 2.026 . . . . 0.0 115.144 172.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.44 -39.58 76.57 Favored 'General case' 0 N--CA 1.505 2.298 0 CA-C-N 120.359 1.436 . . . . 0.0 114.667 167.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.3 m -60.29 -47.51 85.71 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 114.669 -1.15 . . . . 0.0 112.688 172.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -62.92 -27.69 69.55 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 115.774 1.768 . . . . 0.0 115.774 168.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -68.36 -44.48 75.13 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 120.886 1.675 . . . . 0.0 114.523 171.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.9 mt -64.41 -38.57 91.5 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 168.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.0 t -57.58 -53.0 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-O 117.885 -1.055 . . . . 0.0 111.998 169.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -59.63 -37.32 78.33 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 116.436 2.013 . . . . 0.0 116.436 172.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -55.8 -49.02 74.36 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 116.715 -1.612 . . . . 0.0 113.084 170.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 61.3 mtp180 -88.94 7.85 32.45 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 120.515 3.524 . . . . 0.0 120.515 167.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 63.9 mt -66.19 -49.73 66.3 Favored 'General case' 0 CA--C 1.554 1.126 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 151.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 72.3 m-80 . . . . . 0 N--CA 1.503 2.2 0 CA-C-N 121.533 1.969 . . . . 0.0 110.981 -165.595 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.402 ' HA2' ' HB3' ' A' ' 2' ' ' ARG . . . . . . . . 0 N--CA 1.477 1.401 0 CA-C-O 122.732 1.184 . . . . 0.0 115.376 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.403 ' O ' ' HB2' ' A' ' 2' ' ' ARG . 23.2 p90 -173.98 135.74 0.5 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 112.585 -1.807 . . . . 0.0 109.827 168.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 33.6 mt -113.83 108.03 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 173.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.8 mt -110.96 122.4 47.79 Favored 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 123.33 0.652 . . . . 0.0 110.2 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -116.01 116.15 27.4 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 118.394 0.543 . . . . 0.0 110.746 -169.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.16 28.07 35.04 Favored Glycine 0 CA--C 1.548 2.138 0 N-CA-C 117.988 1.955 . . . . 0.0 117.988 176.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -86.68 -57.3 0.33 Allowed Pre-proline 0 CA--C 1.572 1.81 0 CA-C-O 114.297 -2.763 . . . . 0.0 110.791 175.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -61.88 50.25 0.1 OUTLIER 'Trans proline' 0 CA--C 1.578 2.719 0 N-CA-C 120.664 3.294 . . . . 0.0 120.664 167.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 1.264 ' NH2' HH12 ' A' ' 140' ' ' ARG . 0.0 OUTLIER -80.23 7.43 9.42 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 167.721 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.5 t -155.63 135.14 12.47 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 103.221 -2.881 . . . . 0.0 103.221 170.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.0 t -61.77 -34.21 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 CA-C-O 117.287 -1.34 . . . . 0.0 111.541 176.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.98 -35.39 64.27 Favored 'General case' 0 CA--C 1.564 1.505 0 N-CA-C 119.624 3.194 . . . . 0.0 119.624 165.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -72.26 -48.12 45.06 Favored 'General case' 0 CA--C 1.591 2.52 0 CA-C-N 121.679 2.036 . . . . 0.0 112.087 165.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.45 -33.18 75.29 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 116.677 2.103 . . . . 0.0 116.677 -169.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.2 tttp -61.25 -27.72 68.65 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 167.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.82 -42.45 63.8 Favored 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 168.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 36.8 tp -61.62 -40.83 96.23 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 169.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 43.7 t60 -64.09 -41.24 97.37 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 120.045 1.293 . . . . 0.0 113.986 169.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.705 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 29.7 tt0 -54.55 -40.84 69.09 Favored 'General case' 0 CA--C 1.567 1.61 0 CA-C-O 117.948 -1.025 . . . . 0.0 113.608 167.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 1.253 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 26.3 mmt -83.36 -21.26 33.16 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 117.553 2.427 . . . . 0.0 117.553 175.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.6 tt -73.06 -52.39 14.51 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-N 121.437 1.926 . . . . 0.0 110.39 172.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -75.37 -55.85 5.29 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 172.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.705 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 31.8 ttm180 -69.28 -39.81 78.14 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 178.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 1.253 ' HB3' ' O ' ' A' ' 99' ' ' MET . 76.5 ttt180 -63.45 -56.81 13.15 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 119.464 1.029 . . . . 0.0 111.036 165.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.27 50.0 0.74 Allowed Glycine 0 N--CA 1.483 1.794 0 O-C-N 124.184 0.927 . . . . 0.0 113.886 168.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 51.3 p -91.15 150.58 21.32 Favored 'General case' 0 CA--C 1.559 1.29 0 CA-C-N 113.481 -1.36 . . . . 0.0 109.797 176.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -67.94 132.55 47.53 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.899 -0.501 . . . . 0.0 112.053 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 6.3 tp -95.07 101.74 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -95.78 -69.45 0.75 Allowed 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 116.399 -1.763 . . . . 0.0 108.796 169.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -155.33 128.64 8.33 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 121.629 2.013 . . . . 0.0 113.929 177.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 33.3 t -93.72 108.37 20.46 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.726 0 N-CA-C 102.838 -3.023 . . . . 0.0 102.838 163.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.648 HD23 ' HB2' ' A' ' 160' ' ' LYS . 86.9 mt -101.43 110.8 22.87 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.776 0.83 . . . . 0.0 110.716 -169.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -89.57 121.23 31.58 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 121.638 0.732 . . . . 0.0 109.055 172.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -92.61 117.05 29.57 Favored 'General case' 0 CA--C 1.557 1.227 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 175.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.494 ' HB3' ' HA ' ' A' ' 163' ' ' ASP . 19.7 tpt180 -87.55 91.48 8.75 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 112.821 -1.99 . . . . 0.0 107.31 173.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.4 m . . . . . 0 CA--C 1.55 0.969 0 CA-C-N 112.839 -1.982 . . . . 0.0 106.038 -165.405 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.1 t30 . . . . . 0 N--CA 1.5 2.05 0 N-CA-C 114.849 1.425 . . . . 0.0 114.849 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 1.264 HH12 ' NH2' ' A' ' 88' ' ' ARG . 12.2 mmm180 -59.77 -42.13 92.64 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 169.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 58.9 mtt -66.49 -31.01 71.47 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 115.543 1.682 . . . . 0.0 115.543 169.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -63.64 -49.14 74.41 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 169.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . 0.6 HG11 HH22 ' A' ' 88' ' ' ARG . 7.8 p -64.57 -33.41 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 169.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -56.19 -52.36 64.68 Favored 'General case' 0 CA--C 1.581 2.168 0 CA-C-N 119.559 1.072 . . . . 0.0 111.779 167.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 31.1 ttp180 -52.19 -31.55 32.16 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 119.427 3.121 . . . . 0.0 119.427 170.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -48.47 -51.04 28.95 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 170.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -140.34 7.61 2.18 Favored 'General case' 0 CA--C 1.56 1.362 0 N-CA-C 119.944 3.312 . . . . 0.0 119.944 -167.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 23.9 m -55.27 -34.41 64.03 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 116.194 1.924 . . . . 0.0 116.194 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.14 -59.92 5.71 Favored Pre-proline 0 CA--C 1.578 2.054 0 CA-C-O 116.662 -1.637 . . . . 0.0 111.881 172.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -50.15 -31.3 28.12 Favored 'Trans proline' 0 CA--C 1.576 2.616 0 C-N-CA 123.365 2.71 . . . . 0.0 118.374 167.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.01 -55.58 18.13 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 125.391 1.476 . . . . 0.0 112.217 175.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 1.047 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 46.1 tp -65.32 -23.51 67.03 Favored 'General case' 0 CA--C 1.564 1.511 0 CA-C-O 116.504 -1.712 . . . . 0.0 114.704 176.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -71.55 -48.95 45.25 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 122.393 2.361 . . . . 0.0 113.444 165.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -67.16 -51.6 51.71 Favored 'General case' 0 CA--C 1.566 1.57 0 CA-C-N 120.042 1.292 . . . . 0.0 112.014 -177.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -80.81 -25.3 37.9 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-O 114.715 -2.564 . . . . 0.0 112.53 178.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 1.047 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 38.1 ttt180 -64.31 -35.63 81.48 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 124.893 3.497 . . . . 0.0 115.938 168.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -67.94 -37.74 81.97 Favored 'General case' 0 CA--C 1.574 1.89 0 CA-C-N 119.697 1.135 . . . . 0.0 113.949 167.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -80.71 -38.2 29.3 Favored 'General case' 0 CA--C 1.574 1.89 0 N-CA-C 119.351 3.093 . . . . 0.0 119.351 178.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.3 pp -78.08 173.69 11.94 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 119.675 3.213 . . . . 0.0 119.675 -160.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.648 ' HB2' HD23 ' A' ' 111' ' ' LEU . 91.0 mttt -124.83 134.35 52.77 Favored 'General case' 0 CA--C 1.561 1.399 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 166.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 60.4 m -98.1 148.95 23.03 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 122.79 1.281 . . . . 0.0 111.222 -170.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.471 HG13 ' HG3' ' A' ' 174' ' ' ARG . 44.8 t -127.84 138.67 54.05 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.871 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 167.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.494 ' HA ' ' HB3' ' A' ' 114' ' ' ARG . 14.7 t70 -114.95 127.32 55.62 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 170.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -151.53 -159.8 1.07 Allowed 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 -160.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . 0.511 5.7 p . . . . . 0 N--CA 1.497 1.905 0 C-N-CA 129.153 2.981 . . . . 0.0 114.498 -179.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 . . . . . 0 N--CA 1.505 2.313 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . 0.97 ' HB3' HH21 ' A' ' 174' ' ' ARG . 47.6 mt-10 -59.42 -42.04 90.92 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 117.294 -1.336 . . . . 0.0 114.522 175.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 44.4 t -56.54 -38.65 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 CA-C-N 120.991 1.723 . . . . 0.0 113.419 172.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.729 ' CE1' ' HB3' ' A' ' 19' ' ' LYS . 22.8 t80 -57.95 -40.51 80.7 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 120.796 1.635 . . . . 0.0 115.103 166.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.558 ' O ' ' HB2' ' A' ' 177' ' ' ARG . . . -61.03 -50.85 71.64 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.97 HH21 ' HB3' ' A' ' 170' ' ' GLU . 11.7 ptp180 -73.32 -25.19 60.53 Favored 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 117.582 2.438 . . . . 0.0 117.582 171.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.11 -49.73 73.27 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 120.346 1.43 . . . . 0.0 114.715 169.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . 0.254 0.2 OUTLIER -66.77 -37.86 85.44 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 119.531 1.06 . . . . 0.0 113.429 167.471 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . 0.619 ' HB2' ' HA ' ' A' ' 174' ' ' ARG . 17.3 ttt180 -43.55 -44.05 5.89 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 117.126 2.269 . . . . 0.0 117.126 167.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -71.13 -53.98 12.65 Favored 'General case' 0 CA--C 1.564 1.497 0 CA-C-O 118.204 -0.903 . . . . 0.0 113.208 166.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -99.05 -59.6 1.7 Allowed 'General case' 0 CA--C 1.565 1.528 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -169.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.885 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -79.39 -39.14 19.55 Favored Glycine 0 CA--C 1.55 2.276 0 CA-C-N 121.388 1.904 . . . . 0.0 117.737 -171.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.885 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 85.9 tttt . . . . . 0 C--O 1.251 1.142 0 CA-C-N 118.482 1.141 . . . . 0.0 108.623 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.6 mtt . . . . . 0 CA--C 1.555 1.171 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.783 HH21 HD21 ' A' ' 4' ' ' LEU . 2.4 ptm180 -160.96 162.79 32.03 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 -167.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.551 HG13 HG23 ' A' ' 82' ' ' ILE . 8.5 p -131.4 145.69 34.84 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.4 0 CA-C-O 123.299 1.523 . . . . 0.0 110.956 -170.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.783 HD21 HH21 ' A' ' 2' ' ' ARG . 1.2 mm? -118.12 157.07 27.57 Favored 'General case' 0 CA--C 1.562 1.442 0 CA-C-N 112.853 -1.976 . . . . 0.0 108.52 168.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.439 HD22 ' HG2' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -128.23 117.07 20.87 Favored 'General case' 0 CA--C 1.569 1.69 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.201 -174.042 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.0 mt -116.17 158.48 23.2 Favored 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 127.669 2.387 . . . . 0.0 111.749 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.69 118.78 0.63 Allowed Glycine 0 CA--C 1.556 2.61 0 CA-C-O 116.996 -2.002 . . . . 0.0 114.029 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo . . . . . 0 CA--C 1.584 3.002 0 CA-C-N 122.572 3.186 . . . . 0.0 114.009 169.452 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.439 ' HG2' HD22 ' A' ' 5' ' ' LEU . 37.3 mtmm . . . . . 0 N--CA 1.485 1.325 0 N-CA-C 111.434 0.161 . . . . 0.0 111.434 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -54.04 -36.87 57.21 Favored Glycine 0 CA--C 1.552 2.346 0 N-CA-C 120.87 3.108 . . . . 0.0 120.87 -173.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 90.0 m -68.74 -49.09 61.61 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 119.397 1.598 . . . . 0.0 113.145 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.282 25.4 mp0 -77.57 -12.06 59.93 Favored 'General case' 0 CA--C 1.574 1.886 0 CA-C-O 115.325 -2.274 . . . . 0.0 112.071 169.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.07 -45.9 58.93 Favored 'General case' 0 C--N 1.373 1.61 0 CA-C-N 124.809 3.459 . . . . 0.0 114.389 167.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.2 t -67.01 -40.95 86.65 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.766 0 CA-C-O 117.523 -1.227 . . . . 0.0 111.793 171.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -62.62 -45.23 93.83 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 116.605 2.076 . . . . 0.0 116.605 171.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.26 -32.92 73.43 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-N 120.227 1.376 . . . . 0.0 113.85 173.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.03 -40.97 97.52 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 166.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -58.17 -40.25 80.97 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 166.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.9 tptt -68.62 -54.01 19.09 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 177.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.9 mt -83.31 -19.86 35.46 Favored 'General case' 0 CA--C 1.57 1.739 0 N-CA-C 116.972 2.212 . . . . 0.0 116.972 178.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.48 39.89 7.55 Favored Glycine 0 CA--C 1.554 2.482 0 N-CA-C 117.543 1.777 . . . . 0.0 117.543 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.515 ' CG2' ' HA ' ' A' ' 81' ' ' PHE . 18.8 mm -110.1 157.87 36.71 Favored Pre-proline 0 CA--C 1.572 1.827 0 CA-C-N 118.531 1.166 . . . . 0.0 113.457 -168.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -84.49 99.79 0.76 Allowed 'Trans proline' 0 CA--C 1.568 2.182 0 CA-C-N 122.146 1.802 . . . . 0.0 110.062 163.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.26 113.66 4.75 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.448 -0.783 . . . . 0.0 111.276 172.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 32.3 mm -98.12 108.14 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 N-CA-C 104.501 -2.407 . . . . 0.0 104.501 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 73.9 m -95.45 128.45 42.32 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 168.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.3 p -71.27 -8.28 52.6 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 116.94 2.2 . . . . 0.0 116.94 -172.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -87.12 -21.86 47.65 Favored Glycine 0 CA--C 1.551 2.288 0 N-CA-C 118.106 2.003 . . . . 0.0 118.106 165.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -79.79 -51.55 9.03 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -168.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -62.09 -41.85 98.61 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 172.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.431 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 26.0 m-85 -60.73 -37.08 80.54 Favored 'General case' 0 CA--C 1.564 1.513 0 N-CA-C 116.259 1.948 . . . . 0.0 116.259 168.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -60.09 -42.96 95.76 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 120.017 1.28 . . . . 0.0 114.035 167.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -60.33 -38.87 85.11 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 168.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -66.25 -28.14 68.49 Favored 'General case' 0 CA--C 1.575 1.923 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 168.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 73.9 mt -63.73 -46.74 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 CA-C-N 120.131 1.332 . . . . 0.0 111.434 168.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -65.35 -36.39 83.87 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 172.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -78.38 -32.08 48.71 Favored 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.14 73.69 1.28 Allowed Glycine 0 CA--C 1.544 1.855 0 CA-C-O 118.348 -1.251 . . . . 0.0 114.884 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.843 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 68.6 p -97.62 -44.53 6.75 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 178.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.843 ' HB2' ' O ' ' A' ' 43' ' ' THR . 76.9 mttt 102.35 -39.16 0.01 OUTLIER 'General case' 0 CA--C 1.579 2.072 0 CA-C-O 117.372 -1.299 . . . . 0.0 112.202 -171.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -89.01 1.8 54.98 Favored 'General case' 0 CA--C 1.58 2.103 0 CA-C-N 121.805 2.093 . . . . 0.0 113.251 163.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -81.9 -54.48 3.41 Favored Glycine 0 C--N 1.349 1.299 0 O-C-N 120.761 -1.212 . . . . 0.0 114.657 169.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.303 4.0 p -75.95 -52.38 18.02 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.441 0 N-CA-C 115.073 1.509 . . . . 0.0 115.073 -168.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -67.19 -48.93 66.42 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 120.586 1.539 . . . . 0.0 112.307 175.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.81 -19.32 62.01 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.431 ' HB2' ' HB3' ' A' ' 35' ' ' PHE . 14.2 tmtt? -74.64 -47.02 34.37 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 117.111 -1.423 . . . . 0.0 111.825 165.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -67.71 -53.55 26.66 Favored 'General case' 0 CA--C 1.591 2.539 1 CA-C-O 86.12 -16.181 . . . . 0.0 118.001 -173.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 15.9 m-30 -31.62 -64.41 0.16 Allowed 'General case' 0 N--CA 1.496 1.848 1 O-C-N 110.232 -7.793 . . . . 0.0 120.803 146.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.5 tp -60.8 -23.97 65.46 Favored 'General case' 0 CA--C 1.579 2.095 0 CA-C-N 122.201 2.273 . . . . 0.0 116.779 172.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -92.58 -43.27 9.22 Favored 'General case' 0 CA--C 1.569 1.68 0 C-N-CA 126.332 1.853 . . . . 0.0 114.737 168.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.41 -48.01 12.47 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 120.741 1.609 . . . . 0.0 115.318 -176.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.99 41.42 0.71 Allowed Glycine 0 CA--C 1.539 1.542 0 N-CA-C 116.389 1.316 . . . . 0.0 116.389 169.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -105.73 -132.47 0.31 Allowed 'General case' 0 CA--C 1.572 1.802 0 CA-C-O 118.584 -0.722 . . . . 0.0 109.479 168.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.9 mt -108.23 109.95 21.44 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 120.163 1.347 . . . . 0.0 111.334 -168.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.9 p -117.11 129.49 25.29 Favored Pre-proline 0 CA--C 1.573 1.829 0 CA-C-O 117.796 -1.097 . . . . 0.0 110.225 178.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -60.73 145.2 99.31 Favored 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 123.475 2.783 . . . . 0.0 116.288 173.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 98.8 p -78.12 -45.07 24.32 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 178.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -66.82 -40.65 88.08 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 115.726 1.751 . . . . 0.0 115.726 -175.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.67 -43.88 97.13 Favored 'General case' 0 N--CA 1.506 2.341 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 172.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.3 m -61.46 -41.19 96.86 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.201 -1.363 . . . . 0.0 112.986 173.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -65.08 -26.58 68.29 Favored 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 166.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.41 -46.49 73.06 Favored 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 170.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.8 mt -60.64 -48.28 82.49 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 169.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 55.5 t -58.99 -52.17 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 124.024 0.93 . . . . 0.0 112.435 174.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -62.68 -31.16 72.0 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 116.344 1.979 . . . . 0.0 116.344 173.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -58.74 -42.99 90.08 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 117.558 -1.211 . . . . 0.0 113.462 169.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -81.35 -16.78 51.31 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 119.217 3.043 . . . . 0.0 119.217 168.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 88.7 mt -92.82 -17.88 23.57 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 117.067 2.247 . . . . 0.0 117.067 177.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 . . . . . 0 N--CA 1.498 1.95 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 169.17 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.445 0 CA-C-O 122.942 1.301 . . . . 0.0 114.298 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.515 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . 28.8 p90 -165.85 139.56 4.41 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 113.236 -1.482 . . . . 0.0 111.967 175.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.551 HG23 HG13 ' A' ' 3' ' ' VAL . 1.3 mm -101.39 110.39 28.12 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.764 0 N-CA-C 104.624 -2.361 . . . . 0.0 104.624 170.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.9 mt -106.09 130.22 54.03 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 174.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -128.99 117.85 21.62 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 119.206 0.912 . . . . 0.0 110.916 -166.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 76.06 36.72 40.02 Favored Glycine 0 CA--C 1.55 2.231 0 N-CA-C 118.051 1.981 . . . . 0.0 118.051 -176.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . 0.256 2.3 t80 -107.24 -66.14 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.921 0 CA-C-O 113.834 -2.984 . . . . 0.0 112.105 -176.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -61.79 47.97 0.09 OUTLIER 'Trans proline' 0 CA--C 1.576 2.602 0 N-CA-C 122.229 3.896 . . . . 0.0 122.229 171.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.42 -21.76 66.74 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 116.821 2.156 . . . . 0.0 116.821 166.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 36.6 t -131.14 146.84 52.5 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 -172.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -61.89 -35.78 70.02 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.724 0 CA-C-O 117.26 -1.352 . . . . 0.0 110.827 169.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.56 -45.66 81.14 Favored 'General case' 0 CA--C 1.559 1.323 0 N-CA-C 120.524 3.528 . . . . 0.0 120.524 168.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -67.32 -47.47 70.44 Favored 'General case' 0 CA--C 1.588 2.437 0 CA-C-N 122.264 2.302 . . . . 0.0 112.927 169.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.14 -33.1 73.86 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 116.405 2.002 . . . . 0.0 116.405 -169.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -63.46 -28.1 69.73 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 166.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.93 -46.31 62.7 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 169.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 22.6 tp -64.41 -37.96 89.34 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 173.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 56.6 t60 -68.43 -39.35 81.59 Favored 'General case' 0 CA--C 1.567 1.63 0 CA-C-N 119.695 1.134 . . . . 0.0 113.825 169.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.936 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 22.8 mt-10 -52.2 -41.44 62.69 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 166.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 1.056 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 3.3 tpt -84.09 -26.93 28.58 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 117.724 2.49 . . . . 0.0 117.724 175.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . 0.637 HD11 ' HB ' ' A' ' 107' ' ' ILE . 30.9 tp -64.28 -55.33 22.11 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 120.214 1.37 . . . . 0.0 112.393 168.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -80.26 -51.68 8.62 Favored 'General case' 0 CA--C 1.562 1.42 0 CA-C-O 118.671 -0.68 . . . . 0.0 112.715 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.936 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 75.0 mtp180 -71.66 -41.06 69.19 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 176.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 1.056 ' HB3' ' O ' ' A' ' 99' ' ' MET . 0.8 OUTLIER -63.2 -55.14 27.5 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 119.759 1.163 . . . . 0.0 110.59 164.638 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.67 48.4 1.04 Allowed Glycine 0 N--CA 1.482 1.713 0 O-C-N 123.83 0.706 . . . . 0.0 113.274 169.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 29.7 p -99.91 163.61 12.38 Favored 'General case' 0 CA--C 1.56 1.343 0 O-C-N 124.594 0.82 . . . . 0.0 111.074 -178.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -75.56 134.78 40.64 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.64 -0.663 . . . . 0.0 111.748 -169.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.637 ' HB ' HD11 ' A' ' 100' ' ' LEU . 8.0 tp -109.64 106.05 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.42 -68.21 0.81 Allowed 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 117.446 -1.264 . . . . 0.0 107.701 167.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -159.87 136.83 9.34 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 120.601 1.546 . . . . 0.0 115.119 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.537 HG22 HD23 ' A' ' 4' ' ' LEU . 48.7 t -91.35 114.38 28.51 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.734 0 N-CA-C 103.733 -2.691 . . . . 0.0 103.733 162.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 84.3 mt -103.04 110.74 22.77 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.338 0.655 . . . . 0.0 111.959 -169.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -96.06 124.47 40.08 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.313 0.578 . . . . 0.0 110.849 175.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -92.68 123.87 36.28 Favored 'General case' 0 CA--C 1.561 1.388 0 CA-C-O 123.341 1.543 . . . . 0.0 110.147 -173.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -82.09 95.05 7.34 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 112.559 -2.109 . . . . 0.0 109.229 168.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.6 p . . . . . 0 CA--C 1.559 1.299 0 C-N-CA 125.864 1.666 . . . . 0.0 107.348 -168.579 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . 0.416 ' HA ' ' HD3' ' A' ' 142' ' ' LYS . 11.6 t-20 . . . . . 0 N--CA 1.499 2.018 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.01 -38.93 77.09 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 165.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 24.7 ttt -65.03 -33.12 75.28 Favored 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 168.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . 0.416 ' HD3' ' HA ' ' A' ' 139' ' ' ASN . 60.5 mtpt -59.71 -52.23 66.4 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 168.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 14.8 p -62.67 -36.44 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.267 0 N-CA-C 114.109 1.152 . . . . 0.0 114.109 170.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -55.31 -50.29 69.95 Favored 'General case' 0 CA--C 1.581 2.161 0 CA-C-N 120.059 1.299 . . . . 0.0 112.974 169.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -61.55 -45.29 94.8 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 117.72 2.489 . . . . 0.0 117.72 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.01 -38.36 65.04 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 117.345 2.35 . . . . 0.0 117.345 175.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -123.47 -35.91 2.87 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 119.534 3.161 . . . . 0.0 119.534 -165.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 86.0 m -49.31 -31.3 8.85 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 118.441 2.756 . . . . 0.0 118.441 -166.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.17 -63.04 2.66 Favored Pre-proline 0 CA--C 1.582 2.192 0 CA-C-N 121.157 1.799 . . . . 0.0 111.212 170.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -54.21 -32.1 69.21 Favored 'Trans proline' 0 CA--C 1.571 2.363 0 C-N-CA 123.4 2.734 . . . . 0.0 118.899 167.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.3 tp -71.74 -42.87 66.74 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 117.812 -1.09 . . . . 0.0 112.511 174.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 1.048 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 49.5 tp -63.56 -24.43 67.8 Favored 'General case' 0 CA--C 1.569 1.704 0 CA-C-N 120.656 1.571 . . . . 0.0 113.875 170.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -69.84 -49.69 50.0 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 121.829 2.104 . . . . 0.0 113.038 163.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -65.19 -52.31 55.68 Favored 'General case' 0 CA--C 1.564 1.49 0 CA-C-N 121.15 1.795 . . . . 0.0 112.69 -177.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -82.0 -22.52 36.48 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-O 115.128 -2.368 . . . . 0.0 112.804 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 1.048 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 40.3 ttt180 -66.07 -35.87 81.7 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 125.016 3.553 . . . . 0.0 115.653 168.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -68.41 -36.9 79.78 Favored 'General case' 0 CA--C 1.575 1.928 0 CA-C-N 119.673 1.124 . . . . 0.0 114.006 167.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -88.08 -31.98 18.97 Favored 'General case' 0 CA--C 1.575 1.914 0 N-CA-C 119.203 3.038 . . . . 0.0 119.203 -178.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.8 pp -79.87 174.33 11.69 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 118.412 2.745 . . . . 0.0 118.412 -162.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -133.24 137.27 46.02 Favored 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 166.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.0 t -96.34 154.28 17.35 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.341 1.067 . . . . 0.0 112.085 -175.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 59.5 t -127.75 142.82 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 171.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -95.3 132.28 40.48 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 168.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -159.49 99.26 1.44 Allowed 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 122.26 1.029 . . . . 0.0 113.317 -163.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.9 t . . . . . 0 N--CA 1.487 1.396 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 174.431 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 . . . . . 0 N--CA 1.5 2.05 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -61.55 -53.24 58.88 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 119.371 0.987 . . . . 0.0 113.28 169.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 61.6 t -57.73 -37.94 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 176.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -62.07 -33.53 74.57 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 116.45 2.019 . . . . 0.0 116.45 168.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -63.01 -47.28 83.77 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 171.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -61.8 -41.63 97.98 Favored 'General case' 0 CA--C 1.556 1.208 0 N-CA-C 116.676 2.102 . . . . 0.0 116.676 169.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.37 -42.39 91.5 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 116.212 1.931 . . . . 0.0 116.212 171.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.6 mp -65.99 -40.38 91.15 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 117.403 -1.284 . . . . 0.0 114.294 169.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 37.6 mtt180 -53.38 -43.27 67.7 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 116.442 2.015 . . . . 0.0 116.442 168.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -69.7 -41.82 74.89 Favored 'General case' 0 CA--C 1.562 1.438 0 N-CA-C 116.335 1.976 . . . . 0.0 116.335 172.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 6.8 tt -74.87 -57.14 4.09 Favored 'General case' 0 CA--C 1.566 1.566 0 CA-C-N 121.003 1.729 . . . . 0.0 111.729 177.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.643 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -117.36 -59.86 0.3 Allowed Glycine 0 CA--C 1.551 2.333 0 CA-C-O 117.621 -1.655 . . . . 0.0 114.898 -177.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.643 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 36.5 ttmt . . . . . 0 C--O 1.252 1.195 0 CA-C-N 120.608 2.204 . . . . 0.0 107.369 -174.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.1 mtt . . . . . 0 N--CA 1.483 1.213 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.38 165.94 31.58 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 117.744 2.498 . . . . 0.0 117.744 -165.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.65 155.56 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-O 124.044 1.878 . . . . 0.0 112.978 -165.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.7 pp -138.86 127.31 23.03 Favored 'General case' 0 CA--C 1.559 1.313 0 CA-C-N 112.618 -2.083 . . . . 0.0 108.718 168.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 tt -96.53 134.72 39.39 Favored 'General case' 0 CA--C 1.559 1.304 0 CA-C-O 122.879 1.324 . . . . 0.0 113.765 -165.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -135.26 157.41 46.97 Favored 'General case' 0 CA--C 1.56 1.335 0 CA-C-N 112.062 -2.335 . . . . 0.0 111.356 -169.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 156.67 135.98 2.05 Favored Glycine 0 CA--C 1.554 2.495 0 CA-C-O 117.412 -1.771 . . . . 0.0 111.905 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo . . . . . 0 CA--C 1.577 2.625 0 CA-C-N 122.789 3.294 . . . . 0.0 113.241 171.43 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.8 mptt . . . . . 0 N--CA 1.496 1.842 0 CA-C-O 120.746 0.308 . . . . 0.0 111.191 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -40.94 -30.67 0.39 Allowed Glycine 0 CA--C 1.557 2.667 0 N-CA-C 121.254 3.262 . . . . 0.0 121.254 169.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.2 p -58.62 -63.04 1.43 Allowed 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 119.543 1.671 . . . . 0.0 114.507 171.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.264 5.7 mm-40 -75.28 -13.67 60.45 Favored 'General case' 0 CA--C 1.571 1.754 0 CA-C-O 116.536 -1.697 . . . . 0.0 111.432 175.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.83 -48.38 63.68 Favored 'General case' 0 C--N 1.373 1.609 0 CA-C-N 122.532 2.424 . . . . 0.0 113.946 166.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.6 t -66.43 -38.23 81.32 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.834 0 CA-C-O 117.89 -1.053 . . . . 0.0 111.931 176.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -63.09 -51.3 67.15 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 116.809 2.151 . . . . 0.0 116.809 169.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.04 -35.24 78.0 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-N 119.969 1.259 . . . . 0.0 114.255 174.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.63 -45.21 94.92 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 116.405 2.002 . . . . 0.0 116.405 169.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.43 -28.64 63.48 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 164.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.0 tptm -63.82 -62.8 1.41 Allowed 'General case' 0 CA--C 1.552 1.026 0 CA-C-O 116.653 -1.641 . . . . 0.0 114.745 170.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . 0.297 0.6 OUTLIER -83.28 -15.44 50.21 Favored 'General case' 0 N--CA 1.506 2.365 0 N-CA-C 117.006 2.225 . . . . 0.0 117.006 -178.445 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.08 42.32 4.09 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 117.024 1.57 . . . . 0.0 117.024 176.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.553 ' CD1' ' HA ' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -116.69 149.16 43.43 Favored Pre-proline 0 CA--C 1.573 1.865 0 C-N-CA 127.337 2.255 . . . . 0.0 110.776 -168.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.515 ' HD2' HD12 ' A' ' 26' ' ' ILE . 22.2 Cg_endo -73.97 101.71 1.43 Allowed 'Trans proline' 0 CA--C 1.583 2.958 0 C-N-CA 121.794 1.663 . . . . 0.0 113.568 159.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -57.4 119.99 7.44 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.919 -1.113 . . . . 0.0 113.817 169.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.423 HD12 HD13 ' A' ' 34' ' ' LEU . 26.2 mm -101.8 109.34 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 169.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.7 p -95.17 125.05 39.55 Favored 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 103.928 -2.619 . . . . 0.0 103.928 163.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 47.4 p -67.48 -12.23 59.8 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 117.14 2.274 . . . . 0.0 117.14 -168.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -85.86 -19.57 57.55 Favored Glycine 0 CA--C 1.55 2.28 0 N-CA-C 118.347 2.099 . . . . 0.0 118.347 166.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -79.61 -53.44 6.85 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 118.756 1.278 . . . . 0.0 114.062 -168.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.423 HD13 HD12 ' A' ' 29' ' ' ILE . 2.5 pt? -59.18 -39.22 81.87 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 172.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -70.14 -43.16 71.5 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 116.262 -1.828 . . . . 0.0 113.204 171.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 47.5 ttt180 -51.8 -39.84 59.4 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 116.541 2.052 . . . . 0.0 116.541 169.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.9 -43.49 98.74 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 113.736 1.014 . . . . 0.0 113.736 169.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -65.7 -24.63 67.04 Favored 'General case' 0 CA--C 1.585 2.304 0 N-CA-C 116.441 2.015 . . . . 0.0 116.441 167.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.9 mt -62.99 -48.96 85.51 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.381 0 CA-C-N 121.288 1.858 . . . . 0.0 109.468 166.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -61.52 -41.41 97.27 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 114.355 1.242 . . . . 0.0 114.355 175.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -65.95 -40.15 91.07 Favored 'General case' 0 CA--C 1.564 1.489 0 N-CA-C 116.571 2.063 . . . . 0.0 116.571 171.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.85 70.61 1.03 Allowed Glycine 0 CA--C 1.545 1.942 0 CA-C-O 117.901 -1.5 . . . . 0.0 114.789 -179.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.871 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 64.1 p -95.67 -50.79 4.79 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-N 119.414 1.607 . . . . 0.0 114.502 177.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.871 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.251 73.5 mttt 103.99 -40.98 0.01 OUTLIER 'General case' 0 CA--C 1.573 1.846 0 CA-C-O 116.303 -1.808 . . . . 0.0 111.229 -171.257 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.91 -13.99 59.48 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 123.183 2.72 . . . . 0.0 112.901 163.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.494 ' O ' ' HB3' ' A' ' 50' ' ' LYS . . . -58.56 -60.45 8.92 Favored Glycine 0 C--N 1.355 1.587 0 CA-C-N 120.725 1.602 . . . . 0.0 115.032 170.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.281 7.6 p -73.68 -50.63 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.323 0 N-CA-C 116.21 1.93 . . . . 0.0 116.21 -168.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -66.3 -46.4 77.07 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 120.352 1.433 . . . . 0.0 112.384 175.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.58 -30.98 68.88 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -178.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.494 ' HB3' ' O ' ' A' ' 46' ' ' GLY 0.27 0.6 OUTLIER -78.03 -28.21 49.01 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-O 116.827 -1.559 . . . . 0.0 114.873 170.453 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -74.06 -56.52 4.83 Favored 'General case' 0 CA--C 1.595 2.682 1 CA-C-O 87.477 -15.535 . . . . 0.0 117.314 175.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . 0.259 11.4 m-30 -24.28 -66.53 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.836 1 O-C-N 109.279 -8.388 . . . . 0.0 119.929 145.522 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 41.2 mt -53.66 -38.34 64.04 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-N 121.296 1.862 . . . . 0.0 115.735 171.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -80.37 -52.98 7.04 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-O 116.799 -1.572 . . . . 0.0 113.634 170.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -158.42 43.86 0.29 Allowed 'General case' 0 CA--C 1.574 1.87 0 CA-C-N 120.909 1.686 . . . . 0.0 115.463 -168.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -151.17 27.26 1.0 Allowed Glycine 0 CA--C 1.549 2.174 0 CA-C-N 121.942 2.155 . . . . 0.0 118.443 173.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . 0.318 9.1 t70 76.37 -118.46 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 120.034 1.917 . . . . 0.0 111.127 166.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 86.3 mt -75.6 114.48 14.22 Favored 'General case' 0 CA--C 1.559 1.317 0 N-CA-C 115.308 1.596 . . . . 0.0 115.308 -164.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.5 p -118.06 138.29 25.34 Favored Pre-proline 0 CA--C 1.573 1.845 0 C-N-CA 126.089 1.755 . . . . 0.0 108.529 174.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -56.46 135.46 70.39 Favored 'Trans proline' 0 CA--C 1.56 1.807 0 C-N-CA 123.373 2.715 . . . . 0.0 116.191 173.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.6 m -70.38 -48.11 57.77 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -60.5 -43.55 96.91 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 26.4 mt -56.59 -46.82 80.61 Favored 'General case' 0 N--CA 1.509 2.483 0 N-CA-C 116.393 1.998 . . . . 0.0 116.393 175.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.1 m -58.33 -44.54 88.72 Favored 'General case' 0 CA--C 1.565 1.529 0 CA-C-N 113.022 -1.899 . . . . 0.0 113.211 173.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -61.01 -33.25 72.97 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 166.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.35 -43.97 84.54 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 175.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.2 mt -64.24 -44.8 90.7 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 168.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 54.9 t -59.09 -50.24 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 CA-C-O 118.125 -0.94 . . . . 0.0 113.073 172.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -63.0 -35.46 80.29 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 174.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -56.4 -40.23 74.31 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 118.113 -0.946 . . . . 0.0 113.31 169.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.632 HH22 ' HG ' ' A' ' 83' ' ' LEU . 0.2 OUTLIER -67.62 -45.38 75.59 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 165.616 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 83.7 mt -68.83 -7.03 30.55 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 118.12 2.637 . . . . 0.0 118.12 -178.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 . . . . . 0 CA--C 1.582 2.193 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 165.455 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.567 0 N-CA-C 116.614 1.405 . . . . 0.0 116.614 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.553 ' HA ' ' CD1' ' A' ' 26' ' ' ILE 0.311 18.9 p90 -170.09 134.42 1.25 Allowed 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 114.747 -0.726 . . . . 0.0 112.064 168.53 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.1 mp -109.98 109.16 27.4 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.537 0 N-CA-C 104.134 -2.543 . . . . 0.0 104.134 168.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.632 ' HG ' HH22 ' A' ' 71' ' ' ARG . 10.2 mt -105.76 110.49 22.81 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.487 0.715 . . . . 0.0 109.752 169.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -103.73 130.65 51.26 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 118.511 0.596 . . . . 0.0 112.59 -173.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.58 40.32 98.55 Favored Glycine 0 CA--C 1.548 2.146 0 CA-C-O 116.867 -2.074 . . . . 0.0 116.274 -176.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -89.06 -54.27 0.33 Allowed Pre-proline 0 N--CA 1.502 2.172 0 CA-C-N 120.794 2.297 . . . . 0.0 108.205 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -61.18 60.03 0.1 Allowed 'Trans proline' 0 CA--C 1.576 2.588 0 N-CA-C 121.909 3.773 . . . . 0.0 121.909 167.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -56.36 -33.97 66.19 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 163.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.6 t -155.23 158.39 38.78 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -174.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 23.9 t -68.9 -31.57 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 CA-C-O 116.689 -1.624 . . . . 0.0 111.118 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.83 -39.16 76.99 Favored 'General case' 0 CA--C 1.56 1.363 0 N-CA-C 120.133 3.383 . . . . 0.0 120.133 167.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -72.25 -46.35 56.34 Favored 'General case' 0 CA--C 1.592 2.591 0 CA-C-N 122.505 2.411 . . . . 0.0 112.777 167.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.69 -34.79 78.64 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 127.2 2.2 . . . . 0.0 116.178 -168.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 57.9 tttt -61.41 -29.66 70.07 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 166.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.12 -36.77 72.25 Favored 'General case' 0 CA--C 1.568 1.651 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 168.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.7 tp -63.14 -38.29 90.59 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 168.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 31.5 t60 -63.67 -47.26 81.99 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 119.818 1.19 . . . . 0.0 112.973 168.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.919 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 34.4 mt-10 -52.02 -31.01 27.83 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 165.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 1.213 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 23.1 ttt -84.74 -31.58 23.93 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 117.578 2.436 . . . . 0.0 117.578 175.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.6 mt -64.34 -55.88 18.19 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 121.948 2.158 . . . . 0.0 110.927 167.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -76.83 -51.62 10.98 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.919 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 36.5 ttm180 -74.06 -38.51 63.93 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 115.154 1.539 . . . . 0.0 115.154 176.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 1.213 ' HB3' ' O ' ' A' ' 99' ' ' MET . 25.4 tpt180 -62.74 -54.51 38.09 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 119.986 1.266 . . . . 0.0 112.081 166.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 114.07 44.64 0.73 Allowed Glycine 0 N--CA 1.479 1.51 0 O-C-N 123.971 0.794 . . . . 0.0 113.76 168.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 31.3 p -116.23 135.33 53.99 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 177.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -65.88 135.45 54.82 Favored 'General case' 0 N--CA 1.508 2.465 0 CA-C-O 122.601 1.191 . . . . 0.0 112.435 -170.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.5 tp -84.28 99.49 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 CA-C-N 113.262 -1.79 . . . . 0.0 107.04 178.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -97.75 -68.37 0.8 Allowed 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 116.947 -1.501 . . . . 0.0 110.175 169.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -138.02 116.06 11.68 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 120.44 1.473 . . . . 0.0 114.544 -167.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 72.8 t -91.53 117.64 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 101.176 -3.638 . . . . 0.0 101.176 163.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.474 ' HA ' ' O ' ' A' ' 160' ' ' LYS 0.259 6.8 tp -116.16 109.59 17.67 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 114.804 -2.522 . . . . 0.0 115.2 -159.545 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.44 ' N ' ' HB ' ' A' ' 161' ' ' THR . 3.0 tm-20 -110.23 109.5 20.0 Favored 'General case' 0 N--CA 1.517 2.908 0 CA-C-N 123.856 3.025 . . . . 0.0 117.998 -177.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -87.85 123.51 32.69 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 125.667 1.587 . . . . 0.0 110.647 170.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -92.76 101.03 13.41 Favored 'General case' 0 CA--C 1.558 1.271 0 CA-C-N 112.543 -2.117 . . . . 0.0 109.312 169.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.5 p . . . . . 0 CA--C 1.563 1.446 0 C-N-CA 127.279 2.232 . . . . 0.0 107.894 -167.985 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 . . . . . 0 N--CA 1.497 1.891 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 69.2 mtp180 -60.43 -41.86 94.89 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 169.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 62.5 mtt -65.53 -34.18 77.65 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 169.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -64.48 -46.35 83.41 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 170.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.6 p -65.74 -32.95 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 170.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -56.73 -53.13 61.25 Favored 'General case' 0 CA--C 1.581 2.158 0 CA-C-N 119.782 1.173 . . . . 0.0 111.71 167.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 41.3 ttt180 -53.34 -22.75 7.81 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 120.37 3.47 . . . . 0.0 120.37 169.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.37 -56.81 13.67 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-N 119.858 1.208 . . . . 0.0 113.308 169.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -141.99 23.08 2.07 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 118.639 2.829 . . . . 0.0 118.639 -171.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 20.9 m -56.25 -30.26 62.16 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 116.124 1.898 . . . . 0.0 116.124 170.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.464 ' HB3' ' HD3' ' A' ' 150' ' ' PRO . . . -68.0 -60.41 5.26 Favored Pre-proline 0 CA--C 1.583 2.234 0 CA-C-N 120.68 1.582 . . . . 0.0 111.227 169.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.464 ' HD3' ' HB3' ' A' ' 149' ' ' ALA . 75.9 Cg_exo -53.03 -27.93 38.26 Favored 'Trans proline' 0 CA--C 1.568 2.194 0 N-CA-C 119.614 2.89 . . . . 0.0 119.614 168.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 8.2 tt -70.85 -55.58 8.19 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 116.876 -1.535 . . . . 0.0 109.751 172.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 0.942 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 39.5 tp -58.43 -26.47 63.34 Favored 'General case' 0 CA--C 1.564 1.515 0 CA-C-N 121.211 1.823 . . . . 0.0 113.962 -179.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -71.53 -48.02 51.41 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 121.635 2.016 . . . . 0.0 113.409 163.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -69.92 -49.37 52.7 Favored 'General case' 0 CA--C 1.571 1.764 0 CA-C-N 121.591 1.996 . . . . 0.0 112.548 -175.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -82.16 -27.06 32.9 Favored 'General case' 0 CA--C 1.557 1.234 0 CA-C-O 115.215 -2.326 . . . . 0.0 111.437 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 0.942 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 40.8 ttt180 -67.0 -32.66 74.04 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 124.926 3.512 . . . . 0.0 115.723 167.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -67.89 -41.57 82.53 Favored 'General case' 0 CA--C 1.573 1.833 0 CA-C-N 119.713 1.142 . . . . 0.0 113.458 167.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -90.96 -28.47 18.02 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 119.675 3.213 . . . . 0.0 119.675 -176.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.8 pp -80.54 159.36 25.51 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 118.297 2.703 . . . . 0.0 118.297 -162.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 111' ' ' LEU 0.296 97.6 mttt -145.48 101.1 3.54 Favored 'General case' 0 C--N 1.361 1.072 0 CA-C-O 117.748 -1.12 . . . . 0.0 110.791 162.915 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.44 ' HB ' ' N ' ' A' ' 112' ' ' GLU 1.254 24.4 m -131.44 -153.31 0.55 Allowed 'General case' 0 CA--C 1.573 1.856 1 O-C-N 115.74 -4.35 . . . . 0.0 110.059 149.926 . . . . . . . . 4 3 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . 0.361 4.6 t -124.53 -177.81 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.413 0 CA-C-N 111.973 -2.376 . . . . 0.0 112.976 -151.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -112.18 123.36 50.11 Favored 'General case' 0 CA--C 1.564 1.491 0 CA-C-N 111.324 -2.671 . . . . 0.0 104.47 166.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -160.5 122.59 3.19 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.295 0.638 . . . . 0.0 110.546 -161.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.1 t . . . . . 0 N--CA 1.487 1.378 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.754 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 . . . . . 0 N--CA 1.5 2.04 0 N-CA-C 116.126 1.898 . . . . 0.0 116.126 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -60.82 -51.82 67.71 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 170.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 87.5 t -58.81 -35.25 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 CA-C-O 117.311 -1.328 . . . . 0.0 113.949 176.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -60.07 -37.96 81.46 Favored 'General case' 0 N--CA 1.504 2.257 0 CA-C-N 121.262 1.846 . . . . 0.0 115.953 166.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -61.12 -53.55 55.69 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 175.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -56.42 -41.32 76.17 Favored 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 117.478 2.399 . . . . 0.0 117.478 169.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -53.28 -46.29 69.22 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 116.172 1.915 . . . . 0.0 116.172 169.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.7 mp -60.97 -44.99 96.54 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 117.388 -1.291 . . . . 0.0 113.962 168.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -50.66 -42.23 56.33 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 169.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -67.08 -45.17 78.11 Favored 'General case' 0 CA--C 1.561 1.369 0 N-CA-C 116.153 1.908 . . . . 0.0 116.153 171.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 6.6 tt -77.52 -55.15 5.62 Favored 'General case' 0 CA--C 1.568 1.665 0 CA-C-N 121.051 1.75 . . . . 0.0 112.38 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.817 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -130.7 -55.5 0.09 OUTLIER Glycine 0 CA--C 1.553 2.427 0 CA-C-O 117.628 -1.651 . . . . 0.0 115.807 -175.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.817 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 86.3 tttt . . . . . 0 C--O 1.251 1.153 0 CA-C-N 120.533 2.167 . . . . 0.0 108.874 -175.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.5 mtt . . . . . 0 CA--C 1.557 1.219 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.78 169.54 21.41 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 117.612 2.449 . . . . 0.0 117.612 -167.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.427 HG13 ' HA ' ' A' ' 82' ' ' ILE . 7.9 p -127.94 138.43 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 CA-C-N 115.116 -0.947 . . . . 0.0 113.532 -165.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -118.02 120.46 37.85 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 171.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.475 HD13 ' HB2' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -99.02 121.78 41.41 Favored 'General case' 0 CA--C 1.563 1.453 0 CA-C-O 122.376 1.084 . . . . 0.0 112.538 -167.484 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.4 mt -114.23 154.11 28.47 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 111.042 -2.799 . . . . 0.0 109.333 -172.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 175.24 107.9 0.21 Allowed Glycine 0 CA--C 1.549 2.178 0 CA-C-O 116.694 -2.17 . . . . 0.0 109.48 175.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo . . . . . 0 CA--C 1.574 2.525 0 CA-C-N 122.247 3.024 . . . . 0.0 117.863 -179.342 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 48.3 mtpt . . . . . 0 N--CA 1.488 1.454 0 N-CA-C 116.367 1.988 . . . . 0.0 116.367 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -32.59 -36.65 0.04 OUTLIER Glycine 0 CA--C 1.556 2.62 0 N-CA-C 122.877 3.911 . . . . 0.0 122.877 172.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.0 m -62.63 -56.26 19.48 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 120.069 1.934 . . . . 0.0 112.664 174.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.277 17.1 mp0 -74.55 -12.25 60.42 Favored 'General case' 0 CA--C 1.574 1.889 0 CA-C-O 115.427 -2.225 . . . . 0.0 112.655 170.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.475 ' HB2' HD13 ' A' ' 5' ' ' LEU . . . -69.67 -45.27 68.76 Favored 'General case' 0 C--N 1.374 1.664 0 CA-C-N 124.506 3.321 . . . . 0.0 114.513 167.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.7 t -69.95 -38.71 76.19 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.849 0 CA-C-O 117.672 -1.156 . . . . 0.0 111.569 174.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -61.33 -47.21 86.94 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 116.6 2.074 . . . . 0.0 116.6 169.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 mt -65.62 -31.08 71.92 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 172.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.97 -44.25 97.62 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 166.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -58.69 -37.69 76.63 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 168.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -67.1 -50.94 59.86 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 172.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.6 mt -83.69 -19.83 34.59 Favored 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 -177.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.97 36.11 10.52 Favored Glycine 0 CA--C 1.555 2.548 0 N-CA-C 117.889 1.915 . . . . 0.0 117.889 -177.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.4 mm -111.53 158.11 37.31 Favored Pre-proline 0 CA--C 1.572 1.796 0 CA-C-N 119.088 1.444 . . . . 0.0 113.811 -167.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -81.81 100.58 1.1 Allowed 'Trans proline' 0 CA--C 1.573 2.436 0 C-N-CA 122.115 1.876 . . . . 0.0 111.081 162.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -64.47 110.59 2.34 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 124.074 0.949 . . . . 0.0 111.887 171.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.7 mm -99.71 113.6 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 177.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 78.9 p -96.43 136.04 37.47 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 114.942 -1.026 . . . . 0.0 108.691 169.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.0 p -69.73 -7.88 43.23 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 117.585 2.439 . . . . 0.0 117.585 -175.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -90.43 -22.61 33.93 Favored Glycine 0 CA--C 1.545 1.937 0 N-CA-C 118.563 2.185 . . . . 0.0 118.563 165.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -80.74 -51.86 8.18 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -168.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -63.53 -41.44 98.48 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 173.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.488 ' HB3' ' CG ' ' A' ' 50' ' ' LYS . 29.6 m-85 -61.13 -43.4 98.94 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-O 116.431 -1.747 . . . . 0.0 115.136 168.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 72.8 ttt180 -54.97 -44.02 74.04 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 170.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 33.7 ttt180 -59.47 -40.98 88.67 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 114.668 1.358 . . . . 0.0 114.668 168.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -68.33 -24.19 64.8 Favored 'General case' 0 CA--C 1.582 2.188 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 169.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 82.5 mt -63.03 -49.49 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 CA-C-N 120.835 1.652 . . . . 0.0 110.299 167.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -65.26 -35.29 80.58 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 175.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -68.72 -42.8 77.17 Favored 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 174.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.45 69.4 1.27 Allowed Glycine 0 CA--C 1.545 1.947 0 CA-C-O 118.905 -0.942 . . . . 0.0 114.518 -174.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.866 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 64.8 p -91.52 -49.09 6.5 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 178.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.866 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.26 38.8 mttp 110.61 -42.37 0.0 OUTLIER 'General case' 0 CA--C 1.57 1.716 0 CA-C-O 116.135 -1.888 . . . . 0.0 110.876 -172.718 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -83.08 -10.86 58.48 Favored 'General case' 0 CA--C 1.574 1.872 0 CA-C-N 123.425 2.83 . . . . 0.0 113.106 162.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.37 -55.32 24.08 Favored Glycine 0 CA--C 1.544 1.853 0 CA-C-N 120.535 1.516 . . . . 0.0 114.276 169.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.267 1.0 OUTLIER -75.62 -50.21 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 116.729 2.122 . . . . 0.0 116.729 -168.556 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -67.16 -41.4 86.08 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 120.476 1.489 . . . . 0.0 112.565 174.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.88 -25.47 48.59 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -174.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.488 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -75.0 -41.01 60.34 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 117.064 -1.446 . . . . 0.0 111.871 166.699 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -71.63 -51.32 23.78 Favored 'General case' 0 CA--C 1.591 2.536 1 CA-C-O 85.298 -16.572 . . . . 0.0 118.444 -176.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 14.9 m-30 -35.25 -55.4 0.63 Allowed 'General case' 0 N--CA 1.496 1.844 2 O-C-N 108.913 -8.617 . . . . 0.0 121.85 147.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 71.6 mt -60.83 -32.77 72.14 Favored 'General case' 0 N--CA 1.51 2.571 0 CA-C-N 124.283 3.22 . . . . 0.0 114.799 167.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -83.09 -45.25 14.21 Favored 'General case' 0 CA--C 1.568 1.663 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 172.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.15 -28.23 25.67 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 116.81 2.152 . . . . 0.0 116.81 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.64 42.59 4.76 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-N 120.243 1.383 . . . . 0.0 115.952 170.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.423 ' O ' ' NH1' ' A' ' 88' ' ' ARG . 20.2 t70 -105.17 -132.53 0.31 Allowed 'General case' 0 CA--C 1.571 1.75 0 CA-C-O 118.532 -0.747 . . . . 0.0 109.548 169.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 88.8 mt -115.15 111.91 21.73 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 120.054 1.297 . . . . 0.0 110.192 -169.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.1 p -112.74 116.91 47.37 Favored Pre-proline 0 CA--C 1.568 1.651 0 CA-C-O 117.848 -1.072 . . . . 0.0 109.26 -178.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -59.64 144.24 99.48 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 123.477 2.785 . . . . 0.0 116.354 176.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 85.5 p -77.97 178.28 7.61 Favored 'General case' 0 CA--C 1.567 1.604 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 176.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.27 16.8 m-20 80.33 -51.53 0.35 Allowed 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 126.324 1.85 . . . . 0.0 113.998 175.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.9 pp -61.91 -42.46 99.1 Favored 'General case' 0 CA--C 1.563 1.459 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 167.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.2 m -61.43 -50.51 72.5 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.331 1.052 . . . . 0.0 112.805 174.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -64.41 -21.06 66.52 Favored 'General case' 0 CA--C 1.571 1.783 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 167.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -68.52 -47.11 67.8 Favored 'General case' 0 CA--C 1.557 1.234 0 CA-C-N 120.507 1.503 . . . . 0.0 114.0 168.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.9 mt -63.1 -37.74 88.42 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 168.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 56.7 t -58.39 -53.21 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-O 118.08 -0.962 . . . . 0.0 112.059 169.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -60.37 -36.17 77.42 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 172.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -56.61 -48.4 77.53 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 116.642 -1.646 . . . . 0.0 113.097 169.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -87.61 7.53 29.34 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 120.666 3.58 . . . . 0.0 120.666 167.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 69.9 mt -66.44 -49.38 66.92 Favored 'General case' 0 CA--C 1.559 1.296 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 150.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 . . . . . 0 N--CA 1.504 2.258 0 CA-C-N 121.267 1.848 . . . . 0.0 111.535 -167.409 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.551 0 CA-C-O 122.409 1.005 . . . . 0.0 114.061 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -175.83 136.95 0.33 Allowed 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 114.205 -0.998 . . . . 0.0 110.849 -176.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.427 ' HA ' HG13 ' A' ' 3' ' ' VAL . 4.9 mm -108.97 107.89 23.97 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.489 0 N-CA-C 103.224 -2.88 . . . . 0.0 103.224 167.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 79.5 mt -114.62 118.02 32.52 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -178.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -114.54 132.34 56.35 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 118.927 0.785 . . . . 0.0 112.398 -169.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 75.56 36.06 44.78 Favored Glycine 0 CA--C 1.55 2.265 0 N-CA-C 118.803 2.281 . . . . 0.0 118.803 172.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -99.65 -58.52 0.13 Allowed Pre-proline 0 N--CA 1.495 1.787 0 CA-C-O 113.536 -3.126 . . . . 0.0 111.479 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -59.66 61.5 0.07 OUTLIER 'Trans proline' 0 CA--C 1.574 2.492 1 N-CA-C 123.141 4.247 . . . . 0.0 123.141 170.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 1.427 ' CG ' HH12 ' A' ' 140' ' ' ARG . 13.9 ttp180 -52.01 -39.68 59.83 Favored 'General case' 0 CA--C 1.573 1.859 0 N-CA-C 116.124 1.898 . . . . 0.0 116.124 163.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.3 t -154.97 153.7 31.45 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.156 1.383 . . . . 0.0 107.636 -168.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.2 t -60.16 -37.5 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 CA-C-O 117.167 -1.397 . . . . 0.0 112.188 177.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.96 -37.02 80.93 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 120.596 3.554 . . . . 0.0 120.596 172.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -77.81 -46.77 20.58 Favored 'General case' 0 CA--C 1.588 2.418 0 CA-C-N 123.468 2.849 . . . . 0.0 111.635 166.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.16 -32.87 72.6 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 117.999 2.592 . . . . 0.0 117.999 -172.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -57.54 -33.54 68.21 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 168.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.77 -39.88 88.01 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 170.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 39.2 tp -64.62 -40.11 94.9 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 169.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -60.24 -53.06 62.22 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-N 119.715 1.143 . . . . 0.0 113.37 170.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 0.923 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 35.6 mt-10 -48.01 -38.47 17.15 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 167.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 1.216 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 25.0 ttt -84.38 -25.21 29.28 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 117.825 2.528 . . . . 0.0 117.825 176.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 41.9 tp -68.38 -53.7 22.12 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-N 120.59 1.541 . . . . 0.0 110.912 169.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -76.33 -54.4 6.81 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 119.37 0.987 . . . . 0.0 113.416 175.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.923 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 75.9 mtp180 -71.6 -39.39 70.53 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 177.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 1.216 ' HB3' ' O ' ' A' ' 99' ' ' MET . 3.6 tmt_? -61.78 -56.02 23.95 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 119.699 1.136 . . . . 0.0 110.375 164.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 113.26 41.63 0.96 Allowed Glycine 0 N--CA 1.481 1.692 0 O-C-N 124.076 0.86 . . . . 0.0 114.96 167.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 36.5 p -102.13 137.6 40.19 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 169.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -71.14 135.28 47.54 Favored 'General case' 0 N--CA 1.51 2.55 0 CA-C-O 122.699 1.238 . . . . 0.0 112.293 -171.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.2 tp -79.68 102.25 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 CA-C-N 113.356 -1.747 . . . . 0.0 108.089 172.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -96.08 -61.8 1.38 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 117.301 -1.333 . . . . 0.0 110.428 167.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -150.55 112.3 4.5 Favored 'General case' 0 C--N 1.36 1.024 0 CA-C-N 120.309 1.413 . . . . 0.0 113.707 -166.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -97.17 104.67 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.678 0 CA-C-N 115.085 -0.962 . . . . 0.0 111.0 167.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.946 HD12 ' HB3' ' A' ' 160' ' ' LYS 0.311 6.9 tp -103.49 111.23 23.58 Favored 'General case' 0 CA--C 1.556 1.201 0 N-CA-C 118.446 2.758 . . . . 0.0 118.446 -157.073 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.465 ' H ' ' N ' ' A' ' 161' ' ' THR . 68.0 mt-10 -96.72 107.47 19.94 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 122.062 2.21 . . . . 0.0 115.528 -172.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -88.0 108.93 19.45 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 118.706 -2.496 . . . . 0.0 108.324 170.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.681 ' HB3' ' HA ' ' A' ' 163' ' ' ASP . 10.1 tpt180 -95.18 95.14 8.34 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 112.575 -2.102 . . . . 0.0 110.359 -172.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.564 1.483 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 -168.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 . . . . . 0 N--CA 1.496 1.86 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . 1.427 HH12 ' CG ' ' A' ' 88' ' ' ARG . 14.6 tpt180 -63.39 -43.7 96.81 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 169.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 67.4 mtt -66.04 -27.77 68.35 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 169.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -68.05 -44.56 76.11 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 169.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.5 p -66.06 -35.77 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 CA-C-N 120.514 1.507 . . . . 0.0 114.251 170.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -53.35 -56.33 17.61 Favored 'General case' 0 CA--C 1.581 2.151 0 CA-C-N 120.129 1.331 . . . . 0.0 111.522 167.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 49.9 ttt180 -53.88 -27.59 31.16 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 120.326 3.454 . . . . 0.0 120.326 173.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -54.61 -38.25 66.56 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 171.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -141.33 10.03 2.08 Favored 'General case' 0 CA--C 1.561 1.38 0 N-CA-C 119.389 3.107 . . . . 0.0 119.389 -168.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 80.3 m -47.49 -36.49 10.29 Favored 'General case' 0 N--CA 1.505 2.321 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 177.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.62 -60.95 4.13 Favored Pre-proline 0 CA--C 1.578 2.054 0 CA-C-O 116.254 -1.831 . . . . 0.0 112.021 173.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -51.07 -32.9 41.02 Favored 'Trans proline' 0 CA--C 1.578 2.689 0 C-N-CA 123.407 2.738 . . . . 0.0 118.351 167.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -67.08 -50.45 61.66 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 125.02 1.328 . . . . 0.0 111.797 176.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 1.188 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 58.3 tp -63.26 -23.53 67.46 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 170.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -70.41 -50.92 33.55 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 122.696 2.498 . . . . 0.0 113.108 165.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -61.27 -53.75 52.78 Favored 'General case' 0 CA--C 1.571 1.788 0 C-N-CA 124.141 0.976 . . . . 0.0 112.864 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -80.87 -17.62 50.05 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-O 116.006 -1.949 . . . . 0.0 113.82 177.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 1.188 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 31.7 ttt180 -69.66 -33.86 73.19 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 123.591 2.905 . . . . 0.0 115.733 167.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -73.11 -40.47 64.93 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 119.979 1.263 . . . . 0.0 113.659 167.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -82.14 -18.05 44.23 Favored 'General case' 0 CA--C 1.577 1.985 0 N-CA-C 119.142 3.016 . . . . 0.0 119.142 177.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.29 127.19 18.89 Favored 'General case' 0 CA--C 1.585 2.309 1 N-CA-C 123.692 4.701 . . . . 0.0 123.692 -159.754 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.946 ' HB3' HD12 ' A' ' 111' ' ' LEU 0.257 46.7 mmtm -92.88 -154.15 0.38 Allowed 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 123.716 1.722 . . . . 0.0 107.708 155.385 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.627 HG23 ' HB ' ' A' ' 162' ' ' VAL 0.763 0.4 OUTLIER -30.93 -164.83 0.0 OUTLIER 'General case' 0 CA--C 1.62 3.663 1 N-CA-C 128.041 6.312 . . . . 0.0 128.041 -146.103 . . . . . . . . 5 4 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.747 HG21 ' HB3' ' A' ' 174' ' ' ARG 0.475 2.1 t -88.4 -174.42 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.673 3 C-N-CA 139.219 7.008 . . . . 0.0 122.586 -146.687 . . . . . . . . 4 3 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.681 ' HA ' ' HB3' ' A' ' 114' ' ' ARG . 12.6 t70 -102.49 134.77 45.28 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 111.38 -2.645 . . . . 0.0 106.59 168.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -143.37 -146.03 0.18 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 117.057 2.243 . . . . 0.0 117.057 -155.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . 0.532 3.5 p . . . . . 0 N--CA 1.492 1.66 0 C-N-CA 128.503 2.721 . . . . 0.0 114.078 -174.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 . . . . . 0 N--CA 1.5 2.05 0 N-CA-C 114.479 1.289 . . . . 0.0 114.479 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -60.16 -53.4 58.22 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 173.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 18.2 t -66.71 -31.67 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 CA-C-N 119.778 1.172 . . . . 0.0 111.533 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -58.78 -38.17 77.92 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 164.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.46 -50.69 64.43 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . 0.747 ' HB3' HG21 ' A' ' 162' ' ' VAL . 72.9 mtt180 -61.15 -42.18 98.09 Favored 'General case' 0 CA--C 1.557 1.216 0 N-CA-C 117.305 2.335 . . . . 0.0 117.305 169.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.04 -46.87 82.09 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 116.512 2.042 . . . . 0.0 116.512 172.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 6.0 mp -63.5 -39.49 94.57 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 117.832 -1.08 . . . . 0.0 113.756 168.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -50.42 -45.81 56.02 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 169.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -74.57 -42.83 58.05 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 116.14 1.904 . . . . 0.0 116.14 172.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 8.7 tt -73.57 -51.47 16.81 Favored 'General case' 0 CA--C 1.568 1.645 0 CA-C-N 121.005 1.73 . . . . 0.0 113.213 -179.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.923 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -114.74 -59.52 0.37 Allowed Glycine 0 CA--C 1.552 2.385 0 CA-C-O 117.709 -1.606 . . . . 0.0 114.507 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.923 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 63.7 tttm . . . . . 0 C--O 1.25 1.112 0 CA-C-N 120.391 2.096 . . . . 0.0 109.144 -177.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 CA--C 1.554 1.119 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.427 ' HB2' ' O ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -154.35 171.06 19.9 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -167.548 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . 0.413 HG22 ' HB3' ' A' ' 109' ' ' ALA . 77.8 t -133.9 147.86 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.66 0 CA-C-O 124.316 2.008 . . . . 0.0 111.883 -164.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -119.21 140.47 50.16 Favored 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 111.783 -2.462 . . . . 0.0 105.522 167.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -115.84 123.51 48.35 Favored 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 124.906 1.283 . . . . 0.0 109.81 -178.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.8 mp -126.17 157.07 39.11 Favored 'General case' 0 CA--C 1.559 1.304 0 CA-C-N 112.627 -2.079 . . . . 0.0 109.748 -166.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 167.96 154.31 8.64 Favored Glycine 0 CA--C 1.554 2.504 0 N-CA-C 115.494 0.957 . . . . 0.0 115.494 169.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo . . . . . 0 CA--C 1.576 2.576 0 C-N-CA 123.173 2.582 . . . . 0.0 114.195 173.484 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.813 ' HB3' ' OD1' ' A' ' 84' ' ' ASP . 7.7 mptt . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 121.28 0.562 . . . . 0.0 111.1 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -53.01 -27.34 29.86 Favored Glycine 0 CA--C 1.556 2.612 0 N-CA-C 120.952 3.141 . . . . 0.0 120.952 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 51.7 m -63.64 -51.44 65.18 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 119.892 1.846 . . . . 0.0 112.964 171.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.34 2.7 mp0 -77.91 -12.92 60.02 Favored 'General case' 0 CA--C 1.57 1.713 0 CA-C-O 115.088 -2.387 . . . . 0.0 112.537 172.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.43 -43.76 63.37 Favored 'General case' 0 C--N 1.376 1.733 0 CA-C-N 124.598 3.363 . . . . 0.0 114.142 165.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 93.4 t -65.74 -42.7 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-O 117.677 -1.154 . . . . 0.0 112.655 173.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . 0.445 ' HB3' ' HE1' ' A' ' 172' ' ' PHE . 95.1 mttt -68.01 -44.35 76.75 Favored 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 115.797 1.777 . . . . 0.0 115.797 174.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.88 -29.08 68.89 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 120.58 1.536 . . . . 0.0 114.317 171.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.56 -41.3 98.42 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 167.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.97 -40.58 80.96 Favored 'General case' 0 CA--C 1.566 1.559 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 167.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -66.18 -50.86 62.44 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 172.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.2 mt -83.16 -22.72 33.2 Favored 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 116.807 2.151 . . . . 0.0 116.807 -177.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.23 34.6 8.61 Favored Glycine 0 CA--C 1.555 2.547 0 N-CA-C 117.742 1.857 . . . . 0.0 117.742 -174.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.1 mm -105.43 152.46 39.94 Favored Pre-proline 0 CA--C 1.568 1.651 0 CA-C-N 119.149 1.474 . . . . 0.0 112.205 -169.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -82.6 99.74 0.95 Allowed 'Trans proline' 0 CA--C 1.564 1.988 0 CA-C-N 122.06 1.771 . . . . 0.0 108.668 162.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.22 116.92 11.14 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.991 0.9 . . . . 0.0 110.226 176.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 38.6 mm -97.91 108.25 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 -176.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 70.0 p -96.2 129.56 43.48 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 172.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.6 p -71.36 -8.66 55.18 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 -170.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.535 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -92.12 -17.64 46.28 Favored Glycine 0 CA--C 1.55 2.23 0 N-CA-C 118.29 2.076 . . . . 0.0 118.29 165.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -79.37 -55.83 4.77 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 119.097 1.449 . . . . 0.0 113.683 -168.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -60.06 -38.02 81.59 Favored 'General case' 0 CA--C 1.565 1.522 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 173.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.421 ' HB2' ' HB2' ' A' ' 50' ' ' LYS . 41.8 m-85 -67.88 -41.81 82.21 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 116.676 -1.63 . . . . 0.0 113.719 169.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.535 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 35.2 ttt180 -54.05 -40.13 66.84 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 116.587 2.069 . . . . 0.0 116.587 169.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -63.29 -39.72 95.37 Favored 'General case' 0 CA--C 1.566 1.578 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 169.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -67.64 -23.63 65.36 Favored 'General case' 0 CA--C 1.587 2.398 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 167.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.5 mt -62.35 -50.46 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.485 0 CA-C-N 121.609 2.004 . . . . 0.0 109.239 166.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -60.3 -40.99 92.46 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 175.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -70.01 -37.2 75.58 Favored 'General case' 0 CA--C 1.563 1.462 0 N-CA-C 116.84 2.163 . . . . 0.0 116.84 173.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.65 75.07 1.29 Allowed Glycine 0 CA--C 1.544 1.895 0 CA-C-O 117.754 -1.581 . . . . 0.0 114.733 -175.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.939 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 82.2 p -96.45 -62.81 1.21 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 119.683 1.742 . . . . 0.0 111.29 170.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.939 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.302 13.0 mttt 115.83 -42.75 0.01 OUTLIER 'General case' 0 CA--C 1.573 1.861 0 CA-C-O 116.064 -1.922 . . . . 0.0 108.871 -173.423 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.41 -14.96 60.49 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 123.395 2.816 . . . . 0.0 112.891 161.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.456 ' O ' ' HB3' ' A' ' 50' ' ' LYS . . . -58.99 -62.9 5.7 Favored Glycine 0 C--N 1.355 1.598 0 CA-C-N 120.11 1.323 . . . . 0.0 114.148 169.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.295 7.7 p -69.23 -51.4 43.51 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.302 0 N-CA-C 116.862 2.171 . . . . 0.0 116.862 -168.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -67.09 -45.93 75.78 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 119.923 1.238 . . . . 0.0 112.397 176.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.27 -28.97 67.66 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.456 ' HB3' ' O ' ' A' ' 46' ' ' GLY 0.278 4.2 tptt -76.02 -37.43 58.42 Favored 'General case' 0 CA--C 1.559 1.319 0 CA-C-O 116.21 -1.852 . . . . 0.0 113.11 170.986 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -78.31 -45.57 22.36 Favored 'General case' 0 CA--C 1.602 2.968 1 CA-C-O 86.548 -15.977 . . . . 0.0 118.565 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 17.2 m-30 -31.07 -54.18 0.21 Allowed 'General case' 0 N--CA 1.498 1.937 1 O-C-N 108.236 -9.04 . . . . 0.0 120.467 145.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.49 -49.96 63.68 Favored 'General case' 0 CA--C 1.576 1.949 0 CA-C-N 121.796 2.089 . . . . 0.0 114.462 166.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -77.0 -44.81 29.55 Favored 'General case' 0 CA--C 1.565 1.542 0 N-CA-C 115.948 1.832 . . . . 0.0 115.948 177.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -87.22 -24.84 24.28 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 116.148 1.906 . . . . 0.0 116.148 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.32 22.64 11.31 Favored Glycine 0 CA--C 1.544 1.856 0 N-CA-C 117.883 1.913 . . . . 0.0 117.883 168.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -95.62 177.96 5.63 Favored 'General case' 0 CA--C 1.573 1.865 0 CA-C-N 118.617 1.208 . . . . 0.0 110.504 168.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.3 pp -76.64 124.17 27.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.494 -1.378 . . . . 0.0 112.836 -168.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 p -113.4 122.47 35.31 Favored Pre-proline 0 CA--C 1.567 1.627 0 C-N-CA 124.656 1.182 . . . . 0.0 108.601 -177.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -55.51 141.62 82.43 Favored 'Trans proline' 0 C--N 1.37 1.666 0 C-N-CA 123.449 2.766 . . . . 0.0 116.135 174.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.6 m -85.46 177.55 7.73 Favored 'General case' 0 CA--C 1.569 1.707 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.712 177.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.9 t70 82.09 -52.03 0.23 Allowed 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 125.77 1.628 . . . . 0.0 113.64 178.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.2 pp -58.17 -41.75 84.52 Favored 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 116.335 1.976 . . . . 0.0 116.335 168.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.5 m -58.63 -51.96 67.72 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 124.914 1.286 . . . . 0.0 113.313 170.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -62.08 -21.97 65.39 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 167.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -76.95 -45.86 26.15 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 125.366 1.466 . . . . 0.0 114.841 172.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.4 mt -61.97 -45.77 92.21 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 169.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 52.7 t -56.42 -55.55 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-O 117.944 -1.027 . . . . 0.0 111.497 171.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -61.22 -31.08 70.86 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 116.836 2.162 . . . . 0.0 116.836 175.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -60.61 -40.46 91.93 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-O 117.937 -1.03 . . . . 0.0 113.288 167.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -80.92 -23.37 38.95 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 118.521 2.786 . . . . 0.0 118.521 169.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 66.4 mt -85.59 -22.14 28.17 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 116.832 2.16 . . . . 0.0 116.832 178.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 . . . . . 0 N--CA 1.498 1.969 0 N-CA-C 116.994 2.22 . . . . 0.0 116.994 169.434 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.537 1.434 0 CA-C-O 122.302 0.946 . . . . 0.0 113.472 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . 0.427 ' O ' ' HB2' ' A' ' 2' ' ' ARG . 30.3 p90 -179.08 135.04 0.13 Allowed 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 113.862 -1.169 . . . . 0.0 111.121 176.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 22.1 mt -114.33 109.41 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 105.037 -2.208 . . . . 0.0 105.037 172.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.4 mt -101.21 120.95 40.99 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 118.643 -0.694 . . . . 0.0 109.638 174.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.813 ' OD1' ' HB3' ' A' ' 13' ' ' LYS . 25.1 t70 -110.13 129.21 55.74 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 119.006 0.821 . . . . 0.0 110.983 -177.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 74.27 39.62 43.35 Favored Glycine 0 CA--C 1.552 2.361 0 CA-C-O 117.361 -1.799 . . . . 0.0 117.258 -178.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . 0.256 1.0 OUTLIER -103.8 -58.05 0.08 OUTLIER Pre-proline 0 N--CA 1.496 1.834 0 CA-C-O 113.35 -3.214 . . . . 0.0 111.01 -174.439 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -63.22 70.89 0.14 Allowed 'Trans proline' 0 CA--C 1.571 2.35 0 CA-C-N 126.724 3.437 . . . . 0.0 119.29 167.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -67.53 -29.53 68.96 Favored 'General case' 0 CA--C 1.567 1.623 0 C-N-CA 125.907 1.683 . . . . 0.0 114.503 166.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 77.1 p -151.02 159.52 44.5 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.05 1.34 . . . . 0.0 108.78 -172.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.0 t -64.73 -41.69 92.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 CA-C-O 117.425 -1.274 . . . . 0.0 110.752 167.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.16 -37.79 86.58 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 120.672 3.582 . . . . 0.0 120.672 178.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -75.92 -48.29 21.88 Favored 'General case' 0 CA--C 1.583 2.225 0 CA-C-N 122.586 2.448 . . . . 0.0 111.94 167.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.14 -31.5 72.65 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 117.485 2.402 . . . . 0.0 117.485 -171.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 64.3 tttt -60.34 -30.48 69.55 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 168.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.53 -47.6 75.35 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 168.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.9 tp -58.48 -41.96 86.43 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 170.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -72.81 -41.52 64.83 Favored 'General case' 0 CA--C 1.567 1.596 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 176.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 1.334 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 37.7 mt-10 -56.18 -32.62 64.51 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 165.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 1.304 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 26.8 ttt -84.72 -28.5 26.26 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 118.152 2.649 . . . . 0.0 118.152 173.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 64.0 tp -66.88 -54.22 24.48 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-N 120.319 1.418 . . . . 0.0 112.855 169.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -79.7 -49.55 11.93 Favored 'General case' 0 CA--C 1.563 1.472 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 176.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 1.334 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 38.0 mmt180 -68.64 -45.39 71.96 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 175.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 1.304 ' HB3' ' O ' ' A' ' 99' ' ' MET . 74.8 ttt180 -61.4 -57.25 13.01 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 118.843 0.747 . . . . 0.0 111.398 165.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.82 43.16 1.05 Allowed Glycine 0 N--CA 1.479 1.536 0 O-C-N 124.41 1.069 . . . . 0.0 113.941 169.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 40.2 p -90.97 147.18 23.27 Favored 'General case' 0 CA--C 1.559 1.318 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 168.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -65.12 130.62 44.01 Favored 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -169.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.5 tp -90.43 99.17 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 125.344 1.458 . . . . 0.0 107.512 177.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -98.55 -75.15 0.56 Allowed 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 115.898 -2.001 . . . . 0.0 108.419 168.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . 0.413 ' HB3' HG22 ' A' ' 3' ' ' VAL . . . -136.3 117.37 14.36 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 121.644 2.02 . . . . 0.0 113.459 -174.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.4 t -94.99 108.07 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 101.628 -3.471 . . . . 0.0 101.628 167.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.464 HD23 ' HB3' ' A' ' 160' ' ' LYS . 78.8 mt -109.19 105.33 14.73 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -164.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -90.55 130.9 36.54 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.93 0.871 . . . . 0.0 111.478 172.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -100.38 110.1 22.29 Favored 'General case' 0 CA--C 1.559 1.316 0 CA-C-N 114.227 -1.351 . . . . 0.0 109.426 -176.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . . . . . . . . 0.25 71.8 ttt180 -73.11 101.12 3.21 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 126.835 2.054 . . . . 0.0 109.497 169.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.9 p . . . . . 0 CA--C 1.566 1.584 0 CA-C-N 112.416 -2.175 . . . . 0.0 110.491 -165.512 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 . . . . . 0 N--CA 1.494 1.767 0 N-CA-C 113.96 1.096 . . . . 0.0 113.96 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -57.28 -37.98 73.23 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 115.262 1.579 . . . . 0.0 115.262 165.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 24.9 ttt -67.2 -33.97 76.52 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 168.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 60.9 mttm -60.73 -50.73 72.32 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 169.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.4 p -64.08 -31.53 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 170.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -54.45 -49.5 69.92 Favored 'General case' 0 CA--C 1.583 2.226 0 CA-C-N 119.755 1.161 . . . . 0.0 112.104 167.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 66.9 ttt180 -60.04 -41.4 92.21 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 118.461 2.763 . . . . 0.0 118.461 174.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -51.38 -29.06 14.34 Favored 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 118.998 2.962 . . . . 0.0 118.998 172.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -132.9 -37.31 1.01 Allowed 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 119.635 3.198 . . . . 0.0 119.635 -163.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 86.0 m -46.51 -39.69 11.26 Favored 'General case' 0 N--CA 1.504 2.248 0 N-CA-C 118.654 2.835 . . . . 0.0 118.654 -167.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.403 ' HB3' ' HD3' ' A' ' 150' ' ' PRO . . . -68.72 -61.4 3.69 Favored Pre-proline 0 CA--C 1.579 2.087 0 CA-C-O 116.466 -1.731 . . . . 0.0 112.118 175.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.403 ' HD3' ' HB3' ' A' ' 149' ' ' ALA . 86.9 Cg_exo -51.85 -31.16 41.45 Favored 'Trans proline' 0 CA--C 1.579 2.748 0 C-N-CA 123.387 2.725 . . . . 0.0 118.392 167.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.43 -54.38 33.62 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 125.515 1.526 . . . . 0.0 111.955 174.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 1.157 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 52.1 tp -65.47 -21.7 66.66 Favored 'General case' 0 CA--C 1.566 1.566 0 CA-C-O 116.803 -1.57 . . . . 0.0 114.801 175.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -71.44 -50.66 29.59 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 122.227 2.285 . . . . 0.0 113.307 164.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -65.86 -52.48 49.94 Favored 'General case' 0 CA--C 1.566 1.576 0 CA-C-N 120.466 1.484 . . . . 0.0 112.401 -178.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -76.59 -30.48 57.01 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-O 114.994 -2.431 . . . . 0.0 111.393 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 1.157 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 32.1 ttt180 -59.68 -34.05 72.36 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 124.955 3.525 . . . . 0.0 116.91 168.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -68.58 -41.88 79.04 Favored 'General case' 0 CA--C 1.573 1.83 0 CA-C-N 119.659 1.118 . . . . 0.0 113.519 167.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 38.9 mm-40 -90.63 -19.37 23.74 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 119.99 3.33 . . . . 0.0 119.99 -178.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.7 pp -77.97 179.72 6.59 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 119.506 3.15 . . . . 0.0 119.506 -161.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . 0.464 ' HB3' HD23 ' A' ' 111' ' ' LEU . 50.9 mttt -135.59 135.88 40.62 Favored 'General case' 0 CA--C 1.564 1.493 0 N-CA-C 105.113 -2.18 . . . . 0.0 105.113 167.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 42.0 m -100.34 146.15 27.3 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 122.217 1.008 . . . . 0.0 110.269 -172.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 43.1 t -131.36 136.11 58.17 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.392 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 167.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -94.95 126.97 40.65 Favored 'General case' 0 CA--C 1.565 1.555 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 169.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -109.34 7.85 25.29 Favored 'General case' 0 N--CA 1.493 1.678 1 N-CA-C 126.339 5.681 . . . . 0.0 126.339 -159.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . . . . . . . . 0.486 29.2 m . . . . . 0 CA--C 1.594 2.641 1 CA-C-O 109.954 -4.831 . . . . 0.0 107.597 -178.009 . . . . . . . . 2 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 . . . . . 0 N--CA 1.502 2.169 0 N-CA-C 115.925 1.824 . . . . 0.0 115.925 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -60.18 -52.79 63.8 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 169.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 2.7 t -59.27 -35.25 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . 0.445 ' HE1' ' HB3' ' A' ' 19' ' ' LYS . 8.4 t80 -61.16 -40.81 95.27 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 167.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.12 -43.49 95.12 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 115.089 1.515 . . . . 0.0 115.089 175.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 82.2 mtt-85 -71.73 -36.74 70.58 Favored 'General case' 0 CA--C 1.56 1.36 0 N-CA-C 116.265 1.95 . . . . 0.0 116.265 173.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.38 -44.16 92.21 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 171.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.7 mp -64.88 -42.08 95.11 Favored 'General case' 0 CA--C 1.567 1.612 0 CA-C-O 117.148 -1.406 . . . . 0.0 110.656 167.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -46.64 -41.61 14.99 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 117.567 2.432 . . . . 0.0 117.567 168.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -67.1 -48.51 67.95 Favored 'General case' 0 CA--C 1.562 1.431 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 168.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 5.8 tt -86.25 -58.13 2.75 Favored 'General case' 0 CA--C 1.57 1.72 0 CA-C-N 120.275 1.398 . . . . 0.0 113.575 -176.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 0.539 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -118.49 -56.88 0.27 Allowed Glycine 0 CA--C 1.553 2.438 0 CA-C-O 117.339 -1.811 . . . . 0.0 116.353 -174.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 0.539 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 38.9 ttmt . . . . . 0 C--O 1.251 1.166 0 CA-C-N 120.957 2.378 . . . . 0.0 108.207 -173.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.5 ttm . . . . . 0 CA--C 1.56 1.328 0 CA-C-O 122.517 1.151 . . . . 0.0 109.631 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . 0.263 11.4 mpt_? -123.64 162.25 23.43 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 120.582 3.549 . . . . 0.0 120.582 -161.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.8 p -151.08 147.36 15.67 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.744 0 CA-C-O 123.931 1.825 . . . . 0.0 114.424 167.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.3 mt -131.83 133.44 44.68 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-N 111.42 -2.627 . . . . 0.0 108.375 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.48 120.26 41.03 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -169.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.8 mt -110.37 135.74 50.62 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 112.231 -2.258 . . . . 0.0 109.568 175.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 173.84 168.43 34.81 Favored Glycine 0 CA--C 1.56 2.869 0 N-CA-C 115.848 1.099 . . . . 0.0 115.848 171.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo . . . . . 0 CA--C 1.572 2.378 0 C-N-CA 123.44 2.76 . . . . 0.0 116.725 179.594 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt . . . . . 0 N--CA 1.484 1.249 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -57.84 -30.66 63.31 Favored Glycine 0 CA--C 1.552 2.386 0 N-CA-C 120.053 2.781 . . . . 0.0 120.053 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 54.6 m -66.78 -53.82 29.09 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 119.852 1.826 . . . . 0.0 112.539 176.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -74.31 -16.79 60.92 Favored 'General case' 0 CA--C 1.573 1.84 0 CA-C-O 116.057 -1.925 . . . . 0.0 112.403 172.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.57 -41.31 63.09 Favored 'General case' 0 C--N 1.372 1.582 0 CA-C-N 123.288 2.767 . . . . 0.0 114.912 169.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.7 t -69.03 -39.26 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 CA-C-O 117.644 -1.169 . . . . 0.0 111.789 171.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -61.62 -46.39 90.01 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 116.353 1.983 . . . . 0.0 116.353 170.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.93 -33.49 75.94 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 172.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.06 -41.6 96.92 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 167.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -59.49 -38.12 80.03 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 166.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -66.09 -50.78 62.9 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 116.142 1.905 . . . . 0.0 116.142 171.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.5 mt -81.39 -24.49 36.95 Favored 'General case' 0 CA--C 1.571 1.78 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 -178.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.15 37.07 7.89 Favored Glycine 0 CA--C 1.555 2.542 0 N-CA-C 117.771 1.868 . . . . 0.0 117.771 -176.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.1 mm -109.24 159.2 32.17 Favored Pre-proline 0 CA--C 1.567 1.624 0 CA-C-N 118.833 1.317 . . . . 0.0 113.53 -168.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' PRO . . . . . 0.412 ' HB2' HH11 ' A' ' 71' ' ' ARG . 73.1 Cg_exo -71.67 100.6 1.07 Allowed 'Trans proline' 0 CA--C 1.563 1.969 0 C-N-CA 122.0 1.8 . . . . 0.0 114.224 160.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -73.41 109.85 7.25 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.383 -0.823 . . . . 0.0 111.044 167.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.3 mm -98.23 119.84 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 167.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 62.9 p -99.89 124.66 45.43 Favored 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 161.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.5 p -66.05 -18.61 65.45 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 117.306 2.335 . . . . 0.0 117.306 -169.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLY . . . . . 0.429 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -80.29 -18.93 70.37 Favored Glycine 0 CA--C 1.548 2.098 0 N-CA-C 118.805 2.282 . . . . 0.0 118.805 168.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -80.24 -49.86 11.02 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -169.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -69.15 -36.35 77.33 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 174.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PHE . . . . . 0.442 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 42.5 m-85 -66.95 -38.48 86.21 Favored 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 125.379 1.472 . . . . 0.0 114.575 169.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 29.5 ttp180 -61.21 -40.67 94.85 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-N 120.109 1.322 . . . . 0.0 113.578 166.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -59.14 -37.15 76.58 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 168.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -66.36 -31.91 72.97 Favored 'General case' 0 CA--C 1.573 1.828 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 166.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.36 -45.68 97.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 CA-C-N 120.092 1.314 . . . . 0.0 112.65 170.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -68.17 -39.89 82.43 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 120.074 1.307 . . . . 0.0 113.814 174.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -77.05 -28.99 54.96 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 116.849 2.166 . . . . 0.0 116.849 178.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.08 74.17 1.28 Allowed Glycine 0 CA--C 1.542 1.757 0 CA-C-O 118.088 -1.395 . . . . 0.0 115.168 178.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.921 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 62.6 p -91.62 -60.24 1.93 Allowed 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 119.127 1.464 . . . . 0.0 111.285 169.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.921 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.287 13.4 mttt 114.44 -40.88 0.01 OUTLIER 'General case' 0 CA--C 1.567 1.604 0 CA-C-O 115.874 -2.012 . . . . 0.0 109.534 -173.103 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.513 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -73.14 -23.18 60.44 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 123.609 2.913 . . . . 0.0 111.729 161.146 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.55 -54.85 33.21 Favored Glycine 0 C--N 1.352 1.436 0 C-N-CA 125.673 1.606 . . . . 0.0 115.912 174.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.293 0.8 OUTLIER -65.62 -57.0 12.54 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.714 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -179.717 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -67.81 -51.01 53.69 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 120.033 1.288 . . . . 0.0 112.344 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' A' ' 45' ' ' LEU . . . -67.25 -19.51 65.52 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 176.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . 0.442 ' HB2' ' HB3' ' A' ' 35' ' ' PHE . 14.1 tmtt? -74.53 -45.52 45.15 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 120.577 1.535 . . . . 0.0 112.929 167.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -75.08 -48.37 24.24 Favored 'General case' 0 CA--C 1.583 2.227 1 CA-C-O 85.341 -16.552 . . . . 0.0 119.564 -176.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 12.9 m-30 -34.5 -54.33 0.53 Allowed 'General case' 0 N--CA 1.496 1.871 1 O-C-N 109.293 -8.38 . . . . 0.0 120.481 146.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.6 tp -59.41 -30.95 68.83 Favored 'General case' 0 CA--C 1.579 2.093 0 CA-C-N 122.366 2.348 . . . . 0.0 115.569 167.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -91.27 -41.79 10.75 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 115.964 1.838 . . . . 0.0 115.964 170.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.97 -35.29 26.05 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.42 34.04 5.18 Favored Glycine 0 N--CA 1.476 1.344 0 N-CA-C 118.146 2.018 . . . . 0.0 118.146 167.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -93.55 -129.69 0.13 Allowed 'General case' 0 CA--C 1.567 1.612 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 169.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 88.2 mt -103.12 97.58 7.65 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 119.971 1.259 . . . . 0.0 110.322 -169.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 p -104.03 118.2 57.66 Favored Pre-proline 0 CA--C 1.568 1.661 0 CA-C-O 117.603 -1.189 . . . . 0.0 108.786 176.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -57.26 141.4 94.57 Favored 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 123.491 2.794 . . . . 0.0 116.383 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 74.1 m -71.29 -49.91 38.01 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -65.79 -39.02 90.54 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 -177.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 28.4 mt -56.58 -50.57 71.54 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 117.54 2.422 . . . . 0.0 117.54 175.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 35.7 m -64.57 -46.46 82.64 Favored 'General case' 0 CA--C 1.566 1.593 0 CA-C-N 112.553 -2.112 . . . . 0.0 112.982 174.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -61.6 -21.5 64.4 Favored 'General case' 0 CA--C 1.577 2.003 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 165.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -75.11 -40.53 59.81 Favored 'General case' 0 CA--C 1.556 1.19 0 CA-C-N 121.026 1.739 . . . . 0.0 115.228 169.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 mt -59.89 -48.98 79.5 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-N 120.21 1.368 . . . . 0.0 114.129 167.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.491 HG22 HH21 ' A' ' 71' ' ' ARG . 0.4 OUTLIER -57.62 -44.64 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 172.667 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -67.17 -33.27 75.05 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.689 1.737 . . . . 0.0 115.689 169.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -58.62 -42.1 87.45 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 117.524 -1.227 . . . . 0.0 113.125 170.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ARG . . . . . 0.491 HH21 HG22 ' A' ' 68' ' ' VAL . 3.2 ppt_? -80.24 -16.99 53.5 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 118.582 2.808 . . . . 0.0 118.582 167.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 12.3 mt -103.96 3.41 33.49 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 119.192 3.034 . . . . 0.0 119.192 174.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 . . . . . 0 N--CA 1.505 2.285 0 CA-C-O 123.635 1.683 . . . . 0.0 112.558 162.543 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.539 1.551 0 CA-C-O 124.199 1.999 . . . . 0.0 115.933 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -167.48 138.59 3.03 Favored 'General case' 0 CA--C 1.551 1.019 0 CA-C-N 111.386 -2.407 . . . . 0.0 106.099 169.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -115.38 109.34 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 102.847 -3.02 . . . . 0.0 102.847 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.5 mt -109.82 141.96 41.75 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.518 0.727 . . . . 0.0 109.707 175.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -130.88 127.84 39.36 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 118.364 0.529 . . . . 0.0 111.928 169.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.56 39.04 86.98 Favored Glycine 0 CA--C 1.556 2.604 0 N-CA-C 117.378 1.711 . . . . 0.0 117.378 -178.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -99.63 -52.93 0.19 Allowed Pre-proline 0 N--CA 1.498 1.936 0 CA-C-O 115.139 -2.362 . . . . 0.0 108.807 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -66.41 72.06 0.41 Allowed 'Trans proline' 0 CA--C 1.568 2.199 0 CA-C-N 124.211 2.54 . . . . 0.0 117.932 165.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -65.32 -39.28 92.24 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 167.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.0 t -148.96 153.28 37.73 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -169.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.4 t -59.92 -38.49 76.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-O 117.298 -1.334 . . . . 0.0 112.355 178.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.66 -34.2 73.94 Favored 'General case' 0 C--N 1.361 1.074 0 N-CA-C 120.091 3.367 . . . . 0.0 120.091 173.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.04 -49.51 13.86 Favored 'General case' 0 CA--C 1.586 2.349 0 CA-C-N 122.326 2.33 . . . . 0.0 111.46 166.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.0 -31.43 71.81 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 117.102 2.26 . . . . 0.0 117.102 -170.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 58.5 tttt -61.97 -29.26 70.12 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 167.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.37 -39.55 74.55 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 167.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.3 tp -63.11 -36.5 83.79 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 168.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 57.0 t60 -63.84 -43.77 95.15 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 120.261 1.391 . . . . 0.0 113.243 167.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' GLU . . . . . 1.253 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 32.2 mt-10 -54.38 -33.51 59.33 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 167.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' MET . . . . . 0.997 ' O ' ' CB ' ' A' ' 103' ' ' ARG . 1.7 tmt? -85.99 -31.41 22.06 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 118.451 2.759 . . . . 0.0 118.451 171.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 tt -70.89 -53.59 14.53 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-N 121.257 1.844 . . . . 0.0 111.067 172.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -76.56 -50.95 12.61 Favored 'General case' 0 CA--C 1.564 1.507 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 174.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 1.253 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 25.2 mmt85 -71.0 -43.04 68.8 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 177.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.997 ' CB ' ' O ' ' A' ' 99' ' ' MET . 0.2 OUTLIER -61.93 -57.15 12.82 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 118.842 0.747 . . . . 0.0 111.083 165.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 111.54 47.48 0.74 Allowed Glycine 0 N--CA 1.481 1.648 0 O-C-N 124.227 0.954 . . . . 0.0 114.46 167.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 61.9 p -85.48 155.84 21.06 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-N 113.85 -1.175 . . . . 0.0 109.538 168.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -71.34 132.04 44.3 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.343 -0.848 . . . . 0.0 110.982 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 6.5 tp -93.84 96.71 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 -175.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -98.97 -73.29 0.63 Allowed 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 115.796 -2.049 . . . . 0.0 109.062 170.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -149.54 124.89 10.21 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 117.564 2.431 . . . . 0.0 117.564 -167.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 62.0 t -92.84 113.55 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 102.66 -3.089 . . . . 0.0 102.66 160.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 71.5 mt -98.15 101.31 12.74 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.838 -178.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -89.01 115.65 26.73 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.849 169.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -92.91 112.23 24.12 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 124.446 1.098 . . . . 0.0 111.478 -175.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ARG . . . . . 0.449 ' HB3' ' HA ' ' A' ' 163' ' ' ASP . 13.5 tpt180 -81.21 97.38 7.59 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.582 1.553 . . . . 0.0 109.053 168.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' VAL . . . . . 0.502 HG13 HG11 ' A' ' 165' ' ' VAL . 43.5 t . . . . . 0 CA--C 1.566 1.591 0 C-N-CA 126.142 1.777 . . . . 0.0 106.965 -170.724 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 . . . . . 0 N--CA 1.495 1.78 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 43.5 mmt-85 -64.3 -40.57 96.2 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 168.034 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 93.5 mmm -60.47 -26.97 67.18 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 165.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -65.73 -40.08 91.82 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 120.249 1.386 . . . . 0.0 113.43 164.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.8 t -63.47 -27.22 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 CA-C-N 119.794 1.179 . . . . 0.0 112.958 168.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -66.14 -51.56 56.73 Favored 'General case' 0 CA--C 1.575 1.939 0 CA-C-N 120.748 1.613 . . . . 0.0 112.538 165.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 47.9 ttt180 -52.4 -26.59 12.94 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 120.238 3.421 . . . . 0.0 120.238 177.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.81 -67.58 0.3 Allowed 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 119.911 1.232 . . . . 0.0 112.432 169.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -148.84 22.82 0.99 Allowed 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 119.534 3.161 . . . . 0.0 119.534 -168.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 69.4 m -56.48 -29.06 61.3 Favored 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' ALA . . . . . 0.423 ' HB3' ' HD3' ' A' ' 150' ' ' PRO . . . -71.49 -60.89 2.36 Favored Pre-proline 0 CA--C 1.58 2.099 0 CA-C-O 116.093 -1.908 . . . . 0.0 112.118 171.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' PRO . . . . . 0.423 ' HD3' ' HB3' ' A' ' 149' ' ' ALA . 78.5 Cg_exo -52.65 -33.19 57.97 Favored 'Trans proline' 0 CA--C 1.576 2.608 0 C-N-CA 123.458 2.772 . . . . 0.0 118.806 168.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.76 -52.14 53.44 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 125.259 1.423 . . . . 0.0 111.161 174.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' LEU . . . . . 1.154 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 49.1 tp -62.49 -21.78 65.75 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 171.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -72.01 -49.86 33.46 Favored 'General case' 0 CA--C 1.564 1.49 0 CA-C-N 122.759 2.527 . . . . 0.0 113.694 165.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -63.23 -54.06 43.37 Favored 'General case' 0 CA--C 1.567 1.629 0 CA-C-N 120.494 1.497 . . . . 0.0 112.676 178.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -74.06 -32.88 63.48 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-O 115.275 -2.298 . . . . 0.0 112.177 178.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ARG . . . . . 1.154 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 32.6 ttt180 -58.85 -34.91 72.11 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 124.187 3.176 . . . . 0.0 116.939 169.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -68.13 -38.84 82.64 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 167.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -89.3 -26.04 21.35 Favored 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 119.449 3.129 . . . . 0.0 119.449 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.4 pp -81.2 175.45 10.61 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 118.119 2.637 . . . . 0.0 118.119 -163.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 35.9 tttp -123.49 128.99 50.57 Favored 'General case' 0 CA--C 1.561 1.376 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 164.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 11.0 t -101.96 144.63 30.34 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 122.536 1.16 . . . . 0.0 110.065 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 27.7 t -110.52 130.51 63.7 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.325 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 169.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' ASP . . . . . 0.449 ' HA ' ' HB3' ' A' ' 114' ' ' ARG . 16.5 t70 -103.7 117.46 34.42 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 102.593 -3.114 . . . . 0.0 102.593 168.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -121.77 -174.44 2.87 Favored 'General case' 0 CA--C 1.555 1.136 0 N-CA-C 117.831 2.53 . . . . 0.0 117.831 -157.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' VAL . . . . . 0.502 HG11 HG13 ' A' ' 115' ' ' VAL 0.543 0.9 OUTLIER . . . . . 0 CA--C 1.559 1.296 0 CA-C-N 109.667 -3.424 . . . . 0.0 115.008 167.813 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 . . . . . 0 N--CA 1.512 2.644 0 N-CA-C 117.948 2.573 . . . . 0.0 117.948 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -46.51 -50.4 17.14 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 169.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 3.8 t -52.08 -38.77 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 175.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -63.14 -41.81 99.35 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 120.649 1.568 . . . . 0.0 114.829 168.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -57.38 -52.0 67.11 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 174.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 10.4 mtt-85 -66.02 -37.66 86.47 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 117.815 2.524 . . . . 0.0 117.815 174.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.67 -45.56 93.67 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 115.72 1.748 . . . . 0.0 115.72 172.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' LEU . . . . . . . . . . . . 0.281 0.4 OUTLIER -72.27 -35.16 68.66 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 169.935 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -53.3 -41.83 66.02 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 167.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.86 -54.76 29.88 Favored 'General case' 0 CA--C 1.561 1.403 0 N-CA-C 114.73 1.382 . . . . 0.0 114.73 168.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 5.4 tt -81.68 -63.29 1.42 Allowed 'General case' 0 CA--C 1.565 1.558 0 CA-C-O 117.597 -1.192 . . . . 0.0 113.142 -176.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' GLY . . . . . 1.127 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -89.21 -48.72 3.7 Favored Glycine 0 CA--C 1.551 2.337 0 CA-C-N 120.915 1.689 . . . . 0.0 116.106 -174.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' LYS . . . . . 1.127 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.303 0 CA-C-N 119.259 1.529 . . . . 0.0 108.988 -175.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 61.5 mtt . . . . . 0 CA--C 1.558 1.276 0 CA-C-O 122.772 1.273 . . . . 0.0 111.881 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.439 HH11 ' HG3' ' A' ' 2' ' ' ARG 0.3 5.8 ttm-85 -150.27 152.99 35.37 Favored 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 116.612 2.079 . . . . 0.0 116.612 -162.777 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 62.5 t -141.59 145.04 25.04 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 CA-C-O 124.176 1.941 . . . . 0.0 111.098 -174.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -125.26 135.41 52.49 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-N 112.509 -2.132 . . . . 0.0 106.944 175.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.98 114.35 23.68 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-O 122.452 1.12 . . . . 0.0 110.533 -169.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -113.29 160.9 17.85 Favored 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 113.053 -1.885 . . . . 0.0 110.562 -168.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 151.8 149.36 5.06 Favored Glycine 0 CA--C 1.555 2.548 0 CA-C-O 118.2 -1.333 . . . . 0.0 114.129 169.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -56.28 168.27 2.13 Favored 'Trans proline' 0 CA--C 1.574 2.511 0 C-N-CA 123.375 2.717 . . . . 0.0 116.532 169.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 67.8 Cg_exo -50.81 132.53 37.21 Favored 'Trans proline' 0 CA--C 1.561 1.869 0 C-N-CA 123.573 2.848 . . . . 0.0 114.615 170.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 151.3 110.36 0.48 Allowed Glycine 0 C--N 1.345 1.078 0 N-CA-C 107.58 -2.208 . . . . 0.0 107.58 -167.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -27.29 -46.27 0.03 OUTLIER 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 121.751 3.982 . . . . 0.0 121.751 -177.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.437 ' O ' ' CG ' ' A' ' 13' ' ' LYS . . . -71.5 107.35 2.15 Favored Glycine 0 CA--C 1.549 2.204 0 CA-C-N 119.747 1.158 . . . . 0.0 115.362 -176.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.437 ' CG ' ' O ' ' A' ' 12' ' ' GLY . 23.1 mtmm -172.47 -78.09 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.741 0.817 . . . . 0.0 109.088 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -51.27 -27.45 16.11 Favored Glycine 0 CA--C 1.554 2.509 0 N-CA-C 120.416 2.926 . . . . 0.0 120.416 174.8 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.9 m -66.87 -52.29 45.24 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 119.663 1.731 . . . . 0.0 112.682 174.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.25 10.6 mm-40 -75.39 -15.63 60.44 Favored 'General case' 0 N--CA 1.496 1.847 0 CA-C-O 115.904 -1.998 . . . . 0.0 112.455 171.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.85 -44.32 66.66 Favored 'General case' 0 C--N 1.374 1.637 0 CA-C-N 123.684 2.947 . . . . 0.0 114.319 168.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.5 p -68.78 -46.41 79.51 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 CA-C-N 119.282 0.946 . . . . 0.0 112.737 174.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -54.94 -44.25 74.14 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 116.623 2.083 . . . . 0.0 116.623 169.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.1 tp -67.24 -32.54 73.63 Favored 'General case' 0 CA--C 1.572 1.815 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 172.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.78 -38.89 92.42 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 167.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -59.33 -40.72 87.21 Favored 'General case' 0 N--CA 1.492 1.65 0 CA-C-O 117.491 -1.243 . . . . 0.0 114.106 166.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 73.3 mmtt -65.62 -49.09 70.0 Favored 'General case' 0 N--CA 1.494 1.737 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 172.465 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 65.8 mt -82.72 -25.0 33.33 Favored 'General case' 0 CA--C 1.572 1.822 0 N-CA-C 117.383 2.364 . . . . 0.0 117.383 -177.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.56 41.31 7.37 Favored Glycine 0 CA--C 1.556 2.616 0 N-CA-C 117.521 1.768 . . . . 0.0 117.521 -172.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 22.8 mm -115.68 157.91 43.26 Favored Pre-proline 0 CA--C 1.57 1.738 0 CA-C-N 118.678 1.239 . . . . 0.0 113.748 -168.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -74.65 101.19 1.42 Allowed 'Trans proline' 0 CA--C 1.566 2.111 0 C-N-CA 121.885 1.723 . . . . 0.0 113.294 160.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -72.34 107.74 5.09 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.158 -0.964 . . . . 0.0 108.424 165.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.457 ' CD1' ' HB3' ' A' ' 71' ' ' ARG . 31.3 mm -104.25 109.38 27.17 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.962 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 176.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 74.1 p -96.45 128.96 43.86 Favored 'General case' 0 N--CA 1.477 0.919 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 168.585 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 18.4 p -68.36 -16.59 63.99 Favored 'General case' 0 N--CA 1.494 1.738 0 N-CA-C 117.051 2.241 . . . . 0.0 117.051 -171.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -80.37 -23.25 61.1 Favored Glycine 0 CA--C 1.543 1.809 0 N-CA-C 118.932 2.333 . . . . 0.0 118.932 167.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -80.38 -52.63 7.45 Favored 'General case' 0 N--CA 1.491 1.62 0 N-CA-C 114.957 1.466 . . . . 0.0 114.957 -168.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -62.88 -39.09 93.39 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 173.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.479 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 7.9 m-85 -65.2 -47.09 78.11 Favored 'General case' 0 CA--C 1.555 1.146 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 172.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 73.0 ttt180 -54.25 -42.06 69.47 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 168.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.8 ttt180 -59.11 -40.36 85.11 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 114.96 1.467 . . . . 0.0 114.96 168.251 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 60.5 m-80 -68.35 -23.83 64.74 Favored 'General case' 0 CA--C 1.579 2.07 0 N-CA-C 115.384 1.624 . . . . 0.0 115.384 168.332 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 63.6 mt -64.1 -48.69 84.72 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.299 0 CA-C-N 120.75 1.614 . . . . 0.0 110.448 167.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -64.42 -37.67 88.32 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 174.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -67.02 -40.93 87.37 Favored 'General case' 0 CA--C 1.561 1.391 0 N-CA-C 116.236 1.939 . . . . 0.0 116.236 173.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 95.28 69.26 1.04 Allowed Glycine 0 CA--C 1.543 1.844 0 CA-C-O 118.473 -1.182 . . . . 0.0 114.66 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.835 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 67.5 p -92.02 -49.86 6.0 Favored 'General case' 0 N--CA 1.501 2.089 0 CA-C-N 118.737 1.268 . . . . 0.0 114.291 175.743 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.835 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.251 73.8 mttt 105.84 -41.49 0.0 OUTLIER 'General case' 0 CA--C 1.57 1.729 0 CA-C-O 116.376 -1.774 . . . . 0.0 111.307 -172.477 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -81.07 -14.13 58.1 Favored 'General case' 0 CA--C 1.569 1.711 0 CA-C-N 123.059 2.663 . . . . 0.0 112.988 163.788 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.673 ' O ' ' HB3' ' A' ' 50' ' ' LYS . . . -58.22 -56.48 24.97 Favored Glycine 0 C--N 1.355 1.605 0 CA-C-N 120.574 1.534 . . . . 0.0 114.825 169.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.289 6.2 p -76.44 -50.01 23.1 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.478 0 N-CA-C 115.508 1.67 . . . . 0.0 115.508 -169.859 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -64.91 -48.48 74.04 Favored 'General case' 0 N--CA 1.485 1.277 0 CA-C-N 121.09 1.768 . . . . 0.0 112.582 174.191 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.12 -29.15 66.03 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 114.819 1.415 . . . . 0.0 114.819 -177.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.673 ' HB3' ' O ' ' A' ' 46' ' ' GLY . 35.8 tptt -72.78 -34.73 67.14 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 168.021 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.601 ' O ' ' CG ' ' A' ' 51' ' ' ARG . 42.9 ttt180 -74.64 -55.89 5.4 Favored 'General case' 0 CA--C 1.591 2.522 1 CA-C-O 85.878 -16.296 . . . . 0.0 117.639 -179.715 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 12.8 m-30 -27.64 -66.22 0.07 Allowed 'General case' 0 N--CA 1.495 1.814 1 O-C-N 108.766 -8.709 . . . . 0.0 120.43 146.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.6 tp -59.32 -29.32 67.54 Favored 'General case' 0 CA--C 1.573 1.861 0 N-CA-C 116.388 1.996 . . . . 0.0 116.388 174.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -92.39 -41.6 10.24 Favored 'General case' 0 CA--C 1.566 1.588 0 CA-C-O 116.554 -1.689 . . . . 0.0 115.155 169.208 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -87.94 -41.15 13.36 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 121.976 2.171 . . . . 0.0 114.906 -174.561 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.449 ' HA2' HH12 ' A' ' 88' ' ' ARG . . . 128.83 5.35 4.91 Favored Glycine 0 CA--C 1.541 1.669 0 N-CA-C 119.095 2.398 . . . . 0.0 119.095 168.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -83.41 173.71 11.28 Favored 'General case' 0 CA--C 1.575 1.91 0 CA-C-N 119.86 1.83 . . . . 0.0 110.067 167.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.5 pp -76.18 128.77 35.62 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.205 -1.559 . . . . 0.0 114.398 -166.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 4.6 p -115.88 128.72 25.75 Favored Pre-proline 0 CA--C 1.571 1.779 0 CA-C-O 117.656 -1.164 . . . . 0.0 109.447 -179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -60.11 149.33 85.41 Favored 'Trans proline' 0 CA--C 1.559 1.77 0 C-N-CA 123.396 2.731 . . . . 0.0 116.275 173.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 64.0 m -76.87 -45.88 26.63 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 -178.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.1 m-20 -64.27 -46.56 83.17 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 115.699 1.74 . . . . 0.0 115.699 -169.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.407 ' HA ' ' HB2' ' A' ' 66' ' ' GLU . 1.7 pp -57.86 -42.13 83.87 Favored 'General case' 0 CA--C 1.56 1.347 0 N-CA-C 116.709 2.114 . . . . 0.0 116.709 169.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.4 m -61.46 -48.79 79.53 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 113.322 0.86 . . . . 0.0 113.322 174.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -66.94 -20.05 65.83 Favored 'General case' 0 CA--C 1.575 1.919 0 N-CA-C 115.443 1.645 . . . . 0.0 115.443 167.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.407 ' HB2' ' HA ' ' A' ' 63' ' ' LEU . 9.4 mm-40 -72.26 -47.56 49.31 Favored 'General case' 0 CA--C 1.556 1.203 0 CA-C-N 120.529 1.513 . . . . 0.0 114.197 169.771 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.9 mt -63.72 -38.46 91.2 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.695 1.739 . . . . 0.0 115.695 169.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 51.9 t -56.55 -50.93 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 CA-C-O 117.582 -1.199 . . . . 0.0 111.55 167.676 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -60.05 -36.8 78.11 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 116.563 2.06 . . . . 0.0 116.563 172.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.5 t70 -58.16 -45.79 86.82 Favored 'General case' 0 N--CA 1.488 1.433 0 CA-C-O 117.282 -1.342 . . . . 0.0 112.971 169.057 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.457 ' HB3' ' CD1' ' A' ' 29' ' ' ILE . 40.9 mmt180 -87.03 6.12 34.06 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 120.407 3.484 . . . . 0.0 120.407 167.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 50.7 mt -68.2 -49.94 57.5 Favored 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 105.473 -2.047 . . . . 0.0 105.473 153.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 70.8 m-80 49.51 39.15 16.2 Favored 'General case' 0 N--CA 1.503 2.176 0 CA-C-N 121.375 1.898 . . . . 0.0 110.879 -163.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -32.26 -28.11 0.01 OUTLIER Pre-proline 0 CA--C 1.57 1.719 1 N-CA-C 127.822 6.23 . . . . 0.0 127.822 -161.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 63.2 Cg_exo -59.07 -13.98 21.48 Favored 'Trans proline' 0 N--CA 1.511 2.536 1 CA-C-N 130.521 4.793 . . . . 0.0 119.809 169.627 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -96.26 -28.49 14.5 Favored 'General case' 0 CA--C 1.573 1.848 0 CA-C-N 110.756 -2.929 . . . . 0.0 114.196 162.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -114.28 23.59 12.7 Favored 'General case' 0 CA--C 1.577 2.012 0 CA-C-N 123.537 2.881 . . . . 0.0 115.533 179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.87 -38.3 73.11 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 120.863 1.665 . . . . 0.0 114.34 174.386 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 23.8 t30 -101.25 19.75 17.08 Favored 'General case' 0 CA--C 1.578 2.043 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 169.514 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -175.73 150.16 10.6 Favored Glycine 0 C--N 1.359 1.848 0 CA-C-N 122.262 2.301 . . . . 0.0 113.945 168.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 45.2 p90 -176.18 138.93 0.34 Allowed 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 112.018 -2.091 . . . . 0.0 109.58 173.261 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 44.6 mt -111.35 112.99 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.395 0 N-CA-C 104.059 -2.571 . . . . 0.0 104.059 174.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 12.5 mt -96.7 147.42 23.93 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 109.527 -0.546 . . . . 0.0 109.527 168.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 17.8 t0 -134.11 131.72 39.05 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-O 121.8 0.81 . . . . 0.0 111.043 169.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 71.03 37.59 64.16 Favored Glycine 0 CA--C 1.551 2.297 0 CA-C-O 117.249 -1.862 . . . . 0.0 117.62 176.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -104.79 -56.02 0.09 OUTLIER Pre-proline 0 N--CA 1.496 1.834 0 CA-C-O 114.873 -2.489 . . . . 0.0 109.657 177.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -68.79 70.97 1.09 Allowed 'Trans proline' 0 CA--C 1.566 2.088 0 CA-C-N 124.921 2.793 . . . . 0.0 118.873 168.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.449 HH12 ' HA2' ' A' ' 56' ' ' GLY . 4.1 ptm180 -76.46 -31.57 57.88 Favored 'General case' 0 CA--C 1.567 1.602 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 167.205 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.492 ' HA ' ' HG3' ' A' ' 147' ' ' GLU . 77.6 p -141.59 134.62 29.06 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 106.788 -1.56 . . . . 0.0 106.788 -166.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -51.51 -38.29 20.67 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-N 120.298 1.408 . . . . 0.0 113.843 177.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -64.8 -38.62 91.61 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 120.753 3.612 . . . . 0.0 120.753 174.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.9 mm100 -74.32 -47.81 32.26 Favored 'General case' 0 CA--C 1.587 2.401 0 CA-C-N 122.99 2.632 . . . . 0.0 111.802 166.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -57.33 -35.16 69.53 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 118.493 2.775 . . . . 0.0 118.493 -176.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 35.4 tttt -59.93 -26.6 66.09 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 116.571 2.063 . . . . 0.0 116.571 170.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.35 -43.86 84.87 Favored 'General case' 0 CA--C 1.568 1.664 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 168.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 23.6 tp -61.72 -37.93 86.01 Favored 'General case' 0 CA--C 1.569 1.695 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 169.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 28.9 t60 -67.85 -41.65 82.59 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 120.405 1.457 . . . . 0.0 113.749 169.081 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 1.35 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 0.5 OUTLIER -53.24 -35.05 59.56 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 114.637 1.347 . . . . 0.0 114.637 167.414 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 1.183 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 63.3 mtt -85.39 -29.57 24.31 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 118.317 2.71 . . . . 0.0 118.317 171.014 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 tt -69.35 -54.65 13.44 Favored 'General case' 0 N--CA 1.502 2.16 0 CA-C-N 122.076 2.216 . . . . 0.0 111.126 173.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 17.0 mm-40 -77.23 -50.37 13.06 Favored 'General case' 0 CA--C 1.563 1.48 0 N-CA-C 113.525 0.935 . . . . 0.0 113.525 174.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 1.35 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 23.3 tpp180 -71.93 -46.06 58.93 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 114.498 1.296 . . . . 0.0 114.498 178.63 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 1.183 ' HB3' ' O ' ' A' ' 99' ' ' MET . 21.5 tpp180 -63.94 -49.66 71.71 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-N 119.036 0.835 . . . . 0.0 111.793 167.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 106.31 50.07 0.89 Allowed Glycine 0 N--CA 1.485 1.941 0 CA-C-O 121.767 0.648 . . . . 0.0 114.162 167.333 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.8 p -92.67 168.96 10.87 Favored 'General case' 0 CA--C 1.567 1.612 0 CA-C-N 113.207 -1.496 . . . . 0.0 110.712 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -70.47 132.14 45.11 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.034 -1.041 . . . . 0.0 110.919 -175.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 6.4 tp -105.79 96.99 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 174.512 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -100.25 -77.04 0.54 Allowed 'General case' 0 N--CA 1.493 1.677 0 CA-C-O 115.391 -2.242 . . . . 0.0 107.69 166.62 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -140.71 126.14 18.82 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 122.25 2.295 . . . . 0.0 115.5 -171.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 72.8 t -88.92 116.58 30.73 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 N-CA-C 101.406 -3.553 . . . . 0.0 101.406 160.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.294 20.7 tp -112.93 90.22 3.29 Favored 'General case' 0 CA--C 1.552 1.046 0 CA-C-N 113.14 -1.846 . . . . 0.0 109.17 -165.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -89.71 132.22 35.29 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 113.606 0.965 . . . . 0.0 113.606 -177.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -97.73 123.87 41.84 Favored 'General case' 0 CA--C 1.566 1.584 0 CA-C-O 123.202 1.477 . . . . 0.0 110.594 -172.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -93.4 104.01 16.19 Favored 'General case' 0 CA--C 1.554 1.112 0 C-N-CA 127.299 2.24 . . . . 0.0 108.868 173.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.2 m -133.3 143.0 40.43 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.594 0 CA-C-N 113.12 -1.855 . . . . 0.0 109.837 -165.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . 0.656 ' O ' HG22 ' A' ' 119' ' ' VAL . 19.6 m -91.72 155.42 18.29 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 123.417 0.687 . . . . 0.0 112.727 -176.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -45.31 -32.18 1.9 Allowed 'General case' 0 N--CA 1.506 2.366 0 N-CA-C 117.618 2.451 . . . . 0.0 117.618 171.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -48.98 -38.99 24.85 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 117.282 2.326 . . . . 0.0 117.282 171.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.656 HG22 ' O ' ' A' ' 116' ' ' SER . 2.6 m -60.11 -43.26 92.51 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.442 0 N-CA-C 116.683 2.105 . . . . 0.0 116.683 173.184 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 1.113 ' HA ' ' HB2' ' A' ' 123' ' ' ARG . 53.1 mt -58.25 -34.26 70.28 Favored 'General case' 0 N--CA 1.515 2.82 0 CA-C-O 123.315 1.531 . . . . 0.0 113.936 164.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.477 ' O ' ' HB3' ' A' ' 125' ' ' LYS . 15.9 mt -68.9 -21.36 64.24 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 175.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.451 ' O ' ' HA ' ' A' ' 124' ' ' LEU . 9.5 mm-40 -68.59 -60.69 2.24 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-O 113.49 -3.148 . . . . 0.0 106.626 155.572 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 1.113 ' HB2' ' HA ' ' A' ' 120' ' ' LEU . 14.8 mmt180 -25.15 47.74 0.0 OUTLIER 'General case' 0 N--CA 1.531 3.608 3 O-C-N 131.316 5.385 . . . . 0.0 122.118 156.436 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . 0.451 ' HA ' ' O ' ' A' ' 122' ' ' GLU 0.368 0.0 OUTLIER 36.04 27.13 0.01 OUTLIER 'General case' 0 C--N 1.277 -2.574 3 C-N-CA 140.19 7.396 . . . . 0.0 129.594 -150.735 . . . . . . . . 5 4 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.477 ' HB3' ' O ' ' A' ' 121' ' ' LEU . 77.2 tttt -62.86 -18.08 62.38 Favored 'General case' 0 CA--C 1.599 2.856 0 C-N-CA 114.896 -2.721 . . . . 0.0 112.648 150.281 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.873 ' O ' ' HB2' ' A' ' 127' ' ' ARG . . . -83.32 -44.3 7.05 Favored Glycine 0 C--N 1.386 3.33 0 CA-C-N 124.717 3.417 . . . . 0.0 115.615 173.68 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.873 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 76.0 ttt180 153.3 110.51 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 119.351 1.575 . . . . 0.0 109.056 -177.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -166.11 -32.53 0.02 OUTLIER Glycine 0 CA--C 1.547 2.076 0 N-CA-C 117.641 1.817 . . . . 0.0 117.641 -173.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.412 ' HB3' ' H ' ' A' ' 130' ' ' ALA . 94.7 mtt180 -146.24 -157.25 0.78 Allowed 'General case' 0 N--CA 1.495 1.811 0 CA-C-N 120.12 1.96 . . . . 0.0 113.3 -179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.412 ' H ' ' HB3' ' A' ' 129' ' ' ARG . . . -149.88 56.92 0.97 Allowed 'General case' 0 CA--C 1.575 1.912 0 CA-C-N 113.521 -1.672 . . . . 0.0 111.353 -172.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.1 p30 45.66 49.23 11.26 Favored 'General case' 0 N--CA 1.507 2.388 0 N-CA-C 119.177 3.029 . . . . 0.0 119.177 -177.131 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 16.8 m-20 -70.52 -40.24 73.61 Favored 'General case' 0 N--CA 1.508 2.454 0 CA-C-N 113.454 -1.703 . . . . 0.0 109.381 155.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 75.2 p -57.14 -165.72 0.0 OUTLIER 'General case' 0 CA--C 1.584 2.275 0 C-N-CA 128.431 2.692 . . . . 0.0 111.043 157.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.5 t70 70.64 -62.45 0.44 Allowed 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 128.819 2.848 . . . . 0.0 111.792 -167.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -69.27 -42.9 74.91 Favored 'General case' 0 CA--C 1.567 1.609 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 167.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 7.3 t -63.57 -40.32 88.61 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.002 0 CA-C-N 119.379 0.991 . . . . 0.0 113.248 169.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 47.2 mm -63.08 -35.62 72.49 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 CA-C-O 117.821 -1.085 . . . . 0.0 113.748 169.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 26.4 mt -65.45 -46.97 77.78 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 120.654 1.57 . . . . 0.0 114.464 171.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 30.5 t-20 -65.4 -37.39 86.84 Favored 'General case' 0 N--CA 1.501 2.11 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 172.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 59.9 mtp180 -60.58 -42.65 97.14 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 167.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 13.6 tpt -61.5 -32.15 72.17 Favored 'General case' 0 CA--C 1.57 1.722 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 168.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -60.96 -49.1 78.81 Favored 'General case' 0 N--CA 1.487 1.384 0 N-CA-C 114.702 1.371 . . . . 0.0 114.702 166.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 29.1 t -65.13 -25.46 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.4 0 N-CA-C 113.92 1.082 . . . . 0.0 113.92 169.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -65.45 -49.43 69.17 Favored 'General case' 0 CA--C 1.577 1.982 0 CA-C-N 119.74 1.154 . . . . 0.0 111.864 169.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -61.34 -44.51 97.07 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 117.71 2.485 . . . . 0.0 117.71 177.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -56.18 -32.22 64.14 Favored 'General case' 0 N--CA 1.508 2.432 0 N-CA-C 117.785 2.513 . . . . 0.0 117.785 177.048 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.492 ' HG3' ' HA ' ' A' ' 89' ' ' SER . 4.4 mm-40 -121.38 -40.5 2.57 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 118.684 2.846 . . . . 0.0 118.684 -163.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 95.7 m -46.64 -39.96 12.24 Favored 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 118.226 2.676 . . . . 0.0 118.226 -167.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.38 -61.16 4.12 Favored Pre-proline 0 CA--C 1.579 2.07 0 CA-C-O 116.17 -1.871 . . . . 0.0 112.05 173.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -52.01 -32.58 49.0 Favored 'Trans proline' 0 CA--C 1.578 2.692 0 C-N-CA 123.374 2.716 . . . . 0.0 118.568 167.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -66.57 -51.51 55.69 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 125.193 1.397 . . . . 0.0 111.462 176.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 1.187 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 47.7 tp -64.49 -21.23 66.61 Favored 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 115.641 1.719 . . . . 0.0 115.641 171.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.6 mt-10 -71.92 -48.73 43.37 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-N 122.657 2.48 . . . . 0.0 112.944 164.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 11.4 t80 -61.03 -56.74 17.42 Favored 'General case' 0 CA--C 1.57 1.718 0 CA-C-N 120.191 1.359 . . . . 0.0 112.711 178.427 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -77.13 -28.04 54.17 Favored 'General case' 0 CA--C 1.553 1.091 0 CA-C-O 115.348 -2.263 . . . . 0.0 112.774 179.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 1.187 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 38.3 ttt180 -60.35 -37.23 80.04 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-N 124.017 3.099 . . . . 0.0 116.259 169.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -67.76 -37.91 82.74 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 113.851 1.056 . . . . 0.0 113.851 167.358 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -79.96 -33.22 39.7 Favored 'General case' 0 CA--C 1.579 2.09 0 N-CA-C 119.623 3.194 . . . . 0.0 119.623 177.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.1 pp -82.01 174.72 10.98 Favored 'General case' 0 CA--C 1.575 1.907 0 N-CA-C 121.324 3.824 . . . . 0.0 121.324 -159.673 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 92.7 mttt -128.64 139.66 52.15 Favored 'General case' 0 CA--C 1.566 1.577 0 N-CA-C 103.912 -2.625 . . . . 0.0 103.912 164.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.1 t -102.77 152.56 21.1 Favored 'General case' 0 N--CA 1.494 1.756 0 CA-C-O 122.515 1.15 . . . . 0.0 112.362 -178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 53.2 t -120.26 139.29 48.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.377 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 168.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -94.52 134.53 36.96 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 167.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -157.88 95.56 1.42 Allowed 'General case' 0 N--CA 1.484 1.243 0 CA-C-O 122.791 1.281 . . . . 0.0 110.886 -164.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.5 t -151.92 124.95 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.126 0 CA-C-N 113.143 -1.844 . . . . 0.0 106.878 -171.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 78.62 -74.34 2.13 Favored Glycine 0 N--CA 1.483 1.798 0 N-CA-C 117.749 1.86 . . . . 0.0 117.749 168.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 42.9 p -79.59 147.52 32.06 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 112.008 -2.096 . . . . 0.0 112.527 -169.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 65.8 mtt -91.39 -65.31 1.02 Allowed 'General case' 0 N--CA 1.492 1.634 0 C-N-CA 123.259 0.623 . . . . 0.0 111.154 178.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -68.28 -37.88 81.13 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 115.995 1.85 . . . . 0.0 115.995 -176.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -61.26 -48.71 80.16 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 113.81 1.041 . . . . 0.0 113.81 169.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 69.9 t -55.74 -39.44 55.64 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.139 0 N-CA-C 114.604 1.335 . . . . 0.0 114.604 173.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -60.43 -35.62 76.26 Favored 'General case' 0 N--CA 1.497 1.925 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 168.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -58.81 -48.33 81.67 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 171.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 81.5 mtt-85 -60.8 -36.85 80.08 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 117.874 2.546 . . . . 0.0 117.874 168.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.85 -44.09 97.47 Favored 'General case' 0 N--CA 1.488 1.425 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 172.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . 0.272 0.2 OUTLIER -71.26 -38.7 71.87 Favored 'General case' 0 N--CA 1.507 2.383 0 CA-C-N 120.014 1.279 . . . . 0.0 114.332 169.031 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -49.57 -39.3 34.53 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 116.078 1.881 . . . . 0.0 116.078 168.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -70.3 -52.53 22.16 Favored 'General case' 0 CA--C 1.566 1.59 0 N-CA-C 113.421 0.897 . . . . 0.0 113.421 166.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -102.29 -60.03 1.61 Allowed 'General case' 0 CA--C 1.564 1.515 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 -169.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.633 ' O ' ' CB ' ' A' ' 181' ' ' LYS . . . -79.22 -37.0 25.88 Favored Glycine 0 CA--C 1.551 2.34 0 CA-C-N 121.554 1.979 . . . . 0.0 118.036 -170.141 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.633 ' CB ' ' O ' ' A' ' 180' ' ' GLY . 37.2 ttmt . . . . . 0 C--O 1.252 1.212 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 -177.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.7 mtt . . . . . 0 N--CA 1.483 1.217 0 CA-C-O 121.76 0.791 . . . . 0.0 110.523 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.559 ' HG2' ' O ' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -160.42 155.36 24.37 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 114.717 1.377 . . . . 0.0 114.717 -166.8 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 22.6 t -135.07 150.67 29.89 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.887 0 CA-C-N 114.34 -1.3 . . . . 0.0 111.607 -168.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.405 HD22 HH12 ' A' ' 2' ' ' ARG . 2.2 mm? -125.7 122.13 35.42 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 114.003 -1.453 . . . . 0.0 108.607 169.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.8 tt -95.91 119.54 34.59 Favored 'General case' 0 CA--C 1.572 1.8 0 CA-C-O 122.504 1.145 . . . . 0.0 111.94 -173.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 33.0 mt -104.8 160.03 15.32 Favored 'General case' 0 N--CA 1.485 1.31 0 CA-C-N 111.074 -2.785 . . . . 0.0 110.97 175.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 165.68 129.46 1.05 Allowed Glycine 0 CA--C 1.549 2.19 0 CA-C-O 117.355 -1.803 . . . . 0.0 113.77 171.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_exo -58.01 169.72 2.57 Favored 'Trans proline' 0 CA--C 1.581 2.855 0 CA-C-N 122.035 2.917 . . . . 0.0 114.881 168.061 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_exo -50.76 121.51 8.16 Favored 'Trans proline' 0 CA--C 1.561 1.845 0 C-N-CA 123.749 2.966 . . . . 0.0 115.103 176.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 159.91 103.68 0.19 Allowed Glycine 0 CA--C 1.536 1.351 0 N-CA-C 108.133 -1.987 . . . . 0.0 108.133 -167.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.414 ' H ' ' HB2' ' A' ' 120' ' ' LEU . . . -57.46 112.94 1.57 Allowed 'General case' 0 CA--C 1.566 1.561 0 N-CA-C 115.86 1.8 . . . . 0.0 115.86 -178.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -173.13 -117.13 0.44 Allowed Glycine 0 N--CA 1.482 1.754 0 N-CA-C 107.058 -2.417 . . . . 0.0 107.058 173.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 64.6 mttt 64.8 -92.94 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 164.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -50.53 -22.03 5.12 Favored Glycine 0 CA--C 1.554 2.496 0 N-CA-C 120.955 3.142 . . . . 0.0 120.955 174.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 98.1 m -68.27 -53.0 27.54 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 120.036 1.918 . . . . 0.0 112.265 173.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.261 14.4 mm-40 -76.48 -15.43 59.9 Favored 'General case' 0 CA--C 1.574 1.87 0 CA-C-O 115.508 -2.187 . . . . 0.0 112.295 171.418 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.96 -41.49 67.66 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 124.211 3.187 . . . . 0.0 115.265 167.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 96.5 t -70.89 -40.66 76.75 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.882 0 CA-C-O 117.84 -1.076 . . . . 0.0 111.766 173.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -61.44 -42.11 98.24 Favored 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 169.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 23.6 mt -67.93 -32.4 72.82 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 115.186 1.55 . . . . 0.0 115.186 170.841 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.02 -40.12 96.78 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 120.267 1.394 . . . . 0.0 114.446 167.473 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 34.8 mt-10 -59.77 -37.6 79.5 Favored 'General case' 0 CA--C 1.565 1.554 0 N-CA-C 114.889 1.441 . . . . 0.0 114.889 166.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 26.4 mmmt -68.61 -53.99 19.22 Favored 'General case' 0 N--CA 1.492 1.644 0 CA-C-N 120.561 1.528 . . . . 0.0 114.787 174.327 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 6.4 mp -81.73 -22.83 37.07 Favored 'General case' 0 CA--C 1.573 1.861 0 N-CA-C 116.48 2.03 . . . . 0.0 116.48 -177.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.68 38.64 7.46 Favored Glycine 0 CA--C 1.555 2.546 0 N-CA-C 117.507 1.763 . . . . 0.0 117.507 -174.29 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.454 ' CG2' ' HA ' ' A' ' 81' ' ' PHE . 23.6 mm -106.46 157.02 35.99 Favored Pre-proline 0 CA--C 1.565 1.551 0 CA-C-N 118.647 1.224 . . . . 0.0 112.876 -169.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_exo -73.79 102.86 1.56 Allowed 'Trans proline' 0 CA--C 1.558 1.724 0 C-N-CA 121.49 1.46 . . . . 0.0 111.968 159.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 8.7 tm0? -69.48 106.54 3.02 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 166.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 34.2 mm -97.95 109.33 23.44 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.048 0 N-CA-C 104.614 -2.365 . . . . 0.0 104.614 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 63.4 p -95.59 129.22 42.86 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 107.331 -1.359 . . . . 0.0 107.331 169.523 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.3 p -74.07 2.17 9.45 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 117.241 2.311 . . . . 0.0 117.241 -174.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.477 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -97.14 -22.17 18.16 Favored Glycine 0 CA--C 1.54 1.628 0 N-CA-C 118.703 2.241 . . . . 0.0 118.703 163.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -81.21 -54.27 5.65 Favored 'General case' 0 N--CA 1.491 1.589 0 CA-C-N 119.37 1.585 . . . . 0.0 114.618 -168.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.7 pt? -65.44 -38.66 90.52 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 113.037 0.755 . . . . 0.0 113.037 175.117 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.467 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 56.8 m-85 -68.79 -42.48 77.3 Favored 'General case' 0 CA--C 1.56 1.332 0 N-CA-C 115.584 1.698 . . . . 0.0 115.584 173.166 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.477 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 73.9 ttt180 -58.76 -42.24 88.44 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 115.046 1.498 . . . . 0.0 115.046 169.034 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -61.51 -39.02 89.48 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 115.227 1.566 . . . . 0.0 115.227 169.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -68.82 -27.57 65.96 Favored 'General case' 0 CA--C 1.575 1.932 0 N-CA-C 115.258 1.577 . . . . 0.0 115.258 168.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.644 HD11 ' HB3' ' A' ' 50' ' ' LYS . 86.1 mt -63.86 -43.94 97.96 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 CA-C-N 120.104 1.32 . . . . 0.0 111.251 167.251 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -64.02 -42.31 97.17 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 114.297 1.221 . . . . 0.0 114.297 173.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -65.51 -41.74 92.82 Favored 'General case' 0 CA--C 1.561 1.374 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 173.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.4 70.83 1.17 Allowed Glycine 0 CA--C 1.539 1.593 0 CA-C-O 118.091 -1.394 . . . . 0.0 113.368 -177.036 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.545 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 67.0 p -92.16 -65.62 0.99 Allowed 'General case' 0 N--CA 1.483 1.199 0 CA-C-N 119.187 1.494 . . . . 0.0 111.644 177.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.545 ' CB ' ' O ' ' A' ' 43' ' ' THR . 21.2 ptmt 128.81 -55.68 0.0 OUTLIER 'General case' 0 CA--C 1.562 1.422 0 C-N-CA 123.934 0.894 . . . . 0.0 109.899 -166.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -75.76 -6.57 51.25 Favored 'General case' 0 CA--C 1.568 1.638 0 CA-C-O 118.136 -0.935 . . . . 0.0 113.021 167.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -70.22 -54.21 11.8 Favored Glycine 0 CA--C 1.544 1.905 0 CA-C-N 120.652 1.569 . . . . 0.0 113.254 166.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.292 11.9 p -76.22 -46.62 33.03 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.706 0 N-CA-C 116.23 1.937 . . . . 0.0 116.23 -169.122 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -56.38 -49.28 74.91 Favored 'General case' 0 N--CA 1.494 1.766 0 CA-C-N 121.744 2.065 . . . . 0.0 113.339 169.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -64.03 -38.5 91.28 Favored 'General case' 0 C--N 1.348 0.527 0 CA-C-N 113.517 -1.674 . . . . 0.0 114.293 -176.063 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.644 ' HB3' HD11 ' A' ' 39' ' ' ILE . 5.1 tptt -80.14 -17.16 53.27 Favored 'General case' 0 CA--C 1.565 1.545 0 CA-C-O 116.809 -1.567 . . . . 0.0 113.855 173.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 62.6 mtp180 -76.59 -55.61 5.37 Favored 'General case' 0 CA--C 1.598 2.815 1 CA-C-O 86.227 -16.13 . . . . 0.0 118.297 172.572 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . 0.346 0.1 OUTLIER -38.02 -61.57 0.64 Allowed 'General case' 0 N--CA 1.516 2.847 1 O-C-N 109.303 -8.373 . . . . 0.0 120.564 149.349 . . . . . . . . 4 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 60.3 mt -58.05 -23.66 55.31 Favored 'General case' 0 N--CA 1.518 2.948 0 N-CA-C 116.036 1.865 . . . . 0.0 116.036 177.769 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -93.32 -49.41 5.96 Favored 'General case' 0 CA--C 1.571 1.763 0 CA-C-O 116.486 -1.721 . . . . 0.0 114.56 166.685 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -104.28 -5.57 21.72 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 118.112 2.634 . . . . 0.0 118.112 -170.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.673 ' HA2' HH11 ' A' ' 88' ' ' ARG . . . 73.64 47.09 22.22 Favored Glycine 0 CA--C 1.544 1.847 0 CA-C-N 122.203 2.274 . . . . 0.0 115.241 -178.257 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 78.9 m-20 -101.51 -175.3 2.82 Favored 'General case' 0 CA--C 1.568 1.642 0 C-N-CA 123.763 0.825 . . . . 0.0 110.807 -170.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 74.7 mt -100.56 99.6 10.2 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 -179.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 28.4 t -148.26 130.93 7.86 Favored Pre-proline 0 CA--C 1.586 2.353 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 -169.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_exo -50.15 161.01 1.18 Allowed 'Trans proline' 0 CA--C 1.567 2.152 0 C-N-CA 124.446 3.43 . . . . 0.0 120.955 -177.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 58.4 m -91.25 -53.88 4.16 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 -174.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -57.86 -36.35 72.2 Favored 'General case' 0 N--CA 1.506 2.366 0 N-CA-C 117.412 2.375 . . . . 0.0 117.412 -171.235 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 79.5 mt -46.54 -45.56 18.73 Favored 'General case' 0 N--CA 1.506 2.358 0 N-CA-C 118.137 2.643 . . . . 0.0 118.137 170.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 6.2 m -70.04 -48.88 56.1 Favored 'General case' 0 CA--C 1.562 1.422 0 CA-C-N 112.223 -2.262 . . . . 0.0 112.756 177.897 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -59.64 -22.86 62.47 Favored 'General case' 0 CA--C 1.574 1.879 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 167.031 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -75.85 -42.36 49.72 Favored 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 125.395 1.478 . . . . 0.0 114.908 171.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.8 mt -59.53 -50.39 74.1 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 168.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 87.7 t -63.07 -47.8 90.87 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.468 0 CA-C-O 118.023 -0.989 . . . . 0.0 111.72 177.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -64.4 -30.4 71.44 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 116.443 2.016 . . . . 0.0 116.443 172.172 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.0 t70 -60.85 -41.21 95.4 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 119.714 1.143 . . . . 0.0 113.255 168.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 20.5 ttm-85 -81.52 -13.94 57.5 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 119.021 2.971 . . . . 0.0 119.021 169.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.8 mt -95.08 -16.86 22.34 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 117.656 2.465 . . . . 0.0 117.656 175.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 97.3 m-20 -66.81 8.64 0.24 Allowed 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 118.014 2.598 . . . . 0.0 118.014 176.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 14.6 t-20 -68.32 136.82 91.23 Favored Pre-proline 0 CA--C 1.574 1.873 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 163.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 20.8 Cg_endo -52.87 -35.94 72.32 Favored 'Trans proline' 0 N--CA 1.497 1.731 0 N-CA-C 119.292 2.766 . . . . 0.0 119.292 -178.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -70.08 -19.02 63.28 Favored 'General case' 0 CA--C 1.569 1.686 0 N-CA-C 116.485 2.032 . . . . 0.0 116.485 171.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -109.56 16.16 22.4 Favored 'General case' 0 CA--C 1.568 1.638 0 N-CA-C 116.265 1.95 . . . . 0.0 116.265 176.335 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -73.2 -53.56 10.64 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 121.138 1.79 . . . . 0.0 114.535 169.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.559 ' O ' ' HG2' ' A' ' 2' ' ' ARG . 24.7 p30 -74.1 -34.97 64.14 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 115.463 1.653 . . . . 0.0 115.463 172.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.508 ' HA2' ' HB3' ' A' ' 2' ' ' ARG . . . -112.4 148.83 18.34 Favored Glycine 0 N--CA 1.482 1.723 0 CA-C-N 120.095 1.316 . . . . 0.0 114.256 177.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.549 ' H ' ' HB3' ' A' ' 2' ' ' ARG . 37.6 p90 178.58 135.76 0.08 Allowed 'General case' 0 N--CA 1.494 1.768 0 CA-C-N 112.208 -1.996 . . . . 0.0 111.88 -178.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 21.7 mt -115.23 109.55 28.77 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 174.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.7 mt -106.15 126.0 51.68 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 108.88 -0.785 . . . . 0.0 108.88 174.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 58.7 t0 -108.09 127.71 54.04 Favored 'General case' 0 N--CA 1.497 1.905 0 CA-C-N 119.272 0.942 . . . . 0.0 110.36 176.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.39 37.93 80.05 Favored Glycine 0 CA--C 1.556 2.653 0 N-CA-C 117.202 1.641 . . . . 0.0 117.202 -176.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -92.87 -54.06 0.25 Allowed Pre-proline 0 N--CA 1.494 1.765 0 CA-C-O 114.935 -2.46 . . . . 0.0 108.223 175.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -65.3 70.87 0.29 Allowed 'Trans proline' 0 CA--C 1.571 2.344 0 CA-C-N 124.343 2.587 . . . . 0.0 117.289 165.252 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.673 HH11 ' HA2' ' A' ' 56' ' ' GLY . 0.0 OUTLIER -71.67 -24.28 61.81 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 115.333 1.605 . . . . 0.0 115.333 166.714 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.8 t -150.93 151.39 32.09 Favored 'General case' 0 CA--C 1.549 0.917 0 N-CA-C 106.144 -1.798 . . . . 0.0 106.144 -176.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 36.7 t -62.07 -40.25 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.947 0 CA-C-O 117.924 -1.036 . . . . 0.0 112.173 174.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -68.66 -25.37 64.77 Favored 'General case' 0 CA--C 1.55 0.981 0 N-CA-C 119.656 3.206 . . . . 0.0 119.656 174.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -76.04 -51.34 12.52 Favored 'General case' 0 CA--C 1.589 2.462 0 CA-C-N 123.405 2.82 . . . . 0.0 110.078 163.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -54.58 -28.11 43.78 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 117.834 2.531 . . . . 0.0 117.834 -176.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 44.6 tttp -58.79 -32.71 69.58 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 115.529 1.677 . . . . 0.0 115.529 166.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.67 -44.31 86.66 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 114.432 1.271 . . . . 0.0 114.432 169.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 13.6 tp -60.63 -39.03 86.75 Favored 'General case' 0 CA--C 1.568 1.654 0 N-CA-C 115.722 1.749 . . . . 0.0 115.722 170.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 47.8 t60 -70.08 -42.86 72.22 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 120.021 1.282 . . . . 0.0 113.973 171.095 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 1.114 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 32.1 mt-10 -52.1 -36.46 51.0 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 114.61 1.337 . . . . 0.0 114.61 166.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 1.061 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 25.2 ttt -84.37 -24.49 29.67 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 117.927 2.566 . . . . 0.0 117.927 171.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.607 HD21 HD13 ' A' ' 107' ' ' ILE . 66.3 tp -65.77 -55.65 16.12 Favored 'General case' 0 N--CA 1.498 1.954 0 CA-C-N 120.771 1.623 . . . . 0.0 112.572 169.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 54.9 mt-10 -79.79 -50.8 10.02 Favored 'General case' 0 CA--C 1.562 1.427 0 N-CA-C 112.941 0.719 . . . . 0.0 112.941 175.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 1.114 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 73.4 ttt180 -66.87 -45.69 77.29 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 115.236 1.569 . . . . 0.0 115.236 176.612 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 1.061 ' HB3' ' O ' ' A' ' 99' ' ' MET . 1.2 tmt_? -63.24 -55.85 21.44 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.01 0.524 . . . . 0.0 111.168 165.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.34 46.83 1.04 Allowed Glycine 0 N--CA 1.48 1.603 0 O-C-N 124.013 0.82 . . . . 0.0 113.347 169.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 67.4 p -93.53 152.28 19.15 Favored 'General case' 0 CA--C 1.561 1.39 0 O-C-N 124.402 0.707 . . . . 0.0 109.666 175.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -82.73 129.1 34.92 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.444 -0.785 . . . . 0.0 111.557 -169.091 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.607 HD13 HD21 ' A' ' 100' ' ' LEU . 7.6 tp -89.99 107.68 18.55 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 N-CA-C 107.394 -1.335 . . . . 0.0 107.394 -173.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -90.33 -68.04 0.81 Allowed 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 117.006 -1.473 . . . . 0.0 107.082 168.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -159.0 137.92 11.16 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 120.887 1.676 . . . . 0.0 114.513 177.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 12.6 t -91.91 109.71 21.71 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.676 0 N-CA-C 100.863 -3.755 . . . . 0.0 100.863 161.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.309 25.8 tp -111.68 103.61 11.92 Favored 'General case' 0 CA--C 1.558 1.288 0 CA-C-N 114.872 -1.058 . . . . 0.0 111.858 -161.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -94.12 129.65 40.61 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 121.449 0.643 . . . . 0.0 112.248 -177.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 8.1 m-85 -92.55 119.04 31.62 Favored 'General case' 0 CA--C 1.561 1.37 0 CA-C-O 123.157 1.456 . . . . 0.0 110.164 -178.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 76.3 ttt180 -84.08 96.8 9.02 Favored 'General case' 0 N--CA 1.479 0.984 0 CA-C-N 112.527 -2.124 . . . . 0.0 109.347 168.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.0 p -137.36 131.64 44.96 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.276 0 C-N-CA 125.245 1.418 . . . . 0.0 107.922 -168.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 58.5 m -86.28 142.12 28.77 Favored 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 114.111 -1.404 . . . . 0.0 112.329 -169.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -63.1 -26.83 69.01 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 116.76 2.133 . . . . 0.0 116.76 -176.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -58.62 -44.48 90.0 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 114.283 1.216 . . . . 0.0 114.283 170.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -49.79 -45.56 21.53 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 N-CA-C 116.632 2.086 . . . . 0.0 116.632 175.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.414 ' HB2' ' H ' ' A' ' 11' ' ' ALA . 2.9 tm? -64.05 -52.51 59.06 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 124.683 1.193 . . . . 0.0 112.308 171.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.1 mp -50.91 -41.45 58.66 Favored 'General case' 0 N--CA 1.502 2.152 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 170.392 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -60.23 -47.78 84.53 Favored 'General case' 0 N--CA 1.492 1.654 0 C-N-CA 125.11 1.364 . . . . 0.0 114.367 169.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 75.2 ttt180 -52.22 -52.23 53.59 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 116.116 1.895 . . . . 0.0 116.116 168.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 81.3 mt -56.54 -43.14 79.57 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 115.94 1.83 . . . . 0.0 115.94 171.667 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -58.17 -53.45 58.09 Favored 'General case' 0 N--CA 1.486 1.343 0 N-CA-C 116.074 1.879 . . . . 0.0 116.074 173.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -88.49 38.44 3.19 Favored Glycine 0 CA--C 1.551 2.335 0 N-CA-C 117.135 1.614 . . . . 0.0 117.135 171.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 84.2 mtt180 -150.13 -115.61 0.05 Allowed 'General case' 0 N--CA 1.48 1.052 0 CA-C-N 118.491 1.146 . . . . 0.0 109.909 169.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.901 ' O ' ' HB2' ' A' ' 129' ' ' ARG . . . 178.4 -175.83 47.65 Favored Glycine 0 CA--C 1.571 3.532 0 CA-C-N 115.04 -0.982 . . . . 0.0 113.784 -172.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.901 ' HB2' ' O ' ' A' ' 128' ' ' GLY . 18.2 tpt180 158.01 128.16 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.486 0 CA-C-N 121.137 2.469 . . . . 0.0 110.387 176.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -91.01 65.82 5.69 Favored 'General case' 0 CA--C 1.575 1.929 0 C-N-CA 123.443 0.697 . . . . 0.0 112.082 -178.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 65.04 5.75 3.12 Favored 'General case' 0 N--CA 1.507 2.406 0 N-CA-C 119.271 3.063 . . . . 0.0 119.271 179.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -91.54 57.9 3.41 Favored 'General case' 0 N--CA 1.506 2.374 0 CA-C-O 123.662 1.696 . . . . 0.0 107.118 160.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . 0.306 3.0 m -129.32 -118.33 0.24 Allowed 'General case' 0 CA--C 1.558 1.27 0 CA-C-N 112.582 -2.099 . . . . 0.0 109.742 -160.342 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -80.9 -33.38 34.29 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 -179.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -64.46 -48.65 74.45 Favored 'General case' 0 N--CA 1.496 1.866 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 176.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.0 p -58.46 -36.78 60.61 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.948 0 N-CA-C 114.675 1.361 . . . . 0.0 114.675 168.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 1.3 mp -66.27 -34.9 73.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 C-N-CA 124.456 1.102 . . . . 0.0 113.684 169.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 40.6 mt -66.69 -39.38 88.06 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 120.258 1.39 . . . . 0.0 114.131 170.554 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -64.73 -36.71 85.16 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-N 120.347 1.431 . . . . 0.0 114.043 168.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 70.0 mtp180 -57.96 -39.69 78.76 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 165.272 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 25.3 ttt -64.58 -30.96 71.99 Favored 'General case' 0 CA--C 1.569 1.675 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 168.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -62.85 -48.03 80.79 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 168.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.5 p -66.47 -35.61 75.3 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.192 0 N-CA-C 114.285 1.217 . . . . 0.0 114.285 171.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 48.2 t80 -53.94 -54.07 43.92 Favored 'General case' 0 CA--C 1.585 2.3 0 CA-C-N 120.073 1.306 . . . . 0.0 111.436 167.528 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 32.4 ttp180 -51.99 -32.97 35.98 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 119.296 3.073 . . . . 0.0 119.296 172.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 37.5 m-20 -52.86 -38.56 61.69 Favored 'General case' 0 N--CA 1.504 2.232 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 173.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 -140.34 26.73 2.15 Favored 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 117.534 2.42 . . . . 0.0 117.534 -177.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 39.5 m -47.69 -37.39 12.89 Favored 'General case' 0 N--CA 1.504 2.266 0 N-CA-C 116.053 1.872 . . . . 0.0 116.053 173.296 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -69.73 -60.2 3.98 Favored Pre-proline 0 CA--C 1.578 2.026 0 CA-C-O 116.75 -1.595 . . . . 0.0 112.102 172.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 78.0 Cg_exo -49.87 -30.79 24.62 Favored 'Trans proline' 0 CA--C 1.576 2.605 0 C-N-CA 123.375 2.716 . . . . 0.0 118.562 167.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -63.86 -55.39 23.15 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 125.515 1.526 . . . . 0.0 111.722 173.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.917 ' O ' ' HB2' ' A' ' 156' ' ' ARG 0.317 0.0 OUTLIER -63.41 -26.11 68.59 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 115.787 1.773 . . . . 0.0 115.787 177.021 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -70.52 -50.92 32.7 Favored 'General case' 0 N--CA 1.49 1.539 0 CA-C-N 120.68 1.582 . . . . 0.0 114.182 167.234 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -67.93 -53.91 22.75 Favored 'General case' 0 CA--C 1.557 1.225 0 CA-C-N 120.007 1.276 . . . . 0.0 111.398 -176.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . 0.256 67.5 m-85 -84.98 -19.69 31.69 Favored 'General case' 0 CA--C 1.554 1.121 0 CA-C-O 114.959 -2.448 . . . . 0.0 113.387 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.917 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 40.6 ttt180 -70.73 -35.62 72.77 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-N 125.077 3.58 . . . . 0.0 115.073 168.386 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -69.01 -37.59 78.76 Favored 'General case' 0 CA--C 1.573 1.854 0 CA-C-N 120.08 1.309 . . . . 0.0 113.906 167.071 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 47.4 mt-30 -84.2 -33.03 24.24 Favored 'General case' 0 CA--C 1.572 1.791 0 N-CA-C 118.727 2.862 . . . . 0.0 118.727 -179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.8 pp -75.46 172.05 13.2 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 118.437 2.754 . . . . 0.0 118.437 -162.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -131.83 141.31 49.39 Favored 'General case' 0 CA--C 1.558 1.258 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 166.302 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 54.5 m -99.9 146.67 26.39 Favored 'General case' 0 N--CA 1.491 1.583 0 CA-C-O 122.351 1.072 . . . . 0.0 110.731 -173.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 30.0 t -123.39 134.34 66.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 N-CA-C 105.348 -2.093 . . . . 0.0 105.348 167.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -93.83 130.11 39.98 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 105.301 -2.111 . . . . 0.0 105.301 167.776 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -154.7 93.63 1.59 Allowed 'General case' 0 N--CA 1.48 1.03 0 CA-C-O 122.623 1.201 . . . . 0.0 111.9 -163.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.1 t -150.85 126.92 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 CA-C-N 114.16 -1.382 . . . . 0.0 107.391 -176.207 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 78.9 -71.82 2.53 Favored Glycine 0 N--CA 1.483 1.786 0 N-CA-C 118.205 2.042 . . . . 0.0 118.205 167.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 42.7 p -78.09 142.8 37.89 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-N 112.163 -2.018 . . . . 0.0 112.453 -168.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 27.8 ttt -86.93 -68.35 0.75 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 123.456 0.702 . . . . 0.0 111.259 -177.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -70.16 -36.0 74.41 Favored 'General case' 0 N--CA 1.5 2.056 0 N-CA-C 116.153 1.909 . . . . 0.0 116.153 -177.312 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -59.94 -49.61 77.0 Favored 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 170.023 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 94.5 t -56.69 -37.92 55.21 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.228 0 N-CA-C 114.394 1.257 . . . . 0.0 114.394 173.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 13.0 t80 -61.42 -34.55 75.57 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 167.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -61.0 -43.24 99.18 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 114.67 1.359 . . . . 0.0 114.67 170.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 81.1 mtt-85 -66.65 -33.87 76.61 Favored 'General case' 0 CA--C 1.554 1.131 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 169.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.23 -47.1 85.91 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 115.448 1.647 . . . . 0.0 115.448 171.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . 0.294 0.5 OUTLIER -69.3 -34.0 74.02 Favored 'General case' 0 N--CA 1.504 2.228 0 CA-C-N 120.196 1.362 . . . . 0.0 114.506 169.214 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 29.3 mtp180 -49.23 -45.26 44.33 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 166.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -67.39 -51.33 53.23 Favored 'General case' 0 CA--C 1.565 1.546 0 N-CA-C 115.326 1.602 . . . . 0.0 115.326 168.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -74.81 -62.88 1.39 Allowed 'General case' 0 CA--C 1.566 1.571 0 CA-C-O 117.981 -1.009 . . . . 0.0 112.84 -175.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.89 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -91.39 -54.92 1.89 Allowed Glycine 0 CA--C 1.552 2.402 0 CA-C-O 117.983 -1.454 . . . . 0.0 114.802 179.605 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.89 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 55.0 tttp . . . . . 0 C--O 1.251 1.169 0 CA-C-N 119.861 1.83 . . . . 0.0 109.612 -179.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.0 mtt . . . . . 0 CA--C 1.561 1.371 0 CA-C-O 122.933 1.349 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . 0.309 11.7 mpt_? -122.67 167.48 13.38 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 120.747 3.61 . . . . 0.0 120.747 -164.787 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.1 p -148.25 141.24 18.74 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.656 0 CA-C-O 123.87 1.795 . . . . 0.0 112.568 166.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -116.55 136.99 52.52 Favored 'General case' 0 CA--C 1.56 1.341 0 CA-C-N 111.971 -2.377 . . . . 0.0 104.853 166.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.5 mt -111.85 128.81 56.24 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 122.693 1.235 . . . . 0.0 111.433 -176.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.545 HD11 HG12 ' A' ' 110' ' ' VAL . 5.8 mp -130.75 155.42 46.67 Favored 'General case' 0 N--CA 1.483 1.197 0 CA-C-N 111.564 -2.562 . . . . 0.0 111.455 -164.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 144.5 168.87 12.84 Favored Glycine 0 CA--C 1.554 2.522 0 CA-C-O 119.134 -0.814 . . . . 0.0 114.701 169.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -57.53 122.52 11.91 Favored 'Trans proline' 0 CA--C 1.573 2.474 0 C-N-CA 123.462 2.774 . . . . 0.0 113.448 172.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -80.46 108.11 2.1 Favored 'Trans proline' 0 CA--C 1.558 1.7 0 C-N-CA 122.516 2.144 . . . . 0.0 116.007 -166.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -158.35 -93.33 0.1 OUTLIER Glycine 0 CA--C 1.537 1.439 0 N-CA-C 109.06 -1.616 . . . . 0.0 109.06 168.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -72.13 -80.49 0.06 Allowed 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 115.32 1.6 . . . . 0.0 115.32 -169.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.697 ' O ' ' CG ' ' A' ' 13' ' ' LYS . . . -92.85 150.23 19.9 Favored Glycine 0 N--CA 1.486 1.997 0 CA-C-N 119.683 1.129 . . . . 0.0 114.717 -169.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.697 ' CG ' ' O ' ' A' ' 12' ' ' GLY . 0.2 OUTLIER 153.56 -84.71 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 109.905 -0.405 . . . . 0.0 109.905 -172.585 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.12 -32.81 57.11 Favored Glycine 0 CA--C 1.553 2.469 0 N-CA-C 120.057 2.783 . . . . 0.0 120.057 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 78.5 m -63.21 -48.79 76.84 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 119.116 1.458 . . . . 0.0 113.294 172.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.252 6.7 mm-40 -75.57 -15.85 60.32 Favored 'General case' 0 CA--C 1.57 1.713 0 CA-C-O 115.749 -2.072 . . . . 0.0 111.972 172.23 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.31 -47.44 61.12 Favored 'General case' 0 C--N 1.374 1.642 0 CA-C-N 123.605 2.911 . . . . 0.0 114.249 168.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.7 p -66.36 -42.11 90.03 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 174.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 44.2 mtmt -63.96 -41.7 97.48 Favored 'General case' 0 CA--C 1.565 1.54 0 N-CA-C 115.852 1.797 . . . . 0.0 115.852 171.022 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.8 mt -66.35 -30.91 71.4 Favored 'General case' 0 N--CA 1.501 2.103 0 CA-C-N 120.819 1.645 . . . . 0.0 114.724 170.756 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.9 -42.88 98.89 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 114.998 1.481 . . . . 0.0 114.998 167.555 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -58.46 -39.95 81.28 Favored 'General case' 0 CA--C 1.568 1.657 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 167.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.4 tptt -63.47 -55.54 23.32 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 172.301 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 78.0 mt -82.53 -21.51 35.36 Favored 'General case' 0 CA--C 1.571 1.761 0 N-CA-C 117.068 2.247 . . . . 0.0 117.068 -177.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.65 34.87 8.16 Favored Glycine 0 CA--C 1.556 2.614 0 N-CA-C 118.06 1.984 . . . . 0.0 118.06 -177.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.9 mm -109.06 159.42 31.21 Favored Pre-proline 0 CA--C 1.572 1.824 0 CA-C-N 119.059 1.429 . . . . 0.0 113.275 -168.438 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -83.88 101.53 0.9 Allowed 'Trans proline' 0 CA--C 1.568 2.184 0 C-N-CA 121.996 1.797 . . . . 0.0 110.592 163.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -59.54 113.94 2.47 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 123.647 0.779 . . . . 0.0 111.67 168.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 22.0 mm -98.35 106.21 18.42 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.212 0 N-CA-C 103.891 -2.633 . . . . 0.0 103.891 173.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 66.0 p -95.81 131.93 41.59 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 106.949 -1.5 . . . . 0.0 106.949 169.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.6 p -68.59 -11.21 59.7 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 117.312 2.338 . . . . 0.0 117.312 -174.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.512 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -87.65 -20.68 50.35 Favored Glycine 0 CA--C 1.544 1.846 0 N-CA-C 118.769 2.268 . . . . 0.0 118.769 166.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -81.63 -50.99 8.67 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 118.92 1.36 . . . . 0.0 114.652 -169.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -65.36 -37.75 87.98 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 113.906 1.076 . . . . 0.0 113.906 174.254 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.598 ' HB3' ' CB ' ' A' ' 50' ' ' LYS . 27.2 m-85 -67.49 -41.88 83.81 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 114.873 1.434 . . . . 0.0 114.873 169.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.512 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 73.2 ttt180 -57.08 -36.65 70.84 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 115.646 1.721 . . . . 0.0 115.646 165.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 5.5 ttm180 -62.15 -43.05 99.69 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 124.568 1.147 . . . . 0.0 113.956 168.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 38.6 m-80 -60.41 -43.81 96.33 Favored 'General case' 0 CA--C 1.573 1.852 0 CA-C-N 119.149 0.886 . . . . 0.0 113.255 167.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.473 ' HA ' HG23 ' A' ' 43' ' ' THR . 81.2 mt -51.27 -39.06 20.44 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.599 0 C-N-CA 125.93 1.692 . . . . 0.0 113.76 167.762 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -73.22 -32.62 64.88 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 115.786 1.772 . . . . 0.0 115.786 169.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -70.18 -50.43 40.28 Favored 'General case' 0 CA--C 1.553 1.095 0 N-CA-C 114.545 1.313 . . . . 0.0 114.545 175.855 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 166.33 -32.12 0.21 Allowed Glycine 0 CA--C 1.546 2.012 0 N-CA-C 117.818 1.887 . . . . 0.0 117.818 -169.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.618 ' O ' ' HG3' ' A' ' 44' ' ' LYS 0.322 44.7 p 49.45 125.29 0.0 OUTLIER 'General case' 0 N--CA 1.424 -1.749 1 N-CA-C 124.336 4.939 . . . . 0.0 124.336 -176.473 . . . . . . . . 4 3 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.618 ' HG3' ' O ' ' A' ' 43' ' ' THR 0.352 56.5 mtpt -142.46 -24.12 0.66 Allowed 'General case' 0 N--CA 1.507 2.406 0 CA-C-N 110.073 -3.239 . . . . 0.0 118.538 146.13 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -97.86 -24.93 15.21 Favored 'General case' 0 N--CA 1.514 2.726 0 CA-C-N 123.567 2.894 . . . . 0.0 112.332 161.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -40.52 -64.49 1.17 Allowed Glycine 0 CA--C 1.531 1.053 0 C-N-CA 130.583 3.944 . . . . 0.0 115.756 167.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 8.3 p -72.33 -48.65 47.19 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.213 0 N-CA-C 116.223 1.935 . . . . 0.0 116.223 -171.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -66.36 -44.85 82.05 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 120.359 1.436 . . . . 0.0 112.707 176.804 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -67.12 -38.43 85.57 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 115.967 1.84 . . . . 0.0 115.967 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.598 ' CB ' ' HB3' ' A' ' 35' ' ' PHE 0.348 15.3 tptt -81.28 -19.79 42.27 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-O 116.943 -1.503 . . . . 0.0 113.238 174.613 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.596 ' O ' ' CG ' ' A' ' 51' ' ' ARG . 33.9 ttt180 -81.23 -57.76 3.36 Favored 'General case' 0 CA--C 1.59 2.501 1 CA-C-O 85.358 -16.544 . . . . 0.0 118.654 174.711 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 16.8 m-30 -28.28 -62.23 0.11 Allowed 'General case' 0 N--CA 1.497 1.91 1 O-C-N 107.744 -9.347 . . . . 0.0 120.853 147.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.5 tp -59.05 -33.8 71.19 Favored 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 116.415 2.006 . . . . 0.0 116.415 171.65 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.2 t70 -90.04 -39.99 12.58 Favored 'General case' 0 CA--C 1.567 1.603 0 N-CA-C 115.543 1.682 . . . . 0.0 115.543 174.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.53 -40.22 16.56 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 117.004 -1.474 . . . . 0.0 114.776 -178.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 151.15 -38.91 0.83 Allowed Glycine 0 N--CA 1.476 1.333 0 CA-C-N 120.924 1.693 . . . . 0.0 116.729 170.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 30.0 t70 -67.31 171.72 5.59 Favored 'General case' 0 CA--C 1.57 1.741 0 CA-C-N 118.269 1.035 . . . . 0.0 111.626 -177.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 89.4 mt -92.76 135.93 33.69 Favored 'General case' 0 N--CA 1.484 1.243 0 O-C-N 121.383 -0.823 . . . . 0.0 112.12 -167.679 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.543 HG13 HE21 ' A' ' 92' ' ' GLN . 2.4 p -103.99 136.82 19.14 Favored Pre-proline 0 CA--C 1.58 2.12 0 CA-C-O 118.137 -0.935 . . . . 0.0 109.239 173.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_exo -55.31 146.53 60.87 Favored 'Trans proline' 0 CA--C 1.562 1.911 0 C-N-CA 123.836 3.024 . . . . 0.0 116.671 169.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 66.8 m -73.97 -48.68 28.78 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 117.493 2.405 . . . . 0.0 117.493 -168.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -61.52 -39.35 90.71 Favored 'General case' 0 N--CA 1.502 2.148 0 N-CA-C 116.675 2.102 . . . . 0.0 116.675 -170.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 26.2 mt -57.3 -48.52 78.7 Favored 'General case' 0 N--CA 1.506 2.327 0 N-CA-C 116.506 2.039 . . . . 0.0 116.506 172.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.4 m -61.31 -50.9 71.09 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 112.946 -1.934 . . . . 0.0 113.088 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.8 m-20 -64.08 -19.14 65.04 Favored 'General case' 0 CA--C 1.569 1.696 0 N-CA-C 116.245 1.943 . . . . 0.0 116.245 168.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -72.22 -44.12 63.41 Favored 'General case' 0 CA--C 1.558 1.273 0 CA-C-N 121.146 1.793 . . . . 0.0 114.18 168.573 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.9 mt -59.19 -49.96 75.86 Favored 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 120.207 1.367 . . . . 0.0 114.228 167.146 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 67.4 t -60.87 -46.79 95.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 123.811 0.844 . . . . 0.0 113.035 176.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -70.72 -27.16 63.76 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 116.107 1.891 . . . . 0.0 116.107 175.136 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -64.47 -37.98 89.41 Favored 'General case' 0 CA--C 1.563 1.475 0 CA-C-N 119.808 1.186 . . . . 0.0 112.714 167.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 93.0 mtt-85 -79.08 -24.0 43.79 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 118.414 2.746 . . . . 0.0 118.414 169.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 5.0 mp -81.7 -34.46 30.62 Favored 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 117.237 2.31 . . . . 0.0 117.237 176.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 28.2 m120 -71.53 15.96 0.12 Allowed 'General case' 0 N--CA 1.5 2.036 0 N-CA-C 116.832 2.16 . . . . 0.0 116.832 169.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.7 t-20 -75.77 144.35 76.46 Favored Pre-proline 0 CA--C 1.574 1.867 0 CA-C-O 118.024 -0.989 . . . . 0.0 108.947 165.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -47.72 -38.9 30.25 Favored 'Trans proline' 0 N--CA 1.499 1.803 0 N-CA-C 119.156 2.714 . . . . 0.0 119.156 171.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.8 p30 -68.84 -16.03 63.66 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 117.043 2.238 . . . . 0.0 117.043 172.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -117.17 22.44 12.51 Favored 'General case' 0 CA--C 1.572 1.824 0 CA-C-N 121.567 1.985 . . . . 0.0 114.622 170.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.15 -46.29 67.95 Favored 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 121.65 2.023 . . . . 0.0 114.538 172.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 21.6 p30 -88.11 0.85 55.52 Favored 'General case' 0 CA--C 1.57 1.741 0 N-CA-C 117.033 2.235 . . . . 0.0 117.033 172.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -177.61 167.51 38.53 Favored Glycine 0 N--CA 1.477 1.425 0 CA-C-N 121.998 2.181 . . . . 0.0 113.69 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 19.7 p90 -172.63 132.53 0.58 Allowed 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 112.875 -1.662 . . . . 0.0 107.729 -174.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 4.3 mm -101.2 107.67 21.84 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.563 0 N-CA-C 102.729 -3.063 . . . . 0.0 102.729 168.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 5.4 mt -100.97 133.95 44.69 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 169.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -125.32 129.98 51.06 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 119.33 0.968 . . . . 0.0 111.778 177.149 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.02 41.73 80.4 Favored Glycine 0 CA--C 1.546 1.984 0 CA-C-O 116.198 -2.445 . . . . 0.0 116.717 179.721 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . 0.257 1.6 t80 -106.28 -55.22 0.08 OUTLIER Pre-proline 0 N--CA 1.502 2.151 0 CA-C-N 121.281 2.54 . . . . 0.0 108.771 174.236 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -67.53 72.64 0.63 Allowed 'Trans proline' 0 CA--C 1.572 2.382 0 CA-C-N 124.02 2.471 . . . . 0.0 117.688 165.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.99 17.34 17.93 Favored 'General case' 0 CA--C 1.572 1.827 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 168.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 28.7 t -167.55 120.15 0.91 Allowed 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 101.656 -3.461 . . . . 0.0 101.656 -177.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . 0.342 4.6 p -69.01 -21.13 25.25 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 CA-C-O 116.337 -1.792 . . . . 0.0 111.991 -176.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 -64.38 -31.39 72.58 Favored 'General case' 0 CA--C 1.557 1.247 0 N-CA-C 117.896 2.554 . . . . 0.0 117.896 162.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.543 HE21 HG13 ' A' ' 59' ' ' VAL . 2.6 mm-40 -77.28 -51.57 10.67 Favored 'General case' 0 CA--C 1.585 2.32 0 CA-C-N 124.034 3.106 . . . . 0.0 111.412 164.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.27 -29.13 68.61 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 117.274 2.324 . . . . 0.0 117.274 -172.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 64.7 tttt -56.34 -35.32 67.49 Favored 'General case' 0 CA--C 1.557 1.213 0 N-CA-C 115.643 1.72 . . . . 0.0 115.643 167.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.32 -37.33 74.69 Favored 'General case' 0 CA--C 1.566 1.559 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 169.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 22.9 tp -65.55 -34.03 77.29 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 168.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -66.03 -42.28 89.78 Favored 'General case' 0 N--CA 1.497 1.893 0 CA-C-N 121.549 1.977 . . . . 0.0 112.623 169.182 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.971 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 34.9 mt-10 -56.02 -34.92 66.3 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 115.154 1.539 . . . . 0.0 115.154 167.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 1.226 ' O ' ' HB2' ' A' ' 103' ' ' ARG . 20.7 ttt -85.78 -32.99 21.51 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 118.567 2.803 . . . . 0.0 118.567 178.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.8 -44.71 47.97 Favored 'General case' 0 N--CA 1.507 2.387 0 CA-C-N 121.375 1.898 . . . . 0.0 111.705 170.266 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -73.52 -53.5 10.42 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-N 119.221 0.919 . . . . 0.0 113.269 173.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.971 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 72.3 ttt180 -67.71 -40.75 84.24 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 116.013 1.857 . . . . 0.0 116.013 176.038 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 1.226 ' HB2' ' O ' ' A' ' 99' ' ' MET . 15.0 mmm180 -61.42 -60.18 4.11 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 118.622 0.646 . . . . 0.0 111.447 166.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 113.63 49.27 0.56 Allowed Glycine 0 N--CA 1.478 1.478 0 O-C-N 124.629 1.205 . . . . 0.0 113.632 169.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 73.2 p -86.92 146.16 26.27 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-N 114.388 -0.906 . . . . 0.0 109.399 171.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 27.1 m-20 -69.13 132.15 46.11 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.526 -0.734 . . . . 0.0 111.394 -177.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.9 tp -89.25 97.21 6.78 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.429 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 -173.607 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -97.76 -65.58 0.95 Allowed 'General case' 0 N--CA 1.488 1.473 0 CA-C-O 115.802 -2.046 . . . . 0.0 109.163 169.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -149.32 118.08 6.63 Favored 'General case' 0 C--N 1.366 1.295 0 CA-C-N 121.988 2.176 . . . . 0.0 114.88 -170.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.545 HG12 HD11 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -94.99 110.74 24.42 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.162 1 N-CA-C 98.888 -4.486 . . . . 0.0 98.888 161.042 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 40.9 tp -114.02 103.81 11.52 Favored 'General case' 0 CA--C 1.547 0.838 0 CA-C-N 114.15 -1.386 . . . . 0.0 110.246 -162.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 24.8 tt0 -100.2 123.39 44.38 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 112.436 0.532 . . . . 0.0 112.436 -176.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 6.8 m-30 -93.98 126.58 39.27 Favored 'General case' 0 CA--C 1.561 1.369 0 CA-C-O 122.471 1.129 . . . . 0.0 109.562 179.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.405 ' HB3' ' HA ' ' A' ' 163' ' ' ASP . 1.6 tmm_? -82.72 88.31 6.73 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 113.602 -1.635 . . . . 0.0 109.134 168.356 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.49 HG21 ' H ' ' A' ' 12' ' ' GLY . 3.4 p -137.75 139.52 42.79 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.118 0 C-N-CA 125.758 1.623 . . . . 0.0 107.813 -169.496 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.5 m -86.41 127.09 34.79 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 113.526 -1.67 . . . . 0.0 111.023 -179.618 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -64.09 -43.53 95.1 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 114.383 -1.281 . . . . 0.0 114.044 168.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -46.92 -40.64 14.6 Favored 'General case' 0 N--CA 1.481 1.117 0 N-CA-C 117.384 2.365 . . . . 0.0 117.384 -176.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.2 t -59.1 -50.42 79.82 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.591 0 CA-C-N 120.337 1.426 . . . . 0.0 113.856 178.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -63.97 -35.13 79.67 Favored 'General case' 0 CA--C 1.565 1.536 0 CA-C-O 117.512 -1.232 . . . . 0.0 113.304 168.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.612 ' O ' ' HB2' ' A' ' 125' ' ' LYS . 35.2 mt -61.75 -29.4 70.1 Favored 'General case' 0 N--CA 1.505 2.297 0 N-CA-C 116.306 1.965 . . . . 0.0 116.306 169.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -66.42 -51.98 51.28 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 123.868 0.867 . . . . 0.0 112.634 167.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 22.0 mmm180 -47.42 -60.65 2.37 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 115.63 1.715 . . . . 0.0 115.63 171.077 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.5 pp -68.57 -28.04 66.6 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 117.07 2.248 . . . . 0.0 117.07 174.75 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.612 ' HB2' ' O ' ' A' ' 121' ' ' LEU . 46.8 tttm -75.81 -57.27 3.98 Favored 'General case' 0 N--CA 1.484 1.244 0 N-CA-C 115.864 1.801 . . . . 0.0 115.864 -177.391 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -92.12 42.07 2.76 Favored Glycine 0 CA--C 1.549 2.173 0 N-CA-C 116.646 1.418 . . . . 0.0 116.646 177.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 91.2 mtt-85 -149.12 -94.92 0.07 Allowed 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 118.087 0.943 . . . . 0.0 109.739 176.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.658 ' O ' ' HG3' ' A' ' 129' ' ' ARG . . . -96.85 60.61 1.17 Allowed Glycine 0 CA--C 1.554 2.525 0 CA-C-O 117.047 -1.974 . . . . 0.0 115.736 -171.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.658 ' HG3' ' O ' ' A' ' 128' ' ' GLY . 79.3 mtp85 -163.49 151.94 13.74 Favored 'General case' 0 N--CA 1.497 1.903 0 CA-C-N 121.507 2.654 . . . . 0.0 112.729 174.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -95.1 45.87 1.11 Allowed 'General case' 0 CA--C 1.568 1.64 0 N-CA-C 114.405 1.261 . . . . 0.0 114.405 174.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . 0.267 4.8 p-10 40.94 58.88 2.38 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 119.267 3.062 . . . . 0.0 119.267 -175.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . 0.532 ' HB3' ' NH2' ' A' ' 129' ' ' ARG . 23.7 t0 -79.93 -37.88 33.63 Favored 'General case' 0 N--CA 1.505 2.294 0 CA-C-N 112.592 -2.095 . . . . 0.0 111.633 160.03 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 65.1 p -5.35 -79.5 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 129.651 3.18 . . . . 0.0 119.467 165.365 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -59.73 -44.56 93.71 Favored 'General case' 0 N--CA 1.496 1.825 0 N-CA-C 115.746 1.758 . . . . 0.0 115.746 -170.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -66.76 -39.45 87.89 Favored 'General case' 0 N--CA 1.498 1.928 0 N-CA-C 115.117 1.525 . . . . 0.0 115.117 169.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 3.8 t -57.38 -45.04 85.37 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 114.052 1.131 . . . . 0.0 114.052 169.389 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 48.9 mm -69.84 -28.7 37.85 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.787 0 CA-C-O 117.402 -1.285 . . . . 0.0 113.431 172.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 32.3 mt -65.43 -44.34 87.67 Favored 'General case' 0 N--CA 1.494 1.742 0 CA-C-N 121.538 1.972 . . . . 0.0 114.262 169.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 38.0 t-20 -67.61 -41.04 84.63 Favored 'General case' 0 N--CA 1.502 2.135 0 CA-C-N 120.654 1.57 . . . . 0.0 114.71 172.024 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 69.2 mtp180 -60.56 -38.68 85.34 Favored 'General case' 0 N--CA 1.491 1.604 0 N-CA-C 116.434 2.013 . . . . 0.0 116.434 169.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 56.1 mtt -71.62 -29.14 64.33 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 169.219 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -61.91 -50.35 72.53 Favored 'General case' 0 N--CA 1.487 1.401 0 CA-C-N 120.459 1.482 . . . . 0.0 114.834 168.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.5 p -63.52 -33.83 63.86 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 114.665 1.357 . . . . 0.0 114.665 169.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 21.5 t80 -54.21 -48.27 71.22 Favored 'General case' 0 CA--C 1.58 2.112 0 CA-C-N 119.983 1.265 . . . . 0.0 112.403 167.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 70.1 ttt180 -61.26 -45.57 93.98 Favored 'General case' 0 N--CA 1.486 1.344 0 N-CA-C 117.859 2.54 . . . . 0.0 117.859 175.131 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 35.0 m-20 -56.63 -32.1 64.99 Favored 'General case' 0 N--CA 1.507 2.385 0 N-CA-C 117.779 2.511 . . . . 0.0 117.779 177.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -114.61 -39.59 3.75 Favored 'General case' 0 N--CA 1.482 1.164 0 N-CA-C 117.497 2.406 . . . . 0.0 117.497 -167.008 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 99.1 m -49.88 -34.2 19.44 Favored 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 117.525 2.417 . . . . 0.0 117.525 -168.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.442 ' HB3' ' HD3' ' A' ' 150' ' ' PRO . . . -67.8 -61.12 4.59 Favored Pre-proline 0 CA--C 1.581 2.168 0 CA-C-O 116.013 -1.946 . . . . 0.0 112.045 170.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.442 ' HD3' ' HB3' ' A' ' 149' ' ' ALA . 84.8 Cg_exo -55.74 -30.06 74.2 Favored 'Trans proline' 0 CA--C 1.582 2.919 0 N-CA-C 119.947 3.018 . . . . 0.0 119.947 169.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.3 -55.18 30.71 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 126.442 1.897 . . . . 0.0 111.524 169.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 1.3 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 28.9 tp -67.1 -22.52 65.81 Favored 'General case' 0 CA--C 1.562 1.409 0 CA-C-O 116.699 -1.619 . . . . 0.0 114.437 179.594 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -71.99 -49.35 37.91 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-N 122.008 2.185 . . . . 0.0 112.354 164.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 43.4 t80 -67.81 -54.4 19.42 Favored 'General case' 0 CA--C 1.562 1.438 0 CA-C-N 121.214 1.825 . . . . 0.0 112.158 -177.759 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 76.1 m-85 -77.39 -23.27 50.73 Favored 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 114.49 -2.671 . . . . 0.0 112.337 179.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 1.3 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 0.1 OUTLIER -64.45 -40.25 95.38 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 125.878 3.945 . . . . 0.0 115.739 167.735 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -62.09 -37.0 83.4 Favored 'General case' 0 CA--C 1.576 1.947 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 167.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -90.48 -35.63 14.99 Favored 'General case' 0 CA--C 1.576 1.98 0 N-CA-C 118.653 2.834 . . . . 0.0 118.653 -179.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.418 ' HA ' HG23 ' A' ' 110' ' ' VAL . 3.3 pp -71.87 171.81 11.04 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 119.843 3.275 . . . . 0.0 119.843 -163.449 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -129.72 126.3 37.92 Favored 'General case' 0 CA--C 1.566 1.585 0 N-CA-C 104.356 -2.461 . . . . 0.0 104.356 166.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 2.3 t -101.64 160.45 14.44 Favored 'General case' 0 N--CA 1.495 1.811 0 CA-C-O 122.798 1.285 . . . . 0.0 113.265 -169.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.525 HG13 ' HG3' ' A' ' 174' ' ' ARG . 91.9 t -131.74 150.41 33.94 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.887 0 CA-C-N 113.456 -1.702 . . . . 0.0 107.335 169.578 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.405 ' HA ' ' HB3' ' A' ' 114' ' ' ARG . 13.4 t70 -107.06 127.03 53.11 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 167.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -164.83 126.95 2.2 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 113.746 1.017 . . . . 0.0 113.746 -162.506 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.0 t -150.45 129.77 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.549 0 O-C-N 121.34 -0.85 . . . . 0.0 108.845 167.627 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 77.58 -60.3 3.68 Favored Glycine 0 N--CA 1.485 1.902 0 N-CA-C 120.705 3.042 . . . . 0.0 120.705 166.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 42.9 p -70.64 120.29 16.04 Favored 'General case' 0 N--CA 1.492 1.636 0 CA-C-N 113.05 -1.575 . . . . 0.0 111.873 -168.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 27.9 ttt -73.4 -51.54 16.95 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 114.059 1.133 . . . . 0.0 114.059 -173.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -71.99 -44.25 63.78 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 116.158 1.91 . . . . 0.0 116.158 179.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.844 ' HB3' ' NH2' ' A' ' 174' ' ' ARG . 45.1 mt-10 -58.99 -54.9 41.87 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 113.661 0.986 . . . . 0.0 113.661 172.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 93.6 t -58.13 -37.8 64.18 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.342 0 N-CA-C 113.91 1.078 . . . . 0.0 113.91 176.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 15.1 t80 -60.48 -36.13 77.55 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 168.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -63.59 -56.05 18.91 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 114.087 1.143 . . . . 0.0 114.087 175.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.844 ' NH2' ' HB3' ' A' ' 170' ' ' GLU . 9.8 ptp180 -66.07 -25.93 67.26 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 118.001 2.593 . . . . 0.0 118.001 171.736 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.5 -41.62 88.6 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 167.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.3 mp -62.82 -41.69 99.42 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 117.676 -1.154 . . . . 0.0 113.831 167.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -54.96 -45.18 74.89 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 168.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.64 -46.59 88.55 Favored 'General case' 0 CA--C 1.559 1.313 0 N-CA-C 116.655 2.095 . . . . 0.0 116.655 171.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 6.2 tt -83.74 -57.01 3.39 Favored 'General case' 0 CA--C 1.567 1.604 0 CA-C-O 117.68 -1.152 . . . . 0.0 112.428 -179.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.646 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -110.39 -58.89 0.49 Allowed Glycine 0 CA--C 1.552 2.366 0 CA-C-O 117.727 -1.596 . . . . 0.0 114.924 -176.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.646 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 37.0 ttmt . . . . . 0 C--O 1.251 1.151 0 CA-C-N 120.357 2.079 . . . . 0.0 107.328 -175.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 20.0 ptp . . . . . 0 N--CA 1.483 1.205 0 CA-C-O 121.681 0.753 . . . . 0.0 111.551 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.729 ' HB3' ' HA2' ' A' ' 80' ' ' GLY . 0.0 OUTLIER -160.42 159.0 30.47 Favored 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 114.789 1.403 . . . . 0.0 114.789 -168.782 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 99.4 t -136.7 150.2 27.0 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.543 0 CA-C-O 124.107 1.908 . . . . 0.0 110.262 -166.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.638 HD12 HH22 ' A' ' 2' ' ' ARG . 3.7 mt -117.46 134.04 55.29 Favored 'General case' 0 CA--C 1.547 0.836 0 C-N-CA 127.234 2.214 . . . . 0.0 107.039 169.565 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 18.5 tp -116.65 119.35 35.23 Favored 'General case' 0 CA--C 1.571 1.769 0 CA-C-O 123.722 1.725 . . . . 0.0 108.716 -176.239 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -118.41 141.5 48.49 Favored 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 110.504 -3.044 . . . . 0.0 109.794 -166.815 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 171.2 167.85 32.05 Favored Glycine 0 CA--C 1.559 2.796 0 N-CA-C 116.04 1.176 . . . . 0.0 116.04 170.856 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -61.26 153.28 66.36 Favored 'Trans proline' 0 CA--C 1.574 2.5 0 C-N-CA 123.513 2.809 . . . . 0.0 116.002 174.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -84.99 90.35 0.79 Allowed 'Trans proline' 0 CA--C 1.562 1.902 0 C-N-CA 122.562 2.175 . . . . 0.0 114.684 -169.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -171.43 -87.64 0.07 OUTLIER Glycine 0 CA--C 1.536 1.377 0 N-CA-C 110.226 -1.149 . . . . 0.0 110.226 173.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -101.37 149.04 24.46 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 -175.621 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 75.52 110.97 0.11 Allowed Glycine 0 N--CA 1.486 1.969 0 N-CA-C 116.956 1.542 . . . . 0.0 116.956 167.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.5 mtmm 170.56 -74.87 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.219 0.608 . . . . 0.0 110.158 173.756 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -51.06 -36.3 34.75 Favored Glycine 0 CA--C 1.554 2.509 0 N-CA-C 120.466 2.947 . . . . 0.0 120.466 -177.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 58.6 m -65.01 -52.45 56.07 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 119.151 1.475 . . . . 0.0 113.458 177.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.284 21.3 mp0 -76.51 -13.39 60.1 Favored 'General case' 0 CA--C 1.571 1.783 0 CA-C-O 115.545 -2.169 . . . . 0.0 112.329 171.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.39 -45.83 68.36 Favored 'General case' 0 C--N 1.373 1.619 0 CA-C-N 124.131 3.151 . . . . 0.0 114.389 166.901 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 10.9 p -66.22 -43.22 91.92 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 CA-C-O 118.449 -0.786 . . . . 0.0 113.092 173.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.4 ' HB3' ' CE1' ' A' ' 172' ' ' PHE . 97.3 mttt -55.14 -48.61 73.46 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 116.6 2.074 . . . . 0.0 116.6 169.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 mt -66.16 -29.26 69.51 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 172.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.83 -39.83 94.21 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 114.669 1.359 . . . . 0.0 114.669 167.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -59.32 -39.49 83.26 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-O 117.342 -1.313 . . . . 0.0 114.516 166.361 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 81.7 tttt -62.25 -58.89 6.08 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 120.901 1.682 . . . . 0.0 114.905 169.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.3 mt -82.31 -20.2 37.88 Favored 'General case' 0 CA--C 1.571 1.772 0 N-CA-C 117.551 2.426 . . . . 0.0 117.551 -172.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 79.67 44.94 8.88 Favored Glycine 0 CA--C 1.553 2.432 0 CA-C-N 120.734 1.607 . . . . 0.0 117.071 -174.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.402 ' CG2' ' HA ' ' A' ' 81' ' ' PHE . 29.1 mm -112.32 156.02 42.74 Favored Pre-proline 0 CA--C 1.569 1.698 0 CA-C-N 118.219 1.01 . . . . 0.0 113.578 -168.227 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -73.04 100.65 1.24 Allowed 'Trans proline' 0 CA--C 1.562 1.894 0 C-N-CA 121.807 1.671 . . . . 0.0 112.685 160.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -73.23 105.34 4.61 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.302 -0.874 . . . . 0.0 108.809 167.446 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 44.6 mm -99.97 111.9 30.93 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 N-CA-C 105.106 -2.183 . . . . 0.0 105.106 178.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.2 t -96.64 127.84 43.01 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 168.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 19.7 p -73.91 1.31 11.01 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 116.95 2.204 . . . . 0.0 116.95 -172.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -96.57 -18.67 29.71 Favored Glycine 0 CA--C 1.55 2.28 0 N-CA-C 118.014 1.966 . . . . 0.0 118.014 163.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -78.89 -55.87 4.82 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 119.494 1.647 . . . . 0.0 113.594 -168.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -57.0 -39.28 74.4 Favored 'General case' 0 CA--C 1.568 1.648 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 172.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 31.6 m-85 -69.84 -37.46 76.19 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 117.415 -1.279 . . . . 0.0 114.05 169.329 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 73.9 ttt180 -52.9 -39.95 63.16 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 115.478 1.658 . . . . 0.0 115.478 167.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.43 ' HD2' ' HA ' ' A' ' 37' ' ' ARG . 9.8 tpt180 -67.64 -39.99 84.59 Favored 'General case' 0 N--CA 1.496 1.865 0 N-CA-C 113.673 0.99 . . . . 0.0 113.673 172.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 73.8 m-20 -64.99 -31.76 73.16 Favored 'General case' 0 CA--C 1.579 2.074 0 N-CA-C 115.634 1.716 . . . . 0.0 115.634 166.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 57.6 mt -59.89 -45.68 94.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 C-N-CA 126.023 1.729 . . . . 0.0 111.362 167.439 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -63.06 -41.48 99.47 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 114.492 1.293 . . . . 0.0 114.492 172.017 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -71.74 -37.77 70.52 Favored 'General case' 0 CA--C 1.563 1.444 0 N-CA-C 116.823 2.157 . . . . 0.0 116.823 176.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 92.05 71.06 1.18 Allowed Glycine 0 CA--C 1.545 1.967 0 CA-C-O 117.782 -1.566 . . . . 0.0 115.179 -176.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.874 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 59.2 p -92.33 -51.26 5.24 Favored 'General case' 0 N--CA 1.502 2.139 0 CA-C-N 119.684 1.742 . . . . 0.0 114.286 174.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.874 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.25 73.4 mttt 105.87 -40.52 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.777 0 CA-C-O 116.325 -1.798 . . . . 0.0 111.651 -171.549 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -81.06 -14.84 57.43 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 123.066 2.666 . . . . 0.0 112.968 164.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.3 -57.53 19.31 Favored Glycine 0 C--N 1.358 1.755 0 CA-C-N 120.299 1.409 . . . . 0.0 115.082 168.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.268 10.9 p -75.13 -47.5 35.8 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.394 0 N-CA-C 116.45 2.018 . . . . 0.0 116.45 -168.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -65.42 -46.86 78.3 Favored 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 120.783 1.629 . . . . 0.0 112.8 173.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.02 -33.81 75.29 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 -178.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 13.6 tmtt? -66.68 -42.46 86.51 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 114.25 1.204 . . . . 0.0 114.25 168.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.591 ' CG ' ' O ' ' A' ' 51' ' ' ARG . 31.6 ttt180 -73.0 -51.53 17.9 Favored 'General case' 0 CA--C 1.59 2.518 1 CA-C-O 85.079 -16.677 . . . . 0.0 118.318 -173.725 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 16.9 m-30 -31.57 -56.91 0.27 Allowed 'General case' 0 N--CA 1.495 1.793 1 O-C-N 109.216 -8.428 . . . . 0.0 121.693 146.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 35.8 mt -59.17 -44.68 92.16 Favored 'General case' 0 CA--C 1.578 2.039 0 CA-C-N 122.941 2.609 . . . . 0.0 114.411 166.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -80.79 -34.12 34.33 Favored 'General case' 0 CA--C 1.564 1.488 0 N-CA-C 116.941 2.2 . . . . 0.0 116.941 179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -97.05 -33.77 11.41 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 175.159 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 112.47 20.19 6.69 Favored Glycine 0 CA--C 1.546 1.987 0 CA-C-N 122.452 2.387 . . . . 0.0 118.068 169.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -97.98 173.06 7.25 Favored 'General case' 0 CA--C 1.574 1.904 0 CA-C-N 118.998 1.399 . . . . 0.0 110.083 167.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.7 mt -72.71 130.31 40.22 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 119.828 -1.795 . . . . 0.0 114.923 -166.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.4 p -116.35 113.55 40.98 Favored Pre-proline 0 CA--C 1.57 1.745 0 C-N-CA 124.817 1.247 . . . . 0.0 108.936 -178.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_exo -60.6 153.06 64.22 Favored 'Trans proline' 0 CA--C 1.559 1.746 0 C-N-CA 123.425 2.75 . . . . 0.0 116.996 177.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 90.5 p -79.35 172.91 13.14 Favored 'General case' 0 CA--C 1.567 1.62 0 N-CA-C 113.658 0.984 . . . . 0.0 113.658 177.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . 0.427 ' O ' ' HB2' ' A' ' 66' ' ' GLU . 6.0 t70 81.89 -46.12 0.19 Allowed 'General case' 0 N--CA 1.499 2.017 0 C-N-CA 125.839 1.656 . . . . 0.0 114.713 175.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 22.6 mt -60.83 -50.96 71.33 Favored 'General case' 0 N--CA 1.506 2.354 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 168.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.4 m -58.84 -50.83 72.53 Favored 'General case' 0 CA--C 1.566 1.591 0 CA-C-N 112.989 -1.914 . . . . 0.0 112.904 177.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 12.6 m-80 -62.17 -28.44 69.66 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 115.216 1.561 . . . . 0.0 115.216 168.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.427 ' HB2' ' O ' ' A' ' 62' ' ' ASP . 0.0 OUTLIER -64.69 -44.37 90.52 Favored 'General case' 0 CA--C 1.555 1.171 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 171.997 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.3 mt -60.9 -48.99 79.29 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.214 1.191 . . . . 0.0 114.214 167.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 78.5 t -61.39 -51.82 68.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 CA-C-O 117.989 -1.005 . . . . 0.0 111.497 175.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -64.4 -28.38 69.65 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 117.216 2.302 . . . . 0.0 117.216 174.082 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -64.05 -41.43 97.38 Favored 'General case' 0 N--CA 1.488 1.437 0 CA-C-N 119.706 1.139 . . . . 0.0 112.806 168.423 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 27.8 ttm-85 -82.4 -9.2 59.54 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 119.001 2.963 . . . . 0.0 119.001 170.43 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 89.9 mt -99.49 -23.42 15.11 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 175.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 -75.8 23.43 0.13 Allowed 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 116.318 1.97 . . . . 0.0 116.318 172.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -81.04 145.67 57.28 Favored Pre-proline 0 CA--C 1.578 2.024 0 C-N-CA 124.276 1.03 . . . . 0.0 108.661 166.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -49.83 -32.7 30.53 Favored 'Trans proline' 0 N--CA 1.507 2.269 0 N-CA-C 119.447 2.826 . . . . 0.0 119.447 169.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -66.34 -12.71 58.25 Favored 'General case' 0 CA--C 1.564 1.492 0 CA-C-O 116.011 -1.947 . . . . 0.0 115.616 175.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.81 -38.75 76.71 Favored 'General case' 0 CA--C 1.565 1.541 0 CA-C-N 123.254 2.752 . . . . 0.0 111.389 165.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 52.34 37.1 21.49 Favored 'General case' 0 N--CA 1.499 2.02 0 CA-C-N 122.355 2.343 . . . . 0.0 114.973 -173.055 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 64.33 26.23 13.6 Favored 'General case' 0 CA--C 1.59 2.509 0 C-N-CA 124.453 1.101 . . . . 0.0 113.855 -168.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.729 ' HA2' ' HB3' ' A' ' 2' ' ' ARG . . . -133.89 159.98 23.91 Favored Glycine 0 C--N 1.365 2.146 0 CA-C-N 121.077 1.762 . . . . 0.0 112.612 177.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.402 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . 31.5 p90 -178.39 135.32 0.15 Allowed 'General case' 0 N--CA 1.495 1.782 0 CA-C-N 113.355 -1.422 . . . . 0.0 112.111 -168.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 31.3 mt -109.5 106.03 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.545 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 174.235 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.9 mt -99.98 129.84 46.09 Favored 'General case' 0 N--CA 1.493 1.678 0 C-N-CA 124.35 1.06 . . . . 0.0 110.261 179.036 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -124.22 115.96 21.91 Favored 'General case' 0 N--CA 1.495 1.794 0 CA-C-N 118.501 0.591 . . . . 0.0 110.235 -172.528 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 75.18 32.64 55.72 Favored Glycine 0 CA--C 1.551 2.343 0 CA-C-O 117.549 -1.695 . . . . 0.0 117.046 -177.607 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -95.9 -52.77 0.23 Allowed Pre-proline 0 N--CA 1.496 1.863 0 CA-C-O 115.068 -2.396 . . . . 0.0 108.664 174.425 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -66.13 70.7 0.4 Allowed 'Trans proline' 0 CA--C 1.573 2.437 0 CA-C-N 124.57 2.668 . . . . 0.0 117.835 165.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . 0.33 39.2 ttt-85 -72.61 -35.41 67.85 Favored 'General case' 0 CA--C 1.56 1.333 0 N-CA-C 116.789 2.144 . . . . 0.0 116.789 167.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 38.6 t -147.29 135.4 21.45 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 104.558 -2.386 . . . . 0.0 104.558 -169.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . 0.329 4.9 p -69.02 -19.0 23.48 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.995 0 CA-C-O 116.364 -1.779 . . . . 0.0 112.597 -178.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -68.08 -32.7 73.22 Favored 'General case' 0 CA--C 1.558 1.254 0 N-CA-C 118.781 2.882 . . . . 0.0 118.781 165.168 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 2.5 mm-40 -75.83 -50.35 15.39 Favored 'General case' 0 CA--C 1.587 2.387 0 CA-C-N 124.372 3.26 . . . . 0.0 111.204 164.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.73 -27.43 66.47 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 117.984 2.587 . . . . 0.0 117.984 -175.673 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 41.9 tttt -57.32 -33.91 68.2 Favored 'General case' 0 N--CA 1.481 1.085 0 N-CA-C 115.112 1.523 . . . . 0.0 115.112 167.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -62.35 -38.23 88.69 Favored 'General case' 0 CA--C 1.569 1.697 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 167.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 47.3 mt -66.9 -33.19 75.05 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 116.059 1.874 . . . . 0.0 116.059 170.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 12.3 t-80 -63.19 -55.02 28.55 Favored 'General case' 0 N--CA 1.498 1.943 0 CA-C-N 120.064 1.302 . . . . 0.0 112.755 169.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 1.157 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 0.7 OUTLIER -49.73 -36.58 26.09 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 115.761 1.763 . . . . 0.0 115.761 168.13 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 1.125 ' O ' ' HB2' ' A' ' 103' ' ' ARG . 65.6 mtt -84.37 -28.84 26.71 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 117.802 2.519 . . . . 0.0 117.802 175.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 35.9 tp -65.23 -55.05 20.67 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 120.747 1.612 . . . . 0.0 111.862 170.624 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -80.1 -50.74 9.9 Favored 'General case' 0 CA--C 1.562 1.42 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 176.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 1.157 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 94.4 mtt180 -71.86 -42.15 67.21 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 177.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 1.125 ' HB2' ' O ' ' A' ' 99' ' ' MET . 43.6 mtt180 -65.18 -51.52 60.59 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 119.928 1.24 . . . . 0.0 111.621 164.526 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 107.4 44.33 1.26 Allowed Glycine 0 N--CA 1.48 1.612 0 C-N-CA 121.052 -0.594 . . . . 0.0 114.153 167.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 31.1 p -95.18 145.02 25.33 Favored 'General case' 0 CA--C 1.557 1.217 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 169.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -69.44 128.19 35.65 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 121.438 -0.789 . . . . 0.0 112.604 -169.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 4.5 tp -81.0 102.78 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 N-CA-C 106.593 -1.632 . . . . 0.0 106.593 173.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . 0.268 24.2 t70 -96.5 -76.23 0.51 Allowed 'General case' 0 N--CA 1.499 1.985 0 CA-C-O 116.111 -1.899 . . . . 0.0 106.8 167.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -138.87 127.14 22.78 Favored 'General case' 0 N--CA 1.49 1.552 0 CA-C-N 121.141 1.791 . . . . 0.0 114.794 -173.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 4.4 t -93.66 109.92 22.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 N-CA-C 103.144 -2.91 . . . . 0.0 103.144 162.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 91.3 mt -107.09 120.48 42.2 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 122.918 0.487 . . . . 0.0 109.873 -172.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -103.95 128.18 51.48 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 118.033 0.379 . . . . 0.0 110.358 177.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 4.8 m-30 -91.46 119.42 31.41 Favored 'General case' 0 CA--C 1.556 1.192 0 CA-C-O 122.946 1.355 . . . . 0.0 109.584 177.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -82.0 93.59 6.99 Favored 'General case' 0 CA--C 1.557 1.224 0 CA-C-N 112.843 -1.98 . . . . 0.0 108.314 166.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.7 p -137.82 141.44 38.81 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 CA-C-N 113.605 -1.634 . . . . 0.0 108.286 -168.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 1.9 m -84.73 122.03 28.52 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 114.365 -1.289 . . . . 0.0 110.236 169.793 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -59.61 -32.8 70.75 Favored 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 170.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -50.03 -30.26 10.38 Favored 'General case' 0 N--CA 1.479 1.025 0 N-CA-C 117.851 2.537 . . . . 0.0 117.851 174.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.8 t -61.9 -53.88 42.12 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 CA-C-N 121.896 2.134 . . . . 0.0 113.664 176.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 9.5 mp -73.25 -26.07 60.96 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 172.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 9.4 mp -69.26 -35.56 76.22 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 120.942 1.701 . . . . 0.0 114.576 169.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 1.4 pp20? -72.88 -33.79 66.28 Favored 'General case' 0 N--CA 1.496 1.867 0 CA-C-N 120.45 1.477 . . . . 0.0 114.764 170.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 -58.48 -50.17 74.7 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 115.171 1.545 . . . . 0.0 115.171 168.494 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 10.9 mp -64.52 -55.76 18.49 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 114.199 1.185 . . . . 0.0 114.199 173.23 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -73.24 -19.19 61.13 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 118.882 2.919 . . . . 0.0 118.882 -177.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -61.13 -34.63 88.74 Favored Glycine 0 CA--C 1.552 2.363 0 N-CA-C 119.322 2.489 . . . . 0.0 119.322 -176.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 77.8 ttt180 -137.23 94.74 2.98 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-N 118.892 1.346 . . . . 0.0 109.126 176.136 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.492 ' O ' ' HG3' ' A' ' 129' ' ' ARG . . . 84.18 175.13 50.71 Favored Glycine 0 CA--C 1.573 3.702 0 CA-C-O 118.706 -1.052 . . . . 0.0 114.325 179.129 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.492 ' HG3' ' O ' ' A' ' 128' ' ' GLY . 79.0 mtp180 -164.4 112.03 1.09 Allowed 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 121.378 2.589 . . . . 0.0 110.292 176.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -83.7 99.49 10.27 Favored 'General case' 0 CA--C 1.578 2.055 0 N-CA-C 104.834 -2.284 . . . . 0.0 104.834 166.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -84.7 74.83 10.39 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 123.376 2.807 . . . . 0.0 115.25 -166.473 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -116.62 62.0 0.72 Allowed 'General case' 0 CA--C 1.577 1.983 0 N-CA-C 102.813 -3.032 . . . . 0.0 102.813 157.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 73.2 p -140.45 -109.79 0.15 Allowed 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 113.917 -1.492 . . . . 0.0 109.886 -161.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 5.9 m-20 -56.96 -31.27 64.83 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 117.105 2.261 . . . . 0.0 117.105 -169.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -70.65 -46.62 62.91 Favored 'General case' 0 N--CA 1.498 1.952 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 177.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.678 ' O ' ' HG3' ' A' ' 140' ' ' ARG . 18.9 m -62.79 -31.29 51.77 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.622 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 168.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 49.2 mm -64.92 -40.75 90.12 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.893 0 CA-C-O 117.175 -1.393 . . . . 0.0 112.102 167.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -60.61 -41.71 95.35 Favored 'General case' 0 N--CA 1.495 1.814 0 CA-C-N 121.623 2.011 . . . . 0.0 115.68 169.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -60.99 -39.15 88.55 Favored 'General case' 0 N--CA 1.503 2.211 0 N-CA-C 114.487 1.291 . . . . 0.0 114.487 167.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.678 ' HG3' ' O ' ' A' ' 136' ' ' VAL . 27.7 mtp180 -59.78 -38.4 81.75 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 167.008 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 63.3 mtt -65.64 -31.87 73.13 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 169.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -64.12 -49.63 71.43 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 115.141 1.534 . . . . 0.0 115.141 168.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.6 p -65.97 -33.33 62.82 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.106 0 N-CA-C 114.4 1.259 . . . . 0.0 114.4 169.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -54.19 -51.41 64.48 Favored 'General case' 0 CA--C 1.579 2.077 0 CA-C-N 120.175 1.352 . . . . 0.0 111.191 167.506 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 62.9 ttt180 -55.61 -37.09 67.67 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 119.529 3.159 . . . . 0.0 119.529 173.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -51.46 -29.37 15.99 Favored 'General case' 0 N--CA 1.513 2.685 0 N-CA-C 117.844 2.535 . . . . 0.0 117.844 170.625 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 21.9 mm-40 -121.88 -28.94 4.38 Favored 'General case' 0 CA--C 1.559 1.309 0 N-CA-C 118.852 2.908 . . . . 0.0 118.852 -166.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 33.5 m -42.78 -37.08 1.66 Allowed 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 118.053 2.612 . . . . 0.0 118.053 -168.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.5 -62.46 2.99 Favored Pre-proline 0 CA--C 1.581 2.172 0 CA-C-O 116.175 -1.869 . . . . 0.0 111.822 172.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -52.08 -36.56 66.14 Favored 'Trans proline' 0 CA--C 1.58 2.819 0 C-N-CA 123.554 2.836 . . . . 0.0 118.546 167.993 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.68 -54.54 44.09 Favored 'General case' 0 N--CA 1.497 1.916 0 C-N-CA 125.427 1.491 . . . . 0.0 111.973 171.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 1.004 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 44.2 tp -67.39 -23.55 65.58 Favored 'General case' 0 CA--C 1.561 1.396 0 CA-C-O 116.669 -1.634 . . . . 0.0 114.456 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 9.0 mt-10 -72.43 -46.01 57.02 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 122.022 2.192 . . . . 0.0 112.743 165.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -67.81 -52.07 41.37 Favored 'General case' 0 CA--C 1.565 1.534 0 CA-C-N 120.499 1.499 . . . . 0.0 112.245 -177.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -81.03 -24.3 38.01 Favored 'General case' 0 CA--C 1.555 1.161 0 CA-C-O 115.119 -2.372 . . . . 0.0 113.405 178.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 1.004 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 39.8 ttt180 -65.04 -36.41 84.26 Favored 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 124.565 3.348 . . . . 0.0 115.581 168.29 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.4 t70 -68.17 -37.33 80.86 Favored 'General case' 0 CA--C 1.574 1.896 0 CA-C-N 119.806 1.185 . . . . 0.0 114.026 167.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -80.14 -35.93 35.94 Favored 'General case' 0 CA--C 1.575 1.91 0 N-CA-C 119.009 2.966 . . . . 0.0 119.009 178.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.2 pp -79.96 174.77 11.25 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 118.917 2.932 . . . . 0.0 118.917 -161.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 61.3 tttt -135.18 140.64 45.52 Favored 'General case' 0 CA--C 1.564 1.495 0 C-N-CA 125.249 1.42 . . . . 0.0 108.075 167.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 58.0 m -88.76 146.89 24.75 Favored 'General case' 0 N--CA 1.493 1.695 0 CA-C-O 122.358 1.075 . . . . 0.0 112.14 -169.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 58.4 t -134.8 137.49 50.83 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.559 0 N-CA-C 105.445 -2.057 . . . . 0.0 105.445 167.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -95.39 138.78 32.6 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 168.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -162.24 101.31 1.09 Allowed 'General case' 0 N--CA 1.482 1.13 0 O-C-N 121.466 -0.771 . . . . 0.0 112.323 -165.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.9 t -151.14 130.33 3.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 N-CA-C 108.463 -0.94 . . . . 0.0 108.463 173.775 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 78.11 -68.45 2.86 Favored Glycine 0 N--CA 1.483 1.809 0 N-CA-C 119.092 2.397 . . . . 0.0 119.092 166.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 41.6 p -73.06 143.73 47.34 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 112.218 -1.991 . . . . 0.0 112.728 -168.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 27.8 ttt -85.37 -69.44 0.66 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 123.246 0.618 . . . . 0.0 111.044 -176.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 -70.69 -36.02 73.08 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 116.127 1.899 . . . . 0.0 116.127 -176.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -59.63 -51.95 67.62 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 171.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 79.5 t -55.47 -40.33 57.76 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 175.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.4 ' CE1' ' HB3' ' A' ' 19' ' ' LYS . 22.9 t80 -62.97 -33.2 74.89 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 116.426 2.01 . . . . 0.0 116.426 169.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -62.02 -48.98 77.87 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 114.241 1.201 . . . . 0.0 114.241 171.452 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 80.0 mtt180 -58.93 -42.6 90.14 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 117.199 2.296 . . . . 0.0 117.199 169.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -58.93 -43.35 91.13 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 116.233 1.938 . . . . 0.0 116.233 170.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.9 mp -64.84 -42.05 95.24 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 169.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 96.8 mtt180 -54.4 -41.25 69.06 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 116.412 2.004 . . . . 0.0 116.412 169.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -65.24 -51.67 59.36 Favored 'General case' 0 CA--C 1.561 1.37 0 N-CA-C 115.064 1.505 . . . . 0.0 115.064 169.815 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 7.4 tt -74.03 -57.65 3.83 Favored 'General case' 0 CA--C 1.566 1.574 0 CA-C-N 120.026 1.285 . . . . 0.0 112.636 -176.042 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.945 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -110.46 -57.66 0.5 Allowed Glycine 0 CA--C 1.552 2.362 0 CA-C-O 117.744 -1.587 . . . . 0.0 114.762 -179.439 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.945 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 63.6 tttm . . . . . 0 C--O 1.251 1.173 0 CA-C-N 120.306 2.053 . . . . 0.0 109.212 -175.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.4 mmt . . . . . 0 N--CA 1.485 1.291 0 CA-C-O 122.667 1.222 . . . . 0.0 111.444 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . 0.304 8.7 ttm-85 -148.59 147.07 28.57 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 118.162 2.652 . . . . 0.0 118.162 -158.429 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 37.7 t -142.76 148.83 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 CA-C-O 124.624 2.154 . . . . 0.0 110.846 -172.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.4 HD11 HG22 ' A' ' 110' ' ' VAL 0.294 0.0 OUTLIER -135.56 122.03 20.63 Favored 'General case' 0 CA--C 1.564 1.513 0 CA-C-N 112.716 -2.038 . . . . 0.0 106.416 166.095 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 1.9 tt -97.98 133.31 42.63 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 125.823 1.649 . . . . 0.0 110.832 -166.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 8.6 mt -138.4 156.43 47.59 Favored 'General case' 0 CA--C 1.554 1.118 0 CA-C-N 113.98 -1.463 . . . . 0.0 111.174 -166.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 160.6 144.33 3.94 Favored Glycine 0 CA--C 1.555 2.544 0 CA-C-O 118.202 -1.332 . . . . 0.0 114.967 172.345 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -69.86 177.3 5.79 Favored 'Trans proline' 0 CA--C 1.579 2.733 0 CA-C-N 121.367 2.584 . . . . 0.0 114.847 169.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_exo -47.78 132.07 21.06 Favored 'Trans proline' 0 C--N 1.373 1.819 0 C-N-CA 124.057 3.171 . . . . 0.0 117.206 -177.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 145.22 98.76 0.25 Allowed Glycine 0 CA--C 1.533 1.211 0 N-CA-C 105.822 -2.911 . . . . 0.0 105.822 -167.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -72.78 100.64 2.91 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -168.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 179.1 85.49 0.06 OUTLIER Glycine 0 CA--C 1.539 1.563 0 N-CA-C 109.884 -1.286 . . . . 0.0 109.884 179.645 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -159.61 -74.53 0.07 Allowed 'General case' 0 N--CA 1.484 1.274 0 C-N-CA 123.187 0.595 . . . . 0.0 109.519 -170.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -48.22 -33.07 10.33 Favored Glycine 0 CA--C 1.557 2.693 0 N-CA-C 120.175 2.83 . . . . 0.0 120.175 171.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 20.1 m -61.7 -52.18 65.34 Favored 'General case' 0 N--CA 1.496 1.842 0 CA-C-N 118.872 1.336 . . . . 0.0 113.967 170.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.284 2.8 mp0 -75.09 -11.69 60.15 Favored 'General case' 0 CA--C 1.57 1.716 0 CA-C-O 115.719 -2.086 . . . . 0.0 112.683 171.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.91 -45.85 55.91 Favored 'General case' 0 C--N 1.372 1.581 0 CA-C-N 123.778 2.99 . . . . 0.0 113.929 166.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.3 p -65.22 -44.89 95.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.78 0 N-CA-C 113.833 1.049 . . . . 0.0 113.833 173.093 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.481 ' HB3' ' HE2' ' A' ' 172' ' ' PHE . 99.5 mttt -64.12 -46.06 85.84 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 116.325 1.972 . . . . 0.0 116.325 172.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.5 tp -65.26 -29.32 70.09 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 114.874 1.435 . . . . 0.0 114.874 171.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.81 -45.15 93.97 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 116.092 1.886 . . . . 0.0 116.092 168.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -52.71 -39.73 62.3 Favored 'General case' 0 N--CA 1.495 1.784 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 164.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 30.8 mmtp -64.32 -48.2 76.52 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 116.867 2.173 . . . . 0.0 116.867 170.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 32.7 mt -79.6 -19.01 50.33 Favored 'General case' 0 N--CA 1.498 1.926 0 N-CA-C 116.505 2.039 . . . . 0.0 116.505 -179.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 81.99 46.78 6.49 Favored Glycine 0 CA--C 1.554 2.513 0 CA-C-N 120.054 1.297 . . . . 0.0 116.14 -174.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.555 ' CD1' ' HA ' ' A' ' 81' ' ' PHE . 0.2 OUTLIER -130.86 147.93 68.17 Favored Pre-proline 0 CA--C 1.572 1.809 0 C-N-CA 125.855 1.662 . . . . 0.0 110.949 -165.773 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.476 ' HD2' HD12 ' A' ' 26' ' ' ILE . 19.2 Cg_endo -75.55 106.73 2.32 Favored 'Trans proline' 0 CA--C 1.574 2.489 0 C-N-CA 121.85 1.7 . . . . 0.0 111.049 158.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -67.35 132.62 48.05 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 120.643 -1.286 . . . . 0.0 112.028 169.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -94.98 107.25 19.21 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 N-CA-C 103.478 -2.786 . . . . 0.0 103.478 174.077 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 76.3 p -98.24 125.06 43.16 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 107.049 -1.463 . . . . 0.0 107.049 168.669 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 23.9 p -68.76 -4.6 16.57 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 117.68 2.474 . . . . 0.0 117.68 -175.032 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.77 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -89.34 -26.06 26.71 Favored Glycine 0 CA--C 1.539 1.573 0 N-CA-C 118.898 2.319 . . . . 0.0 118.898 165.722 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -82.11 -55.61 4.45 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 114.73 1.381 . . . . 0.0 114.73 -168.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.2 pt? -63.9 -40.1 95.72 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 113.5 0.926 . . . . 0.0 113.5 175.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.481 ' HB3' ' CB ' ' A' ' 50' ' ' LYS . 20.1 m-85 -71.09 -44.97 64.6 Favored 'General case' 0 CA--C 1.55 0.963 0 CA-C-O 116.35 -1.786 . . . . 0.0 114.612 173.006 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.77 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 72.5 ttt180 -52.46 -41.86 63.68 Favored 'General case' 0 N--CA 1.491 1.591 0 N-CA-C 115.862 1.801 . . . . 0.0 115.862 168.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -61.84 -41.25 97.58 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 114.369 1.248 . . . . 0.0 114.369 168.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 51.4 m-80 -67.61 -25.65 65.86 Favored 'General case' 0 CA--C 1.583 2.218 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 168.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 66.8 mt -61.64 -48.38 88.98 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.458 0 CA-C-N 121.054 1.752 . . . . 0.0 110.264 166.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -61.72 -40.91 96.71 Favored 'General case' 0 N--CA 1.491 1.6 0 N-CA-C 114.524 1.305 . . . . 0.0 114.524 175.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -65.94 -44.19 85.79 Favored 'General case' 0 CA--C 1.558 1.257 0 N-CA-C 116.069 1.878 . . . . 0.0 116.069 174.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.06 66.96 1.26 Allowed Glycine 0 CA--C 1.544 1.859 0 CA-C-O 118.784 -1.009 . . . . 0.0 114.301 -176.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.837 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 70.4 p -91.43 -48.45 6.88 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 114.631 1.345 . . . . 0.0 114.631 179.278 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.837 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.274 38.9 mttp 107.77 -41.54 0.0 OUTLIER 'General case' 0 CA--C 1.571 1.752 0 CA-C-O 116.31 -1.805 . . . . 0.0 111.007 -172.431 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.4 pp -79.5 -18.66 51.47 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 123.108 2.686 . . . . 0.0 114.147 163.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.26 -55.77 28.64 Favored Glycine 0 CA--C 1.548 2.141 0 CA-C-O 122.419 1.011 . . . . 0.0 114.951 169.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 1.082 ' O ' ' HB2' ' A' ' 51' ' ' ARG . 1.0 OUTLIER -75.89 -43.73 39.24 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 N-CA-C 117.158 2.281 . . . . 0.0 117.158 -167.988 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.48 ' HG2' HG23 ' A' ' 59' ' ' VAL . 29.7 tt0 -78.45 -24.79 45.86 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-N 122.369 2.349 . . . . 0.0 111.806 170.318 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -66.85 -47.76 70.96 Favored 'General case' 0 N--CA 1.493 1.688 0 CA-C-N 123.163 2.71 . . . . 0.0 112.68 177.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.481 ' CB ' ' HB3' ' A' ' 35' ' ' PHE 0.356 38.5 tptt -81.56 -17.22 49.15 Favored 'General case' 0 CA--C 1.573 1.85 0 O-C-N 124.694 1.247 . . . . 0.0 114.339 173.111 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 1.082 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 21.5 ttt180 -83.61 -54.34 5.0 Favored 'General case' 0 CA--C 1.581 2.173 1 CA-C-O 85.034 -16.698 . . . . 0.0 118.562 175.691 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 46.7 t80 -37.99 -62.8 0.53 Allowed 'General case' 0 C--N 1.368 1.398 1 O-C-N 105.791 -10.568 . . . . 0.0 119.442 148.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . 0.271 1.2 tm? -41.18 -40.65 1.62 Allowed 'General case' 0 CA--C 1.58 2.123 0 CA-C-N 121.968 2.167 . . . . 0.0 116.845 170.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.5 t70 -90.72 -42.91 10.44 Favored 'General case' 0 CA--C 1.572 1.821 0 N-CA-C 117.045 2.239 . . . . 0.0 117.045 169.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -102.69 -23.45 13.83 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 118.31 2.707 . . . . 0.0 118.31 -169.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.48 32.45 7.32 Favored Glycine 0 CA--C 1.543 1.807 0 N-CA-C 118.58 2.192 . . . . 0.0 118.58 169.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -83.78 -127.09 0.03 OUTLIER 'General case' 0 CA--C 1.583 2.234 0 C-N-CA 123.833 0.853 . . . . 0.0 111.106 168.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.2 pp -128.81 179.08 5.91 Favored 'General case' 0 CA--C 1.573 1.835 0 C-N-CA 126.268 1.827 . . . . 0.0 110.462 169.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.48 HG23 ' HG2' ' A' ' 48' ' ' GLU . 0.3 OUTLIER -163.9 138.84 4.76 Favored Pre-proline 0 CA--C 1.574 1.899 0 O-C-N 119.484 -2.01 . . . . 0.0 110.593 170.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -60.01 145.42 98.43 Favored 'Trans proline' 0 CA--C 1.562 1.919 0 C-N-CA 123.432 2.755 . . . . 0.0 115.999 169.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 95.3 p -78.61 173.15 12.72 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 77.27 -38.39 0.29 Allowed 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 117.15 2.278 . . . . 0.0 117.15 173.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . 0.452 ' O ' ' HB2' ' A' ' 66' ' ' GLU . 4.4 pp -54.55 -43.07 71.69 Favored 'General case' 0 N--CA 1.507 2.416 0 N-CA-C 118.03 2.604 . . . . 0.0 118.03 170.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.4 m -60.91 -58.39 8.65 Favored 'General case' 0 CA--C 1.562 1.424 0 CA-C-N 111.5 -2.591 . . . . 0.0 112.082 176.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 61.3 m-20 -62.38 -19.14 63.1 Favored 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 115.318 1.599 . . . . 0.0 115.318 166.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.452 ' HB2' ' O ' ' A' ' 63' ' ' LEU . 6.1 mm-40 -65.52 -44.84 85.67 Favored 'General case' 0 CA--C 1.558 1.276 0 CA-C-N 120.729 1.604 . . . . 0.0 114.036 168.129 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.5 mt -63.66 -43.79 95.69 Favored 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 114.571 1.322 . . . . 0.0 114.571 167.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 81.8 t -59.82 -48.9 85.89 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.01 0 CA-C-O 117.967 -1.016 . . . . 0.0 112.45 170.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -57.6 -37.6 73.49 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 116.976 2.213 . . . . 0.0 116.976 169.739 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 3.9 t70 -60.19 -39.45 86.57 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 169.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 76.8 mtp85 -79.44 -12.41 59.89 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 117.805 2.52 . . . . 0.0 117.805 167.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 2.1 mp -91.65 -23.67 19.76 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 117.527 2.417 . . . . 0.0 117.527 176.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 30.3 p30 -58.9 0.4 0.09 Allowed 'General case' 0 CA--C 1.578 2.054 0 N-CA-C 118.187 2.662 . . . . 0.0 118.187 168.418 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -59.26 -144.9 0.0 OUTLIER Pre-proline 0 CA--C 1.607 3.156 0 N-CA-C 117.513 2.412 . . . . 0.0 117.513 168.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_exo -59.11 38.79 0.05 OUTLIER 'Trans proline' 0 N--CA 1.514 2.699 2 C-N-CA 125.505 4.136 . . . . 0.0 122.552 171.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 60.46 32.57 20.57 Favored 'General case' 0 CA--C 1.588 2.404 0 C-N-CA 125.877 1.671 . . . . 0.0 109.77 -160.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 69.42 16.54 8.24 Favored 'General case' 0 C--N 1.381 1.946 0 CA-C-O 117.081 -1.437 . . . . 0.0 114.346 -166.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 51.95 34.14 13.11 Favored 'General case' 0 CA--C 1.577 1.996 0 CA-C-N 122.39 2.359 . . . . 0.0 113.368 -164.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 19.1 m120 59.55 31.46 20.99 Favored 'General case' 0 CA--C 1.577 1.999 0 CA-C-O 116.834 -1.555 . . . . 0.0 113.66 -166.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -143.49 -168.44 12.14 Favored Glycine 0 C--N 1.375 2.698 0 CA-C-N 122.958 2.617 . . . . 0.0 113.337 -176.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.555 ' HA ' ' CD1' ' A' ' 26' ' ' ILE 0.38 1.6 p90 171.75 139.21 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 113.605 -1.297 . . . . 0.0 111.357 163.11 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.9 mp -115.45 109.26 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 104.063 -2.569 . . . . 0.0 104.063 165.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 28.9 mt -100.36 108.99 21.15 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 107.026 -1.472 . . . . 0.0 107.026 168.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.6 t70 -103.61 129.29 50.85 Favored 'General case' 0 N--CA 1.5 2.036 0 CA-C-N 120.111 1.323 . . . . 0.0 109.961 -173.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 67.49 47.17 64.21 Favored Glycine 0 CA--C 1.548 2.098 0 CA-C-O 116.609 -2.217 . . . . 0.0 116.191 -173.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 3.0 t80 -132.77 73.17 76.45 Favored Pre-proline 0 CA--C 1.568 1.67 0 CA-C-N 121.104 2.452 . . . . 0.0 115.297 -178.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -97.94 -28.27 0.05 OUTLIER 'Trans proline' 0 CA--C 1.561 1.87 0 C-N-CA 122.817 2.344 . . . . 0.0 112.857 156.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 50.1 mtt85 41.64 24.28 0.02 OUTLIER 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 118.324 2.713 . . . . 0.0 118.324 -163.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.521 ' HA ' ' HG3' ' A' ' 147' ' ' GLU . 27.6 t 103.99 153.64 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 127.164 2.185 . . . . 0.0 106.519 -170.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . 0.531 HG12 ' HB2' ' A' ' 147' ' ' GLU 0.307 7.7 p -57.77 -27.34 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.11 0 O-C-N 119.647 -1.908 . . . . 0.0 112.366 169.23 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -70.0 -25.76 63.76 Favored 'General case' 0 CA--C 1.557 1.218 0 N-CA-C 119.471 3.138 . . . . 0.0 119.471 166.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 4.3 tm0? -74.28 -49.96 20.91 Favored 'General case' 0 CA--C 1.59 2.505 0 CA-C-N 124.592 3.36 . . . . 0.0 108.961 162.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -53.09 -25.44 12.9 Favored 'General case' 0 N--CA 1.489 1.503 0 N-CA-C 117.845 2.535 . . . . 0.0 117.845 -176.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 83.5 mttt -59.14 -33.05 70.43 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 166.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.12 -41.29 74.14 Favored 'General case' 0 CA--C 1.571 1.784 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 169.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 28.9 tp -63.16 -36.48 83.77 Favored 'General case' 0 CA--C 1.576 1.945 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 168.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -56.3 -53.6 55.36 Favored 'General case' 0 N--CA 1.5 2.032 0 C-N-CA 125.219 1.408 . . . . 0.0 112.719 167.821 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.806 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 11.0 mm-40 -49.92 -36.55 28.08 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 115.694 1.738 . . . . 0.0 115.694 166.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 1.13 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 24.9 ttt -83.45 -31.75 26.41 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 118.117 2.636 . . . . 0.0 118.117 -179.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -74.52 -44.28 51.96 Favored 'General case' 0 N--CA 1.508 2.449 0 CA-C-N 121.741 2.064 . . . . 0.0 111.486 169.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 53.3 mt-10 -71.91 -57.6 4.17 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 119.496 1.044 . . . . 0.0 113.694 173.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.806 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 76.8 mtp180 -71.76 -36.55 70.43 Favored 'General case' 0 N--CA 1.495 1.822 0 N-CA-C 115.322 1.601 . . . . 0.0 115.322 178.084 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 1.13 ' HB3' ' O ' ' A' ' 99' ' ' MET . 57.4 ttt85 -61.16 -56.59 19.0 Favored 'General case' 0 N--CA 1.489 1.513 0 CA-C-N 119.462 1.028 . . . . 0.0 111.736 165.188 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 111.7 49.87 0.62 Allowed Glycine 0 N--CA 1.481 1.672 0 O-C-N 124.231 0.957 . . . . 0.0 114.09 167.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 62.0 p -97.88 163.74 12.66 Favored 'General case' 0 CA--C 1.561 1.387 0 CA-C-N 114.015 -1.093 . . . . 0.0 111.075 -179.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -84.63 134.57 34.38 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.158 -0.964 . . . . 0.0 109.128 177.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.502 HD11 HG23 ' A' ' 110' ' ' VAL . 8.9 tt -95.88 107.2 19.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 106.012 -1.848 . . . . 0.0 106.012 172.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -89.36 -60.44 1.95 Allowed 'General case' 0 N--CA 1.492 1.636 0 CA-C-O 115.399 -2.239 . . . . 0.0 106.478 166.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -156.13 131.35 9.35 Favored 'General case' 0 C--N 1.369 1.419 0 CA-C-N 122.611 2.46 . . . . 0.0 116.463 179.062 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.502 HG23 HD11 ' A' ' 107' ' ' ILE . 39.2 t -88.66 107.86 18.21 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.629 0 N-CA-C 100.638 -3.838 . . . . 0.0 100.638 160.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.5 HD23 ' HB2' ' A' ' 160' ' ' LYS . 68.6 mt -104.27 108.83 20.42 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 118.318 -0.849 . . . . 0.0 109.616 -168.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -106.84 125.78 51.45 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.966 0.888 . . . . 0.0 109.857 -176.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 6.9 m-85 -100.69 116.64 33.08 Favored 'General case' 0 CA--C 1.557 1.235 0 CA-C-O 122.568 1.175 . . . . 0.0 110.469 -169.37 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 78.4 ttt180 -79.64 97.81 6.68 Favored 'General case' 0 CA--C 1.556 1.191 0 CA-C-N 113.546 -1.661 . . . . 0.0 108.835 165.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.0 p -149.98 124.42 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.553 1.063 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 -169.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 95.1 p -87.59 136.4 32.96 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 113.298 -1.774 . . . . 0.0 111.506 -177.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -59.25 -44.28 92.4 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 113.691 -1.595 . . . . 0.0 114.409 170.915 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -63.49 -26.85 68.91 Favored 'General case' 0 CA--C 1.555 1.159 0 N-CA-C 117.879 2.548 . . . . 0.0 117.879 -174.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -74.97 -45.74 42.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.881 0 CA-C-N 120.673 1.579 . . . . 0.0 114.904 178.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -71.42 -35.55 71.01 Favored 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 116.865 -1.54 . . . . 0.0 113.436 169.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 25.9 mt -66.07 -39.4 90.05 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 121.781 2.082 . . . . 0.0 116.464 170.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -68.34 -35.62 78.04 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 114.433 1.271 . . . . 0.0 114.433 170.222 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 64.4 ttt180 -56.34 -56.8 16.6 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 115.149 1.537 . . . . 0.0 115.149 169.102 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.6 pp -68.46 -36.16 78.6 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 177.725 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -81.17 -60.15 2.39 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 121.211 1.823 . . . . 0.0 113.516 177.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 101.79 -40.62 2.36 Favored Glycine 0 CA--C 1.549 2.208 0 CA-C-N 120.501 1.501 . . . . 0.0 116.49 179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 178.59 111.13 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.075 0 CA-C-N 118.242 1.021 . . . . 0.0 108.647 -174.611 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.17 172.74 48.89 Favored Glycine 0 CA--C 1.57 3.472 0 CA-C-O 118.625 -1.097 . . . . 0.0 113.106 -172.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 1.309 ' HB2' ' OD2' ' A' ' 131' ' ' ASP . 0.1 OUTLIER -160.92 100.32 1.25 Allowed 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 121.638 2.719 . . . . 0.0 114.219 -174.676 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -81.69 -37.7 26.98 Favored 'General case' 0 CA--C 1.576 1.96 0 CA-C-O 118.382 -0.818 . . . . 0.0 110.33 161.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 1.309 ' OD2' ' HB2' ' A' ' 129' ' ' ARG 0.29 20.9 m-20 66.89 -92.32 0.03 OUTLIER 'General case' 0 C--N 1.365 1.267 0 C-N-CA 126.846 2.059 . . . . 0.0 115.545 166.05 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . 0.302 17.9 t70 82.88 -58.16 0.17 Allowed 'General case' 0 N--CA 1.506 2.333 0 CA-C-N 113.704 -1.589 . . . . 0.0 109.165 -161.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 73.0 p -27.78 -68.66 0.06 Allowed 'General case' 0 N--CA 1.504 2.247 0 C-N-CA 127.714 2.406 . . . . 0.0 117.483 164.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -52.03 -38.77 58.11 Favored 'General case' 0 CA--C 1.57 1.743 0 N-CA-C 116.956 2.206 . . . . 0.0 116.956 171.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -67.5 -46.72 72.08 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 114.905 1.446 . . . . 0.0 114.905 175.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 35.0 m -63.0 -32.81 57.45 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.805 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 169.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 1.5 mp -67.5 -32.0 55.15 Favored 'Isoleucine or valine' 0 CA--C 1.577 2.006 0 C-N-CA 125.037 1.335 . . . . 0.0 113.444 167.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 27.2 mt -67.75 -45.71 74.18 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 120.722 1.601 . . . . 0.0 113.551 170.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 17.6 t-20 -61.4 -37.95 85.33 Favored 'General case' 0 N--CA 1.506 2.343 0 CA-C-N 120.228 1.376 . . . . 0.0 113.928 167.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 10.0 tpt180 -55.46 -39.11 69.95 Favored 'General case' 0 N--CA 1.487 1.397 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 166.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -67.6 -32.32 72.96 Favored 'General case' 0 CA--C 1.566 1.588 0 N-CA-C 114.97 1.471 . . . . 0.0 114.97 169.842 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 90.5 mttt -59.58 -54.18 49.44 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 120.561 1.528 . . . . 0.0 114.604 168.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . 0.253 7.3 p -63.67 -29.94 48.59 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 CA-C-O 117.085 -1.436 . . . . 0.0 114.054 170.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 29.7 t80 -56.65 -48.5 77.43 Favored 'General case' 0 CA--C 1.586 2.339 0 CA-C-N 121.441 1.928 . . . . 0.0 111.654 166.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -55.07 -21.2 11.74 Favored 'General case' 0 CA--C 1.564 1.493 0 N-CA-C 119.346 3.091 . . . . 0.0 119.346 170.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -53.31 -45.71 69.1 Favored 'General case' 0 N--CA 1.51 2.541 0 CA-C-N 121.339 1.882 . . . . 0.0 115.725 167.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.531 ' HB2' HG12 ' A' ' 90' ' ' VAL . 0.0 OUTLIER -123.91 -18.57 5.95 Favored 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 120.742 3.608 . . . . 0.0 120.742 -167.31 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 53.7 m -43.72 -31.67 0.85 Allowed 'General case' 0 N--CA 1.502 2.149 0 N-CA-C 117.899 2.555 . . . . 0.0 117.899 -169.081 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -71.48 -64.32 1.16 Allowed Pre-proline 0 CA--C 1.582 2.182 0 CA-C-O 116.123 -1.894 . . . . 0.0 112.21 172.259 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -56.53 -32.79 90.93 Favored 'Trans proline' 0 CA--C 1.579 2.772 0 CA-C-N 124.555 2.662 . . . . 0.0 118.905 168.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -63.2 -46.63 86.14 Favored 'General case' 0 N--CA 1.496 1.851 0 C-N-CA 125.451 1.5 . . . . 0.0 112.711 171.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 1.075 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 54.2 tp -65.96 -21.91 66.45 Favored 'General case' 0 CA--C 1.57 1.719 0 N-CA-C 115.029 1.492 . . . . 0.0 115.029 169.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -70.62 -48.04 57.05 Favored 'General case' 0 CA--C 1.559 1.31 0 CA-C-N 122.362 2.346 . . . . 0.0 112.914 165.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -61.91 -54.31 43.72 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-N 120.271 1.396 . . . . 0.0 113.021 178.548 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . 0.422 ' CD1' HG11 ' A' ' 110' ' ' VAL . 22.0 m-85 -76.43 -27.52 56.28 Favored 'General case' 0 CA--C 1.547 0.85 0 CA-C-O 115.739 -2.076 . . . . 0.0 113.438 178.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 1.075 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 26.0 ttt180 -62.34 -33.81 75.43 Favored 'General case' 0 N--CA 1.486 1.347 0 CA-C-N 124.166 3.166 . . . . 0.0 116.754 169.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -70.57 -40.9 73.06 Favored 'General case' 0 CA--C 1.575 1.922 0 CA-C-N 119.708 1.14 . . . . 0.0 113.64 166.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 73.8 mt-30 -90.66 -19.69 23.34 Favored 'General case' 0 CA--C 1.575 1.932 0 N-CA-C 119.877 3.288 . . . . 0.0 119.877 -176.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.5 pp -78.06 172.16 13.93 Favored 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 119.887 3.291 . . . . 0.0 119.887 -160.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.5 ' HB2' HD23 ' A' ' 111' ' ' LEU . 90.5 mttt -132.65 123.98 27.41 Favored 'General case' 0 CA--C 1.563 1.45 0 N-CA-C 104.349 -2.463 . . . . 0.0 104.349 163.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.9 t -95.94 151.01 19.82 Favored 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 122.034 0.921 . . . . 0.0 111.99 -171.151 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.511 HG13 ' HG3' ' A' ' 174' ' ' ARG . 15.2 t -129.76 129.49 66.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.43 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 178.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -97.22 111.61 23.77 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 104.121 -2.548 . . . . 0.0 104.121 169.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -128.14 42.28 3.35 Favored 'General case' 0 N--CA 1.484 1.272 1 N-CA-C 123.571 4.656 . . . . 0.0 123.571 -156.596 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . 0.501 32.5 m -101.9 -127.39 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.602 2.958 1 CA-C-O 109.702 -4.951 . . . . 0.0 106.98 169.031 . . . . . . . . 3 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 59.62 -17.31 0.03 OUTLIER Glycine 0 C--N 1.392 3.64 3 CA-C-N 134.441 7.837 . . . . 0.0 125.326 -168.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 67.2 p 60.5 94.71 0.04 OUTLIER 'General case' 0 CA--C 1.571 1.784 0 C-N-CA 127.254 2.221 . . . . 0.0 116.232 172.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . 0.271 43.4 tpp 86.94 -91.7 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 126.865 2.066 . . . . 0.0 112.244 166.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -63.83 -37.31 86.9 Favored 'General case' 0 N--CA 1.504 2.261 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -171.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.557 ' HB3' ' NH2' ' A' ' 174' ' ' ARG . 50.3 mt-10 -59.14 -51.95 67.82 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 113.889 1.07 . . . . 0.0 113.889 174.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 4.0 t -59.14 -36.25 61.78 Favored 'Isoleucine or valine' 0 CA--C 1.575 1.925 0 CA-C-O 117.426 -1.273 . . . . 0.0 113.462 177.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.481 ' HE2' ' HB3' ' A' ' 19' ' ' LYS . 21.4 t80 -58.75 -40.64 84.46 Favored 'General case' 0 N--CA 1.501 2.124 0 CA-C-N 121.082 1.764 . . . . 0.0 114.84 166.806 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -61.83 -54.44 42.17 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 114.546 1.313 . . . . 0.0 114.546 178.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.557 ' NH2' ' HB3' ' A' ' 170' ' ' GLU . 11.4 ptp180 -69.08 -25.28 64.36 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 117.841 2.534 . . . . 0.0 117.841 172.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.56 -46.61 85.15 Favored 'General case' 0 N--CA 1.493 1.716 0 CA-C-N 120.637 1.562 . . . . 0.0 113.862 168.013 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 1.3 mp -58.79 -43.91 90.58 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 115.225 1.565 . . . . 0.0 115.225 167.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 38.8 mmt180 -53.47 -43.07 67.85 Favored 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 116.033 1.864 . . . . 0.0 116.033 168.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.09 -44.96 90.73 Favored 'General case' 0 CA--C 1.56 1.364 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 172.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -70.81 -61.56 1.72 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 120.538 1.517 . . . . 0.0 110.897 172.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.885 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . 164.6 52.57 0.02 OUTLIER Glycine 0 CA--C 1.545 1.942 0 N-CA-C 118.795 2.278 . . . . 0.0 118.795 168.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.885 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 85.2 tttt . . . . . 0 C--O 1.252 1.187 0 CA-C-N 120.794 2.297 . . . . 0.0 110.565 168.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.2 mtt . . . . . 0 CA--C 1.556 1.206 0 CA-C-O 122.812 1.292 . . . . 0.0 110.46 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . 0.309 11.6 mpt_? -120.57 171.44 8.56 Favored 'General case' 0 N--CA 1.484 1.26 0 N-CA-C 121.231 3.789 . . . . 0.0 121.231 -163.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.6 p -150.16 144.58 17.42 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.297 0 CA-C-O 123.044 1.402 . . . . 0.0 111.633 166.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.2 pp -138.62 134.16 33.37 Favored 'General case' 0 CA--C 1.563 1.448 0 CA-C-N 113.676 -1.602 . . . . 0.0 109.714 169.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -108.5 121.36 44.81 Favored 'General case' 0 CA--C 1.57 1.734 0 N-CA-C 115.675 1.731 . . . . 0.0 115.675 -161.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 85.7 mt -99.58 144.96 28.07 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 111.443 -2.617 . . . . 0.0 110.358 175.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 163.93 162.26 14.53 Favored Glycine 0 CA--C 1.557 2.681 0 CA-C-O 118.801 -0.999 . . . . 0.0 115.553 169.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -71.3 118.61 5.77 Favored 'Trans proline' 0 CA--C 1.578 2.711 0 C-N-CA 123.475 2.783 . . . . 0.0 111.838 175.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 63.0 Cg_exo -65.19 113.16 2.3 Favored 'Trans proline' 0 CA--C 1.559 1.761 0 C-N-CA 122.936 2.424 . . . . 0.0 118.2 -169.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.87 -87.41 0.07 OUTLIER Glycine 0 CA--C 1.538 1.472 0 N-CA-C 109.363 -1.495 . . . . 0.0 109.363 168.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -84.76 -71.17 0.53 Allowed 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 115.221 1.563 . . . . 0.0 115.221 -172.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.435 ' O ' ' CG ' ' A' ' 13' ' ' LYS . . . -93.06 106.16 3.39 Favored Glycine 0 N--CA 1.484 1.886 0 CA-C-N 119.641 1.109 . . . . 0.0 114.991 -168.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.435 ' CG ' ' O ' ' A' ' 12' ' ' GLY . 3.6 mtmp? -175.48 -85.47 0.01 OUTLIER 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 121.807 0.813 . . . . 0.0 110.347 -179.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -53.8 -28.35 38.81 Favored Glycine 0 CA--C 1.554 2.48 0 N-CA-C 120.421 2.928 . . . . 0.0 120.421 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 24.1 m -65.76 -53.0 46.4 Favored 'General case' 0 N--CA 1.496 1.827 0 CA-C-N 119.328 1.564 . . . . 0.0 113.265 176.011 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.28 20.0 mp0 -76.64 -13.32 60.07 Favored 'General case' 0 CA--C 1.569 1.698 0 CA-C-O 114.895 -2.479 . . . . 0.0 112.43 169.766 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.38 -47.08 68.3 Favored 'General case' 0 C--N 1.376 1.729 0 CA-C-N 125.145 3.611 . . . . 0.0 113.703 166.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.1 p -66.8 -39.94 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.932 0 N-CA-C 114.269 1.211 . . . . 0.0 114.269 174.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.7 mtmm -62.13 -43.99 97.61 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 116.305 1.965 . . . . 0.0 116.305 169.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -63.84 -32.36 73.84 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 119.996 1.271 . . . . 0.0 114.152 171.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.38 -42.3 95.56 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 115.292 1.589 . . . . 0.0 115.292 167.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -58.2 -39.53 79.22 Favored 'General case' 0 CA--C 1.566 1.586 0 N-CA-C 114.739 1.385 . . . . 0.0 114.739 167.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 25.3 mmmt -65.9 -54.88 20.81 Favored 'General case' 0 N--CA 1.492 1.667 0 N-CA-C 115.188 1.551 . . . . 0.0 115.188 174.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.3 mt -83.51 -19.8 35.07 Favored 'General case' 0 N--CA 1.494 1.768 0 N-CA-C 116.775 2.139 . . . . 0.0 116.775 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.02 38.6 7.83 Favored Glycine 0 CA--C 1.554 2.512 0 N-CA-C 117.62 1.808 . . . . 0.0 117.62 -176.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 11.9 mm -107.51 158.52 33.04 Favored Pre-proline 0 CA--C 1.57 1.724 0 CA-C-N 118.565 1.182 . . . . 0.0 113.419 -168.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -82.82 99.77 0.93 Allowed 'Trans proline' 0 CA--C 1.571 2.338 0 C-N-CA 121.867 1.712 . . . . 0.0 111.372 163.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -64.04 112.24 2.88 Favored 'General case' 0 N--CA 1.496 1.858 0 C-N-CA 123.831 0.852 . . . . 0.0 112.117 170.635 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 21.5 mm -99.83 108.48 22.79 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.1 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 59.8 p -97.79 128.64 44.56 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 107.414 -1.328 . . . . 0.0 107.414 168.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.9 p -69.02 -19.34 64.11 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 117.066 2.247 . . . . 0.0 117.066 -169.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -81.67 -19.88 64.96 Favored Glycine 0 CA--C 1.543 1.839 0 N-CA-C 119.102 2.401 . . . . 0.0 119.102 167.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -80.84 -51.4 8.65 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -169.125 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -65.13 -41.07 95.15 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 113.04 0.755 . . . . 0.0 113.04 174.346 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.452 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 25.2 m-85 -66.4 -41.1 89.82 Favored 'General case' 0 CA--C 1.559 1.298 0 N-CA-C 115.702 1.741 . . . . 0.0 115.702 172.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 22.5 tpt180 -59.3 -42.72 91.99 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 120.544 1.52 . . . . 0.0 114.203 168.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 31.5 ttt180 -59.21 -39.21 81.98 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 115.122 1.527 . . . . 0.0 115.122 168.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 68.9 m-80 -69.62 -24.47 63.65 Favored 'General case' 0 CA--C 1.581 2.14 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 168.315 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 70.0 mt -63.17 -49.46 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.248 0 CA-C-N 120.675 1.579 . . . . 0.0 110.96 167.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -67.95 -33.52 74.83 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 114.301 1.222 . . . . 0.0 114.301 175.254 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.2 mm-40 -73.7 -35.86 65.2 Favored 'General case' 0 CA--C 1.564 1.498 0 N-CA-C 116.299 1.962 . . . . 0.0 116.299 173.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.77 73.76 1.28 Allowed Glycine 0 CA--C 1.542 1.76 0 CA-C-O 118.065 -1.409 . . . . 0.0 114.482 -176.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.554 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 64.7 p -90.8 -65.59 1.0 Allowed 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 119.262 1.531 . . . . 0.0 111.911 173.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.554 ' CB ' ' O ' ' A' ' 43' ' ' THR . 21.3 ptmt 130.27 -57.13 0.0 OUTLIER 'General case' 0 CA--C 1.569 1.702 0 C-N-CA 123.661 0.784 . . . . 0.0 109.581 -166.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -80.03 6.83 10.39 Favored 'General case' 0 CA--C 1.575 1.913 0 C-N-CA 124.249 1.019 . . . . 0.0 113.454 166.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.417 ' O ' ' CB ' ' A' ' 50' ' ' LYS . . . -86.79 -52.77 3.05 Favored Glycine 0 CA--C 1.535 1.333 0 O-C-N 121.21 -0.931 . . . . 0.0 112.892 165.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.312 7.4 p -80.14 -52.03 15.22 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.581 0 N-CA-C 116.167 1.914 . . . . 0.0 116.167 -167.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -66.94 -44.37 80.8 Favored 'General case' 0 N--CA 1.489 1.494 0 CA-C-N 121.013 1.733 . . . . 0.0 112.686 172.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.79 -30.8 69.46 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 179.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.452 ' HB2' ' HB3' ' A' ' 35' ' ' PHE . 2.4 tptm -71.97 -36.87 69.95 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 114.113 1.153 . . . . 0.0 114.113 167.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.571 ' HG2' ' O ' ' A' ' 51' ' ' ARG . 46.5 ttt180 -70.78 -58.71 3.35 Favored 'General case' 0 CA--C 1.591 2.534 1 CA-C-O 87.3 -15.619 . . . . 0.0 117.829 -178.531 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . 0.253 10.9 m-30 -26.47 -68.81 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.587 1 O-C-N 110.452 -7.655 . . . . 0.0 119.644 146.512 . . . . . . . . 3 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 26.6 tp -57.3 -32.07 66.29 Favored 'General case' 0 CA--C 1.568 1.636 0 N-CA-C 116.517 2.043 . . . . 0.0 116.517 175.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -88.78 -47.25 8.35 Favored 'General case' 0 CA--C 1.559 1.311 0 CA-C-O 116.831 -1.557 . . . . 0.0 114.395 170.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -158.24 46.33 0.34 Allowed 'General case' 0 CA--C 1.573 1.837 0 CA-C-N 121.401 1.909 . . . . 0.0 113.32 -168.359 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -161.21 60.89 0.29 Allowed Glycine 0 C--N 1.358 1.785 0 CA-C-N 121.906 2.139 . . . . 0.0 111.727 169.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . 0.279 4.8 t70 75.56 -115.05 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 C-N-CA 124.301 1.041 . . . . 0.0 110.423 168.619 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.568 ' HA ' HH22 ' A' ' 88' ' ' ARG . 74.7 mt -133.47 128.79 36.17 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 119.507 1.049 . . . . 0.0 110.628 -174.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.0 p -89.27 141.03 28.79 Favored Pre-proline 0 CA--C 1.578 2.031 0 CA-C-O 117.429 -1.272 . . . . 0.0 108.095 167.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_exo -50.66 143.81 27.7 Favored 'Trans proline' 0 CA--C 1.565 2.03 0 C-N-CA 123.451 2.767 . . . . 0.0 116.696 169.765 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 59.6 m -65.71 -42.75 90.74 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 117.064 2.246 . . . . 0.0 117.064 -169.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -59.5 -37.71 79.01 Favored 'General case' 0 N--CA 1.502 2.162 0 N-CA-C 116.832 2.16 . . . . 0.0 116.832 -175.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 35.5 mt -54.87 -51.82 64.75 Favored 'General case' 0 N--CA 1.504 2.269 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 169.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.7 m -64.99 -50.77 65.01 Favored 'General case' 0 N--CA 1.488 1.475 0 CA-C-N 112.889 -1.96 . . . . 0.0 113.064 -178.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -62.83 -20.01 64.64 Favored 'General case' 0 CA--C 1.567 1.623 0 N-CA-C 115.782 1.771 . . . . 0.0 115.782 167.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 6.6 mm-40 -72.48 -46.87 52.79 Favored 'General case' 0 CA--C 1.556 1.185 0 CA-C-N 120.441 1.473 . . . . 0.0 114.588 170.02 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.1 mt -61.22 -46.0 92.26 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 169.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 97.3 t -61.77 -48.78 87.06 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.745 0 CA-C-O 118.025 -0.988 . . . . 0.0 112.017 175.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -63.03 -35.78 81.36 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 115.993 1.849 . . . . 0.0 115.993 172.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -57.55 -42.83 83.73 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 117.695 -1.145 . . . . 0.0 113.779 170.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 83.2 mtt180 -80.26 -15.55 56.72 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 118.497 2.777 . . . . 0.0 118.497 168.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.419 HD13 HH12 ' A' ' 103' ' ' ARG . 96.6 mt -83.69 -14.69 51.14 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 116.527 2.047 . . . . 0.0 116.527 169.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -68.84 8.1 0.57 Allowed 'General case' 0 N--CA 1.5 2.03 0 N-CA-C 117.17 2.285 . . . . 0.0 117.17 169.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.0 t-20 -76.36 136.45 68.45 Favored Pre-proline 0 CA--C 1.574 1.885 0 CA-C-O 117.79 -1.1 . . . . 0.0 108.568 165.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -49.92 -24.42 10.46 Favored 'Trans proline' 0 N--CA 1.505 2.156 0 N-CA-C 122.25 3.904 . . . . 0.0 122.25 175.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 43.7 m-20 -64.1 -10.73 24.18 Favored 'General case' 0 CA--C 1.573 1.845 0 CA-C-O 116.62 -1.657 . . . . 0.0 114.284 166.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.97 -19.14 57.68 Favored 'General case' 0 CA--C 1.564 1.516 0 CA-C-N 122.42 2.373 . . . . 0.0 115.68 168.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -59.82 -35.13 74.07 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 116.782 2.142 . . . . 0.0 116.782 174.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 68.1 m-80 -106.14 16.72 24.55 Favored 'General case' 0 CA--C 1.574 1.884 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 172.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.26 178.6 38.56 Favored Glycine 0 C--N 1.358 1.782 0 CA-C-N 122.159 2.254 . . . . 0.0 115.266 173.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -173.44 131.87 0.46 Allowed 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 105.487 -2.042 . . . . 0.0 105.487 169.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 4.7 mm -104.65 108.21 24.3 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.504 0 N-CA-C 103.412 -2.81 . . . . 0.0 103.412 170.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 79.8 mt -100.09 138.82 36.63 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 171.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -127.9 127.96 44.31 Favored 'General case' 0 N--CA 1.499 1.991 0 CA-C-N 119.575 1.08 . . . . 0.0 111.859 172.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 67.63 34.02 82.57 Favored Glycine 0 CA--C 1.552 2.373 0 N-CA-C 118.008 1.963 . . . . 0.0 118.008 178.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -94.34 -54.27 0.23 Allowed Pre-proline 0 N--CA 1.496 1.826 0 CA-C-O 114.956 -2.45 . . . . 0.0 108.968 173.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -69.3 68.63 1.42 Allowed 'Trans proline' 0 CA--C 1.565 2.071 0 CA-C-N 124.75 2.732 . . . . 0.0 118.82 167.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.568 HH22 ' HA ' ' A' ' 58' ' ' LEU . 26.8 ptt180 -66.61 -35.57 80.5 Favored 'General case' 0 N--CA 1.489 1.484 0 N-CA-C 116.056 1.873 . . . . 0.0 116.056 166.186 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 37.7 t -149.18 141.17 23.81 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 107.435 -1.32 . . . . 0.0 107.435 -168.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . 0.274 8.4 p -61.7 -27.24 41.77 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.653 0 CA-C-O 115.941 -1.981 . . . . 0.0 113.322 178.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.86 -38.22 88.26 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 120.155 3.391 . . . . 0.0 120.155 166.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -75.68 -47.91 24.26 Favored 'General case' 0 CA--C 1.586 2.34 0 CA-C-N 123.356 2.798 . . . . 0.0 112.299 166.746 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.5 -31.0 70.07 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 117.981 2.586 . . . . 0.0 117.981 -175.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -57.31 -29.72 64.15 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 168.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -67.18 -40.54 86.58 Favored 'General case' 0 CA--C 1.571 1.758 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 167.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . 0.484 ' HA ' ' HG3' ' A' ' 99' ' ' MET . 40.1 tp -62.61 -38.3 89.66 Favored 'General case' 0 N--CA 1.496 1.851 0 N-CA-C 115.136 1.532 . . . . 0.0 115.136 169.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 55.8 t60 -64.89 -44.51 89.37 Favored 'General case' 0 N--CA 1.493 1.719 0 CA-C-N 120.413 1.46 . . . . 0.0 113.313 168.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.839 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 32.0 mt-10 -51.58 -40.52 59.96 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 115.175 1.546 . . . . 0.0 115.175 167.767 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 1.287 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 0.0 OUTLIER -84.63 -19.95 32.14 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 117.934 2.568 . . . . 0.0 117.934 175.184 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 60.2 tp -72.45 -52.71 14.7 Favored 'General case' 0 N--CA 1.5 2.046 0 CA-C-N 121.175 1.807 . . . . 0.0 111.47 170.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 55.2 mt-10 -74.85 -55.9 5.32 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 113.686 0.995 . . . . 0.0 113.686 171.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.839 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 36.9 ttm180 -68.99 -39.22 79.51 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 178.076 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 1.287 ' HB3' ' O ' ' A' ' 99' ' ' MET . 66.1 ttt180 -62.37 -58.38 7.87 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 119.639 1.108 . . . . 0.0 110.365 164.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 111.47 46.66 0.78 Allowed Glycine 0 N--CA 1.479 1.529 0 O-C-N 124.366 1.041 . . . . 0.0 113.651 168.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 37.2 p -101.26 147.21 26.55 Favored 'General case' 0 CA--C 1.556 1.198 0 N-CA-C 108.145 -1.058 . . . . 0.0 108.145 173.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -68.22 130.06 41.79 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.346 -0.846 . . . . 0.0 112.572 -170.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 4.4 tp -85.48 98.53 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 N-CA-C 106.511 -1.663 . . . . 0.0 106.511 175.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -97.51 -67.77 0.83 Allowed 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 115.765 -2.064 . . . . 0.0 108.388 168.858 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -149.34 120.84 7.95 Favored 'General case' 0 C--N 1.367 1.367 0 CA-C-N 121.999 2.181 . . . . 0.0 115.114 -170.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 19.4 t -94.09 109.77 22.54 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.691 0 N-CA-C 104.618 -2.364 . . . . 0.0 104.618 163.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.673 HD23 ' HB2' ' A' ' 160' ' ' LYS . 80.1 mt -105.07 117.97 35.35 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 123.423 0.689 . . . . 0.0 112.082 -172.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -88.68 136.19 33.12 Favored 'General case' 0 N--CA 1.489 1.52 0 CA-C-O 121.398 0.618 . . . . 0.0 112.086 169.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 6.4 m-85 -101.53 112.33 24.85 Favored 'General case' 0 CA--C 1.558 1.28 0 CA-C-O 122.998 1.38 . . . . 0.0 108.118 176.004 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.431 ' HB3' ' HA ' ' A' ' 163' ' ' ASP . 17.0 tpt180 -83.79 101.87 11.92 Favored 'General case' 0 CA--C 1.55 0.96 0 CA-C-N 112.889 -1.959 . . . . 0.0 109.157 171.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.5 p -146.17 124.09 4.41 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.185 0 CA-C-N 113.128 -1.851 . . . . 0.0 106.717 -169.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 11.2 m -61.85 142.09 57.56 Favored 'General case' 0 N--CA 1.487 1.422 0 CA-C-N 113.639 -1.619 . . . . 0.0 113.877 -169.444 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 47.2 mt-10 -54.32 -38.27 65.79 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 116.521 2.045 . . . . 0.0 116.521 178.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -70.66 -39.39 73.6 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 115.969 1.84 . . . . 0.0 115.969 176.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -60.64 -47.58 92.31 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.094 0 CA-C-N 120.488 1.495 . . . . 0.0 114.318 175.685 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.3 pp -67.12 -43.48 82.35 Favored 'General case' 0 N--CA 1.494 1.757 0 CA-C-N 114.423 -1.262 . . . . 0.0 114.233 177.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.2 mp -60.37 -35.68 76.25 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 115.248 1.573 . . . . 0.0 115.248 167.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -60.82 -43.09 98.7 Favored 'General case' 0 N--CA 1.494 1.774 0 N-CA-C 114.262 1.208 . . . . 0.0 114.262 168.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 30.1 ttm180 -57.6 -48.83 78.31 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 115.041 1.497 . . . . 0.0 115.041 168.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -49.46 -48.12 47.89 Favored 'General case' 0 N--CA 1.496 1.871 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 169.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -62.57 -55.28 28.73 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 176.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.744 ' O ' ' HB2' ' A' ' 127' ' ' ARG . . . -112.16 60.81 0.33 Allowed Glycine 0 CA--C 1.543 1.81 0 C-N-CA 123.141 0.4 . . . . 0.0 114.002 178.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.744 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 66.3 ttt180 161.99 89.6 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.831 0 N-CA-C 109.99 -0.374 . . . . 0.0 109.99 177.288 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.525 ' O ' ' HB2' ' A' ' 129' ' ' ARG . . . 174.49 -51.7 0.14 Allowed Glycine 0 CA--C 1.551 2.326 0 CA-C-O 118.244 -1.309 . . . . 0.0 114.301 -178.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.525 ' HB2' ' O ' ' A' ' 128' ' ' GLY . 37.8 ttm180 167.65 -97.0 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 119.483 1.641 . . . . 0.0 107.065 177.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -151.29 -44.92 0.11 Allowed 'General case' 0 N--CA 1.49 1.539 0 CA-C-O 116.964 -1.493 . . . . 0.0 112.636 169.977 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -136.24 61.6 1.64 Allowed 'General case' 0 N--CA 1.496 1.846 0 CA-C-N 121.772 2.078 . . . . 0.0 112.081 175.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -117.97 61.48 0.77 Allowed 'General case' 0 CA--C 1.572 1.824 0 N-CA-C 102.974 -2.972 . . . . 0.0 102.974 159.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 81.6 p -140.09 -112.5 0.15 Allowed 'General case' 0 N--CA 1.485 1.306 0 CA-C-N 114.047 -1.433 . . . . 0.0 110.63 -160.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -55.88 -45.27 78.6 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 117.079 2.251 . . . . 0.0 117.079 -168.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -67.65 -38.16 83.41 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 115.402 1.63 . . . . 0.0 115.402 172.349 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 44.4 t -66.2 -38.2 81.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 CA-C-O 117.871 -1.061 . . . . 0.0 112.795 174.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.5 tp -75.17 -25.24 18.08 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.009 0 CA-C-O 117.26 -1.352 . . . . 0.0 114.276 170.355 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 28.8 mt -66.11 -51.07 61.39 Favored 'General case' 0 N--CA 1.495 1.807 0 CA-C-N 121.824 2.102 . . . . 0.0 113.246 168.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.9 t30 -66.53 -38.69 87.7 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 114.692 1.368 . . . . 0.0 114.692 173.351 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 63.4 mtp180 -63.36 -32.61 74.08 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 116.363 1.986 . . . . 0.0 116.363 170.192 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 48.3 mtt -72.42 -33.0 66.8 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 168.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 57.2 mtmt -61.84 -51.48 68.04 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 115.389 1.626 . . . . 0.0 115.389 169.185 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.3 p -64.26 -34.22 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 CA-C-O 117.466 -1.254 . . . . 0.0 114.128 171.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 41.7 t80 -53.2 -48.08 68.38 Favored 'General case' 0 CA--C 1.591 2.55 0 CA-C-N 120.404 1.456 . . . . 0.0 112.349 167.391 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 63.1 ttt180 -57.42 -37.83 73.39 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 119.115 3.005 . . . . 0.0 119.115 174.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -52.91 -34.16 53.75 Favored 'General case' 0 N--CA 1.512 2.673 0 N-CA-C 117.205 2.298 . . . . 0.0 117.205 170.675 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.2 pp20? -110.83 -28.43 8.4 Favored 'General case' 0 N--CA 1.474 0.764 0 N-CA-C 120.298 3.444 . . . . 0.0 120.298 -165.336 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 56.8 m -63.5 -30.67 71.75 Favored 'General case' 0 N--CA 1.499 2.025 0 N-CA-C 117.093 2.257 . . . . 0.0 117.093 -166.198 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -67.58 -61.55 4.33 Favored Pre-proline 0 CA--C 1.58 2.118 0 CA-C-O 116.583 -1.675 . . . . 0.0 112.616 168.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -65.29 -33.11 49.64 Favored 'Trans proline' 0 C--N 1.376 1.976 0 C-N-CA 123.161 2.574 . . . . 0.0 117.471 176.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.2 tt -63.07 -55.06 28.7 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-O 117.344 -1.312 . . . . 0.0 110.542 168.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.997 ' O ' ' HB2' ' A' ' 156' ' ' ARG 0.335 0.1 OUTLIER -57.21 -27.12 61.71 Favored 'General case' 0 N--CA 1.504 2.252 0 N-CA-C 115.717 1.747 . . . . 0.0 115.717 177.931 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 23.0 mm-40 -73.5 -41.97 62.41 Favored 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 116.126 -1.892 . . . . 0.0 113.115 165.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 14.9 t80 -66.88 -55.82 13.01 Favored 'General case' 0 CA--C 1.564 1.494 0 CA-C-N 122.719 2.509 . . . . 0.0 112.583 -179.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -80.46 -30.74 37.47 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-O 115.174 -2.346 . . . . 0.0 112.017 -179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.997 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 37.6 ttt180 -63.02 -32.63 74.03 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-N 124.418 3.281 . . . . 0.0 116.177 171.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -68.42 -41.12 80.86 Favored 'General case' 0 CA--C 1.574 1.888 0 CA-C-N 119.236 0.926 . . . . 0.0 113.182 165.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -90.81 -21.03 21.69 Favored 'General case' 0 CA--C 1.578 2.047 0 N-CA-C 120.331 3.456 . . . . 0.0 120.331 -176.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.7 pp -80.82 -178.37 6.79 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 119.053 2.983 . . . . 0.0 119.053 -163.119 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.673 ' HB2' HD23 ' A' ' 111' ' ' LEU . 90.5 mttt -130.89 141.52 50.31 Favored 'General case' 0 CA--C 1.564 1.491 0 N-CA-C 107.099 -1.445 . . . . 0.0 107.099 166.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 34.0 m -100.01 145.49 27.82 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 122.408 1.099 . . . . 0.0 110.672 -171.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 38.4 t -133.04 132.39 58.87 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.487 0 N-CA-C 105.916 -1.883 . . . . 0.0 105.916 169.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.431 ' HA ' ' HB3' ' A' ' 114' ' ' ARG . 20.4 t70 -96.14 138.47 33.7 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 167.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . 0.253 . . -125.61 -132.35 0.25 Allowed 'General case' 0 N--CA 1.483 1.212 0 O-C-N 121.64 -0.663 . . . . 0.0 111.433 -165.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 31.3 t 72.24 133.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.886 0 C-N-CA 127.173 2.189 . . . . 0.0 112.674 167.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 78.52 -73.43 2.23 Favored Glycine 0 N--CA 1.479 1.557 0 N-CA-C 117.566 1.787 . . . . 0.0 117.566 167.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 55.3 p -85.08 134.06 34.21 Favored 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 111.87 -2.165 . . . . 0.0 111.329 -169.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 65.3 mtt -85.8 -62.88 1.42 Allowed 'General case' 0 N--CA 1.492 1.657 0 C-N-CA 123.08 0.552 . . . . 0.0 111.468 -179.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -69.89 -36.23 75.26 Favored 'General case' 0 N--CA 1.498 1.971 0 N-CA-C 116.142 1.904 . . . . 0.0 116.142 -178.208 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.734 ' HB3' ' NH2' ' A' ' 174' ' ' ARG . 48.1 mt-10 -61.32 -52.45 64.65 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 118.023 -0.989 . . . . 0.0 113.507 169.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 99.5 t -57.51 -37.9 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 N-CA-C 114.191 1.182 . . . . 0.0 114.191 175.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 6.7 t80 -62.04 -33.9 75.24 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 116.424 2.009 . . . . 0.0 116.424 168.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.78 -53.23 43.11 Favored 'General case' 0 N--CA 1.489 1.485 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 174.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.734 ' NH2' ' HB3' ' A' ' 170' ' ' GLU . 10.5 ptp180 -65.66 -29.64 70.23 Favored 'General case' 0 N--CA 1.489 1.518 0 N-CA-C 117.586 2.439 . . . . 0.0 117.586 170.85 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.71 -45.83 92.28 Favored 'General case' 0 N--CA 1.492 1.661 0 CA-C-N 119.856 1.207 . . . . 0.0 114.172 167.729 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -58.92 -44.7 91.35 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-O 117.013 -1.47 . . . . 0.0 114.698 168.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 26.5 mmm180 -55.79 -43.1 76.49 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 115.674 1.731 . . . . 0.0 115.674 170.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.74 -39.5 94.29 Favored 'General case' 0 CA--C 1.563 1.444 0 N-CA-C 116.477 2.028 . . . . 0.0 116.477 172.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 5.8 tt -75.0 -51.68 13.0 Favored 'General case' 0 N--CA 1.493 1.692 0 CA-C-N 120.968 1.713 . . . . 0.0 112.077 170.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -149.5 -57.48 0.01 OUTLIER Glycine 0 CA--C 1.552 2.377 0 CA-C-O 117.486 -1.73 . . . . 0.0 115.801 -176.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . . . . . . . . . 40.1 ttmt . . . . . 0 C--O 1.252 1.205 0 CA-C-N 120.774 2.287 . . . . 0.0 108.655 -172.777 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.9 ttm . . . . . 0 CA--C 1.56 1.334 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.47 166.77 32.1 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 118.414 2.746 . . . . 0.0 118.414 -166.249 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.4 p -126.71 146.07 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.841 0 CA-C-O 122.923 1.344 . . . . 0.0 114.193 -166.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -119.89 113.34 20.43 Favored 'General case' 0 CA--C 1.559 1.307 0 N-CA-C 104.867 -2.271 . . . . 0.0 104.867 168.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.2 tt -101.73 131.24 48.12 Favored 'General case' 0 CA--C 1.562 1.408 0 C-N-CA 125.788 1.635 . . . . 0.0 111.348 -165.155 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.8 mt -135.48 165.8 24.66 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 125.378 1.471 . . . . 0.0 113.825 -167.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.43 124.7 0.94 Allowed Glycine 0 CA--C 1.557 2.665 0 CA-C-O 117.362 -1.799 . . . . 0.0 111.274 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -72.46 -176.68 2.34 Favored 'Trans proline' 0 CA--C 1.579 2.745 0 CA-C-N 122.522 3.161 . . . . 0.0 114.101 176.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 81.7 Cg_exo -52.18 109.83 0.38 Allowed 'Trans proline' 0 C--N 1.374 1.907 0 C-N-CA 123.748 2.965 . . . . 0.0 114.513 176.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.32 91.68 2.22 Favored Glycine 0 CA--C 1.542 1.731 0 N-CA-C 106.522 -2.631 . . . . 0.0 106.522 -165.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -113.58 164.32 13.81 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 115.637 1.717 . . . . 0.0 115.637 -165.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -159.87 99.32 0.18 Allowed Glycine 0 CA--C 1.539 1.538 0 N-CA-C 107.924 -2.07 . . . . 0.0 107.924 169.707 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 47.0 mtmt -137.19 -73.13 0.43 Allowed 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 113.075 0.768 . . . . 0.0 113.075 -167.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -42.61 -42.15 4.55 Favored Glycine 0 CA--C 1.551 2.332 0 N-CA-C 121.207 3.243 . . . . 0.0 121.207 -175.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 18.1 m -61.97 -57.32 12.14 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 118.992 1.396 . . . . 0.0 113.835 178.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.259 3.7 mm-40 -76.49 -14.22 60.05 Favored 'General case' 0 CA--C 1.573 1.859 0 CA-C-O 116.175 -1.869 . . . . 0.0 111.528 175.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.63 -47.38 60.38 Favored 'General case' 0 C--N 1.373 1.608 0 CA-C-N 123.219 2.736 . . . . 0.0 114.476 168.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.2 p -66.12 -40.76 87.99 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.034 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 172.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -58.94 -44.22 91.36 Favored 'General case' 0 N--CA 1.489 1.482 0 N-CA-C 116.321 1.971 . . . . 0.0 116.321 169.348 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.91 -35.46 80.69 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 172.332 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -59.21 -42.1 90.16 Favored 'General case' 0 N--CA 1.496 1.838 0 N-CA-C 115.368 1.618 . . . . 0.0 115.368 167.677 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.0 mt-10 -59.82 -36.23 76.35 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 115.035 1.494 . . . . 0.0 115.035 167.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 60.3 tttp -64.87 -59.44 4.2 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 115.464 1.653 . . . . 0.0 115.464 170.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 81.1 mt -80.28 -20.92 43.3 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 116.422 2.008 . . . . 0.0 116.422 -176.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.95 34.19 8.46 Favored Glycine 0 CA--C 1.554 2.501 0 N-CA-C 117.681 1.833 . . . . 0.0 117.681 -177.287 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.3 mm -104.64 156.07 36.47 Favored Pre-proline 0 CA--C 1.568 1.649 0 CA-C-N 118.987 1.394 . . . . 0.0 112.561 -169.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -80.72 100.69 1.24 Allowed 'Trans proline' 0 CA--C 1.569 2.257 0 C-N-CA 121.816 1.677 . . . . 0.0 110.099 162.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -58.81 109.11 0.75 Allowed 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 124.347 1.059 . . . . 0.0 112.002 170.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 35.7 mm -98.0 107.64 20.55 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.065 0 N-CA-C 105.139 -2.171 . . . . 0.0 105.139 -179.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 68.9 p -95.46 126.99 41.14 Favored 'General case' 0 CA--C 1.551 1.003 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 167.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.4 p -65.73 -22.1 66.58 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 116.97 2.211 . . . . 0.0 116.97 -169.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.638 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -83.56 -13.02 76.92 Favored Glycine 0 CA--C 1.544 1.871 0 N-CA-C 119.168 2.427 . . . . 0.0 119.168 168.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -81.8 -51.21 8.37 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 119.197 1.498 . . . . 0.0 114.648 -171.144 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -66.2 -42.17 89.18 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 113.023 0.749 . . . . 0.0 113.023 173.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.54 ' HB3' ' CB ' ' A' ' 50' ' ' LYS . 32.9 m-85 -59.56 -43.93 93.41 Favored 'General case' 0 CA--C 1.569 1.674 0 C-N-CA 125.403 1.481 . . . . 0.0 114.477 168.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.638 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 72.2 ttt180 -54.94 -42.56 72.45 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 115.861 1.8 . . . . 0.0 115.861 168.25 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.3 ttt180 -60.36 -36.58 78.37 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 114.982 1.475 . . . . 0.0 114.982 168.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 -69.29 -26.54 64.79 Favored 'General case' 0 CA--C 1.581 2.168 0 N-CA-C 114.594 1.331 . . . . 0.0 114.594 167.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.408 HG12 HG23 ' A' ' 47' ' ' VAL . 58.7 mt -60.67 -52.18 64.49 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.376 0 CA-C-N 120.933 1.697 . . . . 0.0 110.235 167.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -65.4 -35.48 81.06 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 177.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -70.3 -38.44 75.0 Favored 'General case' 0 CA--C 1.562 1.426 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 174.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 89.35 68.84 1.24 Allowed Glycine 0 CA--C 1.543 1.842 0 CA-C-O 118.905 -0.941 . . . . 0.0 114.623 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.822 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 74.5 p -92.63 -47.25 7.2 Favored 'General case' 0 N--CA 1.499 2.023 0 N-CA-C 114.6 1.333 . . . . 0.0 114.6 177.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.822 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.254 75.5 mttt 104.84 -40.04 0.01 OUTLIER 'General case' 0 CA--C 1.57 1.725 0 CA-C-O 116.227 -1.844 . . . . 0.0 111.694 -172.737 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -83.8 -12.41 55.69 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-N 123.09 2.677 . . . . 0.0 112.586 163.224 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.33 -56.23 26.29 Favored Glycine 0 CA--C 1.547 2.047 0 CA-C-N 120.905 1.684 . . . . 0.0 114.167 168.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.408 HG23 HG12 ' A' ' 39' ' ' ILE 0.25 1.0 OUTLIER -74.33 -49.85 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 116.898 2.184 . . . . 0.0 116.898 -169.467 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -67.9 -38.59 83.19 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 119.907 1.23 . . . . 0.0 112.74 174.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -73.26 -35.85 66.29 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-O 117.969 -1.015 . . . . 0.0 113.594 -175.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.54 ' CB ' ' HB3' ' A' ' 35' ' ' PHE 0.33 1.7 tptt -81.14 -24.14 37.81 Favored 'General case' 0 CA--C 1.564 1.487 0 CA-C-O 116.961 -1.495 . . . . 0.0 113.36 173.022 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.585 ' HG2' ' O ' ' A' ' 51' ' ' ARG . 40.6 ttt180 -75.56 -56.99 4.16 Favored 'General case' 0 CA--C 1.591 2.553 1 CA-C-O 86.613 -15.946 . . . . 0.0 117.686 176.815 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . 0.254 15.7 m-30 -27.38 -64.46 0.08 Allowed 'General case' 0 N--CA 1.499 1.979 1 O-C-N 108.837 -8.664 . . . . 0.0 120.192 146.491 . . . . . . . . 3 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.2 tp -53.89 -39.56 65.84 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 116.998 2.222 . . . . 0.0 116.998 172.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -90.18 -41.1 11.8 Favored 'General case' 0 CA--C 1.566 1.559 0 N-CA-C 115.115 1.524 . . . . 0.0 115.115 173.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -153.03 41.63 0.58 Allowed 'General case' 0 CA--C 1.571 1.757 0 CA-C-N 120.86 1.664 . . . . 0.0 114.887 -169.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -165.78 59.26 0.24 Allowed Glycine 0 C--N 1.354 1.559 0 O-C-N 119.419 -2.051 . . . . 0.0 111.779 168.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . 0.273 5.0 t70 71.51 -117.7 0.08 Allowed 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 124.018 0.927 . . . . 0.0 109.555 169.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.1 pp -124.93 143.65 50.76 Favored 'General case' 0 CA--C 1.553 1.08 0 C-N-CA 123.637 0.775 . . . . 0.0 112.06 -176.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.1 p -96.93 130.92 28.86 Favored Pre-proline 0 CA--C 1.573 1.832 0 CA-C-O 117.676 -1.154 . . . . 0.0 107.924 167.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -49.34 134.89 31.91 Favored 'Trans proline' 0 CA--C 1.56 1.821 0 C-N-CA 123.537 2.825 . . . . 0.0 116.042 172.641 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 69.8 m -68.82 175.65 3.5 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -169.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.3 t70 86.09 -44.43 0.05 Allowed 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 126.339 1.856 . . . . 0.0 113.999 -176.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 10.8 mt -60.44 -47.37 86.39 Favored 'General case' 0 N--CA 1.505 2.322 0 N-CA-C 115.324 1.601 . . . . 0.0 115.324 168.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 5.8 m -57.6 -50.26 73.72 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 113.544 -1.662 . . . . 0.0 113.449 177.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 68.0 m-20 -69.76 -21.25 63.45 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 115.166 1.543 . . . . 0.0 115.166 168.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 -65.59 -43.61 89.16 Favored 'General case' 0 CA--C 1.559 1.316 0 CA-C-N 120.557 1.526 . . . . 0.0 114.957 168.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 44.2 mt -65.56 -46.31 79.95 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 167.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -56.71 -50.99 72.2 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 172.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -65.09 -34.22 77.9 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 175.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -58.1 -43.34 87.06 Favored 'General case' 0 CA--C 1.559 1.31 0 CA-C-O 117.793 -1.098 . . . . 0.0 113.497 168.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 15.9 ttt180 -81.76 -9.82 59.52 Favored 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 119.256 3.058 . . . . 0.0 119.256 169.08 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 13.1 tp -87.66 -14.68 39.28 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 115.981 1.845 . . . . 0.0 115.981 169.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -57.45 1.77 0.03 OUTLIER 'General case' 0 CA--C 1.583 2.218 0 N-CA-C 118.441 2.756 . . . . 0.0 118.441 168.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . 0.259 0.8 OUTLIER -48.1 -132.52 0.0 OUTLIER Pre-proline 0 CA--C 1.609 3.244 0 N-CA-C 118.93 2.937 . . . . 0.0 118.93 169.836 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 63.1 Cg_exo -62.74 40.34 0.09 OUTLIER 'Trans proline' 0 C--N 1.387 2.563 0 C-N-CA 124.889 3.726 . . . . 0.0 121.221 169.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 13.7 t70 61.65 31.66 18.62 Favored 'General case' 0 CA--C 1.591 2.549 0 C-N-CA 124.434 1.093 . . . . 0.0 109.608 -161.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 82.32 -1.05 1.41 Allowed 'General case' 0 C--N 1.381 1.965 0 CA-C-O 116.347 -1.787 . . . . 0.0 114.638 -168.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 52.14 31.59 9.25 Favored 'General case' 0 CA--C 1.576 1.975 0 CA-C-N 123.873 3.033 . . . . 0.0 114.209 -165.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 60.02 32.99 21.31 Favored 'General case' 0 CA--C 1.586 2.328 0 CA-C-O 117.058 -1.449 . . . . 0.0 112.273 -166.686 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -179.72 173.64 45.34 Favored Glycine 0 C--N 1.374 2.673 0 CA-C-N 123.185 2.721 . . . . 0.0 117.883 -172.344 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 15.1 p90 -170.46 132.63 0.99 Allowed 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 114.189 -1.005 . . . . 0.0 108.88 -175.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 3.1 mm -102.43 105.48 18.19 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.577 0 N-CA-C 102.745 -3.057 . . . . 0.0 102.745 166.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -110.5 122.76 48.51 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 -176.65 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -121.25 119.67 32.94 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 119.048 0.84 . . . . 0.0 110.467 -165.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 69.39 43.68 68.67 Favored Glycine 0 CA--C 1.548 2.094 0 CA-C-O 116.098 -2.501 . . . . 0.0 116.345 -174.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . 0.257 2.9 t80 -95.97 -57.32 0.2 Allowed Pre-proline 0 N--CA 1.504 2.234 0 CA-C-N 121.737 2.768 . . . . 0.0 108.276 176.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 12.5 Cg_endo -60.59 59.67 0.09 OUTLIER 'Trans proline' 0 CA--C 1.577 2.654 0 N-CA-C 121.547 3.633 . . . . 0.0 121.547 168.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.533 HH11 ' HB2' ' A' ' 89' ' ' SER . 7.0 tmm_? -69.55 -28.43 66.0 Favored 'General case' 0 CA--C 1.566 1.562 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 166.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.533 ' HB2' HH11 ' A' ' 88' ' ' ARG . 30.3 t -151.68 155.51 38.48 Favored 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 120.279 1.399 . . . . 0.0 107.913 -176.184 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.5 t -61.87 -37.0 77.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.844 0 CA-C-O 116.981 -1.485 . . . . 0.0 111.793 173.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -57.34 -40.41 77.94 Favored 'General case' 0 CA--C 1.558 1.268 0 N-CA-C 119.882 3.29 . . . . 0.0 119.882 169.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 22.3 mm100 -71.41 -48.21 51.17 Favored 'General case' 0 CA--C 1.589 2.471 0 CA-C-N 122.279 2.308 . . . . 0.0 113.322 168.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.78 -29.49 66.82 Favored 'General case' 0 N--CA 1.482 1.141 0 C-N-CA 126.894 2.078 . . . . 0.0 116.05 -168.184 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 57.6 tttt -63.68 -31.57 72.78 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 115.065 1.506 . . . . 0.0 115.065 166.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.97 -39.08 69.58 Favored 'General case' 0 CA--C 1.569 1.688 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 169.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 16.8 tp -63.01 -40.88 99.09 Favored 'General case' 0 CA--C 1.568 1.667 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 168.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 15.4 t-80 -58.5 -52.49 65.43 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 119.431 1.014 . . . . 0.0 113.463 169.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.904 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 21.5 mm-40 -48.63 -41.79 32.19 Favored 'General case' 0 N--CA 1.495 1.816 0 N-CA-C 115.956 1.836 . . . . 0.0 115.956 168.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 1.184 ' O ' ' HB2' ' A' ' 103' ' ' ARG . 55.1 mtt -84.12 -20.73 32.03 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 117.956 2.576 . . . . 0.0 117.956 175.569 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.1 tt -75.73 -48.93 19.8 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-N 121.301 1.864 . . . . 0.0 110.866 172.556 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -72.45 -56.28 5.67 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 119.57 1.077 . . . . 0.0 113.199 169.714 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.904 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 70.6 ttt180 -64.15 -44.63 91.54 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 116.353 1.983 . . . . 0.0 116.353 177.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 1.184 ' HB2' ' O ' ' A' ' 99' ' ' MET . 15.3 mtp-105 -65.13 -53.92 37.84 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 118.992 0.814 . . . . 0.0 111.196 165.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 111.02 48.62 0.71 Allowed Glycine 0 N--CA 1.483 1.831 0 C-N-CA 120.808 -0.71 . . . . 0.0 114.752 166.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 71.7 p -89.91 158.14 17.55 Favored 'General case' 0 CA--C 1.563 1.479 0 CA-C-N 113.22 -1.49 . . . . 0.0 110.307 169.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 24.2 t70 -72.55 138.69 47.07 Favored 'General case' 0 N--CA 1.507 2.381 0 CA-C-O 122.37 1.081 . . . . 0.0 111.38 172.835 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.6 tp -98.99 102.72 13.78 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 N-CA-C 106.481 -1.674 . . . . 0.0 106.481 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -95.12 -70.32 0.72 Allowed 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 116.738 -1.601 . . . . 0.0 108.032 166.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.91 124.23 7.61 Favored 'General case' 0 C--N 1.36 1.05 0 CA-C-N 120.938 1.699 . . . . 0.0 113.818 -169.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 24.0 t -92.29 108.92 20.76 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.638 1 N-CA-C 99.97 -4.085 . . . . 0.0 99.97 162.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.255 52.2 tp -118.94 114.48 22.63 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 123.937 0.895 . . . . 0.0 112.607 -159.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 30.8 tt0 -103.17 127.81 50.34 Favored 'General case' 0 CA--C 1.563 1.454 0 CA-C-O 121.448 0.642 . . . . 0.0 112.34 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 57.5 m-85 -95.79 113.9 25.58 Favored 'General case' 0 N--CA 1.483 1.198 0 C-N-CA 124.902 1.281 . . . . 0.0 109.796 178.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 10.2 tpt180 -86.33 96.06 9.85 Favored 'General case' 0 N--CA 1.479 1.025 0 CA-C-N 114.546 -1.206 . . . . 0.0 109.214 170.614 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 56.1 t -132.63 146.66 32.45 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.565 0 C-N-CA 127.891 2.476 . . . . 0.0 106.016 -171.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.8 m -75.94 137.3 40.25 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 113.476 -1.693 . . . . 0.0 112.647 -175.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -65.17 -28.09 69.16 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 116.8 2.148 . . . . 0.0 116.8 174.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -60.35 -35.86 76.66 Favored 'General case' 0 N--CA 1.488 1.427 0 CA-C-N 122.102 2.228 . . . . 0.0 115.588 172.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -62.19 -46.55 96.2 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 169.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -66.18 -52.47 47.84 Favored 'General case' 0 N--CA 1.489 1.518 0 C-N-CA 124.134 0.974 . . . . 0.0 113.505 175.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 7.0 mp -59.68 -34.98 73.56 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 116.137 1.902 . . . . 0.0 116.137 172.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -71.45 -33.87 69.75 Favored 'General case' 0 N--CA 1.5 2.041 0 CA-C-N 120.813 1.642 . . . . 0.0 114.522 169.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 73.4 ttt180 -57.32 -52.6 64.69 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 115.187 1.551 . . . . 0.0 115.187 168.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 72.4 mt -61.19 -48.41 81.65 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 171.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.475 ' HG3' ' NH1' ' A' ' 129' ' ' ARG . 24.0 ttmm -72.78 -54.91 7.62 Favored 'General case' 0 N--CA 1.484 1.255 0 N-CA-C 116.769 2.137 . . . . 0.0 116.769 -173.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -67.2 -44.91 85.26 Favored Glycine 0 CA--C 1.552 2.404 0 N-CA-C 118.072 1.989 . . . . 0.0 118.072 -170.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -92.69 76.84 4.94 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 119.871 1.836 . . . . 0.0 111.428 178.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.595 ' O ' ' HB3' ' A' ' 129' ' ' ARG . . . 72.34 171.9 18.28 Favored Glycine 0 CA--C 1.573 3.661 0 CA-C-O 118.537 -1.146 . . . . 0.0 114.354 -172.587 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.595 ' HB3' ' O ' ' A' ' 128' ' ' GLY . 34.0 ptt180 170.72 163.4 0.08 Allowed 'General case' 0 C--N 1.363 1.171 0 CA-C-N 121.732 2.766 . . . . 0.0 115.848 174.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -157.69 -38.96 0.07 Allowed 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 111.582 -2.554 . . . . 0.0 110.739 166.634 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 40.4 m-20 -59.94 -74.24 0.08 Allowed 'General case' 0 N--CA 1.493 1.681 0 CA-C-N 120.043 1.292 . . . . 0.0 112.402 166.112 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 38.47 40.7 0.39 Allowed 'General case' 0 N--CA 1.505 2.311 0 C-N-CA 124.603 1.161 . . . . 0.0 113.755 -162.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . 0.29 5.9 t 14.86 101.54 0.0 OUTLIER 'General case' 0 CA--C 1.566 1.57 0 C-N-CA 129.727 3.211 . . . . 0.0 118.18 -166.89 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -136.16 -67.69 0.52 Allowed 'General case' 0 N--CA 1.488 1.46 0 CA-C-N 110.571 -3.013 . . . . 0.0 106.78 -179.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 15.6 m-20 -68.37 -35.22 77.4 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 117.897 -1.049 . . . . 0.0 113.306 165.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.806 ' O ' ' HG2' ' A' ' 140' ' ' ARG . 48.9 t -66.99 -34.39 69.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.849 0 CA-C-N 120.256 1.389 . . . . 0.0 112.807 169.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -71.94 -34.95 52.62 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.977 0 CA-C-N 119.729 1.149 . . . . 0.0 113.074 174.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 40.7 mt -69.38 -48.57 60.79 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 119.701 1.137 . . . . 0.0 113.834 173.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -66.43 -38.17 86.82 Favored 'General case' 0 N--CA 1.496 1.829 0 N-CA-C 114.613 1.338 . . . . 0.0 114.613 173.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.806 ' HG2' ' O ' ' A' ' 136' ' ' VAL . 47.8 mmm-85 -60.65 -43.94 97.01 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 114.937 1.458 . . . . 0.0 114.937 169.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 37.0 mtt -64.26 -32.99 74.8 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 115.833 1.79 . . . . 0.0 115.833 169.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 39.8 ttmt -64.44 -48.65 74.51 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 115.823 1.786 . . . . 0.0 115.823 170.167 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.2 p -67.8 -31.26 51.47 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.164 0 N-CA-C 114.639 1.348 . . . . 0.0 114.639 172.195 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -57.8 -52.38 65.72 Favored 'General case' 0 CA--C 1.581 2.164 0 CA-C-N 119.492 1.042 . . . . 0.0 111.452 166.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 50.8 ttt180 -52.83 -25.38 11.3 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 120.2 3.408 . . . . 0.0 120.2 169.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.89 -55.48 19.89 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 114.031 1.123 . . . . 0.0 114.031 170.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -145.43 13.84 1.4 Allowed 'General case' 0 CA--C 1.563 1.467 0 N-CA-C 119.497 3.147 . . . . 0.0 119.497 -169.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 17.7 m -51.9 -29.19 18.96 Favored 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 116.717 2.117 . . . . 0.0 116.717 -179.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.432 ' HB3' ' HD3' ' A' ' 150' ' ' PRO . . . -70.81 -61.33 2.49 Favored Pre-proline 0 CA--C 1.58 2.102 0 CA-C-O 116.148 -1.882 . . . . 0.0 112.142 171.692 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.432 ' HD3' ' HB3' ' A' ' 149' ' ' ALA . 46.8 Cg_exo -55.34 -27.8 59.64 Favored 'Trans proline' 0 CA--C 1.574 2.485 0 N-CA-C 119.492 2.843 . . . . 0.0 119.492 169.207 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -66.88 -53.01 36.54 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 125.156 1.383 . . . . 0.0 110.988 172.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.989 ' O ' ' HB2' ' A' ' 156' ' ' ARG 0.316 0.0 OUTLIER -61.32 -25.01 66.84 Favored 'General case' 0 N--CA 1.501 2.089 0 N-CA-C 116.355 1.983 . . . . 0.0 116.355 174.384 . . . . . . . . 4 4 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.9 mt-10 -71.3 -51.65 23.19 Favored 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 120.601 1.546 . . . . 0.0 113.667 166.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.3 t80 -62.66 -55.23 28.84 Favored 'General case' 0 CA--C 1.565 1.527 0 CA-C-N 120.045 1.293 . . . . 0.0 112.221 -179.861 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -81.52 -25.94 35.53 Favored 'General case' 0 CA--C 1.546 0.811 0 CA-C-O 115.153 -2.356 . . . . 0.0 113.399 -179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.989 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 43.9 ttt180 -67.3 -34.27 77.03 Favored 'General case' 0 N--CA 1.486 1.333 0 CA-C-N 124.438 3.29 . . . . 0.0 115.919 170.785 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 4.5 t70 -69.5 -37.99 77.43 Favored 'General case' 0 CA--C 1.572 1.827 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 166.642 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 57.2 mt-30 -90.15 -24.37 21.08 Favored 'General case' 0 CA--C 1.575 1.926 0 N-CA-C 118.876 2.917 . . . . 0.0 118.876 -177.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.1 pp -76.06 178.75 6.09 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 117.478 2.399 . . . . 0.0 117.478 -165.446 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 6.2 tmtt? -128.91 129.31 45.33 Favored 'General case' 0 CA--C 1.566 1.564 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 169.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 27.1 m -100.38 149.95 23.11 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-O 122.079 0.943 . . . . 0.0 111.006 -171.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 4.1 t -128.14 134.74 64.42 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.663 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 167.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -110.86 121.43 45.32 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 104.435 -2.432 . . . . 0.0 104.435 166.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . 0.289 . . -165.58 162.03 18.8 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 124.095 0.958 . . . . 0.0 111.106 -161.034 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 4.5 t -139.36 119.47 14.15 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 160.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -79.45 72.93 2.45 Favored Glycine 0 N--CA 1.486 1.971 0 N-CA-C 119.866 2.706 . . . . 0.0 119.866 -165.523 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 6.6 t -158.52 60.66 0.44 Allowed 'General case' 0 CA--C 1.566 1.56 0 CA-C-N 111.293 -2.454 . . . . 0.0 108.437 -178.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 2.8 ttt -159.31 -35.39 0.06 Allowed 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 116.679 2.103 . . . . 0.0 116.679 -168.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 7.4 t70 80.79 -37.62 0.14 Allowed 'General case' 0 N--CA 1.508 2.451 0 CA-C-N 120.849 1.659 . . . . 0.0 111.869 -164.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -55.15 -39.04 69.03 Favored 'General case' 0 CA--C 1.559 1.295 0 CA-C-O 116.651 -1.642 . . . . 0.0 113.429 165.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 89.5 t -56.34 -39.26 59.52 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.272 0 CA-C-N 121.363 1.892 . . . . 0.0 114.309 171.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 67.9 t80 -57.77 -39.03 76.5 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-N 120.472 1.487 . . . . 0.0 114.86 166.381 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -60.53 -46.85 88.66 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 115.481 1.659 . . . . 0.0 115.481 173.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 12.2 mtt-85 -61.48 -43.14 99.4 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 116.633 2.086 . . . . 0.0 116.633 169.403 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -55.11 -40.37 70.39 Favored 'General case' 0 N--CA 1.493 1.702 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 169.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 8.4 mp -64.18 -49.12 73.28 Favored 'General case' 0 CA--C 1.565 1.533 0 CA-C-O 118.413 -0.804 . . . . 0.0 112.608 168.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 36.4 mtt180 -51.24 -40.81 59.65 Favored 'General case' 0 N--CA 1.492 1.67 0 N-CA-C 117.581 2.437 . . . . 0.0 117.581 171.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.11 -51.53 66.19 Favored 'General case' 0 CA--C 1.561 1.4 0 N-CA-C 115.963 1.838 . . . . 0.0 115.963 169.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -99.65 -60.46 1.53 Allowed 'General case' 0 CA--C 1.565 1.538 0 CA-C-O 117.993 -1.003 . . . . 0.0 113.469 -169.418 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.803 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -102.82 -50.52 1.08 Allowed Glycine 0 CA--C 1.551 2.34 0 CA-C-N 120.537 1.517 . . . . 0.0 116.885 -169.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.803 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 87.0 tttt . . . . . 0 C--O 1.252 1.201 0 CA-C-N 119.489 1.645 . . . . 0.0 108.356 -174.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.0 mtt . . . . . 0 N--CA 1.482 1.125 0 N-CA-C 109.461 -0.57 . . . . 0.0 109.461 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.578 ' HE ' ' HA2' ' A' ' 80' ' ' GLY . 0.1 OUTLIER -149.01 174.9 11.79 Favored 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 116.685 2.105 . . . . 0.0 116.685 -168.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 93.5 t -133.75 147.22 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-O 122.992 1.377 . . . . 0.0 113.319 -164.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -121.63 117.57 27.03 Favored 'General case' 0 CA--C 1.56 1.347 0 CA-C-N 113.491 -1.686 . . . . 0.0 107.284 169.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 17.5 tp -99.87 125.13 45.79 Favored 'General case' 0 CA--C 1.575 1.908 0 CA-C-O 123.706 1.717 . . . . 0.0 109.389 -170.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.1 mt -122.23 161.01 24.03 Favored 'General case' 0 N--CA 1.484 1.251 0 CA-C-N 110.021 -3.263 . . . . 0.0 112.481 -165.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 148.39 -179.68 25.05 Favored Glycine 0 CA--C 1.559 2.809 0 CA-C-N 115.258 -0.883 . . . . 0.0 114.821 170.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -63.53 130.19 27.47 Favored 'Trans proline' 0 CA--C 1.574 2.508 0 C-N-CA 123.355 2.703 . . . . 0.0 113.765 176.22 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -82.01 131.98 7.16 Favored 'Trans proline' 0 CA--C 1.561 1.844 0 C-N-CA 122.648 2.232 . . . . 0.0 114.808 -169.82 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -164.2 -88.06 0.07 OUTLIER Glycine 0 CA--C 1.537 1.413 0 N-CA-C 109.524 -1.43 . . . . 0.0 109.524 169.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.449 ' H ' ' HB2' ' A' ' 120' ' ' LEU . . . -151.65 106.63 3.27 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 175.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 175.11 -167.64 39.83 Favored Glycine 0 CA--C 1.546 2.018 0 CA-C-N 115.888 -0.596 . . . . 0.0 112.9 -178.086 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.41 ' CB ' ' OD2' ' A' ' 84' ' ' ASP . 0.3 OUTLIER 78.26 -54.77 0.49 Allowed 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 175.577 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -49.48 -27.22 8.09 Favored Glycine 0 CA--C 1.553 2.465 0 N-CA-C 121.201 3.241 . . . . 0.0 121.201 177.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 52.0 m -66.99 -52.75 38.81 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 120.237 2.018 . . . . 0.0 112.598 173.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.291 0.6 OUTLIER -76.19 -13.88 60.17 Favored 'General case' 0 CA--C 1.568 1.667 0 CA-C-O 115.893 -2.003 . . . . 0.0 113.855 170.509 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.31 -47.17 36.37 Favored 'General case' 0 C--N 1.371 1.513 0 CA-C-N 123.421 2.828 . . . . 0.0 113.433 167.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 1.2 t -65.37 -36.74 78.42 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 CA-C-N 120.06 1.3 . . . . 0.0 113.848 172.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -66.44 -45.78 78.67 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 115.487 1.662 . . . . 0.0 115.487 171.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.0 tp -65.49 -30.65 71.45 Favored 'General case' 0 CA--C 1.574 1.902 0 N-CA-C 114.589 1.329 . . . . 0.0 114.589 170.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.22 -39.75 94.63 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 114.934 1.457 . . . . 0.0 114.934 168.062 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -59.93 -37.7 80.25 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 114.335 1.235 . . . . 0.0 114.335 166.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 48.3 tptt -64.3 -56.89 11.43 Favored 'General case' 0 N--CA 1.485 1.325 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 170.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 77.3 mt -83.23 -25.02 32.08 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 117.341 2.348 . . . . 0.0 117.341 -174.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.74 39.73 7.0 Favored Glycine 0 CA--C 1.556 2.612 0 N-CA-C 117.578 1.791 . . . . 0.0 117.578 -173.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 15.2 mm -104.56 154.69 38.27 Favored Pre-proline 0 CA--C 1.567 1.606 0 CA-C-O 117.567 -1.206 . . . . 0.0 113.11 -169.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 65.5 Cg_endo -81.83 98.6 0.98 Allowed 'Trans proline' 0 CA--C 1.569 2.232 0 CA-C-N 122.219 1.828 . . . . 0.0 109.801 162.645 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -73.91 110.42 8.19 Favored 'General case' 0 N--CA 1.493 1.701 0 CA-C-O 121.305 0.574 . . . . 0.0 110.189 176.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.0 mm -100.35 108.97 24.0 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.04 0 N-CA-C 105.515 -2.032 . . . . 0.0 105.515 -178.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 72.7 p -96.98 127.74 43.25 Favored 'General case' 0 N--CA 1.477 0.891 0 N-CA-C 107.156 -1.424 . . . . 0.0 107.156 171.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.0 p -67.29 -18.36 65.16 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 117.356 2.354 . . . . 0.0 117.356 -172.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.429 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -81.06 -20.24 65.49 Favored Glycine 0 CA--C 1.539 1.56 0 N-CA-C 119.242 2.457 . . . . 0.0 119.242 168.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -81.0 -51.47 8.48 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -169.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -64.3 -41.7 96.73 Favored 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 174.846 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.439 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 21.5 m-85 -68.92 -39.69 79.51 Favored 'General case' 0 CA--C 1.561 1.375 0 N-CA-C 115.347 1.61 . . . . 0.0 115.347 174.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 46.4 ttp180 -58.68 -41.71 86.81 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 120.473 1.488 . . . . 0.0 114.322 167.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 30.2 ttt180 -60.54 -38.71 85.36 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 168.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 76.6 m-20 -67.55 -29.32 68.68 Favored 'General case' 0 CA--C 1.572 1.824 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 168.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 79.0 mt -62.7 -45.54 98.58 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 CA-C-N 120.111 1.323 . . . . 0.0 111.921 168.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.3 mm-40 -66.71 -38.96 87.77 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 120.25 1.387 . . . . 0.0 114.438 172.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -78.47 -27.85 46.38 Favored 'General case' 0 CA--C 1.562 1.413 0 N-CA-C 117.065 2.246 . . . . 0.0 117.065 -179.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 82.11 72.99 1.23 Allowed Glycine 0 CA--C 1.545 1.935 0 CA-C-O 118.223 -1.321 . . . . 0.0 115.878 -179.4 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.855 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 81.4 p -91.29 -45.92 8.34 Favored 'General case' 0 N--CA 1.502 2.16 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 172.106 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.855 ' HB2' ' O ' ' A' ' 43' ' ' THR . 75.6 mttt 104.56 -40.36 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.753 0 CA-C-O 116.493 -1.718 . . . . 0.0 111.633 -171.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -83.91 -10.32 58.06 Favored 'General case' 0 CA--C 1.574 1.894 0 CA-C-N 122.762 2.528 . . . . 0.0 113.222 163.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.21 -54.48 23.69 Favored Glycine 0 C--N 1.355 1.588 0 CA-C-N 120.385 1.448 . . . . 0.0 115.531 169.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.286 7.7 p -76.94 -47.5 27.46 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.514 0 N-CA-C 116.077 1.88 . . . . 0.0 116.077 -168.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -64.24 -48.31 76.29 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-N 121.111 1.778 . . . . 0.0 112.692 172.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -70.59 -28.04 64.57 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -178.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.447 ' HA ' ' HD2' ' A' ' 50' ' ' LYS . 10.8 tptt -74.91 -30.59 61.31 Favored 'General case' 0 CA--C 1.566 1.584 0 CA-C-O 115.909 -1.996 . . . . 0.0 113.762 168.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 78.7 ttt180 -57.02 -36.97 71.06 Favored 'General case' 0 CA--C 1.607 3.164 1 CA-C-O 90.989 -13.863 . . . . 0.0 119.424 164.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 9.5 m-30 -92.58 -49.65 6.0 Favored 'General case' 0 CA--C 1.591 2.538 2 O-C-N 110.588 -7.57 . . . . 0.0 100.415 -152.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 12.9 tp -51.38 -46.99 62.97 Favored 'General case' 0 CA--C 1.569 1.683 0 C-N-CA 126.209 1.803 . . . . 0.0 115.516 161.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.4 t70 -78.96 -41.9 28.14 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 115.991 1.848 . . . . 0.0 115.991 176.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -95.38 -38.69 10.38 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 115.652 1.723 . . . . 0.0 115.652 -170.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 0.901 ' HA2' HH22 ' A' ' 88' ' ' ARG . . . 119.79 22.48 3.29 Favored Glycine 0 CA--C 1.541 1.685 0 N-CA-C 118.235 2.054 . . . . 0.0 118.235 168.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -97.3 -179.32 4.47 Favored 'General case' 0 CA--C 1.575 1.941 0 CA-C-N 118.805 1.303 . . . . 0.0 110.243 167.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 95.9 mt -82.34 127.97 33.76 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.184 -1.573 . . . . 0.0 114.382 -166.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.4 p -118.3 124.08 28.87 Favored Pre-proline 0 CA--C 1.572 1.806 0 C-N-CA 124.935 1.294 . . . . 0.0 110.485 -174.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -60.72 153.1 64.69 Favored 'Trans proline' 0 CA--C 1.56 1.81 0 C-N-CA 123.425 2.75 . . . . 0.0 116.337 172.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 97.2 p -80.24 -49.62 11.36 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 115.75 1.759 . . . . 0.0 115.75 -177.275 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.0 m-20 -63.61 -45.69 89.15 Favored 'General case' 0 N--CA 1.502 2.141 0 N-CA-C 115.801 1.778 . . . . 0.0 115.801 -169.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.6 pp -57.76 -43.1 85.23 Favored 'General case' 0 CA--C 1.562 1.421 0 N-CA-C 117.266 2.321 . . . . 0.0 117.266 169.694 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.0 m -62.24 -42.32 99.21 Favored 'General case' 0 N--CA 1.494 1.729 0 C-N-CA 123.93 0.892 . . . . 0.0 112.578 174.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.3 m120 -62.77 -30.57 71.55 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 115.059 1.503 . . . . 0.0 115.059 166.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -67.48 -42.35 83.1 Favored 'General case' 0 CA--C 1.555 1.138 0 N-CA-C 115.317 1.599 . . . . 0.0 115.317 174.497 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.1 mt -64.75 -46.15 83.42 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 168.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -56.08 -51.13 65.39 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.726 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 169.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -60.83 -38.38 85.27 Favored 'General case' 0 N--CA 1.492 1.666 0 N-CA-C 115.794 1.775 . . . . 0.0 115.794 174.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.3 t70 -57.23 -44.18 83.53 Favored 'General case' 0 N--CA 1.488 1.467 0 CA-C-O 117.592 -1.194 . . . . 0.0 113.421 170.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 71.9 mtt180 -84.3 1.84 43.03 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 119.51 3.152 . . . . 0.0 119.51 168.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 21.7 tp -115.64 -5.91 12.18 Favored 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 117.813 2.524 . . . . 0.0 117.813 172.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 93.3 m-20 -54.61 -32.39 58.72 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 115.259 1.577 . . . . 0.0 115.259 169.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.467 ' HB3' ' CD ' ' A' ' 75' ' ' PRO 0.38 2.4 m-20 -8.87 -120.54 0.0 OUTLIER Pre-proline 0 CA--C 1.604 3.022 0 N-CA-C 120.752 3.612 . . . . 0.0 120.752 168.521 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.467 ' CD ' ' HB3' ' A' ' 74' ' ' ASN . 71.5 Cg_exo -64.94 27.29 0.08 OUTLIER 'Trans proline' 0 N--CA 1.52 3.031 1 CA-C-N 128.376 4.027 . . . . 0.0 120.589 167.617 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.0 t70 62.15 28.92 17.38 Favored 'General case' 0 CA--C 1.577 2.014 0 C-N-CA 126.311 1.844 . . . . 0.0 109.142 -158.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 56.67 27.87 13.25 Favored 'General case' 0 CA--C 1.583 2.214 0 CA-C-N 120.694 1.588 . . . . 0.0 113.036 -163.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.08 -40.33 60.19 Favored 'General case' 0 C--N 1.378 1.847 0 CA-C-N 121.746 2.066 . . . . 0.0 114.779 -177.249 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 19.0 m120 -73.45 -18.85 61.08 Favored 'General case' 0 CA--C 1.566 1.561 0 CA-C-O 115.621 -2.133 . . . . 0.0 115.325 172.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.578 ' HA2' ' HE ' ' A' ' 2' ' ' ARG . . . 137.17 -176.7 20.33 Favored Glycine 0 C--N 1.363 2.072 0 CA-C-N 123.332 2.787 . . . . 0.0 113.639 -178.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.463 ' O ' ' HB2' ' A' ' 2' ' ' ARG . 21.9 p90 -167.41 131.52 1.84 Allowed 'General case' 0 N--CA 1.486 1.326 0 CA-C-N 111.719 -2.241 . . . . 0.0 109.092 172.593 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 17.5 mt -110.47 106.56 20.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 N-CA-C 104.099 -2.556 . . . . 0.0 104.099 170.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.7 mt -110.35 112.75 24.9 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 123.718 0.807 . . . . 0.0 108.832 -176.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.41 ' OD2' ' CB ' ' A' ' 13' ' ' LYS . 35.4 t0 -109.46 128.65 55.31 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 118.732 0.696 . . . . 0.0 111.688 -175.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 73.54 35.39 55.77 Favored Glycine 0 CA--C 1.552 2.373 0 CA-C-O 117.563 -1.687 . . . . 0.0 117.279 176.258 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -103.56 -51.89 0.13 Allowed Pre-proline 0 N--CA 1.497 1.906 0 CA-C-O 114.761 -2.542 . . . . 0.0 109.333 173.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 15.3 Cg_endo -62.08 71.61 0.1 Allowed 'Trans proline' 0 CA--C 1.568 2.22 0 CA-C-N 124.874 2.776 . . . . 0.0 118.838 165.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.901 HH22 ' HA2' ' A' ' 56' ' ' GLY . 1.4 ptm180 -78.05 -36.95 47.83 Favored 'General case' 0 CA--C 1.56 1.342 0 N-CA-C 115.54 1.681 . . . . 0.0 115.54 167.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 69.1 p -137.18 151.42 48.77 Favored 'General case' 0 C--N 1.35 0.612 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 -168.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 24.2 t -71.01 -31.03 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 CA-C-O 116.884 -1.532 . . . . 0.0 111.153 -178.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -61.71 -40.21 94.23 Favored 'General case' 0 CA--C 1.56 1.346 0 N-CA-C 120.149 3.388 . . . . 0.0 120.149 168.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 12.7 mm100 -71.25 -49.29 44.7 Favored 'General case' 0 CA--C 1.589 2.456 0 CA-C-N 122.413 2.37 . . . . 0.0 112.462 168.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -69.6 -28.87 66.32 Favored 'General case' 0 N--CA 1.484 1.241 0 C-N-CA 126.756 2.023 . . . . 0.0 115.646 -170.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 2.6 ttpm? -58.54 -31.95 68.42 Favored 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 114.747 1.388 . . . . 0.0 114.747 166.321 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -64.05 -43.81 94.35 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 114.668 1.358 . . . . 0.0 114.668 168.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 38.0 mt -66.69 -33.82 76.49 Favored 'General case' 0 N--CA 1.493 1.698 0 N-CA-C 115.871 1.804 . . . . 0.0 115.871 172.633 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 9.5 t-160 -66.22 -58.38 5.51 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 125.349 1.46 . . . . 0.0 112.646 173.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.933 ' O ' ' CB ' ' A' ' 102' ' ' ARG . 47.8 mt-10 -54.66 -36.48 64.64 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 115.908 1.818 . . . . 0.0 115.908 171.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . . . . . . . . . 24.7 ttt -82.72 -40.62 20.33 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 176.467 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 24.6 tp -57.12 -61.79 2.21 Favored 'General case' 0 N--CA 1.508 2.431 0 CA-C-N 121.503 1.956 . . . . 0.0 110.499 174.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 51.6 mt-10 -81.74 -37.27 27.51 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 -177.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.933 ' CB ' ' O ' ' A' ' 98' ' ' GLU . 52.8 ttt85 -60.29 -41.34 93.15 Favored 'General case' 0 N--CA 1.482 1.136 0 N-CA-C 115.636 1.717 . . . . 0.0 115.636 176.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.544 ' HB2' ' O ' ' A' ' 102' ' ' ARG . 54.9 ttt180 -174.92 41.72 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 114.464 -2.684 . . . . 0.0 115.851 168.057 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -114.77 -61.25 0.38 Allowed Glycine 0 C--N 1.362 2.021 0 CA-C-N 123.565 2.893 . . . . 0.0 113.441 174.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 23.5 p -148.28 159.4 44.02 Favored 'General case' 0 CA--C 1.554 1.13 0 CA-C-O 122.957 1.361 . . . . 0.0 112.894 -159.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -74.68 134.74 41.93 Favored 'General case' 0 N--CA 1.503 2.198 0 CA-C-N 114.379 -1.282 . . . . 0.0 113.439 176.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 4.7 tp -86.65 105.82 15.23 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.516 0 C-N-CA 125.06 1.344 . . . . 0.0 107.714 175.488 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -96.92 -70.4 0.72 Allowed 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 115.136 -2.364 . . . . 0.0 108.115 168.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -140.28 122.65 16.0 Favored 'General case' 0 N--CA 1.487 1.409 0 CA-C-N 122.503 2.41 . . . . 0.0 115.015 -179.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -92.83 107.81 19.54 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.417 0 N-CA-C 100.974 -3.713 . . . . 0.0 100.974 161.768 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.288 59.5 tp -114.5 105.24 12.87 Favored 'General case' 0 CA--C 1.552 1.029 0 CA-C-N 115.121 -0.945 . . . . 0.0 111.753 -161.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -96.04 126.12 41.06 Favored 'General case' 0 N--CA 1.487 1.391 0 C-N-CA 123.16 0.584 . . . . 0.0 111.541 -176.297 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -95.06 114.17 25.95 Favored 'General case' 0 CA--C 1.56 1.355 0 CA-C-O 122.537 1.16 . . . . 0.0 110.185 177.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 17.7 tpt180 -89.03 100.38 13.16 Favored 'General case' 0 CA--C 1.556 1.187 0 CA-C-N 113.597 -1.638 . . . . 0.0 109.459 168.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.4 p -137.97 143.09 34.21 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.387 0 C-N-CA 125.921 1.688 . . . . 0.0 108.376 -168.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 5.8 m -62.29 141.85 58.05 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 115.101 -0.954 . . . . 0.0 112.568 175.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -55.61 -46.05 77.39 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 114.193 1.182 . . . . 0.0 114.193 172.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -46.82 -35.44 6.3 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 117.962 2.579 . . . . 0.0 117.962 177.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.6 t -69.42 -49.66 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 CA-C-N 120.032 1.287 . . . . 0.0 113.141 176.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.449 ' HB2' ' H ' ' A' ' 11' ' ' ALA . 3.8 pp -65.09 -34.95 79.63 Favored 'General case' 0 CA--C 1.561 1.391 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 169.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . 0.571 ' O ' ' HB2' ' A' ' 125' ' ' LYS . 49.8 mt -71.72 -34.82 69.9 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 117.121 2.267 . . . . 0.0 117.121 172.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . 0.575 ' OE2' ' HG3' ' A' ' 123' ' ' ARG . 1.1 pp20? -71.39 -38.66 71.47 Favored 'General case' 0 N--CA 1.495 1.785 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 170.924 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.575 ' HG3' ' OE2' ' A' ' 122' ' ' GLU . 51.4 mtp180 -60.98 -52.13 66.31 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 115.193 1.553 . . . . 0.0 115.193 171.123 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.5 pp -68.87 -34.65 75.8 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 115.872 1.805 . . . . 0.0 115.872 171.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . 0.571 ' HB2' ' O ' ' A' ' 121' ' ' LEU . 82.6 tttt -61.06 -46.82 89.12 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 116.847 2.165 . . . . 0.0 116.847 176.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -53.34 -33.43 46.43 Favored Glycine 0 CA--C 1.558 2.722 0 N-CA-C 118.876 2.31 . . . . 0.0 118.876 173.1 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 51.5 ttp180 -154.46 102.17 2.4 Favored 'General case' 0 N--CA 1.478 0.973 0 CA-C-N 118.837 1.319 . . . . 0.0 108.79 171.006 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -171.86 39.88 0.17 Allowed Glycine 0 CA--C 1.549 2.207 0 N-CA-C 117.271 1.668 . . . . 0.0 117.271 174.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 73.43 -162.11 0.09 Allowed 'General case' 0 N--CA 1.486 1.357 0 CA-C-N 119.616 1.708 . . . . 0.0 114.878 169.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -72.53 -30.22 64.26 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 169.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -89.74 86.44 6.68 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-O 122.778 1.275 . . . . 0.0 108.763 168.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 60.3 m-20 -99.18 67.55 1.6 Allowed 'General case' 0 CA--C 1.564 1.486 0 N-CA-C 105.447 -2.057 . . . . 0.0 105.447 163.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 23.9 p 36.69 108.57 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 118.839 2.903 . . . . 0.0 118.839 -168.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -151.51 -72.85 0.15 Allowed 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 112.432 -2.167 . . . . 0.0 107.38 167.02 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -66.18 -33.04 74.86 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 114.366 1.247 . . . . 0.0 114.366 167.233 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.651 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 95.0 t -66.85 -40.15 85.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 CA-C-O 117.468 -1.253 . . . . 0.0 112.701 171.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.9 tp -74.61 -27.26 20.7 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.083 0 CA-C-N 120.261 1.391 . . . . 0.0 114.326 172.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 43.7 mt -72.59 -48.01 43.3 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 121.503 1.956 . . . . 0.0 113.874 171.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 36.1 t30 -70.32 -36.45 74.28 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 175.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.651 ' HB2' ' O ' ' A' ' 136' ' ' VAL . 14.8 tpt85 -63.42 -45.98 88.5 Favored 'General case' 0 N--CA 1.485 1.317 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 169.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 46.3 mtt -61.31 -29.51 69.92 Favored 'General case' 0 N--CA 1.499 1.982 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 167.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -63.31 -43.76 96.9 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 167.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 20.5 t -70.49 -26.69 29.24 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.533 0 CA-C-N 120.088 1.313 . . . . 0.0 113.521 171.202 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 30.0 t80 -65.34 -56.75 10.89 Favored 'General case' 0 CA--C 1.583 2.242 0 CA-C-N 120.68 1.582 . . . . 0.0 110.766 167.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 54.3 ttt180 -52.78 -26.8 15.42 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 119.711 3.226 . . . . 0.0 119.711 172.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -47.46 -51.42 20.32 Favored 'General case' 0 N--CA 1.495 1.794 0 N-CA-C 114.487 1.292 . . . . 0.0 114.487 169.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -142.55 42.33 1.61 Allowed 'General case' 0 CA--C 1.563 1.461 0 N-CA-C 117.084 2.253 . . . . 0.0 117.084 176.228 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 36.7 m -49.25 -36.65 20.97 Favored 'General case' 0 N--CA 1.504 2.244 0 N-CA-C 115.194 1.553 . . . . 0.0 115.194 166.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.414 ' HB3' ' HD3' ' A' ' 150' ' ' PRO . . . -68.09 -59.28 6.53 Favored Pre-proline 0 CA--C 1.577 2.014 0 CA-C-O 116.556 -1.688 . . . . 0.0 111.891 172.111 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.414 ' HD3' ' HB3' ' A' ' 149' ' ' ALA . 71.8 Cg_exo -53.03 -26.95 34.09 Favored 'Trans proline' 0 CA--C 1.577 2.666 0 N-CA-C 119.608 2.888 . . . . 0.0 119.608 168.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -65.25 -56.31 13.51 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 125.764 1.625 . . . . 0.0 111.371 172.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.868 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 44.4 tp -62.48 -24.19 67.33 Favored 'General case' 0 CA--C 1.571 1.776 0 N-CA-C 115.328 1.603 . . . . 0.0 115.328 175.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -71.23 -47.81 55.06 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 122.247 2.294 . . . . 0.0 113.745 166.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -60.77 -57.02 14.45 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 119.846 1.203 . . . . 0.0 111.966 177.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 76.9 m-85 -80.2 -19.45 46.99 Favored 'General case' 0 N--CA 1.475 0.821 0 CA-C-O 115.409 -2.234 . . . . 0.0 113.803 -178.242 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.868 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 33.2 ttt180 -74.21 -31.09 62.48 Favored 'General case' 0 N--CA 1.481 1.125 0 CA-C-N 124.436 3.289 . . . . 0.0 116.202 168.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -68.77 -44.28 74.02 Favored 'General case' 0 CA--C 1.57 1.738 0 CA-C-N 119.688 1.131 . . . . 0.0 113.126 167.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 66.3 mt-30 -91.43 -30.21 16.62 Favored 'General case' 0 CA--C 1.57 1.748 0 N-CA-C 119.164 3.024 . . . . 0.0 119.164 -176.542 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.5 pp -39.73 156.81 0.02 OUTLIER 'General case' 0 CA--C 1.582 2.183 1 N-CA-C 122.37 4.211 . . . . 0.0 122.37 -164.304 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 27.2 mttt -133.43 113.1 12.15 Favored 'General case' 0 CA--C 1.554 1.097 0 N-CA-C 101.71 -3.441 . . . . 0.0 101.71 164.778 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 60.4 m -94.7 146.58 24.06 Favored 'General case' 0 N--CA 1.489 1.487 0 CA-C-O 122.499 1.142 . . . . 0.0 110.349 -168.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 47.3 t -130.8 130.67 64.52 Favored 'Isoleucine or valine' 0 CA--C 1.558 1.259 0 CA-C-N 113.654 -1.612 . . . . 0.0 106.721 169.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -98.48 117.9 33.96 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 100.892 -3.744 . . . . 0.0 100.892 163.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . 0.293 . . -105.41 -138.01 0.36 Allowed 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 115.69 1.737 . . . . 0.0 115.69 -154.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . 0.252 14.6 m 9.76 92.26 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.573 1.849 1 N-CA-C 123.812 4.745 . . . . 0.0 123.812 -171.559 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -136.31 75.21 0.4 Allowed Glycine 0 N--CA 1.48 1.621 0 CA-C-O 122.966 1.315 . . . . 0.0 112.741 163.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 69.7 p 46.19 53.76 9.04 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 175.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 61.7 mtt 74.62 -68.08 0.23 Allowed 'General case' 0 N--CA 1.498 1.937 0 C-N-CA 125.627 1.571 . . . . 0.0 113.87 175.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -63.06 -39.43 94.71 Favored 'General case' 0 N--CA 1.5 2.073 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 -174.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -61.69 -49.11 77.81 Favored 'General case' 0 N--CA 1.493 1.68 0 CA-C-O 117.737 -1.125 . . . . 0.0 112.535 169.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 3.0 t -54.43 -37.87 39.11 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.403 0 N-CA-C 114.469 1.285 . . . . 0.0 114.469 174.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -62.61 -38.16 89.07 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 116.119 1.896 . . . . 0.0 116.119 169.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -61.83 -48.02 82.46 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 115.105 1.52 . . . . 0.0 115.105 175.552 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.577 ' HA ' ' HB2' ' A' ' 177' ' ' ARG . 1.2 ptt-85 -70.36 -29.14 65.74 Favored 'General case' 0 N--CA 1.488 1.426 0 N-CA-C 117.036 2.235 . . . . 0.0 117.036 170.331 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.77 -46.63 88.75 Favored 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 169.082 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 10.9 mp -64.4 -43.33 94.75 Favored 'General case' 0 N--CA 1.491 1.621 0 CA-C-O 117.411 -1.281 . . . . 0.0 111.402 167.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.577 ' HB2' ' HA ' ' A' ' 174' ' ' ARG . 41.1 mtt180 -46.64 -40.87 13.84 Favored 'General case' 0 N--CA 1.494 1.731 0 N-CA-C 117.883 2.549 . . . . 0.0 117.883 169.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -69.0 -48.72 62.39 Favored 'General case' 0 CA--C 1.562 1.423 0 N-CA-C 115.191 1.552 . . . . 0.0 115.191 169.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.7 tt -83.13 -52.3 6.75 Favored 'General case' 0 N--CA 1.494 1.754 0 CA-C-N 120.583 1.538 . . . . 0.0 114.336 -176.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.461 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -135.18 -60.18 0.06 OUTLIER Glycine 0 CA--C 1.551 2.284 0 CA-C-O 116.952 -2.027 . . . . 0.0 115.594 -170.092 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 39.7 ttmt . . . . . 0 C--O 1.251 1.17 0 CA-C-N 121.548 2.674 . . . . 0.0 109.595 -175.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 53.8 ttp . . . . . 0 CA--C 1.56 1.333 0 CA-C-O 122.382 1.086 . . . . 0.0 109.25 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . 0.275 11.4 mpt_? -124.5 167.73 14.05 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 120.878 3.659 . . . . 0.0 120.878 -162.621 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.3 p -148.11 151.18 13.66 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.695 0 CA-C-O 123.611 1.672 . . . . 0.0 113.067 167.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . 0.285 0.0 OUTLIER -143.56 133.87 24.58 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 113.922 -1.49 . . . . 0.0 110.99 166.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.729 HD11 ' CB ' ' A' ' 13' ' ' LYS . 3.7 tt -95.64 125.51 40.28 Favored 'General case' 0 CA--C 1.572 1.795 0 C-N-CA 125.188 1.395 . . . . 0.0 114.649 -165.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.6 mt -109.78 155.49 21.54 Favored 'General case' 0 CA--C 1.567 1.607 0 CA-C-N 110.559 -3.019 . . . . 0.0 109.847 169.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -174.36 99.49 0.14 Allowed Glycine 0 CA--C 1.55 2.24 0 CA-C-O 116.729 -2.15 . . . . 0.0 113.468 179.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . 0.281 33.3 Cg_endo -66.13 -69.97 0.03 OUTLIER 'Trans proline' 0 CA--C 1.58 2.778 0 CA-C-N 122.277 3.039 . . . . 0.0 111.853 175.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 16.7 Cg_exo -74.94 102.14 1.55 Allowed 'Trans proline' 0 C--N 1.378 2.12 0 CA-C-N 127.247 3.624 . . . . 0.0 111.032 167.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 131.89 99.94 0.78 Allowed Glycine 0 N--CA 1.476 1.302 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -172.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -60.35 -27.75 67.62 Favored 'General case' 0 CA--C 1.569 1.704 0 N-CA-C 118.185 2.661 . . . . 0.0 118.185 176.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -167.65 134.29 3.2 Favored Glycine 0 CA--C 1.545 1.933 0 CA-C-N 120.327 1.421 . . . . 0.0 112.515 173.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.729 ' CB ' HD11 ' A' ' 5' ' ' LEU . 32.1 mmtt -94.73 59.26 2.39 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 176.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -63.91 -35.74 92.4 Favored Glycine 0 CA--C 1.552 2.362 0 N-CA-C 118.609 2.204 . . . . 0.0 118.609 173.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 40.3 m -61.65 -53.48 55.6 Favored 'General case' 0 N--CA 1.495 1.815 0 CA-C-N 119.324 1.562 . . . . 0.0 113.416 174.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.259 0.1 OUTLIER -79.59 -17.45 53.85 Favored 'General case' 0 CA--C 1.58 2.106 0 CA-C-O 116.639 -1.648 . . . . 0.0 111.491 179.942 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -74.28 -43.7 55.79 Favored 'General case' 0 C--N 1.374 1.633 0 CA-C-N 122.712 2.506 . . . . 0.0 115.337 168.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 99.5 t -65.77 -37.99 81.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 CA-C-O 117.691 -1.147 . . . . 0.0 112.335 170.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 70.9 mmtt -59.68 -51.61 69.05 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 115.876 1.806 . . . . 0.0 115.876 169.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 16.5 tp -64.37 -31.5 72.73 Favored 'General case' 0 CA--C 1.575 1.937 0 N-CA-C 114.404 1.261 . . . . 0.0 114.404 174.253 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.29 -39.46 93.97 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 168.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -63.73 -35.13 79.55 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 114.486 1.291 . . . . 0.0 114.486 166.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 43.7 tptt -68.28 -55.49 11.98 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 115.374 1.62 . . . . 0.0 115.374 174.584 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 65.0 mt -83.83 -26.51 29.46 Favored 'General case' 0 CA--C 1.57 1.721 0 N-CA-C 116.648 2.092 . . . . 0.0 116.648 -178.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.27 39.28 6.44 Favored Glycine 0 CA--C 1.555 2.534 0 N-CA-C 117.313 1.685 . . . . 0.0 117.313 -172.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.404 ' CG2' ' HA ' ' A' ' 81' ' ' PHE . 20.4 mm -104.22 153.91 38.63 Favored Pre-proline 0 CA--C 1.567 1.605 0 CA-C-N 119.029 1.414 . . . . 0.0 112.271 -170.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -81.3 101.52 1.25 Allowed 'Trans proline' 0 CA--C 1.568 2.22 0 CA-C-N 121.65 1.625 . . . . 0.0 108.667 161.028 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -73.96 119.24 17.9 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 122.088 0.947 . . . . 0.0 110.197 173.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.477 HD11 ' HB3' ' A' ' 71' ' ' ARG . 1.8 mp -95.28 109.06 21.83 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.069 0 N-CA-C 104.089 -2.56 . . . . 0.0 104.089 176.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 78.0 p -97.41 128.15 43.96 Favored 'General case' 0 N--CA 1.477 0.92 0 N-CA-C 106.262 -1.755 . . . . 0.0 106.262 166.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 24.8 p -67.33 -10.89 55.39 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 117.822 2.526 . . . . 0.0 117.822 -169.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -82.41 -27.85 42.08 Favored Glycine 0 CA--C 1.553 2.409 0 N-CA-C 117.951 1.94 . . . . 0.0 117.951 165.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.2 tt0 -81.3 -46.14 15.17 Favored 'General case' 0 N--CA 1.489 1.515 0 N-CA-C 115.395 1.628 . . . . 0.0 115.395 -168.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -69.68 -37.32 76.61 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 113.723 1.009 . . . . 0.0 113.723 173.181 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.485 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 42.4 m-85 -65.67 -46.85 77.55 Favored 'General case' 0 CA--C 1.557 1.234 0 CA-C-O 116.538 -1.696 . . . . 0.0 112.855 170.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 70.9 ttt180 -54.84 -40.65 69.84 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 115.46 1.652 . . . . 0.0 115.46 168.716 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.8 tpt180 -59.44 -40.47 86.9 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 115.196 1.554 . . . . 0.0 115.196 169.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 46.3 m-80 -68.39 -25.47 65.07 Favored 'General case' 0 CA--C 1.583 2.238 0 N-CA-C 114.745 1.387 . . . . 0.0 114.745 167.703 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . 0.42 HG12 HG23 ' A' ' 47' ' ' VAL . 50.5 mt -62.91 -50.16 80.75 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 CA-C-N 120.383 1.447 . . . . 0.0 110.768 167.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -69.53 -31.55 69.83 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 177.198 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 18.8 mm-40 -67.76 -39.92 84.11 Favored 'General case' 0 CA--C 1.565 1.524 0 N-CA-C 114.983 1.475 . . . . 0.0 114.983 169.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.98 70.73 1.0 Allowed Glycine 0 CA--C 1.536 1.394 0 CA-C-O 118.577 -1.124 . . . . 0.0 112.886 175.172 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.566 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 56.9 p -96.18 -66.4 0.91 Allowed 'General case' 0 N--CA 1.48 1.028 0 CA-C-N 118.291 1.046 . . . . 0.0 110.609 179.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.566 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.0 OUTLIER 124.88 -54.97 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.744 0 CA-C-N 119.436 1.016 . . . . 0.0 110.117 -167.061 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.462 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.8 OUTLIER -71.8 -15.04 62.14 Favored 'General case' 0 CA--C 1.57 1.747 0 CA-C-O 118.48 -0.771 . . . . 0.0 112.54 167.058 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.89 -53.66 44.03 Favored Glycine 0 CA--C 1.555 2.586 0 CA-C-N 120.102 1.319 . . . . 0.0 114.009 166.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.42 HG23 HG12 ' A' ' 39' ' ' ILE . 1.0 OUTLIER -75.05 -50.88 23.2 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 -170.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.1 mt-10 -65.4 -41.8 93.25 Favored 'General case' 0 N--CA 1.488 1.455 0 CA-C-N 120.908 1.685 . . . . 0.0 113.196 172.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.462 ' HB3' ' O ' ' A' ' 45' ' ' LEU . . . -75.57 -24.26 56.61 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -176.105 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.485 ' HB2' ' HB3' ' A' ' 35' ' ' PHE . 9.6 tmtm? -76.18 -38.82 56.09 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 117.127 -1.416 . . . . 0.0 112.978 166.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.603 ' O ' ' CG ' ' A' ' 51' ' ' ARG . 51.1 ttt180 -70.58 -55.45 8.82 Favored 'General case' 0 CA--C 1.591 2.543 1 CA-C-O 86.101 -16.19 . . . . 0.0 118.413 -178.013 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 12.6 m-30 -33.15 -60.32 0.34 Allowed 'General case' 0 N--CA 1.496 1.858 1 O-C-N 109.089 -8.507 . . . . 0.0 121.273 146.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.7 tp -60.75 -23.67 65.14 Favored 'General case' 0 CA--C 1.576 1.966 0 CA-C-N 122.58 2.446 . . . . 0.0 117.226 169.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -93.09 -44.52 8.34 Favored 'General case' 0 CA--C 1.569 1.688 0 C-N-CA 126.112 1.765 . . . . 0.0 114.376 168.344 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -83.23 -36.27 24.74 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 116.669 2.1 . . . . 0.0 116.669 -177.155 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.97 40.04 2.55 Favored Glycine 0 CA--C 1.537 1.412 0 N-CA-C 116.157 1.223 . . . . 0.0 116.157 169.555 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.3 m-20 -103.29 -135.94 0.34 Allowed 'General case' 0 CA--C 1.571 1.753 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 169.169 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 91.6 mt -105.56 108.57 20.16 Favored 'General case' 0 N--CA 1.492 1.63 0 CA-C-N 120.857 1.662 . . . . 0.0 110.304 -170.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.3 p -112.05 109.58 54.6 Favored Pre-proline 0 CA--C 1.565 1.551 0 CA-C-O 117.483 -1.246 . . . . 0.0 108.23 175.46 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -64.28 154.82 69.01 Favored 'Trans proline' 0 CA--C 1.558 1.705 0 C-N-CA 123.094 2.529 . . . . 0.0 116.567 178.627 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 71.9 m -78.03 174.98 10.53 Favored 'General case' 0 CA--C 1.571 1.762 0 CA-C-N 115.499 -0.773 . . . . 0.0 111.969 169.75 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.7 t70 83.17 -47.11 0.13 Allowed 'General case' 0 N--CA 1.498 1.94 0 C-N-CA 125.884 1.674 . . . . 0.0 114.075 178.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 24.9 mt -65.47 -53.98 34.87 Favored 'General case' 0 N--CA 1.505 2.276 0 N-CA-C 113.989 1.107 . . . . 0.0 113.989 168.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 53.7 m -53.68 -49.85 67.1 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 113.112 -1.858 . . . . 0.0 113.678 169.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 4.9 m-80 -59.63 -27.24 66.16 Favored 'General case' 0 N--CA 1.492 1.673 0 N-CA-C 116.534 2.05 . . . . 0.0 116.534 167.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.57 -47.56 54.16 Favored 'General case' 0 CA--C 1.549 0.927 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 173.082 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . 0.381 4.5 pp -74.59 -25.73 59.46 Favored 'General case' 0 CA--C 1.588 2.439 0 CA-C-N 119.743 1.156 . . . . 0.0 112.952 174.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -65.0 -48.01 85.76 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.144 0 CA-C-N 121.78 2.082 . . . . 0.0 112.816 165.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -58.57 -32.82 69.28 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 114.916 1.45 . . . . 0.0 114.916 171.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -59.58 -45.84 90.68 Favored 'General case' 0 CA--C 1.566 1.585 0 CA-C-O 117.555 -1.212 . . . . 0.0 112.697 166.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.477 ' HB3' HD11 ' A' ' 29' ' ' ILE . 83.0 mtt180 -82.93 7.9 14.11 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 118.59 2.811 . . . . 0.0 118.59 167.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.8 mt -123.69 -5.87 8.06 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 118.294 2.701 . . . . 0.0 118.294 170.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 55.9 p30 -73.06 13.32 0.42 Allowed 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 116.294 1.961 . . . . 0.0 116.294 171.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.485 ' HB3' ' CD ' ' A' ' 75' ' ' PRO 0.352 6.1 m120 -73.17 -129.05 0.0 OUTLIER Pre-proline 0 CA--C 1.592 2.58 0 CA-C-O 115.362 -2.256 . . . . 0.0 116.724 -169.367 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.485 ' CD ' ' HB3' ' A' ' 74' ' ' ASN . 68.2 Cg_exo -60.71 40.06 0.06 OUTLIER 'Trans proline' 0 C--N 1.386 2.552 0 N-CA-C 121.973 3.797 . . . . 0.0 121.973 168.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 59.78 33.61 21.77 Favored 'General case' 0 CA--C 1.583 2.246 0 C-N-CA 125.97 1.708 . . . . 0.0 109.848 -161.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 84.24 -3.35 1.05 Allowed 'General case' 0 C--N 1.385 2.133 0 CA-C-O 116.584 -1.674 . . . . 0.0 114.246 -168.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 51.18 34.6 11.54 Favored 'General case' 0 CA--C 1.573 1.861 0 CA-C-N 124.11 3.141 . . . . 0.0 114.701 -166.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 62.42 37.97 13.19 Favored 'General case' 0 CA--C 1.584 2.264 0 CA-C-O 117.057 -1.449 . . . . 0.0 111.928 -167.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 165.42 171.49 31.7 Favored Glycine 0 C--N 1.375 2.697 0 CA-C-N 123.21 2.732 . . . . 0.0 117.325 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.404 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . 13.9 p90 -171.39 135.84 0.97 Allowed 'General case' 0 N--CA 1.48 1.039 0 CA-C-N 113.344 -1.428 . . . . 0.0 107.675 -179.128 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 9.1 mt -111.56 108.92 26.69 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.542 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 172.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 26.2 mt -107.24 121.06 43.78 Favored 'General case' 0 N--CA 1.504 2.235 0 CA-C-O 117.402 -1.285 . . . . 0.0 110.009 177.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -117.74 118.17 31.34 Favored 'General case' 0 N--CA 1.506 2.369 0 CA-C-N 121.566 1.985 . . . . 0.0 111.588 -169.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 74.63 35.8 50.37 Favored Glycine 0 CA--C 1.555 2.537 0 CA-C-O 117.986 -1.452 . . . . 0.0 116.653 -174.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 23.2 t80 -94.64 -52.67 0.24 Allowed Pre-proline 0 N--CA 1.493 1.709 0 CA-C-O 115.361 -2.257 . . . . 0.0 108.672 177.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_endo -68.41 68.71 1.04 Allowed 'Trans proline' 0 CA--C 1.57 2.321 0 CA-C-N 124.071 2.49 . . . . 0.0 117.623 164.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.22 -20.99 61.47 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 165.711 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.2 m -147.19 143.38 28.16 Favored 'General case' 0 CA--C 1.55 0.954 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 -173.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . 0.313 9.8 p -69.54 -23.2 25.98 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 CA-C-O 116.158 -1.877 . . . . 0.0 112.337 175.223 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 12.0 mt-10 -63.43 -31.89 73.17 Favored 'General case' 0 CA--C 1.563 1.449 0 N-CA-C 118.943 2.942 . . . . 0.0 118.943 166.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 15.8 mm100 -76.84 -48.16 19.26 Favored 'General case' 0 CA--C 1.588 2.409 0 CA-C-N 122.281 2.31 . . . . 0.0 112.159 165.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.36 -35.47 80.97 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 126.932 2.093 . . . . 0.0 116.003 -169.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 67.0 tttt -57.71 -29.48 64.74 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 115.683 1.735 . . . . 0.0 115.683 167.036 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.74 -41.0 72.39 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 114.825 1.417 . . . . 0.0 114.825 168.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 23.6 tp -60.41 -40.36 90.69 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 114.679 1.362 . . . . 0.0 114.679 168.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 19.1 t-80 -56.12 -53.08 61.35 Favored 'General case' 0 N--CA 1.497 1.918 0 C-N-CA 124.003 0.921 . . . . 0.0 113.147 168.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.902 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 14.3 mm-40 -46.88 -42.71 17.91 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 116.012 1.856 . . . . 0.0 116.012 167.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 1.284 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 58.7 mtt -83.87 -19.66 34.45 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 117.793 2.516 . . . . 0.0 117.793 177.381 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 60.6 tp -73.81 -50.36 20.83 Favored 'General case' 0 N--CA 1.501 2.097 0 CA-C-N 120.835 1.652 . . . . 0.0 111.741 169.839 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 51.5 mt-10 -74.2 -56.78 4.5 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 113.642 0.978 . . . . 0.0 113.642 171.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.902 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 96.4 mtt180 -68.58 -37.98 80.29 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 116.057 1.873 . . . . 0.0 116.057 177.078 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 1.284 ' HB3' ' O ' ' A' ' 99' ' ' MET . 70.7 ttt180 -62.25 -59.31 5.21 Favored 'General case' 0 N--CA 1.493 1.697 0 CA-C-N 119.857 1.208 . . . . 0.0 110.193 164.083 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 113.11 46.22 0.71 Allowed Glycine 0 N--CA 1.48 1.632 0 O-C-N 124.435 1.085 . . . . 0.0 114.011 167.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.2 p -103.61 146.63 28.28 Favored 'General case' 0 CA--C 1.557 1.232 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 172.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.9 m-20 -68.81 128.96 38.55 Favored 'General case' 0 N--CA 1.502 2.162 0 O-C-N 121.183 -0.948 . . . . 0.0 112.894 -170.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.8 tp -82.23 101.15 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 177.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 31.3 t70 -103.32 -72.0 0.71 Allowed 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 115.737 -2.078 . . . . 0.0 109.21 167.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -142.6 119.76 11.45 Favored 'General case' 0 N--CA 1.483 1.222 0 N-CA-C 116.543 2.053 . . . . 0.0 116.543 -166.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 93.8 t -92.87 114.28 29.38 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 100.532 -3.877 . . . . 0.0 100.532 161.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 32.9 tp -117.96 109.47 16.54 Favored 'General case' 0 CA--C 1.556 1.195 0 C-N-CA 122.778 0.431 . . . . 0.0 111.454 -165.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -96.64 115.91 28.23 Favored 'General case' 0 N--CA 1.485 1.295 0 C-N-CA 122.986 0.514 . . . . 0.0 112.062 -178.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 96.8 m-85 -93.09 108.86 20.36 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 175.448 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.5 ' O ' HG23 ' A' ' 115' ' ' VAL . 80.0 ttt180 -103.13 110.89 23.0 Favored 'General case' 0 C--O 1.239 0.528 0 C-N-CA 123.949 0.899 . . . . 0.0 108.745 172.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.5 HG23 ' O ' ' A' ' 114' ' ' ARG 0.31 1.3 t 179.35 141.1 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.984 0 CA-C-O 123.925 1.821 . . . . 0.0 108.252 159.688 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 92.2 p 59.34 133.11 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.359 0 N-CA-C 119.022 2.971 . . . . 0.0 119.022 169.637 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -72.7 -31.86 65.32 Favored 'General case' 0 N--CA 1.503 2.184 0 N-CA-C 116.366 1.988 . . . . 0.0 116.366 171.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -45.18 -44.89 11.2 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 115.664 1.727 . . . . 0.0 115.664 173.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.2 t -46.96 -48.97 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.455 0 N-CA-C 115.665 1.728 . . . . 0.0 115.665 174.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 5.9 tt -67.17 -40.46 86.61 Favored 'General case' 0 CA--C 1.559 1.289 0 CA-C-O 116.572 -1.68 . . . . 0.0 113.015 173.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . 0.389 0.0 OUTLIER -76.96 -12.89 60.01 Favored 'General case' 0 N--CA 1.51 2.572 0 CA-C-N 121.191 1.814 . . . . 0.0 114.974 173.52 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -73.32 -46.71 47.87 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 121.18 1.809 . . . . 0.0 111.895 166.241 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 1.015 ' O ' ' HB2' ' A' ' 127' ' ' ARG . 18.8 mmt180 -53.52 -48.64 68.85 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 115.085 1.513 . . . . 0.0 115.085 167.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 75.9 mt -58.95 -58.95 6.39 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 169.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 56.0 mtmt -81.02 -59.59 2.6 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 -171.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -91.08 44.83 2.83 Favored Glycine 0 CA--C 1.55 2.277 0 N-CA-C 115.92 1.128 . . . . 0.0 115.92 173.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 1.015 ' HB2' ' O ' ' A' ' 123' ' ' ARG . 18.3 mmm180 -150.5 -73.03 0.17 Allowed 'General case' 0 N--CA 1.481 1.103 0 N-CA-C 107.214 -1.402 . . . . 0.0 107.214 173.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -90.16 38.05 3.27 Favored Glycine 0 CA--C 1.555 2.586 0 N-CA-C 118.024 1.97 . . . . 0.0 118.024 172.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.499 ' HB3' ' H ' ' A' ' 130' ' ' ALA . 98.3 mtt180 71.33 -143.51 0.06 Allowed 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 169.256 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.499 ' H ' ' HB3' ' A' ' 129' ' ' ARG . . . -90.29 64.57 6.04 Favored 'General case' 0 CA--C 1.564 1.517 0 CA-C-N 113.358 -1.746 . . . . 0.0 111.573 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . 0.3 8.0 m-20 75.94 -90.97 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 119.894 1.224 . . . . 0.0 108.469 -169.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . 0.274 16.0 t70 74.3 -56.19 0.65 Allowed 'General case' 0 N--CA 1.508 2.432 0 C-N-CA 125.234 1.413 . . . . 0.0 111.022 -162.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 70.9 p -55.26 -113.17 0.0 OUTLIER 'General case' 0 CA--C 1.57 1.735 0 C-N-CA 130.239 3.415 . . . . 0.0 111.263 164.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 8.3 t70 72.49 -64.05 0.41 Allowed 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 127.197 2.199 . . . . 0.0 110.708 -168.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -68.05 -36.09 79.31 Favored 'General case' 0 CA--C 1.559 1.291 0 CA-C-O 117.662 -1.161 . . . . 0.0 113.863 165.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.8 t -70.89 -37.04 66.63 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.717 0 CA-C-N 120.79 1.632 . . . . 0.0 112.683 174.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.459 ' O ' ' HB3' ' A' ' 140' ' ' ARG . 10.6 tp -69.46 -33.08 55.58 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.252 0 CA-C-N 119.869 1.213 . . . . 0.0 113.278 169.107 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 30.5 mt -62.94 -42.82 99.93 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-N 120.768 1.622 . . . . 0.0 114.075 167.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -62.76 -33.29 74.85 Favored 'General case' 0 N--CA 1.5 2.075 0 N-CA-C 114.654 1.353 . . . . 0.0 114.654 168.372 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.459 ' HB3' ' O ' ' A' ' 137' ' ' ILE . 9.5 tpt180 -57.69 -45.45 85.65 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 166.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 25.1 ttt -64.18 -33.02 74.84 Favored 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 169.049 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 85.0 tttt -60.89 -48.92 79.61 Favored 'General case' 0 N--CA 1.487 1.399 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 169.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 12.4 p -65.32 -33.09 61.29 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.113 0 N-CA-C 114.539 1.311 . . . . 0.0 114.539 169.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 37.2 t80 -55.02 -49.57 71.2 Favored 'General case' 0 CA--C 1.581 2.162 0 CA-C-N 119.922 1.237 . . . . 0.0 111.652 167.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 69.2 ttt180 -56.74 -41.63 77.85 Favored 'General case' 0 N--CA 1.488 1.464 0 N-CA-C 118.878 2.918 . . . . 0.0 118.878 171.857 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -46.71 -42.45 16.65 Favored 'General case' 0 N--CA 1.506 2.342 0 N-CA-C 117.969 2.581 . . . . 0.0 117.969 174.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 18.2 mm-40 -125.69 -29.3 3.17 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 117.597 2.443 . . . . 0.0 117.597 -166.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 51.7 m -45.97 -34.29 3.88 Favored 'General case' 0 N--CA 1.505 2.29 0 N-CA-C 117.543 2.423 . . . . 0.0 117.543 -171.097 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -66.86 -62.49 3.77 Favored Pre-proline 0 CA--C 1.583 2.247 0 CA-C-O 116.144 -1.884 . . . . 0.0 112.09 170.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 89.4 Cg_exo -53.15 -35.86 74.78 Favored 'Trans proline' 0 CA--C 1.584 3.004 0 C-N-CA 123.632 2.888 . . . . 0.0 118.945 168.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.97 -53.75 54.86 Favored 'General case' 0 N--CA 1.496 1.875 0 C-N-CA 126.165 1.786 . . . . 0.0 112.174 169.458 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 1.27 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 28.8 tp -68.09 -21.57 64.96 Favored 'General case' 0 CA--C 1.563 1.467 0 CA-C-O 116.749 -1.596 . . . . 0.0 114.214 179.245 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -71.98 -49.02 40.76 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 121.961 2.164 . . . . 0.0 112.618 164.607 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 14.2 t80 -68.63 -51.75 38.8 Favored 'General case' 0 CA--C 1.567 1.613 0 CA-C-N 120.569 1.531 . . . . 0.0 112.302 -176.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -78.56 -26.23 45.59 Favored 'General case' 0 CA--C 1.554 1.109 0 CA-C-O 114.854 -2.498 . . . . 0.0 113.072 176.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 1.27 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 0.1 OUTLIER -60.96 -41.97 97.37 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 125.24 3.655 . . . . 0.0 115.543 168.393 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -62.87 -36.0 81.86 Favored 'General case' 0 N--CA 1.498 1.938 0 N-CA-C 114.625 1.343 . . . . 0.0 114.625 167.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 57.0 mt-30 -88.3 -34.42 17.68 Favored 'General case' 0 CA--C 1.576 1.977 0 N-CA-C 119.336 3.088 . . . . 0.0 119.336 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.1 pp -80.35 173.71 12.32 Favored 'General case' 0 N--CA 1.498 1.962 0 N-CA-C 117.803 2.52 . . . . 0.0 117.803 -162.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 32.3 ttmt -122.78 123.53 41.25 Favored 'General case' 0 CA--C 1.557 1.221 0 N-CA-C 105.453 -2.054 . . . . 0.0 105.453 166.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 1.4 t -100.2 156.9 16.96 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 123.195 1.474 . . . . 0.0 110.241 -178.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 40.0 t -132.61 143.99 38.09 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.367 0 CA-C-N 113.096 -1.865 . . . . 0.0 106.651 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -95.05 120.25 34.94 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 100.32 -3.955 . . . . 0.0 100.32 164.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . 0.307 . . -99.34 -101.74 0.22 Allowed 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 119.489 3.144 . . . . 0.0 119.489 -150.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.3 t -57.54 95.22 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.564 1.492 0 N-CA-C 117.492 2.405 . . . . 0.0 117.492 -158.005 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -112.77 65.76 0.26 Allowed Glycine 0 N--CA 1.48 1.611 0 CA-C-O 122.211 0.895 . . . . 0.0 112.953 163.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 61.6 p 43.38 65.8 0.92 Allowed 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 116.257 1.947 . . . . 0.0 116.257 177.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 55.2 mtt 80.02 -57.77 0.35 Allowed 'General case' 0 N--CA 1.501 2.082 0 C-N-CA 125.59 1.556 . . . . 0.0 114.917 170.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -75.4 -42.38 53.9 Favored 'General case' 0 N--CA 1.506 2.346 0 N-CA-C 114.37 1.248 . . . . 0.0 114.37 -175.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -63.99 -44.76 91.7 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 114.455 1.28 . . . . 0.0 114.455 174.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -40.58 71.21 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.051 0 CA-C-O 117.947 -1.025 . . . . 0.0 113.667 172.122 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -54.7 -38.81 67.49 Favored 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 116.656 2.095 . . . . 0.0 116.656 166.19 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -62.57 -53.46 54.28 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 113.801 1.037 . . . . 0.0 113.801 176.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.449 ' HA ' ' HB2' ' A' ' 177' ' ' ARG . 74.7 mtt85 -70.94 -28.38 64.44 Favored 'General case' 0 CA--C 1.553 1.072 0 N-CA-C 117.91 2.559 . . . . 0.0 117.91 174.187 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.14 -45.42 94.74 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 167.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.5 mp -62.76 -43.17 99.51 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-O 117.852 -1.07 . . . . 0.0 113.641 168.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.449 ' HB2' ' HA ' ' A' ' 174' ' ' ARG . 39.6 mtt180 -52.56 -42.65 64.64 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 117.034 2.235 . . . . 0.0 117.034 169.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -66.8 -50.86 61.28 Favored 'General case' 0 CA--C 1.558 1.264 0 N-CA-C 115.644 1.72 . . . . 0.0 115.644 172.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -74.86 -59.59 2.67 Favored 'General case' 0 CA--C 1.569 1.688 0 CA-C-N 119.833 1.197 . . . . 0.0 112.565 -179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.638 ' O ' ' CB ' ' A' ' 181' ' ' LYS . . . -106.59 -55.68 0.66 Allowed Glycine 0 CA--C 1.55 2.249 0 CA-C-O 117.902 -1.499 . . . . 0.0 115.095 -175.441 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.638 ' CB ' ' O ' ' A' ' 180' ' ' GLY . 36.5 ttmt . . . . . 0 C--O 1.251 1.139 0 CA-C-N 120.13 1.965 . . . . 0.0 107.507 -175.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 22.9 mmt . . . . . 0 CA--C 1.555 1.154 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.98 169.74 21.03 Favored 'General case' 0 N--CA 1.482 1.166 0 N-CA-C 115.837 1.791 . . . . 0.0 115.837 -165.408 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 86.9 t -131.51 148.57 32.62 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 CA-C-O 123.66 1.695 . . . . 0.0 113.135 -162.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -119.47 113.54 20.92 Favored 'General case' 0 CA--C 1.558 1.262 0 CA-C-N 112.576 -2.102 . . . . 0.0 105.331 169.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.8 tp -99.67 127.03 45.78 Favored 'General case' 0 CA--C 1.562 1.424 0 CA-C-O 123.44 1.59 . . . . 0.0 108.399 -168.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.3 mt -134.67 163.73 29.11 Favored 'General case' 0 N--CA 1.481 1.104 0 CA-C-N 111.695 -2.502 . . . . 0.0 113.277 -164.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 172.96 115.6 0.38 Allowed Glycine 0 CA--C 1.546 2.007 0 CA-C-O 117.015 -1.991 . . . . 0.0 110.953 -171.07 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -57.91 -177.68 0.09 OUTLIER 'Trans proline' 0 CA--C 1.577 2.656 0 CA-C-N 122.147 2.973 . . . . 0.0 115.196 168.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -50.78 112.32 0.74 Allowed 'Trans proline' 0 CA--C 1.56 1.795 0 C-N-CA 123.469 2.779 . . . . 0.0 113.822 172.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 166.06 90.19 0.08 OUTLIER Glycine 0 CA--C 1.533 1.216 0 N-CA-C 111.463 -0.655 . . . . 0.0 111.463 -168.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 53.48 -98.18 0.07 Allowed 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 171.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -167.22 -169.37 30.7 Favored Glycine 0 CA--C 1.548 2.126 0 CA-C-N 120.585 1.539 . . . . 0.0 115.934 -174.026 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.6 mtmt -152.17 -33.28 0.14 Allowed 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 114.781 1.4 . . . . 0.0 114.781 -169.646 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -44.61 -33.49 3.31 Favored Glycine 0 CA--C 1.551 2.332 0 N-CA-C 120.887 3.115 . . . . 0.0 120.887 179.147 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.8 p -57.92 -61.12 2.76 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-N 119.322 1.561 . . . . 0.0 115.21 173.225 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.259 5.2 mm-40 -75.95 -12.53 60.16 Favored 'General case' 0 CA--C 1.567 1.598 0 CA-C-O 116.539 -1.696 . . . . 0.0 111.59 175.09 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -69.68 -50.56 42.73 Favored 'General case' 0 C--N 1.37 1.458 0 CA-C-N 122.57 2.441 . . . . 0.0 113.639 167.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.8 p -66.9 -39.83 84.39 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.147 0 N-CA-C 114.168 1.173 . . . . 0.0 114.168 173.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.539 ' HB3' ' CE1' ' A' ' 172' ' ' PHE . 58.5 mmtt -62.89 -42.48 99.79 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 116.21 1.929 . . . . 0.0 116.21 170.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 20.0 tp -66.67 -36.81 83.42 Favored 'General case' 0 CA--C 1.571 1.766 0 CA-C-N 120.04 1.291 . . . . 0.0 113.53 172.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.24 -39.29 86.21 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 166.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -56.59 -39.88 74.32 Favored 'General case' 0 CA--C 1.567 1.631 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 166.168 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.1 mmmt -68.71 -53.44 22.16 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 174.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 61.1 mt -83.87 -23.81 31.12 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 117.274 2.324 . . . . 0.0 117.274 -176.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.91 35.42 7.72 Favored Glycine 0 CA--C 1.555 2.582 0 N-CA-C 117.8 1.88 . . . . 0.0 117.8 -174.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.0 mm -105.39 155.21 38.3 Favored Pre-proline 0 CA--C 1.57 1.722 0 CA-C-N 119.136 1.468 . . . . 0.0 112.434 -169.345 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -81.95 99.72 1.03 Allowed 'Trans proline' 0 CA--C 1.569 2.23 0 C-N-CA 121.695 1.596 . . . . 0.0 109.953 162.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -64.85 112.69 3.38 Favored 'General case' 0 N--CA 1.495 1.778 0 C-N-CA 123.511 0.724 . . . . 0.0 110.539 170.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 27.3 mm -104.11 108.92 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.14 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 175.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 21.0 t -94.77 136.51 34.99 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 169.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.1 p -70.35 -6.53 35.98 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 117.531 2.419 . . . . 0.0 117.531 -177.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -89.72 -24.05 31.51 Favored Glycine 0 CA--C 1.544 1.886 0 N-CA-C 118.324 2.09 . . . . 0.0 118.324 165.194 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -81.18 -51.23 8.65 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 114.476 1.287 . . . . 0.0 114.476 -168.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -64.71 -39.08 93.04 Favored 'General case' 0 N--CA 1.49 1.535 0 N-CA-C 113.427 0.899 . . . . 0.0 113.427 174.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.544 ' HB3' ' CG ' ' A' ' 50' ' ' LYS . 41.6 m-85 -66.3 -37.6 85.78 Favored 'General case' 0 CA--C 1.556 1.184 0 N-CA-C 116.183 1.92 . . . . 0.0 116.183 169.184 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.471 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 74.4 ttt180 -58.59 -41.05 84.91 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 166.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.1 tpt180 -63.81 -38.88 92.76 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 114.746 1.388 . . . . 0.0 114.746 169.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 66.9 m-20 -64.28 -34.34 77.9 Favored 'General case' 0 CA--C 1.573 1.862 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 167.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 51.8 mt -59.35 -43.53 90.38 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.135 0 C-N-CA 124.994 1.318 . . . . 0.0 111.933 168.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -63.88 -40.62 96.95 Favored 'General case' 0 N--CA 1.489 1.494 0 N-CA-C 114.543 1.312 . . . . 0.0 114.543 170.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -72.68 -40.34 66.33 Favored 'General case' 0 CA--C 1.558 1.257 0 N-CA-C 116.266 1.95 . . . . 0.0 116.266 -179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 84.01 72.12 1.29 Allowed Glycine 0 CA--C 1.542 1.774 0 CA-C-O 118.383 -1.232 . . . . 0.0 113.965 -171.368 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.562 ' O ' ' CB ' ' A' ' 44' ' ' LYS . 76.4 p -91.55 -65.47 1.01 Allowed 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 118.887 1.343 . . . . 0.0 111.267 177.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.562 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.0 OUTLIER 128.3 -55.76 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.942 0.897 . . . . 0.0 110.349 -167.422 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.6 pt? -74.67 -11.17 60.11 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 166.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -66.08 -54.31 25.06 Favored Glycine 0 CA--C 1.546 2.028 0 CA-C-N 119.324 0.965 . . . . 0.0 114.393 167.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.414 ' O ' ' HB2' ' A' ' 51' ' ' ARG 0.268 1.0 OUTLIER -76.44 -47.37 30.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.278 0 N-CA-C 116.593 2.072 . . . . 0.0 116.593 -168.624 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -67.05 -36.81 82.89 Favored 'General case' 0 N--CA 1.49 1.527 0 CA-C-N 120.985 1.72 . . . . 0.0 113.363 171.156 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -74.77 -34.24 62.43 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 114.996 1.48 . . . . 0.0 114.996 -177.32 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.544 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.0 OUTLIER -73.92 -34.06 64.21 Favored 'General case' 0 N--CA 1.488 1.426 0 CA-C-O 117.736 -1.126 . . . . 0.0 112.503 169.573 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.519 ' HG2' ' O ' ' A' ' 51' ' ' ARG . 22.0 ttt180 -74.12 -51.12 16.62 Favored 'General case' 0 CA--C 1.586 2.359 1 CA-C-O 84.252 -17.07 . . . . 0.0 118.583 -178.761 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . 0.251 21.4 m-85 -36.83 -57.42 0.81 Allowed 'General case' 0 N--CA 1.494 1.769 2 O-C-N 107.666 -9.396 . . . . 0.0 122.029 147.869 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 38.4 mt -57.43 -33.92 68.4 Favored 'General case' 0 N--CA 1.511 2.597 0 CA-C-N 123.241 2.746 . . . . 0.0 115.501 168.625 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -90.71 -38.38 13.09 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 116.273 1.953 . . . . 0.0 116.273 175.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -78.96 -37.78 38.71 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 116.256 1.947 . . . . 0.0 116.256 178.203 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.89 40.41 1.44 Allowed Glycine 0 CA--C 1.536 1.403 0 N-CA-C 116.475 1.35 . . . . 0.0 116.475 171.213 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -119.31 -142.94 0.36 Allowed 'General case' 0 CA--C 1.569 1.7 0 N-CA-C 107.141 -1.429 . . . . 0.0 107.141 165.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 79.9 mt -129.92 133.77 47.06 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.307 -0.87 . . . . 0.0 109.77 -170.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.609 HG12 HH22 ' A' ' 88' ' ' ARG . 7.0 p -109.01 133.03 20.85 Favored Pre-proline 0 CA--C 1.573 1.863 0 N-CA-C 107.848 -1.168 . . . . 0.0 107.848 172.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -54.95 146.72 55.85 Favored 'Trans proline' 0 CA--C 1.561 1.838 0 C-N-CA 123.33 2.687 . . . . 0.0 116.839 173.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 96.4 p -72.64 175.6 6.24 Favored 'General case' 0 CA--C 1.57 1.739 0 N-CA-C 113.626 0.973 . . . . 0.0 113.626 176.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 6.6 t70 81.04 -45.18 0.22 Allowed 'General case' 0 N--CA 1.5 2.064 0 C-N-CA 125.822 1.649 . . . . 0.0 114.29 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 34.8 mt -62.3 -54.51 39.55 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 114.029 1.122 . . . . 0.0 114.029 168.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.8 m -56.65 -48.72 76.95 Favored 'General case' 0 CA--C 1.571 1.765 0 CA-C-N 113.051 -1.886 . . . . 0.0 113.07 173.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 39.6 m-80 -58.04 -35.28 71.09 Favored 'General case' 0 N--CA 1.493 1.69 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 168.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -64.95 -44.6 88.9 Favored 'General case' 0 CA--C 1.554 1.12 0 N-CA-C 115.773 1.768 . . . . 0.0 115.773 173.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 13.8 mt -62.93 -44.27 96.53 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 115.263 1.579 . . . . 0.0 115.263 170.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 82.7 t -58.29 -46.77 88.87 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.949 0 CA-C-O 117.799 -1.096 . . . . 0.0 112.463 170.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -60.0 -39.21 84.98 Favored 'General case' 0 N--CA 1.491 1.588 0 N-CA-C 116.013 1.857 . . . . 0.0 116.013 172.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.7 t70 -58.67 -41.83 87.07 Favored 'General case' 0 N--CA 1.49 1.545 0 CA-C-N 120.331 1.423 . . . . 0.0 113.44 169.009 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 75.8 mtt180 -82.11 2.01 33.37 Favored 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 119.198 3.036 . . . . 0.0 119.198 167.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 23.3 tp -121.68 -7.94 9.04 Favored 'General case' 0 CA--C 1.564 1.49 0 N-CA-C 118.407 2.743 . . . . 0.0 118.407 175.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 89.1 m-20 -57.78 -34.13 69.28 Favored 'General case' 0 N--CA 1.504 2.251 0 N-CA-C 115.074 1.509 . . . . 0.0 115.074 174.494 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.494 ' HB3' ' CD ' ' A' ' 75' ' ' PRO 0.299 1.6 m-20 -5.35 -127.58 0.0 OUTLIER Pre-proline 0 CA--C 1.6 2.9 1 N-CA-C 121.97 4.063 . . . . 0.0 121.97 169.668 . . . . . . . . 4 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.494 ' CD ' ' HB3' ' A' ' 74' ' ' ASN . 85.9 Cg_exo -68.38 36.77 0.19 Allowed 'Trans proline' 0 N--CA 1.513 2.676 0 CA-C-N 126.727 3.438 . . . . 0.0 119.893 168.635 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 10.4 t70 62.5 31.88 16.84 Favored 'General case' 0 CA--C 1.587 2.388 0 C-N-CA 124.623 1.169 . . . . 0.0 109.235 -158.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 76.53 5.25 3.55 Favored 'General case' 0 C--N 1.383 2.022 0 CA-C-O 116.787 -1.578 . . . . 0.0 115.078 -168.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 50.83 31.7 6.37 Favored 'General case' 0 CA--C 1.575 1.933 0 CA-C-N 123.144 2.702 . . . . 0.0 114.281 -165.352 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 60.02 34.17 21.4 Favored 'General case' 0 CA--C 1.585 2.32 0 CA-C-O 116.907 -1.521 . . . . 0.0 112.193 -166.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 179.02 171.12 41.86 Favored Glycine 0 C--N 1.377 2.84 0 CA-C-N 123.398 2.817 . . . . 0.0 118.874 -175.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 15.3 p90 -175.89 136.75 0.32 Allowed 'General case' 0 N--CA 1.487 1.406 0 CA-C-N 113.731 -1.234 . . . . 0.0 110.438 -169.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 22.6 mt -113.32 106.27 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 104.816 -2.29 . . . . 0.0 104.816 169.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 58.8 mt -105.72 120.52 41.89 Favored 'General case' 0 N--CA 1.498 1.934 0 C-N-CA 123.151 0.58 . . . . 0.0 109.454 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -113.49 122.09 46.22 Favored 'General case' 0 N--CA 1.497 1.889 0 CA-C-N 118.645 0.657 . . . . 0.0 110.621 -167.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 72.73 38.87 56.61 Favored Glycine 0 CA--C 1.548 2.114 0 CA-C-O 117.287 -1.841 . . . . 0.0 115.801 -178.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -99.66 -54.16 0.18 Allowed Pre-proline 0 N--CA 1.498 1.967 0 CA-C-O 115.359 -2.257 . . . . 0.0 107.536 176.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -60.87 70.04 0.08 OUTLIER 'Trans proline' 0 CA--C 1.575 2.555 0 N-CA-C 118.784 2.571 . . . . 0.0 118.784 164.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.609 HH22 HG12 ' A' ' 59' ' ' VAL . 4.5 ttm105 -69.94 -37.56 75.92 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 116.453 2.02 . . . . 0.0 116.453 168.107 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 33.0 p -151.56 126.95 9.99 Favored 'General case' 0 CA--C 1.548 0.896 0 N-CA-C 104.316 -2.475 . . . . 0.0 104.316 -164.855 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . 0.317 5.8 p -62.28 -21.3 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 CA-C-O 116.089 -1.91 . . . . 0.0 113.6 -173.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -64.09 -36.92 85.61 Favored 'General case' 0 CA--C 1.557 1.221 0 N-CA-C 119.435 3.124 . . . . 0.0 119.435 165.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -73.04 -48.54 35.28 Favored 'General case' 0 CA--C 1.586 2.361 0 CA-C-N 124.422 3.283 . . . . 0.0 111.088 165.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -58.16 -32.03 67.8 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 118.078 2.621 . . . . 0.0 118.078 -174.212 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.519 ' O ' ' HB2' ' A' ' 98' ' ' GLU . 60.2 tttt -59.48 -25.15 64.18 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 116.604 2.076 . . . . 0.0 116.604 168.706 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.62 -45.69 64.76 Favored 'General case' 0 CA--C 1.568 1.648 0 N-CA-C 113.772 1.027 . . . . 0.0 113.772 166.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 11.2 tp -61.48 -43.73 98.34 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 115.153 1.538 . . . . 0.0 115.153 171.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 38.2 t-80 -59.51 -51.11 71.27 Favored 'General case' 0 N--CA 1.498 1.954 0 N-CA-C 113.383 0.883 . . . . 0.0 113.383 168.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.984 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 5.5 tp10 -43.96 -39.3 3.95 Favored 'General case' 0 CA--C 1.573 1.865 0 N-CA-C 115.548 1.684 . . . . 0.0 115.548 166.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 1.122 ' O ' ' HB2' ' A' ' 103' ' ' ARG . 66.5 mtt -83.05 -26.02 31.56 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 117.673 2.471 . . . . 0.0 117.673 174.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 41.1 tp -65.53 -54.94 20.95 Favored 'General case' 0 N--CA 1.499 1.979 0 CA-C-N 120.681 1.582 . . . . 0.0 112.13 169.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -78.29 -51.04 10.73 Favored 'General case' 0 N--CA 1.488 1.466 0 CA-C-N 119.269 0.941 . . . . 0.0 113.281 175.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.984 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 74.8 ttt180 -67.79 -46.43 71.98 Favored 'General case' 0 N--CA 1.488 1.442 0 N-CA-C 115.31 1.596 . . . . 0.0 115.31 177.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 1.122 ' HB2' ' O ' ' A' ' 99' ' ' MET . 58.1 mtt180 -65.09 -51.29 62.25 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 118.892 0.769 . . . . 0.0 111.97 165.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.38 42.66 1.14 Allowed Glycine 0 N--CA 1.482 1.758 0 N-CA-C 114.914 0.726 . . . . 0.0 114.914 167.102 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 41.4 p -97.5 142.65 29.08 Favored 'General case' 0 CA--C 1.559 1.315 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 169.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 29.2 m-20 -66.73 131.92 46.98 Favored 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 114.845 1.424 . . . . 0.0 114.845 -170.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 4.8 tp -84.75 102.89 11.35 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 C-N-CA 125.402 1.481 . . . . 0.0 108.144 175.563 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 55.1 t0 -99.33 -74.27 0.6 Allowed 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 115.369 -2.253 . . . . 0.0 108.412 167.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -137.93 124.94 21.37 Favored 'General case' 0 N--CA 1.494 1.726 0 CA-C-N 122.34 2.336 . . . . 0.0 114.908 -176.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 44.2 t -92.42 109.82 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 1 N-CA-C 98.854 -4.498 . . . . 0.0 98.854 162.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . 0.255 49.9 tp -118.17 111.6 19.05 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.446 -160.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -112.96 128.27 56.44 Favored 'General case' 0 CA--C 1.556 1.201 0 CA-C-O 122.39 1.09 . . . . 0.0 111.507 -171.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 10.2 m-85 -96.45 122.43 39.34 Favored 'General case' 0 CA--C 1.558 1.288 0 CA-C-N 113.612 -1.631 . . . . 0.0 109.853 -179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 76.8 ttt180 -85.58 96.43 9.65 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 112.931 -1.941 . . . . 0.0 110.158 169.394 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.4 p -137.74 147.11 26.45 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.626 0 C-N-CA 125.849 1.659 . . . . 0.0 109.217 -167.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 50.8 m -95.93 139.51 32.02 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 122.957 1.361 . . . . 0.0 113.883 -168.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -61.21 -37.64 83.74 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 112.794 -2.003 . . . . 0.0 115.883 173.623 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -49.5 -33.59 14.9 Favored 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 117.507 2.41 . . . . 0.0 117.507 177.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.1 t -63.45 -48.46 87.0 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.176 0 CA-C-N 119.883 1.219 . . . . 0.0 113.725 178.71 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 5.2 tp -64.97 -38.22 90.23 Favored 'General case' 0 CA--C 1.555 1.142 0 N-CA-C 114.838 1.422 . . . . 0.0 114.838 168.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 9.7 mp -64.09 -42.29 96.98 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 114.703 1.371 . . . . 0.0 114.703 175.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -68.3 -35.31 77.63 Favored 'General case' 0 N--CA 1.496 1.856 0 N-CA-C 114.76 1.392 . . . . 0.0 114.76 169.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.928 ' O ' ' HB3' ' A' ' 127' ' ' ARG . 32.2 ttm180 -56.0 -54.92 39.03 Favored 'General case' 0 N--CA 1.486 1.332 0 N-CA-C 115.305 1.594 . . . . 0.0 115.305 168.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 2.9 pp -70.31 -37.34 74.72 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 178.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 56.8 mtmt -63.9 -48.87 74.91 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 116.352 1.982 . . . . 0.0 116.352 170.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -107.71 63.99 0.27 Allowed Glycine 0 CA--C 1.542 1.754 0 CA-C-N 118.888 0.767 . . . . 0.0 112.405 172.254 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.928 ' HB3' ' O ' ' A' ' 123' ' ' ARG . 24.3 tpt180 -172.56 -85.19 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 -178.592 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -166.99 175.47 42.2 Favored Glycine 0 CA--C 1.57 3.502 0 CA-C-O 118.619 -1.1 . . . . 0.0 113.075 -179.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 88.8 mtt180 -154.09 -144.37 0.14 Allowed 'General case' 0 N--CA 1.498 1.929 0 CA-C-N 121.723 2.761 . . . . 0.0 112.6 -177.411 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -151.31 -25.74 0.2 Allowed 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 111.934 -2.394 . . . . 0.0 114.625 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 3.5 t70 81.1 -43.6 0.19 Allowed 'General case' 0 N--CA 1.504 2.235 0 N-CA-C 117.225 2.306 . . . . 0.0 117.225 -176.069 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -61.7 -30.09 70.53 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 162.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . 0.293 10.0 t -33.68 -51.3 0.38 Allowed 'General case' 0 N--CA 1.493 1.7 1 N-CA-C 122.045 4.091 . . . . 0.0 122.045 176.561 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.7 m-20 -65.98 -51.34 59.33 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 179.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -64.72 -34.29 77.97 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 116.02 1.859 . . . . 0.0 116.02 169.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 17.5 t -61.37 -41.45 89.89 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 C-N-CA 124.875 1.27 . . . . 0.0 113.605 169.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 34.5 mm -69.91 -35.96 67.0 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 CA-C-O 117.658 -1.163 . . . . 0.0 113.17 171.099 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 41.7 mt -62.34 -42.6 99.52 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-N 120.811 1.642 . . . . 0.0 114.313 169.307 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -63.15 -38.49 91.38 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 169.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 8.8 mmm180 -60.11 -35.5 75.37 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 166.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 64.1 mtt -68.63 -29.8 68.38 Favored 'General case' 0 CA--C 1.568 1.642 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 167.778 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 92.3 mttt -62.22 -51.42 67.82 Favored 'General case' 0 N--CA 1.492 1.638 0 CA-C-N 120.424 1.466 . . . . 0.0 114.889 168.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.7 p -64.18 -32.58 57.97 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 N-CA-C 114.643 1.349 . . . . 0.0 114.643 170.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 37.4 t80 -54.7 -50.38 68.43 Favored 'General case' 0 CA--C 1.579 2.066 0 CA-C-N 119.678 1.127 . . . . 0.0 111.965 167.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -58.55 -38.05 76.99 Favored 'General case' 0 CA--C 1.563 1.454 0 N-CA-C 118.401 2.741 . . . . 0.0 118.401 174.203 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -50.67 -33.95 24.6 Favored 'General case' 0 N--CA 1.505 2.278 0 N-CA-C 118.478 2.77 . . . . 0.0 118.478 172.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 66.0 mm-40 -130.3 -28.76 2.08 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 118.473 2.768 . . . . 0.0 118.473 -166.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 62.6 m -47.46 -33.61 6.37 Favored 'General case' 0 N--CA 1.504 2.225 0 N-CA-C 117.503 2.409 . . . . 0.0 117.503 -170.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -66.58 -61.93 4.56 Favored Pre-proline 0 CA--C 1.58 2.129 0 CA-C-O 115.97 -1.967 . . . . 0.0 112.207 171.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_exo -55.17 -31.24 74.9 Favored 'Trans proline' 0 CA--C 1.578 2.718 0 N-CA-C 119.302 2.77 . . . . 0.0 119.302 169.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -61.99 -56.42 19.24 Favored 'General case' 0 N--CA 1.496 1.828 0 C-N-CA 125.409 1.483 . . . . 0.0 111.842 169.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.981 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 42.3 tp -66.07 -23.12 66.46 Favored 'General case' 0 CA--C 1.562 1.435 0 CA-C-O 116.675 -1.631 . . . . 0.0 114.569 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 8.1 mm-40 -71.74 -47.36 54.28 Favored 'General case' 0 N--CA 1.488 1.462 0 CA-C-N 121.976 2.171 . . . . 0.0 112.084 165.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -66.75 -54.99 17.03 Favored 'General case' 0 CA--C 1.564 1.495 0 CA-C-N 120.613 1.551 . . . . 0.0 112.047 -176.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . 0.262 21.4 m-30 -81.94 -19.74 40.07 Favored 'General case' 0 CA--C 1.557 1.215 0 CA-C-O 114.69 -2.576 . . . . 0.0 112.456 178.566 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.981 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 43.5 ttt180 -66.24 -36.04 81.99 Favored 'General case' 0 N--CA 1.487 1.413 1 CA-C-N 126.28 4.127 . . . . 0.0 115.592 167.721 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -68.86 -38.2 79.58 Favored 'General case' 0 CA--C 1.576 1.962 0 CA-C-N 119.848 1.204 . . . . 0.0 113.917 166.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -90.45 -27.58 19.17 Favored 'General case' 0 CA--C 1.576 1.979 0 N-CA-C 119.14 3.015 . . . . 0.0 119.14 -176.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.0 pp -79.76 174.9 11.12 Favored 'General case' 0 N--CA 1.504 2.272 0 CA-C-N 122.773 2.533 . . . . 0.0 116.852 -164.727 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 37.8 tttp -127.38 131.56 50.32 Favored 'General case' 0 CA--C 1.559 1.298 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 168.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 31.5 m -94.93 148.86 21.87 Favored 'General case' 0 N--CA 1.494 1.768 0 CA-C-O 122.224 1.012 . . . . 0.0 112.639 -167.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 36.2 t -132.09 134.34 59.73 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.523 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 166.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.412 ' HB3' ' NH1' ' A' ' 174' ' ' ARG . 13.6 t70 -96.88 131.45 43.63 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 167.778 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -163.61 118.93 1.64 Allowed 'General case' 0 N--CA 1.48 1.026 0 N-CA-C 112.504 0.557 . . . . 0.0 112.504 -163.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.6 t -150.05 127.53 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 CA-C-O 118.257 -0.878 . . . . 0.0 109.345 173.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 77.84 -65.24 3.24 Favored Glycine 0 N--CA 1.484 1.852 0 N-CA-C 119.963 2.745 . . . . 0.0 119.963 166.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 5.8 t -72.79 118.83 16.2 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 112.419 -1.89 . . . . 0.0 111.59 -169.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 64.8 mtt -69.91 -59.61 2.82 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 113.759 1.022 . . . . 0.0 113.759 -170.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -66.93 -37.47 84.4 Favored 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 116.013 1.857 . . . . 0.0 116.013 -178.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -65.46 -45.35 84.06 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 114.253 1.205 . . . . 0.0 114.253 171.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 69.0 t -56.49 -41.86 73.81 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.345 0 CA-C-N 120.622 1.555 . . . . 0.0 113.847 172.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.539 ' CE1' ' HB3' ' A' ' 19' ' ' LYS . 29.3 t80 -57.99 -36.16 72.24 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 115.783 1.771 . . . . 0.0 115.783 167.204 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -61.03 -53.29 59.07 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-O 118.141 -0.933 . . . . 0.0 113.459 176.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.412 ' NH1' ' HB3' ' A' ' 163' ' ' ASP . 93.6 mtt180 -63.96 -32.09 73.5 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 118.206 2.669 . . . . 0.0 118.206 171.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.95 -47.31 87.02 Favored 'General case' 0 N--CA 1.485 1.319 0 N-CA-C 116.577 2.066 . . . . 0.0 116.577 170.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . 0.265 0.2 OUTLIER -71.06 -39.47 72.2 Favored 'General case' 0 N--CA 1.505 2.32 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 169.81 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -48.92 -39.46 26.23 Favored 'General case' 0 N--CA 1.499 2.003 0 N-CA-C 115.843 1.794 . . . . 0.0 115.843 168.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -69.51 -56.7 6.61 Favored 'General case' 0 CA--C 1.566 1.56 0 N-CA-C 112.817 0.673 . . . . 0.0 112.817 166.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -103.84 -56.18 2.25 Favored 'General case' 0 CA--C 1.563 1.462 0 N-CA-C 115.939 1.829 . . . . 0.0 115.939 -168.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.824 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -78.23 -37.08 29.27 Favored Glycine 0 CA--C 1.55 2.258 0 CA-C-N 121.308 1.867 . . . . 0.0 117.764 -169.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.824 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 86.1 tttt . . . . . 0 C--O 1.252 1.186 0 CA-C-N 118.073 0.936 . . . . 0.0 108.523 178.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 19.5 mmt . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 122.278 1.037 . . . . 0.0 111.209 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.457 ' NH1' ' HA2' ' A' ' 80' ' ' GLY 0.324 16.0 ttm-85 -147.25 144.64 29.01 Favored 'General case' 0 N--CA 1.479 1.021 0 N-CA-C 118.423 2.749 . . . . 0.0 118.423 -158.985 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 59.8 t -141.42 147.85 21.74 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.111 0 CA-C-O 123.951 1.834 . . . . 0.0 111.964 -171.355 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.6 mt -133.29 120.74 21.45 Favored 'General case' 0 CA--C 1.553 1.079 0 C-N-CA 126.949 2.099 . . . . 0.0 108.995 -175.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 13.0 tp -105.88 122.51 46.27 Favored 'General case' 0 CA--C 1.577 2.005 0 CA-C-O 123.202 1.477 . . . . 0.0 111.066 -168.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 10.7 mt -120.93 164.67 16.34 Favored 'General case' 0 CA--C 1.563 1.478 0 CA-C-N 110.607 -2.997 . . . . 0.0 112.742 -171.598 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 142.08 170.67 12.66 Favored Glycine 0 CA--C 1.562 2.984 0 CA-C-N 114.789 -1.096 . . . . 0.0 113.563 179.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -68.81 119.45 6.45 Favored 'Trans proline' 0 CA--C 1.579 2.761 0 CA-C-N 121.45 2.625 . . . . 0.0 110.145 170.035 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -79.57 112.26 2.92 Favored 'Trans proline' 0 CA--C 1.56 1.809 0 C-N-CA 122.511 2.141 . . . . 0.0 116.902 -165.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -172.69 -84.21 0.06 OUTLIER Glycine 0 CA--C 1.534 1.229 0 N-CA-C 107.96 -2.056 . . . . 0.0 107.96 168.087 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.15 143.47 35.41 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 175.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 1.065 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . 81.69 -176.04 54.17 Favored Glycine 0 CA--C 1.547 2.045 0 N-CA-C 115.297 0.879 . . . . 0.0 115.297 177.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 1.065 ' HB2' ' O ' ' A' ' 12' ' ' GLY . 45.7 mttt 94.59 -90.2 0.0 OUTLIER 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 113.256 0.836 . . . . 0.0 113.256 170.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -46.39 -40.26 10.8 Favored Glycine 0 CA--C 1.555 2.571 0 N-CA-C 120.939 3.136 . . . . 0.0 120.939 -179.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 1.7 m -52.82 -54.63 31.48 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-N 119.012 1.406 . . . . 0.0 114.359 169.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.25 0.0 OUTLIER -76.67 -17.12 59.32 Favored 'General case' 0 CA--C 1.575 1.927 0 CA-C-O 117.055 -1.45 . . . . 0.0 112.697 177.454 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.23 -44.18 65.83 Favored 'General case' 0 N--CA 1.49 1.534 0 CA-C-N 122.068 2.213 . . . . 0.0 114.629 167.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.9 p -66.13 -46.81 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 172.289 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.675 ' HB3' ' CE1' ' A' ' 172' ' ' PHE . 45.0 mmtm -54.9 -46.74 74.87 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 169.574 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 12.5 tp -70.33 -27.76 64.62 Favored 'General case' 0 CA--C 1.573 1.863 0 N-CA-C 114.048 1.129 . . . . 0.0 114.048 175.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -66.15 -39.06 89.53 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 114.688 1.366 . . . . 0.0 114.688 166.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -58.78 -43.35 90.41 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 117.31 -1.328 . . . . 0.0 114.131 166.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.1 mttm -68.12 -46.83 69.8 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 116.455 2.02 . . . . 0.0 116.455 173.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.0 mt -82.54 -26.63 32.27 Favored 'General case' 0 CA--C 1.574 1.893 0 N-CA-C 117.092 2.256 . . . . 0.0 117.092 -177.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.06 43.47 7.11 Favored Glycine 0 CA--C 1.555 2.557 0 N-CA-C 117.378 1.711 . . . . 0.0 117.378 -173.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 22.2 mm -114.62 157.98 41.43 Favored Pre-proline 0 CA--C 1.57 1.716 0 C-N-CA 124.551 1.14 . . . . 0.0 113.8 -168.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.468 ' HG2' HD22 ' A' ' 74' ' ' ASN . 34.9 Cg_exo -76.3 103.18 1.7 Allowed 'Trans proline' 0 C--N 1.376 2.008 0 CA-C-N 121.582 1.601 . . . . 0.0 111.453 159.138 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.47 107.02 10.81 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.237 -0.914 . . . . 0.0 109.052 168.156 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 13.7 mm -99.17 112.0 30.21 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.977 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 -178.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.3 t -96.44 127.35 42.35 Favored 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 106.413 -1.699 . . . . 0.0 106.413 169.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 42.5 p -69.96 -10.55 58.98 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 116.802 2.149 . . . . 0.0 116.802 -175.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -83.76 -23.2 53.85 Favored Glycine 0 CA--C 1.545 1.912 0 N-CA-C 118.642 2.217 . . . . 0.0 118.642 166.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -80.52 -51.9 8.24 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 114.714 1.375 . . . . 0.0 114.714 -168.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -64.09 -39.21 93.57 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 174.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.447 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 13.5 m-85 -68.16 -42.19 80.42 Favored 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 114.995 1.48 . . . . 0.0 114.995 172.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 29.2 ttp180 -57.33 -41.62 80.33 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-N 120.467 1.485 . . . . 0.0 114.073 167.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.2 ttt180 -58.88 -39.21 80.74 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 168.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 68.7 m-80 -67.18 -27.8 67.57 Favored 'General case' 0 CA--C 1.577 1.988 0 N-CA-C 115.349 1.611 . . . . 0.0 115.349 167.198 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 97.4 mt -63.03 -45.51 98.64 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 CA-C-N 120.476 1.489 . . . . 0.0 111.403 168.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -66.86 -38.04 85.6 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 120.086 1.312 . . . . 0.0 114.285 173.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -67.85 -40.26 83.71 Favored 'General case' 0 CA--C 1.56 1.356 0 N-CA-C 116.339 1.977 . . . . 0.0 116.339 174.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.82 69.36 1.19 Allowed Glycine 0 CA--C 1.545 1.909 0 CA-C-O 118.379 -1.234 . . . . 0.0 114.645 -177.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.855 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 70.8 p -91.58 -49.1 6.48 Favored 'General case' 0 N--CA 1.5 2.025 0 CA-C-N 118.781 1.29 . . . . 0.0 114.341 176.21 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.855 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.255 74.2 mttt 105.96 -41.64 0.0 OUTLIER 'General case' 0 CA--C 1.569 1.705 0 CA-C-O 116.331 -1.795 . . . . 0.0 111.212 -172.181 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -81.3 -13.63 58.22 Favored 'General case' 0 CA--C 1.57 1.717 0 CA-C-N 123.117 2.689 . . . . 0.0 113.231 163.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.53 -55.03 32.26 Favored Glycine 0 C--N 1.354 1.529 0 CA-C-N 120.534 1.515 . . . . 0.0 115.2 169.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.28 8.7 p -76.42 -47.83 28.95 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.474 0 N-CA-C 115.909 1.818 . . . . 0.0 115.909 -169.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 38.0 mt-10 -64.94 -47.42 77.73 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 121.291 1.859 . . . . 0.0 112.957 172.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.19 -31.03 69.35 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 -179.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.447 ' HB2' ' HB3' ' A' ' 35' ' ' PHE . 2.0 tptm -69.7 -36.82 76.28 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 114.248 1.203 . . . . 0.0 114.248 168.045 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.572 ' HG2' ' O ' ' A' ' 51' ' ' ARG . 29.0 ttt180 -74.48 -52.5 11.78 Favored 'General case' 0 CA--C 1.59 2.487 1 CA-C-O 85.183 -16.627 . . . . 0.0 117.991 -178.378 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 18.5 m-30 -30.41 -55.55 0.19 Allowed 'General case' 0 N--CA 1.493 1.717 1 O-C-N 108.661 -8.774 . . . . 0.0 121.6 146.736 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 26.5 mt -61.43 -44.01 97.88 Favored 'General case' 0 CA--C 1.572 1.789 0 CA-C-N 123.455 2.843 . . . . 0.0 114.489 167.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -76.08 -41.68 49.71 Favored 'General case' 0 CA--C 1.568 1.661 0 N-CA-C 116.297 1.962 . . . . 0.0 116.297 176.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -86.45 -33.49 20.38 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 175.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.66 38.12 3.77 Favored Glycine 0 CA--C 1.54 1.607 0 CA-C-N 121.112 1.778 . . . . 0.0 116.521 169.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.7 t70 -101.48 -132.44 0.27 Allowed 'General case' 0 CA--C 1.571 1.773 0 CA-C-O 118.589 -0.72 . . . . 0.0 109.374 169.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.8 pp -120.87 123.5 42.69 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 120.007 1.276 . . . . 0.0 111.491 -169.517 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.49 HG12 HH22 ' A' ' 88' ' ' ARG . 6.1 p -120.71 133.69 24.12 Favored Pre-proline 0 CA--C 1.574 1.893 0 CA-C-O 117.782 -1.104 . . . . 0.0 109.883 -176.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -59.47 148.56 86.45 Favored 'Trans proline' 0 CA--C 1.561 1.829 0 C-N-CA 123.447 2.764 . . . . 0.0 116.505 174.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 88.0 p -80.61 -35.81 33.57 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 117.314 2.338 . . . . 0.0 117.314 -175.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -71.76 -51.6 21.87 Favored 'General case' 0 N--CA 1.508 2.473 0 N-CA-C 114.004 1.113 . . . . 0.0 114.004 -171.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.8 pp -54.51 -42.0 70.29 Favored 'General case' 0 CA--C 1.564 1.496 0 N-CA-C 117.521 2.415 . . . . 0.0 117.521 171.252 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.0 m -61.19 -48.31 82.12 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 123.905 0.882 . . . . 0.0 113.282 172.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -67.04 -19.76 65.73 Favored 'General case' 0 CA--C 1.572 1.817 0 N-CA-C 115.633 1.716 . . . . 0.0 115.633 169.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 22.1 mt-10 -75.17 -42.37 56.02 Favored 'General case' 0 CA--C 1.555 1.152 0 CA-C-N 121.116 1.78 . . . . 0.0 115.128 170.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 6.1 mt -61.53 -47.29 86.23 Favored 'General case' 0 N--CA 1.499 1.992 0 N-CA-C 114.618 1.34 . . . . 0.0 114.618 168.247 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -54.24 -48.42 66.9 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 114.115 1.154 . . . . 0.0 114.115 169.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 18.6 t70 -61.94 -36.17 80.62 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 115.873 1.805 . . . . 0.0 115.873 171.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -55.54 -42.03 74.04 Favored 'General case' 0 N--CA 1.488 1.472 0 CA-C-O 117.95 -1.024 . . . . 0.0 113.611 169.28 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 88.2 mtt-85 -81.14 -21.82 39.49 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 118.112 2.634 . . . . 0.0 118.112 168.395 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 7.0 mp -89.3 7.69 34.32 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 118.331 2.715 . . . . 0.0 118.331 172.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 96.6 m-20 -68.67 4.76 1.28 Allowed 'General case' 0 CA--C 1.585 2.317 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 163.166 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.468 HD22 ' HG2' ' A' ' 27' ' ' PRO 0.293 49.7 p30 -44.33 -156.67 0.0 OUTLIER Pre-proline 0 CA--C 1.594 2.639 0 N-CA-C 120.842 3.645 . . . . 0.0 120.842 164.192 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.413 ' HD2' ' HB2' ' A' ' 74' ' ' ASN . 15.2 Cg_exo -40.2 25.74 0.0 OUTLIER 'Trans proline' 0 N--CA 1.515 2.747 2 C-N-CA 127.699 5.599 . . . . 0.0 125.586 163.193 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 15.6 t70 61.85 27.69 16.89 Favored 'General case' 0 CA--C 1.582 2.197 0 C-N-CA 125.538 1.535 . . . . 0.0 109.154 -160.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 58.61 33.61 23.22 Favored 'General case' 0 CA--C 1.578 2.028 0 CA-C-N 120.952 1.705 . . . . 0.0 112.452 -165.75 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.83 -39.52 92.11 Favored 'General case' 0 C--N 1.38 1.899 0 CA-C-N 121.689 2.041 . . . . 0.0 115.73 176.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 23.6 p30 -74.24 -25.11 59.45 Favored 'General case' 0 CA--C 1.566 1.576 0 N-CA-C 116.488 2.033 . . . . 0.0 116.488 169.269 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.457 ' HA2' ' NH1' ' A' ' 2' ' ' ARG . . . 130.95 -167.71 22.21 Favored Glycine 0 C--N 1.36 1.884 0 CA-C-O 125.52 2.733 . . . . 0.0 113.776 -168.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.405 ' CZ ' ' HD3' ' A' ' 2' ' ' ARG . 21.7 p90 -169.72 135.5 1.49 Allowed 'General case' 0 CA--C 1.56 1.362 0 CA-C-N 109.039 -3.581 . . . . 0.0 105.975 169.382 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 13.9 mt -106.79 106.32 20.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.735 0 N-CA-C 105.192 -2.151 . . . . 0.0 105.192 173.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.3 mt -108.03 114.59 28.61 Favored 'General case' 0 N--CA 1.495 1.781 0 CA-C-O 118.262 -0.875 . . . . 0.0 110.069 -176.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 38.5 t0 -106.77 125.28 50.8 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 119.467 1.031 . . . . 0.0 110.632 179.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 75.19 28.38 62.24 Favored Glycine 0 CA--C 1.551 2.293 0 N-CA-C 118.377 2.111 . . . . 0.0 118.377 177.37 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 2.2 t80 -88.81 -55.0 0.32 Allowed Pre-proline 0 N--CA 1.496 1.865 0 CA-C-O 115.234 -2.317 . . . . 0.0 107.264 168.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -67.56 66.51 0.79 Allowed 'Trans proline' 0 CA--C 1.574 2.475 0 N-CA-C 118.381 2.416 . . . . 0.0 118.381 166.349 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.49 HH22 HG12 ' A' ' 59' ' ' VAL . 8.0 tmm_? -76.41 -20.39 57.17 Favored 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 115.805 1.78 . . . . 0.0 115.805 167.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.491 ' HA ' ' HG3' ' A' ' 147' ' ' GLU . 28.3 t -153.54 127.56 8.98 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 104.197 -2.52 . . . . 0.0 104.197 -167.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . 0.302 5.8 p -61.3 -27.18 41.34 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.968 0 CA-C-O 116.387 -1.768 . . . . 0.0 113.017 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -70.61 -32.6 70.01 Favored 'General case' 0 C--N 1.362 1.132 0 N-CA-C 119.631 3.197 . . . . 0.0 119.631 165.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 5.2 mm100 -74.04 -49.95 21.93 Favored 'General case' 0 CA--C 1.588 2.405 0 CA-C-N 124.391 3.269 . . . . 0.0 111.493 166.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -53.99 -28.02 35.3 Favored 'General case' 0 N--CA 1.488 1.434 0 N-CA-C 118.319 2.711 . . . . 0.0 118.319 178.102 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 32.2 tttp -57.18 -30.35 64.43 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 115.878 1.807 . . . . 0.0 115.878 168.74 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.56 -44.79 81.35 Favored 'General case' 0 CA--C 1.57 1.731 0 N-CA-C 114.206 1.187 . . . . 0.0 114.206 168.218 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 8.9 tp -62.2 -35.57 79.28 Favored 'General case' 0 CA--C 1.573 1.837 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 169.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 13.3 t60 -64.45 -43.8 93.12 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 119.651 1.114 . . . . 0.0 113.175 167.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 1.156 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 0.5 OUTLIER -54.94 -30.61 59.18 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 166.696 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 1.346 ' O ' ' HB2' ' A' ' 103' ' ' ARG . 47.3 mtt -85.28 -33.71 22.08 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 118.946 2.943 . . . . 0.0 118.946 172.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.5 tt -69.51 -54.11 15.78 Favored 'General case' 0 N--CA 1.504 2.27 0 CA-C-N 121.372 1.897 . . . . 0.0 110.906 172.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 64.8 mt-10 -78.15 -49.41 13.9 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-O 117.662 -1.161 . . . . 0.0 114.065 175.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 1.156 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 93.0 mtt180 -75.08 -39.67 60.6 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 177.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 1.346 ' HB2' ' O ' ' A' ' 99' ' ' MET . 32.8 mmt180 -64.36 -54.36 34.07 Favored 'General case' 0 N--CA 1.491 1.597 0 CA-C-N 120.123 1.329 . . . . 0.0 111.538 165.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.3 50.74 0.7 Allowed Glycine 0 N--CA 1.485 1.938 0 O-C-N 123.836 0.71 . . . . 0.0 113.957 168.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 6.0 p -92.65 169.05 10.81 Favored 'General case' 0 CA--C 1.566 1.562 0 CA-C-N 113.188 -1.506 . . . . 0.0 110.247 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -72.42 133.24 44.78 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.1 -1.0 . . . . 0.0 110.72 -174.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 7.8 tp -102.21 98.44 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 177.474 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -98.32 -77.45 0.51 Allowed 'General case' 0 N--CA 1.489 1.502 0 CA-C-O 116.218 -1.849 . . . . 0.0 107.866 168.055 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -152.46 130.55 11.88 Favored 'General case' 0 C--N 1.362 1.149 0 CA-C-N 121.665 2.03 . . . . 0.0 113.94 -169.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 24.1 t -92.72 110.96 23.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 N-CA-C 103.497 -2.779 . . . . 0.0 103.497 162.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.455 HD23 ' HB3' ' A' ' 160' ' ' LYS . 89.4 mt -96.6 95.65 8.11 Favored 'General case' 0 N--CA 1.482 1.173 0 CA-C-N 114.617 -1.174 . . . . 0.0 109.478 -172.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -88.98 123.95 33.79 Favored 'General case' 0 N--CA 1.492 1.652 0 CA-C-O 121.173 0.511 . . . . 0.0 111.608 177.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 4.1 m-30 -90.93 124.07 34.91 Favored 'General case' 0 CA--C 1.559 1.289 0 CA-C-O 123.16 1.457 . . . . 0.0 110.915 -176.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 17.0 tpt180 -85.37 97.35 9.94 Favored 'General case' 0 CA--C 1.555 1.168 0 CA-C-N 112.412 -2.177 . . . . 0.0 108.391 167.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.1 p -134.46 133.49 54.92 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 CA-C-N 113.477 -1.692 . . . . 0.0 107.455 -168.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 6.1 m -74.92 138.98 42.75 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.432 -175.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 5.2 mm-40 -64.97 -26.63 68.38 Favored 'General case' 0 N--CA 1.49 1.566 0 N-CA-C 115.282 1.586 . . . . 0.0 115.282 175.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -52.46 -45.69 66.2 Favored 'General case' 0 CA--C 1.563 1.469 0 CA-C-N 121.704 2.047 . . . . 0.0 114.998 167.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.5 t -65.22 -44.89 95.1 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.191 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 173.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -51.25 -45.14 61.91 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 124.792 1.237 . . . . 0.0 114.123 168.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 8.1 mp -61.58 -37.58 84.39 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 169.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -56.61 -43.66 80.38 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 167.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 86.5 mmt-85 -56.35 -50.75 70.6 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 115.477 1.658 . . . . 0.0 115.477 168.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -52.56 -48.38 66.2 Favored 'General case' 0 N--CA 1.499 2.006 0 N-CA-C 115.434 1.642 . . . . 0.0 115.434 169.533 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -59.07 -43.64 91.77 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 117.249 2.315 . . . . 0.0 117.249 173.685 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -96.26 54.13 1.55 Allowed Glycine 0 CA--C 1.547 2.036 0 N-CA-C 114.979 0.752 . . . . 0.0 114.979 172.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 75.4 mtp85 -150.35 115.14 5.28 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 171.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.597 ' O ' ' CB ' ' A' ' 129' ' ' ARG . . . -78.23 -178.86 49.94 Favored Glycine 0 CA--C 1.572 3.62 0 N-CA-C 116.072 1.189 . . . . 0.0 116.072 -169.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.597 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 33.4 ttm180 101.9 126.48 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 120.93 2.365 . . . . 0.0 109.54 -173.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -68.08 -35.4 78.12 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 117.0 2.222 . . . . 0.0 117.0 -175.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -136.67 58.94 1.71 Allowed 'General case' 0 N--CA 1.496 1.826 0 CA-C-N 120.833 1.652 . . . . 0.0 113.653 -179.076 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -122.67 61.3 1.0 Allowed 'General case' 0 N--CA 1.497 1.895 0 N-CA-C 103.241 -2.874 . . . . 0.0 103.241 158.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 82.7 p -143.0 -115.39 0.1 Allowed 'General case' 0 N--CA 1.483 1.196 0 CA-C-N 113.707 -1.588 . . . . 0.0 110.103 -160.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -59.13 -41.38 88.1 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 117.125 2.268 . . . . 0.0 117.125 -169.165 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -75.07 -36.06 61.79 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 115.518 1.673 . . . . 0.0 115.518 177.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.4 t -64.38 -40.59 89.61 Favored 'Isoleucine or valine' 0 CA--C 1.569 1.68 0 CA-C-O 117.582 -1.199 . . . . 0.0 111.571 169.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.7 tp -74.29 -30.06 25.8 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 CA-C-N 120.503 1.501 . . . . 0.0 113.879 174.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 31.3 mt -63.88 -46.46 84.83 Favored 'General case' 0 N--CA 1.494 1.749 0 CA-C-N 121.139 1.79 . . . . 0.0 113.332 168.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 44.5 t30 -61.96 -40.32 95.16 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 172.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 79.6 mtm180 -62.48 -37.31 85.48 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 115.362 1.616 . . . . 0.0 115.362 168.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 57.8 mtt -67.93 -29.51 68.6 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 168.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 14.3 mptt -63.56 -50.69 68.53 Favored 'General case' 0 N--CA 1.491 1.598 0 CA-C-N 120.412 1.46 . . . . 0.0 114.377 168.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.1 p -65.79 -33.08 61.21 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.221 0 N-CA-C 114.743 1.386 . . . . 0.0 114.743 170.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 9.8 t80 -57.2 -47.0 82.38 Favored 'General case' 0 CA--C 1.583 2.214 0 CA-C-N 119.994 1.27 . . . . 0.0 112.032 168.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 71.1 ttt180 -61.77 -54.08 47.18 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 117.445 2.387 . . . . 0.0 117.445 177.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -51.49 -43.81 62.32 Favored 'General case' 0 N--CA 1.504 2.272 0 N-CA-C 116.922 2.193 . . . . 0.0 116.922 174.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.491 ' HG3' ' HA ' ' A' ' 89' ' ' SER . 32.9 mm-40 -98.84 -42.3 7.24 Favored 'General case' 0 N--CA 1.484 1.252 0 N-CA-C 116.487 2.032 . . . . 0.0 116.487 -167.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 97.8 m -50.76 -33.38 22.95 Favored 'General case' 0 N--CA 1.502 2.154 0 N-CA-C 117.427 2.38 . . . . 0.0 117.427 -167.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.444 ' HB3' ' HD3' ' A' ' 150' ' ' PRO . . . -71.04 -61.38 2.34 Favored Pre-proline 0 CA--C 1.583 2.212 0 CA-C-O 115.83 -2.033 . . . . 0.0 111.844 169.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.444 ' HD3' ' HB3' ' A' ' 149' ' ' ALA . 75.7 Cg_exo -54.31 -37.02 88.56 Favored 'Trans proline' 0 CA--C 1.58 2.796 0 C-N-CA 123.625 2.883 . . . . 0.0 119.3 169.668 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -61.14 -53.27 59.11 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 126.193 1.797 . . . . 0.0 111.58 171.536 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 1.113 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 45.3 tp -64.32 -20.73 66.28 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 115.378 1.621 . . . . 0.0 115.378 174.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -71.6 -50.4 31.25 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 122.436 2.38 . . . . 0.0 112.667 164.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -65.05 -53.16 50.04 Favored 'General case' 0 CA--C 1.568 1.658 0 CA-C-N 120.106 1.321 . . . . 0.0 112.432 -179.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -74.87 -29.23 60.95 Favored 'General case' 0 CA--C 1.552 1.032 0 CA-C-O 115.178 -2.344 . . . . 0.0 113.491 176.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 1.113 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 34.7 ttt180 -60.95 -36.42 79.33 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 124.535 3.334 . . . . 0.0 116.389 169.501 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -67.72 -36.49 80.7 Favored 'General case' 0 CA--C 1.575 1.935 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 166.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 47.1 mt-30 -86.87 -29.5 22.14 Favored 'General case' 0 CA--C 1.577 2.001 0 N-CA-C 119.43 3.122 . . . . 0.0 119.43 -178.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.1 pp -80.4 176.64 9.59 Favored 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 119.673 3.212 . . . . 0.0 119.673 -160.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.455 ' HB3' HD23 ' A' ' 111' ' ' LEU . 6.0 tmtt? -131.0 135.25 47.44 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 104.062 -2.57 . . . . 0.0 104.062 166.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 83.0 m -97.06 148.88 22.56 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.991 -1.068 . . . . 0.0 109.666 -174.745 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 34.3 t -130.38 138.18 54.44 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.442 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 168.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 20.6 t70 -91.14 136.8 32.84 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 169.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -160.26 99.89 1.34 Allowed 'General case' 0 N--CA 1.481 1.085 0 CA-C-O 121.711 0.767 . . . . 0.0 111.516 -163.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.3 t -149.92 126.77 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.441 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 -176.989 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.14 -69.83 3.04 Favored Glycine 0 N--CA 1.482 1.731 0 N-CA-C 117.471 1.748 . . . . 0.0 117.471 168.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 44.5 p -81.23 138.28 35.79 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 112.139 -2.03 . . . . 0.0 111.628 -169.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 53.9 mtt -88.39 -58.05 2.7 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 118.742 -0.647 . . . . 0.0 111.807 175.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -69.57 -37.48 76.99 Favored 'General case' 0 N--CA 1.5 2.068 0 N-CA-C 116.112 1.893 . . . . 0.0 116.112 -177.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.576 ' HB3' HH21 ' A' ' 174' ' ' ARG . 46.8 mt-10 -64.39 -47.7 78.25 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 119.491 1.041 . . . . 0.0 113.635 169.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 99.8 t -58.92 -36.65 62.68 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.206 0 CA-C-N 119.399 0.999 . . . . 0.0 113.543 173.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.675 ' CE1' ' HB3' ' A' ' 19' ' ' LYS . 43.0 t80 -57.34 -36.65 71.44 Favored 'General case' 0 N--CA 1.5 2.031 0 N-CA-C 115.943 1.831 . . . . 0.0 115.943 164.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.43 -54.43 32.72 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 175.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.576 HH21 ' HB3' ' A' ' 170' ' ' GLU . 9.7 ptp180 -66.36 -26.06 67.1 Favored 'General case' 0 N--CA 1.492 1.625 0 N-CA-C 117.588 2.44 . . . . 0.0 117.588 170.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.93 -41.93 95.1 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 120.06 1.3 . . . . 0.0 114.211 167.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 4.5 mp -60.08 -46.14 90.56 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-O 118.265 -0.874 . . . . 0.0 113.035 166.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.433 ' HB2' ' HA ' ' A' ' 174' ' ' ARG . 26.3 mtp180 -51.52 -45.61 62.97 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 116.756 2.132 . . . . 0.0 116.756 169.182 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -59.32 -49.05 79.3 Favored 'General case' 0 CA--C 1.558 1.27 0 N-CA-C 116.309 1.966 . . . . 0.0 116.309 171.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -84.19 -61.34 1.83 Allowed 'General case' 0 CA--C 1.564 1.515 0 CA-C-O 117.781 -1.104 . . . . 0.0 112.326 -177.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.958 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -101.45 -56.62 0.86 Allowed Glycine 0 CA--C 1.551 2.296 0 CA-C-N 120.523 1.51 . . . . 0.0 114.937 -177.092 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.958 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 57.5 tttp . . . . . 0 C--O 1.251 1.132 0 CA-C-N 120.003 1.902 . . . . 0.0 109.195 -176.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.3 mtt . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.456 ' HB2' ' O ' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -149.68 172.97 14.2 Favored 'General case' 0 N--CA 1.485 1.293 0 N-CA-C 116.613 2.079 . . . . 0.0 116.613 -168.024 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 54.7 t -134.25 156.04 40.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 CA-C-O 123.474 1.607 . . . . 0.0 112.802 -162.558 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . 0.259 0.0 OUTLIER -140.77 132.19 26.84 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-N 113.936 -1.484 . . . . 0.0 110.091 167.038 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 1.099 HD21 ' HB3' ' A' ' 13' ' ' LYS . 23.8 tp -99.56 126.37 45.52 Favored 'General case' 0 CA--C 1.573 1.849 0 CA-C-O 123.132 1.444 . . . . 0.0 112.121 -167.666 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 14.3 mt -116.51 153.03 32.89 Favored 'General case' 0 CA--C 1.559 1.305 0 CA-C-N 109.921 -3.309 . . . . 0.0 109.898 -177.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -179.38 108.26 0.24 Allowed Glycine 0 CA--C 1.547 2.036 0 CA-C-O 117.029 -1.984 . . . . 0.0 113.289 -178.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -57.45 175.41 0.39 Allowed 'Trans proline' 0 CA--C 1.579 2.725 0 CA-C-N 121.926 2.863 . . . . 0.0 115.689 168.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 84.5 Cg_exo -47.97 114.76 1.21 Allowed 'Trans proline' 0 CA--C 1.561 1.862 0 C-N-CA 123.94 3.093 . . . . 0.0 116.905 -174.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 160.21 89.86 0.07 OUTLIER Glycine 0 CA--C 1.539 1.57 0 N-CA-C 110.307 -1.117 . . . . 0.0 110.307 -169.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 64.02 -111.6 0.31 Allowed 'General case' 0 N--CA 1.495 1.79 0 C-N-CA 124.951 1.3 . . . . 0.0 114.068 173.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 165.55 118.98 0.46 Allowed Glycine 0 CA--C 1.543 1.803 0 CA-C-N 120.065 1.302 . . . . 0.0 110.438 -171.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 1.099 ' HB3' HD21 ' A' ' 5' ' ' LEU . 0.5 OUTLIER -86.43 10.34 15.43 Favored 'General case' 0 N--CA 1.497 1.92 0 N-CA-C 118.826 2.898 . . . . 0.0 118.826 -169.02 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -55.76 -24.46 40.87 Favored Glycine 0 CA--C 1.561 2.928 0 N-CA-C 118.972 2.349 . . . . 0.0 118.972 168.029 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 16.6 m -63.07 -56.22 18.8 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-N 119.378 1.589 . . . . 0.0 113.331 170.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.48 ' HA ' ' HB2' ' A' ' 19' ' ' LYS 0.286 1.8 mp0 -77.82 -12.29 59.96 Favored 'General case' 0 CA--C 1.571 1.78 0 CA-C-O 115.695 -2.098 . . . . 0.0 112.804 173.54 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.53 -46.83 45.29 Favored 'General case' 0 C--N 1.375 1.697 0 CA-C-N 123.831 3.014 . . . . 0.0 113.744 167.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 46.7 t -67.2 -38.24 80.68 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.995 0 CA-C-N 119.772 1.169 . . . . 0.0 111.893 173.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.48 ' HB2' ' HA ' ' A' ' 16' ' ' GLN . 18.9 mmmt -57.42 -54.34 47.88 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 116.38 1.993 . . . . 0.0 116.38 169.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 15.7 tp -65.09 -29.55 70.43 Favored 'General case' 0 CA--C 1.575 1.924 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 174.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -65.48 -39.13 91.59 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 167.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.6 mm-40 -61.03 -36.05 78.51 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 114.342 1.238 . . . . 0.0 114.342 166.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 23.2 mmmt -65.21 -51.63 59.81 Favored 'General case' 0 N--CA 1.492 1.627 0 N-CA-C 115.431 1.641 . . . . 0.0 115.431 169.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.4 mt -85.15 -25.55 27.39 Favored 'General case' 0 CA--C 1.571 1.751 0 N-CA-C 116.931 2.197 . . . . 0.0 116.931 -174.445 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.04 37.86 7.61 Favored Glycine 0 CA--C 1.554 2.525 0 N-CA-C 117.694 1.838 . . . . 0.0 117.694 -174.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.2 mm -105.21 155.95 36.98 Favored Pre-proline 0 CA--C 1.569 1.681 0 CA-C-N 119.26 1.53 . . . . 0.0 113.281 -168.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -80.64 99.06 1.11 Allowed 'Trans proline' 0 CA--C 1.567 2.125 0 CA-C-N 122.426 1.902 . . . . 0.0 109.549 162.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -72.18 112.47 8.29 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.923 -0.486 . . . . 0.0 110.108 177.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 12.8 mm -98.67 104.26 15.75 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.105 0 N-CA-C 105.634 -1.987 . . . . 0.0 105.634 179.488 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 41.7 t -98.77 127.88 44.83 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 105.968 -1.864 . . . . 0.0 105.968 167.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 37.9 p -67.64 -18.73 65.06 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 117.41 2.374 . . . . 0.0 117.41 -168.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -82.88 -18.66 64.91 Favored Glycine 0 CA--C 1.548 2.126 0 N-CA-C 118.667 2.227 . . . . 0.0 118.667 167.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -78.96 -53.6 6.88 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-N 119.009 1.404 . . . . 0.0 114.189 -169.497 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -65.16 -38.02 89.23 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 114.119 1.155 . . . . 0.0 114.119 174.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.47 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 15.3 m-85 -64.54 -38.53 91.32 Favored 'General case' 0 CA--C 1.559 1.304 0 N-CA-C 115.58 1.696 . . . . 0.0 115.58 168.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 49.0 ttp180 -58.6 -41.68 86.39 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 119.929 1.241 . . . . 0.0 114.273 167.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 13.5 tpt180 -60.65 -41.28 94.67 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 168.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 60.9 m-80 -69.08 -24.31 64.13 Favored 'General case' 0 CA--C 1.579 2.059 0 N-CA-C 115.268 1.581 . . . . 0.0 115.268 169.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 65.6 mt -63.69 -47.98 88.71 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.134 0 CA-C-N 120.245 1.384 . . . . 0.0 110.97 167.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -65.63 -36.7 84.45 Favored 'General case' 0 N--CA 1.491 1.612 0 N-CA-C 114.341 1.238 . . . . 0.0 114.341 174.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -66.46 -42.74 87.1 Favored 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 115.98 1.844 . . . . 0.0 115.98 173.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.79 69.44 1.06 Allowed Glycine 0 CA--C 1.543 1.829 0 CA-C-O 118.607 -1.107 . . . . 0.0 114.101 -178.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.86 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 73.3 p -93.33 -48.74 6.28 Favored 'General case' 0 N--CA 1.499 2.013 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 179.375 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.86 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.253 74.6 mttt 106.17 -41.37 0.0 OUTLIER 'General case' 0 CA--C 1.572 1.818 0 CA-C-O 116.455 -1.736 . . . . 0.0 111.29 -172.607 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.401 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -81.88 -14.14 56.61 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-N 122.955 2.616 . . . . 0.0 112.895 163.789 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -61.54 -55.64 27.69 Favored Glycine 0 C--N 1.352 1.438 0 CA-C-N 120.287 1.403 . . . . 0.0 114.864 170.654 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.297 7.4 p -76.32 -50.41 22.31 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.444 0 N-CA-C 115.883 1.808 . . . . 0.0 115.883 -168.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.4 mt-10 -66.71 -45.94 77.14 Favored 'General case' 0 N--CA 1.489 1.498 0 CA-C-N 121.127 1.785 . . . . 0.0 112.922 173.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' A' ' 45' ' ' LEU . . . -71.47 -27.42 63.23 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 114.935 1.457 . . . . 0.0 114.935 -178.031 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.47 ' HB2' ' HB3' ' A' ' 35' ' ' PHE . 1.3 tmtp? -72.53 -41.97 65.26 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 117.302 -1.333 . . . . 0.0 112.946 166.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.594 ' O ' ' CG ' ' A' ' 51' ' ' ARG . 32.4 ttt180 -71.2 -51.77 22.86 Favored 'General case' 0 CA--C 1.586 2.342 1 CA-C-O 85.232 -16.604 . . . . 0.0 118.623 -174.139 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -34.58 -62.53 0.34 Allowed 'General case' 0 N--CA 1.494 1.732 1 O-C-N 108.992 -8.567 . . . . 0.0 121.129 146.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.5 tp -57.01 -29.47 63.36 Favored 'General case' 0 CA--C 1.582 2.206 0 CA-C-N 122.012 2.187 . . . . 0.0 116.223 171.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -92.58 -39.45 11.33 Favored 'General case' 0 CA--C 1.568 1.672 0 C-N-CA 126.738 2.015 . . . . 0.0 116.27 170.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -87.08 -27.88 22.88 Favored 'General case' 0 N--CA 1.496 1.864 0 N-CA-C 116.874 2.176 . . . . 0.0 116.874 -176.425 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 109.75 22.01 6.87 Favored Glycine 0 CA--C 1.542 1.733 0 N-CA-C 118.588 2.195 . . . . 0.0 118.588 167.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -100.28 -132.23 0.25 Allowed 'General case' 0 CA--C 1.57 1.746 0 CA-C-N 118.935 1.367 . . . . 0.0 110.045 173.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 89.2 mt -116.17 119.31 35.39 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 119.916 1.235 . . . . 0.0 110.874 -168.748 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.491 HG12 HH12 ' A' ' 88' ' ' ARG . 13.2 p -121.37 136.48 25.88 Favored Pre-proline 0 CA--C 1.573 1.846 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.322 176.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 44.0 Cg_exo -61.08 150.01 86.37 Favored 'Trans proline' 0 CA--C 1.561 1.857 0 C-N-CA 123.136 2.557 . . . . 0.0 115.275 169.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 8.1 t -83.85 -33.88 24.75 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -64.0 -44.91 91.22 Favored 'General case' 0 N--CA 1.501 2.107 0 N-CA-C 115.284 1.587 . . . . 0.0 115.284 -174.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.3 pp -56.76 -43.63 80.98 Favored 'General case' 0 CA--C 1.562 1.425 0 N-CA-C 117.09 2.255 . . . . 0.0 117.09 169.573 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.5 m -61.77 -46.21 90.54 Favored 'General case' 0 N--CA 1.492 1.675 0 C-N-CA 123.834 0.854 . . . . 0.0 113.013 174.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.45 -23.63 67.35 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 115.835 1.791 . . . . 0.0 115.835 167.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -74.26 -45.74 45.9 Favored 'General case' 0 CA--C 1.55 0.979 0 N-CA-C 114.731 1.382 . . . . 0.0 114.731 175.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.4 mt -65.79 -45.81 81.01 Favored 'General case' 0 N--CA 1.495 1.795 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 169.371 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 69.0 t -57.65 -53.8 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 CA-C-O 117.645 -1.169 . . . . 0.0 111.688 172.644 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.4 t70 -62.14 -30.7 71.21 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 116.002 1.853 . . . . 0.0 116.002 174.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -57.94 -43.7 86.49 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-O 117.162 -1.399 . . . . 0.0 113.404 169.733 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 6.5 ttm-85 -81.64 -15.34 54.91 Favored 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 118.499 2.778 . . . . 0.0 118.499 168.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 74.7 mt -85.13 -6.62 59.29 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 115.952 1.834 . . . . 0.0 115.952 166.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 95.5 m-20 -72.02 45.42 0.12 Allowed 'General case' 0 N--CA 1.495 1.806 0 CA-C-O 126.237 2.922 . . . . 0.0 118.485 165.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.409 ' HA ' ' H ' ' A' ' 77' ' ' ALA 0.362 0.7 OUTLIER 74.33 90.71 0.06 OUTLIER Pre-proline 0 CA--C 1.556 1.183 2 N-CA-C 123.532 4.642 . . . . 0.0 123.532 146.568 . . . . . . . . 5 4 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_exo -80.92 37.04 0.65 Allowed 'Trans proline' 0 CA--C 1.578 2.687 0 C-N-CA 121.985 1.79 . . . . 0.0 113.002 149.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 63.61 30.43 14.96 Favored 'General case' 0 CA--C 1.594 2.656 0 C-N-CA 125.97 1.708 . . . . 0.0 107.684 -151.578 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.409 ' H ' ' HA ' ' A' ' 74' ' ' ASN . . . 61.41 5.33 1.14 Allowed 'General case' 0 C--N 1.398 2.681 0 CA-C-N 123.027 2.649 . . . . 0.0 114.2 -162.063 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 47.87 34.18 3.79 Favored 'General case' 0 CA--C 1.583 2.217 0 CA-C-N 122.542 2.428 . . . . 0.0 113.829 -158.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 18.3 m120 59.67 28.96 18.5 Favored 'General case' 0 CA--C 1.582 2.183 0 C-N-CA 125.576 1.55 . . . . 0.0 113.828 -166.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 169.89 -169.64 42.27 Favored Glycine 0 C--N 1.373 2.593 0 CA-C-N 123.226 2.739 . . . . 0.0 116.324 -169.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.456 ' O ' ' HB2' ' A' ' 2' ' ' ARG . 17.2 p90 -177.6 132.14 0.16 Allowed 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 112.958 -1.621 . . . . 0.0 109.278 169.675 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 16.7 mt -112.59 109.53 28.88 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 172.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 24.8 mt -104.01 114.33 28.51 Favored 'General case' 0 N--CA 1.496 1.87 0 CA-C-O 117.52 -1.229 . . . . 0.0 109.87 178.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.3 t0 -104.5 125.71 50.92 Favored 'General case' 0 N--CA 1.501 2.095 0 CA-C-N 121.32 1.873 . . . . 0.0 110.884 178.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 74.04 32.36 58.7 Favored Glycine 0 CA--C 1.548 2.147 0 N-CA-C 117.95 1.94 . . . . 0.0 117.95 174.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -91.15 -55.8 0.26 Allowed Pre-proline 0 N--CA 1.496 1.853 0 CA-C-O 115.163 -2.351 . . . . 0.0 108.418 169.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -66.74 63.79 0.57 Allowed 'Trans proline' 0 CA--C 1.575 2.555 0 N-CA-C 120.192 3.112 . . . . 0.0 120.192 168.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.491 HH12 HG12 ' A' ' 59' ' ' VAL 0.331 29.6 ttt180 -69.59 -31.42 69.55 Favored 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 116.892 2.182 . . . . 0.0 116.892 165.877 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 39.9 t -151.72 129.32 11.49 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 104.742 -2.318 . . . . 0.0 104.742 -166.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . 0.33 12.8 p -61.86 -25.3 36.77 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.064 0 CA-C-O 116.726 -1.607 . . . . 0.0 113.718 -172.397 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -58.07 -38.21 75.92 Favored 'General case' 0 CA--C 1.566 1.573 0 N-CA-C 119.506 3.15 . . . . 0.0 119.506 165.185 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 13.8 mm100 -70.09 -47.95 59.72 Favored 'General case' 0 CA--C 1.592 2.589 0 CA-C-N 122.526 2.421 . . . . 0.0 111.939 165.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -65.07 -31.63 72.94 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 127.198 2.199 . . . . 0.0 116.279 -169.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -57.28 -32.61 66.8 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 114.836 1.421 . . . . 0.0 114.836 166.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.62 -43.05 90.74 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 115.131 1.53 . . . . 0.0 115.131 169.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 32.0 tp -64.22 -36.82 85.32 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 115.527 1.677 . . . . 0.0 115.527 169.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 28.3 t-80 -60.26 -53.08 61.92 Favored 'General case' 0 N--CA 1.5 2.053 0 CA-C-N 119.867 1.212 . . . . 0.0 113.042 169.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 1.222 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 35.6 mt-10 -49.01 -34.54 13.4 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 116.017 1.858 . . . . 0.0 116.017 167.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 1.248 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 26.3 mmt -85.96 -30.56 22.68 Favored 'General case' 0 N--CA 1.495 1.811 0 N-CA-C 118.182 2.66 . . . . 0.0 118.182 173.917 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 46.4 tp -67.48 -52.26 41.44 Favored 'General case' 0 N--CA 1.504 2.26 0 CA-C-N 121.281 1.855 . . . . 0.0 112.02 169.81 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -79.01 -51.37 9.68 Favored 'General case' 0 CA--C 1.565 1.549 0 C-N-CA 123.512 0.725 . . . . 0.0 112.675 176.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 1.222 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 72.9 ttt180 -69.65 -44.94 69.53 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 176.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 1.248 ' HB3' ' O ' ' A' ' 99' ' ' MET . 72.0 ttt180 -59.8 -56.18 25.01 Favored 'General case' 0 N--CA 1.49 1.575 0 CA-C-N 118.867 0.758 . . . . 0.0 110.953 164.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.27 43.78 1.05 Allowed Glycine 0 N--CA 1.48 1.588 0 O-C-N 124.282 0.989 . . . . 0.0 114.211 168.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 34.5 p -100.49 143.81 30.23 Favored 'General case' 0 CA--C 1.557 1.234 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 170.459 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 12.7 m-20 -67.4 131.43 45.69 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 114.517 1.303 . . . . 0.0 114.517 -171.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 4.7 tp -82.91 103.19 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 C-N-CA 125.21 1.404 . . . . 0.0 108.257 175.258 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -97.95 -71.66 0.68 Allowed 'General case' 0 N--CA 1.489 1.494 0 CA-C-O 114.925 -2.464 . . . . 0.0 108.237 168.049 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -144.96 125.5 14.06 Favored 'General case' 0 N--CA 1.492 1.645 0 CA-C-N 122.852 2.569 . . . . 0.0 116.366 -174.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 69.2 t -92.3 109.14 21.06 Favored 'Isoleucine or valine' 0 CA--C 1.567 1.626 0 N-CA-C 102.269 -3.234 . . . . 0.0 102.269 162.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.585 HD23 ' HB2' ' A' ' 160' ' ' LYS . 83.2 mt -102.18 107.04 17.98 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.083 0.553 . . . . 0.0 110.559 -173.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -99.3 122.15 42.05 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-O 122.387 1.089 . . . . 0.0 110.409 175.195 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 3.8 m-85 -93.69 123.3 36.92 Favored 'General case' 0 CA--C 1.559 1.304 0 CA-C-N 113.661 -1.609 . . . . 0.0 108.709 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 4.8 tmt_? -82.68 98.27 8.96 Favored 'General case' 0 CA--C 1.555 1.163 0 CA-C-N 112.444 -2.162 . . . . 0.0 108.484 169.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 3.0 p -137.97 136.26 45.2 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.223 0 CA-C-N 112.977 -1.92 . . . . 0.0 107.187 -168.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 65.1 m -88.18 134.03 33.88 Favored 'General case' 0 N--CA 1.483 1.175 0 CA-C-N 113.338 -1.756 . . . . 0.0 113.039 -169.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -63.94 -27.1 68.91 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 116.567 2.062 . . . . 0.0 116.567 175.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -62.02 -30.36 70.9 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 115.691 1.737 . . . . 0.0 115.691 175.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -59.01 -51.19 75.44 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.052 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 177.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.8 tt -72.55 -39.74 67.26 Favored 'General case' 0 CA--C 1.569 1.693 0 CA-C-N 114.543 -1.208 . . . . 0.0 113.185 174.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 6.7 mp -58.31 -35.15 71.42 Favored 'General case' 0 N--CA 1.5 2.029 0 N-CA-C 115.415 1.635 . . . . 0.0 115.415 167.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 19.7 mm-40 -67.77 -43.06 80.67 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 119.387 0.994 . . . . 0.0 113.607 168.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -51.61 -49.78 61.51 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 116.049 1.87 . . . . 0.0 116.049 168.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 10.7 mt -59.16 -60.72 3.42 Favored 'General case' 0 CA--C 1.567 1.616 0 N-CA-C 114.525 1.305 . . . . 0.0 114.525 170.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.7 tmtp? -75.87 -56.9 4.23 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 115.423 1.638 . . . . 0.0 115.423 -170.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -59.0 -33.55 74.68 Favored Glycine 0 CA--C 1.552 2.39 0 N-CA-C 119.16 2.424 . . . . 0.0 119.16 -175.838 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -76.77 -73.42 0.29 Allowed 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 118.965 1.382 . . . . 0.0 111.388 174.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.74 ' O ' ' HB2' ' A' ' 129' ' ' ARG . . . -162.0 -48.53 0.02 OUTLIER Glycine 0 CA--C 1.549 2.179 0 CA-C-O 118.194 -1.337 . . . . 0.0 115.519 179.167 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.74 ' HB2' ' O ' ' A' ' 128' ' ' GLY . 6.4 mmm180 108.41 101.35 0.0 OUTLIER 'General case' 0 N--CA 1.483 1.192 0 CA-C-N 119.721 1.76 . . . . 0.0 108.74 -174.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -98.25 30.92 2.95 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 178.704 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 47.58 55.41 8.41 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 116.862 2.171 . . . . 0.0 116.862 -179.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -91.68 84.91 5.52 Favored 'General case' 0 N--CA 1.489 1.505 1 N-CA-C 97.279 -5.082 . . . . 0.0 97.279 156.972 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 6.8 t -61.24 138.35 58.23 Favored 'General case' 0 CA--C 1.547 0.833 0 N-CA-C 116.718 2.118 . . . . 0.0 116.718 -155.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -48.58 -34.82 12.2 Favored 'General case' 0 CA--C 1.575 1.911 0 CA-C-N 111.509 -2.587 . . . . 0.0 117.271 172.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -67.43 -37.12 82.51 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 115.512 1.671 . . . . 0.0 115.512 172.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.2 t -65.28 -35.94 76.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 CA-C-N 119.073 0.851 . . . . 0.0 113.113 168.012 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 2.2 mp -64.31 -40.83 90.44 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 CA-C-O 118.522 -0.752 . . . . 0.0 112.4 169.638 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 32.5 mt -63.9 -36.37 83.72 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 115.043 1.498 . . . . 0.0 115.043 169.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -64.64 -39.95 94.59 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 114.393 1.257 . . . . 0.0 114.393 169.621 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 14.8 mmm180 -63.05 -36.52 83.85 Favored 'General case' 0 N--CA 1.492 1.675 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 167.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 13.2 tpt -67.09 -29.77 69.62 Favored 'General case' 0 CA--C 1.571 1.762 0 N-CA-C 114.671 1.359 . . . . 0.0 114.671 168.078 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 62.1 mtpt -62.77 -50.71 69.96 Favored 'General case' 0 N--CA 1.487 1.424 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 168.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 10.1 p -64.56 -34.72 71.57 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.282 0 N-CA-C 114.511 1.3 . . . . 0.0 114.511 170.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 34.5 t80 -54.95 -49.36 71.57 Favored 'General case' 0 CA--C 1.578 2.046 0 CA-C-N 119.662 1.119 . . . . 0.0 112.335 167.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -57.19 -39.44 75.38 Favored 'General case' 0 N--CA 1.483 1.194 0 N-CA-C 118.9 2.926 . . . . 0.0 118.9 173.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 19.5 m-20 -57.21 -34.4 68.49 Favored 'General case' 0 N--CA 1.506 2.365 0 N-CA-C 117.011 2.226 . . . . 0.0 117.011 178.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 9.7 mm-40 -131.1 -26.59 2.12 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 119.225 3.046 . . . . 0.0 119.225 -166.241 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 73.2 m -45.4 -32.84 2.28 Favored 'General case' 0 N--CA 1.508 2.452 0 CA-C-N 122.667 2.485 . . . . 0.0 117.425 -171.552 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.403 ' HB3' ' HD3' ' A' ' 150' ' ' PRO . . . -68.53 -62.38 3.04 Favored Pre-proline 0 CA--C 1.584 2.261 0 CA-C-O 115.682 -2.104 . . . . 0.0 112.067 169.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.403 ' HD3' ' HB3' ' A' ' 149' ' ' ALA . 75.3 Cg_exo -56.46 -31.73 86.83 Favored 'Trans proline' 0 CA--C 1.578 2.685 0 N-CA-C 120.083 3.07 . . . . 0.0 120.083 169.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -62.78 -53.17 58.39 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 125.719 1.608 . . . . 0.0 111.03 169.516 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.987 ' O ' ' HB2' ' A' ' 156' ' ' ARG 0.306 0.1 OUTLIER -62.03 -24.94 67.36 Favored 'General case' 0 N--CA 1.5 2.049 0 N-CA-C 116.341 1.978 . . . . 0.0 116.341 175.872 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.2 mt-10 -71.29 -50.73 29.62 Favored 'General case' 0 N--CA 1.489 1.478 0 CA-C-N 120.366 1.439 . . . . 0.0 113.137 166.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 12.7 t80 -64.5 -53.54 46.45 Favored 'General case' 0 CA--C 1.568 1.666 0 CA-C-N 120.416 1.462 . . . . 0.0 112.728 -179.307 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 63.3 m-85 -80.86 -24.66 38.21 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-O 115.209 -2.329 . . . . 0.0 113.724 178.29 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.987 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 14.9 tpt180 -64.37 -37.49 87.68 Favored 'General case' 0 N--CA 1.492 1.651 0 CA-C-N 124.144 3.156 . . . . 0.0 115.175 169.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -67.16 -38.09 84.86 Favored 'General case' 0 CA--C 1.574 1.87 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 167.359 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -80.47 -29.7 37.45 Favored 'General case' 0 CA--C 1.578 2.028 0 N-CA-C 119.713 3.227 . . . . 0.0 119.713 177.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.5 pp -79.21 175.76 10.3 Favored 'General case' 0 N--CA 1.499 1.988 0 N-CA-C 119.933 3.309 . . . . 0.0 119.933 -161.17 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.585 ' HB2' HD23 ' A' ' 111' ' ' LEU . 95.1 mttt -128.55 133.38 48.38 Favored 'General case' 0 CA--C 1.561 1.392 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 166.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 62.4 m -96.07 148.4 22.71 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-O 122.261 1.029 . . . . 0.0 110.818 -172.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 1.018 HG13 ' HB3' ' A' ' 174' ' ' ARG . 58.6 t -130.35 136.14 59.18 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.48 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 167.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.549 ' O ' ' HG3' ' A' ' 174' ' ' ARG . 10.0 t0 -95.07 129.05 42.31 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 106.017 -1.846 . . . . 0.0 106.017 168.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -163.43 120.9 1.86 Allowed 'General case' 0 N--CA 1.481 1.082 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.447 -162.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.9 t -149.32 130.23 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-O 118.419 -0.801 . . . . 0.0 109.075 175.382 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 78.52 -65.98 3.34 Favored Glycine 0 N--CA 1.484 1.845 0 N-CA-C 118.785 2.274 . . . . 0.0 118.785 167.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 40.9 p -70.34 149.95 46.83 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 112.068 -2.066 . . . . 0.0 113.072 -169.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 61.1 mtt -91.97 -60.17 1.92 Allowed 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 118.722 -0.656 . . . . 0.0 111.549 176.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.8 m-20 -69.42 -38.67 77.97 Favored 'General case' 0 N--CA 1.5 2.063 0 N-CA-C 115.87 1.804 . . . . 0.0 115.87 -176.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -64.03 -47.98 78.11 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-N 119.505 1.048 . . . . 0.0 113.653 169.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 99.3 t -56.7 -38.04 55.93 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-N 119.746 1.157 . . . . 0.0 113.647 172.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -59.0 -35.96 74.12 Favored 'General case' 0 N--CA 1.5 2.067 0 N-CA-C 116.619 2.081 . . . . 0.0 116.619 167.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -60.37 -48.31 82.32 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 113.899 1.074 . . . . 0.0 113.899 170.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 1.018 ' HB3' HG13 ' A' ' 162' ' ' VAL . 1.4 mmp_? -50.3 -57.2 8.41 Favored 'General case' 0 N--CA 1.494 1.732 0 N-CA-C 117.337 2.347 . . . . 0.0 117.337 168.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -49.92 -44.5 50.33 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 116.752 2.13 . . . . 0.0 116.752 172.673 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.5 mp -62.69 -43.11 99.63 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 117.515 -1.231 . . . . 0.0 114.013 168.181 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 90.4 mtt180 -53.35 -47.81 69.07 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 171.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -67.87 -45.03 75.71 Favored 'General case' 0 CA--C 1.559 1.303 0 N-CA-C 115.796 1.776 . . . . 0.0 115.796 175.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -81.11 -56.6 3.98 Favored 'General case' 0 CA--C 1.564 1.513 0 CA-C-N 120.063 1.301 . . . . 0.0 112.878 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.65 ' O ' ' CB ' ' A' ' 181' ' ' LYS . . . -101.36 -57.87 0.83 Allowed Glycine 0 CA--C 1.552 2.389 0 CA-C-O 117.803 -1.554 . . . . 0.0 114.836 -177.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.65 ' CB ' ' O ' ' A' ' 180' ' ' GLY . 36.5 ttmt . . . . . 0 C--O 1.251 1.157 0 CA-C-N 120.296 2.048 . . . . 0.0 107.579 -177.314 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.0 tpp . . . . . 0 CA--C 1.56 1.344 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.492 ' NH1' ' HA ' ' A' ' 79' ' ' ASN . 0.0 OUTLIER -160.75 166.95 27.82 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 119.65 3.204 . . . . 0.0 119.65 -166.434 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 13.8 p -123.49 145.0 31.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 CA-C-O 123.237 1.494 . . . . 0.0 113.462 -167.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 6.2 mt -120.85 114.12 21.13 Favored 'General case' 0 CA--C 1.547 0.858 0 CA-C-N 112.123 -2.308 . . . . 0.0 106.27 172.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.3 tt -102.67 126.77 49.88 Favored 'General case' 0 CA--C 1.552 1.023 0 C-N-CA 124.806 1.243 . . . . 0.0 111.014 -165.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.1 mt -139.29 164.23 30.39 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 114.527 -1.215 . . . . 0.0 112.431 -166.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 151.68 171.22 19.31 Favored Glycine 0 CA--C 1.558 2.752 0 CA-C-O 119.088 -0.84 . . . . 0.0 114.728 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -59.75 123.24 12.86 Favored 'Trans proline' 0 CA--C 1.573 2.47 0 C-N-CA 123.576 2.851 . . . . 0.0 113.013 170.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -81.45 104.44 1.49 Allowed 'Trans proline' 0 CA--C 1.56 1.775 0 C-N-CA 122.413 2.076 . . . . 0.0 114.911 -168.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -162.38 -93.43 0.09 OUTLIER Glycine 0 CA--C 1.534 1.233 0 N-CA-C 107.769 -2.132 . . . . 0.0 107.769 169.027 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -90.65 151.41 21.29 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 113.325 0.861 . . . . 0.0 113.325 175.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 89.01 -168.86 35.91 Favored Glycine 0 CA--C 1.546 2.001 0 CA-C-N 115.729 -0.669 . . . . 0.0 114.556 179.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 9.1 mtmp? 80.36 -82.57 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 113.488 0.922 . . . . 0.0 113.488 174.622 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -48.01 -31.09 7.84 Favored Glycine 0 CA--C 1.556 2.618 0 N-CA-C 120.96 3.144 . . . . 0.0 120.96 175.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 33.3 m -66.45 -55.64 14.74 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 119.558 1.679 . . . . 0.0 113.136 176.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.273 10.9 mm-40 -76.86 -12.16 59.93 Favored 'General case' 0 CA--C 1.573 1.848 0 CA-C-O 116.235 -1.841 . . . . 0.0 111.858 172.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.33 -47.65 60.09 Favored 'General case' 0 C--N 1.372 1.554 0 CA-C-N 123.346 2.794 . . . . 0.0 114.387 167.695 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 94.5 t -66.95 -44.72 88.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.794 0 CA-C-O 117.742 -1.123 . . . . 0.0 111.201 173.346 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 97.2 mttt -59.33 -41.41 89.07 Favored 'General case' 0 N--CA 1.487 1.391 0 N-CA-C 116.596 2.073 . . . . 0.0 116.596 171.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.7 tp -66.35 -33.71 76.33 Favored 'General case' 0 N--CA 1.497 1.911 0 CA-C-N 119.721 1.146 . . . . 0.0 113.82 171.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.68 -39.03 89.96 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 115.814 1.783 . . . . 0.0 115.814 167.702 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -63.03 -38.54 91.6 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 166.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 42.1 tptt -64.84 -53.87 39.94 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 175.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 83.6 mt -83.34 -27.19 29.89 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 116.956 2.206 . . . . 0.0 116.956 178.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.06 40.02 5.95 Favored Glycine 0 CA--C 1.555 2.569 0 N-CA-C 117.516 1.766 . . . . 0.0 117.516 -174.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.429 ' CG2' ' HA ' ' A' ' 81' ' ' PHE . 19.2 mm -110.06 160.34 28.56 Favored Pre-proline 0 CA--C 1.567 1.634 0 CA-C-N 118.853 1.326 . . . . 0.0 114.103 -168.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -74.37 103.53 1.71 Allowed 'Trans proline' 0 CA--C 1.565 2.027 0 C-N-CA 121.766 1.644 . . . . 0.0 112.776 159.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 6.3 tm0? -69.5 104.96 2.46 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 165.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 35.2 mm -100.83 107.68 21.7 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 N-CA-C 104.571 -2.381 . . . . 0.0 104.571 177.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 23.0 t -95.59 129.92 42.62 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 168.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 22.4 p -67.17 -19.48 65.58 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 117.037 2.236 . . . . 0.0 117.037 -170.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -84.92 -16.49 65.21 Favored Glycine 0 CA--C 1.544 1.895 0 N-CA-C 119.079 2.392 . . . . 0.0 119.079 168.031 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -80.34 -55.62 4.77 Favored 'General case' 0 N--CA 1.495 1.82 0 CA-C-N 119.529 1.664 . . . . 0.0 114.519 -168.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -59.36 -40.15 85.55 Favored 'General case' 0 N--CA 1.495 1.802 0 N-CA-C 114.438 1.273 . . . . 0.0 114.438 172.267 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.586 ' HB3' ' CB ' ' A' ' 50' ' ' LYS . 6.4 m-85 -60.44 -46.79 88.75 Favored 'General case' 0 CA--C 1.558 1.26 0 N-CA-C 115.976 1.843 . . . . 0.0 115.976 170.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 38.6 ttm180 -55.22 -42.28 73.17 Favored 'General case' 0 N--CA 1.495 1.788 0 N-CA-C 115.095 1.517 . . . . 0.0 115.095 168.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 6.8 ttt180 -59.94 -38.14 81.57 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 167.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -68.97 -23.62 64.14 Favored 'General case' 0 CA--C 1.581 2.168 0 N-CA-C 115.024 1.491 . . . . 0.0 115.024 167.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 53.9 mt -62.91 -49.6 82.97 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.522 0 CA-C-N 120.927 1.694 . . . . 0.0 109.871 166.303 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -60.85 -40.34 92.51 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 114.49 1.293 . . . . 0.0 114.49 176.072 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -67.19 -41.76 85.32 Favored 'General case' 0 CA--C 1.562 1.427 0 N-CA-C 116.268 1.951 . . . . 0.0 116.268 173.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.77 70.0 0.99 Allowed Glycine 0 CA--C 1.544 1.872 0 CA-C-O 118.349 -1.25 . . . . 0.0 114.425 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.855 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 68.5 p -94.0 -50.79 5.15 Favored 'General case' 0 N--CA 1.5 2.048 0 CA-C-N 118.837 1.319 . . . . 0.0 114.407 178.032 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.855 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.251 37.6 mttp 106.24 -41.42 0.0 OUTLIER 'General case' 0 CA--C 1.571 1.755 0 CA-C-O 116.428 -1.749 . . . . 0.0 111.514 -172.234 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.403 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.6 OUTLIER -81.98 -14.02 56.62 Favored 'General case' 0 N--CA 1.493 1.713 0 CA-C-N 122.972 2.623 . . . . 0.0 113.013 163.682 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.23 -57.56 19.08 Favored Glycine 0 C--N 1.353 1.518 0 CA-C-N 120.318 1.417 . . . . 0.0 114.494 170.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.304 4.2 p -75.52 -51.96 19.55 Favored 'Isoleucine or valine' 0 CA--C 1.56 1.353 0 N-CA-C 115.469 1.655 . . . . 0.0 115.469 -169.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -68.73 -44.07 74.58 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-N 120.703 1.592 . . . . 0.0 112.84 176.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.403 ' HB3' ' O ' ' A' ' 45' ' ' LEU . . . -73.74 -29.16 62.07 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-O 117.267 -1.349 . . . . 0.0 114.282 -178.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.586 ' CB ' ' HB3' ' A' ' 35' ' ' PHE 0.273 0.0 OUTLIER -77.77 -33.94 52.55 Favored 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 117.084 -1.436 . . . . 0.0 113.689 169.832 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.543 ' HG2' ' O ' ' A' ' 51' ' ' ARG . 29.1 ttt180 -76.06 -47.1 25.97 Favored 'General case' 0 CA--C 1.584 2.27 1 CA-C-O 84.928 -16.749 . . . . 0.0 118.477 -179.075 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 3.4 m-30 -35.35 -56.71 0.62 Allowed 'General case' 0 N--CA 1.494 1.748 1 O-C-N 107.542 -9.474 . . . . 0.0 120.383 145.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 49.2 mt -54.33 -35.85 63.13 Favored 'General case' 0 N--CA 1.511 2.587 0 CA-C-N 123.869 3.031 . . . . 0.0 115.023 167.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -86.96 -42.17 13.35 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 116.139 1.904 . . . . 0.0 116.139 172.805 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -75.26 -42.79 54.24 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . 1.04 ' HA2' HH12 ' A' ' 88' ' ' ARG . . . 107.61 40.99 1.66 Allowed Glycine 0 CA--C 1.537 1.463 0 N-CA-C 116.466 1.346 . . . . 0.0 116.466 168.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -118.75 -164.53 1.04 Allowed 'General case' 0 CA--C 1.569 1.692 0 C-N-CA 124.052 0.941 . . . . 0.0 111.076 168.049 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 90.5 mt -80.22 108.16 13.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.342 -0.849 . . . . 0.0 112.257 -169.273 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 p -103.57 132.3 21.2 Favored Pre-proline 0 CA--C 1.571 1.761 0 C-N-CA 124.708 1.203 . . . . 0.0 110.002 175.108 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -60.18 145.87 97.56 Favored 'Trans proline' 0 CA--C 1.558 1.724 0 C-N-CA 123.367 2.711 . . . . 0.0 116.238 171.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 73.7 m -82.8 178.64 8.08 Favored 'General case' 0 CA--C 1.571 1.767 0 CA-C-O 121.623 0.725 . . . . 0.0 111.591 170.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 5.0 t70 83.05 -52.81 0.17 Allowed 'General case' 0 N--CA 1.496 1.868 0 C-N-CA 125.926 1.691 . . . . 0.0 113.583 176.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.9 pp -57.85 -42.35 84.26 Favored 'General case' 0 CA--C 1.564 1.516 0 N-CA-C 116.547 2.055 . . . . 0.0 116.547 168.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 3.0 m -59.34 -49.5 77.57 Favored 'General case' 0 N--CA 1.494 1.755 0 C-N-CA 124.354 1.062 . . . . 0.0 113.651 171.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 9.3 m-20 -64.73 -21.04 66.66 Favored 'General case' 0 N--CA 1.492 1.64 0 N-CA-C 116.147 1.906 . . . . 0.0 116.147 167.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.9 mm-40 -77.67 -44.35 28.33 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 114.987 1.477 . . . . 0.0 114.987 173.538 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 11.6 mt -66.37 -44.66 82.54 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 115.087 1.514 . . . . 0.0 115.087 169.564 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 56.1 t -56.5 -52.53 51.8 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.763 0 CA-C-O 118.323 -0.846 . . . . 0.0 111.954 170.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -63.57 -28.35 69.87 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 116.615 2.08 . . . . 0.0 116.615 173.177 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -60.44 -42.0 95.18 Favored 'General case' 0 CA--C 1.563 1.46 0 CA-C-O 117.743 -1.123 . . . . 0.0 113.081 168.461 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 79.5 mtp180 -81.31 -21.41 39.27 Favored 'General case' 0 N--CA 1.495 1.778 0 N-CA-C 119.044 2.979 . . . . 0.0 119.044 168.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 88.4 mt -84.71 -20.08 31.74 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 117.156 2.28 . . . . 0.0 117.156 176.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 88.0 m-20 -70.0 9.02 0.61 Allowed 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 116.959 2.207 . . . . 0.0 116.959 169.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 17.8 t30 -68.94 139.55 90.71 Favored Pre-proline 0 CA--C 1.575 1.906 0 CA-C-O 118.016 -0.992 . . . . 0.0 108.776 164.497 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -55.03 -33.04 81.87 Favored 'Trans proline' 0 N--CA 1.499 1.827 0 N-CA-C 119.395 2.806 . . . . 0.0 119.395 177.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 19.0 m-20 -66.92 -12.73 60.42 Favored 'General case' 0 CA--C 1.569 1.677 0 CA-C-O 116.517 -1.706 . . . . 0.0 115.47 170.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -107.11 18.87 21.18 Favored 'General case' 0 CA--C 1.574 1.896 0 CA-C-N 122.197 2.271 . . . . 0.0 114.437 168.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -67.57 -42.48 82.49 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-N 121.248 1.84 . . . . 0.0 115.16 174.416 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . 0.492 ' HA ' ' NH1' ' A' ' 2' ' ' ARG . 25.3 m120 -111.02 38.01 2.65 Favored 'General case' 0 CA--C 1.58 2.101 0 C-N-CA 123.696 0.798 . . . . 0.0 111.504 168.878 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -172.32 160.23 31.51 Favored Glycine 0 C--N 1.364 2.127 0 CA-C-N 121.897 2.135 . . . . 0.0 114.493 169.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.429 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . 14.5 p90 -175.52 133.83 0.3 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-N 113.674 -1.263 . . . . 0.0 109.946 169.709 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.9 mm -102.45 106.21 19.49 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.736 0 N-CA-C 102.84 -3.022 . . . . 0.0 102.84 167.383 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.2 mt -103.22 134.5 46.53 Favored 'General case' 0 N--CA 1.494 1.775 0 C-N-CA 123.728 0.811 . . . . 0.0 108.812 174.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -133.52 119.64 19.78 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-N 118.987 0.812 . . . . 0.0 111.099 -167.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 77.56 41.17 20.88 Favored Glycine 0 CA--C 1.55 2.223 0 CA-C-O 117.418 -1.768 . . . . 0.0 116.96 178.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . 0.275 0.9 OUTLIER -104.68 -66.84 0.04 OUTLIER Pre-proline 0 N--CA 1.496 1.833 0 CA-C-O 113.202 -3.285 . . . . 0.0 110.433 -175.375 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_exo -63.13 60.38 0.17 Allowed 'Trans proline' 0 CA--C 1.57 2.311 0 CA-C-N 127.169 3.596 . . . . 0.0 121.212 170.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 1.04 HH12 ' HA2' ' A' ' 56' ' ' GLY . 16.4 ptt85 -62.79 -25.75 68.39 Favored 'General case' 0 CA--C 1.57 1.732 0 N-CA-C 117.48 2.4 . . . . 0.0 117.48 167.129 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.467 ' HB2' ' HG3' ' A' ' 147' ' ' GLU . 77.9 p -151.18 138.99 19.83 Favored 'General case' 0 CA--C 1.557 1.222 0 C-N-CA 125.824 1.65 . . . . 0.0 107.045 -167.369 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -55.95 -33.37 35.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 CA-C-N 121.283 1.856 . . . . 0.0 113.462 172.82 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 6.9 mt-10 -61.92 -39.13 90.98 Favored 'General case' 0 C--N 1.362 1.115 0 N-CA-C 120.669 3.581 . . . . 0.0 120.669 172.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 9.6 mm100 -74.87 -46.98 32.64 Favored 'General case' 0 CA--C 1.586 2.351 0 CA-C-N 123.51 2.868 . . . . 0.0 111.847 165.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -60.11 -29.96 68.95 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 118.412 2.745 . . . . 0.0 118.412 -175.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 75.8 tttt -58.65 -34.86 71.68 Favored 'General case' 0 N--CA 1.484 1.247 0 N-CA-C 115.173 1.546 . . . . 0.0 115.173 168.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.75 -42.71 90.6 Favored 'General case' 0 CA--C 1.566 1.592 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 170.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 26.6 tp -68.0 -33.93 75.56 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 171.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 16.8 t-80 -63.12 -52.85 60.93 Favored 'General case' 0 N--CA 1.498 1.938 0 CA-C-N 119.957 1.253 . . . . 0.0 112.816 169.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.982 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 35.6 mt-10 -47.05 -39.39 12.77 Favored 'General case' 0 N--CA 1.498 1.946 0 N-CA-C 115.482 1.66 . . . . 0.0 115.482 166.484 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.83 ' O ' ' HB2' ' A' ' 103' ' ' ARG . 1.7 tpt -83.12 -24.85 32.44 Favored 'General case' 0 CA--C 1.569 1.686 0 N-CA-C 117.756 2.502 . . . . 0.0 117.756 176.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.0 tt -73.8 -49.58 24.58 Favored 'General case' 0 N--CA 1.503 2.212 0 CA-C-N 120.183 1.356 . . . . 0.0 111.68 171.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 53.6 mt-10 -74.78 -54.29 7.61 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 113.318 0.859 . . . . 0.0 113.318 172.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.982 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 92.6 mtt180 -69.82 -40.23 76.04 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 177.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.83 ' HB2' ' O ' ' A' ' 99' ' ' MET . 6.9 ttt-85 -65.31 -53.6 41.54 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-N 119.831 1.196 . . . . 0.0 111.722 164.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 108.26 50.36 0.77 Allowed Glycine 0 N--CA 1.483 1.798 0 O-C-N 123.81 0.694 . . . . 0.0 114.096 167.475 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 68.5 p -88.96 146.2 25.04 Favored 'General case' 0 CA--C 1.558 1.285 0 CA-C-N 113.205 -1.498 . . . . 0.0 109.9 175.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -66.32 132.69 48.94 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.77 -0.581 . . . . 0.0 112.053 179.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 7.1 tp -95.26 100.74 11.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.36 0 N-CA-C 108.036 -1.098 . . . . 0.0 108.036 -175.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -94.27 -66.92 0.88 Allowed 'General case' 0 N--CA 1.494 1.757 0 CA-C-O 117.074 -1.441 . . . . 0.0 108.847 168.109 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -153.91 123.11 6.49 Favored 'General case' 0 C--N 1.358 0.965 0 CA-C-N 120.605 1.548 . . . . 0.0 113.246 -169.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 5.3 t -91.8 109.07 20.8 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.583 0 N-CA-C 100.312 -3.958 . . . . 0.0 100.312 162.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.475 ' HA ' ' O ' ' A' ' 160' ' ' LYS 0.252 37.7 tp -112.97 104.07 12.03 Favored 'General case' 0 CA--C 1.548 0.874 0 CA-C-N 114.957 -1.019 . . . . 0.0 112.369 -159.483 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -99.56 134.31 42.62 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-O 122.071 0.939 . . . . 0.0 110.987 -176.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -94.76 122.17 37.09 Favored 'General case' 0 CA--C 1.561 1.386 0 CA-C-O 122.903 1.335 . . . . 0.0 110.722 -173.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 77.4 ttt180 -85.62 95.05 9.22 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 113.018 -1.901 . . . . 0.0 109.637 169.319 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.1 p -133.92 132.34 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 C-N-CA 125.725 1.61 . . . . 0.0 107.226 -169.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 44.3 t -80.23 147.12 31.37 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 114.465 -1.243 . . . . 0.0 112.432 -169.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -59.59 -27.6 66.43 Favored 'General case' 0 N--CA 1.496 1.843 0 N-CA-C 116.895 2.183 . . . . 0.0 116.895 -179.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -63.02 -42.37 99.79 Favored 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 115.59 1.7 . . . . 0.0 115.59 171.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.6 t -63.57 -48.1 88.41 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.215 0 CA-C-N 120.311 1.414 . . . . 0.0 113.515 -177.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.0 pp -60.32 -37.61 81.13 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 115.311 1.597 . . . . 0.0 115.311 169.746 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 4.0 mp -58.46 -41.62 85.58 Favored 'General case' 0 N--CA 1.5 2.052 0 N-CA-C 114.902 1.445 . . . . 0.0 114.902 167.168 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -56.35 -49.29 74.79 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 170.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 55.6 ttm-85 -55.13 -47.89 74.42 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 116.335 1.976 . . . . 0.0 116.335 171.426 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -59.49 -45.11 92.62 Favored 'General case' 0 N--CA 1.495 1.809 0 N-CA-C 115.515 1.672 . . . . 0.0 115.515 169.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 90.6 mttt -59.74 -38.92 83.06 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 117.423 2.379 . . . . 0.0 117.423 175.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.521 ' O ' ' HB2' ' A' ' 127' ' ' ARG . . . -80.65 24.3 3.82 Favored Glycine 0 CA--C 1.556 2.633 0 N-CA-C 118.639 2.215 . . . . 0.0 118.639 171.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.521 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 98.7 mtt180 80.59 -148.24 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 115.462 1.653 . . . . 0.0 115.462 169.679 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.488 ' H ' ' HB3' ' A' ' 127' ' ' ARG . . . 154.85 -51.67 0.46 Allowed Glycine 0 CA--C 1.552 2.355 0 CA-C-N 112.972 -1.922 . . . . 0.0 113.807 -173.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 77.6 mtp180 -155.99 -101.57 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 CA-C-N 119.562 1.681 . . . . 0.0 107.679 175.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -148.24 -45.07 0.16 Allowed 'General case' 0 N--CA 1.49 1.571 0 CA-C-O 116.99 -1.481 . . . . 0.0 112.529 170.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.9 m-20 -136.28 61.49 1.64 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-N 121.868 2.122 . . . . 0.0 112.078 174.036 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -116.72 62.53 0.72 Allowed 'General case' 0 CA--C 1.573 1.832 0 N-CA-C 102.5 -3.148 . . . . 0.0 102.5 158.681 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 82.6 p -138.29 -114.97 0.16 Allowed 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 113.916 -1.493 . . . . 0.0 110.183 -160.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -59.24 -43.14 92.4 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 116.695 2.109 . . . . 0.0 116.695 -169.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.3 t70 -73.63 -38.27 65.09 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.26 1.578 . . . . 0.0 115.26 177.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 20.4 t -64.25 -39.87 87.06 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.508 0 CA-C-O 117.317 -1.325 . . . . 0.0 112.124 170.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 8.3 tp -75.32 -25.6 18.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.047 0 CA-C-N 120.463 1.483 . . . . 0.0 114.333 173.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 30.0 mt -67.63 -46.67 71.8 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-N 120.92 1.691 . . . . 0.0 113.676 169.115 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 37.3 t30 -68.99 -34.55 75.47 Favored 'General case' 0 N--CA 1.5 2.062 0 N-CA-C 114.98 1.474 . . . . 0.0 114.98 172.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 69.2 mtp180 -60.43 -40.66 91.88 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 167.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 25.8 ttt -65.7 -32.68 74.37 Favored 'General case' 0 CA--C 1.569 1.678 0 N-CA-C 114.628 1.344 . . . . 0.0 114.628 168.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 21.8 ttmm -60.25 -50.04 75.22 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 116.079 1.881 . . . . 0.0 116.079 169.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.0 p -65.57 -32.97 60.56 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 N-CA-C 114.51 1.3 . . . . 0.0 114.51 169.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 6.2 t80 -55.52 -53.44 56.37 Favored 'General case' 0 CA--C 1.58 2.112 0 CA-C-N 119.495 1.043 . . . . 0.0 111.716 169.567 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -62.96 -42.09 99.72 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 118.063 2.616 . . . . 0.0 118.063 175.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -51.26 -44.53 61.8 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 116.975 2.213 . . . . 0.0 116.975 174.961 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.467 ' HG3' ' HB2' ' A' ' 89' ' ' SER . 8.9 mm-40 -124.08 -30.43 3.48 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 118.54 2.792 . . . . 0.0 118.54 -166.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 63.7 m -55.07 -34.86 63.95 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 117.387 2.365 . . . . 0.0 117.387 -167.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -65.15 -60.4 7.98 Favored Pre-proline 0 CA--C 1.579 2.085 0 CA-C-O 116.305 -1.807 . . . . 0.0 111.751 171.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_exo -51.59 -32.24 43.48 Favored 'Trans proline' 0 CA--C 1.579 2.754 0 C-N-CA 123.394 2.729 . . . . 0.0 118.549 166.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -66.77 -51.94 50.02 Favored 'General case' 0 N--CA 1.493 1.687 0 C-N-CA 125.083 1.353 . . . . 0.0 111.305 175.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 1.215 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 38.2 tp -62.43 -22.04 65.87 Favored 'General case' 0 CA--C 1.571 1.752 0 N-CA-C 115.718 1.747 . . . . 0.0 115.718 170.65 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -70.82 -50.2 38.08 Favored 'General case' 0 CA--C 1.56 1.332 0 CA-C-N 122.681 2.491 . . . . 0.0 112.463 165.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -61.13 -56.48 20.37 Favored 'General case' 0 CA--C 1.574 1.895 0 CA-C-N 119.931 1.241 . . . . 0.0 113.488 177.392 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 66.1 m-85 -77.75 -15.16 59.32 Favored 'General case' 0 CA--C 1.562 1.429 0 CA-C-O 116.647 -1.644 . . . . 0.0 114.268 178.47 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 1.215 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 0.1 OUTLIER -68.85 -40.3 79.46 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 121.723 2.056 . . . . 0.0 114.871 166.023 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -65.76 -38.97 90.54 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 113.843 1.053 . . . . 0.0 113.843 167.424 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 45.7 mt-30 -75.47 -18.94 59.72 Favored 'General case' 0 CA--C 1.585 2.305 0 N-CA-C 118.386 2.735 . . . . 0.0 118.386 169.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 1.7 mt -39.26 143.04 0.21 Allowed 'General case' 0 CA--C 1.58 2.101 1 N-CA-C 123.741 4.719 . . . . 0.0 123.741 -164.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 111' ' ' LEU . 28.4 mttm -136.08 121.74 19.65 Favored 'General case' 0 CA--C 1.56 1.332 0 N-CA-C 103.435 -2.802 . . . . 0.0 103.435 160.187 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 5.0 t -103.76 156.42 17.83 Favored 'General case' 0 N--CA 1.5 2.072 0 O-C-N 120.531 -1.356 . . . . 0.0 113.126 -172.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 34.7 t -124.35 142.47 41.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 169.517 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 28.5 t70 -98.76 127.71 44.77 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 104.92 -2.252 . . . . 0.0 104.92 165.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -152.74 92.67 1.68 Allowed 'General case' 0 N--CA 1.48 1.044 0 CA-C-O 122.68 1.229 . . . . 0.0 112.155 -163.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.2 t -150.7 125.73 1.67 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.346 0 CA-C-N 113.927 -1.488 . . . . 0.0 107.178 -175.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 79.01 -72.46 2.46 Favored Glycine 0 N--CA 1.483 1.797 0 N-CA-C 118.349 2.1 . . . . 0.0 118.349 168.337 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 40.8 p -79.09 144.14 34.86 Favored 'General case' 0 N--CA 1.489 1.516 0 CA-C-N 112.124 -2.038 . . . . 0.0 112.371 -169.092 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -96.98 -46.22 6.29 Favored 'General case' 0 N--CA 1.495 1.82 0 N-CA-C 113.526 0.935 . . . . 0.0 113.526 178.181 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -72.73 -42.02 64.54 Favored 'General case' 0 N--CA 1.5 2.034 0 N-CA-C 114.893 1.442 . . . . 0.0 114.893 177.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -62.56 -49.98 73.14 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 117.855 -1.069 . . . . 0.0 113.602 170.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 97.7 t -60.41 -36.05 66.78 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.217 0 CA-C-N 120.029 1.286 . . . . 0.0 114.014 177.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 53.7 t80 -59.31 -38.21 79.68 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 115.398 1.629 . . . . 0.0 115.398 166.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.07 -44.62 91.85 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 174.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 87.6 mtt-85 -62.7 -40.6 97.66 Favored 'General case' 0 CA--C 1.555 1.165 0 N-CA-C 116.512 2.042 . . . . 0.0 116.512 170.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.68 -42.98 94.12 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 115.373 1.62 . . . . 0.0 115.373 169.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 4.9 mp -59.61 -42.61 93.0 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 114.032 1.123 . . . . 0.0 114.032 167.718 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.57 ' HA ' ' HB3' ' A' ' 181' ' ' LYS . 45.1 mtt180 -55.41 -42.18 73.76 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 116.827 2.158 . . . . 0.0 116.827 169.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -62.91 -48.18 80.05 Favored 'General case' 0 CA--C 1.561 1.386 0 N-CA-C 115.971 1.841 . . . . 0.0 115.971 170.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 1.7 tt -83.08 -57.49 3.26 Favored 'General case' 0 CA--C 1.567 1.596 0 CA-C-N 120.778 1.627 . . . . 0.0 113.117 -178.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . . . . . . . . . . . -104.6 -52.4 0.86 Allowed Glycine 0 CA--C 1.547 2.073 0 CA-C-O 117.456 -1.747 . . . . 0.0 114.64 -173.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.57 ' HB3' ' HA ' ' A' ' 177' ' ' ARG . 86.4 tttt . . . . . 0 C--O 1.251 1.184 0 CA-C-N 120.564 2.182 . . . . 0.0 112.735 -176.149 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.0 mtt . . . . . 0 CA--C 1.558 1.283 0 CA-C-O 123.095 1.426 . . . . 0.0 111.652 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 5.5 ttm-85 -141.39 149.46 41.12 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 116.736 2.125 . . . . 0.0 116.736 -161.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 8.7 p -143.84 146.16 21.25 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.861 0 CA-C-O 123.793 1.759 . . . . 0.0 114.797 -178.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -131.86 111.57 11.7 Favored 'General case' 0 N--CA 1.484 1.25 0 CA-C-N 112.417 -2.174 . . . . 0.0 108.009 -178.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 14.5 tp -98.32 131.46 44.61 Favored 'General case' 0 CA--C 1.571 1.75 0 CA-C-O 122.706 1.241 . . . . 0.0 112.314 -167.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 7.7 mt -138.99 163.19 33.02 Favored 'General case' 0 CA--C 1.563 1.454 0 C-N-CA 127.607 2.363 . . . . 0.0 110.782 -166.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 141.89 129.22 2.41 Favored Glycine 0 CA--C 1.553 2.439 0 CA-C-O 116.975 -2.014 . . . . 0.0 111.657 -174.348 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -51.42 143.59 34.53 Favored 'Trans proline' 0 CA--C 1.573 2.429 0 CA-C-N 122.838 3.319 . . . . 0.0 116.024 172.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_exo -54.45 106.81 0.18 Allowed 'Trans proline' 0 CA--C 1.56 1.796 0 C-N-CA 123.471 2.781 . . . . 0.0 116.75 -169.802 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -176.72 73.76 0.08 OUTLIER Glycine 0 N--CA 1.479 1.545 0 CA-C-O 119.65 -0.528 . . . . 0.0 114.393 -169.455 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 39.88 76.59 0.06 Allowed 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 117.468 2.396 . . . . 0.0 117.468 170.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.461 ' O ' ' HG3' ' A' ' 13' ' ' LYS . . . 156.28 107.54 0.27 Allowed Glycine 0 N--CA 1.479 1.536 0 N-CA-C 110.072 -1.211 . . . . 0.0 110.072 -176.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.461 ' HG3' ' O ' ' A' ' 12' ' ' GLY . 19.7 mttt 164.44 -92.29 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.743 0 CA-C-N 116.851 0.325 . . . . 0.0 110.351 -172.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -50.81 -41.21 43.47 Favored Glycine 0 CA--C 1.558 2.72 0 N-CA-C 119.01 2.364 . . . . 0.0 119.01 175.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 85.5 m -58.82 -44.29 90.83 Favored 'General case' 0 N--CA 1.494 1.77 0 N-CA-C 114.093 1.146 . . . . 0.0 114.093 169.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . 0.569 ' HA ' ' HB2' ' A' ' 19' ' ' LYS 0.264 5.1 mm-40 -78.98 -14.05 59.43 Favored 'General case' 0 CA--C 1.576 1.958 0 CA-C-O 116.571 -1.68 . . . . 0.0 112.32 173.536 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -71.68 -45.22 62.58 Favored 'General case' 0 C--N 1.371 1.531 0 CA-C-N 123.062 2.665 . . . . 0.0 113.597 167.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.4 p -65.15 -41.53 91.96 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.216 0 N-CA-C 114.058 1.133 . . . . 0.0 114.058 169.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.679 ' HB3' ' CE1' ' A' ' 172' ' ' PHE . 31.1 mmtp -54.72 -42.13 71.16 Favored 'General case' 0 CA--C 1.568 1.647 0 N-CA-C 116.11 1.892 . . . . 0.0 116.11 168.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 1.09 ' HA ' ' HB3' ' A' ' 23' ' ' LYS . 22.0 mt -68.67 -30.87 69.65 Favored 'General case' 0 CA--C 1.595 2.676 0 N-CA-C 114.331 1.234 . . . . 0.0 114.331 168.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -64.12 -29.58 70.7 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 118.394 -2.692 . . . . 0.0 115.707 167.723 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -64.06 -51.44 64.09 Favored 'General case' 0 CA--C 1.596 2.726 0 CA-C-N 120.324 1.42 . . . . 0.0 110.899 156.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 1.09 ' HB3' ' HA ' ' A' ' 20' ' ' LEU 0.29 4.5 tppt? -53.26 51.93 0.0 OUTLIER 'General case' 0 CA--C 1.576 1.944 2 C-N-CA 133.45 4.7 . . . . 0.0 122.424 166.647 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.709 HD13 HD11 ' A' ' 26' ' ' ILE . 0.2 OUTLIER 67.84 25.19 7.94 Favored 'General case' 0 N--CA 1.522 3.13 2 C-N-CA 144.854 9.262 . . . . 0.0 134.891 -152.331 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 84.44 29.98 28.73 Favored Glycine 0 N--CA 1.506 3.323 0 O-C-N 117.458 -3.276 . . . . 0.0 120.468 157.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.709 HD11 HD13 ' A' ' 24' ' ' LEU . 25.6 mm -90.25 149.23 40.88 Favored Pre-proline 0 CA--C 1.556 1.178 0 CA-C-N 112.381 -1.91 . . . . 0.0 110.969 -168.172 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -77.7 91.66 1.17 Allowed 'Trans proline' 0 CA--C 1.561 1.86 0 CA-C-N 122.082 1.779 . . . . 0.0 111.497 168.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -68.13 108.85 3.28 Favored 'General case' 0 N--CA 1.492 1.625 0 CA-C-N 115.529 -0.76 . . . . 0.0 111.576 175.154 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 22.5 mm -105.65 114.94 46.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.198 0 N-CA-C 105.718 -1.956 . . . . 0.0 105.718 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 82.8 p -96.25 132.36 41.78 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 169.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 26.7 p -68.37 -16.55 63.97 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 117.136 2.272 . . . . 0.0 117.136 -173.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -84.67 -19.83 59.24 Favored Glycine 0 CA--C 1.547 2.053 0 N-CA-C 118.736 2.254 . . . . 0.0 118.736 167.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -81.13 -49.67 10.56 Favored 'General case' 0 N--CA 1.492 1.647 0 N-CA-C 114.663 1.357 . . . . 0.0 114.663 -169.174 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -65.4 -39.49 92.27 Favored 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 113.504 0.927 . . . . 0.0 113.504 173.886 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.712 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 32.8 m-85 -64.59 -40.98 96.49 Favored 'General case' 0 CA--C 1.565 1.548 0 N-CA-C 115.027 1.492 . . . . 0.0 115.027 169.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 75.4 ttt180 -57.28 -41.81 80.44 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 167.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 32.3 ttt180 -61.62 -37.98 85.97 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 115.386 1.624 . . . . 0.0 115.386 168.89 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -68.09 -30.2 69.33 Favored 'General case' 0 CA--C 1.572 1.801 0 N-CA-C 115.106 1.521 . . . . 0.0 115.106 168.307 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 64.9 mt -62.75 -44.74 99.73 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.171 0 C-N-CA 124.893 1.277 . . . . 0.0 112.085 168.38 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -65.05 -42.09 94.58 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 114.132 1.16 . . . . 0.0 114.132 173.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -76.31 -30.93 57.92 Favored 'General case' 0 CA--C 1.563 1.448 0 N-CA-C 116.784 2.142 . . . . 0.0 116.784 178.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.38 71.99 1.28 Allowed Glycine 0 CA--C 1.543 1.833 0 CA-C-O 118.083 -1.399 . . . . 0.0 115.282 178.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.847 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 70.8 p -93.69 -47.77 6.64 Favored 'General case' 0 N--CA 1.501 2.108 0 CA-C-N 119.036 1.418 . . . . 0.0 114.571 174.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.847 ' HB2' ' O ' ' A' ' 43' ' ' THR . 74.8 mttt 103.62 -40.53 0.01 OUTLIER 'General case' 0 CA--C 1.571 1.754 0 CA-C-O 116.247 -1.835 . . . . 0.0 111.527 -171.316 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.05 -12.33 58.33 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-N 123.053 2.66 . . . . 0.0 112.752 163.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -62.95 -56.07 23.0 Favored Glycine 0 C--N 1.353 1.525 0 CA-C-N 120.852 1.66 . . . . 0.0 114.743 170.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.286 7.1 p -74.57 -50.09 27.94 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.416 0 N-CA-C 116.32 1.97 . . . . 0.0 116.32 -169.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -66.49 -44.54 82.35 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 120.303 1.41 . . . . 0.0 112.691 174.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -72.34 -29.41 63.78 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 114.976 1.472 . . . . 0.0 114.976 -178.111 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.712 ' HB2' ' HB3' ' A' ' 35' ' ' PHE 0.294 0.6 OUTLIER -75.34 -35.15 61.23 Favored 'General case' 0 N--CA 1.5 2.042 0 CA-C-O 116.717 -1.611 . . . . 0.0 112.08 168.011 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.487 ' O ' ' CG ' ' A' ' 51' ' ' ARG . 18.8 ttt180 -74.2 -52.82 11.28 Favored 'General case' 0 CA--C 1.591 2.557 1 CA-C-O 87.026 -15.749 . . . . 0.0 118.197 -176.447 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 12.6 m-30 -26.28 -69.12 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.975 1 O-C-N 109.59 -8.193 . . . . 0.0 119.146 144.03 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 29.5 tp -54.12 -33.44 57.81 Favored 'General case' 0 CA--C 1.569 1.676 0 N-CA-C 116.429 2.011 . . . . 0.0 116.429 175.253 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -91.56 -44.13 9.25 Favored 'General case' 0 CA--C 1.564 1.499 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 169.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -155.21 44.41 0.48 Allowed 'General case' 0 CA--C 1.57 1.738 0 N-CA-C 114.391 1.256 . . . . 0.0 114.391 -166.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -162.54 50.44 0.32 Allowed Glycine 0 C--N 1.355 1.599 0 CA-C-N 121.628 2.013 . . . . 0.0 114.636 169.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . 0.294 5.6 t70 72.49 -112.94 0.05 Allowed 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 124.608 1.163 . . . . 0.0 110.4 167.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.6 pp -105.8 144.35 32.66 Favored 'General case' 0 N--CA 1.484 1.248 0 CA-C-O 122.691 1.234 . . . . 0.0 113.232 -169.512 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 p -129.76 140.27 38.13 Favored Pre-proline 0 CA--C 1.575 1.93 0 CA-C-N 113.307 -1.769 . . . . 0.0 109.139 -177.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_exo -55.87 136.96 77.21 Favored 'Trans proline' 0 CA--C 1.56 1.805 0 C-N-CA 123.629 2.886 . . . . 0.0 116.679 173.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 98.6 p -72.42 -48.6 39.94 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 115.651 1.723 . . . . 0.0 115.651 -178.32 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -62.38 -38.74 90.76 Favored 'General case' 0 N--CA 1.5 2.028 0 N-CA-C 116.046 1.869 . . . . 0.0 116.046 -178.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 17.3 mt -58.79 -48.2 82.09 Favored 'General case' 0 N--CA 1.503 2.206 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 172.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.0 m -61.36 -48.14 82.65 Favored 'General case' 0 N--CA 1.491 1.619 0 CA-C-N 113.647 -1.615 . . . . 0.0 113.312 176.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -65.22 -22.04 66.83 Favored 'General case' 0 CA--C 1.57 1.744 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 168.518 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.9 mt-10 -73.03 -42.95 62.61 Favored 'General case' 0 CA--C 1.557 1.242 0 CA-C-N 120.975 1.716 . . . . 0.0 115.443 169.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.7 mt -61.31 -47.24 86.85 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 114.755 1.391 . . . . 0.0 114.755 168.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -57.35 -49.87 78.69 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 N-CA-C 113.597 0.962 . . . . 0.0 113.597 172.393 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -60.71 -37.67 82.49 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 116.083 1.883 . . . . 0.0 116.083 171.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -56.87 -43.78 81.56 Favored 'General case' 0 N--CA 1.487 1.424 0 CA-C-O 117.818 -1.087 . . . . 0.0 113.643 170.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 84.3 mtt-85 -81.4 -10.4 59.53 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 118.891 2.923 . . . . 0.0 118.891 168.038 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 87.7 mt -94.27 -8.71 38.32 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 116.669 2.1 . . . . 0.0 116.669 171.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 90.4 m-20 -66.06 8.07 0.24 Allowed 'General case' 0 N--CA 1.503 2.201 0 N-CA-C 117.863 2.542 . . . . 0.0 117.863 172.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 23.2 t-20 -71.56 143.74 87.91 Favored Pre-proline 0 CA--C 1.579 2.078 0 C-N-CA 124.511 1.124 . . . . 0.0 109.357 164.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -56.6 -27.56 70.34 Favored 'Trans proline' 0 N--CA 1.504 2.113 0 N-CA-C 120.537 3.245 . . . . 0.0 120.537 176.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -63.71 -14.2 50.15 Favored 'General case' 0 CA--C 1.579 2.071 0 CA-C-O 116.689 -1.624 . . . . 0.0 114.739 169.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -72.45 -20.38 61.41 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 122.804 2.547 . . . . 0.0 115.954 168.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -61.66 -38.38 87.52 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 115.766 1.765 . . . . 0.0 115.766 169.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 21.0 p30 -86.12 -7.05 58.86 Favored 'General case' 0 CA--C 1.572 1.8 0 N-CA-C 117.281 2.326 . . . . 0.0 117.281 172.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 171.35 -178.38 43.74 Favored Glycine 0 CA--C 1.539 1.593 0 CA-C-N 121.406 1.912 . . . . 0.0 113.944 -175.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 1.4 p90 179.58 142.0 0.13 Allowed 'General case' 0 N--CA 1.491 1.611 0 CA-C-N 112.948 -1.626 . . . . 0.0 108.145 169.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 9.8 mt -110.11 108.79 26.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 N-CA-C 103.301 -2.852 . . . . 0.0 103.301 169.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 44.6 mt -110.7 120.59 42.89 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 108.89 -0.782 . . . . 0.0 108.89 173.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -111.45 128.16 55.91 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-N 118.917 0.78 . . . . 0.0 110.779 -175.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 75.12 34.47 51.9 Favored Glycine 0 CA--C 1.553 2.413 0 N-CA-C 118.901 2.32 . . . . 0.0 118.901 176.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . 0.254 0.8 OUTLIER -93.37 -62.62 0.17 Allowed Pre-proline 0 CA--C 1.571 1.775 0 CA-C-O 114.126 -2.845 . . . . 0.0 109.538 175.519 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_exo -63.6 56.99 0.19 Allowed 'Trans proline' 0 CA--C 1.57 2.309 0 N-CA-C 121.129 3.473 . . . . 0.0 121.129 169.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -78.25 -5.04 50.75 Favored 'General case' 0 CA--C 1.57 1.75 0 N-CA-C 117.057 2.243 . . . . 0.0 117.057 168.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.6 t -161.22 139.9 9.87 Favored 'General case' 0 N--CA 1.486 1.374 0 N-CA-C 106.127 -1.805 . . . . 0.0 106.127 -171.513 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -58.33 -37.84 65.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 CA-C-N 120.157 1.344 . . . . 0.0 112.778 -178.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.467 ' HB2' ' OE2' ' A' ' 147' ' ' GLU . 0.1 OUTLIER -65.6 -30.83 71.61 Favored 'General case' 0 C--N 1.36 1.035 0 N-CA-C 119.68 3.215 . . . . 0.0 119.68 175.825 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.1 mm100 -80.43 -44.79 18.7 Favored 'General case' 0 CA--C 1.585 2.316 0 CA-C-N 122.008 2.185 . . . . 0.0 112.497 166.257 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -59.16 -35.0 72.75 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 118.428 2.751 . . . . 0.0 118.428 -176.876 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -58.66 -30.63 67.49 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 116.523 2.045 . . . . 0.0 116.523 169.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.51 -43.41 69.71 Favored 'General case' 0 CA--C 1.564 1.495 0 N-CA-C 114.818 1.414 . . . . 0.0 114.818 169.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 10.4 tp -67.89 -35.75 79.05 Favored 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 115.04 1.496 . . . . 0.0 115.04 171.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 24.0 t-80 -58.58 -54.3 48.66 Favored 'General case' 0 N--CA 1.498 1.942 0 CA-C-N 119.672 1.124 . . . . 0.0 112.809 168.66 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 1.136 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 32.3 tt0 -49.55 -32.81 13.28 Favored 'General case' 0 CA--C 1.575 1.906 0 N-CA-C 115.947 1.832 . . . . 0.0 115.947 166.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 1.097 ' O ' ' HB2' ' A' ' 103' ' ' ARG . 1.8 tpt -83.98 -40.54 18.33 Favored 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 117.619 2.452 . . . . 0.0 117.619 178.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -72.23 -45.21 61.2 Favored 'General case' 0 N--CA 1.505 2.317 0 CA-C-N 120.559 1.527 . . . . 0.0 112.504 172.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -76.93 -49.14 16.25 Favored 'General case' 0 CA--C 1.563 1.476 0 N-CA-C 113.216 0.821 . . . . 0.0 113.216 174.2 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 1.136 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 72.7 ttt180 -69.61 -43.57 72.46 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 177.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 1.097 ' HB2' ' O ' ' A' ' 99' ' ' MET . 42.5 mtp180 -63.88 -56.32 16.18 Favored 'General case' 0 N--CA 1.49 1.556 0 CA-C-N 119.009 0.822 . . . . 0.0 111.895 165.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.02 48.75 0.76 Allowed Glycine 0 N--CA 1.48 1.592 0 O-C-N 124.049 0.843 . . . . 0.0 113.554 169.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 82.3 p -82.47 160.09 22.76 Favored 'General case' 0 CA--C 1.562 1.436 0 CA-C-N 113.909 -1.145 . . . . 0.0 110.019 169.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -69.38 128.16 35.58 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.827 -1.17 . . . . 0.0 110.356 -172.671 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 4.6 tp -94.57 93.56 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 -177.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -98.44 -70.95 0.71 Allowed 'General case' 0 N--CA 1.492 1.649 0 CA-C-O 116.043 -1.932 . . . . 0.0 109.176 168.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -151.83 133.93 15.09 Favored 'General case' 0 N--CA 1.48 1.064 0 CA-C-N 121.698 2.044 . . . . 0.0 116.102 -168.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -92.35 122.08 43.5 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.163 0 N-CA-C 100.306 -3.961 . . . . 0.0 100.306 160.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.475 ' HA ' ' O ' ' A' ' 160' ' ' LYS . 44.0 mt -96.91 109.93 22.55 Favored 'General case' 0 N--CA 1.484 1.26 0 CA-C-O 115.526 -2.178 . . . . 0.0 110.429 -176.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.501 ' HB2' HD22 ' A' ' 159' ' ' LEU . 9.5 tm-20 -101.46 113.75 27.14 Favored 'General case' 0 N--CA 1.536 3.831 0 N-CA-C 120.573 3.546 . . . . 0.0 120.573 170.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 69.7 m-85 -86.04 114.63 23.07 Favored 'General case' 0 N--CA 1.498 1.968 0 O-C-N 119.268 -2.145 . . . . 0.0 110.815 170.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.449 ' O ' HG23 ' A' ' 115' ' ' VAL . 79.4 ttt180 -106.18 110.26 22.45 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 114.717 -1.129 . . . . 0.0 110.39 169.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 114' ' ' ARG 0.333 1.0 OUTLIER -179.0 146.41 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.506 2.332 0 CA-C-O 124.075 1.893 . . . . 0.0 108.836 160.021 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . 0.374 75.1 m 56.5 -79.98 0.01 OUTLIER 'General case' 0 CA--C 1.568 1.673 1 N-CA-C 123.223 4.527 . . . . 0.0 123.223 174.391 . . . . . . . . 3 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 25.3 mt-10 78.02 -34.55 0.19 Allowed 'General case' 0 CA--C 1.566 1.563 0 C-N-CA 126.684 1.994 . . . . 0.0 116.019 -166.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -63.37 -31.43 72.58 Favored 'General case' 0 N--CA 1.484 1.229 0 N-CA-C 115.359 1.614 . . . . 0.0 115.359 176.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 1.5 t -52.61 -50.68 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.024 0 C-N-CA 125.231 1.413 . . . . 0.0 114.398 173.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 39.8 tp -64.9 -38.75 92.0 Favored 'General case' 0 CA--C 1.561 1.384 0 C-N-CA 124.179 0.991 . . . . 0.0 113.658 168.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 46.8 mt -57.86 -34.23 69.52 Favored 'General case' 0 N--CA 1.508 2.444 0 N-CA-C 116.135 1.902 . . . . 0.0 116.135 168.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -63.81 -49.79 71.52 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 124.526 1.131 . . . . 0.0 113.825 168.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 24.3 tpt180 -51.64 -53.44 38.67 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 115.959 1.837 . . . . 0.0 115.959 170.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 19.0 mt -56.42 -45.67 80.58 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 115.927 1.825 . . . . 0.0 115.927 170.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 52.7 tttp -60.96 -44.24 97.6 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 117.318 2.34 . . . . 0.0 117.318 175.302 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.737 ' O ' ' HB2' ' A' ' 127' ' ' ARG . . . -95.9 57.74 1.53 Allowed Glycine 0 CA--C 1.544 1.899 0 CA-C-N 118.473 0.579 . . . . 0.0 113.874 170.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.737 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 89.6 mtt180 92.71 91.58 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.975 0 C-N-CA 123.582 0.753 . . . . 0.0 111.768 175.274 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -97.05 -57.24 1.09 Allowed Glycine 0 CA--C 1.55 2.27 0 CA-C-O 117.452 -1.749 . . . . 0.0 114.489 176.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 48.9 mtm180 -156.23 -118.11 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 120.36 2.08 . . . . 0.0 109.568 -178.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -145.79 62.37 1.26 Allowed 'General case' 0 CA--C 1.574 1.896 0 C-N-CA 123.715 0.806 . . . . 0.0 109.935 -174.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 65.49 2.43 2.01 Favored 'General case' 0 N--CA 1.511 2.59 0 N-CA-C 119.27 3.063 . . . . 0.0 119.27 -176.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 16.9 t70 -92.05 62.73 4.27 Favored 'General case' 0 CA--C 1.581 2.139 0 N-CA-C 104.629 -2.36 . . . . 0.0 104.629 159.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 80.8 p -135.26 -110.08 0.21 Allowed 'General case' 0 N--CA 1.491 1.614 0 CA-C-N 114.33 -1.305 . . . . 0.0 110.722 -162.381 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -53.2 -41.35 65.2 Favored 'General case' 0 N--CA 1.5 2.046 0 N-CA-C 117.028 2.233 . . . . 0.0 117.028 -170.571 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -67.6 -40.06 84.75 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 172.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.715 ' O ' ' HB2' ' A' ' 140' ' ' ARG . 17.0 t -63.85 -31.14 51.99 Favored 'Isoleucine or valine' 0 CA--C 1.572 1.816 0 C-N-CA 125.317 1.447 . . . . 0.0 114.395 168.779 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.635 ' O ' ' HB3' ' A' ' 140' ' ' ARG . 1.7 mp -71.6 -38.39 67.03 Favored 'Isoleucine or valine' 0 CA--C 1.577 1.998 0 C-N-CA 124.536 1.134 . . . . 0.0 112.337 169.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 37.1 mt -64.55 -50.91 65.45 Favored 'General case' 0 N--CA 1.498 1.934 0 CA-C-N 120.535 1.516 . . . . 0.0 113.434 173.297 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -65.54 -27.61 68.57 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 114.841 1.423 . . . . 0.0 114.841 168.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.715 ' HB2' ' O ' ' A' ' 136' ' ' VAL . 14.6 tpt180 -53.01 -48.46 67.53 Favored 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 125.231 1.412 . . . . 0.0 114.606 164.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 67.1 mtt -63.6 -35.52 80.8 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 168.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 88.9 mttt -60.75 -49.21 78.4 Favored 'General case' 0 N--CA 1.494 1.75 0 N-CA-C 116.523 2.045 . . . . 0.0 116.523 169.483 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.4 p -64.45 -38.72 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.06 0 N-CA-C 114.156 1.169 . . . . 0.0 114.156 173.648 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 25.3 t80 -54.65 -48.48 72.28 Favored 'General case' 0 CA--C 1.579 2.063 0 C-N-CA 123.958 0.903 . . . . 0.0 112.604 167.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 58.7 ttt180 -56.26 -34.79 66.73 Favored 'General case' 0 N--CA 1.48 1.042 0 N-CA-C 119.333 3.086 . . . . 0.0 119.333 174.119 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.65 -45.91 88.3 Favored 'General case' 0 N--CA 1.504 2.274 0 CA-C-N 120.44 1.473 . . . . 0.0 113.958 178.384 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . 0.467 ' OE2' ' HB2' ' A' ' 91' ' ' GLU . 22.2 mt-10 -142.22 -4.76 1.01 Allowed 'General case' 0 N--CA 1.49 1.547 0 N-CA-C 120.952 3.686 . . . . 0.0 120.952 -166.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 38.0 m -69.12 -30.01 68.19 Favored 'General case' 0 N--CA 1.499 1.976 0 N-CA-C 115.605 1.706 . . . . 0.0 115.605 -171.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -63.76 -56.45 25.46 Favored Pre-proline 0 CA--C 1.579 2.086 0 CA-C-O 116.209 -1.853 . . . . 0.0 111.555 169.026 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -53.33 -32.88 63.45 Favored 'Trans proline' 0 CA--C 1.577 2.659 0 C-N-CA 123.454 2.769 . . . . 0.0 118.745 167.431 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -62.85 -53.96 46.16 Favored 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 124.877 1.271 . . . . 0.0 110.83 172.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 1.2 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 45.1 tp -60.99 -20.71 62.76 Favored 'General case' 0 CA--C 1.569 1.69 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 171.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -71.34 -51.58 23.47 Favored 'General case' 0 CA--C 1.562 1.42 0 CA-C-N 122.744 2.52 . . . . 0.0 113.251 164.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -63.04 -55.57 24.44 Favored 'General case' 0 CA--C 1.57 1.726 0 CA-C-N 120.559 1.527 . . . . 0.0 112.855 178.275 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 80.2 m-85 -72.2 -31.88 66.28 Favored 'General case' 0 CA--C 1.549 0.934 0 CA-C-O 114.591 -2.623 . . . . 0.0 112.106 177.821 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 1.2 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 36.7 ttt180 -59.32 -34.92 72.92 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-N 124.949 3.522 . . . . 0.0 116.864 169.544 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -66.32 -37.53 85.59 Favored 'General case' 0 CA--C 1.572 1.814 0 N-CA-C 113.76 1.022 . . . . 0.0 113.76 166.765 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 49.2 mt-30 -83.41 -39.99 19.9 Favored 'General case' 0 CA--C 1.581 2.16 0 N-CA-C 118.991 2.959 . . . . 0.0 118.991 177.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . 0.501 HD22 ' HB2' ' A' ' 112' ' ' GLU . 2.0 pp -81.48 179.26 7.92 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 120.47 3.508 . . . . 0.0 120.47 -161.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.475 ' O ' ' HA ' ' A' ' 111' ' ' LEU 0.272 83.6 tttt -154.09 103.9 2.59 Favored 'General case' 0 C--N 1.361 1.08 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 166.018 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.465 ' HB ' ' N ' ' A' ' 112' ' ' GLU 1.149 24.3 m -124.44 -151.06 0.46 Allowed 'General case' 0 CA--C 1.568 1.673 1 O-C-N 114.839 -4.913 . . . . 0.0 108.339 149.507 . . . . . . . . 4 3 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . 0.388 2.5 t -121.39 176.49 4.1 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.052 0 CA-C-O 125.008 2.337 . . . . 0.0 113.731 -150.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -101.33 116.07 31.96 Favored 'General case' 0 N--CA 1.49 1.529 0 N-CA-C 101.504 -3.517 . . . . 0.0 101.504 164.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . 0.408 ' HB3' ' HB ' ' A' ' 115' ' ' VAL 0.346 . . -103.9 -120.39 0.2 Allowed 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 120.865 3.654 . . . . 0.0 120.865 -147.659 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.7 t -29.01 91.07 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.568 1.666 0 N-CA-C 118.99 2.959 . . . . 0.0 118.99 -156.07 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . -110.1 63.79 0.27 Allowed Glycine 0 C--N 1.355 1.634 0 CA-C-O 121.879 0.711 . . . . 0.0 113.551 164.554 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 62.0 p 41.11 64.57 0.97 Allowed 'General case' 0 N--CA 1.5 2.032 0 N-CA-C 116.544 2.053 . . . . 0.0 116.544 178.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . 0.253 58.2 mtt 80.57 -64.48 0.18 Allowed 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 125.774 1.63 . . . . 0.0 114.081 171.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -71.8 -41.61 68.07 Favored 'General case' 0 N--CA 1.501 2.081 0 N-CA-C 115.833 1.79 . . . . 0.0 115.833 -172.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -62.73 -52.55 62.81 Favored 'General case' 0 N--CA 1.49 1.574 0 N-CA-C 113.172 0.805 . . . . 0.0 113.172 173.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -54.11 -38.57 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.028 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 173.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.679 ' CE1' ' HB3' ' A' ' 19' ' ' LYS . 5.8 t80 -60.74 -38.67 85.95 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 115.989 1.848 . . . . 0.0 115.989 168.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -61.13 -54.14 48.25 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 113.793 1.035 . . . . 0.0 113.793 174.892 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 55.9 mtt180 -62.31 -37.67 86.48 Favored 'General case' 0 CA--C 1.555 1.136 0 N-CA-C 117.259 2.318 . . . . 0.0 117.259 173.724 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.66 -45.31 85.72 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 115.761 1.763 . . . . 0.0 115.761 168.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -59.35 -40.83 87.64 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 115.599 1.703 . . . . 0.0 115.599 168.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 40.6 mmt180 -71.8 -32.73 67.9 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 174.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -64.53 -48.39 75.25 Favored 'General case' 0 CA--C 1.561 1.378 0 N-CA-C 114.889 1.44 . . . . 0.0 114.889 170.21 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 65.9 tp -71.31 -42.57 68.45 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-N 119.859 1.209 . . . . 0.0 113.836 168.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.736 ' O ' ' CB ' ' A' ' 181' ' ' LYS . . . 97.47 52.61 1.42 Allowed Glycine 0 CA--C 1.554 2.491 0 CA-C-O 118.634 -1.092 . . . . 0.0 113.12 -169.152 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.736 ' CB ' ' O ' ' A' ' 180' ' ' GLY . 56.3 tttp . . . . . 0 C--O 1.251 1.135 0 N-CA-C 106.851 -1.537 . . . . 0.0 106.851 -170.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.2 mtt . . . . . 0 N--CA 1.482 1.156 0 N-CA-C 109.841 -0.429 . . . . 0.0 109.841 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.403 ' HB2' ' O ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -158.96 166.45 31.76 Favored 'General case' 0 N--CA 1.49 1.543 0 N-CA-C 117.416 2.376 . . . . 0.0 117.416 -167.909 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 51.6 t -132.06 150.59 33.84 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 CA-C-O 123.924 1.821 . . . . 0.0 112.939 -164.479 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -130.4 115.9 17.52 Favored 'General case' 0 CA--C 1.559 1.317 0 CA-C-N 112.387 -2.188 . . . . 0.0 108.221 178.663 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.758 HD21 ' HB3' ' A' ' 13' ' ' LYS . 22.9 tp -96.91 127.5 42.95 Favored 'General case' 0 CA--C 1.567 1.629 0 CA-C-O 122.873 1.321 . . . . 0.0 110.314 -173.216 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 9.4 mt -122.28 148.9 44.45 Favored 'General case' 0 N--CA 1.487 1.412 0 CA-C-N 112.048 -2.342 . . . . 0.0 111.658 -169.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 163.33 151.36 6.4 Favored Glycine 0 CA--C 1.558 2.754 0 CA-C-O 118.128 -1.373 . . . . 0.0 115.684 169.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_exo -55.75 155.04 23.57 Favored 'Trans proline' 0 CA--C 1.575 2.544 0 C-N-CA 123.792 2.995 . . . . 0.0 117.542 174.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -81.79 97.11 0.92 Allowed 'Trans proline' 0 CA--C 1.562 1.922 0 C-N-CA 122.828 2.352 . . . . 0.0 115.024 -169.469 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -168.17 -86.1 0.06 OUTLIER Glycine 0 N--CA 1.476 1.328 0 N-CA-C 109.351 -1.5 . . . . 0.0 109.351 172.45 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -63.76 149.81 45.98 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 115.042 1.497 . . . . 0.0 115.042 179.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -80.29 148.02 29.22 Favored Glycine 0 CA--C 1.548 2.096 0 N-CA-C 117.254 1.662 . . . . 0.0 117.254 -168.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.758 ' HB3' HD21 ' A' ' 5' ' ' LEU . 13.6 mptt -119.8 -33.68 3.94 Favored 'General case' 0 N--CA 1.496 1.829 0 C-N-CA 124.626 1.171 . . . . 0.0 114.063 176.451 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -51.66 -23.5 10.26 Favored Glycine 0 CA--C 1.553 2.457 0 N-CA-C 121.045 3.178 . . . . 0.0 121.045 177.604 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 65.1 m -66.83 -54.06 26.3 Favored 'General case' 0 CA--C 1.57 1.741 0 CA-C-N 120.119 1.96 . . . . 0.0 112.276 173.136 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.28 4.0 mm-40 -79.43 -14.39 58.95 Favored 'General case' 0 CA--C 1.579 2.083 0 CA-C-O 116.018 -1.944 . . . . 0.0 111.593 174.778 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.52 -43.18 63.92 Favored 'General case' 0 C--N 1.377 1.772 0 CA-C-N 123.75 2.977 . . . . 0.0 114.585 167.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 70.1 t -64.37 -41.92 93.81 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 CA-C-O 117.525 -1.226 . . . . 0.0 112.322 170.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.729 ' HB3' ' CE1' ' A' ' 172' ' ' PHE . 64.1 mmtt -65.45 -40.62 93.45 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 116.326 1.973 . . . . 0.0 116.326 171.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.6 tp -67.34 -34.67 77.81 Favored 'General case' 0 CA--C 1.572 1.824 0 CA-C-N 120.031 1.287 . . . . 0.0 113.522 173.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.96 -40.02 94.14 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 114.425 1.269 . . . . 0.0 114.425 166.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -56.58 -38.68 72.31 Favored 'General case' 0 CA--C 1.567 1.624 0 N-CA-C 114.906 1.447 . . . . 0.0 114.906 166.412 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.5 mmmp? -69.23 -53.78 18.1 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 120.306 1.412 . . . . 0.0 114.663 173.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 59.4 mt -84.4 -23.52 30.02 Favored 'General case' 0 CA--C 1.57 1.724 0 N-CA-C 117.187 2.292 . . . . 0.0 117.187 -174.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.83 36.49 7.78 Favored Glycine 0 CA--C 1.555 2.555 0 N-CA-C 117.744 1.858 . . . . 0.0 117.744 -174.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.5 mm -104.46 153.67 38.94 Favored Pre-proline 0 CA--C 1.57 1.719 0 CA-C-N 118.899 1.349 . . . . 0.0 112.487 -169.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -82.65 98.13 0.88 Allowed 'Trans proline' 0 CA--C 1.566 2.118 0 CA-C-N 122.222 1.829 . . . . 0.0 109.586 163.383 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.01 114.82 12.76 Favored 'General case' 0 N--CA 1.494 1.733 0 CA-C-O 121.811 0.815 . . . . 0.0 110.266 176.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 25.1 mm -101.99 112.32 34.75 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.6 t -95.08 134.59 37.61 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 170.447 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 21.0 p -68.97 -18.32 64.05 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 117.019 2.229 . . . . 0.0 117.019 -174.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -81.5 -21.23 62.52 Favored Glycine 0 CA--C 1.545 1.919 0 N-CA-C 118.619 2.207 . . . . 0.0 118.619 167.393 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -80.47 -51.75 8.44 Favored 'General case' 0 N--CA 1.491 1.59 0 N-CA-C 114.368 1.247 . . . . 0.0 114.368 -169.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -63.61 -39.57 94.7 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 174.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.417 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 12.5 m-85 -70.28 -39.51 74.87 Favored 'General case' 0 CA--C 1.556 1.174 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 172.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.412 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 47.0 ttp180 -58.97 -40.64 85.39 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 120.182 1.355 . . . . 0.0 114.301 167.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.6 tpt180 -62.51 -39.46 93.59 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 115.116 1.525 . . . . 0.0 115.116 169.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 50.5 m-80 -68.53 -26.56 65.5 Favored 'General case' 0 CA--C 1.578 2.026 0 N-CA-C 115.275 1.583 . . . . 0.0 115.275 168.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 88.1 mt -63.89 -45.38 97.14 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.241 0 CA-C-N 120.267 1.394 . . . . 0.0 111.063 166.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -62.59 -40.86 98.24 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 173.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -64.64 -45.31 87.35 Favored 'General case' 0 CA--C 1.56 1.358 0 N-CA-C 115.813 1.783 . . . . 0.0 115.813 173.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.64 68.46 0.94 Allowed Glycine 0 CA--C 1.541 1.668 0 CA-C-O 118.452 -1.193 . . . . 0.0 113.555 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.807 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 63.9 p -97.48 -41.87 7.98 Favored 'General case' 0 N--CA 1.5 2.057 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -177.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.807 ' HB2' ' O ' ' A' ' 43' ' ' THR . 76.6 mttt 97.67 -38.75 0.01 OUTLIER 'General case' 0 CA--C 1.573 1.863 0 CA-C-O 116.904 -1.522 . . . . 0.0 111.869 -170.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -78.02 -18.66 55.62 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-N 122.246 2.293 . . . . 0.0 113.42 163.497 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.72 -53.4 46.25 Favored Glycine 0 C--N 1.356 1.657 0 CA-C-N 120.366 1.439 . . . . 0.0 115.332 172.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.627 ' O ' ' HB2' ' A' ' 51' ' ' ARG 0.27 11.8 p -77.91 -44.1 28.44 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.649 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 -169.673 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 5.6 tt0 -59.35 -52.95 63.44 Favored 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 121.072 1.76 . . . . 0.0 113.315 169.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.69 -33.25 73.64 Favored 'General case' 0 N--CA 1.484 1.24 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 -176.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.417 ' HB2' ' HB3' ' A' ' 35' ' ' PHE . 13.2 tmtt? -75.28 -19.93 59.41 Favored 'General case' 0 CA--C 1.562 1.442 0 CA-C-O 116.915 -1.517 . . . . 0.0 113.329 166.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . 0.627 ' HB2' ' O ' ' A' ' 47' ' ' VAL . 34.5 ttt180 -76.81 -53.04 8.45 Favored 'General case' 0 CA--C 1.589 2.47 1 CA-C-O 86.371 -16.061 . . . . 0.0 118.169 -179.479 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . 0.34 0.0 OUTLIER -40.92 -61.7 0.93 Allowed 'General case' 0 N--CA 1.511 2.605 1 O-C-N 109.99 -7.944 . . . . 0.0 119.559 147.869 . . . . . . . . 4 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 61.0 mt -52.0 -31.67 30.58 Favored 'General case' 0 N--CA 1.52 3.067 0 N-CA-C 116.182 1.919 . . . . 0.0 116.182 178.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -93.46 -44.22 8.35 Favored 'General case' 0 CA--C 1.567 1.61 0 N-CA-C 116.912 2.19 . . . . 0.0 116.912 170.154 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -110.12 -10.56 14.66 Favored 'General case' 0 N--CA 1.492 1.674 0 N-CA-C 119.041 2.978 . . . . 0.0 119.041 -168.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.51 42.62 9.04 Favored Glycine 0 CA--C 1.541 1.679 0 CA-C-N 122.094 2.225 . . . . 0.0 116.269 -177.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 24.8 t70 -91.31 -175.52 4.28 Favored 'General case' 0 CA--C 1.568 1.636 0 CA-C-O 122.24 1.019 . . . . 0.0 110.739 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 65.4 mt -103.82 104.25 14.23 Favored 'General case' 0 N--CA 1.481 1.094 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 177.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 59.9 t -142.55 122.04 7.83 Favored Pre-proline 0 CA--C 1.584 2.259 0 CA-C-O 117.867 -1.063 . . . . 0.0 108.141 -170.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_exo -57.63 170.1 2.08 Favored 'Trans proline' 0 CA--C 1.567 2.153 0 C-N-CA 124.278 3.319 . . . . 0.0 119.791 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 50.3 m -96.13 -169.4 1.92 Allowed 'General case' 0 CA--C 1.576 1.976 0 C-N-CA 124.444 1.098 . . . . 0.0 112.995 -178.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.278 19.1 m-20 80.55 -51.01 0.33 Allowed 'General case' 0 N--CA 1.493 1.699 0 C-N-CA 126.765 2.026 . . . . 0.0 115.144 172.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -57.44 -39.58 76.57 Favored 'General case' 0 N--CA 1.505 2.298 0 CA-C-N 120.359 1.436 . . . . 0.0 114.667 167.813 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.3 m -60.29 -47.51 85.71 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 114.669 -1.15 . . . . 0.0 112.688 172.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -62.92 -27.69 69.55 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 115.774 1.768 . . . . 0.0 115.774 168.051 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -68.36 -44.48 75.13 Favored 'General case' 0 CA--C 1.553 1.083 0 CA-C-N 120.886 1.675 . . . . 0.0 114.523 171.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 9.9 mt -64.41 -38.57 91.5 Favored 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 168.637 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 49.0 t -57.58 -53.0 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 CA-C-O 117.885 -1.055 . . . . 0.0 111.998 169.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -59.63 -37.32 78.33 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 116.436 2.013 . . . . 0.0 116.436 172.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -55.8 -49.02 74.36 Favored 'General case' 0 N--CA 1.485 1.281 0 CA-C-O 116.715 -1.612 . . . . 0.0 113.084 170.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 61.3 mtp180 -88.94 7.85 32.45 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 120.515 3.524 . . . . 0.0 120.515 167.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 63.9 mt -66.19 -49.73 66.3 Favored 'General case' 0 CA--C 1.554 1.126 0 N-CA-C 105.227 -2.138 . . . . 0.0 105.227 151.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 72.3 m-80 48.81 40.07 15.46 Favored 'General case' 0 N--CA 1.503 2.2 0 CA-C-N 121.533 1.969 . . . . 0.0 110.981 -165.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.8 p-10 -30.53 -32.91 0.03 OUTLIER Pre-proline 0 CA--C 1.573 1.84 1 N-CA-C 127.349 6.055 . . . . 0.0 127.349 -161.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_exo -58.61 -16.24 29.31 Favored 'Trans proline' 0 N--CA 1.511 2.504 1 CA-C-N 129.85 4.553 . . . . 0.0 118.963 168.012 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 22.7 m-20 -96.88 -18.83 19.26 Favored 'General case' 0 CA--C 1.577 2.01 0 CA-C-N 110.82 -2.9 . . . . 0.0 113.587 164.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -109.17 25.04 12.27 Favored 'General case' 0 CA--C 1.58 2.112 0 CA-C-N 125.146 3.612 . . . . 0.0 114.221 168.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -70.6 -36.78 73.71 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-N 120.989 1.722 . . . . 0.0 115.148 178.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 25.4 m120 -105.89 18.99 21.27 Favored 'General case' 0 CA--C 1.576 1.957 0 CA-C-O 117.555 -1.212 . . . . 0.0 113.747 168.779 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.402 ' HA2' ' HB3' ' A' ' 2' ' ' ARG . . . -177.56 153.42 13.38 Favored Glycine 0 C--N 1.361 1.957 0 CA-C-N 122.344 2.338 . . . . 0.0 115.376 169.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.403 ' O ' ' HB2' ' A' ' 2' ' ' ARG . 23.2 p90 -173.98 135.74 0.5 Allowed 'General case' 0 N--CA 1.491 1.624 0 CA-C-N 112.585 -1.807 . . . . 0.0 109.827 168.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 33.6 mt -113.83 108.03 24.45 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 173.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 6.8 mt -110.96 122.4 47.79 Favored 'General case' 0 N--CA 1.498 1.949 0 C-N-CA 123.33 0.652 . . . . 0.0 110.2 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -116.01 116.15 27.4 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-N 118.394 0.543 . . . . 0.0 110.746 -169.244 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 84.16 28.07 35.04 Favored Glycine 0 CA--C 1.548 2.138 0 N-CA-C 117.988 1.955 . . . . 0.0 117.988 176.146 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 2.5 t80 -86.68 -57.3 0.33 Allowed Pre-proline 0 CA--C 1.572 1.81 0 CA-C-O 114.297 -2.763 . . . . 0.0 110.791 175.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_exo -61.88 50.25 0.1 OUTLIER 'Trans proline' 0 CA--C 1.578 2.719 0 N-CA-C 120.664 3.294 . . . . 0.0 120.664 167.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 1.264 ' NH2' HH12 ' A' ' 140' ' ' ARG . 0.0 OUTLIER -80.23 7.43 9.42 Favored 'General case' 0 CA--C 1.57 1.727 0 N-CA-C 115.988 1.847 . . . . 0.0 115.988 167.721 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 48.5 t -155.63 135.14 12.47 Favored 'General case' 0 CA--C 1.548 0.902 0 N-CA-C 103.221 -2.881 . . . . 0.0 103.221 170.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 12.0 t -61.77 -34.21 61.33 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.314 0 CA-C-O 117.287 -1.34 . . . . 0.0 111.541 176.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -54.98 -35.39 64.27 Favored 'General case' 0 CA--C 1.564 1.505 0 N-CA-C 119.624 3.194 . . . . 0.0 119.624 165.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 29.0 mm100 -72.26 -48.12 45.06 Favored 'General case' 0 CA--C 1.591 2.52 0 CA-C-N 121.679 2.036 . . . . 0.0 112.087 165.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -64.45 -33.18 75.29 Favored 'General case' 0 N--CA 1.486 1.346 0 N-CA-C 116.677 2.103 . . . . 0.0 116.677 -169.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 38.2 tttp -61.25 -27.72 68.65 Favored 'General case' 0 N--CA 1.483 1.196 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 167.043 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -72.82 -42.45 63.8 Favored 'General case' 0 CA--C 1.567 1.617 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 168.295 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 36.8 tp -61.62 -40.83 96.23 Favored 'General case' 0 N--CA 1.496 1.842 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 169.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 43.7 t60 -64.09 -41.24 97.37 Favored 'General case' 0 N--CA 1.49 1.529 0 CA-C-N 120.045 1.293 . . . . 0.0 113.986 169.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.705 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 29.7 tt0 -54.55 -40.84 69.09 Favored 'General case' 0 CA--C 1.567 1.61 0 CA-C-O 117.948 -1.025 . . . . 0.0 113.608 167.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 1.253 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 26.3 mmt -83.36 -21.26 33.16 Favored 'General case' 0 N--CA 1.492 1.637 0 N-CA-C 117.553 2.427 . . . . 0.0 117.553 175.637 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 2.6 tt -73.06 -52.39 14.51 Favored 'General case' 0 N--CA 1.5 2.04 0 CA-C-N 121.437 1.926 . . . . 0.0 110.39 172.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 59.3 mt-10 -75.37 -55.85 5.29 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 172.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.705 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 31.8 ttm180 -69.28 -39.81 78.14 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 178.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 1.253 ' HB3' ' O ' ' A' ' 99' ' ' MET . 76.5 ttt180 -63.45 -56.81 13.15 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 119.464 1.029 . . . . 0.0 111.036 165.159 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 109.27 50.0 0.74 Allowed Glycine 0 N--CA 1.483 1.794 0 O-C-N 124.184 0.927 . . . . 0.0 113.886 168.267 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 51.3 p -91.15 150.58 21.32 Favored 'General case' 0 CA--C 1.559 1.29 0 CA-C-N 113.481 -1.36 . . . . 0.0 109.797 176.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 -67.94 132.55 47.53 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.899 -0.501 . . . . 0.0 112.053 178.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 6.3 tp -95.07 101.74 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 106.855 -1.535 . . . . 0.0 106.855 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -95.78 -69.45 0.75 Allowed 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 116.399 -1.763 . . . . 0.0 108.796 169.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -155.33 128.64 8.33 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 121.629 2.013 . . . . 0.0 113.929 177.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 33.3 t -93.72 108.37 20.46 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.726 0 N-CA-C 102.838 -3.023 . . . . 0.0 102.838 163.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.648 HD23 ' HB2' ' A' ' 160' ' ' LYS . 86.9 mt -101.43 110.8 22.87 Favored 'General case' 0 N--CA 1.491 1.576 0 C-N-CA 123.776 0.83 . . . . 0.0 110.716 -169.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -89.57 121.23 31.58 Favored 'General case' 0 N--CA 1.485 1.314 0 CA-C-O 121.638 0.732 . . . . 0.0 109.055 172.199 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 4.3 m-85 -92.61 117.05 29.57 Favored 'General case' 0 CA--C 1.557 1.227 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 175.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.494 ' HB3' ' HA ' ' A' ' 163' ' ' ASP . 19.7 tpt180 -87.55 91.48 8.75 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 112.821 -1.99 . . . . 0.0 107.31 173.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.4 m -142.16 116.21 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.969 0 CA-C-N 112.839 -1.982 . . . . 0.0 106.038 -165.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 18.9 p -66.86 120.7 14.0 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-O 121.997 0.903 . . . . 0.0 113.01 -172.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -54.89 -45.93 74.73 Favored 'General case' 0 N--CA 1.499 1.998 0 N-CA-C 115.573 1.694 . . . . 0.0 115.573 -178.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -49.2 -29.5 5.69 Favored 'General case' 0 CA--C 1.558 1.255 0 N-CA-C 118.217 2.673 . . . . 0.0 118.217 176.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 4.5 t -63.5 -48.26 87.85 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 CA-C-N 120.625 1.557 . . . . 0.0 113.865 178.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 9.0 mp -73.24 -23.32 60.33 Favored 'General case' 0 N--CA 1.501 2.118 0 CA-C-O 116.74 -1.6 . . . . 0.0 113.992 168.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 48.0 mt -66.07 -45.88 79.72 Favored 'General case' 0 N--CA 1.502 2.125 0 CA-C-N 121.996 2.18 . . . . 0.0 115.143 169.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -65.09 -36.8 85.45 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 114.316 1.228 . . . . 0.0 114.316 170.037 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 70.0 ttt180 -55.35 -55.92 26.0 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 115.593 1.701 . . . . 0.0 115.593 168.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 3.7 pp -66.76 -34.21 77.34 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 177.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -77.33 -64.83 1.05 Allowed 'General case' 0 N--CA 1.486 1.328 0 CA-C-N 120.91 1.686 . . . . 0.0 113.335 173.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.563 ' O ' ' HB2' ' A' ' 127' ' ' ARG . . . 60.01 43.94 97.71 Favored Glycine 0 CA--C 1.548 2.148 0 N-CA-C 118.616 2.206 . . . . 0.0 118.616 170.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.563 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 76.6 mtp85 76.14 93.38 0.07 Allowed 'General case' 0 N--CA 1.484 1.248 0 CA-C-N 118.028 0.914 . . . . 0.0 111.104 -174.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 96.02 -176.43 33.18 Favored Glycine 0 CA--C 1.572 3.606 0 CA-C-O 118.854 -0.97 . . . . 0.0 113.278 -172.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 32.7 ptt180 -171.37 177.39 3.55 Favored 'General case' 0 N--CA 1.485 1.318 0 CA-C-N 121.316 2.558 . . . . 0.0 114.428 -176.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -127.91 30.18 5.31 Favored 'General case' 0 CA--C 1.571 1.758 0 CA-C-N 113.233 -1.803 . . . . 0.0 113.806 168.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 57.72 12.09 1.53 Allowed 'General case' 0 N--CA 1.506 2.335 0 N-CA-C 119.138 3.014 . . . . 0.0 119.138 -179.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -87.19 52.08 2.42 Favored 'General case' 0 CA--C 1.58 2.106 0 CA-C-O 122.988 1.375 . . . . 0.0 109.176 162.24 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 73.3 p -140.55 -118.83 0.12 Allowed 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 113.998 -1.455 . . . . 0.0 109.494 -162.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -56.85 -41.28 77.66 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 116.728 2.121 . . . . 0.0 116.728 -169.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -71.64 -38.91 70.68 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 177.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.997 ' O ' ' HG2' ' A' ' 140' ' ' ARG . 50.8 t -62.72 -38.58 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.774 0 C-N-CA 124.122 0.969 . . . . 0.0 112.539 168.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 1.7 mp -72.35 -29.81 32.89 Favored 'Isoleucine or valine' 0 CA--C 1.576 1.962 0 CA-C-O 117.546 -1.216 . . . . 0.0 113.205 173.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 31.2 mt -66.66 -46.38 75.9 Favored 'General case' 0 N--CA 1.493 1.698 0 CA-C-N 121.382 1.901 . . . . 0.0 113.881 170.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 4.1 t30 -65.94 -37.52 86.26 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 114.849 1.425 . . . . 0.0 114.849 171.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 1.264 HH12 ' NH2' ' A' ' 88' ' ' ARG . 12.2 mmm180 -59.77 -42.13 92.64 Favored 'General case' 0 N--CA 1.493 1.711 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 169.484 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 58.9 mtt -66.49 -31.01 71.47 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 115.543 1.682 . . . . 0.0 115.543 169.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 61.7 tttm -63.64 -49.14 74.41 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 115.64 1.718 . . . . 0.0 115.64 169.411 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . 0.6 HG11 HH22 ' A' ' 88' ' ' ARG . 7.8 p -64.57 -33.41 62.91 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.104 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 169.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 24.0 t80 -56.19 -52.36 64.68 Favored 'General case' 0 CA--C 1.581 2.168 0 CA-C-N 119.559 1.072 . . . . 0.0 111.779 167.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 31.1 ttp180 -52.19 -31.55 32.16 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 119.427 3.121 . . . . 0.0 119.427 170.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -48.47 -51.04 28.95 Favored 'General case' 0 N--CA 1.503 2.177 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 170.75 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -140.34 7.61 2.18 Favored 'General case' 0 CA--C 1.56 1.362 0 N-CA-C 119.944 3.312 . . . . 0.0 119.944 -167.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 23.9 m -55.27 -34.41 64.03 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 116.194 1.924 . . . . 0.0 116.194 178.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.14 -59.92 5.71 Favored Pre-proline 0 CA--C 1.578 2.054 0 CA-C-O 116.662 -1.637 . . . . 0.0 111.881 172.678 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_exo -50.15 -31.3 28.12 Favored 'Trans proline' 0 CA--C 1.576 2.616 0 C-N-CA 123.365 2.71 . . . . 0.0 118.374 167.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.01 -55.58 18.13 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 125.391 1.476 . . . . 0.0 112.217 175.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 1.047 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 46.1 tp -65.32 -23.51 67.03 Favored 'General case' 0 CA--C 1.564 1.511 0 CA-C-O 116.504 -1.712 . . . . 0.0 114.704 176.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -71.55 -48.95 45.25 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-N 122.393 2.361 . . . . 0.0 113.444 165.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 7.1 t80 -67.16 -51.6 51.71 Favored 'General case' 0 CA--C 1.566 1.57 0 CA-C-N 120.042 1.292 . . . . 0.0 112.014 -177.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 83.4 m-85 -80.81 -25.3 37.9 Favored 'General case' 0 CA--C 1.554 1.127 0 CA-C-O 114.715 -2.564 . . . . 0.0 112.53 178.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 1.047 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 38.1 ttt180 -64.31 -35.63 81.48 Favored 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 124.893 3.497 . . . . 0.0 115.938 168.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -67.94 -37.74 81.97 Favored 'General case' 0 CA--C 1.574 1.89 0 CA-C-N 119.697 1.135 . . . . 0.0 113.949 167.303 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 40.9 mt-30 -80.71 -38.2 29.3 Favored 'General case' 0 CA--C 1.574 1.89 0 N-CA-C 119.351 3.093 . . . . 0.0 119.351 178.385 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.3 pp -78.08 173.69 11.94 Favored 'General case' 0 N--CA 1.497 1.901 0 N-CA-C 119.675 3.213 . . . . 0.0 119.675 -160.271 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.648 ' HB2' HD23 ' A' ' 111' ' ' LEU . 91.0 mttt -124.83 134.35 52.77 Favored 'General case' 0 CA--C 1.561 1.399 0 N-CA-C 105.939 -1.875 . . . . 0.0 105.939 166.027 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 60.4 m -98.1 148.95 23.03 Favored 'General case' 0 N--CA 1.491 1.609 0 CA-C-O 122.79 1.281 . . . . 0.0 111.222 -170.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.471 HG13 ' HG3' ' A' ' 174' ' ' ARG . 44.8 t -127.84 138.67 54.05 Favored 'Isoleucine or valine' 0 CA--C 1.574 1.871 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 167.024 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.494 ' HA ' ' HB3' ' A' ' 114' ' ' ARG . 14.7 t70 -114.95 127.32 55.62 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 106.261 -1.755 . . . . 0.0 106.261 170.308 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -151.53 -159.8 1.07 Allowed 'General case' 0 CA--C 1.566 1.583 0 N-CA-C 116.392 1.997 . . . . 0.0 116.392 -160.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.509 HG22 ' H ' ' A' ' 166' ' ' GLY 0.511 5.7 p 58.28 178.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.905 0 C-N-CA 129.153 2.981 . . . . 0.0 114.498 -179.376 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.509 ' H ' HG22 ' A' ' 165' ' ' VAL . . . 72.52 -17.41 1.52 Allowed Glycine 0 CA--C 1.559 2.843 0 N-CA-C 117.821 1.888 . . . . 0.0 117.821 -151.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 82.7 p -141.28 145.38 35.44 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 118.735 1.267 . . . . 0.0 110.91 -168.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 26.4 ptt? -88.88 -67.62 0.82 Allowed 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 118.751 -0.642 . . . . 0.0 112.143 174.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -70.03 -37.04 75.49 Favored 'General case' 0 N--CA 1.505 2.313 0 N-CA-C 115.961 1.837 . . . . 0.0 115.961 -176.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . 0.97 ' HB3' HH21 ' A' ' 174' ' ' ARG . 47.6 mt-10 -59.42 -42.04 90.92 Favored 'General case' 0 N--CA 1.489 1.475 0 CA-C-O 117.294 -1.336 . . . . 0.0 114.522 175.305 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 44.4 t -56.54 -38.65 57.79 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.224 0 CA-C-N 120.991 1.723 . . . . 0.0 113.419 172.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.729 ' CE1' ' HB3' ' A' ' 19' ' ' LYS . 22.8 t80 -57.95 -40.51 80.7 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 120.796 1.635 . . . . 0.0 115.103 166.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.558 ' O ' ' HB2' ' A' ' 177' ' ' ARG . . . -61.03 -50.85 71.64 Favored 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 179.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.97 HH21 ' HB3' ' A' ' 170' ' ' GLU . 11.7 ptp180 -73.32 -25.19 60.53 Favored 'General case' 0 CA--C 1.559 1.322 0 N-CA-C 117.582 2.438 . . . . 0.0 117.582 171.056 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.11 -49.73 73.27 Favored 'General case' 0 N--CA 1.49 1.554 0 CA-C-N 120.346 1.43 . . . . 0.0 114.715 169.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . 0.254 0.2 OUTLIER -66.77 -37.86 85.44 Favored 'General case' 0 N--CA 1.503 2.208 0 CA-C-N 119.531 1.06 . . . . 0.0 113.429 167.471 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . 0.619 ' HB2' ' HA ' ' A' ' 174' ' ' ARG . 17.3 ttt180 -43.55 -44.05 5.89 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 117.126 2.269 . . . . 0.0 117.126 167.594 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -71.13 -53.98 12.65 Favored 'General case' 0 CA--C 1.564 1.497 0 CA-C-O 118.204 -0.903 . . . . 0.0 113.208 166.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -99.05 -59.6 1.7 Allowed 'General case' 0 CA--C 1.565 1.528 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -169.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.885 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -79.39 -39.14 19.55 Favored Glycine 0 CA--C 1.55 2.276 0 CA-C-N 121.388 1.904 . . . . 0.0 117.737 -171.46 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.885 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 85.9 tttt . . . . . 0 C--O 1.251 1.142 0 CA-C-N 118.482 1.141 . . . . 0.0 108.623 -178.71 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.6 mtt . . . . . 0 CA--C 1.555 1.171 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.783 HH21 HD21 ' A' ' 4' ' ' LEU . 2.4 ptm180 -160.96 162.79 32.03 Favored 'General case' 0 N--CA 1.495 1.815 0 N-CA-C 116.495 2.035 . . . . 0.0 116.495 -167.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.551 HG13 HG23 ' A' ' 82' ' ' ILE . 8.5 p -131.4 145.69 34.84 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.4 0 CA-C-O 123.299 1.523 . . . . 0.0 110.956 -170.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.783 HD21 HH21 ' A' ' 2' ' ' ARG . 1.2 mm? -118.12 157.07 27.57 Favored 'General case' 0 CA--C 1.562 1.442 0 CA-C-N 112.853 -1.976 . . . . 0.0 108.52 168.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.439 HD22 ' HG2' ' A' ' 13' ' ' LYS . 0.4 OUTLIER -128.23 117.07 20.87 Favored 'General case' 0 CA--C 1.569 1.69 0 CA-C-N 115.134 -0.939 . . . . 0.0 112.201 -174.042 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 16.0 mt -116.17 158.48 23.2 Favored 'General case' 0 CA--C 1.562 1.405 0 C-N-CA 127.669 2.387 . . . . 0.0 111.749 179.419 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.69 118.78 0.63 Allowed Glycine 0 CA--C 1.556 2.61 0 CA-C-O 116.996 -2.002 . . . . 0.0 114.029 178.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -70.83 -178.07 2.56 Favored 'Trans proline' 0 CA--C 1.584 3.002 0 CA-C-N 122.572 3.186 . . . . 0.0 114.009 169.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_exo -48.03 125.98 12.52 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 124.132 3.221 . . . . 0.0 116.111 -178.652 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.57 101.74 2.41 Favored Glycine 0 CA--C 1.538 1.476 0 N-CA-C 106.093 -2.803 . . . . 0.0 106.093 -165.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -81.02 129.58 34.61 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 113.931 1.086 . . . . 0.0 113.931 -169.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -166.57 98.94 0.15 Allowed Glycine 0 N--CA 1.48 1.598 0 N-CA-C 110.332 -1.107 . . . . 0.0 110.332 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.439 ' HG2' HD22 ' A' ' 5' ' ' LEU . 37.3 mtmm -158.34 -65.63 0.09 Allowed 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 122.896 0.478 . . . . 0.0 111.434 -172.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -54.04 -36.87 57.21 Favored Glycine 0 CA--C 1.552 2.346 0 N-CA-C 120.87 3.108 . . . . 0.0 120.87 -173.096 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 90.0 m -68.74 -49.09 61.61 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-N 119.397 1.598 . . . . 0.0 113.145 179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.282 25.4 mp0 -77.57 -12.06 59.93 Favored 'General case' 0 CA--C 1.574 1.886 0 CA-C-O 115.325 -2.274 . . . . 0.0 112.071 169.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.07 -45.9 58.93 Favored 'General case' 0 C--N 1.373 1.61 0 CA-C-N 124.809 3.459 . . . . 0.0 114.389 167.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 86.2 t -67.01 -40.95 86.65 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.766 0 CA-C-O 117.523 -1.227 . . . . 0.0 111.793 171.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 62.3 mmtt -62.62 -45.23 93.83 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 116.605 2.076 . . . . 0.0 116.605 171.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -68.26 -32.92 73.43 Favored 'General case' 0 N--CA 1.501 2.114 0 CA-C-N 120.227 1.376 . . . . 0.0 113.85 173.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -62.03 -40.97 97.52 Favored 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 166.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -58.17 -40.25 80.97 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 166.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 36.9 tptt -68.62 -54.01 19.09 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 115.177 1.547 . . . . 0.0 115.177 177.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 92.9 mt -83.31 -19.86 35.46 Favored 'General case' 0 CA--C 1.57 1.739 0 N-CA-C 116.972 2.212 . . . . 0.0 116.972 178.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.48 39.89 7.55 Favored Glycine 0 CA--C 1.554 2.482 0 N-CA-C 117.543 1.777 . . . . 0.0 117.543 -177.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.515 ' CG2' ' HA ' ' A' ' 81' ' ' PHE . 18.8 mm -110.1 157.87 36.71 Favored Pre-proline 0 CA--C 1.572 1.827 0 CA-C-N 118.531 1.166 . . . . 0.0 113.457 -168.261 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -84.49 99.79 0.76 Allowed 'Trans proline' 0 CA--C 1.568 2.182 0 CA-C-N 122.146 1.802 . . . . 0.0 110.062 163.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -66.26 113.66 4.75 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.448 -0.783 . . . . 0.0 111.276 172.027 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 32.3 mm -98.12 108.14 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 N-CA-C 104.501 -2.407 . . . . 0.0 104.501 179.58 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 73.9 m -95.45 128.45 42.32 Favored 'General case' 0 N--CA 1.477 0.915 0 N-CA-C 105.763 -1.94 . . . . 0.0 105.763 168.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 25.3 p -71.27 -8.28 52.6 Favored 'General case' 0 N--CA 1.492 1.648 0 N-CA-C 116.94 2.2 . . . . 0.0 116.94 -172.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -87.12 -21.86 47.65 Favored Glycine 0 CA--C 1.551 2.288 0 N-CA-C 118.106 2.003 . . . . 0.0 118.106 165.361 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -79.79 -51.55 9.03 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 114.507 1.299 . . . . 0.0 114.507 -168.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -62.09 -41.85 98.61 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 113.107 0.78 . . . . 0.0 113.107 172.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.431 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 26.0 m-85 -60.73 -37.08 80.54 Favored 'General case' 0 CA--C 1.564 1.513 0 N-CA-C 116.259 1.948 . . . . 0.0 116.259 168.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 49.4 ttp180 -60.09 -42.96 95.76 Favored 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 120.017 1.28 . . . . 0.0 114.035 167.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 33.8 ttt180 -60.33 -38.87 85.11 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 168.105 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 76.5 m-20 -66.25 -28.14 68.49 Favored 'General case' 0 CA--C 1.575 1.923 0 N-CA-C 115.383 1.623 . . . . 0.0 115.383 168.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 73.9 mt -63.73 -46.74 93.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.107 0 CA-C-N 120.131 1.332 . . . . 0.0 111.434 168.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -65.35 -36.39 83.87 Favored 'General case' 0 N--CA 1.492 1.639 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 172.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -78.38 -32.08 48.71 Favored 'General case' 0 CA--C 1.562 1.422 0 N-CA-C 116.715 2.117 . . . . 0.0 116.715 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 87.14 73.69 1.28 Allowed Glycine 0 CA--C 1.544 1.855 0 CA-C-O 118.348 -1.251 . . . . 0.0 114.884 -179.788 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.843 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 68.6 p -97.62 -44.53 6.75 Favored 'General case' 0 N--CA 1.502 2.172 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 178.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.843 ' HB2' ' O ' ' A' ' 43' ' ' THR . 76.9 mttt 102.35 -39.16 0.01 OUTLIER 'General case' 0 CA--C 1.579 2.072 0 CA-C-O 117.372 -1.299 . . . . 0.0 112.202 -171.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -89.01 1.8 54.98 Favored 'General case' 0 CA--C 1.58 2.103 0 CA-C-N 121.805 2.093 . . . . 0.0 113.251 163.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -81.9 -54.48 3.41 Favored Glycine 0 C--N 1.349 1.299 0 O-C-N 120.761 -1.212 . . . . 0.0 114.657 169.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.303 4.0 p -75.95 -52.38 18.02 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.441 0 N-CA-C 115.073 1.509 . . . . 0.0 115.073 -168.387 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -67.19 -48.93 66.42 Favored 'General case' 0 N--CA 1.487 1.376 0 CA-C-N 120.586 1.539 . . . . 0.0 112.307 175.235 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -71.81 -19.32 62.01 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -179.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.431 ' HB2' ' HB3' ' A' ' 35' ' ' PHE . 14.2 tmtt? -74.64 -47.02 34.37 Favored 'General case' 0 N--CA 1.485 1.303 0 CA-C-O 117.111 -1.423 . . . . 0.0 111.825 165.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 60.0 mtp180 -67.71 -53.55 26.66 Favored 'General case' 0 CA--C 1.591 2.539 1 CA-C-O 86.12 -16.181 . . . . 0.0 118.001 -173.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 15.9 m-30 -31.62 -64.41 0.16 Allowed 'General case' 0 N--CA 1.496 1.848 1 O-C-N 110.232 -7.793 . . . . 0.0 120.803 146.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.5 tp -60.8 -23.97 65.46 Favored 'General case' 0 CA--C 1.579 2.095 0 CA-C-N 122.201 2.273 . . . . 0.0 116.779 172.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 2.8 t70 -92.58 -43.27 9.22 Favored 'General case' 0 CA--C 1.569 1.68 0 C-N-CA 126.332 1.853 . . . . 0.0 114.737 168.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -81.41 -48.01 12.47 Favored 'General case' 0 N--CA 1.493 1.69 0 CA-C-N 120.741 1.609 . . . . 0.0 115.318 -176.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 116.99 41.42 0.71 Allowed Glycine 0 CA--C 1.539 1.542 0 N-CA-C 116.389 1.316 . . . . 0.0 116.389 169.383 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -105.73 -132.47 0.31 Allowed 'General case' 0 CA--C 1.572 1.802 0 CA-C-O 118.584 -0.722 . . . . 0.0 109.479 168.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 85.9 mt -108.23 109.95 21.44 Favored 'General case' 0 N--CA 1.492 1.629 0 CA-C-N 120.163 1.347 . . . . 0.0 111.334 -168.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.9 p -117.11 129.49 25.29 Favored Pre-proline 0 CA--C 1.573 1.829 0 CA-C-O 117.796 -1.097 . . . . 0.0 110.225 178.593 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -60.73 145.2 99.31 Favored 'Trans proline' 0 C--N 1.373 1.835 0 C-N-CA 123.475 2.783 . . . . 0.0 116.288 173.722 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 98.8 p -78.12 -45.07 24.32 Favored 'General case' 0 N--CA 1.49 1.571 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 178.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 17.2 m-20 -66.82 -40.65 88.08 Favored 'General case' 0 N--CA 1.502 2.151 0 N-CA-C 115.726 1.751 . . . . 0.0 115.726 -175.713 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.67 -43.88 97.13 Favored 'General case' 0 N--CA 1.506 2.341 0 N-CA-C 115.165 1.543 . . . . 0.0 115.165 172.219 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 8.3 m -61.46 -41.19 96.86 Favored 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 114.201 -1.363 . . . . 0.0 112.986 173.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -65.08 -26.58 68.29 Favored 'General case' 0 CA--C 1.562 1.419 0 N-CA-C 115.468 1.655 . . . . 0.0 115.468 166.74 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -67.41 -46.49 73.06 Favored 'General case' 0 CA--C 1.555 1.139 0 N-CA-C 115.726 1.75 . . . . 0.0 115.726 170.392 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 14.8 mt -60.64 -48.28 82.49 Favored 'General case' 0 N--CA 1.497 1.903 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 169.129 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 55.5 t -58.99 -52.17 63.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.72 0 C-N-CA 124.024 0.93 . . . . 0.0 112.435 174.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -62.68 -31.16 72.0 Favored 'General case' 0 N--CA 1.493 1.688 0 N-CA-C 116.344 1.979 . . . . 0.0 116.344 173.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -58.74 -42.99 90.08 Favored 'General case' 0 N--CA 1.488 1.451 0 CA-C-O 117.558 -1.211 . . . . 0.0 113.462 169.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 75.3 mtt180 -81.35 -16.78 51.31 Favored 'General case' 0 N--CA 1.494 1.729 0 N-CA-C 119.217 3.043 . . . . 0.0 119.217 168.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 88.7 mt -92.82 -17.88 23.57 Favored 'General case' 0 N--CA 1.494 1.728 0 N-CA-C 117.067 2.247 . . . . 0.0 117.067 177.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 -71.95 9.03 1.02 Allowed 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 169.17 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.9 t-20 -67.95 141.77 94.78 Favored Pre-proline 0 CA--C 1.574 1.896 0 CA-C-O 117.816 -1.088 . . . . 0.0 109.837 166.116 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -48.59 -36.69 32.56 Favored 'Trans proline' 0 N--CA 1.5 1.898 0 N-CA-C 119.419 2.815 . . . . 0.0 119.419 174.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 18.8 p30 -65.65 -19.54 65.95 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 116.824 2.157 . . . . 0.0 116.824 172.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -100.7 9.19 42.75 Favored 'General case' 0 CA--C 1.572 1.811 0 CA-C-N 121.696 2.044 . . . . 0.0 115.897 171.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.62 -45.23 83.87 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 121.148 1.794 . . . . 0.0 114.51 169.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 69.6 m-80 -93.17 16.18 13.62 Favored 'General case' 0 CA--C 1.577 1.998 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 173.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 166.82 163.95 21.55 Favored Glycine 0 C--N 1.354 1.552 0 CA-C-N 121.336 1.88 . . . . 0.0 114.298 169.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.515 ' HA ' ' CG2' ' A' ' 26' ' ' ILE . 28.8 p90 -165.85 139.56 4.41 Favored 'General case' 0 N--CA 1.493 1.71 0 CA-C-N 113.236 -1.482 . . . . 0.0 111.967 175.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.551 HG23 HG13 ' A' ' 3' ' ' VAL . 1.3 mm -101.39 110.39 28.12 Favored 'Isoleucine or valine' 0 CA--C 1.571 1.764 0 N-CA-C 104.624 -2.361 . . . . 0.0 104.624 170.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.9 mt -106.09 130.22 54.03 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.664 -0.865 . . . . 0.0 108.664 174.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -128.99 117.85 21.62 Favored 'General case' 0 N--CA 1.496 1.873 0 CA-C-N 119.206 0.912 . . . . 0.0 110.916 -166.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 76.06 36.72 40.02 Favored Glycine 0 CA--C 1.55 2.231 0 N-CA-C 118.051 1.981 . . . . 0.0 118.051 -176.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . 0.256 2.3 t80 -107.24 -66.14 0.04 OUTLIER Pre-proline 0 N--CA 1.497 1.921 0 CA-C-O 113.834 -2.984 . . . . 0.0 112.105 -176.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 33.6 Cg_exo -61.79 47.97 0.09 OUTLIER 'Trans proline' 0 CA--C 1.576 2.602 0 N-CA-C 122.229 3.896 . . . . 0.0 122.229 171.155 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -64.42 -21.76 66.74 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 116.821 2.156 . . . . 0.0 116.821 166.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 36.6 t -131.14 146.84 52.5 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 -172.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -61.89 -35.78 70.02 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.724 0 CA-C-O 117.26 -1.352 . . . . 0.0 110.827 169.543 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.56 -45.66 81.14 Favored 'General case' 0 CA--C 1.559 1.323 0 N-CA-C 120.524 3.528 . . . . 0.0 120.524 168.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.8 mm100 -67.32 -47.47 70.44 Favored 'General case' 0 CA--C 1.588 2.437 0 CA-C-N 122.264 2.302 . . . . 0.0 112.927 169.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -68.14 -33.1 73.86 Favored 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 116.405 2.002 . . . . 0.0 116.405 -169.179 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 84.8 mttt -63.46 -28.1 69.73 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 166.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.93 -46.31 62.7 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 114.499 1.296 . . . . 0.0 114.499 169.013 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 22.6 tp -64.41 -37.96 89.34 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 114.986 1.476 . . . . 0.0 114.986 173.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 56.6 t60 -68.43 -39.35 81.59 Favored 'General case' 0 CA--C 1.567 1.63 0 CA-C-N 119.695 1.134 . . . . 0.0 113.825 169.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.936 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 22.8 mt-10 -52.2 -41.44 62.69 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 166.654 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 1.056 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 3.3 tpt -84.09 -26.93 28.58 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 117.724 2.49 . . . . 0.0 117.724 175.478 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . 0.637 HD11 ' HB ' ' A' ' 107' ' ' ILE . 30.9 tp -64.28 -55.33 22.11 Favored 'General case' 0 N--CA 1.501 2.096 0 CA-C-N 120.214 1.37 . . . . 0.0 112.393 168.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.6 mm-40 -80.26 -51.68 8.62 Favored 'General case' 0 CA--C 1.562 1.42 0 CA-C-O 118.671 -0.68 . . . . 0.0 112.715 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.936 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 75.0 mtp180 -71.66 -41.06 69.19 Favored 'General case' 0 N--CA 1.494 1.775 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 176.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 1.056 ' HB3' ' O ' ' A' ' 99' ' ' MET . 0.8 OUTLIER -63.2 -55.14 27.5 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 119.759 1.163 . . . . 0.0 110.59 164.638 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 105.67 48.4 1.04 Allowed Glycine 0 N--CA 1.482 1.713 0 O-C-N 123.83 0.706 . . . . 0.0 113.274 169.246 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 29.7 p -99.91 163.61 12.38 Favored 'General case' 0 CA--C 1.56 1.343 0 O-C-N 124.594 0.82 . . . . 0.0 111.074 -178.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 23.9 m-20 -75.56 134.78 40.64 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 121.64 -0.663 . . . . 0.0 111.748 -169.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.637 ' HB ' HD11 ' A' ' 100' ' ' LEU . 8.0 tp -109.64 106.05 19.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 N-CA-C 107.251 -1.388 . . . . 0.0 107.251 179.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.42 -68.21 0.81 Allowed 'General case' 0 N--CA 1.492 1.64 0 CA-C-O 117.446 -1.264 . . . . 0.0 107.701 167.239 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -159.87 136.83 9.34 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 120.601 1.546 . . . . 0.0 115.119 179.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.537 HG22 HD23 ' A' ' 4' ' ' LEU . 48.7 t -91.35 114.38 28.51 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.734 0 N-CA-C 103.733 -2.691 . . . . 0.0 103.733 162.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 84.3 mt -103.04 110.74 22.77 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 123.338 0.655 . . . . 0.0 111.959 -169.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -96.06 124.47 40.08 Favored 'General case' 0 N--CA 1.486 1.373 0 CA-C-O 121.313 0.578 . . . . 0.0 110.849 175.581 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 3.4 m-85 -92.68 123.87 36.28 Favored 'General case' 0 CA--C 1.561 1.388 0 CA-C-O 123.341 1.543 . . . . 0.0 110.147 -173.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 74.3 ttt180 -82.09 95.05 7.34 Favored 'General case' 0 N--CA 1.479 0.978 0 CA-C-N 112.559 -2.109 . . . . 0.0 109.229 168.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 1.6 p -138.55 139.3 41.55 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.299 0 C-N-CA 125.864 1.666 . . . . 0.0 107.348 -168.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.4 m -76.94 140.35 40.45 Favored 'General case' 0 N--CA 1.486 1.369 0 CA-C-N 114.341 -1.299 . . . . 0.0 112.699 -169.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -57.16 -41.78 79.83 Favored 'General case' 0 N--CA 1.5 2.066 0 N-CA-C 115.441 1.645 . . . . 0.0 115.441 169.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -47.41 -36.91 10.48 Favored 'General case' 0 N--CA 1.487 1.383 0 N-CA-C 117.992 2.59 . . . . 0.0 117.992 174.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.3 t -61.14 -51.24 75.43 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.329 0 CA-C-N 119.856 1.207 . . . . 0.0 113.714 176.423 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 14.0 tp -61.08 -39.93 91.78 Favored 'General case' 0 N--CA 1.488 1.47 0 N-CA-C 115.097 1.517 . . . . 0.0 115.097 168.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 9.0 mp -62.45 -43.88 97.75 Favored 'General case' 0 N--CA 1.498 1.932 0 N-CA-C 114.92 1.452 . . . . 0.0 114.92 174.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -66.61 -35.92 81.35 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 114.968 1.47 . . . . 0.0 114.968 171.668 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.442 ' O ' ' HB3' ' A' ' 127' ' ' ARG . 98.9 mtt180 -57.28 -52.85 63.69 Favored 'General case' 0 N--CA 1.49 1.573 0 N-CA-C 115.274 1.583 . . . . 0.0 115.274 168.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 10.5 mp -60.81 -48.96 79.43 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 115.255 1.576 . . . . 0.0 115.255 174.009 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 93.8 mttt -60.15 -46.98 87.84 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 116.406 2.002 . . . . 0.0 116.406 176.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.591 ' O ' ' HB2' ' A' ' 127' ' ' ARG . . . -102.3 56.35 0.66 Allowed Glycine 0 CA--C 1.546 1.979 0 CA-C-N 118.746 0.703 . . . . 0.0 113.978 169.794 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.591 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 35.9 ttm180 154.25 91.76 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 178.224 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.745 ' O ' ' HB2' ' A' ' 129' ' ' ARG . . . -174.42 -44.71 0.05 OUTLIER Glycine 0 CA--C 1.548 2.151 0 N-CA-C 116.639 1.416 . . . . 0.0 116.639 -175.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.745 ' HB2' ' O ' ' A' ' 128' ' ' GLY . 94.2 mtt180 89.6 -128.99 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.161 0 CA-C-N 119.626 1.713 . . . . 0.0 112.319 -175.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.485 ' H ' ' HB3' ' A' ' 129' ' ' ARG . . . -93.68 -41.08 9.9 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 115.127 1.529 . . . . 0.0 115.127 -175.343 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -138.05 62.64 1.56 Allowed 'General case' 0 N--CA 1.496 1.866 0 CA-C-N 121.426 1.921 . . . . 0.0 113.131 177.343 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -121.83 62.96 0.92 Allowed 'General case' 0 CA--C 1.571 1.778 0 N-CA-C 102.445 -3.168 . . . . 0.0 102.445 159.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 76.2 p -143.7 -117.55 0.09 Allowed 'General case' 0 N--CA 1.485 1.292 0 CA-C-N 113.98 -1.464 . . . . 0.0 110.374 -160.385 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 16.0 m-20 -84.87 -33.5 22.79 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 115.513 1.671 . . . . 0.0 115.513 -171.061 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -68.22 -40.03 82.2 Favored 'General case' 0 N--CA 1.494 1.739 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 177.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 5.0 p -59.97 -46.45 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 172.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 10.8 tp -70.88 -26.81 28.48 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.955 0 N-CA-C 114.282 1.216 . . . . 0.0 114.282 174.452 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 33.7 mt -66.66 -40.7 88.76 Favored 'General case' 0 N--CA 1.493 1.712 0 CA-C-N 120.51 1.505 . . . . 0.0 114.175 168.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . 0.416 ' HA ' ' HD3' ' A' ' 142' ' ' LYS . 11.6 t-20 -68.62 -37.12 79.49 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 120.495 1.498 . . . . 0.0 114.316 170.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.01 -38.93 77.09 Favored 'General case' 0 N--CA 1.497 1.876 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 165.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 24.7 ttt -65.03 -33.12 75.28 Favored 'General case' 0 CA--C 1.567 1.634 0 N-CA-C 115.036 1.495 . . . . 0.0 115.036 168.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . 0.416 ' HD3' ' HA ' ' A' ' 139' ' ' ASN . 60.5 mtpt -59.71 -52.23 66.4 Favored 'General case' 0 N--CA 1.49 1.532 0 N-CA-C 115.666 1.728 . . . . 0.0 115.666 168.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 14.8 p -62.67 -36.44 75.25 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.267 0 N-CA-C 114.109 1.152 . . . . 0.0 114.109 170.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 12.8 t80 -55.31 -50.29 69.95 Favored 'General case' 0 CA--C 1.581 2.161 0 CA-C-N 120.059 1.299 . . . . 0.0 112.974 169.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -61.55 -45.29 94.8 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 117.72 2.489 . . . . 0.0 117.72 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -54.01 -38.36 65.04 Favored 'General case' 0 N--CA 1.503 2.193 0 N-CA-C 117.345 2.35 . . . . 0.0 117.345 175.663 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 2.3 mp0 -123.47 -35.91 2.87 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 119.534 3.161 . . . . 0.0 119.534 -165.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 86.0 m -49.31 -31.3 8.85 Favored 'General case' 0 N--CA 1.503 2.204 0 N-CA-C 118.441 2.756 . . . . 0.0 118.441 -166.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.17 -63.04 2.66 Favored Pre-proline 0 CA--C 1.582 2.192 0 CA-C-N 121.157 1.799 . . . . 0.0 111.212 170.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -54.21 -32.1 69.21 Favored 'Trans proline' 0 CA--C 1.571 2.363 0 C-N-CA 123.4 2.734 . . . . 0.0 118.899 167.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 7.3 tp -71.74 -42.87 66.74 Favored 'General case' 0 N--CA 1.491 1.576 0 CA-C-O 117.812 -1.09 . . . . 0.0 112.511 174.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 1.048 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 49.5 tp -63.56 -24.43 67.8 Favored 'General case' 0 CA--C 1.569 1.704 0 CA-C-N 120.656 1.571 . . . . 0.0 113.875 170.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -69.84 -49.69 50.0 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 121.829 2.104 . . . . 0.0 113.038 163.3 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -65.19 -52.31 55.68 Favored 'General case' 0 CA--C 1.564 1.49 0 CA-C-N 121.15 1.795 . . . . 0.0 112.69 -177.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 67.5 m-85 -82.0 -22.52 36.48 Favored 'General case' 0 CA--C 1.552 1.04 0 CA-C-O 115.128 -2.368 . . . . 0.0 112.804 179.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 1.048 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 40.3 ttt180 -66.07 -35.87 81.7 Favored 'General case' 0 N--CA 1.487 1.402 0 CA-C-N 125.016 3.553 . . . . 0.0 115.653 168.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.3 t70 -68.41 -36.9 79.78 Favored 'General case' 0 CA--C 1.575 1.928 0 CA-C-N 119.673 1.124 . . . . 0.0 114.006 167.043 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 45.4 mt-30 -88.08 -31.98 18.97 Favored 'General case' 0 CA--C 1.575 1.914 0 N-CA-C 119.203 3.038 . . . . 0.0 119.203 -178.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.8 pp -79.87 174.33 11.69 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 118.412 2.745 . . . . 0.0 118.412 -162.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 61.7 mttp -133.24 137.27 46.02 Favored 'General case' 0 CA--C 1.555 1.167 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 166.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 6.0 t -96.34 154.28 17.35 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.341 1.067 . . . . 0.0 112.085 -175.429 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 59.5 t -127.75 142.82 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 171.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -95.3 132.28 40.48 Favored 'General case' 0 N--CA 1.493 1.7 0 N-CA-C 106.536 -1.653 . . . . 0.0 106.536 168.68 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -159.49 99.26 1.44 Allowed 'General case' 0 N--CA 1.48 1.073 0 CA-C-O 122.26 1.029 . . . . 0.0 113.317 -163.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 2.9 t -150.92 130.81 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 174.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 79.58 -70.99 2.76 Favored Glycine 0 N--CA 1.482 1.735 0 N-CA-C 118.314 2.086 . . . . 0.0 118.314 167.375 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 40.6 p -76.98 142.36 40.01 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 112.215 -1.992 . . . . 0.0 112.26 -169.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 61.3 mtt -88.35 -61.65 1.66 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-O 118.699 -0.667 . . . . 0.0 111.579 178.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -69.64 -37.63 76.84 Favored 'General case' 0 N--CA 1.5 2.05 0 N-CA-C 116.176 1.917 . . . . 0.0 116.176 -176.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -61.55 -53.24 58.88 Favored 'General case' 0 N--CA 1.491 1.588 0 CA-C-N 119.371 0.987 . . . . 0.0 113.28 169.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 61.6 t -57.73 -37.94 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 N-CA-C 114.43 1.27 . . . . 0.0 114.43 176.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 37.9 t80 -62.07 -33.53 74.57 Favored 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 116.45 2.019 . . . . 0.0 116.45 168.609 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -63.01 -47.28 83.77 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 114.325 1.231 . . . . 0.0 114.325 171.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 85.8 mtt180 -61.8 -41.63 97.98 Favored 'General case' 0 CA--C 1.556 1.208 0 N-CA-C 116.676 2.102 . . . . 0.0 116.676 169.881 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -59.37 -42.39 91.5 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 116.212 1.931 . . . . 0.0 116.212 171.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.6 mp -65.99 -40.38 91.15 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 117.403 -1.284 . . . . 0.0 114.294 169.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 37.6 mtt180 -53.38 -43.27 67.7 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 116.442 2.015 . . . . 0.0 116.442 168.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -69.7 -41.82 74.89 Favored 'General case' 0 CA--C 1.562 1.438 0 N-CA-C 116.335 1.976 . . . . 0.0 116.335 172.858 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 6.8 tt -74.87 -57.14 4.09 Favored 'General case' 0 CA--C 1.566 1.566 0 CA-C-N 121.003 1.729 . . . . 0.0 111.729 177.044 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.643 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -117.36 -59.86 0.3 Allowed Glycine 0 CA--C 1.551 2.333 0 CA-C-O 117.621 -1.655 . . . . 0.0 114.898 -177.099 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.643 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 36.5 ttmt . . . . . 0 C--O 1.252 1.195 0 CA-C-N 120.608 2.204 . . . . 0.0 107.369 -174.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 59.1 mtt . . . . . 0 N--CA 1.483 1.213 0 N-CA-C 109.359 -0.608 . . . . 0.0 109.359 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.38 165.94 31.58 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 117.744 2.498 . . . . 0.0 117.744 -165.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 7.6 p -124.65 155.56 32.71 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.362 0 CA-C-O 124.044 1.878 . . . . 0.0 112.978 -165.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 1.7 pp -138.86 127.31 23.03 Favored 'General case' 0 CA--C 1.559 1.313 0 CA-C-N 112.618 -2.083 . . . . 0.0 108.718 168.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 2.5 tt -96.53 134.72 39.39 Favored 'General case' 0 CA--C 1.559 1.304 0 CA-C-O 122.879 1.324 . . . . 0.0 113.765 -165.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -135.26 157.41 46.97 Favored 'General case' 0 CA--C 1.56 1.335 0 CA-C-N 112.062 -2.335 . . . . 0.0 111.356 -169.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 156.67 135.98 2.05 Favored Glycine 0 CA--C 1.554 2.495 0 CA-C-O 117.412 -1.771 . . . . 0.0 111.905 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.21 154.1 75.3 Favored 'Trans proline' 0 CA--C 1.577 2.625 0 CA-C-N 122.789 3.294 . . . . 0.0 113.241 171.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_exo -43.28 132.02 6.62 Favored 'Trans proline' 0 C--N 1.371 1.74 0 C-N-CA 124.359 3.373 . . . . 0.0 118.519 -169.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 164.24 89.98 0.08 OUTLIER Glycine 0 CA--C 1.536 1.384 0 CA-C-N 116.343 -0.389 . . . . 0.0 112.658 -170.161 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . 48.45 -83.47 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.799 0 N-CA-C 120.602 3.556 . . . . 0.0 120.602 167.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -74.92 -115.22 0.09 OUTLIER Glycine 0 CA--C 1.544 1.901 0 N-CA-C 117.247 1.659 . . . . 0.0 117.247 -167.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 11.8 mptt 78.28 -83.8 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 C-N-CA 124.503 1.121 . . . . 0.0 111.191 -169.366 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -40.94 -30.67 0.39 Allowed Glycine 0 CA--C 1.557 2.667 0 N-CA-C 121.254 3.262 . . . . 0.0 121.254 169.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 23.2 p -58.62 -63.04 1.43 Allowed 'General case' 0 N--CA 1.496 1.841 0 CA-C-N 119.543 1.671 . . . . 0.0 114.507 171.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.264 5.7 mm-40 -75.28 -13.67 60.45 Favored 'General case' 0 CA--C 1.571 1.754 0 CA-C-O 116.536 -1.697 . . . . 0.0 111.432 175.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -68.83 -48.38 63.68 Favored 'General case' 0 C--N 1.373 1.609 0 CA-C-N 122.532 2.424 . . . . 0.0 113.946 166.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 85.6 t -66.43 -38.23 81.32 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.834 0 CA-C-O 117.89 -1.053 . . . . 0.0 111.931 176.32 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 23.6 mmmt -63.09 -51.3 67.15 Favored 'General case' 0 N--CA 1.487 1.388 0 N-CA-C 116.809 2.151 . . . . 0.0 116.809 169.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -62.04 -35.24 78.0 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-N 119.969 1.259 . . . . 0.0 114.255 174.771 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.63 -45.21 94.92 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 116.405 2.002 . . . . 0.0 116.405 169.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -57.43 -28.64 63.48 Favored 'General case' 0 CA--C 1.572 1.799 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 164.3 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.0 tptm -63.82 -62.8 1.41 Allowed 'General case' 0 CA--C 1.552 1.026 0 CA-C-O 116.653 -1.641 . . . . 0.0 114.745 170.211 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . 0.297 0.6 OUTLIER -83.28 -15.44 50.21 Favored 'General case' 0 N--CA 1.506 2.365 0 N-CA-C 117.006 2.225 . . . . 0.0 117.006 -178.445 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.08 42.32 4.09 Favored Glycine 0 N--CA 1.496 2.699 0 N-CA-C 117.024 1.57 . . . . 0.0 117.024 176.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.553 ' CD1' ' HA ' ' A' ' 81' ' ' PHE . 0.1 OUTLIER -116.69 149.16 43.43 Favored Pre-proline 0 CA--C 1.573 1.865 0 C-N-CA 127.337 2.255 . . . . 0.0 110.776 -168.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.515 ' HD2' HD12 ' A' ' 26' ' ' ILE . 22.2 Cg_endo -73.97 101.71 1.43 Allowed 'Trans proline' 0 CA--C 1.583 2.958 0 C-N-CA 121.794 1.663 . . . . 0.0 113.568 159.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -57.4 119.99 7.44 Favored 'General case' 0 N--CA 1.503 2.188 0 O-C-N 120.919 -1.113 . . . . 0.0 113.817 169.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.423 HD12 HD13 ' A' ' 34' ' ' LEU . 26.2 mm -101.8 109.34 25.75 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 169.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 50.7 p -95.17 125.05 39.55 Favored 'General case' 0 CA--C 1.556 1.189 0 N-CA-C 103.928 -2.619 . . . . 0.0 103.928 163.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 47.4 p -67.48 -12.23 59.8 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 117.14 2.274 . . . . 0.0 117.14 -168.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -85.86 -19.57 57.55 Favored Glycine 0 CA--C 1.55 2.28 0 N-CA-C 118.347 2.099 . . . . 0.0 118.347 166.376 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -79.61 -53.44 6.85 Favored 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 118.756 1.278 . . . . 0.0 114.062 -168.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.423 HD13 HD12 ' A' ' 29' ' ' ILE . 2.5 pt? -59.18 -39.22 81.87 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 115.05 1.5 . . . . 0.0 115.05 172.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . . . . . . . . . 35.4 m-85 -70.14 -43.16 71.5 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-O 116.262 -1.828 . . . . 0.0 113.204 171.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.475 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 47.5 ttt180 -51.8 -39.84 59.4 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 116.541 2.052 . . . . 0.0 116.541 169.216 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -61.9 -43.49 98.74 Favored 'General case' 0 CA--C 1.57 1.717 0 N-CA-C 113.736 1.014 . . . . 0.0 113.736 169.382 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 60.8 m-80 -65.7 -24.63 67.04 Favored 'General case' 0 CA--C 1.585 2.304 0 N-CA-C 116.441 2.015 . . . . 0.0 116.441 167.397 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.9 mt -62.99 -48.96 85.51 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.381 0 CA-C-N 121.288 1.858 . . . . 0.0 109.468 166.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -61.52 -41.41 97.27 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 114.355 1.242 . . . . 0.0 114.355 175.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 41.7 mt-10 -65.95 -40.15 91.07 Favored 'General case' 0 CA--C 1.564 1.489 0 N-CA-C 116.571 2.063 . . . . 0.0 116.571 171.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 96.85 70.61 1.03 Allowed Glycine 0 CA--C 1.545 1.942 0 CA-C-O 117.901 -1.5 . . . . 0.0 114.789 -179.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.871 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 64.1 p -95.67 -50.79 4.79 Favored 'General case' 0 N--CA 1.501 2.121 0 CA-C-N 119.414 1.607 . . . . 0.0 114.502 177.42 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.871 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.251 73.5 mttt 103.99 -40.98 0.01 OUTLIER 'General case' 0 CA--C 1.573 1.846 0 CA-C-O 116.303 -1.808 . . . . 0.0 111.229 -171.257 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -78.91 -13.99 59.48 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 123.183 2.72 . . . . 0.0 112.901 163.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.494 ' O ' ' HB3' ' A' ' 50' ' ' LYS . . . -58.56 -60.45 8.92 Favored Glycine 0 C--N 1.355 1.587 0 CA-C-N 120.725 1.602 . . . . 0.0 115.032 170.063 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.281 7.6 p -73.68 -50.63 28.62 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.323 0 N-CA-C 116.21 1.93 . . . . 0.0 116.21 -168.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -66.3 -46.4 77.07 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 120.352 1.433 . . . . 0.0 112.384 175.621 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -69.58 -30.98 68.88 Favored 'General case' 0 N--CA 1.482 1.17 0 N-CA-C 114.593 1.331 . . . . 0.0 114.593 -178.092 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.494 ' HB3' ' O ' ' A' ' 46' ' ' GLY 0.27 0.6 OUTLIER -78.03 -28.21 49.01 Favored 'General case' 0 CA--C 1.558 1.269 0 CA-C-O 116.827 -1.559 . . . . 0.0 114.873 170.453 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 68.7 mtp180 -74.06 -56.52 4.83 Favored 'General case' 0 CA--C 1.595 2.682 1 CA-C-O 87.477 -15.535 . . . . 0.0 117.314 175.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . 0.259 11.4 m-30 -24.28 -66.53 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.836 1 O-C-N 109.279 -8.388 . . . . 0.0 119.929 145.522 . . . . . . . . 3 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 41.2 mt -53.66 -38.34 64.04 Favored 'General case' 0 N--CA 1.505 2.29 0 CA-C-N 121.296 1.862 . . . . 0.0 115.735 171.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -80.37 -52.98 7.04 Favored 'General case' 0 N--CA 1.485 1.275 0 CA-C-O 116.799 -1.572 . . . . 0.0 113.634 170.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -158.42 43.86 0.29 Allowed 'General case' 0 CA--C 1.574 1.87 0 CA-C-N 120.909 1.686 . . . . 0.0 115.463 -168.714 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . -151.17 27.26 1.0 Allowed Glycine 0 CA--C 1.549 2.174 0 CA-C-N 121.942 2.155 . . . . 0.0 118.443 173.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . 0.318 9.1 t70 76.37 -118.46 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 120.034 1.917 . . . . 0.0 111.127 166.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 86.3 mt -75.6 114.48 14.22 Favored 'General case' 0 CA--C 1.559 1.317 0 N-CA-C 115.308 1.596 . . . . 0.0 115.308 -164.736 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.5 p -118.06 138.29 25.34 Favored Pre-proline 0 CA--C 1.573 1.845 0 C-N-CA 126.089 1.755 . . . . 0.0 108.529 174.61 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 77.0 Cg_exo -56.46 135.46 70.39 Favored 'Trans proline' 0 CA--C 1.56 1.807 0 C-N-CA 123.373 2.715 . . . . 0.0 116.191 173.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 70.6 m -70.38 -48.11 57.77 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 114.488 1.292 . . . . 0.0 114.488 176.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.4 m-20 -60.5 -43.55 96.91 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 -179.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 26.4 mt -56.59 -46.82 80.61 Favored 'General case' 0 N--CA 1.509 2.483 0 N-CA-C 116.393 1.998 . . . . 0.0 116.393 175.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 2.1 m -58.33 -44.54 88.72 Favored 'General case' 0 CA--C 1.565 1.529 0 CA-C-N 113.022 -1.899 . . . . 0.0 113.211 173.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -61.01 -33.25 72.97 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 166.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -66.35 -43.97 84.54 Favored 'General case' 0 CA--C 1.548 0.894 0 N-CA-C 115.228 1.566 . . . . 0.0 115.228 175.586 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 17.2 mt -64.24 -44.8 90.7 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 114.533 1.308 . . . . 0.0 114.533 168.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 54.9 t -59.09 -50.24 80.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.851 0 CA-C-O 118.125 -0.94 . . . . 0.0 113.073 172.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -63.0 -35.46 80.29 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 116.286 1.958 . . . . 0.0 116.286 174.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -56.4 -40.23 74.31 Favored 'General case' 0 N--CA 1.492 1.635 0 CA-C-O 118.113 -0.946 . . . . 0.0 113.31 169.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.632 HH22 ' HG ' ' A' ' 83' ' ' LEU . 0.2 OUTLIER -67.62 -45.38 75.59 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 114.843 1.423 . . . . 0.0 114.843 165.616 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 83.7 mt -68.83 -7.03 30.55 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 118.12 2.637 . . . . 0.0 118.12 -178.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -73.06 6.63 2.57 Favored 'General case' 0 CA--C 1.582 2.193 0 N-CA-C 115.986 1.847 . . . . 0.0 115.986 165.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.401 ' HB2' ' HD2' ' A' ' 75' ' ' PRO . 15.6 p30 -52.58 -170.44 0.0 OUTLIER Pre-proline 0 CA--C 1.574 1.871 0 N-CA-C 120.688 3.588 . . . . 0.0 120.688 167.094 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . 0.401 ' HD2' ' HB2' ' A' ' 74' ' ' ASN . 19.0 Cg_exo -35.6 39.86 0.0 OUTLIER 'Trans proline' 0 C--N 1.385 2.495 2 C-N-CA 127.666 5.578 . . . . 0.0 125.331 163.086 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 12.8 t70 59.66 34.1 22.09 Favored 'General case' 0 CA--C 1.582 2.183 0 C-N-CA 124.307 1.043 . . . . 0.0 110.366 -164.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.405 ' HB1' ' O ' ' A' ' 80' ' ' GLY 0.258 . . 78.92 4.4 2.4 Favored 'General case' 0 C--N 1.376 1.73 0 CA-C-O 116.269 -1.824 . . . . 0.0 114.996 -169.47 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 51.06 30.6 5.59 Favored 'General case' 0 CA--C 1.58 2.129 0 CA-C-N 123.441 2.837 . . . . 0.0 113.719 -164.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 6.4 t-20 59.58 32.98 21.93 Favored 'General case' 0 CA--C 1.581 2.163 0 CA-C-O 116.765 -1.588 . . . . 0.0 113.101 -165.882 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.405 ' O ' ' HB1' ' A' ' 77' ' ' ALA . . . -170.68 174.28 44.55 Favored Glycine 0 C--N 1.376 2.759 0 CA-C-N 123.508 2.867 . . . . 0.0 116.614 -178.048 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.553 ' HA ' ' CD1' ' A' ' 26' ' ' ILE 0.311 18.9 p90 -170.09 134.42 1.25 Allowed 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 114.747 -0.726 . . . . 0.0 112.064 168.53 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 1.1 mp -109.98 109.16 27.4 Favored 'Isoleucine or valine' 0 CA--C 1.565 1.537 0 N-CA-C 104.134 -2.543 . . . . 0.0 104.134 168.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.632 ' HG ' HH22 ' A' ' 71' ' ' ARG . 10.2 mt -105.76 110.49 22.81 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 123.487 0.715 . . . . 0.0 109.752 169.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 66.2 t0 -103.73 130.65 51.26 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-N 118.511 0.596 . . . . 0.0 112.59 -173.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 63.58 40.32 98.55 Favored Glycine 0 CA--C 1.548 2.146 0 CA-C-O 116.867 -2.074 . . . . 0.0 116.274 -176.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -89.06 -54.27 0.33 Allowed Pre-proline 0 N--CA 1.502 2.172 0 CA-C-N 120.794 2.297 . . . . 0.0 108.205 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 16.9 Cg_endo -61.18 60.03 0.1 Allowed 'Trans proline' 0 CA--C 1.576 2.588 0 N-CA-C 121.909 3.773 . . . . 0.0 121.909 167.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.8 tmm_? -56.36 -33.97 66.19 Favored 'General case' 0 CA--C 1.569 1.684 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 163.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.6 t -155.23 158.39 38.78 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 107.15 -1.426 . . . . 0.0 107.15 -174.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 23.9 t -68.9 -31.57 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.935 0 CA-C-O 116.689 -1.624 . . . . 0.0 111.118 179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -57.83 -39.16 76.99 Favored 'General case' 0 CA--C 1.56 1.363 0 N-CA-C 120.133 3.383 . . . . 0.0 120.133 167.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 12.9 mm100 -72.25 -46.35 56.34 Favored 'General case' 0 CA--C 1.592 2.591 0 CA-C-N 122.505 2.411 . . . . 0.0 112.777 167.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -66.69 -34.79 78.64 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 127.2 2.2 . . . . 0.0 116.178 -168.933 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 57.9 tttt -61.41 -29.66 70.07 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 115.298 1.592 . . . . 0.0 115.298 166.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -71.12 -36.77 72.25 Favored 'General case' 0 CA--C 1.568 1.651 0 N-CA-C 114.759 1.392 . . . . 0.0 114.759 168.288 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.7 tp -63.14 -38.29 90.59 Favored 'General case' 0 N--CA 1.495 1.777 0 N-CA-C 115.017 1.488 . . . . 0.0 115.017 168.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 31.5 t60 -63.67 -47.26 81.99 Favored 'General case' 0 N--CA 1.494 1.773 0 CA-C-N 119.818 1.19 . . . . 0.0 112.973 168.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.919 ' O ' ' HB3' ' A' ' 102' ' ' ARG . 34.4 mt-10 -52.02 -31.01 27.83 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 114.926 1.454 . . . . 0.0 114.926 165.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 1.213 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 23.1 ttt -84.74 -31.58 23.93 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 117.578 2.436 . . . . 0.0 117.578 175.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 16.6 mt -64.34 -55.88 18.19 Favored 'General case' 0 N--CA 1.499 2.015 0 CA-C-N 121.948 2.158 . . . . 0.0 110.927 167.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -76.83 -51.62 10.98 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -179.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.919 ' HB3' ' O ' ' A' ' 98' ' ' GLU . 36.5 ttm180 -74.06 -38.51 63.93 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 115.154 1.539 . . . . 0.0 115.154 176.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 1.213 ' HB3' ' O ' ' A' ' 99' ' ' MET . 25.4 tpt180 -62.74 -54.51 38.09 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 119.986 1.266 . . . . 0.0 112.081 166.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 114.07 44.64 0.73 Allowed Glycine 0 N--CA 1.479 1.51 0 O-C-N 123.971 0.794 . . . . 0.0 113.76 168.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 31.3 p -116.23 135.33 53.99 Favored 'General case' 0 CA--C 1.55 0.976 0 N-CA-C 107.054 -1.462 . . . . 0.0 107.054 177.432 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -65.88 135.45 54.82 Favored 'General case' 0 N--CA 1.508 2.465 0 CA-C-O 122.601 1.191 . . . . 0.0 112.435 -170.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.5 tp -84.28 99.49 6.7 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.392 0 CA-C-N 113.262 -1.79 . . . . 0.0 107.04 178.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -97.75 -68.37 0.8 Allowed 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 116.947 -1.501 . . . . 0.0 110.175 169.053 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -138.02 116.06 11.68 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 120.44 1.473 . . . . 0.0 114.544 -167.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 72.8 t -91.53 117.64 35.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 101.176 -3.638 . . . . 0.0 101.176 163.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.474 ' HA ' ' O ' ' A' ' 160' ' ' LYS 0.259 6.8 tp -116.16 109.59 17.67 Favored 'General case' 0 CA--C 1.547 0.84 0 CA-C-O 114.804 -2.522 . . . . 0.0 115.2 -159.545 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.44 ' N ' ' HB ' ' A' ' 161' ' ' THR . 3.0 tm-20 -110.23 109.5 20.0 Favored 'General case' 0 N--CA 1.517 2.908 0 CA-C-N 123.856 3.025 . . . . 0.0 117.998 -177.14 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -87.85 123.51 32.69 Favored 'General case' 0 N--CA 1.486 1.333 0 C-N-CA 125.667 1.587 . . . . 0.0 110.647 170.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . . 5.7 tpt180 -92.76 101.03 13.41 Favored 'General case' 0 CA--C 1.558 1.271 0 CA-C-N 112.543 -2.117 . . . . 0.0 109.312 169.47 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 2.5 p -135.89 141.94 40.46 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.446 0 C-N-CA 127.279 2.232 . . . . 0.0 107.894 -167.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 4.6 m -83.9 137.49 33.63 Favored 'General case' 0 N--CA 1.49 1.543 0 CA-C-N 114.071 -1.422 . . . . 0.0 114.423 -167.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -58.32 -46.57 85.92 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 115.28 1.585 . . . . 0.0 115.28 168.984 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -45.56 -36.47 4.67 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 117.995 2.591 . . . . 0.0 117.995 177.824 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 2.2 t -59.84 -52.78 57.07 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 N-CA-C 113.765 1.024 . . . . 0.0 113.765 177.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 5.3 tt -67.41 -36.65 81.7 Favored 'General case' 0 CA--C 1.56 1.357 0 CA-C-O 117.255 -1.355 . . . . 0.0 113.0 171.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.3 mp -59.46 -32.3 70.11 Favored 'General case' 0 N--CA 1.503 2.202 0 CA-C-N 120.852 1.66 . . . . 0.0 115.18 168.851 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 19.2 mm-40 -66.6 -47.3 73.12 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 119.231 0.923 . . . . 0.0 113.436 168.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -51.63 -54.99 21.9 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 116.316 1.969 . . . . 0.0 116.316 169.134 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 79.8 mt -52.95 -48.37 67.4 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 169.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 38.1 tptt -61.72 -42.64 99.22 Favored 'General case' 0 N--CA 1.489 1.491 0 N-CA-C 116.949 2.203 . . . . 0.0 116.949 177.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.6 ' O ' ' HB2' ' A' ' 127' ' ' ARG . . . -96.74 57.79 1.3 Allowed Glycine 0 CA--C 1.545 1.908 0 CA-C-N 118.642 0.656 . . . . 0.0 113.983 170.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.6 ' HB2' ' O ' ' A' ' 126' ' ' GLY . 74.3 mtp180 107.13 96.07 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 C-N-CA 123.873 0.869 . . . . 0.0 110.481 174.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 139.37 64.19 0.04 OUTLIER Glycine 0 CA--C 1.549 2.186 0 CA-C-O 117.069 -1.962 . . . . 0.0 112.906 177.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 41.7 ptt85 -165.3 95.88 0.67 Allowed 'General case' 0 N--CA 1.486 1.33 0 CA-C-N 121.751 2.776 . . . . 0.0 112.01 -179.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -122.21 58.77 1.03 Allowed 'General case' 0 CA--C 1.573 1.863 0 C-N-CA 123.729 0.812 . . . . 0.0 109.809 171.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 63.89 8.09 3.66 Favored 'General case' 0 N--CA 1.506 2.341 0 N-CA-C 119.289 3.07 . . . . 0.0 119.289 -176.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -91.75 60.22 3.9 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 106.115 -1.809 . . . . 0.0 106.115 160.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 82.6 p -139.05 -113.24 0.15 Allowed 'General case' 0 N--CA 1.487 1.378 0 CA-C-N 114.146 -1.388 . . . . 0.0 110.284 -162.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 -58.63 -42.09 87.46 Favored 'General case' 0 N--CA 1.497 1.911 0 N-CA-C 116.875 2.176 . . . . 0.0 116.875 -170.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -66.93 -35.77 80.74 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 172.051 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.631 ' O ' ' HG3' ' A' ' 140' ' ' ARG . 60.7 t -64.58 -42.54 95.44 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 C-N-CA 124.293 1.037 . . . . 0.0 112.3 173.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.1 tp -72.64 -28.58 28.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.027 0 N-CA-C 114.268 1.21 . . . . 0.0 114.268 171.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 32.3 mt -64.67 -44.33 90.7 Favored 'General case' 0 N--CA 1.495 1.825 0 CA-C-N 121.152 1.796 . . . . 0.0 113.887 168.672 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -65.27 -36.95 85.7 Favored 'General case' 0 N--CA 1.497 1.891 0 N-CA-C 114.636 1.347 . . . . 0.0 114.636 170.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.631 ' HG3' ' O ' ' A' ' 136' ' ' VAL . 69.2 mtp180 -60.43 -41.86 94.89 Favored 'General case' 0 N--CA 1.492 1.658 0 N-CA-C 116.144 1.905 . . . . 0.0 116.144 169.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 62.5 mtt -65.53 -34.18 77.65 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 115.231 1.567 . . . . 0.0 115.231 169.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 82.3 tttt -64.48 -46.35 83.41 Favored 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 170.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 8.6 p -65.74 -32.95 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 N-CA-C 114.526 1.306 . . . . 0.0 114.526 170.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 33.7 t80 -56.73 -53.13 61.25 Favored 'General case' 0 CA--C 1.581 2.158 0 CA-C-N 119.782 1.173 . . . . 0.0 111.71 167.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 41.3 ttt180 -53.34 -22.75 7.81 Favored 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 120.37 3.47 . . . . 0.0 120.37 169.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -53.37 -56.81 13.67 Favored 'General case' 0 N--CA 1.499 1.982 0 CA-C-N 119.858 1.208 . . . . 0.0 113.308 169.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -141.99 23.08 2.07 Favored 'General case' 0 CA--C 1.563 1.475 0 N-CA-C 118.639 2.829 . . . . 0.0 118.639 -171.679 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 20.9 m -56.25 -30.26 62.16 Favored 'General case' 0 N--CA 1.502 2.155 0 N-CA-C 116.124 1.898 . . . . 0.0 116.124 170.719 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.464 ' HB3' ' HD3' ' A' ' 150' ' ' PRO . . . -68.0 -60.41 5.26 Favored Pre-proline 0 CA--C 1.583 2.234 0 CA-C-N 120.68 1.582 . . . . 0.0 111.227 169.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.464 ' HD3' ' HB3' ' A' ' 149' ' ' ALA . 75.9 Cg_exo -53.03 -27.93 38.26 Favored 'Trans proline' 0 CA--C 1.568 2.194 0 N-CA-C 119.614 2.89 . . . . 0.0 119.614 168.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 8.2 tt -70.85 -55.58 8.19 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-O 116.876 -1.535 . . . . 0.0 109.751 172.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 0.942 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 39.5 tp -58.43 -26.47 63.34 Favored 'General case' 0 CA--C 1.564 1.515 0 CA-C-N 121.211 1.823 . . . . 0.0 113.962 -179.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 5.7 mt-10 -71.53 -48.02 51.41 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 121.635 2.016 . . . . 0.0 113.409 163.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -69.92 -49.37 52.7 Favored 'General case' 0 CA--C 1.571 1.764 0 CA-C-N 121.591 1.996 . . . . 0.0 112.548 -175.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 48.4 m-85 -82.16 -27.06 32.9 Favored 'General case' 0 CA--C 1.557 1.234 0 CA-C-O 115.215 -2.326 . . . . 0.0 111.437 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 0.942 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 40.8 ttt180 -67.0 -32.66 74.04 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 124.926 3.512 . . . . 0.0 115.723 167.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -67.89 -41.57 82.53 Favored 'General case' 0 CA--C 1.573 1.833 0 CA-C-N 119.713 1.142 . . . . 0.0 113.458 167.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 40.2 mt-30 -90.96 -28.47 18.02 Favored 'General case' 0 CA--C 1.57 1.746 0 N-CA-C 119.675 3.213 . . . . 0.0 119.675 -176.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.8 pp -80.54 159.36 25.51 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 118.297 2.703 . . . . 0.0 118.297 -162.319 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.474 ' O ' ' HA ' ' A' ' 111' ' ' LEU 0.296 97.6 mttt -145.48 101.1 3.54 Favored 'General case' 0 C--N 1.361 1.072 0 CA-C-O 117.748 -1.12 . . . . 0.0 110.791 162.915 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.44 ' HB ' ' N ' ' A' ' 112' ' ' GLU 1.254 24.4 m -131.44 -153.31 0.55 Allowed 'General case' 0 CA--C 1.573 1.856 1 O-C-N 115.74 -4.35 . . . . 0.0 110.059 149.926 . . . . . . . . 4 3 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . 0.361 4.6 t -124.53 -177.81 1.69 Allowed 'Isoleucine or valine' 0 CA--C 1.562 1.413 0 CA-C-N 111.973 -2.376 . . . . 0.0 112.976 -151.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -112.18 123.36 50.11 Favored 'General case' 0 CA--C 1.564 1.491 0 CA-C-N 111.324 -2.671 . . . . 0.0 104.47 166.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -160.5 122.59 3.19 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.295 0.638 . . . . 0.0 110.546 -161.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . . 3.1 t -149.76 128.63 3.22 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 78.02 -55.12 3.9 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 120.258 2.863 . . . . 0.0 120.258 168.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 52.9 p -74.41 119.41 18.58 Favored 'General case' 0 N--CA 1.491 1.625 0 CA-C-N 114.051 -1.074 . . . . 0.0 111.062 -169.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 64.7 mtt -73.76 -63.66 1.16 Allowed 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 112.772 0.656 . . . . 0.0 112.772 -172.256 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -67.58 -36.03 80.13 Favored 'General case' 0 N--CA 1.5 2.04 0 N-CA-C 116.126 1.898 . . . . 0.0 116.126 -179.759 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -60.82 -51.82 67.71 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 114.155 1.169 . . . . 0.0 114.155 170.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 87.5 t -58.81 -35.25 55.04 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.17 0 CA-C-O 117.311 -1.328 . . . . 0.0 113.949 176.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 34.8 t80 -60.07 -37.96 81.46 Favored 'General case' 0 N--CA 1.504 2.257 0 CA-C-N 121.262 1.846 . . . . 0.0 115.953 166.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -61.12 -53.55 55.69 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 175.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 56.7 mtt180 -56.42 -41.32 76.17 Favored 'General case' 0 CA--C 1.553 1.078 0 N-CA-C 117.478 2.399 . . . . 0.0 117.478 169.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -53.28 -46.29 69.22 Favored 'General case' 0 N--CA 1.493 1.707 0 N-CA-C 116.172 1.915 . . . . 0.0 116.172 169.24 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 3.7 mp -60.97 -44.99 96.54 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-O 117.388 -1.291 . . . . 0.0 113.962 168.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -50.66 -42.23 56.33 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 116.654 2.094 . . . . 0.0 116.654 169.909 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -67.08 -45.17 78.11 Favored 'General case' 0 CA--C 1.561 1.369 0 N-CA-C 116.153 1.908 . . . . 0.0 116.153 171.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 6.6 tt -77.52 -55.15 5.62 Favored 'General case' 0 CA--C 1.568 1.665 0 CA-C-N 121.051 1.75 . . . . 0.0 112.38 179.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.817 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -130.7 -55.5 0.09 OUTLIER Glycine 0 CA--C 1.553 2.427 0 CA-C-O 117.628 -1.651 . . . . 0.0 115.807 -175.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.817 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 86.3 tttt . . . . . 0 C--O 1.251 1.153 0 CA-C-N 120.533 2.167 . . . . 0.0 108.874 -175.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 60.5 mtt . . . . . 0 CA--C 1.557 1.219 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.78 169.54 21.41 Favored 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 117.612 2.449 . . . . 0.0 117.612 -167.224 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.427 HG13 ' HA ' ' A' ' 82' ' ' ILE . 7.9 p -127.94 138.43 54.72 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 CA-C-N 115.116 -0.947 . . . . 0.0 113.532 -165.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -118.02 120.46 37.85 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 107.084 -1.45 . . . . 0.0 107.084 171.008 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.475 HD13 ' HB2' ' A' ' 17' ' ' ALA . 0.7 OUTLIER -99.02 121.78 41.41 Favored 'General case' 0 CA--C 1.563 1.453 0 CA-C-O 122.376 1.084 . . . . 0.0 112.538 -167.484 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 15.4 mt -114.23 154.11 28.47 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 111.042 -2.799 . . . . 0.0 109.333 -172.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 175.24 107.9 0.21 Allowed Glycine 0 CA--C 1.549 2.178 0 CA-C-O 116.694 -2.17 . . . . 0.0 109.48 175.203 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -55.39 173.95 0.29 Allowed 'Trans proline' 0 CA--C 1.574 2.525 0 CA-C-N 122.247 3.024 . . . . 0.0 117.863 -179.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_exo -46.7 116.17 1.52 Allowed 'Trans proline' 0 C--N 1.376 1.988 0 C-N-CA 124.248 3.299 . . . . 0.0 115.642 -177.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 130.79 101.94 0.92 Allowed Glycine 0 CA--C 1.534 1.273 0 N-CA-C 106.523 -2.631 . . . . 0.0 106.523 -166.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -79.17 132.96 36.72 Favored 'General case' 0 CA--C 1.557 1.25 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 -167.854 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.475 ' O ' ' HB2' ' A' ' 13' ' ' LYS . . . -153.37 -115.96 0.61 Allowed Glycine 0 CA--C 1.542 1.72 0 N-CA-C 105.882 -2.887 . . . . 0.0 105.882 167.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.475 ' HB2' ' O ' ' A' ' 12' ' ' GLY . 48.3 mtpt 79.35 -88.03 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 N-CA-C 116.367 1.988 . . . . 0.0 116.367 164.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -32.59 -36.65 0.04 OUTLIER Glycine 0 CA--C 1.556 2.62 0 N-CA-C 122.877 3.911 . . . . 0.0 122.877 172.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 32.0 m -62.63 -56.26 19.48 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-N 120.069 1.934 . . . . 0.0 112.664 174.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.277 17.1 mp0 -74.55 -12.25 60.42 Favored 'General case' 0 CA--C 1.574 1.889 0 CA-C-O 115.427 -2.225 . . . . 0.0 112.655 170.194 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.475 ' HB2' HD13 ' A' ' 5' ' ' LEU . . . -69.67 -45.27 68.76 Favored 'General case' 0 C--N 1.374 1.664 0 CA-C-N 124.506 3.321 . . . . 0.0 114.513 167.249 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 47.7 t -69.95 -38.71 76.19 Favored 'Isoleucine or valine' 0 CA--C 1.573 1.849 0 CA-C-O 117.672 -1.156 . . . . 0.0 111.569 174.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -61.33 -47.21 86.94 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 116.6 2.074 . . . . 0.0 116.6 169.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.7 mt -65.62 -31.08 71.92 Favored 'General case' 0 N--CA 1.499 2.016 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 172.408 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -60.97 -44.25 97.62 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 114.867 1.432 . . . . 0.0 114.867 166.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -58.69 -37.69 76.63 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 168.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 2.9 mmmp? -67.1 -50.94 59.86 Favored 'General case' 0 N--CA 1.489 1.498 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 172.223 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 72.6 mt -83.69 -19.83 34.59 Favored 'General case' 0 CA--C 1.572 1.809 0 N-CA-C 116.911 2.189 . . . . 0.0 116.911 -177.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.97 36.11 10.52 Favored Glycine 0 CA--C 1.555 2.548 0 N-CA-C 117.889 1.915 . . . . 0.0 117.889 -177.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 16.4 mm -111.53 158.11 37.31 Favored Pre-proline 0 CA--C 1.572 1.796 0 CA-C-N 119.088 1.444 . . . . 0.0 113.811 -167.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo -81.81 100.58 1.1 Allowed 'Trans proline' 0 CA--C 1.573 2.436 0 C-N-CA 122.115 1.876 . . . . 0.0 111.081 162.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -64.47 110.59 2.34 Favored 'General case' 0 N--CA 1.495 1.782 0 C-N-CA 124.074 0.949 . . . . 0.0 111.887 171.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 19.7 mm -99.71 113.6 35.48 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.056 0 N-CA-C 105.901 -1.888 . . . . 0.0 105.901 177.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 78.9 p -96.43 136.04 37.47 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 114.942 -1.026 . . . . 0.0 108.691 169.247 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 32.0 p -69.73 -7.88 43.23 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 117.585 2.439 . . . . 0.0 117.585 -175.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -90.43 -22.61 33.93 Favored Glycine 0 CA--C 1.545 1.937 0 N-CA-C 118.563 2.185 . . . . 0.0 118.563 165.828 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -80.74 -51.86 8.18 Favored 'General case' 0 N--CA 1.493 1.687 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 -168.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.4 pt? -63.53 -41.44 98.48 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 173.57 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.488 ' HB3' ' CG ' ' A' ' 50' ' ' LYS . 29.6 m-85 -61.13 -43.4 98.94 Favored 'General case' 0 CA--C 1.553 1.072 0 CA-C-O 116.431 -1.747 . . . . 0.0 115.136 168.516 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.424 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 72.8 ttt180 -54.97 -44.02 74.04 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 115.667 1.729 . . . . 0.0 115.667 170.331 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 33.7 ttt180 -59.47 -40.98 88.67 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 114.668 1.358 . . . . 0.0 114.668 168.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -68.33 -24.19 64.8 Favored 'General case' 0 CA--C 1.582 2.188 0 N-CA-C 115.53 1.678 . . . . 0.0 115.53 169.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 82.5 mt -63.03 -49.49 83.31 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.236 0 CA-C-N 120.835 1.652 . . . . 0.0 110.299 167.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -65.26 -35.29 80.58 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 114.699 1.37 . . . . 0.0 114.699 175.035 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -68.72 -42.8 77.17 Favored 'General case' 0 CA--C 1.558 1.269 0 N-CA-C 116.168 1.914 . . . . 0.0 116.168 174.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.45 69.4 1.27 Allowed Glycine 0 CA--C 1.545 1.947 0 CA-C-O 118.905 -0.942 . . . . 0.0 114.518 -174.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.866 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 64.8 p -91.52 -49.09 6.5 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 178.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.866 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.26 38.8 mttp 110.61 -42.37 0.0 OUTLIER 'General case' 0 CA--C 1.57 1.716 0 CA-C-O 116.135 -1.888 . . . . 0.0 110.876 -172.718 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 1.4 pt? -83.08 -10.86 58.48 Favored 'General case' 0 CA--C 1.574 1.872 0 CA-C-N 123.425 2.83 . . . . 0.0 113.106 162.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.37 -55.32 24.08 Favored Glycine 0 CA--C 1.544 1.853 0 CA-C-N 120.535 1.516 . . . . 0.0 114.276 169.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.267 1.0 OUTLIER -75.62 -50.21 24.36 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.141 0 N-CA-C 116.729 2.122 . . . . 0.0 116.729 -168.556 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -67.16 -41.4 86.08 Favored 'General case' 0 N--CA 1.483 1.22 0 CA-C-N 120.476 1.489 . . . . 0.0 112.565 174.495 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -77.88 -25.47 48.59 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -174.505 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.488 ' CG ' ' HB3' ' A' ' 35' ' ' PHE . 0.1 OUTLIER -75.0 -41.01 60.34 Favored 'General case' 0 N--CA 1.486 1.348 0 CA-C-O 117.064 -1.446 . . . . 0.0 111.871 166.699 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 55.0 mtp180 -71.63 -51.32 23.78 Favored 'General case' 0 CA--C 1.591 2.536 1 CA-C-O 85.298 -16.572 . . . . 0.0 118.444 -176.282 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 14.9 m-30 -35.25 -55.4 0.63 Allowed 'General case' 0 N--CA 1.496 1.844 2 O-C-N 108.913 -8.617 . . . . 0.0 121.85 147.209 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 71.6 mt -60.83 -32.77 72.14 Favored 'General case' 0 N--CA 1.51 2.571 0 CA-C-N 124.283 3.22 . . . . 0.0 114.799 167.917 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 3.2 t70 -83.09 -45.25 14.21 Favored 'General case' 0 CA--C 1.568 1.663 0 N-CA-C 115.471 1.656 . . . . 0.0 115.471 172.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -85.15 -28.23 25.67 Favored 'General case' 0 N--CA 1.493 1.693 0 N-CA-C 116.81 2.152 . . . . 0.0 116.81 -179.105 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.64 42.59 4.76 Favored Glycine 0 CA--C 1.536 1.392 0 CA-C-N 120.243 1.383 . . . . 0.0 115.952 170.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.423 ' O ' ' NH1' ' A' ' 88' ' ' ARG . 20.2 t70 -105.17 -132.53 0.31 Allowed 'General case' 0 CA--C 1.571 1.75 0 CA-C-O 118.532 -0.747 . . . . 0.0 109.548 169.328 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 88.8 mt -115.15 111.91 21.73 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-N 120.054 1.297 . . . . 0.0 110.192 -169.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.1 p -112.74 116.91 47.37 Favored Pre-proline 0 CA--C 1.568 1.651 0 CA-C-O 117.848 -1.072 . . . . 0.0 109.26 -178.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_exo -59.64 144.24 99.48 Favored 'Trans proline' 0 C--N 1.371 1.762 0 C-N-CA 123.477 2.785 . . . . 0.0 116.354 176.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 85.5 p -77.97 178.28 7.61 Favored 'General case' 0 CA--C 1.567 1.604 0 N-CA-C 113.441 0.904 . . . . 0.0 113.441 176.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . 0.27 16.8 m-20 80.33 -51.53 0.35 Allowed 'General case' 0 CA--C 1.559 1.289 0 C-N-CA 126.324 1.85 . . . . 0.0 113.998 175.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 1.9 pp -61.91 -42.46 99.1 Favored 'General case' 0 CA--C 1.563 1.459 0 N-CA-C 115.938 1.829 . . . . 0.0 115.938 167.249 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 4.2 m -61.43 -50.51 72.5 Favored 'General case' 0 N--CA 1.493 1.676 0 C-N-CA 124.331 1.052 . . . . 0.0 112.805 174.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.5 m-20 -64.41 -21.06 66.52 Favored 'General case' 0 CA--C 1.571 1.783 0 N-CA-C 115.616 1.71 . . . . 0.0 115.616 167.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -68.52 -47.11 67.8 Favored 'General case' 0 CA--C 1.557 1.234 0 CA-C-N 120.507 1.503 . . . . 0.0 114.0 168.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 15.9 mt -63.1 -37.74 88.42 Favored 'General case' 0 N--CA 1.494 1.743 0 N-CA-C 116.031 1.863 . . . . 0.0 116.031 168.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 56.7 t -58.39 -53.21 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.87 0 CA-C-O 118.08 -0.962 . . . . 0.0 112.059 169.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -60.37 -36.17 77.42 Favored 'General case' 0 N--CA 1.492 1.635 0 N-CA-C 116.199 1.926 . . . . 0.0 116.199 172.82 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 5.3 t70 -56.61 -48.4 77.53 Favored 'General case' 0 N--CA 1.486 1.332 0 CA-C-O 116.642 -1.646 . . . . 0.0 113.097 169.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 89.3 mtt180 -87.61 7.53 29.34 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 120.666 3.58 . . . . 0.0 120.666 167.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 69.9 mt -66.44 -49.38 66.92 Favored 'General case' 0 CA--C 1.559 1.296 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 150.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 73.0 m-80 50.39 33.96 8.41 Favored 'General case' 0 N--CA 1.504 2.258 0 CA-C-N 121.267 1.848 . . . . 0.0 111.535 -167.409 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . 0.277 16.4 p-10 -15.57 -48.47 0.03 OUTLIER Pre-proline 0 CA--C 1.587 2.387 1 N-CA-C 127.815 6.228 . . . . 0.0 127.815 -162.604 . . . . . . . . 3 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -57.51 -22.67 52.19 Favored 'Trans proline' 0 N--CA 1.512 2.6 1 CA-C-N 130.288 4.71 . . . . 0.0 117.419 166.763 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -81.81 -18.21 44.8 Favored 'General case' 0 CA--C 1.58 2.098 0 CA-C-N 110.426 -3.079 . . . . 0.0 113.231 163.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -65.01 -27.42 68.81 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 124.134 3.152 . . . . 0.0 114.48 165.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . 57.21 37.8 28.52 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 121.595 1.998 . . . . 0.0 114.273 -174.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 66.1 m-80 57.53 38.87 28.13 Favored 'General case' 0 CA--C 1.582 2.191 0 CA-C-O 117.554 -1.213 . . . . 0.0 112.023 -167.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -157.29 163.86 32.65 Favored Glycine 0 C--N 1.372 2.53 0 CA-C-N 122.28 2.309 . . . . 0.0 114.061 -178.014 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 10.4 p90 -175.83 136.95 0.33 Allowed 'General case' 0 N--CA 1.488 1.472 0 CA-C-N 114.205 -0.998 . . . . 0.0 110.849 -176.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.427 ' HA ' HG13 ' A' ' 3' ' ' VAL . 4.9 mm -108.97 107.89 23.97 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.489 0 N-CA-C 103.224 -2.88 . . . . 0.0 103.224 167.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 79.5 mt -114.62 118.02 32.52 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 -178.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 8.2 t0 -114.54 132.34 56.35 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 118.927 0.785 . . . . 0.0 112.398 -169.604 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 75.56 36.06 44.78 Favored Glycine 0 CA--C 1.55 2.265 0 N-CA-C 118.803 2.281 . . . . 0.0 118.803 172.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -99.65 -58.52 0.13 Allowed Pre-proline 0 N--CA 1.495 1.787 0 CA-C-O 113.536 -3.126 . . . . 0.0 111.479 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -59.66 61.5 0.07 OUTLIER 'Trans proline' 0 CA--C 1.574 2.492 1 N-CA-C 123.141 4.247 . . . . 0.0 123.141 170.487 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 1.427 ' CG ' HH12 ' A' ' 140' ' ' ARG . 13.9 ttp180 -52.01 -39.68 59.83 Favored 'General case' 0 CA--C 1.573 1.859 0 N-CA-C 116.124 1.898 . . . . 0.0 116.124 163.418 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 24.3 t -154.97 153.7 31.45 Favored 'General case' 0 N--CA 1.479 0.981 0 C-N-CA 125.156 1.383 . . . . 0.0 107.636 -168.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 3.2 t -60.16 -37.5 73.53 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.124 0 CA-C-O 117.167 -1.397 . . . . 0.0 112.188 177.609 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.96 -37.02 80.93 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 120.596 3.554 . . . . 0.0 120.596 172.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 3.0 mm-40 -77.81 -46.77 20.58 Favored 'General case' 0 CA--C 1.588 2.418 0 CA-C-N 123.468 2.849 . . . . 0.0 111.635 166.397 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -61.16 -32.87 72.6 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 117.999 2.592 . . . . 0.0 117.999 -172.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -57.54 -33.54 68.21 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 115.591 1.7 . . . . 0.0 115.591 168.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -66.77 -39.88 88.01 Favored 'General case' 0 CA--C 1.568 1.646 0 N-CA-C 115.355 1.613 . . . . 0.0 115.355 170.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 39.2 tp -64.62 -40.11 94.9 Favored 'General case' 0 N--CA 1.495 1.817 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 169.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 11.5 t-80 -60.24 -53.06 62.22 Favored 'General case' 0 N--CA 1.499 1.998 0 CA-C-N 119.715 1.143 . . . . 0.0 113.37 170.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 0.923 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 35.6 mt-10 -48.01 -38.47 17.15 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 115.893 1.812 . . . . 0.0 115.893 167.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 1.216 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 25.0 ttt -84.38 -25.21 29.28 Favored 'General case' 0 N--CA 1.493 1.699 0 N-CA-C 117.825 2.528 . . . . 0.0 117.825 176.737 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 41.9 tp -68.38 -53.7 22.12 Favored 'General case' 0 N--CA 1.502 2.144 0 CA-C-N 120.59 1.541 . . . . 0.0 110.912 169.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 51.2 mt-10 -76.33 -54.4 6.81 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-N 119.37 0.987 . . . . 0.0 113.416 175.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.923 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 75.9 mtp180 -71.6 -39.39 70.53 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 115.401 1.63 . . . . 0.0 115.401 177.473 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 1.216 ' HB3' ' O ' ' A' ' 99' ' ' MET . 3.6 tmt_? -61.78 -56.02 23.95 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 119.699 1.136 . . . . 0.0 110.375 164.787 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 113.26 41.63 0.96 Allowed Glycine 0 N--CA 1.481 1.692 0 O-C-N 124.076 0.86 . . . . 0.0 114.96 167.546 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 36.5 p -102.13 137.6 40.19 Favored 'General case' 0 CA--C 1.555 1.158 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 169.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -71.14 135.28 47.54 Favored 'General case' 0 N--CA 1.51 2.55 0 CA-C-O 122.699 1.238 . . . . 0.0 112.293 -171.252 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 5.2 tp -79.68 102.25 5.53 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 CA-C-N 113.356 -1.747 . . . . 0.0 108.089 172.773 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -96.08 -61.8 1.38 Allowed 'General case' 0 N--CA 1.493 1.719 0 CA-C-O 117.301 -1.333 . . . . 0.0 110.428 167.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -150.55 112.3 4.5 Favored 'General case' 0 C--N 1.36 1.024 0 CA-C-N 120.309 1.413 . . . . 0.0 113.707 -166.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 3.5 p -97.17 104.67 16.17 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.678 0 CA-C-N 115.085 -0.962 . . . . 0.0 111.0 167.805 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.946 HD12 ' HB3' ' A' ' 160' ' ' LYS 0.311 6.9 tp -103.49 111.23 23.58 Favored 'General case' 0 CA--C 1.556 1.201 0 N-CA-C 118.446 2.758 . . . . 0.0 118.446 -157.073 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.465 ' H ' ' N ' ' A' ' 161' ' ' THR . 68.0 mt-10 -96.72 107.47 19.94 Favored 'General case' 0 N--CA 1.494 1.769 0 CA-C-N 122.062 2.21 . . . . 0.0 115.528 -172.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 82.7 m-85 -88.0 108.93 19.45 Favored 'General case' 0 N--CA 1.485 1.283 0 O-C-N 118.706 -2.496 . . . . 0.0 108.324 170.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.681 ' HB3' ' HA ' ' A' ' 163' ' ' ASP . 10.1 tpt180 -95.18 95.14 8.34 Favored 'General case' 0 N--CA 1.481 1.119 0 CA-C-N 112.575 -2.102 . . . . 0.0 110.359 -172.676 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -127.19 122.47 60.0 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.483 0 N-CA-C 106.337 -1.727 . . . . 0.0 106.337 -168.453 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 52.0 p -59.24 140.12 56.29 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 115.291 1.589 . . . . 0.0 115.291 -172.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -52.94 -36.08 59.41 Favored 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 116.628 2.085 . . . . 0.0 116.628 177.815 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -52.53 -32.82 42.43 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 116.956 2.206 . . . . 0.0 116.956 174.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -59.48 -47.25 91.48 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.184 0 N-CA-C 115.848 1.796 . . . . 0.0 115.848 170.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 34.5 tp -65.02 -40.13 94.41 Favored 'General case' 0 CA--C 1.563 1.464 0 CA-C-N 114.506 -1.225 . . . . 0.0 114.059 170.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 69.1 mt -59.1 -47.53 84.92 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 115.732 1.752 . . . . 0.0 115.732 171.463 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 13.0 pt-20 -63.64 -40.53 97.12 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 173.436 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 96.7 mtt180 -58.69 -47.45 84.47 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 116.048 1.87 . . . . 0.0 116.048 168.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 5.6 mp -52.85 -51.86 59.42 Favored 'General case' 0 N--CA 1.494 1.744 0 N-CA-C 115.376 1.621 . . . . 0.0 115.376 171.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 17.4 ptpt -74.84 -61.65 1.81 Allowed 'General case' 0 N--CA 1.488 1.455 0 N-CA-C 114.183 1.179 . . . . 0.0 114.183 178.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 85.62 -41.01 3.04 Favored Glycine 0 CA--C 1.555 2.553 0 N-CA-C 116.128 1.211 . . . . 0.0 116.128 -175.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -151.98 -93.04 0.05 Allowed 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 178.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.579 ' O ' ' HB2' ' A' ' 129' ' ' ARG . . . -113.07 50.47 0.77 Allowed Glycine 0 CA--C 1.551 2.319 0 CA-C-O 118.095 -1.392 . . . . 0.0 114.873 171.434 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.579 ' HB2' ' O ' ' A' ' 128' ' ' GLY . 78.5 mtp180 82.45 101.34 0.05 Allowed 'General case' 0 N--CA 1.485 1.301 0 CA-C-N 119.893 1.847 . . . . 0.0 112.323 175.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -101.53 32.1 3.49 Favored 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 115.676 1.732 . . . . 0.0 115.676 176.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 46.66 50.76 12.82 Favored 'General case' 0 N--CA 1.503 2.197 0 N-CA-C 118.194 2.664 . . . . 0.0 118.194 -177.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -100.15 86.74 3.29 Favored 'General case' 0 N--CA 1.487 1.404 1 N-CA-C 96.837 -5.246 . . . . 0.0 96.837 158.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 33.6 p -49.34 134.31 18.76 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 118.408 2.744 . . . . 0.0 118.408 -156.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -58.48 -36.83 74.36 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 111.116 -2.765 . . . . 0.0 115.259 169.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 11.5 m-20 -64.15 -37.28 86.9 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 115.984 1.846 . . . . 0.0 115.984 169.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.4 t -64.67 -44.0 96.62 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.112 0 CA-C-N 120.718 1.599 . . . . 0.0 113.026 174.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.1 tp -69.5 -33.2 56.03 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.098 0 N-CA-C 114.36 1.244 . . . . 0.0 114.36 172.221 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 42.6 mt -64.95 -40.76 95.51 Favored 'General case' 0 N--CA 1.495 1.798 0 CA-C-N 120.37 1.441 . . . . 0.0 114.107 168.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -65.47 -38.23 89.18 Favored 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 115.176 1.547 . . . . 0.0 115.176 172.29 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 1.427 HH12 ' CG ' ' A' ' 88' ' ' ARG . 14.6 tpt180 -63.39 -43.7 96.81 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 115.661 1.726 . . . . 0.0 115.661 169.686 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 67.4 mtt -66.04 -27.77 68.35 Favored 'General case' 0 CA--C 1.569 1.705 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 169.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 52.7 mtmt -68.05 -44.56 76.11 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 114.991 1.478 . . . . 0.0 114.991 169.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 7.5 p -66.06 -35.77 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.219 0 CA-C-N 120.514 1.507 . . . . 0.0 114.251 170.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 65.8 t80 -53.35 -56.33 17.61 Favored 'General case' 0 CA--C 1.581 2.151 0 CA-C-N 120.129 1.331 . . . . 0.0 111.522 167.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 49.9 ttt180 -53.88 -27.59 31.16 Favored 'General case' 0 N--CA 1.483 1.181 0 N-CA-C 120.326 3.454 . . . . 0.0 120.326 173.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 27.0 m-20 -54.61 -38.25 66.56 Favored 'General case' 0 N--CA 1.503 2.195 0 N-CA-C 114.894 1.442 . . . . 0.0 114.894 171.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -141.33 10.03 2.08 Favored 'General case' 0 CA--C 1.561 1.38 0 N-CA-C 119.389 3.107 . . . . 0.0 119.389 -168.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 80.3 m -47.49 -36.49 10.29 Favored 'General case' 0 N--CA 1.505 2.321 0 N-CA-C 116.362 1.986 . . . . 0.0 116.362 177.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . . . . . . . . . . . -68.62 -60.95 4.13 Favored Pre-proline 0 CA--C 1.578 2.054 0 CA-C-O 116.254 -1.831 . . . . 0.0 112.021 173.39 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_exo -51.07 -32.9 41.02 Favored 'Trans proline' 0 CA--C 1.578 2.689 0 C-N-CA 123.407 2.738 . . . . 0.0 118.351 167.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -67.08 -50.45 61.66 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 125.02 1.328 . . . . 0.0 111.797 176.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 1.188 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 58.3 tp -63.26 -23.53 67.46 Favored 'General case' 0 CA--C 1.571 1.756 0 N-CA-C 115.851 1.797 . . . . 0.0 115.851 170.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -70.41 -50.92 33.55 Favored 'General case' 0 N--CA 1.493 1.702 0 CA-C-N 122.696 2.498 . . . . 0.0 113.108 165.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -61.27 -53.75 52.78 Favored 'General case' 0 CA--C 1.571 1.788 0 C-N-CA 124.141 0.976 . . . . 0.0 112.864 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 73.6 m-85 -80.87 -17.62 50.05 Favored 'General case' 0 CA--C 1.558 1.265 0 CA-C-O 116.006 -1.949 . . . . 0.0 113.82 177.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 1.188 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 31.7 ttt180 -69.66 -33.86 73.19 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 123.591 2.905 . . . . 0.0 115.733 167.212 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -73.11 -40.47 64.93 Favored 'General case' 0 N--CA 1.497 1.886 0 CA-C-N 119.979 1.263 . . . . 0.0 113.659 167.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -82.14 -18.05 44.23 Favored 'General case' 0 CA--C 1.577 1.985 0 N-CA-C 119.142 3.016 . . . . 0.0 119.142 177.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.29 127.19 18.89 Favored 'General case' 0 CA--C 1.585 2.309 1 N-CA-C 123.692 4.701 . . . . 0.0 123.692 -159.754 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.946 ' HB3' HD12 ' A' ' 111' ' ' LEU 0.257 46.7 mmtm -92.88 -154.15 0.38 Allowed 'General case' 0 N--CA 1.493 1.688 0 CA-C-O 123.716 1.722 . . . . 0.0 107.708 155.385 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.627 HG23 ' HB ' ' A' ' 162' ' ' VAL 0.763 0.4 OUTLIER -30.93 -164.83 0.0 OUTLIER 'General case' 0 CA--C 1.62 3.663 1 N-CA-C 128.041 6.312 . . . . 0.0 128.041 -146.103 . . . . . . . . 5 4 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.747 HG21 ' HB3' ' A' ' 174' ' ' ARG 0.475 2.1 t -88.4 -174.42 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.569 1.673 3 C-N-CA 139.219 7.008 . . . . 0.0 122.586 -146.687 . . . . . . . . 4 3 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.681 ' HA ' ' HB3' ' A' ' 114' ' ' ARG . 12.6 t70 -102.49 134.77 45.28 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 111.38 -2.645 . . . . 0.0 106.59 168.455 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -143.37 -146.03 0.18 Allowed 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 117.057 2.243 . . . . 0.0 117.057 -155.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . 0.532 3.5 p 59.14 170.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 C-N-CA 128.503 2.721 . . . . 0.0 114.078 -174.548 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 80.81 -36.74 2.3 Favored Glycine 0 CA--C 1.568 3.362 0 C-N-CA 119.051 -1.547 . . . . 0.0 114.689 -149.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 72.0 p 36.31 86.82 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 117.69 2.478 . . . . 0.0 117.69 170.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 21.5 ptt? -159.24 -114.01 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 CA-C-O 117.618 -1.182 . . . . 0.0 108.749 168.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -79.44 -36.82 38.32 Favored 'General case' 0 N--CA 1.5 2.05 0 CA-C-N 121.236 1.835 . . . . 0.0 114.479 -179.344 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -60.16 -53.4 58.22 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 114.77 1.396 . . . . 0.0 114.77 173.197 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 18.2 t -66.71 -31.67 54.56 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 CA-C-N 119.778 1.172 . . . . 0.0 111.533 -179.301 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 7.6 t80 -58.78 -38.17 77.92 Favored 'General case' 0 N--CA 1.498 1.93 0 N-CA-C 115.743 1.757 . . . . 0.0 115.743 164.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -65.46 -50.69 64.43 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 113.51 0.93 . . . . 0.0 113.51 179.276 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . 0.747 ' HB3' HG21 ' A' ' 162' ' ' VAL . 72.9 mtt180 -61.15 -42.18 98.09 Favored 'General case' 0 CA--C 1.557 1.216 0 N-CA-C 117.305 2.335 . . . . 0.0 117.305 169.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -57.04 -46.87 82.09 Favored 'General case' 0 N--CA 1.492 1.649 0 N-CA-C 116.512 2.042 . . . . 0.0 116.512 172.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 6.0 mp -63.5 -39.49 94.57 Favored 'General case' 0 N--CA 1.486 1.361 0 CA-C-O 117.832 -1.08 . . . . 0.0 113.756 168.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 65.6 mtt180 -50.42 -45.81 56.02 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 117.075 2.25 . . . . 0.0 117.075 169.267 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -74.57 -42.83 58.05 Favored 'General case' 0 N--CA 1.486 1.337 0 N-CA-C 116.14 1.904 . . . . 0.0 116.14 172.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 8.7 tt -73.57 -51.47 16.81 Favored 'General case' 0 CA--C 1.568 1.645 0 CA-C-N 121.005 1.73 . . . . 0.0 113.213 -179.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.923 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -114.74 -59.52 0.37 Allowed Glycine 0 CA--C 1.552 2.385 0 CA-C-O 117.709 -1.606 . . . . 0.0 114.507 179.316 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.923 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 63.7 tttm . . . . . 0 C--O 1.25 1.112 0 CA-C-N 120.391 2.096 . . . . 0.0 109.144 -177.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 CA--C 1.554 1.119 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.427 ' HB2' ' O ' ' A' ' 81' ' ' PHE . 0.0 OUTLIER -154.35 171.06 19.9 Favored 'General case' 0 N--CA 1.483 1.179 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -167.548 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . 0.413 HG22 ' HB3' ' A' ' 109' ' ' ALA . 77.8 t -133.9 147.86 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.568 1.66 0 CA-C-O 124.316 2.008 . . . . 0.0 111.883 -164.297 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -119.21 140.47 50.16 Favored 'General case' 0 CA--C 1.564 1.51 0 CA-C-N 111.783 -2.462 . . . . 0.0 105.522 167.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -115.84 123.51 48.35 Favored 'General case' 0 CA--C 1.562 1.42 0 C-N-CA 124.906 1.283 . . . . 0.0 109.81 -178.05 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 5.8 mp -126.17 157.07 39.11 Favored 'General case' 0 CA--C 1.559 1.304 0 CA-C-N 112.627 -2.079 . . . . 0.0 109.748 -166.182 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 167.96 154.31 8.64 Favored Glycine 0 CA--C 1.554 2.504 0 N-CA-C 115.494 0.957 . . . . 0.0 115.494 169.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -73.85 177.42 8.13 Favored 'Trans proline' 0 CA--C 1.576 2.576 0 C-N-CA 123.173 2.582 . . . . 0.0 114.195 173.484 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 64.4 Cg_exo -55.02 111.16 0.66 Allowed 'Trans proline' 0 CA--C 1.561 1.854 0 C-N-CA 123.44 2.76 . . . . 0.0 113.831 173.117 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 161.43 95.02 0.1 Allowed Glycine 0 CA--C 1.535 1.301 0 N-CA-C 107.532 -2.227 . . . . 0.0 107.532 -167.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -61.38 120.36 10.3 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 115.489 1.662 . . . . 0.0 115.489 -170.404 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 165.56 84.99 0.06 OUTLIER Glycine 0 CA--C 1.543 1.821 0 N-CA-C 111.497 -0.641 . . . . 0.0 111.497 177.09 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.813 ' HB3' ' OD1' ' A' ' 84' ' ' ASP . 7.7 mptt -153.1 -69.58 0.15 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 123.576 0.75 . . . . 0.0 111.1 -174.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -53.01 -27.34 29.86 Favored Glycine 0 CA--C 1.556 2.612 0 N-CA-C 120.952 3.141 . . . . 0.0 120.952 179.793 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 51.7 m -63.64 -51.44 65.18 Favored 'General case' 0 N--CA 1.498 1.927 0 CA-C-N 119.892 1.846 . . . . 0.0 112.964 171.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . 0.34 2.7 mp0 -77.91 -12.92 60.02 Favored 'General case' 0 CA--C 1.57 1.713 0 CA-C-O 115.088 -2.387 . . . . 0.0 112.537 172.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -72.43 -43.76 63.37 Favored 'General case' 0 C--N 1.376 1.733 0 CA-C-N 124.598 3.363 . . . . 0.0 114.142 165.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 93.4 t -65.74 -42.7 93.04 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.873 0 CA-C-O 117.677 -1.154 . . . . 0.0 112.655 173.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . 0.445 ' HB3' ' HE1' ' A' ' 172' ' ' PHE . 95.1 mttt -68.01 -44.35 76.75 Favored 'General case' 0 CA--C 1.56 1.354 0 N-CA-C 115.797 1.777 . . . . 0.0 115.797 174.906 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -66.88 -29.08 68.89 Favored 'General case' 0 N--CA 1.5 2.031 0 CA-C-N 120.58 1.536 . . . . 0.0 114.317 171.756 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -63.56 -41.3 98.42 Favored 'General case' 0 N--CA 1.493 1.691 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 167.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -57.97 -40.58 80.96 Favored 'General case' 0 CA--C 1.566 1.559 0 N-CA-C 114.835 1.42 . . . . 0.0 114.835 167.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 70.8 mmtt -66.18 -50.86 62.44 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 115.82 1.785 . . . . 0.0 115.82 172.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 85.2 mt -83.16 -22.72 33.2 Favored 'General case' 0 CA--C 1.572 1.798 0 N-CA-C 116.807 2.151 . . . . 0.0 116.807 -177.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.23 34.6 8.61 Favored Glycine 0 CA--C 1.555 2.547 0 N-CA-C 117.742 1.857 . . . . 0.0 117.742 -174.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.1 mm -105.43 152.46 39.94 Favored Pre-proline 0 CA--C 1.568 1.651 0 CA-C-N 119.149 1.474 . . . . 0.0 112.205 -169.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -82.6 99.74 0.95 Allowed 'Trans proline' 0 CA--C 1.564 1.988 0 CA-C-N 122.06 1.771 . . . . 0.0 108.668 162.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -70.22 116.92 11.14 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-O 121.991 0.9 . . . . 0.0 110.226 176.262 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 38.6 mm -97.91 108.25 21.53 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.06 0 N-CA-C 105.122 -2.177 . . . . 0.0 105.122 -176.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 70.0 p -96.2 129.56 43.48 Favored 'General case' 0 N--CA 1.48 1.035 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 172.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 41.6 p -71.36 -8.66 55.18 Favored 'General case' 0 N--CA 1.491 1.577 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 -170.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.535 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -92.12 -17.64 46.28 Favored Glycine 0 CA--C 1.55 2.23 0 N-CA-C 118.29 2.076 . . . . 0.0 118.29 165.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -79.37 -55.83 4.77 Favored 'General case' 0 N--CA 1.492 1.647 0 CA-C-N 119.097 1.449 . . . . 0.0 113.683 -168.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 pt? -60.06 -38.02 81.59 Favored 'General case' 0 CA--C 1.565 1.522 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 173.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.421 ' HB2' ' HB2' ' A' ' 50' ' ' LYS . 41.8 m-85 -67.88 -41.81 82.21 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-O 116.676 -1.63 . . . . 0.0 113.719 169.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.535 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 35.2 ttt180 -54.05 -40.13 66.84 Favored 'General case' 0 N--CA 1.488 1.463 0 N-CA-C 116.587 2.069 . . . . 0.0 116.587 169.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.1 ttt180 -63.29 -39.72 95.37 Favored 'General case' 0 CA--C 1.566 1.578 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 169.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 61.3 m-80 -67.64 -23.63 65.36 Favored 'General case' 0 CA--C 1.587 2.398 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 167.171 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 50.5 mt -62.35 -50.46 79.84 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.485 0 CA-C-N 121.609 2.004 . . . . 0.0 109.239 166.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -60.3 -40.99 92.46 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 114.39 1.256 . . . . 0.0 114.39 175.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -70.01 -37.2 75.58 Favored 'General case' 0 CA--C 1.563 1.462 0 N-CA-C 116.84 2.163 . . . . 0.0 116.84 173.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 91.65 75.07 1.29 Allowed Glycine 0 CA--C 1.544 1.895 0 CA-C-O 117.754 -1.581 . . . . 0.0 114.733 -175.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.939 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 82.2 p -96.45 -62.81 1.21 Allowed 'General case' 0 N--CA 1.495 1.821 0 CA-C-N 119.683 1.742 . . . . 0.0 111.29 170.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.939 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.302 13.0 mttt 115.83 -42.75 0.01 OUTLIER 'General case' 0 CA--C 1.573 1.861 0 CA-C-O 116.064 -1.922 . . . . 0.0 108.871 -173.423 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -75.41 -14.96 60.49 Favored 'General case' 0 N--CA 1.498 1.958 0 CA-C-N 123.395 2.816 . . . . 0.0 112.891 161.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.456 ' O ' ' HB3' ' A' ' 50' ' ' LYS . . . -58.99 -62.9 5.7 Favored Glycine 0 C--N 1.355 1.598 0 CA-C-N 120.11 1.323 . . . . 0.0 114.148 169.455 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.295 7.7 p -69.23 -51.4 43.51 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.302 0 N-CA-C 116.862 2.171 . . . . 0.0 116.862 -168.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -67.09 -45.93 75.78 Favored 'General case' 0 N--CA 1.481 1.1 0 CA-C-N 119.923 1.238 . . . . 0.0 112.397 176.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . . . . . . . . . . . -68.27 -28.97 67.66 Favored 'General case' 0 N--CA 1.485 1.308 0 N-CA-C 115.15 1.537 . . . . 0.0 115.15 -179.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.456 ' HB3' ' O ' ' A' ' 46' ' ' GLY 0.278 4.2 tptt -76.02 -37.43 58.42 Favored 'General case' 0 CA--C 1.559 1.319 0 CA-C-O 116.21 -1.852 . . . . 0.0 113.11 170.986 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 18.4 ptp180 -78.31 -45.57 22.36 Favored 'General case' 0 CA--C 1.602 2.968 1 CA-C-O 86.548 -15.977 . . . . 0.0 118.565 -179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 17.2 m-30 -31.07 -54.18 0.21 Allowed 'General case' 0 N--CA 1.498 1.937 1 O-C-N 108.236 -9.04 . . . . 0.0 120.467 145.215 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -52.49 -49.96 63.68 Favored 'General case' 0 CA--C 1.576 1.949 0 CA-C-N 121.796 2.089 . . . . 0.0 114.462 166.066 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -77.0 -44.81 29.55 Favored 'General case' 0 CA--C 1.565 1.542 0 N-CA-C 115.948 1.832 . . . . 0.0 115.948 177.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -87.22 -24.84 24.28 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 116.148 1.906 . . . . 0.0 116.148 -178.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 100.32 22.64 11.31 Favored Glycine 0 CA--C 1.544 1.856 0 N-CA-C 117.883 1.913 . . . . 0.0 117.883 168.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -95.62 177.96 5.63 Favored 'General case' 0 CA--C 1.573 1.865 0 CA-C-N 118.617 1.208 . . . . 0.0 110.504 168.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.3 pp -76.64 124.17 27.24 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 120.494 -1.378 . . . . 0.0 112.836 -168.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 p -113.4 122.47 35.31 Favored Pre-proline 0 CA--C 1.567 1.627 0 C-N-CA 124.656 1.182 . . . . 0.0 108.601 -177.325 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -55.51 141.62 82.43 Favored 'Trans proline' 0 C--N 1.37 1.666 0 C-N-CA 123.449 2.766 . . . . 0.0 116.135 174.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 17.6 m -85.46 177.55 7.73 Favored 'General case' 0 CA--C 1.569 1.707 0 CA-C-N 115.712 -0.677 . . . . 0.0 111.712 177.044 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 4.9 t70 82.09 -52.03 0.23 Allowed 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 125.77 1.628 . . . . 0.0 113.64 178.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 2.2 pp -58.17 -41.75 84.52 Favored 'General case' 0 CA--C 1.565 1.523 0 N-CA-C 116.335 1.976 . . . . 0.0 116.335 168.387 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 12.5 m -58.63 -51.96 67.72 Favored 'General case' 0 N--CA 1.492 1.658 0 C-N-CA 124.914 1.286 . . . . 0.0 113.313 170.864 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -62.08 -21.97 65.39 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 116.178 1.918 . . . . 0.0 116.178 167.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -76.95 -45.86 26.15 Favored 'General case' 0 CA--C 1.556 1.182 0 C-N-CA 125.366 1.466 . . . . 0.0 114.841 172.499 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 12.4 mt -61.97 -45.77 92.21 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 114.852 1.427 . . . . 0.0 114.852 169.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 52.7 t -56.42 -55.55 18.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 CA-C-O 117.944 -1.027 . . . . 0.0 111.497 171.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -61.22 -31.08 70.86 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 116.836 2.162 . . . . 0.0 116.836 175.485 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -60.61 -40.46 91.93 Favored 'General case' 0 CA--C 1.563 1.472 0 CA-C-O 117.937 -1.03 . . . . 0.0 113.288 167.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . . . . . . . . . 10.3 tpp180 -80.92 -23.37 38.95 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 118.521 2.786 . . . . 0.0 118.521 169.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 66.4 mt -85.59 -22.14 28.17 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 116.832 2.16 . . . . 0.0 116.832 178.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 83.5 m-20 -68.77 8.37 0.52 Allowed 'General case' 0 N--CA 1.498 1.969 0 N-CA-C 116.994 2.22 . . . . 0.0 116.994 169.434 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -66.45 144.0 98.47 Favored Pre-proline 0 CA--C 1.576 1.957 0 C-N-CA 124.261 1.025 . . . . 0.0 109.957 165.294 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 31.1 Cg_endo -50.44 -37.37 51.18 Favored 'Trans proline' 0 N--CA 1.5 1.875 0 N-CA-C 118.412 2.428 . . . . 0.0 118.412 171.386 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 16.6 m-20 -68.85 -15.03 63.39 Favored 'General case' 0 CA--C 1.57 1.72 0 CA-C-O 116.367 -1.778 . . . . 0.0 115.674 174.264 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -111.67 20.71 16.84 Favored 'General case' 0 CA--C 1.574 1.887 0 CA-C-N 122.566 2.439 . . . . 0.0 114.401 168.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -68.54 -52.4 32.41 Favored 'General case' 0 N--CA 1.49 1.528 0 CA-C-N 121.453 1.933 . . . . 0.0 113.664 171.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 21.5 p30 -93.99 20.88 7.27 Favored 'General case' 0 CA--C 1.577 1.985 0 N-CA-C 115.739 1.755 . . . . 0.0 115.739 171.262 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . -173.29 159.49 29.63 Favored Glycine 0 C--N 1.358 1.77 0 CA-C-N 122.028 2.195 . . . . 0.0 113.472 176.305 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . 0.427 ' O ' ' HB2' ' A' ' 2' ' ' ARG . 30.3 p90 -179.08 135.04 0.13 Allowed 'General case' 0 N--CA 1.492 1.662 0 CA-C-N 113.862 -1.169 . . . . 0.0 111.121 176.073 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 22.1 mt -114.33 109.41 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 105.037 -2.208 . . . . 0.0 105.037 172.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.4 mt -101.21 120.95 40.99 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 118.643 -0.694 . . . . 0.0 109.638 174.184 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.813 ' OD1' ' HB3' ' A' ' 13' ' ' LYS . 25.1 t70 -110.13 129.21 55.74 Favored 'General case' 0 N--CA 1.497 1.879 0 CA-C-N 119.006 0.821 . . . . 0.0 110.983 -177.138 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 74.27 39.62 43.35 Favored Glycine 0 CA--C 1.552 2.361 0 CA-C-O 117.361 -1.799 . . . . 0.0 117.258 -178.5 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . 0.256 1.0 OUTLIER -103.8 -58.05 0.08 OUTLIER Pre-proline 0 N--CA 1.496 1.834 0 CA-C-O 113.35 -3.214 . . . . 0.0 111.01 -174.439 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_exo -63.22 70.89 0.14 Allowed 'Trans proline' 0 CA--C 1.571 2.35 0 CA-C-N 126.724 3.437 . . . . 0.0 119.29 167.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 5.8 tmm_? -67.53 -29.53 68.96 Favored 'General case' 0 CA--C 1.567 1.623 0 C-N-CA 125.907 1.683 . . . . 0.0 114.503 166.359 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 77.1 p -151.02 159.52 44.5 Favored 'General case' 0 CA--C 1.551 1.009 0 C-N-CA 125.05 1.34 . . . . 0.0 108.78 -172.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 2.0 t -64.73 -41.69 92.92 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 CA-C-O 117.425 -1.274 . . . . 0.0 110.752 167.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -62.16 -37.79 86.58 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 120.672 3.582 . . . . 0.0 120.672 178.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -75.92 -48.29 21.88 Favored 'General case' 0 CA--C 1.583 2.225 0 CA-C-N 122.586 2.448 . . . . 0.0 111.94 167.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -63.14 -31.5 72.65 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 117.485 2.402 . . . . 0.0 117.485 -171.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 64.3 tttt -60.34 -30.48 69.55 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 115.863 1.801 . . . . 0.0 115.863 168.557 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -65.53 -47.6 75.35 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 113.97 1.1 . . . . 0.0 113.97 168.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 30.9 tp -58.48 -41.96 86.43 Favored 'General case' 0 N--CA 1.491 1.618 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 170.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 6.3 t60 -72.81 -41.52 64.83 Favored 'General case' 0 CA--C 1.567 1.596 0 N-CA-C 113.838 1.051 . . . . 0.0 113.838 176.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 1.334 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 37.7 mt-10 -56.18 -32.62 64.51 Favored 'General case' 0 N--CA 1.497 1.875 0 N-CA-C 114.271 1.211 . . . . 0.0 114.271 165.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 1.304 ' O ' ' HB3' ' A' ' 103' ' ' ARG . 26.8 ttt -84.72 -28.5 26.26 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 118.152 2.649 . . . . 0.0 118.152 173.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 64.0 tp -66.88 -54.22 24.48 Favored 'General case' 0 N--CA 1.501 2.076 0 CA-C-N 120.319 1.418 . . . . 0.0 112.855 169.102 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -79.7 -49.55 11.93 Favored 'General case' 0 CA--C 1.563 1.472 0 N-CA-C 112.796 0.665 . . . . 0.0 112.796 176.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 1.334 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 38.0 mmt180 -68.64 -45.39 71.96 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 115.021 1.489 . . . . 0.0 115.021 175.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 1.304 ' HB3' ' O ' ' A' ' 99' ' ' MET . 74.8 ttt180 -61.4 -57.25 13.01 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-N 118.843 0.747 . . . . 0.0 111.398 165.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 110.82 43.16 1.05 Allowed Glycine 0 N--CA 1.479 1.536 0 O-C-N 124.41 1.069 . . . . 0.0 113.941 169.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 40.2 p -90.97 147.18 23.27 Favored 'General case' 0 CA--C 1.559 1.318 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 168.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -65.12 130.62 44.01 Favored 'General case' 0 N--CA 1.503 2.224 0 N-CA-C 114.363 1.246 . . . . 0.0 114.363 -169.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.5 tp -90.43 99.17 9.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 125.344 1.458 . . . . 0.0 107.512 177.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -98.55 -75.15 0.56 Allowed 'General case' 0 N--CA 1.496 1.831 0 CA-C-O 115.898 -2.001 . . . . 0.0 108.419 168.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . 0.413 ' HB3' HG22 ' A' ' 3' ' ' VAL . . . -136.3 117.37 14.36 Favored 'General case' 0 N--CA 1.487 1.389 0 CA-C-N 121.644 2.02 . . . . 0.0 113.459 -174.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 8.4 t -94.99 108.07 20.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 N-CA-C 101.628 -3.471 . . . . 0.0 101.628 167.796 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.464 HD23 ' HB3' ' A' ' 160' ' ' LYS . 78.8 mt -109.19 105.33 14.73 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 113.865 1.061 . . . . 0.0 113.865 -164.114 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -90.55 130.9 36.54 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.93 0.871 . . . . 0.0 111.478 172.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -100.38 110.1 22.29 Favored 'General case' 0 CA--C 1.559 1.316 0 CA-C-N 114.227 -1.351 . . . . 0.0 109.426 -176.603 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . . . . . . . . 0.25 71.8 ttt180 -73.11 101.12 3.21 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 126.835 2.054 . . . . 0.0 109.497 169.039 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . . . . . . . . . 11.9 p -130.4 161.79 39.55 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.584 0 CA-C-N 112.416 -2.175 . . . . 0.0 110.491 -165.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 9.1 m -103.81 151.86 22.57 Favored 'General case' 0 N--CA 1.491 1.61 0 CA-C-N 115.126 -0.943 . . . . 0.0 112.164 -168.842 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -59.77 -45.82 91.09 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 168.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -51.65 -39.24 57.79 Favored 'General case' 0 N--CA 1.488 1.447 0 N-CA-C 117.343 2.349 . . . . 0.0 117.343 179.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 3.4 m -61.36 -46.3 96.88 Favored 'Isoleucine or valine' 0 CA--C 1.562 1.405 0 N-CA-C 117.011 2.226 . . . . 0.0 117.011 172.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.484 ' O ' ' HB2' ' A' ' 123' ' ' ARG . 8.6 tt -55.47 -39.39 70.32 Favored 'General case' 0 N--CA 1.499 2.005 0 CA-C-N 115.039 -0.982 . . . . 0.0 113.547 166.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 25.4 mt -60.26 -38.12 82.56 Favored 'General case' 0 N--CA 1.503 2.22 0 N-CA-C 115.301 1.593 . . . . 0.0 115.301 170.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 41.6 mt-10 -57.01 -47.32 81.14 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 113.435 0.902 . . . . 0.0 113.435 167.176 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.484 ' HB2' ' O ' ' A' ' 120' ' ' LEU . 31.2 mmt180 -51.61 -45.37 63.21 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 116.702 2.112 . . . . 0.0 116.702 167.409 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 70.6 mt -60.82 -48.12 83.23 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 115.042 1.497 . . . . 0.0 115.042 171.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -56.72 -45.9 81.63 Favored 'General case' 0 N--CA 1.495 1.776 0 N-CA-C 116.627 2.084 . . . . 0.0 116.627 172.753 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -102.77 70.54 0.31 Allowed Glycine 0 CA--C 1.543 1.81 0 N-CA-C 109.723 -1.351 . . . . 0.0 109.723 167.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -38.66 134.46 0.94 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 119.032 2.975 . . . . 0.0 119.032 -168.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 129' ' ' ARG . . . -162.16 -164.35 16.94 Favored Glycine 0 CA--C 1.569 3.416 0 CA-C-N 115.229 -0.896 . . . . 0.0 112.421 -174.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . 0.473 ' HB2' ' O ' ' A' ' 128' ' ' GLY . 2.2 mpt_? 73.53 -138.31 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 CA-C-N 120.988 2.394 . . . . 0.0 113.484 176.218 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.445 ' H ' ' HB3' ' A' ' 129' ' ' ARG . . . -121.47 36.37 4.63 Favored 'General case' 0 CA--C 1.572 1.803 0 CA-C-N 111.452 -2.613 . . . . 0.0 112.164 167.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 49.8 m-20 -73.61 92.28 1.93 Allowed 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 126.05 1.74 . . . . 0.0 110.34 -178.137 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 18.6 m-20 -88.09 63.73 7.42 Favored 'General case' 0 CA--C 1.574 1.891 0 CA-C-N 111.664 -2.516 . . . . 0.0 106.98 163.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . . . . . . . . . 32.0 p -0.35 117.92 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 120.937 3.68 . . . . 0.0 120.937 -165.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . 0.293 1.2 p30 76.69 -42.45 0.43 Allowed 'General case' 0 N--CA 1.502 2.146 0 CA-C-N 111.013 -2.812 . . . . 0.0 116.011 168.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -69.43 -35.29 75.56 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 114.981 1.474 . . . . 0.0 114.981 172.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 2.6 t -59.15 -46.31 92.11 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 N-CA-C 114.179 1.177 . . . . 0.0 114.179 169.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.4 tp -73.6 -31.25 31.75 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.973 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 175.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 38.5 tp -66.95 -37.5 84.39 Favored 'General case' 0 CA--C 1.571 1.781 0 CA-C-N 120.962 1.71 . . . . 0.0 113.381 168.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -68.79 -36.1 77.85 Favored 'General case' 0 N--CA 1.494 1.767 0 CA-C-N 120.797 1.635 . . . . 0.0 113.96 169.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . . . . . . . . . 78.9 mtp180 -57.28 -37.98 73.23 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 115.262 1.579 . . . . 0.0 115.262 165.297 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 24.9 ttt -67.2 -33.97 76.52 Favored 'General case' 0 CA--C 1.57 1.736 0 N-CA-C 115.24 1.57 . . . . 0.0 115.24 168.678 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 60.9 mttm -60.73 -50.73 72.32 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 115.388 1.625 . . . . 0.0 115.388 169.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 11.4 p -64.08 -31.53 53.69 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 N-CA-C 114.79 1.404 . . . . 0.0 114.79 170.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -54.45 -49.5 69.92 Favored 'General case' 0 CA--C 1.583 2.226 0 CA-C-N 119.755 1.161 . . . . 0.0 112.104 167.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 66.9 ttt180 -60.04 -41.4 92.21 Favored 'General case' 0 N--CA 1.488 1.436 0 N-CA-C 118.461 2.763 . . . . 0.0 118.461 174.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -51.38 -29.06 14.34 Favored 'General case' 0 N--CA 1.508 2.46 0 N-CA-C 118.998 2.962 . . . . 0.0 118.998 172.702 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 7.5 mm-40 -132.9 -37.31 1.01 Allowed 'General case' 0 N--CA 1.486 1.36 0 N-CA-C 119.635 3.198 . . . . 0.0 119.635 -163.243 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 86.0 m -46.51 -39.69 11.26 Favored 'General case' 0 N--CA 1.504 2.248 0 N-CA-C 118.654 2.835 . . . . 0.0 118.654 -167.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.403 ' HB3' ' HD3' ' A' ' 150' ' ' PRO . . . -68.72 -61.4 3.69 Favored Pre-proline 0 CA--C 1.579 2.087 0 CA-C-O 116.466 -1.731 . . . . 0.0 112.118 175.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.403 ' HD3' ' HB3' ' A' ' 149' ' ' ALA . 86.9 Cg_exo -51.85 -31.16 41.45 Favored 'Trans proline' 0 CA--C 1.579 2.748 0 C-N-CA 123.387 2.725 . . . . 0.0 118.392 167.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -64.43 -54.38 33.62 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 125.515 1.526 . . . . 0.0 111.955 174.153 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 1.157 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 52.1 tp -65.47 -21.7 66.66 Favored 'General case' 0 CA--C 1.566 1.566 0 CA-C-O 116.803 -1.57 . . . . 0.0 114.801 175.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -71.44 -50.66 29.59 Favored 'General case' 0 N--CA 1.488 1.452 0 CA-C-N 122.227 2.285 . . . . 0.0 113.307 164.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 16.5 t80 -65.86 -52.48 49.94 Favored 'General case' 0 CA--C 1.566 1.576 0 CA-C-N 120.466 1.484 . . . . 0.0 112.401 -178.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 90.8 m-85 -76.59 -30.48 57.01 Favored 'General case' 0 CA--C 1.555 1.149 0 CA-C-O 114.994 -2.431 . . . . 0.0 111.393 179.025 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 1.157 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 32.1 ttt180 -59.68 -34.05 72.36 Favored 'General case' 0 N--CA 1.487 1.418 0 CA-C-N 124.955 3.525 . . . . 0.0 116.91 168.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.9 t70 -68.58 -41.88 79.04 Favored 'General case' 0 CA--C 1.573 1.83 0 CA-C-N 119.659 1.118 . . . . 0.0 113.519 167.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 38.9 mm-40 -90.63 -19.37 23.74 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 119.99 3.33 . . . . 0.0 119.99 -178.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 2.7 pp -77.97 179.72 6.59 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 119.506 3.15 . . . . 0.0 119.506 -161.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . 0.464 ' HB3' HD23 ' A' ' 111' ' ' LEU . 50.9 mttt -135.59 135.88 40.62 Favored 'General case' 0 CA--C 1.564 1.493 0 N-CA-C 105.113 -2.18 . . . . 0.0 105.113 167.934 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 42.0 m -100.34 146.15 27.3 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 122.217 1.008 . . . . 0.0 110.269 -172.127 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 43.1 t -131.36 136.11 58.17 Favored 'Isoleucine or valine' 0 CA--C 1.561 1.392 0 N-CA-C 105.809 -1.923 . . . . 0.0 105.809 167.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -94.95 126.97 40.65 Favored 'General case' 0 CA--C 1.565 1.555 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 169.379 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -109.34 7.85 25.29 Favored 'General case' 0 N--CA 1.493 1.678 1 N-CA-C 126.339 5.681 . . . . 0.0 126.339 -159.596 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . . . . . . . . 0.486 29.2 m -111.17 -127.79 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.594 2.641 1 CA-C-O 109.954 -4.831 . . . . 0.0 107.597 -178.009 . . . . . . . . 3 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 53.38 -3.11 0.01 OUTLIER Glycine 0 C--N 1.391 3.591 3 CA-C-N 133.611 7.459 . . . . 0.0 126.235 -168.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 69.0 p 59.51 80.12 0.21 Allowed 'General case' 0 N--CA 1.492 1.667 0 C-N-CA 127.377 2.271 . . . . 0.0 115.501 173.834 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . 0.25 59.2 mtt 78.01 -75.51 0.05 Allowed 'General case' 0 N--CA 1.496 1.874 0 C-N-CA 126.202 1.801 . . . . 0.0 114.119 167.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 19.6 m-20 -61.51 -39.48 91.13 Favored 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 115.925 1.824 . . . . 0.0 115.925 -174.373 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -60.18 -52.79 63.8 Favored 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 169.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 2.7 t -59.27 -35.25 56.96 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 N-CA-C 113.845 1.054 . . . . 0.0 113.845 179.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . 0.445 ' HE1' ' HB3' ' A' ' 19' ' ' LYS . 8.4 t80 -61.16 -40.81 95.27 Favored 'General case' 0 N--CA 1.497 1.881 0 N-CA-C 114.933 1.457 . . . . 0.0 114.933 167.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -64.12 -43.49 95.12 Favored 'General case' 0 N--CA 1.49 1.562 0 N-CA-C 115.089 1.515 . . . . 0.0 115.089 175.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 82.2 mtt-85 -71.73 -36.74 70.58 Favored 'General case' 0 CA--C 1.56 1.36 0 N-CA-C 116.265 1.95 . . . . 0.0 116.265 173.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.38 -44.16 92.21 Favored 'General case' 0 N--CA 1.491 1.622 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 171.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . . 5.7 mp -64.88 -42.08 95.11 Favored 'General case' 0 CA--C 1.567 1.612 0 CA-C-O 117.148 -1.406 . . . . 0.0 110.656 167.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 52.7 mtt180 -46.64 -41.61 14.99 Favored 'General case' 0 N--CA 1.493 1.722 0 N-CA-C 117.567 2.432 . . . . 0.0 117.567 168.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -67.1 -48.51 67.95 Favored 'General case' 0 CA--C 1.562 1.431 0 N-CA-C 115.224 1.564 . . . . 0.0 115.224 168.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 5.8 tt -86.25 -58.13 2.75 Favored 'General case' 0 CA--C 1.57 1.72 0 CA-C-N 120.275 1.398 . . . . 0.0 113.575 -176.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 0.539 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -118.49 -56.88 0.27 Allowed Glycine 0 CA--C 1.553 2.438 0 CA-C-O 117.339 -1.811 . . . . 0.0 116.353 -174.811 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 0.539 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 38.9 ttmt . . . . . 0 C--O 1.251 1.166 0 CA-C-N 120.957 2.378 . . . . 0.0 108.207 -173.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 41.5 ttm . . . . . 0 CA--C 1.56 1.328 0 CA-C-O 122.517 1.151 . . . . 0.0 109.631 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . 0.263 11.4 mpt_? -123.64 162.25 23.43 Favored 'General case' 0 N--CA 1.482 1.165 0 N-CA-C 120.582 3.549 . . . . 0.0 120.582 -161.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 9.8 p -151.08 147.36 15.67 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.744 0 CA-C-O 123.931 1.825 . . . . 0.0 114.424 167.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.3 mt -131.83 133.44 44.68 Favored 'General case' 0 CA--C 1.557 1.238 0 CA-C-N 111.42 -2.627 . . . . 0.0 108.375 178.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -112.48 120.26 41.03 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 113.357 0.873 . . . . 0.0 113.357 -169.062 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.8 mt -110.37 135.74 50.62 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 112.231 -2.258 . . . . 0.0 109.568 175.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 173.84 168.43 34.81 Favored Glycine 0 CA--C 1.56 2.869 0 N-CA-C 115.848 1.099 . . . . 0.0 115.848 171.591 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_exo -62.44 152.59 76.27 Favored 'Trans proline' 0 CA--C 1.572 2.378 0 C-N-CA 123.44 2.76 . . . . 0.0 116.725 179.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.475 ' HG3' ' HB3' ' A' ' 140' ' ' ARG . 74.4 Cg_endo -77.47 98.93 1.25 Allowed 'Trans proline' 0 CA--C 1.56 1.815 0 C-N-CA 123.296 2.664 . . . . 0.0 113.589 -173.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.691 ' HA2' ' HG2' ' A' ' 123' ' ' ARG . . . 137.81 -64.43 0.56 Allowed Glycine 0 N--CA 1.485 1.925 0 N-CA-C 111.452 -0.659 . . . . 0.0 111.452 -169.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -33.11 159.29 0.0 OUTLIER 'General case' 0 CA--C 1.565 1.539 0 N-CA-C 119.839 3.274 . . . . 0.0 119.839 173.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.86 116.3 9.02 Favored Glycine 0 CA--C 1.546 2.003 0 N-CA-C 115.293 0.877 . . . . 0.0 115.293 -174.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 57.7 mtmt -152.3 -75.09 0.14 Allowed 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 123.261 0.624 . . . . 0.0 109.761 -169.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -57.84 -30.66 63.31 Favored Glycine 0 CA--C 1.552 2.386 0 N-CA-C 120.053 2.781 . . . . 0.0 120.053 -179.426 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 54.6 m -66.78 -53.82 29.09 Favored 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 119.852 1.826 . . . . 0.0 112.539 176.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLN . . . . . . . . . . . . . 4.2 mm-40 -74.31 -16.79 60.92 Favored 'General case' 0 CA--C 1.573 1.84 0 CA-C-O 116.057 -1.925 . . . . 0.0 112.403 172.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -73.57 -41.31 63.09 Favored 'General case' 0 C--N 1.372 1.582 0 CA-C-N 123.288 2.767 . . . . 0.0 114.912 169.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 87.7 t -69.03 -39.26 79.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.912 0 CA-C-O 117.644 -1.169 . . . . 0.0 111.789 171.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 96.3 mttt -61.62 -46.39 90.01 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 116.353 1.983 . . . . 0.0 116.353 170.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -65.93 -33.49 75.94 Favored 'General case' 0 N--CA 1.498 1.965 0 N-CA-C 113.747 1.017 . . . . 0.0 113.747 172.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.06 -41.6 96.92 Favored 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 115.409 1.633 . . . . 0.0 115.409 167.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -59.49 -38.12 80.03 Favored 'General case' 0 N--CA 1.49 1.534 0 N-CA-C 114.572 1.323 . . . . 0.0 114.572 166.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 61.6 tttm -66.09 -50.78 62.9 Favored 'General case' 0 N--CA 1.485 1.285 0 N-CA-C 116.142 1.905 . . . . 0.0 116.142 171.169 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 84.5 mt -81.39 -24.49 36.95 Favored 'General case' 0 CA--C 1.571 1.78 0 N-CA-C 116.332 1.975 . . . . 0.0 116.332 -178.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.15 37.07 7.89 Favored Glycine 0 CA--C 1.555 2.542 0 N-CA-C 117.771 1.868 . . . . 0.0 117.771 -176.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 14.1 mm -109.24 159.2 32.17 Favored Pre-proline 0 CA--C 1.567 1.624 0 CA-C-N 118.833 1.317 . . . . 0.0 113.53 -168.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.412 ' HB2' HH11 ' A' ' 71' ' ' ARG . 73.1 Cg_exo -71.67 100.6 1.07 Allowed 'Trans proline' 0 CA--C 1.563 1.969 0 C-N-CA 122.0 1.8 . . . . 0.0 114.224 160.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 15.2 tm0? -73.41 109.85 7.25 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.383 -0.823 . . . . 0.0 111.044 167.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 20.3 mm -98.23 119.84 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.221 0 N-CA-C 108.701 -0.851 . . . . 0.0 108.701 167.419 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 62.9 p -99.89 124.66 45.43 Favored 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 104.444 -2.428 . . . . 0.0 104.444 161.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 28.5 p -66.05 -18.61 65.45 Favored 'General case' 0 N--CA 1.492 1.671 0 N-CA-C 117.306 2.335 . . . . 0.0 117.306 -169.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.429 ' O ' ' HB2' ' A' ' 36' ' ' ARG . . . -80.29 -18.93 70.37 Favored Glycine 0 CA--C 1.548 2.098 0 N-CA-C 118.805 2.282 . . . . 0.0 118.805 168.187 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -80.24 -49.86 11.02 Favored 'General case' 0 N--CA 1.491 1.598 0 N-CA-C 114.514 1.302 . . . . 0.0 114.514 -169.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 pt? -69.15 -36.35 77.33 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 113.945 1.091 . . . . 0.0 113.945 174.439 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PHE . . . . . 0.442 ' HB3' ' HB2' ' A' ' 50' ' ' LYS . 42.5 m-85 -66.95 -38.48 86.21 Favored 'General case' 0 CA--C 1.565 1.533 0 C-N-CA 125.379 1.472 . . . . 0.0 114.575 169.539 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . 0.429 ' HB2' ' O ' ' A' ' 32' ' ' GLY . 29.5 ttp180 -61.21 -40.67 94.85 Favored 'General case' 0 CA--C 1.568 1.643 0 CA-C-N 120.109 1.322 . . . . 0.0 113.578 166.779 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -59.14 -37.15 76.58 Favored 'General case' 0 N--CA 1.497 1.923 0 N-CA-C 114.718 1.377 . . . . 0.0 114.718 168.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -66.36 -31.91 72.97 Favored 'General case' 0 CA--C 1.573 1.828 0 N-CA-C 115.107 1.521 . . . . 0.0 115.107 166.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ILE . . . . . . . . . . . . . 96.9 mt -63.36 -45.68 97.46 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.131 0 CA-C-N 120.092 1.314 . . . . 0.0 112.65 170.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -68.17 -39.89 82.43 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-N 120.074 1.307 . . . . 0.0 113.814 174.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 -77.05 -28.99 54.96 Favored 'General case' 0 CA--C 1.561 1.398 0 N-CA-C 116.849 2.166 . . . . 0.0 116.849 178.143 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 88.08 74.17 1.28 Allowed Glycine 0 CA--C 1.542 1.757 0 CA-C-O 118.088 -1.395 . . . . 0.0 115.168 178.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.921 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 62.6 p -91.62 -60.24 1.93 Allowed 'General case' 0 N--CA 1.495 1.792 0 CA-C-N 119.127 1.464 . . . . 0.0 111.285 169.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.921 ' HB2' ' O ' ' A' ' 43' ' ' THR 0.287 13.4 mttt 114.44 -40.88 0.01 OUTLIER 'General case' 0 CA--C 1.567 1.604 0 CA-C-O 115.874 -2.012 . . . . 0.0 109.534 -173.103 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.513 ' O ' ' HB3' ' A' ' 49' ' ' ALA . 0.4 OUTLIER -73.14 -23.18 60.44 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 123.609 2.913 . . . . 0.0 111.729 161.146 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.55 -54.85 33.21 Favored Glycine 0 C--N 1.352 1.436 0 C-N-CA 125.673 1.606 . . . . 0.0 115.912 174.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . 0.293 0.8 OUTLIER -65.62 -57.0 12.54 Favored 'Isoleucine or valine' 0 CA--C 1.57 1.714 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 -179.717 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -67.81 -51.01 53.69 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 120.033 1.288 . . . . 0.0 112.344 -179.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ALA . . . . . 0.513 ' HB3' ' O ' ' A' ' 45' ' ' LEU . . . -67.25 -19.51 65.52 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 115.287 1.588 . . . . 0.0 115.287 176.618 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . 0.442 ' HB2' ' HB3' ' A' ' 35' ' ' PHE . 14.1 tmtt? -74.53 -45.52 45.15 Favored 'General case' 0 N--CA 1.486 1.334 0 CA-C-N 120.577 1.535 . . . . 0.0 112.929 167.911 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -75.08 -48.37 24.24 Favored 'General case' 0 CA--C 1.583 2.227 1 CA-C-O 85.341 -16.552 . . . . 0.0 119.564 -176.066 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' TYR . . . . . . . . . . . . . 12.9 m-30 -34.5 -54.33 0.53 Allowed 'General case' 0 N--CA 1.496 1.871 1 O-C-N 109.293 -8.38 . . . . 0.0 120.481 146.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 19.6 tp -59.41 -30.95 68.83 Favored 'General case' 0 CA--C 1.579 2.093 0 CA-C-N 122.366 2.348 . . . . 0.0 115.569 167.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASP . . . . . . . . . . . . . 10.8 t0 -91.27 -41.79 10.75 Favored 'General case' 0 CA--C 1.569 1.683 0 N-CA-C 115.964 1.838 . . . . 0.0 115.964 170.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . . . . . . . . . . . -82.97 -35.29 26.05 Favored 'General case' 0 N--CA 1.496 1.836 0 N-CA-C 115.904 1.816 . . . . 0.0 115.904 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 99.42 34.04 5.18 Favored Glycine 0 N--CA 1.476 1.344 0 N-CA-C 118.146 2.018 . . . . 0.0 118.146 167.358 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -93.55 -129.69 0.13 Allowed 'General case' 0 CA--C 1.567 1.612 0 N-CA-C 108.644 -0.872 . . . . 0.0 108.644 169.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 88.2 mt -103.12 97.58 7.65 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 119.971 1.259 . . . . 0.0 110.322 -169.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 p -104.03 118.2 57.66 Favored Pre-proline 0 CA--C 1.568 1.661 0 CA-C-O 117.603 -1.189 . . . . 0.0 108.786 176.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -57.26 141.4 94.57 Favored 'Trans proline' 0 C--N 1.372 1.785 0 C-N-CA 123.491 2.794 . . . . 0.0 116.383 178.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 74.1 m -71.29 -49.91 38.01 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -179.723 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -65.79 -39.02 90.54 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 116.469 2.026 . . . . 0.0 116.469 -177.083 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' LEU . . . . . . . . . . . . . 28.4 mt -56.58 -50.57 71.54 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 117.54 2.422 . . . . 0.0 117.54 175.029 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 35.7 m -64.57 -46.46 82.64 Favored 'General case' 0 CA--C 1.566 1.593 0 CA-C-N 112.553 -2.112 . . . . 0.0 112.982 174.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.8 m-20 -61.6 -21.5 64.4 Favored 'General case' 0 CA--C 1.577 2.003 0 N-CA-C 115.179 1.548 . . . . 0.0 115.179 165.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.2 mt-10 -75.11 -40.53 59.81 Favored 'General case' 0 CA--C 1.556 1.19 0 CA-C-N 121.026 1.739 . . . . 0.0 115.228 169.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 3.5 mt -59.89 -48.98 79.5 Favored 'General case' 0 N--CA 1.502 2.163 0 CA-C-N 120.21 1.368 . . . . 0.0 114.129 167.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.491 HG22 HH21 ' A' ' 71' ' ' ARG . 0.4 OUTLIER -57.62 -44.64 85.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 115.85 1.796 . . . . 0.0 115.85 172.667 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -67.17 -33.27 75.05 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 115.689 1.737 . . . . 0.0 115.689 169.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 4.1 t70 -58.62 -42.1 87.45 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 117.524 -1.227 . . . . 0.0 113.125 170.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ARG . . . . . 0.491 HH21 HG22 ' A' ' 68' ' ' VAL . 3.2 ppt_? -80.24 -16.99 53.5 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 118.582 2.808 . . . . 0.0 118.582 167.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.401 ' C ' ' H ' ' A' ' 74' ' ' ASN . 12.3 mt -103.96 3.41 33.49 Favored 'General case' 0 N--CA 1.488 1.446 0 N-CA-C 119.192 3.034 . . . . 0.0 119.192 174.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -77.95 37.06 0.24 Allowed 'General case' 0 N--CA 1.505 2.285 0 CA-C-O 123.635 1.683 . . . . 0.0 112.558 162.543 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.401 ' H ' ' C ' ' A' ' 72' ' ' LEU 0.336 7.3 m120 -122.64 146.02 46.66 Favored Pre-proline 0 CA--C 1.569 1.677 0 C-N-CA 128.272 2.629 . . . . 0.0 106.835 -172.564 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PRO . . . . . . . . . . . . . 0.5 OUTLIER -49.45 -23.25 7.19 Favored 'Trans proline' 0 N--CA 1.507 2.293 0 N-CA-C 122.091 3.843 . . . . 0.0 122.091 175.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -63.53 -12.28 31.01 Favored 'General case' 0 CA--C 1.571 1.788 0 CA-C-O 115.558 -2.163 . . . . 0.0 114.344 166.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -70.89 -21.78 62.36 Favored 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 123.795 2.998 . . . . 0.0 114.867 167.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -65.47 -38.37 89.59 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 120.711 1.596 . . . . 0.0 115.079 167.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ASN . . . . . . . . . . . . . 23.9 p30 -92.18 -9.39 42.51 Favored 'General case' 0 CA--C 1.568 1.644 0 N-CA-C 117.533 2.42 . . . . 0.0 117.533 178.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.76 -178.2 30.03 Favored Glycine 0 C--N 1.357 1.726 0 CA-C-N 122.794 2.543 . . . . 0.0 115.933 -176.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' PHE . . . . . . . . . . . . . 32.0 p90 -167.48 138.59 3.03 Favored 'General case' 0 CA--C 1.551 1.019 0 CA-C-N 111.386 -2.407 . . . . 0.0 106.099 169.432 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -115.38 109.34 27.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 N-CA-C 102.847 -3.02 . . . . 0.0 102.847 179.502 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 11.5 mt -109.82 141.96 41.75 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 123.518 0.727 . . . . 0.0 109.707 175.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 15.6 t0 -130.88 127.84 39.36 Favored 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 118.364 0.529 . . . . 0.0 111.928 169.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLY . . . . . . . . . . . . . . . 68.56 39.04 86.98 Favored Glycine 0 CA--C 1.556 2.604 0 N-CA-C 117.378 1.711 . . . . 0.0 117.378 -178.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' TYR . . . . . . . . . . . . . 11.9 t80 -99.63 -52.93 0.19 Allowed Pre-proline 0 N--CA 1.498 1.936 0 CA-C-O 115.139 -2.362 . . . . 0.0 108.807 179.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_endo -66.41 72.06 0.41 Allowed 'Trans proline' 0 CA--C 1.568 2.199 0 CA-C-N 124.211 2.54 . . . . 0.0 117.932 165.26 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 7.6 ptm180 -65.32 -39.28 92.24 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 115.881 1.808 . . . . 0.0 115.881 167.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 23.0 t -148.96 153.28 37.73 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 107.795 -1.187 . . . . 0.0 107.795 -169.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' VAL . . . . . . . . . . . . . 1.4 t -59.92 -38.49 76.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 CA-C-O 117.298 -1.334 . . . . 0.0 112.355 178.414 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -60.66 -34.2 73.94 Favored 'General case' 0 C--N 1.361 1.074 0 N-CA-C 120.091 3.367 . . . . 0.0 120.091 173.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -78.04 -49.51 13.86 Favored 'General case' 0 CA--C 1.586 2.349 0 CA-C-N 122.326 2.33 . . . . 0.0 111.46 166.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ALA . . . . . . . . . . . . . . . -62.0 -31.43 71.81 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 117.102 2.26 . . . . 0.0 117.102 -170.113 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 58.5 tttt -61.97 -29.26 70.12 Favored 'General case' 0 N--CA 1.482 1.154 0 N-CA-C 115.711 1.745 . . . . 0.0 115.711 167.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ALA . . . . . . . . . . . . . . . -70.37 -39.55 74.55 Favored 'General case' 0 CA--C 1.568 1.645 0 N-CA-C 114.414 1.264 . . . . 0.0 114.414 167.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LEU . . . . . . . . . . . . . 14.3 tp -63.11 -36.5 83.79 Favored 'General case' 0 CA--C 1.57 1.725 0 N-CA-C 114.694 1.368 . . . . 0.0 114.694 168.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' HIS . . . . . . . . . . . . . 57.0 t60 -63.84 -43.77 95.15 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-N 120.261 1.391 . . . . 0.0 113.243 167.579 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' GLU . . . . . 1.253 ' O ' ' HB2' ' A' ' 102' ' ' ARG . 32.2 mt-10 -54.38 -33.51 59.33 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 167.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' MET . . . . . 0.997 ' O ' ' CB ' ' A' ' 103' ' ' ARG . 1.7 tmt? -85.99 -31.41 22.06 Favored 'General case' 0 N--CA 1.492 1.638 0 N-CA-C 118.451 2.759 . . . . 0.0 118.451 171.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LEU . . . . . . . . . . . . . 1.7 tt -70.89 -53.59 14.53 Favored 'General case' 0 N--CA 1.501 2.113 0 CA-C-N 121.257 1.844 . . . . 0.0 111.067 172.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -76.56 -50.95 12.61 Favored 'General case' 0 CA--C 1.564 1.507 0 N-CA-C 113.585 0.957 . . . . 0.0 113.585 174.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 1.253 ' HB2' ' O ' ' A' ' 98' ' ' GLU . 25.2 mmt85 -71.0 -43.04 68.8 Favored 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 115.212 1.56 . . . . 0.0 115.212 177.494 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.997 ' CB ' ' O ' ' A' ' 99' ' ' MET . 0.2 OUTLIER -61.93 -57.15 12.82 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 118.842 0.747 . . . . 0.0 111.083 165.995 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 111.54 47.48 0.74 Allowed Glycine 0 N--CA 1.481 1.648 0 O-C-N 124.227 0.954 . . . . 0.0 114.46 167.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 61.9 p -85.48 155.84 21.06 Favored 'General case' 0 CA--C 1.562 1.421 0 CA-C-N 113.85 -1.175 . . . . 0.0 109.538 168.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -71.34 132.04 44.3 Favored 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.343 -0.848 . . . . 0.0 110.982 -179.167 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 6.5 tp -93.84 96.71 6.29 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 -175.761 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -98.97 -73.29 0.63 Allowed 'General case' 0 N--CA 1.488 1.46 0 CA-C-O 115.796 -2.049 . . . . 0.0 109.062 170.734 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ALA . . . . . . . . . . . . . . . -149.54 124.89 10.21 Favored 'General case' 0 N--CA 1.488 1.448 0 N-CA-C 117.564 2.431 . . . . 0.0 117.564 -167.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 62.0 t -92.84 113.55 28.04 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 N-CA-C 102.66 -3.089 . . . . 0.0 102.66 160.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 71.5 mt -98.15 101.31 12.74 Favored 'General case' 0 N--CA 1.481 1.096 0 CA-C-N 114.722 -1.126 . . . . 0.0 109.838 -178.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -89.01 115.65 26.73 Favored 'General case' 0 N--CA 1.489 1.523 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.849 169.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PHE . . . . . . . . . . . . . 50.6 m-85 -92.91 112.23 24.12 Favored 'General case' 0 CA--C 1.558 1.285 0 C-N-CA 124.446 1.098 . . . . 0.0 111.478 -175.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ARG . . . . . 0.449 ' HB3' ' HA ' ' A' ' 163' ' ' ASP . 13.5 tpt180 -81.21 97.38 7.59 Favored 'General case' 0 CA--C 1.553 1.061 0 C-N-CA 125.582 1.553 . . . . 0.0 109.053 168.616 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' VAL . . . . . 0.502 HG13 HG11 ' A' ' 165' ' ' VAL . 43.5 t -125.58 150.11 30.69 Favored 'Isoleucine or valine' 0 CA--C 1.566 1.591 0 C-N-CA 126.142 1.777 . . . . 0.0 106.965 -170.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' SER . . . . . . . . . . . . . 63.5 p -70.63 143.0 51.59 Favored 'General case' 0 N--CA 1.491 1.608 0 CA-C-N 114.58 -1.191 . . . . 0.0 113.014 178.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -57.95 -30.05 65.66 Favored 'General case' 0 N--CA 1.5 2.048 0 N-CA-C 116.023 1.86 . . . . 0.0 116.023 176.808 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -54.5 -35.77 63.47 Favored 'General case' 0 CA--C 1.565 1.543 0 N-CA-C 116.451 2.019 . . . . 0.0 116.451 169.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . . . . . . . . . 5.3 t -64.16 -42.64 96.19 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.284 0 CA-C-N 119.542 1.065 . . . . 0.0 113.016 170.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -60.32 -32.44 71.24 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 114.927 1.454 . . . . 0.0 114.927 167.364 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' LEU . . . . . . . . . . . . . 10.7 mp -65.39 -40.2 93.15 Favored 'General case' 0 N--CA 1.498 1.927 0 N-CA-C 114.258 1.207 . . . . 0.0 114.258 169.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLU . . . . . . . . . . . . . 17.7 mm-40 -62.58 -46.45 88.26 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 114.768 1.396 . . . . 0.0 114.768 171.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.691 ' HG2' ' HA2' ' A' ' 10' ' ' GLY . 21.9 tpt180 -56.62 -43.96 80.71 Favored 'General case' 0 N--CA 1.492 1.629 0 N-CA-C 115.457 1.651 . . . . 0.0 115.457 169.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LEU . . . . . . . . . . . . . 8.7 mt -53.95 -59.51 4.54 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 114.549 1.314 . . . . 0.0 114.549 167.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.0 ttmp? -77.28 -65.83 0.9 Allowed 'General case' 0 N--CA 1.483 1.212 0 N-CA-C 115.295 1.591 . . . . 0.0 115.295 -174.336 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.745 ' O ' ' CB ' ' A' ' 127' ' ' ARG . . . 68.34 63.9 3.36 Favored Glycine 0 CA--C 1.548 2.107 0 N-CA-C 115.438 0.935 . . . . 0.0 115.438 -173.379 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . 0.745 ' CB ' ' O ' ' A' ' 126' ' ' GLY . 11.3 tpt180 108.76 -86.71 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 112.683 0.623 . . . . 0.0 112.683 175.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . -148.45 70.13 0.33 Allowed Glycine 0 CA--C 1.554 2.487 0 CA-C-O 116.858 -2.079 . . . . 0.0 111.546 -169.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ARG . . . . . . . . . . . . . 26.3 mtt180 -149.06 94.72 2.28 Favored 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 121.58 2.69 . . . . 0.0 108.17 -173.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -72.04 -29.54 64.27 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 118.106 2.632 . . . . 0.0 118.106 -170.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 14.6 m-20 -56.42 -76.92 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 CA-C-N 120.567 1.531 . . . . 0.0 111.965 168.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASP . . . . . . . . . . . . . 2.7 p30 35.51 42.57 0.13 Allowed 'General case' 0 N--CA 1.51 2.551 0 N-CA-C 114.63 1.344 . . . . 0.0 114.63 -166.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' THR . . . . . 0.412 ' HB ' ' H ' ' A' ' 136' ' ' VAL 0.285 0.6 OUTLIER 8.7 116.67 0.0 OUTLIER 'General case' 0 CA--C 1.554 1.13 0 N-CA-C 119.695 3.22 . . . . 0.0 119.695 -159.347 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ASP . . . . . . . . . . . . . 18.0 m-20 -55.54 -38.69 69.61 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 112.641 -2.072 . . . . 0.0 113.695 165.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -63.95 -33.54 75.95 Favored 'General case' 0 CA--C 1.561 1.378 0 N-CA-C 115.581 1.697 . . . . 0.0 115.581 166.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.412 ' H ' ' HB ' ' A' ' 133' ' ' THR . 0.9 OUTLIER -58.18 -50.23 79.0 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 CA-C-N 121.902 2.137 . . . . 0.0 113.338 169.988 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 11.0 tp -69.6 -32.01 51.0 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 114.324 1.231 . . . . 0.0 114.324 176.205 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' LEU . . . . . . . . . . . . . 47.9 mt -65.86 -36.49 83.58 Favored 'General case' 0 N--CA 1.495 1.786 0 CA-C-N 119.834 1.197 . . . . 0.0 113.977 167.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -64.61 -37.18 86.67 Favored 'General case' 0 N--CA 1.495 1.78 0 N-CA-C 114.912 1.449 . . . . 0.0 114.912 170.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' ARG . . . . . 0.475 ' HB3' ' HG3' ' A' ' 9' ' ' PRO . 43.5 mmt-85 -64.3 -40.57 96.2 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 168.034 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' MET . . . . . . . . . . . . . 93.5 mmm -60.47 -26.97 67.18 Favored 'General case' 0 N--CA 1.497 1.885 0 N-CA-C 114.71 1.374 . . . . 0.0 114.71 165.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -65.73 -40.08 91.82 Favored 'General case' 0 N--CA 1.489 1.504 0 CA-C-N 120.249 1.386 . . . . 0.0 113.43 164.137 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' VAL . . . . . . . . . . . . . 3.8 t -63.47 -27.22 42.56 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 CA-C-N 119.794 1.179 . . . . 0.0 112.958 168.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -66.14 -51.56 56.73 Favored 'General case' 0 CA--C 1.575 1.939 0 CA-C-N 120.748 1.613 . . . . 0.0 112.538 165.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ARG . . . . . . . . . . . . . 47.9 ttt180 -52.4 -26.59 12.94 Favored 'General case' 0 N--CA 1.482 1.13 0 N-CA-C 120.238 3.421 . . . . 0.0 120.238 177.309 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -56.81 -67.58 0.3 Allowed 'General case' 0 N--CA 1.496 1.844 0 CA-C-N 119.911 1.232 . . . . 0.0 112.432 169.441 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -148.84 22.82 0.99 Allowed 'General case' 0 N--CA 1.488 1.452 0 N-CA-C 119.534 3.161 . . . . 0.0 119.534 -168.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' THR . . . . . . . . . . . . . 69.4 m -56.48 -29.06 61.3 Favored 'General case' 0 N--CA 1.502 2.126 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 178.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ALA . . . . . 0.423 ' HB3' ' HD3' ' A' ' 150' ' ' PRO . . . -71.49 -60.89 2.36 Favored Pre-proline 0 CA--C 1.58 2.099 0 CA-C-O 116.093 -1.908 . . . . 0.0 112.118 171.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' PRO . . . . . 0.423 ' HD3' ' HB3' ' A' ' 149' ' ' ALA . 78.5 Cg_exo -52.65 -33.19 57.97 Favored 'Trans proline' 0 CA--C 1.576 2.608 0 C-N-CA 123.458 2.772 . . . . 0.0 118.806 168.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LEU . . . . . . . . . . . . . 2.1 tm? -65.76 -52.14 53.44 Favored 'General case' 0 N--CA 1.49 1.558 0 C-N-CA 125.259 1.423 . . . . 0.0 111.161 174.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' LEU . . . . . 1.154 ' O ' ' HB2' ' A' ' 156' ' ' ARG . 49.1 tp -62.49 -21.78 65.75 Favored 'General case' 0 CA--C 1.57 1.737 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 171.352 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 32.3 tt0 -72.01 -49.86 33.46 Favored 'General case' 0 CA--C 1.564 1.49 0 CA-C-N 122.759 2.527 . . . . 0.0 113.694 165.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 16.0 t80 -63.23 -54.06 43.37 Favored 'General case' 0 CA--C 1.567 1.629 0 CA-C-N 120.494 1.497 . . . . 0.0 112.676 178.447 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' TYR . . . . . . . . . . . . . 89.8 m-85 -74.06 -32.88 63.48 Favored 'General case' 0 CA--C 1.55 0.98 0 CA-C-O 115.275 -2.298 . . . . 0.0 112.177 178.067 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ARG . . . . . 1.154 ' HB2' ' O ' ' A' ' 152' ' ' LEU . 32.6 ttt180 -58.85 -34.91 72.11 Favored 'General case' 0 N--CA 1.488 1.44 0 CA-C-N 124.187 3.176 . . . . 0.0 116.939 169.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -68.13 -38.84 82.64 Favored 'General case' 0 CA--C 1.57 1.747 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 167.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -89.3 -26.04 21.35 Favored 'General case' 0 CA--C 1.577 1.99 0 N-CA-C 119.449 3.129 . . . . 0.0 119.449 -179.519 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' LEU . . . . . . . . . . . . . 3.4 pp -81.2 175.45 10.61 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 118.119 2.637 . . . . 0.0 118.119 -163.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' LYS . . . . . . . . . . . . . 35.9 tttp -123.49 128.99 50.57 Favored 'General case' 0 CA--C 1.561 1.376 0 N-CA-C 104.596 -2.372 . . . . 0.0 104.596 164.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 11.0 t -101.96 144.63 30.34 Favored 'General case' 0 N--CA 1.487 1.39 0 CA-C-O 122.536 1.16 . . . . 0.0 110.065 -179.316 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 27.7 t -110.52 130.51 63.7 Favored 'Isoleucine or valine' 0 CA--C 1.559 1.325 0 N-CA-C 105.888 -1.893 . . . . 0.0 105.888 169.794 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' ASP . . . . . 0.449 ' HA ' ' HB3' ' A' ' 114' ' ' ARG . 16.5 t70 -103.7 117.46 34.42 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 102.593 -3.114 . . . . 0.0 102.593 168.129 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -121.77 -174.44 2.87 Favored 'General case' 0 CA--C 1.555 1.136 0 N-CA-C 117.831 2.53 . . . . 0.0 117.831 -157.042 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' VAL . . . . . 0.502 HG11 HG13 ' A' ' 115' ' ' VAL 0.543 0.9 OUTLIER 69.5 -115.31 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.559 1.296 0 CA-C-N 109.667 -3.424 . . . . 0.0 115.008 167.813 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . . . . . . . . . . . 78.61 -68.9 2.91 Favored Glycine 0 CA--C 1.556 2.639 1 CA-C-N 126.201 4.092 . . . . 0.0 112.709 -159.189 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' THR . . . . . . . . . . . . . 35.5 p -129.4 -153.05 0.54 Allowed 'General case' 0 CA--C 1.582 2.19 0 C-N-CA 127.601 2.36 . . . . 0.0 108.915 179.573 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' MET . . . . . . . . . . . . . 14.8 tpt -98.97 -59.43 1.73 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 120.83 -1.169 . . . . 0.0 112.835 174.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -57.41 -31.75 66.16 Favored 'General case' 0 N--CA 1.512 2.644 0 N-CA-C 117.948 2.573 . . . . 0.0 117.948 -177.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -46.51 -50.4 17.14 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 169.41 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' VAL . . . . . . . . . . . . . 3.8 t -52.08 -38.77 24.73 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 175.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 30.5 t80 -63.14 -41.81 99.35 Favored 'General case' 0 N--CA 1.498 1.966 0 CA-C-N 120.649 1.568 . . . . 0.0 114.829 168.455 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . . . . . . . . . . . -57.38 -52.0 67.11 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 114.351 1.241 . . . . 0.0 114.351 174.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' ARG . . . . . . . . . . . . . 10.4 mtt-85 -66.02 -37.66 86.47 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 117.815 2.524 . . . . 0.0 117.815 174.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -60.67 -45.56 93.67 Favored 'General case' 0 N--CA 1.486 1.367 0 N-CA-C 115.72 1.748 . . . . 0.0 115.72 172.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' LEU . . . . . . . . . . . . 0.281 0.4 OUTLIER -72.27 -35.16 68.66 Favored 'General case' 0 N--CA 1.501 2.116 0 N-CA-C 115.104 1.52 . . . . 0.0 115.104 169.935 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' ARG . . . . . . . . . . . . . 95.5 mtt180 -53.3 -41.83 66.02 Favored 'General case' 0 N--CA 1.496 1.85 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 167.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' ALA . . . . . . . . . . . . . . . -63.86 -54.76 29.88 Favored 'General case' 0 CA--C 1.561 1.403 0 N-CA-C 114.73 1.382 . . . . 0.0 114.73 168.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' LEU . . . . . . . . . . . . . 5.4 tt -81.68 -63.29 1.42 Allowed 'General case' 0 CA--C 1.565 1.558 0 CA-C-O 117.597 -1.192 . . . . 0.0 113.142 -176.112 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' GLY . . . . . 1.127 ' O ' ' HB2' ' A' ' 181' ' ' LYS . . . -89.21 -48.72 3.7 Favored Glycine 0 CA--C 1.551 2.337 0 CA-C-N 120.915 1.689 . . . . 0.0 116.106 -174.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' LYS . . . . . 1.127 ' HB2' ' O ' ' A' ' 180' ' ' GLY . 0.0 OUTLIER . . . . . 0 C--O 1.254 1.303 0 CA-C-N 119.259 1.529 . . . . 0.0 108.988 -175.836 . . . . . . . . 2 2 . 1 stop_ save_